data_1buq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1buq _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.45 -3.63 13.77 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.852 1.448 . . . . 0.0 110.19 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.24 -45.38 72.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.877 . . . . 0.0 109.385 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.472 ' NE2' ' O ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -66.68 -55.39 15.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.59 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.434 ' SD ' ' O ' ' A' ' 75' ' ' ALA . 27.4 mtt -58.0 -48.74 79.11 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.231 -0.918 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 m -54.4 -38.1 65.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.285 -0.884 . . . . 0.0 109.054 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.29 -43.06 42.9 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.571 HG12 ' CE1' ' A' ' 103' ' ' PHE . 2.3 t -55.76 -49.92 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.482 HG12 ' CG2' ' A' ' 71' ' ' VAL . 5.1 t -54.71 -41.09 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 13' ' ' ARG . 25.7 tt0 -63.17 -75.13 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.344 1.068 . . . . 0.0 108.145 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.429 ' HB3' HD11 ' A' ' 29' ' ' LEU . 6.6 mtp85 -43.67 -45.97 7.18 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -48.93 -45.72 42.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.61 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -86.0 -37.48 11.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.383 -0.823 . . . . 0.0 109.071 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.89 -37.92 21.12 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' HB3' HG13 ' A' ' 26' ' ' ILE . . . -72.0 -32.87 67.62 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.644 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 2.4 mt -67.34 -59.45 3.4 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -48.02 -39.86 21.05 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.599 0.714 . . . . 0.0 109.25 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.41 6.06 42.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.545 -0.722 . . . . 0.0 109.652 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' CA ' HD23 ' A' ' 59' ' ' LEU . . . 47.73 30.87 7.02 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -96.94 88.4 4.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -1.106 . . . . 0.0 109.723 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.523 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 3.3 mm? -51.83 -20.25 2.13 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.195 -0.94 . . . . 0.0 109.815 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.14 -56.26 16.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.253 -0.904 . . . . 0.0 109.303 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.35 -29.34 63.11 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.613 ' CG2' ' CE2' ' A' ' 30' ' ' PHE . 12.3 mt -69.06 -62.27 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 60.4 t -57.34 -37.91 59.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.95 26.33 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.545 HD21 ' N ' ' A' ' 14' ' ' TYR . 7.8 tp -59.1 -22.7 61.25 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.613 ' CE2' ' CG2' ' A' ' 26' ' ' ILE . 20.4 m-30 -88.47 136.53 32.94 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.675 -0.641 . . . . 0.0 109.651 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -51.12 -178.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.273 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.46 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -66.27 -23.52 66.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 109.527 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.534 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 25.2 p-10 -148.37 45.55 1.05 Allowed 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.528 ' CB ' HD13 ' A' ' 51' ' ' ILE . . . -51.61 -178.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.791 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -126.05 135.92 52.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.501 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 37' ' ' GLU . 6.6 t -113.84 169.02 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.129 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.57 ' N ' ' CG1' ' A' ' 36' ' ' VAL . 28.1 mt-10 -150.4 106.07 3.4 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -174.45 153.71 1.89 Allowed Pre-proline 0 C--N 1.3 -1.575 0 C-N-CA 118.607 -1.237 . . . . 0.0 109.804 -178.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.517 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 44.7 Cg_endo -73.88 -66.67 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.916 -2.118 . . . . 0.0 111.522 0.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 39' ' ' PRO . 23.8 m -159.06 87.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.948 -1.095 . . . . 0.0 109.596 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . 164.33 38.75 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER 72.92 55.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.325 -1.103 . . . . 0.0 109.962 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.538 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 3.8 mt-10 -132.57 58.38 35.77 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.807 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 52.1 Cg_endo -79.71 175.07 10.96 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.825 1.683 . . . . 0.0 111.271 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.551 ' HG3' ' CD2' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -150.99 100.17 2.77 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.416 ' HB2' HG22 ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.43 166.73 13.52 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.186 -0.946 . . . . 0.0 110.103 -179.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 33' ' ' ASP . . . 86.36 -169.8 41.96 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 3.4 m -103.45 -46.63 4.51 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.223 -1.163 . . . . 0.0 108.978 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -58.29 -23.74 57.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.247 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.505 ' HB1' ' CD ' ' A' ' 45' ' ' ARG . . . -89.86 -52.51 4.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.398 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.562 HG22 ' CD2' ' A' ' 30' ' ' PHE . 80.1 mt -57.22 -46.8 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.197 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.532 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 1.5 ttt180 -70.0 -56.25 7.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -0.888 . . . . 0.0 108.906 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 14.4 tt0 -45.88 -29.92 1.54 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 108.658 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.551 ' CD2' ' HG3' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -84.1 -70.28 0.58 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.514 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -46.7 -28.05 1.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.486 ' N ' HD13 ' A' ' 23' ' ' LEU . . . -75.07 -50.8 15.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 12.8 t-20 -55.51 -34.55 64.75 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 t -64.83 -36.63 84.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.523 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 7.4 tp -69.45 -19.28 63.77 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.535 -0.728 . . . . 0.0 109.706 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 33.9 mtmt -55.53 -25.58 38.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 109.36 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.54 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -89.87 121.32 69.05 Favored Pre-proline 0 C--N 1.305 -1.328 0 O-C-N 121.272 -0.893 . . . . 0.0 108.777 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.463 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 48.7 Cg_endo -74.04 103.2 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.71 1.374 . . . . 0.0 111.152 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.556 ' CB ' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -136.15 -178.54 5.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.527 ' CB ' ' OG ' ' A' ' 85' ' ' SER . . . -117.88 127.29 53.72 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.419 HG13 HG21 ' A' ' 15' ' ' VAL . 4.6 t -116.43 115.92 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.181 -0.95 . . . . 0.0 109.841 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 67' ' ' LEU . 1.2 tt0 -150.17 95.74 2.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.294 -0.879 . . . . 0.0 109.216 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.509 ' N ' HD22 ' A' ' 67' ' ' LEU . 4.4 mt -42.81 166.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.974 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.67 -39.9 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.565 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -81.77 -146.01 0.06 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 25.0 tt0 -113.15 129.61 56.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.09 -1.006 . . . . 0.0 109.642 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.482 ' CG2' HG12 ' A' ' 11' ' ' VAL . 19.2 t -67.92 152.28 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.38 -0.825 . . . . 0.0 108.919 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 19.2 mtt-85 -114.64 135.29 54.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.136 -0.978 . . . . 0.0 109.672 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.515 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -149.95 112.86 4.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.293 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -130.09 155.71 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -0.903 . . . . 0.0 109.489 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.434 ' O ' ' SD ' ' A' ' 7' ' ' MET . . . 43.64 -147.42 0.07 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 103' ' ' PHE . 81.6 m-20 -82.64 -3.19 55.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.941 . . . . 0.0 109.526 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.548 ' CG ' ' HG3' ' A' ' 102' ' ' ARG . 0.8 OUTLIER -104.85 -163.55 0.97 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.219 -0.926 . . . . 0.0 109.613 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.522 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 178.37 166.33 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 109.485 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' A' ' 72' ' ' ARG . . . -150.31 140.06 21.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 108.948 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 39.8 p90 -150.58 169.23 22.04 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.877 -1.14 . . . . 0.0 109.941 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.476 ' HB1' HG13 ' A' ' 98' ' ' ILE . . . -141.84 -175.37 4.37 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.502 -0.749 . . . . 0.0 109.591 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.49 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 9.8 p90 177.05 -159.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.805 . . . . 0.0 109.351 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -137.92 151.79 48.34 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.564 -0.71 . . . . 0.0 109.73 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.556 HG11 ' CB ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -122.11 124.34 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.416 -0.802 . . . . 0.0 109.081 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.527 ' OG ' ' CB ' ' A' ' 64' ' ' ALA . 5.1 p -114.66 92.81 4.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.6 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.525 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . 18.8 p90 -115.47 177.93 4.48 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.345 -0.847 . . . . 0.0 109.126 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 88' ' ' PHE . 30.7 tt0 -107.37 166.92 10.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 110.12 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.573 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -116.84 -161.31 0.8 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.4 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -7.44 28.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 109.78 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.11 -40.38 0.03 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.4 mtt-85 -95.72 -176.9 3.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -1.161 . . . . 0.0 109.609 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.441 ' O ' ' CD ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -115.62 127.19 55.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.573 ' OG1' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -118.3 142.57 47.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.776 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 122' ' ' HIS . 1.2 t -116.15 175.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.559 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 4.1 t -145.37 144.14 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.881 -1.137 . . . . 0.0 109.737 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.479 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -133.06 71.64 77.4 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.345 -0.847 . . . . 0.0 110.408 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.559 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 49.6 Cg_endo -95.23 -176.18 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 121.492 1.461 . . . . 0.0 110.947 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.476 HG13 ' HB1' ' A' ' 81' ' ' ALA . 2.9 mp -137.68 139.59 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 8.9 t0 -111.99 163.14 14.59 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.95 -1.093 . . . . 0.0 110.261 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.512 ' HB3' ' CB ' ' A' ' 113' ' ' ARG . 4.3 t-80 -116.39 176.29 5.17 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.55 ' CZ ' ' CG1' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -149.94 142.63 24.59 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.008 -1.057 . . . . 0.0 110.556 -178.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.548 ' HG3' ' CG ' ' A' ' 77' ' ' GLU . 3.1 ttm180 -135.65 107.64 7.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.484 -0.76 . . . . 0.0 109.106 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.571 ' CE1' HG12 ' A' ' 10' ' ' VAL . 14.2 m-85 -105.42 179.5 4.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.607 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.461 ' HB3' HG21 ' A' ' 110' ' ' VAL . 3.8 p30 -127.04 -0.67 6.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.933 . . . . 0.0 109.596 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.43 -87.57 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.472 ' O ' ' NE2' ' A' ' 6' ' ' HIS . . . 176.05 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -1.184 . . . . 0.0 109.598 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -127.56 -37.16 0.46 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 107' ' ' GLY . 8.0 mtmm -146.7 -164.76 2.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -1.125 . . . . 0.0 109.255 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.528 ' CG2' HG12 ' A' ' 10' ' ' VAL . 91.2 t -115.16 158.87 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.027 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.525 ' O ' ' CA ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -132.6 -54.21 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.567 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.535 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -127.17 156.9 41.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.041 -1.037 . . . . 0.0 109.013 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.574 ' HE1' ' CE1' ' A' ' 30' ' ' PHE . 21.5 ttm -154.0 147.24 24.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.122 -0.986 . . . . 0.0 109.655 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.515 ' CG ' ' OE1' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -123.33 174.21 7.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.377 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.468 ' HB2' ' OD2' ' A' ' 38' ' ' ASP . . . -147.83 149.13 31.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.568 ' CD1' ' CB ' ' B' ' 279' ' ' ALA . 1.7 tt -143.03 143.73 32.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.138 -0.976 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.528 ' O ' ' CG2' ' B' ' 274' ' ' VAL . 15.4 p90 171.95 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . 167.07 -176.9 41.92 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.561 -1.305 . . . . 0.0 110.185 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.534 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 17.6 tt0 -69.39 -6.06 27.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.433 -1.04 . . . . 0.0 109.509 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -91.38 -29.24 17.2 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.928 0.87 . . . . 0.0 108.936 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.8 m-20 -88.79 12.51 14.82 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.534 ' CG1' ' HA ' ' A' ' 118' ' ' GLU . 5.0 mm -89.87 -169.92 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.549 ' HB2' HG11 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.63 99.79 2.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 109.805 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -117.13 135.74 53.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.149 -0.97 . . . . 0.0 109.549 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 152.85 -145.91 13.89 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.177 -1.19 . . . . 0.0 109.509 179.944 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 201' ' ' MET . . . . . 0.463 ' O ' ' CB ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.239 0.542 . . . . 0.0 110.174 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' B' ' 201' ' ' MET . 0.6 OUTLIER 72.6 98.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.563 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' THR . . . . . 0.429 ' C ' ' O ' ' B' ' 202' ' ' ASN . 1.2 t -43.43 112.04 1.18 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.0 109.54 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.49 -3.29 13.16 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.828 1.436 . . . . 0.0 110.046 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -38.62 84.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.884 . . . . 0.0 109.385 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -51.8 56.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.351 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' MET . . . . . 0.446 ' SD ' ' O ' ' B' ' 275' ' ' ALA . 21.9 mtm -59.91 -30.06 68.78 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.293 -0.879 . . . . 0.0 109.624 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 5.0 m -72.55 -33.81 67.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.91 . . . . 0.0 109.195 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.9 75.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.934 . . . . 0.0 108.859 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.593 ' CG1' ' CZ ' ' B' ' 301' ' ' PHE . 2.3 t -52.74 -45.99 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.532 HG12 ' CG2' ' B' ' 271' ' ' VAL . 4.4 t -61.86 -39.63 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.599 -0.688 . . . . 0.0 109.951 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' B' ' 213' ' ' ARG . 21.8 tt0 -62.63 -75.4 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' B' ' 212' ' ' GLN . 0.0 OUTLIER -43.35 -44.84 5.81 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.971 0.891 . . . . 0.0 108.622 179.157 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' TYR . . . . . 0.633 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -50.42 -46.98 56.74 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.606 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 0.9 OUTLIER -85.77 -37.65 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.359 -0.838 . . . . 0.0 109.297 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.72 -36.5 16.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.525 ' HB3' ' CG1' ' B' ' 226' ' ' ILE . . . -73.08 -34.19 66.06 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.633 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 1.2 mt -65.26 -58.22 6.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -50.37 -45.04 54.98 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.555 0.693 . . . . 0.0 109.164 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.64 5.95 43.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.52 -0.737 . . . . 0.0 109.633 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' B' ' 217' ' ' ALA . . . 50.4 37.96 33.35 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' B' ' 217' ' ' ALA . 11.3 t0 -97.77 72.41 2.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.42 -1.047 . . . . 0.0 109.864 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' LEU . . . . . 0.565 ' CD1' ' HB3' ' B' ' 255' ' ' PHE . 7.7 tp -47.08 -43.65 20.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 108.705 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -43.32 -35.28 1.45 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -80.32 -35.79 25.6 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.544 HD12 ' CD1' ' B' ' 255' ' ' PHE . 19.9 mt -62.1 -57.19 13.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.496 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 92.6 t -56.44 -37.41 51.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.07 -54.92 41.58 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.3 tp -63.8 -22.06 66.73 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . 0.494 ' CG ' HG23 ' B' ' 251' ' ' ILE . 2.0 m-85 -85.42 130.01 34.68 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.525 -0.735 . . . . 0.0 109.383 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' B' ' 309' ' ' VAL . . . -47.0 172.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.152 -0.968 . . . . 0.0 109.383 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.458 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -57.3 -24.99 58.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 109.816 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . 0.525 ' CB ' ' HA2' ' B' ' 247' ' ' GLY . 13.2 p-10 -150.24 45.55 0.89 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.583 -0.698 . . . . 0.0 109.212 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.528 ' N ' ' CD1' ' B' ' 251' ' ' ILE . . . -57.57 159.9 4.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.334 -0.854 . . . . 0.0 109.706 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' THR . . . . . 0.534 ' CG2' ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -106.95 144.12 34.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.558 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.55 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 42.8 t -132.72 121.4 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.081 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' GLU . . . . . 0.527 ' HB2' ' CG ' ' B' ' 313' ' ' ARG . 3.3 mt-10 -89.26 109.18 20.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 108.89 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' B' ' 237' ' ' GLU . 9.8 t70 -179.17 141.92 0.38 Allowed Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.837 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 47.3 Cg_endo -72.66 -177.57 18.89 Favored 'Cis proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.291 -1.962 . . . . 0.0 110.761 -0.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 8.0 m -62.34 152.34 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.254 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.07 20.73 9.27 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' SER . . . . . 0.523 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -116.59 -155.41 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -1.066 . . . . 0.0 109.511 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.77 128.84 25.58 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.066 -1.022 . . . . 0.0 109.894 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' PRO . . . . . 0.55 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.4 Cg_endo -65.25 -169.94 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.983 1.518 . . . . 0.0 111.243 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.535 ' CB ' ' HB3' ' B' ' 250' ' ' ALA . 0.5 OUTLIER -151.14 100.88 2.82 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.534 ' HB3' ' CG2' ' B' ' 235' ' ' THR . 0.2 OUTLIER -89.44 153.61 20.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 110.363 -178.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . 0.525 ' HA2' ' CB ' ' B' ' 233' ' ' ASP . . . 108.03 159.94 20.45 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 6.3 m -70.4 -44.74 67.37 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.219 -1.165 . . . . 0.0 109.103 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -63.08 -36.84 84.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -0.911 . . . . 0.0 109.06 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.535 ' HB3' ' CB ' ' B' ' 245' ' ' ARG . . . -74.18 -59.84 2.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' B' ' 234' ' ' ALA . 30.1 mt -48.45 -41.23 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.28 -0.887 . . . . 0.0 108.916 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' ARG . . . . . 0.508 ' HG2' ' CD2' ' B' ' 223' ' ' LEU . 13.0 ttm180 -78.34 -56.49 4.41 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 253' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 17.5 tt0 -46.65 -27.03 1.03 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.058 -1.027 . . . . 0.0 108.29 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 0.6 OUTLIER -86.22 -71.14 0.56 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 255' ' ' PHE . . . . . 0.565 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -48.09 -31.62 5.77 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . 0.512 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -67.04 -47.73 70.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -56.49 -31.94 64.53 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 29.6 t -73.14 -36.37 66.66 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 259' ' ' LEU . . . . . 0.411 HD21 ' C ' ' B' ' 221' ' ' GLY . 8.2 tp -68.22 -27.84 66.72 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.382 -0.824 . . . . 0.0 109.282 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -47.21 -25.74 1.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.235 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 261' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.74 112.67 53.3 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.403 -0.811 . . . . 0.0 108.912 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 262' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.34 97.75 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.823 1.433 . . . . 0.0 110.493 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' B' ' 261' ' ' LEU . 0.3 OUTLIER -131.66 -172.07 2.77 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.79 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . 0.452 ' CB ' ' OG ' ' B' ' 285' ' ' SER . . . -119.19 127.4 53.26 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 3.6 t -107.88 118.8 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.281 -0.887 . . . . 0.0 109.575 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 266' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.4 tt0 -150.08 106.81 3.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 109.285 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.9 OUTLIER -47.15 174.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.839 . . . . 0.0 109.767 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 268' ' ' THR . . . . . 0.455 HG22 ' O ' ' B' ' 267' ' ' LEU . 1.7 p -148.49 -38.92 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.63 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 269' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' B' ' 270' ' ' GLU . 0.6 OUTLIER -99.69 -147.06 0.34 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 109.405 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 270' ' ' GLU . . . . . 0.442 ' N ' ' CG ' ' B' ' 269' ' ' GLN . 26.0 tt0 -111.45 132.24 54.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.205 -0.934 . . . . 0.0 109.562 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 271' ' ' VAL . . . . . 0.532 ' CG2' HG12 ' B' ' 211' ' ' VAL . 30.3 t -64.04 151.11 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.263 -0.898 . . . . 0.0 109.12 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' B' ' 279' ' ' ALA . 0.0 OUTLIER -117.46 135.44 53.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.082 -1.011 . . . . 0.0 109.742 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -147.13 127.72 14.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.865 . . . . 0.0 109.464 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 274' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -140.27 156.39 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 0.0 109.567 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 275' ' ' ALA . . . . . 0.446 ' O ' ' SD ' ' B' ' 207' ' ' MET . . . 42.35 -145.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.447 -0.783 . . . . 0.0 109.469 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 276' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 1.3 m120 -83.54 -11.08 57.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.116 -0.99 . . . . 0.0 109.473 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . 0.466 ' CG ' ' CG ' ' B' ' 302' ' ' ARG . 1.5 mt-10 -93.28 -162.44 0.94 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.431 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 278' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' B' ' 273' ' ' ALA . . . 178.15 160.8 0.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.452 -0.78 . . . . 0.0 109.623 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 279' ' ' ALA . . . . . 0.568 ' CB ' ' CD1' ' A' ' 115' ' ' LEU . . . -147.67 139.62 24.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.044 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 26.4 p90 -150.76 171.38 17.27 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.906 -1.121 . . . . 0.0 109.748 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . 0.529 ' CB ' HG21 ' B' ' 298' ' ' ILE . . . -143.11 164.34 30.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.298 -0.877 . . . . 0.0 110.238 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 282' ' ' PHE . . . . . 0.482 ' O ' ' HD2' ' B' ' 297' ' ' PRO . 2.1 p90 -158.45 -172.57 3.91 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 283' ' ' THR . . . . . 0.468 HG22 ' HA ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -130.31 141.22 50.61 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 284' ' ' VAL . . . . . 0.475 ' O ' HG22 ' B' ' 294' ' ' VAL . 23.9 t -106.21 112.09 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 108.974 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 285' ' ' SER . . . . . 0.452 ' OG ' ' CB ' ' B' ' 264' ' ' ALA . 15.7 p -101.25 76.62 1.73 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.879 . . . . 0.0 109.257 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.484 ' HB3' ' HB3' ' B' ' 263' ' ' LEU . 13.8 p90 -89.86 176.33 6.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.346 -0.846 . . . . 0.0 109.591 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -128.33 151.51 49.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.333 -0.855 . . . . 0.0 109.306 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . 0.444 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.6 OUTLIER -100.94 -166.09 1.27 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.395 -0.816 . . . . 0.0 109.376 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.9 43.51 1.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 0.0 109.075 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 154.29 -22.24 0.66 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 291' ' ' ARG . . . . . 0.468 ' O ' ' HD3' ' B' ' 292' ' ' LYS . 8.8 mtt180 -123.92 176.22 6.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.555 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 292' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' B' ' 291' ' ' ARG . 7.7 mmtp -131.22 115.05 15.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.223 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 293' ' ' THR . . . . . 0.479 ' OG1' ' CZ ' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -119.73 142.91 48.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.206 -0.933 . . . . 0.0 110.025 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 294' ' ' VAL . . . . . 0.479 HG12 ' CB ' ' B' ' 322' ' ' HIS . 12.4 p -120.99 170.96 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.552 HG11 ' HD3' ' B' ' 297' ' ' PRO . 54.2 t -139.81 158.21 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.911 -1.118 . . . . 0.0 110.07 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 296' ' ' ALA . . . . . 0.537 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -137.43 74.29 47.68 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.812 . . . . 0.0 109.791 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 297' ' ' PRO . . . . . 0.552 ' HD3' HG11 ' B' ' 295' ' ' VAL . 47.3 Cg_endo -97.36 -173.36 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.623 1.549 . . . . 0.0 110.749 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.529 HD13 ' CZ ' ' A' ' 72' ' ' ARG . 2.7 mp -139.79 161.99 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . 0.575 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 11.5 t0 -131.75 155.69 47.27 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.097 -1.002 . . . . 0.0 110.012 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 300' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' B' ' 299' ' ' ASP . 0.1 OUTLIER -111.66 174.06 6.05 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 301' ' ' PHE . . . . . 0.593 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.91 151.78 36.44 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.014 -1.054 . . . . 0.0 110.473 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.466 ' CG ' ' CG ' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -145.0 94.44 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 109.533 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 303' ' ' PHE . . . . . 0.583 ' CE1' HG12 ' B' ' 210' ' ' VAL . 12.2 m-85 -90.63 -163.52 1.04 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 304' ' ' ASN . . . . . 0.534 ' OD1' ' CG2' ' B' ' 310' ' ' VAL . 0.2 OUTLIER -139.6 7.31 2.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.727 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . 116.22 68.31 0.41 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . 54.35 41.26 32.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -1.165 . . . . 0.0 109.444 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 307' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' B' ' 308' ' ' LYS . . . -125.1 35.2 3.18 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 308' ' ' LYS . . . . . 0.558 ' CB ' ' O ' ' B' ' 307' ' ' GLY . 9.2 mttm 83.05 -161.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 122.012 -0.699 . . . . 0.0 109.404 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 309' ' ' VAL . . . . . 0.538 ' CG2' HG12 ' B' ' 210' ' ' VAL . 98.6 t -99.36 136.52 30.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.342 -0.849 . . . . 0.0 109.501 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . 0.534 ' CG2' ' OD1' ' B' ' 304' ' ' ASN . 2.9 t -108.78 -71.45 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 109.357 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 311' ' ' SER . . . . . 0.464 ' HB2' ' HD3' ' B' ' 302' ' ' ARG . 0.4 OUTLIER -113.9 169.0 9.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.183 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 312' ' ' MET . . . . . 0.474 ' HG3' ' CD1' ' B' ' 301' ' ' PHE . 13.4 ttp -158.65 152.27 23.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.947 . . . . 0.0 109.778 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 313' ' ' ARG . . . . . 0.527 ' CG ' ' HB2' ' B' ' 237' ' ' GLU . 0.1 OUTLIER -131.07 170.22 14.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.38 -0.825 . . . . 0.0 109.29 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -144.9 130.02 18.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.192 -0.943 . . . . 0.0 109.247 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 315' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 79' ' ' ALA . 1.1 tt -123.93 144.54 49.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.182 -0.949 . . . . 0.0 109.925 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 316' ' ' PHE . . . . . 0.531 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 12.2 p90 173.57 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 317' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' B' ' 321' ' ' ILE . . . 162.4 -176.07 38.79 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 318' ' ' GLU . . . . . 0.514 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 6.2 tt0 -72.36 -3.4 23.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -1.139 . . . . 0.0 109.385 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -93.75 -29.12 15.54 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.955 0.883 . . . . 0.0 108.873 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 320' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' B' ' 296' ' ' ALA . 1.4 m-20 -89.02 7.87 32.59 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 321' ' ' ILE . . . . . 0.542 HG21 ' CG2' ' B' ' 295' ' ' VAL . 4.6 mm -90.65 -167.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 322' ' ' HIS . . . . . 0.479 ' CB ' HG12 ' B' ' 294' ' ' VAL . 0.2 OUTLIER -151.06 158.88 44.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 0.0 109.593 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 109.518 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 3' ' ' THR . 13.4 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HA ' ' CE ' ' A' ' 7' ' ' MET . 43.8 Cg_endo -70.67 -5.44 16.77 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.926 1.487 . . . . 0.0 109.535 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -43.93 88.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.496 -0.752 . . . . 0.0 109.361 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -61.52 -47.05 87.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.211 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.437 ' CE ' ' HA ' ' A' ' 4' ' ' PRO . 11.6 mtt -57.52 -39.5 76.71 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.29 -0.881 . . . . 0.0 109.227 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 m -52.77 -37.01 58.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.335 -0.853 . . . . 0.0 108.987 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.17 -50.67 73.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.297 -0.877 . . . . 0.0 109.051 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.583 HG12 ' CE1' ' A' ' 101' ' ' PHE . 1.1 t -48.79 -34.48 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 108.788 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.525 ' CG1' HG21 ' A' ' 71' ' ' VAL . 8.0 t -81.07 -41.91 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.399 -0.813 . . . . 0.0 109.222 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 15' ' ' VAL . 8.5 tt0 -63.35 -73.54 0.11 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.272 1.034 . . . . 0.0 108.573 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HD2' ' CD1' ' A' ' 29' ' ' LEU . 1.1 mtm180 -42.62 -45.13 4.51 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.615 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -44.21 -41.9 6.13 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.005 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.622 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 1.5 t -90.43 -38.53 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.742 . . . . 0.0 109.02 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . . . -48.87 -35.31 14.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.528 ' CB ' HG12 ' A' ' 26' ' ' ILE . . . -74.15 -35.42 64.04 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.622 ' CD1' ' HA ' ' A' ' 15' ' ' VAL . 2.3 mt -62.13 -58.47 7.67 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -50.69 -38.27 46.0 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.439 0.638 . . . . 0.0 109.334 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.86 -2.31 58.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.635 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 59' ' ' LEU . . . 52.51 40.14 54.15 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.465 ' O ' HG13 ' A' ' 26' ' ' ILE . 8.5 t70 -106.76 86.37 2.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -1.087 . . . . 0.0 109.608 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.589 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 3.5 mm? -52.08 -20.02 2.25 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 2.2 m-20 -65.36 -56.74 10.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.486 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -61.14 -27.66 67.72 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.58 HD13 ' CE1' ' A' ' 55' ' ' PHE . 10.1 mt -71.31 -64.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.507 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 96.6 t -58.3 -35.79 55.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.453 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . . . -60.02 -56.41 21.98 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.53 ' CD1' ' HD2' ' A' ' 13' ' ' ARG . 5.9 tp -58.87 -25.53 63.41 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.562 ' CE1' ' HE1' ' A' ' 112' ' ' MET . 14.6 m-30 -87.67 148.35 24.83 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.752 -0.593 . . . . 0.0 109.636 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -55.0 -166.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.739 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.481 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -83.09 -23.88 32.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 109.577 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.521 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 21.7 p-10 -144.37 39.45 1.3 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 110' ' ' VAL . . . -54.09 177.71 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.468 -0.77 . . . . 0.0 109.795 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.465 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -129.32 135.69 49.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.387 -0.821 . . . . 0.0 109.232 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 27.2 t -123.63 120.35 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.585 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 3.2 mt-10 -91.11 104.77 17.31 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.572 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 30.2 t70 -178.92 137.05 0.32 Allowed Pre-proline 0 C--N 1.298 -1.647 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.165 -178.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.549 ' O ' ' O ' ' A' ' 40' ' ' VAL . 47.5 Cg_endo -71.91 -148.97 0.41 Allowed 'Cis proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.311 -1.954 . . . . 0.0 110.644 0.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.549 ' O ' ' O ' ' A' ' 39' ' ' PRO . 5.4 m -52.8 -140.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 122.084 0.945 . . . . 0.0 111.834 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 42' ' ' SER . . . -39.26 -23.66 0.03 OUTLIER Glycine 0 N--CA 1.495 2.575 0 O-C-N 121.174 -0.954 . . . . 0.0 111.604 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.538 ' CB ' ' HG2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -29.56 -93.7 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.016 -0.697 . . . . 0.0 110.874 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 42' ' ' SER . 0.0 OUTLIER 169.42 122.32 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.992 -1.068 . . . . 0.0 111.005 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.9 Cg_endo -66.24 -167.85 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.662 1.575 . . . . 0.0 111.281 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.578 ' HB2' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -151.57 130.3 12.37 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.465 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.5 OUTLIER -112.7 147.47 36.73 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.672 -1.268 . . . . 0.0 110.702 -178.225 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 105.02 163.19 23.92 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 2.7 m -69.15 -64.51 0.86 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.076 -1.25 . . . . 0.0 108.902 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -48.11 -23.7 0.91 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.159 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.575 ' CB ' ' CG ' ' A' ' 45' ' ' ARG . . . -90.02 -56.54 3.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.506 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 45' ' ' ARG . 9.0 mm -52.34 -41.87 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.309 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.507 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 19.5 ttt180 -73.38 -49.12 28.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 108.814 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 14.0 mt-10 -52.34 -30.0 26.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.146 -0.971 . . . . 0.0 108.486 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -81.82 -71.5 0.48 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.58 ' CE1' HD13 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -48.89 -29.1 4.31 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.11 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.516 ' N ' HD13 ' A' ' 23' ' ' LEU . . . -72.61 -38.05 67.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 23.9 t30 -65.22 -33.62 76.44 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 45.7 t -69.09 -41.75 77.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.475 -0.765 . . . . 0.0 108.941 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.589 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 9.5 tp -59.57 -18.95 45.16 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.271 -0.893 . . . . 0.0 109.074 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 28.9 mtmt -69.66 -5.58 25.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 108.973 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.572 ' CD2' HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -89.12 112.52 51.55 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 86' ' ' PHE . 42.1 Cg_endo -68.56 91.03 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.713 1.375 . . . . 0.0 111.076 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.605 HD22 ' CG ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -150.59 167.42 27.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.222 -0.924 . . . . 0.0 110.108 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.37 127.4 52.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.77 124.53 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.786 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.99 113.34 4.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.21 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.31 177.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 109.845 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 69' ' ' GLN . 9.9 t -156.24 -38.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 109.816 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.489 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 3.1 pt20 -97.71 -147.24 0.31 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.551 -0.718 . . . . 0.0 109.361 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.494 ' O ' ' NE ' ' A' ' 72' ' ' ARG . 29.9 tt0 -114.55 135.54 54.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.945 . . . . 0.0 109.649 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.525 HG21 ' CG1' ' A' ' 11' ' ' VAL . 79.3 t -66.21 152.2 9.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.365 -0.835 . . . . 0.0 109.154 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -118.33 140.48 49.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.089 . . . . 0.0 110.138 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . . . -150.25 134.67 17.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.428 -0.795 . . . . 0.0 109.141 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -159.62 163.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.943 -1.098 . . . . 0.0 110.212 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . 39.17 -97.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.786 -0.571 . . . . 0.0 110.232 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 103' ' ' PHE . 4.1 m-20 -135.74 10.3 3.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.022 -1.049 . . . . 0.0 109.717 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -116.22 -161.17 0.78 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.148 -0.97 . . . . 0.0 109.371 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 101' ' ' PHE . . . -176.58 129.81 0.2 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.475 -0.766 . . . . 0.0 109.629 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.525 ' HB2' ' CD1' ' B' ' 315' ' ' LEU . . . -114.88 130.82 56.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.998 . . . . 0.0 109.287 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 15.2 p90 -150.47 173.19 14.35 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.819 -1.176 . . . . 0.0 109.783 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.545 ' HB2' ' CG1' ' A' ' 98' ' ' ILE . . . -150.27 -167.58 2.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 110.627 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.471 ' CD2' ' C ' ' A' ' 81' ' ' ALA . 9.1 p90 178.06 -168.93 0.08 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -135.94 141.16 44.46 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 110.05 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.526 HG12 ' CD1' ' A' ' 63' ' ' LEU . 2.2 t -110.95 118.19 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 108.882 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.502 ' HB3' ' CG2' ' A' ' 94' ' ' VAL . 1.7 p -118.65 110.08 16.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.128 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.605 ' CG ' HD22 ' A' ' 63' ' ' LEU . 10.5 p90 -130.23 -177.71 4.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.289 -0.882 . . . . 0.0 109.712 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.428 ' CD ' ' O ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -122.93 152.25 41.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.389 -0.819 . . . . 0.0 109.09 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER -110.08 178.5 4.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.223 -0.923 . . . . 0.0 109.775 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -65.23 68.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.442 -0.786 . . . . 0.0 109.679 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 88' ' ' PHE . . . 115.81 -30.06 6.82 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 23.3 mtt85 -111.6 -171.9 1.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -1.157 . . . . 0.0 109.691 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.465 ' C ' ' CD ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -147.03 146.97 30.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 109.346 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.561 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -141.3 153.84 45.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.435 -0.791 . . . . 0.0 110.223 -179.309 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.571 HG13 ' CG ' ' A' ' 122' ' ' HIS . 0.4 OUTLIER -132.79 172.33 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.536 HG11 ' N ' ' A' ' 96' ' ' ALA . 52.5 t -150.15 146.73 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.542 -1.349 . . . . 0.0 110.646 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.536 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -127.69 74.22 78.3 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.518 ' HD3' HG11 ' A' ' 95' ' ' VAL . 48.5 Cg_endo -94.76 -179.36 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.58 1.52 . . . . 0.0 111.833 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.545 ' CG1' ' HB2' ' A' ' 81' ' ' ALA . 3.2 mp -143.74 144.18 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 4.3 t0 -117.87 163.12 17.02 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 110.155 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.2 OUTLIER -115.55 176.56 5.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.583 ' CE1' HG12 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -150.29 135.88 18.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.026 -1.046 . . . . 0.0 110.383 -178.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.475 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -121.01 107.67 12.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.381 -0.824 . . . . 0.0 109.075 179.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.572 ' CE1' ' O ' ' A' ' 108' ' ' LYS . 0.4 OUTLIER -89.26 166.22 13.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.363 -0.836 . . . . 0.0 109.38 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.542 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 1.7 p30 -115.81 -5.97 12.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 109.166 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . 177.26 -60.92 0.1 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 161.17 77.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.507 -0.996 . . . . 0.0 109.38 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.54 -66.32 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.572 ' O ' ' CE1' ' A' ' 103' ' ' PHE . 14.8 mttm -108.4 178.13 4.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -1.191 . . . . 0.0 109.602 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.555 ' CG2' ' CG2' ' A' ' 10' ' ' VAL . 49.6 t -109.05 153.35 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.336 -0.852 . . . . 0.0 109.233 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.542 ' CG2' ' HB3' ' A' ' 104' ' ' ASN . 44.8 t -124.18 -62.37 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -0.969 . . . . 0.0 109.53 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB2' ' CB ' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -116.31 164.53 14.38 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.974 -1.079 . . . . 0.0 109.463 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.572 ' HE1' ' CE1' ' A' ' 101' ' ' PHE . 19.3 ttm -153.29 137.67 16.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.325 -0.86 . . . . 0.0 109.5 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.482 ' HA ' ' HB2' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -113.21 168.57 9.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.448 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 37' ' ' GLU . . . -150.4 130.11 13.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.16 -0.962 . . . . 0.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.542 ' CD2' ' CB ' ' B' ' 279' ' ' ALA . 0.6 OUTLIER -130.94 142.6 50.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.532 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 50.3 p90 166.5 -162.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . 177.5 178.83 47.41 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.219 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.482 ' HA ' HG12 ' A' ' 121' ' ' ILE . 16.8 tt0 -50.2 -21.83 1.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.145 -1.209 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.455 ' HD3' ' OE2' ' B' ' 270' ' ' GLU . 0.6 OUTLIER -73.41 -22.11 60.32 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.009 0.909 . . . . 0.0 108.829 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.53 ' OD1' ' CD1' ' A' ' 121' ' ' ILE . 0.3 OUTLIER -88.56 -4.57 58.56 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.5 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.53 ' CD1' ' OD1' ' A' ' 120' ' ' ASN . 2.2 mm -91.75 -162.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.03 -1.044 . . . . 0.0 108.212 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.571 ' CG ' HG13 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -152.25 -169.4 3.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.004 -1.06 . . . . 0.0 109.606 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.55 -176.24 5.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.875 . . . . 0.0 109.54 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.81 -175.35 41.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.275 -1.133 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 201' ' ' MET . . . . . 0.524 ' O ' ' CB ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.298 0.57 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' B' ' 201' ' ' MET . 2.6 t30 77.05 177.9 0.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.239 -0.913 . . . . 0.0 109.713 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.37 128.57 66.69 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.398 -0.814 . . . . 0.0 109.736 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' PRO . . . . . 0.482 ' HA ' ' CE ' ' B' ' 207' ' ' MET . 42.5 Cg_endo -69.76 -7.01 19.96 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.023 1.539 . . . . 0.0 109.153 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . 0.436 ' O ' ' HB ' ' B' ' 208' ' ' THR . 0.3 OUTLIER -61.66 -45.67 93.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.436 -0.79 . . . . 0.0 108.91 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -64.1 -43.7 94.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 108.904 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' MET . . . . . 0.482 ' CE ' ' HA ' ' B' ' 204' ' ' PRO . 16.7 mtt -54.9 -24.66 24.55 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.29 -0.881 . . . . 0.0 109.156 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.436 ' HB ' ' O ' ' B' ' 205' ' ' GLU . 11.2 m -72.7 -41.64 65.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.405 -0.809 . . . . 0.0 108.983 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.35 -41.34 51.41 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.319 -0.863 . . . . 0.0 108.761 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.585 HG11 ' CZ ' ' B' ' 301' ' ' PHE . 1.2 t -54.81 -44.58 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.524 ' CG1' HG21 ' B' ' 271' ' ' VAL . 6.6 t -72.42 -41.66 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.459 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 213' ' ' ARG . 23.7 tt0 -59.92 -74.16 0.08 Allowed 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.265 1.031 . . . . 0.0 108.281 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' B' ' 212' ' ' GLN . 2.7 mtt85 -43.54 -45.51 6.62 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.977 0.894 . . . . 0.0 108.659 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.5 OUTLIER -49.9 -44.77 50.26 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.603 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 0.9 OUTLIER -87.17 -38.54 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.372 -0.83 . . . . 0.0 109.274 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.42 -37.74 17.88 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.531 ' HB3' ' CG1' ' B' ' 226' ' ' ILE . . . -72.06 -34.39 68.7 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.608 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 1.9 mt -64.54 -57.97 7.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -49.97 -42.27 48.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.567 0.698 . . . . 0.0 109.224 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.49 -1.04 57.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.884 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . 0.534 ' CA ' HD23 ' B' ' 259' ' ' LEU . . . 57.43 47.58 87.06 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.478 ' O ' ' HB1' ' B' ' 217' ' ' ALA . 26.7 t70 -113.38 92.64 4.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.852 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' LEU . . . . . 0.539 ' CD2' HD22 ' B' ' 259' ' ' LEU . 2.5 mm? -62.46 -12.48 22.25 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.184 -0.947 . . . . 0.0 109.565 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -59.36 3.5 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.293 -0.879 . . . . 0.0 109.424 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -59.6 -28.44 65.23 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.583 HG23 ' CE2' ' B' ' 230' ' ' PHE . 23.0 mt -69.02 -62.01 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.545 -0.973 . . . . 0.0 108.47 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 65.3 t -58.37 -36.11 57.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -57.33 13.47 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.523 ' O ' ' CG2' ' B' ' 309' ' ' VAL . 9.8 tp -57.19 -29.07 63.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . 0.583 ' CE2' HG23 ' B' ' 226' ' ' ILE . 17.1 m-30 -82.18 127.22 32.94 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.644 -0.66 . . . . 0.0 109.619 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -45.68 171.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 109.582 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -24.39 66.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.729 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . 0.559 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 55.4 p-10 -134.03 44.43 2.73 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.668 -0.645 . . . . 0.0 109.556 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' B' ' 310' ' ' VAL . . . -71.41 -169.94 0.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' THR . . . . . 0.504 ' OG1' ' CB ' ' B' ' 311' ' ' SER . 15.1 p -142.34 175.06 10.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.303 -0.873 . . . . 0.0 109.329 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' B' ' 244' ' ' PRO . 40.0 t -158.94 110.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' GLU . . . . . 0.566 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 17.7 mt-10 -88.27 105.98 17.91 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' ASP . . . . . 0.467 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 8.8 t0 -174.68 142.47 0.77 Allowed Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.106 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 47.1 Cg_endo -72.14 -168.49 5.53 Favored 'Cis proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.345 -1.939 . . . . 0.0 110.873 -0.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.465 ' CG1' ' HA ' ' B' ' 315' ' ' LEU . 3.7 m -64.79 146.14 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.276 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 54.12 32.22 49.87 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.2 OUTLIER -120.1 -156.38 0.66 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -1.096 . . . . 0.0 109.607 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . 0.412 ' HA ' ' HD2' ' B' ' 244' ' ' PRO . 19.5 mt-10 -120.76 118.37 30.67 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.166 -0.959 . . . . 0.0 110.026 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' PRO . . . . . 0.566 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.1 Cg_endo -64.82 -169.05 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.938 1.494 . . . . 0.0 111.55 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.583 ' HG3' ' CD2' ' B' ' 254' ' ' PHE . 6.5 mtt180 -150.83 106.17 3.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.19 158.08 18.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 110.154 -179.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 87.7 157.2 31.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' THR . . . . . 0.503 ' CG2' HG13 ' B' ' 227' ' ' VAL . 6.9 m -67.2 -41.41 85.88 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.35 -1.088 . . . . 0.0 109.197 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -60.92 -32.85 72.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.291 -0.881 . . . . 0.0 109.186 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' B' ' 245' ' ' ARG . . . -89.8 -55.07 3.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.372 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.508 HD11 ' N ' ' B' ' 247' ' ' GLY . 14.3 mt -54.11 -44.9 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 0.0 108.887 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' ARG . . . . . 0.526 ' HB2' ' CG2' ' B' ' 227' ' ' VAL . 25.8 ttt-85 -70.56 -53.14 17.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 253' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 23.2 tt0 -50.41 -32.31 17.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.151 -0.968 . . . . 0.0 109.015 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.583 ' CD2' ' HG3' ' B' ' 245' ' ' ARG . 0.2 OUTLIER -80.26 -70.51 0.52 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 255' ' ' PHE . . . . . 0.534 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -47.89 -26.4 1.68 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' B' ' 252' ' ' ARG . . . -76.61 -44.39 34.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.085 -1.009 . . . . 0.0 108.675 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 257' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 5.1 t-20 -65.09 -25.63 67.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 108.75 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 21.5 t -75.36 -39.37 59.34 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 259' ' ' LEU . . . . . 0.539 HD22 ' CD2' ' B' ' 223' ' ' LEU . 8.2 tp -64.96 -20.04 66.28 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.456 -0.777 . . . . 0.0 109.17 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 260' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 2.2 mttt -49.14 -27.73 3.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.413 -0.805 . . . . 0.0 109.505 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 261' ' ' LEU . . . . . 0.565 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.5 OUTLIER -89.95 118.88 69.28 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.217 -0.927 . . . . 0.0 109.078 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 262' ' ' PRO . . . . . 0.417 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 43.9 Cg_endo -70.21 105.06 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.768 1.404 . . . . 0.0 110.535 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.565 ' CD2' ' CD2' ' B' ' 261' ' ' LEU . 0.0 OUTLIER -137.73 153.17 49.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.509 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . 0.45 ' HB2' ' OG ' ' B' ' 285' ' ' SER . . . -89.98 129.12 36.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 108.877 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 98.3 t -111.98 118.58 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.663 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 4.1 tt0 -150.26 96.51 2.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.308 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.9 mp -45.14 171.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.752 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 268' ' ' THR . . . . . 0.428 HG22 ' O ' ' B' ' 267' ' ' LEU . 34.2 p -146.86 -37.97 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.87 . . . . 0.0 109.711 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 269' ' ' GLN . . . . . 0.506 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 15.3 pt20 -91.46 -146.61 0.21 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 109.433 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 270' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 58.1 tt0 -115.06 134.67 54.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.677 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 271' ' ' VAL . . . . . 0.524 HG21 ' CG1' ' B' ' 211' ' ' VAL . 56.3 t -65.7 153.36 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.372 -0.83 . . . . 0.0 109.189 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.0 OUTLIER -113.97 135.72 53.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.078 -1.013 . . . . 0.0 110.134 -179.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.1 149.49 30.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.148 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 274' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -153.38 -155.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.039 -1.038 . . . . 0.0 109.939 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 275' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . -23.39 -96.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 120.954 0.406 . . . . 0.0 111.815 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 276' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' B' ' 303' ' ' PHE . 47.5 t30 -116.23 -1.57 12.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.855 -1.153 . . . . 0.0 110.725 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . 0.452 ' HG3' ' HG3' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -109.25 -162.08 0.79 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.811 -1.181 . . . . 0.0 109.557 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 278' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' B' ' 301' ' ' PHE . . . -179.98 159.99 0.84 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.49 -0.756 . . . . 0.0 109.349 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 279' ' ' ALA . . . . . 0.542 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . . . -150.33 138.27 20.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 109.041 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 35.0 p90 -150.61 172.06 16.13 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.931 -1.106 . . . . 0.0 109.851 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . 0.483 ' HB1' HG13 ' B' ' 298' ' ' ILE . . . -146.44 -168.62 3.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 0.0 109.962 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 282' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' B' ' 281' ' ' ALA . 31.3 p90 170.28 -167.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.227 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.93 142.51 50.92 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.443 -0.786 . . . . 0.0 109.677 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 284' ' ' VAL . . . . . 0.519 ' CG1' HD21 ' B' ' 263' ' ' LEU . 74.4 t -114.36 113.02 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.862 . . . . 0.0 109.322 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 285' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' B' ' 264' ' ' ALA . 4.4 p -109.14 115.07 29.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.308 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' B' ' 286' ' ' PHE . 6.5 p90 -137.65 160.79 38.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -137.76 153.03 49.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.501 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 2.3 p90 -148.02 12.67 0.98 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 109.871 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -168.07 -147.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.113 -0.992 . . . . 0.0 109.406 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -76.66 -23.33 70.28 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -105.48 -179.82 4.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -1.09 . . . . 0.0 109.298 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 292' ' ' LYS . . . . . 0.454 ' O ' ' HD2' ' B' ' 292' ' ' LYS . 0.1 OUTLIER -149.26 128.16 12.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.525 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 293' ' ' THR . . . . . 0.46 HG22 ' HA ' ' B' ' 323' ' ' ALA . 0.0 OUTLIER -105.19 142.72 34.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.248 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 294' ' ' VAL . . . . . 0.508 HG11 ' HB2' ' B' ' 322' ' ' HIS . 0.6 OUTLIER -113.52 174.96 2.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.192 -0.943 . . . . 0.0 108.615 179.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.572 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 3.0 t -145.87 145.17 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -0.981 . . . . 0.0 109.426 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 296' ' ' ALA . . . . . 0.524 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -132.58 71.36 78.93 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.223 -0.923 . . . . 0.0 110.362 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 297' ' ' PRO . . . . . 0.572 ' HD3' ' CG1' ' B' ' 295' ' ' VAL . 49.9 Cg_endo -95.61 -173.45 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.575 1.516 . . . . 0.0 110.692 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.483 HG13 ' HB1' ' B' ' 281' ' ' ALA . 2.7 mp -140.99 149.72 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . 0.581 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 5.7 t0 -115.0 161.07 18.83 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.929 -1.107 . . . . 0.0 110.111 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 300' ' ' HIS . . . . . 0.496 ' NE2' HD11 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -117.85 166.76 12.09 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 301' ' ' PHE . . . . . 0.585 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 0.2 OUTLIER -142.27 149.36 39.46 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.146 -0.971 . . . . 0.0 110.774 -178.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.452 ' HG3' ' HG3' ' B' ' 277' ' ' GLU . 30.8 ttt-85 -142.74 107.79 4.94 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 303' ' ' PHE . . . . . 0.575 ' CE1' HG23 ' B' ' 210' ' ' VAL . 26.0 m-85 -89.28 -174.84 4.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 109.358 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 304' ' ' ASN . . . . . 0.528 ' HB3' ' CG2' ' B' ' 310' ' ' VAL . 0.5 OUTLIER -112.63 -43.3 3.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.46 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 305' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -165.05 27.85 0.2 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 306' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 74.87 38.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -1.18 . . . . 0.0 109.534 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -131.43 -39.21 0.25 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 308' ' ' LYS . . . . . 0.431 ' HG3' ' OD1' ' B' ' 304' ' ' ASN . 2.1 pttt -153.65 -175.3 5.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -1.134 . . . . 0.0 109.497 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 309' ' ' VAL . . . . . 0.531 ' CG2' HG21 ' B' ' 210' ' ' VAL . 84.9 t -89.87 159.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 109.332 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' B' ' 234' ' ' ALA . 45.0 t -136.18 -75.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.722 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 311' ' ' SER . . . . . 0.504 ' CB ' ' OG1' ' B' ' 235' ' ' THR . 70.5 m -122.22 160.7 24.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.032 . . . . 0.0 110.057 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 312' ' ' MET . . . . . 0.579 ' CE ' ' CE1' ' B' ' 230' ' ' PHE . 2.3 ttm -139.04 158.45 44.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.435 -0.791 . . . . 0.0 109.531 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 313' ' ' ARG . . . . . 0.496 ' CZ ' ' OE1' ' B' ' 237' ' ' GLU . 0.8 OUTLIER -133.7 149.34 51.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 109.325 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 314' ' ' ALA . . . . . 0.406 ' CB ' ' OD2' ' B' ' 238' ' ' ASP . . . -125.29 132.4 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.973 . . . . 0.0 109.708 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 315' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 79' ' ' ALA . 1.2 tt -131.84 143.52 50.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.592 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 316' ' ' PHE . . . . . 0.526 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 14.2 p90 171.91 -158.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 317' ' ' GLY . . . . . 0.513 ' O ' ' CD1' ' B' ' 321' ' ' ILE . . . 168.87 -177.3 42.77 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 318' ' ' GLU . . . . . 0.529 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 13.1 tt0 -71.14 -4.8 27.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -1.118 . . . . 0.0 109.374 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -90.7 -30.86 16.85 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.902 0.858 . . . . 0.0 109.012 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 320' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -89.3 7.27 36.45 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.2 0.524 . . . . 0.0 109.59 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 321' ' ' ILE . . . . . 0.529 ' CG1' ' HA ' ' B' ' 318' ' ' GLU . 4.2 mm -90.82 -162.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 322' ' ' HIS . . . . . 0.508 ' HB2' HG11 ' B' ' 294' ' ' VAL . 60.3 t60 -151.27 154.32 36.55 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.087 -1.008 . . . . 0.0 109.637 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.46 ' HA ' HG22 ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.925 . . . . 0.0 109.414 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 8' ' ' THR . 44.1 Cg_endo -71.64 -3.74 13.68 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.913 1.481 . . . . 0.0 110.039 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -57.41 -41.32 80.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.938 . . . . 0.0 109.407 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.22 -62.87 1.24 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.944 . . . . 0.0 108.989 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.634 ' CE ' ' CD2' ' A' ' 103' ' ' PHE . 27.5 mmt -54.39 -33.28 58.93 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.271 -0.893 . . . . 0.0 109.691 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 6.9 m -66.46 -34.25 77.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.406 -0.808 . . . . 0.0 109.207 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.61 -46.43 70.43 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.172 -0.955 . . . . 0.0 108.662 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.632 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 1.5 t -58.27 -19.57 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.565 HG22 ' CE2' ' A' ' 101' ' ' PHE . 14.4 t -90.51 -42.9 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.492 -0.755 . . . . 0.0 109.07 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' ARG . 25.9 tt0 -61.55 -74.22 0.09 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.231 1.015 . . . . 0.0 108.292 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' GLN . 4.2 mtm-85 -42.78 -45.59 4.87 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.601 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -49.24 -43.21 42.53 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.613 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 1.1 t -88.72 -38.67 11.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.458 -0.776 . . . . 0.0 109.253 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.47 -35.69 13.52 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.528 ' CB ' HG13 ' A' ' 26' ' ' ILE . . . -74.13 -34.56 63.92 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.613 ' CD1' ' HA ' ' A' ' 15' ' ' VAL . 2.2 mt -63.63 -58.71 6.07 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 65' ' ' VAL . 1.7 t-20 -51.36 -44.8 62.17 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.35 11.0 20.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.687 -0.633 . . . . 0.0 109.533 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.428 ' HA2' HD21 ' A' ' 59' ' ' LEU . . . 45.69 29.63 3.04 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' ALA . 10.4 t0 -92.09 60.44 3.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.454 -1.027 . . . . 0.0 109.812 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.576 ' CD2' ' CG ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -45.8 -37.16 5.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 108.888 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' LEU . 5.9 m-20 -41.06 -29.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -89.17 -36.89 7.38 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.528 HG13 ' CB ' ' A' ' 17' ' ' ALA . 28.7 mt -59.24 -55.13 25.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.511 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 60.0 t -54.82 -39.63 48.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.24 -52.47 65.2 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 109' ' ' VAL . 1.0 OUTLIER -67.58 -15.86 63.88 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 31' ' ' ALA . 2.6 m-85 -94.26 119.75 33.5 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.476 -0.765 . . . . 0.0 109.675 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -46.53 171.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.44 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.417 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.2 OUTLIER -73.72 -25.36 60.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.52 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.554 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -121.24 41.23 3.38 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.403 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 110' ' ' VAL . . . -71.88 153.89 41.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.882 . . . . 0.0 109.919 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.528 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -112.8 159.67 18.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.235 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.549 ' CG1' ' N ' ' A' ' 37' ' ' GLU . 24.0 t -148.19 167.98 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.327 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.549 ' N ' ' CG1' ' A' ' 36' ' ' VAL . 14.1 mt-10 -147.39 111.22 5.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -178.31 149.63 0.68 Allowed Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 118.695 -1.202 . . . . 0.0 110.075 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.48 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 48.3 Cg_endo -74.13 175.31 47.21 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.052 -2.062 . . . . 0.0 111.014 -0.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.575 HG12 ' CE1' ' A' ' 116' ' ' PHE . 7.2 m -42.12 122.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.489 -0.757 . . . . 0.0 109.652 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . 112.56 53.16 0.5 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.1 OUTLIER 78.53 -151.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -1.079 . . . . 0.0 109.961 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.629 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 4.1 mt-10 67.53 54.36 0.7 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.266 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.629 ' HD3' ' N ' ' A' ' 43' ' ' GLU . 55.7 Cg_endo -86.44 174.41 5.96 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.725 1.381 . . . . 0.0 110.576 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.527 ' O ' ' CD1' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -151.41 109.1 3.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.528 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.1 OUTLIER -105.04 136.61 44.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.018 -1.051 . . . . 0.0 110.492 -178.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 103.43 158.44 24.91 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.417 ' OG1' ' HA ' ' A' ' 32' ' ' ASP . 7.2 m -60.88 -64.19 1.04 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.412 -1.052 . . . . 0.0 109.194 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -45.79 -25.2 0.47 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.088 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.494 ' CB ' ' HG3' ' A' ' 45' ' ' ARG . . . -86.92 -53.25 5.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.309 -0.869 . . . . 0.0 109.519 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 45' ' ' ARG . 4.1 mm -55.74 -48.92 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.347 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.576 ' CG ' ' CD2' ' A' ' 23' ' ' LEU . 6.7 ttt180 -68.48 -53.01 26.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.406 -0.809 . . . . 0.0 109.119 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 13.1 tt0 -51.26 -32.16 23.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 108.66 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.493 ' CD1' ' HD3' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -83.87 -70.62 0.55 Allowed 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.556 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -45.34 -31.17 1.51 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 52' ' ' ARG . . . -66.4 -46.22 77.34 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 37.1 t-20 -60.62 -36.17 77.94 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.4 t -68.6 -35.28 77.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.428 HD21 ' HA2' ' A' ' 21' ' ' GLY . 8.9 tp -64.94 -20.39 66.44 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.456 -0.777 . . . . 0.0 109.051 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.469 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 3.1 mttp -67.04 -7.72 24.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.486 -0.759 . . . . 0.0 109.341 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.603 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 13.5 tp -88.88 108.94 26.62 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 48.7 Cg_endo -73.82 92.15 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.846 1.445 . . . . 0.0 111.909 -178.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.603 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -140.62 178.61 7.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.014 . . . . 0.0 109.366 178.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.17 129.02 49.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.498 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 8.6 t -112.56 113.54 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.692 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' LEU . 4.7 tt0 -150.59 97.19 2.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.815 . . . . 0.0 109.076 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.9 mp -44.84 170.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.338 -0.851 . . . . 0.0 109.67 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.411 ' CG2' ' N ' ' A' ' 69' ' ' GLN . 14.6 t -146.53 -38.86 0.22 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.704 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.411 ' N ' ' CG2' ' A' ' 68' ' ' THR . 5.9 pt20 -90.33 -148.39 0.2 Allowed 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 109.331 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -117.15 131.81 56.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.765 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.521 HG11 ' N ' ' A' ' 72' ' ' ARG . 93.4 t -60.88 148.47 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.365 -0.834 . . . . 0.0 109.226 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.521 ' N ' HG11 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -112.66 92.68 4.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 109.819 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.461 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -108.0 147.83 30.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.152 -0.968 . . . . 0.0 109.873 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -160.76 152.63 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.301 -0.874 . . . . 0.0 110.009 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.472 ' HB1' ' HA3' ' B' ' 241' ' ' GLY . . . 41.53 -145.43 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.595 -0.691 . . . . 0.0 109.964 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -85.01 4.06 35.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 110.001 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.471 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -113.27 -160.49 0.72 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 109.441 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.477 ' CB ' ' HB3' ' A' ' 101' ' ' PHE . . . 174.01 162.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.491 ' HB1' ' CE1' ' A' ' 100' ' ' HIS . . . -150.25 133.29 16.16 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.576 ' CE1' ' HB3' ' A' ' 99' ' ' ASP . 34.4 p90 -149.51 167.98 24.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.797 -1.189 . . . . 0.0 110.298 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.48 ' HB1' HG13 ' A' ' 98' ' ' ILE . . . -141.62 167.76 21.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.54 -0.725 . . . . 0.0 109.679 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -159.35 -172.78 3.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.25 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.96 140.44 53.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.378 -0.826 . . . . 0.0 109.658 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.586 ' CG1' ' CD2' ' A' ' 63' ' ' LEU . 22.6 t -121.17 116.04 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.484 -0.76 . . . . 0.0 109.177 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.529 ' HB3' ' CG2' ' A' ' 94' ' ' VAL . 69.6 p -118.2 128.17 54.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.96 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.581 ' CE1' ' HB ' ' A' ' 93' ' ' THR . 3.0 p90 -143.95 171.01 14.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.379 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.45 ' HA ' ' HG3' ' A' ' 92' ' ' LYS . 2.5 tm-20 -104.6 156.65 17.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.636 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.573 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -117.82 -161.16 0.81 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 109.306 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.64 75.95 2.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 109.686 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . 116.61 -11.7 15.9 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 19.8 mtp180 -149.67 164.15 35.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -1.153 . . . . 0.0 109.592 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HG3' ' HA ' ' A' ' 87' ' ' GLU . 18.4 tttt -107.91 151.75 25.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.552 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.581 ' HB ' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -138.13 155.14 49.03 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.317 -0.864 . . . . 0.0 109.915 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.576 HG13 ' CG ' ' A' ' 122' ' ' HIS . 0.4 OUTLIER -140.22 170.46 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.56 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 4.8 t -146.53 145.52 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.823 -1.173 . . . . 0.0 109.941 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.527 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -136.46 71.88 58.74 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.434 -0.791 . . . . 0.0 109.786 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.56 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 52.1 Cg_endo -95.69 -171.11 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 121.741 1.627 . . . . 0.0 110.86 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.48 HG13 ' HB1' ' A' ' 81' ' ' ALA . 2.8 mp -140.82 146.34 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.576 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 23.0 t0 -118.61 160.94 20.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.921 -1.112 . . . . 0.0 109.83 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.491 ' CE1' ' HB1' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -109.74 -179.72 3.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.432 -0.793 . . . . 0.0 108.916 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.578 ' CE1' ' CG1' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -150.14 147.18 27.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.12 -0.987 . . . . 0.0 110.553 -178.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.522 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -140.98 102.61 4.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.264 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.634 ' CD2' ' CE ' ' A' ' 7' ' ' MET . 4.0 m-85 -89.77 -175.88 4.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.536 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 2.7 p30 -126.53 -34.93 2.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 109.372 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.503 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . -155.45 -63.29 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 164.6 61.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -1.17 . . . . 0.0 109.404 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.52 -53.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -129.43 -166.23 1.63 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -1.126 . . . . 0.0 109.705 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 29' ' ' LEU . 25.8 t -109.93 160.72 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 108.906 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 54.2 t -132.61 -60.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.962 -1.086 . . . . 0.0 110.181 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.522 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -122.42 157.22 32.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.869 -1.144 . . . . 0.0 109.969 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.512 ' CE ' ' OD2' ' A' ' 99' ' ' ASP . 8.9 ttp -152.75 157.0 40.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.393 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.511 ' NH1' ' HB3' ' A' ' 37' ' ' GLU . 1.1 tpt180 -139.18 132.0 29.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 109.308 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.516 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . . . -93.0 129.08 39.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.06 -1.025 . . . . 0.0 109.663 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 116' ' ' PHE . 0.6 OUTLIER -127.21 143.31 51.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.859 . . . . 0.0 109.632 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.575 ' CE1' HG12 ' A' ' 40' ' ' VAL . 47.1 p90 168.94 -154.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.499 ' O ' HG12 ' A' ' 121' ' ' ILE . . . 167.35 161.68 17.28 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.564 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 11.8 tt0 -44.12 -24.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.398 -1.06 . . . . 0.0 109.783 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 117' ' ' GLY . 0.8 OUTLIER -71.37 -35.06 70.98 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.821 0.819 . . . . 0.0 109.723 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 117' ' ' GLY . 0.4 OUTLIER -89.54 1.47 55.9 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.051 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.564 ' CG1' ' HA ' ' A' ' 118' ' ' GLU . 3.7 mm -91.44 -171.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 0.0 108.502 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.576 ' CG ' HG13 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -151.93 143.22 23.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.702 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.16 114.87 3.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.97 -116.21 0.7 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.346 -1.091 . . . . 0.0 109.386 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.243 0.544 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.474 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 4.6 m-20 -149.3 68.03 1.03 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 109.628 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 1.5 m -67.4 111.54 7.64 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.875 . . . . 0.0 109.624 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 49.1 Cg_endo -74.74 0.19 9.07 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.923 1.486 . . . . 0.0 110.367 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -65.81 -57.08 8.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 109.598 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -60.57 -48.55 81.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' MET . . . . . 0.53 ' HA ' ' CZ ' ' B' ' 303' ' ' PHE . 19.8 mtm -61.56 -15.19 36.35 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.332 -0.855 . . . . 0.0 109.896 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' B' ' 204' ' ' PRO . 15.5 m -81.85 -38.54 25.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.253 -0.904 . . . . 0.0 109.253 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.9 -42.83 59.62 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.26 -0.9 . . . . 0.0 108.599 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.641 ' CG1' ' CE1' ' B' ' 301' ' ' PHE . 0.9 OUTLIER -52.31 -24.86 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.193 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.609 ' CG2' ' CE2' ' B' ' 301' ' ' PHE . 26.1 t -86.86 -45.24 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.481 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.6 tt0 -57.74 -73.49 0.07 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.528 ' HD2' ' CD1' ' B' ' 229' ' ' LEU . 0.7 OUTLIER -43.88 -45.34 7.49 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' TYR . . . . . 0.602 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -48.28 -43.17 32.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.619 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.1 t -89.27 -39.9 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.297 -0.877 . . . . 0.0 109.003 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.34 -36.36 14.29 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.528 ' HB3' ' CG1' ' B' ' 226' ' ' ILE . . . -74.08 -35.62 64.25 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.619 ' CD1' ' HA ' ' B' ' 215' ' ' VAL . 3.3 mt -61.56 -59.27 5.48 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.0 -41.07 46.34 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -88.91 5.33 44.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . 0.525 ' CA ' HD23 ' B' ' 259' ' ' LEU . . . 46.86 35.81 8.13 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -97.33 78.35 2.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -1.071 . . . . 0.0 109.887 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' LEU . . . . . 0.581 ' CD2' ' CD2' ' B' ' 259' ' ' LEU . 3.9 mm? -50.45 -21.13 1.34 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.286 -0.884 . . . . 0.0 109.856 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -62.17 -54.54 39.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.902 . . . . 0.0 109.536 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' B' ' 229' ' ' LEU . . . -64.3 -34.4 89.81 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' B' ' 217' ' ' ALA . 6.9 mt -62.36 -56.02 20.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.529 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 26.9 t -63.37 -43.03 98.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.74 -49.79 69.95 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.528 ' CD1' ' HD2' ' B' ' 213' ' ' ARG . 2.4 tp -68.99 -16.7 63.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . 0.463 ' HB2' ' HA ' ' B' ' 227' ' ' VAL . 2.2 m-85 -91.72 140.3 29.83 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.334 -0.854 . . . . 0.0 109.517 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -49.18 177.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.575 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.459 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.1 OUTLIER -66.21 -24.18 66.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.547 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . 0.525 ' CB ' ' HA2' ' B' ' 247' ' ' GLY . 4.4 p30 -146.96 47.1 1.17 Allowed 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.651 -0.656 . . . . 0.0 109.31 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' B' ' 310' ' ' VAL . . . -59.45 167.09 2.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.329 -0.857 . . . . 0.0 109.496 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' THR . . . . . 0.53 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -109.4 164.84 12.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 46.1 t -154.68 115.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.91 . . . . 0.0 109.488 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.0 mm-40 -94.85 109.68 21.64 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' B' ' 237' ' ' GLU . 10.0 t70 -178.21 142.69 0.45 Allowed Pre-proline 0 C--N 1.302 -1.486 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.042 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 47.0 Cg_endo -73.41 174.87 48.23 Favored 'Cis proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.29 -1.962 . . . . 0.0 111.072 -0.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.513 ' CG1' ' HA ' ' B' ' 315' ' ' LEU . 29.2 m -57.01 115.3 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.84 . . . . 0.0 109.598 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . 0.472 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . 83.28 57.35 2.51 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' SER . . . . . 0.519 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 3.3 m -149.01 -105.03 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -1.187 . . . . 0.0 109.747 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' B' ' 243' ' ' GLU . 7.5 pt-20 -165.85 111.08 0.75 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.931 -1.106 . . . . 0.0 110.185 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' PRO . . . . . 0.578 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.9 Cg_endo -65.75 179.15 1.87 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.97 1.511 . . . . 0.0 111.239 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.584 ' HB2' ' CD2' ' B' ' 254' ' ' PHE . 0.3 OUTLIER -150.9 103.0 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.53 ' HB2' ' CG2' ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.28 150.57 22.55 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.252 -0.905 . . . . 0.0 110.166 -179.133 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . 0.525 ' HA2' ' CB ' ' B' ' 233' ' ' ASP . . . 117.32 157.56 10.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 4.5 m -54.73 -72.18 0.07 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.228 -1.16 . . . . 0.0 108.937 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -52.67 -32.73 43.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 0.0 109.164 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' B' ' 246' ' ' SER . . . -71.11 -23.96 62.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.558 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.478 HG12 ' O ' ' B' ' 247' ' ' GLY . 4.7 mm -90.11 -37.27 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.202 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' ARG . . . . . 0.529 ' HB2' ' CG2' ' B' ' 227' ' ' VAL . 21.7 ttm180 -79.6 -59.64 2.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.133 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 253' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 4.7 tt0 -45.6 -26.86 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.981 -1.074 . . . . 0.0 108.863 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.1 OUTLIER -86.44 -69.81 0.65 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 255' ' ' PHE . . . . . 0.521 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -52.75 -20.43 3.17 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.466 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' B' ' 252' ' ' ARG . . . -80.95 -43.96 18.92 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 257' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 10.0 t-20 -61.14 -38.89 88.02 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 33.8 t -62.1 -31.82 72.31 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 259' ' ' LEU . . . . . 0.581 ' CD2' ' CD2' ' B' ' 223' ' ' LEU . 6.7 tp -70.97 -26.52 63.2 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.467 -0.771 . . . . 0.0 109.366 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 260' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 7.7 mttp -48.91 -23.03 0.96 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.222 -0.924 . . . . 0.0 109.152 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 261' ' ' LEU . . . . . 0.586 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.46 112.9 54.3 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 262' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 43.2 Cg_endo -70.28 107.83 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.806 1.424 . . . . 0.0 110.618 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.602 ' CB ' ' CG1' ' B' ' 284' ' ' VAL . 0.0 OUTLIER -139.84 173.04 11.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.751 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' B' ' 284' ' ' VAL . . . -104.65 127.28 52.36 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 77.9 t -112.29 112.63 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.962 . . . . 0.0 110.142 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 13.4 tt0 -150.49 97.14 2.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.34 -0.85 . . . . 0.0 109.158 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -44.7 170.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 110.016 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.92 -38.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 109.558 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 269' ' ' GLN . . . . . 0.517 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 19.4 pt20 -93.2 -146.34 0.23 Allowed 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.635 -0.665 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 270' ' ' GLU . . . . . 0.517 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 28.7 tt0 -115.32 133.09 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.0 109.659 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 271' ' ' VAL . . . . . 0.517 HG11 ' N ' ' B' ' 272' ' ' ARG . 53.4 t -68.31 147.49 12.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 109.245 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.536 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.4 OUTLIER -103.01 139.26 38.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 109.952 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -148.25 147.39 29.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 109.083 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 274' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.2 OUTLIER -138.27 -155.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.114 -0.992 . . . . 0.0 109.99 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 275' ' ' ALA . . . . . 0.454 ' O ' ' SD ' ' B' ' 207' ' ' MET . . . -39.71 -87.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.639 -0.663 . . . . 0.0 110.468 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 276' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' B' ' 303' ' ' PHE . 6.7 m120 -116.45 20.53 14.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.146 -0.971 . . . . 0.0 110.276 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . 0.476 ' HG2' ' HA ' ' B' ' 302' ' ' ARG . 0.3 OUTLIER -128.18 -160.05 0.99 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.007 -1.058 . . . . 0.0 109.399 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 278' ' ' ALA . . . . . 0.512 ' CB ' ' HB3' ' B' ' 301' ' ' PHE . . . 171.06 157.93 0.08 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.477 -0.764 . . . . 0.0 109.932 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 279' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -150.31 136.14 18.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 43.9 p90 -150.11 168.45 23.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.785 -1.197 . . . . 0.0 110.564 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . 0.535 ' HB1' ' CG1' ' B' ' 298' ' ' ILE . . . -145.83 169.32 18.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.699 -0.625 . . . . 0.0 109.417 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 282' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 6.9 p90 -166.1 -169.11 1.38 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.78 141.43 51.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.436 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 284' ' ' VAL . . . . . 0.602 ' CG1' ' CB ' ' B' ' 263' ' ' LEU . 42.9 t -128.95 112.47 25.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.294 -0.878 . . . . 0.0 109.29 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 285' ' ' SER . . . . . 0.469 ' HA ' HG22 ' B' ' 294' ' ' VAL . 0.1 OUTLIER -104.49 122.89 46.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 109.448 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.563 ' CD2' HD23 ' B' ' 261' ' ' LEU . 7.1 p90 -137.72 171.26 14.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.223 -0.923 . . . . 0.0 109.907 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 287' ' ' GLU . . . . . 0.405 ' OE1' ' HB3' ' B' ' 292' ' ' LYS . 42.5 tt0 -150.35 150.56 31.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.477 -0.765 . . . . 0.0 109.073 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.1 OUTLIER -137.72 2.46 2.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 109.881 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' B' ' 290' ' ' GLY . 2.1 tt0 -169.86 -173.63 1.63 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.099 -1.0 . . . . 0.0 109.113 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 290' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' B' ' 289' ' ' GLN . . . -46.65 -25.41 2.18 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 2.3 mtm105 -100.43 130.8 46.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -1.074 . . . . 0.0 109.285 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 292' ' ' LYS . . . . . 0.405 ' HB3' ' OE1' ' B' ' 287' ' ' GLU . 0.0 OUTLIER -106.03 141.44 37.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.521 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 293' ' ' THR . . . . . 0.543 ' CG2' ' HA ' ' B' ' 323' ' ' ALA . 0.0 OUTLIER -119.49 146.08 45.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 0.0 109.861 -179.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 294' ' ' VAL . . . . . 0.483 HG13 ' HB3' ' B' ' 322' ' ' HIS . 3.9 p -113.53 171.08 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 108.845 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.562 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 24.6 t -142.13 144.04 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 110.355 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 296' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' B' ' 320' ' ' ASN . . . -138.52 70.86 45.43 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.599 -0.688 . . . . 0.0 109.683 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 297' ' ' PRO . . . . . 0.562 ' HD3' ' CG1' ' B' ' 295' ' ' VAL . 51.4 Cg_endo -95.67 -175.12 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.732 1.621 . . . . 0.0 111.545 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.535 ' CG1' ' HB1' ' B' ' 281' ' ' ALA . 2.5 mp -139.18 147.04 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . 0.582 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 7.1 t0 -118.51 164.03 15.89 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.862 -1.149 . . . . 0.0 110.362 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 300' ' ' HIS . . . . . 0.52 ' NE2' HD11 ' A' ' 115' ' ' LEU . 1.7 t60 -113.8 175.99 5.23 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 301' ' ' PHE . . . . . 0.641 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -150.09 141.52 23.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.014 -1.054 . . . . 0.0 110.922 -178.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.522 ' CB ' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -130.24 105.97 8.27 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 303' ' ' PHE . . . . . 0.626 ' CZ ' ' CG2' ' B' ' 210' ' ' VAL . 0.4 OUTLIER -89.29 179.15 6.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.593 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 304' ' ' ASN . . . . . 0.518 ' OD1' ' CG2' ' B' ' 310' ' ' VAL . 0.5 OUTLIER -139.54 7.87 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 0.0 109.617 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 305' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . 150.39 -68.22 0.34 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 306' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 164.83 76.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -1.135 . . . . 0.0 109.541 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.32 -35.74 0.02 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -165.84 -174.82 3.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -1.119 . . . . 0.0 109.39 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 309' ' ' VAL . . . . . 0.505 HG21 ' CG1' ' B' ' 210' ' ' VAL . 40.4 t -104.36 149.87 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 109.025 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . 0.518 ' CG2' ' OD1' ' B' ' 304' ' ' ASN . 38.8 t -122.97 -22.48 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.008 . . . . 0.0 109.691 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 311' ' ' SER . . . . . 0.522 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -151.09 156.28 40.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.97 . . . . 0.0 109.494 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 312' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 17.8 ttp -160.16 148.07 16.65 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.2 -0.937 . . . . 0.0 109.811 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 313' ' ' ARG . . . . . 0.464 ' O ' ' OD1' ' B' ' 299' ' ' ASP . 0.1 OUTLIER -130.24 175.01 9.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.42 -0.8 . . . . 0.0 108.955 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 314' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' B' ' 299' ' ' ASP . . . -142.68 145.34 33.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 109.662 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 315' ' ' LEU . . . . . 0.513 ' HA ' ' CG1' ' B' ' 240' ' ' VAL . 0.1 OUTLIER -136.64 139.76 42.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.893 . . . . 0.0 109.417 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 316' ' ' PHE . . . . . 0.549 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 31.0 p90 173.13 -160.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 317' ' ' GLY . . . . . 0.536 ' O ' ' CD1' ' B' ' 321' ' ' ILE . . . 157.4 -174.87 34.89 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 318' ' ' GLU . . . . . 0.435 ' HA ' HD12 ' B' ' 321' ' ' ILE . 67.1 tt0 -54.21 -17.84 3.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 109.57 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.39 -28.26 27.08 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.852 0.835 . . . . 0.0 109.533 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 320' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -91.79 -30.33 16.28 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.357 0.599 . . . . 0.0 109.401 -179.536 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 321' ' ' ILE . . . . . 0.537 HG21 ' CG2' ' B' ' 295' ' ' VAL . 1.4 mt -87.0 -171.54 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 322' ' ' HIS . . . . . 0.483 ' HB3' HG13 ' B' ' 294' ' ' VAL . 0.1 OUTLIER -151.02 163.01 39.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.037 -1.039 . . . . 0.0 109.922 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.543 ' HA ' ' CG2' ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.491 ' CG2' ' O ' ' A' ' 3' ' ' THR . 9.0 t . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.461 ' O ' ' OG1' ' A' ' 8' ' ' THR . 45.2 Cg_endo -72.26 -10.11 25.27 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.923 1.486 . . . . 0.0 110.112 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -52.85 59.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.343 -0.848 . . . . 0.0 109.416 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -63.4 -52.21 62.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.39 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.56 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 8.6 mtt -65.49 -9.66 27.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.356 -0.84 . . . . 0.0 109.684 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 4' ' ' PRO . 13.1 m -86.64 -39.56 15.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.298 -0.876 . . . . 0.0 109.428 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.27 -47.58 83.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.952 . . . . 0.0 109.349 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.564 ' CG1' ' CE1' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -48.03 -24.13 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 108.778 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.527 HG12 ' CG2' ' A' ' 71' ' ' VAL . 12.5 t -86.26 -42.56 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 109.538 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 13' ' ' ARG . 14.6 tt0 -61.23 -74.15 0.09 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.231 1.015 . . . . 0.0 108.323 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.558 ' NH2' ' CD1' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -42.75 -44.49 4.4 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.958 0.885 . . . . 0.0 108.711 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -51.39 -49.59 61.26 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.608 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -81.51 -41.37 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.398 -0.814 . . . . 0.0 109.362 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.23 -37.04 15.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.757 -1.214 . . . . 0.0 107.736 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.482 ' CB ' ' OD1' ' A' ' 22' ' ' ASP . . . -73.83 -32.09 63.53 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.644 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 0.8 OUTLIER -65.42 -56.57 11.78 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.01 -42.47 38.09 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.582 0.706 . . . . 0.0 109.312 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.528 ' CB ' ' OD2' ' A' ' 22' ' ' ASP . . . -89.22 -6.73 56.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.518 -0.739 . . . . 0.0 109.705 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . 62.43 21.31 62.19 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.528 ' OD2' ' CB ' ' A' ' 20' ' ' ALA . 1.5 p30 -89.35 68.56 7.98 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.994 -1.297 . . . . 0.0 109.732 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.608 ' CD1' ' HB3' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -46.54 -35.55 5.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.249 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 22' ' ' ASP . 8.5 p-10 -41.92 -34.79 0.73 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.46 -32.27 16.67 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' LEU . 40.5 mt -62.67 -56.66 16.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.481 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 49.2 t -56.83 -34.29 43.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.3 -55.7 25.68 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.558 ' CD1' ' NH2' ' A' ' 13' ' ' ARG . 3.5 tp -62.99 -21.92 66.48 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' ALA . 9.4 m-30 -87.63 138.69 31.25 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -50.59 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 109.726 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.2 -24.39 62.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.594 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.547 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 4.6 p-10 -150.16 53.49 0.91 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.561 ' N ' ' CD1' ' A' ' 51' ' ' ILE . . . -65.78 151.86 45.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 109.653 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 46' ' ' SER . 0.2 OUTLIER -92.89 145.99 23.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 109.256 179.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 53.2 t -137.98 116.6 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.103 -0.998 . . . . 0.0 109.711 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 3.1 mm-40 -89.2 110.91 21.6 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.502 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 9.7 t70 -178.86 143.98 0.43 Allowed Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.702 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 48.9 Cg_endo -74.13 -168.27 6.08 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.258 -1.976 . . . . 0.0 110.925 -0.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.589 ' CG2' ' CG1' ' B' ' 274' ' ' VAL . 32.7 m -80.53 50.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.8 . . . . 0.0 109.351 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.37 34.18 0.05 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.517 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -153.54 -148.06 0.24 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.445 -1.032 . . . . 0.0 109.144 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -125.47 140.25 35.9 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.997 -1.065 . . . . 0.0 110.073 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.527 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 37.9 Cg_endo -63.58 -176.0 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.276 1.672 . . . . 0.0 111.051 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -150.87 108.15 3.61 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -89.17 151.82 21.96 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.167 -178.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 33' ' ' ASP . . . 110.45 158.04 16.12 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.8 m -67.04 -51.36 55.73 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.13 -1.218 . . . . 0.0 109.146 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -58.4 -41.47 84.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.227 -0.921 . . . . 0.0 109.08 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 45' ' ' ARG . . . -67.31 -57.51 6.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.153 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 34' ' ' ALA . 23.5 mt -55.02 -47.89 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.575 ' CG ' ' CD2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -69.14 -57.87 4.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.118 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 37.4 tt0 -45.59 -30.01 1.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.053 -1.03 . . . . 0.0 108.839 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.502 ' CZ ' ' O ' ' A' ' 38' ' ' ASP . 1.3 t80 -82.44 -69.5 0.62 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.608 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -48.58 -36.08 14.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.76 -47.33 75.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 109.039 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 23.1 t-20 -57.51 -41.45 80.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.32 -0.862 . . . . 0.0 108.921 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.9 t -65.43 -32.34 73.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.348 -0.845 . . . . 0.0 109.005 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.456 ' CD2' ' O ' ' A' ' 21' ' ' GLY . 8.1 tp -67.02 -19.6 65.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -57.25 -22.54 42.03 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.6 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -89.62 119.39 69.52 Favored Pre-proline 0 C--N 1.306 -1.324 0 O-C-N 121.189 -0.944 . . . . 0.0 108.528 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 49.1 Cg_endo -74.94 106.86 2.35 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.768 1.404 . . . . 0.0 110.762 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.6 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -138.84 163.08 33.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 110.055 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.527 ' CB ' ' OG ' ' A' ' 85' ' ' SER . . . -97.26 124.01 41.23 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.425 HG13 HG21 ' A' ' 15' ' ' VAL . 48.6 t -107.4 114.15 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.908 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 67' ' ' LEU . 6.2 tt0 -150.34 101.31 2.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 109.195 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 82' ' ' PHE . 1.9 mp -44.97 170.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.864 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.9 p -133.41 -36.51 0.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.742 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 70' ' ' GLU . 1.2 pt20 -101.38 -145.18 0.35 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.512 -0.743 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 69' ' ' GLN . 26.9 tt0 -110.78 133.03 53.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 109.513 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.527 ' CG2' HG12 ' A' ' 11' ' ' VAL . 28.5 t -58.03 154.71 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.342 -0.849 . . . . 0.0 109.412 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 1.9 mpt_? -121.01 130.2 53.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.516 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -150.5 120.39 7.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.629 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -122.44 -161.32 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 109.672 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 76' ' ' ASN . . . -81.73 144.88 30.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.444 -0.785 . . . . 0.0 110.216 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 75' ' ' ALA . 1.3 t-20 80.95 -44.18 0.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.733 -0.605 . . . . 0.0 110.422 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -144.39 -159.93 1.06 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.961 -1.087 . . . . 0.0 110.412 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.517 ' CB ' ' HB3' ' A' ' 101' ' ' PHE . . . -169.21 163.15 10.9 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.594 ' CB ' ' CD2' ' B' ' 315' ' ' LEU . . . -149.4 138.78 21.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.91 -1.118 . . . . 0.0 109.962 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 29.7 p90 -150.34 167.48 26.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.023 -1.048 . . . . 0.0 109.384 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.529 ' CB ' HG21 ' A' ' 98' ' ' ILE . . . -139.94 -169.68 2.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 110.518 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.639 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 0.0 OUTLIER 172.84 -175.11 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.96 141.22 51.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.248 -0.908 . . . . 0.0 109.592 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.533 HG11 ' CB ' ' A' ' 63' ' ' LEU . 14.2 t -108.95 115.53 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.277 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.527 ' OG ' ' CB ' ' A' ' 64' ' ' ALA . 21.8 p -112.11 106.4 15.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.12 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.593 ' CZ ' ' HB ' ' A' ' 93' ' ' THR . 6.6 p90 -125.62 176.26 7.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.743 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -121.28 164.77 16.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.596 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.584 ' CE1' ' CE1' ' A' ' 86' ' ' PHE . 0.9 OUTLIER -115.58 -92.3 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.649 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -137.42 -36.21 0.65 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.864 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.78 -28.12 1.19 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 45.5 mtt85 -126.64 -179.51 4.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -1.184 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -127.6 122.43 33.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.679 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 19.3 m -96.55 172.15 8.1 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.344 -0.847 . . . . 0.0 109.559 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.528 HG12 ' CB ' ' A' ' 122' ' ' HIS . 14.0 p -148.0 170.99 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 108.715 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.551 HG11 ' HD3' ' A' ' 97' ' ' PRO . 43.9 t -148.22 156.78 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.079 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.516 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -135.28 75.27 59.54 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.457 -0.777 . . . . 0.0 109.339 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.551 ' HD3' HG11 ' A' ' 95' ' ' VAL . 45.7 Cg_endo -98.19 178.48 0.39 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.789 1.659 . . . . 0.0 111.539 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.529 HG21 ' CB ' ' A' ' 81' ' ' ALA . 2.8 mp -137.93 151.93 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 13.5 t0 -122.8 164.48 18.3 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.941 -1.1 . . . . 0.0 110.203 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.552 ' CE1' HD11 ' B' ' 315' ' ' LEU . 0.1 OUTLIER -112.16 172.15 7.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 109.236 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.564 ' CE1' ' CG1' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -147.28 140.86 25.54 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.24 -0.912 . . . . 0.0 110.374 -178.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.467 ' HA ' ' HG3' ' A' ' 77' ' ' GLU . 1.4 ttt180 -130.31 110.42 11.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.871 . . . . 0.0 109.121 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.56 ' CE2' ' HA ' ' A' ' 7' ' ' MET . 0.6 OUTLIER -89.73 176.15 6.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.333 -0.855 . . . . 0.0 109.664 -179.511 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.542 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -114.03 -36.39 4.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.298 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . 176.54 -46.07 0.11 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 163.29 76.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -1.169 . . . . 0.0 109.593 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.0 -45.44 0.04 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.83 -169.43 2.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -1.133 . . . . 0.0 109.292 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.519 ' CG1' ' N ' ' A' ' 110' ' ' VAL . 54.5 t -94.04 166.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.209 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.542 ' CG2' ' HB3' ' A' ' 104' ' ' ASN . 10.8 t -131.76 -63.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -0.958 . . . . 0.0 109.745 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.458 ' HB2' ' HD3' ' A' ' 102' ' ' ARG . 3.2 m -128.18 171.05 12.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.946 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.511 ' CE ' ' OD2' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -151.75 147.53 26.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.42 -0.8 . . . . 0.0 109.081 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.459 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -121.36 162.18 20.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.568 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -111.01 133.48 53.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.848 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.65 ' O ' ' CD1' ' A' ' 116' ' ' PHE . 9.3 tp -109.48 -143.47 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.808 . . . . 0.0 108.957 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.65 ' CD1' ' O ' ' A' ' 115' ' ' LEU . 26.2 p90 39.0 -161.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.725 0.774 . . . . 0.0 110.481 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.578 ' N ' ' CD2' ' A' ' 116' ' ' PHE . . . 179.4 -149.37 8.67 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.438 ' C ' HG12 ' A' ' 121' ' ' ILE . 21.5 tt0 -80.69 -1.98 44.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -1.155 . . . . 0.0 109.412 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE2' ' CG ' ' B' ' 204' ' ' PRO . 5.7 tttm -93.19 -26.94 17.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 122.064 0.935 . . . . 0.0 108.921 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -88.55 17.7 5.2 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.349 0.595 . . . . 0.0 109.437 -179.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.522 HG21 ' CG2' ' A' ' 95' ' ' VAL . 5.2 mm -90.01 -174.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.528 ' CB ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -150.87 173.6 14.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.962 -1.086 . . . . 0.0 109.899 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -152.34 110.36 3.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.409 -0.807 . . . . 0.0 109.29 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.37 115.07 3.95 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.328 -1.101 . . . . 0.0 109.47 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 201' ' ' MET . . . . . 0.498 ' O ' ' CG ' ' B' ' 201' ' ' MET . 1.4 ptt? . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.256 0.551 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' B' ' 203' ' ' THR . 0.7 OUTLIER -127.09 64.91 1.3 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' THR . . . . . 0.412 ' C ' ' O ' ' B' ' 202' ' ' ASN . 5.0 t -43.92 109.1 0.77 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.476 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' PRO . . . . . 0.494 ' CG ' ' HE2' ' A' ' 119' ' ' LYS . 44.5 Cg_endo -71.42 -4.11 14.33 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.957 1.504 . . . . 0.0 110.264 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -45.88 56.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.196 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -51.41 67.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.362 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' MET . . . . . 0.455 ' HE1' ' O ' ' B' ' 275' ' ' ALA . 12.5 mtm -59.81 -51.15 70.97 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.242 -0.911 . . . . 0.0 109.487 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.472 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 8.2 m -53.26 -33.02 51.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 109.193 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.55 -46.23 66.7 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.051 -1.031 . . . . 0.0 108.405 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.612 HG13 ' CE2' ' B' ' 301' ' ' PHE . 0.9 OUTLIER -53.48 -43.24 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.526 ' CG1' HG23 ' B' ' 271' ' ' VAL . 11.3 t -59.4 -41.72 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.594 -0.691 . . . . 0.0 109.834 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' B' ' 213' ' ' ARG . 9.7 tt0 -60.47 -75.26 0.06 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' B' ' 212' ' ' GLN . 0.6 OUTLIER -43.83 -44.38 6.8 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' TYR . . . . . 0.633 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 3.8 t80 -53.71 -49.25 68.5 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.604 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 0.9 OUTLIER -83.25 -44.36 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.406 -0.809 . . . . 0.0 109.832 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.0 -37.04 8.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 0.0 108.022 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -74.1 -34.68 64.03 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.633 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 5.2 mt -63.29 -59.91 4.1 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' ASN . . . . . 0.414 ' ND2' ' OE1' ' B' ' 266' ' ' GLU . 16.4 t30 -51.01 -45.6 61.26 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.565 0.697 . . . . 0.0 109.289 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.38 9.68 25.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.572 -0.705 . . . . 0.0 109.511 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' B' ' 217' ' ' ALA . . . 48.06 32.21 8.98 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' B' ' 217' ' ' ALA . 12.5 t70 -89.99 66.49 6.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -1.117 . . . . 0.0 109.743 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' LEU . . . . . 0.565 ' CD1' ' HB3' ' B' ' 255' ' ' PHE . 5.9 tp -47.58 -42.38 23.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 108.736 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' B' ' 223' ' ' LEU . 3.4 m-20 -42.28 -31.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' B' ' 228' ' ' ALA . . . -88.14 -38.71 7.18 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.574 HD13 ' CD2' ' B' ' 255' ' ' PHE . 17.1 mt -58.23 -53.36 47.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.516 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 85.0 t -57.17 -37.99 58.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' B' ' 225' ' ' GLY . . . -58.33 -54.82 42.67 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.533 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 8.5 tp -63.32 -20.48 65.53 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . 0.623 ' CD2' ' CG2' ' B' ' 251' ' ' ILE . 0.6 OUTLIER -82.71 132.08 35.19 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.492 -0.755 . . . . 0.0 109.502 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -51.04 -177.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.268 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -25.89 66.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 109.885 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . 0.536 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 13.4 p-10 -150.61 53.84 0.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.62 -0.675 . . . . 0.0 109.341 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' B' ' 310' ' ' VAL . . . -62.19 165.55 5.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.742 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' THR . . . . . 0.529 ' CG2' ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -116.25 140.78 48.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.22 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.51 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 38.9 t -130.11 117.8 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -0.885 . . . . 0.0 109.126 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' GLU . . . . . 0.541 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 27.7 mt-10 -88.84 106.98 18.73 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' ASP . . . . . 0.455 ' CG ' ' HA ' ' B' ' 239' ' ' PRO . 9.8 t70 -176.03 142.17 0.61 Allowed Pre-proline 0 C--N 1.3 -1.577 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.597 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' B' ' 238' ' ' ASP . 47.2 Cg_endo -73.74 -165.09 3.61 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.216 -1.993 . . . . 0.0 110.685 0.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.491 HG21 HG13 ' A' ' 74' ' ' VAL . 5.5 m -87.8 41.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 109.345 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -165.71 26.01 0.17 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' SER . . . . . 0.433 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 1.4 m -148.01 -141.82 0.12 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.415 -1.05 . . . . 0.0 108.913 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . 0.401 ' HG2' ' C ' ' B' ' 242' ' ' SER . 8.2 mm-40 -133.72 142.35 43.39 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.914 -1.116 . . . . 0.0 109.954 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' PRO . . . . . 0.541 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.8 Cg_endo -63.39 -170.86 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.284 1.676 . . . . 0.0 111.436 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.47 ' O ' HD13 ' B' ' 251' ' ' ILE . 0.0 OUTLIER -151.09 111.5 4.18 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.529 ' HB3' ' CG2' ' B' ' 235' ' ' THR . 1.9 p -94.04 155.28 17.2 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.101 -0.999 . . . . 0.0 110.452 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.21 162.32 21.78 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 6.5 m -73.7 -44.91 55.18 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.185 -1.185 . . . . 0.0 109.093 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -64.26 -20.25 65.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.244 -0.91 . . . . 0.0 109.207 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' B' ' 254' ' ' PHE . . . -90.15 -54.43 4.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.352 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.623 ' CG2' ' CD2' ' B' ' 230' ' ' PHE . 6.4 mm -54.97 -44.58 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' ARG . . . . . 0.516 ' HB2' ' CG2' ' B' ' 227' ' ' VAL . 17.8 ttt85 -73.34 -56.03 5.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.212 -0.93 . . . . 0.0 108.807 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 253' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 17.7 tt0 -45.94 -27.92 1.01 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.024 . . . . 0.0 108.546 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 1.0 OUTLIER -85.79 -70.94 0.56 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 255' ' ' PHE . . . . . 0.574 ' CD2' HD13 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -48.45 -23.97 1.12 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . 0.531 ' CB ' HD21 ' B' ' 223' ' ' LEU . . . -80.49 -51.16 9.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 108.898 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 257' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 0.2 OUTLIER -56.62 -35.02 67.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 1.6 t -74.81 -38.6 62.04 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 259' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' B' ' 255' ' ' PHE . 8.6 tp -62.22 -29.47 70.41 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.373 -0.829 . . . . 0.0 109.02 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 260' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 14.7 mttm -44.35 -27.11 0.4 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 261' ' ' LEU . . . . . 0.559 ' CD2' HD23 ' B' ' 263' ' ' LEU . 3.3 tt -89.69 113.85 58.37 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 262' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 48.7 Cg_endo -73.59 107.27 2.36 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.915 1.481 . . . . 0.0 112.176 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.559 HD23 ' CD2' ' B' ' 261' ' ' LEU . 0.8 OUTLIER -130.24 -170.28 2.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.398 -0.814 . . . . 0.0 109.43 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' B' ' 285' ' ' SER . . . -119.9 128.0 53.22 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 265' ' ' VAL . . . . . 0.439 ' CG1' HG21 ' B' ' 215' ' ' VAL . 43.0 t -115.43 113.25 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.055 -1.028 . . . . 0.0 110.037 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 266' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.3 tp10 -150.31 94.16 2.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.417 -0.802 . . . . 0.0 108.942 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.4 mp -46.89 175.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 0.0 110.004 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 268' ' ' THR . . . . . 0.456 ' O ' ' O ' ' B' ' 269' ' ' GLN . 41.7 p -133.57 -76.28 0.48 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.46 -0.775 . . . . 0.0 108.951 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 269' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' B' ' 268' ' ' THR . 3.4 pt20 -61.07 -143.7 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 270' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 24.4 tt0 -115.76 131.31 56.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 109.872 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 271' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' B' ' 280' ' ' PHE . 83.0 t -45.41 146.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.386 -0.822 . . . . 0.0 109.042 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.519 ' N ' HG11 ' B' ' 271' ' ' VAL . 0.3 OUTLIER -102.08 82.19 2.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.696 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -89.38 145.03 25.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.115 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 274' ' ' VAL . . . . . 0.589 ' CG1' ' CG2' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -122.43 -169.02 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.156 -0.965 . . . . 0.0 109.924 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 275' ' ' ALA . . . . . 0.455 ' O ' ' HE1' ' B' ' 207' ' ' MET . . . -38.39 -94.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.574 -0.704 . . . . 0.0 110.787 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 276' ' ' ASN . . . . . 0.451 ' O ' ' OD1' ' B' ' 276' ' ' ASN . 21.8 t-20 -92.76 -28.24 16.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.115 -0.991 . . . . 0.0 110.621 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . 0.505 ' CG ' ' HG3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -92.74 -166.6 1.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.952 -1.092 . . . . 0.0 109.575 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 278' ' ' ALA . . . . . 0.484 ' CB ' ' HB2' ' B' ' 301' ' ' PHE . . . -160.69 161.14 32.22 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.468 -0.77 . . . . 0.0 109.571 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 279' ' ' ALA . . . . . 0.543 ' CB ' ' CD1' ' A' ' 115' ' ' LEU . . . -150.9 131.13 13.58 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . 0.592 ' CE1' ' HB3' ' B' ' 299' ' ' ASP . 41.8 p90 -147.55 159.53 43.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.797 -1.19 . . . . 0.0 110.491 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . 0.533 ' CB ' HG21 ' B' ' 298' ' ' ILE . . . -139.57 160.88 38.85 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.406 0.622 . . . . 0.0 109.375 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 282' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 3.8 p90 -162.29 -168.34 1.84 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 108.982 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.27 139.78 53.59 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.713 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 284' ' ' VAL . . . . . 0.526 ' CG1' ' CD2' ' B' ' 263' ' ' LEU . 42.0 t -107.83 114.7 47.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 285' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' B' ' 264' ' ' ALA . 96.9 p -115.5 98.99 7.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.955 . . . . 0.0 110.119 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.584 ' CE1' ' HB ' ' B' ' 293' ' ' THR . 30.0 p90 -108.75 -171.86 1.94 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 108.815 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.45 153.1 33.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.98 -1.075 . . . . 0.0 109.809 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . 0.527 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.1 OUTLIER -105.55 -163.91 0.98 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.43 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -40.58 92.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.924 . . . . 0.0 109.972 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -139.65 4.51 2.75 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.148 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -140.82 -176.25 4.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -1.186 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 292' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -118.75 140.98 49.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.178 -0.952 . . . . 0.0 109.305 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 293' ' ' THR . . . . . 0.584 ' HB ' ' CE1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -125.32 146.04 49.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.406 -0.809 . . . . 0.0 109.433 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 294' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' B' ' 284' ' ' VAL . 7.9 p -125.28 171.89 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.143 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.535 HG13 ' HG3' ' B' ' 297' ' ' PRO . 2.8 t -149.43 146.98 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 109.065 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 296' ' ' ALA . . . . . 0.53 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -125.84 71.32 67.77 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.179 -0.951 . . . . 0.0 111.266 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 297' ' ' PRO . . . . . 0.535 ' HG3' HG13 ' B' ' 295' ' ' VAL . 53.3 Cg_endo -93.24 179.68 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.593 1.312 . . . . 0.0 110.996 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.533 HG21 ' CB ' ' B' ' 281' ' ' ALA . 3.0 mp -141.38 148.81 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . 0.592 ' HB3' ' CE1' ' B' ' 280' ' ' PHE . 17.2 t0 -121.38 157.52 30.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.958 -1.089 . . . . 0.0 110.401 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 300' ' ' HIS . . . . . 0.562 ' CD2' HD12 ' A' ' 115' ' ' LEU . 3.0 t-160 -113.73 151.7 31.54 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 301' ' ' PHE . . . . . 0.612 ' CE2' HG13 ' B' ' 210' ' ' VAL . 0.5 OUTLIER -126.91 151.86 47.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.271 -0.893 . . . . 0.0 110.828 -178.271 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.505 ' HG3' ' CG ' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -146.27 93.56 2.33 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 303' ' ' PHE . . . . . 0.6 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 8.2 m-30 -89.81 -165.55 1.37 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.126 -0.984 . . . . 0.0 109.962 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 304' ' ' ASN . . . . . 0.537 ' OD1' ' CG1' ' B' ' 310' ' ' VAL . 0.4 OUTLIER -140.15 27.22 2.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.427 -0.796 . . . . 0.0 109.437 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . 119.54 -61.08 0.49 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . 179.67 33.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -1.127 . . . . 0.0 109.272 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 307' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' B' ' 308' ' ' LYS . . . -108.35 33.3 6.33 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 308' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' B' ' 307' ' ' GLY . 0.3 OUTLIER 83.51 -162.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.972 -0.722 . . . . 0.0 109.164 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 309' ' ' VAL . . . . . 0.546 ' CG2' HG12 ' B' ' 210' ' ' VAL . 49.7 t -90.5 143.81 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.384 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . 0.537 ' CG1' ' OD1' ' B' ' 304' ' ' ASN . 0.1 OUTLIER -126.19 -27.1 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.102 -0.999 . . . . 0.0 109.991 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 311' ' ' SER . . . . . 0.496 ' CB ' ' HD3' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -143.41 164.04 31.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.109 -0.994 . . . . 0.0 109.374 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 312' ' ' MET . . . . . 0.472 ' O ' ' HG3' ' B' ' 237' ' ' GLU . 0.0 OUTLIER -160.38 155.85 25.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 313' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' B' ' 300' ' ' HIS . 0.0 OUTLIER -150.22 118.47 6.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.159 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -100.07 139.73 35.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 110.629 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 315' ' ' LEU . . . . . 0.594 ' CD2' ' CB ' ' A' ' 79' ' ' ALA . 3.7 tt -128.65 138.46 52.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.84 . . . . 0.0 109.335 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 316' ' ' PHE . . . . . 0.578 ' CD2' ' OD1' ' B' ' 320' ' ' ASN . 0.1 OUTLIER 172.51 -159.51 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 317' ' ' GLY . . . . . 0.487 ' O ' ' OD1' ' B' ' 320' ' ' ASN . . . 171.27 177.63 41.2 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.292 -1.433 . . . . 0.0 110.485 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 318' ' ' GLU . . . . . 0.504 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 47.9 tt0 -51.54 -21.41 2.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.201 -1.176 . . . . 0.0 108.931 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.14 -22.18 59.56 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.019 0.914 . . . . 0.0 108.726 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 320' ' ' ASN . . . . . 0.578 ' OD1' ' CD2' ' B' ' 316' ' ' PHE . 0.3 OUTLIER -88.51 1.51 54.7 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 321' ' ' ILE . . . . . 0.533 HG21 ' CG2' ' B' ' 295' ' ' VAL . 4.0 mm -89.89 179.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.121 -0.987 . . . . 0.0 108.504 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 322' ' ' HIS . . . . . 0.477 ' HB2' HG11 ' B' ' 294' ' ' VAL . 0.2 OUTLIER -151.51 177.42 10.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.967 -1.083 . . . . 0.0 109.807 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.462 179.781 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.454 ' O ' ' HE2' ' A' ' 7' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.3 -3.5 13.07 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.854 1.449 . . . . 0.0 110.285 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -61.88 -39.22 91.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.257 -0.902 . . . . 0.0 109.292 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -86.93 -43.99 11.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.335 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.454 ' HE2' ' O ' ' A' ' 3' ' ' THR . 25.6 mtt -56.94 -35.87 69.59 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.261 -0.899 . . . . 0.0 109.542 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 11' ' ' VAL . 11.2 m -67.41 -39.16 85.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -43.66 62.77 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.639 ' CG1' ' CZ ' ' A' ' 101' ' ' PHE . 1.3 t -53.96 -22.64 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.569 HG21 ' CD1' ' A' ' 80' ' ' PHE . 4.3 t -90.12 -41.35 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 108.979 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.3 tt0 -65.5 -74.18 0.11 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.496 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . 2.2 mtt85 -42.27 -45.46 4.2 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.547 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -46.1 -43.73 15.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.095 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.603 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 1.4 t -90.34 -37.24 9.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.544 -0.722 . . . . 0.0 109.136 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -49.26 -34.91 16.29 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HB3' HG13 ' A' ' 26' ' ' ILE . . . -74.73 -33.3 62.34 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.603 ' CD1' ' HA ' ' A' ' 15' ' ' VAL . 3.8 mt -65.96 -58.85 4.6 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.75 -41.86 24.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.621 0.724 . . . . 0.0 109.251 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.85 7.98 31.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.548 ' CA ' HD23 ' A' ' 59' ' ' LEU . . . 47.94 31.94 8.43 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -100.17 92.99 5.48 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.324 -1.104 . . . . 0.0 109.755 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.569 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 3.4 mm? -59.17 -15.27 13.82 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.224 -0.923 . . . . 0.0 109.529 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -62.23 -54.14 45.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 109.178 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 28' ' ' ALA . . . -63.12 -35.68 92.41 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.568 HG22 ' CD1' ' A' ' 55' ' ' PHE . 8.8 mt -62.8 -56.45 17.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 52' ' ' ARG . 95.7 t -63.72 -37.9 80.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.468 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . . . -60.82 -50.28 74.1 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.496 ' CD2' ' HB3' ' A' ' 13' ' ' ARG . 7.7 tp -66.08 -23.32 66.5 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.4 ' O ' ' O ' ' A' ' 31' ' ' ALA . 3.6 m-85 -88.4 141.1 28.81 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.562 -0.711 . . . . 0.0 109.655 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 109' ' ' VAL . . . -48.5 172.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 109.458 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.455 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -63.29 -24.1 67.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 109.294 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.537 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 20.4 p-10 -146.58 35.12 0.95 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.566 ' N ' ' CD1' ' A' ' 51' ' ' ILE . . . -51.01 169.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.822 . . . . 0.0 109.772 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.496 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -122.76 140.31 53.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.541 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 44' ' ' PRO . 48.2 t -131.49 120.66 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.262 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.529 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 3.4 mt-10 -88.46 107.0 18.64 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.569 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 9.1 t0 -179.78 143.29 0.37 Allowed Pre-proline 0 C--N 1.302 -1.486 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.547 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.479 ' HA ' ' CG ' ' A' ' 38' ' ' ASP . 50.1 Cg_endo -76.25 -175.14 15.86 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.205 -1.998 . . . . 0.0 110.403 -0.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.569 HG12 ' CE1' ' A' ' 116' ' ' PHE . 19.8 m -72.58 150.89 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 108.875 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.35 -1.76 69.48 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.463 ' OG ' ' HG2' ' A' ' 39' ' ' PRO . 1.4 m -115.46 -142.3 0.38 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.27 -1.135 . . . . 0.0 109.308 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.24 141.76 16.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.987 -1.071 . . . . 0.0 110.048 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 39.6 Cg_endo -65.56 -175.44 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.817 1.678 . . . . 0.0 111.592 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.575 ' HB2' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -150.78 106.86 3.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.496 ' HB2' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.28 157.01 18.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.276 -0.89 . . . . 0.0 110.601 -178.35 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 106.3 157.18 21.69 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 7.3 m -64.55 -55.26 21.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.243 -1.151 . . . . 0.0 109.138 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -55.27 -33.02 62.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.89 . . . . 0.0 109.009 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' HB3' ' CG ' ' A' ' 45' ' ' ARG . . . -77.46 -60.52 2.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.383 -0.823 . . . . 0.0 109.357 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 34' ' ' ALA . 44.5 mt -48.08 -40.9 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.267 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HB2' HG23 ' A' ' 27' ' ' VAL . 49.2 ttp180 -79.1 -58.39 3.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.814 . . . . 0.0 109.124 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.532 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 49.8 tt0 -46.2 -27.37 0.97 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.021 -1.05 . . . . 0.0 108.619 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -85.02 -71.36 0.53 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.568 ' CD1' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -49.31 -33.01 12.21 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.433 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . . . -69.12 -46.82 66.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 108.78 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 26.9 t-20 -58.41 -35.45 72.09 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.6 t -64.93 -38.09 89.82 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.569 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 7.6 tp -68.78 -22.04 64.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.486 -0.759 . . . . 0.0 109.68 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 25.9 mtpt -50.39 -26.37 4.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 109.692 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.581 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.71 126.7 56.96 Favored Pre-proline 0 C--N 1.305 -1.349 0 O-C-N 121.226 -0.921 . . . . 0.0 109.049 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.441 ' C ' ' HG ' ' A' ' 63' ' ' LEU . 44.0 Cg_endo -71.49 101.62 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.834 1.439 . . . . 0.0 110.371 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.581 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -138.64 155.86 47.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.462 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.79 132.66 35.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 108.778 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 18' ' ' LEU . 16.2 t -107.22 125.02 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.048 -1.033 . . . . 0.0 110.127 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' LEU . 14.8 tt0 -150.26 103.12 3.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.44 -0.788 . . . . 0.0 108.961 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 68' ' ' THR . 3.8 mt -55.09 -108.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 110.062 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.668 ' O ' ' N ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER 158.26 43.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.555 ' CG ' ' O ' ' A' ' 68' ' ' THR . 5.1 pt20 50.64 -54.02 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' A' ' 68' ' ' THR . 23.1 tt0 -60.77 116.19 4.23 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.624 -1.297 . . . . 0.0 110.761 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.454 HG21 HG12 ' A' ' 11' ' ' VAL . 35.8 t -135.3 163.54 35.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -132.03 135.12 46.28 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.454 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.527 ' N ' ' NE ' ' A' ' 72' ' ' ARG . . . -145.44 111.63 5.66 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.55 HG22 ' NH2' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -100.11 -163.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 110.429 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -35.69 -94.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.771 -0.581 . . . . 0.0 111.241 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 8.1 t-20 -100.32 -2.9 32.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.07 -1.019 . . . . 0.0 110.748 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.515 ' OE1' ' NE ' ' B' ' 313' ' ' ARG . 0.4 OUTLIER -111.29 -162.03 0.78 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.769 -1.207 . . . . 0.0 109.719 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 101' ' ' PHE . . . -176.09 162.14 2.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.602 -0.686 . . . . 0.0 109.372 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.555 ' O ' ' CB ' ' A' ' 72' ' ' ARG . . . -150.17 130.09 13.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.172 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 31.4 p90 -150.83 168.79 23.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.678 -1.263 . . . . 0.0 109.948 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.546 ' CB ' HG21 ' A' ' 98' ' ' ILE . . . -141.8 -178.3 5.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.472 -0.767 . . . . 0.0 109.862 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.53 ' CB ' ' HA ' ' A' ' 67' ' ' LEU . 1.9 p90 -172.65 -159.25 0.12 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.386 -0.821 . . . . 0.0 109.257 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.86 149.43 43.41 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.083 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.475 HG12 HD22 ' A' ' 63' ' ' LEU . 55.6 t -124.77 112.51 32.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.509 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -113.5 103.9 11.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.902 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.57 ' CD2' HD23 ' A' ' 63' ' ' LEU . 45.6 p90 -123.1 164.77 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.393 -0.817 . . . . 0.0 108.931 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 38.0 tt0 -141.46 152.25 44.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.059 -1.026 . . . . 0.0 109.83 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.425 ' N ' ' HG2' ' A' ' 87' ' ' GLU . 7.3 m-85 -93.61 -146.4 0.24 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.419 -0.801 . . . . 0.0 109.297 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -0.72 30.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.958 . . . . 0.0 109.719 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.71 -68.63 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 1.6 ttt85 -55.49 155.11 5.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -1.137 . . . . 0.0 109.557 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -131.71 120.43 22.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.757 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -121.46 143.26 49.34 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER -117.37 179.52 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.103 -0.998 . . . . 0.0 108.74 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.56 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 3.0 t -148.15 146.5 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.07 -1.019 . . . . 0.0 109.533 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.524 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -133.64 71.13 75.51 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.34 -0.85 . . . . 0.0 110.281 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.56 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 49.7 Cg_endo -95.46 -174.54 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.537 1.491 . . . . 0.0 110.973 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.546 HG21 ' CB ' ' A' ' 81' ' ' ALA . 2.9 mp -139.14 166.28 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 21.1 t0 -131.27 154.66 48.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.922 -1.111 . . . . 0.0 110.192 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.517 ' NE2' ' CD1' ' B' ' 315' ' ' LEU . 0.3 OUTLIER -108.77 172.75 6.66 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.639 ' CZ ' ' CG1' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -147.41 150.88 35.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.82 -1.175 . . . . 0.0 110.857 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.467 ' HD2' ' HB2' ' A' ' 111' ' ' SER . 0.0 OUTLIER -139.78 109.53 6.33 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.544 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -89.27 -166.12 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 109.777 -179.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.524 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -135.9 -38.71 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.439 -0.788 . . . . 0.0 109.34 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . -174.46 -47.67 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 163.2 77.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -1.094 . . . . 0.0 109.503 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -167.21 -67.94 0.03 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -139.78 -163.87 1.58 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.232 -1.158 . . . . 0.0 109.482 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.529 HG12 ' CE1' ' A' ' 101' ' ' PHE . 94.0 t -100.79 147.63 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.871 . . . . 0.0 109.337 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.524 ' CG2' ' HB3' ' A' ' 104' ' ' ASN . 93.2 t -111.9 -66.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 109.746 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.467 ' HB2' ' HD2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -116.25 166.25 12.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.055 -1.028 . . . . 0.0 109.736 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 100' ' ' HIS . 12.2 ttp -160.28 154.61 23.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.345 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.456 ' HD2' ' CB ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -144.35 126.59 15.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.167 -0.958 . . . . 0.0 109.482 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.501 ' CB ' ' OD2' ' A' ' 38' ' ' ASP . . . -96.71 132.21 42.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 109.752 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.515 ' CD2' ' HB2' ' B' ' 279' ' ' ALA . 1.3 tt -117.92 143.84 45.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.002 . . . . 0.0 109.834 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.569 ' CE1' HG12 ' A' ' 40' ' ' VAL . 9.2 p90 172.54 -158.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . 169.53 -173.05 43.79 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.507 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 26.6 tt0 -72.79 -2.65 21.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.302 -1.117 . . . . 0.0 109.68 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -92.71 -30.96 15.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.997 0.903 . . . . 0.0 108.995 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.3 m-20 -89.11 11.38 18.69 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.679 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.525 ' CD1' ' O ' ' A' ' 117' ' ' GLY . 4.4 mm -92.66 -160.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.191 -0.943 . . . . 0.0 108.587 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.498 ' HB2' HG11 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -151.22 159.93 44.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.071 . . . . 0.0 109.795 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.478 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.66 81.74 1.03 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.371 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -119.19 140.16 14.82 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.207 -1.173 . . . . 0.0 109.454 179.889 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 201' ' ' MET . . . . . 0.405 ' O ' ' C ' ' B' ' 202' ' ' ASN . 5.1 mpp? . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.258 0.551 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.46 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 8.8 m120 45.33 44.48 9.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.436 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' THR . . . . . 0.497 ' CG2' ' HB2' ' B' ' 205' ' ' GLU . 5.3 m -89.59 108.64 26.46 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.4 Cg_endo -72.26 -2.48 11.73 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.973 1.512 . . . . 0.0 110.165 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . 0.497 ' HB2' ' CG2' ' B' ' 203' ' ' THR . 3.5 tt0 -58.92 -63.48 1.28 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -0.869 . . . . 0.0 109.353 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -61.98 -45.03 95.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.915 . . . . 0.0 109.51 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' MET . . . . . 0.424 ' HA ' ' CE2' ' B' ' 303' ' ' PHE . 73.3 mtm -60.9 -41.48 96.15 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.255 -0.903 . . . . 0.0 109.608 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.429 ' O ' ' N ' ' B' ' 211' ' ' VAL . 18.1 m -64.46 -44.08 92.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.946 . . . . 0.0 109.252 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.64 -43.73 57.19 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.581 HG12 ' CZ ' ' B' ' 303' ' ' PHE . 0.9 OUTLIER -53.57 -26.03 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.544 HG22 ' CD2' ' B' ' 301' ' ' PHE . 13.5 t -89.8 -43.27 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 108.984 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' B' ' 215' ' ' VAL . 5.7 tt0 -62.71 -73.98 0.1 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' B' ' 212' ' ' GLN . 1.4 mtt85 -42.21 -45.06 3.99 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' TYR . . . . . 0.639 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.3 OUTLIER -48.05 -43.13 30.04 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.28 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.601 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.16 -40.25 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.407 -0.808 . . . . 0.0 109.178 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.8 -37.24 13.17 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' B' ' 226' ' ' ILE . . . -72.97 -35.21 66.87 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.639 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 5.2 mt -63.84 -60.84 2.77 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -49.29 -40.36 34.37 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.532 0.682 . . . . 0.0 109.252 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.22 0.02 57.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.553 -0.717 . . . . 0.0 109.799 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . 0.526 ' CA ' HD23 ' B' ' 259' ' ' LEU . . . 54.52 45.4 76.9 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.442 ' O ' HG13 ' B' ' 226' ' ' ILE . 45.7 t0 -111.14 83.75 1.82 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 110.061 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' B' ' 259' ' ' LEU . 3.9 mm? -53.31 -19.37 3.23 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.24 -0.913 . . . . 0.0 109.78 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.89 -56.94 11.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.235 -0.916 . . . . 0.0 109.213 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -60.61 -31.92 76.62 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.448 HG12 ' HB2' ' B' ' 217' ' ' ALA . 7.2 mt -65.28 -60.45 2.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 61.1 t -59.14 -40.26 80.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.16 -51.33 66.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.532 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 8.6 tp -66.48 -21.83 66.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . 0.493 ' O ' ' O ' ' B' ' 227' ' ' VAL . 3.9 m-30 -95.71 134.93 38.06 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.338 -0.851 . . . . 0.0 110.015 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' B' ' 230' ' ' PHE . . . -44.54 164.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.036 -1.04 . . . . 0.0 109.383 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.471 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.1 OUTLIER -61.9 -24.63 67.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.489 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . 0.534 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 2.6 p30 -138.53 43.08 2.15 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' B' ' 310' ' ' VAL . . . -64.04 169.26 4.49 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.327 -0.858 . . . . 0.0 109.808 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' THR . . . . . 0.544 ' CG2' ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -119.79 140.07 51.33 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.446 -0.784 . . . . 0.0 109.007 179.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' B' ' 244' ' ' PRO . 37.3 t -132.44 121.19 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.577 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' B' ' 314' ' ' ALA . 1.5 mt-10 -89.2 105.85 18.05 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' ASP . . . . . 0.533 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 27.0 t70 -179.61 142.06 0.36 Allowed Pre-proline 0 C--N 1.302 -1.464 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.337 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . 0.479 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 47.7 Cg_endo -72.61 -176.72 16.71 Favored 'Cis proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.209 -1.996 . . . . 0.0 110.693 -0.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.495 HG23 ' CG1' ' A' ' 74' ' ' VAL . 26.9 m -82.86 49.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -175.1 30.88 0.09 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 75.4 m -149.46 -99.1 0.07 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -1.118 . . . . 0.0 109.38 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -176.9 139.46 0.46 Allowed Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.099 -1.001 . . . . 0.0 110.037 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' PRO . . . . . 0.509 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.1 Cg_endo -65.12 -176.64 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.123 1.591 . . . . 0.0 111.138 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.59 ' HB2' ' CD2' ' B' ' 254' ' ' PHE . 12.1 ttm-85 -151.88 121.76 7.05 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.544 ' HB3' ' CG2' ' B' ' 235' ' ' THR . 1.0 OUTLIER -103.21 155.71 18.23 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.011 -1.056 . . . . 0.0 110.164 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.89 161.96 21.07 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 3.7 m -70.02 -59.75 2.72 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.22 -1.165 . . . . 0.0 109.259 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -53.66 -23.53 11.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.313 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' B' ' 254' ' ' PHE . . . -87.69 -54.34 4.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.62 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.466 HG12 ' O ' ' B' ' 247' ' ' GLY . 7.1 mm -53.35 -40.93 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 109.543 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 252' ' ' ARG . . . . . 0.526 ' HB2' ' CG2' ' B' ' 227' ' ' VAL . 24.6 ttp85 -79.09 -51.54 9.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.064 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 253' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 21.6 tt0 -52.06 -27.32 13.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.03 -1.044 . . . . 0.0 108.578 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.1 OUTLIER -83.9 -70.11 0.59 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 255' ' ' PHE . . . . . 0.53 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -52.94 -20.43 3.37 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.389 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' B' ' 252' ' ' ARG . . . -79.31 -39.67 32.27 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 257' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 62.4 t30 -62.86 -26.13 68.62 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 30.3 t -74.71 -41.55 59.99 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 259' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' B' ' 223' ' ' LEU . 9.9 tp -61.4 -23.4 65.77 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.499 -0.751 . . . . 0.0 109.378 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 260' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 0.0 OUTLIER -50.62 -29.51 11.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.889 . . . . 0.0 109.345 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 261' ' ' LEU . . . . . 0.568 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.8 OUTLIER -92.64 107.36 23.54 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 108.534 179.385 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 262' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 47.9 Cg_endo -73.52 115.21 4.26 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.899 1.473 . . . . 0.0 111.702 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.568 ' CD2' ' CD2' ' B' ' 261' ' ' LEU . 0.1 OUTLIER -138.96 -166.49 2.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.477 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . 0.408 ' HB2' ' OG ' ' B' ' 285' ' ' SER . . . -114.28 127.25 55.78 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 265' ' ' VAL . . . . . 0.457 HG13 HG21 ' B' ' 215' ' ' VAL . 46.6 t -120.86 118.75 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -0.999 . . . . 0.0 109.919 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.2 OUTLIER -150.14 108.5 3.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.334 -0.854 . . . . 0.0 109.2 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.9 OUTLIER -47.38 174.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.504 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.43 -39.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.663 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 269' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 7.5 pt20 -94.63 -148.82 0.28 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.638 -0.664 . . . . 0.0 109.294 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 270' ' ' GLU . . . . . 0.498 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 32.5 tt0 -113.42 131.52 55.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 109.72 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 271' ' ' VAL . . . . . 0.507 ' CG2' HG12 ' B' ' 211' ' ' VAL . 57.0 t -65.1 153.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.347 -0.845 . . . . 0.0 109.247 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 2.5 mtt180 -116.12 131.59 56.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.212 -0.93 . . . . 0.0 109.964 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.19 133.97 16.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.391 -0.818 . . . . 0.0 109.179 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 274' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -127.3 -163.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.104 -0.997 . . . . 0.0 109.811 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 275' ' ' ALA . . . . . 0.542 ' O ' ' CB ' ' B' ' 276' ' ' ASN . . . -86.38 68.17 10.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.433 -0.792 . . . . 0.0 110.386 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 276' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' B' ' 275' ' ' ALA . 2.9 m-20 160.69 -61.36 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.421 -0.799 . . . . 0.0 109.47 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . 0.466 ' HG2' ' HG2' ' B' ' 302' ' ' ARG . 0.0 OUTLIER -122.39 -161.11 0.92 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.455 -0.778 . . . . 0.0 109.214 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 278' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 301' ' ' PHE . . . -169.78 139.41 1.96 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.478 -0.764 . . . . 0.0 109.12 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 279' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -126.73 139.49 53.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.96 -1.087 . . . . 0.0 109.456 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 23.8 p90 -150.57 172.47 15.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.054 -1.029 . . . . 0.0 109.631 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . 0.533 ' HB1' ' CG1' ' B' ' 298' ' ' ILE . . . -147.18 175.59 10.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 110.183 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 282' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 6.7 p90 -167.76 -167.89 0.92 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.73 141.78 48.71 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.987 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 284' ' ' VAL . . . . . 0.559 ' CG1' HD22 ' B' ' 263' ' ' LEU . 0.5 OUTLIER -114.7 120.93 65.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 285' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' B' ' 285' ' ' SER . 37.8 p -123.86 80.7 1.83 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.11 -0.994 . . . . 0.0 109.97 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.57 ' CZ ' ' OG1' ' B' ' 293' ' ' THR . 44.1 p90 -89.89 -172.5 3.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.202 -0.936 . . . . 0.0 108.643 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.72 150.42 49.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.873 -1.142 . . . . 0.0 110.099 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . 0.584 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.4 OUTLIER -117.21 88.49 2.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 0.0 108.99 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . 0.52 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 0.2 OUTLIER 42.13 -93.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.269 -0.894 . . . . 0.0 110.021 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 290' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' B' ' 288' ' ' PHE . . . -101.55 -13.43 32.66 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 291' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' B' ' 288' ' ' PHE . 7.8 mtt-85 -101.98 159.85 15.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.239 . . . . 0.0 109.774 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 292' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -122.01 129.74 52.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 293' ' ' THR . . . . . 0.584 ' OG1' ' CD2' ' B' ' 288' ' ' PHE . 0.0 OUTLIER -123.18 144.47 49.34 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.258 -0.901 . . . . 0.0 109.921 -179.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 294' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' B' ' 322' ' ' HIS . 12.3 p -126.19 168.25 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.875 . . . . 0.0 108.773 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.556 HG11 ' HD3' ' B' ' 297' ' ' PRO . 30.9 t -137.7 160.17 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.944 -1.098 . . . . 0.0 110.62 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 296' ' ' ALA . . . . . 0.533 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -144.49 64.62 12.16 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 297' ' ' PRO . . . . . 0.556 ' HD3' HG11 ' B' ' 295' ' ' VAL . 46.3 Cg_endo -97.57 179.78 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.707 1.605 . . . . 0.0 111.749 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.533 ' CG1' ' HB1' ' B' ' 281' ' ' ALA . 2.6 mp -141.05 154.46 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . 0.584 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 18.4 t0 -123.01 164.25 18.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.784 -1.198 . . . . 0.0 110.541 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 300' ' ' HIS . . . . . 0.516 ' O ' ' CG ' ' B' ' 312' ' ' MET . 0.1 OUTLIER -116.66 166.32 12.25 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 301' ' ' PHE . . . . . 0.544 ' CD2' HG22 ' B' ' 211' ' ' VAL . 0.1 OUTLIER -145.18 145.85 31.51 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.883 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.466 ' HG2' ' HG2' ' B' ' 277' ' ' GLU . 0.8 OUTLIER -138.53 110.4 7.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.37 -0.831 . . . . 0.0 109.25 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 303' ' ' PHE . . . . . 0.581 ' CZ ' HG12 ' B' ' 210' ' ' VAL . 5.1 m-85 -89.9 -168.44 2.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.564 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 304' ' ' ASN . . . . . 0.512 ' ND2' HG23 ' B' ' 310' ' ' VAL . 0.9 OUTLIER -137.55 -40.72 0.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 305' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -148.1 -65.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 306' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 164.9 56.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -1.146 . . . . 0.0 109.546 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -148.04 -41.04 0.04 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -154.86 -169.31 3.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -1.209 . . . . 0.0 109.542 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 309' ' ' VAL . . . . . 0.501 HG11 ' N ' ' B' ' 310' ' ' VAL . 50.0 t -99.24 151.41 4.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 109.286 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' B' ' 234' ' ' ALA . 45.3 t -121.74 -63.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 13.8 m -116.48 165.62 13.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.154 -0.966 . . . . 0.0 109.518 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 312' ' ' MET . . . . . 0.516 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 28.8 ttp -155.18 156.48 35.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.754 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 313' ' ' ARG . . . . . 0.515 ' NE ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -123.98 179.85 4.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.351 -0.843 . . . . 0.0 108.998 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 314' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' B' ' 237' ' ' GLU . . . -138.42 125.14 20.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.977 -1.077 . . . . 0.0 110.529 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 315' ' ' LEU . . . . . 0.655 ' O ' ' CD1' ' B' ' 316' ' ' PHE . 5.6 tp -104.44 -175.32 2.76 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 316' ' ' PHE . . . . . 0.662 ' CG ' ' N ' ' B' ' 317' ' ' GLY . 0.0 OUTLIER 99.56 -160.73 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.626 0.726 . . . . 0.0 109.889 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 317' ' ' GLY . . . . . 0.662 ' N ' ' CG ' ' B' ' 316' ' ' PHE . . . 160.42 -162.33 33.25 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 318' ' ' GLU . . . . . 0.504 ' HA ' HD11 ' B' ' 321' ' ' ILE . 5.1 tt0 -78.16 6.45 8.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -1.143 . . . . 0.0 109.622 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -115.17 -17.85 11.29 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.192 -0.943 . . . . 0.0 110.078 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 320' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.2 OUTLIER -88.8 -14.9 35.92 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.215 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 321' ' ' ILE . . . . . 0.555 HG21 ' CG2' ' B' ' 295' ' ' VAL . 0.9 OUTLIER -87.84 -164.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 322' ' ' HIS . . . . . 0.482 ' HB2' HG12 ' B' ' 294' ' ' VAL . 0.0 OUTLIER -150.99 154.84 37.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.969 -1.082 . . . . 0.0 109.756 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.468 179.921 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.513 ' CG2' ' O ' ' A' ' 3' ' ' THR . 11.1 t . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.84 -9.69 25.18 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.889 1.468 . . . . 0.0 110.065 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -66.35 -49.45 66.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.229 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -52.7 61.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.192 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 mtm -59.62 -25.58 64.76 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.329 -0.857 . . . . 0.0 109.346 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -72.98 -30.69 64.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 0.0 109.128 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.25 -51.97 66.17 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.639 ' CG2' ' CZ ' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -47.91 -29.13 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.163 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.591 ' CG2' ' CE2' ' A' ' 101' ' ' PHE . 24.9 t -87.95 -45.18 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.5 -0.75 . . . . 0.0 109.363 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 13' ' ' ARG . 3.6 tt0 -58.43 -73.37 0.08 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.447 ' HA ' ' HB2' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -43.02 -44.78 4.89 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.079 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.643 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -50.5 -44.26 55.94 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.489 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.604 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -86.37 -41.46 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 108.99 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . . . -49.41 -35.19 18.41 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.537 ' CA ' ' OD1' ' A' ' 22' ' ' ASP . . . -74.25 -32.82 63.1 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.643 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 1.8 mt -65.1 -57.13 9.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.48 -39.73 24.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.01 -11.57 43.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.583 -0.698 . . . . 0.0 109.464 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.523 ' CA ' HD23 ' A' ' 59' ' ' LEU . . . 62.68 25.92 67.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.537 ' OD1' ' CA ' ' A' ' 17' ' ' ALA . 16.0 p30 -89.41 85.48 6.56 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.131 -1.217 . . . . 0.0 109.649 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.575 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 3.6 mm? -49.76 -21.8 1.21 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.259 -0.901 . . . . 0.0 109.783 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.53 -51.8 68.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -40.8 95.02 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' A' ' 17' ' ' ALA . 7.7 mt -59.86 -54.67 31.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 48.5 t -64.33 -41.18 91.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.17 -49.82 70.9 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 tp -67.14 -14.22 62.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.595 ' CZ ' ' CE ' ' A' ' 112' ' ' MET . 3.0 m-85 -89.48 136.01 33.27 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -54.42 -167.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 109.552 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -76.89 -23.51 52.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.251 -0.906 . . . . 0.0 109.7 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.535 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -143.66 45.51 1.49 Allowed 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -59.04 157.63 9.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.966 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.534 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -117.81 139.27 51.32 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.485 -0.759 . . . . 0.0 109.284 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 42.7 t -129.24 141.1 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.418 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 11.5 mt-10 -111.24 112.79 24.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' GLU . 19.7 t70 -179.27 141.38 0.36 Allowed Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.568 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.489 ' O ' HG21 ' A' ' 40' ' ' VAL . 46.2 Cg_endo -72.56 131.69 23.34 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.286 -1.964 . . . . 0.0 110.6 -0.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.552 HG11 ' CE1' ' A' ' 116' ' ' PHE . 14.0 m 40.73 -147.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.464 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 42' ' ' SER . . . -67.28 1.21 6.95 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.04 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.471 ' OG ' ' HG2' ' A' ' 39' ' ' PRO . 68.8 m -48.06 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.902 -1.352 . . . . 0.0 110.163 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -133.29 107.64 12.28 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.003 . . . . 0.0 110.608 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 42.5 Cg_endo -68.47 -167.74 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 124.016 1.535 . . . . 0.0 110.428 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.585 ' HG3' ' CG ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -151.43 112.31 4.26 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.534 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.2 OUTLIER -103.57 140.2 37.85 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 110.257 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 107.8 160.81 20.93 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 3.0 m -76.07 -42.38 47.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.269 -1.136 . . . . 0.0 109.086 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.63 -38.11 83.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.29 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.48 -43.59 59.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.314 -0.866 . . . . 0.0 109.368 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.532 HD12 ' CG2' ' A' ' 36' ' ' VAL . 5.4 mm -58.49 -46.45 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.31 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 36.7 ttt-85 -66.31 -55.46 15.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 108.945 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 52' ' ' ARG . 2.3 mt-10 -45.09 -28.56 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 108.568 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.585 ' CG ' ' HG3' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -85.09 -70.08 0.61 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.535 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -51.73 -20.95 2.37 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' CB ' ' HG ' ' A' ' 23' ' ' LEU . . . -82.21 -46.0 14.32 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 24.5 t-20 -60.96 -50.04 75.01 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.4 t -51.79 -26.27 9.34 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.575 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 5.4 tp -76.95 -28.24 55.13 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.591 -0.693 . . . . 0.0 109.739 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -44.35 -31.44 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 108.633 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.599 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.19 100.27 11.35 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 45.9 Cg_endo -71.71 129.54 15.7 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.991 1.521 . . . . 0.0 111.899 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.599 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -139.98 178.04 7.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.509 ' CB ' ' OG ' ' A' ' 85' ' ' SER . . . -92.23 127.8 37.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.264 -0.898 . . . . 0.0 108.58 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.52 112.18 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 110.056 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -150.86 105.3 3.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.812 . . . . 0.0 109.193 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mp -55.5 173.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.96 . . . . 0.0 109.861 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -134.72 -81.13 0.44 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.339 -0.851 . . . . 0.0 109.327 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 68' ' ' THR . 5.5 pt20 -60.22 -143.28 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.647 -0.658 . . . . 0.0 109.435 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -114.29 134.8 54.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.963 -1.086 . . . . 0.0 110.001 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.535 HG11 ' N ' ' A' ' 72' ' ' ARG . 10.6 t -63.09 148.71 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.423 -0.798 . . . . 0.0 109.036 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.535 ' N ' HG11 ' A' ' 71' ' ' VAL . 3.4 mmm180 -98.97 130.57 45.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.931 . . . . 0.0 109.287 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.427 ' C ' ' CG2' ' A' ' 74' ' ' VAL . . . -145.92 135.96 23.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 109.342 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -163.9 155.48 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.67 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.471 ' HB1' ' HA2' ' B' ' 241' ' ' GLY . . . 49.76 -152.03 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.473 -0.767 . . . . 0.0 109.855 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 103' ' ' PHE . 98.3 m-20 -87.36 16.98 4.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.454 -0.779 . . . . 0.0 109.331 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.461 ' HG3' ' HA ' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -123.6 -159.26 0.84 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.342 -0.849 . . . . 0.0 109.076 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 101' ' ' PHE . . . 178.04 160.3 0.53 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.439 -0.788 . . . . 0.0 109.542 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 72' ' ' ARG . . . -150.27 133.54 16.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.015 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 33.5 p90 -148.96 163.67 36.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.836 -1.165 . . . . 0.0 110.241 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.519 ' CB ' HG21 ' A' ' 98' ' ' ILE . . . -140.78 150.13 42.97 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -149.56 -172.51 4.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.175 -0.953 . . . . 0.0 109.401 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.29 141.74 51.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.406 -0.808 . . . . 0.0 109.611 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 63' ' ' LEU . 19.9 t -112.01 111.71 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.394 -0.816 . . . . 0.0 109.156 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.509 ' OG ' ' CB ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -106.12 113.1 26.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.824 . . . . 0.0 109.57 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 86' ' ' PHE . 0.8 OUTLIER -128.02 148.13 50.53 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.195 -0.941 . . . . 0.0 109.536 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -91.7 178.64 5.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.541 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.576 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.5 OUTLIER -142.19 -163.49 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.34 -0.85 . . . . 0.0 109.382 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.69 60.95 2.87 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.026 -1.047 . . . . 0.0 109.491 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.84 3.41 26.69 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -136.81 164.36 28.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.137 -1.213 . . . . 0.0 109.667 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' CD ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -126.52 122.27 34.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.844 . . . . 0.0 109.233 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.576 ' OG1' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -117.23 154.6 30.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.722 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.531 ' CG1' ' CB ' ' A' ' 122' ' ' HIS . 7.3 p -138.46 170.75 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 108.861 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.576 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 3.5 t -144.91 147.05 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.034 -1.041 . . . . 0.0 109.268 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.518 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -132.55 69.65 79.67 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.121 -0.987 . . . . 0.0 111.026 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.576 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 49.3 Cg_endo -96.35 -173.08 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.503 1.469 . . . . 0.0 110.424 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.519 HG21 ' CB ' ' A' ' 81' ' ' ALA . 2.9 mp -134.46 157.36 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 15.8 t0 -127.05 153.25 46.2 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.156 -0.965 . . . . 0.0 110.11 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.518 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -108.88 171.27 7.53 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.591 ' CE2' ' CG2' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -142.37 148.38 37.79 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.101 -0.999 . . . . 0.0 110.486 -178.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.514 ' CD ' ' HB2' ' A' ' 111' ' ' SER . 0.0 OUTLIER -133.85 107.43 7.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.561 -0.712 . . . . 0.0 109.085 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.639 ' CZ ' ' CG2' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -89.72 -176.37 4.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 109.56 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.525 ' OD1' ' CG2' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -138.9 -100.08 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.433 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.67 -38.93 0.04 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -171.48 32.8 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.45 -1.029 . . . . 0.0 108.74 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 108' ' ' LYS . . . -123.72 15.56 7.96 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 22.2 mmmt 81.79 -150.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.653 -0.91 . . . . 0.0 109.624 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.483 HG22 HG21 ' A' ' 10' ' ' VAL . 18.2 t -88.2 122.66 40.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.525 ' CG2' ' OD1' ' A' ' 104' ' ' ASN . 49.1 t -105.24 -8.58 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.079 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.514 ' HB2' ' CD ' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -160.37 153.22 21.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.957 -1.089 . . . . 0.0 110.137 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.595 ' CE ' ' CZ ' ' A' ' 30' ' ' PHE . 19.0 ttm -160.05 141.82 12.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.494 -0.754 . . . . 0.0 109.211 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.465 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 1.0 OUTLIER -123.56 174.21 7.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.116 -0.99 . . . . 0.0 109.269 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 99' ' ' ASP . . . -147.47 134.91 20.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.945 . . . . 0.0 109.263 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.519 ' CD1' ' HB1' ' B' ' 279' ' ' ALA . 0.1 OUTLIER -125.01 141.17 52.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 110.063 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.552 ' CE1' HG11 ' A' ' 40' ' ' VAL . 50.0 p90 172.86 -160.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . 172.31 -171.03 44.0 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.531 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 3.1 tt0 -69.87 -5.01 22.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.444 -1.033 . . . . 0.0 109.7 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.452 ' HE3' ' OE2' ' B' ' 270' ' ' GLU . 0.3 OUTLIER -90.47 -31.74 16.66 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.958 0.885 . . . . 0.0 109.142 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.437 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.8 m-20 -89.36 8.6 29.83 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.19 0.519 . . . . 0.0 109.665 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.531 ' CG1' ' HA ' ' A' ' 118' ' ' GLU . 4.9 mm -90.28 -172.53 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 108.897 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.531 ' CB ' ' CG1' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -151.7 156.76 41.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.914 . . . . 0.0 109.506 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.7 135.24 13.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.506 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.59 138.66 9.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.202 -1.175 . . . . 0.0 109.535 -179.861 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.242 0.544 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -116.06 92.6 3.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.441 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.92 119.42 69.38 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.827 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.32 -4.69 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.858 1.452 . . . . 0.0 109.586 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.04 -40.84 68.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.373 -0.83 . . . . 0.0 109.237 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -65.83 -55.7 15.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.128 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 15.4 mtm -55.98 -24.62 39.68 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.289 -0.882 . . . . 0.0 109.13 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.408 ' O ' ' N ' ' B' ' 211' ' ' VAL . 5.4 m -73.91 -34.06 64.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.346 -0.846 . . . . 0.0 109.136 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.1 -46.44 65.25 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.183 -0.948 . . . . 0.0 108.482 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.618 ' CG2' ' CZ ' ' B' ' 303' ' ' PHE . 1.0 OUTLIER -54.97 -24.84 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.493 ' CG1' HG12 ' B' ' 271' ' ' VAL . 16.8 t -90.21 -43.94 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.421 -0.799 . . . . 0.0 109.045 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' B' ' 213' ' ' ARG . 7.6 tt0 -60.45 -73.61 0.09 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.528 ' HD3' ' CD1' ' B' ' 229' ' ' LEU . 0.0 OUTLIER -43.22 -45.23 5.62 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.236 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' TYR . . . . . 0.641 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -50.09 -44.84 52.19 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.606 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 0.9 OUTLIER -86.94 -39.32 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.317 -0.865 . . . . 0.0 109.172 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' B' ' 213' ' ' ARG . . . -48.35 -36.51 14.62 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -73.97 -33.87 64.02 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.641 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 2.7 mt -64.05 -59.07 4.91 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -51.19 -45.5 61.84 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.509 0.671 . . . . 0.0 109.194 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.54 8.6 30.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.579 -0.701 . . . . 0.0 109.681 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' B' ' 217' ' ' ALA . . . 49.48 33.72 17.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.5 t70 -90.58 67.73 6.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -1.131 . . . . 0.0 109.685 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' LEU . . . . . 0.562 ' CD2' ' CG ' ' B' ' 252' ' ' ARG . 7.3 tp -50.38 -45.2 55.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.076 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' B' ' 223' ' ' LEU . 5.3 m-20 -43.44 -32.64 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -83.86 -33.51 21.14 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.481 ' N ' ' O ' ' B' ' 223' ' ' LEU . 17.2 mt -61.9 -56.02 20.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 97.0 t -59.71 -37.33 70.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.93 -51.82 68.06 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.528 ' CD1' ' HD3' ' B' ' 213' ' ' ARG . 2.9 tp -68.06 -14.89 63.32 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.536 -0.727 . . . . 0.0 109.057 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . 0.484 ' CD2' ' CG2' ' B' ' 251' ' ' ILE . 2.4 m-85 -94.78 149.18 21.51 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.457 -0.777 . . . . 0.0 109.527 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -59.24 168.23 1.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.429 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.458 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -55.72 -24.4 34.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.372 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . 0.531 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 8.8 p-10 -150.56 51.36 0.88 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' B' ' 310' ' ' VAL . . . -60.58 158.94 11.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.608 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' THR . . . . . 0.519 ' CG2' ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -100.27 141.34 33.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.447 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.545 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 85.4 t -134.41 136.39 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.258 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' GLU . . . . . 0.464 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 1.5 mt-10 -112.39 113.28 25.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 108.559 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' ASP . . . . . 0.524 ' O ' ' CE2' ' B' ' 254' ' ' PHE . 9.6 t70 -179.55 141.74 0.36 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 109.664 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' B' ' 241' ' ' GLY . 49.1 Cg_endo -75.14 -176.65 18.56 Favored 'Cis proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.25 -1.979 . . . . 0.0 110.485 -0.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 6.2 m -65.18 75.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.284 -0.885 . . . . 0.0 108.982 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' B' ' 239' ' ' PRO . . . -162.78 24.37 0.2 Allowed Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' B' ' 241' ' ' GLY . 0.5 OUTLIER 67.24 48.92 1.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -1.14 . . . . 0.0 109.741 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . 0.511 ' N ' ' HD3' ' B' ' 244' ' ' PRO . 2.1 mt-10 -131.89 58.57 38.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.144 -0.972 . . . . 0.0 109.466 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' PRO . . . . . 0.545 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 48.5 Cg_endo -77.83 169.69 20.24 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 124.276 1.671 . . . . 0.0 110.942 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.457 ' HD2' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -151.32 100.79 2.78 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.519 ' HB3' ' CG2' ' B' ' 235' ' ' THR . 0.2 OUTLIER -92.02 161.77 14.65 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.121 -0.987 . . . . 0.0 110.152 -178.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 100.66 158.26 27.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 5.3 m -69.98 -48.7 57.17 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.195 -1.179 . . . . 0.0 108.971 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -61.81 -25.27 67.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.904 . . . . 0.0 109.274 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' B' ' 246' ' ' SER . . . -90.13 -58.78 2.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.394 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.525 ' CD1' ' O ' ' B' ' 247' ' ' GLY . 17.4 mt -47.45 -41.22 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.284 -0.885 . . . . 0.0 109.012 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 252' ' ' ARG . . . . . 0.562 ' CG ' ' CD2' ' B' ' 223' ' ' LEU . 28.6 ttt180 -76.75 -57.99 3.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.456 -0.778 . . . . 0.0 108.978 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 253' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 62.5 mt-10 -45.27 -28.32 0.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.025 -1.047 . . . . 0.0 108.589 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' B' ' 238' ' ' ASP . 0.8 OUTLIER -85.39 -71.02 0.55 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 255' ' ' PHE . . . . . 0.551 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -49.12 -23.59 1.31 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . 0.521 ' CB ' HD21 ' B' ' 223' ' ' LEU . . . -76.38 -49.67 16.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 257' ' ' ASN . . . . . 0.51 ' ND2' ' HE2' ' B' ' 260' ' ' LYS . 0.3 OUTLIER -55.33 -29.43 58.29 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 42.9 t -75.44 -31.8 60.46 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 259' ' ' LEU . . . . . 0.407 HD23 ' O ' ' B' ' 221' ' ' GLY . 7.3 tp -71.77 -25.78 62.17 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.44 -0.787 . . . . 0.0 109.302 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 260' ' ' LYS . . . . . 0.51 ' HE2' ' ND2' ' B' ' 257' ' ' ASN . 12.0 mtmt -54.12 -23.83 15.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.296 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 261' ' ' LEU . . . . . 0.548 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.8 OUTLIER -89.92 120.34 69.35 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 0.0 108.698 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 262' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' B' ' 286' ' ' PHE . 42.9 Cg_endo -69.94 104.05 1.29 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.752 1.396 . . . . 0.0 110.584 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.548 ' CD2' ' CD2' ' B' ' 261' ' ' LEU . 0.0 OUTLIER -138.91 149.79 45.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.742 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . 0.443 ' HB2' ' OG ' ' B' ' 285' ' ' SER . . . -91.62 129.55 37.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -0.824 . . . . 0.0 108.925 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 265' ' ' VAL . . . . . 0.416 HG21 ' HB3' ' B' ' 218' ' ' LEU . 3.0 t -110.18 116.09 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.87 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.1 OUTLIER -150.33 91.47 1.76 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 0.0 109.24 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -45.21 170.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.724 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.1 -39.56 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.299 -0.876 . . . . 0.0 109.675 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 269' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -87.75 -154.2 0.25 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 270' ' ' GLU . . . . . 0.452 ' OE2' ' HE3' ' A' ' 119' ' ' LYS . 51.7 tt0 -107.39 131.24 54.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.138 -0.976 . . . . 0.0 109.53 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 271' ' ' VAL . . . . . 0.498 HG11 ' N ' ' B' ' 272' ' ' ARG . 26.7 t -67.35 150.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.292 -0.88 . . . . 0.0 108.762 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 5.5 mtt180 -104.01 136.94 42.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 109.963 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . 0.459 ' HA ' ' HB1' ' B' ' 278' ' ' ALA . . . -150.18 126.14 10.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.412 -0.805 . . . . 0.0 109.275 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 274' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -155.33 160.74 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.215 -0.928 . . . . 0.0 109.4 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 275' ' ' ALA . . . . . 0.512 ' HB2' ' CG2' ' A' ' 40' ' ' VAL . . . 43.87 -145.56 0.1 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 276' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' B' ' 303' ' ' PHE . 1.5 t-20 -90.59 13.26 16.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 0.0 109.708 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' B' ' 301' ' ' PHE . 0.9 OUTLIER -122.16 -161.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.078 -1.014 . . . . 0.0 109.733 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 278' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' B' ' 301' ' ' PHE . . . 177.74 148.79 0.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 279' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -134.69 139.69 45.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.007 -1.058 . . . . 0.0 108.868 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 33.3 p90 -150.47 165.18 33.99 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.694 -1.254 . . . . 0.0 110.651 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . 0.529 ' HB1' ' CG1' ' B' ' 298' ' ' ILE . . . -143.45 176.86 8.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 282' ' ' PHE . . . . . 0.407 ' HE1' ' CE2' ' B' ' 280' ' ' PHE . 14.4 p90 -178.14 -170.21 0.23 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.284 -0.885 . . . . 0.0 109.6 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.58 142.33 50.74 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.518 -0.739 . . . . 0.0 109.551 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 284' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' B' ' 263' ' ' LEU . 45.2 t -113.89 113.6 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.453 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 285' ' ' SER . . . . . 0.532 ' HA ' ' CG2' ' B' ' 294' ' ' VAL . 91.9 p -105.75 110.6 22.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.168 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' B' ' 286' ' ' PHE . 4.3 p90 -127.43 157.86 38.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.164 -0.96 . . . . 0.0 109.787 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 287' ' ' GLU . . . . . 0.459 ' HG3' ' HB2' ' B' ' 292' ' ' LYS . 11.6 tm-20 -144.71 167.61 22.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.307 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . 0.419 ' N ' ' CD ' ' B' ' 287' ' ' GLU . 0.1 OUTLIER -122.02 -75.98 0.59 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.052 -1.03 . . . . 0.0 109.894 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' B' ' 289' ' ' GLN . 0.0 OUTLIER -158.99 60.1 0.42 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.503 -0.748 . . . . 0.0 109.778 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 129.88 -45.76 1.12 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -103.26 129.67 50.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.374 -1.074 . . . . 0.0 109.189 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 292' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' B' ' 286' ' ' PHE . 0.2 OUTLIER -118.54 145.7 45.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 109.701 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 293' ' ' THR . . . . . 0.466 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -136.16 145.39 45.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.666 -0.646 . . . . 0.0 109.649 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 294' ' ' VAL . . . . . 0.532 ' CG2' ' HA ' ' B' ' 285' ' ' SER . 0.5 OUTLIER -117.32 176.35 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 108.581 179.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.569 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 2.5 t -149.58 145.25 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.227 -0.921 . . . . 0.0 109.069 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 296' ' ' ALA . . . . . 0.511 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -131.02 71.3 82.45 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.079 -1.013 . . . . 0.0 110.923 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 297' ' ' PRO . . . . . 0.569 ' HD3' ' CG1' ' B' ' 295' ' ' VAL . 52.3 Cg_endo -96.88 -173.08 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.717 1.611 . . . . 0.0 110.677 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.529 ' CG1' ' HB1' ' B' ' 281' ' ' ALA . 2.5 mp -139.49 151.97 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . 0.582 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 17.5 t0 -124.13 160.2 28.33 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.999 -1.063 . . . . 0.0 110.311 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 300' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' B' ' 312' ' ' MET . 63.0 t60 -110.88 173.79 6.17 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 301' ' ' PHE . . . . . 0.53 ' CE1' HG11 ' B' ' 210' ' ' VAL . 0.1 OUTLIER -149.55 138.96 21.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 110.491 -178.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.531 ' CB ' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -123.46 110.36 15.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.423 -0.798 . . . . 0.0 109.097 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 303' ' ' PHE . . . . . 0.618 ' CZ ' ' CG2' ' B' ' 210' ' ' VAL . 0.4 OUTLIER -89.78 -176.21 4.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 0.0 109.687 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 304' ' ' ASN . . . . . 0.53 ' OD1' ' CG2' ' B' ' 310' ' ' VAL . 0.1 OUTLIER -142.05 -100.06 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.583 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 305' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -98.8 -55.58 1.06 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 306' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 163.13 76.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -1.099 . . . . 0.0 109.39 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -167.53 -51.73 0.03 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 308' ' ' LYS . . . . . 0.513 ' N ' ' HD2' ' B' ' 308' ' ' LYS . 0.0 OUTLIER -150.11 -167.43 2.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -1.213 . . . . 0.0 109.659 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 309' ' ' VAL . . . . . 0.463 HG22 HG21 ' B' ' 210' ' ' VAL . 62.0 t -102.66 148.28 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.332 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . 0.53 ' CG2' ' OD1' ' B' ' 304' ' ' ASN . 24.1 t -110.97 -31.91 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.089 -1.007 . . . . 0.0 110.192 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 311' ' ' SER . . . . . 0.531 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 1.3 m -144.94 165.02 29.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.789 -1.194 . . . . 0.0 110.009 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 312' ' ' MET . . . . . 0.523 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 11.0 ttp -156.2 161.5 40.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.695 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 313' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' B' ' 300' ' ' HIS . 9.0 tpt180 -150.39 117.18 5.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.226 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 314' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' B' ' 299' ' ' ASP . . . -94.59 144.93 25.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.152 -0.968 . . . . 0.0 110.033 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 315' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' B' ' 316' ' ' PHE . 0.5 OUTLIER -132.31 139.72 48.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 109.564 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 316' ' ' PHE . . . . . 0.528 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 47.9 p90 170.68 -158.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 317' ' ' GLY . . . . . 0.467 ' N ' ' CD2' ' B' ' 316' ' ' PHE . . . 178.83 -175.7 47.51 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 318' ' ' GLU . . . . . 0.538 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 25.7 tt0 -73.36 -1.91 20.07 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.295 -1.121 . . . . 0.0 109.442 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -92.71 -29.62 15.97 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.24 -0.912 . . . . 0.0 108.983 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 320' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -88.89 16.01 7.57 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 321' ' ' ILE . . . . . 0.538 ' CG1' ' HA ' ' B' ' 318' ' ' GLU . 5.1 mm -89.72 -165.07 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 322' ' ' HIS . . . . . 0.524 ' CB ' HG11 ' B' ' 294' ' ' VAL . 0.2 OUTLIER -151.9 161.27 42.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.94 -1.1 . . . . 0.0 109.67 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 109.361 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.456 ' O ' ' SD ' ' A' ' 7' ' ' MET . 1.8 t . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 44.5 Cg_endo -71.2 -3.82 13.68 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.891 1.469 . . . . 0.0 110.379 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -72.8 -25.58 61.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.912 . . . . 0.0 109.224 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.47 -59.31 2.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -51.47 -21.39 2.37 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.118 -0.989 . . . . 0.0 109.722 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.481 ' O ' ' N ' ' A' ' 11' ' ' VAL . 14.3 m -74.66 -39.81 61.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.222 -0.924 . . . . 0.0 109.099 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.89 -42.76 48.68 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.643 ' CG1' ' CZ ' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -53.82 -23.95 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.132 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.557 HG22 ' CE2' ' A' ' 101' ' ' PHE . 10.1 t -89.94 -43.06 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.349 -0.844 . . . . 0.0 109.066 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 13' ' ' ARG . 24.6 tt0 -61.82 -73.52 0.1 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.281 1.039 . . . . 0.0 108.284 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 12' ' ' GLN . 0.6 OUTLIER -42.45 -44.29 3.97 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.665 ' CE1' ' CE2' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -51.27 -48.45 62.2 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.621 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -82.24 -44.24 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.382 -0.824 . . . . 0.0 109.375 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -47.57 -37.99 13.45 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.84 -36.04 67.38 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.631 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 2.9 mt -61.0 -59.82 4.77 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -53.49 -42.67 67.54 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.48 0.657 . . . . 0.0 109.762 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.19 5.54 44.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.82 . . . . 0.0 110.006 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.529 ' HA2' ' CD2' ' A' ' 59' ' ' LEU . . . 54.76 46.11 76.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HB3' ' HA ' ' A' ' 17' ' ' ALA . 15.6 t0 -104.74 58.35 0.7 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -1.068 . . . . 0.0 109.945 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.568 ' CD2' ' CG ' ' A' ' 52' ' ' ARG . 6.0 tp -52.86 -45.84 67.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.131 -0.981 . . . . 0.0 108.921 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -46.74 -42.99 17.68 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.17 -29.57 60.22 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 29' ' ' LEU . 32.5 mt -63.66 -59.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.463 ' HA ' ' HB2' ' A' ' 30' ' ' PHE . 92.9 t -49.45 -35.7 9.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.83 90.73 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.522 ' CD2' ' HA ' ' A' ' 10' ' ' VAL . 1.9 tp -75.39 -20.15 59.12 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.463 ' HB2' ' HA ' ' A' ' 27' ' ' VAL . 4.9 m-85 -95.99 141.86 28.89 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.532 -0.73 . . . . 0.0 109.642 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -49.0 177.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.927 . . . . 0.0 109.457 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -69.63 -24.12 63.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.24 -0.912 . . . . 0.0 109.826 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.529 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 4.9 p-10 -144.83 52.33 1.23 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.576 ' CB ' ' CD1' ' A' ' 51' ' ' ILE . . . -59.38 165.02 2.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.443 -0.786 . . . . 0.0 110.194 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.526 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -115.75 140.94 48.73 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 25.0 t -128.51 170.29 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 109.654 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 5.0 mt-10 -141.27 113.3 7.89 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.571 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 6.0 t70 -168.37 139.95 2.26 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.759 -1.213 . . . . 0.0 109.957 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.509 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 43.8 Cg_endo -74.95 -78.27 0.0 OUTLIER 'Cis proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.441 -1.9 . . . . 0.0 111.608 0.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.3 m -153.3 66.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.876 -1.14 . . . . 0.0 109.331 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . -173.05 46.99 0.16 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER 72.97 51.14 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -1.132 . . . . 0.0 110.077 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.537 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 2.3 mt-10 -132.92 58.66 37.2 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.056 -1.027 . . . . 0.0 109.742 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 43' ' ' GLU . 50.7 Cg_endo -79.99 -179.29 5.16 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.066 1.561 . . . . 0.0 111.284 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.577 ' HG3' ' CD1' ' A' ' 54' ' ' PHE . 23.2 mmt180 -150.88 96.16 2.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.526 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.1 OUTLIER -92.81 158.35 15.93 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.19 -0.944 . . . . 0.0 110.285 -178.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 33' ' ' ASP . . . 88.95 -169.93 37.26 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 1.9 m -103.13 -51.85 3.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.076 -1.249 . . . . 0.0 108.842 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -52.05 -23.49 5.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.312 -0.867 . . . . 0.0 109.15 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.32 -55.28 3.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.388 -0.82 . . . . 0.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.576 ' CD1' ' CB ' ' A' ' 34' ' ' ALA . 59.7 mt -54.08 -43.41 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 109.132 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.568 ' CG ' ' CD2' ' A' ' 23' ' ' LEU . 16.2 ttt180 -70.28 -47.91 59.12 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.193 -0.942 . . . . 0.0 108.784 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 5.4 mt-10 -51.12 -34.19 29.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.038 . . . . 0.0 108.44 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.577 ' CD1' ' HG3' ' A' ' 45' ' ' ARG . 1.4 t80 -82.93 -70.5 0.55 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.665 ' CE2' ' CE1' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -44.63 -26.76 0.41 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -75.03 -53.22 9.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 108.993 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 56' ' ' ALA . 14.1 t-20 -45.66 -34.6 3.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 108.609 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 t -71.87 -33.56 68.49 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.529 ' CD2' ' HA2' ' A' ' 21' ' ' GLY . 5.3 tp -77.21 -33.87 56.16 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.326 -0.859 . . . . 0.0 109.329 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -61.94 -26.97 68.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 109.443 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.538 ' CD2' ' HG ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -89.43 131.87 38.97 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 0.0 108.681 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 86' ' ' PHE . 41.6 Cg_endo -68.04 80.64 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.755 1.398 . . . . 0.0 110.501 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.58 ' CD2' ' CG1' ' A' ' 84' ' ' VAL . 3.2 mt -111.22 146.55 36.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.435 -0.79 . . . . 0.0 109.605 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.458 ' HB2' ' OG ' ' A' ' 85' ' ' SER . . . -91.91 126.75 37.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 108.647 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.411 HG13 HG21 ' A' ' 15' ' ' VAL . 2.7 t -113.45 118.13 57.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.673 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 67' ' ' LEU . 27.1 tt0 -150.16 104.54 3.28 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.337 -0.852 . . . . 0.0 109.169 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.5 mp -45.59 171.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.222 -0.924 . . . . 0.0 109.847 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -144.38 -82.27 0.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.403 -0.811 . . . . 0.0 109.01 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 2.9 pt20 -60.08 -146.06 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 61.5 tt0 -114.84 130.37 56.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.066 -1.021 . . . . 0.0 109.761 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.523 ' CG1' HG23 ' A' ' 11' ' ' VAL . 88.7 t -60.0 145.03 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.292 -0.88 . . . . 0.0 109.14 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.531 ' CD ' HD23 ' B' ' 315' ' ' LEU . 17.7 mtt180 -111.72 130.04 55.92 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.396 -0.921 . . . . 0.0 109.931 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.493 ' C ' ' CG2' ' A' ' 74' ' ' VAL . . . -139.74 157.7 45.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.538 ' CG1' HG23 ' B' ' 240' ' ' VAL . 0.5 OUTLIER -157.22 -153.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 110.312 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.533 ' CB ' ' HA3' ' B' ' 241' ' ' GLY . . . -33.91 -96.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 120.926 0.393 . . . . 0.0 111.161 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 103' ' ' PHE . 65.4 m-20 -114.37 26.96 9.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.948 -1.095 . . . . 0.0 110.496 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -137.55 -160.98 1.11 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.026 -1.046 . . . . 0.0 109.388 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 101' ' ' PHE . . . 171.28 143.48 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.476 -0.765 . . . . 0.0 109.861 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.594 ' CB ' ' CD1' ' B' ' 315' ' ' LEU . . . -132.62 130.46 40.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 108.786 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.697 ' CE1' ' CD2' ' A' ' 101' ' ' PHE . 2.1 p90 -150.6 156.06 40.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.759 -1.213 . . . . 0.0 109.989 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.54 ' CB ' HG21 ' A' ' 98' ' ' ILE . . . -133.32 156.49 47.51 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.611 0.719 . . . . 0.0 110.33 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -149.46 -171.06 3.8 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.87 140.09 52.83 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.076 -1.015 . . . . 0.0 109.972 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.58 ' CG1' ' CD2' ' A' ' 63' ' ' LEU . 38.3 t -116.76 115.2 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 78.2 p -126.67 99.73 5.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.086 -1.009 . . . . 0.0 110.334 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.572 ' CZ ' ' HB ' ' A' ' 93' ' ' THR . 52.8 p90 -93.36 -164.22 1.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.204 -0.935 . . . . 0.0 108.629 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -144.19 152.06 40.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.022 -1.049 . . . . 0.0 110.086 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.409 ' CZ ' ' HE2' ' A' ' 86' ' ' PHE . 4.2 m-85 -107.21 -173.35 2.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.403 -0.811 . . . . 0.0 109.39 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -49.19 -54.6 15.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.358 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -138.04 4.61 3.23 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -105.86 -177.4 3.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 109.515 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.438 ' O ' ' CD ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -145.49 118.98 9.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.297 -0.877 . . . . 0.0 109.752 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.572 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -120.26 143.35 48.36 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.389 -0.82 . . . . 0.0 109.417 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.527 ' CG1' ' CB ' ' A' ' 122' ' ' HIS . 13.3 p -126.23 169.52 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.22 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.547 HG11 ' N ' ' A' ' 96' ' ' ALA . 53.1 t -140.63 152.11 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.765 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.547 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -129.56 71.63 82.06 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 109.222 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.522 ' HD3' HG11 ' A' ' 95' ' ' VAL . 48.7 Cg_endo -97.34 -178.6 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.726 1.617 . . . . 0.0 111.578 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.54 HG21 ' CB ' ' A' ' 81' ' ' ALA . 3.1 mp -138.6 169.4 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 23.4 t0 -135.76 154.79 51.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.907 -1.121 . . . . 0.0 110.041 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.523 ' CB ' ' HB3' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -114.08 175.23 5.56 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.697 ' CD2' ' CE1' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -150.42 152.4 34.26 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.999 -1.063 . . . . 0.0 110.823 -178.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.465 ' HD2' ' HB2' ' A' ' 111' ' ' SER . 0.0 OUTLIER -142.25 108.31 5.2 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.555 ' CZ ' ' CG2' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -89.24 -177.53 5.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 109.598 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.518 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -149.75 -176.09 5.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.339 -0.851 . . . . 0.0 109.698 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.88 76.78 1.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -172.34 -75.15 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.22 -1.164 . . . . 0.0 109.58 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 157.66 -20.6 0.38 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.49 -164.31 1.03 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -1.174 . . . . 0.0 109.587 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.554 ' CG2' ' CG2' ' A' ' 10' ' ' VAL . 60.9 t -109.43 148.97 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.897 . . . . 0.0 109.176 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.543 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 96.9 t -125.93 -61.75 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.055 -1.028 . . . . 0.0 109.678 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 102' ' ' ARG . 1.5 m -112.29 161.6 16.44 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.876 -1.14 . . . . 0.0 109.738 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 100' ' ' HIS . 15.2 ttp -158.97 155.89 28.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 109.448 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.523 ' HB3' ' CB ' ' A' ' 100' ' ' HIS . 30.8 ttm180 -140.34 168.2 20.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.87 . . . . 0.0 108.946 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.505 ' N ' ' CG ' ' A' ' 113' ' ' ARG . . . -144.58 130.86 19.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.976 -1.077 . . . . 0.0 109.682 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.561 ' O ' ' HB3' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -111.84 132.48 54.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 109.723 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' A' ' 115' ' ' LEU . 9.0 p90 167.7 -158.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.44 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . 164.35 -163.93 36.4 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.495 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 4.3 tt0 -73.88 -2.35 23.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -1.185 . . . . 0.0 109.261 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -92.57 -29.44 16.16 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.954 0.883 . . . . 0.0 109.057 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 96' ' ' ALA . 1.5 m-20 -89.04 10.73 20.57 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.332 0.587 . . . . 0.0 109.476 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.536 HG21 ' CG2' ' A' ' 95' ' ' VAL . 4.3 mm -94.23 -167.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.331 -0.856 . . . . 0.0 108.738 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.527 ' CB ' ' CG1' ' A' ' 94' ' ' VAL . 1.6 t60 -151.21 153.8 35.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.098 -1.001 . . . . 0.0 109.609 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.459 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.01 89.13 1.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -91.81 139.67 14.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.262 -1.14 . . . . 0.0 109.449 -179.973 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.5 ptt? . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.182 0.515 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.456 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 1.4 t-20 175.48 171.24 0.32 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.668 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 2.5 m -59.34 110.03 2.39 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.331 -0.856 . . . . 0.0 109.53 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.8 Cg_endo -73.63 -7.15 19.82 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.994 1.523 . . . . 0.0 110.074 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.57 -45.21 72.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.329 -0.857 . . . . 0.0 109.191 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' B' ' 209' ' ' ALA . 0.2 OUTLIER -62.56 -52.42 63.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.214 -0.929 . . . . 0.0 109.107 179.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' MET . . . . . 0.594 ' HA ' ' CZ ' ' B' ' 303' ' ' PHE . 74.9 mtm -62.06 -42.35 99.1 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.334 -0.854 . . . . 0.0 109.498 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 9.6 m -56.1 -37.15 68.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.171 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' B' ' 206' ' ' HIS . . . -52.42 -46.23 66.28 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.646 ' CG1' ' CE1' ' B' ' 301' ' ' PHE . 2.5 t -53.24 -30.38 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.577 HG22 ' CD1' ' B' ' 280' ' ' PHE . 21.0 t -84.47 -43.52 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.225 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.4 tt0 -61.71 -73.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.088 0.947 . . . . 0.0 108.624 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.516 ' HD2' ' CD1' ' B' ' 229' ' ' LEU . 0.0 OUTLIER -41.4 -45.18 3.04 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' TYR . . . . . 0.569 ' CD1' HD13 ' B' ' 218' ' ' LEU . 1.6 t80 -45.41 -45.45 12.77 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.624 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.1 t -90.51 -40.35 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' B' ' 220' ' ' ALA . . . -49.21 -37.58 23.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.535 ' CB ' HG12 ' B' ' 226' ' ' ILE . . . -73.05 -31.64 64.54 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.624 ' CD1' ' HA ' ' B' ' 215' ' ' VAL . 5.5 mt -66.91 -59.89 3.12 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' B' ' 265' ' ' VAL . 0.7 OUTLIER -55.59 -37.56 68.25 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.564 0.697 . . . . 0.0 109.534 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' B' ' 216' ' ' ALA . . . -88.59 -6.1 57.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 109.624 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . 0.544 ' CA ' HD23 ' B' ' 259' ' ' LEU . . . 55.41 47.52 75.4 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.42 ' OD2' ' HB3' ' B' ' 224' ' ' ASP . 16.5 t70 -114.32 77.04 1.03 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -1.092 . . . . 0.0 109.753 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' LEU . . . . . 0.579 ' CD2' ' CD2' ' B' ' 259' ' ' LEU . 1.4 mm? -46.75 -27.2 1.12 Allowed 'General case' 0 C--N 1.307 -1.239 0 O-C-N 121.138 -0.977 . . . . 0.0 109.561 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.42 ' HB3' ' OD2' ' B' ' 222' ' ' ASP . 16.4 t0 -60.01 -50.03 75.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.325 -0.86 . . . . 0.0 109.596 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -66.64 -29.28 74.5 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.622 ' CG2' ' CD2' ' B' ' 255' ' ' PHE . 11.4 mt -66.19 -60.65 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.443 -1.034 . . . . 0.0 108.35 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.52 HG23 ' CG ' ' B' ' 252' ' ' ARG . 38.9 t -58.14 -42.31 82.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -53.25 -51.35 62.48 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 8.7 tp -64.23 -19.55 65.44 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . 0.618 ' CD2' ' CG2' ' B' ' 251' ' ' ILE . 5.9 m-85 -93.04 145.94 24.01 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.429 -0.794 . . . . 0.0 109.93 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -57.63 -163.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 109.406 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' B' ' 248' ' ' THR . 0.3 OUTLIER -77.76 -24.26 49.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . 0.545 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 3.2 p30 -150.4 45.06 0.88 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.578 -0.701 . . . . 0.0 109.481 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' B' ' 310' ' ' VAL . . . -54.71 175.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 109.518 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' THR . . . . . 0.503 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -129.07 137.93 51.56 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.26 -0.9 . . . . 0.0 110.233 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.536 HG21 ' CE ' ' B' ' 312' ' ' MET . 7.0 t -124.32 119.72 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 0.0 OUTLIER -88.52 111.22 21.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' B' ' 237' ' ' GLU . 30.6 t70 -179.93 143.23 0.36 Allowed Pre-proline 0 C--N 1.301 -1.511 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.561 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 48.9 Cg_endo -73.96 172.79 59.73 Favored 'Cis proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.214 -1.994 . . . . 0.0 110.782 -0.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.538 HG23 ' CG1' ' A' ' 74' ' ' VAL . 3.3 m -57.92 146.7 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 109.037 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . 0.533 ' HA3' ' CB ' ' A' ' 75' ' ' ALA . . . 68.39 7.58 52.94 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' SER . . . . . 0.526 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -111.66 -153.77 0.53 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -1.121 . . . . 0.0 109.235 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -122.99 130.88 24.43 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.039 -1.038 . . . . 0.0 110.169 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' PRO . . . . . 0.583 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.4 Cg_endo -63.4 -165.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.138 1.599 . . . . 0.0 111.334 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.583 ' NH1' ' CG1' ' B' ' 251' ' ' ILE . 0.0 OUTLIER -151.74 146.15 25.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.541 ' N ' ' HG2' ' B' ' 245' ' ' ARG . 0.3 OUTLIER -136.98 138.67 40.79 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.931 -1.105 . . . . 0.0 110.865 -178.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . 0.545 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 122.88 146.58 7.19 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' THR . . . . . 0.501 ' N ' ' O ' ' B' ' 232' ' ' ASP . 3.1 m -57.85 -70.21 0.14 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.406 -1.055 . . . . 0.0 109.553 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' B' ' 248' ' ' THR . . . -45.36 -25.68 0.43 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 109.173 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.545 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -84.21 -57.51 3.14 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.366 -0.834 . . . . 0.0 109.55 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.618 ' CG2' ' CD2' ' B' ' 230' ' ' PHE . 45.0 mt -44.82 -36.94 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -0.981 . . . . 0.0 108.944 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 252' ' ' ARG . . . . . 0.52 ' CG ' HG23 ' B' ' 227' ' ' VAL . 5.5 ttp180 -76.76 -52.73 9.03 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.506 -0.746 . . . . 0.0 109.14 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -50.9 -32.26 20.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 108.831 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.479 ' HB2' ' HD3' ' B' ' 245' ' ' ARG . 1.0 OUTLIER -82.62 -71.14 0.5 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 255' ' ' PHE . . . . . 0.622 ' CD2' ' CG2' ' B' ' 226' ' ' ILE . 0.2 OUTLIER -46.96 -26.03 0.92 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . 0.521 ' N ' HD13 ' B' ' 223' ' ' LEU . . . -74.33 -51.33 15.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 108.614 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -46.94 -32.2 3.68 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 35.2 t -69.5 -37.89 77.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.1 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 259' ' ' LEU . . . . . 0.579 ' CD2' ' CD2' ' B' ' 223' ' ' LEU . 7.3 tp -71.64 -32.3 67.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.526 -0.734 . . . . 0.0 109.888 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -47.27 -25.98 1.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.184 -0.947 . . . . 0.0 109.284 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 261' ' ' LEU . . . . . 0.599 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.3 OUTLIER -96.52 120.42 62.22 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 109.101 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 262' ' ' PRO . . . . . 0.441 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 46.7 Cg_endo -72.42 108.59 2.55 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.743 1.391 . . . . 0.0 110.728 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.599 ' CD2' ' CD2' ' B' ' 261' ' ' LEU . 0.0 OUTLIER -137.97 163.4 31.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.193 -0.942 . . . . 0.0 109.719 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' B' ' 284' ' ' VAL . . . -92.25 130.23 38.01 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 265' ' ' VAL . . . . . 0.527 ' O ' ' ND2' ' B' ' 219' ' ' ASN . 2.0 t -117.66 117.58 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 110.104 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 29.8 tt0 -150.22 108.82 3.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.17 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . 0.496 HD21 ' CG2' ' B' ' 271' ' ' VAL . 0.6 OUTLIER -48.68 178.42 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.258 -0.901 . . . . 0.0 109.849 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 268' ' ' THR . . . . . 0.465 ' O ' ' O ' ' B' ' 269' ' ' GLN . 29.6 p -143.56 -82.71 0.17 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.84 . . . . 0.0 109.291 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 269' ' ' GLN . . . . . 0.505 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 12.0 pt20 -60.36 -144.41 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 270' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 38.7 tt0 -114.54 134.08 55.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 109.833 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 271' ' ' VAL . . . . . 0.518 HG12 ' CG1' ' B' ' 211' ' ' VAL . 41.6 t -62.09 158.69 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.374 -0.829 . . . . 0.0 109.153 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' B' ' 279' ' ' ALA . 0.0 OUTLIER -122.82 135.32 54.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.025 -1.047 . . . . 0.0 110.262 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.19 128.45 12.05 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 274' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -137.81 152.7 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.902 -1.124 . . . . 0.0 110.557 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 275' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . 37.72 -96.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.881 -0.512 . . . . 0.0 110.524 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 276' ' ' ASN . . . . . 0.588 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 2.9 p-10 -124.97 -10.95 7.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.082 -1.011 . . . . 0.0 109.97 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . 0.47 ' OE2' ' NH1' ' A' ' 113' ' ' ARG . 1.0 OUTLIER -99.7 -163.57 1.04 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.834 -1.166 . . . . 0.0 109.199 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 278' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' B' ' 272' ' ' ARG . . . 179.68 166.86 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 110.047 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 279' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' B' ' 272' ' ' ARG . . . -150.07 132.93 16.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . 0.577 ' CD1' HG22 ' B' ' 211' ' ' VAL . 21.9 p90 -150.25 170.44 18.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.624 -1.298 . . . . 0.0 110.315 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . 0.492 ' HB1' HG13 ' B' ' 298' ' ' ILE . . . -145.27 -175.27 4.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.634 -0.666 . . . . 0.0 109.625 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 282' ' ' PHE . . . . . 0.509 ' CE1' ' CE2' ' B' ' 280' ' ' PHE . 8.1 p90 -179.14 -173.86 0.3 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.327 -0.858 . . . . 0.0 109.333 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.81 153.83 50.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.442 -0.786 . . . . 0.0 109.733 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 284' ' ' VAL . . . . . 0.522 ' CG1' HD22 ' B' ' 263' ' ' LEU . 3.7 t -142.6 119.28 6.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.373 -0.829 . . . . 0.0 109.102 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.85 100.46 7.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.155 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.576 ' CD1' HD23 ' B' ' 263' ' ' LEU . 37.1 p90 -110.53 164.34 12.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.172 -0.955 . . . . 0.0 109.712 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 287' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' B' ' 288' ' ' PHE . 2.8 tm-20 -132.8 169.66 16.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.0 OUTLIER -118.23 -78.13 0.58 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.928 . . . . 0.0 109.88 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.22 10.48 1.29 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.388 -0.82 . . . . 0.0 110.046 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 290' ' ' GLY . . . . . 0.461 ' N ' ' OE2' ' B' ' 287' ' ' GLU . . . -178.34 -71.54 0.06 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 291' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' B' ' 287' ' ' GLU . 0.3 OUTLIER -73.72 151.59 40.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.238 -1.154 . . . . 0.0 109.06 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 292' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -128.09 120.02 26.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.062 -1.024 . . . . 0.0 110.066 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 293' ' ' THR . . . . . 0.579 ' CB ' ' HB2' ' B' ' 322' ' ' HIS . 0.6 OUTLIER -97.25 -167.17 1.5 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 294' ' ' VAL . . . . . 0.583 ' O ' ' O ' ' B' ' 321' ' ' ILE . 1.7 p -153.61 -169.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.719 -1.238 . . . . 0.0 109.579 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.565 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 6.7 t -154.87 141.05 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.809 -1.182 . . . . 0.0 109.184 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 296' ' ' ALA . . . . . 0.415 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -141.25 69.87 27.49 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.091 -1.005 . . . . 0.0 109.779 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 297' ' ' PRO . . . . . 0.628 ' CB ' ' CD1' ' B' ' 316' ' ' PHE . 52.1 Cg_endo -98.7 169.27 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.869 1.713 . . . . 0.0 112.454 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.492 HG13 ' HB1' ' B' ' 281' ' ' ALA . 2.5 mp -136.56 135.42 49.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . 0.576 ' HB3' ' CE1' ' B' ' 280' ' ' PHE . 3.9 t0 -112.33 156.68 22.06 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.782 -1.199 . . . . 0.0 111.054 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 300' ' ' HIS . . . . . 0.51 ' O ' ' CG ' ' B' ' 312' ' ' MET . 71.6 t60 -108.62 171.59 7.33 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 301' ' ' PHE . . . . . 0.646 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.49 145.61 29.2 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.461 -1.399 . . . . 0.0 111.131 -178.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.451 ' HB3' ' HB2' ' B' ' 311' ' ' SER . 8.7 ttt85 -141.16 120.24 12.85 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 303' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' B' ' 207' ' ' MET . 2.7 m-85 -90.88 -175.41 4.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.108 -0.995 . . . . 0.0 109.879 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 304' ' ' ASN . . . . . 0.526 ' CA ' HG23 ' B' ' 310' ' ' VAL . 0.6 OUTLIER -114.23 -44.32 3.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 109.291 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 305' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -178.02 40.75 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 306' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 77.02 66.11 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -1.09 . . . . 0.0 109.625 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -159.6 -65.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.92 -166.25 2.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -1.14 . . . . 0.0 109.338 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 309' ' ' VAL . . . . . 0.521 HG21 ' CE1' ' B' ' 301' ' ' PHE . 42.5 t -90.0 157.3 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.138 -0.976 . . . . 0.0 109.115 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . 0.526 HG23 ' CA ' ' B' ' 304' ' ' ASN . 0.7 OUTLIER -133.22 -38.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 109.779 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 311' ' ' SER . . . . . 0.451 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 68.6 m -143.67 163.51 33.04 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.088 -1.008 . . . . 0.0 109.319 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 312' ' ' MET . . . . . 0.536 ' CE ' HG21 ' B' ' 236' ' ' VAL . 2.1 ttp -157.08 167.66 29.76 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.279 -0.888 . . . . 0.0 109.936 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 313' ' ' ARG . . . . . 0.487 ' HA ' ' HB2' ' B' ' 237' ' ' GLU . 5.2 mmt180 -146.83 151.81 37.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.406 -0.808 . . . . 0.0 108.972 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -113.38 147.39 37.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 110.1 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 315' ' ' LEU . . . . . 0.676 ' O ' ' CD1' ' B' ' 316' ' ' PHE . 3.1 tp -110.22 -143.01 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.729 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 316' ' ' PHE . . . . . 0.676 ' CD1' ' O ' ' B' ' 315' ' ' LEU . 42.4 p90 44.84 -165.35 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.713 . . . . 0.0 110.029 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 317' ' ' GLY . . . . . 0.529 ' N ' ' CD2' ' B' ' 316' ' ' PHE . . . -163.66 -161.08 12.29 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 318' ' ' GLU . . . . . 0.499 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 7.2 tt0 -79.26 5.07 13.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -1.169 . . . . 0.0 109.606 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.6 -34.81 13.17 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.185 -0.947 . . . . 0.0 109.5 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 320' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -101.05 32.12 3.35 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 321' ' ' ILE . . . . . 0.583 ' O ' ' O ' ' B' ' 294' ' ' VAL . 19.6 mm -94.96 -116.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.738 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 322' ' ' HIS . . . . . 0.579 ' HB2' ' CB ' ' B' ' 293' ' ' THR . 5.8 p-80 -88.22 101.61 14.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.719 . . . . 0.0 112.5 -176.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.451 0 O-C-N 121.503 -0.748 . . . . 0.0 109.488 177.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 8' ' ' THR . 44.9 Cg_endo -71.85 -9.63 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.968 1.51 . . . . 0.0 110.038 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.64 -48.85 75.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.386 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -54.39 36.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.235 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.3 mtt -60.97 -31.0 70.59 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.176 -0.952 . . . . 0.0 109.294 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 11' ' ' VAL . 6.9 m -69.27 -36.65 77.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.12 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.06 -43.04 50.95 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.622 ' CG1' ' CE1' ' A' ' 101' ' ' PHE . 1.5 t -56.73 -22.67 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.573 ' CG2' ' CE2' ' A' ' 101' ' ' PHE . 15.9 t -90.35 -43.24 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.38 -0.825 . . . . 0.0 109.02 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 15' ' ' VAL . 6.6 tt0 -61.73 -74.0 0.09 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -42.77 -45.16 4.7 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.6 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -49.36 -44.7 45.0 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.615 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -87.65 -37.86 11.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.367 -0.833 . . . . 0.0 109.052 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -49.05 -37.55 21.31 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.7 -32.01 65.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.615 ' CD1' ' HA ' ' A' ' 15' ' ' VAL . 2.2 mt -67.23 -58.58 4.58 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 65' ' ' VAL . 4.4 t-20 -50.86 -42.56 58.88 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.481 0.657 . . . . 0.0 109.435 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.27 -2.58 58.52 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 109.573 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.529 ' CA ' HD23 ' A' ' 59' ' ' LEU . . . 56.73 47.77 82.81 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' CB ' ' A' ' 24' ' ' ASP . 6.9 t0 -112.08 82.23 1.59 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.204 -1.174 . . . . 0.0 109.909 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.585 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 3.2 mm? -48.96 -22.54 0.87 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.216 -0.928 . . . . 0.0 109.616 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 19.3 t0 -58.26 -49.83 75.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.837 . . . . 0.0 109.393 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.79 -43.07 92.57 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.502 HG22 ' CD1' ' A' ' 55' ' ' PHE . 9.7 mt -56.19 -52.84 46.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.533 ' CG2' ' HG3' ' A' ' 52' ' ' ARG . 7.1 t -65.68 -47.44 86.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 24' ' ' ASP . . . -50.49 -46.81 57.22 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.517 ' CD2' ' HA ' ' A' ' 10' ' ' VAL . 7.8 tp -68.66 -21.37 64.45 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.641 ' CD2' ' CG2' ' A' ' 51' ' ' ILE . 3.1 m-85 -82.78 139.17 33.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.538 -0.726 . . . . 0.0 109.651 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . -60.49 -169.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.451 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -70.94 -23.69 62.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.377 -0.827 . . . . 0.0 109.788 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.526 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -148.95 49.96 0.98 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.653 -0.655 . . . . 0.0 109.476 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -58.86 167.55 1.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -126.32 138.07 53.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' A' ' 37' ' ' GLU . 23.6 t -129.0 167.68 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.064 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.536 ' N ' ' CG1' ' A' ' 36' ' ' VAL . 3.0 mt-10 -143.74 118.07 9.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 108.936 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.527 ' OD2' ' CB ' ' A' ' 114' ' ' ALA . 4.1 t70 -174.94 139.7 0.63 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 109.594 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 38' ' ' ASP . 45.3 Cg_endo -71.81 -174.3 11.37 Favored 'Cis proline' 0 N--CA 1.489 1.259 0 C-N-CA 122.15 -2.021 . . . . 0.0 110.649 0.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' B' ' 274' ' ' VAL . 15.4 m -67.02 59.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 109.625 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 39' ' ' PRO . . . -140.42 -83.56 0.09 OUTLIER Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.424 ' C ' ' HG2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -165.5 50.92 0.1 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.641 -0.917 . . . . 0.0 109.708 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.556 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 2.4 mm-40 -134.7 58.6 29.86 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.678 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.528 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 48.5 Cg_endo -79.29 -177.74 4.11 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.204 1.633 . . . . 0.0 110.394 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.56 ' HD3' ' CD1' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -150.39 102.44 3.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 108.96 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.527 ' HB2' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -92.25 149.34 21.51 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.146 -0.971 . . . . 0.0 110.203 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 98.67 168.22 31.06 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 3.7 m -80.88 -57.06 3.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -1.114 . . . . 0.0 109.093 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.87 -30.53 46.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.139 -0.976 . . . . 0.0 109.118 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.51 ' CB ' ' HG3' ' A' ' 45' ' ' ARG . . . -78.75 -53.43 7.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.431 -0.793 . . . . 0.0 109.094 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.641 ' CG2' ' CD2' ' A' ' 30' ' ' PHE . 6.5 mm -50.36 -36.07 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.392 -0.818 . . . . 0.0 109.294 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.533 ' HG3' ' CG2' ' A' ' 27' ' ' VAL . 7.6 ttp180 -74.58 -59.94 2.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 109.083 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 52' ' ' ARG . 2.0 tt0 -44.32 -27.4 0.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 108.825 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.56 ' CD1' ' HD3' ' A' ' 45' ' ' ARG . 0.6 OUTLIER -85.66 -70.08 0.62 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.529 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -53.05 -18.69 2.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.821 -0.549 . . . . 0.0 109.764 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.516 ' CB ' ' HG ' ' A' ' 23' ' ' LEU . . . -86.06 -35.78 20.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.957 . . . . 0.0 108.7 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 4.3 t30 -69.06 -39.7 78.96 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 t -63.93 -33.81 76.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 108.821 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.585 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 8.5 tp -63.75 -20.63 65.9 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.39 -0.819 . . . . 0.0 109.645 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -53.43 -20.97 5.25 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.079 -1.013 . . . . 0.0 108.914 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.581 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.8 113.73 58.03 Favored Pre-proline 0 N--CA 1.486 1.34 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 43.8 Cg_endo -70.56 106.14 1.75 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.791 1.416 . . . . 0.0 111.149 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.581 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.65 160.23 39.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.897 . . . . 0.0 109.718 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.28 127.87 36.27 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.458 ' CG1' HG11 ' A' ' 15' ' ' VAL . 17.6 t -105.96 114.13 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.136 -0.977 . . . . 0.0 109.916 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 67' ' ' LEU . 28.2 tt0 -150.47 98.51 2.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.25 -0.906 . . . . 0.0 109.041 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -47.04 173.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.909 . . . . 0.0 109.507 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 69' ' ' GLN . 2.5 p -142.94 -81.86 0.19 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.375 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -58.43 -151.72 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.422 ' CD ' ' HE2' ' B' ' 319' ' ' LYS . 39.8 tt0 -108.94 131.67 54.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.102 -0.999 . . . . 0.0 109.761 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.511 HG11 ' N ' ' A' ' 72' ' ' ARG . 54.1 t -58.41 147.56 6.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.375 -0.828 . . . . 0.0 109.21 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -104.01 132.61 50.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 109.673 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.464 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -139.75 141.15 36.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' B' ' 316' ' ' PHE . 0.2 OUTLIER -123.71 -157.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.899 . . . . 0.0 109.315 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -38.67 -93.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 110.22 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 3.4 m120 -104.63 -18.24 14.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -0.998 . . . . 0.0 109.79 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 101' ' ' PHE . 4.4 mt-10 -90.35 -161.82 0.83 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.125 -0.984 . . . . 0.0 109.293 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.517 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 177.55 164.75 0.61 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 72' ' ' ARG . . . -150.37 138.88 20.56 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.63 ' CE1' ' CE2' ' A' ' 101' ' ' PHE . 22.2 p90 -150.42 161.34 42.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.76 -1.213 . . . . 0.0 110.335 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.519 ' HB2' ' CG2' ' A' ' 98' ' ' ILE . . . -139.43 160.37 40.0 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.546 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 1.5 p90 -157.69 -176.68 6.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 0.0 109.558 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -118.24 143.03 46.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.452 -0.78 . . . . 0.0 109.284 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.538 ' CG1' ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -120.83 124.1 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.493 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 1.7 p -109.94 110.55 21.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 108.918 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 93' ' ' THR . 9.0 p90 -131.39 167.47 19.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.064 -1.022 . . . . 0.0 110.225 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.518 ' HB2' ' CB ' ' A' ' 92' ' ' LYS . 42.9 tt0 -148.73 167.35 25.78 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -146.77 -100.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.952 -1.093 . . . . 0.0 110.192 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.49 ' HG2' ' N ' ' A' ' 90' ' ' GLY . 1.0 OUTLIER -61.39 -25.4 67.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 110.005 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.49 ' N ' ' HG2' ' A' ' 89' ' ' GLN . . . 168.36 -65.92 0.18 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.53 ' O ' ' CE1' ' A' ' 88' ' ' PHE . 1.6 ttm180 -55.77 118.46 4.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -1.115 . . . . 0.0 108.977 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.518 ' CB ' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -90.57 125.23 35.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.091 -1.006 . . . . 0.0 109.592 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.534 ' O ' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -106.11 143.36 34.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.333 -0.855 . . . . 0.0 109.451 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER -108.31 178.07 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.568 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 3.5 t -150.87 144.78 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.029 -1.044 . . . . 0.0 110.038 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.515 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -133.29 71.36 76.73 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.532 -0.73 . . . . 0.0 110.037 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.568 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 51.9 Cg_endo -95.56 -175.57 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.529 1.486 . . . . 0.0 110.986 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.519 ' CG2' ' HB2' ' A' ' 81' ' ' ALA . 3.0 mp -139.91 136.23 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.594 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 5.1 t0 -109.74 161.92 14.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.995 -1.065 . . . . 0.0 110.071 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' A' ' 112' ' ' MET . 59.6 t-80 -109.47 171.23 7.56 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.63 ' CE2' ' CE1' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -146.23 145.28 30.35 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.952 -1.093 . . . . 0.0 110.544 -178.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.425 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 3.3 ttm180 -144.57 114.64 7.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 0.0 108.973 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.497 ' N ' ' CD1' ' A' ' 103' ' ' PHE . 4.2 m-85 -94.97 -171.72 2.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.191 -0.943 . . . . 0.0 109.489 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.506 ' HB3' ' CG1' ' A' ' 110' ' ' VAL . 1.2 p30 -127.19 -34.12 2.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.446 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . -161.38 24.3 0.24 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 71.15 60.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -1.106 . . . . 0.0 109.515 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.19 -62.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -128.13 -164.7 1.4 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -1.134 . . . . 0.0 109.407 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 30' ' ' PHE . 62.7 t -106.13 139.89 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.172 -0.955 . . . . 0.0 109.376 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 104' ' ' ASN . 0.5 OUTLIER -123.27 -24.56 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -0.971 . . . . 0.0 109.833 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.459 ' OG ' ' OG1' ' A' ' 35' ' ' THR . 0.5 OUTLIER -153.79 156.32 37.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.986 . . . . 0.0 109.576 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.563 ' HE3' ' CE1' ' A' ' 30' ' ' PHE . 12.4 ttm -160.09 145.97 15.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.935 . . . . 0.0 109.671 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.473 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 7.7 mtt-85 -128.71 150.38 50.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 0.0 109.063 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.527 ' CB ' ' OD2' ' A' ' 38' ' ' ASP . . . -118.49 150.87 38.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 109.693 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.529 ' CD1' ' HB2' ' B' ' 279' ' ' ALA . 0.8 OUTLIER -146.88 145.24 29.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.325 -0.859 . . . . 0.0 109.665 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.54 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 33.9 p90 164.45 -163.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.485 ' O ' HG12 ' A' ' 121' ' ' ILE . . . -179.9 -169.26 39.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.508 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 21.7 tt0 -68.93 -6.65 28.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -1.076 . . . . 0.0 109.465 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -88.47 -29.8 19.88 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 122.016 0.913 . . . . 0.0 109.071 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -88.79 3.73 50.04 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.508 ' CG1' ' HA ' ' A' ' 118' ' ' GLU . 2.8 mm -91.41 -164.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.495 ' O ' ' CG2' ' A' ' 93' ' ' THR . 0.2 OUTLIER -151.8 176.91 10.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.819 -1.176 . . . . 0.0 109.896 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.532 ' HA ' ' CG2' ' A' ' 93' ' ' THR . . . -155.43 136.02 13.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -0.804 . . . . 0.0 109.254 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 92' ' ' LYS . . . 76.73 -117.43 4.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.249 -1.148 . . . . 0.0 109.49 180.0 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 1.6 ttp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.234 0.54 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.462 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 21.7 t30 65.6 63.29 0.62 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 109.581 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 2.1 t -43.61 103.29 0.31 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.933 . . . . 0.0 109.589 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 47.8 Cg_endo -74.11 -13.18 23.61 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.987 1.519 . . . . 0.0 110.348 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.9 -46.45 87.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.617 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -60.15 -52.41 65.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.086 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' MET . . . . . 0.406 ' HE1' ' ND2' ' B' ' 202' ' ' ASN . 73.7 mtm -68.06 -18.36 64.66 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.421 -0.8 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.476 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 5.9 m -84.22 -33.78 24.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -57.96 -48.68 79.23 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.201 -0.937 . . . . 0.0 109.206 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.612 ' CG1' ' CZ ' ' B' ' 301' ' ' PHE . 0.9 OUTLIER -49.6 -32.58 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.935 . . . . 0.0 108.531 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' B' ' 208' ' ' THR . 4.4 t -71.83 -39.83 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 109.419 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.2 tt0 -64.82 -74.54 0.1 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' B' ' 212' ' ' GLN . 0.4 OUTLIER -42.0 -44.14 3.41 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 122.031 0.919 . . . . 0.0 108.697 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' TYR . . . . . 0.634 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -49.46 -45.41 46.63 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.619 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.4 t -88.75 -37.36 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.3 -0.875 . . . . 0.0 109.127 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.82 -34.69 12.92 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' B' ' 226' ' ' ILE . . . -75.24 -33.91 61.36 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.634 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 2.2 mt -65.09 -58.53 5.81 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -48.36 -41.03 27.51 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.593 0.711 . . . . 0.0 109.182 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.45 4.42 49.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.71 . . . . 0.0 109.842 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . 0.534 ' CA ' HD23 ' B' ' 259' ' ' LEU . . . 48.77 31.63 10.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -97.97 87.46 3.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.325 -1.103 . . . . 0.0 109.787 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' B' ' 259' ' ' LEU . 3.7 mm? -51.9 -19.95 2.04 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.193 -0.942 . . . . 0.0 109.848 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' B' ' 228' ' ' ALA . 73.0 m-20 -61.58 -54.06 48.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.256 -0.902 . . . . 0.0 109.264 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' B' ' 228' ' ' ALA . . . -61.05 -38.37 95.44 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.448 HG12 ' HB2' ' B' ' 217' ' ' ALA . 8.7 mt -61.32 -57.32 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.466 ' HA ' ' HB2' ' B' ' 230' ' ' PHE . 24.7 t -60.7 -42.98 94.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.444 ' HB2' ' HA2' ' B' ' 225' ' ' GLY . . . -54.11 -50.17 67.48 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' B' ' 309' ' ' VAL . 8.2 tp -67.92 -22.87 65.04 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . 0.548 ' CD2' HG23 ' B' ' 251' ' ' ILE . 5.3 m-85 -88.41 136.58 32.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.572 -0.705 . . . . 0.0 109.915 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' B' ' 309' ' ' VAL . . . -52.21 -174.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 109.354 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -25.07 49.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.749 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . 0.53 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 0.2 OUTLIER -135.32 44.99 2.52 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' B' ' 310' ' ' VAL . . . -63.62 150.17 44.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.357 -0.839 . . . . 0.0 109.989 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -108.83 149.18 29.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.478 -0.764 . . . . 0.0 109.033 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 48.7 t -140.12 122.39 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 109.695 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' GLU . . . . . 0.513 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.6 mt-10 -89.6 104.1 16.69 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' ASP . . . . . 0.546 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 22.7 t70 179.66 142.16 0.33 Allowed Pre-proline 0 C--N 1.301 -1.535 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.027 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . 0.493 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 47.5 Cg_endo -72.71 176.34 40.68 Favored 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.283 -1.965 . . . . 0.0 111.041 0.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.508 ' CG2' HG13 ' A' ' 74' ' ' VAL . 5.0 m -61.29 153.58 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 0.0 109.15 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 55.76 18.23 16.82 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -118.05 -154.57 0.57 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.41 -1.053 . . . . 0.0 109.257 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -124.63 128.88 24.81 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 110.126 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' PRO . . . . . 0.539 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.3 Cg_endo -64.93 -174.11 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.934 1.492 . . . . 0.0 111.145 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.528 ' HG3' ' CB ' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.65 103.24 3.09 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.527 ' HB2' ' CG2' ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.24 152.12 21.75 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.17 -0.956 . . . . 0.0 109.674 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 110.25 162.64 18.8 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 5.3 m -77.16 -36.57 55.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.184 -1.186 . . . . 0.0 109.129 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -73.79 -19.69 60.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 108.97 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.528 ' CB ' ' HG3' ' B' ' 245' ' ' ARG . . . -90.36 -45.07 9.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.401 -0.812 . . . . 0.0 109.306 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.548 HG23 ' CD2' ' B' ' 230' ' ' PHE . 10.3 mm -61.89 -50.48 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 0.0 109.521 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 252' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' B' ' 256' ' ' ALA . 21.0 ttp180 -66.34 -52.39 47.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.049 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 253' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 22.4 mt-10 -47.91 -32.48 6.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.966 -1.083 . . . . 0.0 108.448 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.546 ' CZ ' ' O ' ' B' ' 238' ' ' ASP . 0.6 OUTLIER -84.48 -70.81 0.55 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 255' ' ' PHE . . . . . 0.523 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -49.64 -22.57 1.37 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.469 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . 0.526 ' CB ' ' HG ' ' B' ' 223' ' ' LEU . . . -84.35 -49.11 9.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 108.744 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 257' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' B' ' 253' ' ' GLU . 0.3 OUTLIER -57.38 -37.49 72.76 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.236 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 7.6 t -65.57 -32.34 73.88 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 259' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' B' ' 223' ' ' LEU . 9.5 tp -64.68 -22.43 66.98 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.413 -0.804 . . . . 0.0 109.248 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 260' ' ' LYS . . . . . 0.485 ' O ' ' HD3' ' B' ' 262' ' ' PRO . 0.0 OUTLIER -50.75 -22.53 2.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.838 . . . . 0.0 108.9 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 261' ' ' LEU . . . . . 0.577 HD23 ' CD1' ' B' ' 263' ' ' LEU . 0.0 OUTLIER -98.89 103.68 20.84 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 262' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 51.5 Cg_endo -76.68 125.27 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.812 1.427 . . . . 0.0 112.11 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.596 HD22 ' CD1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -145.59 176.68 9.43 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.53 125.08 36.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 26.1 t -111.48 115.38 49.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 109.979 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 266' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.2 tp10 -150.14 89.56 1.6 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.387 -0.821 . . . . 0.0 108.938 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . 0.52 ' CD2' HG23 ' B' ' 215' ' ' VAL . 1.0 OUTLIER -52.84 -170.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.351 -0.843 . . . . 0.0 110.0 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 268' ' ' THR . . . . . 0.667 ' O ' ' N ' ' B' ' 270' ' ' GLU . 6.5 p -136.68 53.13 1.92 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.844 . . . . 0.0 108.819 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 269' ' ' GLN . . . . . 0.549 ' CG ' ' O ' ' B' ' 268' ' ' THR . 17.9 pt20 50.7 -55.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 270' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' B' ' 268' ' ' THR . 35.5 tt0 -48.89 115.26 1.2 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.492 -1.38 . . . . 0.0 110.213 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 271' ' ' VAL . . . . . 0.45 HG11 ' HB3' ' B' ' 280' ' ' PHE . 37.7 t -138.14 154.31 28.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.7 OUTLIER -114.66 130.21 56.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.857 -1.152 . . . . 0.0 110.003 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' B' ' 278' ' ' ALA . . . -150.47 133.21 15.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.396 -0.815 . . . . 0.0 109.001 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 274' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -150.34 158.86 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.935 -1.103 . . . . 0.0 110.435 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 275' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . 39.26 -101.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.77 -0.581 . . . . 0.0 110.321 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 276' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 2.8 m120 -121.35 -20.47 6.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.957 -1.089 . . . . 0.0 109.691 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . 0.501 ' OE2' ' NE ' ' B' ' 302' ' ' ARG . 3.9 mt-10 -92.59 -164.95 1.25 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.042 -1.037 . . . . 0.0 109.5 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 278' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' B' ' 273' ' ' ALA . . . 177.77 154.69 0.32 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 109.519 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 279' ' ' ALA . . . . . 0.537 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -136.79 141.17 42.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.945 . . . . 0.0 108.66 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . 0.574 ' CE1' ' HB3' ' B' ' 299' ' ' ASP . 37.9 p90 -150.72 171.15 17.61 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.735 -1.228 . . . . 0.0 110.028 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . 0.464 ' HB2' HG22 ' B' ' 298' ' ' ILE . . . -145.68 -179.86 6.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.751 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 282' ' ' PHE . . . . . 0.406 ' CE1' ' HE2' ' B' ' 280' ' ' PHE . 7.0 p90 -174.32 -173.58 0.79 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.292 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 283' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -124.7 141.53 52.04 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.413 -0.805 . . . . 0.0 109.541 179.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 284' ' ' VAL . . . . . 0.544 HG12 ' CD1' ' B' ' 263' ' ' LEU . 42.1 t -120.04 113.87 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 109.469 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 1.2 p -106.14 131.75 53.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.033 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' B' ' 286' ' ' PHE . 1.0 OUTLIER -149.73 157.69 43.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.977 -1.077 . . . . 0.0 110.009 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 287' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' B' ' 292' ' ' LYS . 1.2 pt-20 -98.19 158.09 15.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 109.14 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . 0.499 ' C ' ' CG ' ' B' ' 289' ' ' GLN . 0.6 OUTLIER -124.63 77.55 1.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.897 . . . . 0.0 109.594 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . 0.499 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 0.4 OUTLIER 40.36 57.36 2.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.424 -0.797 . . . . 0.0 110.262 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 107.63 -2.06 34.28 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.207 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -127.37 173.9 9.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.056 -1.261 . . . . 0.0 109.635 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 292' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' B' ' 287' ' ' GLU . 0.1 OUTLIER -138.17 140.1 39.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.384 179.534 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 293' ' ' THR . . . . . 0.429 HG22 ' HA ' ' B' ' 323' ' ' ALA . 0.0 OUTLIER -144.94 148.59 34.01 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.715 -0.616 . . . . 0.0 109.464 -179.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 294' ' ' VAL . . . . . 0.551 ' CG1' ' CD2' ' B' ' 322' ' ' HIS . 9.8 p -125.96 170.46 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.169 -0.957 . . . . 0.0 108.468 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.546 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 3.8 t -147.46 145.81 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.004 -1.06 . . . . 0.0 109.784 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 296' ' ' ALA . . . . . 0.531 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -130.18 72.67 81.83 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 110.148 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 297' ' ' PRO . . . . . 0.546 ' HD3' ' CG1' ' B' ' 295' ' ' VAL . 50.7 Cg_endo -92.5 -175.42 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.757 1.398 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.467 HG13 ' O ' ' B' ' 297' ' ' PRO . 3.2 mp -143.43 134.8 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . 0.574 ' HB3' ' CE1' ' B' ' 280' ' ' PHE . 11.3 t0 -108.42 162.89 13.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.951 -1.093 . . . . 0.0 110.317 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 300' ' ' HIS . . . . . 0.527 ' O ' ' CG ' ' B' ' 312' ' ' MET . 59.9 t60 -112.58 172.71 6.76 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 301' ' ' PHE . . . . . 0.612 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.13 145.12 29.47 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.994 -1.066 . . . . 0.0 110.475 -178.478 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.519 ' CD ' ' HB2' ' B' ' 311' ' ' SER . 2.6 ttt-85 -139.3 107.0 5.61 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 303' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' B' ' 276' ' ' ASN . 5.4 m-85 -90.72 -171.38 3.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.184 -0.948 . . . . 0.0 109.871 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 304' ' ' ASN . . . . . 0.516 ' OD1' ' CG2' ' B' ' 310' ' ' VAL . 0.5 OUTLIER -124.32 -37.65 2.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.854 . . . . 0.0 109.271 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 305' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -164.29 24.42 0.18 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 306' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 75.76 64.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -1.183 . . . . 0.0 109.581 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -158.53 -58.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.32 -168.29 1.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -1.14 . . . . 0.0 109.381 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 309' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' B' ' 231' ' ' ALA . 70.1 t -108.49 135.05 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -0.947 . . . . 0.0 109.115 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . 0.574 ' O ' ' CB ' ' B' ' 234' ' ' ALA . 10.0 t -110.54 -75.33 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.021 . . . . 0.0 109.979 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 311' ' ' SER . . . . . 0.519 ' HB2' ' CD ' ' B' ' 302' ' ' ARG . 28.8 m -107.45 162.01 14.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.634 -1.291 . . . . 0.0 109.615 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 312' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 15.3 ttp -153.95 150.31 28.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 313' ' ' ARG . . . . . 0.495 ' CG ' ' HB2' ' B' ' 237' ' ' GLU . 2.0 mtm-85 -127.79 150.47 49.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.377 -0.827 . . . . 0.0 109.068 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 314' ' ' ALA . . . . . 0.49 ' CB ' ' OD1' ' B' ' 238' ' ' ASP . . . -110.52 130.44 55.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.084 -1.01 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 315' ' ' LEU . . . . . 0.549 ' O ' ' HB3' ' B' ' 316' ' ' PHE . 0.4 OUTLIER -124.99 135.98 53.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.092 -1.005 . . . . 0.0 110.074 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 316' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' B' ' 315' ' ' LEU . 34.3 p90 165.91 -156.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 317' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' B' ' 321' ' ' ILE . . . 165.1 -174.47 41.01 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 318' ' ' GLU . . . . . 0.533 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 13.0 tt0 -68.25 -7.18 28.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -1.134 . . . . 0.0 109.474 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 319' ' ' LYS . . . . . 0.422 ' HE2' ' CD ' ' A' ' 70' ' ' GLU . 3.5 tttp -89.55 -30.48 18.17 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.04 0.924 . . . . 0.0 109.108 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 320' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.11 6.46 39.83 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 321' ' ' ILE . . . . . 0.533 ' CG1' ' HA ' ' B' ' 318' ' ' GLU . 4.1 mm -90.09 -170.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 322' ' ' HIS . . . . . 0.551 ' CD2' ' CG1' ' B' ' 294' ' ' VAL . 0.1 OUTLIER -151.9 174.05 14.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.909 -1.119 . . . . 0.0 110.11 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.429 ' HA ' HG22 ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.078 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.98 -4.25 15.08 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.871 1.458 . . . . 0.0 110.202 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.97 -44.77 53.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -50.53 72.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.41 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.566 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 64.9 mtm -60.89 -27.76 68.39 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.214 -0.929 . . . . 0.0 109.735 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.439 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 15.9 m -76.99 -37.49 55.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.366 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.59 -46.38 77.26 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.183 -0.948 . . . . 0.0 108.953 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.626 ' CG1' ' CZ ' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -49.46 -43.43 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.526 ' CG1' HD21 ' A' ' 67' ' ' LEU . 4.9 t -60.15 -40.08 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.709 -0.619 . . . . 0.0 109.725 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 13' ' ' ARG . 17.3 tt0 -63.83 -75.63 0.08 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.158 -0.963 . . . . 0.0 108.621 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.503 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -43.06 -44.64 4.93 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.612 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -49.33 -46.13 46.44 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.607 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -88.28 -39.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.59 -36.43 15.62 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 22' ' ' ASP . . . -73.82 -33.2 64.07 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.612 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 2.0 mt -64.2 -58.24 7.15 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -51.08 -46.75 61.86 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.708 0.766 . . . . 0.0 109.149 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.32 10.14 23.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.533 -0.729 . . . . 0.0 109.445 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . 47.77 30.1 6.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 17' ' ' ALA . 19.2 t70 -90.03 62.75 5.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -1.152 . . . . 0.0 109.81 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.606 ' CD1' ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -47.58 -38.03 13.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.11 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 23' ' ' LEU . 1.7 m-20 -43.21 -36.71 1.85 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.97 -30.86 30.47 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' LEU . 49.6 mt -61.51 -55.97 20.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 30' ' ' PHE . 29.7 t -60.0 -38.2 75.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.28 -54.17 50.0 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.506 ' CD2' ' HA ' ' A' ' 10' ' ' VAL . 9.1 tp -62.58 -23.43 67.02 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 31' ' ' ALA . 3.6 m-30 -91.27 142.79 27.33 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.483 -0.761 . . . . 0.0 109.7 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -52.36 -174.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.383 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.47 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.4 OUTLIER -81.32 -24.69 36.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.651 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.57 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -132.7 42.41 3.09 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.586 -0.696 . . . . 0.0 109.446 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 110' ' ' VAL . . . -59.95 157.39 12.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 109.896 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -111.66 144.91 40.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.007 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 55.7 t -133.1 130.64 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.069 -1.019 . . . . 0.0 109.835 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.547 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 23.1 mt-10 -107.92 110.13 21.81 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.506 ' HA ' ' C ' ' A' ' 39' ' ' PRO . 17.6 t70 179.19 139.89 0.28 Allowed Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.782 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 43.5 Cg_endo -69.65 -179.84 20.09 Favored 'Cis proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.353 -1.936 . . . . 0.0 111.055 -0.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -55.07 139.99 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 110.024 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' B' ' 275' ' ' ALA . . . 49.55 38.39 28.21 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.545 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -116.03 -141.77 0.37 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.41 -1.053 . . . . 0.0 109.802 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 7.1 pm0 -119.12 101.48 49.73 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.838 -1.164 . . . . 0.0 110.764 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 37.5 Cg_endo -63.31 175.87 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.984 1.518 . . . . 0.0 110.707 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.54 ' HG3' ' CB ' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -151.49 114.27 4.67 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.522 ' HB2' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -99.93 155.47 17.67 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 110.074 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 109.21 155.95 16.86 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 7.3 m -66.92 -56.46 10.16 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.322 -1.105 . . . . 0.0 108.977 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -57.93 -18.92 26.33 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.291 -0.881 . . . . 0.0 109.119 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.54 ' CB ' ' HG3' ' A' ' 45' ' ' ARG . . . -89.54 -54.84 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.381 -0.824 . . . . 0.0 109.182 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.494 HD11 ' CG2' ' A' ' 36' ' ' VAL . 2.9 mm -51.58 -39.88 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.391 -0.818 . . . . 0.0 109.203 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.58 ' CG ' ' CD2' ' A' ' 23' ' ' LEU . 5.0 ttt85 -74.38 -55.34 6.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.026 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 4.8 mt-10 -49.12 -27.75 3.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.07 -1.019 . . . . 0.0 108.867 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.65 -71.5 0.57 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.606 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -47.28 -39.06 13.68 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 52' ' ' ARG . . . -57.82 -50.92 71.65 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 39.6 t-20 -53.99 -42.55 69.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.9 t -59.58 -31.55 69.56 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.421 HD12 ' HA2' ' A' ' 21' ' ' GLY . 7.5 tp -68.76 -20.26 64.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 11.8 mttm -67.75 -6.35 20.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.563 -0.711 . . . . 0.0 109.252 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.566 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -88.31 113.17 54.07 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD2' HD12 ' A' ' 61' ' ' LEU . 47.0 Cg_endo -73.39 82.16 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.737 1.388 . . . . 0.0 112.047 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.566 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -140.18 164.6 29.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.027 -1.045 . . . . 0.0 109.048 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.517 ' CB ' ' OG ' ' A' ' 85' ' ' SER . . . -89.82 129.39 36.21 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.967 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.61 117.31 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.665 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -140.09 108.87 5.95 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.317 -0.865 . . . . 0.0 109.226 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.528 HD13 ' CG1' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -48.52 178.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.805 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.686 ' O ' ' N ' ' A' ' 70' ' ' GLU . 4.6 p -126.89 44.53 2.88 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.384 -0.822 . . . . 0.0 109.094 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.537 ' CG ' ' O ' ' A' ' 68' ' ' THR . 4.2 pt20 49.94 -55.39 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.686 ' N ' ' O ' ' A' ' 68' ' ' THR . 67.7 tt0 -63.32 118.15 7.62 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.535 -1.353 . . . . 0.0 110.227 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.455 ' O ' ' NZ ' ' B' ' 319' ' ' LYS . 29.9 t -130.57 146.0 34.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.657 ' CZ ' ' CG2' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -118.17 130.65 56.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.895 -1.128 . . . . 0.0 109.731 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.538 ' N ' ' HD2' ' A' ' 72' ' ' ARG . . . -147.44 117.45 7.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.717 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.657 ' CG2' ' CZ ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -135.77 160.72 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.964 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . 40.48 -143.43 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.751 -0.593 . . . . 0.0 109.914 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 103' ' ' PHE . 7.6 m-20 -90.38 12.24 19.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.105 -0.997 . . . . 0.0 109.611 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.516 ' CG ' ' HG3' ' A' ' 102' ' ' ARG . 2.3 mt-10 -115.51 -161.51 0.79 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.09 -1.006 . . . . 0.0 109.466 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . . . -179.24 163.89 1.32 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.388 -0.82 . . . . 0.0 109.962 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.553 ' HB2' ' CG ' ' A' ' 72' ' ' ARG . . . -151.7 131.68 13.4 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 31.3 p90 -151.09 174.89 12.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.733 -1.229 . . . . 0.0 109.958 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.537 ' CB ' HG21 ' A' ' 98' ' ' ILE . . . -144.39 176.94 8.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 109.91 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -165.05 -169.0 1.55 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.496 -0.753 . . . . 0.0 109.133 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.75 147.8 50.1 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 110.104 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.539 ' CG2' HG13 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -117.51 124.33 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 109.067 179.55 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.521 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 27.8 p -118.17 120.76 38.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.588 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.585 ' CZ ' ' HB ' ' A' ' 93' ' ' THR . 7.2 p90 -147.04 -173.5 4.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -121.79 169.33 10.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 -159.35 0.95 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 109.957 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -104.0 89.11 3.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.25 -18.17 52.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -143.91 167.11 23.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -1.08 . . . . 0.0 109.264 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -113.34 145.06 41.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.35 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.585 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -139.14 142.75 38.02 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 110.178 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.541 ' CG1' ' N ' ' A' ' 95' ' ' VAL . 0.8 OUTLIER -123.62 179.19 2.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.558 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 6.8 t -146.81 142.26 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.891 -1.131 . . . . 0.0 109.796 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.512 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -134.08 72.2 72.23 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.527 -0.733 . . . . 0.0 109.956 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.558 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 48.8 Cg_endo -94.7 -175.36 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.631 1.554 . . . . 0.0 110.973 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.537 HG21 ' CB ' ' A' ' 81' ' ' ALA . 2.7 mp -137.55 163.83 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 12.2 t0 -132.98 156.33 47.52 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.011 -1.056 . . . . 0.0 110.234 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 101' ' ' PHE . 53.5 t60 -111.84 167.84 10.05 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.626 ' CZ ' ' CG1' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -139.08 153.92 48.1 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 110.607 -178.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.516 ' HG3' ' CG ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -143.15 98.84 3.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 109.186 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.57 ' CZ ' HG13 ' A' ' 10' ' ' VAL . 5.8 m-85 -90.09 159.73 16.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 109.62 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.529 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -101.24 4.45 41.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.204 -0.935 . . . . 0.0 109.795 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.37 -76.41 0.15 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 177.96 71.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -1.159 . . . . 0.0 109.592 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.06 -65.88 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.87 -163.8 1.22 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -1.1 . . . . 0.0 109.327 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.574 HG21 ' CE1' ' A' ' 101' ' ' PHE . 37.7 t -106.27 158.16 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.099 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.547 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -127.44 -75.15 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.177 -0.952 . . . . 0.0 109.266 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.466 ' OG ' ' OG1' ' A' ' 35' ' ' THR . 3.3 m -108.36 161.77 14.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.11 -0.994 . . . . 0.0 109.167 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 11.5 ttp -160.01 148.25 17.01 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.178 -0.951 . . . . 0.0 110.072 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.612 ' NH2' ' CE1' ' B' ' 300' ' ' HIS . 0.0 OUTLIER -134.33 158.39 43.92 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.468 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . . . -125.77 141.71 51.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 109.78 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.511 ' CD2' ' HB2' ' B' ' 279' ' ' ALA . 0.7 OUTLIER -129.21 146.65 51.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.357 -0.839 . . . . 0.0 109.485 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.527 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 0.1 OUTLIER 176.54 -155.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.691 0.758 . . . . 0.0 109.484 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.502 ' N ' ' CG ' ' A' ' 116' ' ' PHE . . . 163.38 176.84 35.77 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.506 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 24.2 tt0 -68.64 -7.74 35.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -1.109 . . . . 0.0 109.49 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.503 ' CE ' ' OE2' ' B' ' 270' ' ' GLU . 14.5 tttp -89.52 -27.54 20.23 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.997 0.904 . . . . 0.0 108.778 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -89.16 9.81 24.21 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.527 ' CG2' HG21 ' A' ' 95' ' ' VAL . 3.6 mm -96.04 -159.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.278 -0.889 . . . . 0.0 108.637 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.534 ' CB ' HG11 ' A' ' 94' ' ' VAL . 20.3 t-80 -151.32 168.88 23.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.074 -1.016 . . . . 0.0 109.864 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 122' ' ' HIS . . . -144.77 167.83 21.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.372 -0.83 . . . . 0.0 109.413 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.46 177.65 35.9 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.223 -1.163 . . . . 0.0 109.492 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 80.9 mtp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.272 0.558 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -166.41 46.43 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.394 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 7.5 t -58.54 121.86 56.21 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 109.702 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.06 -4.89 15.79 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.853 1.449 . . . . 0.0 109.478 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -55.25 32.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.367 -0.833 . . . . 0.0 109.301 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -49.61 75.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 108.857 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' MET . . . . . 0.513 ' CE ' ' HA ' ' B' ' 306' ' ' ALA . 24.0 mmt -50.28 -41.84 51.34 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.348 -0.845 . . . . 0.0 109.404 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.428 ' O ' ' N ' ' B' ' 211' ' ' VAL . 4.8 m -60.36 -34.93 74.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.485 -0.759 . . . . 0.0 109.084 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -51.36 -42.74 61.52 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.291 -0.881 . . . . 0.0 108.739 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.614 ' CG1' ' CE1' ' B' ' 301' ' ' PHE . 0.9 OUTLIER -57.75 -26.62 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.569 HG22 ' CE2' ' B' ' 301' ' ' PHE . 25.5 t -90.09 -44.63 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.858 . . . . 0.0 109.308 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 213' ' ' ARG . 5.4 tt0 -58.05 -73.19 0.08 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' B' ' 212' ' ' GLN . 0.3 OUTLIER -43.42 -45.14 6.13 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.98 0.895 . . . . 0.0 108.693 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' TYR . . . . . 0.626 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.3 OUTLIER -52.02 -42.46 63.07 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.594 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 0.9 OUTLIER -87.67 -38.88 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.284 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.66 -35.08 13.02 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -75.32 -32.79 61.05 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.626 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 1.7 mt -64.59 -57.9 7.83 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 8.5 t30 -54.35 -46.33 72.93 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.497 0.665 . . . . 0.0 109.312 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -88.92 9.6 24.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.599 -0.688 . . . . 0.0 109.733 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . 0.536 ' HA2' ' CD2' ' B' ' 259' ' ' LEU . . . 48.9 34.29 15.24 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' B' ' 217' ' ' ALA . 16.8 t0 -91.56 61.66 4.34 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.251 -1.146 . . . . 0.0 109.812 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' LEU . . . . . 0.575 ' CD2' ' CG ' ' B' ' 252' ' ' ARG . 6.7 tp -46.31 -43.58 15.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 108.695 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' B' ' 223' ' ' LEU . 2.2 m-20 -42.69 -33.28 0.7 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -85.15 -33.93 16.17 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.477 ' CG1' ' HB3' ' B' ' 217' ' ' ALA . 23.3 mt -60.82 -53.78 44.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.536 ' CG1' HG23 ' B' ' 248' ' ' THR . 72.5 t -59.18 -35.97 60.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.69 -56.1 26.6 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.538 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 9.3 tp -58.7 -21.6 55.18 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . 0.58 ' CZ ' ' HE3' ' B' ' 312' ' ' MET . 5.0 m-85 -86.89 139.59 30.48 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.497 -0.752 . . . . 0.0 109.61 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -54.8 -167.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.674 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.476 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.5 OUTLIER -81.12 -23.15 38.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.0 109.373 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . 0.541 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 0.1 OUTLIER -144.4 44.81 1.42 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.542 ' CB ' HD13 ' B' ' 251' ' ' ILE . . . -56.76 -170.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.648 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' THR . . . . . 0.446 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.1 OUTLIER -134.61 141.01 46.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.4 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.546 ' CG1' ' N ' ' B' ' 237' ' ' GLU . 34.6 t -116.43 166.84 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.189 -0.945 . . . . 0.0 109.112 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' GLU . . . . . 0.546 ' N ' ' CG1' ' B' ' 236' ' ' VAL . 1.1 mm-40 -151.66 116.95 5.29 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' ASP . . . . . 0.495 ' CB ' ' HA ' ' B' ' 239' ' ' PRO . 0.8 OUTLIER 175.01 167.12 0.36 Allowed Pre-proline 0 C--N 1.301 -1.5 0 C-N-CA 118.118 -1.433 . . . . 0.0 110.354 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . 0.542 ' O ' ' CG1' ' B' ' 240' ' ' VAL . 45.7 Cg_endo -73.12 -28.03 7.52 Favored 'Cis proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.727 -2.197 . . . . 0.0 110.649 0.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' B' ' 239' ' ' PRO . 2.1 m -166.88 101.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 109.197 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.23 42.96 63.88 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' SER . . . . . 0.497 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 27.8 m -118.83 -112.44 0.34 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.314 -1.109 . . . . 0.0 109.817 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . 0.445 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 39.0 mt-10 -121.82 100.62 43.31 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.915 -1.116 . . . . 0.0 110.383 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' PRO . . . . . 0.542 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 39.4 Cg_endo -65.43 -172.6 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.561 1.507 . . . . 0.0 110.652 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.618 ' CD ' ' CD1' ' B' ' 254' ' ' PHE . 0.0 OUTLIER -150.52 98.05 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.063 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.35 166.62 13.63 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.301 -0.875 . . . . 0.0 109.896 -179.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 90.48 171.09 43.84 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' THR . . . . . 0.536 HG23 ' CG1' ' B' ' 227' ' ' VAL . 1.8 m -89.42 -22.36 22.57 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.749 -1.442 . . . . 0.0 109.27 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -82.0 -28.02 32.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.268 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.518 ' CB ' ' HG3' ' B' ' 245' ' ' ARG . . . -88.98 -53.48 4.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.322 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.572 ' CG2' ' CD2' ' B' ' 230' ' ' PHE . 94.6 mt -45.25 -36.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.942 . . . . 0.0 108.852 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 252' ' ' ARG . . . . . 0.575 ' CG ' ' CD2' ' B' ' 223' ' ' LEU . 28.8 ttp180 -79.86 -54.18 6.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -48.95 -28.49 3.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.043 -1.035 . . . . 0.0 108.239 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.618 ' CD1' ' CD ' ' B' ' 245' ' ' ARG . 0.7 OUTLIER -83.54 -70.74 0.54 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 255' ' ' PHE . . . . . 0.572 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.1 OUTLIER -47.2 -24.96 0.8 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . 0.533 ' CB ' HD21 ' B' ' 223' ' ' LEU . . . -76.32 -48.61 19.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 108.642 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 257' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 31.1 t-20 -59.13 -31.96 69.42 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 3.0 t -72.72 -35.94 67.67 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 259' ' ' LEU . . . . . 0.536 ' CD2' ' HA2' ' B' ' 221' ' ' GLY . 8.3 tp -66.81 -26.56 66.99 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.406 -0.809 . . . . 0.0 109.145 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 260' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 2.1 mttt -46.15 -25.91 0.67 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.06 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 261' ' ' LEU . . . . . 0.531 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.75 112.31 51.22 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 262' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 44.4 Cg_endo -71.39 117.49 5.18 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.854 1.45 . . . . 0.0 110.841 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.536 ' CD1' HG12 ' B' ' 284' ' ' VAL . 0.0 OUTLIER -145.88 164.4 32.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 109.614 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -95.11 123.75 38.78 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 265' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' B' ' 219' ' ' ASN . 6.2 t -113.46 115.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.291 -0.88 . . . . 0.0 109.794 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 266' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.1 OUTLIER -149.84 99.37 2.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -0.906 . . . . 0.0 109.229 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -45.15 170.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.912 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 12.0 p -142.24 -37.96 0.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 109.608 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 269' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 3.7 pt20 -95.93 -144.74 0.27 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.654 -0.654 . . . . 0.0 109.324 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 270' ' ' GLU . . . . . 0.518 ' O ' ' CZ ' ' B' ' 272' ' ' ARG . 22.2 tt0 -117.53 134.1 55.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.041 -1.037 . . . . 0.0 109.829 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 271' ' ' VAL . . . . . 0.525 ' CG2' HG13 ' B' ' 211' ' ' VAL . 76.1 t -64.84 148.97 11.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.414 -0.804 . . . . 0.0 109.17 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 11.9 mmt180 -103.4 137.84 40.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -148.76 139.22 22.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 109.077 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 274' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -160.3 157.58 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.068 -1.02 . . . . 0.0 110.088 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 275' ' ' ALA . . . . . 0.451 ' HB3' ' HA3' ' A' ' 41' ' ' GLY . . . 40.59 -102.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.653 -0.655 . . . . 0.0 110.095 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 276' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 98.3 m-20 -129.3 5.31 5.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.898 -1.126 . . . . 0.0 109.628 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . 0.523 ' CG ' ' HG2' ' B' ' 302' ' ' ARG . 0.3 OUTLIER -112.6 -162.65 0.81 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.087 -1.008 . . . . 0.0 108.972 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 278' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' B' ' 301' ' ' PHE . . . 177.17 142.47 0.08 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.623 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 279' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -125.92 136.45 53.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 108.604 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' B' ' 299' ' ' ASP . 30.0 p90 -149.72 172.46 15.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.74 -1.225 . . . . 0.0 109.982 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . 0.522 ' HB2' ' CG1' ' B' ' 298' ' ' ILE . . . -148.23 -164.95 2.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.808 . . . . 0.0 109.991 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 282' ' ' PHE . . . . . 0.49 ' CD2' ' C ' ' B' ' 281' ' ' ALA . 14.2 p90 172.14 -169.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.45 -0.781 . . . . 0.0 109.384 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.15 147.3 52.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.394 -0.816 . . . . 0.0 109.645 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 284' ' ' VAL . . . . . 0.536 HG12 ' CD1' ' B' ' 263' ' ' LEU . 3.3 t -123.8 121.13 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.868 . . . . 0.0 109.429 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 285' ' ' SER . . . . . 0.501 ' HA ' ' CG2' ' B' ' 294' ' ' VAL . 16.7 p -115.52 117.84 31.47 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' B' ' 293' ' ' THR . 11.4 p90 -142.24 173.65 11.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.084 -1.01 . . . . 0.0 110.217 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 287' ' ' GLU . . . . . 0.505 ' CG ' ' O ' ' B' ' 291' ' ' ARG . 36.1 tt0 -148.42 154.03 39.35 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.1 OUTLIER -128.01 -96.36 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.036 -1.04 . . . . 0.0 110.358 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -110.16 93.92 4.75 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.122 -0.987 . . . . 0.0 110.443 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 62.14 11.34 32.01 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 291' ' ' ARG . . . . . 0.567 ' HB3' ' CE2' ' B' ' 288' ' ' PHE . 26.9 mtt180 -130.94 144.79 51.73 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.206 -1.173 . . . . 0.0 109.578 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 292' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 120.78 18.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.347 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 293' ' ' THR . . . . . 0.575 ' O ' ' CD1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -122.57 143.58 49.65 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.403 -0.81 . . . . 0.0 109.717 -179.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 294' ' ' VAL . . . . . 0.517 HG11 ' CB ' ' B' ' 322' ' ' HIS . 0.8 OUTLIER -112.92 173.55 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.556 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 2.6 t -150.41 144.41 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.955 -1.091 . . . . 0.0 110.034 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 296' ' ' ALA . . . . . 0.506 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -133.34 73.81 73.14 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.425 -0.797 . . . . 0.0 109.208 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 297' ' ' PRO . . . . . 0.578 ' HB3' ' CD2' ' B' ' 316' ' ' PHE . 50.2 Cg_endo -94.48 -179.21 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.907 1.478 . . . . 0.0 111.797 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.522 ' CG1' ' HB2' ' B' ' 281' ' ' ALA . 2.9 mp -137.34 138.45 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . 0.577 ' HB3' ' CE1' ' B' ' 280' ' ' PHE . 14.7 t0 -113.75 164.16 14.08 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.984 -1.073 . . . . 0.0 110.24 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 300' ' ' HIS . . . . . 0.612 ' CE1' ' NH2' ' A' ' 113' ' ' ARG . 7.4 t-160 -112.22 173.43 6.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 109.09 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 301' ' ' PHE . . . . . 0.614 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.2 OUTLIER -145.27 149.03 34.13 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.214 -0.929 . . . . 0.0 110.163 -178.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.537 ' CB ' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -138.01 104.26 5.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.828 . . . . 0.0 109.284 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 303' ' ' PHE . . . . . 0.585 ' CZ ' HG12 ' B' ' 210' ' ' VAL . 11.6 m-85 -89.96 171.62 9.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.081 -1.012 . . . . 0.0 109.512 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 304' ' ' ASN . . . . . 0.488 ' ND2' HG23 ' B' ' 310' ' ' VAL . 1.4 p30 -119.16 -14.25 9.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.427 -0.796 . . . . 0.0 109.132 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 305' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -172.49 -62.81 0.05 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 306' ' ' ALA . . . . . 0.513 ' HA ' ' CE ' ' B' ' 207' ' ' MET . . . 162.74 76.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -1.097 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.52 -64.48 0.06 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -119.35 -172.94 2.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -1.148 . . . . 0.0 109.664 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 309' ' ' VAL . . . . . 0.562 ' CG1' ' CE ' ' B' ' 312' ' ' MET . 89.7 t -110.43 150.33 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.216 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . 0.488 HG23 ' ND2' ' B' ' 304' ' ' ASN . 42.6 t -123.27 -20.22 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.141 -0.974 . . . . 0.0 109.923 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 311' ' ' SER . . . . . 0.537 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -157.85 166.86 31.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.952 -1.092 . . . . 0.0 110.023 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 312' ' ' MET . . . . . 0.58 ' HE3' ' CZ ' ' B' ' 230' ' ' PHE . 1.6 ttm -156.69 154.29 29.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -0.853 . . . . 0.0 109.428 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 313' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' B' ' 299' ' ' ASP . 1.2 ttt180 -130.14 153.38 48.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.227 -0.92 . . . . 0.0 109.378 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 314' ' ' ALA . . . . . 0.459 ' HB1' ' OD1' ' B' ' 238' ' ' ASP . . . -100.45 157.18 16.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.738 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 315' ' ' LEU . . . . . 0.648 ' O ' ' CD1' ' B' ' 316' ' ' PHE . 9.0 tp -137.1 -143.78 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.427 -0.796 . . . . 0.0 109.019 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 316' ' ' PHE . . . . . 0.648 ' CD1' ' O ' ' B' ' 315' ' ' LEU . 31.0 p90 39.4 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.772 0.796 . . . . 0.0 110.313 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 317' ' ' GLY . . . . . 0.579 ' N ' ' CD2' ' B' ' 316' ' ' PHE . . . 173.62 -152.52 15.52 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 318' ' ' GLU . . . . . 0.532 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 6.8 tt0 -72.25 -2.36 18.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -1.153 . . . . 0.0 109.71 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 319' ' ' LYS . . . . . 0.455 ' NZ ' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -92.2 -32.58 15.02 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.221 -0.925 . . . . 0.0 109.316 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 320' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -89.31 19.23 4.51 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.251 0.548 . . . . 0.0 109.821 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 321' ' ' ILE . . . . . 0.532 ' CG1' ' HA ' ' B' ' 318' ' ' GLU . 5.1 mm -89.82 -167.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 322' ' ' HIS . . . . . 0.517 ' CB ' HG11 ' B' ' 294' ' ' VAL . 0.2 OUTLIER -151.67 155.14 37.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.056 -1.027 . . . . 0.0 109.247 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.116 -0.99 . . . . 0.0 109.773 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 3' ' ' THR . 9.8 t . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.469 ' O ' ' HB ' ' A' ' 8' ' ' THR . 45.5 Cg_endo -72.78 -10.52 25.04 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.869 1.457 . . . . 0.0 110.17 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -32.77 68.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 109.692 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.85 -51.0 5.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.926 . . . . 0.0 109.423 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.43 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 17.3 mtt -61.14 -48.19 82.76 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.268 -0.895 . . . . 0.0 109.902 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 4' ' ' PRO . 17.7 m -53.53 -39.05 64.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.487 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.81 -48.06 73.26 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.259 -0.901 . . . . 0.0 108.866 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.613 ' CG1' ' CE1' ' A' ' 101' ' ' PHE . 1.2 t -52.49 -28.68 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.604 ' CG2' ' CE2' ' A' ' 101' ' ' PHE . 6.6 t -85.47 -42.61 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.239 -0.913 . . . . 0.0 109.354 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.2 tt0 -59.61 -73.65 0.08 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.532 ' HD2' ' CD1' ' A' ' 29' ' ' LEU . 2.7 mtm180 -43.45 -46.12 6.63 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.541 ' O ' ' CD1' ' A' ' 14' ' ' TYR . 0.8 OUTLIER -53.13 -41.22 64.85 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.633 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -84.01 -36.58 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.092 -1.005 . . . . 0.0 108.928 179.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.71 -39.55 65.3 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -71.22 -32.36 68.7 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.633 ' CD1' ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -63.27 -58.18 8.01 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 65' ' ' VAL . 2.4 t-20 -51.13 -42.47 60.75 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.64 0.733 . . . . 0.0 109.269 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.58 2.35 53.23 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.68 -0.637 . . . . 0.0 109.604 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' CD2' ' A' ' 59' ' ' LEU . . . 49.79 38.24 29.61 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' O ' HG13 ' A' ' 26' ' ' ILE . 29.6 t70 -92.18 77.85 5.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -1.033 . . . . 0.0 109.865 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.591 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 2.8 mm? -50.69 -29.05 10.27 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.334 -0.853 . . . . 0.0 110.12 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -63.93 -56.43 15.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.975 . . . . 0.0 109.366 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.43 ' N ' ' OD2' ' A' ' 22' ' ' ASP . . . -59.0 -28.24 63.41 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 22' ' ' ASP . 55.8 mt -63.62 -58.08 8.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 43.6 t -55.82 -41.26 65.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.48 -49.98 71.09 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.532 ' CD1' ' HD2' ' A' ' 13' ' ' ARG . 2.9 tp -72.35 -21.0 61.37 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.553 -0.717 . . . . 0.0 109.265 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.602 ' CZ ' ' CE ' ' A' ' 112' ' ' MET . 7.2 m-85 -92.41 140.84 29.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.372 -0.83 . . . . 0.0 109.561 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 109' ' ' VAL . . . -51.67 178.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.073 -1.017 . . . . 0.0 109.344 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.02 -23.89 59.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.175 -0.953 . . . . 0.0 109.241 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.508 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -137.75 30.41 2.56 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.759 -0.588 . . . . 0.0 109.633 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -53.21 -173.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.159 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.518 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.2 OUTLIER -145.3 147.38 32.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.16 -0.963 . . . . 0.0 110.187 -179.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.498 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 9.5 t -134.56 118.16 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.529 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 2.3 mm-40 -88.3 104.94 17.21 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.529 ' O ' ' CE2' ' A' ' 54' ' ' PHE . 9.9 t0 -176.99 142.76 0.53 Allowed Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.92 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 47.8 Cg_endo -73.85 -166.48 4.63 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.28 -1.967 . . . . 0.0 110.651 -0.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.54 ' CG2' HG13 ' B' ' 274' ' ' VAL . 15.3 m -75.97 141.64 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.132 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.29 1.63 64.98 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.526 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -105.59 -155.26 0.54 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.265 -1.138 . . . . 0.0 109.355 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.442 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 27.9 mm-40 -127.74 131.88 24.05 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.08 -1.012 . . . . 0.0 110.07 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.0 Cg_endo -64.0 -166.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.575 1.517 . . . . 0.0 111.073 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.564 ' CG ' ' CB ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -150.62 102.64 3.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.509 -0.744 . . . . 0.0 109.049 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.2 147.04 24.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.21 -0.931 . . . . 0.0 109.768 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 111.26 159.8 16.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.501 ' CG2' HG13 ' A' ' 27' ' ' VAL . 11.3 m -70.97 -43.33 68.29 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.059 -1.26 . . . . 0.0 109.291 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -66.78 -31.78 72.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.15 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.564 ' CB ' ' CG ' ' A' ' 45' ' ' ARG . . . -80.44 -60.37 2.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.898 . . . . 0.0 109.331 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 47' ' ' GLY . 39.3 mt -43.35 -38.28 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.371 -0.831 . . . . 0.0 109.003 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 4.8 ttt-85 -84.98 -55.18 4.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.536 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 26.1 tt0 -47.71 -26.08 1.43 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.551 ' CD1' ' HD3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -84.2 -71.79 0.5 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.554 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -52.46 -20.82 3.13 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.24 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.509 ' N ' HD13 ' A' ' 23' ' ' LEU . . . -76.4 -44.73 34.84 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 48.8 t30 -64.49 -32.0 73.45 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 t -72.09 -35.35 69.2 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.591 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 3.1 tp -69.61 -24.82 63.72 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.458 -0.776 . . . . 0.0 109.383 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -43.85 -27.5 0.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 108.823 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.59 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -91.63 109.02 33.67 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.438 ' C ' ' HG ' ' A' ' 63' ' ' LEU . 45.1 Cg_endo -70.65 110.85 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.844 1.444 . . . . 0.0 111.332 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.59 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -138.46 173.1 11.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 109.497 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.519 ' CB ' ' OG ' ' A' ' 85' ' ' SER . . . -102.36 127.54 49.32 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.512 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 95.8 t -108.23 124.72 64.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 110.034 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -150.04 112.12 4.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.566 ' CD2' ' CG2' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -48.03 176.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.219 -0.926 . . . . 0.0 109.811 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.52 -81.97 0.43 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.278 -0.889 . . . . 0.0 109.293 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.587 ' HG2' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -123.43 -55.33 1.75 Allowed 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.807 -179.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.587 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 17.2 tt0 -140.55 153.99 46.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.94 -1.1 . . . . 0.0 110.442 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.566 ' CG2' ' CD2' ' A' ' 67' ' ' LEU . 19.0 t -99.57 149.12 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -95.26 128.96 42.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.483 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . . . -148.25 137.1 21.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.142 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -165.64 154.19 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 109.793 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.527 ' CB ' HG13 ' B' ' 240' ' ' VAL . . . 43.14 -147.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 0.0 109.827 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 103' ' ' PHE . 30.8 m-80 -88.98 26.54 1.54 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.279 -0.888 . . . . 0.0 109.609 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -129.68 -159.57 0.97 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.268 -0.895 . . . . 0.0 109.061 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 101' ' ' PHE . . . 168.18 157.59 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.41 -0.806 . . . . 0.0 109.794 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.555 ' O ' ' CB ' ' A' ' 72' ' ' ARG . . . -151.2 139.37 20.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 108.902 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.586 ' CE1' ' HB3' ' A' ' 99' ' ' ASP . 24.4 p90 -149.57 161.77 41.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.655 -1.278 . . . . 0.0 109.787 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.529 ' CB ' HG22 ' A' ' 98' ' ' ILE . . . -130.69 -174.99 3.52 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.574 0.702 . . . . 0.0 110.016 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CE2' ' CE2' ' A' ' 80' ' ' PHE . 19.6 p90 172.21 -172.11 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.546 -0.721 . . . . 0.0 109.22 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.34 141.11 51.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.482 -0.761 . . . . 0.0 109.551 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.546 HG11 ' CB ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -101.83 122.13 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 108.952 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.519 ' OG ' ' CB ' ' A' ' 64' ' ' ALA . 1.1 p -118.07 102.76 9.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 109.683 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.575 ' CZ ' ' HB ' ' A' ' 93' ' ' THR . 17.7 p90 -123.02 159.72 27.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.096 -1.003 . . . . 0.0 109.276 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -95.71 171.01 8.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.133 -0.979 . . . . 0.0 109.651 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.08 -160.99 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 109.578 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.83 36.44 1.54 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.319 -0.863 . . . . 0.0 109.095 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.49 -30.3 0.17 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -137.29 -167.78 2.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -1.172 . . . . 0.0 109.352 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.01 136.18 50.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 109.692 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.575 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -120.4 157.48 29.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.271 -0.893 . . . . 0.0 109.874 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 122' ' ' HIS . 12.0 p -138.24 163.9 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.314 -0.866 . . . . 0.0 109.138 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.567 ' CG1' ' ND2' ' A' ' 120' ' ' ASN . 41.4 t -142.44 155.49 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.987 -1.071 . . . . 0.0 109.93 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.525 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -127.86 73.81 78.77 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.494 -0.754 . . . . 0.0 109.818 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.512 ' HB3' ' ND2' ' A' ' 120' ' ' ASN . 44.0 Cg_endo -95.39 175.49 0.98 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.586 1.524 . . . . 0.0 111.578 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.529 HG22 ' CB ' ' A' ' 81' ' ' ALA . 3.4 mp -143.19 152.39 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.586 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 12.7 t0 -125.42 161.49 26.94 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.004 -1.06 . . . . 0.0 110.229 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 113' ' ' ARG . 5.2 t60 -108.22 179.82 4.1 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.632 ' CE1' ' CE ' ' A' ' 112' ' ' MET . 0.3 OUTLIER -146.24 160.18 42.33 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.756 -1.215 . . . . 0.0 110.597 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.546 ' CB ' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -147.09 103.92 3.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.588 ' CZ ' ' CG2' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -90.0 -171.06 3.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.165 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.543 ' OD1' ' CG2' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -139.42 -101.89 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.462 -0.774 . . . . 0.0 109.526 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . -96.44 21.03 47.8 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 77.35 66.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -1.112 . . . . 0.0 109.502 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.54 -65.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -128.93 -178.23 4.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -1.134 . . . . 0.0 109.507 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.523 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 45.3 t -94.0 141.52 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.375 -0.828 . . . . 0.0 109.395 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.543 ' CG2' ' OD1' ' A' ' 104' ' ' ASN . 24.6 t -121.95 -15.22 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 109.976 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.546 ' CB ' ' CB ' ' A' ' 102' ' ' ARG . 0.3 OUTLIER -158.68 157.32 31.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.93 -1.106 . . . . 0.0 109.956 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.632 ' CE ' ' CE1' ' A' ' 101' ' ' PHE . 8.0 ttm -155.46 160.43 40.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.426 -0.796 . . . . 0.0 109.456 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 100' ' ' HIS . 10.1 ttp180 -149.75 114.41 5.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.858 . . . . 0.0 109.403 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 99' ' ' ASP . . . -89.98 137.59 32.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.082 -1.011 . . . . 0.0 109.461 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.56 ' CD2' ' CB ' ' B' ' 279' ' ' ALA . 1.0 OUTLIER -134.12 143.65 48.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.965 . . . . 0.0 110.102 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.538 ' O ' ' CG2' ' B' ' 274' ' ' VAL . 32.9 p90 164.36 -163.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . -176.15 -179.86 46.85 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.246 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.515 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 11.9 tt0 -50.63 -21.46 1.58 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -1.138 . . . . 0.0 109.304 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -22.55 60.7 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.017 0.913 . . . . 0.0 108.668 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.567 ' ND2' ' CG1' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -88.72 3.27 51.45 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.676 -179.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.522 HG21 ' CG2' ' A' ' 95' ' ' VAL . 4.2 mm -93.39 -179.34 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.028 -1.045 . . . . 0.0 109.372 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.532 ' CB ' ' O ' ' A' ' 94' ' ' VAL . 0.7 OUTLIER -151.56 161.46 42.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.509 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.38 152.86 29.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.513 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.9 -128.4 9.49 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.277 -1.131 . . . . 0.0 109.505 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.219 0.533 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -120.92 55.79 1.03 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.1 111.0 44.3 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.348 -0.845 . . . . 0.0 109.558 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' B' ' 208' ' ' THR . 44.3 Cg_endo -71.38 -8.57 23.63 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.832 1.438 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -66.41 -45.46 79.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.043 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -55.69 6.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 109.161 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 13.0 mmt -53.52 -41.96 66.89 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.432 ' CB ' ' O ' ' B' ' 204' ' ' PRO . 6.0 m -63.38 -35.51 80.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 109.06 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -51.13 -44.08 61.29 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.218 -0.926 . . . . 0.0 108.72 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.649 ' CG1' ' CE1' ' B' ' 301' ' ' PHE . 1.1 t -57.08 -25.44 22.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.621 ' CG2' ' CE2' ' B' ' 301' ' ' PHE . 23.9 t -88.43 -44.88 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.832 . . . . 0.0 109.159 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' B' ' 213' ' ' ARG . 24.6 tt0 -58.99 -73.96 0.07 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' B' ' 212' ' ' GLN . 0.2 OUTLIER -42.77 -44.53 4.44 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' TYR . . . . . 0.64 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -51.21 -44.87 61.71 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.543 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.6 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.08 -41.23 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.39 -35.03 11.82 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' B' ' 221' ' ' GLY . . . -75.86 -33.46 60.0 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.64 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 3.1 mt -62.84 -57.39 11.03 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' B' ' 265' ' ' VAL . 4.6 t30 -53.68 -45.67 70.4 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.576 0.703 . . . . 0.0 109.578 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.14 7.23 36.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.476 -0.765 . . . . 0.0 109.745 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' B' ' 217' ' ' ALA . . . 51.83 42.06 52.51 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.476 ' OD2' ' HA3' ' B' ' 225' ' ' GLY . 18.0 t70 -97.8 61.44 1.57 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.112 . . . . 0.0 109.928 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' LEU . . . . . 0.586 ' CD1' ' HB3' ' B' ' 255' ' ' PHE . 7.1 tp -47.79 -44.12 28.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 108.883 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' B' ' 223' ' ' LEU . 3.9 t0 -43.86 -39.5 3.92 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . 0.476 ' HA3' ' OD2' ' B' ' 222' ' ' ASP . . . -80.77 -32.35 33.42 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.532 HD12 ' CD2' ' B' ' 255' ' ' PHE . 13.8 mt -61.97 -58.48 7.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' B' ' 252' ' ' ARG . 50.7 t -54.57 -39.73 47.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.71 -54.63 41.94 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 7.7 tp -61.76 -22.9 65.8 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' B' ' 231' ' ' ALA . 6.5 m-85 -90.85 132.43 35.9 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.428 -0.795 . . . . 0.0 109.918 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' B' ' 309' ' ' VAL . . . -50.66 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 0.0 109.652 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' B' ' 248' ' ' THR . 0.2 OUTLIER -76.31 -24.4 54.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 109.733 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . 0.503 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 0.1 OUTLIER -133.46 39.76 3.2 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.474 -0.766 . . . . 0.0 109.764 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' B' ' 251' ' ' ILE . . . -64.0 144.49 57.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.138 -0.976 . . . . 0.0 109.346 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -106.18 139.58 40.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 0.0 109.6 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' B' ' 244' ' ' PRO . 55.2 t -132.72 118.39 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.411 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' GLU . . . . . 0.515 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 29.3 mt-10 -89.42 106.24 18.32 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' ASP . . . . . 0.53 ' O ' ' CE2' ' B' ' 254' ' ' PHE . 28.4 t70 -179.67 141.68 0.35 Allowed Pre-proline 0 C--N 1.302 -1.484 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.492 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . 0.477 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 48.4 Cg_endo -74.11 169.89 72.47 Favored 'Cis proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.295 -1.961 . . . . 0.0 110.545 0.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.527 HG13 ' CB ' ' A' ' 75' ' ' ALA . 8.0 t -67.47 113.99 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.179 -0.951 . . . . 0.0 109.236 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . 0.46 ' HA2' ' HB1' ' A' ' 75' ' ' ALA . . . 112.93 -2.52 25.74 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 17.5 m -109.38 -113.05 0.31 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -1.124 . . . . 0.0 109.212 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . 0.469 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 1.2 pp20? -164.34 131.46 2.42 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.904 -1.122 . . . . 0.0 109.612 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' PRO . . . . . 0.515 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.8 Cg_endo -64.83 -177.34 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.011 1.532 . . . . 0.0 111.13 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.541 ' HG3' ' CD1' ' B' ' 254' ' ' PHE . 11.1 mmt180 -150.54 99.94 2.8 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.523 ' HB2' ' CG2' ' B' ' 235' ' ' THR . 0.0 OUTLIER -88.88 164.71 15.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.32 -0.863 . . . . 0.0 109.748 -179.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 101.46 162.19 27.19 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' THR . . . . . 0.525 ' N ' ' O ' ' B' ' 232' ' ' ASP . 5.9 m -70.04 -52.81 20.99 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.163 -1.198 . . . . 0.0 109.382 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -59.68 -40.75 88.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.162 -0.961 . . . . 0.0 109.438 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' B' ' 246' ' ' SER . . . -68.37 -54.9 14.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 109.605 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' B' ' 234' ' ' ALA . 8.5 mm -47.39 -36.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.115 -0.991 . . . . 0.0 109.116 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 252' ' ' ARG . . . . . 0.575 ' CG ' ' CD2' ' B' ' 223' ' ' LEU . 6.9 ttt180 -84.96 -55.16 4.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 253' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 5.5 mt-10 -48.7 -26.98 2.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.992 -1.068 . . . . 0.0 108.327 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.541 ' CD1' ' HG3' ' B' ' 245' ' ' ARG . 0.2 OUTLIER -86.71 -72.6 0.5 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 255' ' ' PHE . . . . . 0.586 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -49.1 -26.55 2.77 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.18 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . 0.531 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -70.38 -41.69 72.75 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -58.86 -27.4 65.13 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 41.9 t -77.69 -34.27 52.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 259' ' ' LEU . . . . . 0.444 HD12 ' HA2' ' B' ' 221' ' ' GLY . 7.9 tp -70.04 -26.7 64.16 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.436 -0.79 . . . . 0.0 109.47 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -49.43 -31.43 9.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.278 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 261' ' ' LEU . . . . . 0.577 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.9 OUTLIER -90.03 114.6 61.45 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.287 -0.883 . . . . 0.0 109.006 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 262' ' ' PRO . . . . . 0.442 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 43.3 Cg_endo -70.44 109.25 2.39 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.719 1.379 . . . . 0.0 110.665 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.581 ' CB ' ' CG1' ' B' ' 284' ' ' VAL . 0.0 OUTLIER -140.29 159.65 41.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.486 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -92.81 128.41 38.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.87 . . . . 0.0 108.694 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 265' ' ' VAL . . . . . 0.498 ' N ' ' OD1' ' B' ' 219' ' ' ASN . 11.0 t -107.67 113.83 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 109.697 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 266' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' B' ' 267' ' ' LEU . 6.7 tt0 -150.47 95.47 2.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.4 -0.813 . . . . 0.0 109.042 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.5 mp -44.75 169.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.2 -0.938 . . . . 0.0 109.836 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 5.1 t -127.65 -31.64 2.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 269' ' ' GLN . . . . . 0.522 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 13.7 pt20 -107.88 -151.42 0.47 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.524 -0.735 . . . . 0.0 109.459 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 270' ' ' GLU . . . . . 0.522 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 42.2 tt0 -106.64 129.96 54.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.486 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 271' ' ' VAL . . . . . 0.536 HG12 ' CG1' ' B' ' 211' ' ' VAL . 16.6 t -60.24 150.85 6.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.398 -0.813 . . . . 0.0 109.367 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 4.9 tpp180 -104.98 131.36 52.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 108.875 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . 0.522 ' HA ' ' CB ' ' B' ' 278' ' ' ALA . . . -148.0 126.23 12.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.089 -1.007 . . . . 0.0 109.9 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 274' ' ' VAL . . . . . 0.54 HG13 ' CG2' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -121.95 -155.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.245 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 275' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' B' ' 276' ' ' ASN . . . -83.85 126.5 33.02 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.384 -0.822 . . . . 0.0 110.678 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 276' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' B' ' 275' ' ' ALA . 57.1 m-20 69.27 -2.35 1.88 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.706 -0.621 . . . . 0.0 111.721 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . 0.484 ' CG ' ' O ' ' B' ' 301' ' ' PHE . 3.4 tt0 -150.67 -160.47 1.17 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.418 -1.426 . . . . 0.0 110.518 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 278' ' ' ALA . . . . . 0.522 ' CB ' ' HA ' ' B' ' 273' ' ' ALA . . . 165.45 152.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 279' ' ' ALA . . . . . 0.56 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . . . -138.91 136.92 36.0 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 33.5 p90 -149.97 167.38 26.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.831 -1.168 . . . . 0.0 110.546 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . 0.531 ' CB ' HG21 ' B' ' 298' ' ' ILE . . . -142.68 -162.02 1.35 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.415 0.626 . . . . 0.0 109.448 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 282' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 0.0 OUTLIER 163.92 -175.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.885 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 283' ' ' THR . . . . . 0.439 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -127.86 141.11 51.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.436 -0.79 . . . . 0.0 109.733 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 284' ' ' VAL . . . . . 0.581 ' CG1' ' CB ' ' B' ' 263' ' ' LEU . 66.6 t -111.24 113.53 44.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.47 -0.769 . . . . 0.0 108.929 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 53.7 p -105.63 84.26 2.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.908 . . . . 0.0 110.028 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.57 ' CE1' ' HB ' ' B' ' 293' ' ' THR . 34.3 p90 -89.95 177.5 6.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.878 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -127.58 153.47 46.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.12 -0.988 . . . . 0.0 109.617 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -103.11 -98.03 0.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.379 -0.826 . . . . 0.0 109.586 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -140.31 47.09 1.8 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.194 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 139.99 -42.31 1.23 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -94.63 -166.69 1.52 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.508 -0.995 . . . . 0.0 108.877 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 292' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -149.29 123.35 9.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.044 -1.035 . . . . 0.0 109.744 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 293' ' ' THR . . . . . 0.57 ' HB ' ' CE1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -111.04 147.28 35.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.377 -0.827 . . . . 0.0 109.22 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 294' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' B' ' 322' ' ' HIS . 11.1 p -127.52 167.95 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 109.681 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.538 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 3.5 t -140.18 148.21 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 108.999 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 296' ' ' ALA . . . . . 0.527 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -132.1 71.48 79.89 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 0.0 110.895 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 297' ' ' PRO . . . . . 0.538 ' HD3' ' CG1' ' B' ' 295' ' ' VAL . 51.1 Cg_endo -93.82 -174.28 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.486 1.458 . . . . 0.0 110.292 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.531 HG21 ' CB ' ' B' ' 281' ' ' ALA . 2.6 mp -140.04 162.64 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.875 . . . . 0.0 108.945 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . 0.573 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 14.0 t0 -133.1 157.49 45.16 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.11 -0.994 . . . . 0.0 110.084 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 300' ' ' HIS . . . . . 0.518 ' N ' ' OD1' ' B' ' 299' ' ' ASP . 0.3 OUTLIER -112.81 167.25 10.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 301' ' ' PHE . . . . . 0.649 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.2 OUTLIER -137.94 157.74 45.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.979 -1.076 . . . . 0.0 110.536 -178.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.475 ' HA ' ' HG3' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -150.09 104.33 3.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 303' ' ' PHE . . . . . 0.613 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 6.9 m-85 -89.6 129.72 36.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.469 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 304' ' ' ASN . . . . . 0.566 ' N ' ' ND2' ' B' ' 304' ' ' ASN . 0.0 OUTLIER -137.42 14.63 2.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.294 -0.878 . . . . 0.0 109.428 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . -135.69 5.87 4.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . 50.1 25.22 1.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -1.134 . . . . 0.0 109.602 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -161.25 -42.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -123.54 -168.12 1.72 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -1.091 . . . . 0.0 109.46 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 309' ' ' VAL . . . . . 0.508 HG21 ' CE1' ' B' ' 301' ' ' PHE . 38.2 t -111.84 138.26 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.941 . . . . 0.0 108.993 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . 0.523 ' HB ' ' ND2' ' B' ' 304' ' ' ASN . 2.7 t -121.3 -6.93 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.849 -1.157 . . . . 0.0 109.788 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 311' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.4 OUTLIER -155.23 152.93 29.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 0.0 109.347 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 312' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 300' ' ' HIS . 5.7 ttp -160.22 154.97 24.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 109.865 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 313' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' B' ' 299' ' ' ASP . 0.0 OUTLIER -137.77 163.7 30.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 109.067 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -142.5 141.56 32.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.019 -1.051 . . . . 0.0 109.72 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 315' ' ' LEU . . . . . 0.498 ' O ' ' HB3' ' B' ' 316' ' ' PHE . 0.3 OUTLIER -137.9 139.13 39.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 109.726 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 316' ' ' PHE . . . . . 0.501 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 14.6 p90 173.76 -157.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.567 0.699 . . . . 0.0 109.352 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 317' ' ' GLY . . . . . 0.437 ' N ' ' CD2' ' B' ' 316' ' ' PHE . . . 165.29 -168.37 39.31 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 318' ' ' GLU . . . . . 0.526 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 15.7 tt0 -71.54 -4.37 26.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -1.164 . . . . 0.0 109.355 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 319' ' ' LYS . . . . . 0.463 ' HD3' ' OE1' ' A' ' 70' ' ' GLU . 2.4 tttm -89.72 -28.39 19.44 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 122.02 0.914 . . . . 0.0 108.87 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 320' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.1 OUTLIER -89.24 4.48 48.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 321' ' ' ILE . . . . . 0.526 ' CG1' ' HA ' ' B' ' 318' ' ' GLU . 5.0 mm -89.86 -173.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.325 -0.86 . . . . 0.0 108.83 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 322' ' ' HIS . . . . . 0.534 ' HB3' ' CG1' ' B' ' 294' ' ' VAL . 0.2 OUTLIER -150.86 -164.74 2.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.071 -1.018 . . . . 0.0 109.792 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.081 179.839 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.58 ' O ' ' CE1' ' A' ' 6' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.465 ' HA ' ' HE2' ' A' ' 7' ' ' MET . 42.6 Cg_endo -70.08 -4.81 15.0 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.761 1.401 . . . . 0.0 109.877 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.455 ' HB2' HG21 ' A' ' 3' ' ' THR . 0.0 OUTLIER -56.84 -52.81 63.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.304 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 3' ' ' THR . 36.9 p-80 -70.3 -41.94 72.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.903 . . . . 0.0 109.273 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.577 ' CG ' ' NE2' ' A' ' 6' ' ' HIS . 10.3 mtt -59.07 -44.29 91.83 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.199 -0.938 . . . . 0.0 109.342 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.47 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 14.2 m -64.9 -38.46 91.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.315 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.66 77.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 108.872 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.64 ' CG1' ' CZ ' ' A' ' 101' ' ' PHE . 1.4 t -55.12 -20.68 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.587 HG21 ' CD2' ' A' ' 80' ' ' PHE . 18.5 t -90.61 -43.5 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.409 -0.807 . . . . 0.0 109.236 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 13' ' ' ARG . 24.1 tt0 -61.19 -73.72 0.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.259 1.028 . . . . 0.0 108.313 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.449 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -42.07 -44.16 3.5 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.157 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.642 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -50.01 -46.61 52.94 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.616 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -86.23 -39.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.355 -0.84 . . . . 0.0 109.083 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.61 -36.68 16.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.526 ' HB3' ' CG1' ' A' ' 26' ' ' ILE . . . -74.37 -32.0 62.59 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.642 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 1.8 mt -65.3 -58.4 6.01 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.439 ' CG ' ' O ' ' A' ' 65' ' ' VAL . 24.4 t30 -52.56 -46.4 66.83 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.596 0.712 . . . . 0.0 109.089 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.96 10.67 20.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.649 -0.657 . . . . 0.0 109.476 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.489 ' CA ' ' CD2' ' A' ' 59' ' ' LEU . . . 45.52 27.81 2.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.47 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 1.8 t70 -89.93 67.81 7.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -1.091 . . . . 0.0 109.866 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.598 ' CD1' ' HB3' ' A' ' 55' ' ' PHE . 4.6 tp -47.8 -41.31 23.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 109.165 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' LEU . 5.2 m-20 -41.49 -28.83 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -88.04 -35.87 8.71 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.526 ' CG1' ' HB3' ' A' ' 17' ' ' ALA . 22.0 mt -59.54 -53.82 43.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.538 HG23 ' CG ' ' A' ' 52' ' ' ARG . 91.1 t -59.72 -43.23 91.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.98 -43.62 66.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.532 ' CD2' ' HA ' ' A' ' 10' ' ' VAL . 6.6 tp -73.39 -27.91 61.72 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.465 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 8.8 m-85 -84.83 138.45 32.56 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.32 -0.862 . . . . 0.0 109.841 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -51.68 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 109.697 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.469 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -70.72 -23.42 62.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.622 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.539 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -148.51 41.08 0.95 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.623 -0.673 . . . . 0.0 109.264 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 110' ' ' VAL . . . -52.95 151.77 4.44 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.253 -0.904 . . . . 0.0 109.699 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.46 ' OG1' ' OG ' ' A' ' 111' ' ' SER . 0.1 OUTLIER -100.34 144.44 29.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.387 -0.82 . . . . 0.0 109.432 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.58 ' CG1' ' N ' ' A' ' 37' ' ' GLU . 2.1 t -123.58 169.14 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 108.899 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -142.65 105.39 4.52 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.205 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 37' ' ' GLU . 4.6 t70 177.67 142.93 0.26 Allowed Pre-proline 0 N--CA 1.495 1.777 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.065 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 46.6 Cg_endo -75.45 -176.34 18.04 Favored 'Cis proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.191 -2.004 . . . . 0.0 110.163 -0.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.469 HG23 ' CB ' ' B' ' 274' ' ' VAL . 3.5 m -80.11 83.73 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.091 -1.006 . . . . 0.0 109.125 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.86 -13.92 1.33 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.534 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -108.57 -149.23 0.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -1.084 . . . . 0.0 109.417 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -109.93 133.92 20.83 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.916 -1.115 . . . . 0.0 110.721 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.59 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.3 Cg_endo -63.65 -161.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.157 1.904 . . . . 0.0 111.369 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.54 ' HB3' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -150.17 123.31 8.86 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.94 152.3 34.85 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.025 -1.047 . . . . 0.0 110.448 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 93.85 162.83 36.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 2.9 m -72.12 -57.58 4.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -1.113 . . . . 0.0 109.17 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -47.66 -29.28 2.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -90.07 -61.88 1.59 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.35 -0.844 . . . . 0.0 109.383 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.536 ' CD1' ' HD2' ' A' ' 45' ' ' ARG . 7.7 mm -45.36 -33.7 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.307 -0.871 . . . . 0.0 109.173 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.561 ' CG ' ' CD2' ' A' ' 23' ' ' LEU . 53.6 ttp85 -86.83 -61.45 1.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 108.924 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 26.1 tt0 -44.38 -28.8 0.59 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 108.564 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.54 ' CD2' ' HB3' ' A' ' 45' ' ' ARG . 1.2 t80 -80.71 -70.6 0.51 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.598 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -47.0 -25.52 0.82 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' CA ' HD21 ' A' ' 23' ' ' LEU . . . -76.24 -55.08 5.9 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -51.25 -30.77 18.7 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.6 t -76.09 -34.31 59.52 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.489 ' CD2' ' CA ' ' A' ' 21' ' ' GLY . 7.7 tp -68.82 -21.59 64.3 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.418 -0.802 . . . . 0.0 108.995 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -55.35 -18.68 7.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.364 -0.835 . . . . 0.0 109.049 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.52 ' O ' ' CD1' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -89.64 125.34 61.55 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.281 -0.887 . . . . 0.0 108.881 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 86' ' ' PHE . 44.8 Cg_endo -71.44 103.08 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.791 1.416 . . . . 0.0 110.621 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.588 ' CB ' ' CG1' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -136.8 160.03 40.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.1 -1.0 . . . . 0.0 110.021 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.51 ' CB ' ' OG ' ' A' ' 85' ' ' SER . . . -99.47 129.1 45.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.439 ' O ' ' CG ' ' A' ' 19' ' ' ASN . 3.3 t -111.55 114.87 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.716 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -150.5 101.1 2.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.582 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -49.82 -179.71 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.234 -0.916 . . . . 0.0 109.556 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.6 t -162.2 -37.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.199 -0.938 . . . . 0.0 109.773 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -93.67 -147.68 0.25 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.57 -0.706 . . . . 0.0 109.27 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 23.4 tt0 -115.82 130.39 56.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.188 -0.945 . . . . 0.0 109.687 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.529 ' CG2' HG12 ' A' ' 11' ' ' VAL . 33.7 t -64.19 154.51 6.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.396 -0.815 . . . . 0.0 109.115 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.508 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 3.9 mmt180 -115.56 130.27 56.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.534 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.452 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -147.65 128.32 14.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -0.851 . . . . 0.0 109.228 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -152.3 160.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 0.0 109.26 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 47.95 -144.43 0.37 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.263 -0.898 . . . . 0.0 109.387 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -90.16 -8.44 51.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.088 -1.008 . . . . 0.0 109.645 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.474 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 3.1 mt-10 -104.13 -162.87 0.93 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.236 -0.915 . . . . 0.0 109.501 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 101' ' ' PHE . . . -175.71 168.56 3.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.0 109.677 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.58 ' HB1' ' CD2' ' A' ' 100' ' ' HIS . . . -150.52 136.66 18.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.02 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 15.2 p90 -150.01 167.46 26.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.953 -1.092 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.534 ' HB1' ' CG1' ' A' ' 98' ' ' ILE . . . -142.85 168.14 20.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.456 0.646 . . . . 0.0 109.622 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 4.5 p90 -164.59 -169.05 1.64 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -0.838 . . . . 0.0 109.277 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.87 141.83 50.34 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.484 -0.76 . . . . 0.0 109.814 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.588 ' CG1' ' CB ' ' A' ' 63' ' ' LEU . 16.4 t -118.12 112.98 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.364 -0.835 . . . . 0.0 109.116 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.521 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 96.5 p -107.42 99.07 8.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.205 -0.935 . . . . 0.0 109.271 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.539 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . 21.4 p90 -117.41 176.36 5.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.377 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.495 ' HG2' ' N ' ' A' ' 88' ' ' PHE . 60.7 tt0 -149.98 151.23 33.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.756 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.566 ' CZ ' ' OG1' ' A' ' 93' ' ' THR . 7.9 m-85 -96.71 -141.85 0.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.412 -0.805 . . . . 0.0 109.289 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -102.68 45.59 0.96 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.02 -1.05 . . . . 0.0 109.321 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.52 -42.95 0.46 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -107.7 164.75 11.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -1.191 . . . . 0.0 109.488 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -133.54 123.63 25.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 109.531 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.566 ' OG1' ' CZ ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -117.8 148.68 41.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.845 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.557 HG11 ' CG ' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -117.95 178.17 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 108.812 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.554 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 2.5 t -150.33 141.36 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.099 -1.001 . . . . 0.0 109.848 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.452 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -129.1 73.02 81.98 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.482 -0.761 . . . . 0.0 109.877 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.554 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 50.4 Cg_endo -95.16 -179.37 0.58 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.448 1.432 . . . . 0.0 111.648 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.534 ' CG1' ' HB1' ' A' ' 81' ' ' ALA . 2.7 mp -141.48 133.42 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 5.2 t0 -107.29 162.73 13.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.865 -1.147 . . . . 0.0 110.413 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.58 ' CD2' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -114.75 173.66 6.36 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.111 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.64 ' CZ ' ' CG1' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -145.44 146.38 31.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.895 -1.128 . . . . 0.0 110.72 -178.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.474 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -138.55 102.5 4.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.419 -0.801 . . . . 0.0 109.375 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.46 ' CE2' HG21 ' A' ' 10' ' ' VAL . 16.6 m-85 -89.6 174.28 7.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 109.381 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.522 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 0.5 OUTLIER -114.27 -14.35 12.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.858 . . . . 0.0 109.122 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . 114.93 78.84 0.8 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 163.23 -21.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.35 -1.088 . . . . 0.0 109.721 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 122.19 -35.65 3.43 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -59.56 175.5 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -1.184 . . . . 0.0 109.567 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 110' ' ' VAL . 45.8 t -113.27 145.96 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.064 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 5.1 t -121.18 -73.39 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.103 -0.998 . . . . 0.0 109.389 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.46 ' OG ' ' OG1' ' A' ' 35' ' ' THR . 0.6 OUTLIER -114.66 166.64 11.52 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.029 -1.044 . . . . 0.0 109.047 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 19.6 ttp -154.92 137.41 15.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.165 -0.96 . . . . 0.0 109.902 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.472 ' HA ' ' HB2' ' A' ' 37' ' ' GLU . 3.0 mtm180 -111.55 161.59 16.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.79 . . . . 0.0 108.955 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.409 ' O ' ' CG1' ' A' ' 40' ' ' VAL . . . -143.47 132.26 22.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.98 -1.075 . . . . 0.0 109.77 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.516 ' O ' ' HB3' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -123.3 137.09 54.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.771 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.516 ' HB3' ' O ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER 171.14 -162.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.508 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . 167.75 175.96 38.0 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.359 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.491 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 37.4 tt0 -48.95 -22.91 0.94 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -1.194 . . . . 0.0 109.281 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.483 ' NZ ' ' CD ' ' B' ' 270' ' ' GLU . 0.3 OUTLIER -73.33 -22.55 60.29 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.043 0.925 . . . . 0.0 108.92 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.523 ' OD1' ' CD1' ' A' ' 121' ' ' ILE . 0.5 OUTLIER -88.54 0.73 56.03 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.634 -179.422 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.523 ' CD1' ' OD1' ' A' ' 120' ' ' ASN . 3.0 mm -89.59 -159.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.912 -1.117 . . . . 0.0 108.703 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.557 ' CG ' HG11 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.39 -168.4 3.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 109.637 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.438 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.41 147.16 23.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.542 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.91 118.45 1.47 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.264 -1.139 . . . . 0.0 109.479 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 34.1 mtp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.312 0.577 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.465 ' HB3' ' HE1' ' B' ' 207' ' ' MET . 6.9 m-80 -121.11 96.37 5.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.543 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 2.5 t -45.92 109.51 0.99 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.316 -0.865 . . . . 0.0 109.565 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.38 -2.95 12.49 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.894 1.471 . . . . 0.0 110.182 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.3 -49.25 77.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 109.35 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -65.11 -51.72 59.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.583 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 207' ' ' MET . . . . . 0.465 ' HE1' ' HB3' ' B' ' 202' ' ' ASN . 25.2 mtt -60.24 -47.5 85.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.257 -0.902 . . . . 0.0 109.789 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 15.6 m -56.6 -38.72 72.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.164 -0.96 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -56.62 -49.07 76.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.121 -0.987 . . . . 0.0 108.99 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.639 ' CG1' ' CE1' ' B' ' 301' ' ' PHE . 0.9 OUTLIER -52.27 -24.16 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.509 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.521 HG22 ' CE2' ' B' ' 301' ' ' PHE . 23.2 t -85.82 -44.77 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.4 -0.813 . . . . 0.0 109.302 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' B' ' 213' ' ' ARG . 7.4 tt0 -57.11 -73.89 0.06 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' B' ' 212' ' ' GLN . 1.3 mtt85 -43.59 -44.89 6.46 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' TYR . . . . . 0.63 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -51.24 -45.4 61.97 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.61 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.0 OUTLIER -86.14 -37.7 11.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -49.13 -36.01 18.0 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -74.3 -31.84 62.64 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.63 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 0.8 OUTLIER -65.65 -57.72 7.44 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 0.2 OUTLIER -56.04 -45.12 79.3 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.542 0.687 . . . . 0.0 109.148 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' B' ' 221' ' ' GLY . . . -89.36 11.21 19.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.525 -0.734 . . . . 0.0 109.603 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' B' ' 217' ' ' ALA . . . 45.3 32.51 3.72 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.2 t70 -90.18 63.19 5.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.48 -1.012 . . . . 0.0 109.829 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' LEU . . . . . 0.588 ' CD1' ' HB3' ' B' ' 255' ' ' PHE . 6.1 tp -48.51 -43.97 35.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.099 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' B' ' 223' ' ' LEU . 26.2 t0 -42.49 -31.02 0.39 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -86.33 -32.56 16.24 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' B' ' 223' ' ' LEU . 27.2 mt -62.77 -56.66 16.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.465 HG21 ' HB2' ' B' ' 252' ' ' ARG . 78.7 t -56.3 -35.19 42.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.58 -56.38 22.07 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.538 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 8.0 tp -59.9 -25.79 65.39 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.556 -0.715 . . . . 0.0 109.08 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' B' ' 231' ' ' ALA . 7.4 m-85 -86.42 130.07 34.63 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.496 -0.752 . . . . 0.0 109.779 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -43.0 166.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 109.665 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -24.2 5.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.349 -0.844 . . . . 0.0 110.071 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . 0.52 ' CB ' ' HA2' ' B' ' 247' ' ' GLY . 2.0 p30 -148.84 54.13 0.99 Allowed 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.572 -0.705 . . . . 0.0 109.437 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.559 ' N ' ' CD1' ' B' ' 251' ' ' ILE . . . -68.04 165.08 18.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.659 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' THR . . . . . 0.519 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -115.71 156.54 25.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 109.767 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.516 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 53.9 t -143.31 116.83 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.076 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.2 mt-10 -88.9 105.52 17.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 108.873 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' ASP . . . . . 0.514 ' OD2' ' CB ' ' B' ' 314' ' ' ALA . 9.9 t70 179.54 141.63 0.31 Allowed Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.919 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . 0.462 ' HG2' ' OG ' ' B' ' 242' ' ' SER . 48.5 Cg_endo -74.63 -173.85 12.81 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.048 -2.063 . . . . 0.0 110.343 -0.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.2 t -76.84 135.12 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.131 -0.98 . . . . 0.0 109.124 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 89.73 -3.78 83.34 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' SER . . . . . 0.462 ' OG ' ' HG2' ' B' ' 239' ' ' PRO . 67.5 m -107.08 -132.76 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -1.145 . . . . 0.0 109.149 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' B' ' 242' ' ' SER . 19.9 mt-10 -148.43 133.62 9.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 120.616 -1.303 . . . . 0.0 110.042 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.4 Cg_endo -64.39 -172.7 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.133 1.596 . . . . 0.0 111.3 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.538 ' HB2' ' CD2' ' B' ' 254' ' ' PHE . 0.0 OUTLIER -150.69 105.99 3.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -93.0 162.24 14.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.282 -0.887 . . . . 0.0 110.616 -178.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . 0.52 ' HA2' ' CB ' ' B' ' 233' ' ' ASP . . . 97.51 159.35 30.9 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 248' ' ' THR . . . . . 0.41 HG22 HG12 ' B' ' 227' ' ' VAL . 7.3 m -73.23 -45.39 56.32 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.162 -1.199 . . . . 0.0 109.014 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -63.95 -24.17 67.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.826 . . . . 0.0 109.025 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' B' ' 246' ' ' SER . . . -90.02 -59.05 2.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.313 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.559 ' CD1' ' N ' ' B' ' 234' ' ' ALA . 21.7 mt -47.58 -39.25 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.364 -0.835 . . . . 0.0 109.255 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 252' ' ' ARG . . . . . 0.535 ' HG2' ' CD2' ' B' ' 223' ' ' LEU . 15.6 ttt180 -76.0 -57.16 4.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 109.068 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 253' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 8.0 mt-10 -46.4 -29.39 1.68 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.033 -1.042 . . . . 0.0 108.609 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.538 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.8 OUTLIER -83.74 -72.64 0.45 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 255' ' ' PHE . . . . . 0.588 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.1 OUTLIER -48.84 -24.54 1.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.552 -0.718 . . . . 0.0 109.166 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . 0.53 ' CA ' HD21 ' B' ' 223' ' ' LEU . . . -74.91 -44.91 46.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 108.707 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 257' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 5.3 t30 -56.73 -34.33 67.41 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 18.8 t -72.29 -47.0 53.34 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.49 -0.756 . . . . 0.0 109.179 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 259' ' ' LEU . . . . . 0.466 ' CD1' ' HA2' ' B' ' 221' ' ' GLY . 9.5 tp -57.46 -18.11 16.68 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.345 -0.847 . . . . 0.0 109.315 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 260' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 1.8 mttm -64.44 -19.6 65.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 109.592 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 261' ' ' LEU . . . . . 0.593 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.3 OUTLIER -89.37 120.43 69.7 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 262' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 45.0 Cg_endo -70.57 94.55 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.791 1.416 . . . . 0.0 110.755 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.593 ' CD2' ' CD2' ' B' ' 261' ' ' LEU . 0.0 OUTLIER -133.15 157.16 46.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.0 109.498 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . 0.436 ' HB2' ' OG ' ' B' ' 285' ' ' SER . . . -92.35 127.03 37.68 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 265' ' ' VAL . . . . . 0.401 ' O ' ' OD1' ' B' ' 219' ' ' ASN . 30.9 t -107.28 114.26 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 2.3 tt0 -150.1 95.76 2.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.084 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' B' ' 266' ' ' GLU . 2.7 mp -43.86 169.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 268' ' ' THR . . . . . 0.465 ' O ' ' O ' ' B' ' 269' ' ' GLN . 0.0 OUTLIER -129.01 -78.56 0.56 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.523 -0.736 . . . . 0.0 109.213 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 269' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' B' ' 268' ' ' THR . 2.0 pt20 -59.3 -149.19 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 270' ' ' GLU . . . . . 0.483 ' CD ' ' NZ ' ' A' ' 119' ' ' LYS . 31.6 tt0 -111.51 131.45 55.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.033 -1.042 . . . . 0.0 109.68 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 271' ' ' VAL . . . . . 0.53 HG11 ' N ' ' B' ' 272' ' ' ARG . 72.8 t -52.85 144.06 4.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.32 -0.863 . . . . 0.0 109.342 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.53 ' N ' HG11 ' B' ' 271' ' ' VAL . 0.0 OUTLIER -105.75 130.25 53.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.935 . . . . 0.0 109.503 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . 0.465 ' HA ' ' CB ' ' B' ' 278' ' ' ALA . . . -147.25 137.09 23.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 109.321 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 274' ' ' VAL . . . . . 0.512 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -155.07 149.71 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 0.0 109.174 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 275' ' ' ALA . . . . . 0.428 ' O ' ' SD ' ' B' ' 207' ' ' MET . . . 49.82 -144.86 0.47 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.159 -0.963 . . . . 0.0 109.358 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 276' ' ' ASN . . . . . 0.471 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 2.0 m-20 -83.71 -20.7 32.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.728 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . 0.459 ' HG3' ' HG3' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -89.88 -161.71 0.81 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.161 -0.962 . . . . 0.0 109.583 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 278' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' B' ' 301' ' ' PHE . . . 170.1 162.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.755 . . . . 0.0 109.079 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 279' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -150.66 141.51 22.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.065 . . . . 0.0 109.236 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 21.1 p90 -141.63 154.55 45.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.827 -1.171 . . . . 0.0 110.705 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . 0.583 ' CB ' ' CD1' ' B' ' 298' ' ' ILE . . . -119.43 168.53 10.86 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 282' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 0.0 OUTLIER -177.14 -173.44 0.45 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.898 . . . . 0.0 109.766 179.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 283' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -135.19 141.1 45.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.375 -0.828 . . . . 0.0 110.215 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 284' ' ' VAL . . . . . 0.537 ' CG1' ' CB ' ' B' ' 263' ' ' LEU . 8.0 t -109.21 134.56 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 108.795 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 285' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' B' ' 264' ' ' ALA . 29.0 p -125.73 100.78 6.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.987 . . . . 0.0 110.08 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.579 ' CE1' ' HB ' ' B' ' 293' ' ' THR . 33.9 p90 -117.34 -168.73 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 108.785 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 287' ' ' GLU . . . . . 0.469 ' N ' ' CD2' ' B' ' 286' ' ' PHE . 16.7 tt0 -149.85 158.59 44.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.93 -1.106 . . . . 0.0 110.09 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . 0.405 ' CZ ' ' HE2' ' B' ' 286' ' ' PHE . 33.1 m-85 -105.6 -167.84 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.451 -0.781 . . . . 0.0 109.587 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.91 -20.94 3.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.378 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -160.66 -45.24 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -74.49 142.72 44.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -1.165 . . . . 0.0 109.522 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 292' ' ' LYS . . . . . 0.514 ' HG2' ' N ' ' B' ' 293' ' ' THR . 2.3 tmtt? -103.85 145.32 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.277 -0.89 . . . . 0.0 109.412 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 293' ' ' THR . . . . . 0.579 ' HB ' ' CE1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -135.88 143.29 44.96 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.452 -0.78 . . . . 0.0 110.297 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 294' ' ' VAL . . . . . 0.527 HG13 ' CB ' ' B' ' 322' ' ' HIS . 9.0 p -121.26 169.41 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.533 ' CG2' HG21 ' B' ' 321' ' ' ILE . 22.8 t -136.48 160.71 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.758 -1.214 . . . . 0.0 110.499 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 296' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' B' ' 320' ' ' ASN . . . -140.62 62.54 18.62 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.629 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 297' ' ' PRO . . . . . 0.529 ' HD3' HG11 ' B' ' 295' ' ' VAL . 43.5 Cg_endo -97.37 167.28 0.87 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.449 1.433 . . . . 0.0 112.01 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.583 ' CD1' ' CB ' ' B' ' 281' ' ' ALA . 3.9 mm -129.2 165.05 30.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . 0.609 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 14.7 t0 -135.06 156.27 49.31 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.201 -0.937 . . . . 0.0 109.909 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 300' ' ' HIS . . . . . 0.535 ' O ' ' CG ' ' B' ' 312' ' ' MET . 0.2 OUTLIER -108.19 175.36 5.5 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 301' ' ' PHE . . . . . 0.639 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -149.74 136.62 19.48 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 110.026 -178.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.459 ' HG3' ' HG3' ' B' ' 277' ' ' GLU . 10.4 ttt85 -138.48 113.76 9.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 109.11 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 303' ' ' PHE . . . . . 0.567 ' CZ ' HG12 ' B' ' 210' ' ' VAL . 3.9 m-85 -95.09 178.82 5.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.468 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 304' ' ' ASN . . . . . 0.532 ' HB3' ' CG1' ' B' ' 310' ' ' VAL . 3.6 p30 -111.87 -21.8 11.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.358 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . 122.35 32.76 0.94 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . -144.49 9.47 1.39 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.218 -1.166 . . . . 0.0 109.964 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 87.05 -19.28 31.31 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.81 -177.26 6.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -1.205 . . . . 0.0 109.561 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 309' ' ' VAL . . . . . 0.527 ' CG2' ' CG2' ' B' ' 210' ' ' VAL . 61.0 t -112.69 137.12 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.163 -0.961 . . . . 0.0 109.154 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . 0.532 ' CG1' ' HB3' ' B' ' 304' ' ' ASN . 0.0 OUTLIER -119.37 -61.57 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.079 -1.013 . . . . 0.0 109.799 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.91 162.85 17.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.045 -1.035 . . . . 0.0 109.67 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 312' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 29.2 ttp -159.02 145.93 17.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 313' ' ' ARG . . . . . 0.527 ' HB2' ' CB ' ' B' ' 300' ' ' HIS . 48.1 mtp180 -125.18 173.15 8.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.223 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 314' ' ' ALA . . . . . 0.514 ' CB ' ' OD2' ' B' ' 238' ' ' ASP . . . -150.17 150.88 32.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.032 . . . . 0.0 109.445 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 315' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -136.25 142.52 44.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 110.048 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 316' ' ' PHE . . . . . 0.541 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 1.2 p90 174.63 -155.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.652 0.739 . . . . 0.0 109.125 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 317' ' ' GLY . . . . . 0.478 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 159.79 -172.14 36.28 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 318' ' ' GLU . . . . . 0.518 ' HA ' HD12 ' B' ' 321' ' ' ILE . 6.3 tt0 -65.29 -6.73 10.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -1.108 . . . . 0.0 109.7 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -101.12 -17.99 16.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.323 -0.861 . . . . 0.0 109.699 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 320' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' B' ' 296' ' ' ALA . 1.4 m-20 -88.94 -23.18 22.75 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.607 -0.683 . . . . 0.0 110.189 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 321' ' ' ILE . . . . . 0.533 HG21 ' CG2' ' B' ' 295' ' ' VAL . 0.6 OUTLIER -87.18 -158.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.072 -1.018 . . . . 0.0 108.546 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 322' ' ' HIS . . . . . 0.527 ' CB ' HG13 ' B' ' 294' ' ' VAL . 0.3 OUTLIER -151.61 161.61 42.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.974 -1.079 . . . . 0.0 110.064 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.496 ' HA ' HG22 ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.353 -0.842 . . . . 0.0 109.414 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.464 ' O ' ' HE3' ' A' ' 7' ' ' MET . 7.1 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.41 -8.68 23.83 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.864 1.455 . . . . 0.0 109.784 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -61.81 -60.26 3.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.812 . . . . 0.0 109.243 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -61.33 -45.19 95.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.156 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.464 ' HE3' ' O ' ' A' ' 3' ' ' THR . 27.5 mtt -58.73 -28.81 66.2 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.223 -0.923 . . . . 0.0 109.333 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 11' ' ' VAL . 17.5 m -74.33 -44.14 53.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 109.059 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.25 -40.23 23.99 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.567 HG21 ' CE2' ' A' ' 103' ' ' PHE . 1.2 t -53.35 -26.76 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.544 HG21 ' CD1' ' A' ' 80' ' ' PHE . 7.6 t -90.02 -42.55 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.491 -0.756 . . . . 0.0 109.101 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 15' ' ' VAL . 20.7 tt0 -62.05 -73.92 0.1 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.0 OUTLIER -41.61 -44.18 2.99 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 122.041 0.924 . . . . 0.0 108.524 178.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.641 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -53.39 -45.58 69.33 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.42 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.601 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -84.63 -38.98 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 0.0 109.555 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.69 -35.74 14.63 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.521 ' HB3' ' CG1' ' A' ' 26' ' ' ILE . . . -74.88 -31.69 61.66 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.641 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 1.2 mt -65.7 -58.83 4.77 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -51.9 -45.38 64.18 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . -89.5 9.98 24.53 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.574 -0.704 . . . . 0.0 109.645 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.458 ' CA ' HD23 ' A' ' 59' ' ' LEU . . . 45.32 31.52 3.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 17' ' ' ALA . 6.8 t0 -89.82 68.64 7.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -1.062 . . . . 0.0 109.936 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.598 ' CD1' ' HB3' ' A' ' 55' ' ' PHE . 4.9 tp -49.35 -42.12 40.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -42.1 -30.56 0.3 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.96 -37.2 7.95 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.521 ' CG1' ' HB3' ' A' ' 17' ' ' ALA . 22.0 mt -59.64 -53.59 46.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.526 HG21 ' CG ' ' A' ' 52' ' ' ARG . 84.9 t -58.57 -36.17 58.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.6 -50.83 71.94 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.535 ' CD2' ' HA ' ' A' ' 10' ' ' VAL . 7.5 tp -65.61 -21.72 66.6 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.547 -0.721 . . . . 0.0 109.182 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.51 ' CG ' HG22 ' A' ' 51' ' ' ILE . 2.8 m-85 -84.6 135.5 34.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.419 -0.801 . . . . 0.0 109.609 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 109' ' ' VAL . . . -54.17 -175.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.471 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.4 OUTLIER -75.76 -23.23 55.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.885 . . . . 0.0 109.54 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.536 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -140.13 36.76 1.92 Allowed 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.59 -0.694 . . . . 0.0 109.357 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -51.38 -176.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.499 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.534 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.3 OUTLIER -142.49 134.13 26.72 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.373 -0.83 . . . . 0.0 109.432 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 44' ' ' PRO . 31.6 t -127.27 128.3 70.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.337 -0.852 . . . . 0.0 108.88 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 38' ' ' ASP . 21.9 mt-10 -101.15 114.18 27.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.474 ' CG ' ' HA ' ' A' ' 39' ' ' PRO . 12.1 t70 -179.33 142.63 0.38 Allowed Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.608 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.474 ' HA ' ' CG ' ' A' ' 38' ' ' ASP . 46.9 Cg_endo -73.75 -179.26 24.86 Favored 'Cis proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.194 -2.002 . . . . 0.0 110.797 -0.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.526 ' CG2' HG13 ' B' ' 274' ' ' VAL . 27.6 m -66.9 82.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . -170.69 28.5 0.12 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER 70.5 47.46 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -1.11 . . . . 0.0 109.86 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.543 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 4.7 mt-10 -132.83 57.5 28.8 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 109.844 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 43' ' ' GLU . 50.3 Cg_endo -79.84 177.22 8.62 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 124.163 1.612 . . . . 0.0 110.653 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HD3' ' CA ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -151.59 107.22 3.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 109.251 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.534 ' HB2' ' CG2' ' A' ' 35' ' ' THR . 0.1 OUTLIER -89.56 157.45 18.06 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.263 -0.898 . . . . 0.0 110.117 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 100.52 166.37 28.55 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 3.0 m -75.2 -58.63 3.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.138 -1.213 . . . . 0.0 109.012 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -54.44 -44.88 72.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.211 -0.931 . . . . 0.0 109.076 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.53 ' CA ' ' HD3' ' A' ' 45' ' ' ARG . . . -59.26 -34.01 71.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.45 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.522 HD12 ' CG2' ' A' ' 36' ' ' VAL . 7.6 mm -79.72 -36.23 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.526 ' CG ' HG21 ' A' ' 27' ' ' VAL . 26.7 ttp85 -78.51 -56.64 4.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.068 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.9 mt-10 -45.76 -27.25 0.79 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -83.14 -70.22 0.57 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.174 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.598 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.26 -24.1 1.08 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.521 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -78.85 -47.31 16.83 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 19.2 t-20 -64.65 -28.37 69.57 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.6 t -78.08 -42.26 32.72 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.458 HD23 ' CA ' ' A' ' 21' ' ' GLY . 8.9 tp -60.85 -17.86 52.57 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.405 -0.809 . . . . 0.0 108.903 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 4.8 mttm -55.16 -18.64 6.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.479 -0.763 . . . . 0.0 108.972 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.523 ' O ' ' CD2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -89.16 118.25 69.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.162 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 43.8 Cg_endo -71.34 110.42 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.748 1.393 . . . . 0.0 110.716 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.538 ' HB3' ' HB3' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -145.82 176.44 9.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.888 . . . . 0.0 110.053 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.73 126.12 54.88 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.513 ' CG2' ' HB3' ' A' ' 18' ' ' LEU . 3.7 t -104.29 117.96 50.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.682 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -146.09 105.57 3.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.133 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -47.41 175.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -0.929 . . . . 0.0 109.633 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 67' ' ' LEU . 2.7 p -155.8 -38.01 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.705 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 5.7 pt20 -99.21 -152.47 0.41 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.63 -0.669 . . . . 0.0 109.198 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 30.4 tt0 -109.8 130.38 55.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.15 -0.969 . . . . 0.0 109.787 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.514 HG21 ' CG1' ' A' ' 11' ' ' VAL . 37.2 t -60.01 145.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.333 -0.855 . . . . 0.0 108.996 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.536 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 1.7 ttm180 -106.26 134.48 49.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.662 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.487 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -146.7 145.51 30.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 109.232 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' B' ' 316' ' ' PHE . 0.2 OUTLIER -136.03 -151.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.191 -0.943 . . . . 0.0 109.562 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -34.59 -90.85 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.973 -0.454 . . . . 0.0 110.804 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 4.9 p-10 -112.89 -15.8 12.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.083 -1.011 . . . . 0.0 110.328 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.626 ' HG2' ' N ' ' A' ' 78' ' ' ALA . 1.4 tt0 -108.5 162.55 14.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.019 -1.051 . . . . 0.0 108.999 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.626 ' N ' ' HG2' ' A' ' 77' ' ' GLU . . . -143.12 177.16 8.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.38 -0.825 . . . . 0.0 110.224 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.56 ' CB ' ' CD1' ' B' ' 315' ' ' LEU . . . -150.1 137.07 19.41 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.66 ' CE1' ' CE2' ' A' ' 101' ' ' PHE . 31.8 p90 -150.32 170.83 18.09 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.706 -1.246 . . . . 0.0 110.137 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.539 ' CB ' HG21 ' A' ' 98' ' ' ILE . . . -139.62 -166.4 2.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.556 -0.715 . . . . 0.0 109.56 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CD2' ' C ' ' A' ' 81' ' ' ALA . 6.8 p90 174.23 -171.46 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.441 -0.787 . . . . 0.0 109.075 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.73 144.0 50.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.357 -0.84 . . . . 0.0 109.808 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 95' ' ' VAL . 12.1 t -116.78 115.0 47.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.52 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -106.58 103.43 12.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.077 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.564 ' CE1' ' HB ' ' A' ' 93' ' ' THR . 4.3 p90 -122.23 177.04 5.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.228 -0.92 . . . . 0.0 109.561 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -106.25 -179.95 4.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.174 -0.954 . . . . 0.0 110.466 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.497 ' C ' ' CG ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -137.67 43.18 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 109.549 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.497 ' CG ' ' C ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER 39.71 75.97 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.421 -0.799 . . . . 0.0 109.886 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.52 -41.49 2.01 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -125.46 179.35 5.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.41 -1.053 . . . . 0.0 108.928 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.502 ' HG2' ' N ' ' A' ' 93' ' ' THR . 0.4 OUTLIER -126.11 140.8 52.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.007 -1.058 . . . . 0.0 109.884 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.564 ' HB ' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -136.81 152.58 50.44 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.545 HG11 ' CG ' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -126.52 -178.85 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.994 . . . . 0.0 109.112 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.56 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 2.9 t -150.01 141.04 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 108.992 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.442 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -129.38 71.63 82.03 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.394 -0.816 . . . . 0.0 110.528 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.56 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 54.0 Cg_endo -95.88 -173.55 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.559 1.506 . . . . 0.0 110.854 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.539 HG21 ' CB ' ' A' ' 81' ' ' ALA . 3.1 mp -141.88 167.03 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.587 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 32.8 t0 -135.24 159.26 42.12 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 109.828 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.525 ' O ' ' CG ' ' A' ' 112' ' ' MET . 71.2 t60 -123.78 133.71 53.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.426 -0.797 . . . . 0.0 108.876 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.66 ' CE2' ' CE1' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -109.76 145.67 36.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.203 -0.935 . . . . 0.0 109.89 -179.039 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 111' ' ' SER . 6.2 ttt180 -145.06 114.22 7.0 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 10' ' ' VAL . 21.4 m-85 -89.61 -166.58 1.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.046 -1.034 . . . . 0.0 109.693 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -132.11 -43.01 0.97 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . -142.78 -62.23 0.02 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 163.87 76.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -1.149 . . . . 0.0 109.608 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -166.07 -49.53 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.27 -162.7 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -1.209 . . . . 0.0 109.545 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.532 HG23 ' CG2' ' A' ' 10' ' ' VAL . 54.5 t -97.46 143.18 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.331 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 56.6 t -125.12 -11.93 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.777 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.464 ' OG ' ' OG1' ' A' ' 35' ' ' THR . 13.0 m -159.09 156.1 28.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.412 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.562 ' SD ' ' CE1' ' A' ' 101' ' ' PHE . 8.4 ttp -160.31 149.3 17.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.969 . . . . 0.0 109.86 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -129.7 147.24 51.47 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.77 132.33 54.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.999 -1.063 . . . . 0.0 110.035 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' B' ' 279' ' ' ALA . 0.4 OUTLIER -122.43 141.65 51.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.363 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.55 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 4.3 p90 175.02 -152.47 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.476 ' N ' ' CG ' ' A' ' 116' ' ' PHE . . . 166.31 169.08 29.46 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.478 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 19.8 tt0 -68.64 -6.45 25.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -1.096 . . . . 0.0 109.473 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.85 -26.17 18.62 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.981 0.896 . . . . 0.0 108.886 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.496 ' OD1' ' NH2' ' B' ' 272' ' ' ARG . 0.1 OUTLIER -88.9 14.12 11.15 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.519 ' CG2' HG21 ' A' ' 95' ' ' VAL . 4.5 mm -90.68 -150.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.545 ' CG ' HG11 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.79 174.19 13.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.005 . . . . 0.0 109.538 179.372 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.56 88.12 1.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.9 . . . . 0.0 109.32 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -66.77 133.62 32.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.347 -1.09 . . . . 0.0 109.508 -179.972 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 201' ' ' MET . . . . . 0.463 ' O ' ' HB2' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.244 0.545 . . . . 0.0 110.144 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' B' ' 201' ' ' MET . 4.1 m-80 61.88 77.48 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -0.828 . . . . 0.0 109.673 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 203' ' ' THR . . . . . 0.411 HG22 ' O ' ' B' ' 203' ' ' THR . 3.0 t -61.96 116.69 23.03 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.668 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.52 -3.8 13.75 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.868 1.457 . . . . 0.0 109.96 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -59.71 -63.11 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.489 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -58.06 -43.98 87.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 109.397 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 18.1 mtt -57.61 -28.53 63.73 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.289 -0.882 . . . . 0.0 109.629 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.44 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 6.0 m -76.69 -35.89 57.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.076 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -53.85 -45.45 70.93 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.238 -0.914 . . . . 0.0 108.809 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.633 ' CG1' ' CE1' ' B' ' 301' ' ' PHE . 1.2 t -51.72 -27.1 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.617 ' CG2' ' CE2' ' B' ' 301' ' ' PHE . 40.1 t -83.4 -46.05 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.485 -0.759 . . . . 0.0 109.706 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' B' ' 213' ' ' ARG . 28.4 tt0 -56.86 -73.6 0.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.245 1.022 . . . . 0.0 108.312 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' B' ' 212' ' ' GLN . 1.6 mtt85 -43.06 -44.38 4.8 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.972 0.891 . . . . 0.0 108.655 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' TYR . . . . . 0.637 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -51.26 -45.3 62.0 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.568 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.599 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.2 t -88.42 -40.12 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.903 . . . . 0.0 109.359 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.23 -36.23 13.47 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.521 ' HB3' ' CG1' ' B' ' 226' ' ' ILE . . . -74.56 -33.63 62.74 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.637 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 3.4 mt -63.86 -58.58 6.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -53.38 -46.1 69.49 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.461 0.648 . . . . 0.0 109.476 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.32 9.22 26.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.529 -0.732 . . . . 0.0 109.649 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . 0.516 ' CA ' HD23 ' B' ' 259' ' ' LEU . . . 48.6 37.19 19.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' B' ' 217' ' ' ALA . 25.5 t0 -97.93 61.17 1.52 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -1.114 . . . . 0.0 109.791 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' LEU . . . . . 0.57 ' CD2' ' CG ' ' B' ' 252' ' ' ARG . 2.2 tp -46.89 -39.45 12.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.03 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' B' ' 223' ' ' LEU . 0.5 OUTLIER -40.63 -31.31 0.15 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' B' ' 223' ' ' LEU . . . -88.86 -37.27 7.39 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.521 ' CG1' ' HB3' ' B' ' 217' ' ' ALA . 12.5 mt -58.54 -54.11 37.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' B' ' 252' ' ' ARG . 46.6 t -58.43 -41.69 82.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.41 ' HB2' ' HA2' ' B' ' 225' ' ' GLY . . . -55.34 -46.88 76.35 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 4.4 tp -69.75 -30.16 67.68 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.594 -0.691 . . . . 0.0 109.234 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . 0.583 ' CD2' HG23 ' B' ' 251' ' ' ILE . 4.8 m-85 -79.46 129.92 34.92 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.393 -0.817 . . . . 0.0 109.726 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -49.19 179.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.466 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -66.91 -23.49 65.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.769 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . 0.505 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 0.0 OUTLIER -146.94 53.76 1.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.482 -0.761 . . . . 0.0 109.584 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.545 ' CA ' ' O ' ' B' ' 310' ' ' VAL . . . -64.47 155.91 31.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' THR . . . . . 0.487 ' N ' ' O ' ' B' ' 310' ' ' VAL . 0.0 OUTLIER -98.36 160.06 14.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.399 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.583 ' CG1' ' N ' ' B' ' 237' ' ' GLU . 1.9 t -139.49 173.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 108.875 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' GLU . . . . . 0.583 ' N ' ' CG1' ' B' ' 236' ' ' VAL . 4.7 mt-10 -150.14 104.29 3.26 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' ASP . . . . . 0.546 ' OD2' ' CB ' ' B' ' 314' ' ' ALA . 0.4 OUTLIER -177.37 139.03 0.42 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.95 -1.094 . . . . 0.0 109.559 -178.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . 0.465 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 45.9 Cg_endo -72.87 -173.21 10.54 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.185 -2.006 . . . . 0.0 110.358 -0.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.479 HG21 ' CG1' ' A' ' 74' ' ' VAL . 34.8 m -70.52 81.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.968 . . . . 0.0 109.292 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' B' ' 242' ' ' SER . . . -174.57 35.22 0.11 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' B' ' 241' ' ' GLY . 0.5 OUTLIER 70.16 53.25 0.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -1.141 . . . . 0.0 109.786 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' B' ' 238' ' ' ASP . 1.4 mt-10 -130.11 61.37 58.09 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.374 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 50.7 Cg_endo -78.03 169.24 20.76 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.287 1.678 . . . . 0.0 110.822 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' B' ' 244' ' ' PRO . 0.0 OUTLIER -150.36 99.09 2.74 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -91.23 167.62 12.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 110.348 -178.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . 0.505 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 92.42 162.51 37.21 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 248' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 1.9 m -75.13 -49.44 19.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -1.16 . . . . 0.0 108.882 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -56.6 -42.24 78.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.891 . . . . 0.0 109.122 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' B' ' 246' ' ' SER . . . -66.44 -55.01 17.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.935 . . . . 0.0 109.362 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.583 HG23 ' CD2' ' B' ' 230' ' ' PHE . 12.6 mm -53.71 -45.54 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 252' ' ' ARG . . . . . 0.57 ' CG ' ' CD2' ' B' ' 223' ' ' LEU . 8.4 ttm180 -73.39 -57.82 3.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.128 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 253' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 31.2 tt0 -45.64 -27.83 0.86 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.095 -1.003 . . . . 0.0 108.704 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 1.0 OUTLIER -87.49 -71.09 0.58 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 255' ' ' PHE . . . . . 0.567 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -48.24 -24.44 1.18 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' B' ' 252' ' ' ARG . . . -79.72 -48.44 13.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.857 . . . . 0.0 108.89 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 257' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 18.4 t30 -60.04 -33.52 72.15 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.34 -0.85 . . . . 0.0 108.743 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 9.7 t -71.44 -38.26 71.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 259' ' ' LEU . . . . . 0.516 HD23 ' CA ' ' B' ' 221' ' ' GLY . 9.2 tp -62.59 -21.43 65.62 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.392 -0.818 . . . . 0.0 109.028 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 260' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 20.9 mtmt -64.48 -11.12 30.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.313 -0.867 . . . . 0.0 109.178 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 261' ' ' LEU . . . . . 0.586 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.3 OUTLIER -89.3 117.69 68.44 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 262' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 41.5 Cg_endo -68.72 80.21 0.63 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.833 1.438 . . . . 0.0 110.683 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.586 ' CD2' ' CD2' ' B' ' 261' ' ' LEU . 0.0 OUTLIER -118.27 165.47 13.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.357 -0.839 . . . . 0.0 109.616 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' B' ' 285' ' ' SER . . . -101.8 130.81 48.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -0.816 . . . . 0.0 108.859 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 265' ' ' VAL . . . . . 0.419 HG13 HG11 ' B' ' 215' ' ' VAL . 30.0 t -116.92 114.3 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.031 -1.043 . . . . 0.0 110.085 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 28.7 tt0 -150.33 100.78 2.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.83 . . . . 0.0 109.148 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . 0.527 ' O ' ' CG2' ' B' ' 268' ' ' THR . 0.6 OUTLIER -48.27 177.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.725 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 268' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' B' ' 267' ' ' LEU . 80.8 p -159.16 -37.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.336 -0.852 . . . . 0.0 109.768 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 269' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' B' ' 270' ' ' GLU . 0.0 OUTLIER -93.55 -150.45 0.28 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.563 -0.71 . . . . 0.0 109.427 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 270' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' B' ' 269' ' ' GLN . 27.1 tt0 -112.55 130.56 55.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.652 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 271' ' ' VAL . . . . . 0.526 HG11 ' N ' ' B' ' 272' ' ' ARG . 75.5 t -67.54 147.71 12.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.356 -0.84 . . . . 0.0 109.082 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.526 ' N ' HG11 ' B' ' 271' ' ' VAL . 0.8 OUTLIER -103.71 138.11 40.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.175 -0.953 . . . . 0.0 109.896 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . 0.463 ' HA ' ' HB1' ' B' ' 278' ' ' ALA . . . -150.1 132.32 15.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 274' ' ' VAL . . . . . 0.55 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.2 OUTLIER -125.87 -152.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.95 . . . . 0.0 109.797 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 275' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' B' ' 274' ' ' VAL . . . -35.7 -96.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.898 -0.502 . . . . 0.0 110.899 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 276' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' B' ' 303' ' ' PHE . 1.9 m-20 -110.42 17.09 21.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.017 -1.052 . . . . 0.0 110.268 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . 0.453 ' OE2' ' NH1' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -124.33 -160.04 0.91 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.932 -1.105 . . . . 0.0 109.628 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 278' ' ' ALA . . . . . 0.517 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . 172.08 160.18 0.1 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.545 -0.722 . . . . 0.0 109.65 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 279' ' ' ALA . . . . . 0.522 ' HB2' ' CD2' ' A' ' 115' ' ' LEU . . . -150.73 133.93 16.16 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . 0.582 ' CE1' ' HB3' ' B' ' 299' ' ' ASP . 22.6 p90 -150.2 168.5 23.8 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.838 -1.164 . . . . 0.0 110.275 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . 0.536 ' CB ' HG21 ' B' ' 298' ' ' ILE . . . -138.46 -164.83 1.7 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 282' ' ' PHE . . . . . 0.439 ' CD2' ' C ' ' B' ' 281' ' ' ALA . 8.2 p90 168.16 -169.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 283' ' ' THR . . . . . 0.453 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -124.07 141.17 52.28 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 109.54 179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 284' ' ' VAL . . . . . 0.5 HG11 ' CB ' ' B' ' 263' ' ' LEU . 40.0 t -124.35 113.21 35.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.158 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 285' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' B' ' 294' ' ' VAL . 3.5 p -113.76 117.44 31.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.325 -0.86 . . . . 0.0 109.452 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.56 ' CE1' ' HB ' ' B' ' 293' ' ' THR . 17.0 p90 -123.27 176.27 6.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.19 -0.944 . . . . 0.0 109.555 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 287' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' B' ' 291' ' ' ARG . 29.8 tt0 -128.46 151.93 48.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.555 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . 0.47 ' CE2' ' CZ ' ' B' ' 286' ' ' PHE . 28.1 m-85 -95.16 -107.2 0.14 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.213 -0.93 . . . . 0.0 109.388 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.61 -17.92 7.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.984 -1.072 . . . . 0.0 109.444 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -149.59 -40.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 291' ' ' ARG . . . . . 0.446 ' O ' ' HG3' ' B' ' 287' ' ' GLU . 33.1 mtt85 -90.4 -176.91 4.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -1.117 . . . . 0.0 109.417 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 292' ' ' LYS . . . . . 0.468 ' O ' ' CD ' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -136.75 133.95 36.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.312 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 293' ' ' THR . . . . . 0.56 ' HB ' ' CE1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -118.32 145.99 44.68 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.186 -0.946 . . . . 0.0 110.094 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 294' ' ' VAL . . . . . 0.513 HG11 ' CB ' ' B' ' 322' ' ' HIS . 11.8 p -116.47 163.74 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.335 -0.853 . . . . 0.0 108.866 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.559 ' CG2' HG21 ' B' ' 321' ' ' ILE . 49.1 t -139.41 156.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.032 -1.043 . . . . 0.0 110.444 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 296' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' B' ' 320' ' ' ASN . . . -142.13 68.73 22.63 Favored Pre-proline 0 N--CA 1.495 1.802 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 297' ' ' PRO . . . . . 0.518 ' HD3' HG11 ' B' ' 295' ' ' VAL . 48.3 Cg_endo -97.03 -175.42 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.877 1.718 . . . . 0.0 111.487 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.536 HG21 ' CB ' ' B' ' 281' ' ' ALA . 3.0 mp -140.44 169.4 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . 0.582 ' HB3' ' CE1' ' B' ' 280' ' ' PHE . 39.1 t0 -138.86 158.8 43.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.021 -1.049 . . . . 0.0 110.014 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 300' ' ' HIS . . . . . 0.512 ' HB2' ' CB ' ' B' ' 313' ' ' ARG . 0.2 OUTLIER -113.87 172.96 6.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.382 -0.824 . . . . 0.0 108.944 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 301' ' ' PHE . . . . . 0.633 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.2 OUTLIER -144.95 146.64 32.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.123 -0.986 . . . . 0.0 110.49 -178.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.533 ' HB3' ' CB ' ' B' ' 311' ' ' SER . 25.4 ttt180 -144.16 108.72 4.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.476 -0.765 . . . . 0.0 108.952 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 303' ' ' PHE . . . . . 0.566 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 37.3 m-85 -89.83 179.88 5.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.799 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 304' ' ' ASN . . . . . 0.534 ' ND2' HG23 ' B' ' 310' ' ' VAL . 0.1 OUTLIER -150.13 16.79 0.85 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.332 -0.855 . . . . 0.0 109.245 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 305' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . 98.21 154.03 28.98 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 306' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 79.49 -5.68 1.9 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.405 -1.056 . . . . 0.0 109.824 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 83.14 -10.19 58.9 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.3 174.15 4.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.103 -1.233 . . . . 0.0 109.455 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 309' ' ' VAL . . . . . 0.51 HG22 ' CG2' ' B' ' 210' ' ' VAL . 95.1 t -109.89 151.9 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.158 -0.964 . . . . 0.0 109.027 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . 0.545 ' O ' ' CA ' ' B' ' 234' ' ' ALA . 53.3 t -137.32 -56.56 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.957 -1.089 . . . . 0.0 110.156 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 311' ' ' SER . . . . . 0.533 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -118.48 160.61 21.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.615 -1.303 . . . . 0.0 109.917 -179.541 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 312' ' ' MET . . . . . 0.537 ' CE ' ' CZ ' ' B' ' 230' ' ' PHE . 10.2 ttm -159.92 141.69 12.92 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.431 -0.793 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 313' ' ' ARG . . . . . 0.512 ' CB ' ' HB2' ' B' ' 300' ' ' HIS . 0.3 OUTLIER -116.95 158.38 24.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.393 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 314' ' ' ALA . . . . . 0.546 ' CB ' ' OD2' ' B' ' 238' ' ' ASP . . . -124.31 138.03 54.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.28 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 315' ' ' LEU . . . . . 0.56 ' CD1' ' CB ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -133.73 142.27 47.89 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.137 -0.977 . . . . 0.0 109.89 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 316' ' ' PHE . . . . . 0.525 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 53.7 p90 171.18 -156.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 317' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' B' ' 321' ' ' ILE . . . 154.71 176.59 27.15 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 318' ' ' GLU . . . . . 0.466 ' HA ' HD12 ' B' ' 321' ' ' ILE . 13.4 tt0 -55.43 -17.74 5.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -1.185 . . . . 0.0 109.136 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -87.49 -24.99 23.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.871 0.843 . . . . 0.0 109.077 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 320' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.27 -34.89 16.44 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 321' ' ' ILE . . . . . 0.559 HG21 ' CG2' ' B' ' 295' ' ' VAL . 0.9 OUTLIER -86.32 -172.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.799 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 322' ' ' HIS . . . . . 0.513 ' CB ' HG11 ' B' ' 294' ' ' VAL . 0.0 OUTLIER -151.63 172.8 15.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.091 -1.005 . . . . 0.0 109.814 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.53 ' HA ' ' CG2' ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.402 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.501 ' HB ' ' NE2' ' A' ' 6' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.458 ' HA ' ' HE3' ' A' ' 7' ' ' MET . 48.5 Cg_endo -75.03 1.65 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.973 1.512 . . . . 0.0 110.279 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -58.63 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 110.048 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.501 ' NE2' ' HB ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -45.57 -32.75 2.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.115 -0.99 . . . . 0.0 109.279 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.528 ' HB3' ' CB ' ' A' ' 73' ' ' ALA . 25.3 mtm -70.89 -57.69 4.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 109.732 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 11' ' ' VAL . 16.6 m -58.57 -38.14 77.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.81 -42.66 47.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.195 -0.941 . . . . 0.0 108.652 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.599 ' CG1' ' CZ ' ' A' ' 101' ' ' PHE . 2.9 t -60.03 -20.93 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.563 HG22 ' CE2' ' A' ' 101' ' ' PHE . 40.0 t -90.47 -47.91 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -58.26 -61.76 2.33 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.125 -0.984 . . . . 0.0 109.022 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.417 ' CB ' HD21 ' A' ' 29' ' ' LEU . 3.2 mtm-85 -53.97 -46.66 71.7 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.909 0.861 . . . . 0.0 108.838 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.632 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -48.72 -42.69 35.93 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.619 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 1.3 t -88.5 -38.74 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.315 -0.866 . . . . 0.0 109.379 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.45 -37.72 18.0 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.462 ' HB2' HG12 ' A' ' 26' ' ' ILE . . . -72.62 -33.76 66.87 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.632 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 4.5 mt -65.31 -60.58 2.83 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -51.0 -41.19 59.6 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.567 0.698 . . . . 0.0 109.23 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.31 2.26 54.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.484 -0.76 . . . . 0.0 109.55 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.547 ' CA ' ' CD2' ' A' ' 59' ' ' LEU . . . 52.24 41.89 54.96 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.405 ' O ' HG13 ' A' ' 26' ' ' ILE . 45.6 t0 -105.17 80.18 1.57 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -1.091 . . . . 0.0 110.052 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.591 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 3.9 mm? -51.37 -20.67 1.84 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.188 -0.945 . . . . 0.0 109.745 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -61.12 -54.85 39.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.256 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -64.71 -29.57 75.59 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.569 HG22 ' CD1' ' A' ' 55' ' ' PHE . 6.9 mt -66.26 -59.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 60.0 t -61.53 -40.55 86.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.13 -51.83 65.19 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 109' ' ' VAL . 8.6 tp -64.3 -26.4 68.47 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.495 ' CD2' HG22 ' A' ' 51' ' ' ILE . 5.2 m-85 -87.57 131.11 34.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.495 -0.753 . . . . 0.0 109.766 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -45.44 171.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.834 . . . . 0.0 109.642 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.466 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -61.75 -24.02 66.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.709 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.528 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -141.05 52.03 1.59 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.571 -0.706 . . . . 0.0 109.681 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 110' ' ' VAL . . . -67.16 168.51 10.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.517 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -127.76 137.67 52.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.391 -0.818 . . . . 0.0 109.302 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 55.8 t -133.29 123.73 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.275 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.511 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 96.0 mt-10 -89.17 108.4 19.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 108.58 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 9.8 t0 -177.99 142.29 0.45 Allowed Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 119.229 -0.989 . . . . 0.0 110.058 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 47.7 Cg_endo -72.75 -179.24 23.67 Favored 'Cis proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.214 -1.994 . . . . 0.0 110.564 -0.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.49 ' O ' ' CG2' ' A' ' 40' ' ' VAL . 14.4 m -73.57 112.81 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.497 ' HA2' ' ND2' ' B' ' 276' ' ' ASN . . . 103.99 12.65 29.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.526 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 4.0 m -118.56 -107.04 0.38 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -1.145 . . . . 0.0 109.458 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -166.87 130.64 1.53 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.874 -1.141 . . . . 0.0 109.88 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 41.6 Cg_endo -67.3 -168.25 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.952 1.501 . . . . 0.0 111.201 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.522 ' HG3' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -150.43 102.82 3.08 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.517 ' HB2' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.93 152.04 21.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.325 -0.86 . . . . 0.0 110.024 -179.151 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.528 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 104.43 173.96 25.03 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 4.7 m -79.36 -68.81 0.63 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.05 -1.265 . . . . 0.0 109.376 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -47.16 -32.92 4.7 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.135 -0.978 . . . . 0.0 109.012 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.522 ' CB ' ' HG3' ' A' ' 45' ' ' ARG . . . -70.96 -51.17 27.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.18 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.495 HG22 ' CD2' ' A' ' 30' ' ' PHE . 7.5 mm -58.67 -43.65 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.534 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 18.8 ttt180 -73.29 -56.11 5.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 108.983 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 52' ' ' ARG . 14.6 tt0 -45.74 -27.04 0.74 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 108.617 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -88.27 -71.09 0.6 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.72 0.772 . . . . 0.0 108.918 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.569 ' CD1' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -52.1 -20.92 2.79 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.476 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 52' ' ' ARG . . . -80.82 -45.52 16.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.175 -0.953 . . . . 0.0 108.452 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 2.4 t30 -56.82 -30.52 63.83 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.4 t -69.92 -37.8 76.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.591 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 8.0 tp -67.27 -19.68 65.53 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.45 -0.781 . . . . 0.0 109.735 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 2.7 mtmt -56.36 -25.57 49.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.552 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.89 125.69 59.94 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.179 -0.951 . . . . 0.0 109.079 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 44.1 Cg_endo -70.78 101.1 1.01 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.759 1.4 . . . . 0.0 110.349 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.552 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -137.99 150.31 46.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.568 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.461 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -89.65 127.52 35.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.193 -0.942 . . . . 0.0 108.793 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 t -108.43 114.01 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 0.0 109.851 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 67' ' ' LEU . 16.8 tt0 -150.44 98.68 2.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.384 -0.822 . . . . 0.0 109.194 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.8 mp -45.38 170.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 109.807 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 t -144.58 -38.63 0.28 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.404 -0.81 . . . . 0.0 109.612 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.511 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 13.9 pt20 -90.92 -146.31 0.19 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.553 -0.717 . . . . 0.0 109.268 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.511 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 23.6 tt0 -115.34 135.2 54.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.106 -0.996 . . . . 0.0 109.768 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.513 HG11 ' N ' ' A' ' 72' ' ' ARG . 78.1 t -72.06 145.2 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.293 -0.879 . . . . 0.0 109.345 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.524 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -107.5 135.46 48.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 0.0 109.65 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 7' ' ' MET . . . -150.37 129.79 12.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 109.878 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -138.38 145.68 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 109.899 179.577 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . 41.68 -101.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.466 -0.771 . . . . 0.0 110.077 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.574 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -121.39 -11.44 8.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.952 -1.092 . . . . 0.0 109.69 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.465 ' HG3' ' HA ' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -89.74 -161.12 0.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.121 -0.987 . . . . 0.0 109.06 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.487 ' HB1' ' HA ' ' A' ' 73' ' ' ALA . . . 169.22 159.38 0.05 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.272 -0.893 . . . . 0.0 109.972 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.574 ' HB1' ' CD2' ' A' ' 100' ' ' HIS . . . -149.96 132.33 15.59 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 37.4 p90 -150.42 168.77 23.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.891 -1.131 . . . . 0.0 110.436 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.469 ' HB1' HG13 ' A' ' 98' ' ' ILE . . . -143.8 161.86 37.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.683 -0.636 . . . . 0.0 109.312 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 2.1 p90 -157.13 -169.72 3.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.213 -0.929 . . . . 0.0 109.335 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.61 141.12 52.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.457 -0.777 . . . . 0.0 109.903 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.486 ' CG1' ' HB3' ' A' ' 63' ' ' LEU . 73.3 t -112.7 114.15 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.52 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 19.5 p -108.69 97.32 6.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.182 -0.949 . . . . 0.0 110.296 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 18.4 p90 -111.17 -176.45 2.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.264 -0.897 . . . . 0.0 108.618 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 2.7 tm-20 -148.78 150.33 32.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.885 -1.134 . . . . 0.0 110.126 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.41 ' O ' ' CD ' ' A' ' 87' ' ' GLU . 65.6 m-85 -90.29 -116.07 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.31 1.03 19.83 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.912 -1.117 . . . . 0.0 109.446 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -164.19 -58.8 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.459 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 3.3 mtt85 -81.76 158.51 24.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -1.133 . . . . 0.0 109.485 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -119.59 132.44 55.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 109.765 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -114.89 143.84 44.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.863 . . . . 0.0 109.255 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.529 HG11 ' N ' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -117.23 173.44 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 108.922 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.54 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 2.8 t -145.96 145.93 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 109.32 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.521 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . -127.71 72.95 78.52 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.54 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 50.0 Cg_endo -91.58 -177.0 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.731 1.385 . . . . 0.0 110.821 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.47 HG21 ' O ' ' A' ' 80' ' ' PHE . 2.5 mp -140.84 142.8 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 13.6 t0 -116.46 160.05 21.14 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.952 -1.092 . . . . 0.0 110.215 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.574 ' CD2' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -113.12 176.25 5.1 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.599 ' CZ ' ' CG1' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -148.14 137.86 22.38 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.035 -1.041 . . . . 0.0 109.926 -179.145 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.465 ' HA ' ' HG3' ' A' ' 77' ' ' GLU . 64.2 ttt-85 -141.44 103.15 4.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.576 ' CE1' HG12 ' A' ' 10' ' ' VAL . 10.9 m-30 -92.31 -171.81 2.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.51 ' N ' HG23 ' A' ' 110' ' ' VAL . 3.6 p30 -112.66 -25.45 9.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . -157.62 -69.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 171.38 73.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -1.103 . . . . 0.0 109.388 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -178.84 -52.44 0.08 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -117.61 174.3 6.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -1.117 . . . . 0.0 109.498 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.527 ' CG2' HG12 ' A' ' 10' ' ' VAL . 88.8 t -97.83 167.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.069 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 3.1 t -140.52 -72.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.028 -1.045 . . . . 0.0 109.964 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 35' ' ' THR . 19.7 m -119.43 163.41 17.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 109.939 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.538 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 2.8 ttp -148.28 164.39 34.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.467 -0.77 . . . . 0.0 109.555 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.511 ' NH1' ' OE2' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -143.24 123.45 13.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 109.318 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.472 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . . . -104.99 130.46 53.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.105 -0.997 . . . . 0.0 109.652 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' B' ' 279' ' ' ALA . 0.6 OUTLIER -126.15 147.58 49.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.608 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.541 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 9.7 p90 174.09 -155.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . 167.8 -179.23 41.26 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.516 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 24.4 tt0 -70.26 -4.77 23.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -1.165 . . . . 0.0 109.694 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -90.62 -29.64 17.66 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -89.29 13.31 13.74 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.198 0.523 . . . . 0.0 109.697 -179.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.536 HG21 ' CG2' ' A' ' 95' ' ' VAL . 4.4 mm -91.91 -163.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.146 -0.971 . . . . 0.0 108.748 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.527 ' CB ' HG13 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -151.43 161.63 42.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.427 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.53 113.18 3.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.8 -119.61 4.21 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.29 -1.123 . . . . 0.0 109.545 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 201' ' ' MET . . . . . 0.402 ' CE ' ' OE1' ' A' ' 118' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.222 0.534 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.464 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 7.4 m-80 44.94 68.85 0.5 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.568 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 203' ' ' THR . . . . . 0.459 ' O ' ' CG2' ' B' ' 203' ' ' THR . 9.7 t -52.51 107.74 0.91 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 0.0 109.661 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 204' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 50.6 Cg_endo -77.2 5.9 4.71 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.912 1.48 . . . . 0.0 110.491 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' B' ' 204' ' ' PRO . 0.0 OUTLIER -40.76 -72.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.289 -0.882 . . . . 0.0 110.183 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 206' ' ' HIS . . . . . 0.568 ' CE1' ' HG3' ' B' ' 207' ' ' MET . 11.8 p80 -54.59 -35.84 63.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 109.957 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 207' ' ' MET . . . . . 0.568 ' HG3' ' CE1' ' B' ' 206' ' ' HIS . 15.8 mtt -65.57 -56.92 9.68 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.172 -0.955 . . . . 0.0 109.836 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.457 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 8.2 m -56.18 -31.1 63.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.701 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.99 -51.37 67.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.149 -0.969 . . . . 0.0 108.696 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.635 ' CG1' ' CZ ' ' B' ' 301' ' ' PHE . 1.0 OUTLIER -55.56 -20.61 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.567 HG22 ' CE2' ' B' ' 301' ' ' PHE . 16.2 t -90.24 -43.01 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.553 -0.717 . . . . 0.0 109.123 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' B' ' 213' ' ' ARG . 6.0 tt0 -60.66 -74.09 0.08 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' B' ' 212' ' ' GLN . 1.6 mtt-85 -42.3 -44.88 4.03 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.964 0.888 . . . . 0.0 108.605 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' TYR . . . . . 0.581 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -49.7 -45.15 48.68 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.608 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.24 -38.88 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.309 -0.869 . . . . 0.0 109.097 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -49.1 -35.75 17.03 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -75.3 -31.0 60.53 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.608 ' CD1' ' HA ' ' B' ' 215' ' ' VAL . 1.1 mt -65.4 -56.4 12.73 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 0.2 OUTLIER -53.06 -47.31 68.55 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.604 0.716 . . . . 0.0 109.348 179.462 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.22 6.56 39.65 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.713 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 217' ' ' ALA . . . 51.48 39.55 44.93 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.9 t0 -96.04 66.48 2.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.306 -1.114 . . . . 0.0 109.893 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' LEU . . . . . 0.593 ' CD2' ' CG ' ' B' ' 252' ' ' ARG . 6.1 tp -47.59 -43.34 25.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.163 -0.96 . . . . 0.0 108.909 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' B' ' 228' ' ' ALA . 0.2 OUTLIER -43.59 -38.21 2.88 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -80.6 -29.01 45.23 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.512 HD11 ' CD1' ' B' ' 223' ' ' LEU . 36.9 mt -65.92 -56.27 15.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.467 HG12 HG22 ' B' ' 248' ' ' THR . 77.3 t -59.86 -35.97 63.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' B' ' 224' ' ' ASP . . . -60.22 -56.21 24.38 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.5 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 9.2 tp -59.3 -23.0 62.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . 0.465 ' HA ' ' HB ' ' B' ' 309' ' ' VAL . 3.9 m-85 -88.92 143.35 26.93 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.41 -0.806 . . . . 0.0 109.484 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -53.79 -170.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.855 . . . . 0.0 109.322 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.458 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -75.61 -24.2 56.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 109.673 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . 0.529 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 15.1 p30 -145.06 44.2 1.33 Allowed 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.592 -0.693 . . . . 0.0 109.608 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.502 ' CA ' ' O ' ' B' ' 310' ' ' VAL . . . -55.9 168.53 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.918 . . . . 0.0 109.339 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' THR . . . . . 0.517 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -121.68 142.68 49.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.611 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 32.3 t -131.63 121.16 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 109.507 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' GLU . . . . . 0.507 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.1 mt-10 -88.53 112.43 22.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' B' ' 239' ' ' PRO . 12.6 t70 -176.08 145.57 0.75 Allowed Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.265 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 53.6 Cg_endo -79.66 -92.41 0.0 OUTLIER 'Cis proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.506 -1.872 . . . . 0.0 110.915 -0.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.38 126.55 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.912 -1.118 . . . . 0.0 108.95 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 86.53 -8.37 75.26 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' SER . . . . . 0.535 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.2 OUTLIER -97.93 -146.24 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -1.062 . . . . 0.0 109.152 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -135.17 141.78 39.29 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.882 -1.136 . . . . 0.0 110.247 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' PRO . . . . . 0.539 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.4 Cg_endo -64.55 -169.5 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.271 1.669 . . . . 0.0 110.883 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.575 ' HG3' ' CD1' ' B' ' 254' ' ' PHE . 1.5 mtt-85 -150.34 101.77 3.01 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.517 ' HB2' ' CG2' ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.2 164.38 15.0 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.307 -0.87 . . . . 0.0 110.119 -179.03 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 98.39 160.45 30.17 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 248' ' ' THR . . . . . 0.467 HG22 HG12 ' B' ' 227' ' ' VAL . 4.1 m -74.32 -33.15 63.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.167 -1.196 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -72.63 -43.88 62.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.281 -0.887 . . . . 0.0 109.34 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' B' ' 245' ' ' ARG . . . -67.75 -56.97 7.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.445 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' B' ' 247' ' ' GLY . 43.2 mt -47.53 -40.27 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.878 . . . . 0.0 108.885 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 252' ' ' ARG . . . . . 0.593 ' CG ' ' CD2' ' B' ' 223' ' ' LEU . 25.1 ttp85 -78.02 -52.72 8.35 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 253' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 4.0 mt-10 -50.82 -26.53 5.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 108.472 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.575 ' CD1' ' HG3' ' B' ' 245' ' ' ARG . 0.8 OUTLIER -87.65 -71.36 0.57 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 255' ' ' PHE . . . . . 0.576 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.1 OUTLIER -48.95 -33.26 10.56 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . 0.523 ' CA ' HD21 ' B' ' 223' ' ' LEU . . . -63.8 -49.71 71.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 257' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 8.5 t30 -54.99 -36.49 65.48 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 4.7 t -65.63 -36.19 82.99 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.429 -0.794 . . . . 0.0 108.961 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 259' ' ' LEU . . . . . 0.459 HD12 ' HA2' ' B' ' 221' ' ' GLY . 8.1 tp -67.07 -22.5 65.84 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.493 -0.754 . . . . 0.0 109.189 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 260' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' B' ' 262' ' ' PRO . 1.2 mttm -56.25 -20.34 17.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.132 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 261' ' ' LEU . . . . . 0.556 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.3 OUTLIER -92.35 107.38 23.15 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 262' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 49.4 Cg_endo -74.44 107.4 2.44 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.822 1.433 . . . . 0.0 112.151 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.579 HD23 ' CD1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -141.91 -162.83 1.46 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 0.0 109.567 178.608 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -123.67 125.84 45.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 265' ' ' VAL . . . . . 0.466 HG13 HG12 ' B' ' 215' ' ' VAL . 21.6 t -105.4 119.11 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.97 . . . . 0.0 109.806 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 266' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.2 OUTLIER -147.88 107.33 3.93 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.234 -0.916 . . . . 0.0 109.284 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.7 OUTLIER -49.77 -179.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.905 . . . . 0.0 109.574 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.15 -39.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 109.677 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 269' ' ' GLN . . . . . 0.426 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 8.9 pt20 -98.72 -148.62 0.34 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 109.231 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 270' ' ' GLU . . . . . 0.426 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 28.1 tt0 -113.11 131.25 55.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.106 -0.996 . . . . 0.0 109.516 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 271' ' ' VAL . . . . . 0.477 HG11 ' N ' ' B' ' 272' ' ' ARG . 48.1 t -65.6 148.52 12.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.12 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 1.2 mtt180 -103.24 133.49 48.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -0.95 . . . . 0.0 109.732 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . 0.475 ' HA ' ' HB1' ' B' ' 278' ' ' ALA . . . -150.14 137.44 19.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.368 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 274' ' ' VAL . . . . . 0.541 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -130.02 -152.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 0.0 109.589 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 275' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . -32.67 -91.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.147 0.498 . . . . 0.0 110.799 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 276' ' ' ASN . . . . . 0.497 ' ND2' ' HA2' ' A' ' 41' ' ' GLY . 11.2 p30 -112.54 -18.18 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.944 -1.098 . . . . 0.0 110.269 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . 0.465 ' HG3' ' HG2' ' B' ' 302' ' ' ARG . 2.8 mt-10 -90.62 -163.27 1.0 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 109.578 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 278' ' ' ALA . . . . . 0.53 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . 174.89 163.79 0.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.516 -0.74 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 279' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -150.55 138.81 20.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 108.623 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . 0.576 ' CE2' ' HB3' ' B' ' 299' ' ' ASP . 33.3 p90 -150.39 167.25 27.63 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.71 -1.244 . . . . 0.0 110.462 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . 0.536 ' CB ' HG21 ' B' ' 298' ' ' ILE . . . -142.96 151.7 41.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.719 -0.613 . . . . 0.0 109.378 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 282' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 1.2 p90 -145.37 -169.95 3.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.181 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.57 142.95 47.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.461 -0.774 . . . . 0.0 109.961 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 284' ' ' VAL . . . . . 0.548 HG11 ' CB ' ' B' ' 263' ' ' LEU . 2.9 t -125.86 115.54 43.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 285' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' B' ' 294' ' ' VAL . 53.1 p -119.7 106.02 11.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 109.988 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.581 ' CE1' ' HB ' ' B' ' 293' ' ' THR . 13.6 p90 -114.41 173.82 6.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.0 108.846 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.11 157.09 16.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.024 -1.048 . . . . 0.0 110.803 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . 0.54 ' O ' ' N ' ' B' ' 290' ' ' GLY . 0.0 OUTLIER -117.57 74.09 0.92 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.594 -0.691 . . . . 0.0 109.147 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . 0.513 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 0.2 OUTLIER 43.94 -91.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.062 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 290' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' B' ' 288' ' ' PHE . . . -101.0 7.11 57.01 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.295 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -132.72 -178.94 5.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -1.22 . . . . 0.0 109.803 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 292' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -122.42 144.2 49.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.84 . . . . 0.0 109.344 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 293' ' ' THR . . . . . 0.613 ' CB ' ' HB2' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -140.22 159.19 42.73 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.148 -0.97 . . . . 0.0 109.364 -179.06 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 294' ' ' VAL . . . . . 0.6 ' O ' ' HB3' ' B' ' 322' ' ' HIS . 3.9 p -151.65 -177.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 120.686 -1.259 . . . . 0.0 110.266 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.565 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 29.0 t -151.95 148.89 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.106 -1.621 . . . . 0.0 109.187 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 296' ' ' ALA . . . . . 0.529 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -145.07 67.84 13.58 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.068 -1.02 . . . . 0.0 110.238 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 297' ' ' PRO . . . . . 0.565 ' HD3' ' CG1' ' B' ' 295' ' ' VAL . 50.0 Cg_endo -98.03 -175.78 0.22 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.94 1.76 . . . . 0.0 111.018 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.536 HG21 ' CB ' ' B' ' 281' ' ' ALA . 2.9 mp -139.88 147.29 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . 0.576 ' HB3' ' CE2' ' B' ' 280' ' ' PHE . 9.4 t0 -118.42 157.83 26.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.858 -1.151 . . . . 0.0 110.223 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 300' ' ' HIS . . . . . 0.525 ' O ' ' CG ' ' B' ' 312' ' ' MET . 0.3 OUTLIER -110.52 172.3 6.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.336 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 301' ' ' PHE . . . . . 0.635 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -146.48 133.94 20.83 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.048 -1.032 . . . . 0.0 110.129 -178.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.478 ' O ' ' HB ' ' B' ' 310' ' ' VAL . 0.3 OUTLIER -139.69 111.96 7.63 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 303' ' ' PHE . . . . . 0.551 ' CE1' HG12 ' B' ' 210' ' ' VAL . 8.3 m-30 -91.87 177.63 6.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.268 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 304' ' ' ASN . . . . . 0.506 ' N ' ' CG2' ' B' ' 310' ' ' VAL . 6.7 p30 -92.61 -28.9 16.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.931 . . . . 0.0 109.276 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 305' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -166.53 -50.74 0.03 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 306' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 163.04 76.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -1.135 . . . . 0.0 109.336 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.52 -63.71 0.06 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.53 -163.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -1.179 . . . . 0.0 109.841 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 309' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' B' ' 310' ' ' VAL . 17.0 t -106.98 168.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.338 -0.851 . . . . 0.0 109.162 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . 0.55 ' N ' ' CG1' ' B' ' 309' ' ' VAL . 24.6 t -139.86 -73.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 0.0 109.919 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 311' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' B' ' 235' ' ' THR . 9.3 m -125.38 163.24 23.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.185 -0.947 . . . . 0.0 110.164 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 312' ' ' MET . . . . . 0.567 ' SD ' ' CE1' ' B' ' 301' ' ' PHE . 0.0 OUTLIER -143.44 171.3 14.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -0.822 . . . . 0.0 109.487 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 313' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' B' ' 300' ' ' HIS . 1.5 ttp85 -150.2 120.0 7.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 109.571 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -101.07 136.63 40.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.977 . . . . 0.0 109.721 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 315' ' ' LEU . . . . . 0.529 ' CD1' ' HB1' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -126.24 148.7 49.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.896 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 316' ' ' PHE . . . . . 0.534 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 2.2 p90 168.22 -169.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 317' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' B' ' 321' ' ' ILE . . . -157.24 167.58 33.94 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.262 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 318' ' ' GLU . . . . . 0.533 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 5.8 tt0 -63.81 -9.88 17.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.43 -1.041 . . . . 0.0 109.889 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -88.37 -32.81 18.19 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 320' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' B' ' 296' ' ' ALA . 0.7 OUTLIER -98.44 28.64 4.03 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 321' ' ' ILE . . . . . 0.533 ' CG1' ' HA ' ' B' ' 318' ' ' GLU . 19.5 mm -91.01 -120.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.005 -1.059 . . . . 0.0 110.332 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 322' ' ' HIS . . . . . 0.613 ' HB2' ' CB ' ' B' ' 293' ' ' THR . 14.4 p80 -125.69 134.25 51.88 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.016 -1.052 . . . . 0.0 112.489 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.377 0 O-C-N 121.393 -0.817 . . . . 0.0 109.841 177.818 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.518 HG23 ' CE1' ' A' ' 6' ' ' HIS . 1.3 t . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HA ' ' HB2' ' A' ' 7' ' ' MET . 46.3 Cg_endo -73.9 -0.46 9.49 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.863 1.454 . . . . 0.0 110.185 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.19 -92.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.602 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.518 ' CE1' HG23 ' A' ' 3' ' ' THR . 1.6 p-80 -52.54 -41.28 63.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.143 -0.973 . . . . 0.0 109.259 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.527 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 34.5 mmt -53.17 -39.86 63.93 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.199 -0.938 . . . . 0.0 109.788 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.424 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 6.0 m -74.19 -36.63 64.02 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.21 -43.81 64.44 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.641 ' CG1' ' CE1' ' A' ' 101' ' ' PHE . 2.1 t -49.55 -33.93 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.584 ' CG2' ' CE2' ' A' ' 101' ' ' PHE . 29.9 t -76.33 -45.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.438 -0.789 . . . . 0.0 109.791 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 15' ' ' VAL . 17.0 tt0 -59.4 -73.68 0.08 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.212 1.006 . . . . 0.0 108.494 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.3 mtt180 -42.68 -44.91 4.5 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.636 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -49.5 -44.98 46.51 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.612 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 1.3 t -88.88 -38.72 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.334 -0.854 . . . . 0.0 109.243 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.94 -36.47 17.44 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 22' ' ' ASP . . . -74.0 -32.58 63.47 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.636 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 2.4 mt -64.96 -58.75 5.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -51.14 -45.8 61.77 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . -89.58 10.19 23.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.64 -0.662 . . . . 0.0 109.459 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.534 ' CA ' ' CD2' ' A' ' 59' ' ' LEU . . . 45.7 31.92 4.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' ALA . 7.6 t70 -89.75 66.19 7.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.501 -0.999 . . . . 0.0 109.804 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.611 ' CD1' ' HB3' ' A' ' 55' ' ' PHE . 8.2 tp -47.9 -42.61 27.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 108.962 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -42.03 -32.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.4 -36.82 10.29 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.473 HG12 ' HB3' ' A' ' 17' ' ' ALA . 25.3 mt -59.32 -54.07 39.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 52.4 t -58.18 -40.9 79.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.22 -52.73 60.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' A' ' 10' ' ' VAL . 9.6 tp -61.71 -27.89 69.02 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.587 ' CE1' ' HE3' ' A' ' 112' ' ' MET . 5.6 m-85 -79.08 128.33 33.14 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.556 -0.715 . . . . 0.0 109.811 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -45.86 172.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 109.655 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.431 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -60.08 -24.15 64.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 109.87 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.544 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -148.01 38.66 0.91 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.58 -0.7 . . . . 0.0 109.506 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB2' HD13 ' A' ' 51' ' ' ILE . . . -54.91 173.65 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.632 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.547 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -114.57 140.09 49.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.426 -0.796 . . . . 0.0 109.127 179.657 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.563 HG13 ' CD2' ' A' ' 54' ' ' PHE . 1.2 t -113.43 171.83 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 108.715 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.591 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -151.26 121.11 7.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.882 . . . . 0.0 108.873 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER 172.69 148.2 0.2 Allowed Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.549 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.554 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 46.7 Cg_endo -80.93 -84.38 0.0 OUTLIER 'Cis proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.165 -2.015 . . . . 0.0 110.599 -0.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' B' ' 275' ' ' ALA . 2.2 m -146.95 73.71 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.203 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.29 -5.5 3.88 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.554 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 3.4 t -97.27 -131.04 0.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.19 -1.183 . . . . 0.0 109.199 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -138.62 128.37 14.7 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.565 -1.334 . . . . 0.0 110.423 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.591 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 37.9 Cg_endo -62.5 -175.56 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.707 1.605 . . . . 0.0 111.055 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.532 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -151.11 100.52 2.78 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.45 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.547 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.3 OUTLIER -90.37 171.58 9.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.205 -0.935 . . . . 0.0 110.63 -178.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 95.77 154.85 30.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 5.5 m -64.7 -36.83 85.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.19 -1.182 . . . . 0.0 109.259 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -70.79 -43.97 67.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.154 -0.966 . . . . 0.0 109.319 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 46' ' ' SER . . . -74.41 -57.13 4.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.582 HG22 ' CD1' ' A' ' 30' ' ' PHE . 43.0 mt -43.71 -37.11 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.235 -0.916 . . . . 0.0 109.052 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 2.5 ttt180 -81.25 -63.62 1.36 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.0 109.147 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 4.2 tt0 -45.11 -28.75 0.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.934 . . . . 0.0 108.825 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.563 ' CD2' HG13 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -79.88 -71.42 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.611 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -46.62 -25.75 0.77 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.469 ' HA ' HD21 ' A' ' 23' ' ' LEU . . . -71.2 -47.17 59.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 11.1 t-20 -57.51 -30.87 65.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.388 -0.82 . . . . 0.0 108.793 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 t -72.55 -40.83 66.37 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.534 ' CD2' ' CA ' ' A' ' 21' ' ' GLY . 9.0 tp -65.11 -21.93 66.87 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.453 -0.779 . . . . 0.0 109.273 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.467 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 4.8 mttp -47.47 -27.5 1.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.043 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -90.03 107.72 21.26 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.306 -0.871 . . . . 0.0 108.718 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 44.5 Cg_endo -70.93 116.09 4.53 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.795 1.419 . . . . 0.0 110.675 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.54 ' CD2' ' O ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -150.3 -171.13 3.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.969 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.59 126.84 54.71 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.38 123.52 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 109.895 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -150.23 98.71 2.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.141 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 66' ' ' GLU . 2.1 mp -44.87 170.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 110.039 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 69' ' ' GLN . 0.6 OUTLIER -129.27 -83.3 0.56 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 68' ' ' THR . 2.8 pt20 -59.37 -148.07 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.675 -0.641 . . . . 0.0 109.319 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 31.6 tt0 -109.1 132.43 54.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.056 -1.028 . . . . 0.0 109.647 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.535 HG12 ' CG1' ' A' ' 11' ' ' VAL . 48.7 t -57.4 149.48 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.293 -0.88 . . . . 0.0 109.259 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.51 ' HA ' ' NE ' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -114.28 132.91 55.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.029 -1.044 . . . . 0.0 109.968 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.458 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -150.17 112.04 4.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.39 -0.819 . . . . 0.0 109.253 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -131.81 158.71 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.225 -0.922 . . . . 0.0 109.501 -179.814 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 48.58 -147.52 0.26 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.304 -0.873 . . . . 0.0 109.622 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -82.24 -24.12 34.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.532 ' CG ' ' HA ' ' A' ' 102' ' ' ARG . 3.3 mt-10 -89.92 -162.41 0.88 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.111 -0.993 . . . . 0.0 109.539 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 101' ' ' PHE . . . -178.46 168.95 1.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.522 -0.736 . . . . 0.0 109.366 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.527 ' HB2' ' CD2' ' B' ' 315' ' ' LEU . . . -150.17 136.27 18.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.155 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.685 ' CE1' ' CE2' ' A' ' 101' ' ' PHE . 14.4 p90 -149.79 162.25 40.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.95 -1.094 . . . . 0.0 110.15 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.527 ' C ' ' CD2' ' A' ' 82' ' ' PHE . . . -136.45 -173.0 3.29 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.638 0.732 . . . . 0.0 110.118 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.527 ' CD2' ' C ' ' A' ' 81' ' ' ALA . 6.0 p90 177.08 -169.81 0.07 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -133.33 140.41 47.39 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 110.042 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 37.7 t -107.94 113.35 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 33.6 p -108.12 84.7 1.99 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 109.743 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.581 ' CZ ' ' OG1' ' A' ' 93' ' ' THR . 15.5 p90 -93.62 -179.21 4.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.083 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.433 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 18.5 tt0 -111.36 149.59 30.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.034 -1.041 . . . . 0.0 110.325 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.587 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -114.19 104.98 12.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.453 -0.779 . . . . 0.0 109.021 179.443 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.497 ' CG ' ' C ' ' A' ' 88' ' ' PHE . 1.1 pt20 40.74 -93.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.412 -0.805 . . . . 0.0 109.894 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 88' ' ' PHE . . . -101.9 -31.84 5.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -90.08 -178.27 5.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -1.232 . . . . 0.0 109.632 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.458 ' HE3' ' OXT' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -127.46 140.63 52.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.587 ' OG1' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -124.59 159.81 29.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.393 -0.817 . . . . 0.0 109.645 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.578 ' CG1' ' CB ' ' A' ' 122' ' ' HIS . 7.2 p -139.28 174.88 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.165 -0.96 . . . . 0.0 109.31 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.552 HG13 ' HD3' ' A' ' 97' ' ' PRO . 78.3 t -142.94 163.12 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.078 -1.014 . . . . 0.0 109.942 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.532 ' N ' HG13 ' A' ' 95' ' ' VAL . . . -138.0 70.63 49.32 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.527 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.552 ' HD3' HG13 ' A' ' 95' ' ' VAL . 46.1 Cg_endo -97.83 179.25 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.871 1.714 . . . . 0.0 111.447 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.526 HD12 ' NE ' ' B' ' 272' ' ' ARG . 2.8 mp -142.06 156.25 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.577 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 19.9 t0 -130.16 159.58 36.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.967 -1.083 . . . . 0.0 110.072 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 113' ' ' ARG . 85.9 t60 -109.87 170.74 7.88 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.685 ' CE2' ' CE1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -140.85 136.02 31.95 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.07 -1.018 . . . . 0.0 110.006 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.532 ' HA ' ' CG ' ' A' ' 77' ' ' GLU . 3.2 ttt85 -131.3 109.13 10.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.593 ' CE1' HG12 ' A' ' 10' ' ' VAL . 10.1 m-85 -108.42 -177.48 3.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 107' ' ' GLY . 6.1 p30 -106.72 6.34 29.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.573 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . 120.51 -30.51 5.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 164.36 37.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -1.151 . . . . 0.0 109.364 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 108' ' ' LYS . . . -130.58 47.62 1.01 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 7.3 mmtt 84.19 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.055 -0.674 . . . . 0.0 109.421 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 110' ' ' VAL . 40.4 t -89.83 166.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 109.329 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.542 ' N ' ' CG1' ' A' ' 109' ' ' VAL . 72.3 t -138.19 -59.78 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.531 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.529 ' HB2' ' CD ' ' A' ' 102' ' ' ARG . 1.1 m -139.6 163.5 32.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.612 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.587 ' HE3' ' CE1' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -145.45 155.37 43.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.883 . . . . 0.0 109.779 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -141.31 108.18 5.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.376 -0.828 . . . . 0.0 108.985 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.48 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -89.89 148.02 23.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.071 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.559 HD11 ' CE1' ' B' ' 300' ' ' HIS . 1.4 tt -136.36 139.98 42.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.433 -0.792 . . . . 0.0 109.575 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.52 ' HA ' ' NH2' ' B' ' 272' ' ' ARG . 2.8 p90 172.42 -158.44 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.624 0.726 . . . . 0.0 109.4 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.409 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . 174.49 179.85 45.36 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.522 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 18.6 tt0 -72.73 -3.22 23.86 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.311 -1.111 . . . . 0.0 109.397 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -91.16 -29.15 17.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.946 0.879 . . . . 0.0 108.996 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -88.85 15.95 7.64 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.324 0.583 . . . . 0.0 109.712 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.522 ' CG1' ' HA ' ' A' ' 118' ' ' GLU . 4.0 mm -89.97 -162.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.578 ' CB ' ' CG1' ' A' ' 94' ' ' VAL . 2.9 t-80 -151.67 153.56 34.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.862 -1.149 . . . . 0.0 110.047 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.481 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.8 125.3 6.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.336 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.12 -164.95 32.59 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.458 ' OXT' ' HE3' ' A' ' 92' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.325 -1.103 . . . . 0.0 109.45 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 201' ' ' MET . . . . . 0.427 ' O ' ' C ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.251 0.548 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.457 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 30.7 m120 43.7 74.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.484 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 4.8 t -87.64 109.61 27.95 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.625 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 204' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.4 Cg_endo -72.93 -1.35 10.34 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.91 1.479 . . . . 0.0 110.245 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -49.39 72.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -66.15 -55.0 18.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.504 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 207' ' ' MET . . . . . 0.444 ' SD ' ' O ' ' B' ' 275' ' ' ALA . 69.2 mtm -58.32 -43.72 88.32 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.231 -0.918 . . . . 0.0 109.781 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.471 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 19.1 m -70.79 -42.04 70.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.574 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.35 -45.2 65.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 108.747 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.597 ' CG2' ' CG2' ' B' ' 309' ' ' VAL . 1.3 t -56.99 -20.64 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.55 HG21 ' CD1' ' B' ' 280' ' ' PHE . 10.7 t -90.29 -41.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 0.0 109.198 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' B' ' 213' ' ' ARG . 14.0 tt0 -60.49 -74.77 0.07 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' B' ' 212' ' ' GLN . 0.0 OUTLIER -42.09 -43.43 3.26 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 122.137 0.97 . . . . 0.0 108.697 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' TYR . . . . . 0.635 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 1.2 t80 -55.84 -49.27 73.76 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.415 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.606 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 0.9 OUTLIER -83.01 -42.58 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.722 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.45 -36.67 10.36 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -74.89 -32.98 61.98 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.635 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 0.9 OUTLIER -62.68 -56.18 20.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' B' ' 265' ' ' VAL . 4.0 t-20 -53.24 -48.41 68.24 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.652 0.739 . . . . 0.0 109.523 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.01 10.0 23.13 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.845 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 217' ' ' ALA . . . 50.06 37.83 30.72 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' B' ' 217' ' ' ALA . 9.4 t0 -93.03 61.29 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.332 -1.099 . . . . 0.0 109.815 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' LEU . . . . . 0.573 ' CD1' ' HB3' ' B' ' 255' ' ' PHE . 5.8 tp -46.2 -42.53 14.27 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.153 -0.967 . . . . 0.0 108.648 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -43.7 -37.88 2.86 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -81.78 -33.46 27.26 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.49 HD12 ' CD2' ' B' ' 255' ' ' PHE . 27.9 mt -61.25 -55.18 26.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 88.8 t -58.02 -37.13 59.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.19 25.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 9.8 tp -59.71 -24.39 63.94 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' B' ' 231' ' ' ALA . 5.1 m-85 -82.59 136.62 34.77 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.494 -0.754 . . . . 0.0 109.362 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.534 ' CB ' HG22 ' B' ' 310' ' ' VAL . . . -52.33 -174.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.382 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.473 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.3 OUTLIER -69.67 -26.38 64.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.445 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . 0.536 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 3.5 p30 -151.4 54.87 0.86 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.498 -0.751 . . . . 0.0 109.68 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.507 ' CA ' ' O ' ' B' ' 310' ' ' VAL . . . -60.36 -167.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' THR . . . . . 0.471 ' N ' ' O ' ' B' ' 310' ' ' VAL . 0.2 OUTLIER -130.6 133.96 46.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.895 . . . . 0.0 109.244 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' B' ' 237' ' ' GLU . 23.1 t -111.95 167.66 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -0.865 . . . . 0.0 109.188 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' GLU . . . . . 0.555 ' N ' ' CG1' ' B' ' 236' ' ' VAL . 21.8 mt-10 -150.88 115.54 5.19 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' ASP . . . . . 0.476 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 0.6 OUTLIER -177.11 148.17 0.73 Allowed Pre-proline 0 N--CA 1.491 1.582 0 C-N-CA 118.355 -1.338 . . . . 0.0 110.38 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 47.6 Cg_endo -73.34 -55.32 0.14 OUTLIER 'Cis proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.941 -2.108 . . . . 0.0 110.989 -0.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.463 HG11 ' O ' ' B' ' 239' ' ' PRO . 34.6 m -150.43 111.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 109.792 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.14 43.39 63.12 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' SER . . . . . 0.522 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 73.7 m -114.73 -96.57 0.45 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -1.117 . . . . 0.0 109.944 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . 0.407 ' HA ' ' HD2' ' B' ' 244' ' ' PRO . 0.0 OUTLIER -142.86 89.9 7.82 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.272 -0.893 . . . . 0.0 110.609 -179.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' PRO . . . . . 0.548 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 37.9 Cg_endo -63.38 179.57 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.117 1.588 . . . . 0.0 110.507 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.581 ' HB2' ' CD1' ' B' ' 254' ' ' PHE . 0.0 OUTLIER -150.64 100.46 2.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.952 . . . . 0.0 109.629 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.79 167.05 13.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.32 -0.863 . . . . 0.0 109.64 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 97.78 159.5 30.66 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 248' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 2.1 m -69.58 -38.57 77.41 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.946 -1.326 . . . . 0.0 109.145 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -69.48 -41.4 76.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' B' ' 246' ' ' SER . . . -72.92 -56.99 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' B' ' 247' ' ' GLY . 30.0 mt -46.67 -42.26 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.188 -0.945 . . . . 0.0 108.772 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 252' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' B' ' 227' ' ' VAL . 8.3 ttt180 -79.08 -50.75 10.55 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 253' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 46.4 mt-10 -51.12 -31.03 18.05 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.581 ' CD1' ' HB2' ' B' ' 245' ' ' ARG . 1.1 t80 -83.47 -71.93 0.48 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 255' ' ' PHE . . . . . 0.573 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -46.0 -26.34 0.7 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' B' ' 252' ' ' ARG . . . -70.65 -48.26 55.86 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 257' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 4.7 t-20 -61.98 -31.02 71.34 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 2.8 t -71.56 -32.59 68.28 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 259' ' ' LEU . . . . . 0.443 HD12 ' HA2' ' B' ' 221' ' ' GLY . 8.7 tp -66.19 -22.15 66.34 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 260' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 16.1 mtmt -61.51 -13.57 22.26 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 261' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' B' ' 263' ' ' LEU . 0.1 OUTLIER -88.63 110.46 37.26 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.248 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 262' ' ' PRO . . . . . 0.496 ' HD2' HD12 ' B' ' 261' ' ' LEU . 52.1 Cg_endo -80.94 91.68 1.12 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.705 1.371 . . . . 0.0 112.328 -178.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.588 HD22 ' CD1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -138.48 163.77 31.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.082 -1.011 . . . . 0.0 108.819 178.186 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -89.81 127.27 35.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.18 -0.95 . . . . 0.0 109.021 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 265' ' ' VAL . . . . . 0.507 ' O ' ' ND2' ' B' ' 219' ' ' ASN . 93.9 t -104.44 112.44 38.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.269 -0.895 . . . . 0.0 109.528 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 266' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.6 tp10 -147.47 98.14 2.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.053 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . 0.507 ' HA ' ' CB ' ' B' ' 282' ' ' PHE . 1.7 mp -44.41 169.35 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 110.059 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 268' ' ' THR . . . . . 0.502 ' OG1' ' N ' ' B' ' 269' ' ' GLN . 0.4 OUTLIER -122.28 -83.08 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 269' ' ' GLN . . . . . 0.502 ' N ' ' OG1' ' B' ' 268' ' ' THR . 2.6 pt20 -61.17 -140.4 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -117.57 130.67 56.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.875 -1.141 . . . . 0.0 109.993 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 271' ' ' VAL . . . . . 0.52 ' CG1' ' HB3' ' B' ' 280' ' ' PHE . 56.5 t -48.71 149.19 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.355 -0.841 . . . . 0.0 108.936 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.526 ' NE ' HD12 ' A' ' 98' ' ' ILE . 31.1 mtp85 -108.11 129.18 55.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.043 -1.036 . . . . 0.0 109.714 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . 0.485 ' C ' ' CG2' ' B' ' 274' ' ' VAL . . . -143.91 144.95 31.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.292 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 274' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -167.31 146.55 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 109.099 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 275' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . 58.27 -139.11 0.81 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.093 -1.005 . . . . 0.0 109.094 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 276' ' ' ASN . . . . . 0.544 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 18.0 m-20 -91.31 -31.26 16.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.977 -1.077 . . . . 0.0 109.891 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . 0.669 ' HG2' ' N ' ' B' ' 278' ' ' ALA . 0.0 OUTLIER -97.99 153.6 18.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 109.647 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 278' ' ' ALA . . . . . 0.669 ' N ' ' HG2' ' B' ' 277' ' ' GLU . . . -136.04 169.66 17.25 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.388 0.613 . . . . 0.0 109.877 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 279' ' ' ALA . . . . . 0.58 ' HB2' ' CE1' ' B' ' 300' ' ' HIS . . . -141.66 141.66 33.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.388 -0.82 . . . . 0.0 109.182 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . 0.587 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 36.0 p90 -150.26 157.92 43.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.848 -1.158 . . . . 0.0 110.324 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . 0.537 ' CB ' HG21 ' B' ' 298' ' ' ILE . . . -137.26 -169.27 2.46 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.484 0.659 . . . . 0.0 110.038 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 282' ' ' PHE . . . . . 0.507 ' CB ' ' HA ' ' B' ' 267' ' ' LEU . 30.5 p90 168.55 -168.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 283' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -130.92 140.79 50.23 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.346 -0.846 . . . . 0.0 109.527 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 284' ' ' VAL . . . . . 0.544 ' CG1' ' HB2' ' B' ' 263' ' ' LEU . 0.4 OUTLIER -100.87 119.32 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -0.872 . . . . 0.0 108.892 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 86.7 p -109.17 118.23 36.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 0.0 109.836 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.65 ' CE2' ' CG2' ' B' ' 293' ' ' THR . 0.7 OUTLIER -140.32 153.43 46.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.935 . . . . 0.0 109.44 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 287' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' B' ' 291' ' ' ARG . 81.9 tt0 -96.5 164.53 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' B' ' 289' ' ' GLN . 1.0 OUTLIER -115.42 -173.8 2.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.688 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' B' ' 288' ' ' PHE . 0.0 OUTLIER -43.22 -30.43 0.48 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.707 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -150.0 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 291' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' B' ' 287' ' ' GLU . 0.0 OUTLIER -83.35 -165.03 0.99 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -1.188 . . . . 0.0 109.532 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 292' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' B' ' 287' ' ' GLU . 0.3 OUTLIER -149.78 143.64 25.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.85 . . . . 0.0 109.306 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 293' ' ' THR . . . . . 0.65 ' CG2' ' CE2' ' B' ' 286' ' ' PHE . 1.4 t -129.5 -176.19 3.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.999 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 294' ' ' VAL . . . . . 0.542 ' CG1' ' HB3' ' B' ' 322' ' ' HIS . 6.3 p -152.2 171.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' B' ' 321' ' ' ILE . 46.0 t -143.6 155.52 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.86 -1.15 . . . . 0.0 109.835 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 296' ' ' ALA . . . . . 0.52 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -126.33 72.83 72.6 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 297' ' ' PRO . . . . . 0.523 ' HD3' HG11 ' B' ' 295' ' ' VAL . 43.9 Cg_endo -95.85 176.27 0.82 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.539 1.493 . . . . 0.0 111.188 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.537 HG21 ' CB ' ' B' ' 281' ' ' ALA . 3.0 mp -142.35 158.79 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . 0.587 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 17.1 t0 -131.27 168.24 17.85 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.115 -0.99 . . . . 0.0 109.959 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 300' ' ' HIS . . . . . 0.58 ' CE1' ' HB2' ' B' ' 279' ' ' ALA . 1.2 t-80 -131.5 138.61 49.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 108.983 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 301' ' ' PHE . . . . . 0.589 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.4 OUTLIER -112.65 150.13 31.88 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 -178.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -140.8 142.83 34.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.607 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 303' ' ' PHE . . . . . 0.569 ' CE2' HG21 ' B' ' 210' ' ' VAL . 2.1 m-85 -128.99 175.43 8.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.843 . . . . 0.0 108.967 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 304' ' ' ASN . . . . . 0.534 ' OD1' ' CB ' ' B' ' 310' ' ' VAL . 0.2 OUTLIER -150.3 18.59 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.242 -0.911 . . . . 0.0 109.142 178.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 305' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -160.69 -88.53 0.07 OUTLIER Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 306' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 162.75 63.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -1.108 . . . . 0.0 109.666 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 307' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' B' ' 308' ' ' LYS . . . 166.96 -26.15 0.15 Allowed Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.079 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 308' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' B' ' 307' ' ' GLY . 1.2 mmtp -128.98 164.02 24.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -1.208 . . . . 0.0 109.918 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 309' ' ' VAL . . . . . 0.597 ' CG2' ' CG2' ' B' ' 210' ' ' VAL . 2.5 t -103.9 157.04 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . 0.534 ' CB ' ' OD1' ' B' ' 304' ' ' ASN . 22.1 t -142.77 -35.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.913 -1.117 . . . . 0.0 110.279 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 311' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -126.25 150.71 48.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.714 -1.241 . . . . 0.0 109.921 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 312' ' ' MET . . . . . 0.528 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 8.4 ttp -154.84 149.58 26.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.477 -0.764 . . . . 0.0 109.337 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 313' ' ' ARG . . . . . 0.454 ' HA ' ' HB2' ' B' ' 237' ' ' GLU . 13.4 ttp180 -141.92 124.39 15.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 109.625 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 314' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' B' ' 299' ' ' ASP . . . -97.95 130.83 44.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.449 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 315' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -117.84 136.06 53.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.908 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 316' ' ' PHE . . . . . 0.527 ' HB3' ' O ' ' B' ' 315' ' ' LEU . 7.2 p90 170.46 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 317' ' ' GLY . . . . . 0.447 ' N ' ' CD2' ' B' ' 316' ' ' PHE . . . 169.77 -173.46 43.95 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 318' ' ' GLU . . . . . 0.445 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 19.0 tt0 -73.51 -2.46 22.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.286 -1.126 . . . . 0.0 109.161 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 16.8 tttp -91.67 -27.69 17.94 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.935 0.874 . . . . 0.0 108.887 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 320' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -88.88 17.34 5.76 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.335 0.588 . . . . 0.0 109.665 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 321' ' ' ILE . . . . . 0.537 HG21 ' CG2' ' B' ' 295' ' ' VAL . 4.9 mm -89.83 178.21 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 322' ' ' HIS . . . . . 0.542 ' HB3' ' CG1' ' B' ' 294' ' ' VAL . 0.2 OUTLIER -152.26 64.43 0.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.835 -1.166 . . . . 0.0 110.312 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.484 ' HA ' ' OG1' ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.075 -1.016 . . . . 0.0 109.532 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 3' ' ' THR . 10.7 t . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.466 ' HB2' ' OG1' ' A' ' 8' ' ' THR . 46.6 Cg_endo -72.88 -8.55 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.941 1.495 . . . . 0.0 110.12 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -45.36 -36.75 4.4 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -90.31 -59.46 2.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.71 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.565 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -55.32 -22.04 17.42 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.142 -0.974 . . . . 0.0 109.946 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 4' ' ' PRO . 17.4 m -83.42 -40.6 19.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.431 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.78 -39.47 38.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 108.841 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.573 HG13 ' CZ ' ' A' ' 101' ' ' PHE . 1.1 t -56.45 -26.82 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.581 HG22 ' CE2' ' A' ' 101' ' ' PHE . 3.5 t -81.63 -39.14 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.405 -0.81 . . . . 0.0 109.327 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 13' ' ' ARG . 7.5 tt0 -62.87 -74.73 0.09 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.135 0.969 . . . . 0.0 108.434 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -42.78 -44.56 4.47 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.994 0.902 . . . . 0.0 108.6 179.361 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.561 ' CE1' HG22 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -50.74 -44.47 58.39 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.606 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 1.4 t -90.13 -39.87 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.304 -0.873 . . . . 0.0 109.401 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -49.05 -33.41 11.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 22' ' ' ASP . . . -77.3 -31.91 55.04 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.606 ' CD1' ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -64.2 -56.75 12.51 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -53.58 -48.81 68.86 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.624 0.726 . . . . 0.0 109.488 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.85 11.49 17.79 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.668 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.521 ' CA ' HD23 ' A' ' 59' ' ' LEU . . . 47.04 35.27 8.2 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' ALA . 15.0 t0 -89.8 62.15 5.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -1.094 . . . . 0.0 109.615 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.577 ' CD1' ' HB3' ' A' ' 55' ' ' PHE . 6.5 tp -46.69 -43.4 17.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 108.85 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -42.73 -33.17 0.69 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.13 -38.03 10.6 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' LEU . 14.7 mt -57.71 -56.68 14.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.522 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 43.8 t -55.85 -41.59 67.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.02 -53.28 58.81 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.551 ' CD2' ' HA ' ' A' ' 10' ' ' VAL . 7.7 tp -66.24 -20.72 66.2 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.578 ' CD2' HG22 ' A' ' 51' ' ' ILE . 3.0 m-85 -88.41 131.98 34.64 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.546 -0.721 . . . . 0.0 109.654 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -47.98 176.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.836 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.47 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.5 OUTLIER -67.07 -24.78 66.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.534 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 7.0 p-10 -144.0 54.1 1.3 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 109.55 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 51' ' ' ILE . . . -72.69 155.29 40.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.641 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.503 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -101.93 167.06 10.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.235 -0.915 . . . . 0.0 109.25 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 35' ' ' THR . 35.0 t -161.85 108.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.558 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 9.2 mp0 -88.66 103.51 16.0 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.582 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 27.5 t70 -173.16 143.74 1.1 Allowed Pre-proline 0 C--N 1.3 -1.568 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.919 -177.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 49.6 Cg_endo -73.5 174.84 48.5 Favored 'Cis proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.345 -1.94 . . . . 0.0 111.227 -0.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' B' ' 275' ' ' ALA . 21.9 m -63.89 105.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.81 . . . . 0.0 109.253 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.533 ' CA ' ' HB3' ' B' ' 275' ' ' ALA . . . 122.13 -6.98 10.05 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.534 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -105.09 -155.93 0.56 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.36 -1.082 . . . . 0.0 109.02 179.702 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -125.16 128.96 24.66 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.029 -1.044 . . . . 0.0 109.964 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 36.9 Cg_endo -62.01 179.19 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.638 1.558 . . . . 0.0 111.371 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.517 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -150.42 105.91 3.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -88.66 157.31 18.6 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.248 -0.907 . . . . 0.0 110.015 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 109.24 162.03 19.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 3.9 m -67.25 -58.38 4.95 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.148 -1.207 . . . . 0.0 109.11 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.531 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -55.56 -37.83 68.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.273 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.517 ' CB ' ' HB3' ' A' ' 45' ' ' ARG . . . -68.99 -51.67 36.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.701 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.578 HG22 ' CD2' ' A' ' 30' ' ' PHE . 8.8 mm -55.8 -47.14 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 109.283 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.572 ' CG ' ' CD2' ' A' ' 23' ' ' LEU . 26.3 ttp180 -73.58 -52.48 13.31 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 23.6 tt0 -48.38 -30.79 5.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.089 -1.007 . . . . 0.0 108.469 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.582 ' CZ ' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -83.78 -72.05 0.48 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.577 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -47.31 -25.04 0.88 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -74.15 -47.96 32.52 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 5.4 t30 -57.41 -37.36 72.62 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 t -67.66 -35.74 79.43 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.521 HD23 ' CA ' ' A' ' 21' ' ' GLY . 8.2 tp -67.48 -29.23 68.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.456 -0.777 . . . . 0.0 109.053 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 17.0 mttm -47.08 -30.48 2.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 108.911 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.529 ' O ' ' CD1' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.4 110.52 39.4 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.9 111.06 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.85 1.447 . . . . 0.0 111.027 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.544 ' CB ' ' HB3' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -136.94 162.96 31.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.347 -0.845 . . . . 0.0 109.715 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.426 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -92.08 127.95 37.74 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.461 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 21.8 t -115.13 120.08 63.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.054 -1.029 . . . . 0.0 109.967 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 67' ' ' LEU . 1.0 OUTLIER -150.12 106.25 3.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -47.8 177.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 0.0 109.924 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 69' ' ' GLN . 21.9 p -145.07 -81.63 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.386 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.7 OUTLIER -59.88 -144.86 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.479 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 48.9 tt0 -114.44 131.63 56.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.007 -1.058 . . . . 0.0 109.933 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.531 ' CG2' HG12 ' A' ' 11' ' ' VAL . 13.1 t -61.92 160.49 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.465 -0.772 . . . . 0.0 109.087 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 5.1 ttp180 -122.52 134.74 54.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.229 -0.919 . . . . 0.0 109.824 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . . . -147.89 160.45 42.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.405 -0.809 . . . . 0.0 109.183 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -159.14 -159.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.725 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB3' ' CA ' ' B' ' 241' ' ' GLY . . . -29.52 -85.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.055 -0.403 . . . . 0.0 111.35 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.504 ' O ' ' N ' ' A' ' 103' ' ' PHE . 9.9 m120 -124.62 21.07 8.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.904 -1.123 . . . . 0.0 110.781 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -129.99 -160.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.916 -1.115 . . . . 0.0 109.442 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.522 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 170.05 147.55 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.981 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 72' ' ' ARG . . . -136.12 130.73 33.78 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 30.2 p90 -147.92 170.1 18.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.792 -1.192 . . . . 0.0 110.462 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . . . -143.96 -166.43 2.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.599 -0.688 . . . . 0.0 109.893 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.457 ' HB3' ' O ' ' A' ' 81' ' ' ALA . 18.9 p90 168.83 -168.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 0.0 109.238 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -130.76 144.78 51.68 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.649 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.54 HG11 ' CB ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -112.96 122.24 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.166 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 85' ' ' SER . 1.4 p -117.75 107.11 13.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 109.029 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 86' ' ' PHE . 2.0 p90 -130.04 151.74 50.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.068 -1.02 . . . . 0.0 110.181 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.512 ' HG2' ' N ' ' A' ' 88' ' ' PHE . 84.2 tt0 -127.75 159.93 33.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.441 -0.787 . . . . 0.0 109.039 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -150.5 -99.61 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.058 -1.026 . . . . 0.0 110.326 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 88' ' ' PHE . 19.1 tt0 -48.91 -99.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 109.898 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.464 ' N ' ' HG2' ' A' ' 89' ' ' GLN . . . -123.92 -28.19 1.3 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -96.66 150.18 20.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -1.116 . . . . 0.0 109.352 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -113.11 146.53 39.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.103 -0.998 . . . . 0.0 109.172 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.0 145.97 51.1 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.53 -0.731 . . . . 0.0 109.842 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.533 HG12 ' CB ' ' A' ' 122' ' ' HIS . 5.4 p -121.19 166.38 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.922 . . . . 0.0 108.861 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.542 ' CG2' HG21 ' A' ' 121' ' ' ILE . 62.3 t -140.94 160.21 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.019 -1.05 . . . . 0.0 110.304 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.528 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -138.76 75.11 37.37 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.562 -0.711 . . . . 0.0 109.51 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.514 ' HD3' HG11 ' A' ' 95' ' ' VAL . 48.1 Cg_endo -97.11 -175.6 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.814 1.676 . . . . 0.0 111.2 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.502 HD11 ' ND2' ' A' ' 120' ' ' ASN . 2.6 mp -135.26 157.1 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 7.6 t0 -128.66 162.25 27.78 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.204 -0.935 . . . . 0.0 109.813 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.591 ' NE2' ' CD2' ' B' ' 300' ' ' HIS . 0.2 OUTLIER -114.11 173.54 6.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 108.906 179.49 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.581 ' CE2' HG22 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -148.16 144.9 28.08 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.97 -1.081 . . . . 0.0 110.45 -178.561 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.523 ' CB ' ' HB2' ' A' ' 111' ' ' SER . 0.4 OUTLIER -139.99 105.63 5.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.151 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.568 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 5.2 m-85 -91.06 -171.21 2.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.71 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.533 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 4.3 p30 -126.28 -47.97 1.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.272 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . -163.94 27.24 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 77.07 67.62 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.169 -1.194 . . . . 0.0 109.545 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.27 -39.33 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -165.6 -162.54 0.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -1.113 . . . . 0.0 109.258 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.471 HG21 HG12 ' A' ' 10' ' ' VAL . 41.0 t -106.25 144.24 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.248 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 104' ' ' ASN . 5.0 t -125.99 -28.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 109.898 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.523 ' HB2' ' CB ' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -149.59 155.11 39.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.067 -1.021 . . . . 0.0 109.472 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.507 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 3.2 ttp -155.91 148.74 24.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.194 -0.941 . . . . 0.0 109.926 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.496 ' NE ' ' OE1' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -130.55 173.52 10.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 108.964 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.413 ' O ' HG13 ' A' ' 40' ' ' VAL . . . -144.37 142.85 30.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.149 -0.97 . . . . 0.0 109.52 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -138.61 140.24 38.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.172 -0.955 . . . . 0.0 109.907 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.524 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 51.9 p90 170.21 -161.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.518 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . 174.6 -165.6 37.04 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.527 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 8.3 tt0 -73.13 -3.32 25.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.444 -1.033 . . . . 0.0 109.337 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.26 -31.31 16.18 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.97 0.89 . . . . 0.0 109.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.502 ' ND2' HD11 ' A' ' 98' ' ' ILE . 1.9 m-20 -89.61 8.58 30.63 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.233 0.54 . . . . 0.0 109.559 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.542 HG21 ' CG2' ' A' ' 95' ' ' VAL . 4.5 mm -91.89 -170.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 108.84 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.533 ' CB ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.35 159.75 44.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.097 -1.002 . . . . 0.0 109.618 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.78 133.94 12.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.959 . . . . 0.0 109.479 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 134.35 -123.69 3.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.291 -1.123 . . . . 0.0 109.444 -179.81 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.0 ptp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.208 0.528 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 18.7 p-10 -113.15 100.09 8.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.558 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 203' ' ' THR . . . . . 0.522 ' O ' ' CG2' ' B' ' 203' ' ' THR . 12.5 t -90.34 108.44 26.72 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.542 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 204' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' B' ' 208' ' ' THR . 45.1 Cg_endo -72.15 -1.96 10.87 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.853 1.449 . . . . 0.0 110.457 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.77 -47.37 83.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.557 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -54.9 24.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.267 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 75.9 mtm -61.42 -41.27 96.91 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.286 -0.884 . . . . 0.0 109.382 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 208' ' ' THR . . . . . 0.499 ' CB ' ' O ' ' B' ' 204' ' ' PRO . 15.4 m -64.18 -35.95 82.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.84 . . . . 0.0 109.235 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.09 -42.37 49.99 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.139 -0.976 . . . . 0.0 108.59 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.604 ' CG1' ' CZ ' ' B' ' 303' ' ' PHE . 1.5 t -60.06 -20.7 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.579 HG22 ' CE2' ' B' ' 301' ' ' PHE . 4.4 t -88.32 -40.61 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.833 . . . . 0.0 108.89 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' B' ' 213' ' ' ARG . 24.6 tt0 -61.53 -74.35 0.08 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.46 ' HD2' HD11 ' B' ' 229' ' ' LEU . 1.0 OUTLIER -43.68 -45.52 7.0 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' TYR . . . . . 0.568 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.5 OUTLIER -49.88 -42.88 48.75 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.603 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.4 t -89.77 -37.85 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.251 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -49.49 -35.6 20.35 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.473 ' HB3' ' CG1' ' B' ' 226' ' ' ILE . . . -74.69 -30.95 61.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.603 ' CD1' ' HA ' ' B' ' 215' ' ' VAL . 2.3 mt -66.86 -58.11 5.66 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' B' ' 265' ' ' VAL . 2.1 t-20 -50.85 -45.31 59.73 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.602 0.715 . . . . 0.0 109.302 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.31 1.36 55.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.624 -0.672 . . . . 0.0 109.748 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . 0.538 ' CA ' ' CD2' ' B' ' 259' ' ' LEU . . . 53.76 44.13 70.0 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.465 ' O ' HG13 ' B' ' 226' ' ' ILE . 30.3 t0 -102.87 83.96 2.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.902 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' LEU . . . . . 0.595 ' CD2' ' CD2' ' B' ' 259' ' ' LEU . 3.7 mm? -53.04 -18.4 2.03 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.139 -0.976 . . . . 0.0 110.063 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -64.05 -57.16 10.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.093 -1.004 . . . . 0.0 109.473 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . 0.439 ' HA2' ' HB2' ' B' ' 228' ' ' ALA . . . -62.92 -27.64 70.61 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.473 ' CG1' ' HB3' ' B' ' 217' ' ' ALA . 7.0 mt -67.86 -61.46 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.454 -1.027 . . . . 0.0 108.315 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.514 HG23 ' CG ' ' B' ' 252' ' ' ARG . 51.2 t -59.49 -40.33 81.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.439 ' HB2' ' HA2' ' B' ' 225' ' ' GLY . . . -54.87 -53.47 55.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 4.7 tp -62.8 -21.78 66.14 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . 0.465 ' HB2' ' HA ' ' B' ' 227' ' ' VAL . 3.7 m-30 -92.71 139.11 30.9 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.452 -0.78 . . . . 0.0 109.784 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -50.71 -176.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 109.822 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.474 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -68.57 -25.16 64.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.879 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' ASP . . . . . 0.525 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 10.0 p-10 -144.17 52.51 1.28 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.495 -0.753 . . . . 0.0 109.137 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' B' ' 310' ' ' VAL . . . -65.43 158.6 26.31 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 109.617 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' THR . . . . . 0.508 ' CG2' ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -107.34 147.18 30.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.875 . . . . 0.0 109.107 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' B' ' 244' ' ' PRO . 52.8 t -141.4 111.05 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 1.5 mm-40 -89.91 105.14 17.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' ASP . . . . . 0.585 ' O ' ' CE2' ' B' ' 254' ' ' PHE . 21.8 t70 178.91 143.24 0.31 Allowed Pre-proline 0 C--N 1.301 -1.528 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.307 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . 0.492 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 48.5 Cg_endo -73.6 173.87 53.66 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.264 -1.973 . . . . 0.0 110.905 -0.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' B' ' 316' ' ' PHE . 6.5 m -69.81 112.7 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 108.972 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . 0.536 ' CA ' ' HB3' ' A' ' 75' ' ' ALA . . . 115.06 -2.13 22.67 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' SER . . . . . 0.471 ' OG ' ' HG2' ' B' ' 239' ' ' PRO . 64.6 m -113.35 -134.83 0.35 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.305 -1.114 . . . . 0.0 108.893 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . 0.531 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 4.3 mt-10 -142.03 133.52 13.26 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.863 -1.148 . . . . 0.0 109.755 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.9 Cg_endo -63.39 -171.53 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.082 1.569 . . . . 0.0 111.34 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.529 ' HB2' ' CG ' ' B' ' 254' ' ' PHE . 0.0 OUTLIER -150.74 96.91 2.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' SER . . . . . 0.508 ' HB3' ' CG2' ' B' ' 235' ' ' THR . 0.2 OUTLIER -88.88 150.47 22.86 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.238 -0.914 . . . . 0.0 109.987 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.24 163.18 21.88 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 248' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 2.2 m -70.04 -61.45 1.77 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -1.209 . . . . 0.0 109.148 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -55.36 -22.98 21.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.241 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.518 ' CB ' ' HG3' ' B' ' 245' ' ' ARG . . . -88.45 -48.62 7.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.46 HD13 ' O ' ' B' ' 245' ' ' ARG . 4.5 mm -53.65 -43.7 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.132 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 252' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' B' ' 256' ' ' ALA . 44.0 ttp85 -75.54 -52.65 10.13 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 108.94 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 253' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 29.9 mt-10 -48.4 -27.72 2.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.809 -1.182 . . . . 0.0 108.427 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.585 ' CE2' ' O ' ' B' ' 238' ' ' ASP . 0.3 OUTLIER -85.84 -71.7 0.52 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.681 0.753 . . . . 0.0 109.021 179.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 255' ' ' PHE . . . . . 0.527 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -52.6 -21.76 4.25 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.241 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' B' ' 252' ' ' ARG . . . -80.33 -46.8 15.5 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 257' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 18.7 t-20 -58.19 -31.17 67.04 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 33.7 t -70.66 -31.63 68.62 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 259' ' ' LEU . . . . . 0.595 ' CD2' ' CD2' ' B' ' 223' ' ' LEU . 5.7 tp -71.12 -27.72 63.78 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 260' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 0.7 OUTLIER -44.73 -27.83 0.55 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.455 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 261' ' ' LEU . . . . . 0.576 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.3 OUTLIER -90.72 114.29 60.8 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 262' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 44.3 Cg_endo -72.02 107.93 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.766 1.403 . . . . 0.0 110.892 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 263' ' ' LEU . . . . . 0.576 ' CD2' ' CD2' ' B' ' 261' ' ' LEU . 0.0 OUTLIER -137.3 162.54 33.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 109.854 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 264' ' ' ALA . . . . . 0.452 ' HB2' ' OG ' ' B' ' 285' ' ' SER . . . -96.46 123.67 40.19 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 265' ' ' VAL . . . . . 0.514 ' O ' ' ND2' ' B' ' 219' ' ' ASN . 4.4 t -105.06 117.32 50.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.643 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 266' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' B' ' 267' ' ' LEU . 2.0 tt0 -147.78 104.97 3.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.22 -0.925 . . . . 0.0 109.153 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.1 mt -47.11 174.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.293 -0.879 . . . . 0.0 109.695 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 1.7 t -146.54 -40.31 0.21 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.67 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 269' ' ' GLN . . . . . 0.505 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 13.7 pt20 -102.66 -152.25 0.44 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.647 -0.658 . . . . 0.0 109.267 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 270' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 26.6 tt0 -106.43 130.59 54.21 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.61 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 271' ' ' VAL . . . . . 0.521 ' CG1' HG23 ' B' ' 211' ' ' VAL . 81.4 t -66.81 147.62 12.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.344 -0.848 . . . . 0.0 109.245 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 2.4 tpm_? -102.89 135.95 43.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.952 . . . . 0.0 109.765 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . 0.473 ' HA ' ' HB1' ' B' ' 278' ' ' ALA . . . -149.8 146.36 27.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.39 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 274' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -162.24 146.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.13 -0.981 . . . . 0.0 110.228 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 275' ' ' ALA . . . . . 0.533 ' HB3' ' CA ' ' A' ' 41' ' ' GLY . . . 39.57 -97.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.802 -0.561 . . . . 0.0 110.621 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 276' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' B' ' 303' ' ' PHE . 60.1 m-20 -130.74 34.04 4.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.025 -1.047 . . . . 0.0 110.237 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' B' ' 278' ' ' ALA . 0.9 OUTLIER -139.49 -158.4 0.85 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 108.792 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 278' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' B' ' 277' ' ' GLU . . . 165.96 149.6 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.72 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 279' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -135.98 130.75 34.1 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 22.8 p90 -150.07 175.45 11.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.601 -1.312 . . . . 0.0 110.697 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . 0.524 ' HB2' ' CG1' ' B' ' 298' ' ' ILE . . . -150.11 -179.0 6.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.585 -0.697 . . . . 0.0 109.197 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 282' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 2.8 p90 -172.92 -162.14 0.16 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 109.492 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 283' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -133.61 147.44 51.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.512 -0.742 . . . . 0.0 109.887 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 284' ' ' VAL . . . . . 0.531 HG11 ' CB ' ' B' ' 263' ' ' LEU . 4.0 t -123.36 116.53 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 109.41 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 285' ' ' SER . . . . . 0.497 ' CB ' HG23 ' B' ' 294' ' ' VAL . 90.9 p -111.95 114.69 27.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 109.098 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.533 ' HB3' ' HB3' ' B' ' 263' ' ' LEU . 55.6 p90 -143.21 167.39 22.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 110.084 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 287' ' ' GLU . . . . . 0.448 ' HG2' ' N ' ' B' ' 288' ' ' PHE . 30.1 tt0 -144.1 153.25 41.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 109.255 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.3 OUTLIER -135.89 4.34 3.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.716 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -170.3 -148.81 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.254 -0.904 . . . . 0.0 109.383 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -74.8 -11.95 83.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -113.8 140.41 48.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -1.115 . . . . 0.0 109.273 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 292' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' B' ' 292' ' ' LYS . 18.9 ptmt -125.78 172.47 9.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 109.635 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 293' ' ' THR . . . . . 0.533 ' CG2' ' HA ' ' B' ' 323' ' ' ALA . 32.2 m -156.65 171.53 20.17 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.366 -0.834 . . . . 0.0 109.095 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 294' ' ' VAL . . . . . 0.553 HG13 ' CB ' ' B' ' 322' ' ' HIS . 0.4 OUTLIER -134.17 165.94 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.549 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 3.4 t -136.81 145.8 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.016 -1.052 . . . . 0.0 109.66 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 296' ' ' ALA . . . . . 0.525 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -132.52 72.9 77.5 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.433 -0.792 . . . . 0.0 110.023 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 297' ' ' PRO . . . . . 0.549 ' HD3' ' CG1' ' B' ' 295' ' ' VAL . 49.2 Cg_endo -92.95 -177.01 0.67 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.87 1.458 . . . . 0.0 111.113 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.524 ' CG1' ' HB2' ' B' ' 281' ' ' ALA . 2.7 mp -134.38 144.61 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . 0.572 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 5.6 t0 -117.13 166.95 11.63 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.824 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 300' ' ' HIS . . . . . 0.591 ' CD2' ' NE2' ' A' ' 100' ' ' HIS . 1.6 t-80 -117.58 173.58 6.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 108.916 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 301' ' ' PHE . . . . . 0.58 ' CZ ' HG13 ' B' ' 210' ' ' VAL . 0.1 OUTLIER -145.67 145.82 31.06 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.071 -1.018 . . . . 0.0 110.583 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.48 ' HD3' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -137.66 98.73 3.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 109.156 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 303' ' ' PHE . . . . . 0.604 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 4.5 m-85 -89.74 176.51 6.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 109.57 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 304' ' ' ASN . . . . . 0.523 ' HB3' ' CG2' ' B' ' 310' ' ' VAL . 2.9 p30 -118.64 -27.03 5.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.222 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 305' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -159.35 -63.96 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 306' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 163.63 76.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -1.127 . . . . 0.0 109.563 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 175.87 -57.14 0.11 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -111.33 -172.75 2.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -1.149 . . . . 0.0 109.504 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 309' ' ' VAL . . . . . 0.469 HG22 HG12 ' B' ' 210' ' ' VAL . 85.8 t -119.72 164.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.033 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . 0.545 ' O ' ' CB ' ' B' ' 234' ' ' ALA . 5.0 t -134.82 -72.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.963 -1.085 . . . . 0.0 110.018 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 311' ' ' SER . . . . . 0.48 ' HB2' ' HD3' ' B' ' 302' ' ' ARG . 31.6 m -112.44 162.48 15.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.899 -1.126 . . . . 0.0 109.837 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 312' ' ' MET . . . . . 0.544 ' CE ' ' CE2' ' B' ' 214' ' ' TYR . 2.6 ttt -159.94 137.99 10.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 313' ' ' ARG . . . . . 0.522 ' CD ' ' CZ ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -125.69 159.27 32.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.144 -0.972 . . . . 0.0 108.812 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 314' ' ' ALA . . . . . 0.542 ' CB ' ' OD1' ' B' ' 238' ' ' ASP . . . -125.18 150.38 47.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.904 -1.122 . . . . 0.0 109.841 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 315' ' ' LEU . . . . . 0.47 ' O ' ' HB3' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -141.02 140.8 34.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.39 -0.819 . . . . 0.0 109.774 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 316' ' ' PHE . . . . . 0.533 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 53.7 p90 173.12 -160.96 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 317' ' ' GLY . . . . . 0.467 ' O ' HG12 ' B' ' 321' ' ' ILE . . . 173.48 -172.38 45.17 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 318' ' ' GLU . . . . . 0.509 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 22.3 tt0 -68.4 -6.69 25.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.419 -1.047 . . . . 0.0 109.714 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -87.08 -31.84 20.26 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.045 0.926 . . . . 0.0 108.939 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 320' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.61 14.28 11.99 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.742 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 321' ' ' ILE . . . . . 0.538 ' CG2' HG21 ' B' ' 295' ' ' VAL . 4.0 mm -100.84 -166.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 0.0 108.902 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 322' ' ' HIS . . . . . 0.553 ' CB ' HG13 ' B' ' 294' ' ' VAL . 0.3 OUTLIER -151.25 -172.41 4.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.116 -0.99 . . . . 0.0 109.613 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.533 ' HA ' ' CG2' ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.225 0.536 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.565 ' ND2' ' N ' ' A' ' 3' ' ' THR . 0.8 OUTLIER -152.29 157.53 41.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 109.597 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.565 ' N ' ' ND2' ' A' ' 2' ' ' ASN . 0.6 OUTLIER -88.07 109.97 31.98 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.322 -0.861 . . . . 0.0 109.64 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 45.6 Cg_endo -72.45 -3.63 13.77 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.852 1.448 . . . . 0.0 110.19 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.24 -45.38 72.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.877 . . . . 0.0 109.385 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.472 ' NE2' ' O ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -66.68 -55.39 15.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.59 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.5 ' HE3' ' ND2' ' A' ' 2' ' ' ASN . 27.4 mtt -58.0 -48.74 79.11 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.231 -0.918 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 m -54.4 -38.1 65.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.285 -0.884 . . . . 0.0 109.054 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.29 -43.06 42.9 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.571 HG12 ' CE1' ' A' ' 103' ' ' PHE . 2.3 t -55.76 -49.92 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.482 HG12 ' CG2' ' A' ' 71' ' ' VAL . 5.1 t -54.71 -41.09 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 13' ' ' ARG . 25.7 tt0 -63.17 -75.13 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.344 1.068 . . . . 0.0 108.145 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.429 ' HB3' HD11 ' A' ' 29' ' ' LEU . 6.6 mtp85 -43.67 -45.97 7.18 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -48.93 -45.72 42.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.61 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -86.0 -37.48 11.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.383 -0.823 . . . . 0.0 109.071 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.89 -37.92 21.12 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' HB3' HG13 ' A' ' 26' ' ' ILE . . . -72.0 -32.87 67.62 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.644 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 2.4 mt -67.34 -59.45 3.4 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -48.02 -39.86 21.05 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.599 0.714 . . . . 0.0 109.25 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.41 6.06 42.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.545 -0.722 . . . . 0.0 109.652 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' CA ' HD23 ' A' ' 59' ' ' LEU . . . 47.73 30.87 7.02 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -96.94 88.4 4.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -1.106 . . . . 0.0 109.723 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.523 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 3.3 mm? -51.83 -20.25 2.13 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.195 -0.94 . . . . 0.0 109.815 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.14 -56.26 16.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.253 -0.904 . . . . 0.0 109.303 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.35 -29.34 63.11 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.613 ' CG2' ' CE2' ' A' ' 30' ' ' PHE . 12.3 mt -69.06 -62.27 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 60.4 t -57.34 -37.91 59.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.95 26.33 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.545 HD21 ' N ' ' A' ' 14' ' ' TYR . 7.8 tp -59.1 -22.7 61.25 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.613 ' CE2' ' CG2' ' A' ' 26' ' ' ILE . 20.4 m-30 -88.47 136.53 32.94 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.675 -0.641 . . . . 0.0 109.651 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -51.12 -178.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.273 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.46 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -66.27 -23.52 66.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 109.527 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.534 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 25.2 p-10 -148.37 45.55 1.05 Allowed 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.528 ' CB ' HD13 ' A' ' 51' ' ' ILE . . . -51.61 -178.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.791 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -126.05 135.92 52.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.501 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 37' ' ' GLU . 6.6 t -113.84 169.02 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.129 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.57 ' N ' ' CG1' ' A' ' 36' ' ' VAL . 28.1 mt-10 -150.4 106.07 3.4 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -174.45 153.71 1.89 Allowed Pre-proline 0 C--N 1.3 -1.575 0 C-N-CA 118.607 -1.237 . . . . 0.0 109.804 -178.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.517 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 44.7 Cg_endo -73.88 -66.67 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.916 -2.118 . . . . 0.0 111.522 0.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 39' ' ' PRO . 23.8 m -159.06 87.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.948 -1.095 . . . . 0.0 109.596 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . 164.33 38.75 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER 72.92 55.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.325 -1.103 . . . . 0.0 109.962 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.538 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 3.8 mt-10 -132.57 58.38 35.77 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.807 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 52.1 Cg_endo -79.71 175.07 10.96 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.825 1.683 . . . . 0.0 111.271 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.551 ' HG3' ' CD2' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -150.99 100.17 2.77 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.416 ' HB2' HG22 ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.43 166.73 13.52 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.186 -0.946 . . . . 0.0 110.103 -179.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 33' ' ' ASP . . . 86.36 -169.8 41.96 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 3.4 m -103.45 -46.63 4.51 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.223 -1.163 . . . . 0.0 108.978 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -58.29 -23.74 57.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.247 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.505 ' HB1' ' CD ' ' A' ' 45' ' ' ARG . . . -89.86 -52.51 4.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.398 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.562 HG22 ' CD2' ' A' ' 30' ' ' PHE . 80.1 mt -57.22 -46.8 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.197 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.532 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 1.5 ttt180 -70.0 -56.25 7.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -0.888 . . . . 0.0 108.906 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 14.4 tt0 -45.88 -29.92 1.54 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 108.658 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.551 ' CD2' ' HG3' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -84.1 -70.28 0.58 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.514 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -46.7 -28.05 1.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.486 ' N ' HD13 ' A' ' 23' ' ' LEU . . . -75.07 -50.8 15.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 12.8 t-20 -55.51 -34.55 64.75 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.781 ' OG ' ' H12' ' A' ' 126' ' ' NTH . 14.3 t -64.83 -36.63 84.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.523 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 7.4 tp -69.45 -19.28 63.77 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.535 -0.728 . . . . 0.0 109.706 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 33.9 mtmt -55.53 -25.58 38.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 109.36 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.54 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -89.87 121.32 69.05 Favored Pre-proline 0 C--N 1.305 -1.328 0 O-C-N 121.272 -0.893 . . . . 0.0 108.777 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.463 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 48.7 Cg_endo -74.04 103.2 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.71 1.374 . . . . 0.0 111.152 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.556 ' CB ' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -136.15 -178.54 5.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.527 ' CB ' ' OG ' ' A' ' 85' ' ' SER . . . -117.88 127.29 53.72 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.419 HG13 HG21 ' A' ' 15' ' ' VAL . 4.6 t -116.43 115.92 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.181 -0.95 . . . . 0.0 109.841 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 67' ' ' LEU . 1.2 tt0 -150.17 95.74 2.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.294 -0.879 . . . . 0.0 109.216 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.509 ' N ' HD22 ' A' ' 67' ' ' LEU . 4.4 mt -42.81 166.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.974 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.67 -39.9 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.565 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -81.77 -146.01 0.06 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 25.0 tt0 -113.15 129.61 56.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.09 -1.006 . . . . 0.0 109.642 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.482 ' CG2' HG12 ' A' ' 11' ' ' VAL . 19.2 t -67.92 152.28 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.38 -0.825 . . . . 0.0 108.919 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 19.2 mtt-85 -114.64 135.29 54.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.136 -0.978 . . . . 0.0 109.672 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.515 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -149.95 112.86 4.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.293 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -130.09 155.71 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -0.903 . . . . 0.0 109.489 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.434 ' O ' ' SD ' ' A' ' 7' ' ' MET . . . 43.64 -147.42 0.07 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 103' ' ' PHE . 81.6 m-20 -82.64 -3.19 55.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.941 . . . . 0.0 109.526 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.548 ' CG ' ' HG3' ' A' ' 102' ' ' ARG . 0.8 OUTLIER -104.85 -163.55 0.97 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.219 -0.926 . . . . 0.0 109.613 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.522 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 178.37 166.33 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 109.485 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' A' ' 72' ' ' ARG . . . -150.31 140.06 21.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 108.948 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 39.8 p90 -150.58 169.23 22.04 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.877 -1.14 . . . . 0.0 109.941 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.476 ' HB1' HG13 ' A' ' 98' ' ' ILE . . . -141.84 -175.37 4.37 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.502 -0.749 . . . . 0.0 109.591 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.49 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 9.8 p90 177.05 -159.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.805 . . . . 0.0 109.351 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -137.92 151.79 48.34 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.564 -0.71 . . . . 0.0 109.73 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.556 HG11 ' CB ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -122.11 124.34 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.416 -0.802 . . . . 0.0 109.081 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.527 ' OG ' ' CB ' ' A' ' 64' ' ' ALA . 5.1 p -114.66 92.81 4.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.6 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.729 ' CZ ' H222 ' A' ' 126' ' ' NTH . 18.8 p90 -115.47 177.93 4.48 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.345 -0.847 . . . . 0.0 109.126 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 88' ' ' PHE . 30.7 tt0 -107.37 166.92 10.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 110.12 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.573 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -116.84 -161.31 0.8 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.4 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -7.44 28.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 109.78 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.11 -40.38 0.03 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.4 mtt-85 -95.72 -176.9 3.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -1.161 . . . . 0.0 109.609 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.441 ' O ' ' CD ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -115.62 127.19 55.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.573 ' OG1' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -118.3 142.57 47.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.776 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 122' ' ' HIS . 1.2 t -116.15 175.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.559 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 4.1 t -145.37 144.14 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.881 -1.137 . . . . 0.0 109.737 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.479 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -133.06 71.64 77.4 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.345 -0.847 . . . . 0.0 110.408 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.559 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 49.6 Cg_endo -95.23 -176.18 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 121.492 1.461 . . . . 0.0 110.947 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.476 HG13 ' HB1' ' A' ' 81' ' ' ALA . 2.9 mp -137.68 139.59 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 8.9 t0 -111.99 163.14 14.59 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.95 -1.093 . . . . 0.0 110.261 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.512 ' HB3' ' CB ' ' A' ' 113' ' ' ARG . 4.3 t-80 -116.39 176.29 5.17 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.55 ' CZ ' ' CG1' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -149.94 142.63 24.59 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.008 -1.057 . . . . 0.0 110.556 -178.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.548 ' HG3' ' CG ' ' A' ' 77' ' ' GLU . 3.1 ttm180 -135.65 107.64 7.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.484 -0.76 . . . . 0.0 109.106 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.571 ' CE1' HG12 ' A' ' 10' ' ' VAL . 14.2 m-85 -105.42 179.5 4.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.607 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.461 ' HB3' HG21 ' A' ' 110' ' ' VAL . 3.8 p30 -127.04 -0.67 6.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.933 . . . . 0.0 109.596 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.43 -87.57 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.472 ' O ' ' NE2' ' A' ' 6' ' ' HIS . . . 176.05 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -1.184 . . . . 0.0 109.598 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -127.56 -37.16 0.46 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 107' ' ' GLY . 8.0 mtmm -146.7 -164.76 2.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -1.125 . . . . 0.0 109.255 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.528 ' CG2' HG12 ' A' ' 10' ' ' VAL . 91.2 t -115.16 158.87 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.027 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.525 ' O ' ' CA ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -132.6 -54.21 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.567 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.535 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -127.17 156.9 41.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.041 -1.037 . . . . 0.0 109.013 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.574 ' HE1' ' CE1' ' A' ' 30' ' ' PHE . 21.5 ttm -154.0 147.24 24.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.122 -0.986 . . . . 0.0 109.655 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.515 ' CG ' ' OE1' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -123.33 174.21 7.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.377 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.468 ' HB2' ' OD2' ' A' ' 38' ' ' ASP . . . -147.83 149.13 31.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.568 ' CD1' ' CB ' ' B' ' 279' ' ' ALA . 1.7 tt -143.03 143.73 32.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.138 -0.976 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.528 ' O ' ' CG2' ' B' ' 274' ' ' VAL . 15.4 p90 171.95 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . 167.07 -176.9 41.92 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.561 -1.305 . . . . 0.0 110.185 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.534 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 17.6 tt0 -69.39 -6.06 27.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.433 -1.04 . . . . 0.0 109.509 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -91.38 -29.24 17.2 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.928 0.87 . . . . 0.0 108.936 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.8 m-20 -88.79 12.51 14.82 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.534 ' CG1' ' HA ' ' A' ' 118' ' ' GLU . 5.0 mm -89.87 -169.92 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.549 ' HB2' HG11 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.63 99.79 2.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 109.805 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -117.13 135.74 53.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.149 -0.97 . . . . 0.0 109.549 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 152.85 -145.91 13.89 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.177 -1.19 . . . . 0.0 109.509 179.944 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.463 ' O ' ' CB ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.239 0.542 . . . . 0.0 110.174 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' B' ' 201' ' ' MET . 0.6 OUTLIER 72.6 98.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.563 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' THR . . . . . 0.429 ' C ' ' O ' ' B' ' 202' ' ' ASN . 1.2 t -43.43 112.04 1.18 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.0 109.54 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.49 -3.29 13.16 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.828 1.436 . . . . 0.0 110.046 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -38.62 84.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.884 . . . . 0.0 109.385 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -51.8 56.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.351 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' MET . . . . . 0.446 ' SD ' ' O ' ' B' ' 275' ' ' ALA . 21.9 mtm -59.91 -30.06 68.78 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.293 -0.879 . . . . 0.0 109.624 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 5.0 m -72.55 -33.81 67.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.91 . . . . 0.0 109.195 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.9 75.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.934 . . . . 0.0 108.859 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.593 ' CG1' ' CZ ' ' B' ' 301' ' ' PHE . 2.3 t -52.74 -45.99 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.532 HG12 ' CG2' ' B' ' 271' ' ' VAL . 4.4 t -61.86 -39.63 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.599 -0.688 . . . . 0.0 109.951 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' B' ' 213' ' ' ARG . 21.8 tt0 -62.63 -75.4 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' B' ' 212' ' ' GLN . 0.0 OUTLIER -43.35 -44.84 5.81 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.971 0.891 . . . . 0.0 108.622 179.157 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' TYR . . . . . 0.633 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -50.42 -46.98 56.74 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.606 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 0.9 OUTLIER -85.77 -37.65 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.359 -0.838 . . . . 0.0 109.297 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.72 -36.5 16.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.525 ' HB3' ' CG1' ' B' ' 226' ' ' ILE . . . -73.08 -34.19 66.06 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.633 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 1.2 mt -65.26 -58.22 6.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -50.37 -45.04 54.98 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.555 0.693 . . . . 0.0 109.164 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.64 5.95 43.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.52 -0.737 . . . . 0.0 109.633 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' B' ' 217' ' ' ALA . . . 50.4 37.96 33.35 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' B' ' 217' ' ' ALA . 11.3 t0 -97.77 72.41 2.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.42 -1.047 . . . . 0.0 109.864 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' LEU . . . . . 0.565 ' CD1' ' HB3' ' B' ' 255' ' ' PHE . 7.7 tp -47.08 -43.65 20.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 108.705 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -43.32 -35.28 1.45 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -80.32 -35.79 25.6 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.544 HD12 ' CD1' ' B' ' 255' ' ' PHE . 19.9 mt -62.1 -57.19 13.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.496 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 92.6 t -56.44 -37.41 51.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.07 -54.92 41.58 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.3 tp -63.8 -22.06 66.73 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . 0.494 ' CG ' HG23 ' B' ' 251' ' ' ILE . 2.0 m-85 -85.42 130.01 34.68 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.525 -0.735 . . . . 0.0 109.383 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' B' ' 309' ' ' VAL . . . -47.0 172.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.152 -0.968 . . . . 0.0 109.383 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.458 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -57.3 -24.99 58.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 109.816 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.525 ' CB ' ' HA2' ' B' ' 247' ' ' GLY . 13.2 p-10 -150.24 45.55 0.89 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.583 -0.698 . . . . 0.0 109.212 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.528 ' N ' ' CD1' ' B' ' 251' ' ' ILE . . . -57.57 159.9 4.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.334 -0.854 . . . . 0.0 109.706 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' THR . . . . . 0.534 ' CG2' ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -106.95 144.12 34.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.558 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.55 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 42.8 t -132.72 121.4 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.081 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' GLU . . . . . 0.527 ' HB2' ' CG ' ' B' ' 313' ' ' ARG . 3.3 mt-10 -89.26 109.18 20.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 108.89 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' B' ' 237' ' ' GLU . 9.8 t70 -179.17 141.92 0.38 Allowed Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.837 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 47.3 Cg_endo -72.66 -177.57 18.89 Favored 'Cis proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.291 -1.962 . . . . 0.0 110.761 -0.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 8.0 m -62.34 152.34 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.254 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.07 20.73 9.27 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' SER . . . . . 0.523 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -116.59 -155.41 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -1.066 . . . . 0.0 109.511 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.77 128.84 25.58 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.066 -1.022 . . . . 0.0 109.894 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' PRO . . . . . 0.55 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.4 Cg_endo -65.25 -169.94 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.983 1.518 . . . . 0.0 111.243 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.535 ' CB ' ' HB3' ' B' ' 250' ' ' ALA . 0.5 OUTLIER -151.14 100.88 2.82 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.534 ' HB3' ' CG2' ' B' ' 235' ' ' THR . 0.2 OUTLIER -89.44 153.61 20.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 110.363 -178.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . 0.525 ' HA2' ' CB ' ' B' ' 233' ' ' ASP . . . 108.03 159.94 20.45 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 6.3 m -70.4 -44.74 67.37 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.219 -1.165 . . . . 0.0 109.103 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -63.08 -36.84 84.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -0.911 . . . . 0.0 109.06 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.535 ' HB3' ' CB ' ' B' ' 245' ' ' ARG . . . -74.18 -59.84 2.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' B' ' 234' ' ' ALA . 30.1 mt -48.45 -41.23 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.28 -0.887 . . . . 0.0 108.916 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' ARG . . . . . 0.508 ' HG2' ' CD2' ' B' ' 223' ' ' LEU . 13.0 ttm180 -78.34 -56.49 4.41 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 17.5 tt0 -46.65 -27.03 1.03 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.058 -1.027 . . . . 0.0 108.29 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 0.6 OUTLIER -86.22 -71.14 0.56 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.565 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -48.09 -31.62 5.77 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . 0.512 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -67.04 -47.73 70.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -56.49 -31.94 64.53 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' SER . . . . . 0.602 ' OG ' ' H12' ' B' ' 326' ' ' NTH . 29.6 t -73.14 -36.37 66.66 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . 0.411 HD21 ' C ' ' B' ' 221' ' ' GLY . 8.2 tp -68.22 -27.84 66.72 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.382 -0.824 . . . . 0.0 109.282 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -47.21 -25.74 1.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.235 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.74 112.67 53.3 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.403 -0.811 . . . . 0.0 108.912 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.34 97.75 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.823 1.433 . . . . 0.0 110.493 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' B' ' 261' ' ' LEU . 0.3 OUTLIER -131.66 -172.07 2.77 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.79 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . 0.452 ' CB ' ' OG ' ' B' ' 285' ' ' SER . . . -119.19 127.4 53.26 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 3.6 t -107.88 118.8 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.281 -0.887 . . . . 0.0 109.575 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.4 tt0 -150.08 106.81 3.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 109.285 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.9 OUTLIER -47.15 174.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.839 . . . . 0.0 109.767 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' THR . . . . . 0.455 HG22 ' O ' ' B' ' 267' ' ' LEU . 1.7 p -148.49 -38.92 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.63 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' B' ' 270' ' ' GLU . 0.6 OUTLIER -99.69 -147.06 0.34 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 109.405 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.442 ' N ' ' CG ' ' B' ' 269' ' ' GLN . 26.0 tt0 -111.45 132.24 54.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.205 -0.934 . . . . 0.0 109.562 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . 0.532 ' CG2' HG12 ' B' ' 211' ' ' VAL . 30.3 t -64.04 151.11 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.263 -0.898 . . . . 0.0 109.12 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' B' ' 279' ' ' ALA . 0.0 OUTLIER -117.46 135.44 53.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.082 -1.011 . . . . 0.0 109.742 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -147.13 127.72 14.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.865 . . . . 0.0 109.464 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -140.27 156.39 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 0.0 109.567 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . 0.446 ' O ' ' SD ' ' B' ' 207' ' ' MET . . . 42.35 -145.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.447 -0.783 . . . . 0.0 109.469 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 1.3 m120 -83.54 -11.08 57.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.116 -0.99 . . . . 0.0 109.473 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . 0.466 ' CG ' ' CG ' ' B' ' 302' ' ' ARG . 1.5 mt-10 -93.28 -162.44 0.94 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.431 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' B' ' 273' ' ' ALA . . . 178.15 160.8 0.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.452 -0.78 . . . . 0.0 109.623 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' ALA . . . . . 0.568 ' CB ' ' CD1' ' A' ' 115' ' ' LEU . . . -147.67 139.62 24.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.044 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 26.4 p90 -150.76 171.38 17.27 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.906 -1.121 . . . . 0.0 109.748 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.529 ' CB ' HG21 ' B' ' 298' ' ' ILE . . . -143.11 164.34 30.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.298 -0.877 . . . . 0.0 110.238 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' PHE . . . . . 0.482 ' O ' ' HD2' ' B' ' 297' ' ' PRO . 2.1 p90 -158.45 -172.57 3.91 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' THR . . . . . 0.468 HG22 ' HA ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -130.31 141.22 50.61 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 284' ' ' VAL . . . . . 0.475 ' O ' HG22 ' B' ' 294' ' ' VAL . 23.9 t -106.21 112.09 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 108.974 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 285' ' ' SER . . . . . 0.452 ' OG ' ' CB ' ' B' ' 264' ' ' ALA . 15.7 p -101.25 76.62 1.73 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.879 . . . . 0.0 109.257 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.774 ' CE1' H221 ' B' ' 326' ' ' NTH . 13.8 p90 -89.86 176.33 6.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.346 -0.846 . . . . 0.0 109.591 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -128.33 151.51 49.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.333 -0.855 . . . . 0.0 109.306 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.444 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.6 OUTLIER -100.94 -166.09 1.27 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.395 -0.816 . . . . 0.0 109.376 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.9 43.51 1.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 0.0 109.075 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 154.29 -22.24 0.66 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 291' ' ' ARG . . . . . 0.468 ' O ' ' HD3' ' B' ' 292' ' ' LYS . 8.8 mtt180 -123.92 176.22 6.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.555 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 292' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' B' ' 291' ' ' ARG . 7.7 mmtp -131.22 115.05 15.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.223 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 293' ' ' THR . . . . . 0.479 ' OG1' ' CZ ' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -119.73 142.91 48.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.206 -0.933 . . . . 0.0 110.025 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 294' ' ' VAL . . . . . 0.479 HG12 ' CB ' ' B' ' 322' ' ' HIS . 12.4 p -120.99 170.96 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.552 HG11 ' HD3' ' B' ' 297' ' ' PRO . 54.2 t -139.81 158.21 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.911 -1.118 . . . . 0.0 110.07 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 296' ' ' ALA . . . . . 0.537 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -137.43 74.29 47.68 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.812 . . . . 0.0 109.791 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 297' ' ' PRO . . . . . 0.552 ' HD3' HG11 ' B' ' 295' ' ' VAL . 47.3 Cg_endo -97.36 -173.36 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.623 1.549 . . . . 0.0 110.749 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.529 HD13 ' CZ ' ' A' ' 72' ' ' ARG . 2.7 mp -139.79 161.99 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . 0.575 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 11.5 t0 -131.75 155.69 47.27 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.097 -1.002 . . . . 0.0 110.012 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' B' ' 299' ' ' ASP . 0.1 OUTLIER -111.66 174.06 6.05 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' PHE . . . . . 0.593 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.91 151.78 36.44 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.014 -1.054 . . . . 0.0 110.473 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.466 ' CG ' ' CG ' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -145.0 94.44 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 109.533 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' PHE . . . . . 0.583 ' CE1' HG12 ' B' ' 210' ' ' VAL . 12.2 m-85 -90.63 -163.52 1.04 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' ASN . . . . . 0.534 ' OD1' ' CG2' ' B' ' 310' ' ' VAL . 0.2 OUTLIER -139.6 7.31 2.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.727 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . 116.22 68.31 0.41 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . 54.35 41.26 32.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -1.165 . . . . 0.0 109.444 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 307' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' B' ' 308' ' ' LYS . . . -125.1 35.2 3.18 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 308' ' ' LYS . . . . . 0.558 ' CB ' ' O ' ' B' ' 307' ' ' GLY . 9.2 mttm 83.05 -161.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 122.012 -0.699 . . . . 0.0 109.404 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 309' ' ' VAL . . . . . 0.538 ' CG2' HG12 ' B' ' 210' ' ' VAL . 98.6 t -99.36 136.52 30.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.342 -0.849 . . . . 0.0 109.501 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.534 ' CG2' ' OD1' ' B' ' 304' ' ' ASN . 2.9 t -108.78 -71.45 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 109.357 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 311' ' ' SER . . . . . 0.464 ' HB2' ' HD3' ' B' ' 302' ' ' ARG . 0.4 OUTLIER -113.9 169.0 9.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.183 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 312' ' ' MET . . . . . 0.474 ' HG3' ' CD1' ' B' ' 301' ' ' PHE . 13.4 ttp -158.65 152.27 23.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.947 . . . . 0.0 109.778 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 313' ' ' ARG . . . . . 0.527 ' CG ' ' HB2' ' B' ' 237' ' ' GLU . 0.1 OUTLIER -131.07 170.22 14.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.38 -0.825 . . . . 0.0 109.29 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -144.9 130.02 18.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.192 -0.943 . . . . 0.0 109.247 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 315' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 79' ' ' ALA . 1.1 tt -123.93 144.54 49.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.182 -0.949 . . . . 0.0 109.925 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 316' ' ' PHE . . . . . 0.531 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 12.2 p90 173.57 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 317' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' B' ' 321' ' ' ILE . . . 162.4 -176.07 38.79 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 318' ' ' GLU . . . . . 0.514 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 6.2 tt0 -72.36 -3.4 23.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -1.139 . . . . 0.0 109.385 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -93.75 -29.12 15.54 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.955 0.883 . . . . 0.0 108.873 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 320' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' B' ' 296' ' ' ALA . 1.4 m-20 -89.02 7.87 32.59 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 321' ' ' ILE . . . . . 0.542 HG21 ' CG2' ' B' ' 295' ' ' VAL . 4.6 mm -90.65 -167.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 322' ' ' HIS . . . . . 0.479 ' CB ' HG12 ' B' ' 294' ' ' VAL . 0.2 OUTLIER -151.06 158.88 44.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 0.0 109.593 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -155.26 81.46 1.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 109.518 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -115.68 177.65 17.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.244 -1.151 . . . . 0.0 109.493 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' NTH . . . . . 0.781 ' H12' ' OG ' ' A' ' 58' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 326' ' ' NTH . . . . . 0.774 H221 ' CE1' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.527 ' O ' ' CE ' ' A' ' 7' ' ' MET . 1.1 ptp . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.331 0.586 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.3 t30 45.57 -167.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 3' ' ' THR . 13.4 t -71.87 122.52 87.5 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.719 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HA ' ' CE ' ' A' ' 7' ' ' MET . 43.8 Cg_endo -70.67 -5.44 16.77 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.926 1.487 . . . . 0.0 109.535 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -43.93 88.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.496 -0.752 . . . . 0.0 109.361 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -61.52 -47.05 87.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.211 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.527 ' CE ' ' O ' ' A' ' 1' ' ' MET . 11.6 mtt -57.52 -39.5 76.71 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.29 -0.881 . . . . 0.0 109.227 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 m -52.77 -37.01 58.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.335 -0.853 . . . . 0.0 108.987 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.17 -50.67 73.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.297 -0.877 . . . . 0.0 109.051 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.583 HG12 ' CE1' ' A' ' 101' ' ' PHE . 1.1 t -48.79 -34.48 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 108.788 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.525 ' CG1' HG21 ' A' ' 71' ' ' VAL . 8.0 t -81.07 -41.91 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.399 -0.813 . . . . 0.0 109.222 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 15' ' ' VAL . 8.5 tt0 -63.35 -73.54 0.11 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.272 1.034 . . . . 0.0 108.573 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HD2' ' CD1' ' A' ' 29' ' ' LEU . 1.1 mtm180 -42.62 -45.13 4.51 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.615 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -44.21 -41.9 6.13 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.005 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.622 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 1.5 t -90.43 -38.53 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.742 . . . . 0.0 109.02 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . . . -48.87 -35.31 14.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.528 ' CB ' HG12 ' A' ' 26' ' ' ILE . . . -74.15 -35.42 64.04 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.622 ' CD1' ' HA ' ' A' ' 15' ' ' VAL . 2.3 mt -62.13 -58.47 7.67 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -50.69 -38.27 46.0 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.439 0.638 . . . . 0.0 109.334 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.86 -2.31 58.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.635 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 59' ' ' LEU . . . 52.51 40.14 54.15 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.465 ' O ' HG13 ' A' ' 26' ' ' ILE . 8.5 t70 -106.76 86.37 2.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -1.087 . . . . 0.0 109.608 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.589 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 3.5 mm? -52.08 -20.02 2.25 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 2.2 m-20 -65.36 -56.74 10.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.486 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -61.14 -27.66 67.72 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.58 HD13 ' CE1' ' A' ' 55' ' ' PHE . 10.1 mt -71.31 -64.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.507 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 96.6 t -58.3 -35.79 55.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.453 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . . . -60.02 -56.41 21.98 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.53 ' CD1' ' HD2' ' A' ' 13' ' ' ARG . 5.9 tp -58.87 -25.53 63.41 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.562 ' CE1' ' HE1' ' A' ' 112' ' ' MET . 14.6 m-30 -87.67 148.35 24.83 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.752 -0.593 . . . . 0.0 109.636 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -55.0 -166.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.739 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.481 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -83.09 -23.88 32.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 109.577 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.521 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 21.7 p-10 -144.37 39.45 1.3 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 110' ' ' VAL . . . -54.09 177.71 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.468 -0.77 . . . . 0.0 109.795 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.465 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -129.32 135.69 49.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.387 -0.821 . . . . 0.0 109.232 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 27.2 t -123.63 120.35 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.585 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 3.2 mt-10 -91.11 104.77 17.31 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.678 ' OD2' ' H10' ' A' ' 126' ' ' NTH . 30.2 t70 -178.92 137.05 0.32 Allowed Pre-proline 0 C--N 1.298 -1.647 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.165 -178.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.549 ' O ' ' O ' ' A' ' 40' ' ' VAL . 47.5 Cg_endo -71.91 -148.97 0.41 Allowed 'Cis proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.311 -1.954 . . . . 0.0 110.644 0.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.549 ' O ' ' O ' ' A' ' 39' ' ' PRO . 5.4 m -52.8 -140.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 122.084 0.945 . . . . 0.0 111.834 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 42' ' ' SER . . . -39.26 -23.66 0.03 OUTLIER Glycine 0 N--CA 1.495 2.575 0 O-C-N 121.174 -0.954 . . . . 0.0 111.604 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.538 ' CB ' ' HG2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -29.56 -93.7 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.016 -0.697 . . . . 0.0 110.874 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 42' ' ' SER . 0.0 OUTLIER 169.42 122.32 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.992 -1.068 . . . . 0.0 111.005 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.9 Cg_endo -66.24 -167.85 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.662 1.575 . . . . 0.0 111.281 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.578 ' HB2' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -151.57 130.3 12.37 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.465 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.5 OUTLIER -112.7 147.47 36.73 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.672 -1.268 . . . . 0.0 110.702 -178.225 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 105.02 163.19 23.92 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 2.7 m -69.15 -64.51 0.86 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.076 -1.25 . . . . 0.0 108.902 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -48.11 -23.7 0.91 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.159 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.575 ' CB ' ' CG ' ' A' ' 45' ' ' ARG . . . -90.02 -56.54 3.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.506 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 45' ' ' ARG . 9.0 mm -52.34 -41.87 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.309 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.507 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 19.5 ttt180 -73.38 -49.12 28.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 108.814 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 14.0 mt-10 -52.34 -30.0 26.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.146 -0.971 . . . . 0.0 108.486 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -81.82 -71.5 0.48 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.58 ' CE1' HD13 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -48.89 -29.1 4.31 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.11 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.516 ' N ' HD13 ' A' ' 23' ' ' LEU . . . -72.61 -38.05 67.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 23.9 t30 -65.22 -33.62 76.44 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.586 ' OG ' ' H12' ' A' ' 126' ' ' NTH . 45.7 t -69.09 -41.75 77.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.475 -0.765 . . . . 0.0 108.941 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.589 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 9.5 tp -59.57 -18.95 45.16 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.271 -0.893 . . . . 0.0 109.074 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 28.9 mtmt -69.66 -5.58 25.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 108.973 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.758 ' CD1' H122 ' A' ' 126' ' ' NTH . 0.3 OUTLIER -89.12 112.52 51.55 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 86' ' ' PHE . 42.1 Cg_endo -68.56 91.03 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.713 1.375 . . . . 0.0 111.076 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.605 HD22 ' CG ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -150.59 167.42 27.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.222 -0.924 . . . . 0.0 110.108 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.37 127.4 52.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.77 124.53 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.786 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.99 113.34 4.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.21 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.31 177.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 109.845 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 69' ' ' GLN . 9.9 t -156.24 -38.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 109.816 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.489 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 3.1 pt20 -97.71 -147.24 0.31 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.551 -0.718 . . . . 0.0 109.361 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.494 ' O ' ' NE ' ' A' ' 72' ' ' ARG . 29.9 tt0 -114.55 135.54 54.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.945 . . . . 0.0 109.649 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.525 HG21 ' CG1' ' A' ' 11' ' ' VAL . 79.3 t -66.21 152.2 9.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.365 -0.835 . . . . 0.0 109.154 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -118.33 140.48 49.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.089 . . . . 0.0 110.138 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . . . -150.25 134.67 17.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.428 -0.795 . . . . 0.0 109.141 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -159.62 163.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.943 -1.098 . . . . 0.0 110.212 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . 39.17 -97.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.786 -0.571 . . . . 0.0 110.232 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 103' ' ' PHE . 4.1 m-20 -135.74 10.3 3.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.022 -1.049 . . . . 0.0 109.717 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -116.22 -161.17 0.78 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.148 -0.97 . . . . 0.0 109.371 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 101' ' ' PHE . . . -176.58 129.81 0.2 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.475 -0.766 . . . . 0.0 109.629 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.525 ' HB2' ' CD1' ' B' ' 315' ' ' LEU . . . -114.88 130.82 56.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.998 . . . . 0.0 109.287 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 15.2 p90 -150.47 173.19 14.35 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.819 -1.176 . . . . 0.0 109.783 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.545 ' HB2' ' CG1' ' A' ' 98' ' ' ILE . . . -150.27 -167.58 2.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 110.627 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.471 ' CD2' ' C ' ' A' ' 81' ' ' ALA . 9.1 p90 178.06 -168.93 0.08 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -135.94 141.16 44.46 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 110.05 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.526 HG12 ' CD1' ' A' ' 63' ' ' LEU . 2.2 t -110.95 118.19 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 108.882 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.502 ' HB3' ' CG2' ' A' ' 94' ' ' VAL . 1.7 p -118.65 110.08 16.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.128 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.605 ' CG ' HD22 ' A' ' 63' ' ' LEU . 10.5 p90 -130.23 -177.71 4.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.289 -0.882 . . . . 0.0 109.712 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.428 ' CD ' ' O ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -122.93 152.25 41.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.389 -0.819 . . . . 0.0 109.09 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER -110.08 178.5 4.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.223 -0.923 . . . . 0.0 109.775 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -65.23 68.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.442 -0.786 . . . . 0.0 109.679 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 88' ' ' PHE . . . 115.81 -30.06 6.82 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 23.3 mtt85 -111.6 -171.9 1.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -1.157 . . . . 0.0 109.691 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.465 ' C ' ' CD ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -147.03 146.97 30.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 109.346 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.561 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -141.3 153.84 45.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.435 -0.791 . . . . 0.0 110.223 -179.309 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.571 HG13 ' CG ' ' A' ' 122' ' ' HIS . 0.4 OUTLIER -132.79 172.33 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.536 HG11 ' N ' ' A' ' 96' ' ' ALA . 52.5 t -150.15 146.73 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.542 -1.349 . . . . 0.0 110.646 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.536 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -127.69 74.22 78.3 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.518 ' HD3' HG11 ' A' ' 95' ' ' VAL . 48.5 Cg_endo -94.76 -179.36 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.58 1.52 . . . . 0.0 111.833 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.545 ' CG1' ' HB2' ' A' ' 81' ' ' ALA . 3.2 mp -143.74 144.18 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 4.3 t0 -117.87 163.12 17.02 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 110.155 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.2 OUTLIER -115.55 176.56 5.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.583 ' CE1' HG12 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -150.29 135.88 18.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.026 -1.046 . . . . 0.0 110.383 -178.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.475 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -121.01 107.67 12.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.381 -0.824 . . . . 0.0 109.075 179.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.572 ' CE1' ' O ' ' A' ' 108' ' ' LYS . 0.4 OUTLIER -89.26 166.22 13.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.363 -0.836 . . . . 0.0 109.38 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.542 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 1.7 p30 -115.81 -5.97 12.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 109.166 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . 177.26 -60.92 0.1 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 161.17 77.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.507 -0.996 . . . . 0.0 109.38 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.54 -66.32 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.572 ' O ' ' CE1' ' A' ' 103' ' ' PHE . 14.8 mttm -108.4 178.13 4.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -1.191 . . . . 0.0 109.602 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.555 ' CG2' ' CG2' ' A' ' 10' ' ' VAL . 49.6 t -109.05 153.35 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.336 -0.852 . . . . 0.0 109.233 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.542 ' CG2' ' HB3' ' A' ' 104' ' ' ASN . 44.8 t -124.18 -62.37 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -0.969 . . . . 0.0 109.53 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB2' ' CB ' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -116.31 164.53 14.38 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.974 -1.079 . . . . 0.0 109.463 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.572 ' HE1' ' CE1' ' A' ' 101' ' ' PHE . 19.3 ttm -153.29 137.67 16.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.325 -0.86 . . . . 0.0 109.5 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.482 ' HA ' ' HB2' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -113.21 168.57 9.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.448 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 37' ' ' GLU . . . -150.4 130.11 13.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.16 -0.962 . . . . 0.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.542 ' CD2' ' CB ' ' B' ' 279' ' ' ALA . 0.6 OUTLIER -130.94 142.6 50.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.758 ' CZ ' ' H62' ' A' ' 126' ' ' NTH . 50.3 p90 166.5 -162.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . 177.5 178.83 47.41 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.219 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.482 ' HA ' HG12 ' A' ' 121' ' ' ILE . 16.8 tt0 -50.2 -21.83 1.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.145 -1.209 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.455 ' HD3' ' OE2' ' B' ' 270' ' ' GLU . 0.6 OUTLIER -73.41 -22.11 60.32 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.009 0.909 . . . . 0.0 108.829 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.53 ' OD1' ' CD1' ' A' ' 121' ' ' ILE . 0.3 OUTLIER -88.56 -4.57 58.56 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.5 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.53 ' CD1' ' OD1' ' A' ' 120' ' ' ASN . 2.2 mm -91.75 -162.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.03 -1.044 . . . . 0.0 108.212 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.571 ' CG ' HG13 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -152.25 -169.4 3.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.004 -1.06 . . . . 0.0 109.606 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.55 -176.24 5.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.875 . . . . 0.0 109.54 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.81 -175.35 41.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.275 -1.133 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.524 ' O ' ' CB ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.298 0.57 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' B' ' 201' ' ' MET . 2.6 t30 77.05 177.9 0.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.239 -0.913 . . . . 0.0 109.713 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.37 128.57 66.69 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.398 -0.814 . . . . 0.0 109.736 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' PRO . . . . . 0.482 ' HA ' ' CE ' ' B' ' 207' ' ' MET . 42.5 Cg_endo -69.76 -7.01 19.96 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.023 1.539 . . . . 0.0 109.153 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . 0.436 ' O ' ' HB ' ' B' ' 208' ' ' THR . 0.3 OUTLIER -61.66 -45.67 93.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.436 -0.79 . . . . 0.0 108.91 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -64.1 -43.7 94.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 108.904 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' MET . . . . . 0.482 ' CE ' ' HA ' ' B' ' 204' ' ' PRO . 16.7 mtt -54.9 -24.66 24.55 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.29 -0.881 . . . . 0.0 109.156 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.436 ' HB ' ' O ' ' B' ' 205' ' ' GLU . 11.2 m -72.7 -41.64 65.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.405 -0.809 . . . . 0.0 108.983 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.35 -41.34 51.41 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.319 -0.863 . . . . 0.0 108.761 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.585 HG11 ' CZ ' ' B' ' 301' ' ' PHE . 1.2 t -54.81 -44.58 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.524 ' CG1' HG21 ' B' ' 271' ' ' VAL . 6.6 t -72.42 -41.66 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.459 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 213' ' ' ARG . 23.7 tt0 -59.92 -74.16 0.08 Allowed 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.265 1.031 . . . . 0.0 108.281 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' B' ' 212' ' ' GLN . 2.7 mtt85 -43.54 -45.51 6.62 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.977 0.894 . . . . 0.0 108.659 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.5 OUTLIER -49.9 -44.77 50.26 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.603 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 0.9 OUTLIER -87.17 -38.54 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.372 -0.83 . . . . 0.0 109.274 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.42 -37.74 17.88 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.531 ' HB3' ' CG1' ' B' ' 226' ' ' ILE . . . -72.06 -34.39 68.7 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.608 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 1.9 mt -64.54 -57.97 7.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -49.97 -42.27 48.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.567 0.698 . . . . 0.0 109.224 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.49 -1.04 57.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.884 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.534 ' CA ' HD23 ' B' ' 259' ' ' LEU . . . 57.43 47.58 87.06 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.478 ' O ' ' HB1' ' B' ' 217' ' ' ALA . 26.7 t70 -113.38 92.64 4.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.852 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' LEU . . . . . 0.539 ' CD2' HD22 ' B' ' 259' ' ' LEU . 2.5 mm? -62.46 -12.48 22.25 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.184 -0.947 . . . . 0.0 109.565 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -59.36 3.5 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.293 -0.879 . . . . 0.0 109.424 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -59.6 -28.44 65.23 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.583 HG23 ' CE2' ' B' ' 230' ' ' PHE . 23.0 mt -69.02 -62.01 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.545 -0.973 . . . . 0.0 108.47 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 65.3 t -58.37 -36.11 57.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -57.33 13.47 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.523 ' O ' ' CG2' ' B' ' 309' ' ' VAL . 9.8 tp -57.19 -29.07 63.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . 0.583 ' CE2' HG23 ' B' ' 226' ' ' ILE . 17.1 m-30 -82.18 127.22 32.94 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.644 -0.66 . . . . 0.0 109.619 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -45.68 171.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 109.582 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -24.39 66.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.729 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.559 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 55.4 p-10 -134.03 44.43 2.73 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.668 -0.645 . . . . 0.0 109.556 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' B' ' 310' ' ' VAL . . . -71.41 -169.94 0.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' THR . . . . . 0.504 ' OG1' ' CB ' ' B' ' 311' ' ' SER . 15.1 p -142.34 175.06 10.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.303 -0.873 . . . . 0.0 109.329 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' B' ' 244' ' ' PRO . 40.0 t -158.94 110.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' GLU . . . . . 0.566 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 17.7 mt-10 -88.27 105.98 17.91 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' ASP . . . . . 0.467 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 8.8 t0 -174.68 142.47 0.77 Allowed Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.106 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 47.1 Cg_endo -72.14 -168.49 5.53 Favored 'Cis proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.345 -1.939 . . . . 0.0 110.873 -0.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.465 ' CG1' ' HA ' ' B' ' 315' ' ' LEU . 3.7 m -64.79 146.14 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.276 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 54.12 32.22 49.87 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.2 OUTLIER -120.1 -156.38 0.66 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -1.096 . . . . 0.0 109.607 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . 0.412 ' HA ' ' HD2' ' B' ' 244' ' ' PRO . 19.5 mt-10 -120.76 118.37 30.67 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.166 -0.959 . . . . 0.0 110.026 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' PRO . . . . . 0.566 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.1 Cg_endo -64.82 -169.05 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.938 1.494 . . . . 0.0 111.55 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.583 ' HG3' ' CD2' ' B' ' 254' ' ' PHE . 6.5 mtt180 -150.83 106.17 3.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.19 158.08 18.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 110.154 -179.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 87.7 157.2 31.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' THR . . . . . 0.503 ' CG2' HG13 ' B' ' 227' ' ' VAL . 6.9 m -67.2 -41.41 85.88 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.35 -1.088 . . . . 0.0 109.197 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -60.92 -32.85 72.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.291 -0.881 . . . . 0.0 109.186 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' B' ' 245' ' ' ARG . . . -89.8 -55.07 3.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.372 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.508 HD11 ' N ' ' B' ' 247' ' ' GLY . 14.3 mt -54.11 -44.9 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 0.0 108.887 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' ARG . . . . . 0.526 ' HB2' ' CG2' ' B' ' 227' ' ' VAL . 25.8 ttt-85 -70.56 -53.14 17.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 23.2 tt0 -50.41 -32.31 17.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.151 -0.968 . . . . 0.0 109.015 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.583 ' CD2' ' HG3' ' B' ' 245' ' ' ARG . 0.2 OUTLIER -80.26 -70.51 0.52 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.534 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -47.89 -26.4 1.68 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' B' ' 252' ' ' ARG . . . -76.61 -44.39 34.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.085 -1.009 . . . . 0.0 108.675 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 5.1 t-20 -65.09 -25.63 67.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 108.75 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 21.5 t -75.36 -39.37 59.34 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . 0.539 HD22 ' CD2' ' B' ' 223' ' ' LEU . 8.2 tp -64.96 -20.04 66.28 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.456 -0.777 . . . . 0.0 109.17 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 2.2 mttt -49.14 -27.73 3.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.413 -0.805 . . . . 0.0 109.505 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' LEU . . . . . 0.565 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.5 OUTLIER -89.95 118.88 69.28 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.217 -0.927 . . . . 0.0 109.078 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' PRO . . . . . 0.417 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 43.9 Cg_endo -70.21 105.06 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.768 1.404 . . . . 0.0 110.535 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.565 ' CD2' ' CD2' ' B' ' 261' ' ' LEU . 0.0 OUTLIER -137.73 153.17 49.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.509 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . 0.45 ' HB2' ' OG ' ' B' ' 285' ' ' SER . . . -89.98 129.12 36.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 108.877 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 98.3 t -111.98 118.58 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.663 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 4.1 tt0 -150.26 96.51 2.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.308 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.9 mp -45.14 171.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.752 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 268' ' ' THR . . . . . 0.428 HG22 ' O ' ' B' ' 267' ' ' LEU . 34.2 p -146.86 -37.97 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.87 . . . . 0.0 109.711 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 269' ' ' GLN . . . . . 0.506 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 15.3 pt20 -91.46 -146.61 0.21 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 109.433 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 58.1 tt0 -115.06 134.67 54.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.677 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . 0.524 HG21 ' CG1' ' B' ' 211' ' ' VAL . 56.3 t -65.7 153.36 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.372 -0.83 . . . . 0.0 109.189 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.0 OUTLIER -113.97 135.72 53.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.078 -1.013 . . . . 0.0 110.134 -179.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.1 149.49 30.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.148 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 274' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -153.38 -155.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.039 -1.038 . . . . 0.0 109.939 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . -23.39 -96.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 120.954 0.406 . . . . 0.0 111.815 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 276' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' B' ' 303' ' ' PHE . 47.5 t30 -116.23 -1.57 12.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.855 -1.153 . . . . 0.0 110.725 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . 0.452 ' HG3' ' HG3' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -109.25 -162.08 0.79 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.811 -1.181 . . . . 0.0 109.557 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 278' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' B' ' 301' ' ' PHE . . . -179.98 159.99 0.84 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.49 -0.756 . . . . 0.0 109.349 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 279' ' ' ALA . . . . . 0.542 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . . . -150.33 138.27 20.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 109.041 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 35.0 p90 -150.61 172.06 16.13 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.931 -1.106 . . . . 0.0 109.851 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.483 ' HB1' HG13 ' B' ' 298' ' ' ILE . . . -146.44 -168.62 3.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 0.0 109.962 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 282' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' B' ' 281' ' ' ALA . 31.3 p90 170.28 -167.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.227 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.93 142.51 50.92 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.443 -0.786 . . . . 0.0 109.677 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 284' ' ' VAL . . . . . 0.519 ' CG1' HD21 ' B' ' 263' ' ' LEU . 74.4 t -114.36 113.02 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.862 . . . . 0.0 109.322 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 285' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' B' ' 264' ' ' ALA . 4.4 p -109.14 115.07 29.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.308 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.782 ' CZ ' H221 ' B' ' 326' ' ' NTH . 6.5 p90 -137.65 160.79 38.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -137.76 153.03 49.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.501 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 2.3 p90 -148.02 12.67 0.98 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 109.871 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -168.07 -147.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.113 -0.992 . . . . 0.0 109.406 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -76.66 -23.33 70.28 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -105.48 -179.82 4.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -1.09 . . . . 0.0 109.298 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 292' ' ' LYS . . . . . 0.454 ' O ' ' HD2' ' B' ' 292' ' ' LYS . 0.1 OUTLIER -149.26 128.16 12.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.525 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 293' ' ' THR . . . . . 0.46 HG22 ' HA ' ' B' ' 323' ' ' ALA . 0.0 OUTLIER -105.19 142.72 34.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.248 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 294' ' ' VAL . . . . . 0.508 HG11 ' HB2' ' B' ' 322' ' ' HIS . 0.6 OUTLIER -113.52 174.96 2.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.192 -0.943 . . . . 0.0 108.615 179.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.572 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 3.0 t -145.87 145.17 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -0.981 . . . . 0.0 109.426 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 296' ' ' ALA . . . . . 0.524 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -132.58 71.36 78.93 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.223 -0.923 . . . . 0.0 110.362 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 297' ' ' PRO . . . . . 0.572 ' HD3' ' CG1' ' B' ' 295' ' ' VAL . 49.9 Cg_endo -95.61 -173.45 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.575 1.516 . . . . 0.0 110.692 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.483 HG13 ' HB1' ' B' ' 281' ' ' ALA . 2.7 mp -140.99 149.72 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . 0.581 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 5.7 t0 -115.0 161.07 18.83 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.929 -1.107 . . . . 0.0 110.111 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.496 ' NE2' HD11 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -117.85 166.76 12.09 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' PHE . . . . . 0.585 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 0.2 OUTLIER -142.27 149.36 39.46 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.146 -0.971 . . . . 0.0 110.774 -178.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.452 ' HG3' ' HG3' ' B' ' 277' ' ' GLU . 30.8 ttt-85 -142.74 107.79 4.94 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 303' ' ' PHE . . . . . 0.575 ' CE1' HG23 ' B' ' 210' ' ' VAL . 26.0 m-85 -89.28 -174.84 4.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 109.358 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 304' ' ' ASN . . . . . 0.528 ' HB3' ' CG2' ' B' ' 310' ' ' VAL . 0.5 OUTLIER -112.63 -43.3 3.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.46 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 305' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -165.05 27.85 0.2 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 306' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 74.87 38.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -1.18 . . . . 0.0 109.534 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -131.43 -39.21 0.25 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 308' ' ' LYS . . . . . 0.431 ' HG3' ' OD1' ' B' ' 304' ' ' ASN . 2.1 pttt -153.65 -175.3 5.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -1.134 . . . . 0.0 109.497 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 309' ' ' VAL . . . . . 0.531 ' CG2' HG21 ' B' ' 210' ' ' VAL . 84.9 t -89.87 159.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 109.332 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' B' ' 234' ' ' ALA . 45.0 t -136.18 -75.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.722 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 311' ' ' SER . . . . . 0.504 ' CB ' ' OG1' ' B' ' 235' ' ' THR . 70.5 m -122.22 160.7 24.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.032 . . . . 0.0 110.057 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 312' ' ' MET . . . . . 0.579 ' CE ' ' CE1' ' B' ' 230' ' ' PHE . 2.3 ttm -139.04 158.45 44.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.435 -0.791 . . . . 0.0 109.531 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 313' ' ' ARG . . . . . 0.496 ' CZ ' ' OE1' ' B' ' 237' ' ' GLU . 0.8 OUTLIER -133.7 149.34 51.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 109.325 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 314' ' ' ALA . . . . . 0.406 ' CB ' ' OD2' ' B' ' 238' ' ' ASP . . . -125.29 132.4 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.973 . . . . 0.0 109.708 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 315' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 79' ' ' ALA . 1.2 tt -131.84 143.52 50.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.592 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 316' ' ' PHE . . . . . 0.526 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 14.2 p90 171.91 -158.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 317' ' ' GLY . . . . . 0.513 ' O ' ' CD1' ' B' ' 321' ' ' ILE . . . 168.87 -177.3 42.77 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 318' ' ' GLU . . . . . 0.529 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 13.1 tt0 -71.14 -4.8 27.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -1.118 . . . . 0.0 109.374 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -90.7 -30.86 16.85 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.902 0.858 . . . . 0.0 109.012 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 320' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -89.3 7.27 36.45 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.2 0.524 . . . . 0.0 109.59 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 321' ' ' ILE . . . . . 0.529 ' CG1' ' HA ' ' B' ' 318' ' ' GLU . 4.2 mm -90.82 -162.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 322' ' ' HIS . . . . . 0.508 ' HB2' HG11 ' B' ' 294' ' ' VAL . 60.3 t60 -151.27 154.32 36.55 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.087 -1.008 . . . . 0.0 109.637 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.46 ' HA ' HG22 ' B' ' 293' ' ' THR . . . -155.14 86.54 1.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.925 . . . . 0.0 109.414 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -127.36 159.94 21.42 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.219 -1.165 . . . . 0.0 109.528 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' NTH . . . . . 0.758 ' H62' ' CZ ' ' A' ' 116' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 326' ' ' NTH . . . . . 0.782 H221 ' CZ ' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 tpp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.23 0.538 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.456 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 73.5 m-80 -49.94 108.76 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 0.0 109.408 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.92 111.5 22.18 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.277 -0.889 . . . . 0.0 109.608 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 8' ' ' THR . 44.1 Cg_endo -71.64 -3.74 13.68 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.913 1.481 . . . . 0.0 110.039 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -57.41 -41.32 80.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.938 . . . . 0.0 109.407 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.22 -62.87 1.24 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.944 . . . . 0.0 108.989 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.634 ' CE ' ' CD2' ' A' ' 103' ' ' PHE . 27.5 mmt -54.39 -33.28 58.93 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.271 -0.893 . . . . 0.0 109.691 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 6.9 m -66.46 -34.25 77.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.406 -0.808 . . . . 0.0 109.207 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.61 -46.43 70.43 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.172 -0.955 . . . . 0.0 108.662 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.632 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 1.5 t -58.27 -19.57 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.565 HG22 ' CE2' ' A' ' 101' ' ' PHE . 14.4 t -90.51 -42.9 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.492 -0.755 . . . . 0.0 109.07 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' ARG . 25.9 tt0 -61.55 -74.22 0.09 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.231 1.015 . . . . 0.0 108.292 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' GLN . 4.2 mtm-85 -42.78 -45.59 4.87 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.601 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -49.24 -43.21 42.53 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.613 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 1.1 t -88.72 -38.67 11.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.458 -0.776 . . . . 0.0 109.253 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.47 -35.69 13.52 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.528 ' CB ' HG13 ' A' ' 26' ' ' ILE . . . -74.13 -34.56 63.92 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.613 ' CD1' ' HA ' ' A' ' 15' ' ' VAL . 2.2 mt -63.63 -58.71 6.07 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 65' ' ' VAL . 1.7 t-20 -51.36 -44.8 62.17 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.35 11.0 20.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.687 -0.633 . . . . 0.0 109.533 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.428 ' HA2' HD21 ' A' ' 59' ' ' LEU . . . 45.69 29.63 3.04 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' ALA . 10.4 t0 -92.09 60.44 3.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.454 -1.027 . . . . 0.0 109.812 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.576 ' CD2' ' CG ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -45.8 -37.16 5.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 108.888 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' LEU . 5.9 m-20 -41.06 -29.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -89.17 -36.89 7.38 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.528 HG13 ' CB ' ' A' ' 17' ' ' ALA . 28.7 mt -59.24 -55.13 25.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.511 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 60.0 t -54.82 -39.63 48.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.24 -52.47 65.2 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 109' ' ' VAL . 1.0 OUTLIER -67.58 -15.86 63.88 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 31' ' ' ALA . 2.6 m-85 -94.26 119.75 33.5 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.476 -0.765 . . . . 0.0 109.675 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -46.53 171.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.44 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.417 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.2 OUTLIER -73.72 -25.36 60.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.52 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.554 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -121.24 41.23 3.38 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.403 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 110' ' ' VAL . . . -71.88 153.89 41.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.882 . . . . 0.0 109.919 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.528 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -112.8 159.67 18.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.235 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.549 ' CG1' ' N ' ' A' ' 37' ' ' GLU . 24.0 t -148.19 167.98 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.327 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.549 ' N ' ' CG1' ' A' ' 36' ' ' VAL . 14.1 mt-10 -147.39 111.22 5.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -178.31 149.63 0.68 Allowed Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 118.695 -1.202 . . . . 0.0 110.075 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.48 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 48.3 Cg_endo -74.13 175.31 47.21 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.052 -2.062 . . . . 0.0 111.014 -0.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.575 HG12 ' CE1' ' A' ' 116' ' ' PHE . 7.2 m -42.12 122.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.489 -0.757 . . . . 0.0 109.652 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . 112.56 53.16 0.5 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.1 OUTLIER 78.53 -151.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -1.079 . . . . 0.0 109.961 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.629 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 4.1 mt-10 67.53 54.36 0.7 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.266 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.629 ' HD3' ' N ' ' A' ' 43' ' ' GLU . 55.7 Cg_endo -86.44 174.41 5.96 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.725 1.381 . . . . 0.0 110.576 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.527 ' O ' ' CD1' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -151.41 109.1 3.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.528 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.1 OUTLIER -105.04 136.61 44.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.018 -1.051 . . . . 0.0 110.492 -178.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 103.43 158.44 24.91 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.417 ' OG1' ' HA ' ' A' ' 32' ' ' ASP . 7.2 m -60.88 -64.19 1.04 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.412 -1.052 . . . . 0.0 109.194 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -45.79 -25.2 0.47 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.088 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.494 ' CB ' ' HG3' ' A' ' 45' ' ' ARG . . . -86.92 -53.25 5.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.309 -0.869 . . . . 0.0 109.519 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 45' ' ' ARG . 4.1 mm -55.74 -48.92 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.347 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.576 ' CG ' ' CD2' ' A' ' 23' ' ' LEU . 6.7 ttt180 -68.48 -53.01 26.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.406 -0.809 . . . . 0.0 109.119 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 13.1 tt0 -51.26 -32.16 23.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 108.66 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.493 ' CD1' ' HD3' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -83.87 -70.62 0.55 Allowed 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.556 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -45.34 -31.17 1.51 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 52' ' ' ARG . . . -66.4 -46.22 77.34 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 37.1 t-20 -60.62 -36.17 77.94 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.734 ' OG ' H112 ' A' ' 126' ' ' NTH . 39.4 t -68.6 -35.28 77.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.428 HD21 ' HA2' ' A' ' 21' ' ' GLY . 8.9 tp -64.94 -20.39 66.44 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.456 -0.777 . . . . 0.0 109.051 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.469 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 3.1 mttp -67.04 -7.72 24.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.486 -0.759 . . . . 0.0 109.341 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.603 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 13.5 tp -88.88 108.94 26.62 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 48.7 Cg_endo -73.82 92.15 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.846 1.445 . . . . 0.0 111.909 -178.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.603 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -140.62 178.61 7.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.014 . . . . 0.0 109.366 178.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.17 129.02 49.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.498 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 8.6 t -112.56 113.54 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.692 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' LEU . 4.7 tt0 -150.59 97.19 2.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.815 . . . . 0.0 109.076 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.9 mp -44.84 170.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.338 -0.851 . . . . 0.0 109.67 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.411 ' CG2' ' N ' ' A' ' 69' ' ' GLN . 14.6 t -146.53 -38.86 0.22 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.704 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.411 ' N ' ' CG2' ' A' ' 68' ' ' THR . 5.9 pt20 -90.33 -148.39 0.2 Allowed 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 109.331 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -117.15 131.81 56.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.765 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.521 HG11 ' N ' ' A' ' 72' ' ' ARG . 93.4 t -60.88 148.47 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.365 -0.834 . . . . 0.0 109.226 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.521 ' N ' HG11 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -112.66 92.68 4.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 109.819 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.461 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -108.0 147.83 30.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.152 -0.968 . . . . 0.0 109.873 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -160.76 152.63 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.301 -0.874 . . . . 0.0 110.009 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.472 ' HB1' ' HA3' ' B' ' 241' ' ' GLY . . . 41.53 -145.43 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.595 -0.691 . . . . 0.0 109.964 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -85.01 4.06 35.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 110.001 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.471 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -113.27 -160.49 0.72 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 109.441 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.477 ' CB ' ' HB3' ' A' ' 101' ' ' PHE . . . 174.01 162.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.491 ' HB1' ' CE1' ' A' ' 100' ' ' HIS . . . -150.25 133.29 16.16 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.576 ' CE1' ' HB3' ' A' ' 99' ' ' ASP . 34.4 p90 -149.51 167.98 24.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.797 -1.189 . . . . 0.0 110.298 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.48 ' HB1' HG13 ' A' ' 98' ' ' ILE . . . -141.62 167.76 21.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.54 -0.725 . . . . 0.0 109.679 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -159.35 -172.78 3.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.25 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.96 140.44 53.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.378 -0.826 . . . . 0.0 109.658 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.586 ' CG1' ' CD2' ' A' ' 63' ' ' LEU . 22.6 t -121.17 116.04 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.484 -0.76 . . . . 0.0 109.177 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.529 ' HB3' ' CG2' ' A' ' 94' ' ' VAL . 69.6 p -118.2 128.17 54.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.96 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.581 ' CE1' ' HB ' ' A' ' 93' ' ' THR . 3.0 p90 -143.95 171.01 14.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.379 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.45 ' HA ' ' HG3' ' A' ' 92' ' ' LYS . 2.5 tm-20 -104.6 156.65 17.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.636 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.573 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -117.82 -161.16 0.81 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 109.306 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.64 75.95 2.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 109.686 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . 116.61 -11.7 15.9 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 19.8 mtp180 -149.67 164.15 35.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -1.153 . . . . 0.0 109.592 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HG3' ' HA ' ' A' ' 87' ' ' GLU . 18.4 tttt -107.91 151.75 25.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.552 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.581 ' HB ' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -138.13 155.14 49.03 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.317 -0.864 . . . . 0.0 109.915 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.576 HG13 ' CG ' ' A' ' 122' ' ' HIS . 0.4 OUTLIER -140.22 170.46 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.56 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 4.8 t -146.53 145.52 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.823 -1.173 . . . . 0.0 109.941 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.527 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -136.46 71.88 58.74 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.434 -0.791 . . . . 0.0 109.786 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.56 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 52.1 Cg_endo -95.69 -171.11 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 121.741 1.627 . . . . 0.0 110.86 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.48 HG13 ' HB1' ' A' ' 81' ' ' ALA . 2.8 mp -140.82 146.34 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.576 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 23.0 t0 -118.61 160.94 20.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.921 -1.112 . . . . 0.0 109.83 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.491 ' CE1' ' HB1' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -109.74 -179.72 3.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.432 -0.793 . . . . 0.0 108.916 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.578 ' CE1' ' CG1' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -150.14 147.18 27.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.12 -0.987 . . . . 0.0 110.553 -178.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.522 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -140.98 102.61 4.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.264 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.634 ' CD2' ' CE ' ' A' ' 7' ' ' MET . 4.0 m-85 -89.77 -175.88 4.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.536 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 2.7 p30 -126.53 -34.93 2.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 109.372 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.503 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . -155.45 -63.29 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 164.6 61.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -1.17 . . . . 0.0 109.404 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.52 -53.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -129.43 -166.23 1.63 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -1.126 . . . . 0.0 109.705 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 29' ' ' LEU . 25.8 t -109.93 160.72 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 108.906 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 54.2 t -132.61 -60.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.962 -1.086 . . . . 0.0 110.181 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.522 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -122.42 157.22 32.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.869 -1.144 . . . . 0.0 109.969 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.512 ' CE ' ' OD2' ' A' ' 99' ' ' ASP . 8.9 ttp -152.75 157.0 40.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.393 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' NH1' ' HB3' ' A' ' 37' ' ' GLU . 1.1 tpt180 -139.18 132.0 29.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 109.308 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.516 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . . . -93.0 129.08 39.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.06 -1.025 . . . . 0.0 109.663 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 116' ' ' PHE . 0.6 OUTLIER -127.21 143.31 51.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.859 . . . . 0.0 109.632 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.575 ' CE1' HG12 ' A' ' 40' ' ' VAL . 47.1 p90 168.94 -154.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.499 ' O ' HG12 ' A' ' 121' ' ' ILE . . . 167.35 161.68 17.28 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.564 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 11.8 tt0 -44.12 -24.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.398 -1.06 . . . . 0.0 109.783 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 117' ' ' GLY . 0.8 OUTLIER -71.37 -35.06 70.98 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.821 0.819 . . . . 0.0 109.723 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 117' ' ' GLY . 0.4 OUTLIER -89.54 1.47 55.9 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.051 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.564 ' CG1' ' HA ' ' A' ' 118' ' ' GLU . 3.7 mm -91.44 -171.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 0.0 108.502 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.576 ' CG ' HG13 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -151.93 143.22 23.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.702 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.16 114.87 3.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.97 -116.21 0.7 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.346 -1.091 . . . . 0.0 109.386 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.243 0.544 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.474 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 4.6 m-20 -149.3 68.03 1.03 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 109.628 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 1.5 m -67.4 111.54 7.64 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.875 . . . . 0.0 109.624 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 49.1 Cg_endo -74.74 0.19 9.07 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.923 1.486 . . . . 0.0 110.367 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -65.81 -57.08 8.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 109.598 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -60.57 -48.55 81.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' MET . . . . . 0.53 ' HA ' ' CZ ' ' B' ' 303' ' ' PHE . 19.8 mtm -61.56 -15.19 36.35 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.332 -0.855 . . . . 0.0 109.896 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' B' ' 204' ' ' PRO . 15.5 m -81.85 -38.54 25.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.253 -0.904 . . . . 0.0 109.253 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.9 -42.83 59.62 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.26 -0.9 . . . . 0.0 108.599 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.641 ' CG1' ' CE1' ' B' ' 301' ' ' PHE . 0.9 OUTLIER -52.31 -24.86 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.193 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.609 ' CG2' ' CE2' ' B' ' 301' ' ' PHE . 26.1 t -86.86 -45.24 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.481 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.6 tt0 -57.74 -73.49 0.07 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.528 ' HD2' ' CD1' ' B' ' 229' ' ' LEU . 0.7 OUTLIER -43.88 -45.34 7.49 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' TYR . . . . . 0.602 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -48.28 -43.17 32.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.619 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.1 t -89.27 -39.9 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.297 -0.877 . . . . 0.0 109.003 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.34 -36.36 14.29 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.528 ' HB3' ' CG1' ' B' ' 226' ' ' ILE . . . -74.08 -35.62 64.25 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.619 ' CD1' ' HA ' ' B' ' 215' ' ' VAL . 3.3 mt -61.56 -59.27 5.48 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.0 -41.07 46.34 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -88.91 5.33 44.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.525 ' CA ' HD23 ' B' ' 259' ' ' LEU . . . 46.86 35.81 8.13 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -97.33 78.35 2.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -1.071 . . . . 0.0 109.887 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' LEU . . . . . 0.581 ' CD2' ' CD2' ' B' ' 259' ' ' LEU . 3.9 mm? -50.45 -21.13 1.34 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.286 -0.884 . . . . 0.0 109.856 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -62.17 -54.54 39.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.902 . . . . 0.0 109.536 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' B' ' 229' ' ' LEU . . . -64.3 -34.4 89.81 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' B' ' 217' ' ' ALA . 6.9 mt -62.36 -56.02 20.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.529 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 26.9 t -63.37 -43.03 98.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.74 -49.79 69.95 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.528 ' CD1' ' HD2' ' B' ' 213' ' ' ARG . 2.4 tp -68.99 -16.7 63.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . 0.463 ' HB2' ' HA ' ' B' ' 227' ' ' VAL . 2.2 m-85 -91.72 140.3 29.83 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.334 -0.854 . . . . 0.0 109.517 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -49.18 177.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.575 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.459 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.1 OUTLIER -66.21 -24.18 66.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.547 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.525 ' CB ' ' HA2' ' B' ' 247' ' ' GLY . 4.4 p30 -146.96 47.1 1.17 Allowed 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.651 -0.656 . . . . 0.0 109.31 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' B' ' 310' ' ' VAL . . . -59.45 167.09 2.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.329 -0.857 . . . . 0.0 109.496 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' THR . . . . . 0.53 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -109.4 164.84 12.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 46.1 t -154.68 115.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.91 . . . . 0.0 109.488 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.0 mm-40 -94.85 109.68 21.64 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' ASP . . . . . 0.596 ' OD2' ' H62' ' B' ' 326' ' ' NTH . 10.0 t70 -178.21 142.69 0.45 Allowed Pre-proline 0 C--N 1.302 -1.486 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.042 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 47.0 Cg_endo -73.41 174.87 48.23 Favored 'Cis proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.29 -1.962 . . . . 0.0 111.072 -0.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.513 ' CG1' ' HA ' ' B' ' 315' ' ' LEU . 29.2 m -57.01 115.3 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.84 . . . . 0.0 109.598 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . 0.472 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . 83.28 57.35 2.51 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' SER . . . . . 0.519 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 3.3 m -149.01 -105.03 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -1.187 . . . . 0.0 109.747 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' B' ' 243' ' ' GLU . 7.5 pt-20 -165.85 111.08 0.75 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.931 -1.106 . . . . 0.0 110.185 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' PRO . . . . . 0.578 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.9 Cg_endo -65.75 179.15 1.87 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.97 1.511 . . . . 0.0 111.239 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.584 ' HB2' ' CD2' ' B' ' 254' ' ' PHE . 0.3 OUTLIER -150.9 103.0 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.53 ' HB2' ' CG2' ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.28 150.57 22.55 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.252 -0.905 . . . . 0.0 110.166 -179.133 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . 0.525 ' HA2' ' CB ' ' B' ' 233' ' ' ASP . . . 117.32 157.56 10.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 4.5 m -54.73 -72.18 0.07 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.228 -1.16 . . . . 0.0 108.937 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -52.67 -32.73 43.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 0.0 109.164 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' B' ' 246' ' ' SER . . . -71.11 -23.96 62.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.558 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.478 HG12 ' O ' ' B' ' 247' ' ' GLY . 4.7 mm -90.11 -37.27 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.202 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' ARG . . . . . 0.529 ' HB2' ' CG2' ' B' ' 227' ' ' VAL . 21.7 ttm180 -79.6 -59.64 2.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.133 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 4.7 tt0 -45.6 -26.86 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.981 -1.074 . . . . 0.0 108.863 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.1 OUTLIER -86.44 -69.81 0.65 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.521 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -52.75 -20.43 3.17 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.466 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' B' ' 252' ' ' ARG . . . -80.95 -43.96 18.92 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 10.0 t-20 -61.14 -38.89 88.02 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 33.8 t -62.1 -31.82 72.31 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . 0.581 ' CD2' ' CD2' ' B' ' 223' ' ' LEU . 6.7 tp -70.97 -26.52 63.2 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.467 -0.771 . . . . 0.0 109.366 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 7.7 mttp -48.91 -23.03 0.96 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.222 -0.924 . . . . 0.0 109.152 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' LEU . . . . . 0.586 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.46 112.9 54.3 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 43.2 Cg_endo -70.28 107.83 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.806 1.424 . . . . 0.0 110.618 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.602 ' CB ' ' CG1' ' B' ' 284' ' ' VAL . 0.0 OUTLIER -139.84 173.04 11.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.751 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' B' ' 284' ' ' VAL . . . -104.65 127.28 52.36 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 77.9 t -112.29 112.63 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.962 . . . . 0.0 110.142 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 13.4 tt0 -150.49 97.14 2.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.34 -0.85 . . . . 0.0 109.158 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -44.7 170.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 110.016 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.92 -38.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 109.558 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 269' ' ' GLN . . . . . 0.517 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 19.4 pt20 -93.2 -146.34 0.23 Allowed 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.635 -0.665 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.517 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 28.7 tt0 -115.32 133.09 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.0 109.659 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . 0.517 HG11 ' N ' ' B' ' 272' ' ' ARG . 53.4 t -68.31 147.49 12.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 109.245 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.536 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.4 OUTLIER -103.01 139.26 38.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 109.952 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -148.25 147.39 29.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 109.083 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 274' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.2 OUTLIER -138.27 -155.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.114 -0.992 . . . . 0.0 109.99 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . 0.454 ' O ' ' SD ' ' B' ' 207' ' ' MET . . . -39.71 -87.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.639 -0.663 . . . . 0.0 110.468 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 276' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' B' ' 303' ' ' PHE . 6.7 m120 -116.45 20.53 14.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.146 -0.971 . . . . 0.0 110.276 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . 0.476 ' HG2' ' HA ' ' B' ' 302' ' ' ARG . 0.3 OUTLIER -128.18 -160.05 0.99 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.007 -1.058 . . . . 0.0 109.399 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 278' ' ' ALA . . . . . 0.512 ' CB ' ' HB3' ' B' ' 301' ' ' PHE . . . 171.06 157.93 0.08 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.477 -0.764 . . . . 0.0 109.932 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 279' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -150.31 136.14 18.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 43.9 p90 -150.11 168.45 23.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.785 -1.197 . . . . 0.0 110.564 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.535 ' HB1' ' CG1' ' B' ' 298' ' ' ILE . . . -145.83 169.32 18.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.699 -0.625 . . . . 0.0 109.417 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 282' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 6.9 p90 -166.1 -169.11 1.38 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.78 141.43 51.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.436 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 284' ' ' VAL . . . . . 0.602 ' CG1' ' CB ' ' B' ' 263' ' ' LEU . 42.9 t -128.95 112.47 25.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.294 -0.878 . . . . 0.0 109.29 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 285' ' ' SER . . . . . 0.469 ' HA ' HG22 ' B' ' 294' ' ' VAL . 0.1 OUTLIER -104.49 122.89 46.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 109.448 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.563 ' CD2' HD23 ' B' ' 261' ' ' LEU . 7.1 p90 -137.72 171.26 14.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.223 -0.923 . . . . 0.0 109.907 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 287' ' ' GLU . . . . . 0.405 ' OE1' ' HB3' ' B' ' 292' ' ' LYS . 42.5 tt0 -150.35 150.56 31.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.477 -0.765 . . . . 0.0 109.073 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.1 OUTLIER -137.72 2.46 2.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 109.881 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' B' ' 290' ' ' GLY . 2.1 tt0 -169.86 -173.63 1.63 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.099 -1.0 . . . . 0.0 109.113 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 290' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' B' ' 289' ' ' GLN . . . -46.65 -25.41 2.18 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 291' ' ' ARG . . . . . 0.428 ' HG2' ' HA ' ' B' ' 325' ' ' ALA . 2.3 mtm105 -100.43 130.8 46.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -1.074 . . . . 0.0 109.285 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 292' ' ' LYS . . . . . 0.405 ' HB3' ' OE1' ' B' ' 287' ' ' GLU . 0.0 OUTLIER -106.03 141.44 37.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.521 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 293' ' ' THR . . . . . 0.543 ' CG2' ' HA ' ' B' ' 323' ' ' ALA . 0.0 OUTLIER -119.49 146.08 45.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 0.0 109.861 -179.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 294' ' ' VAL . . . . . 0.483 HG13 ' HB3' ' B' ' 322' ' ' HIS . 3.9 p -113.53 171.08 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 108.845 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.562 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 24.6 t -142.13 144.04 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 110.355 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 296' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' B' ' 320' ' ' ASN . . . -138.52 70.86 45.43 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.599 -0.688 . . . . 0.0 109.683 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 297' ' ' PRO . . . . . 0.562 ' HD3' ' CG1' ' B' ' 295' ' ' VAL . 51.4 Cg_endo -95.67 -175.12 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.732 1.621 . . . . 0.0 111.545 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.535 ' CG1' ' HB1' ' B' ' 281' ' ' ALA . 2.5 mp -139.18 147.04 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . 0.582 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 7.1 t0 -118.51 164.03 15.89 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.862 -1.149 . . . . 0.0 110.362 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.52 ' NE2' HD11 ' A' ' 115' ' ' LEU . 1.7 t60 -113.8 175.99 5.23 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' PHE . . . . . 0.641 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -150.09 141.52 23.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.014 -1.054 . . . . 0.0 110.922 -178.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.522 ' CB ' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -130.24 105.97 8.27 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 303' ' ' PHE . . . . . 0.626 ' CZ ' ' CG2' ' B' ' 210' ' ' VAL . 0.4 OUTLIER -89.29 179.15 6.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.593 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 304' ' ' ASN . . . . . 0.518 ' OD1' ' CG2' ' B' ' 310' ' ' VAL . 0.5 OUTLIER -139.54 7.87 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 0.0 109.617 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 305' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . 150.39 -68.22 0.34 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 306' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 164.83 76.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -1.135 . . . . 0.0 109.541 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.32 -35.74 0.02 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -165.84 -174.82 3.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -1.119 . . . . 0.0 109.39 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 309' ' ' VAL . . . . . 0.505 HG21 ' CG1' ' B' ' 210' ' ' VAL . 40.4 t -104.36 149.87 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 109.025 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.518 ' CG2' ' OD1' ' B' ' 304' ' ' ASN . 38.8 t -122.97 -22.48 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.008 . . . . 0.0 109.691 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 311' ' ' SER . . . . . 0.522 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -151.09 156.28 40.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.97 . . . . 0.0 109.494 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 312' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 17.8 ttp -160.16 148.07 16.65 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.2 -0.937 . . . . 0.0 109.811 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 313' ' ' ARG . . . . . 0.464 ' O ' ' OD1' ' B' ' 299' ' ' ASP . 0.1 OUTLIER -130.24 175.01 9.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.42 -0.8 . . . . 0.0 108.955 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 314' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' B' ' 299' ' ' ASP . . . -142.68 145.34 33.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 109.662 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 315' ' ' LEU . . . . . 0.513 ' HA ' ' CG1' ' B' ' 240' ' ' VAL . 0.1 OUTLIER -136.64 139.76 42.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.893 . . . . 0.0 109.417 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 316' ' ' PHE . . . . . 0.549 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 31.0 p90 173.13 -160.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 317' ' ' GLY . . . . . 0.536 ' O ' ' CD1' ' B' ' 321' ' ' ILE . . . 157.4 -174.87 34.89 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 318' ' ' GLU . . . . . 0.435 ' HA ' HD12 ' B' ' 321' ' ' ILE . 67.1 tt0 -54.21 -17.84 3.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 109.57 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.39 -28.26 27.08 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.852 0.835 . . . . 0.0 109.533 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 320' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -91.79 -30.33 16.28 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.357 0.599 . . . . 0.0 109.401 -179.536 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 321' ' ' ILE . . . . . 0.537 HG21 ' CG2' ' B' ' 295' ' ' VAL . 1.4 mt -87.0 -171.54 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 322' ' ' HIS . . . . . 0.483 ' HB3' HG13 ' B' ' 294' ' ' VAL . 0.1 OUTLIER -151.02 163.01 39.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.037 -1.039 . . . . 0.0 109.922 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.543 ' HA ' ' CG2' ' B' ' 293' ' ' THR . . . -155.62 119.07 4.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -172.81 -174.3 39.89 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 325' ' ' ALA . . . . . 0.428 ' HA ' ' HG2' ' B' ' 291' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.338 -1.095 . . . . 0.0 109.432 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' NTH . . . . . 0.734 H112 ' OG ' ' A' ' 58' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 326' ' ' NTH . . . . . 0.596 ' H62' ' OD2' ' B' ' 238' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.463 ' HG2' ' OD1' ' A' ' 2' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.332 0.587 . . . . 0.0 110.189 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.463 ' OD1' ' HG2' ' A' ' 1' ' ' MET . 1.7 m120 -156.25 108.18 2.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -0.918 . . . . 0.0 109.391 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.491 ' CG2' ' O ' ' A' ' 3' ' ' THR . 9.0 t -90.15 108.48 26.58 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.858 . . . . 0.0 109.504 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.461 ' O ' ' OG1' ' A' ' 8' ' ' THR . 45.2 Cg_endo -72.26 -10.11 25.27 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.923 1.486 . . . . 0.0 110.112 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -52.85 59.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.343 -0.848 . . . . 0.0 109.416 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -63.4 -52.21 62.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.39 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.56 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 8.6 mtt -65.49 -9.66 27.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.356 -0.84 . . . . 0.0 109.684 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 4' ' ' PRO . 13.1 m -86.64 -39.56 15.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.298 -0.876 . . . . 0.0 109.428 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.27 -47.58 83.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.952 . . . . 0.0 109.349 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.564 ' CG1' ' CE1' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -48.03 -24.13 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 108.778 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.527 HG12 ' CG2' ' A' ' 71' ' ' VAL . 12.5 t -86.26 -42.56 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 109.538 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 13' ' ' ARG . 14.6 tt0 -61.23 -74.15 0.09 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.231 1.015 . . . . 0.0 108.323 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.558 ' NH2' ' CD1' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -42.75 -44.49 4.4 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.958 0.885 . . . . 0.0 108.711 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -51.39 -49.59 61.26 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.608 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -81.51 -41.37 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.398 -0.814 . . . . 0.0 109.362 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.23 -37.04 15.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.757 -1.214 . . . . 0.0 107.736 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.482 ' CB ' ' OD1' ' A' ' 22' ' ' ASP . . . -73.83 -32.09 63.53 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.644 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 0.8 OUTLIER -65.42 -56.57 11.78 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.01 -42.47 38.09 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.582 0.706 . . . . 0.0 109.312 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.528 ' CB ' ' OD2' ' A' ' 22' ' ' ASP . . . -89.22 -6.73 56.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.518 -0.739 . . . . 0.0 109.705 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . 62.43 21.31 62.19 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.528 ' OD2' ' CB ' ' A' ' 20' ' ' ALA . 1.5 p30 -89.35 68.56 7.98 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.994 -1.297 . . . . 0.0 109.732 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.608 ' CD1' ' HB3' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -46.54 -35.55 5.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.249 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 22' ' ' ASP . 8.5 p-10 -41.92 -34.79 0.73 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.46 -32.27 16.67 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' LEU . 40.5 mt -62.67 -56.66 16.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.481 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 49.2 t -56.83 -34.29 43.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.3 -55.7 25.68 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.558 ' CD1' ' NH2' ' A' ' 13' ' ' ARG . 3.5 tp -62.99 -21.92 66.48 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' ALA . 9.4 m-30 -87.63 138.69 31.25 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -50.59 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 109.726 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.2 -24.39 62.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.594 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.547 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 4.6 p-10 -150.16 53.49 0.91 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.561 ' N ' ' CD1' ' A' ' 51' ' ' ILE . . . -65.78 151.86 45.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 109.653 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 46' ' ' SER . 0.2 OUTLIER -92.89 145.99 23.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 109.256 179.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 53.2 t -137.98 116.6 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.103 -0.998 . . . . 0.0 109.711 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 3.1 mm-40 -89.2 110.91 21.6 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.502 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 9.7 t70 -178.86 143.98 0.43 Allowed Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.702 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 48.9 Cg_endo -74.13 -168.27 6.08 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.258 -1.976 . . . . 0.0 110.925 -0.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.589 ' CG2' ' CG1' ' B' ' 274' ' ' VAL . 32.7 m -80.53 50.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.8 . . . . 0.0 109.351 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.37 34.18 0.05 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.517 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -153.54 -148.06 0.24 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.445 -1.032 . . . . 0.0 109.144 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -125.47 140.25 35.9 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.997 -1.065 . . . . 0.0 110.073 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.527 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 37.9 Cg_endo -63.58 -176.0 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.276 1.672 . . . . 0.0 111.051 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -150.87 108.15 3.61 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -89.17 151.82 21.96 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.167 -178.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 33' ' ' ASP . . . 110.45 158.04 16.12 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.8 m -67.04 -51.36 55.73 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.13 -1.218 . . . . 0.0 109.146 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -58.4 -41.47 84.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.227 -0.921 . . . . 0.0 109.08 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 45' ' ' ARG . . . -67.31 -57.51 6.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.153 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 34' ' ' ALA . 23.5 mt -55.02 -47.89 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.575 ' CG ' ' CD2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -69.14 -57.87 4.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.118 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 37.4 tt0 -45.59 -30.01 1.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.053 -1.03 . . . . 0.0 108.839 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.502 ' CZ ' ' O ' ' A' ' 38' ' ' ASP . 1.3 t80 -82.44 -69.5 0.62 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.608 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -48.58 -36.08 14.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.76 -47.33 75.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 109.039 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 23.1 t-20 -57.51 -41.45 80.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.32 -0.862 . . . . 0.0 108.921 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.459 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 11.9 t -65.43 -32.34 73.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.348 -0.845 . . . . 0.0 109.005 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.456 ' CD2' ' O ' ' A' ' 21' ' ' GLY . 8.1 tp -67.02 -19.6 65.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -57.25 -22.54 42.03 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.6 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -89.62 119.39 69.52 Favored Pre-proline 0 C--N 1.306 -1.324 0 O-C-N 121.189 -0.944 . . . . 0.0 108.528 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 49.1 Cg_endo -74.94 106.86 2.35 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.768 1.404 . . . . 0.0 110.762 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.6 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -138.84 163.08 33.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 110.055 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.527 ' CB ' ' OG ' ' A' ' 85' ' ' SER . . . -97.26 124.01 41.23 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.425 HG13 HG21 ' A' ' 15' ' ' VAL . 48.6 t -107.4 114.15 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.908 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 67' ' ' LEU . 6.2 tt0 -150.34 101.31 2.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 109.195 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 82' ' ' PHE . 1.9 mp -44.97 170.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.864 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.9 p -133.41 -36.51 0.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.742 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 70' ' ' GLU . 1.2 pt20 -101.38 -145.18 0.35 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.512 -0.743 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 69' ' ' GLN . 26.9 tt0 -110.78 133.03 53.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 109.513 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.527 ' CG2' HG12 ' A' ' 11' ' ' VAL . 28.5 t -58.03 154.71 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.342 -0.849 . . . . 0.0 109.412 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 1.9 mpt_? -121.01 130.2 53.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.516 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -150.5 120.39 7.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.629 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -122.44 -161.32 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 109.672 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 76' ' ' ASN . . . -81.73 144.88 30.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.444 -0.785 . . . . 0.0 110.216 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 75' ' ' ALA . 1.3 t-20 80.95 -44.18 0.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.733 -0.605 . . . . 0.0 110.422 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -144.39 -159.93 1.06 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.961 -1.087 . . . . 0.0 110.412 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.517 ' CB ' ' HB3' ' A' ' 101' ' ' PHE . . . -169.21 163.15 10.9 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.594 ' CB ' ' CD2' ' B' ' 315' ' ' LEU . . . -149.4 138.78 21.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.91 -1.118 . . . . 0.0 109.962 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 29.7 p90 -150.34 167.48 26.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.023 -1.048 . . . . 0.0 109.384 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.529 ' CB ' HG21 ' A' ' 98' ' ' ILE . . . -139.94 -169.68 2.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 110.518 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.639 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 0.0 OUTLIER 172.84 -175.11 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.96 141.22 51.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.248 -0.908 . . . . 0.0 109.592 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.533 HG11 ' CB ' ' A' ' 63' ' ' LEU . 14.2 t -108.95 115.53 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.277 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.527 ' OG ' ' CB ' ' A' ' 64' ' ' ALA . 21.8 p -112.11 106.4 15.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.12 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.77 ' CZ ' H222 ' A' ' 126' ' ' NTH . 6.6 p90 -125.62 176.26 7.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.743 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -121.28 164.77 16.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.596 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.584 ' CE1' ' CE1' ' A' ' 86' ' ' PHE . 0.9 OUTLIER -115.58 -92.3 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.649 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -137.42 -36.21 0.65 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.864 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.78 -28.12 1.19 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 45.5 mtt85 -126.64 -179.51 4.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -1.184 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -127.6 122.43 33.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.679 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 19.3 m -96.55 172.15 8.1 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.344 -0.847 . . . . 0.0 109.559 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.528 HG12 ' CB ' ' A' ' 122' ' ' HIS . 14.0 p -148.0 170.99 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 108.715 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.551 HG11 ' HD3' ' A' ' 97' ' ' PRO . 43.9 t -148.22 156.78 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.079 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.516 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -135.28 75.27 59.54 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.457 -0.777 . . . . 0.0 109.339 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.551 ' HD3' HG11 ' A' ' 95' ' ' VAL . 45.7 Cg_endo -98.19 178.48 0.39 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.789 1.659 . . . . 0.0 111.539 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.529 HG21 ' CB ' ' A' ' 81' ' ' ALA . 2.8 mp -137.93 151.93 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 13.5 t0 -122.8 164.48 18.3 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.941 -1.1 . . . . 0.0 110.203 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.552 ' CE1' HD11 ' B' ' 315' ' ' LEU . 0.1 OUTLIER -112.16 172.15 7.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 109.236 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.564 ' CE1' ' CG1' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -147.28 140.86 25.54 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.24 -0.912 . . . . 0.0 110.374 -178.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.467 ' HA ' ' HG3' ' A' ' 77' ' ' GLU . 1.4 ttt180 -130.31 110.42 11.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.871 . . . . 0.0 109.121 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.56 ' CE2' ' HA ' ' A' ' 7' ' ' MET . 0.6 OUTLIER -89.73 176.15 6.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.333 -0.855 . . . . 0.0 109.664 -179.511 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.542 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -114.03 -36.39 4.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.298 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . 176.54 -46.07 0.11 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 163.29 76.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -1.169 . . . . 0.0 109.593 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.0 -45.44 0.04 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.83 -169.43 2.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -1.133 . . . . 0.0 109.292 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.519 ' CG1' ' N ' ' A' ' 110' ' ' VAL . 54.5 t -94.04 166.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.209 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.542 ' CG2' ' HB3' ' A' ' 104' ' ' ASN . 10.8 t -131.76 -63.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -0.958 . . . . 0.0 109.745 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.458 ' HB2' ' HD3' ' A' ' 102' ' ' ARG . 3.2 m -128.18 171.05 12.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.946 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.511 ' CE ' ' OD2' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -151.75 147.53 26.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.42 -0.8 . . . . 0.0 109.081 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.459 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -121.36 162.18 20.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.568 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -111.01 133.48 53.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.848 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.65 ' O ' ' CD1' ' A' ' 116' ' ' PHE . 9.3 tp -109.48 -143.47 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.808 . . . . 0.0 108.957 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.65 ' CD1' ' O ' ' A' ' 115' ' ' LEU . 26.2 p90 39.0 -161.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.725 0.774 . . . . 0.0 110.481 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.578 ' N ' ' CD2' ' A' ' 116' ' ' PHE . . . 179.4 -149.37 8.67 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.438 ' C ' HG12 ' A' ' 121' ' ' ILE . 21.5 tt0 -80.69 -1.98 44.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -1.155 . . . . 0.0 109.412 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE2' ' CG ' ' B' ' 204' ' ' PRO . 5.7 tttm -93.19 -26.94 17.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 122.064 0.935 . . . . 0.0 108.921 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -88.55 17.7 5.2 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.349 0.595 . . . . 0.0 109.437 -179.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.522 HG21 ' CG2' ' A' ' 95' ' ' VAL . 5.2 mm -90.01 -174.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.528 ' CB ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -150.87 173.6 14.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.962 -1.086 . . . . 0.0 109.899 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -152.34 110.36 3.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.409 -0.807 . . . . 0.0 109.29 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.37 115.07 3.95 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.328 -1.101 . . . . 0.0 109.47 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.498 ' O ' ' CG ' ' B' ' 201' ' ' MET . 1.4 ptt? . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.256 0.551 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' B' ' 203' ' ' THR . 0.7 OUTLIER -127.09 64.91 1.3 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' THR . . . . . 0.412 ' C ' ' O ' ' B' ' 202' ' ' ASN . 5.0 t -43.92 109.1 0.77 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.476 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' PRO . . . . . 0.494 ' CG ' ' HE2' ' A' ' 119' ' ' LYS . 44.5 Cg_endo -71.42 -4.11 14.33 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.957 1.504 . . . . 0.0 110.264 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -45.88 56.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.196 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -51.41 67.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.362 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' MET . . . . . 0.455 ' HE1' ' O ' ' B' ' 275' ' ' ALA . 12.5 mtm -59.81 -51.15 70.97 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.242 -0.911 . . . . 0.0 109.487 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.472 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 8.2 m -53.26 -33.02 51.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 109.193 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.55 -46.23 66.7 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.051 -1.031 . . . . 0.0 108.405 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.612 HG13 ' CE2' ' B' ' 301' ' ' PHE . 0.9 OUTLIER -53.48 -43.24 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.526 ' CG1' HG23 ' B' ' 271' ' ' VAL . 11.3 t -59.4 -41.72 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.594 -0.691 . . . . 0.0 109.834 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' B' ' 213' ' ' ARG . 9.7 tt0 -60.47 -75.26 0.06 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' B' ' 212' ' ' GLN . 0.6 OUTLIER -43.83 -44.38 6.8 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' TYR . . . . . 0.633 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 3.8 t80 -53.71 -49.25 68.5 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.604 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 0.9 OUTLIER -83.25 -44.36 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.406 -0.809 . . . . 0.0 109.832 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.0 -37.04 8.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 0.0 108.022 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -74.1 -34.68 64.03 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.633 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 5.2 mt -63.29 -59.91 4.1 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . 0.414 ' ND2' ' OE1' ' B' ' 266' ' ' GLU . 16.4 t30 -51.01 -45.6 61.26 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.565 0.697 . . . . 0.0 109.289 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.38 9.68 25.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.572 -0.705 . . . . 0.0 109.511 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' B' ' 217' ' ' ALA . . . 48.06 32.21 8.98 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' B' ' 217' ' ' ALA . 12.5 t70 -89.99 66.49 6.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -1.117 . . . . 0.0 109.743 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' LEU . . . . . 0.565 ' CD1' ' HB3' ' B' ' 255' ' ' PHE . 5.9 tp -47.58 -42.38 23.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 108.736 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' B' ' 223' ' ' LEU . 3.4 m-20 -42.28 -31.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' B' ' 228' ' ' ALA . . . -88.14 -38.71 7.18 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.574 HD13 ' CD2' ' B' ' 255' ' ' PHE . 17.1 mt -58.23 -53.36 47.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.516 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 85.0 t -57.17 -37.99 58.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' B' ' 225' ' ' GLY . . . -58.33 -54.82 42.67 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.533 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 8.5 tp -63.32 -20.48 65.53 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . 0.623 ' CD2' ' CG2' ' B' ' 251' ' ' ILE . 0.6 OUTLIER -82.71 132.08 35.19 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.492 -0.755 . . . . 0.0 109.502 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -51.04 -177.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.268 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -25.89 66.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 109.885 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.536 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 13.4 p-10 -150.61 53.84 0.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.62 -0.675 . . . . 0.0 109.341 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' B' ' 310' ' ' VAL . . . -62.19 165.55 5.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.742 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' THR . . . . . 0.529 ' CG2' ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -116.25 140.78 48.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.22 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.51 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 38.9 t -130.11 117.8 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -0.885 . . . . 0.0 109.126 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' GLU . . . . . 0.541 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 27.7 mt-10 -88.84 106.98 18.73 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' ASP . . . . . 0.455 ' CG ' ' HA ' ' B' ' 239' ' ' PRO . 9.8 t70 -176.03 142.17 0.61 Allowed Pre-proline 0 C--N 1.3 -1.577 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.597 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' B' ' 238' ' ' ASP . 47.2 Cg_endo -73.74 -165.09 3.61 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.216 -1.993 . . . . 0.0 110.685 0.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.491 HG21 HG13 ' A' ' 74' ' ' VAL . 5.5 m -87.8 41.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 109.345 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -165.71 26.01 0.17 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' SER . . . . . 0.433 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 1.4 m -148.01 -141.82 0.12 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.415 -1.05 . . . . 0.0 108.913 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . 0.401 ' HG2' ' C ' ' B' ' 242' ' ' SER . 8.2 mm-40 -133.72 142.35 43.39 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.914 -1.116 . . . . 0.0 109.954 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' PRO . . . . . 0.541 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.8 Cg_endo -63.39 -170.86 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.284 1.676 . . . . 0.0 111.436 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.47 ' O ' HD13 ' B' ' 251' ' ' ILE . 0.0 OUTLIER -151.09 111.5 4.18 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.529 ' HB3' ' CG2' ' B' ' 235' ' ' THR . 1.9 p -94.04 155.28 17.2 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.101 -0.999 . . . . 0.0 110.452 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.21 162.32 21.78 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 6.5 m -73.7 -44.91 55.18 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.185 -1.185 . . . . 0.0 109.093 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -64.26 -20.25 65.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.244 -0.91 . . . . 0.0 109.207 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' B' ' 254' ' ' PHE . . . -90.15 -54.43 4.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.352 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.623 ' CG2' ' CD2' ' B' ' 230' ' ' PHE . 6.4 mm -54.97 -44.58 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' ARG . . . . . 0.516 ' HB2' ' CG2' ' B' ' 227' ' ' VAL . 17.8 ttt85 -73.34 -56.03 5.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.212 -0.93 . . . . 0.0 108.807 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 17.7 tt0 -45.94 -27.92 1.01 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.024 . . . . 0.0 108.546 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 1.0 OUTLIER -85.79 -70.94 0.56 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.574 ' CD2' HD13 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -48.45 -23.97 1.12 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . 0.531 ' CB ' HD21 ' B' ' 223' ' ' LEU . . . -80.49 -51.16 9.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 108.898 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 0.2 OUTLIER -56.62 -35.02 67.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' SER . . . . . 0.614 ' OG ' H111 ' B' ' 326' ' ' NTH . 1.6 t -74.81 -38.6 62.04 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' B' ' 255' ' ' PHE . 8.6 tp -62.22 -29.47 70.41 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.373 -0.829 . . . . 0.0 109.02 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 14.7 mttm -44.35 -27.11 0.4 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' LEU . . . . . 0.559 ' CD2' HD23 ' B' ' 263' ' ' LEU . 3.3 tt -89.69 113.85 58.37 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 48.7 Cg_endo -73.59 107.27 2.36 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.915 1.481 . . . . 0.0 112.176 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.559 HD23 ' CD2' ' B' ' 261' ' ' LEU . 0.8 OUTLIER -130.24 -170.28 2.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.398 -0.814 . . . . 0.0 109.43 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' B' ' 285' ' ' SER . . . -119.9 128.0 53.22 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . 0.439 ' CG1' HG21 ' B' ' 215' ' ' VAL . 43.0 t -115.43 113.25 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.055 -1.028 . . . . 0.0 110.037 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.3 tp10 -150.31 94.16 2.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.417 -0.802 . . . . 0.0 108.942 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.4 mp -46.89 175.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 0.0 110.004 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 268' ' ' THR . . . . . 0.456 ' O ' ' O ' ' B' ' 269' ' ' GLN . 41.7 p -133.57 -76.28 0.48 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.46 -0.775 . . . . 0.0 108.951 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 269' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' B' ' 268' ' ' THR . 3.4 pt20 -61.07 -143.7 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 24.4 tt0 -115.76 131.31 56.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 109.872 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' B' ' 280' ' ' PHE . 83.0 t -45.41 146.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.386 -0.822 . . . . 0.0 109.042 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.519 ' N ' HG11 ' B' ' 271' ' ' VAL . 0.3 OUTLIER -102.08 82.19 2.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.696 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -89.38 145.03 25.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.115 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 274' ' ' VAL . . . . . 0.589 ' CG1' ' CG2' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -122.43 -169.02 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.156 -0.965 . . . . 0.0 109.924 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . 0.455 ' O ' ' HE1' ' B' ' 207' ' ' MET . . . -38.39 -94.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.574 -0.704 . . . . 0.0 110.787 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 276' ' ' ASN . . . . . 0.451 ' O ' ' OD1' ' B' ' 276' ' ' ASN . 21.8 t-20 -92.76 -28.24 16.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.115 -0.991 . . . . 0.0 110.621 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . 0.505 ' CG ' ' HG3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -92.74 -166.6 1.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.952 -1.092 . . . . 0.0 109.575 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 278' ' ' ALA . . . . . 0.484 ' CB ' ' HB2' ' B' ' 301' ' ' PHE . . . -160.69 161.14 32.22 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.468 -0.77 . . . . 0.0 109.571 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 279' ' ' ALA . . . . . 0.543 ' CB ' ' CD1' ' A' ' 115' ' ' LEU . . . -150.9 131.13 13.58 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . 0.592 ' CE1' ' HB3' ' B' ' 299' ' ' ASP . 41.8 p90 -147.55 159.53 43.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.797 -1.19 . . . . 0.0 110.491 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.533 ' CB ' HG21 ' B' ' 298' ' ' ILE . . . -139.57 160.88 38.85 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.406 0.622 . . . . 0.0 109.375 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 282' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 3.8 p90 -162.29 -168.34 1.84 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 108.982 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.27 139.78 53.59 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.713 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 284' ' ' VAL . . . . . 0.526 ' CG1' ' CD2' ' B' ' 263' ' ' LEU . 42.0 t -107.83 114.7 47.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 285' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' B' ' 264' ' ' ALA . 96.9 p -115.5 98.99 7.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.955 . . . . 0.0 110.119 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.671 ' CE1' H221 ' B' ' 326' ' ' NTH . 30.0 p90 -108.75 -171.86 1.94 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 108.815 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.45 153.1 33.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.98 -1.075 . . . . 0.0 109.809 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.527 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.1 OUTLIER -105.55 -163.91 0.98 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.43 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -40.58 92.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.924 . . . . 0.0 109.972 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -139.65 4.51 2.75 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.148 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -140.82 -176.25 4.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -1.186 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 292' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -118.75 140.98 49.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.178 -0.952 . . . . 0.0 109.305 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 293' ' ' THR . . . . . 0.584 ' HB ' ' CE1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -125.32 146.04 49.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.406 -0.809 . . . . 0.0 109.433 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 294' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' B' ' 284' ' ' VAL . 7.9 p -125.28 171.89 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.143 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.535 HG13 ' HG3' ' B' ' 297' ' ' PRO . 2.8 t -149.43 146.98 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 109.065 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 296' ' ' ALA . . . . . 0.53 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -125.84 71.32 67.77 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.179 -0.951 . . . . 0.0 111.266 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 297' ' ' PRO . . . . . 0.535 ' HG3' HG13 ' B' ' 295' ' ' VAL . 53.3 Cg_endo -93.24 179.68 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.593 1.312 . . . . 0.0 110.996 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.533 HG21 ' CB ' ' B' ' 281' ' ' ALA . 3.0 mp -141.38 148.81 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . 0.592 ' HB3' ' CE1' ' B' ' 280' ' ' PHE . 17.2 t0 -121.38 157.52 30.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.958 -1.089 . . . . 0.0 110.401 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.562 ' CD2' HD12 ' A' ' 115' ' ' LEU . 3.0 t-160 -113.73 151.7 31.54 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 301' ' ' PHE . . . . . 0.612 ' CE2' HG13 ' B' ' 210' ' ' VAL . 0.5 OUTLIER -126.91 151.86 47.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.271 -0.893 . . . . 0.0 110.828 -178.271 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.505 ' HG3' ' CG ' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -146.27 93.56 2.33 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 303' ' ' PHE . . . . . 0.6 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 8.2 m-30 -89.81 -165.55 1.37 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.126 -0.984 . . . . 0.0 109.962 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 304' ' ' ASN . . . . . 0.537 ' OD1' ' CG1' ' B' ' 310' ' ' VAL . 0.4 OUTLIER -140.15 27.22 2.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.427 -0.796 . . . . 0.0 109.437 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . 119.54 -61.08 0.49 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . 179.67 33.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -1.127 . . . . 0.0 109.272 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 307' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' B' ' 308' ' ' LYS . . . -108.35 33.3 6.33 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 308' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' B' ' 307' ' ' GLY . 0.3 OUTLIER 83.51 -162.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.972 -0.722 . . . . 0.0 109.164 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 309' ' ' VAL . . . . . 0.546 ' CG2' HG12 ' B' ' 210' ' ' VAL . 49.7 t -90.5 143.81 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.384 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.537 ' CG1' ' OD1' ' B' ' 304' ' ' ASN . 0.1 OUTLIER -126.19 -27.1 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.102 -0.999 . . . . 0.0 109.991 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 311' ' ' SER . . . . . 0.496 ' CB ' ' HD3' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -143.41 164.04 31.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.109 -0.994 . . . . 0.0 109.374 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 312' ' ' MET . . . . . 0.472 ' O ' ' HG3' ' B' ' 237' ' ' GLU . 0.0 OUTLIER -160.38 155.85 25.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 313' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' B' ' 300' ' ' HIS . 0.0 OUTLIER -150.22 118.47 6.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.159 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -100.07 139.73 35.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 110.629 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 315' ' ' LEU . . . . . 0.594 ' CD2' ' CB ' ' A' ' 79' ' ' ALA . 3.7 tt -128.65 138.46 52.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.84 . . . . 0.0 109.335 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 316' ' ' PHE . . . . . 0.578 ' CD2' ' OD1' ' B' ' 320' ' ' ASN . 0.1 OUTLIER 172.51 -159.51 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 317' ' ' GLY . . . . . 0.487 ' O ' ' OD1' ' B' ' 320' ' ' ASN . . . 171.27 177.63 41.2 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.292 -1.433 . . . . 0.0 110.485 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 318' ' ' GLU . . . . . 0.504 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 47.9 tt0 -51.54 -21.41 2.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.201 -1.176 . . . . 0.0 108.931 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.14 -22.18 59.56 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.019 0.914 . . . . 0.0 108.726 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 320' ' ' ASN . . . . . 0.578 ' OD1' ' CD2' ' B' ' 316' ' ' PHE . 0.3 OUTLIER -88.51 1.51 54.7 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 321' ' ' ILE . . . . . 0.533 HG21 ' CG2' ' B' ' 295' ' ' VAL . 4.0 mm -89.89 179.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.121 -0.987 . . . . 0.0 108.504 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 322' ' ' HIS . . . . . 0.477 ' HB2' HG11 ' B' ' 294' ' ' VAL . 0.2 OUTLIER -151.51 177.42 10.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.967 -1.083 . . . . 0.0 109.807 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -155.23 126.67 7.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.462 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -120.88 120.95 4.66 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.224 -1.162 . . . . 0.0 109.495 -179.943 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' NTH . . . . . 0.77 H222 ' CZ ' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 326' ' ' NTH . . . . . 0.671 H221 ' CE1' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.446 ' O ' ' C ' ' A' ' 2' ' ' ASN . 7.4 mtt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.126 0.489 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.456 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.4 p-10 39.85 61.11 1.53 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.516 -0.74 . . . . 0.0 109.677 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.454 ' O ' ' HE2' ' A' ' 7' ' ' MET . 0.8 OUTLIER -83.62 110.37 24.36 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 44.2 Cg_endo -71.3 -3.5 13.07 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.854 1.449 . . . . 0.0 110.285 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -61.88 -39.22 91.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.257 -0.902 . . . . 0.0 109.292 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -86.93 -43.99 11.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.335 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.454 ' HE2' ' O ' ' A' ' 3' ' ' THR . 25.6 mtt -56.94 -35.87 69.59 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.261 -0.899 . . . . 0.0 109.542 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 11' ' ' VAL . 11.2 m -67.41 -39.16 85.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -43.66 62.77 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.639 ' CG1' ' CZ ' ' A' ' 101' ' ' PHE . 1.3 t -53.96 -22.64 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.569 HG21 ' CD1' ' A' ' 80' ' ' PHE . 4.3 t -90.12 -41.35 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 108.979 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.3 tt0 -65.5 -74.18 0.11 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.496 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . 2.2 mtt85 -42.27 -45.46 4.2 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.547 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -46.1 -43.73 15.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.095 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.603 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 1.4 t -90.34 -37.24 9.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.544 -0.722 . . . . 0.0 109.136 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -49.26 -34.91 16.29 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HB3' HG13 ' A' ' 26' ' ' ILE . . . -74.73 -33.3 62.34 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.603 ' CD1' ' HA ' ' A' ' 15' ' ' VAL . 3.8 mt -65.96 -58.85 4.6 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.75 -41.86 24.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.621 0.724 . . . . 0.0 109.251 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.85 7.98 31.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.548 ' CA ' HD23 ' A' ' 59' ' ' LEU . . . 47.94 31.94 8.43 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -100.17 92.99 5.48 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.324 -1.104 . . . . 0.0 109.755 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.569 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 3.4 mm? -59.17 -15.27 13.82 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.224 -0.923 . . . . 0.0 109.529 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -62.23 -54.14 45.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 109.178 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 28' ' ' ALA . . . -63.12 -35.68 92.41 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.568 HG22 ' CD1' ' A' ' 55' ' ' PHE . 8.8 mt -62.8 -56.45 17.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 52' ' ' ARG . 95.7 t -63.72 -37.9 80.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.468 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . . . -60.82 -50.28 74.1 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.496 ' CD2' ' HB3' ' A' ' 13' ' ' ARG . 7.7 tp -66.08 -23.32 66.5 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.4 ' O ' ' O ' ' A' ' 31' ' ' ALA . 3.6 m-85 -88.4 141.1 28.81 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.562 -0.711 . . . . 0.0 109.655 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 109' ' ' VAL . . . -48.5 172.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 109.458 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.455 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -63.29 -24.1 67.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 109.294 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.537 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 20.4 p-10 -146.58 35.12 0.95 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.566 ' N ' ' CD1' ' A' ' 51' ' ' ILE . . . -51.01 169.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.822 . . . . 0.0 109.772 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.496 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -122.76 140.31 53.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.541 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 44' ' ' PRO . 48.2 t -131.49 120.66 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.262 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.529 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 3.4 mt-10 -88.46 107.0 18.64 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.569 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 9.1 t0 -179.78 143.29 0.37 Allowed Pre-proline 0 C--N 1.302 -1.486 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.547 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.479 ' HA ' ' CG ' ' A' ' 38' ' ' ASP . 50.1 Cg_endo -76.25 -175.14 15.86 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.205 -1.998 . . . . 0.0 110.403 -0.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.569 HG12 ' CE1' ' A' ' 116' ' ' PHE . 19.8 m -72.58 150.89 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 108.875 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.35 -1.76 69.48 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.463 ' OG ' ' HG2' ' A' ' 39' ' ' PRO . 1.4 m -115.46 -142.3 0.38 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.27 -1.135 . . . . 0.0 109.308 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.24 141.76 16.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.987 -1.071 . . . . 0.0 110.048 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 39.6 Cg_endo -65.56 -175.44 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.817 1.678 . . . . 0.0 111.592 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.575 ' HB2' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -150.78 106.86 3.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.496 ' HB2' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.28 157.01 18.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.276 -0.89 . . . . 0.0 110.601 -178.35 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 106.3 157.18 21.69 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 7.3 m -64.55 -55.26 21.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.243 -1.151 . . . . 0.0 109.138 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -55.27 -33.02 62.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.89 . . . . 0.0 109.009 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' HB3' ' CG ' ' A' ' 45' ' ' ARG . . . -77.46 -60.52 2.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.383 -0.823 . . . . 0.0 109.357 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 34' ' ' ALA . 44.5 mt -48.08 -40.9 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.267 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HB2' HG23 ' A' ' 27' ' ' VAL . 49.2 ttp180 -79.1 -58.39 3.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.814 . . . . 0.0 109.124 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.532 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 49.8 tt0 -46.2 -27.37 0.97 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.021 -1.05 . . . . 0.0 108.619 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -85.02 -71.36 0.53 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.568 ' CD1' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -49.31 -33.01 12.21 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.433 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . . . -69.12 -46.82 66.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 108.78 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 26.9 t-20 -58.41 -35.45 72.09 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.712 ' OG ' ' H12' ' A' ' 126' ' ' NTH . 25.6 t -64.93 -38.09 89.82 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.569 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 7.6 tp -68.78 -22.04 64.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.486 -0.759 . . . . 0.0 109.68 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 25.9 mtpt -50.39 -26.37 4.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 109.692 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.614 HD12 H212 ' A' ' 126' ' ' NTH . 0.5 OUTLIER -89.71 126.7 56.96 Favored Pre-proline 0 C--N 1.305 -1.349 0 O-C-N 121.226 -0.921 . . . . 0.0 109.049 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.441 ' C ' ' HG ' ' A' ' 63' ' ' LEU . 44.0 Cg_endo -71.49 101.62 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.834 1.439 . . . . 0.0 110.371 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.581 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -138.64 155.86 47.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.462 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.79 132.66 35.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 108.778 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 18' ' ' LEU . 16.2 t -107.22 125.02 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.048 -1.033 . . . . 0.0 110.127 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' LEU . 14.8 tt0 -150.26 103.12 3.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.44 -0.788 . . . . 0.0 108.961 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 68' ' ' THR . 3.8 mt -55.09 -108.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 110.062 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.668 ' O ' ' N ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER 158.26 43.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.555 ' CG ' ' O ' ' A' ' 68' ' ' THR . 5.1 pt20 50.64 -54.02 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' A' ' 68' ' ' THR . 23.1 tt0 -60.77 116.19 4.23 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.624 -1.297 . . . . 0.0 110.761 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.454 HG21 HG12 ' A' ' 11' ' ' VAL . 35.8 t -135.3 163.54 35.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -132.03 135.12 46.28 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.454 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' N ' ' NE ' ' A' ' 72' ' ' ARG . . . -145.44 111.63 5.66 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.55 HG22 ' NH2' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -100.11 -163.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 110.429 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -35.69 -94.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.771 -0.581 . . . . 0.0 111.241 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 8.1 t-20 -100.32 -2.9 32.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.07 -1.019 . . . . 0.0 110.748 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.515 ' OE1' ' NE ' ' B' ' 313' ' ' ARG . 0.4 OUTLIER -111.29 -162.03 0.78 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.769 -1.207 . . . . 0.0 109.719 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 101' ' ' PHE . . . -176.09 162.14 2.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.602 -0.686 . . . . 0.0 109.372 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.555 ' O ' ' CB ' ' A' ' 72' ' ' ARG . . . -150.17 130.09 13.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.172 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 31.4 p90 -150.83 168.79 23.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.678 -1.263 . . . . 0.0 109.948 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.546 ' CB ' HG21 ' A' ' 98' ' ' ILE . . . -141.8 -178.3 5.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.472 -0.767 . . . . 0.0 109.862 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.53 ' CB ' ' HA ' ' A' ' 67' ' ' LEU . 1.9 p90 -172.65 -159.25 0.12 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.386 -0.821 . . . . 0.0 109.257 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.86 149.43 43.41 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.083 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.475 HG12 HD22 ' A' ' 63' ' ' LEU . 55.6 t -124.77 112.51 32.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.509 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -113.5 103.9 11.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.902 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.68 ' CZ ' H221 ' A' ' 126' ' ' NTH . 45.6 p90 -123.1 164.77 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.393 -0.817 . . . . 0.0 108.931 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 38.0 tt0 -141.46 152.25 44.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.059 -1.026 . . . . 0.0 109.83 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.425 ' N ' ' HG2' ' A' ' 87' ' ' GLU . 7.3 m-85 -93.61 -146.4 0.24 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.419 -0.801 . . . . 0.0 109.297 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -0.72 30.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.958 . . . . 0.0 109.719 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.71 -68.63 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 1.6 ttt85 -55.49 155.11 5.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -1.137 . . . . 0.0 109.557 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -131.71 120.43 22.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.757 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -121.46 143.26 49.34 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER -117.37 179.52 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.103 -0.998 . . . . 0.0 108.74 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.56 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 3.0 t -148.15 146.5 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.07 -1.019 . . . . 0.0 109.533 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.524 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -133.64 71.13 75.51 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.34 -0.85 . . . . 0.0 110.281 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.56 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 49.7 Cg_endo -95.46 -174.54 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.537 1.491 . . . . 0.0 110.973 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.546 HG21 ' CB ' ' A' ' 81' ' ' ALA . 2.9 mp -139.14 166.28 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 21.1 t0 -131.27 154.66 48.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.922 -1.111 . . . . 0.0 110.192 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.517 ' NE2' ' CD1' ' B' ' 315' ' ' LEU . 0.3 OUTLIER -108.77 172.75 6.66 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.639 ' CZ ' ' CG1' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -147.41 150.88 35.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.82 -1.175 . . . . 0.0 110.857 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.467 ' HD2' ' HB2' ' A' ' 111' ' ' SER . 0.0 OUTLIER -139.78 109.53 6.33 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.544 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -89.27 -166.12 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 109.777 -179.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.524 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -135.9 -38.71 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.439 -0.788 . . . . 0.0 109.34 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . -174.46 -47.67 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 163.2 77.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -1.094 . . . . 0.0 109.503 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -167.21 -67.94 0.03 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -139.78 -163.87 1.58 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.232 -1.158 . . . . 0.0 109.482 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.529 HG12 ' CE1' ' A' ' 101' ' ' PHE . 94.0 t -100.79 147.63 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.871 . . . . 0.0 109.337 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.524 ' CG2' ' HB3' ' A' ' 104' ' ' ASN . 93.2 t -111.9 -66.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 109.746 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.467 ' HB2' ' HD2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -116.25 166.25 12.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.055 -1.028 . . . . 0.0 109.736 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 100' ' ' HIS . 12.2 ttp -160.28 154.61 23.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.345 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.456 ' HD2' ' CB ' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -144.35 126.59 15.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.167 -0.958 . . . . 0.0 109.482 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.501 ' CB ' ' OD2' ' A' ' 38' ' ' ASP . . . -96.71 132.21 42.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 109.752 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.515 ' CD2' ' HB2' ' B' ' 279' ' ' ALA . 1.3 tt -117.92 143.84 45.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.002 . . . . 0.0 109.834 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.569 ' CE1' HG12 ' A' ' 40' ' ' VAL . 9.2 p90 172.54 -158.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . 169.53 -173.05 43.79 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.507 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 26.6 tt0 -72.79 -2.65 21.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.302 -1.117 . . . . 0.0 109.68 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -92.71 -30.96 15.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.997 0.903 . . . . 0.0 108.995 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.3 m-20 -89.11 11.38 18.69 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.679 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.525 ' CD1' ' O ' ' A' ' 117' ' ' GLY . 4.4 mm -92.66 -160.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.191 -0.943 . . . . 0.0 108.587 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.498 ' HB2' HG11 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -151.22 159.93 44.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.071 . . . . 0.0 109.795 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.478 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.66 81.74 1.03 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.371 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -119.19 140.16 14.82 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.207 -1.173 . . . . 0.0 109.454 179.889 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.405 ' O ' ' C ' ' B' ' 202' ' ' ASN . 5.1 mpp? . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.258 0.551 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.46 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 8.8 m120 45.33 44.48 9.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.436 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' THR . . . . . 0.497 ' CG2' ' HB2' ' B' ' 205' ' ' GLU . 5.3 m -89.59 108.64 26.46 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.4 Cg_endo -72.26 -2.48 11.73 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.973 1.512 . . . . 0.0 110.165 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . 0.497 ' HB2' ' CG2' ' B' ' 203' ' ' THR . 3.5 tt0 -58.92 -63.48 1.28 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -0.869 . . . . 0.0 109.353 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -61.98 -45.03 95.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.915 . . . . 0.0 109.51 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' MET . . . . . 0.424 ' HA ' ' CE2' ' B' ' 303' ' ' PHE . 73.3 mtm -60.9 -41.48 96.15 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.255 -0.903 . . . . 0.0 109.608 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.429 ' O ' ' N ' ' B' ' 211' ' ' VAL . 18.1 m -64.46 -44.08 92.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.946 . . . . 0.0 109.252 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.64 -43.73 57.19 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.581 HG12 ' CZ ' ' B' ' 303' ' ' PHE . 0.9 OUTLIER -53.57 -26.03 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.544 HG22 ' CD2' ' B' ' 301' ' ' PHE . 13.5 t -89.8 -43.27 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 108.984 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' B' ' 215' ' ' VAL . 5.7 tt0 -62.71 -73.98 0.1 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' B' ' 212' ' ' GLN . 1.4 mtt85 -42.21 -45.06 3.99 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' TYR . . . . . 0.639 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.3 OUTLIER -48.05 -43.13 30.04 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.28 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.601 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.16 -40.25 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.407 -0.808 . . . . 0.0 109.178 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.8 -37.24 13.17 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' B' ' 226' ' ' ILE . . . -72.97 -35.21 66.87 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.639 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 5.2 mt -63.84 -60.84 2.77 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -49.29 -40.36 34.37 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.532 0.682 . . . . 0.0 109.252 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.22 0.02 57.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.553 -0.717 . . . . 0.0 109.799 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.526 ' CA ' HD23 ' B' ' 259' ' ' LEU . . . 54.52 45.4 76.9 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.442 ' O ' HG13 ' B' ' 226' ' ' ILE . 45.7 t0 -111.14 83.75 1.82 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 110.061 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' B' ' 259' ' ' LEU . 3.9 mm? -53.31 -19.37 3.23 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.24 -0.913 . . . . 0.0 109.78 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.89 -56.94 11.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.235 -0.916 . . . . 0.0 109.213 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -60.61 -31.92 76.62 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.448 HG12 ' HB2' ' B' ' 217' ' ' ALA . 7.2 mt -65.28 -60.45 2.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 61.1 t -59.14 -40.26 80.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.16 -51.33 66.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.532 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 8.6 tp -66.48 -21.83 66.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . 0.493 ' O ' ' O ' ' B' ' 227' ' ' VAL . 3.9 m-30 -95.71 134.93 38.06 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.338 -0.851 . . . . 0.0 110.015 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' B' ' 230' ' ' PHE . . . -44.54 164.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.036 -1.04 . . . . 0.0 109.383 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.471 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.1 OUTLIER -61.9 -24.63 67.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.489 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.534 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 2.6 p30 -138.53 43.08 2.15 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' B' ' 310' ' ' VAL . . . -64.04 169.26 4.49 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.327 -0.858 . . . . 0.0 109.808 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' THR . . . . . 0.544 ' CG2' ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -119.79 140.07 51.33 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.446 -0.784 . . . . 0.0 109.007 179.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' B' ' 244' ' ' PRO . 37.3 t -132.44 121.19 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.577 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' B' ' 314' ' ' ALA . 1.5 mt-10 -89.2 105.85 18.05 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' ASP . . . . . 0.559 ' OD2' ' H61' ' B' ' 326' ' ' NTH . 27.0 t70 -179.61 142.06 0.36 Allowed Pre-proline 0 C--N 1.302 -1.464 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.337 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.479 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 47.7 Cg_endo -72.61 -176.72 16.71 Favored 'Cis proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.209 -1.996 . . . . 0.0 110.693 -0.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.495 HG23 ' CG1' ' A' ' 74' ' ' VAL . 26.9 m -82.86 49.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -175.1 30.88 0.09 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 75.4 m -149.46 -99.1 0.07 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -1.118 . . . . 0.0 109.38 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -176.9 139.46 0.46 Allowed Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.099 -1.001 . . . . 0.0 110.037 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' PRO . . . . . 0.509 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.1 Cg_endo -65.12 -176.64 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.123 1.591 . . . . 0.0 111.138 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.59 ' HB2' ' CD2' ' B' ' 254' ' ' PHE . 12.1 ttm-85 -151.88 121.76 7.05 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.544 ' HB3' ' CG2' ' B' ' 235' ' ' THR . 1.0 OUTLIER -103.21 155.71 18.23 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.011 -1.056 . . . . 0.0 110.164 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.89 161.96 21.07 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 3.7 m -70.02 -59.75 2.72 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.22 -1.165 . . . . 0.0 109.259 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -53.66 -23.53 11.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.313 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' B' ' 254' ' ' PHE . . . -87.69 -54.34 4.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.62 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.466 HG12 ' O ' ' B' ' 247' ' ' GLY . 7.1 mm -53.35 -40.93 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 109.543 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' ARG . . . . . 0.526 ' HB2' ' CG2' ' B' ' 227' ' ' VAL . 24.6 ttp85 -79.09 -51.54 9.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.064 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 21.6 tt0 -52.06 -27.32 13.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.03 -1.044 . . . . 0.0 108.578 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.1 OUTLIER -83.9 -70.11 0.59 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.53 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -52.94 -20.43 3.37 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.389 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' B' ' 252' ' ' ARG . . . -79.31 -39.67 32.27 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 62.4 t30 -62.86 -26.13 68.62 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' SER . . . . . 0.472 ' OG ' ' H12' ' B' ' 326' ' ' NTH . 30.3 t -74.71 -41.55 59.99 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' B' ' 223' ' ' LEU . 9.9 tp -61.4 -23.4 65.77 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.499 -0.751 . . . . 0.0 109.378 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 0.0 OUTLIER -50.62 -29.51 11.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.889 . . . . 0.0 109.345 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' LEU . . . . . 0.568 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.8 OUTLIER -92.64 107.36 23.54 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 108.534 179.385 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 47.9 Cg_endo -73.52 115.21 4.26 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.899 1.473 . . . . 0.0 111.702 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.568 ' CD2' ' CD2' ' B' ' 261' ' ' LEU . 0.1 OUTLIER -138.96 -166.49 2.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.477 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . 0.408 ' HB2' ' OG ' ' B' ' 285' ' ' SER . . . -114.28 127.25 55.78 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . 0.457 HG13 HG21 ' B' ' 215' ' ' VAL . 46.6 t -120.86 118.75 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -0.999 . . . . 0.0 109.919 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.2 OUTLIER -150.14 108.5 3.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.334 -0.854 . . . . 0.0 109.2 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.9 OUTLIER -47.38 174.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.504 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.43 -39.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.663 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 269' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 7.5 pt20 -94.63 -148.82 0.28 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.638 -0.664 . . . . 0.0 109.294 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.498 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 32.5 tt0 -113.42 131.52 55.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 109.72 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . 0.507 ' CG2' HG12 ' B' ' 211' ' ' VAL . 57.0 t -65.1 153.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.347 -0.845 . . . . 0.0 109.247 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 2.5 mtt180 -116.12 131.59 56.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.212 -0.93 . . . . 0.0 109.964 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.19 133.97 16.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.391 -0.818 . . . . 0.0 109.179 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 274' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -127.3 -163.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.104 -0.997 . . . . 0.0 109.811 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . 0.542 ' O ' ' CB ' ' B' ' 276' ' ' ASN . . . -86.38 68.17 10.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.433 -0.792 . . . . 0.0 110.386 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 276' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' B' ' 275' ' ' ALA . 2.9 m-20 160.69 -61.36 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.421 -0.799 . . . . 0.0 109.47 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . 0.466 ' HG2' ' HG2' ' B' ' 302' ' ' ARG . 0.0 OUTLIER -122.39 -161.11 0.92 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.455 -0.778 . . . . 0.0 109.214 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 278' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' B' ' 301' ' ' PHE . . . -169.78 139.41 1.96 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.478 -0.764 . . . . 0.0 109.12 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 279' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -126.73 139.49 53.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.96 -1.087 . . . . 0.0 109.456 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 23.8 p90 -150.57 172.47 15.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.054 -1.029 . . . . 0.0 109.631 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.533 ' HB1' ' CG1' ' B' ' 298' ' ' ILE . . . -147.18 175.59 10.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 110.183 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 282' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 6.7 p90 -167.76 -167.89 0.92 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.73 141.78 48.71 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.987 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 284' ' ' VAL . . . . . 0.559 ' CG1' HD22 ' B' ' 263' ' ' LEU . 0.5 OUTLIER -114.7 120.93 65.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 285' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' B' ' 285' ' ' SER . 37.8 p -123.86 80.7 1.83 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.11 -0.994 . . . . 0.0 109.97 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.57 ' CZ ' ' OG1' ' B' ' 293' ' ' THR . 44.1 p90 -89.89 -172.5 3.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.202 -0.936 . . . . 0.0 108.643 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.72 150.42 49.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.873 -1.142 . . . . 0.0 110.099 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.584 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.4 OUTLIER -117.21 88.49 2.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 0.0 108.99 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . 0.52 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 0.2 OUTLIER 42.13 -93.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.269 -0.894 . . . . 0.0 110.021 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 290' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' B' ' 288' ' ' PHE . . . -101.55 -13.43 32.66 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 291' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' B' ' 288' ' ' PHE . 7.8 mtt-85 -101.98 159.85 15.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.239 . . . . 0.0 109.774 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 292' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -122.01 129.74 52.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 293' ' ' THR . . . . . 0.584 ' OG1' ' CD2' ' B' ' 288' ' ' PHE . 0.0 OUTLIER -123.18 144.47 49.34 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.258 -0.901 . . . . 0.0 109.921 -179.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 294' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' B' ' 322' ' ' HIS . 12.3 p -126.19 168.25 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.875 . . . . 0.0 108.773 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.556 HG11 ' HD3' ' B' ' 297' ' ' PRO . 30.9 t -137.7 160.17 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.944 -1.098 . . . . 0.0 110.62 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 296' ' ' ALA . . . . . 0.533 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -144.49 64.62 12.16 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 297' ' ' PRO . . . . . 0.556 ' HD3' HG11 ' B' ' 295' ' ' VAL . 46.3 Cg_endo -97.57 179.78 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.707 1.605 . . . . 0.0 111.749 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.533 ' CG1' ' HB1' ' B' ' 281' ' ' ALA . 2.6 mp -141.05 154.46 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . 0.584 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 18.4 t0 -123.01 164.25 18.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.784 -1.198 . . . . 0.0 110.541 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.516 ' O ' ' CG ' ' B' ' 312' ' ' MET . 0.1 OUTLIER -116.66 166.32 12.25 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 301' ' ' PHE . . . . . 0.544 ' CD2' HG22 ' B' ' 211' ' ' VAL . 0.1 OUTLIER -145.18 145.85 31.51 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.883 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.466 ' HG2' ' HG2' ' B' ' 277' ' ' GLU . 0.8 OUTLIER -138.53 110.4 7.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.37 -0.831 . . . . 0.0 109.25 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 303' ' ' PHE . . . . . 0.581 ' CZ ' HG12 ' B' ' 210' ' ' VAL . 5.1 m-85 -89.9 -168.44 2.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.564 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 304' ' ' ASN . . . . . 0.512 ' ND2' HG23 ' B' ' 310' ' ' VAL . 0.9 OUTLIER -137.55 -40.72 0.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 305' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -148.1 -65.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 306' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 164.9 56.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -1.146 . . . . 0.0 109.546 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -148.04 -41.04 0.04 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -154.86 -169.31 3.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -1.209 . . . . 0.0 109.542 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 309' ' ' VAL . . . . . 0.501 HG11 ' N ' ' B' ' 310' ' ' VAL . 50.0 t -99.24 151.41 4.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 109.286 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' B' ' 234' ' ' ALA . 45.3 t -121.74 -63.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 13.8 m -116.48 165.62 13.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.154 -0.966 . . . . 0.0 109.518 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 312' ' ' MET . . . . . 0.516 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 28.8 ttp -155.18 156.48 35.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.754 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 313' ' ' ARG . . . . . 0.515 ' NE ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -123.98 179.85 4.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.351 -0.843 . . . . 0.0 108.998 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 314' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' B' ' 237' ' ' GLU . . . -138.42 125.14 20.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.977 -1.077 . . . . 0.0 110.529 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 315' ' ' LEU . . . . . 0.655 ' O ' ' CD1' ' B' ' 316' ' ' PHE . 5.6 tp -104.44 -175.32 2.76 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 316' ' ' PHE . . . . . 0.662 ' CG ' ' N ' ' B' ' 317' ' ' GLY . 0.0 OUTLIER 99.56 -160.73 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.626 0.726 . . . . 0.0 109.889 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 317' ' ' GLY . . . . . 0.662 ' N ' ' CG ' ' B' ' 316' ' ' PHE . . . 160.42 -162.33 33.25 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 318' ' ' GLU . . . . . 0.504 ' HA ' HD11 ' B' ' 321' ' ' ILE . 5.1 tt0 -78.16 6.45 8.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -1.143 . . . . 0.0 109.622 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -115.17 -17.85 11.29 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.192 -0.943 . . . . 0.0 110.078 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 320' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.2 OUTLIER -88.8 -14.9 35.92 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.215 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 321' ' ' ILE . . . . . 0.555 HG21 ' CG2' ' B' ' 295' ' ' VAL . 0.9 OUTLIER -87.84 -164.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 322' ' ' HIS . . . . . 0.482 ' HB2' HG12 ' B' ' 294' ' ' VAL . 0.0 OUTLIER -150.99 154.84 37.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.969 -1.082 . . . . 0.0 109.756 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -155.52 110.89 3.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.468 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -171.33 -132.55 1.5 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.3 -1.118 . . . . 0.0 109.508 -179.841 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' NTH . . . . . 0.712 ' H12' ' OG ' ' A' ' 58' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 326' ' ' NTH . . . . . 0.559 ' H61' ' OD2' ' B' ' 238' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.227 0.536 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 3' ' ' THR . 28.6 m120 -131.76 43.96 2.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.364 -0.835 . . . . 0.0 109.393 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.513 ' CG2' ' O ' ' A' ' 3' ' ' THR . 11.1 t -44.2 108.73 0.75 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.48 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.84 -9.69 25.18 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.889 1.468 . . . . 0.0 110.065 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -66.35 -49.45 66.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.229 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -52.7 61.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.192 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 mtm -59.62 -25.58 64.76 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.329 -0.857 . . . . 0.0 109.346 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -72.98 -30.69 64.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 0.0 109.128 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.25 -51.97 66.17 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.639 ' CG2' ' CZ ' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -47.91 -29.13 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.163 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.591 ' CG2' ' CE2' ' A' ' 101' ' ' PHE . 24.9 t -87.95 -45.18 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.5 -0.75 . . . . 0.0 109.363 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 13' ' ' ARG . 3.6 tt0 -58.43 -73.37 0.08 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.447 ' HA ' ' HB2' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -43.02 -44.78 4.89 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.079 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.643 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -50.5 -44.26 55.94 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.489 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.604 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -86.37 -41.46 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 108.99 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . . . -49.41 -35.19 18.41 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.537 ' CA ' ' OD1' ' A' ' 22' ' ' ASP . . . -74.25 -32.82 63.1 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.643 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 1.8 mt -65.1 -57.13 9.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.48 -39.73 24.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.01 -11.57 43.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.583 -0.698 . . . . 0.0 109.464 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.523 ' CA ' HD23 ' A' ' 59' ' ' LEU . . . 62.68 25.92 67.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.537 ' OD1' ' CA ' ' A' ' 17' ' ' ALA . 16.0 p30 -89.41 85.48 6.56 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.131 -1.217 . . . . 0.0 109.649 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.575 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 3.6 mm? -49.76 -21.8 1.21 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.259 -0.901 . . . . 0.0 109.783 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.53 -51.8 68.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -40.8 95.02 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' A' ' 17' ' ' ALA . 7.7 mt -59.86 -54.67 31.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 48.5 t -64.33 -41.18 91.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.17 -49.82 70.9 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 tp -67.14 -14.22 62.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.595 ' CZ ' ' CE ' ' A' ' 112' ' ' MET . 3.0 m-85 -89.48 136.01 33.27 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -54.42 -167.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 109.552 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -76.89 -23.51 52.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.251 -0.906 . . . . 0.0 109.7 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.535 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -143.66 45.51 1.49 Allowed 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -59.04 157.63 9.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.966 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.534 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -117.81 139.27 51.32 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.485 -0.759 . . . . 0.0 109.284 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 42.7 t -129.24 141.1 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.418 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 11.5 mt-10 -111.24 112.79 24.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.653 ' OD2' ' H61' ' A' ' 126' ' ' NTH . 19.7 t70 -179.27 141.38 0.36 Allowed Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.568 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.489 ' O ' HG21 ' A' ' 40' ' ' VAL . 46.2 Cg_endo -72.56 131.69 23.34 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.286 -1.964 . . . . 0.0 110.6 -0.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.552 HG11 ' CE1' ' A' ' 116' ' ' PHE . 14.0 m 40.73 -147.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.464 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 42' ' ' SER . . . -67.28 1.21 6.95 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.04 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.471 ' OG ' ' HG2' ' A' ' 39' ' ' PRO . 68.8 m -48.06 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.902 -1.352 . . . . 0.0 110.163 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -133.29 107.64 12.28 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.003 . . . . 0.0 110.608 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 42.5 Cg_endo -68.47 -167.74 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 124.016 1.535 . . . . 0.0 110.428 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.585 ' HG3' ' CG ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -151.43 112.31 4.26 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.534 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.2 OUTLIER -103.57 140.2 37.85 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 110.257 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 107.8 160.81 20.93 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 3.0 m -76.07 -42.38 47.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.269 -1.136 . . . . 0.0 109.086 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.63 -38.11 83.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.29 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.48 -43.59 59.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.314 -0.866 . . . . 0.0 109.368 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.532 HD12 ' CG2' ' A' ' 36' ' ' VAL . 5.4 mm -58.49 -46.45 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.31 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 36.7 ttt-85 -66.31 -55.46 15.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 108.945 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 52' ' ' ARG . 2.3 mt-10 -45.09 -28.56 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 108.568 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.585 ' CG ' ' HG3' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -85.09 -70.08 0.61 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.535 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -51.73 -20.95 2.37 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' CB ' ' HG ' ' A' ' 23' ' ' LEU . . . -82.21 -46.0 14.32 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 24.5 t-20 -60.96 -50.04 75.01 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.631 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 7.4 t -51.79 -26.27 9.34 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.575 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 5.4 tp -76.95 -28.24 55.13 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.591 -0.693 . . . . 0.0 109.739 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -44.35 -31.44 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 108.633 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.599 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.19 100.27 11.35 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 45.9 Cg_endo -71.71 129.54 15.7 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.991 1.521 . . . . 0.0 111.899 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.599 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -139.98 178.04 7.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.509 ' CB ' ' OG ' ' A' ' 85' ' ' SER . . . -92.23 127.8 37.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.264 -0.898 . . . . 0.0 108.58 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.52 112.18 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 110.056 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -150.86 105.3 3.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.812 . . . . 0.0 109.193 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mp -55.5 173.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.96 . . . . 0.0 109.861 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -134.72 -81.13 0.44 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.339 -0.851 . . . . 0.0 109.327 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 68' ' ' THR . 5.5 pt20 -60.22 -143.28 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.647 -0.658 . . . . 0.0 109.435 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -114.29 134.8 54.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.963 -1.086 . . . . 0.0 110.001 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.535 HG11 ' N ' ' A' ' 72' ' ' ARG . 10.6 t -63.09 148.71 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.423 -0.798 . . . . 0.0 109.036 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.535 ' N ' HG11 ' A' ' 71' ' ' VAL . 3.4 mmm180 -98.97 130.57 45.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.931 . . . . 0.0 109.287 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.427 ' C ' ' CG2' ' A' ' 74' ' ' VAL . . . -145.92 135.96 23.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 109.342 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -163.9 155.48 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.67 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.471 ' HB1' ' HA2' ' B' ' 241' ' ' GLY . . . 49.76 -152.03 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.473 -0.767 . . . . 0.0 109.855 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 103' ' ' PHE . 98.3 m-20 -87.36 16.98 4.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.454 -0.779 . . . . 0.0 109.331 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.461 ' HG3' ' HA ' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -123.6 -159.26 0.84 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.342 -0.849 . . . . 0.0 109.076 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 101' ' ' PHE . . . 178.04 160.3 0.53 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.439 -0.788 . . . . 0.0 109.542 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 72' ' ' ARG . . . -150.27 133.54 16.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.015 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 33.5 p90 -148.96 163.67 36.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.836 -1.165 . . . . 0.0 110.241 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.519 ' CB ' HG21 ' A' ' 98' ' ' ILE . . . -140.78 150.13 42.97 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -149.56 -172.51 4.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.175 -0.953 . . . . 0.0 109.401 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.29 141.74 51.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.406 -0.808 . . . . 0.0 109.611 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 63' ' ' LEU . 19.9 t -112.01 111.71 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.394 -0.816 . . . . 0.0 109.156 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.509 ' OG ' ' CB ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -106.12 113.1 26.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.824 . . . . 0.0 109.57 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.892 ' CE2' H221 ' A' ' 126' ' ' NTH . 0.8 OUTLIER -128.02 148.13 50.53 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.195 -0.941 . . . . 0.0 109.536 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -91.7 178.64 5.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.541 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.576 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.5 OUTLIER -142.19 -163.49 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.34 -0.85 . . . . 0.0 109.382 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.69 60.95 2.87 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.026 -1.047 . . . . 0.0 109.491 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.84 3.41 26.69 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -136.81 164.36 28.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.137 -1.213 . . . . 0.0 109.667 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' CD ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -126.52 122.27 34.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.844 . . . . 0.0 109.233 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.576 ' OG1' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -117.23 154.6 30.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.722 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.531 ' CG1' ' CB ' ' A' ' 122' ' ' HIS . 7.3 p -138.46 170.75 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 108.861 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.576 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 3.5 t -144.91 147.05 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.034 -1.041 . . . . 0.0 109.268 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.518 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -132.55 69.65 79.67 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.121 -0.987 . . . . 0.0 111.026 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.576 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 49.3 Cg_endo -96.35 -173.08 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.503 1.469 . . . . 0.0 110.424 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.519 HG21 ' CB ' ' A' ' 81' ' ' ALA . 2.9 mp -134.46 157.36 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 15.8 t0 -127.05 153.25 46.2 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.156 -0.965 . . . . 0.0 110.11 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.518 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -108.88 171.27 7.53 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.591 ' CE2' ' CG2' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -142.37 148.38 37.79 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.101 -0.999 . . . . 0.0 110.486 -178.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.514 ' CD ' ' HB2' ' A' ' 111' ' ' SER . 0.0 OUTLIER -133.85 107.43 7.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.561 -0.712 . . . . 0.0 109.085 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.639 ' CZ ' ' CG2' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -89.72 -176.37 4.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 109.56 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.525 ' OD1' ' CG2' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -138.9 -100.08 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.433 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.67 -38.93 0.04 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -171.48 32.8 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.45 -1.029 . . . . 0.0 108.74 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 108' ' ' LYS . . . -123.72 15.56 7.96 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 22.2 mmmt 81.79 -150.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.653 -0.91 . . . . 0.0 109.624 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.483 HG22 HG21 ' A' ' 10' ' ' VAL . 18.2 t -88.2 122.66 40.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.525 ' CG2' ' OD1' ' A' ' 104' ' ' ASN . 49.1 t -105.24 -8.58 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.079 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.514 ' HB2' ' CD ' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -160.37 153.22 21.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.957 -1.089 . . . . 0.0 110.137 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.595 ' CE ' ' CZ ' ' A' ' 30' ' ' PHE . 19.0 ttm -160.05 141.82 12.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.494 -0.754 . . . . 0.0 109.211 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.465 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 1.0 OUTLIER -123.56 174.21 7.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.116 -0.99 . . . . 0.0 109.269 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 99' ' ' ASP . . . -147.47 134.91 20.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.945 . . . . 0.0 109.263 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.519 ' CD1' ' HB1' ' B' ' 279' ' ' ALA . 0.1 OUTLIER -125.01 141.17 52.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 110.063 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.552 ' CE1' HG11 ' A' ' 40' ' ' VAL . 50.0 p90 172.86 -160.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . 172.31 -171.03 44.0 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.531 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 3.1 tt0 -69.87 -5.01 22.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.444 -1.033 . . . . 0.0 109.7 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.452 ' HE3' ' OE2' ' B' ' 270' ' ' GLU . 0.3 OUTLIER -90.47 -31.74 16.66 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.958 0.885 . . . . 0.0 109.142 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.437 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.8 m-20 -89.36 8.6 29.83 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.19 0.519 . . . . 0.0 109.665 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.531 ' CG1' ' HA ' ' A' ' 118' ' ' GLU . 4.9 mm -90.28 -172.53 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 108.897 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.531 ' CB ' ' CG1' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -151.7 156.76 41.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.914 . . . . 0.0 109.506 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.7 135.24 13.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.506 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.59 138.66 9.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.202 -1.175 . . . . 0.0 109.535 -179.861 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.242 0.544 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -116.06 92.6 3.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.441 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.92 119.42 69.38 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.827 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.32 -4.69 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.858 1.452 . . . . 0.0 109.586 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.04 -40.84 68.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.373 -0.83 . . . . 0.0 109.237 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -65.83 -55.7 15.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.128 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 15.4 mtm -55.98 -24.62 39.68 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.289 -0.882 . . . . 0.0 109.13 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.408 ' O ' ' N ' ' B' ' 211' ' ' VAL . 5.4 m -73.91 -34.06 64.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.346 -0.846 . . . . 0.0 109.136 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.1 -46.44 65.25 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.183 -0.948 . . . . 0.0 108.482 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.618 ' CG2' ' CZ ' ' B' ' 303' ' ' PHE . 1.0 OUTLIER -54.97 -24.84 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.493 ' CG1' HG12 ' B' ' 271' ' ' VAL . 16.8 t -90.21 -43.94 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.421 -0.799 . . . . 0.0 109.045 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' B' ' 213' ' ' ARG . 7.6 tt0 -60.45 -73.61 0.09 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.528 ' HD3' ' CD1' ' B' ' 229' ' ' LEU . 0.0 OUTLIER -43.22 -45.23 5.62 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.236 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' TYR . . . . . 0.641 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -50.09 -44.84 52.19 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.606 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 0.9 OUTLIER -86.94 -39.32 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.317 -0.865 . . . . 0.0 109.172 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' B' ' 213' ' ' ARG . . . -48.35 -36.51 14.62 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -73.97 -33.87 64.02 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.641 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 2.7 mt -64.05 -59.07 4.91 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -51.19 -45.5 61.84 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.509 0.671 . . . . 0.0 109.194 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.54 8.6 30.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.579 -0.701 . . . . 0.0 109.681 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' B' ' 217' ' ' ALA . . . 49.48 33.72 17.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.5 t70 -90.58 67.73 6.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -1.131 . . . . 0.0 109.685 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' LEU . . . . . 0.562 ' CD2' ' CG ' ' B' ' 252' ' ' ARG . 7.3 tp -50.38 -45.2 55.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.076 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' B' ' 223' ' ' LEU . 5.3 m-20 -43.44 -32.64 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -83.86 -33.51 21.14 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.481 ' N ' ' O ' ' B' ' 223' ' ' LEU . 17.2 mt -61.9 -56.02 20.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 97.0 t -59.71 -37.33 70.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.93 -51.82 68.06 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.528 ' CD1' ' HD3' ' B' ' 213' ' ' ARG . 2.9 tp -68.06 -14.89 63.32 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.536 -0.727 . . . . 0.0 109.057 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . 0.484 ' CD2' ' CG2' ' B' ' 251' ' ' ILE . 2.4 m-85 -94.78 149.18 21.51 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.457 -0.777 . . . . 0.0 109.527 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -59.24 168.23 1.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.429 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.458 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -55.72 -24.4 34.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.372 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.531 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 8.8 p-10 -150.56 51.36 0.88 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' B' ' 310' ' ' VAL . . . -60.58 158.94 11.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.608 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' THR . . . . . 0.519 ' CG2' ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -100.27 141.34 33.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.447 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.545 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 85.4 t -134.41 136.39 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.258 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' GLU . . . . . 0.464 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 1.5 mt-10 -112.39 113.28 25.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 108.559 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' ASP . . . . . 0.524 ' O ' ' CE2' ' B' ' 254' ' ' PHE . 9.6 t70 -179.55 141.74 0.36 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 109.664 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' B' ' 241' ' ' GLY . 49.1 Cg_endo -75.14 -176.65 18.56 Favored 'Cis proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.25 -1.979 . . . . 0.0 110.485 -0.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 6.2 m -65.18 75.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.284 -0.885 . . . . 0.0 108.982 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' B' ' 239' ' ' PRO . . . -162.78 24.37 0.2 Allowed Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' B' ' 241' ' ' GLY . 0.5 OUTLIER 67.24 48.92 1.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -1.14 . . . . 0.0 109.741 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . 0.511 ' N ' ' HD3' ' B' ' 244' ' ' PRO . 2.1 mt-10 -131.89 58.57 38.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.144 -0.972 . . . . 0.0 109.466 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' PRO . . . . . 0.545 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 48.5 Cg_endo -77.83 169.69 20.24 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 124.276 1.671 . . . . 0.0 110.942 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.457 ' HD2' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -151.32 100.79 2.78 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.519 ' HB3' ' CG2' ' B' ' 235' ' ' THR . 0.2 OUTLIER -92.02 161.77 14.65 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.121 -0.987 . . . . 0.0 110.152 -178.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 100.66 158.26 27.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 5.3 m -69.98 -48.7 57.17 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.195 -1.179 . . . . 0.0 108.971 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -61.81 -25.27 67.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.904 . . . . 0.0 109.274 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' B' ' 246' ' ' SER . . . -90.13 -58.78 2.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.394 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.525 ' CD1' ' O ' ' B' ' 247' ' ' GLY . 17.4 mt -47.45 -41.22 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.284 -0.885 . . . . 0.0 109.012 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' ARG . . . . . 0.562 ' CG ' ' CD2' ' B' ' 223' ' ' LEU . 28.6 ttt180 -76.75 -57.99 3.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.456 -0.778 . . . . 0.0 108.978 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 62.5 mt-10 -45.27 -28.32 0.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.025 -1.047 . . . . 0.0 108.589 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' B' ' 238' ' ' ASP . 0.8 OUTLIER -85.39 -71.02 0.55 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.551 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -49.12 -23.59 1.31 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . 0.521 ' CB ' HD21 ' B' ' 223' ' ' LEU . . . -76.38 -49.67 16.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' ASN . . . . . 0.51 ' ND2' ' HE2' ' B' ' 260' ' ' LYS . 0.3 OUTLIER -55.33 -29.43 58.29 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' SER . . . . . 0.562 ' OG ' ' H12' ' B' ' 326' ' ' NTH . 42.9 t -75.44 -31.8 60.46 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . 0.407 HD23 ' O ' ' B' ' 221' ' ' GLY . 7.3 tp -71.77 -25.78 62.17 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.44 -0.787 . . . . 0.0 109.302 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . 0.51 ' HE2' ' ND2' ' B' ' 257' ' ' ASN . 12.0 mtmt -54.12 -23.83 15.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.296 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' LEU . . . . . 0.548 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.8 OUTLIER -89.92 120.34 69.35 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 0.0 108.698 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' B' ' 286' ' ' PHE . 42.9 Cg_endo -69.94 104.05 1.29 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.752 1.396 . . . . 0.0 110.584 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.548 ' CD2' ' CD2' ' B' ' 261' ' ' LEU . 0.0 OUTLIER -138.91 149.79 45.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.742 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . 0.443 ' HB2' ' OG ' ' B' ' 285' ' ' SER . . . -91.62 129.55 37.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -0.824 . . . . 0.0 108.925 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . 0.416 HG21 ' HB3' ' B' ' 218' ' ' LEU . 3.0 t -110.18 116.09 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.87 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.1 OUTLIER -150.33 91.47 1.76 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 0.0 109.24 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -45.21 170.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.724 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.1 -39.56 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.299 -0.876 . . . . 0.0 109.675 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 269' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -87.75 -154.2 0.25 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.452 ' OE2' ' HE3' ' A' ' 119' ' ' LYS . 51.7 tt0 -107.39 131.24 54.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.138 -0.976 . . . . 0.0 109.53 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . 0.498 HG11 ' N ' ' B' ' 272' ' ' ARG . 26.7 t -67.35 150.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.292 -0.88 . . . . 0.0 108.762 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 5.5 mtt180 -104.01 136.94 42.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 109.963 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . 0.459 ' HA ' ' HB1' ' B' ' 278' ' ' ALA . . . -150.18 126.14 10.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.412 -0.805 . . . . 0.0 109.275 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 274' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -155.33 160.74 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.215 -0.928 . . . . 0.0 109.4 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . 0.512 ' HB2' ' CG2' ' A' ' 40' ' ' VAL . . . 43.87 -145.56 0.1 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 276' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' B' ' 303' ' ' PHE . 1.5 t-20 -90.59 13.26 16.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 0.0 109.708 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' B' ' 301' ' ' PHE . 0.9 OUTLIER -122.16 -161.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.078 -1.014 . . . . 0.0 109.733 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 278' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' B' ' 301' ' ' PHE . . . 177.74 148.79 0.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 279' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -134.69 139.69 45.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.007 -1.058 . . . . 0.0 108.868 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 33.3 p90 -150.47 165.18 33.99 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.694 -1.254 . . . . 0.0 110.651 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.529 ' HB1' ' CG1' ' B' ' 298' ' ' ILE . . . -143.45 176.86 8.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 282' ' ' PHE . . . . . 0.407 ' HE1' ' CE2' ' B' ' 280' ' ' PHE . 14.4 p90 -178.14 -170.21 0.23 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.284 -0.885 . . . . 0.0 109.6 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.58 142.33 50.74 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.518 -0.739 . . . . 0.0 109.551 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 284' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' B' ' 263' ' ' LEU . 45.2 t -113.89 113.6 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.453 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 285' ' ' SER . . . . . 0.532 ' HA ' ' CG2' ' B' ' 294' ' ' VAL . 91.9 p -105.75 110.6 22.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.168 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.918 ' CZ ' H221 ' B' ' 326' ' ' NTH . 4.3 p90 -127.43 157.86 38.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.164 -0.96 . . . . 0.0 109.787 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 287' ' ' GLU . . . . . 0.459 ' HG3' ' HB2' ' B' ' 292' ' ' LYS . 11.6 tm-20 -144.71 167.61 22.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.307 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.419 ' N ' ' CD ' ' B' ' 287' ' ' GLU . 0.1 OUTLIER -122.02 -75.98 0.59 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.052 -1.03 . . . . 0.0 109.894 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' B' ' 289' ' ' GLN . 0.0 OUTLIER -158.99 60.1 0.42 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.503 -0.748 . . . . 0.0 109.778 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 129.88 -45.76 1.12 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -103.26 129.67 50.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.374 -1.074 . . . . 0.0 109.189 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 292' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' B' ' 286' ' ' PHE . 0.2 OUTLIER -118.54 145.7 45.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 109.701 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 293' ' ' THR . . . . . 0.466 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -136.16 145.39 45.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.666 -0.646 . . . . 0.0 109.649 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 294' ' ' VAL . . . . . 0.532 ' CG2' ' HA ' ' B' ' 285' ' ' SER . 0.5 OUTLIER -117.32 176.35 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 108.581 179.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.569 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 2.5 t -149.58 145.25 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.227 -0.921 . . . . 0.0 109.069 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 296' ' ' ALA . . . . . 0.511 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -131.02 71.3 82.45 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.079 -1.013 . . . . 0.0 110.923 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 297' ' ' PRO . . . . . 0.569 ' HD3' ' CG1' ' B' ' 295' ' ' VAL . 52.3 Cg_endo -96.88 -173.08 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.717 1.611 . . . . 0.0 110.677 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.529 ' CG1' ' HB1' ' B' ' 281' ' ' ALA . 2.5 mp -139.49 151.97 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . 0.582 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 17.5 t0 -124.13 160.2 28.33 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.999 -1.063 . . . . 0.0 110.311 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' B' ' 312' ' ' MET . 63.0 t60 -110.88 173.79 6.17 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 301' ' ' PHE . . . . . 0.53 ' CE1' HG11 ' B' ' 210' ' ' VAL . 0.1 OUTLIER -149.55 138.96 21.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 110.491 -178.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.531 ' CB ' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -123.46 110.36 15.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.423 -0.798 . . . . 0.0 109.097 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 303' ' ' PHE . . . . . 0.618 ' CZ ' ' CG2' ' B' ' 210' ' ' VAL . 0.4 OUTLIER -89.78 -176.21 4.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 0.0 109.687 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 304' ' ' ASN . . . . . 0.53 ' OD1' ' CG2' ' B' ' 310' ' ' VAL . 0.1 OUTLIER -142.05 -100.06 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.583 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 305' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -98.8 -55.58 1.06 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 306' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 163.13 76.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -1.099 . . . . 0.0 109.39 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -167.53 -51.73 0.03 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 308' ' ' LYS . . . . . 0.513 ' N ' ' HD2' ' B' ' 308' ' ' LYS . 0.0 OUTLIER -150.11 -167.43 2.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -1.213 . . . . 0.0 109.659 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 309' ' ' VAL . . . . . 0.463 HG22 HG21 ' B' ' 210' ' ' VAL . 62.0 t -102.66 148.28 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.332 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.53 ' CG2' ' OD1' ' B' ' 304' ' ' ASN . 24.1 t -110.97 -31.91 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.089 -1.007 . . . . 0.0 110.192 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 311' ' ' SER . . . . . 0.531 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 1.3 m -144.94 165.02 29.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.789 -1.194 . . . . 0.0 110.009 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 312' ' ' MET . . . . . 0.523 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 11.0 ttp -156.2 161.5 40.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.695 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 313' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' B' ' 300' ' ' HIS . 9.0 tpt180 -150.39 117.18 5.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.226 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 314' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' B' ' 299' ' ' ASP . . . -94.59 144.93 25.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.152 -0.968 . . . . 0.0 110.033 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 315' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' B' ' 316' ' ' PHE . 0.5 OUTLIER -132.31 139.72 48.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 109.564 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 316' ' ' PHE . . . . . 0.528 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 47.9 p90 170.68 -158.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 317' ' ' GLY . . . . . 0.467 ' N ' ' CD2' ' B' ' 316' ' ' PHE . . . 178.83 -175.7 47.51 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 318' ' ' GLU . . . . . 0.538 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 25.7 tt0 -73.36 -1.91 20.07 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.295 -1.121 . . . . 0.0 109.442 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -92.71 -29.62 15.97 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.24 -0.912 . . . . 0.0 108.983 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 320' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -88.89 16.01 7.57 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 321' ' ' ILE . . . . . 0.538 ' CG1' ' HA ' ' B' ' 318' ' ' GLU . 5.1 mm -89.72 -165.07 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 322' ' ' HIS . . . . . 0.524 ' CB ' HG11 ' B' ' 294' ' ' VAL . 0.2 OUTLIER -151.9 161.27 42.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.94 -1.1 . . . . 0.0 109.67 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' B' ' 293' ' ' THR . . . -155.37 113.47 3.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 109.361 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -120.8 152.87 16.75 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.263 -1.14 . . . . 0.0 109.479 179.931 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' NTH . . . . . 0.892 H221 ' CE2' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 326' ' ' NTH . . . . . 0.918 H221 ' CZ ' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.505 ' CE ' ' OE1' ' B' ' 318' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.24 0.543 . . . . 0.0 110.221 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 3' ' ' THR . 8.2 t-20 -120.57 125.71 48.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 0.0 109.43 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.456 ' O ' ' SD ' ' A' ' 7' ' ' MET . 1.8 t -44.26 106.7 0.54 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.875 . . . . 0.0 109.351 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 44.5 Cg_endo -71.2 -3.82 13.68 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.891 1.469 . . . . 0.0 110.379 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -72.8 -25.58 61.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.912 . . . . 0.0 109.224 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.47 -59.31 2.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -51.47 -21.39 2.37 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.118 -0.989 . . . . 0.0 109.722 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.481 ' O ' ' N ' ' A' ' 11' ' ' VAL . 14.3 m -74.66 -39.81 61.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.222 -0.924 . . . . 0.0 109.099 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.89 -42.76 48.68 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.643 ' CG1' ' CZ ' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -53.82 -23.95 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.132 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.557 HG22 ' CE2' ' A' ' 101' ' ' PHE . 10.1 t -89.94 -43.06 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.349 -0.844 . . . . 0.0 109.066 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 13' ' ' ARG . 24.6 tt0 -61.82 -73.52 0.1 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.281 1.039 . . . . 0.0 108.284 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 12' ' ' GLN . 0.6 OUTLIER -42.45 -44.29 3.97 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.665 ' CE1' ' CE2' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -51.27 -48.45 62.2 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.621 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -82.24 -44.24 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.382 -0.824 . . . . 0.0 109.375 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -47.57 -37.99 13.45 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.84 -36.04 67.38 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.631 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 2.9 mt -61.0 -59.82 4.77 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -53.49 -42.67 67.54 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.48 0.657 . . . . 0.0 109.762 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.19 5.54 44.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.82 . . . . 0.0 110.006 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.529 ' HA2' ' CD2' ' A' ' 59' ' ' LEU . . . 54.76 46.11 76.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HB3' ' HA ' ' A' ' 17' ' ' ALA . 15.6 t0 -104.74 58.35 0.7 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -1.068 . . . . 0.0 109.945 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.568 ' CD2' ' CG ' ' A' ' 52' ' ' ARG . 6.0 tp -52.86 -45.84 67.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.131 -0.981 . . . . 0.0 108.921 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -46.74 -42.99 17.68 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.17 -29.57 60.22 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 29' ' ' LEU . 32.5 mt -63.66 -59.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.463 ' HA ' ' HB2' ' A' ' 30' ' ' PHE . 92.9 t -49.45 -35.7 9.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.83 90.73 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.522 ' CD2' ' HA ' ' A' ' 10' ' ' VAL . 1.9 tp -75.39 -20.15 59.12 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.463 ' HB2' ' HA ' ' A' ' 27' ' ' VAL . 4.9 m-85 -95.99 141.86 28.89 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.532 -0.73 . . . . 0.0 109.642 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -49.0 177.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.927 . . . . 0.0 109.457 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -69.63 -24.12 63.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.24 -0.912 . . . . 0.0 109.826 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.529 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 4.9 p-10 -144.83 52.33 1.23 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.576 ' CB ' ' CD1' ' A' ' 51' ' ' ILE . . . -59.38 165.02 2.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.443 -0.786 . . . . 0.0 110.194 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.526 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -115.75 140.94 48.73 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 25.0 t -128.51 170.29 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 109.654 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 5.0 mt-10 -141.27 113.3 7.89 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.571 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 6.0 t70 -168.37 139.95 2.26 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.759 -1.213 . . . . 0.0 109.957 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.509 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 43.8 Cg_endo -74.95 -78.27 0.0 OUTLIER 'Cis proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.441 -1.9 . . . . 0.0 111.608 0.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.3 m -153.3 66.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.876 -1.14 . . . . 0.0 109.331 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . -173.05 46.99 0.16 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER 72.97 51.14 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -1.132 . . . . 0.0 110.077 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.537 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 2.3 mt-10 -132.92 58.66 37.2 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.056 -1.027 . . . . 0.0 109.742 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 43' ' ' GLU . 50.7 Cg_endo -79.99 -179.29 5.16 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.066 1.561 . . . . 0.0 111.284 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.577 ' HG3' ' CD1' ' A' ' 54' ' ' PHE . 23.2 mmt180 -150.88 96.16 2.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.526 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.1 OUTLIER -92.81 158.35 15.93 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.19 -0.944 . . . . 0.0 110.285 -178.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 33' ' ' ASP . . . 88.95 -169.93 37.26 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 1.9 m -103.13 -51.85 3.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.076 -1.249 . . . . 0.0 108.842 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -52.05 -23.49 5.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.312 -0.867 . . . . 0.0 109.15 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.32 -55.28 3.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.388 -0.82 . . . . 0.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.576 ' CD1' ' CB ' ' A' ' 34' ' ' ALA . 59.7 mt -54.08 -43.41 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 109.132 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.568 ' CG ' ' CD2' ' A' ' 23' ' ' LEU . 16.2 ttt180 -70.28 -47.91 59.12 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.193 -0.942 . . . . 0.0 108.784 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 5.4 mt-10 -51.12 -34.19 29.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.038 . . . . 0.0 108.44 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.577 ' CD1' ' HG3' ' A' ' 45' ' ' ARG . 1.4 t80 -82.93 -70.5 0.55 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.665 ' CE2' ' CE1' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -44.63 -26.76 0.41 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -75.03 -53.22 9.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 108.993 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 56' ' ' ALA . 14.1 t-20 -45.66 -34.6 3.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 108.609 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.753 ' HB2' ' H12' ' A' ' 126' ' ' NTH . 5.8 t -71.87 -33.56 68.49 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.529 ' CD2' ' HA2' ' A' ' 21' ' ' GLY . 5.3 tp -77.21 -33.87 56.16 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.326 -0.859 . . . . 0.0 109.329 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -61.94 -26.97 68.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 109.443 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.742 HD12 H212 ' A' ' 126' ' ' NTH . 1.0 OUTLIER -89.43 131.87 38.97 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 0.0 108.681 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 86' ' ' PHE . 41.6 Cg_endo -68.04 80.64 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.755 1.398 . . . . 0.0 110.501 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.58 ' CD2' ' CG1' ' A' ' 84' ' ' VAL . 3.2 mt -111.22 146.55 36.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.435 -0.79 . . . . 0.0 109.605 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.458 ' HB2' ' OG ' ' A' ' 85' ' ' SER . . . -91.91 126.75 37.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 108.647 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.411 HG13 HG21 ' A' ' 15' ' ' VAL . 2.7 t -113.45 118.13 57.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.673 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 67' ' ' LEU . 27.1 tt0 -150.16 104.54 3.28 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.337 -0.852 . . . . 0.0 109.169 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.5 mp -45.59 171.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.222 -0.924 . . . . 0.0 109.847 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -144.38 -82.27 0.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.403 -0.811 . . . . 0.0 109.01 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 2.9 pt20 -60.08 -146.06 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 61.5 tt0 -114.84 130.37 56.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.066 -1.021 . . . . 0.0 109.761 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.523 ' CG1' HG23 ' A' ' 11' ' ' VAL . 88.7 t -60.0 145.03 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.292 -0.88 . . . . 0.0 109.14 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.531 ' CD ' HD23 ' B' ' 315' ' ' LEU . 17.7 mtt180 -111.72 130.04 55.92 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.396 -0.921 . . . . 0.0 109.931 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.493 ' C ' ' CG2' ' A' ' 74' ' ' VAL . . . -139.74 157.7 45.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.538 ' CG1' HG23 ' B' ' 240' ' ' VAL . 0.5 OUTLIER -157.22 -153.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 110.312 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.533 ' CB ' ' HA3' ' B' ' 241' ' ' GLY . . . -33.91 -96.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 120.926 0.393 . . . . 0.0 111.161 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 103' ' ' PHE . 65.4 m-20 -114.37 26.96 9.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.948 -1.095 . . . . 0.0 110.496 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -137.55 -160.98 1.11 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.026 -1.046 . . . . 0.0 109.388 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 101' ' ' PHE . . . 171.28 143.48 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.476 -0.765 . . . . 0.0 109.861 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.594 ' CB ' ' CD1' ' B' ' 315' ' ' LEU . . . -132.62 130.46 40.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 108.786 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.697 ' CE1' ' CD2' ' A' ' 101' ' ' PHE . 2.1 p90 -150.6 156.06 40.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.759 -1.213 . . . . 0.0 109.989 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.54 ' CB ' HG21 ' A' ' 98' ' ' ILE . . . -133.32 156.49 47.51 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.611 0.719 . . . . 0.0 110.33 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -149.46 -171.06 3.8 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.87 140.09 52.83 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.076 -1.015 . . . . 0.0 109.972 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.58 ' CG1' ' CD2' ' A' ' 63' ' ' LEU . 38.3 t -116.76 115.2 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 78.2 p -126.67 99.73 5.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.086 -1.009 . . . . 0.0 110.334 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.705 ' CE1' H221 ' A' ' 126' ' ' NTH . 52.8 p90 -93.36 -164.22 1.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.204 -0.935 . . . . 0.0 108.629 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -144.19 152.06 40.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.022 -1.049 . . . . 0.0 110.086 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.409 ' CZ ' ' HE2' ' A' ' 86' ' ' PHE . 4.2 m-85 -107.21 -173.35 2.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.403 -0.811 . . . . 0.0 109.39 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -49.19 -54.6 15.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.358 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -138.04 4.61 3.23 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -105.86 -177.4 3.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 109.515 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.438 ' O ' ' CD ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -145.49 118.98 9.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.297 -0.877 . . . . 0.0 109.752 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.572 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -120.26 143.35 48.36 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.389 -0.82 . . . . 0.0 109.417 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.527 ' CG1' ' CB ' ' A' ' 122' ' ' HIS . 13.3 p -126.23 169.52 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.22 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.547 HG11 ' N ' ' A' ' 96' ' ' ALA . 53.1 t -140.63 152.11 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.765 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.547 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -129.56 71.63 82.06 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 109.222 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.522 ' HD3' HG11 ' A' ' 95' ' ' VAL . 48.7 Cg_endo -97.34 -178.6 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.726 1.617 . . . . 0.0 111.578 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.54 HG21 ' CB ' ' A' ' 81' ' ' ALA . 3.1 mp -138.6 169.4 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 23.4 t0 -135.76 154.79 51.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.907 -1.121 . . . . 0.0 110.041 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.523 ' CB ' ' HB3' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -114.08 175.23 5.56 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.697 ' CD2' ' CE1' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -150.42 152.4 34.26 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.999 -1.063 . . . . 0.0 110.823 -178.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.465 ' HD2' ' HB2' ' A' ' 111' ' ' SER . 0.0 OUTLIER -142.25 108.31 5.2 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.555 ' CZ ' ' CG2' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -89.24 -177.53 5.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 109.598 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.518 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -149.75 -176.09 5.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.339 -0.851 . . . . 0.0 109.698 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.88 76.78 1.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -172.34 -75.15 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.22 -1.164 . . . . 0.0 109.58 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 157.66 -20.6 0.38 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.49 -164.31 1.03 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -1.174 . . . . 0.0 109.587 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.554 ' CG2' ' CG2' ' A' ' 10' ' ' VAL . 60.9 t -109.43 148.97 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.897 . . . . 0.0 109.176 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.543 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 96.9 t -125.93 -61.75 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.055 -1.028 . . . . 0.0 109.678 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 102' ' ' ARG . 1.5 m -112.29 161.6 16.44 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.876 -1.14 . . . . 0.0 109.738 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 100' ' ' HIS . 15.2 ttp -158.97 155.89 28.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 109.448 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.523 ' HB3' ' CB ' ' A' ' 100' ' ' HIS . 30.8 ttm180 -140.34 168.2 20.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.87 . . . . 0.0 108.946 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.505 ' N ' ' CG ' ' A' ' 113' ' ' ARG . . . -144.58 130.86 19.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.976 -1.077 . . . . 0.0 109.682 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.561 ' O ' ' HB3' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -111.84 132.48 54.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 109.723 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.682 ' CZ ' ' H62' ' A' ' 126' ' ' NTH . 9.0 p90 167.7 -158.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.44 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . 164.35 -163.93 36.4 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.495 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 4.3 tt0 -73.88 -2.35 23.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -1.185 . . . . 0.0 109.261 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -92.57 -29.44 16.16 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.954 0.883 . . . . 0.0 109.057 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 96' ' ' ALA . 1.5 m-20 -89.04 10.73 20.57 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.332 0.587 . . . . 0.0 109.476 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.536 HG21 ' CG2' ' A' ' 95' ' ' VAL . 4.3 mm -94.23 -167.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.331 -0.856 . . . . 0.0 108.738 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.527 ' CB ' ' CG1' ' A' ' 94' ' ' VAL . 1.6 t60 -151.21 153.8 35.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.098 -1.001 . . . . 0.0 109.609 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.459 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.01 89.13 1.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -91.81 139.67 14.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.262 -1.14 . . . . 0.0 109.449 -179.973 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.5 ptt? . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.182 0.515 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.456 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 1.4 t-20 175.48 171.24 0.32 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.668 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 2.5 m -59.34 110.03 2.39 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.331 -0.856 . . . . 0.0 109.53 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.8 Cg_endo -73.63 -7.15 19.82 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.994 1.523 . . . . 0.0 110.074 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.57 -45.21 72.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.329 -0.857 . . . . 0.0 109.191 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' B' ' 209' ' ' ALA . 0.2 OUTLIER -62.56 -52.42 63.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.214 -0.929 . . . . 0.0 109.107 179.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' MET . . . . . 0.594 ' HA ' ' CZ ' ' B' ' 303' ' ' PHE . 74.9 mtm -62.06 -42.35 99.1 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.334 -0.854 . . . . 0.0 109.498 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 9.6 m -56.1 -37.15 68.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.171 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' B' ' 206' ' ' HIS . . . -52.42 -46.23 66.28 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.646 ' CG1' ' CE1' ' B' ' 301' ' ' PHE . 2.5 t -53.24 -30.38 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.577 HG22 ' CD1' ' B' ' 280' ' ' PHE . 21.0 t -84.47 -43.52 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.225 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.4 tt0 -61.71 -73.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.088 0.947 . . . . 0.0 108.624 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.516 ' HD2' ' CD1' ' B' ' 229' ' ' LEU . 0.0 OUTLIER -41.4 -45.18 3.04 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' TYR . . . . . 0.569 ' CD1' HD13 ' B' ' 218' ' ' LEU . 1.6 t80 -45.41 -45.45 12.77 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.624 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.1 t -90.51 -40.35 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' B' ' 220' ' ' ALA . . . -49.21 -37.58 23.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.535 ' CB ' HG12 ' B' ' 226' ' ' ILE . . . -73.05 -31.64 64.54 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.624 ' CD1' ' HA ' ' B' ' 215' ' ' VAL . 5.5 mt -66.91 -59.89 3.12 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' B' ' 265' ' ' VAL . 0.7 OUTLIER -55.59 -37.56 68.25 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.564 0.697 . . . . 0.0 109.534 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' B' ' 216' ' ' ALA . . . -88.59 -6.1 57.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 109.624 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.544 ' CA ' HD23 ' B' ' 259' ' ' LEU . . . 55.41 47.52 75.4 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.42 ' OD2' ' HB3' ' B' ' 224' ' ' ASP . 16.5 t70 -114.32 77.04 1.03 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -1.092 . . . . 0.0 109.753 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' LEU . . . . . 0.579 ' CD2' ' CD2' ' B' ' 259' ' ' LEU . 1.4 mm? -46.75 -27.2 1.12 Allowed 'General case' 0 C--N 1.307 -1.239 0 O-C-N 121.138 -0.977 . . . . 0.0 109.561 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.42 ' HB3' ' OD2' ' B' ' 222' ' ' ASP . 16.4 t0 -60.01 -50.03 75.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.325 -0.86 . . . . 0.0 109.596 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -66.64 -29.28 74.5 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.622 ' CG2' ' CD2' ' B' ' 255' ' ' PHE . 11.4 mt -66.19 -60.65 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.443 -1.034 . . . . 0.0 108.35 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.52 HG23 ' CG ' ' B' ' 252' ' ' ARG . 38.9 t -58.14 -42.31 82.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -53.25 -51.35 62.48 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 8.7 tp -64.23 -19.55 65.44 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . 0.618 ' CD2' ' CG2' ' B' ' 251' ' ' ILE . 5.9 m-85 -93.04 145.94 24.01 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.429 -0.794 . . . . 0.0 109.93 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -57.63 -163.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 109.406 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' B' ' 248' ' ' THR . 0.3 OUTLIER -77.76 -24.26 49.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.545 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 3.2 p30 -150.4 45.06 0.88 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.578 -0.701 . . . . 0.0 109.481 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' B' ' 310' ' ' VAL . . . -54.71 175.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 109.518 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' THR . . . . . 0.503 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -129.07 137.93 51.56 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.26 -0.9 . . . . 0.0 110.233 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.536 HG21 ' CE ' ' B' ' 312' ' ' MET . 7.0 t -124.32 119.72 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 0.0 OUTLIER -88.52 111.22 21.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' ASP . . . . . 0.68 ' OD2' ' H61' ' B' ' 326' ' ' NTH . 30.6 t70 -179.93 143.23 0.36 Allowed Pre-proline 0 C--N 1.301 -1.511 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.561 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 48.9 Cg_endo -73.96 172.79 59.73 Favored 'Cis proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.214 -1.994 . . . . 0.0 110.782 -0.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.538 HG23 ' CG1' ' A' ' 74' ' ' VAL . 3.3 m -57.92 146.7 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 109.037 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . 0.533 ' HA3' ' CB ' ' A' ' 75' ' ' ALA . . . 68.39 7.58 52.94 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' SER . . . . . 0.526 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -111.66 -153.77 0.53 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -1.121 . . . . 0.0 109.235 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -122.99 130.88 24.43 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.039 -1.038 . . . . 0.0 110.169 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' PRO . . . . . 0.583 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.4 Cg_endo -63.4 -165.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.138 1.599 . . . . 0.0 111.334 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.583 ' NH1' ' CG1' ' B' ' 251' ' ' ILE . 0.0 OUTLIER -151.74 146.15 25.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.541 ' N ' ' HG2' ' B' ' 245' ' ' ARG . 0.3 OUTLIER -136.98 138.67 40.79 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.931 -1.105 . . . . 0.0 110.865 -178.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . 0.545 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 122.88 146.58 7.19 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' THR . . . . . 0.501 ' N ' ' O ' ' B' ' 232' ' ' ASP . 3.1 m -57.85 -70.21 0.14 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.406 -1.055 . . . . 0.0 109.553 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' B' ' 248' ' ' THR . . . -45.36 -25.68 0.43 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 109.173 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.545 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -84.21 -57.51 3.14 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.366 -0.834 . . . . 0.0 109.55 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.618 ' CG2' ' CD2' ' B' ' 230' ' ' PHE . 45.0 mt -44.82 -36.94 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -0.981 . . . . 0.0 108.944 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' ARG . . . . . 0.52 ' CG ' HG23 ' B' ' 227' ' ' VAL . 5.5 ttp180 -76.76 -52.73 9.03 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.506 -0.746 . . . . 0.0 109.14 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -50.9 -32.26 20.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 108.831 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.479 ' HB2' ' HD3' ' B' ' 245' ' ' ARG . 1.0 OUTLIER -82.62 -71.14 0.5 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.622 ' CD2' ' CG2' ' B' ' 226' ' ' ILE . 0.2 OUTLIER -46.96 -26.03 0.92 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . 0.521 ' N ' HD13 ' B' ' 223' ' ' LEU . . . -74.33 -51.33 15.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 108.614 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -46.94 -32.2 3.68 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' SER . . . . . 0.784 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 35.2 t -69.5 -37.89 77.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.1 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . 0.579 ' CD2' ' CD2' ' B' ' 223' ' ' LEU . 7.3 tp -71.64 -32.3 67.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.526 -0.734 . . . . 0.0 109.888 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -47.27 -25.98 1.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.184 -0.947 . . . . 0.0 109.284 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' LEU . . . . . 0.76 HD12 H211 ' B' ' 326' ' ' NTH . 0.3 OUTLIER -96.52 120.42 62.22 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 109.101 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' PRO . . . . . 0.441 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 46.7 Cg_endo -72.42 108.59 2.55 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.743 1.391 . . . . 0.0 110.728 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.599 ' CD2' ' CD2' ' B' ' 261' ' ' LEU . 0.0 OUTLIER -137.97 163.4 31.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.193 -0.942 . . . . 0.0 109.719 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' B' ' 284' ' ' VAL . . . -92.25 130.23 38.01 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . 0.527 ' O ' ' ND2' ' B' ' 219' ' ' ASN . 2.0 t -117.66 117.58 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 110.104 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 29.8 tt0 -150.22 108.82 3.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.17 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . 0.496 HD21 ' CG2' ' B' ' 271' ' ' VAL . 0.6 OUTLIER -48.68 178.42 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.258 -0.901 . . . . 0.0 109.849 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 268' ' ' THR . . . . . 0.465 ' O ' ' O ' ' B' ' 269' ' ' GLN . 29.6 p -143.56 -82.71 0.17 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.84 . . . . 0.0 109.291 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 269' ' ' GLN . . . . . 0.505 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 12.0 pt20 -60.36 -144.41 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 38.7 tt0 -114.54 134.08 55.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 109.833 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . 0.518 HG12 ' CG1' ' B' ' 211' ' ' VAL . 41.6 t -62.09 158.69 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.374 -0.829 . . . . 0.0 109.153 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' B' ' 279' ' ' ALA . 0.0 OUTLIER -122.82 135.32 54.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.025 -1.047 . . . . 0.0 110.262 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.19 128.45 12.05 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 274' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -137.81 152.7 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.902 -1.124 . . . . 0.0 110.557 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . 37.72 -96.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.881 -0.512 . . . . 0.0 110.524 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 276' ' ' ASN . . . . . 0.588 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 2.9 p-10 -124.97 -10.95 7.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.082 -1.011 . . . . 0.0 109.97 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . 0.47 ' OE2' ' NH1' ' A' ' 113' ' ' ARG . 1.0 OUTLIER -99.7 -163.57 1.04 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.834 -1.166 . . . . 0.0 109.199 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 278' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' B' ' 272' ' ' ARG . . . 179.68 166.86 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 110.047 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 279' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' B' ' 272' ' ' ARG . . . -150.07 132.93 16.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . 0.577 ' CD1' HG22 ' B' ' 211' ' ' VAL . 21.9 p90 -150.25 170.44 18.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.624 -1.298 . . . . 0.0 110.315 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.492 ' HB1' HG13 ' B' ' 298' ' ' ILE . . . -145.27 -175.27 4.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.634 -0.666 . . . . 0.0 109.625 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 282' ' ' PHE . . . . . 0.509 ' CE1' ' CE2' ' B' ' 280' ' ' PHE . 8.1 p90 -179.14 -173.86 0.3 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.327 -0.858 . . . . 0.0 109.333 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.81 153.83 50.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.442 -0.786 . . . . 0.0 109.733 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 284' ' ' VAL . . . . . 0.522 ' CG1' HD22 ' B' ' 263' ' ' LEU . 3.7 t -142.6 119.28 6.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.373 -0.829 . . . . 0.0 109.102 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.85 100.46 7.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.155 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.576 ' CD1' HD23 ' B' ' 263' ' ' LEU . 37.1 p90 -110.53 164.34 12.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.172 -0.955 . . . . 0.0 109.712 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 287' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' B' ' 288' ' ' PHE . 2.8 tm-20 -132.8 169.66 16.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.0 OUTLIER -118.23 -78.13 0.58 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.928 . . . . 0.0 109.88 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.22 10.48 1.29 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.388 -0.82 . . . . 0.0 110.046 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 290' ' ' GLY . . . . . 0.461 ' N ' ' OE2' ' B' ' 287' ' ' GLU . . . -178.34 -71.54 0.06 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 291' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' B' ' 287' ' ' GLU . 0.3 OUTLIER -73.72 151.59 40.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.238 -1.154 . . . . 0.0 109.06 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 292' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' B' ' 324' ' ' GLY . 0.0 OUTLIER -128.09 120.02 26.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.062 -1.024 . . . . 0.0 110.066 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 293' ' ' THR . . . . . 0.579 ' CB ' ' HB2' ' B' ' 322' ' ' HIS . 0.6 OUTLIER -97.25 -167.17 1.5 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 294' ' ' VAL . . . . . 0.583 ' O ' ' O ' ' B' ' 321' ' ' ILE . 1.7 p -153.61 -169.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.719 -1.238 . . . . 0.0 109.579 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.565 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 6.7 t -154.87 141.05 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.809 -1.182 . . . . 0.0 109.184 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 296' ' ' ALA . . . . . 0.415 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -141.25 69.87 27.49 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.091 -1.005 . . . . 0.0 109.779 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 297' ' ' PRO . . . . . 0.628 ' CB ' ' CD1' ' B' ' 316' ' ' PHE . 52.1 Cg_endo -98.7 169.27 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.869 1.713 . . . . 0.0 112.454 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.492 HG13 ' HB1' ' B' ' 281' ' ' ALA . 2.5 mp -136.56 135.42 49.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . 0.576 ' HB3' ' CE1' ' B' ' 280' ' ' PHE . 3.9 t0 -112.33 156.68 22.06 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.782 -1.199 . . . . 0.0 111.054 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.51 ' O ' ' CG ' ' B' ' 312' ' ' MET . 71.6 t60 -108.62 171.59 7.33 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 301' ' ' PHE . . . . . 0.646 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.49 145.61 29.2 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.461 -1.399 . . . . 0.0 111.131 -178.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.451 ' HB3' ' HB2' ' B' ' 311' ' ' SER . 8.7 ttt85 -141.16 120.24 12.85 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 303' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' B' ' 207' ' ' MET . 2.7 m-85 -90.88 -175.41 4.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.108 -0.995 . . . . 0.0 109.879 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 304' ' ' ASN . . . . . 0.526 ' CA ' HG23 ' B' ' 310' ' ' VAL . 0.6 OUTLIER -114.23 -44.32 3.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 109.291 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 305' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -178.02 40.75 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 306' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 77.02 66.11 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -1.09 . . . . 0.0 109.625 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -159.6 -65.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.92 -166.25 2.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -1.14 . . . . 0.0 109.338 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 309' ' ' VAL . . . . . 0.521 HG21 ' CE1' ' B' ' 301' ' ' PHE . 42.5 t -90.0 157.3 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.138 -0.976 . . . . 0.0 109.115 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.526 HG23 ' CA ' ' B' ' 304' ' ' ASN . 0.7 OUTLIER -133.22 -38.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 109.779 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 311' ' ' SER . . . . . 0.451 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 68.6 m -143.67 163.51 33.04 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.088 -1.008 . . . . 0.0 109.319 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 312' ' ' MET . . . . . 0.536 ' CE ' HG21 ' B' ' 236' ' ' VAL . 2.1 ttp -157.08 167.66 29.76 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.279 -0.888 . . . . 0.0 109.936 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 313' ' ' ARG . . . . . 0.487 ' HA ' ' HB2' ' B' ' 237' ' ' GLU . 5.2 mmt180 -146.83 151.81 37.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.406 -0.808 . . . . 0.0 108.972 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -113.38 147.39 37.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 110.1 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 315' ' ' LEU . . . . . 0.676 ' O ' ' CD1' ' B' ' 316' ' ' PHE . 3.1 tp -110.22 -143.01 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.729 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 316' ' ' PHE . . . . . 0.688 ' HZ ' ' H62' ' B' ' 326' ' ' NTH . 42.4 p90 44.84 -165.35 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.713 . . . . 0.0 110.029 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 317' ' ' GLY . . . . . 0.529 ' N ' ' CD2' ' B' ' 316' ' ' PHE . . . -163.66 -161.08 12.29 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 318' ' ' GLU . . . . . 0.505 ' OE1' ' CE ' ' A' ' 1' ' ' MET . 7.2 tt0 -79.26 5.07 13.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -1.169 . . . . 0.0 109.606 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.6 -34.81 13.17 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.185 -0.947 . . . . 0.0 109.5 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 320' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -101.05 32.12 3.35 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 321' ' ' ILE . . . . . 0.583 ' O ' ' O ' ' B' ' 294' ' ' VAL . 19.6 mm -94.96 -116.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.738 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 322' ' ' HIS . . . . . 0.579 ' HB2' ' CB ' ' B' ' 293' ' ' THR . 5.8 p-80 -88.22 101.61 14.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.719 . . . . 0.0 112.5 -176.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -156.28 115.25 3.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.503 -0.748 . . . . 0.0 109.488 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' B' ' 292' ' ' LYS . . . 179.69 139.45 3.72 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.191 -1.182 . . . . 0.0 109.497 -179.984 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' NTH . . . . . 0.753 ' H12' ' HB2' ' A' ' 58' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 326' ' ' NTH . . . . . 0.784 ' H11' ' OG ' ' B' ' 258' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.313 0.578 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.512 ' HB3' ' CE ' ' A' ' 7' ' ' MET . 7.9 m120 -108.71 148.14 30.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.504 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.58 107.99 0.98 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.668 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 8' ' ' THR . 44.9 Cg_endo -71.85 -9.63 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.968 1.51 . . . . 0.0 110.038 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.64 -48.85 75.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.386 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -54.39 36.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.235 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.512 ' CE ' ' HB3' ' A' ' 2' ' ' ASN . 22.3 mtt -60.97 -31.0 70.59 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.176 -0.952 . . . . 0.0 109.294 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 11' ' ' VAL . 6.9 m -69.27 -36.65 77.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.12 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.06 -43.04 50.95 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.622 ' CG1' ' CE1' ' A' ' 101' ' ' PHE . 1.5 t -56.73 -22.67 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.573 ' CG2' ' CE2' ' A' ' 101' ' ' PHE . 15.9 t -90.35 -43.24 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.38 -0.825 . . . . 0.0 109.02 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 15' ' ' VAL . 6.6 tt0 -61.73 -74.0 0.09 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -42.77 -45.16 4.7 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.6 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -49.36 -44.7 45.0 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.615 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -87.65 -37.86 11.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.367 -0.833 . . . . 0.0 109.052 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -49.05 -37.55 21.31 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.7 -32.01 65.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.615 ' CD1' ' HA ' ' A' ' 15' ' ' VAL . 2.2 mt -67.23 -58.58 4.58 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 65' ' ' VAL . 4.4 t-20 -50.86 -42.56 58.88 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.481 0.657 . . . . 0.0 109.435 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.27 -2.58 58.52 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 109.573 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.529 ' CA ' HD23 ' A' ' 59' ' ' LEU . . . 56.73 47.77 82.81 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' CB ' ' A' ' 24' ' ' ASP . 6.9 t0 -112.08 82.23 1.59 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.204 -1.174 . . . . 0.0 109.909 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.585 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 3.2 mm? -48.96 -22.54 0.87 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.216 -0.928 . . . . 0.0 109.616 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 19.3 t0 -58.26 -49.83 75.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.837 . . . . 0.0 109.393 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.79 -43.07 92.57 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.502 HG22 ' CD1' ' A' ' 55' ' ' PHE . 9.7 mt -56.19 -52.84 46.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.533 ' CG2' ' HG3' ' A' ' 52' ' ' ARG . 7.1 t -65.68 -47.44 86.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 24' ' ' ASP . . . -50.49 -46.81 57.22 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.517 ' CD2' ' HA ' ' A' ' 10' ' ' VAL . 7.8 tp -68.66 -21.37 64.45 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.641 ' CD2' ' CG2' ' A' ' 51' ' ' ILE . 3.1 m-85 -82.78 139.17 33.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.538 -0.726 . . . . 0.0 109.651 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . -60.49 -169.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.451 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -70.94 -23.69 62.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.377 -0.827 . . . . 0.0 109.788 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.526 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -148.95 49.96 0.98 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.653 -0.655 . . . . 0.0 109.476 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -58.86 167.55 1.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -126.32 138.07 53.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' A' ' 37' ' ' GLU . 23.6 t -129.0 167.68 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.064 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.536 ' N ' ' CG1' ' A' ' 36' ' ' VAL . 3.0 mt-10 -143.74 118.07 9.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 108.936 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.527 ' OD2' ' CB ' ' A' ' 114' ' ' ALA . 4.1 t70 -174.94 139.7 0.63 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 109.594 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 38' ' ' ASP . 45.3 Cg_endo -71.81 -174.3 11.37 Favored 'Cis proline' 0 N--CA 1.489 1.259 0 C-N-CA 122.15 -2.021 . . . . 0.0 110.649 0.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' B' ' 274' ' ' VAL . 15.4 m -67.02 59.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 109.625 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 39' ' ' PRO . . . -140.42 -83.56 0.09 OUTLIER Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.424 ' C ' ' HG2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -165.5 50.92 0.1 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.641 -0.917 . . . . 0.0 109.708 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.556 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 2.4 mm-40 -134.7 58.6 29.86 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.678 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.528 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 48.5 Cg_endo -79.29 -177.74 4.11 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.204 1.633 . . . . 0.0 110.394 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.56 ' HD3' ' CD1' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -150.39 102.44 3.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 108.96 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.527 ' HB2' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -92.25 149.34 21.51 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.146 -0.971 . . . . 0.0 110.203 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 98.67 168.22 31.06 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 3.7 m -80.88 -57.06 3.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -1.114 . . . . 0.0 109.093 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.87 -30.53 46.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.139 -0.976 . . . . 0.0 109.118 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.51 ' CB ' ' HG3' ' A' ' 45' ' ' ARG . . . -78.75 -53.43 7.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.431 -0.793 . . . . 0.0 109.094 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.641 ' CG2' ' CD2' ' A' ' 30' ' ' PHE . 6.5 mm -50.36 -36.07 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.392 -0.818 . . . . 0.0 109.294 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.533 ' HG3' ' CG2' ' A' ' 27' ' ' VAL . 7.6 ttp180 -74.58 -59.94 2.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 109.083 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 52' ' ' ARG . 2.0 tt0 -44.32 -27.4 0.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 108.825 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.56 ' CD1' ' HD3' ' A' ' 45' ' ' ARG . 0.6 OUTLIER -85.66 -70.08 0.62 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.529 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -53.05 -18.69 2.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.821 -0.549 . . . . 0.0 109.764 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.516 ' CB ' ' HG ' ' A' ' 23' ' ' LEU . . . -86.06 -35.78 20.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.957 . . . . 0.0 108.7 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 4.3 t30 -69.06 -39.7 78.96 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.578 ' OG ' ' H10' ' A' ' 126' ' ' NTH . 3.4 t -63.93 -33.81 76.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 108.821 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.585 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 8.5 tp -63.75 -20.63 65.9 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.39 -0.819 . . . . 0.0 109.645 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -53.43 -20.97 5.25 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.079 -1.013 . . . . 0.0 108.914 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.683 ' CD1' H182 ' A' ' 126' ' ' NTH . 0.5 OUTLIER -89.8 113.73 58.03 Favored Pre-proline 0 N--CA 1.486 1.34 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 43.8 Cg_endo -70.56 106.14 1.75 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.791 1.416 . . . . 0.0 111.149 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.581 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.65 160.23 39.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.897 . . . . 0.0 109.718 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.28 127.87 36.27 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.458 ' CG1' HG11 ' A' ' 15' ' ' VAL . 17.6 t -105.96 114.13 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.136 -0.977 . . . . 0.0 109.916 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 67' ' ' LEU . 28.2 tt0 -150.47 98.51 2.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.25 -0.906 . . . . 0.0 109.041 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -47.04 173.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.909 . . . . 0.0 109.507 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 69' ' ' GLN . 2.5 p -142.94 -81.86 0.19 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.375 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -58.43 -151.72 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.422 ' CD ' ' HE2' ' B' ' 319' ' ' LYS . 39.8 tt0 -108.94 131.67 54.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.102 -0.999 . . . . 0.0 109.761 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.511 HG11 ' N ' ' A' ' 72' ' ' ARG . 54.1 t -58.41 147.56 6.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.375 -0.828 . . . . 0.0 109.21 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -104.01 132.61 50.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 109.673 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.464 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -139.75 141.15 36.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' B' ' 316' ' ' PHE . 0.2 OUTLIER -123.71 -157.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.899 . . . . 0.0 109.315 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -38.67 -93.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 110.22 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 3.4 m120 -104.63 -18.24 14.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -0.998 . . . . 0.0 109.79 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 101' ' ' PHE . 4.4 mt-10 -90.35 -161.82 0.83 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.125 -0.984 . . . . 0.0 109.293 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.517 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 177.55 164.75 0.61 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 72' ' ' ARG . . . -150.37 138.88 20.56 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.63 ' CE1' ' CE2' ' A' ' 101' ' ' PHE . 22.2 p90 -150.42 161.34 42.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.76 -1.213 . . . . 0.0 110.335 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.519 ' HB2' ' CG2' ' A' ' 98' ' ' ILE . . . -139.43 160.37 40.0 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.546 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 1.5 p90 -157.69 -176.68 6.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 0.0 109.558 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -118.24 143.03 46.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.452 -0.78 . . . . 0.0 109.284 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.538 ' CG1' ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -120.83 124.1 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.493 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 1.7 p -109.94 110.55 21.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 108.918 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.65 ' CZ ' H211 ' A' ' 126' ' ' NTH . 9.0 p90 -131.39 167.47 19.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.064 -1.022 . . . . 0.0 110.225 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.518 ' HB2' ' CB ' ' A' ' 92' ' ' LYS . 42.9 tt0 -148.73 167.35 25.78 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -146.77 -100.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.952 -1.093 . . . . 0.0 110.192 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.49 ' HG2' ' N ' ' A' ' 90' ' ' GLY . 1.0 OUTLIER -61.39 -25.4 67.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 110.005 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.49 ' N ' ' HG2' ' A' ' 89' ' ' GLN . . . 168.36 -65.92 0.18 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.53 ' O ' ' CE1' ' A' ' 88' ' ' PHE . 1.6 ttm180 -55.77 118.46 4.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -1.115 . . . . 0.0 108.977 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.518 ' CB ' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -90.57 125.23 35.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.091 -1.006 . . . . 0.0 109.592 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.534 ' O ' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -106.11 143.36 34.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.333 -0.855 . . . . 0.0 109.451 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER -108.31 178.07 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.568 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 3.5 t -150.87 144.78 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.029 -1.044 . . . . 0.0 110.038 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.515 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -133.29 71.36 76.73 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.532 -0.73 . . . . 0.0 110.037 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.568 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 51.9 Cg_endo -95.56 -175.57 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.529 1.486 . . . . 0.0 110.986 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.519 ' CG2' ' HB2' ' A' ' 81' ' ' ALA . 3.0 mp -139.91 136.23 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.594 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 5.1 t0 -109.74 161.92 14.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.995 -1.065 . . . . 0.0 110.071 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' A' ' 112' ' ' MET . 59.6 t-80 -109.47 171.23 7.56 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.63 ' CE2' ' CE1' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -146.23 145.28 30.35 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.952 -1.093 . . . . 0.0 110.544 -178.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.425 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 3.3 ttm180 -144.57 114.64 7.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 0.0 108.973 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.497 ' N ' ' CD1' ' A' ' 103' ' ' PHE . 4.2 m-85 -94.97 -171.72 2.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.191 -0.943 . . . . 0.0 109.489 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.506 ' HB3' ' CG1' ' A' ' 110' ' ' VAL . 1.2 p30 -127.19 -34.12 2.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.446 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . -161.38 24.3 0.24 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 71.15 60.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -1.106 . . . . 0.0 109.515 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.19 -62.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -128.13 -164.7 1.4 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -1.134 . . . . 0.0 109.407 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 30' ' ' PHE . 62.7 t -106.13 139.89 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.172 -0.955 . . . . 0.0 109.376 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 104' ' ' ASN . 0.5 OUTLIER -123.27 -24.56 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -0.971 . . . . 0.0 109.833 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.459 ' OG ' ' OG1' ' A' ' 35' ' ' THR . 0.5 OUTLIER -153.79 156.32 37.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.986 . . . . 0.0 109.576 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.563 ' HE3' ' CE1' ' A' ' 30' ' ' PHE . 12.4 ttm -160.09 145.97 15.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.935 . . . . 0.0 109.671 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.473 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 7.7 mtt-85 -128.71 150.38 50.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 0.0 109.063 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.527 ' CB ' ' OD2' ' A' ' 38' ' ' ASP . . . -118.49 150.87 38.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 109.693 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.529 ' CD1' ' HB2' ' B' ' 279' ' ' ALA . 0.8 OUTLIER -146.88 145.24 29.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.325 -0.859 . . . . 0.0 109.665 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.54 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 33.9 p90 164.45 -163.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.485 ' O ' HG12 ' A' ' 121' ' ' ILE . . . -179.9 -169.26 39.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.508 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 21.7 tt0 -68.93 -6.65 28.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -1.076 . . . . 0.0 109.465 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -88.47 -29.8 19.88 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 122.016 0.913 . . . . 0.0 109.071 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -88.79 3.73 50.04 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.508 ' CG1' ' HA ' ' A' ' 118' ' ' GLU . 2.8 mm -91.41 -164.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.495 ' O ' ' CG2' ' A' ' 93' ' ' THR . 0.2 OUTLIER -151.8 176.91 10.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.819 -1.176 . . . . 0.0 109.896 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.532 ' HA ' ' CG2' ' A' ' 93' ' ' THR . . . -155.43 136.02 13.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -0.804 . . . . 0.0 109.254 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 92' ' ' LYS . . . 76.73 -117.43 4.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.249 -1.148 . . . . 0.0 109.49 180.0 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 1.6 ttp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.234 0.54 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.462 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 21.7 t30 65.6 63.29 0.62 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 109.581 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 2.1 t -43.61 103.29 0.31 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.933 . . . . 0.0 109.589 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 47.8 Cg_endo -74.11 -13.18 23.61 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.987 1.519 . . . . 0.0 110.348 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.9 -46.45 87.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.617 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -60.15 -52.41 65.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.086 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' MET . . . . . 0.406 ' HE1' ' ND2' ' B' ' 202' ' ' ASN . 73.7 mtm -68.06 -18.36 64.66 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.421 -0.8 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.476 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 5.9 m -84.22 -33.78 24.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -57.96 -48.68 79.23 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.201 -0.937 . . . . 0.0 109.206 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.612 ' CG1' ' CZ ' ' B' ' 301' ' ' PHE . 0.9 OUTLIER -49.6 -32.58 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.935 . . . . 0.0 108.531 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' B' ' 208' ' ' THR . 4.4 t -71.83 -39.83 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 109.419 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.2 tt0 -64.82 -74.54 0.1 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' B' ' 212' ' ' GLN . 0.4 OUTLIER -42.0 -44.14 3.41 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 122.031 0.919 . . . . 0.0 108.697 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' TYR . . . . . 0.634 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -49.46 -45.41 46.63 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.619 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.4 t -88.75 -37.36 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.3 -0.875 . . . . 0.0 109.127 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.82 -34.69 12.92 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' B' ' 226' ' ' ILE . . . -75.24 -33.91 61.36 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.634 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 2.2 mt -65.09 -58.53 5.81 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -48.36 -41.03 27.51 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.593 0.711 . . . . 0.0 109.182 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.45 4.42 49.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.71 . . . . 0.0 109.842 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.534 ' CA ' HD23 ' B' ' 259' ' ' LEU . . . 48.77 31.63 10.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -97.97 87.46 3.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.325 -1.103 . . . . 0.0 109.787 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' B' ' 259' ' ' LEU . 3.7 mm? -51.9 -19.95 2.04 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.193 -0.942 . . . . 0.0 109.848 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' B' ' 228' ' ' ALA . 73.0 m-20 -61.58 -54.06 48.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.256 -0.902 . . . . 0.0 109.264 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' B' ' 228' ' ' ALA . . . -61.05 -38.37 95.44 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.448 HG12 ' HB2' ' B' ' 217' ' ' ALA . 8.7 mt -61.32 -57.32 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.466 ' HA ' ' HB2' ' B' ' 230' ' ' PHE . 24.7 t -60.7 -42.98 94.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.444 ' HB2' ' HA2' ' B' ' 225' ' ' GLY . . . -54.11 -50.17 67.48 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' B' ' 309' ' ' VAL . 8.2 tp -67.92 -22.87 65.04 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . 0.548 ' CD2' HG23 ' B' ' 251' ' ' ILE . 5.3 m-85 -88.41 136.58 32.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.572 -0.705 . . . . 0.0 109.915 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' B' ' 309' ' ' VAL . . . -52.21 -174.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 109.354 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -25.07 49.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.749 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.53 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 0.2 OUTLIER -135.32 44.99 2.52 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' B' ' 310' ' ' VAL . . . -63.62 150.17 44.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.357 -0.839 . . . . 0.0 109.989 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -108.83 149.18 29.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.478 -0.764 . . . . 0.0 109.033 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 48.7 t -140.12 122.39 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 109.695 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' GLU . . . . . 0.513 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.6 mt-10 -89.6 104.1 16.69 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' ASP . . . . . 0.546 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 22.7 t70 179.66 142.16 0.33 Allowed Pre-proline 0 C--N 1.301 -1.535 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.027 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.493 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 47.5 Cg_endo -72.71 176.34 40.68 Favored 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.283 -1.965 . . . . 0.0 111.041 0.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.508 ' CG2' HG13 ' A' ' 74' ' ' VAL . 5.0 m -61.29 153.58 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 0.0 109.15 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 55.76 18.23 16.82 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -118.05 -154.57 0.57 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.41 -1.053 . . . . 0.0 109.257 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -124.63 128.88 24.81 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 110.126 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' PRO . . . . . 0.539 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.3 Cg_endo -64.93 -174.11 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.934 1.492 . . . . 0.0 111.145 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.528 ' HG3' ' CB ' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.65 103.24 3.09 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.527 ' HB2' ' CG2' ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.24 152.12 21.75 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.17 -0.956 . . . . 0.0 109.674 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 110.25 162.64 18.8 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 5.3 m -77.16 -36.57 55.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.184 -1.186 . . . . 0.0 109.129 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -73.79 -19.69 60.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 108.97 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.528 ' CB ' ' HG3' ' B' ' 245' ' ' ARG . . . -90.36 -45.07 9.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.401 -0.812 . . . . 0.0 109.306 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.548 HG23 ' CD2' ' B' ' 230' ' ' PHE . 10.3 mm -61.89 -50.48 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 0.0 109.521 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' B' ' 256' ' ' ALA . 21.0 ttp180 -66.34 -52.39 47.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.049 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 22.4 mt-10 -47.91 -32.48 6.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.966 -1.083 . . . . 0.0 108.448 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.546 ' CZ ' ' O ' ' B' ' 238' ' ' ASP . 0.6 OUTLIER -84.48 -70.81 0.55 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.523 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -49.64 -22.57 1.37 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.469 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . 0.526 ' CB ' ' HG ' ' B' ' 223' ' ' LEU . . . -84.35 -49.11 9.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 108.744 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' B' ' 253' ' ' GLU . 0.3 OUTLIER -57.38 -37.49 72.76 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.236 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' SER . . . . . 0.665 ' OG ' H111 ' B' ' 326' ' ' NTH . 7.6 t -65.57 -32.34 73.88 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' B' ' 223' ' ' LEU . 9.5 tp -64.68 -22.43 66.98 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.413 -0.804 . . . . 0.0 109.248 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . 0.485 ' O ' ' HD3' ' B' ' 262' ' ' PRO . 0.0 OUTLIER -50.75 -22.53 2.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.838 . . . . 0.0 108.9 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' LEU . . . . . 0.843 HD22 H121 ' B' ' 326' ' ' NTH . 0.0 OUTLIER -98.89 103.68 20.84 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 51.5 Cg_endo -76.68 125.27 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.812 1.427 . . . . 0.0 112.11 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.596 HD22 ' CD1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -145.59 176.68 9.43 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.53 125.08 36.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 26.1 t -111.48 115.38 49.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 109.979 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 266' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.2 tp10 -150.14 89.56 1.6 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.387 -0.821 . . . . 0.0 108.938 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . 0.52 ' CD2' HG23 ' B' ' 215' ' ' VAL . 1.0 OUTLIER -52.84 -170.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.351 -0.843 . . . . 0.0 110.0 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 268' ' ' THR . . . . . 0.667 ' O ' ' N ' ' B' ' 270' ' ' GLU . 6.5 p -136.68 53.13 1.92 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.844 . . . . 0.0 108.819 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 269' ' ' GLN . . . . . 0.549 ' CG ' ' O ' ' B' ' 268' ' ' THR . 17.9 pt20 50.7 -55.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' B' ' 268' ' ' THR . 35.5 tt0 -48.89 115.26 1.2 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.492 -1.38 . . . . 0.0 110.213 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . 0.45 HG11 ' HB3' ' B' ' 280' ' ' PHE . 37.7 t -138.14 154.31 28.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.7 OUTLIER -114.66 130.21 56.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.857 -1.152 . . . . 0.0 110.003 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' B' ' 278' ' ' ALA . . . -150.47 133.21 15.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.396 -0.815 . . . . 0.0 109.001 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 274' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -150.34 158.86 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.935 -1.103 . . . . 0.0 110.435 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . 39.26 -101.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.77 -0.581 . . . . 0.0 110.321 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 276' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 2.8 m120 -121.35 -20.47 6.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.957 -1.089 . . . . 0.0 109.691 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . 0.501 ' OE2' ' NE ' ' B' ' 302' ' ' ARG . 3.9 mt-10 -92.59 -164.95 1.25 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.042 -1.037 . . . . 0.0 109.5 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 278' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' B' ' 273' ' ' ALA . . . 177.77 154.69 0.32 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 109.519 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 279' ' ' ALA . . . . . 0.537 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -136.79 141.17 42.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.945 . . . . 0.0 108.66 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . 0.574 ' CE1' ' HB3' ' B' ' 299' ' ' ASP . 37.9 p90 -150.72 171.15 17.61 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.735 -1.228 . . . . 0.0 110.028 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.464 ' HB2' HG22 ' B' ' 298' ' ' ILE . . . -145.68 -179.86 6.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.751 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 282' ' ' PHE . . . . . 0.406 ' CE1' ' HE2' ' B' ' 280' ' ' PHE . 7.0 p90 -174.32 -173.58 0.79 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.292 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 283' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -124.7 141.53 52.04 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.413 -0.805 . . . . 0.0 109.541 179.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 284' ' ' VAL . . . . . 0.544 HG12 ' CD1' ' B' ' 263' ' ' LEU . 42.1 t -120.04 113.87 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 109.469 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 1.2 p -106.14 131.75 53.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.033 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.898 ' CZ ' H212 ' B' ' 326' ' ' NTH . 1.0 OUTLIER -149.73 157.69 43.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.977 -1.077 . . . . 0.0 110.009 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 287' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' B' ' 292' ' ' LYS . 1.2 pt-20 -98.19 158.09 15.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 109.14 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.499 ' C ' ' CG ' ' B' ' 289' ' ' GLN . 0.6 OUTLIER -124.63 77.55 1.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.897 . . . . 0.0 109.594 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . 0.499 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 0.4 OUTLIER 40.36 57.36 2.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.424 -0.797 . . . . 0.0 110.262 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 107.63 -2.06 34.28 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.207 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -127.37 173.9 9.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.056 -1.261 . . . . 0.0 109.635 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 292' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' B' ' 287' ' ' GLU . 0.1 OUTLIER -138.17 140.1 39.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.384 179.534 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 293' ' ' THR . . . . . 0.429 HG22 ' HA ' ' B' ' 323' ' ' ALA . 0.0 OUTLIER -144.94 148.59 34.01 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.715 -0.616 . . . . 0.0 109.464 -179.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 294' ' ' VAL . . . . . 0.551 ' CG1' ' CD2' ' B' ' 322' ' ' HIS . 9.8 p -125.96 170.46 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.169 -0.957 . . . . 0.0 108.468 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.546 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 3.8 t -147.46 145.81 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.004 -1.06 . . . . 0.0 109.784 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 296' ' ' ALA . . . . . 0.531 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -130.18 72.67 81.83 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 110.148 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 297' ' ' PRO . . . . . 0.546 ' HD3' ' CG1' ' B' ' 295' ' ' VAL . 50.7 Cg_endo -92.5 -175.42 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.757 1.398 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.467 HG13 ' O ' ' B' ' 297' ' ' PRO . 3.2 mp -143.43 134.8 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . 0.574 ' HB3' ' CE1' ' B' ' 280' ' ' PHE . 11.3 t0 -108.42 162.89 13.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.951 -1.093 . . . . 0.0 110.317 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.527 ' O ' ' CG ' ' B' ' 312' ' ' MET . 59.9 t60 -112.58 172.71 6.76 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 301' ' ' PHE . . . . . 0.612 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.13 145.12 29.47 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.994 -1.066 . . . . 0.0 110.475 -178.478 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.519 ' CD ' ' HB2' ' B' ' 311' ' ' SER . 2.6 ttt-85 -139.3 107.0 5.61 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 303' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' B' ' 276' ' ' ASN . 5.4 m-85 -90.72 -171.38 3.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.184 -0.948 . . . . 0.0 109.871 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 304' ' ' ASN . . . . . 0.516 ' OD1' ' CG2' ' B' ' 310' ' ' VAL . 0.5 OUTLIER -124.32 -37.65 2.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.854 . . . . 0.0 109.271 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 305' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -164.29 24.42 0.18 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 306' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 75.76 64.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -1.183 . . . . 0.0 109.581 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -158.53 -58.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.32 -168.29 1.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -1.14 . . . . 0.0 109.381 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 309' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' B' ' 231' ' ' ALA . 70.1 t -108.49 135.05 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -0.947 . . . . 0.0 109.115 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.574 ' O ' ' CB ' ' B' ' 234' ' ' ALA . 10.0 t -110.54 -75.33 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.021 . . . . 0.0 109.979 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 311' ' ' SER . . . . . 0.519 ' HB2' ' CD ' ' B' ' 302' ' ' ARG . 28.8 m -107.45 162.01 14.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.634 -1.291 . . . . 0.0 109.615 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 312' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 15.3 ttp -153.95 150.31 28.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 313' ' ' ARG . . . . . 0.495 ' CG ' ' HB2' ' B' ' 237' ' ' GLU . 2.0 mtm-85 -127.79 150.47 49.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.377 -0.827 . . . . 0.0 109.068 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 314' ' ' ALA . . . . . 0.745 ' HB1' ' H7 ' ' B' ' 326' ' ' NTH . . . -110.52 130.44 55.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.084 -1.01 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 315' ' ' LEU . . . . . 0.549 ' O ' ' HB3' ' B' ' 316' ' ' PHE . 0.4 OUTLIER -124.99 135.98 53.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.092 -1.005 . . . . 0.0 110.074 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 316' ' ' PHE . . . . . 0.638 ' CE1' ' H62' ' B' ' 326' ' ' NTH . 34.3 p90 165.91 -156.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 317' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' B' ' 321' ' ' ILE . . . 165.1 -174.47 41.01 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 318' ' ' GLU . . . . . 0.533 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 13.0 tt0 -68.25 -7.18 28.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -1.134 . . . . 0.0 109.474 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 319' ' ' LYS . . . . . 0.422 ' HE2' ' CD ' ' A' ' 70' ' ' GLU . 3.5 tttp -89.55 -30.48 18.17 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.04 0.924 . . . . 0.0 109.108 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 320' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.11 6.46 39.83 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 321' ' ' ILE . . . . . 0.533 ' CG1' ' HA ' ' B' ' 318' ' ' GLU . 4.1 mm -90.09 -170.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 322' ' ' HIS . . . . . 0.551 ' CD2' ' CG1' ' B' ' 294' ' ' VAL . 0.1 OUTLIER -151.9 174.05 14.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.909 -1.119 . . . . 0.0 110.11 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.429 ' HA ' HG22 ' B' ' 293' ' ' THR . . . -155.67 173.68 16.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.078 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 174.95 141.58 3.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.172 -1.193 . . . . 0.0 109.595 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' NTH . . . . . 0.683 H182 ' CD1' ' A' ' 61' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 326' ' ' NTH . . . . . 0.898 H212 ' CZ ' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 2' ' ' ASN . 1.4 mtt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.207 0.527 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.475 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 33.8 m-20 -169.03 44.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.93 . . . . 0.0 109.626 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.3 m -83.2 110.6 24.83 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.824 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 46.6 Cg_endo -72.98 -4.25 15.08 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.871 1.458 . . . . 0.0 110.202 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.97 -44.77 53.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -50.53 72.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.41 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.566 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 64.9 mtm -60.89 -27.76 68.39 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.214 -0.929 . . . . 0.0 109.735 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.439 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 15.9 m -76.99 -37.49 55.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.366 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.59 -46.38 77.26 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.183 -0.948 . . . . 0.0 108.953 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.626 ' CG1' ' CZ ' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -49.46 -43.43 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.526 ' CG1' HD21 ' A' ' 67' ' ' LEU . 4.9 t -60.15 -40.08 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.709 -0.619 . . . . 0.0 109.725 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 13' ' ' ARG . 17.3 tt0 -63.83 -75.63 0.08 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.158 -0.963 . . . . 0.0 108.621 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.503 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -43.06 -44.64 4.93 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.612 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -49.33 -46.13 46.44 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.607 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -88.28 -39.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.59 -36.43 15.62 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 22' ' ' ASP . . . -73.82 -33.2 64.07 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.612 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 2.0 mt -64.2 -58.24 7.15 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -51.08 -46.75 61.86 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.708 0.766 . . . . 0.0 109.149 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.32 10.14 23.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.533 -0.729 . . . . 0.0 109.445 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 17' ' ' ALA . . . 47.77 30.1 6.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 17' ' ' ALA . 19.2 t70 -90.03 62.75 5.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -1.152 . . . . 0.0 109.81 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.606 ' CD1' ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -47.58 -38.03 13.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.11 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 23' ' ' LEU . 1.7 m-20 -43.21 -36.71 1.85 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.97 -30.86 30.47 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' LEU . 49.6 mt -61.51 -55.97 20.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 30' ' ' PHE . 29.7 t -60.0 -38.2 75.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.28 -54.17 50.0 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.506 ' CD2' ' HA ' ' A' ' 10' ' ' VAL . 9.1 tp -62.58 -23.43 67.02 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 31' ' ' ALA . 3.6 m-30 -91.27 142.79 27.33 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.483 -0.761 . . . . 0.0 109.7 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -52.36 -174.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.383 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.47 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.4 OUTLIER -81.32 -24.69 36.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.651 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.57 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -132.7 42.41 3.09 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.586 -0.696 . . . . 0.0 109.446 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 110' ' ' VAL . . . -59.95 157.39 12.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 109.896 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -111.66 144.91 40.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.007 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 55.7 t -133.1 130.64 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.069 -1.019 . . . . 0.0 109.835 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.547 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 23.1 mt-10 -107.92 110.13 21.81 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.653 ' OD2' ' H62' ' A' ' 126' ' ' NTH . 17.6 t70 179.19 139.89 0.28 Allowed Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.782 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 43.5 Cg_endo -69.65 -179.84 20.09 Favored 'Cis proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.353 -1.936 . . . . 0.0 111.055 -0.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -55.07 139.99 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 110.024 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' B' ' 275' ' ' ALA . . . 49.55 38.39 28.21 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.545 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -116.03 -141.77 0.37 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.41 -1.053 . . . . 0.0 109.802 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 7.1 pm0 -119.12 101.48 49.73 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.838 -1.164 . . . . 0.0 110.764 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 37.5 Cg_endo -63.31 175.87 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.984 1.518 . . . . 0.0 110.707 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.54 ' HG3' ' CB ' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -151.49 114.27 4.67 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.522 ' HB2' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -99.93 155.47 17.67 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 110.074 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 109.21 155.95 16.86 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 7.3 m -66.92 -56.46 10.16 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.322 -1.105 . . . . 0.0 108.977 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -57.93 -18.92 26.33 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.291 -0.881 . . . . 0.0 109.119 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.54 ' CB ' ' HG3' ' A' ' 45' ' ' ARG . . . -89.54 -54.84 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.381 -0.824 . . . . 0.0 109.182 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.494 HD11 ' CG2' ' A' ' 36' ' ' VAL . 2.9 mm -51.58 -39.88 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.391 -0.818 . . . . 0.0 109.203 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.58 ' CG ' ' CD2' ' A' ' 23' ' ' LEU . 5.0 ttt85 -74.38 -55.34 6.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.026 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 4.8 mt-10 -49.12 -27.75 3.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.07 -1.019 . . . . 0.0 108.867 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.65 -71.5 0.57 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.606 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -47.28 -39.06 13.68 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 52' ' ' ARG . . . -57.82 -50.92 71.65 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 39.6 t-20 -53.99 -42.55 69.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.824 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 6.9 t -59.58 -31.55 69.56 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.421 HD12 ' HA2' ' A' ' 21' ' ' GLY . 7.5 tp -68.76 -20.26 64.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 11.8 mttm -67.75 -6.35 20.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.563 -0.711 . . . . 0.0 109.252 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.566 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -88.31 113.17 54.07 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD2' HD12 ' A' ' 61' ' ' LEU . 47.0 Cg_endo -73.39 82.16 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.737 1.388 . . . . 0.0 112.047 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.566 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -140.18 164.6 29.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.027 -1.045 . . . . 0.0 109.048 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.517 ' CB ' ' OG ' ' A' ' 85' ' ' SER . . . -89.82 129.39 36.21 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.967 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.61 117.31 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.665 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -140.09 108.87 5.95 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.317 -0.865 . . . . 0.0 109.226 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.528 HD13 ' CG1' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -48.52 178.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.805 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.686 ' O ' ' N ' ' A' ' 70' ' ' GLU . 4.6 p -126.89 44.53 2.88 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.384 -0.822 . . . . 0.0 109.094 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.537 ' CG ' ' O ' ' A' ' 68' ' ' THR . 4.2 pt20 49.94 -55.39 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.686 ' N ' ' O ' ' A' ' 68' ' ' THR . 67.7 tt0 -63.32 118.15 7.62 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.535 -1.353 . . . . 0.0 110.227 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.455 ' O ' ' NZ ' ' B' ' 319' ' ' LYS . 29.9 t -130.57 146.0 34.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.657 ' CZ ' ' CG2' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -118.17 130.65 56.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.895 -1.128 . . . . 0.0 109.731 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.538 ' N ' ' HD2' ' A' ' 72' ' ' ARG . . . -147.44 117.45 7.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.717 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.657 ' CG2' ' CZ ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -135.77 160.72 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.964 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . 40.48 -143.43 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.751 -0.593 . . . . 0.0 109.914 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 103' ' ' PHE . 7.6 m-20 -90.38 12.24 19.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.105 -0.997 . . . . 0.0 109.611 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.516 ' CG ' ' HG3' ' A' ' 102' ' ' ARG . 2.3 mt-10 -115.51 -161.51 0.79 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.09 -1.006 . . . . 0.0 109.466 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . . . -179.24 163.89 1.32 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.388 -0.82 . . . . 0.0 109.962 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.553 ' HB2' ' CG ' ' A' ' 72' ' ' ARG . . . -151.7 131.68 13.4 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 31.3 p90 -151.09 174.89 12.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.733 -1.229 . . . . 0.0 109.958 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.537 ' CB ' HG21 ' A' ' 98' ' ' ILE . . . -144.39 176.94 8.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 109.91 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -165.05 -169.0 1.55 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.496 -0.753 . . . . 0.0 109.133 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.75 147.8 50.1 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 110.104 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.539 ' CG2' HG13 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -117.51 124.33 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 109.067 179.55 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.521 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 27.8 p -118.17 120.76 38.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.588 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.683 ' CZ ' H221 ' A' ' 126' ' ' NTH . 7.2 p90 -147.04 -173.5 4.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -121.79 169.33 10.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 -159.35 0.95 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 109.957 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -104.0 89.11 3.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.25 -18.17 52.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -143.91 167.11 23.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -1.08 . . . . 0.0 109.264 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -113.34 145.06 41.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.35 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.585 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -139.14 142.75 38.02 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 110.178 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.541 ' CG1' ' N ' ' A' ' 95' ' ' VAL . 0.8 OUTLIER -123.62 179.19 2.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.558 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 6.8 t -146.81 142.26 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.891 -1.131 . . . . 0.0 109.796 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.512 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -134.08 72.2 72.23 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.527 -0.733 . . . . 0.0 109.956 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.558 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 48.8 Cg_endo -94.7 -175.36 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.631 1.554 . . . . 0.0 110.973 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.537 HG21 ' CB ' ' A' ' 81' ' ' ALA . 2.7 mp -137.55 163.83 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 12.2 t0 -132.98 156.33 47.52 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.011 -1.056 . . . . 0.0 110.234 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 101' ' ' PHE . 53.5 t60 -111.84 167.84 10.05 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.626 ' CZ ' ' CG1' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -139.08 153.92 48.1 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 110.607 -178.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.516 ' HG3' ' CG ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -143.15 98.84 3.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 109.186 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.57 ' CZ ' HG13 ' A' ' 10' ' ' VAL . 5.8 m-85 -90.09 159.73 16.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 109.62 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.529 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -101.24 4.45 41.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.204 -0.935 . . . . 0.0 109.795 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.37 -76.41 0.15 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 177.96 71.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -1.159 . . . . 0.0 109.592 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.06 -65.88 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.87 -163.8 1.22 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -1.1 . . . . 0.0 109.327 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.574 HG21 ' CE1' ' A' ' 101' ' ' PHE . 37.7 t -106.27 158.16 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.099 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.547 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -127.44 -75.15 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.177 -0.952 . . . . 0.0 109.266 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.466 ' OG ' ' OG1' ' A' ' 35' ' ' THR . 3.3 m -108.36 161.77 14.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.11 -0.994 . . . . 0.0 109.167 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 11.5 ttp -160.01 148.25 17.01 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.178 -0.951 . . . . 0.0 110.072 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.612 ' NH2' ' CE1' ' B' ' 300' ' ' HIS . 0.0 OUTLIER -134.33 158.39 43.92 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.468 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . . . -125.77 141.71 51.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 109.78 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.511 ' CD2' ' HB2' ' B' ' 279' ' ' ALA . 0.7 OUTLIER -129.21 146.65 51.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.357 -0.839 . . . . 0.0 109.485 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.527 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 0.1 OUTLIER 176.54 -155.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.691 0.758 . . . . 0.0 109.484 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.502 ' N ' ' CG ' ' A' ' 116' ' ' PHE . . . 163.38 176.84 35.77 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.506 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 24.2 tt0 -68.64 -7.74 35.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -1.109 . . . . 0.0 109.49 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.503 ' CE ' ' OE2' ' B' ' 270' ' ' GLU . 14.5 tttp -89.52 -27.54 20.23 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.997 0.904 . . . . 0.0 108.778 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -89.16 9.81 24.21 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.527 ' CG2' HG21 ' A' ' 95' ' ' VAL . 3.6 mm -96.04 -159.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.278 -0.889 . . . . 0.0 108.637 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.534 ' CB ' HG11 ' A' ' 94' ' ' VAL . 20.3 t-80 -151.32 168.88 23.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.074 -1.016 . . . . 0.0 109.864 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 122' ' ' HIS . . . -144.77 167.83 21.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.372 -0.83 . . . . 0.0 109.413 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.46 177.65 35.9 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.223 -1.163 . . . . 0.0 109.492 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 80.9 mtp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.272 0.558 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -166.41 46.43 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.394 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 7.5 t -58.54 121.86 56.21 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 109.702 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.06 -4.89 15.79 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.853 1.449 . . . . 0.0 109.478 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -55.25 32.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.367 -0.833 . . . . 0.0 109.301 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -49.61 75.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 108.857 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' MET . . . . . 0.513 ' CE ' ' HA ' ' B' ' 306' ' ' ALA . 24.0 mmt -50.28 -41.84 51.34 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.348 -0.845 . . . . 0.0 109.404 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.428 ' O ' ' N ' ' B' ' 211' ' ' VAL . 4.8 m -60.36 -34.93 74.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.485 -0.759 . . . . 0.0 109.084 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -51.36 -42.74 61.52 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.291 -0.881 . . . . 0.0 108.739 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.614 ' CG1' ' CE1' ' B' ' 301' ' ' PHE . 0.9 OUTLIER -57.75 -26.62 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.569 HG22 ' CE2' ' B' ' 301' ' ' PHE . 25.5 t -90.09 -44.63 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.858 . . . . 0.0 109.308 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 213' ' ' ARG . 5.4 tt0 -58.05 -73.19 0.08 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' B' ' 212' ' ' GLN . 0.3 OUTLIER -43.42 -45.14 6.13 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.98 0.895 . . . . 0.0 108.693 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' TYR . . . . . 0.626 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.3 OUTLIER -52.02 -42.46 63.07 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.594 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 0.9 OUTLIER -87.67 -38.88 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.284 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.66 -35.08 13.02 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -75.32 -32.79 61.05 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.626 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 1.7 mt -64.59 -57.9 7.83 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 8.5 t30 -54.35 -46.33 72.93 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.497 0.665 . . . . 0.0 109.312 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -88.92 9.6 24.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.599 -0.688 . . . . 0.0 109.733 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.536 ' HA2' ' CD2' ' B' ' 259' ' ' LEU . . . 48.9 34.29 15.24 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' B' ' 217' ' ' ALA . 16.8 t0 -91.56 61.66 4.34 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.251 -1.146 . . . . 0.0 109.812 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' LEU . . . . . 0.575 ' CD2' ' CG ' ' B' ' 252' ' ' ARG . 6.7 tp -46.31 -43.58 15.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 108.695 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' B' ' 223' ' ' LEU . 2.2 m-20 -42.69 -33.28 0.7 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -85.15 -33.93 16.17 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.477 ' CG1' ' HB3' ' B' ' 217' ' ' ALA . 23.3 mt -60.82 -53.78 44.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.536 ' CG1' HG23 ' B' ' 248' ' ' THR . 72.5 t -59.18 -35.97 60.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.69 -56.1 26.6 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.538 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 9.3 tp -58.7 -21.6 55.18 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . 0.58 ' CZ ' ' HE3' ' B' ' 312' ' ' MET . 5.0 m-85 -86.89 139.59 30.48 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.497 -0.752 . . . . 0.0 109.61 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -54.8 -167.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.674 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.476 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.5 OUTLIER -81.12 -23.15 38.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.0 109.373 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.541 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 0.1 OUTLIER -144.4 44.81 1.42 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.542 ' CB ' HD13 ' B' ' 251' ' ' ILE . . . -56.76 -170.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.648 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' THR . . . . . 0.446 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.1 OUTLIER -134.61 141.01 46.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.4 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.546 ' CG1' ' N ' ' B' ' 237' ' ' GLU . 34.6 t -116.43 166.84 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.189 -0.945 . . . . 0.0 109.112 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' GLU . . . . . 0.546 ' N ' ' CG1' ' B' ' 236' ' ' VAL . 1.1 mm-40 -151.66 116.95 5.29 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' ASP . . . . . 0.495 ' CB ' ' HA ' ' B' ' 239' ' ' PRO . 0.8 OUTLIER 175.01 167.12 0.36 Allowed Pre-proline 0 C--N 1.301 -1.5 0 C-N-CA 118.118 -1.433 . . . . 0.0 110.354 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.542 ' O ' ' CG1' ' B' ' 240' ' ' VAL . 45.7 Cg_endo -73.12 -28.03 7.52 Favored 'Cis proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.727 -2.197 . . . . 0.0 110.649 0.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' B' ' 239' ' ' PRO . 2.1 m -166.88 101.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 109.197 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.23 42.96 63.88 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' SER . . . . . 0.497 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 27.8 m -118.83 -112.44 0.34 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.314 -1.109 . . . . 0.0 109.817 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . 0.445 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 39.0 mt-10 -121.82 100.62 43.31 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.915 -1.116 . . . . 0.0 110.383 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' PRO . . . . . 0.542 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 39.4 Cg_endo -65.43 -172.6 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.561 1.507 . . . . 0.0 110.652 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.618 ' CD ' ' CD1' ' B' ' 254' ' ' PHE . 0.0 OUTLIER -150.52 98.05 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.063 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.35 166.62 13.63 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.301 -0.875 . . . . 0.0 109.896 -179.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 90.48 171.09 43.84 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' THR . . . . . 0.536 HG23 ' CG1' ' B' ' 227' ' ' VAL . 1.8 m -89.42 -22.36 22.57 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.749 -1.442 . . . . 0.0 109.27 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -82.0 -28.02 32.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.268 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.518 ' CB ' ' HG3' ' B' ' 245' ' ' ARG . . . -88.98 -53.48 4.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.322 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.572 ' CG2' ' CD2' ' B' ' 230' ' ' PHE . 94.6 mt -45.25 -36.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.942 . . . . 0.0 108.852 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' ARG . . . . . 0.575 ' CG ' ' CD2' ' B' ' 223' ' ' LEU . 28.8 ttp180 -79.86 -54.18 6.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -48.95 -28.49 3.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.043 -1.035 . . . . 0.0 108.239 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.618 ' CD1' ' CD ' ' B' ' 245' ' ' ARG . 0.7 OUTLIER -83.54 -70.74 0.54 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.572 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.1 OUTLIER -47.2 -24.96 0.8 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . 0.533 ' CB ' HD21 ' B' ' 223' ' ' LEU . . . -76.32 -48.61 19.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 108.642 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 31.1 t-20 -59.13 -31.96 69.42 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' SER . . . . . 0.72 ' OG ' H111 ' B' ' 326' ' ' NTH . 3.0 t -72.72 -35.94 67.67 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . 0.536 ' CD2' ' HA2' ' B' ' 221' ' ' GLY . 8.3 tp -66.81 -26.56 66.99 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.406 -0.809 . . . . 0.0 109.145 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 2.1 mttt -46.15 -25.91 0.67 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.06 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' LEU . . . . . 0.531 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.75 112.31 51.22 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 44.4 Cg_endo -71.39 117.49 5.18 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.854 1.45 . . . . 0.0 110.841 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.536 ' CD1' HG12 ' B' ' 284' ' ' VAL . 0.0 OUTLIER -145.88 164.4 32.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 109.614 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -95.11 123.75 38.78 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' B' ' 219' ' ' ASN . 6.2 t -113.46 115.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.291 -0.88 . . . . 0.0 109.794 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 266' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.1 OUTLIER -149.84 99.37 2.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -0.906 . . . . 0.0 109.229 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -45.15 170.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.912 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 12.0 p -142.24 -37.96 0.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 109.608 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 269' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 3.7 pt20 -95.93 -144.74 0.27 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.654 -0.654 . . . . 0.0 109.324 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.518 ' O ' ' CZ ' ' B' ' 272' ' ' ARG . 22.2 tt0 -117.53 134.1 55.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.041 -1.037 . . . . 0.0 109.829 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . 0.525 ' CG2' HG13 ' B' ' 211' ' ' VAL . 76.1 t -64.84 148.97 11.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.414 -0.804 . . . . 0.0 109.17 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 11.9 mmt180 -103.4 137.84 40.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -148.76 139.22 22.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 109.077 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 274' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -160.3 157.58 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.068 -1.02 . . . . 0.0 110.088 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . 0.451 ' HB3' ' HA3' ' A' ' 41' ' ' GLY . . . 40.59 -102.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.653 -0.655 . . . . 0.0 110.095 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 276' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 98.3 m-20 -129.3 5.31 5.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.898 -1.126 . . . . 0.0 109.628 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . 0.523 ' CG ' ' HG2' ' B' ' 302' ' ' ARG . 0.3 OUTLIER -112.6 -162.65 0.81 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.087 -1.008 . . . . 0.0 108.972 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 278' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' B' ' 301' ' ' PHE . . . 177.17 142.47 0.08 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.623 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 279' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -125.92 136.45 53.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 108.604 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' B' ' 299' ' ' ASP . 30.0 p90 -149.72 172.46 15.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.74 -1.225 . . . . 0.0 109.982 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.522 ' HB2' ' CG1' ' B' ' 298' ' ' ILE . . . -148.23 -164.95 2.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.808 . . . . 0.0 109.991 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 282' ' ' PHE . . . . . 0.49 ' CD2' ' C ' ' B' ' 281' ' ' ALA . 14.2 p90 172.14 -169.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.45 -0.781 . . . . 0.0 109.384 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.15 147.3 52.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.394 -0.816 . . . . 0.0 109.645 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 284' ' ' VAL . . . . . 0.536 HG12 ' CD1' ' B' ' 263' ' ' LEU . 3.3 t -123.8 121.13 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.868 . . . . 0.0 109.429 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 285' ' ' SER . . . . . 0.501 ' HA ' ' CG2' ' B' ' 294' ' ' VAL . 16.7 p -115.52 117.84 31.47 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.65 ' CZ ' H222 ' B' ' 326' ' ' NTH . 11.4 p90 -142.24 173.65 11.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.084 -1.01 . . . . 0.0 110.217 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 287' ' ' GLU . . . . . 0.505 ' CG ' ' O ' ' B' ' 291' ' ' ARG . 36.1 tt0 -148.42 154.03 39.35 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.1 OUTLIER -128.01 -96.36 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.036 -1.04 . . . . 0.0 110.358 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -110.16 93.92 4.75 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.122 -0.987 . . . . 0.0 110.443 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 62.14 11.34 32.01 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 291' ' ' ARG . . . . . 0.567 ' HB3' ' CE2' ' B' ' 288' ' ' PHE . 26.9 mtt180 -130.94 144.79 51.73 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.206 -1.173 . . . . 0.0 109.578 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 292' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 120.78 18.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.347 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 293' ' ' THR . . . . . 0.575 ' O ' ' CD1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -122.57 143.58 49.65 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.403 -0.81 . . . . 0.0 109.717 -179.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 294' ' ' VAL . . . . . 0.517 HG11 ' CB ' ' B' ' 322' ' ' HIS . 0.8 OUTLIER -112.92 173.55 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.556 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 2.6 t -150.41 144.41 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.955 -1.091 . . . . 0.0 110.034 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 296' ' ' ALA . . . . . 0.506 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -133.34 73.81 73.14 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.425 -0.797 . . . . 0.0 109.208 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 297' ' ' PRO . . . . . 0.578 ' HB3' ' CD2' ' B' ' 316' ' ' PHE . 50.2 Cg_endo -94.48 -179.21 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.907 1.478 . . . . 0.0 111.797 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.522 ' CG1' ' HB2' ' B' ' 281' ' ' ALA . 2.9 mp -137.34 138.45 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . 0.577 ' HB3' ' CE1' ' B' ' 280' ' ' PHE . 14.7 t0 -113.75 164.16 14.08 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.984 -1.073 . . . . 0.0 110.24 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.612 ' CE1' ' NH2' ' A' ' 113' ' ' ARG . 7.4 t-160 -112.22 173.43 6.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 109.09 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 301' ' ' PHE . . . . . 0.614 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.2 OUTLIER -145.27 149.03 34.13 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.214 -0.929 . . . . 0.0 110.163 -178.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.537 ' CB ' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -138.01 104.26 5.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.828 . . . . 0.0 109.284 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 303' ' ' PHE . . . . . 0.585 ' CZ ' HG12 ' B' ' 210' ' ' VAL . 11.6 m-85 -89.96 171.62 9.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.081 -1.012 . . . . 0.0 109.512 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 304' ' ' ASN . . . . . 0.488 ' ND2' HG23 ' B' ' 310' ' ' VAL . 1.4 p30 -119.16 -14.25 9.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.427 -0.796 . . . . 0.0 109.132 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 305' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -172.49 -62.81 0.05 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 306' ' ' ALA . . . . . 0.513 ' HA ' ' CE ' ' B' ' 207' ' ' MET . . . 162.74 76.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -1.097 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.52 -64.48 0.06 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -119.35 -172.94 2.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -1.148 . . . . 0.0 109.664 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 309' ' ' VAL . . . . . 0.562 ' CG1' ' CE ' ' B' ' 312' ' ' MET . 89.7 t -110.43 150.33 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.216 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.488 HG23 ' ND2' ' B' ' 304' ' ' ASN . 42.6 t -123.27 -20.22 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.141 -0.974 . . . . 0.0 109.923 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 311' ' ' SER . . . . . 0.537 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -157.85 166.86 31.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.952 -1.092 . . . . 0.0 110.023 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 312' ' ' MET . . . . . 0.58 ' HE3' ' CZ ' ' B' ' 230' ' ' PHE . 1.6 ttm -156.69 154.29 29.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -0.853 . . . . 0.0 109.428 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 313' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' B' ' 299' ' ' ASP . 1.2 ttt180 -130.14 153.38 48.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.227 -0.92 . . . . 0.0 109.378 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 314' ' ' ALA . . . . . 0.459 ' HB1' ' OD1' ' B' ' 238' ' ' ASP . . . -100.45 157.18 16.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.738 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 315' ' ' LEU . . . . . 0.648 ' O ' ' CD1' ' B' ' 316' ' ' PHE . 9.0 tp -137.1 -143.78 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.427 -0.796 . . . . 0.0 109.019 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 316' ' ' PHE . . . . . 0.648 ' CD1' ' O ' ' B' ' 315' ' ' LEU . 31.0 p90 39.4 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.772 0.796 . . . . 0.0 110.313 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 317' ' ' GLY . . . . . 0.579 ' N ' ' CD2' ' B' ' 316' ' ' PHE . . . 173.62 -152.52 15.52 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 318' ' ' GLU . . . . . 0.532 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 6.8 tt0 -72.25 -2.36 18.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -1.153 . . . . 0.0 109.71 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 319' ' ' LYS . . . . . 0.455 ' NZ ' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -92.2 -32.58 15.02 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.221 -0.925 . . . . 0.0 109.316 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 320' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -89.31 19.23 4.51 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.251 0.548 . . . . 0.0 109.821 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 321' ' ' ILE . . . . . 0.532 ' CG1' ' HA ' ' B' ' 318' ' ' GLU . 5.1 mm -89.82 -167.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 322' ' ' HIS . . . . . 0.517 ' CB ' HG11 ' B' ' 294' ' ' VAL . 0.2 OUTLIER -151.67 155.14 37.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.056 -1.027 . . . . 0.0 109.247 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' B' ' 293' ' ' THR . . . -156.15 89.26 1.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.116 -0.99 . . . . 0.0 109.773 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -107.3 111.05 3.36 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.409 -1.054 . . . . 0.0 109.441 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' NTH . . . . . 0.824 ' H11' ' OG ' ' A' ' 58' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 326' ' ' NTH . . . . . 0.72 H111 ' OG ' ' B' ' 258' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' C ' ' A' ' 2' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.209 0.528 . . . . 0.0 110.12 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.478 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.3 t30 43.62 40.43 2.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 3' ' ' THR . 9.8 t -90.58 107.68 21.93 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.389 -0.819 . . . . 0.0 109.536 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 45.5 Cg_endo -72.78 -10.52 25.04 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.869 1.457 . . . . 0.0 110.17 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -32.77 68.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 109.692 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.85 -51.0 5.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.926 . . . . 0.0 109.423 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.43 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 17.3 mtt -61.14 -48.19 82.76 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.268 -0.895 . . . . 0.0 109.902 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 4' ' ' PRO . 17.7 m -53.53 -39.05 64.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.487 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.81 -48.06 73.26 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.259 -0.901 . . . . 0.0 108.866 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.613 ' CG1' ' CE1' ' A' ' 101' ' ' PHE . 1.2 t -52.49 -28.68 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.604 ' CG2' ' CE2' ' A' ' 101' ' ' PHE . 6.6 t -85.47 -42.61 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.239 -0.913 . . . . 0.0 109.354 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.2 tt0 -59.61 -73.65 0.08 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.532 ' HD2' ' CD1' ' A' ' 29' ' ' LEU . 2.7 mtm180 -43.45 -46.12 6.63 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.541 ' O ' ' CD1' ' A' ' 14' ' ' TYR . 0.8 OUTLIER -53.13 -41.22 64.85 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.633 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -84.01 -36.58 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.092 -1.005 . . . . 0.0 108.928 179.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.71 -39.55 65.3 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -71.22 -32.36 68.7 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.633 ' CD1' ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -63.27 -58.18 8.01 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 65' ' ' VAL . 2.4 t-20 -51.13 -42.47 60.75 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.64 0.733 . . . . 0.0 109.269 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.58 2.35 53.23 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.68 -0.637 . . . . 0.0 109.604 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' CD2' ' A' ' 59' ' ' LEU . . . 49.79 38.24 29.61 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' O ' HG13 ' A' ' 26' ' ' ILE . 29.6 t70 -92.18 77.85 5.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -1.033 . . . . 0.0 109.865 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.591 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 2.8 mm? -50.69 -29.05 10.27 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.334 -0.853 . . . . 0.0 110.12 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -63.93 -56.43 15.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.975 . . . . 0.0 109.366 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.43 ' N ' ' OD2' ' A' ' 22' ' ' ASP . . . -59.0 -28.24 63.41 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 22' ' ' ASP . 55.8 mt -63.62 -58.08 8.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 43.6 t -55.82 -41.26 65.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.48 -49.98 71.09 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.532 ' CD1' ' HD2' ' A' ' 13' ' ' ARG . 2.9 tp -72.35 -21.0 61.37 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.553 -0.717 . . . . 0.0 109.265 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.602 ' CZ ' ' CE ' ' A' ' 112' ' ' MET . 7.2 m-85 -92.41 140.84 29.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.372 -0.83 . . . . 0.0 109.561 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 109' ' ' VAL . . . -51.67 178.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.073 -1.017 . . . . 0.0 109.344 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.02 -23.89 59.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.175 -0.953 . . . . 0.0 109.241 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.508 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -137.75 30.41 2.56 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.759 -0.588 . . . . 0.0 109.633 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -53.21 -173.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.159 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.518 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.2 OUTLIER -145.3 147.38 32.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.16 -0.963 . . . . 0.0 110.187 -179.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.498 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 9.5 t -134.56 118.16 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.529 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 2.3 mm-40 -88.3 104.94 17.21 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.529 ' O ' ' CE2' ' A' ' 54' ' ' PHE . 9.9 t0 -176.99 142.76 0.53 Allowed Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.92 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 47.8 Cg_endo -73.85 -166.48 4.63 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.28 -1.967 . . . . 0.0 110.651 -0.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.54 ' CG2' HG13 ' B' ' 274' ' ' VAL . 15.3 m -75.97 141.64 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.132 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.29 1.63 64.98 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.526 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -105.59 -155.26 0.54 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.265 -1.138 . . . . 0.0 109.355 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.442 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 27.9 mm-40 -127.74 131.88 24.05 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.08 -1.012 . . . . 0.0 110.07 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.0 Cg_endo -64.0 -166.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.575 1.517 . . . . 0.0 111.073 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.564 ' CG ' ' CB ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -150.62 102.64 3.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.509 -0.744 . . . . 0.0 109.049 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.2 147.04 24.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.21 -0.931 . . . . 0.0 109.768 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 111.26 159.8 16.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.501 ' CG2' HG13 ' A' ' 27' ' ' VAL . 11.3 m -70.97 -43.33 68.29 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.059 -1.26 . . . . 0.0 109.291 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -66.78 -31.78 72.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.15 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.564 ' CB ' ' CG ' ' A' ' 45' ' ' ARG . . . -80.44 -60.37 2.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.898 . . . . 0.0 109.331 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 47' ' ' GLY . 39.3 mt -43.35 -38.28 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.371 -0.831 . . . . 0.0 109.003 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 4.8 ttt-85 -84.98 -55.18 4.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.536 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 26.1 tt0 -47.71 -26.08 1.43 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.551 ' CD1' ' HD3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -84.2 -71.79 0.5 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.554 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -52.46 -20.82 3.13 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.24 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.509 ' N ' HD13 ' A' ' 23' ' ' LEU . . . -76.4 -44.73 34.84 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 48.8 t30 -64.49 -32.0 73.45 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 t -72.09 -35.35 69.2 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.591 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 3.1 tp -69.61 -24.82 63.72 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.458 -0.776 . . . . 0.0 109.383 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -43.85 -27.5 0.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 108.823 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.59 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -91.63 109.02 33.67 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.438 ' C ' ' HG ' ' A' ' 63' ' ' LEU . 45.1 Cg_endo -70.65 110.85 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.844 1.444 . . . . 0.0 111.332 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.59 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -138.46 173.1 11.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 109.497 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.519 ' CB ' ' OG ' ' A' ' 85' ' ' SER . . . -102.36 127.54 49.32 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.512 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 95.8 t -108.23 124.72 64.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 110.034 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -150.04 112.12 4.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.566 ' CD2' ' CG2' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -48.03 176.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.219 -0.926 . . . . 0.0 109.811 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.52 -81.97 0.43 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.278 -0.889 . . . . 0.0 109.293 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.587 ' HG2' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -123.43 -55.33 1.75 Allowed 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.807 -179.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.587 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 17.2 tt0 -140.55 153.99 46.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.94 -1.1 . . . . 0.0 110.442 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.566 ' CG2' ' CD2' ' A' ' 67' ' ' LEU . 19.0 t -99.57 149.12 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -95.26 128.96 42.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.483 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . . . -148.25 137.1 21.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.142 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -165.64 154.19 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 109.793 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' CB ' HG13 ' B' ' 240' ' ' VAL . . . 43.14 -147.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 0.0 109.827 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 103' ' ' PHE . 30.8 m-80 -88.98 26.54 1.54 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.279 -0.888 . . . . 0.0 109.609 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -129.68 -159.57 0.97 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.268 -0.895 . . . . 0.0 109.061 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 101' ' ' PHE . . . 168.18 157.59 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.41 -0.806 . . . . 0.0 109.794 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.555 ' O ' ' CB ' ' A' ' 72' ' ' ARG . . . -151.2 139.37 20.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 108.902 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.586 ' CE1' ' HB3' ' A' ' 99' ' ' ASP . 24.4 p90 -149.57 161.77 41.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.655 -1.278 . . . . 0.0 109.787 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.529 ' CB ' HG22 ' A' ' 98' ' ' ILE . . . -130.69 -174.99 3.52 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.574 0.702 . . . . 0.0 110.016 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CE2' ' CE2' ' A' ' 80' ' ' PHE . 19.6 p90 172.21 -172.11 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.546 -0.721 . . . . 0.0 109.22 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.34 141.11 51.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.482 -0.761 . . . . 0.0 109.551 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.546 HG11 ' CB ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -101.83 122.13 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 108.952 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.519 ' OG ' ' CB ' ' A' ' 64' ' ' ALA . 1.1 p -118.07 102.76 9.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 109.683 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.575 ' CZ ' ' HB ' ' A' ' 93' ' ' THR . 17.7 p90 -123.02 159.72 27.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.096 -1.003 . . . . 0.0 109.276 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -95.71 171.01 8.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.133 -0.979 . . . . 0.0 109.651 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.08 -160.99 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 109.578 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.83 36.44 1.54 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.319 -0.863 . . . . 0.0 109.095 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.49 -30.3 0.17 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -137.29 -167.78 2.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -1.172 . . . . 0.0 109.352 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.01 136.18 50.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 109.692 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.575 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -120.4 157.48 29.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.271 -0.893 . . . . 0.0 109.874 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 122' ' ' HIS . 12.0 p -138.24 163.9 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.314 -0.866 . . . . 0.0 109.138 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.567 ' CG1' ' ND2' ' A' ' 120' ' ' ASN . 41.4 t -142.44 155.49 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.987 -1.071 . . . . 0.0 109.93 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.525 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -127.86 73.81 78.77 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.494 -0.754 . . . . 0.0 109.818 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.512 ' HB3' ' ND2' ' A' ' 120' ' ' ASN . 44.0 Cg_endo -95.39 175.49 0.98 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.586 1.524 . . . . 0.0 111.578 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.529 HG22 ' CB ' ' A' ' 81' ' ' ALA . 3.4 mp -143.19 152.39 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.586 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 12.7 t0 -125.42 161.49 26.94 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.004 -1.06 . . . . 0.0 110.229 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 113' ' ' ARG . 5.2 t60 -108.22 179.82 4.1 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.632 ' CE1' ' CE ' ' A' ' 112' ' ' MET . 0.3 OUTLIER -146.24 160.18 42.33 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.756 -1.215 . . . . 0.0 110.597 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.546 ' CB ' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -147.09 103.92 3.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.588 ' CZ ' ' CG2' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -90.0 -171.06 3.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.165 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.543 ' OD1' ' CG2' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -139.42 -101.89 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.462 -0.774 . . . . 0.0 109.526 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . -96.44 21.03 47.8 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 77.35 66.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -1.112 . . . . 0.0 109.502 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.54 -65.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -128.93 -178.23 4.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -1.134 . . . . 0.0 109.507 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.523 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 45.3 t -94.0 141.52 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.375 -0.828 . . . . 0.0 109.395 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.543 ' CG2' ' OD1' ' A' ' 104' ' ' ASN . 24.6 t -121.95 -15.22 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 109.976 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.546 ' CB ' ' CB ' ' A' ' 102' ' ' ARG . 0.3 OUTLIER -158.68 157.32 31.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.93 -1.106 . . . . 0.0 109.956 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.632 ' CE ' ' CE1' ' A' ' 101' ' ' PHE . 8.0 ttm -155.46 160.43 40.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.426 -0.796 . . . . 0.0 109.456 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 100' ' ' HIS . 10.1 ttp180 -149.75 114.41 5.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.858 . . . . 0.0 109.403 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 99' ' ' ASP . . . -89.98 137.59 32.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.082 -1.011 . . . . 0.0 109.461 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.56 ' CD2' ' CB ' ' B' ' 279' ' ' ALA . 1.0 OUTLIER -134.12 143.65 48.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.965 . . . . 0.0 110.102 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.69 ' CE2' ' H61' ' A' ' 126' ' ' NTH . 32.9 p90 164.36 -163.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . -176.15 -179.86 46.85 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.246 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.515 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 11.9 tt0 -50.63 -21.46 1.58 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -1.138 . . . . 0.0 109.304 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -22.55 60.7 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.017 0.913 . . . . 0.0 108.668 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.567 ' ND2' ' CG1' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -88.72 3.27 51.45 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.676 -179.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.522 HG21 ' CG2' ' A' ' 95' ' ' VAL . 4.2 mm -93.39 -179.34 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.028 -1.045 . . . . 0.0 109.372 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.532 ' CB ' ' O ' ' A' ' 94' ' ' VAL . 0.7 OUTLIER -151.56 161.46 42.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.509 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.38 152.86 29.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.513 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.9 -128.4 9.49 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.277 -1.131 . . . . 0.0 109.505 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.219 0.533 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -120.92 55.79 1.03 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.1 111.0 44.3 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.348 -0.845 . . . . 0.0 109.558 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' B' ' 208' ' ' THR . 44.3 Cg_endo -71.38 -8.57 23.63 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.832 1.438 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -66.41 -45.46 79.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.043 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -55.69 6.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 109.161 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 13.0 mmt -53.52 -41.96 66.89 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.432 ' CB ' ' O ' ' B' ' 204' ' ' PRO . 6.0 m -63.38 -35.51 80.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 109.06 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -51.13 -44.08 61.29 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.218 -0.926 . . . . 0.0 108.72 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.649 ' CG1' ' CE1' ' B' ' 301' ' ' PHE . 1.1 t -57.08 -25.44 22.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.621 ' CG2' ' CE2' ' B' ' 301' ' ' PHE . 23.9 t -88.43 -44.88 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.832 . . . . 0.0 109.159 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' B' ' 213' ' ' ARG . 24.6 tt0 -58.99 -73.96 0.07 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' B' ' 212' ' ' GLN . 0.2 OUTLIER -42.77 -44.53 4.44 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' TYR . . . . . 0.64 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -51.21 -44.87 61.71 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.543 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.6 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.08 -41.23 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.39 -35.03 11.82 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' B' ' 221' ' ' GLY . . . -75.86 -33.46 60.0 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.64 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 3.1 mt -62.84 -57.39 11.03 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' B' ' 265' ' ' VAL . 4.6 t30 -53.68 -45.67 70.4 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.576 0.703 . . . . 0.0 109.578 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.14 7.23 36.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.476 -0.765 . . . . 0.0 109.745 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' B' ' 217' ' ' ALA . . . 51.83 42.06 52.51 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.476 ' OD2' ' HA3' ' B' ' 225' ' ' GLY . 18.0 t70 -97.8 61.44 1.57 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.112 . . . . 0.0 109.928 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' LEU . . . . . 0.586 ' CD1' ' HB3' ' B' ' 255' ' ' PHE . 7.1 tp -47.79 -44.12 28.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 108.883 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' B' ' 223' ' ' LEU . 3.9 t0 -43.86 -39.5 3.92 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . 0.476 ' HA3' ' OD2' ' B' ' 222' ' ' ASP . . . -80.77 -32.35 33.42 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.532 HD12 ' CD2' ' B' ' 255' ' ' PHE . 13.8 mt -61.97 -58.48 7.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' B' ' 252' ' ' ARG . 50.7 t -54.57 -39.73 47.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.71 -54.63 41.94 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 7.7 tp -61.76 -22.9 65.8 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' B' ' 231' ' ' ALA . 6.5 m-85 -90.85 132.43 35.9 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.428 -0.795 . . . . 0.0 109.918 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' B' ' 309' ' ' VAL . . . -50.66 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 0.0 109.652 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' B' ' 248' ' ' THR . 0.2 OUTLIER -76.31 -24.4 54.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 109.733 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.503 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 0.1 OUTLIER -133.46 39.76 3.2 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.474 -0.766 . . . . 0.0 109.764 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' B' ' 251' ' ' ILE . . . -64.0 144.49 57.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.138 -0.976 . . . . 0.0 109.346 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -106.18 139.58 40.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 0.0 109.6 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' B' ' 244' ' ' PRO . 55.2 t -132.72 118.39 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.411 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' GLU . . . . . 0.515 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 29.3 mt-10 -89.42 106.24 18.32 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' ASP . . . . . 0.639 ' OD2' ' H61' ' B' ' 326' ' ' NTH . 28.4 t70 -179.67 141.68 0.35 Allowed Pre-proline 0 C--N 1.302 -1.484 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.492 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.477 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 48.4 Cg_endo -74.11 169.89 72.47 Favored 'Cis proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.295 -1.961 . . . . 0.0 110.545 0.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.527 HG13 ' CB ' ' A' ' 75' ' ' ALA . 8.0 t -67.47 113.99 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.179 -0.951 . . . . 0.0 109.236 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . 0.46 ' HA2' ' HB1' ' A' ' 75' ' ' ALA . . . 112.93 -2.52 25.74 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 17.5 m -109.38 -113.05 0.31 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -1.124 . . . . 0.0 109.212 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . 0.469 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 1.2 pp20? -164.34 131.46 2.42 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.904 -1.122 . . . . 0.0 109.612 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' PRO . . . . . 0.515 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.8 Cg_endo -64.83 -177.34 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.011 1.532 . . . . 0.0 111.13 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.541 ' HG3' ' CD1' ' B' ' 254' ' ' PHE . 11.1 mmt180 -150.54 99.94 2.8 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.523 ' HB2' ' CG2' ' B' ' 235' ' ' THR . 0.0 OUTLIER -88.88 164.71 15.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.32 -0.863 . . . . 0.0 109.748 -179.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 101.46 162.19 27.19 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' THR . . . . . 0.525 ' N ' ' O ' ' B' ' 232' ' ' ASP . 5.9 m -70.04 -52.81 20.99 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.163 -1.198 . . . . 0.0 109.382 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -59.68 -40.75 88.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.162 -0.961 . . . . 0.0 109.438 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' B' ' 246' ' ' SER . . . -68.37 -54.9 14.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 109.605 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' B' ' 234' ' ' ALA . 8.5 mm -47.39 -36.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.115 -0.991 . . . . 0.0 109.116 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' ARG . . . . . 0.575 ' CG ' ' CD2' ' B' ' 223' ' ' LEU . 6.9 ttt180 -84.96 -55.16 4.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 5.5 mt-10 -48.7 -26.98 2.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.992 -1.068 . . . . 0.0 108.327 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.541 ' CD1' ' HG3' ' B' ' 245' ' ' ARG . 0.2 OUTLIER -86.71 -72.6 0.5 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.586 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -49.1 -26.55 2.77 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.18 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . 0.531 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -70.38 -41.69 72.75 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -58.86 -27.4 65.13 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' SER . . . . . 0.73 ' OG ' ' H12' ' B' ' 326' ' ' NTH . 41.9 t -77.69 -34.27 52.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . 0.444 HD12 ' HA2' ' B' ' 221' ' ' GLY . 7.9 tp -70.04 -26.7 64.16 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.436 -0.79 . . . . 0.0 109.47 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -49.43 -31.43 9.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.278 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' LEU . . . . . 0.577 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.9 OUTLIER -90.03 114.6 61.45 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.287 -0.883 . . . . 0.0 109.006 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' PRO . . . . . 0.442 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 43.3 Cg_endo -70.44 109.25 2.39 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.719 1.379 . . . . 0.0 110.665 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.581 ' CB ' ' CG1' ' B' ' 284' ' ' VAL . 0.0 OUTLIER -140.29 159.65 41.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.486 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -92.81 128.41 38.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.87 . . . . 0.0 108.694 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . 0.498 ' N ' ' OD1' ' B' ' 219' ' ' ASN . 11.0 t -107.67 113.83 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 109.697 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 266' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' B' ' 267' ' ' LEU . 6.7 tt0 -150.47 95.47 2.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.4 -0.813 . . . . 0.0 109.042 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.5 mp -44.75 169.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.2 -0.938 . . . . 0.0 109.836 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 5.1 t -127.65 -31.64 2.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 269' ' ' GLN . . . . . 0.522 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 13.7 pt20 -107.88 -151.42 0.47 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.524 -0.735 . . . . 0.0 109.459 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.522 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 42.2 tt0 -106.64 129.96 54.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.486 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . 0.536 HG12 ' CG1' ' B' ' 211' ' ' VAL . 16.6 t -60.24 150.85 6.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.398 -0.813 . . . . 0.0 109.367 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 4.9 tpp180 -104.98 131.36 52.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 108.875 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . 0.522 ' HA ' ' CB ' ' B' ' 278' ' ' ALA . . . -148.0 126.23 12.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.089 -1.007 . . . . 0.0 109.9 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 274' ' ' VAL . . . . . 0.54 HG13 ' CG2' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -121.95 -155.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.245 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' B' ' 276' ' ' ASN . . . -83.85 126.5 33.02 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.384 -0.822 . . . . 0.0 110.678 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 276' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' B' ' 275' ' ' ALA . 57.1 m-20 69.27 -2.35 1.88 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.706 -0.621 . . . . 0.0 111.721 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . 0.484 ' CG ' ' O ' ' B' ' 301' ' ' PHE . 3.4 tt0 -150.67 -160.47 1.17 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.418 -1.426 . . . . 0.0 110.518 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 278' ' ' ALA . . . . . 0.522 ' CB ' ' HA ' ' B' ' 273' ' ' ALA . . . 165.45 152.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 279' ' ' ALA . . . . . 0.56 ' CB ' ' CD2' ' A' ' 115' ' ' LEU . . . -138.91 136.92 36.0 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 33.5 p90 -149.97 167.38 26.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.831 -1.168 . . . . 0.0 110.546 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.531 ' CB ' HG21 ' B' ' 298' ' ' ILE . . . -142.68 -162.02 1.35 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.415 0.626 . . . . 0.0 109.448 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 282' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 0.0 OUTLIER 163.92 -175.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.885 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 283' ' ' THR . . . . . 0.439 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -127.86 141.11 51.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.436 -0.79 . . . . 0.0 109.733 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 284' ' ' VAL . . . . . 0.581 ' CG1' ' CB ' ' B' ' 263' ' ' LEU . 66.6 t -111.24 113.53 44.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.47 -0.769 . . . . 0.0 108.929 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 53.7 p -105.63 84.26 2.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.908 . . . . 0.0 110.028 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.892 ' CE1' H221 ' B' ' 326' ' ' NTH . 34.3 p90 -89.95 177.5 6.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.878 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -127.58 153.47 46.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.12 -0.988 . . . . 0.0 109.617 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -103.11 -98.03 0.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.379 -0.826 . . . . 0.0 109.586 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -140.31 47.09 1.8 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.194 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 139.99 -42.31 1.23 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -94.63 -166.69 1.52 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.508 -0.995 . . . . 0.0 108.877 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 292' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -149.29 123.35 9.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.044 -1.035 . . . . 0.0 109.744 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 293' ' ' THR . . . . . 0.57 ' HB ' ' CE1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -111.04 147.28 35.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.377 -0.827 . . . . 0.0 109.22 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 294' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' B' ' 322' ' ' HIS . 11.1 p -127.52 167.95 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 109.681 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.538 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 3.5 t -140.18 148.21 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 108.999 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 296' ' ' ALA . . . . . 0.527 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -132.1 71.48 79.89 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 0.0 110.895 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 297' ' ' PRO . . . . . 0.538 ' HD3' ' CG1' ' B' ' 295' ' ' VAL . 51.1 Cg_endo -93.82 -174.28 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.486 1.458 . . . . 0.0 110.292 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.531 HG21 ' CB ' ' B' ' 281' ' ' ALA . 2.6 mp -140.04 162.64 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.875 . . . . 0.0 108.945 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . 0.573 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 14.0 t0 -133.1 157.49 45.16 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.11 -0.994 . . . . 0.0 110.084 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.518 ' N ' ' OD1' ' B' ' 299' ' ' ASP . 0.3 OUTLIER -112.81 167.25 10.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 301' ' ' PHE . . . . . 0.649 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.2 OUTLIER -137.94 157.74 45.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.979 -1.076 . . . . 0.0 110.536 -178.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.475 ' HA ' ' HG3' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -150.09 104.33 3.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 303' ' ' PHE . . . . . 0.613 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 6.9 m-85 -89.6 129.72 36.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.469 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 304' ' ' ASN . . . . . 0.566 ' N ' ' ND2' ' B' ' 304' ' ' ASN . 0.0 OUTLIER -137.42 14.63 2.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.294 -0.878 . . . . 0.0 109.428 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . -135.69 5.87 4.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . 50.1 25.22 1.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -1.134 . . . . 0.0 109.602 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -161.25 -42.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -123.54 -168.12 1.72 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -1.091 . . . . 0.0 109.46 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 309' ' ' VAL . . . . . 0.508 HG21 ' CE1' ' B' ' 301' ' ' PHE . 38.2 t -111.84 138.26 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.941 . . . . 0.0 108.993 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.523 ' HB ' ' ND2' ' B' ' 304' ' ' ASN . 2.7 t -121.3 -6.93 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.849 -1.157 . . . . 0.0 109.788 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 311' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.4 OUTLIER -155.23 152.93 29.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 0.0 109.347 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 312' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 300' ' ' HIS . 5.7 ttp -160.22 154.97 24.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 109.865 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 313' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' B' ' 299' ' ' ASP . 0.0 OUTLIER -137.77 163.7 30.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 109.067 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -142.5 141.56 32.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.019 -1.051 . . . . 0.0 109.72 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 315' ' ' LEU . . . . . 0.498 ' O ' ' HB3' ' B' ' 316' ' ' PHE . 0.3 OUTLIER -137.9 139.13 39.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 109.726 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 316' ' ' PHE . . . . . 0.501 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 14.6 p90 173.76 -157.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.567 0.699 . . . . 0.0 109.352 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 317' ' ' GLY . . . . . 0.437 ' N ' ' CD2' ' B' ' 316' ' ' PHE . . . 165.29 -168.37 39.31 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 318' ' ' GLU . . . . . 0.526 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 15.7 tt0 -71.54 -4.37 26.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -1.164 . . . . 0.0 109.355 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 319' ' ' LYS . . . . . 0.463 ' HD3' ' OE1' ' A' ' 70' ' ' GLU . 2.4 tttm -89.72 -28.39 19.44 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 122.02 0.914 . . . . 0.0 108.87 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 320' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.1 OUTLIER -89.24 4.48 48.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 321' ' ' ILE . . . . . 0.526 ' CG1' ' HA ' ' B' ' 318' ' ' GLU . 5.0 mm -89.86 -173.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.325 -0.86 . . . . 0.0 108.83 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 322' ' ' HIS . . . . . 0.534 ' HB3' ' CG1' ' B' ' 294' ' ' VAL . 0.2 OUTLIER -150.86 -164.74 2.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.071 -1.018 . . . . 0.0 109.792 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -146.62 -175.08 4.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.081 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -170.52 154.31 22.76 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.306 -1.114 . . . . 0.0 109.459 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' NTH . . . . . 0.69 ' H61' ' CE2' ' A' ' 116' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 326' ' ' NTH . . . . . 0.892 H221 ' CE1' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.173 0.511 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.479 ' HB3' ' HE1' ' A' ' 7' ' ' MET . 99.5 m-20 -59.8 152.73 22.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.395 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.58 ' O ' ' CE1' ' A' ' 6' ' ' HIS . 0.8 OUTLIER -80.72 116.67 63.76 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.343 -0.848 . . . . 0.0 109.786 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.465 ' HA ' ' HE2' ' A' ' 7' ' ' MET . 42.6 Cg_endo -70.08 -4.81 15.0 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.761 1.401 . . . . 0.0 109.877 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.455 ' HB2' HG21 ' A' ' 3' ' ' THR . 0.0 OUTLIER -56.84 -52.81 63.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.304 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 3' ' ' THR . 36.9 p-80 -70.3 -41.94 72.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.903 . . . . 0.0 109.273 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.577 ' CG ' ' NE2' ' A' ' 6' ' ' HIS . 10.3 mtt -59.07 -44.29 91.83 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.199 -0.938 . . . . 0.0 109.342 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.47 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 14.2 m -64.9 -38.46 91.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.315 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.66 77.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 108.872 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.64 ' CG1' ' CZ ' ' A' ' 101' ' ' PHE . 1.4 t -55.12 -20.68 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.587 HG21 ' CD2' ' A' ' 80' ' ' PHE . 18.5 t -90.61 -43.5 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.409 -0.807 . . . . 0.0 109.236 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 13' ' ' ARG . 24.1 tt0 -61.19 -73.72 0.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.259 1.028 . . . . 0.0 108.313 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.449 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -42.07 -44.16 3.5 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.157 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.642 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -50.01 -46.61 52.94 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.616 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -86.23 -39.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.355 -0.84 . . . . 0.0 109.083 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.61 -36.68 16.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.526 ' HB3' ' CG1' ' A' ' 26' ' ' ILE . . . -74.37 -32.0 62.59 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.642 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 1.8 mt -65.3 -58.4 6.01 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.439 ' CG ' ' O ' ' A' ' 65' ' ' VAL . 24.4 t30 -52.56 -46.4 66.83 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.596 0.712 . . . . 0.0 109.089 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.96 10.67 20.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.649 -0.657 . . . . 0.0 109.476 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.489 ' CA ' ' CD2' ' A' ' 59' ' ' LEU . . . 45.52 27.81 2.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.47 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 1.8 t70 -89.93 67.81 7.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -1.091 . . . . 0.0 109.866 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.598 ' CD1' ' HB3' ' A' ' 55' ' ' PHE . 4.6 tp -47.8 -41.31 23.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 109.165 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' LEU . 5.2 m-20 -41.49 -28.83 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -88.04 -35.87 8.71 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.526 ' CG1' ' HB3' ' A' ' 17' ' ' ALA . 22.0 mt -59.54 -53.82 43.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.538 HG23 ' CG ' ' A' ' 52' ' ' ARG . 91.1 t -59.72 -43.23 91.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.98 -43.62 66.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.532 ' CD2' ' HA ' ' A' ' 10' ' ' VAL . 6.6 tp -73.39 -27.91 61.72 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.465 ' HA ' ' HB ' ' A' ' 109' ' ' VAL . 8.8 m-85 -84.83 138.45 32.56 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.32 -0.862 . . . . 0.0 109.841 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -51.68 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 109.697 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.469 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -70.72 -23.42 62.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.622 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.539 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -148.51 41.08 0.95 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.623 -0.673 . . . . 0.0 109.264 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 110' ' ' VAL . . . -52.95 151.77 4.44 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.253 -0.904 . . . . 0.0 109.699 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.46 ' OG1' ' OG ' ' A' ' 111' ' ' SER . 0.1 OUTLIER -100.34 144.44 29.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.387 -0.82 . . . . 0.0 109.432 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.58 ' CG1' ' N ' ' A' ' 37' ' ' GLU . 2.1 t -123.58 169.14 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 108.899 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -142.65 105.39 4.52 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.205 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 37' ' ' GLU . 4.6 t70 177.67 142.93 0.26 Allowed Pre-proline 0 N--CA 1.495 1.777 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.065 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 46.6 Cg_endo -75.45 -176.34 18.04 Favored 'Cis proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.191 -2.004 . . . . 0.0 110.163 -0.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.469 HG23 ' CB ' ' B' ' 274' ' ' VAL . 3.5 m -80.11 83.73 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.091 -1.006 . . . . 0.0 109.125 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.86 -13.92 1.33 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.534 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -108.57 -149.23 0.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -1.084 . . . . 0.0 109.417 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -109.93 133.92 20.83 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.916 -1.115 . . . . 0.0 110.721 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.59 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.3 Cg_endo -63.65 -161.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.157 1.904 . . . . 0.0 111.369 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.54 ' HB3' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -150.17 123.31 8.86 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.94 152.3 34.85 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.025 -1.047 . . . . 0.0 110.448 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 93.85 162.83 36.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 2.9 m -72.12 -57.58 4.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -1.113 . . . . 0.0 109.17 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -47.66 -29.28 2.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -90.07 -61.88 1.59 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.35 -0.844 . . . . 0.0 109.383 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.536 ' CD1' ' HD2' ' A' ' 45' ' ' ARG . 7.7 mm -45.36 -33.7 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.307 -0.871 . . . . 0.0 109.173 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.561 ' CG ' ' CD2' ' A' ' 23' ' ' LEU . 53.6 ttp85 -86.83 -61.45 1.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 108.924 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 26.1 tt0 -44.38 -28.8 0.59 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 108.564 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.54 ' CD2' ' HB3' ' A' ' 45' ' ' ARG . 1.2 t80 -80.71 -70.6 0.51 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.598 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -47.0 -25.52 0.82 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' CA ' HD21 ' A' ' 23' ' ' LEU . . . -76.24 -55.08 5.9 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -51.25 -30.77 18.7 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.707 ' OG ' H111 ' A' ' 126' ' ' NTH . 1.6 t -76.09 -34.31 59.52 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.489 ' CD2' ' CA ' ' A' ' 21' ' ' GLY . 7.7 tp -68.82 -21.59 64.3 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.418 -0.802 . . . . 0.0 108.995 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -55.35 -18.68 7.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.364 -0.835 . . . . 0.0 109.049 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.547 HD11 H183 ' A' ' 126' ' ' NTH . 0.7 OUTLIER -89.64 125.34 61.55 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.281 -0.887 . . . . 0.0 108.881 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 86' ' ' PHE . 44.8 Cg_endo -71.44 103.08 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.791 1.416 . . . . 0.0 110.621 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.588 ' CB ' ' CG1' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -136.8 160.03 40.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.1 -1.0 . . . . 0.0 110.021 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.51 ' CB ' ' OG ' ' A' ' 85' ' ' SER . . . -99.47 129.1 45.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.439 ' O ' ' CG ' ' A' ' 19' ' ' ASN . 3.3 t -111.55 114.87 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.716 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -150.5 101.1 2.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.582 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -49.82 -179.71 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.234 -0.916 . . . . 0.0 109.556 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.6 t -162.2 -37.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.199 -0.938 . . . . 0.0 109.773 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -93.67 -147.68 0.25 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.57 -0.706 . . . . 0.0 109.27 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 23.4 tt0 -115.82 130.39 56.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.188 -0.945 . . . . 0.0 109.687 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.529 ' CG2' HG12 ' A' ' 11' ' ' VAL . 33.7 t -64.19 154.51 6.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.396 -0.815 . . . . 0.0 109.115 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.508 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 3.9 mmt180 -115.56 130.27 56.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.534 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.452 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -147.65 128.32 14.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -0.851 . . . . 0.0 109.228 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -152.3 160.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 0.0 109.26 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 47.95 -144.43 0.37 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.263 -0.898 . . . . 0.0 109.387 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -90.16 -8.44 51.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.088 -1.008 . . . . 0.0 109.645 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.474 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 3.1 mt-10 -104.13 -162.87 0.93 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.236 -0.915 . . . . 0.0 109.501 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 101' ' ' PHE . . . -175.71 168.56 3.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.0 109.677 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.58 ' HB1' ' CD2' ' A' ' 100' ' ' HIS . . . -150.52 136.66 18.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.02 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 15.2 p90 -150.01 167.46 26.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.953 -1.092 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.534 ' HB1' ' CG1' ' A' ' 98' ' ' ILE . . . -142.85 168.14 20.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.456 0.646 . . . . 0.0 109.622 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 4.5 p90 -164.59 -169.05 1.64 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -0.838 . . . . 0.0 109.277 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.87 141.83 50.34 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.484 -0.76 . . . . 0.0 109.814 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.588 ' CG1' ' CB ' ' A' ' 63' ' ' LEU . 16.4 t -118.12 112.98 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.364 -0.835 . . . . 0.0 109.116 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.521 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 96.5 p -107.42 99.07 8.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.205 -0.935 . . . . 0.0 109.271 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.803 ' CE2' H211 ' A' ' 126' ' ' NTH . 21.4 p90 -117.41 176.36 5.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.377 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.495 ' HG2' ' N ' ' A' ' 88' ' ' PHE . 60.7 tt0 -149.98 151.23 33.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.756 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.566 ' CZ ' ' OG1' ' A' ' 93' ' ' THR . 7.9 m-85 -96.71 -141.85 0.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.412 -0.805 . . . . 0.0 109.289 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -102.68 45.59 0.96 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.02 -1.05 . . . . 0.0 109.321 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.52 -42.95 0.46 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -107.7 164.75 11.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -1.191 . . . . 0.0 109.488 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -133.54 123.63 25.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 109.531 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.566 ' OG1' ' CZ ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -117.8 148.68 41.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.845 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.557 HG11 ' CG ' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -117.95 178.17 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 108.812 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.554 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 2.5 t -150.33 141.36 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.099 -1.001 . . . . 0.0 109.848 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.452 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -129.1 73.02 81.98 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.482 -0.761 . . . . 0.0 109.877 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.554 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 50.4 Cg_endo -95.16 -179.37 0.58 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.448 1.432 . . . . 0.0 111.648 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.534 ' CG1' ' HB1' ' A' ' 81' ' ' ALA . 2.7 mp -141.48 133.42 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 5.2 t0 -107.29 162.73 13.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.865 -1.147 . . . . 0.0 110.413 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.58 ' CD2' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -114.75 173.66 6.36 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.111 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.64 ' CZ ' ' CG1' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -145.44 146.38 31.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.895 -1.128 . . . . 0.0 110.72 -178.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.474 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -138.55 102.5 4.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.419 -0.801 . . . . 0.0 109.375 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.46 ' CE2' HG21 ' A' ' 10' ' ' VAL . 16.6 m-85 -89.6 174.28 7.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 109.381 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.522 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 0.5 OUTLIER -114.27 -14.35 12.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.858 . . . . 0.0 109.122 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . 114.93 78.84 0.8 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 163.23 -21.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.35 -1.088 . . . . 0.0 109.721 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 122.19 -35.65 3.43 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -59.56 175.5 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -1.184 . . . . 0.0 109.567 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 110' ' ' VAL . 45.8 t -113.27 145.96 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.064 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 5.1 t -121.18 -73.39 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.103 -0.998 . . . . 0.0 109.389 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.46 ' OG ' ' OG1' ' A' ' 35' ' ' THR . 0.6 OUTLIER -114.66 166.64 11.52 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.029 -1.044 . . . . 0.0 109.047 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 19.6 ttp -154.92 137.41 15.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.165 -0.96 . . . . 0.0 109.902 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.472 ' HA ' ' HB2' ' A' ' 37' ' ' GLU . 3.0 mtm180 -111.55 161.59 16.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.79 . . . . 0.0 108.955 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.409 ' O ' ' CG1' ' A' ' 40' ' ' VAL . . . -143.47 132.26 22.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.98 -1.075 . . . . 0.0 109.77 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.516 ' O ' ' HB3' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -123.3 137.09 54.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.771 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.516 ' HB3' ' O ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER 171.14 -162.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.508 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . 167.75 175.96 38.0 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.359 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.491 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 37.4 tt0 -48.95 -22.91 0.94 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -1.194 . . . . 0.0 109.281 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.483 ' NZ ' ' CD ' ' B' ' 270' ' ' GLU . 0.3 OUTLIER -73.33 -22.55 60.29 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.043 0.925 . . . . 0.0 108.92 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.523 ' OD1' ' CD1' ' A' ' 121' ' ' ILE . 0.5 OUTLIER -88.54 0.73 56.03 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.634 -179.422 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.523 ' CD1' ' OD1' ' A' ' 120' ' ' ASN . 3.0 mm -89.59 -159.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.912 -1.117 . . . . 0.0 108.703 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.557 ' CG ' HG11 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.39 -168.4 3.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 109.637 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.438 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.41 147.16 23.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.542 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.91 118.45 1.47 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.264 -1.139 . . . . 0.0 109.479 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 34.1 mtp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.312 0.577 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.465 ' HB3' ' HE1' ' B' ' 207' ' ' MET . 6.9 m-80 -121.11 96.37 5.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.543 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 2.5 t -45.92 109.51 0.99 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.316 -0.865 . . . . 0.0 109.565 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.38 -2.95 12.49 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.894 1.471 . . . . 0.0 110.182 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.3 -49.25 77.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 109.35 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -65.11 -51.72 59.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.583 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' MET . . . . . 0.465 ' HE1' ' HB3' ' B' ' 202' ' ' ASN . 25.2 mtt -60.24 -47.5 85.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.257 -0.902 . . . . 0.0 109.789 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 15.6 m -56.6 -38.72 72.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.164 -0.96 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -56.62 -49.07 76.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.121 -0.987 . . . . 0.0 108.99 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.639 ' CG1' ' CE1' ' B' ' 301' ' ' PHE . 0.9 OUTLIER -52.27 -24.16 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.509 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.521 HG22 ' CE2' ' B' ' 301' ' ' PHE . 23.2 t -85.82 -44.77 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.4 -0.813 . . . . 0.0 109.302 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' B' ' 213' ' ' ARG . 7.4 tt0 -57.11 -73.89 0.06 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' B' ' 212' ' ' GLN . 1.3 mtt85 -43.59 -44.89 6.46 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' TYR . . . . . 0.63 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -51.24 -45.4 61.97 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.61 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.0 OUTLIER -86.14 -37.7 11.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -49.13 -36.01 18.0 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -74.3 -31.84 62.64 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.63 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 0.8 OUTLIER -65.65 -57.72 7.44 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 0.2 OUTLIER -56.04 -45.12 79.3 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.542 0.687 . . . . 0.0 109.148 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' B' ' 221' ' ' GLY . . . -89.36 11.21 19.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.525 -0.734 . . . . 0.0 109.603 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' B' ' 217' ' ' ALA . . . 45.3 32.51 3.72 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.2 t70 -90.18 63.19 5.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.48 -1.012 . . . . 0.0 109.829 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' LEU . . . . . 0.588 ' CD1' ' HB3' ' B' ' 255' ' ' PHE . 6.1 tp -48.51 -43.97 35.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.099 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' B' ' 223' ' ' LEU . 26.2 t0 -42.49 -31.02 0.39 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -86.33 -32.56 16.24 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' B' ' 223' ' ' LEU . 27.2 mt -62.77 -56.66 16.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.465 HG21 ' HB2' ' B' ' 252' ' ' ARG . 78.7 t -56.3 -35.19 42.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.58 -56.38 22.07 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.538 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 8.0 tp -59.9 -25.79 65.39 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.556 -0.715 . . . . 0.0 109.08 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' B' ' 231' ' ' ALA . 7.4 m-85 -86.42 130.07 34.63 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.496 -0.752 . . . . 0.0 109.779 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -43.0 166.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 109.665 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -24.2 5.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.349 -0.844 . . . . 0.0 110.071 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.52 ' CB ' ' HA2' ' B' ' 247' ' ' GLY . 2.0 p30 -148.84 54.13 0.99 Allowed 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.572 -0.705 . . . . 0.0 109.437 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.559 ' N ' ' CD1' ' B' ' 251' ' ' ILE . . . -68.04 165.08 18.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.659 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' THR . . . . . 0.519 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -115.71 156.54 25.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 109.767 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.516 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 53.9 t -143.31 116.83 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.076 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.2 mt-10 -88.9 105.52 17.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 108.873 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' ASP . . . . . 0.514 ' OD2' ' CB ' ' B' ' 314' ' ' ALA . 9.9 t70 179.54 141.63 0.31 Allowed Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.919 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.462 ' HG2' ' OG ' ' B' ' 242' ' ' SER . 48.5 Cg_endo -74.63 -173.85 12.81 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.048 -2.063 . . . . 0.0 110.343 -0.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.2 t -76.84 135.12 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.131 -0.98 . . . . 0.0 109.124 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 89.73 -3.78 83.34 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' SER . . . . . 0.462 ' OG ' ' HG2' ' B' ' 239' ' ' PRO . 67.5 m -107.08 -132.76 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -1.145 . . . . 0.0 109.149 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' B' ' 242' ' ' SER . 19.9 mt-10 -148.43 133.62 9.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 120.616 -1.303 . . . . 0.0 110.042 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.4 Cg_endo -64.39 -172.7 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.133 1.596 . . . . 0.0 111.3 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.538 ' HB2' ' CD2' ' B' ' 254' ' ' PHE . 0.0 OUTLIER -150.69 105.99 3.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -93.0 162.24 14.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.282 -0.887 . . . . 0.0 110.616 -178.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . 0.52 ' HA2' ' CB ' ' B' ' 233' ' ' ASP . . . 97.51 159.35 30.9 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' THR . . . . . 0.41 HG22 HG12 ' B' ' 227' ' ' VAL . 7.3 m -73.23 -45.39 56.32 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.162 -1.199 . . . . 0.0 109.014 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -63.95 -24.17 67.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.826 . . . . 0.0 109.025 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' B' ' 246' ' ' SER . . . -90.02 -59.05 2.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.313 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.559 ' CD1' ' N ' ' B' ' 234' ' ' ALA . 21.7 mt -47.58 -39.25 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.364 -0.835 . . . . 0.0 109.255 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' ARG . . . . . 0.535 ' HG2' ' CD2' ' B' ' 223' ' ' LEU . 15.6 ttt180 -76.0 -57.16 4.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 109.068 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 8.0 mt-10 -46.4 -29.39 1.68 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.033 -1.042 . . . . 0.0 108.609 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.538 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.8 OUTLIER -83.74 -72.64 0.45 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.588 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.1 OUTLIER -48.84 -24.54 1.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.552 -0.718 . . . . 0.0 109.166 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . 0.53 ' CA ' HD21 ' B' ' 223' ' ' LEU . . . -74.91 -44.91 46.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 108.707 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 257' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 5.3 t30 -56.73 -34.33 67.41 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 258' ' ' SER . . . . . 0.489 ' OG ' ' H12' ' B' ' 326' ' ' NTH . 18.8 t -72.29 -47.0 53.34 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.49 -0.756 . . . . 0.0 109.179 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . 0.466 ' CD1' ' HA2' ' B' ' 221' ' ' GLY . 9.5 tp -57.46 -18.11 16.68 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.345 -0.847 . . . . 0.0 109.315 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 1.8 mttm -64.44 -19.6 65.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 109.592 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 261' ' ' LEU . . . . . 0.593 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.3 OUTLIER -89.37 120.43 69.7 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 262' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 45.0 Cg_endo -70.57 94.55 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.791 1.416 . . . . 0.0 110.755 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.593 ' CD2' ' CD2' ' B' ' 261' ' ' LEU . 0.0 OUTLIER -133.15 157.16 46.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.0 109.498 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . 0.436 ' HB2' ' OG ' ' B' ' 285' ' ' SER . . . -92.35 127.03 37.68 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . 0.401 ' O ' ' OD1' ' B' ' 219' ' ' ASN . 30.9 t -107.28 114.26 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 2.3 tt0 -150.1 95.76 2.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.084 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' B' ' 266' ' ' GLU . 2.7 mp -43.86 169.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 268' ' ' THR . . . . . 0.465 ' O ' ' O ' ' B' ' 269' ' ' GLN . 0.0 OUTLIER -129.01 -78.56 0.56 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.523 -0.736 . . . . 0.0 109.213 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 269' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' B' ' 268' ' ' THR . 2.0 pt20 -59.3 -149.19 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.483 ' CD ' ' NZ ' ' A' ' 119' ' ' LYS . 31.6 tt0 -111.51 131.45 55.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.033 -1.042 . . . . 0.0 109.68 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . 0.53 HG11 ' N ' ' B' ' 272' ' ' ARG . 72.8 t -52.85 144.06 4.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.32 -0.863 . . . . 0.0 109.342 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.53 ' N ' HG11 ' B' ' 271' ' ' VAL . 0.0 OUTLIER -105.75 130.25 53.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.935 . . . . 0.0 109.503 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . 0.465 ' HA ' ' CB ' ' B' ' 278' ' ' ALA . . . -147.25 137.09 23.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 109.321 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 274' ' ' VAL . . . . . 0.512 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -155.07 149.71 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 0.0 109.174 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . 0.428 ' O ' ' SD ' ' B' ' 207' ' ' MET . . . 49.82 -144.86 0.47 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.159 -0.963 . . . . 0.0 109.358 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 276' ' ' ASN . . . . . 0.471 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 2.0 m-20 -83.71 -20.7 32.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.728 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . 0.459 ' HG3' ' HG3' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -89.88 -161.71 0.81 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.161 -0.962 . . . . 0.0 109.583 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 278' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' B' ' 301' ' ' PHE . . . 170.1 162.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.755 . . . . 0.0 109.079 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 279' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -150.66 141.51 22.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.065 . . . . 0.0 109.236 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 21.1 p90 -141.63 154.55 45.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.827 -1.171 . . . . 0.0 110.705 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.583 ' CB ' ' CD1' ' B' ' 298' ' ' ILE . . . -119.43 168.53 10.86 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 282' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 0.0 OUTLIER -177.14 -173.44 0.45 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.898 . . . . 0.0 109.766 179.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 283' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -135.19 141.1 45.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.375 -0.828 . . . . 0.0 110.215 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 284' ' ' VAL . . . . . 0.537 ' CG1' ' CB ' ' B' ' 263' ' ' LEU . 8.0 t -109.21 134.56 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 108.795 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 285' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' B' ' 264' ' ' ALA . 29.0 p -125.73 100.78 6.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.987 . . . . 0.0 110.08 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.728 ' CE1' H222 ' B' ' 326' ' ' NTH . 33.9 p90 -117.34 -168.73 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 108.785 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 287' ' ' GLU . . . . . 0.469 ' N ' ' CD2' ' B' ' 286' ' ' PHE . 16.7 tt0 -149.85 158.59 44.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.93 -1.106 . . . . 0.0 110.09 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.405 ' CZ ' ' HE2' ' B' ' 286' ' ' PHE . 33.1 m-85 -105.6 -167.84 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.451 -0.781 . . . . 0.0 109.587 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.91 -20.94 3.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.378 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -160.66 -45.24 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -74.49 142.72 44.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -1.165 . . . . 0.0 109.522 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 292' ' ' LYS . . . . . 0.514 ' HG2' ' N ' ' B' ' 293' ' ' THR . 2.3 tmtt? -103.85 145.32 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.277 -0.89 . . . . 0.0 109.412 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 293' ' ' THR . . . . . 0.579 ' HB ' ' CE1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -135.88 143.29 44.96 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.452 -0.78 . . . . 0.0 110.297 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 294' ' ' VAL . . . . . 0.527 HG13 ' CB ' ' B' ' 322' ' ' HIS . 9.0 p -121.26 169.41 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.533 ' CG2' HG21 ' B' ' 321' ' ' ILE . 22.8 t -136.48 160.71 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.758 -1.214 . . . . 0.0 110.499 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 296' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' B' ' 320' ' ' ASN . . . -140.62 62.54 18.62 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.629 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 297' ' ' PRO . . . . . 0.529 ' HD3' HG11 ' B' ' 295' ' ' VAL . 43.5 Cg_endo -97.37 167.28 0.87 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.449 1.433 . . . . 0.0 112.01 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.583 ' CD1' ' CB ' ' B' ' 281' ' ' ALA . 3.9 mm -129.2 165.05 30.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . 0.609 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 14.7 t0 -135.06 156.27 49.31 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.201 -0.937 . . . . 0.0 109.909 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.535 ' O ' ' CG ' ' B' ' 312' ' ' MET . 0.2 OUTLIER -108.19 175.36 5.5 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 301' ' ' PHE . . . . . 0.639 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -149.74 136.62 19.48 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 110.026 -178.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.459 ' HG3' ' HG3' ' B' ' 277' ' ' GLU . 10.4 ttt85 -138.48 113.76 9.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 109.11 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 303' ' ' PHE . . . . . 0.567 ' CZ ' HG12 ' B' ' 210' ' ' VAL . 3.9 m-85 -95.09 178.82 5.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.468 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 304' ' ' ASN . . . . . 0.532 ' HB3' ' CG1' ' B' ' 310' ' ' VAL . 3.6 p30 -111.87 -21.8 11.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.358 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . 122.35 32.76 0.94 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . -144.49 9.47 1.39 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.218 -1.166 . . . . 0.0 109.964 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 87.05 -19.28 31.31 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.81 -177.26 6.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -1.205 . . . . 0.0 109.561 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 309' ' ' VAL . . . . . 0.527 ' CG2' ' CG2' ' B' ' 210' ' ' VAL . 61.0 t -112.69 137.12 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.163 -0.961 . . . . 0.0 109.154 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.532 ' CG1' ' HB3' ' B' ' 304' ' ' ASN . 0.0 OUTLIER -119.37 -61.57 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.079 -1.013 . . . . 0.0 109.799 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.91 162.85 17.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.045 -1.035 . . . . 0.0 109.67 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 312' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 29.2 ttp -159.02 145.93 17.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 313' ' ' ARG . . . . . 0.527 ' HB2' ' CB ' ' B' ' 300' ' ' HIS . 48.1 mtp180 -125.18 173.15 8.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.223 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 314' ' ' ALA . . . . . 0.514 ' CB ' ' OD2' ' B' ' 238' ' ' ASP . . . -150.17 150.88 32.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.032 . . . . 0.0 109.445 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 315' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -136.25 142.52 44.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 110.048 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 316' ' ' PHE . . . . . 0.541 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 1.2 p90 174.63 -155.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.652 0.739 . . . . 0.0 109.125 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 317' ' ' GLY . . . . . 0.478 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 159.79 -172.14 36.28 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 318' ' ' GLU . . . . . 0.518 ' HA ' HD12 ' B' ' 321' ' ' ILE . 6.3 tt0 -65.29 -6.73 10.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -1.108 . . . . 0.0 109.7 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -101.12 -17.99 16.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.323 -0.861 . . . . 0.0 109.699 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 320' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' B' ' 296' ' ' ALA . 1.4 m-20 -88.94 -23.18 22.75 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.607 -0.683 . . . . 0.0 110.189 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 321' ' ' ILE . . . . . 0.748 HG23 H221 ' B' ' 326' ' ' NTH . 0.6 OUTLIER -87.18 -158.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.072 -1.018 . . . . 0.0 108.546 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 322' ' ' HIS . . . . . 0.527 ' CB ' HG13 ' B' ' 294' ' ' VAL . 0.3 OUTLIER -151.61 161.61 42.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.974 -1.079 . . . . 0.0 110.064 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.496 ' HA ' HG22 ' B' ' 293' ' ' THR . . . -155.27 110.58 3.04 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.353 -0.842 . . . . 0.0 109.414 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -121.93 160.17 16.38 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.361 -1.082 . . . . 0.0 109.415 179.869 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' NTH . . . . . 0.803 H211 ' CE2' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 326' ' ' NTH . . . . . 0.748 H221 HG23 ' B' ' 321' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.486 ' O ' ' CB ' ' A' ' 2' ' ' ASN . 1.9 ttp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.275 0.56 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 1' ' ' MET . 2.0 p30 165.18 107.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.33 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.464 ' O ' ' HE3' ' A' ' 7' ' ' MET . 7.1 t -73.68 111.76 13.47 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.614 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 43.8 Cg_endo -71.41 -8.68 23.83 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.864 1.455 . . . . 0.0 109.784 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -61.81 -60.26 3.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.812 . . . . 0.0 109.243 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -61.33 -45.19 95.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.156 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.464 ' HE3' ' O ' ' A' ' 3' ' ' THR . 27.5 mtt -58.73 -28.81 66.2 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.223 -0.923 . . . . 0.0 109.333 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 11' ' ' VAL . 17.5 m -74.33 -44.14 53.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 109.059 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.25 -40.23 23.99 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.567 HG21 ' CE2' ' A' ' 103' ' ' PHE . 1.2 t -53.35 -26.76 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.544 HG21 ' CD1' ' A' ' 80' ' ' PHE . 7.6 t -90.02 -42.55 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.491 -0.756 . . . . 0.0 109.101 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 15' ' ' VAL . 20.7 tt0 -62.05 -73.92 0.1 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.0 OUTLIER -41.61 -44.18 2.99 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 122.041 0.924 . . . . 0.0 108.524 178.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.641 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -53.39 -45.58 69.33 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.42 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.601 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -84.63 -38.98 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 0.0 109.555 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.69 -35.74 14.63 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.521 ' HB3' ' CG1' ' A' ' 26' ' ' ILE . . . -74.88 -31.69 61.66 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.641 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 1.2 mt -65.7 -58.83 4.77 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -51.9 -45.38 64.18 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . -89.5 9.98 24.53 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.574 -0.704 . . . . 0.0 109.645 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.458 ' CA ' HD23 ' A' ' 59' ' ' LEU . . . 45.32 31.52 3.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 17' ' ' ALA . 6.8 t0 -89.82 68.64 7.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -1.062 . . . . 0.0 109.936 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.598 ' CD1' ' HB3' ' A' ' 55' ' ' PHE . 4.9 tp -49.35 -42.12 40.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -42.1 -30.56 0.3 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.96 -37.2 7.95 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.521 ' CG1' ' HB3' ' A' ' 17' ' ' ALA . 22.0 mt -59.64 -53.59 46.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.526 HG21 ' CG ' ' A' ' 52' ' ' ARG . 84.9 t -58.57 -36.17 58.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.6 -50.83 71.94 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.535 ' CD2' ' HA ' ' A' ' 10' ' ' VAL . 7.5 tp -65.61 -21.72 66.6 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.547 -0.721 . . . . 0.0 109.182 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.51 ' CG ' HG22 ' A' ' 51' ' ' ILE . 2.8 m-85 -84.6 135.5 34.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.419 -0.801 . . . . 0.0 109.609 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 109' ' ' VAL . . . -54.17 -175.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.471 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.4 OUTLIER -75.76 -23.23 55.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.885 . . . . 0.0 109.54 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.536 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -140.13 36.76 1.92 Allowed 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.59 -0.694 . . . . 0.0 109.357 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -51.38 -176.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.499 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.534 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.3 OUTLIER -142.49 134.13 26.72 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.373 -0.83 . . . . 0.0 109.432 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 44' ' ' PRO . 31.6 t -127.27 128.3 70.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.337 -0.852 . . . . 0.0 108.88 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 38' ' ' ASP . 21.9 mt-10 -101.15 114.18 27.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.617 ' OD2' ' H62' ' A' ' 126' ' ' NTH . 12.1 t70 -179.33 142.63 0.38 Allowed Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.608 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.474 ' HA ' ' CG ' ' A' ' 38' ' ' ASP . 46.9 Cg_endo -73.75 -179.26 24.86 Favored 'Cis proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.194 -2.002 . . . . 0.0 110.797 -0.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.526 ' CG2' HG13 ' B' ' 274' ' ' VAL . 27.6 m -66.9 82.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . -170.69 28.5 0.12 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER 70.5 47.46 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -1.11 . . . . 0.0 109.86 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.543 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 4.7 mt-10 -132.83 57.5 28.8 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 109.844 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 43' ' ' GLU . 50.3 Cg_endo -79.84 177.22 8.62 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 124.163 1.612 . . . . 0.0 110.653 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HD3' ' CA ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -151.59 107.22 3.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 109.251 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.534 ' HB2' ' CG2' ' A' ' 35' ' ' THR . 0.1 OUTLIER -89.56 157.45 18.06 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.263 -0.898 . . . . 0.0 110.117 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 100.52 166.37 28.55 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 3.0 m -75.2 -58.63 3.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.138 -1.213 . . . . 0.0 109.012 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -54.44 -44.88 72.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.211 -0.931 . . . . 0.0 109.076 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.53 ' CA ' ' HD3' ' A' ' 45' ' ' ARG . . . -59.26 -34.01 71.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.45 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.522 HD12 ' CG2' ' A' ' 36' ' ' VAL . 7.6 mm -79.72 -36.23 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.526 ' CG ' HG21 ' A' ' 27' ' ' VAL . 26.7 ttp85 -78.51 -56.64 4.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.068 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.9 mt-10 -45.76 -27.25 0.79 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -83.14 -70.22 0.57 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.174 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.598 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.26 -24.1 1.08 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.521 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -78.85 -47.31 16.83 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 19.2 t-20 -64.65 -28.37 69.57 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.655 ' OG ' H111 ' A' ' 126' ' ' NTH . 1.6 t -78.08 -42.26 32.72 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.458 HD23 ' CA ' ' A' ' 21' ' ' GLY . 8.9 tp -60.85 -17.86 52.57 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.405 -0.809 . . . . 0.0 108.903 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 4.8 mttm -55.16 -18.64 6.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.479 -0.763 . . . . 0.0 108.972 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.69 ' HB2' H183 ' A' ' 126' ' ' NTH . 0.3 OUTLIER -89.16 118.25 69.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.162 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 43.8 Cg_endo -71.34 110.42 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.748 1.393 . . . . 0.0 110.716 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.538 ' HB3' ' HB3' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -145.82 176.44 9.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.888 . . . . 0.0 110.053 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.73 126.12 54.88 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.513 ' CG2' ' HB3' ' A' ' 18' ' ' LEU . 3.7 t -104.29 117.96 50.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.682 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -146.09 105.57 3.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.133 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -47.41 175.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -0.929 . . . . 0.0 109.633 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 67' ' ' LEU . 2.7 p -155.8 -38.01 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.705 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 5.7 pt20 -99.21 -152.47 0.41 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.63 -0.669 . . . . 0.0 109.198 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 30.4 tt0 -109.8 130.38 55.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.15 -0.969 . . . . 0.0 109.787 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.514 HG21 ' CG1' ' A' ' 11' ' ' VAL . 37.2 t -60.01 145.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.333 -0.855 . . . . 0.0 108.996 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.536 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 1.7 ttm180 -106.26 134.48 49.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.662 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.487 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -146.7 145.51 30.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 109.232 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' B' ' 316' ' ' PHE . 0.2 OUTLIER -136.03 -151.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.191 -0.943 . . . . 0.0 109.562 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -34.59 -90.85 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.973 -0.454 . . . . 0.0 110.804 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 4.9 p-10 -112.89 -15.8 12.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.083 -1.011 . . . . 0.0 110.328 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.626 ' HG2' ' N ' ' A' ' 78' ' ' ALA . 1.4 tt0 -108.5 162.55 14.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.019 -1.051 . . . . 0.0 108.999 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.626 ' N ' ' HG2' ' A' ' 77' ' ' GLU . . . -143.12 177.16 8.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.38 -0.825 . . . . 0.0 110.224 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.56 ' CB ' ' CD1' ' B' ' 315' ' ' LEU . . . -150.1 137.07 19.41 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.66 ' CE1' ' CE2' ' A' ' 101' ' ' PHE . 31.8 p90 -150.32 170.83 18.09 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.706 -1.246 . . . . 0.0 110.137 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.539 ' CB ' HG21 ' A' ' 98' ' ' ILE . . . -139.62 -166.4 2.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.556 -0.715 . . . . 0.0 109.56 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CD2' ' C ' ' A' ' 81' ' ' ALA . 6.8 p90 174.23 -171.46 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.441 -0.787 . . . . 0.0 109.075 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.73 144.0 50.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.357 -0.84 . . . . 0.0 109.808 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 95' ' ' VAL . 12.1 t -116.78 115.0 47.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.52 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -106.58 103.43 12.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.077 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.564 ' CE1' ' HB ' ' A' ' 93' ' ' THR . 4.3 p90 -122.23 177.04 5.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.228 -0.92 . . . . 0.0 109.561 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -106.25 -179.95 4.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.174 -0.954 . . . . 0.0 110.466 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.497 ' C ' ' CG ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -137.67 43.18 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 109.549 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.497 ' CG ' ' C ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER 39.71 75.97 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.421 -0.799 . . . . 0.0 109.886 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.52 -41.49 2.01 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -125.46 179.35 5.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.41 -1.053 . . . . 0.0 108.928 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.502 ' HG2' ' N ' ' A' ' 93' ' ' THR . 0.4 OUTLIER -126.11 140.8 52.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.007 -1.058 . . . . 0.0 109.884 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.564 ' HB ' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -136.81 152.58 50.44 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.545 HG11 ' CG ' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -126.52 -178.85 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.994 . . . . 0.0 109.112 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.56 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 2.9 t -150.01 141.04 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 108.992 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.442 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -129.38 71.63 82.03 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.394 -0.816 . . . . 0.0 110.528 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.56 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 54.0 Cg_endo -95.88 -173.55 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.559 1.506 . . . . 0.0 110.854 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.539 HG21 ' CB ' ' A' ' 81' ' ' ALA . 3.1 mp -141.88 167.03 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.587 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 32.8 t0 -135.24 159.26 42.12 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 109.828 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.525 ' O ' ' CG ' ' A' ' 112' ' ' MET . 71.2 t60 -123.78 133.71 53.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.426 -0.797 . . . . 0.0 108.876 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.66 ' CE2' ' CE1' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -109.76 145.67 36.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.203 -0.935 . . . . 0.0 109.89 -179.039 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 111' ' ' SER . 6.2 ttt180 -145.06 114.22 7.0 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 10' ' ' VAL . 21.4 m-85 -89.61 -166.58 1.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.046 -1.034 . . . . 0.0 109.693 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -132.11 -43.01 0.97 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . -142.78 -62.23 0.02 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 163.87 76.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -1.149 . . . . 0.0 109.608 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -166.07 -49.53 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.27 -162.7 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -1.209 . . . . 0.0 109.545 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.532 HG23 ' CG2' ' A' ' 10' ' ' VAL . 54.5 t -97.46 143.18 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.331 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 56.6 t -125.12 -11.93 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.777 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.464 ' OG ' ' OG1' ' A' ' 35' ' ' THR . 13.0 m -159.09 156.1 28.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.412 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.562 ' SD ' ' CE1' ' A' ' 101' ' ' PHE . 8.4 ttp -160.31 149.3 17.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.969 . . . . 0.0 109.86 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -129.7 147.24 51.47 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.77 132.33 54.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.999 -1.063 . . . . 0.0 110.035 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' B' ' 279' ' ' ALA . 0.4 OUTLIER -122.43 141.65 51.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.363 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.55 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 4.3 p90 175.02 -152.47 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.476 ' N ' ' CG ' ' A' ' 116' ' ' PHE . . . 166.31 169.08 29.46 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.478 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 19.8 tt0 -68.64 -6.45 25.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -1.096 . . . . 0.0 109.473 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.85 -26.17 18.62 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.981 0.896 . . . . 0.0 108.886 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.496 ' OD1' ' NH2' ' B' ' 272' ' ' ARG . 0.1 OUTLIER -88.9 14.12 11.15 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.519 ' CG2' HG21 ' A' ' 95' ' ' VAL . 4.5 mm -90.68 -150.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.545 ' CG ' HG11 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.79 174.19 13.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.005 . . . . 0.0 109.538 179.372 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.56 88.12 1.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.9 . . . . 0.0 109.32 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -66.77 133.62 32.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.347 -1.09 . . . . 0.0 109.508 -179.972 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.463 ' O ' ' HB2' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.244 0.545 . . . . 0.0 110.144 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' B' ' 201' ' ' MET . 4.1 m-80 61.88 77.48 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -0.828 . . . . 0.0 109.673 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' THR . . . . . 0.411 HG22 ' O ' ' B' ' 203' ' ' THR . 3.0 t -61.96 116.69 23.03 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.668 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.52 -3.8 13.75 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.868 1.457 . . . . 0.0 109.96 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -59.71 -63.11 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.489 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -58.06 -43.98 87.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 109.397 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 18.1 mtt -57.61 -28.53 63.73 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.289 -0.882 . . . . 0.0 109.629 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.44 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 6.0 m -76.69 -35.89 57.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.076 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -53.85 -45.45 70.93 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.238 -0.914 . . . . 0.0 108.809 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.633 ' CG1' ' CE1' ' B' ' 301' ' ' PHE . 1.2 t -51.72 -27.1 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.617 ' CG2' ' CE2' ' B' ' 301' ' ' PHE . 40.1 t -83.4 -46.05 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.485 -0.759 . . . . 0.0 109.706 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' B' ' 213' ' ' ARG . 28.4 tt0 -56.86 -73.6 0.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.245 1.022 . . . . 0.0 108.312 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' B' ' 212' ' ' GLN . 1.6 mtt85 -43.06 -44.38 4.8 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.972 0.891 . . . . 0.0 108.655 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' TYR . . . . . 0.637 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -51.26 -45.3 62.0 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.568 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.599 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.2 t -88.42 -40.12 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.903 . . . . 0.0 109.359 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.23 -36.23 13.47 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.521 ' HB3' ' CG1' ' B' ' 226' ' ' ILE . . . -74.56 -33.63 62.74 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.637 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 3.4 mt -63.86 -58.58 6.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -53.38 -46.1 69.49 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.461 0.648 . . . . 0.0 109.476 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.32 9.22 26.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.529 -0.732 . . . . 0.0 109.649 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.516 ' CA ' HD23 ' B' ' 259' ' ' LEU . . . 48.6 37.19 19.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' B' ' 217' ' ' ALA . 25.5 t0 -97.93 61.17 1.52 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -1.114 . . . . 0.0 109.791 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' LEU . . . . . 0.57 ' CD2' ' CG ' ' B' ' 252' ' ' ARG . 2.2 tp -46.89 -39.45 12.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.03 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' B' ' 223' ' ' LEU . 0.5 OUTLIER -40.63 -31.31 0.15 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' B' ' 223' ' ' LEU . . . -88.86 -37.27 7.39 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.521 ' CG1' ' HB3' ' B' ' 217' ' ' ALA . 12.5 mt -58.54 -54.11 37.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' B' ' 252' ' ' ARG . 46.6 t -58.43 -41.69 82.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.41 ' HB2' ' HA2' ' B' ' 225' ' ' GLY . . . -55.34 -46.88 76.35 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 4.4 tp -69.75 -30.16 67.68 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.594 -0.691 . . . . 0.0 109.234 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . 0.583 ' CD2' HG23 ' B' ' 251' ' ' ILE . 4.8 m-85 -79.46 129.92 34.92 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.393 -0.817 . . . . 0.0 109.726 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -49.19 179.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.466 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -66.91 -23.49 65.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.769 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.505 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 0.0 OUTLIER -146.94 53.76 1.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.482 -0.761 . . . . 0.0 109.584 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.545 ' CA ' ' O ' ' B' ' 310' ' ' VAL . . . -64.47 155.91 31.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' THR . . . . . 0.487 ' N ' ' O ' ' B' ' 310' ' ' VAL . 0.0 OUTLIER -98.36 160.06 14.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.399 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.583 ' CG1' ' N ' ' B' ' 237' ' ' GLU . 1.9 t -139.49 173.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 108.875 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' GLU . . . . . 0.583 ' N ' ' CG1' ' B' ' 236' ' ' VAL . 4.7 mt-10 -150.14 104.29 3.26 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' ASP . . . . . 0.546 ' OD2' ' CB ' ' B' ' 314' ' ' ALA . 0.4 OUTLIER -177.37 139.03 0.42 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.95 -1.094 . . . . 0.0 109.559 -178.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.465 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 45.9 Cg_endo -72.87 -173.21 10.54 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.185 -2.006 . . . . 0.0 110.358 -0.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.479 HG21 ' CG1' ' A' ' 74' ' ' VAL . 34.8 m -70.52 81.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.968 . . . . 0.0 109.292 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' B' ' 242' ' ' SER . . . -174.57 35.22 0.11 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' B' ' 241' ' ' GLY . 0.5 OUTLIER 70.16 53.25 0.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -1.141 . . . . 0.0 109.786 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' B' ' 238' ' ' ASP . 1.4 mt-10 -130.11 61.37 58.09 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.374 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 50.7 Cg_endo -78.03 169.24 20.76 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.287 1.678 . . . . 0.0 110.822 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' B' ' 244' ' ' PRO . 0.0 OUTLIER -150.36 99.09 2.74 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -91.23 167.62 12.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 110.348 -178.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . 0.505 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 92.42 162.51 37.21 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 1.9 m -75.13 -49.44 19.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -1.16 . . . . 0.0 108.882 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -56.6 -42.24 78.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.891 . . . . 0.0 109.122 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' B' ' 246' ' ' SER . . . -66.44 -55.01 17.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.935 . . . . 0.0 109.362 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.583 HG23 ' CD2' ' B' ' 230' ' ' PHE . 12.6 mm -53.71 -45.54 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' ARG . . . . . 0.57 ' CG ' ' CD2' ' B' ' 223' ' ' LEU . 8.4 ttm180 -73.39 -57.82 3.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.128 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 31.2 tt0 -45.64 -27.83 0.86 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.095 -1.003 . . . . 0.0 108.704 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 1.0 OUTLIER -87.49 -71.09 0.58 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.567 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -48.24 -24.44 1.18 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' B' ' 252' ' ' ARG . . . -79.72 -48.44 13.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.857 . . . . 0.0 108.89 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 257' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 18.4 t30 -60.04 -33.52 72.15 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.34 -0.85 . . . . 0.0 108.743 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 258' ' ' SER . . . . . 0.659 ' OG ' ' H12' ' B' ' 326' ' ' NTH . 9.7 t -71.44 -38.26 71.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . 0.516 HD23 ' CA ' ' B' ' 221' ' ' GLY . 9.2 tp -62.59 -21.43 65.62 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.392 -0.818 . . . . 0.0 109.028 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 20.9 mtmt -64.48 -11.12 30.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.313 -0.867 . . . . 0.0 109.178 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 261' ' ' LEU . . . . . 0.632 HD11 H122 ' B' ' 326' ' ' NTH . 0.3 OUTLIER -89.3 117.69 68.44 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 262' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 41.5 Cg_endo -68.72 80.21 0.63 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.833 1.438 . . . . 0.0 110.683 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.586 ' CD2' ' CD2' ' B' ' 261' ' ' LEU . 0.0 OUTLIER -118.27 165.47 13.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.357 -0.839 . . . . 0.0 109.616 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' B' ' 285' ' ' SER . . . -101.8 130.81 48.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -0.816 . . . . 0.0 108.859 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . 0.419 HG13 HG11 ' B' ' 215' ' ' VAL . 30.0 t -116.92 114.3 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.031 -1.043 . . . . 0.0 110.085 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 28.7 tt0 -150.33 100.78 2.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.83 . . . . 0.0 109.148 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . 0.527 ' O ' ' CG2' ' B' ' 268' ' ' THR . 0.6 OUTLIER -48.27 177.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.725 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 268' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' B' ' 267' ' ' LEU . 80.8 p -159.16 -37.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.336 -0.852 . . . . 0.0 109.768 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 269' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' B' ' 270' ' ' GLU . 0.0 OUTLIER -93.55 -150.45 0.28 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.563 -0.71 . . . . 0.0 109.427 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' B' ' 269' ' ' GLN . 27.1 tt0 -112.55 130.56 55.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.652 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . 0.526 HG11 ' N ' ' B' ' 272' ' ' ARG . 75.5 t -67.54 147.71 12.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.356 -0.84 . . . . 0.0 109.082 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.526 ' N ' HG11 ' B' ' 271' ' ' VAL . 0.8 OUTLIER -103.71 138.11 40.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.175 -0.953 . . . . 0.0 109.896 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . 0.463 ' HA ' ' HB1' ' B' ' 278' ' ' ALA . . . -150.1 132.32 15.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 274' ' ' VAL . . . . . 0.55 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.2 OUTLIER -125.87 -152.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.95 . . . . 0.0 109.797 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' B' ' 274' ' ' VAL . . . -35.7 -96.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.898 -0.502 . . . . 0.0 110.899 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 276' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' B' ' 303' ' ' PHE . 1.9 m-20 -110.42 17.09 21.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.017 -1.052 . . . . 0.0 110.268 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . 0.453 ' OE2' ' NH1' ' A' ' 113' ' ' ARG . 0.5 OUTLIER -124.33 -160.04 0.91 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.932 -1.105 . . . . 0.0 109.628 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 278' ' ' ALA . . . . . 0.517 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . 172.08 160.18 0.1 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.545 -0.722 . . . . 0.0 109.65 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 279' ' ' ALA . . . . . 0.522 ' HB2' ' CD2' ' A' ' 115' ' ' LEU . . . -150.73 133.93 16.16 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . 0.582 ' CE1' ' HB3' ' B' ' 299' ' ' ASP . 22.6 p90 -150.2 168.5 23.8 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.838 -1.164 . . . . 0.0 110.275 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.536 ' CB ' HG21 ' B' ' 298' ' ' ILE . . . -138.46 -164.83 1.7 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 282' ' ' PHE . . . . . 0.439 ' CD2' ' C ' ' B' ' 281' ' ' ALA . 8.2 p90 168.16 -169.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 283' ' ' THR . . . . . 0.453 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -124.07 141.17 52.28 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 109.54 179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 284' ' ' VAL . . . . . 0.5 HG11 ' CB ' ' B' ' 263' ' ' LEU . 40.0 t -124.35 113.21 35.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.158 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 285' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' B' ' 294' ' ' VAL . 3.5 p -113.76 117.44 31.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.325 -0.86 . . . . 0.0 109.452 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.792 ' CE1' H222 ' B' ' 326' ' ' NTH . 17.0 p90 -123.27 176.27 6.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.19 -0.944 . . . . 0.0 109.555 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 287' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' B' ' 291' ' ' ARG . 29.8 tt0 -128.46 151.93 48.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.555 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.47 ' CE2' ' CZ ' ' B' ' 286' ' ' PHE . 28.1 m-85 -95.16 -107.2 0.14 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.213 -0.93 . . . . 0.0 109.388 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.61 -17.92 7.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.984 -1.072 . . . . 0.0 109.444 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -149.59 -40.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 291' ' ' ARG . . . . . 0.446 ' O ' ' HG3' ' B' ' 287' ' ' GLU . 33.1 mtt85 -90.4 -176.91 4.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -1.117 . . . . 0.0 109.417 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 292' ' ' LYS . . . . . 0.468 ' O ' ' CD ' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -136.75 133.95 36.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.312 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 293' ' ' THR . . . . . 0.56 ' HB ' ' CE1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -118.32 145.99 44.68 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.186 -0.946 . . . . 0.0 110.094 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 294' ' ' VAL . . . . . 0.513 HG11 ' CB ' ' B' ' 322' ' ' HIS . 11.8 p -116.47 163.74 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.335 -0.853 . . . . 0.0 108.866 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.559 ' CG2' HG21 ' B' ' 321' ' ' ILE . 49.1 t -139.41 156.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.032 -1.043 . . . . 0.0 110.444 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 296' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' B' ' 320' ' ' ASN . . . -142.13 68.73 22.63 Favored Pre-proline 0 N--CA 1.495 1.802 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 297' ' ' PRO . . . . . 0.518 ' HD3' HG11 ' B' ' 295' ' ' VAL . 48.3 Cg_endo -97.03 -175.42 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.877 1.718 . . . . 0.0 111.487 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.536 HG21 ' CB ' ' B' ' 281' ' ' ALA . 3.0 mp -140.44 169.4 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . 0.582 ' HB3' ' CE1' ' B' ' 280' ' ' PHE . 39.1 t0 -138.86 158.8 43.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.021 -1.049 . . . . 0.0 110.014 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.512 ' HB2' ' CB ' ' B' ' 313' ' ' ARG . 0.2 OUTLIER -113.87 172.96 6.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.382 -0.824 . . . . 0.0 108.944 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 301' ' ' PHE . . . . . 0.633 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.2 OUTLIER -144.95 146.64 32.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.123 -0.986 . . . . 0.0 110.49 -178.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.533 ' HB3' ' CB ' ' B' ' 311' ' ' SER . 25.4 ttt180 -144.16 108.72 4.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.476 -0.765 . . . . 0.0 108.952 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 303' ' ' PHE . . . . . 0.566 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 37.3 m-85 -89.83 179.88 5.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.799 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 304' ' ' ASN . . . . . 0.534 ' ND2' HG23 ' B' ' 310' ' ' VAL . 0.1 OUTLIER -150.13 16.79 0.85 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.332 -0.855 . . . . 0.0 109.245 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 305' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . 98.21 154.03 28.98 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 306' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 79.49 -5.68 1.9 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.405 -1.056 . . . . 0.0 109.824 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 83.14 -10.19 58.9 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.3 174.15 4.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.103 -1.233 . . . . 0.0 109.455 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 309' ' ' VAL . . . . . 0.51 HG22 ' CG2' ' B' ' 210' ' ' VAL . 95.1 t -109.89 151.9 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.158 -0.964 . . . . 0.0 109.027 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.545 ' O ' ' CA ' ' B' ' 234' ' ' ALA . 53.3 t -137.32 -56.56 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.957 -1.089 . . . . 0.0 110.156 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 311' ' ' SER . . . . . 0.533 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -118.48 160.61 21.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.615 -1.303 . . . . 0.0 109.917 -179.541 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 312' ' ' MET . . . . . 0.537 ' CE ' ' CZ ' ' B' ' 230' ' ' PHE . 10.2 ttm -159.92 141.69 12.92 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.431 -0.793 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 313' ' ' ARG . . . . . 0.512 ' CB ' ' HB2' ' B' ' 300' ' ' HIS . 0.3 OUTLIER -116.95 158.38 24.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.393 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 314' ' ' ALA . . . . . 0.546 ' CB ' ' OD2' ' B' ' 238' ' ' ASP . . . -124.31 138.03 54.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.28 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 315' ' ' LEU . . . . . 0.56 ' CD1' ' CB ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -133.73 142.27 47.89 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.137 -0.977 . . . . 0.0 109.89 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 316' ' ' PHE . . . . . 0.525 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 53.7 p90 171.18 -156.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 317' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' B' ' 321' ' ' ILE . . . 154.71 176.59 27.15 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 318' ' ' GLU . . . . . 0.466 ' HA ' HD12 ' B' ' 321' ' ' ILE . 13.4 tt0 -55.43 -17.74 5.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -1.185 . . . . 0.0 109.136 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -87.49 -24.99 23.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.871 0.843 . . . . 0.0 109.077 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 320' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.27 -34.89 16.44 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 321' ' ' ILE . . . . . 0.708 HG23 H221 ' B' ' 326' ' ' NTH . 0.9 OUTLIER -86.32 -172.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.799 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 322' ' ' HIS . . . . . 0.513 ' CB ' HG11 ' B' ' 294' ' ' VAL . 0.0 OUTLIER -151.63 172.8 15.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.091 -1.005 . . . . 0.0 109.814 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.53 ' HA ' ' CG2' ' B' ' 293' ' ' THR . . . -155.42 85.69 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.402 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -95.58 165.02 24.52 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.261 -1.14 . . . . 0.0 109.558 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' NTH . . . . . 0.69 H183 ' HB2' ' A' ' 61' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 326' ' ' NTH . . . . . 0.792 H222 ' CE1' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ptt? . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.234 0.54 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.47 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.4 m120 -127.82 126.39 41.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.87 . . . . 0.0 109.308 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.501 ' HB ' ' NE2' ' A' ' 6' ' ' HIS . 0.6 OUTLIER -90.19 108.98 30.05 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.789 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 48.5 Cg_endo -75.03 1.65 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.973 1.512 . . . . 0.0 110.279 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -58.63 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 110.048 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.501 ' NE2' ' HB ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -45.57 -32.75 2.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.115 -0.99 . . . . 0.0 109.279 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.528 ' HB3' ' CB ' ' A' ' 73' ' ' ALA . 25.3 mtm -70.89 -57.69 4.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 109.732 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 11' ' ' VAL . 16.6 m -58.57 -38.14 77.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.81 -42.66 47.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.195 -0.941 . . . . 0.0 108.652 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.599 ' CG1' ' CZ ' ' A' ' 101' ' ' PHE . 2.9 t -60.03 -20.93 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.563 HG22 ' CE2' ' A' ' 101' ' ' PHE . 40.0 t -90.47 -47.91 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -58.26 -61.76 2.33 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.125 -0.984 . . . . 0.0 109.022 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.417 ' CB ' HD21 ' A' ' 29' ' ' LEU . 3.2 mtm-85 -53.97 -46.66 71.7 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.909 0.861 . . . . 0.0 108.838 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.632 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -48.72 -42.69 35.93 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.619 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 1.3 t -88.5 -38.74 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.315 -0.866 . . . . 0.0 109.379 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.45 -37.72 18.0 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.462 ' HB2' HG12 ' A' ' 26' ' ' ILE . . . -72.62 -33.76 66.87 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.632 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 4.5 mt -65.31 -60.58 2.83 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -51.0 -41.19 59.6 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.567 0.698 . . . . 0.0 109.23 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.31 2.26 54.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.484 -0.76 . . . . 0.0 109.55 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.547 ' CA ' ' CD2' ' A' ' 59' ' ' LEU . . . 52.24 41.89 54.96 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.405 ' O ' HG13 ' A' ' 26' ' ' ILE . 45.6 t0 -105.17 80.18 1.57 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -1.091 . . . . 0.0 110.052 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.591 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 3.9 mm? -51.37 -20.67 1.84 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.188 -0.945 . . . . 0.0 109.745 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -61.12 -54.85 39.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.256 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -64.71 -29.57 75.59 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.569 HG22 ' CD1' ' A' ' 55' ' ' PHE . 6.9 mt -66.26 -59.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 60.0 t -61.53 -40.55 86.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.13 -51.83 65.19 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 109' ' ' VAL . 8.6 tp -64.3 -26.4 68.47 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.495 ' CD2' HG22 ' A' ' 51' ' ' ILE . 5.2 m-85 -87.57 131.11 34.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.495 -0.753 . . . . 0.0 109.766 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -45.44 171.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.834 . . . . 0.0 109.642 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.466 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -61.75 -24.02 66.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.709 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.528 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -141.05 52.03 1.59 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.571 -0.706 . . . . 0.0 109.681 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 110' ' ' VAL . . . -67.16 168.51 10.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.517 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -127.76 137.67 52.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.391 -0.818 . . . . 0.0 109.302 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 55.8 t -133.29 123.73 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.275 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.511 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 96.0 mt-10 -89.17 108.4 19.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 108.58 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 9.8 t0 -177.99 142.29 0.45 Allowed Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 119.229 -0.989 . . . . 0.0 110.058 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 47.7 Cg_endo -72.75 -179.24 23.67 Favored 'Cis proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.214 -1.994 . . . . 0.0 110.564 -0.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.49 ' O ' ' CG2' ' A' ' 40' ' ' VAL . 14.4 m -73.57 112.81 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.497 ' HA2' ' ND2' ' B' ' 276' ' ' ASN . . . 103.99 12.65 29.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.526 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 4.0 m -118.56 -107.04 0.38 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -1.145 . . . . 0.0 109.458 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -166.87 130.64 1.53 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.874 -1.141 . . . . 0.0 109.88 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 41.6 Cg_endo -67.3 -168.25 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.952 1.501 . . . . 0.0 111.201 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.522 ' HG3' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -150.43 102.82 3.08 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.517 ' HB2' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.93 152.04 21.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.325 -0.86 . . . . 0.0 110.024 -179.151 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.528 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 104.43 173.96 25.03 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 4.7 m -79.36 -68.81 0.63 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.05 -1.265 . . . . 0.0 109.376 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -47.16 -32.92 4.7 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.135 -0.978 . . . . 0.0 109.012 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.522 ' CB ' ' HG3' ' A' ' 45' ' ' ARG . . . -70.96 -51.17 27.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.18 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.495 HG22 ' CD2' ' A' ' 30' ' ' PHE . 7.5 mm -58.67 -43.65 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.534 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 18.8 ttt180 -73.29 -56.11 5.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 108.983 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 52' ' ' ARG . 14.6 tt0 -45.74 -27.04 0.74 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 108.617 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -88.27 -71.09 0.6 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.72 0.772 . . . . 0.0 108.918 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.569 ' CD1' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -52.1 -20.92 2.79 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.476 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 52' ' ' ARG . . . -80.82 -45.52 16.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.175 -0.953 . . . . 0.0 108.452 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 2.4 t30 -56.82 -30.52 63.83 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.4 t -69.92 -37.8 76.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.591 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 8.0 tp -67.27 -19.68 65.53 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.45 -0.781 . . . . 0.0 109.735 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 2.7 mtmt -56.36 -25.57 49.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.552 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.89 125.69 59.94 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.179 -0.951 . . . . 0.0 109.079 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 44.1 Cg_endo -70.78 101.1 1.01 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.759 1.4 . . . . 0.0 110.349 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.552 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -137.99 150.31 46.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.568 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.461 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -89.65 127.52 35.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.193 -0.942 . . . . 0.0 108.793 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 t -108.43 114.01 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 0.0 109.851 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 67' ' ' LEU . 16.8 tt0 -150.44 98.68 2.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.384 -0.822 . . . . 0.0 109.194 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.8 mp -45.38 170.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 109.807 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 t -144.58 -38.63 0.28 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.404 -0.81 . . . . 0.0 109.612 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.511 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 13.9 pt20 -90.92 -146.31 0.19 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.553 -0.717 . . . . 0.0 109.268 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.511 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 23.6 tt0 -115.34 135.2 54.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.106 -0.996 . . . . 0.0 109.768 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.513 HG11 ' N ' ' A' ' 72' ' ' ARG . 78.1 t -72.06 145.2 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.293 -0.879 . . . . 0.0 109.345 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.524 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -107.5 135.46 48.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 0.0 109.65 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 7' ' ' MET . . . -150.37 129.79 12.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 109.878 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -138.38 145.68 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 109.899 179.577 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . 41.68 -101.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.466 -0.771 . . . . 0.0 110.077 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.574 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -121.39 -11.44 8.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.952 -1.092 . . . . 0.0 109.69 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.465 ' HG3' ' HA ' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -89.74 -161.12 0.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.121 -0.987 . . . . 0.0 109.06 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.487 ' HB1' ' HA ' ' A' ' 73' ' ' ALA . . . 169.22 159.38 0.05 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.272 -0.893 . . . . 0.0 109.972 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.574 ' HB1' ' CD2' ' A' ' 100' ' ' HIS . . . -149.96 132.33 15.59 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 37.4 p90 -150.42 168.77 23.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.891 -1.131 . . . . 0.0 110.436 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.469 ' HB1' HG13 ' A' ' 98' ' ' ILE . . . -143.8 161.86 37.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.683 -0.636 . . . . 0.0 109.312 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 2.1 p90 -157.13 -169.72 3.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.213 -0.929 . . . . 0.0 109.335 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.61 141.12 52.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.457 -0.777 . . . . 0.0 109.903 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.486 ' CG1' ' HB3' ' A' ' 63' ' ' LEU . 73.3 t -112.7 114.15 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.52 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 19.5 p -108.69 97.32 6.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.182 -0.949 . . . . 0.0 110.296 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.763 ' CZ ' H221 ' A' ' 126' ' ' NTH . 18.4 p90 -111.17 -176.45 2.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.264 -0.897 . . . . 0.0 108.618 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 2.7 tm-20 -148.78 150.33 32.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.885 -1.134 . . . . 0.0 110.126 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.41 ' O ' ' CD ' ' A' ' 87' ' ' GLU . 65.6 m-85 -90.29 -116.07 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.31 1.03 19.83 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.912 -1.117 . . . . 0.0 109.446 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -164.19 -58.8 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.459 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 3.3 mtt85 -81.76 158.51 24.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -1.133 . . . . 0.0 109.485 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -119.59 132.44 55.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 109.765 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -114.89 143.84 44.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.863 . . . . 0.0 109.255 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.529 HG11 ' N ' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -117.23 173.44 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 108.922 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.54 ' CG1' ' HD3' ' A' ' 97' ' ' PRO . 2.8 t -145.96 145.93 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 109.32 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.521 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . -127.71 72.95 78.52 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.54 ' HD3' ' CG1' ' A' ' 95' ' ' VAL . 50.0 Cg_endo -91.58 -177.0 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.731 1.385 . . . . 0.0 110.821 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.47 HG21 ' O ' ' A' ' 80' ' ' PHE . 2.5 mp -140.84 142.8 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 13.6 t0 -116.46 160.05 21.14 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.952 -1.092 . . . . 0.0 110.215 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.574 ' CD2' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -113.12 176.25 5.1 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.599 ' CZ ' ' CG1' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -148.14 137.86 22.38 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.035 -1.041 . . . . 0.0 109.926 -179.145 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.465 ' HA ' ' HG3' ' A' ' 77' ' ' GLU . 64.2 ttt-85 -141.44 103.15 4.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.576 ' CE1' HG12 ' A' ' 10' ' ' VAL . 10.9 m-30 -92.31 -171.81 2.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.51 ' N ' HG23 ' A' ' 110' ' ' VAL . 3.6 p30 -112.66 -25.45 9.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . -157.62 -69.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 171.38 73.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -1.103 . . . . 0.0 109.388 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -178.84 -52.44 0.08 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -117.61 174.3 6.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -1.117 . . . . 0.0 109.498 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.527 ' CG2' HG12 ' A' ' 10' ' ' VAL . 88.8 t -97.83 167.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.069 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 3.1 t -140.52 -72.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.028 -1.045 . . . . 0.0 109.964 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 35' ' ' THR . 19.7 m -119.43 163.41 17.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 109.939 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.538 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 2.8 ttp -148.28 164.39 34.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.467 -0.77 . . . . 0.0 109.555 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' NH1' ' OE2' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -143.24 123.45 13.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 109.318 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.472 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . . . -104.99 130.46 53.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.105 -0.997 . . . . 0.0 109.652 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' B' ' 279' ' ' ALA . 0.6 OUTLIER -126.15 147.58 49.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.608 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.541 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 9.7 p90 174.09 -155.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . 167.8 -179.23 41.26 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.516 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 24.4 tt0 -70.26 -4.77 23.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -1.165 . . . . 0.0 109.694 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -90.62 -29.64 17.66 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -89.29 13.31 13.74 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.198 0.523 . . . . 0.0 109.697 -179.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.536 HG21 ' CG2' ' A' ' 95' ' ' VAL . 4.4 mm -91.91 -163.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.146 -0.971 . . . . 0.0 108.748 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.527 ' CB ' HG13 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -151.43 161.63 42.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.427 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.53 113.18 3.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.8 -119.61 4.21 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.29 -1.123 . . . . 0.0 109.545 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.402 ' CE ' ' OE1' ' A' ' 118' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.222 0.534 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.464 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 7.4 m-80 44.94 68.85 0.5 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.568 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' THR . . . . . 0.459 ' O ' ' CG2' ' B' ' 203' ' ' THR . 9.7 t -52.51 107.74 0.91 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 0.0 109.661 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 50.6 Cg_endo -77.2 5.9 4.71 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.912 1.48 . . . . 0.0 110.491 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' B' ' 204' ' ' PRO . 0.0 OUTLIER -40.76 -72.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.289 -0.882 . . . . 0.0 110.183 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' HIS . . . . . 0.568 ' CE1' ' HG3' ' B' ' 207' ' ' MET . 11.8 p80 -54.59 -35.84 63.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 109.957 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' MET . . . . . 0.568 ' HG3' ' CE1' ' B' ' 206' ' ' HIS . 15.8 mtt -65.57 -56.92 9.68 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.172 -0.955 . . . . 0.0 109.836 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.457 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 8.2 m -56.18 -31.1 63.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.701 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.99 -51.37 67.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.149 -0.969 . . . . 0.0 108.696 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.635 ' CG1' ' CZ ' ' B' ' 301' ' ' PHE . 1.0 OUTLIER -55.56 -20.61 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.567 HG22 ' CE2' ' B' ' 301' ' ' PHE . 16.2 t -90.24 -43.01 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.553 -0.717 . . . . 0.0 109.123 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' B' ' 213' ' ' ARG . 6.0 tt0 -60.66 -74.09 0.08 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' B' ' 212' ' ' GLN . 1.6 mtt-85 -42.3 -44.88 4.03 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.964 0.888 . . . . 0.0 108.605 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' TYR . . . . . 0.581 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -49.7 -45.15 48.68 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.608 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.24 -38.88 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.309 -0.869 . . . . 0.0 109.097 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -49.1 -35.75 17.03 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -75.3 -31.0 60.53 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.608 ' CD1' ' HA ' ' B' ' 215' ' ' VAL . 1.1 mt -65.4 -56.4 12.73 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 0.2 OUTLIER -53.06 -47.31 68.55 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.604 0.716 . . . . 0.0 109.348 179.462 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.22 6.56 39.65 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.713 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 217' ' ' ALA . . . 51.48 39.55 44.93 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.9 t0 -96.04 66.48 2.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.306 -1.114 . . . . 0.0 109.893 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' LEU . . . . . 0.593 ' CD2' ' CG ' ' B' ' 252' ' ' ARG . 6.1 tp -47.59 -43.34 25.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.163 -0.96 . . . . 0.0 108.909 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' B' ' 228' ' ' ALA . 0.2 OUTLIER -43.59 -38.21 2.88 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -80.6 -29.01 45.23 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.512 HD11 ' CD1' ' B' ' 223' ' ' LEU . 36.9 mt -65.92 -56.27 15.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.467 HG12 HG22 ' B' ' 248' ' ' THR . 77.3 t -59.86 -35.97 63.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' B' ' 224' ' ' ASP . . . -60.22 -56.21 24.38 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.5 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 9.2 tp -59.3 -23.0 62.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . 0.465 ' HA ' ' HB ' ' B' ' 309' ' ' VAL . 3.9 m-85 -88.92 143.35 26.93 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.41 -0.806 . . . . 0.0 109.484 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -53.79 -170.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.855 . . . . 0.0 109.322 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.458 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -75.61 -24.2 56.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 109.673 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.529 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 15.1 p30 -145.06 44.2 1.33 Allowed 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.592 -0.693 . . . . 0.0 109.608 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.502 ' CA ' ' O ' ' B' ' 310' ' ' VAL . . . -55.9 168.53 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.918 . . . . 0.0 109.339 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' THR . . . . . 0.517 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -121.68 142.68 49.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.611 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 32.3 t -131.63 121.16 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 109.507 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' GLU . . . . . 0.507 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.1 mt-10 -88.53 112.43 22.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' ASP . . . . . 0.775 ' OD2' ' H62' ' B' ' 326' ' ' NTH . 12.6 t70 -176.08 145.57 0.75 Allowed Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.265 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 53.6 Cg_endo -79.66 -92.41 0.0 OUTLIER 'Cis proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.506 -1.872 . . . . 0.0 110.915 -0.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.38 126.55 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.912 -1.118 . . . . 0.0 108.95 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 86.53 -8.37 75.26 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' SER . . . . . 0.535 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.2 OUTLIER -97.93 -146.24 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -1.062 . . . . 0.0 109.152 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -135.17 141.78 39.29 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.882 -1.136 . . . . 0.0 110.247 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' PRO . . . . . 0.539 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.4 Cg_endo -64.55 -169.5 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.271 1.669 . . . . 0.0 110.883 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.575 ' HG3' ' CD1' ' B' ' 254' ' ' PHE . 1.5 mtt-85 -150.34 101.77 3.01 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.517 ' HB2' ' CG2' ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.2 164.38 15.0 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.307 -0.87 . . . . 0.0 110.119 -179.03 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 98.39 160.45 30.17 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' THR . . . . . 0.467 HG22 HG12 ' B' ' 227' ' ' VAL . 4.1 m -74.32 -33.15 63.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.167 -1.196 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -72.63 -43.88 62.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.281 -0.887 . . . . 0.0 109.34 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' B' ' 245' ' ' ARG . . . -67.75 -56.97 7.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.445 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' B' ' 247' ' ' GLY . 43.2 mt -47.53 -40.27 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.878 . . . . 0.0 108.885 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' ARG . . . . . 0.593 ' CG ' ' CD2' ' B' ' 223' ' ' LEU . 25.1 ttp85 -78.02 -52.72 8.35 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 4.0 mt-10 -50.82 -26.53 5.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 108.472 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.575 ' CD1' ' HG3' ' B' ' 245' ' ' ARG . 0.8 OUTLIER -87.65 -71.36 0.57 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.576 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.1 OUTLIER -48.95 -33.26 10.56 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . 0.523 ' CA ' HD21 ' B' ' 223' ' ' LEU . . . -63.8 -49.71 71.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 257' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 8.5 t30 -54.99 -36.49 65.48 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 258' ' ' SER . . . . . 0.658 ' HB2' ' H10' ' B' ' 326' ' ' NTH . 4.7 t -65.63 -36.19 82.99 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.429 -0.794 . . . . 0.0 108.961 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . 0.459 HD12 ' HA2' ' B' ' 221' ' ' GLY . 8.1 tp -67.07 -22.5 65.84 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.493 -0.754 . . . . 0.0 109.189 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' B' ' 262' ' ' PRO . 1.2 mttm -56.25 -20.34 17.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.132 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 261' ' ' LEU . . . . . 0.556 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.3 OUTLIER -92.35 107.38 23.15 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 262' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 49.4 Cg_endo -74.44 107.4 2.44 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.822 1.433 . . . . 0.0 112.151 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.579 HD23 ' CD1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -141.91 -162.83 1.46 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 0.0 109.567 178.608 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -123.67 125.84 45.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . 0.466 HG13 HG12 ' B' ' 215' ' ' VAL . 21.6 t -105.4 119.11 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.97 . . . . 0.0 109.806 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 266' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.2 OUTLIER -147.88 107.33 3.93 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.234 -0.916 . . . . 0.0 109.284 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.7 OUTLIER -49.77 -179.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.905 . . . . 0.0 109.574 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.15 -39.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 109.677 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 269' ' ' GLN . . . . . 0.426 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 8.9 pt20 -98.72 -148.62 0.34 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 109.231 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.426 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 28.1 tt0 -113.11 131.25 55.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.106 -0.996 . . . . 0.0 109.516 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . 0.477 HG11 ' N ' ' B' ' 272' ' ' ARG . 48.1 t -65.6 148.52 12.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.12 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 1.2 mtt180 -103.24 133.49 48.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -0.95 . . . . 0.0 109.732 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . 0.475 ' HA ' ' HB1' ' B' ' 278' ' ' ALA . . . -150.14 137.44 19.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.368 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 274' ' ' VAL . . . . . 0.541 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -130.02 -152.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 0.0 109.589 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . -32.67 -91.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.147 0.498 . . . . 0.0 110.799 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 276' ' ' ASN . . . . . 0.497 ' ND2' ' HA2' ' A' ' 41' ' ' GLY . 11.2 p30 -112.54 -18.18 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.944 -1.098 . . . . 0.0 110.269 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . 0.465 ' HG3' ' HG2' ' B' ' 302' ' ' ARG . 2.8 mt-10 -90.62 -163.27 1.0 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 109.578 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 278' ' ' ALA . . . . . 0.53 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . 174.89 163.79 0.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.516 -0.74 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 279' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -150.55 138.81 20.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 108.623 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . 0.576 ' CE2' ' HB3' ' B' ' 299' ' ' ASP . 33.3 p90 -150.39 167.25 27.63 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.71 -1.244 . . . . 0.0 110.462 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.536 ' CB ' HG21 ' B' ' 298' ' ' ILE . . . -142.96 151.7 41.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.719 -0.613 . . . . 0.0 109.378 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 282' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 1.2 p90 -145.37 -169.95 3.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.181 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.57 142.95 47.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.461 -0.774 . . . . 0.0 109.961 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 284' ' ' VAL . . . . . 0.548 HG11 ' CB ' ' B' ' 263' ' ' LEU . 2.9 t -125.86 115.54 43.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 285' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' B' ' 294' ' ' VAL . 53.1 p -119.7 106.02 11.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 109.988 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.581 ' CE1' ' HB ' ' B' ' 293' ' ' THR . 13.6 p90 -114.41 173.82 6.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.0 108.846 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.11 157.09 16.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.024 -1.048 . . . . 0.0 110.803 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.54 ' O ' ' N ' ' B' ' 290' ' ' GLY . 0.0 OUTLIER -117.57 74.09 0.92 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.594 -0.691 . . . . 0.0 109.147 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . 0.513 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 0.2 OUTLIER 43.94 -91.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.062 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 290' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' B' ' 288' ' ' PHE . . . -101.0 7.11 57.01 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.295 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -132.72 -178.94 5.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -1.22 . . . . 0.0 109.803 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 292' ' ' LYS . . . . . 0.535 ' O ' ' CA ' ' B' ' 324' ' ' GLY . 1.6 mmtp -122.42 144.2 49.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.84 . . . . 0.0 109.344 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 293' ' ' THR . . . . . 0.613 ' CB ' ' HB2' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -140.22 159.19 42.73 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.148 -0.97 . . . . 0.0 109.364 -179.06 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 294' ' ' VAL . . . . . 0.6 ' O ' ' HB3' ' B' ' 322' ' ' HIS . 3.9 p -151.65 -177.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 120.686 -1.259 . . . . 0.0 110.266 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.565 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 29.0 t -151.95 148.89 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.106 -1.621 . . . . 0.0 109.187 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 296' ' ' ALA . . . . . 0.529 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -145.07 67.84 13.58 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.068 -1.02 . . . . 0.0 110.238 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 297' ' ' PRO . . . . . 0.565 ' HD3' ' CG1' ' B' ' 295' ' ' VAL . 50.0 Cg_endo -98.03 -175.78 0.22 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.94 1.76 . . . . 0.0 111.018 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.536 HG21 ' CB ' ' B' ' 281' ' ' ALA . 2.9 mp -139.88 147.29 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . 0.576 ' HB3' ' CE2' ' B' ' 280' ' ' PHE . 9.4 t0 -118.42 157.83 26.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.858 -1.151 . . . . 0.0 110.223 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.525 ' O ' ' CG ' ' B' ' 312' ' ' MET . 0.3 OUTLIER -110.52 172.3 6.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.336 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 301' ' ' PHE . . . . . 0.635 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -146.48 133.94 20.83 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.048 -1.032 . . . . 0.0 110.129 -178.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.478 ' O ' ' HB ' ' B' ' 310' ' ' VAL . 0.3 OUTLIER -139.69 111.96 7.63 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 303' ' ' PHE . . . . . 0.551 ' CE1' HG12 ' B' ' 210' ' ' VAL . 8.3 m-30 -91.87 177.63 6.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.268 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 304' ' ' ASN . . . . . 0.506 ' N ' ' CG2' ' B' ' 310' ' ' VAL . 6.7 p30 -92.61 -28.9 16.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.931 . . . . 0.0 109.276 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 305' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -166.53 -50.74 0.03 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 306' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 163.04 76.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -1.135 . . . . 0.0 109.336 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.52 -63.71 0.06 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.53 -163.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -1.179 . . . . 0.0 109.841 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 309' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' B' ' 310' ' ' VAL . 17.0 t -106.98 168.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.338 -0.851 . . . . 0.0 109.162 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.55 ' N ' ' CG1' ' B' ' 309' ' ' VAL . 24.6 t -139.86 -73.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 0.0 109.919 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 311' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' B' ' 235' ' ' THR . 9.3 m -125.38 163.24 23.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.185 -0.947 . . . . 0.0 110.164 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 312' ' ' MET . . . . . 0.567 ' SD ' ' CE1' ' B' ' 301' ' ' PHE . 0.0 OUTLIER -143.44 171.3 14.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -0.822 . . . . 0.0 109.487 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 313' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' B' ' 300' ' ' HIS . 1.5 ttp85 -150.2 120.0 7.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 109.571 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -101.07 136.63 40.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.977 . . . . 0.0 109.721 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 315' ' ' LEU . . . . . 0.529 ' CD1' ' HB1' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -126.24 148.7 49.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.896 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 316' ' ' PHE . . . . . 0.534 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 2.2 p90 168.22 -169.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 317' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' B' ' 321' ' ' ILE . . . -157.24 167.58 33.94 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.262 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 318' ' ' GLU . . . . . 0.533 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 5.8 tt0 -63.81 -9.88 17.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.43 -1.041 . . . . 0.0 109.889 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -88.37 -32.81 18.19 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 320' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' B' ' 296' ' ' ALA . 0.7 OUTLIER -98.44 28.64 4.03 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 321' ' ' ILE . . . . . 0.533 ' CG1' ' HA ' ' B' ' 318' ' ' GLU . 19.5 mm -91.01 -120.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.005 -1.059 . . . . 0.0 110.332 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 322' ' ' HIS . . . . . 0.799 ' CD2' H211 ' B' ' 326' ' ' NTH . 14.4 p80 -125.69 134.25 51.88 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.016 -1.052 . . . . 0.0 112.489 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' B' ' 324' ' ' GLY . . . -159.54 122.13 3.5 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.393 -0.817 . . . . 0.0 109.841 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' B' ' 292' ' ' LYS . . . 40.94 -117.96 1.13 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.274 -1.133 . . . . 0.0 109.391 179.944 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' NTH . . . . . 0.763 H221 ' CZ ' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 326' ' ' NTH . . . . . 0.799 H211 ' CD2' ' B' ' 322' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.276 0.56 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.453 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 5.8 m-20 55.37 43.08 29.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.451 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.518 HG23 ' CE1' ' A' ' 6' ' ' HIS . 1.3 t -75.38 112.14 17.4 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.707 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 46.3 Cg_endo -73.9 -0.46 9.49 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.863 1.454 . . . . 0.0 110.185 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.19 -92.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.602 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.518 ' CE1' HG23 ' A' ' 3' ' ' THR . 1.6 p-80 -52.54 -41.28 63.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.143 -0.973 . . . . 0.0 109.259 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.527 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 34.5 mmt -53.17 -39.86 63.93 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.199 -0.938 . . . . 0.0 109.788 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.424 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 6.0 m -74.19 -36.63 64.02 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.21 -43.81 64.44 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.641 ' CG1' ' CE1' ' A' ' 101' ' ' PHE . 2.1 t -49.55 -33.93 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.584 ' CG2' ' CE2' ' A' ' 101' ' ' PHE . 29.9 t -76.33 -45.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.438 -0.789 . . . . 0.0 109.791 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 15' ' ' VAL . 17.0 tt0 -59.4 -73.68 0.08 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.212 1.006 . . . . 0.0 108.494 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.3 mtt180 -42.68 -44.91 4.5 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.636 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -49.5 -44.98 46.51 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.612 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 1.3 t -88.88 -38.72 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.334 -0.854 . . . . 0.0 109.243 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.94 -36.47 17.44 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 22' ' ' ASP . . . -74.0 -32.58 63.47 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.636 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 2.4 mt -64.96 -58.75 5.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -51.14 -45.8 61.77 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . -89.58 10.19 23.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.64 -0.662 . . . . 0.0 109.459 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.534 ' CA ' ' CD2' ' A' ' 59' ' ' LEU . . . 45.7 31.92 4.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' ALA . 7.6 t70 -89.75 66.19 7.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.501 -0.999 . . . . 0.0 109.804 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.611 ' CD1' ' HB3' ' A' ' 55' ' ' PHE . 8.2 tp -47.9 -42.61 27.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 108.962 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -42.03 -32.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.4 -36.82 10.29 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.473 HG12 ' HB3' ' A' ' 17' ' ' ALA . 25.3 mt -59.32 -54.07 39.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 52.4 t -58.18 -40.9 79.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.22 -52.73 60.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' A' ' 10' ' ' VAL . 9.6 tp -61.71 -27.89 69.02 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.587 ' CE1' ' HE3' ' A' ' 112' ' ' MET . 5.6 m-85 -79.08 128.33 33.14 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.556 -0.715 . . . . 0.0 109.811 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -45.86 172.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 109.655 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.431 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -60.08 -24.15 64.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 109.87 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.544 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -148.01 38.66 0.91 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.58 -0.7 . . . . 0.0 109.506 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB2' HD13 ' A' ' 51' ' ' ILE . . . -54.91 173.65 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.632 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.547 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -114.57 140.09 49.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.426 -0.796 . . . . 0.0 109.127 179.657 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.563 HG13 ' CD2' ' A' ' 54' ' ' PHE . 1.2 t -113.43 171.83 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 108.715 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.591 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -151.26 121.11 7.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.882 . . . . 0.0 108.873 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.536 ' OD2' ' H61' ' A' ' 126' ' ' NTH . 0.2 OUTLIER 172.69 148.2 0.2 Allowed Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.549 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.554 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 46.7 Cg_endo -80.93 -84.38 0.0 OUTLIER 'Cis proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.165 -2.015 . . . . 0.0 110.599 -0.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' B' ' 275' ' ' ALA . 2.2 m -146.95 73.71 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.203 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.29 -5.5 3.88 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.554 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 3.4 t -97.27 -131.04 0.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.19 -1.183 . . . . 0.0 109.199 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -138.62 128.37 14.7 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.565 -1.334 . . . . 0.0 110.423 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.591 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 37.9 Cg_endo -62.5 -175.56 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.707 1.605 . . . . 0.0 111.055 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.532 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -151.11 100.52 2.78 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.45 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.547 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.3 OUTLIER -90.37 171.58 9.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.205 -0.935 . . . . 0.0 110.63 -178.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 95.77 154.85 30.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 5.5 m -64.7 -36.83 85.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.19 -1.182 . . . . 0.0 109.259 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -70.79 -43.97 67.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.154 -0.966 . . . . 0.0 109.319 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 46' ' ' SER . . . -74.41 -57.13 4.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.582 HG22 ' CD1' ' A' ' 30' ' ' PHE . 43.0 mt -43.71 -37.11 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.235 -0.916 . . . . 0.0 109.052 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 2.5 ttt180 -81.25 -63.62 1.36 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.0 109.147 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 4.2 tt0 -45.11 -28.75 0.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.934 . . . . 0.0 108.825 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.563 ' CD2' HG13 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -79.88 -71.42 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.611 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -46.62 -25.75 0.77 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.469 ' HA ' HD21 ' A' ' 23' ' ' LEU . . . -71.2 -47.17 59.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 11.1 t-20 -57.51 -30.87 65.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.388 -0.82 . . . . 0.0 108.793 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.54 ' OG ' ' H10' ' A' ' 126' ' ' NTH . 35.6 t -72.55 -40.83 66.37 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.534 ' CD2' ' CA ' ' A' ' 21' ' ' GLY . 9.0 tp -65.11 -21.93 66.87 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.453 -0.779 . . . . 0.0 109.273 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.467 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 4.8 mttp -47.47 -27.5 1.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.043 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -90.03 107.72 21.26 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.306 -0.871 . . . . 0.0 108.718 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 44.5 Cg_endo -70.93 116.09 4.53 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.795 1.419 . . . . 0.0 110.675 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.54 ' CD2' ' O ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -150.3 -171.13 3.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.969 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.59 126.84 54.71 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.38 123.52 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 109.895 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -150.23 98.71 2.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.141 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 66' ' ' GLU . 2.1 mp -44.87 170.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 110.039 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 69' ' ' GLN . 0.6 OUTLIER -129.27 -83.3 0.56 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 68' ' ' THR . 2.8 pt20 -59.37 -148.07 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.675 -0.641 . . . . 0.0 109.319 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 31.6 tt0 -109.1 132.43 54.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.056 -1.028 . . . . 0.0 109.647 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.535 HG12 ' CG1' ' A' ' 11' ' ' VAL . 48.7 t -57.4 149.48 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.293 -0.88 . . . . 0.0 109.259 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.51 ' HA ' ' NE ' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -114.28 132.91 55.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.029 -1.044 . . . . 0.0 109.968 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.458 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . . . -150.17 112.04 4.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.39 -0.819 . . . . 0.0 109.253 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -131.81 158.71 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.225 -0.922 . . . . 0.0 109.501 -179.814 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 48.58 -147.52 0.26 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.304 -0.873 . . . . 0.0 109.622 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -82.24 -24.12 34.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.532 ' CG ' ' HA ' ' A' ' 102' ' ' ARG . 3.3 mt-10 -89.92 -162.41 0.88 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.111 -0.993 . . . . 0.0 109.539 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 101' ' ' PHE . . . -178.46 168.95 1.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.522 -0.736 . . . . 0.0 109.366 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.527 ' HB2' ' CD2' ' B' ' 315' ' ' LEU . . . -150.17 136.27 18.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.155 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.685 ' CE1' ' CE2' ' A' ' 101' ' ' PHE . 14.4 p90 -149.79 162.25 40.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.95 -1.094 . . . . 0.0 110.15 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.527 ' C ' ' CD2' ' A' ' 82' ' ' PHE . . . -136.45 -173.0 3.29 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.638 0.732 . . . . 0.0 110.118 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.527 ' CD2' ' C ' ' A' ' 81' ' ' ALA . 6.0 p90 177.08 -169.81 0.07 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -133.33 140.41 47.39 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 110.042 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 37.7 t -107.94 113.35 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 33.6 p -108.12 84.7 1.99 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 109.743 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.907 ' CE1' H211 ' A' ' 126' ' ' NTH . 15.5 p90 -93.62 -179.21 4.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.083 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 18.5 tt0 -111.36 149.59 30.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.034 -1.041 . . . . 0.0 110.325 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.587 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -114.19 104.98 12.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.453 -0.779 . . . . 0.0 109.021 179.443 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.497 ' CG ' ' C ' ' A' ' 88' ' ' PHE . 1.1 pt20 40.74 -93.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.412 -0.805 . . . . 0.0 109.894 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 88' ' ' PHE . . . -101.9 -31.84 5.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -90.08 -178.27 5.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -1.232 . . . . 0.0 109.632 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.458 ' HE3' ' OXT' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -127.46 140.63 52.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.587 ' OG1' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -124.59 159.81 29.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.393 -0.817 . . . . 0.0 109.645 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.578 ' CG1' ' CB ' ' A' ' 122' ' ' HIS . 7.2 p -139.28 174.88 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.165 -0.96 . . . . 0.0 109.31 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.552 HG13 ' HD3' ' A' ' 97' ' ' PRO . 78.3 t -142.94 163.12 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.078 -1.014 . . . . 0.0 109.942 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.532 ' N ' HG13 ' A' ' 95' ' ' VAL . . . -138.0 70.63 49.32 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.527 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.552 ' HD3' HG13 ' A' ' 95' ' ' VAL . 46.1 Cg_endo -97.83 179.25 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.871 1.714 . . . . 0.0 111.447 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.526 HD12 ' NE ' ' B' ' 272' ' ' ARG . 2.8 mp -142.06 156.25 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.577 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 19.9 t0 -130.16 159.58 36.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.967 -1.083 . . . . 0.0 110.072 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 113' ' ' ARG . 85.9 t60 -109.87 170.74 7.88 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.685 ' CE2' ' CE1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -140.85 136.02 31.95 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.07 -1.018 . . . . 0.0 110.006 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.532 ' HA ' ' CG ' ' A' ' 77' ' ' GLU . 3.2 ttt85 -131.3 109.13 10.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.593 ' CE1' HG12 ' A' ' 10' ' ' VAL . 10.1 m-85 -108.42 -177.48 3.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 107' ' ' GLY . 6.1 p30 -106.72 6.34 29.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.573 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . 120.51 -30.51 5.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 164.36 37.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -1.151 . . . . 0.0 109.364 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 108' ' ' LYS . . . -130.58 47.62 1.01 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 7.3 mmtt 84.19 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.055 -0.674 . . . . 0.0 109.421 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 110' ' ' VAL . 40.4 t -89.83 166.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 109.329 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.542 ' N ' ' CG1' ' A' ' 109' ' ' VAL . 72.3 t -138.19 -59.78 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.531 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.529 ' HB2' ' CD ' ' A' ' 102' ' ' ARG . 1.1 m -139.6 163.5 32.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.612 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.587 ' HE3' ' CE1' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -145.45 155.37 43.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.883 . . . . 0.0 109.779 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -141.31 108.18 5.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.376 -0.828 . . . . 0.0 108.985 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.48 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . . . -89.89 148.02 23.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.071 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.559 HD11 ' CE1' ' B' ' 300' ' ' HIS . 1.4 tt -136.36 139.98 42.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.433 -0.792 . . . . 0.0 109.575 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.52 ' HA ' ' NH2' ' B' ' 272' ' ' ARG . 2.8 p90 172.42 -158.44 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.624 0.726 . . . . 0.0 109.4 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.409 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . 174.49 179.85 45.36 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.522 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 18.6 tt0 -72.73 -3.22 23.86 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.311 -1.111 . . . . 0.0 109.397 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -91.16 -29.15 17.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.946 0.879 . . . . 0.0 108.996 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -88.85 15.95 7.64 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.324 0.583 . . . . 0.0 109.712 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.522 ' CG1' ' HA ' ' A' ' 118' ' ' GLU . 4.0 mm -89.97 -162.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.578 ' CB ' ' CG1' ' A' ' 94' ' ' VAL . 2.9 t-80 -151.67 153.56 34.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.862 -1.149 . . . . 0.0 110.047 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.481 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.8 125.3 6.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.336 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.12 -164.95 32.59 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.458 ' OXT' ' HE3' ' A' ' 92' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.325 -1.103 . . . . 0.0 109.45 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.427 ' O ' ' C ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.251 0.548 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.457 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 30.7 m120 43.7 74.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.484 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 4.8 t -87.64 109.61 27.95 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.625 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.4 Cg_endo -72.93 -1.35 10.34 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.91 1.479 . . . . 0.0 110.245 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -49.39 72.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -66.15 -55.0 18.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.504 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' MET . . . . . 0.444 ' SD ' ' O ' ' B' ' 275' ' ' ALA . 69.2 mtm -58.32 -43.72 88.32 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.231 -0.918 . . . . 0.0 109.781 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.471 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 19.1 m -70.79 -42.04 70.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.574 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.35 -45.2 65.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 108.747 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.597 ' CG2' ' CG2' ' B' ' 309' ' ' VAL . 1.3 t -56.99 -20.64 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.55 HG21 ' CD1' ' B' ' 280' ' ' PHE . 10.7 t -90.29 -41.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 0.0 109.198 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' B' ' 213' ' ' ARG . 14.0 tt0 -60.49 -74.77 0.07 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' B' ' 212' ' ' GLN . 0.0 OUTLIER -42.09 -43.43 3.26 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 122.137 0.97 . . . . 0.0 108.697 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' TYR . . . . . 0.635 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 1.2 t80 -55.84 -49.27 73.76 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.415 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.606 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 0.9 OUTLIER -83.01 -42.58 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.722 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.45 -36.67 10.36 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -74.89 -32.98 61.98 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.635 ' CD1' ' CE1' ' B' ' 214' ' ' TYR . 0.9 OUTLIER -62.68 -56.18 20.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' B' ' 265' ' ' VAL . 4.0 t-20 -53.24 -48.41 68.24 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.652 0.739 . . . . 0.0 109.523 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.01 10.0 23.13 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.845 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 217' ' ' ALA . . . 50.06 37.83 30.72 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' B' ' 217' ' ' ALA . 9.4 t0 -93.03 61.29 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.332 -1.099 . . . . 0.0 109.815 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' LEU . . . . . 0.573 ' CD1' ' HB3' ' B' ' 255' ' ' PHE . 5.8 tp -46.2 -42.53 14.27 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.153 -0.967 . . . . 0.0 108.648 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -43.7 -37.88 2.86 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -81.78 -33.46 27.26 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.49 HD12 ' CD2' ' B' ' 255' ' ' PHE . 27.9 mt -61.25 -55.18 26.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 88.8 t -58.02 -37.13 59.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.19 25.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 9.8 tp -59.71 -24.39 63.94 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' B' ' 231' ' ' ALA . 5.1 m-85 -82.59 136.62 34.77 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.494 -0.754 . . . . 0.0 109.362 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.534 ' CB ' HG22 ' B' ' 310' ' ' VAL . . . -52.33 -174.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.382 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.473 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.3 OUTLIER -69.67 -26.38 64.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.445 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.536 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 3.5 p30 -151.4 54.87 0.86 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.498 -0.751 . . . . 0.0 109.68 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.507 ' CA ' ' O ' ' B' ' 310' ' ' VAL . . . -60.36 -167.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' THR . . . . . 0.471 ' N ' ' O ' ' B' ' 310' ' ' VAL . 0.2 OUTLIER -130.6 133.96 46.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.895 . . . . 0.0 109.244 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' B' ' 237' ' ' GLU . 23.1 t -111.95 167.66 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -0.865 . . . . 0.0 109.188 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' GLU . . . . . 0.555 ' N ' ' CG1' ' B' ' 236' ' ' VAL . 21.8 mt-10 -150.88 115.54 5.19 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' ASP . . . . . 0.493 ' OD2' ' H10' ' B' ' 326' ' ' NTH . 0.6 OUTLIER -177.11 148.17 0.73 Allowed Pre-proline 0 N--CA 1.491 1.582 0 C-N-CA 118.355 -1.338 . . . . 0.0 110.38 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 47.6 Cg_endo -73.34 -55.32 0.14 OUTLIER 'Cis proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.941 -2.108 . . . . 0.0 110.989 -0.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.463 HG11 ' O ' ' B' ' 239' ' ' PRO . 34.6 m -150.43 111.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 109.792 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.14 43.39 63.12 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' SER . . . . . 0.522 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 73.7 m -114.73 -96.57 0.45 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -1.117 . . . . 0.0 109.944 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . 0.407 ' HA ' ' HD2' ' B' ' 244' ' ' PRO . 0.0 OUTLIER -142.86 89.9 7.82 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.272 -0.893 . . . . 0.0 110.609 -179.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' PRO . . . . . 0.548 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 37.9 Cg_endo -63.38 179.57 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.117 1.588 . . . . 0.0 110.507 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.581 ' HB2' ' CD1' ' B' ' 254' ' ' PHE . 0.0 OUTLIER -150.64 100.46 2.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.952 . . . . 0.0 109.629 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.79 167.05 13.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.32 -0.863 . . . . 0.0 109.64 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 97.78 159.5 30.66 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 2.1 m -69.58 -38.57 77.41 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.946 -1.326 . . . . 0.0 109.145 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -69.48 -41.4 76.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' B' ' 246' ' ' SER . . . -72.92 -56.99 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' B' ' 247' ' ' GLY . 30.0 mt -46.67 -42.26 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.188 -0.945 . . . . 0.0 108.772 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' ARG . . . . . 0.533 ' HB2' ' CG2' ' B' ' 227' ' ' VAL . 8.3 ttt180 -79.08 -50.75 10.55 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 46.4 mt-10 -51.12 -31.03 18.05 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.581 ' CD1' ' HB2' ' B' ' 245' ' ' ARG . 1.1 t80 -83.47 -71.93 0.48 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.573 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -46.0 -26.34 0.7 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' B' ' 252' ' ' ARG . . . -70.65 -48.26 55.86 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 257' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 4.7 t-20 -61.98 -31.02 71.34 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 258' ' ' SER . . . . . 0.803 ' OG ' ' H12' ' B' ' 326' ' ' NTH . 2.8 t -71.56 -32.59 68.28 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . 0.443 HD12 ' HA2' ' B' ' 221' ' ' GLY . 8.7 tp -66.19 -22.15 66.34 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 16.1 mtmt -61.51 -13.57 22.26 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 261' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' B' ' 263' ' ' LEU . 0.1 OUTLIER -88.63 110.46 37.26 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.248 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 262' ' ' PRO . . . . . 0.496 ' HD2' HD12 ' B' ' 261' ' ' LEU . 52.1 Cg_endo -80.94 91.68 1.12 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.705 1.371 . . . . 0.0 112.328 -178.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.588 HD22 ' CD1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -138.48 163.77 31.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.082 -1.011 . . . . 0.0 108.819 178.186 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -89.81 127.27 35.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.18 -0.95 . . . . 0.0 109.021 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . 0.507 ' O ' ' ND2' ' B' ' 219' ' ' ASN . 93.9 t -104.44 112.44 38.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.269 -0.895 . . . . 0.0 109.528 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 266' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.6 tp10 -147.47 98.14 2.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.053 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . 0.507 ' HA ' ' CB ' ' B' ' 282' ' ' PHE . 1.7 mp -44.41 169.35 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 110.059 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 268' ' ' THR . . . . . 0.502 ' OG1' ' N ' ' B' ' 269' ' ' GLN . 0.4 OUTLIER -122.28 -83.08 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 269' ' ' GLN . . . . . 0.502 ' N ' ' OG1' ' B' ' 268' ' ' THR . 2.6 pt20 -61.17 -140.4 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -117.57 130.67 56.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.875 -1.141 . . . . 0.0 109.993 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . 0.52 ' CG1' ' HB3' ' B' ' 280' ' ' PHE . 56.5 t -48.71 149.19 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.355 -0.841 . . . . 0.0 108.936 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.526 ' NE ' HD12 ' A' ' 98' ' ' ILE . 31.1 mtp85 -108.11 129.18 55.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.043 -1.036 . . . . 0.0 109.714 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . 0.485 ' C ' ' CG2' ' B' ' 274' ' ' VAL . . . -143.91 144.95 31.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.292 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 274' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -167.31 146.55 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 109.099 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . 58.27 -139.11 0.81 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.093 -1.005 . . . . 0.0 109.094 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 276' ' ' ASN . . . . . 0.544 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 18.0 m-20 -91.31 -31.26 16.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.977 -1.077 . . . . 0.0 109.891 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . 0.669 ' HG2' ' N ' ' B' ' 278' ' ' ALA . 0.0 OUTLIER -97.99 153.6 18.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 109.647 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 278' ' ' ALA . . . . . 0.669 ' N ' ' HG2' ' B' ' 277' ' ' GLU . . . -136.04 169.66 17.25 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.388 0.613 . . . . 0.0 109.877 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 279' ' ' ALA . . . . . 0.58 ' HB2' ' CE1' ' B' ' 300' ' ' HIS . . . -141.66 141.66 33.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.388 -0.82 . . . . 0.0 109.182 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . 0.587 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 36.0 p90 -150.26 157.92 43.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.848 -1.158 . . . . 0.0 110.324 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.537 ' CB ' HG21 ' B' ' 298' ' ' ILE . . . -137.26 -169.27 2.46 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.484 0.659 . . . . 0.0 110.038 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 282' ' ' PHE . . . . . 0.507 ' CB ' ' HA ' ' B' ' 267' ' ' LEU . 30.5 p90 168.55 -168.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 283' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -130.92 140.79 50.23 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.346 -0.846 . . . . 0.0 109.527 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 284' ' ' VAL . . . . . 0.544 ' CG1' ' HB2' ' B' ' 263' ' ' LEU . 0.4 OUTLIER -100.87 119.32 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -0.872 . . . . 0.0 108.892 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 86.7 p -109.17 118.23 36.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 0.0 109.836 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.863 ' CE2' H221 ' B' ' 326' ' ' NTH . 0.7 OUTLIER -140.32 153.43 46.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.935 . . . . 0.0 109.44 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 287' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' B' ' 291' ' ' ARG . 81.9 tt0 -96.5 164.53 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' B' ' 289' ' ' GLN . 1.0 OUTLIER -115.42 -173.8 2.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.688 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' B' ' 288' ' ' PHE . 0.0 OUTLIER -43.22 -30.43 0.48 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.707 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -150.0 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 291' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' B' ' 287' ' ' GLU . 0.0 OUTLIER -83.35 -165.03 0.99 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -1.188 . . . . 0.0 109.532 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 292' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' B' ' 287' ' ' GLU . 0.3 OUTLIER -149.78 143.64 25.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.85 . . . . 0.0 109.306 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 293' ' ' THR . . . . . 0.65 ' CG2' ' CE2' ' B' ' 286' ' ' PHE . 1.4 t -129.5 -176.19 3.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.999 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 294' ' ' VAL . . . . . 0.542 ' CG1' ' HB3' ' B' ' 322' ' ' HIS . 6.3 p -152.2 171.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' B' ' 321' ' ' ILE . 46.0 t -143.6 155.52 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.86 -1.15 . . . . 0.0 109.835 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 296' ' ' ALA . . . . . 0.52 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -126.33 72.83 72.6 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 297' ' ' PRO . . . . . 0.523 ' HD3' HG11 ' B' ' 295' ' ' VAL . 43.9 Cg_endo -95.85 176.27 0.82 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.539 1.493 . . . . 0.0 111.188 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.537 HG21 ' CB ' ' B' ' 281' ' ' ALA . 3.0 mp -142.35 158.79 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . 0.587 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 17.1 t0 -131.27 168.24 17.85 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.115 -0.99 . . . . 0.0 109.959 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.58 ' CE1' ' HB2' ' B' ' 279' ' ' ALA . 1.2 t-80 -131.5 138.61 49.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 108.983 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 301' ' ' PHE . . . . . 0.589 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.4 OUTLIER -112.65 150.13 31.88 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 -178.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -140.8 142.83 34.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.607 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 303' ' ' PHE . . . . . 0.569 ' CE2' HG21 ' B' ' 210' ' ' VAL . 2.1 m-85 -128.99 175.43 8.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.843 . . . . 0.0 108.967 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 304' ' ' ASN . . . . . 0.534 ' OD1' ' CB ' ' B' ' 310' ' ' VAL . 0.2 OUTLIER -150.3 18.59 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.242 -0.911 . . . . 0.0 109.142 178.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 305' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -160.69 -88.53 0.07 OUTLIER Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 306' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 162.75 63.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -1.108 . . . . 0.0 109.666 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 307' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' B' ' 308' ' ' LYS . . . 166.96 -26.15 0.15 Allowed Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.079 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 308' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' B' ' 307' ' ' GLY . 1.2 mmtp -128.98 164.02 24.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -1.208 . . . . 0.0 109.918 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 309' ' ' VAL . . . . . 0.597 ' CG2' ' CG2' ' B' ' 210' ' ' VAL . 2.5 t -103.9 157.04 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.534 ' CB ' ' OD1' ' B' ' 304' ' ' ASN . 22.1 t -142.77 -35.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.913 -1.117 . . . . 0.0 110.279 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 311' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -126.25 150.71 48.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.714 -1.241 . . . . 0.0 109.921 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 312' ' ' MET . . . . . 0.528 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 8.4 ttp -154.84 149.58 26.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.477 -0.764 . . . . 0.0 109.337 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 313' ' ' ARG . . . . . 0.454 ' HA ' ' HB2' ' B' ' 237' ' ' GLU . 13.4 ttp180 -141.92 124.39 15.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 109.625 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 314' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' B' ' 299' ' ' ASP . . . -97.95 130.83 44.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.449 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 315' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -117.84 136.06 53.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.908 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 316' ' ' PHE . . . . . 0.798 ' CE2' ' H71' ' B' ' 326' ' ' NTH . 7.2 p90 170.46 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 317' ' ' GLY . . . . . 0.447 ' N ' ' CD2' ' B' ' 316' ' ' PHE . . . 169.77 -173.46 43.95 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 318' ' ' GLU . . . . . 0.445 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 19.0 tt0 -73.51 -2.46 22.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.286 -1.126 . . . . 0.0 109.161 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 16.8 tttp -91.67 -27.69 17.94 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.935 0.874 . . . . 0.0 108.887 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 320' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -88.88 17.34 5.76 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.335 0.588 . . . . 0.0 109.665 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 321' ' ' ILE . . . . . 0.537 HG21 ' CG2' ' B' ' 295' ' ' VAL . 4.9 mm -89.83 178.21 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 322' ' ' HIS . . . . . 0.542 ' HB3' ' CG1' ' B' ' 294' ' ' VAL . 0.2 OUTLIER -152.26 64.43 0.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.835 -1.166 . . . . 0.0 110.312 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.484 ' HA ' ' OG1' ' B' ' 293' ' ' THR . . . -90.75 118.56 30.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.075 -1.016 . . . . 0.0 109.532 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 179.18 -123.74 0.87 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.186 -1.185 . . . . 0.0 109.507 179.845 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' NTH . . . . . 0.907 H211 ' CE1' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 326' ' ' NTH . . . . . 0.863 H221 ' CE2' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.289 0.566 . . . . 0.0 110.326 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.461 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 34.1 t30 -117.53 50.02 1.16 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.548 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 3' ' ' THR . 10.7 t -90.14 108.55 27.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 109.361 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.466 ' HB2' ' OG1' ' A' ' 8' ' ' THR . 46.6 Cg_endo -72.88 -8.55 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.941 1.495 . . . . 0.0 110.12 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -45.36 -36.75 4.4 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -90.31 -59.46 2.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.71 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.565 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -55.32 -22.04 17.42 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.142 -0.974 . . . . 0.0 109.946 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 4' ' ' PRO . 17.4 m -83.42 -40.6 19.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.431 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.78 -39.47 38.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 108.841 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.573 HG13 ' CZ ' ' A' ' 101' ' ' PHE . 1.1 t -56.45 -26.82 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.581 HG22 ' CE2' ' A' ' 101' ' ' PHE . 3.5 t -81.63 -39.14 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.405 -0.81 . . . . 0.0 109.327 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 13' ' ' ARG . 7.5 tt0 -62.87 -74.73 0.09 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.135 0.969 . . . . 0.0 108.434 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -42.78 -44.56 4.47 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.994 0.902 . . . . 0.0 108.6 179.361 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.561 ' CE1' HG22 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -50.74 -44.47 58.39 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.606 ' HA ' ' CD1' ' A' ' 18' ' ' LEU . 1.4 t -90.13 -39.87 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.304 -0.873 . . . . 0.0 109.401 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -49.05 -33.41 11.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 22' ' ' ASP . . . -77.3 -31.91 55.04 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.606 ' CD1' ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -64.2 -56.75 12.51 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -53.58 -48.81 68.86 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.624 0.726 . . . . 0.0 109.488 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.85 11.49 17.79 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.668 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.521 ' CA ' HD23 ' A' ' 59' ' ' LEU . . . 47.04 35.27 8.2 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' ALA . 15.0 t0 -89.8 62.15 5.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -1.094 . . . . 0.0 109.615 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.577 ' CD1' ' HB3' ' A' ' 55' ' ' PHE . 6.5 tp -46.69 -43.4 17.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 108.85 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -42.73 -33.17 0.69 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.13 -38.03 10.6 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' LEU . 14.7 mt -57.71 -56.68 14.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.522 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 43.8 t -55.85 -41.59 67.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.02 -53.28 58.81 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.551 ' CD2' ' HA ' ' A' ' 10' ' ' VAL . 7.7 tp -66.24 -20.72 66.2 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.578 ' CD2' HG22 ' A' ' 51' ' ' ILE . 3.0 m-85 -88.41 131.98 34.64 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.546 -0.721 . . . . 0.0 109.654 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -47.98 176.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.836 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.47 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.5 OUTLIER -67.07 -24.78 66.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.534 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 7.0 p-10 -144.0 54.1 1.3 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 109.55 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 51' ' ' ILE . . . -72.69 155.29 40.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.641 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.503 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -101.93 167.06 10.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.235 -0.915 . . . . 0.0 109.25 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 35' ' ' THR . 35.0 t -161.85 108.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.558 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 9.2 mp0 -88.66 103.51 16.0 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.641 ' OD2' ' H62' ' A' ' 126' ' ' NTH . 27.5 t70 -173.16 143.74 1.1 Allowed Pre-proline 0 C--N 1.3 -1.568 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.919 -177.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 49.6 Cg_endo -73.5 174.84 48.5 Favored 'Cis proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.345 -1.94 . . . . 0.0 111.227 -0.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' B' ' 275' ' ' ALA . 21.9 m -63.89 105.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.81 . . . . 0.0 109.253 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.533 ' CA ' ' HB3' ' B' ' 275' ' ' ALA . . . 122.13 -6.98 10.05 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.534 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -105.09 -155.93 0.56 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.36 -1.082 . . . . 0.0 109.02 179.702 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -125.16 128.96 24.66 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.029 -1.044 . . . . 0.0 109.964 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 36.9 Cg_endo -62.01 179.19 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.638 1.558 . . . . 0.0 111.371 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.517 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -150.42 105.91 3.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -88.66 157.31 18.6 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.248 -0.907 . . . . 0.0 110.015 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 109.24 162.03 19.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 3.9 m -67.25 -58.38 4.95 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.148 -1.207 . . . . 0.0 109.11 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.531 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -55.56 -37.83 68.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.273 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' CB ' ' HB3' ' A' ' 45' ' ' ARG . . . -68.99 -51.67 36.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.701 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.578 HG22 ' CD2' ' A' ' 30' ' ' PHE . 8.8 mm -55.8 -47.14 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 109.283 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.572 ' CG ' ' CD2' ' A' ' 23' ' ' LEU . 26.3 ttp180 -73.58 -52.48 13.31 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 23.6 tt0 -48.38 -30.79 5.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.089 -1.007 . . . . 0.0 108.469 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.582 ' CZ ' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -83.78 -72.05 0.48 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.577 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -47.31 -25.04 0.88 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -74.15 -47.96 32.52 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 5.4 t30 -57.41 -37.36 72.62 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.601 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 39.8 t -67.66 -35.74 79.43 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.521 HD23 ' CA ' ' A' ' 21' ' ' GLY . 8.2 tp -67.48 -29.23 68.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.456 -0.777 . . . . 0.0 109.053 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 17.0 mttm -47.08 -30.48 2.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 108.911 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.529 ' O ' ' CD1' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.4 110.52 39.4 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.9 111.06 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.85 1.447 . . . . 0.0 111.027 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.544 ' CB ' ' HB3' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -136.94 162.96 31.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.347 -0.845 . . . . 0.0 109.715 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.426 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -92.08 127.95 37.74 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.461 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 21.8 t -115.13 120.08 63.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.054 -1.029 . . . . 0.0 109.967 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 67' ' ' LEU . 1.0 OUTLIER -150.12 106.25 3.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -47.8 177.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 0.0 109.924 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 69' ' ' GLN . 21.9 p -145.07 -81.63 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.386 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.7 OUTLIER -59.88 -144.86 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.479 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 48.9 tt0 -114.44 131.63 56.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.007 -1.058 . . . . 0.0 109.933 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.531 ' CG2' HG12 ' A' ' 11' ' ' VAL . 13.1 t -61.92 160.49 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.465 -0.772 . . . . 0.0 109.087 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 5.1 ttp180 -122.52 134.74 54.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.229 -0.919 . . . . 0.0 109.824 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . . . -147.89 160.45 42.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.405 -0.809 . . . . 0.0 109.183 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -159.14 -159.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.725 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB3' ' CA ' ' B' ' 241' ' ' GLY . . . -29.52 -85.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.055 -0.403 . . . . 0.0 111.35 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.504 ' O ' ' N ' ' A' ' 103' ' ' PHE . 9.9 m120 -124.62 21.07 8.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.904 -1.123 . . . . 0.0 110.781 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -129.99 -160.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.916 -1.115 . . . . 0.0 109.442 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.522 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 170.05 147.55 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.981 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 72' ' ' ARG . . . -136.12 130.73 33.78 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 30.2 p90 -147.92 170.1 18.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.792 -1.192 . . . . 0.0 110.462 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . . . -143.96 -166.43 2.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.599 -0.688 . . . . 0.0 109.893 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.457 ' HB3' ' O ' ' A' ' 81' ' ' ALA . 18.9 p90 168.83 -168.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 0.0 109.238 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -130.76 144.78 51.68 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.649 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.54 HG11 ' CB ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -112.96 122.24 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.166 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 85' ' ' SER . 1.4 p -117.75 107.11 13.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 109.029 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.756 ' CE2' H221 ' A' ' 126' ' ' NTH . 2.0 p90 -130.04 151.74 50.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.068 -1.02 . . . . 0.0 110.181 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.512 ' HG2' ' N ' ' A' ' 88' ' ' PHE . 84.2 tt0 -127.75 159.93 33.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.441 -0.787 . . . . 0.0 109.039 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -150.5 -99.61 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.058 -1.026 . . . . 0.0 110.326 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 88' ' ' PHE . 19.1 tt0 -48.91 -99.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 109.898 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.464 ' N ' ' HG2' ' A' ' 89' ' ' GLN . . . -123.92 -28.19 1.3 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -96.66 150.18 20.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -1.116 . . . . 0.0 109.352 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -113.11 146.53 39.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.103 -0.998 . . . . 0.0 109.172 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.0 145.97 51.1 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.53 -0.731 . . . . 0.0 109.842 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.533 HG12 ' CB ' ' A' ' 122' ' ' HIS . 5.4 p -121.19 166.38 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.922 . . . . 0.0 108.861 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.542 ' CG2' HG21 ' A' ' 121' ' ' ILE . 62.3 t -140.94 160.21 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.019 -1.05 . . . . 0.0 110.304 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.528 ' N ' HG11 ' A' ' 95' ' ' VAL . . . -138.76 75.11 37.37 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.562 -0.711 . . . . 0.0 109.51 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.514 ' HD3' HG11 ' A' ' 95' ' ' VAL . 48.1 Cg_endo -97.11 -175.6 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.814 1.676 . . . . 0.0 111.2 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.502 HD11 ' ND2' ' A' ' 120' ' ' ASN . 2.6 mp -135.26 157.1 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 7.6 t0 -128.66 162.25 27.78 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.204 -0.935 . . . . 0.0 109.813 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.591 ' NE2' ' CD2' ' B' ' 300' ' ' HIS . 0.2 OUTLIER -114.11 173.54 6.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 108.906 179.49 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.581 ' CE2' HG22 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -148.16 144.9 28.08 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.97 -1.081 . . . . 0.0 110.45 -178.561 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.523 ' CB ' ' HB2' ' A' ' 111' ' ' SER . 0.4 OUTLIER -139.99 105.63 5.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.151 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.568 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 5.2 m-85 -91.06 -171.21 2.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.71 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.533 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 4.3 p30 -126.28 -47.97 1.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.272 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . -163.94 27.24 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 77.07 67.62 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.169 -1.194 . . . . 0.0 109.545 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.27 -39.33 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -165.6 -162.54 0.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -1.113 . . . . 0.0 109.258 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.471 HG21 HG12 ' A' ' 10' ' ' VAL . 41.0 t -106.25 144.24 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.248 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 104' ' ' ASN . 5.0 t -125.99 -28.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 109.898 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.523 ' HB2' ' CB ' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -149.59 155.11 39.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.067 -1.021 . . . . 0.0 109.472 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.507 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 3.2 ttp -155.91 148.74 24.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.194 -0.941 . . . . 0.0 109.926 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.496 ' NE ' ' OE1' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -130.55 173.52 10.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 108.964 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.413 ' O ' HG13 ' A' ' 40' ' ' VAL . . . -144.37 142.85 30.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.149 -0.97 . . . . 0.0 109.52 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -138.61 140.24 38.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.172 -0.955 . . . . 0.0 109.907 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.524 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 51.9 p90 170.21 -161.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.518 ' O ' ' CD1' ' A' ' 121' ' ' ILE . . . 174.6 -165.6 37.04 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.527 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 8.3 tt0 -73.13 -3.32 25.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.444 -1.033 . . . . 0.0 109.337 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.26 -31.31 16.18 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.97 0.89 . . . . 0.0 109.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.502 ' ND2' HD11 ' A' ' 98' ' ' ILE . 1.9 m-20 -89.61 8.58 30.63 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.233 0.54 . . . . 0.0 109.559 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.542 HG21 ' CG2' ' A' ' 95' ' ' VAL . 4.5 mm -91.89 -170.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 108.84 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.533 ' CB ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.35 159.75 44.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.097 -1.002 . . . . 0.0 109.618 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.78 133.94 12.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.959 . . . . 0.0 109.479 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 134.35 -123.69 3.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.291 -1.123 . . . . 0.0 109.444 -179.81 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.0 ptp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.208 0.528 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 18.7 p-10 -113.15 100.09 8.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.558 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' THR . . . . . 0.522 ' O ' ' CG2' ' B' ' 203' ' ' THR . 12.5 t -90.34 108.44 26.72 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.542 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' B' ' 208' ' ' THR . 45.1 Cg_endo -72.15 -1.96 10.87 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.853 1.449 . . . . 0.0 110.457 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.77 -47.37 83.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.557 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -54.9 24.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.267 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 75.9 mtm -61.42 -41.27 96.91 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.286 -0.884 . . . . 0.0 109.382 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.499 ' CB ' ' O ' ' B' ' 204' ' ' PRO . 15.4 m -64.18 -35.95 82.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.84 . . . . 0.0 109.235 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.09 -42.37 49.99 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.139 -0.976 . . . . 0.0 108.59 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.604 ' CG1' ' CZ ' ' B' ' 303' ' ' PHE . 1.5 t -60.06 -20.7 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.579 HG22 ' CE2' ' B' ' 301' ' ' PHE . 4.4 t -88.32 -40.61 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.833 . . . . 0.0 108.89 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' B' ' 213' ' ' ARG . 24.6 tt0 -61.53 -74.35 0.08 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.46 ' HD2' HD11 ' B' ' 229' ' ' LEU . 1.0 OUTLIER -43.68 -45.52 7.0 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' TYR . . . . . 0.568 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.5 OUTLIER -49.88 -42.88 48.75 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.603 ' HA ' ' CD1' ' B' ' 218' ' ' LEU . 1.4 t -89.77 -37.85 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.251 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -49.49 -35.6 20.35 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.473 ' HB3' ' CG1' ' B' ' 226' ' ' ILE . . . -74.69 -30.95 61.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.603 ' CD1' ' HA ' ' B' ' 215' ' ' VAL . 2.3 mt -66.86 -58.11 5.66 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' B' ' 265' ' ' VAL . 2.1 t-20 -50.85 -45.31 59.73 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.602 0.715 . . . . 0.0 109.302 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.31 1.36 55.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.624 -0.672 . . . . 0.0 109.748 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.538 ' CA ' ' CD2' ' B' ' 259' ' ' LEU . . . 53.76 44.13 70.0 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.465 ' O ' HG13 ' B' ' 226' ' ' ILE . 30.3 t0 -102.87 83.96 2.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.902 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' LEU . . . . . 0.595 ' CD2' ' CD2' ' B' ' 259' ' ' LEU . 3.7 mm? -53.04 -18.4 2.03 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.139 -0.976 . . . . 0.0 110.063 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -64.05 -57.16 10.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.093 -1.004 . . . . 0.0 109.473 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . 0.439 ' HA2' ' HB2' ' B' ' 228' ' ' ALA . . . -62.92 -27.64 70.61 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.473 ' CG1' ' HB3' ' B' ' 217' ' ' ALA . 7.0 mt -67.86 -61.46 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.454 -1.027 . . . . 0.0 108.315 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.514 HG23 ' CG ' ' B' ' 252' ' ' ARG . 51.2 t -59.49 -40.33 81.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.439 ' HB2' ' HA2' ' B' ' 225' ' ' GLY . . . -54.87 -53.47 55.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' B' ' 210' ' ' VAL . 4.7 tp -62.8 -21.78 66.14 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . 0.465 ' HB2' ' HA ' ' B' ' 227' ' ' VAL . 3.7 m-30 -92.71 139.11 30.9 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.452 -0.78 . . . . 0.0 109.784 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -50.71 -176.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 109.822 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.474 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -68.57 -25.16 64.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.879 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' ASP . . . . . 0.525 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 10.0 p-10 -144.17 52.51 1.28 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.495 -0.753 . . . . 0.0 109.137 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' B' ' 310' ' ' VAL . . . -65.43 158.6 26.31 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 109.617 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' THR . . . . . 0.508 ' CG2' ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -107.34 147.18 30.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.875 . . . . 0.0 109.107 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' B' ' 244' ' ' PRO . 52.8 t -141.4 111.05 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 1.5 mm-40 -89.91 105.14 17.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' ASP . . . . . 0.585 ' O ' ' CE2' ' B' ' 254' ' ' PHE . 21.8 t70 178.91 143.24 0.31 Allowed Pre-proline 0 C--N 1.301 -1.528 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.307 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.492 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 48.5 Cg_endo -73.6 173.87 53.66 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.264 -1.973 . . . . 0.0 110.905 -0.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' B' ' 316' ' ' PHE . 6.5 m -69.81 112.7 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 108.972 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . 0.536 ' CA ' ' HB3' ' A' ' 75' ' ' ALA . . . 115.06 -2.13 22.67 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' SER . . . . . 0.471 ' OG ' ' HG2' ' B' ' 239' ' ' PRO . 64.6 m -113.35 -134.83 0.35 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.305 -1.114 . . . . 0.0 108.893 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . 0.531 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 4.3 mt-10 -142.03 133.52 13.26 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.863 -1.148 . . . . 0.0 109.755 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.9 Cg_endo -63.39 -171.53 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.082 1.569 . . . . 0.0 111.34 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.529 ' HB2' ' CG ' ' B' ' 254' ' ' PHE . 0.0 OUTLIER -150.74 96.91 2.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' SER . . . . . 0.508 ' HB3' ' CG2' ' B' ' 235' ' ' THR . 0.2 OUTLIER -88.88 150.47 22.86 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.238 -0.914 . . . . 0.0 109.987 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.24 163.18 21.88 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 2.2 m -70.04 -61.45 1.77 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -1.209 . . . . 0.0 109.148 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -55.36 -22.98 21.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.241 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.518 ' CB ' ' HG3' ' B' ' 245' ' ' ARG . . . -88.45 -48.62 7.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.46 HD13 ' O ' ' B' ' 245' ' ' ARG . 4.5 mm -53.65 -43.7 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.132 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' B' ' 256' ' ' ALA . 44.0 ttp85 -75.54 -52.65 10.13 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 108.94 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 29.9 mt-10 -48.4 -27.72 2.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.809 -1.182 . . . . 0.0 108.427 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.585 ' CE2' ' O ' ' B' ' 238' ' ' ASP . 0.3 OUTLIER -85.84 -71.7 0.52 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.681 0.753 . . . . 0.0 109.021 179.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.527 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -52.6 -21.76 4.25 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.241 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' B' ' 252' ' ' ARG . . . -80.33 -46.8 15.5 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 257' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 18.7 t-20 -58.19 -31.17 67.04 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 258' ' ' SER . . . . . 0.737 ' OG ' H112 ' B' ' 326' ' ' NTH . 33.7 t -70.66 -31.63 68.62 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . 0.595 ' CD2' ' CD2' ' B' ' 223' ' ' LEU . 5.7 tp -71.12 -27.72 63.78 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 0.7 OUTLIER -44.73 -27.83 0.55 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.455 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 261' ' ' LEU . . . . . 0.576 ' CD2' ' CD2' ' B' ' 263' ' ' LEU . 0.3 OUTLIER -90.72 114.29 60.8 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 262' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 44.3 Cg_endo -72.02 107.93 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.766 1.403 . . . . 0.0 110.892 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . 0.576 ' CD2' ' CD2' ' B' ' 261' ' ' LEU . 0.0 OUTLIER -137.3 162.54 33.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 109.854 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . 0.452 ' HB2' ' OG ' ' B' ' 285' ' ' SER . . . -96.46 123.67 40.19 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . 0.514 ' O ' ' ND2' ' B' ' 219' ' ' ASN . 4.4 t -105.06 117.32 50.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.643 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 266' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' B' ' 267' ' ' LEU . 2.0 tt0 -147.78 104.97 3.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.22 -0.925 . . . . 0.0 109.153 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.1 mt -47.11 174.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.293 -0.879 . . . . 0.0 109.695 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 1.7 t -146.54 -40.31 0.21 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.67 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 269' ' ' GLN . . . . . 0.505 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 13.7 pt20 -102.66 -152.25 0.44 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.647 -0.658 . . . . 0.0 109.267 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 26.6 tt0 -106.43 130.59 54.21 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.61 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . 0.521 ' CG1' HG23 ' B' ' 211' ' ' VAL . 81.4 t -66.81 147.62 12.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.344 -0.848 . . . . 0.0 109.245 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 2.4 tpm_? -102.89 135.95 43.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.952 . . . . 0.0 109.765 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . 0.473 ' HA ' ' HB1' ' B' ' 278' ' ' ALA . . . -149.8 146.36 27.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.39 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 274' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -162.24 146.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.13 -0.981 . . . . 0.0 110.228 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . 0.533 ' HB3' ' CA ' ' A' ' 41' ' ' GLY . . . 39.57 -97.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.802 -0.561 . . . . 0.0 110.621 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 276' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' B' ' 303' ' ' PHE . 60.1 m-20 -130.74 34.04 4.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.025 -1.047 . . . . 0.0 110.237 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' B' ' 278' ' ' ALA . 0.9 OUTLIER -139.49 -158.4 0.85 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 108.792 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 278' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' B' ' 277' ' ' GLU . . . 165.96 149.6 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.72 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 279' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -135.98 130.75 34.1 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 22.8 p90 -150.07 175.45 11.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.601 -1.312 . . . . 0.0 110.697 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.524 ' HB2' ' CG1' ' B' ' 298' ' ' ILE . . . -150.11 -179.0 6.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.585 -0.697 . . . . 0.0 109.197 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 282' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 2.8 p90 -172.92 -162.14 0.16 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 109.492 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 283' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -133.61 147.44 51.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.512 -0.742 . . . . 0.0 109.887 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 284' ' ' VAL . . . . . 0.531 HG11 ' CB ' ' B' ' 263' ' ' LEU . 4.0 t -123.36 116.53 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 109.41 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 285' ' ' SER . . . . . 0.497 ' CB ' HG23 ' B' ' 294' ' ' VAL . 90.9 p -111.95 114.69 27.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 109.098 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.533 ' HB3' ' HB3' ' B' ' 263' ' ' LEU . 55.6 p90 -143.21 167.39 22.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 110.084 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 287' ' ' GLU . . . . . 0.448 ' HG2' ' N ' ' B' ' 288' ' ' PHE . 30.1 tt0 -144.1 153.25 41.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 109.255 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.3 OUTLIER -135.89 4.34 3.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.716 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -170.3 -148.81 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.254 -0.904 . . . . 0.0 109.383 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -74.8 -11.95 83.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 291' ' ' ARG . . . . . 0.443 ' HG2' ' HA ' ' B' ' 325' ' ' ALA . 14.5 mtp180 -113.8 140.41 48.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -1.115 . . . . 0.0 109.273 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 292' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' B' ' 292' ' ' LYS . 18.9 ptmt -125.78 172.47 9.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 109.635 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 293' ' ' THR . . . . . 0.533 ' CG2' ' HA ' ' B' ' 323' ' ' ALA . 32.2 m -156.65 171.53 20.17 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.366 -0.834 . . . . 0.0 109.095 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 294' ' ' VAL . . . . . 0.553 HG13 ' CB ' ' B' ' 322' ' ' HIS . 0.4 OUTLIER -134.17 165.94 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.549 ' CG1' ' HD3' ' B' ' 297' ' ' PRO . 3.4 t -136.81 145.8 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.016 -1.052 . . . . 0.0 109.66 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 296' ' ' ALA . . . . . 0.525 ' N ' HG11 ' B' ' 295' ' ' VAL . . . -132.52 72.9 77.5 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.433 -0.792 . . . . 0.0 110.023 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 297' ' ' PRO . . . . . 0.549 ' HD3' ' CG1' ' B' ' 295' ' ' VAL . 49.2 Cg_endo -92.95 -177.01 0.67 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.87 1.458 . . . . 0.0 111.113 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.524 ' CG1' ' HB2' ' B' ' 281' ' ' ALA . 2.7 mp -134.38 144.61 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . 0.572 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 5.6 t0 -117.13 166.95 11.63 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.824 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 300' ' ' HIS . . . . . 0.591 ' CD2' ' NE2' ' A' ' 100' ' ' HIS . 1.6 t-80 -117.58 173.58 6.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 108.916 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 301' ' ' PHE . . . . . 0.58 ' CZ ' HG13 ' B' ' 210' ' ' VAL . 0.1 OUTLIER -145.67 145.82 31.06 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.071 -1.018 . . . . 0.0 110.583 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.48 ' HD3' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -137.66 98.73 3.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 109.156 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 303' ' ' PHE . . . . . 0.604 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 4.5 m-85 -89.74 176.51 6.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 109.57 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 304' ' ' ASN . . . . . 0.523 ' HB3' ' CG2' ' B' ' 310' ' ' VAL . 2.9 p30 -118.64 -27.03 5.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.222 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 305' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' B' ' 306' ' ' ALA . . . -159.35 -63.96 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 306' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' B' ' 305' ' ' GLY . . . 163.63 76.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -1.127 . . . . 0.0 109.563 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 175.87 -57.14 0.11 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -111.33 -172.75 2.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -1.149 . . . . 0.0 109.504 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 309' ' ' VAL . . . . . 0.469 HG22 HG12 ' B' ' 210' ' ' VAL . 85.8 t -119.72 164.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.033 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.545 ' O ' ' CB ' ' B' ' 234' ' ' ALA . 5.0 t -134.82 -72.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.963 -1.085 . . . . 0.0 110.018 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 311' ' ' SER . . . . . 0.48 ' HB2' ' HD3' ' B' ' 302' ' ' ARG . 31.6 m -112.44 162.48 15.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.899 -1.126 . . . . 0.0 109.837 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 312' ' ' MET . . . . . 0.544 ' CE ' ' CE2' ' B' ' 214' ' ' TYR . 2.6 ttt -159.94 137.99 10.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 313' ' ' ARG . . . . . 0.522 ' CD ' ' CZ ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -125.69 159.27 32.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.144 -0.972 . . . . 0.0 108.812 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 314' ' ' ALA . . . . . 0.542 ' CB ' ' OD1' ' B' ' 238' ' ' ASP . . . -125.18 150.38 47.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.904 -1.122 . . . . 0.0 109.841 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 315' ' ' LEU . . . . . 0.47 ' O ' ' HB3' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -141.02 140.8 34.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.39 -0.819 . . . . 0.0 109.774 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 316' ' ' PHE . . . . . 0.533 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 53.7 p90 173.12 -160.96 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 317' ' ' GLY . . . . . 0.467 ' O ' HG12 ' B' ' 321' ' ' ILE . . . 173.48 -172.38 45.17 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 318' ' ' GLU . . . . . 0.509 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 22.3 tt0 -68.4 -6.69 25.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.419 -1.047 . . . . 0.0 109.714 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -87.08 -31.84 20.26 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.045 0.926 . . . . 0.0 108.939 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 320' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.61 14.28 11.99 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.742 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 321' ' ' ILE . . . . . 0.538 ' CG2' HG21 ' B' ' 295' ' ' VAL . 4.0 mm -100.84 -166.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 0.0 108.902 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 322' ' ' HIS . . . . . 0.553 ' CB ' HG13 ' B' ' 294' ' ' VAL . 0.3 OUTLIER -151.25 -172.41 4.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.116 -0.99 . . . . 0.0 109.613 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.533 ' HA ' ' CG2' ' B' ' 293' ' ' THR . . . -155.45 128.65 8.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -122.32 135.13 10.09 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 325' ' ' ALA . . . . . 0.443 ' HA ' ' HG2' ' B' ' 291' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.21 -1.17 . . . . 0.0 109.472 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' NTH . . . . . 0.756 H221 ' CE2' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 326' ' ' NTH . . . . . 0.737 H112 ' OG ' ' B' ' 258' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.45 -3.63 13.77 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.852 1.448 . . . . 0.0 110.19 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.24 -45.38 72.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.877 . . . . 0.0 109.385 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.472 ' NE2' ' O ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -66.68 -55.39 15.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.59 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.434 ' SD ' ' O ' ' A' ' 75' ' ' ALA . 27.4 mtt -58.0 -48.74 79.11 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.231 -0.918 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 m -54.4 -38.1 65.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.285 -0.884 . . . . 0.0 109.054 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -49.29 -43.06 42.9 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.828 HG11 ' CE1' ' A' ' 103' ' ' PHE . 2.3 t -55.76 -49.92 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.99 HG11 HG21 ' A' ' 71' ' ' VAL . 5.1 t -54.71 -41.09 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 13' ' ' ARG . 25.7 tt0 -63.17 -75.13 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.344 1.068 . . . . 0.0 108.145 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.515 ' HB3' HD13 ' A' ' 29' ' ' LEU . 6.6 mtp85 -43.67 -45.97 7.18 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -48.93 -45.72 42.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.923 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -86.0 -37.48 11.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.383 -0.823 . . . . 0.0 109.071 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.89 -37.92 21.12 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.489 ' HB3' HG12 ' A' ' 26' ' ' ILE . . . -72.0 -32.87 67.62 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.923 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.4 mt -67.34 -59.45 3.4 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -48.02 -39.86 21.05 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.599 0.714 . . . . 0.0 109.25 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.41 6.06 42.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.545 -0.722 . . . . 0.0 109.652 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.984 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 47.73 30.87 7.02 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -96.94 88.4 4.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -1.106 . . . . 0.0 109.723 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.074 HD13 HD12 ' A' ' 26' ' ' ILE . 3.3 mm? -51.83 -20.25 2.13 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.195 -0.94 . . . . 0.0 109.815 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.14 -56.26 16.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.253 -0.904 . . . . 0.0 109.303 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.35 -29.34 63.11 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.074 HD12 HD13 ' A' ' 23' ' ' LEU . 12.3 mt -69.06 -62.27 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.549 HG21 ' HB2' ' A' ' 52' ' ' ARG . 60.4 t -57.34 -37.91 59.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.95 26.33 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 10' ' ' VAL . 7.8 tp -59.1 -22.7 61.25 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.939 ' CE2' HG22 ' A' ' 26' ' ' ILE . 20.4 m-30 -88.47 136.53 32.94 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.675 -0.641 . . . . 0.0 109.651 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -51.12 -178.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.273 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -23.52 66.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 109.527 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.534 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 25.2 p-10 -148.37 45.55 1.05 Allowed 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.835 ' HB3' HD13 ' A' ' 51' ' ' ILE . . . -51.61 -178.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.791 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -126.05 135.92 52.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.501 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 37' ' ' GLU . 6.6 t -113.84 169.02 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.129 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.57 ' N ' ' CG1' ' A' ' 36' ' ' VAL . 28.1 mt-10 -150.4 106.07 3.4 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.541 ' OD1' ' HA ' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -174.45 153.71 1.89 Allowed Pre-proline 0 C--N 1.3 -1.575 0 C-N-CA 118.607 -1.237 . . . . 0.0 109.804 -178.002 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.558 ' O ' HG13 ' A' ' 40' ' ' VAL . 44.7 Cg_endo -73.88 -66.67 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.916 -2.118 . . . . 0.0 111.522 0.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 40' ' ' VAL . 23.8 m -159.06 87.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.948 -1.095 . . . . 0.0 109.596 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . 164.33 38.75 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER 72.92 55.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.325 -1.103 . . . . 0.0 109.962 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.548 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 3.8 mt-10 -132.57 58.38 35.77 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.807 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 52.1 Cg_endo -79.71 175.07 10.96 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.825 1.683 . . . . 0.0 111.271 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.788 ' CD ' ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -150.99 100.17 2.77 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.601 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -89.43 166.73 13.52 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.186 -0.946 . . . . 0.0 110.103 -179.202 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 33' ' ' ASP . . . 86.36 -169.8 41.96 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.546 HG23 HG11 ' A' ' 27' ' ' VAL . 3.4 m -103.45 -46.63 4.51 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.223 -1.163 . . . . 0.0 108.978 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -58.29 -23.74 57.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.247 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.788 ' HB1' ' CD ' ' A' ' 45' ' ' ARG . . . -89.86 -52.51 4.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.398 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.835 HD13 ' HB3' ' A' ' 34' ' ' ALA . 80.1 mt -57.22 -46.8 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.197 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.549 ' HB2' HG21 ' A' ' 27' ' ' VAL . 1.5 ttt180 -70.0 -56.25 7.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -0.888 . . . . 0.0 108.906 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 14.4 tt0 -45.88 -29.92 1.54 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 108.658 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.57 ' CD2' ' HG3' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -84.1 -70.28 0.58 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.624 ' C ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -46.7 -28.05 1.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.444 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . . . -75.07 -50.8 15.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 12.8 t-20 -55.51 -34.55 64.75 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 t -64.83 -36.63 84.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.984 HD21 ' CA ' ' A' ' 21' ' ' GLY . 7.4 tp -69.45 -19.28 63.77 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.535 -0.728 . . . . 0.0 109.706 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 33.9 mtmt -55.53 -25.58 38.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 109.36 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.007 HD22 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -89.87 121.32 69.05 Favored Pre-proline 0 C--N 1.305 -1.328 0 O-C-N 121.272 -0.893 . . . . 0.0 108.777 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 48.7 Cg_endo -74.04 103.2 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.71 1.374 . . . . 0.0 111.152 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.007 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.15 -178.54 5.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.006 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -117.88 127.29 53.72 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.521 HG13 ' CD2' ' A' ' 82' ' ' PHE . 4.6 t -116.43 115.92 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.181 -0.95 . . . . 0.0 109.841 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 67' ' ' LEU . 1.2 tt0 -150.17 95.74 2.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.294 -0.879 . . . . 0.0 109.216 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.691 HD21 HG21 ' A' ' 15' ' ' VAL . 4.4 mt -42.81 166.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.974 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.67 -39.9 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.565 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -81.77 -146.01 0.06 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 25.0 tt0 -113.15 129.61 56.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.09 -1.006 . . . . 0.0 109.642 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.99 HG21 HG11 ' A' ' 11' ' ' VAL . 19.2 t -67.92 152.28 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.38 -0.825 . . . . 0.0 108.919 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 19.2 mtt-85 -114.64 135.29 54.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.136 -0.978 . . . . 0.0 109.672 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.525 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -149.95 112.86 4.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.293 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -130.09 155.71 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -0.903 . . . . 0.0 109.489 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.434 ' O ' ' SD ' ' A' ' 7' ' ' MET . . . 43.64 -147.42 0.07 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 81.6 m-20 -82.64 -3.19 55.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.941 . . . . 0.0 109.526 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.578 ' CG ' ' HG3' ' A' ' 102' ' ' ARG . 0.8 OUTLIER -104.85 -163.55 0.97 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.219 -0.926 . . . . 0.0 109.613 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 178.37 166.33 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 109.485 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.762 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.31 140.06 21.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 108.948 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.626 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 39.8 p90 -150.58 169.23 22.04 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.877 -1.14 . . . . 0.0 109.941 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.753 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -141.84 -175.37 4.37 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.502 -0.749 . . . . 0.0 109.591 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.645 ' HB3' HD22 ' A' ' 67' ' ' LEU . 9.8 p90 177.05 -159.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.805 . . . . 0.0 109.351 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -137.92 151.79 48.34 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.564 -0.71 . . . . 0.0 109.73 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.633 HG12 ' CB ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -122.11 124.34 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.416 -0.802 . . . . 0.0 109.081 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 1.006 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 5.1 p -114.66 92.81 4.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.6 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.541 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . 18.8 p90 -115.47 177.93 4.48 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.345 -0.847 . . . . 0.0 109.126 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 88' ' ' PHE . 30.7 tt0 -107.37 166.92 10.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 110.12 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.521 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -116.84 -161.31 0.8 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.4 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -7.44 28.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 109.78 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.11 -40.38 0.03 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.4 mtt-85 -95.72 -176.9 3.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -1.161 . . . . 0.0 109.609 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -115.62 127.19 55.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.897 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -118.3 142.57 47.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.776 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 122' ' ' HIS . 1.2 t -116.15 175.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 1.056 HG12 ' HD3' ' A' ' 97' ' ' PRO . 4.1 t -145.37 144.14 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.881 -1.137 . . . . 0.0 109.737 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.436 ' O ' ' CG ' ' A' ' 120' ' ' ASN . . . -133.06 71.64 77.4 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.345 -0.847 . . . . 0.0 110.408 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 1.056 ' HD3' HG12 ' A' ' 95' ' ' VAL . 49.6 Cg_endo -95.23 -176.18 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 121.492 1.461 . . . . 0.0 110.947 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.753 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.9 mp -137.68 139.59 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.626 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 8.9 t0 -111.99 163.14 14.59 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.95 -1.093 . . . . 0.0 110.261 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.536 ' HB3' ' CB ' ' A' ' 113' ' ' ARG . 4.3 t-80 -116.39 176.29 5.17 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.561 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -149.94 142.63 24.59 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.008 -1.057 . . . . 0.0 110.556 -178.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.612 ' O ' HG23 ' A' ' 110' ' ' VAL . 3.1 ttm180 -135.65 107.64 7.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.484 -0.76 . . . . 0.0 109.106 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.828 ' CE1' HG11 ' A' ' 10' ' ' VAL . 14.2 m-85 -105.42 179.5 4.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.607 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -127.04 -0.67 6.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.933 . . . . 0.0 109.596 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -175.43 -87.57 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 176.05 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -1.184 . . . . 0.0 109.598 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -127.56 -37.16 0.46 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 107' ' ' GLY . 8.0 mtmm -146.7 -164.76 2.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -1.125 . . . . 0.0 109.255 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.574 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 91.2 t -115.16 158.87 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.027 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -132.6 -54.21 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.567 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.56 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -127.17 156.9 41.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.041 -1.037 . . . . 0.0 109.013 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.512 ' HE1' ' CE1' ' A' ' 30' ' ' PHE . 21.5 ttm -154.0 147.24 24.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.122 -0.986 . . . . 0.0 109.655 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.536 ' CB ' ' HB3' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -123.33 174.21 7.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.377 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 99' ' ' ASP . . . -147.83 149.13 31.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.706 HD13 ' HB2' ' B' ' 279' ' ' ALA . 1.7 tt -143.03 143.73 32.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.138 -0.976 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.528 ' O ' ' CG2' ' B' ' 274' ' ' VAL . 15.4 p90 171.95 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.561 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 167.07 -176.9 41.92 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.561 -1.305 . . . . 0.0 110.185 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.545 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 17.6 tt0 -69.39 -6.06 27.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.433 -1.04 . . . . 0.0 109.509 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -91.38 -29.24 17.2 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.928 0.87 . . . . 0.0 108.936 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.8 m-20 -88.79 12.51 14.82 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.707 HG22 ' H ' ' A' ' 122' ' ' HIS . 5.0 mm -89.87 -169.92 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.897 ' O ' HG22 ' A' ' 93' ' ' THR . 0.1 OUTLIER -151.63 99.79 2.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 109.805 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -117.13 135.74 53.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.149 -0.97 . . . . 0.0 109.549 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 152.85 -145.91 13.89 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.177 -1.19 . . . . 0.0 109.509 179.944 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 201' ' ' MET . . . . . 0.463 ' O ' ' CB ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.239 0.542 . . . . 0.0 110.174 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' B' ' 201' ' ' MET . 0.6 OUTLIER 72.6 98.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.563 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 203' ' ' THR . . . . . 0.429 ' C ' ' O ' ' B' ' 202' ' ' ASN . 1.2 t -43.43 112.04 1.18 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.0 109.54 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.49 -3.29 13.16 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.828 1.436 . . . . 0.0 110.046 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -38.62 84.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.884 . . . . 0.0 109.385 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -51.8 56.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.351 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 207' ' ' MET . . . . . 0.522 ' HB2' ' HB1' ' B' ' 273' ' ' ALA . 21.9 mtm -59.91 -30.06 68.78 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.293 -0.879 . . . . 0.0 109.624 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 5.0 m -72.55 -33.81 67.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.91 . . . . 0.0 109.195 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.9 75.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.934 . . . . 0.0 108.859 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.856 HG11 ' CE1' ' B' ' 303' ' ' PHE . 2.3 t -52.74 -45.99 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.818 HG11 HG21 ' B' ' 271' ' ' VAL . 4.4 t -61.86 -39.63 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.599 -0.688 . . . . 0.0 109.951 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 212' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' B' ' 213' ' ' ARG . 21.8 tt0 -62.63 -75.4 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.758 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.0 OUTLIER -43.35 -44.84 5.81 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.971 0.891 . . . . 0.0 108.622 179.157 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 214' ' ' TYR . . . . . 0.633 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -50.42 -46.98 56.74 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.865 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -85.77 -37.65 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.359 -0.838 . . . . 0.0 109.297 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 216' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.72 -36.5 16.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -73.08 -34.19 66.06 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' B' ' 215' ' ' VAL . 1.2 mt -65.26 -58.22 6.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -50.37 -45.04 54.98 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.555 0.693 . . . . 0.0 109.164 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.64 5.95 43.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.52 -0.737 . . . . 0.0 109.633 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.686 ' HA2' HD11 ' B' ' 259' ' ' LEU . . . 50.4 37.96 33.35 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 222' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' B' ' 217' ' ' ALA . 11.3 t0 -97.77 72.41 2.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.42 -1.047 . . . . 0.0 109.864 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 223' ' ' LEU . . . . . 1.038 HD11 ' HB3' ' B' ' 255' ' ' PHE . 7.7 tp -47.08 -43.65 20.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 108.705 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -43.32 -35.28 1.45 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -80.32 -35.79 25.6 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 1.007 HD12 HD12 ' B' ' 223' ' ' LEU . 19.9 mt -62.1 -57.19 13.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.637 ' CG1' HG23 ' B' ' 248' ' ' THR . 92.6 t -56.44 -37.41 51.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.07 -54.92 41.58 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.773 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.3 tp -63.8 -22.06 66.73 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 230' ' ' PHE . . . . . 0.693 ' CG ' HG21 ' B' ' 251' ' ' ILE . 2.0 m-85 -85.42 130.01 34.68 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.525 -0.735 . . . . 0.0 109.383 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -47.0 172.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.152 -0.968 . . . . 0.0 109.383 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.3 -24.99 58.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 109.816 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.527 ' CB ' ' HA2' ' B' ' 247' ' ' GLY . 13.2 p-10 -150.24 45.55 0.89 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.583 -0.698 . . . . 0.0 109.212 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.822 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -57.57 159.9 4.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.334 -0.854 . . . . 0.0 109.706 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 235' ' ' THR . . . . . 1.006 HG23 ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -106.95 144.12 34.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.558 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.55 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 42.8 t -132.72 121.4 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.081 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 237' ' ' GLU . . . . . 0.551 ' HB2' ' CG ' ' B' ' 313' ' ' ARG . 3.3 mt-10 -89.26 109.18 20.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 108.89 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 238' ' ' ASP . . . . . 0.506 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 9.8 t70 -179.17 141.92 0.38 Allowed Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.837 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 239' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' B' ' 238' ' ' ASP . 47.3 Cg_endo -72.66 -177.57 18.89 Favored 'Cis proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.291 -1.962 . . . . 0.0 110.761 -0.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 8.0 m -62.34 152.34 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.254 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.07 20.73 9.27 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 242' ' ' SER . . . . . 0.498 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -116.59 -155.41 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -1.066 . . . . 0.0 109.511 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.77 128.84 25.58 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.066 -1.022 . . . . 0.0 109.894 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 244' ' ' PRO . . . . . 0.55 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.4 Cg_endo -65.25 -169.94 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.983 1.518 . . . . 0.0 111.243 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.712 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.5 OUTLIER -151.14 100.88 2.82 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 246' ' ' SER . . . . . 1.006 ' HB3' HG23 ' B' ' 235' ' ' THR . 0.2 OUTLIER -89.44 153.61 20.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 110.363 -178.42 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 247' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' B' ' 233' ' ' ASP . . . 108.03 159.94 20.45 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 248' ' ' THR . . . . . 0.637 HG23 ' CG1' ' B' ' 227' ' ' VAL . 6.3 m -70.4 -44.74 67.37 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.219 -1.165 . . . . 0.0 109.103 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -63.08 -36.84 84.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -0.911 . . . . 0.0 109.06 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.712 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -74.18 -59.84 2.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.822 HD11 ' N ' ' B' ' 234' ' ' ALA . 30.1 mt -48.45 -41.23 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.28 -0.887 . . . . 0.0 108.916 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 252' ' ' ARG . . . . . 0.641 ' CG ' HD23 ' B' ' 223' ' ' LEU . 13.0 ttm180 -78.34 -56.49 4.41 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 253' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 17.5 tt0 -46.65 -27.03 1.03 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.058 -1.027 . . . . 0.0 108.29 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 0.6 OUTLIER -86.22 -71.14 0.56 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.307 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 255' ' ' PHE . . . . . 1.038 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -48.09 -31.62 5.77 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 256' ' ' ALA . . . . . 0.704 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -67.04 -47.73 70.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -56.49 -31.94 64.53 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 29.6 t -73.14 -36.37 66.66 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 259' ' ' LEU . . . . . 0.686 HD11 ' HA2' ' B' ' 221' ' ' GLY . 8.2 tp -68.22 -27.84 66.72 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.382 -0.824 . . . . 0.0 109.282 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -47.21 -25.74 1.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.235 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 261' ' ' LEU . . . . . 0.709 ' O ' HD23 ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.74 112.67 53.3 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.403 -0.811 . . . . 0.0 108.912 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 262' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.34 97.75 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.823 1.433 . . . . 0.0 110.493 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.976 HD13 HG13 ' B' ' 284' ' ' VAL . 0.3 OUTLIER -131.66 -172.07 2.77 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.79 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 264' ' ' ALA . . . . . 0.987 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -119.19 127.4 53.26 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 265' ' ' VAL . . . . . 0.71 HG21 ' HB3' ' B' ' 218' ' ' LEU . 3.6 t -107.88 118.8 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.281 -0.887 . . . . 0.0 109.575 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 266' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.4 tt0 -150.08 106.81 3.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 109.285 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.9 OUTLIER -47.15 174.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.839 . . . . 0.0 109.767 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 1.7 p -148.49 -38.92 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.63 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 269' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' B' ' 270' ' ' GLU . 0.6 OUTLIER -99.69 -147.06 0.34 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 109.405 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 270' ' ' GLU . . . . . 0.442 ' N ' ' CG ' ' B' ' 269' ' ' GLN . 26.0 tt0 -111.45 132.24 54.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.205 -0.934 . . . . 0.0 109.562 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 271' ' ' VAL . . . . . 0.822 HG13 ' HB3' ' B' ' 280' ' ' PHE . 30.3 t -64.04 151.11 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.263 -0.898 . . . . 0.0 109.12 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' B' ' 279' ' ' ALA . 0.0 OUTLIER -117.46 135.44 53.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.082 -1.011 . . . . 0.0 109.742 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 273' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' B' ' 207' ' ' MET . . . -147.13 127.72 14.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.865 . . . . 0.0 109.464 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 274' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -140.27 156.39 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 0.0 109.567 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 275' ' ' ALA . . . . . 0.446 ' O ' ' SD ' ' B' ' 207' ' ' MET . . . 42.35 -145.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.447 -0.783 . . . . 0.0 109.469 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 276' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 2.4 m-20 -83.54 -11.08 57.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.116 -0.99 . . . . 0.0 109.473 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 277' ' ' GLU . . . . . 0.5 ' HG2' ' HG3' ' B' ' 302' ' ' ARG . 1.5 mt-10 -93.28 -162.44 0.94 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.431 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 278' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 178.15 160.8 0.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.452 -0.78 . . . . 0.0 109.623 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 279' ' ' ALA . . . . . 0.706 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -147.67 139.62 24.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.044 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 280' ' ' PHE . . . . . 0.822 ' HB3' HG13 ' B' ' 271' ' ' VAL . 26.4 p90 -150.76 171.38 17.27 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.906 -1.121 . . . . 0.0 109.748 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.912 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -143.11 164.34 30.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.298 -0.877 . . . . 0.0 110.238 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 282' ' ' PHE . . . . . 0.5 ' O ' ' HD2' ' B' ' 297' ' ' PRO . 2.1 p90 -158.45 -172.57 3.91 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 283' ' ' THR . . . . . 0.878 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -130.31 141.22 50.61 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 284' ' ' VAL . . . . . 0.976 HG13 HD13 ' B' ' 263' ' ' LEU . 23.9 t -106.21 112.09 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 108.974 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 285' ' ' SER . . . . . 0.987 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 15.7 p -101.25 76.62 1.73 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.879 . . . . 0.0 109.257 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.534 ' HB3' ' HB3' ' B' ' 263' ' ' LEU . 13.8 p90 -89.86 176.33 6.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.346 -0.846 . . . . 0.0 109.591 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -128.33 151.51 49.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.333 -0.855 . . . . 0.0 109.306 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 288' ' ' PHE . . . . . 0.444 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.6 OUTLIER -100.94 -166.09 1.27 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.395 -0.816 . . . . 0.0 109.376 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.9 43.51 1.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 0.0 109.075 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 154.29 -22.24 0.66 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 291' ' ' ARG . . . . . 0.483 ' O ' ' HD3' ' B' ' 292' ' ' LYS . 8.8 mtt180 -123.92 176.22 6.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.555 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 292' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' B' ' 291' ' ' ARG . 7.7 mmtp -131.22 115.05 15.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.223 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 293' ' ' THR . . . . . 0.482 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -119.73 142.91 48.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.206 -0.933 . . . . 0.0 110.025 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 294' ' ' VAL . . . . . 0.572 HG22 ' N ' ' B' ' 295' ' ' VAL . 12.4 p -120.99 170.96 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 0.975 HG22 HG23 ' B' ' 321' ' ' ILE . 54.2 t -139.81 158.21 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.911 -1.118 . . . . 0.0 110.07 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 296' ' ' ALA . . . . . 0.435 ' N ' HG12 ' B' ' 295' ' ' VAL . . . -137.43 74.29 47.68 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.812 . . . . 0.0 109.791 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 297' ' ' PRO . . . . . 0.594 ' HD3' HG12 ' B' ' 295' ' ' VAL . 47.3 Cg_endo -97.36 -173.36 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.623 1.549 . . . . 0.0 110.749 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.912 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.7 mp -139.79 161.99 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 299' ' ' ASP . . . . . 0.61 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 11.5 t0 -131.75 155.69 47.27 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.097 -1.002 . . . . 0.0 110.012 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 300' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' B' ' 299' ' ' ASP . 0.1 OUTLIER -111.66 174.06 6.05 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 301' ' ' PHE . . . . . 0.593 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.91 151.78 36.44 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.014 -1.054 . . . . 0.0 110.473 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.5 ' HG3' ' HG2' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -145.0 94.44 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 109.533 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 303' ' ' PHE . . . . . 0.856 ' CE1' HG11 ' B' ' 210' ' ' VAL . 12.2 m-85 -90.63 -163.52 1.04 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 304' ' ' ASN . . . . . 0.737 ' ND2' HG22 ' B' ' 310' ' ' VAL . 1.8 p30 -139.6 7.31 2.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.727 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . 116.22 68.31 0.41 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . 54.35 41.26 32.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -1.165 . . . . 0.0 109.444 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 307' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' B' ' 308' ' ' LYS . . . -125.1 35.2 3.18 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 308' ' ' LYS . . . . . 0.558 ' CB ' ' O ' ' B' ' 307' ' ' GLY . 9.2 mttm 83.05 -161.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 122.012 -0.699 . . . . 0.0 109.404 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 309' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 98.6 t -99.36 136.52 30.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.342 -0.849 . . . . 0.0 109.501 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 310' ' ' VAL . . . . . 0.737 HG22 ' ND2' ' B' ' 304' ' ' ASN . 2.9 t -108.78 -71.45 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 109.357 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 311' ' ' SER . . . . . 0.499 ' HB2' ' HD3' ' B' ' 302' ' ' ARG . 0.4 OUTLIER -113.9 169.0 9.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.183 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 312' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' B' ' 300' ' ' HIS . 13.4 ttp -158.65 152.27 23.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.947 . . . . 0.0 109.778 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 313' ' ' ARG . . . . . 0.551 ' CG ' ' HB2' ' B' ' 237' ' ' GLU . 0.1 OUTLIER -131.07 170.22 14.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.38 -0.825 . . . . 0.0 109.29 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -144.9 130.02 18.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.192 -0.943 . . . . 0.0 109.247 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 315' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 79' ' ' ALA . 1.1 tt -123.93 144.54 49.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.182 -0.949 . . . . 0.0 109.925 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 316' ' ' PHE . . . . . 0.531 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 12.2 p90 173.57 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 317' ' ' GLY . . . . . 0.576 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 162.4 -176.07 38.79 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 318' ' ' GLU . . . . . 0.518 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 6.2 tt0 -72.36 -3.4 23.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -1.139 . . . . 0.0 109.385 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -93.75 -29.12 15.54 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.955 0.883 . . . . 0.0 108.873 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 320' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' B' ' 296' ' ' ALA . 1.4 m-20 -89.02 7.87 32.59 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 321' ' ' ILE . . . . . 0.975 HG23 HG22 ' B' ' 295' ' ' VAL . 4.6 mm -90.65 -167.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 322' ' ' HIS . . . . . 0.684 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.2 OUTLIER -151.06 158.88 44.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 0.0 109.593 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.4 ' HA ' HG22 ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 109.518 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 3' ' ' THR . 13.4 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HA ' ' CE ' ' A' ' 7' ' ' MET . 43.8 Cg_endo -70.67 -5.44 16.77 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.926 1.487 . . . . 0.0 109.535 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -43.93 88.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.496 -0.752 . . . . 0.0 109.361 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -61.52 -47.05 87.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.211 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.413 ' CE ' ' HA ' ' A' ' 4' ' ' PRO . 11.6 mtt -57.52 -39.5 76.71 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.29 -0.881 . . . . 0.0 109.227 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 m -52.77 -37.01 58.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.335 -0.853 . . . . 0.0 108.987 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.17 -50.67 73.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.297 -0.877 . . . . 0.0 109.051 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.748 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.1 t -48.79 -34.48 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 108.788 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.717 HG11 ' CG2' ' A' ' 71' ' ' VAL . 8.0 t -81.07 -41.91 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.399 -0.813 . . . . 0.0 109.222 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 15' ' ' VAL . 8.5 tt0 -63.35 -73.54 0.11 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.272 1.034 . . . . 0.0 108.573 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.827 ' HD2' HD13 ' A' ' 29' ' ' LEU . 1.1 mtm180 -42.62 -45.13 4.51 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.629 ' CE1' HD11 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -44.21 -41.9 6.13 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.005 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.958 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.5 t -90.43 -38.53 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.742 . . . . 0.0 109.02 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -48.87 -35.31 14.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.597 ' HB3' HG12 ' A' ' 26' ' ' ILE . . . -74.15 -35.42 64.04 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.958 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.3 mt -62.13 -58.47 7.67 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -50.69 -38.27 46.0 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.439 0.638 . . . . 0.0 109.334 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.86 -2.31 58.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.635 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.877 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 52.51 40.14 54.15 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.474 ' O ' HG13 ' A' ' 26' ' ' ILE . 8.5 t70 -106.76 86.37 2.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -1.087 . . . . 0.0 109.608 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.971 ' CD2' HD22 ' A' ' 59' ' ' LEU . 3.5 mm? -52.08 -20.02 2.25 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 2.2 m-20 -65.36 -56.74 10.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.486 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -61.14 -27.66 67.72 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.862 HD12 HD13 ' A' ' 23' ' ' LEU . 10.1 mt -71.31 -64.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.844 HG21 ' HB2' ' A' ' 52' ' ' ARG . 96.6 t -58.3 -35.79 55.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 24' ' ' ASP . . . -60.02 -56.41 21.98 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.827 HD13 ' HD2' ' A' ' 13' ' ' ARG . 5.9 tp -58.87 -25.53 63.41 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.7 ' CE1' ' HE1' ' A' ' 112' ' ' MET . 14.6 m-30 -87.67 148.35 24.83 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.752 -0.593 . . . . 0.0 109.636 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -55.0 -166.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.739 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.437 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -83.09 -23.88 32.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 109.577 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.54 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 21.7 p-10 -144.37 39.45 1.3 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.616 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -54.09 177.71 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.468 -0.77 . . . . 0.0 109.795 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.462 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -129.32 135.69 49.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.387 -0.821 . . . . 0.0 109.232 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 27.2 t -123.63 120.35 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.631 ' O ' ' HB3' ' A' ' 114' ' ' ALA . 3.2 mt-10 -91.11 104.77 17.31 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.572 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 30.2 t70 -178.92 137.05 0.32 Allowed Pre-proline 0 C--N 1.298 -1.647 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.165 -178.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.549 ' O ' ' O ' ' A' ' 40' ' ' VAL . 47.5 Cg_endo -71.91 -148.97 0.41 Allowed 'Cis proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.311 -1.954 . . . . 0.0 110.644 0.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.957 HG11 HG11 ' B' ' 274' ' ' VAL . 5.4 m -52.8 -140.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 122.084 0.945 . . . . 0.0 111.834 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.694 ' N ' HG23 ' A' ' 40' ' ' VAL . . . -39.26 -23.66 0.03 OUTLIER Glycine 0 N--CA 1.495 2.575 0 O-C-N 121.174 -0.954 . . . . 0.0 111.604 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.541 ' CB ' ' HG2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -29.56 -93.7 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.016 -0.697 . . . . 0.0 110.874 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 42' ' ' SER . 0.0 OUTLIER 169.42 122.32 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.992 -1.068 . . . . 0.0 111.005 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.9 Cg_endo -66.24 -167.85 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.662 1.575 . . . . 0.0 111.281 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 1.083 ' CG ' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -151.57 130.3 12.37 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.211 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.462 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.5 OUTLIER -112.7 147.47 36.73 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.672 -1.268 . . . . 0.0 110.702 -178.225 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.54 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 105.02 163.19 23.92 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 2.7 m -69.15 -64.51 0.86 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.076 -1.25 . . . . 0.0 108.902 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -48.11 -23.7 0.91 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.159 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.083 ' HB1' ' CG ' ' A' ' 45' ' ' ARG . . . -90.02 -56.54 3.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.506 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 51' ' ' ILE . 9.0 mm -52.34 -41.87 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.309 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.844 ' HB2' HG21 ' A' ' 27' ' ' VAL . 19.5 ttt180 -73.38 -49.12 28.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 108.814 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 14.0 mt-10 -52.34 -30.0 26.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.146 -0.971 . . . . 0.0 108.486 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -81.82 -71.5 0.48 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.581 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.858 ' CD1' HG21 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -48.89 -29.1 4.31 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.11 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 52' ' ' ARG . . . -72.61 -38.05 67.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.491 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 23.9 t30 -65.22 -33.62 76.44 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 45.7 t -69.09 -41.75 77.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.475 -0.765 . . . . 0.0 108.941 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.971 HD22 ' CD2' ' A' ' 23' ' ' LEU . 9.5 tp -59.57 -18.95 45.16 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.271 -0.893 . . . . 0.0 109.074 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 57' ' ' ASN . 28.9 mtmt -69.66 -5.58 25.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 108.973 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.789 HD22 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -89.12 112.52 51.55 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.569 ' HD2' HD23 ' A' ' 61' ' ' LEU . 42.1 Cg_endo -68.56 91.03 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.713 1.375 . . . . 0.0 111.076 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.789 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -150.59 167.42 27.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.222 -0.924 . . . . 0.0 110.108 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.37 127.4 52.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.77 124.53 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.786 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.99 113.34 4.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.21 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.31 177.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 109.845 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.455 HG23 ' N ' ' A' ' 69' ' ' GLN . 9.9 t -156.24 -38.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 109.816 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 3.1 pt20 -97.71 -147.24 0.31 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.551 -0.718 . . . . 0.0 109.361 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.494 ' O ' ' NE ' ' A' ' 72' ' ' ARG . 29.9 tt0 -114.55 135.54 54.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.945 . . . . 0.0 109.649 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.717 ' CG2' HG11 ' A' ' 11' ' ' VAL . 79.3 t -66.21 152.2 9.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.365 -0.835 . . . . 0.0 109.154 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -118.33 140.48 49.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.089 . . . . 0.0 110.138 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . . . -150.25 134.67 17.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.428 -0.795 . . . . 0.0 109.141 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.684 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -159.62 163.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.943 -1.098 . . . . 0.0 110.212 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.52 ' HB1' ' HA3' ' B' ' 241' ' ' GLY . . . 39.17 -97.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.786 -0.571 . . . . 0.0 110.232 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 103' ' ' PHE . 4.1 m-20 -135.74 10.3 3.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.022 -1.049 . . . . 0.0 109.717 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.506 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -116.22 -161.17 0.78 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.148 -0.97 . . . . 0.0 109.371 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.873 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . -176.58 129.81 0.2 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.475 -0.766 . . . . 0.0 109.629 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -114.88 130.82 56.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.998 . . . . 0.0 109.287 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.631 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 15.2 p90 -150.47 173.19 14.35 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.819 -1.176 . . . . 0.0 109.783 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.572 ' HB2' ' CG1' ' A' ' 98' ' ' ILE . . . -150.27 -167.58 2.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 110.627 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.481 ' O ' ' HD2' ' A' ' 97' ' ' PRO . 9.1 p90 178.06 -168.93 0.08 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -135.94 141.16 44.46 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 110.05 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.735 HG13 ' CB ' ' A' ' 63' ' ' LEU . 2.2 t -110.95 118.19 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 108.882 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.725 ' HA ' HG23 ' A' ' 94' ' ' VAL . 1.7 p -118.65 110.08 16.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.128 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.572 ' CZ ' ' HB ' ' A' ' 93' ' ' THR . 10.5 p90 -130.23 -177.71 4.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.289 -0.882 . . . . 0.0 109.712 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -122.93 152.25 41.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.389 -0.819 . . . . 0.0 109.09 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER -110.08 178.5 4.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.223 -0.923 . . . . 0.0 109.775 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -65.23 68.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.442 -0.786 . . . . 0.0 109.679 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 88' ' ' PHE . . . 115.81 -30.06 6.82 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 23.3 mtt85 -111.6 -171.9 1.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -1.157 . . . . 0.0 109.691 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -147.03 146.97 30.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 109.346 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.572 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -141.3 153.84 45.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.435 -0.791 . . . . 0.0 110.223 -179.309 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.725 HG23 ' HA ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -132.79 172.33 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.751 HG22 HG23 ' A' ' 121' ' ' ILE . 52.5 t -150.15 146.73 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.542 -1.349 . . . . 0.0 110.646 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.69 74.22 78.3 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.707 ' HD3' HG12 ' A' ' 95' ' ' VAL . 48.5 Cg_endo -94.76 -179.36 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.58 1.52 . . . . 0.0 111.833 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 80' ' ' PHE . 3.2 mp -143.74 144.18 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 4.3 t0 -117.87 163.12 17.02 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 110.155 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.2 OUTLIER -115.55 176.56 5.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.873 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -150.29 135.88 18.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.026 -1.046 . . . . 0.0 110.383 -178.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.506 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -121.01 107.67 12.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.381 -0.824 . . . . 0.0 109.075 179.345 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.748 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -89.26 166.22 13.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.363 -0.836 . . . . 0.0 109.38 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.773 ' HB3' HG21 ' A' ' 110' ' ' VAL . 8.9 p-10 -115.81 -5.97 12.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 109.166 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.711 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 177.26 -60.92 0.1 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 161.17 77.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.507 -0.996 . . . . 0.0 109.38 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.54 -66.32 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.572 ' O ' ' CE1' ' A' ' 103' ' ' PHE . 14.8 mttm -108.4 178.13 4.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -1.191 . . . . 0.0 109.602 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.646 ' CG2' HG22 ' A' ' 10' ' ' VAL . 49.6 t -109.05 153.35 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.336 -0.852 . . . . 0.0 109.233 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.773 HG21 ' HB3' ' A' ' 104' ' ' ASN . 44.8 t -124.18 -62.37 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -0.969 . . . . 0.0 109.53 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -116.31 164.53 14.38 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.974 -1.079 . . . . 0.0 109.463 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.7 ' HE1' ' CE1' ' A' ' 30' ' ' PHE . 19.3 ttm -153.29 137.67 16.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.325 -0.86 . . . . 0.0 109.5 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.506 ' HB2' ' HB3' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -113.21 168.57 9.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.448 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . -150.4 130.11 13.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.16 -0.962 . . . . 0.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 1.06 HD22 ' HB3' ' B' ' 279' ' ' ALA . 0.6 OUTLIER -130.94 142.6 50.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.532 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 50.3 p90 166.5 -162.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.603 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . 177.5 178.83 47.41 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.219 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.51 ' HA ' HG12 ' A' ' 121' ' ' ILE . 16.8 tt0 -50.2 -21.83 1.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.145 -1.209 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.48 ' HD3' ' OE2' ' B' ' 270' ' ' GLU . 0.6 OUTLIER -73.41 -22.11 60.32 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.009 0.909 . . . . 0.0 108.829 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.68 ' ND2' ' CD1' ' A' ' 121' ' ' ILE . 0.5 OUTLIER -88.56 -4.57 58.56 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.5 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.751 HG23 HG22 ' A' ' 95' ' ' VAL . 2.2 mm -91.75 -162.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.03 -1.044 . . . . 0.0 108.212 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.615 ' CB ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -152.25 -169.4 3.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.004 -1.06 . . . . 0.0 109.606 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.55 -176.24 5.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.875 . . . . 0.0 109.54 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.81 -175.35 41.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.275 -1.133 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 201' ' ' MET . . . . . 0.524 ' O ' ' CB ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.298 0.57 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' B' ' 201' ' ' MET . 2.6 t30 77.05 177.9 0.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.239 -0.913 . . . . 0.0 109.713 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.37 128.57 66.69 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.398 -0.814 . . . . 0.0 109.736 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 204' ' ' PRO . . . . . 0.441 ' HA ' ' CE ' ' B' ' 207' ' ' MET . 42.5 Cg_endo -69.76 -7.01 19.96 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.023 1.539 . . . . 0.0 109.153 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 205' ' ' GLU . . . . . 0.446 ' O ' ' HB ' ' B' ' 208' ' ' THR . 0.3 OUTLIER -61.66 -45.67 93.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.436 -0.79 . . . . 0.0 108.91 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -64.1 -43.7 94.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 108.904 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 207' ' ' MET . . . . . 0.441 ' CE ' ' HA ' ' B' ' 204' ' ' PRO . 16.7 mtt -54.9 -24.66 24.55 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.29 -0.881 . . . . 0.0 109.156 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' B' ' 205' ' ' GLU . 11.2 m -72.7 -41.64 65.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.405 -0.809 . . . . 0.0 108.983 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.35 -41.34 51.41 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.319 -0.863 . . . . 0.0 108.761 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.994 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.2 t -54.81 -44.58 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.818 HG11 ' CG2' ' B' ' 271' ' ' VAL . 6.6 t -72.42 -41.66 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.459 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 212' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 213' ' ' ARG . 23.7 tt0 -59.92 -74.16 0.08 Allowed 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.265 1.031 . . . . 0.0 108.281 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.469 ' HB3' HD22 ' B' ' 229' ' ' LEU . 2.7 mtt85 -43.54 -45.51 6.62 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.977 0.894 . . . . 0.0 108.659 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 214' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.5 OUTLIER -49.9 -44.77 50.26 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.907 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -87.17 -38.54 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.372 -0.83 . . . . 0.0 109.274 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 216' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.42 -37.74 17.88 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' B' ' 222' ' ' ASP . . . -72.06 -34.39 68.7 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' B' ' 215' ' ' VAL . 1.9 mt -64.54 -57.97 7.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -49.97 -42.27 48.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.567 0.698 . . . . 0.0 109.224 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.49 -1.04 57.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.884 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.876 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 57.43 47.58 87.06 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 222' ' ' ASP . . . . . 0.536 ' O ' ' HB1' ' B' ' 217' ' ' ALA . 26.7 t70 -113.38 92.64 4.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.852 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 223' ' ' LEU . . . . . 1.079 HD13 HD12 ' B' ' 226' ' ' ILE . 2.5 mm? -62.46 -12.48 22.25 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.184 -0.947 . . . . 0.0 109.565 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -59.36 3.5 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.293 -0.879 . . . . 0.0 109.424 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -59.6 -28.44 65.23 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 1.079 HD12 HD13 ' B' ' 223' ' ' LEU . 23.0 mt -69.02 -62.01 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.545 -0.973 . . . . 0.0 108.47 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.888 HG11 HG23 ' B' ' 248' ' ' THR . 65.3 t -58.37 -36.11 57.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -57.33 13.47 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.994 HD21 ' HA ' ' B' ' 210' ' ' VAL . 9.8 tp -57.19 -29.07 63.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 230' ' ' PHE . . . . . 0.696 ' CE2' HG22 ' B' ' 226' ' ' ILE . 17.1 m-30 -82.18 127.22 32.94 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.644 -0.66 . . . . 0.0 109.619 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -45.68 171.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 109.582 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -24.39 66.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.729 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.577 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 55.4 p-10 -134.03 44.43 2.73 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.668 -0.645 . . . . 0.0 109.556 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' B' ' 310' ' ' VAL . . . -71.41 -169.94 0.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 235' ' ' THR . . . . . 0.715 HG22 ' HB2' ' B' ' 246' ' ' SER . 15.1 p -142.34 175.06 10.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.303 -0.873 . . . . 0.0 109.329 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.583 HG23 ' O ' ' B' ' 235' ' ' THR . 40.0 t -158.94 110.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 237' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 17.7 mt-10 -88.27 105.98 17.91 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 238' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 8.8 t0 -174.68 142.47 0.77 Allowed Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.106 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 239' ' ' PRO . . . . . 0.512 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 47.1 Cg_endo -72.14 -168.49 5.53 Favored 'Cis proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.345 -1.939 . . . . 0.0 110.873 -0.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' B' ' 315' ' ' LEU . 3.7 m -64.79 146.14 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.276 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 241' ' ' GLY . . . . . 0.52 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . 54.12 32.22 49.87 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 242' ' ' SER . . . . . 0.512 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.2 OUTLIER -120.1 -156.38 0.66 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -1.096 . . . . 0.0 109.607 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 243' ' ' GLU . . . . . 0.429 ' HA ' ' HD2' ' B' ' 244' ' ' PRO . 19.5 mt-10 -120.76 118.37 30.67 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.166 -0.959 . . . . 0.0 110.026 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 244' ' ' PRO . . . . . 0.578 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.1 Cg_endo -64.82 -169.05 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.938 1.494 . . . . 0.0 111.55 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.766 ' HB3' ' HB1' ' B' ' 250' ' ' ALA . 6.5 mtt180 -150.83 106.17 3.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.866 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.19 158.08 18.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 110.154 -179.071 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 247' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 87.7 157.2 31.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 248' ' ' THR . . . . . 0.888 HG23 HG11 ' B' ' 227' ' ' VAL . 6.9 m -67.2 -41.41 85.88 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.35 -1.088 . . . . 0.0 109.197 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -60.92 -32.85 72.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.291 -0.881 . . . . 0.0 109.186 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -89.8 -55.07 3.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.372 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.551 HD12 ' C ' ' B' ' 247' ' ' GLY . 14.3 mt -54.11 -44.9 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 0.0 108.887 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 252' ' ' ARG . . . . . 0.712 ' HB2' HG21 ' B' ' 227' ' ' VAL . 25.8 ttt-85 -70.56 -53.14 17.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 253' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 23.2 tt0 -50.41 -32.31 17.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.151 -0.968 . . . . 0.0 109.015 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.582 ' CD2' ' HG3' ' B' ' 245' ' ' ARG . 0.2 OUTLIER -80.26 -70.51 0.52 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 255' ' ' PHE . . . . . 0.538 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -47.89 -26.4 1.68 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 256' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' B' ' 252' ' ' ARG . . . -76.61 -44.39 34.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.085 -1.009 . . . . 0.0 108.675 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 257' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 5.6 t30 -65.09 -25.63 67.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 108.75 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 21.5 t -75.36 -39.37 59.34 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 259' ' ' LEU . . . . . 0.906 HD22 ' CD2' ' B' ' 223' ' ' LEU . 8.2 tp -64.96 -20.04 66.28 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.456 -0.777 . . . . 0.0 109.17 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 260' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 2.2 mttt -49.14 -27.73 3.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.413 -0.805 . . . . 0.0 109.505 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 261' ' ' LEU . . . . . 0.899 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.5 OUTLIER -89.95 118.88 69.28 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.217 -0.927 . . . . 0.0 109.078 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 262' ' ' PRO . . . . . 0.43 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 43.9 Cg_endo -70.21 105.06 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.768 1.404 . . . . 0.0 110.535 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.899 ' CD2' HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -137.73 153.17 49.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.509 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -89.98 129.12 36.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 108.877 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 265' ' ' VAL . . . . . 0.551 HG11 HG22 ' B' ' 215' ' ' VAL . 98.3 t -111.98 118.58 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.663 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 4.1 tt0 -150.26 96.51 2.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.308 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.9 mp -45.14 171.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.752 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 34.2 p -146.86 -37.97 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.87 . . . . 0.0 109.711 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 269' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 15.3 pt20 -91.46 -146.61 0.21 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 109.433 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 270' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 58.1 tt0 -115.06 134.67 54.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.677 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 271' ' ' VAL . . . . . 0.818 ' CG2' HG11 ' B' ' 211' ' ' VAL . 56.3 t -65.7 153.36 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.372 -0.83 . . . . 0.0 109.189 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.0 OUTLIER -113.97 135.72 53.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.078 -1.013 . . . . 0.0 110.134 -179.648 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 273' ' ' ALA . . . . . 0.438 ' HB1' ' CB ' ' B' ' 207' ' ' MET . . . -150.1 149.49 30.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.148 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 274' ' ' VAL . . . . . 0.957 HG11 HG11 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -153.38 -155.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.039 -1.038 . . . . 0.0 109.939 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 275' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . -23.39 -96.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 120.954 0.406 . . . . 0.0 111.815 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 276' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' B' ' 303' ' ' PHE . 47.5 t30 -116.23 -1.57 12.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.855 -1.153 . . . . 0.0 110.725 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 277' ' ' GLU . . . . . 0.468 ' HG3' ' HG3' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -109.25 -162.08 0.79 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.811 -1.181 . . . . 0.0 109.557 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 278' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . -179.98 159.99 0.84 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.49 -0.756 . . . . 0.0 109.349 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 279' ' ' ALA . . . . . 1.06 ' HB3' HD22 ' A' ' 115' ' ' LEU . . . -150.33 138.27 20.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 109.041 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 280' ' ' PHE . . . . . 0.748 ' CD2' HG22 ' B' ' 211' ' ' VAL . 35.0 p90 -150.61 172.06 16.13 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.931 -1.106 . . . . 0.0 109.851 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.828 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -146.44 -168.62 3.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 0.0 109.962 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 282' ' ' PHE . . . . . 0.451 ' HB3' ' O ' ' B' ' 281' ' ' ALA . 31.3 p90 170.28 -167.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.227 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.93 142.51 50.92 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.443 -0.786 . . . . 0.0 109.677 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 284' ' ' VAL . . . . . 0.813 HG11 HD22 ' B' ' 263' ' ' LEU . 74.4 t -114.36 113.02 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.862 . . . . 0.0 109.322 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 4.4 p -109.14 115.07 29.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.308 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' B' ' 286' ' ' PHE . 6.5 p90 -137.65 160.79 38.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -137.76 153.03 49.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.501 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 288' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 2.3 p90 -148.02 12.67 0.98 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 109.871 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -168.07 -147.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.113 -0.992 . . . . 0.0 109.406 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -76.66 -23.33 70.28 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -105.48 -179.82 4.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -1.09 . . . . 0.0 109.298 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 292' ' ' LYS . . . . . 0.454 ' O ' ' HD2' ' B' ' 292' ' ' LYS . 0.1 OUTLIER -149.26 128.16 12.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.525 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 293' ' ' THR . . . . . 0.815 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -105.19 142.72 34.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.248 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 294' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' B' ' 322' ' ' HIS . 0.6 OUTLIER -113.52 174.96 2.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.192 -0.943 . . . . 0.0 108.615 179.715 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 1.073 HG22 HG23 ' B' ' 321' ' ' ILE . 3.0 t -145.87 145.17 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -0.981 . . . . 0.0 109.426 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 296' ' ' ALA . . . . . 0.524 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -132.58 71.36 78.93 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.223 -0.923 . . . . 0.0 110.362 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 297' ' ' PRO . . . . . 1.046 ' HD3' HG12 ' B' ' 295' ' ' VAL . 49.9 Cg_endo -95.61 -173.45 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.575 1.516 . . . . 0.0 110.692 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.828 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.7 mp -140.99 149.72 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 299' ' ' ASP . . . . . 0.622 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 5.7 t0 -115.0 161.07 18.83 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.929 -1.107 . . . . 0.0 110.111 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 300' ' ' HIS . . . . . 0.513 ' HB3' ' HB2' ' B' ' 313' ' ' ARG . 0.1 OUTLIER -117.85 166.76 12.09 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 301' ' ' PHE . . . . . 0.808 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.2 OUTLIER -142.27 149.36 39.46 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.146 -0.971 . . . . 0.0 110.774 -178.597 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.468 ' HG3' ' HG3' ' B' ' 277' ' ' GLU . 30.8 ttt-85 -142.74 107.79 4.94 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 303' ' ' PHE . . . . . 0.774 ' CE1' HG21 ' B' ' 210' ' ' VAL . 26.0 m-85 -89.28 -174.84 4.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 109.358 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 304' ' ' ASN . . . . . 0.693 ' HB3' HG21 ' B' ' 310' ' ' VAL . 0.5 OUTLIER -112.63 -43.3 3.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.46 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 305' ' ' GLY . . . . . 0.688 ' O ' ' HB3' ' B' ' 306' ' ' ALA . . . -165.05 27.85 0.2 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 306' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' B' ' 305' ' ' GLY . . . 74.87 38.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -1.18 . . . . 0.0 109.534 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -131.43 -39.21 0.25 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 308' ' ' LYS . . . . . 0.457 ' HG3' ' OD1' ' B' ' 304' ' ' ASN . 2.1 pttt -153.65 -175.3 5.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -1.134 . . . . 0.0 109.497 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 309' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 84.9 t -89.87 159.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 109.332 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 310' ' ' VAL . . . . . 0.693 HG21 ' HB3' ' B' ' 304' ' ' ASN . 45.0 t -136.18 -75.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.722 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 311' ' ' SER . . . . . 0.504 ' CB ' ' OG1' ' B' ' 235' ' ' THR . 70.5 m -122.22 160.7 24.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.032 . . . . 0.0 110.057 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 312' ' ' MET . . . . . 0.676 ' HE1' ' CE1' ' B' ' 230' ' ' PHE . 2.3 ttm -139.04 158.45 44.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.435 -0.791 . . . . 0.0 109.531 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 313' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' B' ' 300' ' ' HIS . 0.8 OUTLIER -133.7 149.34 51.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 109.325 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 314' ' ' ALA . . . . . 0.406 ' CB ' ' OD2' ' B' ' 238' ' ' ASP . . . -125.29 132.4 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.973 . . . . 0.0 109.708 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 315' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' A' ' 79' ' ' ALA . 1.2 tt -131.84 143.52 50.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.592 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 316' ' ' PHE . . . . . 0.684 ' O ' HG11 ' A' ' 74' ' ' VAL . 14.2 p90 171.91 -158.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 317' ' ' GLY . . . . . 0.548 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 168.87 -177.3 42.77 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 318' ' ' GLU . . . . . 0.537 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 13.1 tt0 -71.14 -4.8 27.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -1.118 . . . . 0.0 109.374 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -90.7 -30.86 16.85 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.902 0.858 . . . . 0.0 109.012 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 320' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -89.3 7.27 36.45 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.2 0.524 . . . . 0.0 109.59 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 321' ' ' ILE . . . . . 1.073 HG23 HG22 ' B' ' 295' ' ' VAL . 4.2 mm -90.82 -162.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 322' ' ' HIS . . . . . 0.815 ' O ' HG22 ' B' ' 293' ' ' THR . 60.3 t60 -151.27 154.32 36.55 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.087 -1.008 . . . . 0.0 109.637 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.925 . . . . 0.0 109.414 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 8' ' ' THR . 44.1 Cg_endo -71.64 -3.74 13.68 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.913 1.481 . . . . 0.0 110.039 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -57.41 -41.32 80.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.938 . . . . 0.0 109.407 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.22 -62.87 1.24 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.944 . . . . 0.0 108.989 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.707 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 27.5 mmt -54.39 -33.28 58.93 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.271 -0.893 . . . . 0.0 109.691 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 6.9 m -66.46 -34.25 77.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.406 -0.808 . . . . 0.0 109.207 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.61 -46.43 70.43 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.172 -0.955 . . . . 0.0 108.662 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.035 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.5 t -58.27 -19.57 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.868 HG21 HG11 ' A' ' 71' ' ' VAL . 14.4 t -90.51 -42.9 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.492 -0.755 . . . . 0.0 109.07 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' ARG . 25.9 tt0 -61.55 -74.22 0.09 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.231 1.015 . . . . 0.0 108.292 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' GLN . 4.2 mtm-85 -42.78 -45.59 4.87 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.601 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -49.24 -43.21 42.53 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.908 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.1 t -88.72 -38.67 11.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.458 -0.776 . . . . 0.0 109.253 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.47 -35.69 13.52 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.554 ' CB ' HG13 ' A' ' 26' ' ' ILE . . . -74.13 -34.56 63.92 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.908 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.2 mt -63.63 -58.71 6.07 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -51.36 -44.8 62.17 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.35 11.0 20.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.687 -0.633 . . . . 0.0 109.533 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.792 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 45.69 29.63 3.04 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' ALA . 10.4 t0 -92.09 60.44 3.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.454 -1.027 . . . . 0.0 109.812 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.072 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -45.8 -37.16 5.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 108.888 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' LEU . 5.9 m-20 -41.06 -29.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -89.17 -36.89 7.38 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.585 HG22 ' HD2' ' A' ' 30' ' ' PHE . 28.7 mt -59.24 -55.13 25.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.542 ' CG1' HG23 ' A' ' 48' ' ' THR . 60.0 t -54.82 -39.63 48.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -57.24 -52.47 65.2 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.035 HD21 ' HA ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -67.58 -15.86 63.88 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.094 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.722 ' CG ' HG21 ' A' ' 51' ' ' ILE . 2.6 m-85 -94.26 119.75 33.5 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.476 -0.765 . . . . 0.0 109.675 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -46.53 171.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.44 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.434 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.2 OUTLIER -73.72 -25.36 60.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.52 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.582 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -121.24 41.23 3.38 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.403 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -71.88 153.89 41.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.882 . . . . 0.0 109.919 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.661 HG23 ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -112.8 159.67 18.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.235 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.609 ' CG2' HD12 ' A' ' 51' ' ' ILE . 24.0 t -148.19 167.98 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.327 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.562 ' N ' HG12 ' A' ' 36' ' ' VAL . 14.1 mt-10 -147.39 111.22 5.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.788 ' OD1' ' HB3' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -178.31 149.63 0.68 Allowed Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 118.695 -1.202 . . . . 0.0 110.075 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.541 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 48.3 Cg_endo -74.13 175.31 47.21 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.052 -2.062 . . . . 0.0 111.014 -0.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.932 HG13 ' CE1' ' A' ' 116' ' ' PHE . 7.2 m -42.12 122.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.489 -0.757 . . . . 0.0 109.652 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . 112.56 53.16 0.5 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.1 OUTLIER 78.53 -151.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -1.079 . . . . 0.0 109.961 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.638 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 4.1 mt-10 67.53 54.36 0.7 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.266 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.638 ' HD3' ' N ' ' A' ' 43' ' ' GLU . 55.7 Cg_endo -86.44 174.41 5.96 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.725 1.381 . . . . 0.0 110.576 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.904 ' HG3' ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -151.41 109.1 3.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.661 ' HB3' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -105.04 136.61 44.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.018 -1.051 . . . . 0.0 110.492 -178.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 103.43 158.44 24.91 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.542 HG23 ' CG1' ' A' ' 27' ' ' VAL . 7.2 m -60.88 -64.19 1.04 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.412 -1.052 . . . . 0.0 109.194 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -45.79 -25.2 0.47 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.088 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.904 ' HB1' ' HG3' ' A' ' 45' ' ' ARG . . . -86.92 -53.25 5.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.309 -0.869 . . . . 0.0 109.519 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.722 HG21 ' CG ' ' A' ' 30' ' ' PHE . 4.1 mm -55.74 -48.92 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.347 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.851 ' HA ' HD21 ' A' ' 23' ' ' LEU . 6.7 ttt180 -68.48 -53.01 26.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.406 -0.809 . . . . 0.0 109.119 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 13.1 tt0 -51.26 -32.16 23.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 108.66 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -83.87 -70.62 0.55 Allowed 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 1.072 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -45.34 -31.17 1.51 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.578 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 52' ' ' ARG . . . -66.4 -46.22 77.34 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 37.1 t-20 -60.62 -36.17 77.94 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.4 t -68.6 -35.28 77.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.792 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.9 tp -64.94 -20.39 66.44 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.456 -0.777 . . . . 0.0 109.051 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 3.1 mttp -67.04 -7.72 24.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.486 -0.759 . . . . 0.0 109.341 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.017 ' CD2' HD21 ' A' ' 63' ' ' LEU . 13.5 tp -88.88 108.94 26.62 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 48.7 Cg_endo -73.82 92.15 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.846 1.445 . . . . 0.0 111.909 -178.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.046 HD22 ' CG1' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -140.62 178.61 7.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.014 . . . . 0.0 109.366 178.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.577 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -103.17 129.02 49.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.6 t -112.56 113.54 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.692 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' LEU . 4.7 tt0 -150.59 97.19 2.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.815 . . . . 0.0 109.076 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.9 mp -44.84 170.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.338 -0.851 . . . . 0.0 109.67 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.463 HG23 ' N ' ' A' ' 69' ' ' GLN . 14.6 t -146.53 -38.86 0.22 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.704 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.463 ' N ' HG23 ' A' ' 68' ' ' THR . 5.9 pt20 -90.33 -148.39 0.2 Allowed 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 109.331 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -117.15 131.81 56.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.765 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.022 HG13 ' HB3' ' A' ' 80' ' ' PHE . 93.4 t -60.88 148.47 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.365 -0.834 . . . . 0.0 109.226 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -112.66 92.68 4.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 109.819 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 7' ' ' MET . . . -108.0 147.83 30.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.152 -0.968 . . . . 0.0 109.873 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.006 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -160.76 152.63 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.301 -0.874 . . . . 0.0 110.009 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.795 ' HB1' ' HA3' ' B' ' 241' ' ' GLY . . . 41.53 -145.43 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.595 -0.691 . . . . 0.0 109.964 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 103' ' ' PHE . 4.1 m-20 -85.01 4.06 35.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 110.001 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -113.27 -160.49 0.72 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 109.441 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.985 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 174.01 162.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.732 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.25 133.29 16.16 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 1.022 ' HB3' HG13 ' A' ' 71' ' ' VAL . 34.4 p90 -149.51 167.98 24.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.797 -1.189 . . . . 0.0 110.298 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -141.62 167.76 21.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.54 -0.725 . . . . 0.0 109.679 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -159.35 -172.78 3.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.25 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.96 140.44 53.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.378 -0.826 . . . . 0.0 109.658 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.046 ' CG1' HD22 ' A' ' 63' ' ' LEU . 22.6 t -121.17 116.04 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.484 -0.76 . . . . 0.0 109.177 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.662 ' CB ' HG23 ' A' ' 94' ' ' VAL . 69.6 p -118.2 128.17 54.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.96 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.682 ' CD1' HD23 ' A' ' 63' ' ' LEU . 3.0 p90 -143.95 171.01 14.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.379 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.47 ' HA ' ' HG3' ' A' ' 92' ' ' LYS . 2.5 tm-20 -104.6 156.65 17.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.636 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.556 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -117.82 -161.16 0.81 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 109.306 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.64 75.95 2.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 109.686 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . 116.61 -11.7 15.9 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 19.8 mtp180 -149.67 164.15 35.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -1.153 . . . . 0.0 109.592 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' A' ' 87' ' ' GLU . 18.4 tttt -107.91 151.75 25.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.552 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.592 ' HB ' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -138.13 155.14 49.03 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.317 -0.864 . . . . 0.0 109.915 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.662 HG23 ' CB ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -140.22 170.46 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 1.001 HG12 ' HD3' ' A' ' 97' ' ' PRO . 4.8 t -146.53 145.52 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.823 -1.173 . . . . 0.0 109.941 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . -136.46 71.88 58.74 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.434 -0.791 . . . . 0.0 109.786 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 1.001 ' HD3' HG12 ' A' ' 95' ' ' VAL . 52.1 Cg_endo -95.69 -171.11 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 121.741 1.627 . . . . 0.0 110.86 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.706 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.8 mp -140.82 146.34 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 23.0 t0 -118.61 160.94 20.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.921 -1.112 . . . . 0.0 109.83 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -109.74 -179.72 3.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.432 -0.793 . . . . 0.0 108.916 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.985 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -150.14 147.18 27.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.12 -0.987 . . . . 0.0 110.553 -178.699 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.54 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -140.98 102.61 4.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.264 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.725 ' CZ ' HG11 ' A' ' 10' ' ' VAL . 4.0 m-85 -89.77 -175.88 4.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.928 ' HB3' HG21 ' A' ' 110' ' ' VAL . 9.6 p-10 -126.53 -34.93 2.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 109.372 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.681 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -155.45 -63.29 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 164.6 61.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -1.17 . . . . 0.0 109.404 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.52 -53.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -129.43 -166.23 1.63 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -1.126 . . . . 0.0 109.705 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.598 HG22 ' CG1' ' A' ' 10' ' ' VAL . 25.8 t -109.93 160.72 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 108.906 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.928 HG21 ' HB3' ' A' ' 104' ' ' ASN . 54.2 t -132.61 -60.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.962 -1.086 . . . . 0.0 110.181 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.54 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -122.42 157.22 32.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.869 -1.144 . . . . 0.0 109.969 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.512 ' CE ' ' OD2' ' A' ' 99' ' ' ASP . 8.9 ttp -152.75 157.0 40.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.393 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.533 ' NH1' ' HB3' ' A' ' 37' ' ' GLU . 1.1 tpt180 -139.18 132.0 29.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 109.308 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.788 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . . . -93.0 129.08 39.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.06 -1.025 . . . . 0.0 109.663 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.747 HD13 ' CE1' ' B' ' 300' ' ' HIS . 0.6 OUTLIER -127.21 143.31 51.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.859 . . . . 0.0 109.632 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.932 ' CE1' HG13 ' A' ' 40' ' ' VAL . 47.1 p90 168.94 -154.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.506 ' O ' HG12 ' A' ' 121' ' ' ILE . . . 167.35 161.68 17.28 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.58 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 11.8 tt0 -44.12 -24.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.398 -1.06 . . . . 0.0 109.783 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 117' ' ' GLY . 0.8 OUTLIER -71.37 -35.06 70.98 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.821 0.819 . . . . 0.0 109.723 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 117' ' ' GLY . 0.4 OUTLIER -89.54 1.47 55.9 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.051 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.686 HG23 HG22 ' A' ' 95' ' ' VAL . 3.7 mm -91.44 -171.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 0.0 108.502 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.665 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -151.93 143.22 23.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.702 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.419 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.16 114.87 3.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.97 -116.21 0.7 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.346 -1.091 . . . . 0.0 109.386 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.243 0.544 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.472 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 4.6 m-20 -149.3 68.03 1.03 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 109.628 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 203' ' ' THR . . . . . 0.423 HG22 ' HB2' ' B' ' 205' ' ' GLU . 1.5 m -67.4 111.54 7.64 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.875 . . . . 0.0 109.624 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 204' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 49.1 Cg_endo -74.74 0.19 9.07 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.923 1.486 . . . . 0.0 110.367 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 205' ' ' GLU . . . . . 0.423 ' HB2' HG22 ' B' ' 203' ' ' THR . 7.3 mt-10 -65.81 -57.08 8.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 109.598 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -60.57 -48.55 81.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 207' ' ' MET . . . . . 0.546 ' HA ' ' CZ ' ' B' ' 303' ' ' PHE . 19.8 mtm -61.56 -15.19 36.35 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.332 -0.855 . . . . 0.0 109.896 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.433 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 15.5 m -81.85 -38.54 25.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.253 -0.904 . . . . 0.0 109.253 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.9 -42.83 59.62 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.26 -0.9 . . . . 0.0 108.599 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.693 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -52.31 -24.86 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.193 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.966 HG11 HG21 ' B' ' 271' ' ' VAL . 26.1 t -86.86 -45.24 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.481 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 212' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.6 tt0 -57.74 -73.49 0.07 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.922 ' HD2' HD13 ' B' ' 229' ' ' LEU . 0.7 OUTLIER -43.88 -45.34 7.49 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 214' ' ' TYR . . . . . 0.602 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -48.28 -43.17 32.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.31 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.958 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.1 t -89.27 -39.9 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.297 -0.877 . . . . 0.0 109.003 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 216' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' B' ' 213' ' ' ARG . . . -48.34 -36.36 14.29 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.649 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -74.08 -35.62 64.25 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.958 HD12 ' HA ' ' B' ' 215' ' ' VAL . 3.3 mt -61.56 -59.27 5.48 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.0 -41.07 46.34 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -88.91 5.33 44.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 1.042 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 46.86 35.81 8.13 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -97.33 78.35 2.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -1.071 . . . . 0.0 109.887 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 223' ' ' LEU . . . . . 1.05 ' CD2' HD22 ' B' ' 259' ' ' LEU . 3.9 mm? -50.45 -21.13 1.34 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.286 -0.884 . . . . 0.0 109.856 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -62.17 -54.54 39.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.902 . . . . 0.0 109.536 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 225' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' B' ' 229' ' ' LEU . . . -64.3 -34.4 89.81 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.748 HG21 ' CD2' ' B' ' 255' ' ' PHE . 6.9 mt -62.36 -56.02 20.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.715 HG21 ' HB2' ' B' ' 252' ' ' ARG . 26.9 t -63.37 -43.03 98.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.74 -49.79 69.95 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.922 HD13 ' HD2' ' B' ' 213' ' ' ARG . 2.4 tp -68.99 -16.7 63.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 230' ' ' PHE . . . . . 0.474 ' HB2' ' HA ' ' B' ' 227' ' ' VAL . 2.2 m-85 -91.72 140.3 29.83 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.334 -0.854 . . . . 0.0 109.517 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -49.18 177.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.575 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -24.18 66.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.547 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.531 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 4.4 p30 -146.96 47.1 1.17 Allowed 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.651 -0.656 . . . . 0.0 109.31 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.583 ' O ' HD11 ' B' ' 251' ' ' ILE . . . -59.45 167.09 2.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.329 -0.857 . . . . 0.0 109.496 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 235' ' ' THR . . . . . 0.907 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -109.4 164.84 12.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.581 HG23 HD12 ' B' ' 251' ' ' ILE . 46.1 t -154.68 115.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.91 . . . . 0.0 109.488 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 237' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.0 mm-40 -94.85 109.68 21.64 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 238' ' ' ASP . . . . . 0.478 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 10.0 t70 -178.21 142.69 0.45 Allowed Pre-proline 0 C--N 1.302 -1.486 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.042 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 239' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 47.0 Cg_endo -73.41 174.87 48.23 Favored 'Cis proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.29 -1.962 . . . . 0.0 111.072 -0.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.649 HG13 ' CE1' ' B' ' 316' ' ' PHE . 29.2 m -57.01 115.3 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.84 . . . . 0.0 109.598 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 241' ' ' GLY . . . . . 0.795 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . 83.28 57.35 2.51 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 242' ' ' SER . . . . . 0.506 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 3.3 m -149.01 -105.03 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -1.187 . . . . 0.0 109.747 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 243' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' B' ' 243' ' ' GLU . 7.5 pt-20 -165.85 111.08 0.75 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.931 -1.106 . . . . 0.0 110.185 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 244' ' ' PRO . . . . . 0.583 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.9 Cg_endo -65.75 179.15 1.87 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.97 1.511 . . . . 0.0 111.239 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.608 ' HB2' ' CD2' ' B' ' 254' ' ' PHE . 0.3 OUTLIER -150.9 103.0 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.907 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.28 150.57 22.55 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.252 -0.905 . . . . 0.0 110.166 -179.133 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 247' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 117.32 157.56 10.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 4.5 m -54.73 -72.18 0.07 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.228 -1.16 . . . . 0.0 108.937 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -52.67 -32.73 43.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 0.0 109.164 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.552 ' HB3' ' C ' ' B' ' 246' ' ' SER . . . -71.11 -23.96 62.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.558 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.583 HD11 ' O ' ' B' ' 234' ' ' ALA . 4.7 mm -90.11 -37.27 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.202 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 252' ' ' ARG . . . . . 0.715 ' HB2' HG21 ' B' ' 227' ' ' VAL . 21.7 ttm180 -79.6 -59.64 2.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.133 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 253' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 4.7 tt0 -45.6 -26.86 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.981 -1.074 . . . . 0.0 108.863 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.608 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.1 OUTLIER -86.44 -69.81 0.65 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 255' ' ' PHE . . . . . 0.748 ' CD2' HG21 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -52.75 -20.43 3.17 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.466 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 256' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' B' ' 252' ' ' ARG . . . -80.95 -43.96 18.92 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 257' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 10.0 t-20 -61.14 -38.89 88.02 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 33.8 t -62.1 -31.82 72.31 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 259' ' ' LEU . . . . . 1.05 HD22 ' CD2' ' B' ' 223' ' ' LEU . 6.7 tp -70.97 -26.52 63.2 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.467 -0.771 . . . . 0.0 109.366 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 260' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 7.7 mttp -48.91 -23.03 0.96 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.222 -0.924 . . . . 0.0 109.152 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 261' ' ' LEU . . . . . 0.91 HD22 HD21 ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.46 112.9 54.3 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 262' ' ' PRO . . . . . 0.505 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 43.2 Cg_endo -70.28 107.83 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.806 1.424 . . . . 0.0 110.618 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.91 HD21 HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -139.84 173.04 11.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.751 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 264' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' B' ' 284' ' ' VAL . . . -104.65 127.28 52.36 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 265' ' ' VAL . . . . . 0.401 HG11 HG22 ' B' ' 215' ' ' VAL . 77.9 t -112.29 112.63 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.962 . . . . 0.0 110.142 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 13.4 tt0 -150.49 97.14 2.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.34 -0.85 . . . . 0.0 109.158 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -44.7 170.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 110.016 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.92 -38.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 109.558 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 269' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 19.4 pt20 -93.2 -146.34 0.23 Allowed 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.635 -0.665 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 270' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 28.7 tt0 -115.32 133.09 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.0 109.659 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 271' ' ' VAL . . . . . 0.999 HG13 ' HB3' ' B' ' 280' ' ' PHE . 53.4 t -68.31 147.49 12.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 109.245 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.536 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.4 OUTLIER -103.01 139.26 38.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 109.952 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 273' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -148.25 147.39 29.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 109.083 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 274' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.2 OUTLIER -138.27 -155.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.114 -0.992 . . . . 0.0 109.99 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 275' ' ' ALA . . . . . 0.454 ' O ' ' SD ' ' B' ' 207' ' ' MET . . . -39.71 -87.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.639 -0.663 . . . . 0.0 110.468 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 276' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' B' ' 303' ' ' PHE . 6.7 m120 -116.45 20.53 14.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.146 -0.971 . . . . 0.0 110.276 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 277' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 0.3 OUTLIER -128.18 -160.05 0.99 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.007 -1.058 . . . . 0.0 109.399 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 278' ' ' ALA . . . . . 1.041 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 171.06 157.93 0.08 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.477 -0.764 . . . . 0.0 109.932 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 279' ' ' ALA . . . . . 0.625 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -150.31 136.14 18.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 280' ' ' PHE . . . . . 0.999 ' HB3' HG13 ' B' ' 271' ' ' VAL . 43.9 p90 -150.11 168.45 23.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.785 -1.197 . . . . 0.0 110.564 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.949 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -145.83 169.32 18.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.699 -0.625 . . . . 0.0 109.417 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 282' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 6.9 p90 -166.1 -169.11 1.38 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.78 141.43 51.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.436 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 284' ' ' VAL . . . . . 0.846 HG11 HD22 ' B' ' 263' ' ' LEU . 42.9 t -128.95 112.47 25.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.294 -0.878 . . . . 0.0 109.29 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 285' ' ' SER . . . . . 0.636 ' OG ' HG23 ' B' ' 294' ' ' VAL . 0.1 OUTLIER -104.49 122.89 46.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 109.448 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.505 ' HB2' ' O ' ' B' ' 262' ' ' PRO . 7.1 p90 -137.72 171.26 14.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.223 -0.923 . . . . 0.0 109.907 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 287' ' ' GLU . . . . . 0.424 ' OE1' ' HB3' ' B' ' 292' ' ' LYS . 42.5 tt0 -150.35 150.56 31.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.477 -0.765 . . . . 0.0 109.073 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 288' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.1 OUTLIER -137.72 2.46 2.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 109.881 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 289' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' B' ' 290' ' ' GLY . 2.1 tt0 -169.86 -173.63 1.63 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.099 -1.0 . . . . 0.0 109.113 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 290' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' B' ' 289' ' ' GLN . . . -46.65 -25.41 2.18 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 2.3 mtm105 -100.43 130.8 46.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -1.074 . . . . 0.0 109.285 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 292' ' ' LYS . . . . . 0.424 ' HB3' ' OE1' ' B' ' 287' ' ' GLU . 0.0 OUTLIER -106.03 141.44 37.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.521 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 293' ' ' THR . . . . . 0.715 HG22 ' HA ' ' B' ' 323' ' ' ALA . 0.0 OUTLIER -119.49 146.08 45.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 0.0 109.861 -179.516 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 294' ' ' VAL . . . . . 0.636 HG23 ' OG ' ' B' ' 285' ' ' SER . 3.9 p -113.53 171.08 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 108.845 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 1.015 HG12 ' HD3' ' B' ' 297' ' ' PRO . 24.6 t -142.13 144.04 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 110.355 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 296' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' B' ' 320' ' ' ASN . . . -138.52 70.86 45.43 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.599 -0.688 . . . . 0.0 109.683 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 297' ' ' PRO . . . . . 1.015 ' HD3' HG12 ' B' ' 295' ' ' VAL . 51.4 Cg_endo -95.67 -175.12 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.732 1.621 . . . . 0.0 111.545 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.949 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.5 mp -139.18 147.04 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 299' ' ' ASP . . . . . 0.623 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 7.1 t0 -118.51 164.03 15.89 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.862 -1.149 . . . . 0.0 110.362 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 300' ' ' HIS . . . . . 0.747 ' CE1' HD13 ' A' ' 115' ' ' LEU . 1.7 t60 -113.8 175.99 5.23 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 301' ' ' PHE . . . . . 1.041 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.1 OUTLIER -150.09 141.52 23.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.014 -1.054 . . . . 0.0 110.922 -178.457 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.504 ' HA ' ' HG2' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -130.24 105.97 8.27 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 303' ' ' PHE . . . . . 0.649 ' CZ ' HG21 ' B' ' 210' ' ' VAL . 0.4 OUTLIER -89.29 179.15 6.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.593 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 304' ' ' ASN . . . . . 0.879 ' OD1' HG23 ' B' ' 310' ' ' VAL . 0.5 OUTLIER -139.54 7.87 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 0.0 109.617 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 305' ' ' GLY . . . . . 0.698 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . 150.39 -68.22 0.34 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 306' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 164.83 76.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -1.135 . . . . 0.0 109.541 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.32 -35.74 0.02 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -165.84 -174.82 3.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -1.119 . . . . 0.0 109.39 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 309' ' ' VAL . . . . . 0.56 HG21 ' HE1' ' B' ' 301' ' ' PHE . 40.4 t -104.36 149.87 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 109.025 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 310' ' ' VAL . . . . . 0.879 HG23 ' OD1' ' B' ' 304' ' ' ASN . 38.8 t -122.97 -22.48 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.008 . . . . 0.0 109.691 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 311' ' ' SER . . . . . 0.503 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -151.09 156.28 40.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.97 . . . . 0.0 109.494 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 312' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 17.8 ttp -160.16 148.07 16.65 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.2 -0.937 . . . . 0.0 109.811 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 313' ' ' ARG . . . . . 0.472 ' HB2' ' HB2' ' B' ' 300' ' ' HIS . 0.1 OUTLIER -130.24 175.01 9.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.42 -0.8 . . . . 0.0 108.955 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 314' ' ' ALA . . . . . 0.599 ' O ' HG12 ' B' ' 240' ' ' VAL . . . -142.68 145.34 33.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 109.662 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 315' ' ' LEU . . . . . 0.732 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -136.64 139.76 42.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.893 . . . . 0.0 109.417 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 316' ' ' PHE . . . . . 1.006 ' O ' HG11 ' A' ' 74' ' ' VAL . 31.0 p90 173.13 -160.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 317' ' ' GLY . . . . . 0.725 ' C ' HD12 ' B' ' 321' ' ' ILE . . . 157.4 -174.87 34.89 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 318' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -54.21 -17.84 3.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 109.57 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.39 -28.26 27.08 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.852 0.835 . . . . 0.0 109.533 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 320' ' ' ASN . . . . . 0.721 ' OD1' HD12 ' B' ' 298' ' ' ILE . 0.3 OUTLIER -91.79 -30.33 16.28 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.357 0.599 . . . . 0.0 109.401 -179.536 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 321' ' ' ILE . . . . . 0.964 ' CG2' HG22 ' B' ' 295' ' ' VAL . 1.4 mt -87.0 -171.54 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 322' ' ' HIS . . . . . 0.748 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.1 OUTLIER -151.02 163.01 39.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.037 -1.039 . . . . 0.0 109.922 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.715 ' HA ' HG22 ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.722 HG23 ' O ' ' A' ' 3' ' ' THR . 9.0 t . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 8' ' ' THR . 45.2 Cg_endo -72.26 -10.11 25.27 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.923 1.486 . . . . 0.0 110.112 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -52.85 59.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.343 -0.848 . . . . 0.0 109.416 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -63.4 -52.21 62.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.39 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.573 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 8.6 mtt -65.49 -9.66 27.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.356 -0.84 . . . . 0.0 109.684 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.408 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 13.1 m -86.64 -39.56 15.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.298 -0.876 . . . . 0.0 109.428 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.411 ' HB1' HH12 ' A' ' 13' ' ' ARG . . . -58.27 -47.58 83.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.952 . . . . 0.0 109.349 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.89 ' HA ' HD21 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -48.03 -24.13 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 108.778 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.754 HG11 ' CG2' ' A' ' 71' ' ' VAL . 12.5 t -86.26 -42.56 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 109.538 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 13' ' ' ARG . 14.6 tt0 -61.23 -74.15 0.09 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.231 1.015 . . . . 0.0 108.323 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.933 ' HD2' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -42.75 -44.49 4.4 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.958 0.885 . . . . 0.0 108.711 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -51.39 -49.59 61.26 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.83 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -81.51 -41.37 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.398 -0.814 . . . . 0.0 109.362 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.23 -37.04 15.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.757 -1.214 . . . . 0.0 107.736 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -73.83 -32.09 63.53 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.83 HD12 ' HA ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -65.42 -56.57 11.78 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.01 -42.47 38.09 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.582 0.706 . . . . 0.0 109.312 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.978 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . . . -89.22 -6.73 56.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.518 -0.739 . . . . 0.0 109.705 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.772 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 62.43 21.31 62.19 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.978 ' OD2' ' HB3' ' A' ' 20' ' ' ALA . 1.5 p30 -89.35 68.56 7.98 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.994 -1.297 . . . . 0.0 109.732 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.053 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -46.54 -35.55 5.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.249 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' A' ' 22' ' ' ASP . 8.5 p-10 -41.92 -34.79 0.73 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -86.46 -32.27 16.67 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.561 HD12 HD12 ' A' ' 23' ' ' LEU . 40.5 mt -62.67 -56.66 16.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' A' ' 52' ' ' ARG . 49.2 t -56.83 -34.29 43.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -62.3 -55.7 25.68 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.933 HD13 ' HD2' ' A' ' 13' ' ' ARG . 3.5 tp -62.99 -21.92 66.48 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' ALA . 9.4 m-30 -87.63 138.69 31.25 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -50.59 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 109.726 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.2 -24.39 62.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.594 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.549 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 4.6 p-10 -150.16 53.49 0.91 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.822 ' N ' HD11 ' A' ' 51' ' ' ILE . . . -65.78 151.86 45.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 109.653 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 145.99 23.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 109.256 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 53.2 t -137.98 116.6 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.103 -0.998 . . . . 0.0 109.711 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 3.1 mm-40 -89.2 110.91 21.6 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.502 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 9.7 t70 -178.86 143.98 0.43 Allowed Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.702 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 48.9 Cg_endo -74.13 -168.27 6.08 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.258 -1.976 . . . . 0.0 110.925 -0.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.728 ' HB ' HG11 ' B' ' 274' ' ' VAL . 32.7 m -80.53 50.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.8 . . . . 0.0 109.351 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.37 34.18 0.05 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.518 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -153.54 -148.06 0.24 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.445 -1.032 . . . . 0.0 109.144 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -125.47 140.25 35.9 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.997 -1.065 . . . . 0.0 110.073 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.527 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 37.9 Cg_endo -63.58 -176.0 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.276 1.672 . . . . 0.0 111.051 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.789 ' CG ' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -150.87 108.15 3.61 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.17 151.82 21.96 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.167 -178.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.549 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 110.45 158.04 16.12 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.513 HG23 ' CG1' ' A' ' 27' ' ' VAL . 7.8 m -67.04 -51.36 55.73 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.13 -1.218 . . . . 0.0 109.146 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -58.4 -41.47 84.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.227 -0.921 . . . . 0.0 109.08 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.789 ' HB1' ' CG ' ' A' ' 45' ' ' ARG . . . -67.31 -57.51 6.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.153 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.822 HD11 ' N ' ' A' ' 34' ' ' ALA . 23.5 mt -55.02 -47.89 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.901 ' HG3' HD23 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -69.14 -57.87 4.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.118 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 37.4 tt0 -45.59 -30.01 1.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.053 -1.03 . . . . 0.0 108.839 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.502 ' CZ ' ' O ' ' A' ' 38' ' ' ASP . 1.3 t80 -82.44 -69.5 0.62 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 1.053 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -48.58 -36.08 14.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.76 -47.33 75.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 109.039 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 23.1 t-20 -57.51 -41.45 80.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.32 -0.862 . . . . 0.0 108.921 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.9 t -65.43 -32.34 73.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.348 -0.845 . . . . 0.0 109.005 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.772 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.1 tp -67.02 -19.6 65.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -57.25 -22.54 42.03 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.779 HD23 HD23 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -89.62 119.39 69.52 Favored Pre-proline 0 C--N 1.306 -1.324 0 O-C-N 121.189 -0.944 . . . . 0.0 108.528 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 49.1 Cg_endo -74.94 106.86 2.35 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.768 1.404 . . . . 0.0 110.762 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.831 ' CB ' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.84 163.08 33.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 110.055 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.023 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -97.26 124.01 41.23 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.6 t -107.4 114.15 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.908 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 67' ' ' LEU . 6.2 tt0 -150.34 101.31 2.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 109.195 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 81' ' ' ALA . 1.9 mp -44.97 170.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.864 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.9 p -133.41 -36.51 0.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.742 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.564 ' NE2' ' O ' ' A' ' 70' ' ' GLU . 3.4 pt20 -101.38 -145.18 0.35 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.512 -0.743 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.564 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 26.9 tt0 -110.78 133.03 53.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 109.513 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.754 ' CG2' HG11 ' A' ' 11' ' ' VAL . 28.5 t -58.03 154.71 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.342 -0.849 . . . . 0.0 109.412 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 1.9 mpt_? -121.01 130.2 53.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.516 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.418 ' HB1' ' CB ' ' A' ' 7' ' ' MET . . . -150.5 120.39 7.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.629 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.647 ' CB ' HG21 ' B' ' 240' ' ' VAL . 0.0 OUTLIER -122.44 -161.32 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 109.672 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 76' ' ' ASN . . . -81.73 144.88 30.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.444 -0.785 . . . . 0.0 110.216 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 75' ' ' ALA . 1.3 t-20 80.95 -44.18 0.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.733 -0.605 . . . . 0.0 110.422 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -144.39 -159.93 1.06 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.961 -1.087 . . . . 0.0 110.412 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 1.008 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . -169.21 163.15 10.9 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.912 ' HB3' HD22 ' B' ' 315' ' ' LEU . . . -149.4 138.78 21.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.91 -1.118 . . . . 0.0 109.962 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.665 ' HB3' HG13 ' A' ' 71' ' ' VAL . 29.7 p90 -150.34 167.48 26.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.023 -1.048 . . . . 0.0 109.384 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.967 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -139.94 -169.68 2.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 110.518 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.639 ' CD1' ' N ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER 172.84 -175.11 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -127.96 141.22 51.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.248 -0.908 . . . . 0.0 109.592 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.831 HG13 ' CB ' ' A' ' 63' ' ' LEU . 14.2 t -108.95 115.53 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.277 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 1.023 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 21.8 p -112.11 106.4 15.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.12 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.604 ' CZ ' ' HB ' ' A' ' 93' ' ' THR . 6.6 p90 -125.62 176.26 7.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.743 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -121.28 164.77 16.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.596 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.584 ' CE1' ' CE1' ' A' ' 86' ' ' PHE . 0.9 OUTLIER -115.58 -92.3 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.649 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -137.42 -36.21 0.65 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.864 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.78 -28.12 1.19 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.488 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 45.5 mtt85 -126.64 -179.51 4.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -1.184 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -127.6 122.43 33.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.679 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.855 HG23 ' HA ' ' A' ' 123' ' ' ALA . 19.3 m -96.55 172.15 8.1 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.344 -0.847 . . . . 0.0 109.559 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.611 HG13 ' CB ' ' A' ' 122' ' ' HIS . 14.0 p -148.0 170.99 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 108.715 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.624 ' O ' HG22 ' A' ' 83' ' ' THR . 43.9 t -148.22 156.78 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.079 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.476 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . -135.28 75.27 59.54 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.457 -0.777 . . . . 0.0 109.339 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.581 ' HD3' HG12 ' A' ' 95' ' ' VAL . 45.7 Cg_endo -98.19 178.48 0.39 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.789 1.659 . . . . 0.0 111.539 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.967 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.8 mp -137.93 151.93 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.624 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 13.5 t0 -122.8 164.48 18.3 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.941 -1.1 . . . . 0.0 110.203 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.505 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -112.16 172.15 7.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 109.236 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 1.008 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -147.28 140.86 25.54 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.24 -0.912 . . . . 0.0 110.374 -178.692 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.502 ' HA ' ' HG3' ' A' ' 77' ' ' GLU . 1.4 ttt180 -130.31 110.42 11.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.871 . . . . 0.0 109.121 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.615 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -89.73 176.15 6.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.333 -0.855 . . . . 0.0 109.664 -179.511 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.761 ' HB3' HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -114.03 -36.39 4.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.298 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 176.54 -46.07 0.11 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 163.29 76.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -1.169 . . . . 0.0 109.593 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.411 ' C ' ' HD3' ' A' ' 108' ' ' LYS . . . -171.0 -45.44 0.04 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 107' ' ' GLY . 0.0 OUTLIER -161.83 -169.43 2.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -1.133 . . . . 0.0 109.292 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.615 HG12 ' N ' ' A' ' 110' ' ' VAL . 54.5 t -94.04 166.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.209 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.761 HG21 ' HB3' ' A' ' 104' ' ' ASN . 10.8 t -131.76 -63.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -0.958 . . . . 0.0 109.745 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.461 ' HB2' ' HD3' ' A' ' 102' ' ' ARG . 3.2 m -128.18 171.05 12.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.946 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.511 ' CE ' ' OD2' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -151.75 147.53 26.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.42 -0.8 . . . . 0.0 109.081 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -121.36 162.18 20.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.568 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -111.01 133.48 53.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.848 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.834 HD11 ' HB2' ' B' ' 279' ' ' ALA . 9.3 tp -109.48 -143.47 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.808 . . . . 0.0 108.957 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.734 ' O ' HG22 ' B' ' 274' ' ' VAL . 26.2 p90 39.0 -161.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.725 0.774 . . . . 0.0 110.481 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.644 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 179.4 -149.37 8.67 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.46 ' C ' HG12 ' A' ' 121' ' ' ILE . 21.5 tt0 -80.69 -1.98 44.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -1.155 . . . . 0.0 109.412 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.521 ' HE2' ' CG ' ' B' ' 204' ' ' PRO . 5.7 tttm -93.19 -26.94 17.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 122.064 0.935 . . . . 0.0 108.921 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -88.55 17.7 5.2 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.349 0.595 . . . . 0.0 109.437 -179.628 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.644 HD11 ' O ' ' A' ' 117' ' ' GLY . 5.2 mm -90.01 -174.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.633 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -150.87 173.6 14.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.962 -1.086 . . . . 0.0 109.899 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.855 ' HA ' HG23 ' A' ' 93' ' ' THR . . . -152.34 110.36 3.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.409 -0.807 . . . . 0.0 109.29 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.37 115.07 3.95 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.328 -1.101 . . . . 0.0 109.47 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 201' ' ' MET . . . . . 0.498 ' CG ' ' O ' ' B' ' 201' ' ' MET . 1.4 ptt? . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.256 0.551 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' B' ' 203' ' ' THR . 0.7 OUTLIER -127.09 64.91 1.3 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 203' ' ' THR . . . . . 0.612 HG23 ' O ' ' B' ' 203' ' ' THR . 5.0 t -43.92 109.1 0.77 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.476 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 204' ' ' PRO . . . . . 0.521 ' CG ' ' HE2' ' A' ' 119' ' ' LYS . 44.5 Cg_endo -71.42 -4.11 14.33 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.957 1.504 . . . . 0.0 110.264 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -45.88 56.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.196 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 206' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.2 OUTLIER -62.26 -51.41 67.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.362 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 12.5 mtm -59.81 -51.15 70.97 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.242 -0.911 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 8.2 m -53.26 -33.02 51.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 109.193 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 209' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 206' ' ' HIS . . . -52.55 -46.23 66.7 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.051 -1.031 . . . . 0.0 108.405 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 1.035 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -53.48 -43.24 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.979 HG11 HG21 ' B' ' 271' ' ' VAL . 11.3 t -59.4 -41.72 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.594 -0.691 . . . . 0.0 109.834 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 212' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' B' ' 213' ' ' ARG . 9.7 tt0 -60.47 -75.26 0.06 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.767 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.6 OUTLIER -43.83 -44.38 6.8 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 214' ' ' TYR . . . . . 0.633 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 3.8 t80 -53.71 -49.25 68.5 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.931 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -83.25 -44.36 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.406 -0.809 . . . . 0.0 109.832 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 216' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.0 -37.04 8.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 0.0 108.022 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.545 ' HB1' HG13 ' B' ' 226' ' ' ILE . . . -74.1 -34.68 64.03 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.931 HD12 ' HA ' ' B' ' 215' ' ' VAL . 5.2 mt -63.29 -59.91 4.1 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 219' ' ' ASN . . . . . 0.414 ' ND2' ' OE1' ' B' ' 266' ' ' GLU . 16.4 t30 -51.01 -45.6 61.26 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.565 0.697 . . . . 0.0 109.289 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.38 9.68 25.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.572 -0.705 . . . . 0.0 109.511 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.583 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 48.06 32.21 8.98 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 222' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' B' ' 217' ' ' ALA . 12.5 t70 -89.99 66.49 6.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -1.117 . . . . 0.0 109.743 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 223' ' ' LEU . . . . . 1.069 HD11 ' HB3' ' B' ' 255' ' ' PHE . 5.9 tp -47.58 -42.38 23.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 108.736 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' B' ' 223' ' ' LEU . 3.4 m-20 -42.28 -31.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 225' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' B' ' 228' ' ' ALA . . . -88.14 -38.71 7.18 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.826 HD12 HD12 ' B' ' 223' ' ' LEU . 17.1 mt -58.23 -53.36 47.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 85.0 t -57.17 -37.99 58.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' B' ' 225' ' ' GLY . . . -58.33 -54.82 42.67 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 1.035 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.5 tp -63.32 -20.48 65.53 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 230' ' ' PHE . . . . . 0.803 ' CG ' HG21 ' B' ' 251' ' ' ILE . 0.6 OUTLIER -82.71 132.08 35.19 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.492 -0.755 . . . . 0.0 109.502 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -51.04 -177.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.268 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -25.89 66.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 109.885 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.552 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 13.4 p-10 -150.61 53.84 0.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.62 -0.675 . . . . 0.0 109.341 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' B' ' 310' ' ' VAL . . . -62.19 165.55 5.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.742 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 235' ' ' THR . . . . . 0.848 HG23 ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -116.25 140.78 48.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.22 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.521 HG23 HD12 ' B' ' 251' ' ' ILE . 38.9 t -130.11 117.8 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -0.885 . . . . 0.0 109.126 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 237' ' ' GLU . . . . . 0.544 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 27.7 mt-10 -88.84 106.98 18.73 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 238' ' ' ASP . . . . . 0.487 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 9.8 t70 -176.03 142.17 0.61 Allowed Pre-proline 0 C--N 1.3 -1.577 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.597 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 239' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' B' ' 238' ' ' ASP . 47.2 Cg_endo -73.74 -165.09 3.61 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.216 -1.993 . . . . 0.0 110.685 0.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.647 HG21 ' CB ' ' A' ' 74' ' ' VAL . 5.5 m -87.8 41.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 109.345 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -165.71 26.01 0.17 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 242' ' ' SER . . . . . 0.427 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 1.4 m -148.01 -141.82 0.12 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.415 -1.05 . . . . 0.0 108.913 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -133.72 142.35 43.39 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.914 -1.116 . . . . 0.0 109.954 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 244' ' ' PRO . . . . . 0.544 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.8 Cg_endo -63.39 -170.86 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.284 1.676 . . . . 0.0 111.436 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.736 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -151.09 111.5 4.18 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.848 ' HB3' HG23 ' B' ' 235' ' ' THR . 1.9 p -94.04 155.28 17.2 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.101 -0.999 . . . . 0.0 110.452 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 247' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.21 162.32 21.78 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 6.5 m -73.7 -44.91 55.18 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.185 -1.185 . . . . 0.0 109.093 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -64.26 -20.25 65.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.244 -0.91 . . . . 0.0 109.207 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.736 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -90.15 -54.43 4.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.352 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.803 HG21 ' CG ' ' B' ' 230' ' ' PHE . 6.4 mm -54.97 -44.58 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 252' ' ' ARG . . . . . 0.761 ' HG3' HD23 ' B' ' 223' ' ' LEU . 17.8 ttt85 -73.34 -56.03 5.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.212 -0.93 . . . . 0.0 108.807 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 253' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 17.7 tt0 -45.94 -27.92 1.01 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.024 . . . . 0.0 108.546 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 1.0 OUTLIER -85.79 -70.94 0.56 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 255' ' ' PHE . . . . . 1.069 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -48.45 -23.97 1.12 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 256' ' ' ALA . . . . . 0.724 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -80.49 -51.16 9.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 108.898 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 257' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 0.2 OUTLIER -56.62 -35.02 67.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 1.6 t -74.81 -38.6 62.04 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 259' ' ' LEU . . . . . 0.583 HD21 ' CA ' ' B' ' 221' ' ' GLY . 8.6 tp -62.22 -29.47 70.41 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.373 -0.829 . . . . 0.0 109.02 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 260' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 14.7 mttm -44.35 -27.11 0.4 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 261' ' ' LEU . . . . . 0.833 HD22 HD21 ' B' ' 263' ' ' LEU . 3.3 tt -89.69 113.85 58.37 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 262' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 48.7 Cg_endo -73.59 107.27 2.36 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.915 1.481 . . . . 0.0 112.176 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.909 HD22 ' CG1' ' B' ' 284' ' ' VAL . 0.8 OUTLIER -130.24 -170.28 2.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.398 -0.814 . . . . 0.0 109.43 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 264' ' ' ALA . . . . . 0.72 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -119.9 128.0 53.22 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 265' ' ' VAL . . . . . 0.551 HG21 ' HB3' ' B' ' 218' ' ' LEU . 43.0 t -115.43 113.25 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.055 -1.028 . . . . 0.0 110.037 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 266' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.3 tp10 -150.31 94.16 2.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.417 -0.802 . . . . 0.0 108.942 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.524 HD11 HG11 ' B' ' 215' ' ' VAL . 1.4 mp -46.89 175.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 0.0 110.004 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 268' ' ' THR . . . . . 0.456 ' O ' ' O ' ' B' ' 269' ' ' GLN . 41.7 p -133.57 -76.28 0.48 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.46 -0.775 . . . . 0.0 108.951 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 269' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' B' ' 268' ' ' THR . 15.7 pt20 -61.07 -143.7 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 270' ' ' GLU . . . . . 0.415 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 24.4 tt0 -115.76 131.31 56.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 109.872 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 271' ' ' VAL . . . . . 1.011 HG13 ' HB3' ' B' ' 280' ' ' PHE . 83.0 t -45.41 146.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.386 -0.822 . . . . 0.0 109.042 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.52 ' NE ' HD11 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -102.08 82.19 2.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.696 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -89.38 145.03 25.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.115 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 274' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 116' ' ' PHE . 0.5 OUTLIER -122.43 -169.02 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.156 -0.965 . . . . 0.0 109.924 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 275' ' ' ALA . . . . . 0.588 ' H ' HG12 ' B' ' 274' ' ' VAL . . . -38.39 -94.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.574 -0.704 . . . . 0.0 110.787 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 276' ' ' ASN . . . . . 0.451 ' O ' ' OD1' ' B' ' 276' ' ' ASN . 21.8 t-20 -92.76 -28.24 16.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.115 -0.991 . . . . 0.0 110.621 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 277' ' ' GLU . . . . . 0.527 ' CG ' ' HG3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -92.74 -166.6 1.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.952 -1.092 . . . . 0.0 109.575 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 278' ' ' ALA . . . . . 0.93 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . -160.69 161.14 32.22 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.468 -0.77 . . . . 0.0 109.571 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 279' ' ' ALA . . . . . 0.834 ' HB2' HD11 ' A' ' 115' ' ' LEU . . . -150.9 131.13 13.58 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 280' ' ' PHE . . . . . 1.011 ' HB3' HG13 ' B' ' 271' ' ' VAL . 41.8 p90 -147.55 159.53 43.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.797 -1.19 . . . . 0.0 110.491 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 1.009 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -139.57 160.88 38.85 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.406 0.622 . . . . 0.0 109.375 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 282' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 3.8 p90 -162.29 -168.34 1.84 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 108.982 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.27 139.78 53.59 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.713 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 284' ' ' VAL . . . . . 0.909 ' CG1' HD22 ' B' ' 263' ' ' LEU . 42.0 t -107.83 114.7 47.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 285' ' ' SER . . . . . 0.72 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 96.9 p -115.5 98.99 7.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.955 . . . . 0.0 110.119 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.868 ' CD1' HD23 ' B' ' 263' ' ' LEU . 30.0 p90 -108.75 -171.86 1.94 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 108.815 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.45 153.1 33.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.98 -1.075 . . . . 0.0 109.809 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 288' ' ' PHE . . . . . 0.527 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.1 OUTLIER -105.55 -163.91 0.98 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.43 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -40.58 92.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.924 . . . . 0.0 109.972 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -139.65 4.51 2.75 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.148 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -140.82 -176.25 4.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -1.186 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 292' ' ' LYS . . . . . 0.477 ' O ' ' HD3' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -118.75 140.98 49.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.178 -0.952 . . . . 0.0 109.305 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 293' ' ' THR . . . . . 0.595 ' HB ' ' CE1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -125.32 146.04 49.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.406 -0.809 . . . . 0.0 109.433 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 294' ' ' VAL . . . . . 0.572 HG22 ' H ' ' B' ' 295' ' ' VAL . 7.9 p -125.28 171.89 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.143 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 1.025 HG12 ' HD3' ' B' ' 297' ' ' PRO . 2.8 t -149.43 146.98 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 109.065 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 296' ' ' ALA . . . . . . . . . . . . . . . -125.84 71.32 67.77 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.179 -0.951 . . . . 0.0 111.266 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 297' ' ' PRO . . . . . 1.025 ' HD3' HG12 ' B' ' 295' ' ' VAL . 53.3 Cg_endo -93.24 179.68 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.593 1.312 . . . . 0.0 110.996 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 1.009 HG23 ' HB2' ' B' ' 281' ' ' ALA . 3.0 mp -141.38 148.81 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 299' ' ' ASP . . . . . 0.619 ' HB3' ' CE1' ' B' ' 280' ' ' PHE . 17.2 t0 -121.38 157.52 30.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.958 -1.089 . . . . 0.0 110.401 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 300' ' ' HIS . . . . . 0.561 ' ND1' HD11 ' A' ' 115' ' ' LEU . 5.4 t60 -113.73 151.7 31.54 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 301' ' ' PHE . . . . . 0.93 ' CB ' ' HB3' ' B' ' 278' ' ' ALA . 0.5 OUTLIER -126.91 151.86 47.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.271 -0.893 . . . . 0.0 110.828 -178.271 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.529 ' O ' HG23 ' B' ' 310' ' ' VAL . 0.0 OUTLIER -146.27 93.56 2.33 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 303' ' ' PHE . . . . . 0.755 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 8.2 m-30 -89.81 -165.55 1.37 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.126 -0.984 . . . . 0.0 109.962 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 304' ' ' ASN . . . . . 0.537 ' OD1' ' CG1' ' B' ' 310' ' ' VAL . 0.4 OUTLIER -140.15 27.22 2.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.427 -0.796 . . . . 0.0 109.437 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 305' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . 119.54 -61.08 0.49 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 306' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 179.67 33.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -1.127 . . . . 0.0 109.272 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 307' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' B' ' 308' ' ' LYS . . . -108.35 33.3 6.33 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 308' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' B' ' 307' ' ' GLY . 0.3 OUTLIER 83.51 -162.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.972 -0.722 . . . . 0.0 109.164 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 309' ' ' VAL . . . . . 0.615 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 49.7 t -90.5 143.81 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.384 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 310' ' ' VAL . . . . . 0.537 ' CG1' ' OD1' ' B' ' 304' ' ' ASN . 0.1 OUTLIER -126.19 -27.1 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.102 -0.999 . . . . 0.0 109.991 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 311' ' ' SER . . . . . 0.497 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -143.41 164.04 31.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.109 -0.994 . . . . 0.0 109.374 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 312' ' ' MET . . . . . 0.469 ' O ' ' HG3' ' B' ' 237' ' ' GLU . 0.0 OUTLIER -160.38 155.85 25.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 313' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' B' ' 300' ' ' HIS . 0.0 OUTLIER -150.22 118.47 6.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.159 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 314' ' ' ALA . . . . . 0.428 ' O ' HG12 ' B' ' 240' ' ' VAL . . . -100.07 139.73 35.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 110.629 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 315' ' ' LEU . . . . . 0.912 HD22 ' HB3' ' A' ' 79' ' ' ALA . 3.7 tt -128.65 138.46 52.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.84 . . . . 0.0 109.335 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 316' ' ' PHE . . . . . 0.578 ' CD2' ' OD1' ' B' ' 320' ' ' ASN . 0.1 OUTLIER 172.51 -159.51 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 317' ' ' GLY . . . . . 0.487 ' O ' ' OD1' ' B' ' 320' ' ' ASN . . . 171.27 177.63 41.2 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.292 -1.433 . . . . 0.0 110.485 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 318' ' ' GLU . . . . . 0.508 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 47.9 tt0 -51.54 -21.41 2.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.201 -1.176 . . . . 0.0 108.931 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.14 -22.18 59.56 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.019 0.914 . . . . 0.0 108.726 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 320' ' ' ASN . . . . . 0.67 ' ND2' HG13 ' B' ' 295' ' ' VAL . 0.3 OUTLIER -88.51 1.51 54.7 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 321' ' ' ILE . . . . . 0.789 ' HA ' HG22 ' B' ' 295' ' ' VAL . 4.0 mm -89.89 179.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.121 -0.987 . . . . 0.0 108.504 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 322' ' ' HIS . . . . . 0.542 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.2 OUTLIER -151.51 177.42 10.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.967 -1.083 . . . . 0.0 109.807 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.462 179.781 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.3 -3.5 13.07 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.854 1.449 . . . . 0.0 110.285 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -61.88 -39.22 91.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.257 -0.902 . . . . 0.0 109.292 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -86.93 -43.99 11.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.335 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.6 mtt -56.94 -35.87 69.59 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.261 -0.899 . . . . 0.0 109.542 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.443 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 11.2 m -67.41 -39.16 85.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -43.66 62.77 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.674 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.3 t -53.96 -22.64 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.711 HG11 ' CG2' ' A' ' 71' ' ' VAL . 4.3 t -90.12 -41.35 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 108.979 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.3 tt0 -65.5 -74.18 0.11 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.903 ' HB3' HD22 ' A' ' 29' ' ' LEU . 2.2 mtt85 -42.27 -45.46 4.2 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.608 ' CD1' HG23 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -46.1 -43.73 15.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.095 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.915 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.4 t -90.34 -37.24 9.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.544 -0.722 . . . . 0.0 109.136 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -49.26 -34.91 16.29 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.564 ' HB3' HG12 ' A' ' 26' ' ' ILE . . . -74.73 -33.3 62.34 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.915 HD12 ' HA ' ' A' ' 15' ' ' VAL . 3.8 mt -65.96 -58.85 4.6 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.75 -41.86 24.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.621 0.724 . . . . 0.0 109.251 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.85 7.98 31.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.863 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 47.94 31.94 8.43 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 16.7 t0 -100.17 92.99 5.48 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.324 -1.104 . . . . 0.0 109.755 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.028 HD13 HD12 ' A' ' 26' ' ' ILE . 3.4 mm? -59.17 -15.27 13.82 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.224 -0.923 . . . . 0.0 109.529 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.23 -54.14 45.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 109.178 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.12 -35.68 92.41 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.028 HD12 HD13 ' A' ' 23' ' ' LEU . 8.8 mt -62.8 -56.45 17.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' A' ' 52' ' ' ARG . 95.7 t -63.72 -37.9 80.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.28 74.1 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.903 HD22 ' HB3' ' A' ' 13' ' ' ARG . 7.7 tp -66.08 -23.32 66.5 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CD2' HG22 ' A' ' 26' ' ' ILE . 3.6 m-85 -88.4 141.1 28.81 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.562 -0.711 . . . . 0.0 109.655 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -48.5 172.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 109.458 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.29 -24.1 67.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 109.294 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.632 ' C ' HD11 ' A' ' 51' ' ' ILE . 20.4 p-10 -146.58 35.12 0.95 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.972 ' N ' HD11 ' A' ' 51' ' ' ILE . . . -51.01 169.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.822 . . . . 0.0 109.772 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 1.007 HG23 ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -122.76 140.31 53.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.541 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.515 HG22 ' HB3' ' A' ' 112' ' ' MET . 48.2 t -131.49 120.66 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.262 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 3.4 mt-10 -88.46 107.0 18.64 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.569 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 9.1 t0 -179.78 143.29 0.37 Allowed Pre-proline 0 C--N 1.302 -1.486 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.547 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HA ' ' CG ' ' A' ' 38' ' ' ASP . 50.1 Cg_endo -76.25 -175.14 15.86 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.205 -1.998 . . . . 0.0 110.403 -0.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.004 HG21 HG11 ' B' ' 274' ' ' VAL . 19.8 m -72.58 150.89 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 108.875 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.35 -1.76 69.48 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.463 ' OG ' ' HG2' ' A' ' 39' ' ' PRO . 1.4 m -115.46 -142.3 0.38 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.27 -1.135 . . . . 0.0 109.308 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.24 141.76 16.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.987 -1.071 . . . . 0.0 110.048 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 39.6 Cg_endo -65.56 -175.44 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.817 1.678 . . . . 0.0 111.592 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.598 ' HB2' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -150.78 106.86 3.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 1.007 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.28 157.01 18.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.276 -0.89 . . . . 0.0 110.601 -178.35 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.557 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 106.3 157.18 21.69 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 m -64.55 -55.26 21.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.243 -1.151 . . . . 0.0 109.138 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -55.27 -33.02 62.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.89 . . . . 0.0 109.009 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.576 ' HB1' ' CG ' ' A' ' 45' ' ' ARG . . . -77.46 -60.52 2.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.383 -0.823 . . . . 0.0 109.357 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.972 HD11 ' N ' ' A' ' 34' ' ' ALA . 44.5 mt -48.08 -40.9 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.267 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB2' HG21 ' A' ' 27' ' ' VAL . 49.2 ttp180 -79.1 -58.39 3.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.814 . . . . 0.0 109.124 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.532 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 49.8 tt0 -46.2 -27.37 0.97 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.021 -1.05 . . . . 0.0 108.619 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.598 ' CD2' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -85.02 -71.36 0.53 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.587 ' HB3' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -49.31 -33.01 12.21 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.451 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . . . -69.12 -46.82 66.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 108.78 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 26.9 t-20 -58.41 -35.45 72.09 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.6 t -64.93 -38.09 89.82 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.921 HD22 ' CD2' ' A' ' 23' ' ' LEU . 7.6 tp -68.78 -22.04 64.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.486 -0.759 . . . . 0.0 109.68 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 25.9 mtpt -50.39 -26.37 4.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 109.692 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.895 HD22 ' CD2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.71 126.7 56.96 Favored Pre-proline 0 C--N 1.305 -1.349 0 O-C-N 121.226 -0.921 . . . . 0.0 109.049 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.454 ' C ' ' HG ' ' A' ' 63' ' ' LEU . 44.0 Cg_endo -71.49 101.62 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.834 1.439 . . . . 0.0 110.371 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.895 ' CD2' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -138.64 155.86 47.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.462 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -89.79 132.66 35.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 108.778 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.608 HG11 ' HB3' ' A' ' 18' ' ' LEU . 16.2 t -107.22 125.02 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.048 -1.033 . . . . 0.0 110.127 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' LEU . 14.8 tt0 -150.26 103.12 3.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.44 -0.788 . . . . 0.0 108.961 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.763 HD11 ' HB ' ' A' ' 15' ' ' VAL . 3.8 mt -55.09 -108.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 110.062 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.668 ' O ' ' N ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER 158.26 43.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.685 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.555 ' CG ' ' O ' ' A' ' 68' ' ' THR . 5.1 pt20 50.64 -54.02 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' A' ' 68' ' ' THR . 23.1 tt0 -60.77 116.19 4.23 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.624 -1.297 . . . . 0.0 110.761 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.711 ' CG2' HG11 ' A' ' 11' ' ' VAL . 35.8 t -135.3 163.54 35.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.702 ' CZ ' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -132.03 135.12 46.28 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.454 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.527 ' N ' ' NE ' ' A' ' 72' ' ' ARG . . . -145.44 111.63 5.66 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.041 HG11 HG21 ' B' ' 240' ' ' VAL . 0.1 OUTLIER -100.11 -163.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 110.429 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -35.69 -94.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.771 -0.581 . . . . 0.0 111.241 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 8.1 t-20 -100.32 -2.9 32.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.07 -1.019 . . . . 0.0 110.748 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.515 ' OE1' ' NE ' ' B' ' 313' ' ' ARG . 0.4 OUTLIER -111.29 -162.03 0.78 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.769 -1.207 . . . . 0.0 109.719 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 1.04 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . -176.09 162.14 2.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.602 -0.686 . . . . 0.0 109.372 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 1.006 ' HB2' HD11 ' B' ' 315' ' ' LEU . . . -150.17 130.09 13.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.172 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 31.4 p90 -150.83 168.79 23.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.678 -1.263 . . . . 0.0 109.948 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.888 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -141.8 -178.3 5.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.472 -0.767 . . . . 0.0 109.862 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CB ' ' HA ' ' A' ' 67' ' ' LEU . 1.9 p90 -172.65 -159.25 0.12 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.386 -0.821 . . . . 0.0 109.257 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.86 149.43 43.41 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.083 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.611 HG11 HD22 ' A' ' 63' ' ' LEU . 55.6 t -124.77 112.51 32.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.51 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -113.5 103.9 11.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.902 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.583 ' CD2' HD23 ' A' ' 63' ' ' LEU . 45.6 p90 -123.1 164.77 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.393 -0.817 . . . . 0.0 108.931 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 38.0 tt0 -141.46 152.25 44.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.059 -1.026 . . . . 0.0 109.83 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.437 ' N ' ' HG2' ' A' ' 87' ' ' GLU . 7.3 m-85 -93.61 -146.4 0.24 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.419 -0.801 . . . . 0.0 109.297 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -0.72 30.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.958 . . . . 0.0 109.719 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.71 -68.63 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 1.6 ttt85 -55.49 155.11 5.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -1.137 . . . . 0.0 109.557 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.439 ' HD2' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -131.71 120.43 22.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.757 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -121.46 143.26 49.34 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER -117.37 179.52 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.103 -0.998 . . . . 0.0 108.74 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 1.012 HG12 ' HD3' ' A' ' 97' ' ' PRO . 3.0 t -148.15 146.5 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.07 -1.019 . . . . 0.0 109.533 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.44 ' O ' ' CG ' ' A' ' 120' ' ' ASN . . . -133.64 71.13 75.51 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.34 -0.85 . . . . 0.0 110.281 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 1.012 ' HD3' HG12 ' A' ' 95' ' ' VAL . 49.7 Cg_endo -95.46 -174.54 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.537 1.491 . . . . 0.0 110.973 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.888 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.9 mp -139.14 166.28 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 21.1 t0 -131.27 154.66 48.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.922 -1.111 . . . . 0.0 110.192 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.517 ' NE2' ' CD1' ' B' ' 315' ' ' LEU . 0.3 OUTLIER -108.77 172.75 6.66 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 1.04 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -147.41 150.88 35.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.82 -1.175 . . . . 0.0 110.857 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.488 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -139.78 109.53 6.33 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.674 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -89.27 -166.12 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 109.777 -179.332 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.871 ' HB3' HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -135.9 -38.71 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.439 -0.788 . . . . 0.0 109.34 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.714 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -174.46 -47.67 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 163.2 77.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -1.094 . . . . 0.0 109.503 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -167.21 -67.94 0.03 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -139.78 -163.87 1.58 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.232 -1.158 . . . . 0.0 109.482 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.774 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 94.0 t -100.79 147.63 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.871 . . . . 0.0 109.337 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.871 HG21 ' HB3' ' A' ' 104' ' ' ASN . 93.2 t -111.9 -66.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 109.746 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -116.25 166.25 12.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.055 -1.028 . . . . 0.0 109.736 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.515 ' HB3' HG22 ' A' ' 36' ' ' VAL . 12.2 ttp -160.28 154.61 23.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.345 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.49 HH22 HD12 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -144.35 126.59 15.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.167 -0.958 . . . . 0.0 109.482 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.554 ' HB3' ' OD2' ' A' ' 38' ' ' ASP . . . -96.71 132.21 42.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 109.752 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.653 HD13 ' HB2' ' B' ' 279' ' ' ALA . 1.3 tt -117.92 143.84 45.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.002 . . . . 0.0 109.834 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.549 ' CE1' HG13 ' A' ' 40' ' ' VAL . 9.2 p90 172.54 -158.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.622 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 169.53 -173.05 43.79 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.517 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 26.6 tt0 -72.79 -2.65 21.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.302 -1.117 . . . . 0.0 109.68 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -92.71 -30.96 15.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.997 0.903 . . . . 0.0 108.995 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.3 m-20 -89.11 11.38 18.69 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.679 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.982 HG23 HG22 ' A' ' 95' ' ' VAL . 4.4 mm -92.66 -160.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.191 -0.943 . . . . 0.0 108.587 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.697 ' O ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -151.22 159.93 44.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.071 . . . . 0.0 109.795 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.66 81.74 1.03 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.371 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -119.19 140.16 14.82 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.207 -1.173 . . . . 0.0 109.454 179.889 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 201' ' ' MET . . . . . 0.405 ' O ' ' C ' ' B' ' 202' ' ' ASN . 5.1 mpp? . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.258 0.551 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.477 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 8.8 m120 45.33 44.48 9.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.436 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 203' ' ' THR . . . . . 0.515 ' CG2' ' HB2' ' B' ' 205' ' ' GLU . 5.3 m -89.59 108.64 26.46 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 204' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.4 Cg_endo -72.26 -2.48 11.73 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.973 1.512 . . . . 0.0 110.165 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 205' ' ' GLU . . . . . 0.515 ' HB2' ' CG2' ' B' ' 203' ' ' THR . 3.5 tt0 -58.92 -63.48 1.28 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -0.869 . . . . 0.0 109.353 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -61.98 -45.03 95.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.915 . . . . 0.0 109.51 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 207' ' ' MET . . . . . 0.434 ' HA ' ' CE2' ' B' ' 303' ' ' PHE . 73.3 mtm -60.9 -41.48 96.15 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.255 -0.903 . . . . 0.0 109.608 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 18.1 m -64.46 -44.08 92.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.946 . . . . 0.0 109.252 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.64 -43.73 57.19 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.845 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -53.57 -26.03 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.817 HG11 ' CG2' ' B' ' 271' ' ' VAL . 13.5 t -89.8 -43.27 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 108.984 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 212' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' B' ' 215' ' ' VAL . 5.7 tt0 -62.71 -73.98 0.1 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.833 ' HB3' HD22 ' B' ' 229' ' ' LEU . 1.4 mtt85 -42.21 -45.06 3.99 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 214' ' ' TYR . . . . . 0.639 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.3 OUTLIER -48.05 -43.13 30.04 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.28 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.952 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.16 -40.25 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.407 -0.808 . . . . 0.0 109.178 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 216' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.8 -37.24 13.17 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.609 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -72.97 -35.21 66.87 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' B' ' 215' ' ' VAL . 5.2 mt -63.84 -60.84 2.77 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -49.29 -40.36 34.37 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.532 0.682 . . . . 0.0 109.252 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.22 0.02 57.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.553 -0.717 . . . . 0.0 109.799 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.972 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 54.52 45.4 76.9 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 222' ' ' ASP . . . . . 0.454 ' O ' HG13 ' B' ' 226' ' ' ILE . 45.7 t0 -111.14 83.75 1.82 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 110.061 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 223' ' ' LEU . . . . . 0.984 ' CD2' HD22 ' B' ' 259' ' ' LEU . 3.9 mm? -53.31 -19.37 3.23 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.24 -0.913 . . . . 0.0 109.78 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.89 -56.94 11.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.235 -0.916 . . . . 0.0 109.213 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -60.61 -31.92 76.62 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.896 HD12 HD13 ' B' ' 223' ' ' LEU . 7.2 mt -65.28 -60.45 2.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.726 HG21 ' HB2' ' B' ' 252' ' ' ARG . 61.1 t -59.14 -40.26 80.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.16 -51.33 66.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.845 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.6 tp -66.48 -21.83 66.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 230' ' ' PHE . . . . . 0.493 ' O ' ' O ' ' B' ' 227' ' ' VAL . 3.9 m-30 -95.71 134.93 38.06 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.338 -0.851 . . . . 0.0 110.015 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -44.54 164.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.036 -1.04 . . . . 0.0 109.383 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' B' ' 248' ' ' THR . 0.1 OUTLIER -61.9 -24.63 67.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.489 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.553 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 2.6 p30 -138.53 43.08 2.15 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' B' ' 310' ' ' VAL . . . -64.04 169.26 4.49 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.327 -0.858 . . . . 0.0 109.808 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 235' ' ' THR . . . . . 0.873 HG23 ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -119.79 140.07 51.33 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.446 -0.784 . . . . 0.0 109.007 179.572 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.502 ' O ' ' HB3' ' B' ' 244' ' ' PRO . 37.3 t -132.44 121.19 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.577 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 237' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' B' ' 314' ' ' ALA . 1.5 mt-10 -89.2 105.85 18.05 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 238' ' ' ASP . . . . . 0.533 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 27.0 t70 -179.61 142.06 0.36 Allowed Pre-proline 0 C--N 1.302 -1.464 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.337 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 239' ' ' PRO . . . . . 0.503 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 47.7 Cg_endo -72.61 -176.72 16.71 Favored 'Cis proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.209 -1.996 . . . . 0.0 110.693 -0.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 1.041 HG21 HG11 ' A' ' 74' ' ' VAL . 26.9 m -82.86 49.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -175.1 30.88 0.09 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 242' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 75.4 m -149.46 -99.1 0.07 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -1.118 . . . . 0.0 109.38 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -176.9 139.46 0.46 Allowed Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.099 -1.001 . . . . 0.0 110.037 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 244' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' B' ' 236' ' ' VAL . 38.1 Cg_endo -65.12 -176.64 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.123 1.591 . . . . 0.0 111.138 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.74 ' HG2' ' HB1' ' B' ' 250' ' ' ALA . 12.1 ttm-85 -151.88 121.76 7.05 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.873 ' HB3' HG23 ' B' ' 235' ' ' THR . 1.0 OUTLIER -103.21 155.71 18.23 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.011 -1.056 . . . . 0.0 110.164 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 247' ' ' GLY . . . . . 0.553 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.89 161.96 21.07 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 248' ' ' THR . . . . . 0.454 ' N ' ' O ' ' B' ' 232' ' ' ASP . 3.7 m -70.02 -59.75 2.72 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.22 -1.165 . . . . 0.0 109.259 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -53.66 -23.53 11.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.313 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.74 ' HB1' ' HG2' ' B' ' 245' ' ' ARG . . . -87.69 -54.34 4.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.62 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.528 HD11 ' O ' ' B' ' 234' ' ' ALA . 7.1 mm -53.35 -40.93 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 109.543 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 252' ' ' ARG . . . . . 0.726 ' HB2' HG21 ' B' ' 227' ' ' VAL . 24.6 ttp85 -79.09 -51.54 9.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.064 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 253' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 21.6 tt0 -52.06 -27.32 13.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.03 -1.044 . . . . 0.0 108.578 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.1 OUTLIER -83.9 -70.11 0.59 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.319 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 255' ' ' PHE . . . . . 0.588 ' C ' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -52.94 -20.43 3.37 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.389 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 256' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' B' ' 252' ' ' ARG . . . -79.31 -39.67 32.27 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 257' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 62.4 t30 -62.86 -26.13 68.62 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 30.3 t -74.71 -41.55 59.99 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 259' ' ' LEU . . . . . 0.984 HD22 ' CD2' ' B' ' 223' ' ' LEU . 9.9 tp -61.4 -23.4 65.77 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.499 -0.751 . . . . 0.0 109.378 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 260' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' B' ' 262' ' ' PRO . 0.0 OUTLIER -50.62 -29.51 11.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.889 . . . . 0.0 109.345 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 261' ' ' LEU . . . . . 1.051 HD22 HD21 ' B' ' 263' ' ' LEU . 0.8 OUTLIER -92.64 107.36 23.54 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 108.534 179.385 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 262' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 47.9 Cg_endo -73.52 115.21 4.26 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.899 1.473 . . . . 0.0 111.702 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 1.051 HD21 HD22 ' B' ' 261' ' ' LEU . 0.1 OUTLIER -138.96 -166.49 2.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.477 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 264' ' ' ALA . . . . . 0.746 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -114.28 127.25 55.78 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.86 118.75 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -0.999 . . . . 0.0 109.919 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.2 OUTLIER -150.14 108.5 3.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.334 -0.854 . . . . 0.0 109.2 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.9 OUTLIER -47.38 174.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.504 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.43 -39.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.663 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 269' ' ' GLN . . . . . 0.497 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 7.5 pt20 -94.63 -148.82 0.28 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.638 -0.664 . . . . 0.0 109.294 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 270' ' ' GLU . . . . . 0.497 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 32.5 tt0 -113.42 131.52 55.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 109.72 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 271' ' ' VAL . . . . . 0.817 ' CG2' HG11 ' B' ' 211' ' ' VAL . 57.0 t -65.1 153.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.347 -0.845 . . . . 0.0 109.247 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 2.5 mtt180 -116.12 131.59 56.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.212 -0.93 . . . . 0.0 109.964 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 273' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.19 133.97 16.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.391 -0.818 . . . . 0.0 109.179 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 274' ' ' VAL . . . . . 1.004 HG11 HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -127.3 -163.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.104 -0.997 . . . . 0.0 109.811 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 275' ' ' ALA . . . . . 0.542 ' O ' ' CB ' ' B' ' 276' ' ' ASN . . . -86.38 68.17 10.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.433 -0.792 . . . . 0.0 110.386 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 276' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' B' ' 275' ' ' ALA . 2.9 m-20 160.69 -61.36 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.421 -0.799 . . . . 0.0 109.47 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 277' ' ' GLU . . . . . 0.495 ' HG2' ' HG2' ' B' ' 302' ' ' ARG . 0.0 OUTLIER -122.39 -161.11 0.92 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.455 -0.778 . . . . 0.0 109.214 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 278' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . -169.78 139.41 1.96 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.478 -0.764 . . . . 0.0 109.12 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 279' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -126.73 139.49 53.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.96 -1.087 . . . . 0.0 109.456 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 280' ' ' PHE . . . . . 0.68 ' HB3' HG13 ' B' ' 271' ' ' VAL . 23.8 p90 -150.57 172.47 15.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.054 -1.029 . . . . 0.0 109.631 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.899 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -147.18 175.59 10.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 110.183 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 282' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 6.7 p90 -167.76 -167.89 0.92 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 283' ' ' THR . . . . . 0.673 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -132.73 141.78 48.71 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.987 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 284' ' ' VAL . . . . . 0.718 ' CG1' HD22 ' B' ' 263' ' ' LEU . 0.5 OUTLIER -114.7 120.93 65.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 285' ' ' SER . . . . . 0.746 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 37.8 p -123.86 80.7 1.83 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.11 -0.994 . . . . 0.0 109.97 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.661 ' HB3' HD23 ' B' ' 263' ' ' LEU . 44.1 p90 -89.89 -172.5 3.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.202 -0.936 . . . . 0.0 108.643 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.72 150.42 49.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.873 -1.142 . . . . 0.0 110.099 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 288' ' ' PHE . . . . . 0.568 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.4 OUTLIER -117.21 88.49 2.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 0.0 108.99 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 289' ' ' GLN . . . . . 0.52 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 1.3 pt20 42.13 -93.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.269 -0.894 . . . . 0.0 110.021 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 290' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' B' ' 288' ' ' PHE . . . -101.55 -13.43 32.66 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 291' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' B' ' 288' ' ' PHE . 7.8 mtt-85 -101.98 159.85 15.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.239 . . . . 0.0 109.774 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 292' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -122.01 129.74 52.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 293' ' ' THR . . . . . 0.571 ' HB ' ' CZ ' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -123.18 144.47 49.34 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.258 -0.901 . . . . 0.0 109.921 -179.437 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 294' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' B' ' 322' ' ' HIS . 12.3 p -126.19 168.25 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.875 . . . . 0.0 108.773 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 0.929 HG22 ' CG2' ' B' ' 321' ' ' ILE . 30.9 t -137.7 160.17 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.944 -1.098 . . . . 0.0 110.62 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 296' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' B' ' 320' ' ' ASN . . . -144.49 64.62 12.16 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 297' ' ' PRO . . . . . 0.583 ' HD3' HG12 ' B' ' 295' ' ' VAL . 46.3 Cg_endo -97.57 179.78 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.707 1.605 . . . . 0.0 111.749 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.899 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.6 mp -141.05 154.46 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 299' ' ' ASP . . . . . 0.627 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 18.4 t0 -123.01 164.25 18.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.784 -1.198 . . . . 0.0 110.541 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 300' ' ' HIS . . . . . 0.516 ' O ' ' CG ' ' B' ' 312' ' ' MET . 0.1 OUTLIER -116.66 166.32 12.25 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 301' ' ' PHE . . . . . 0.683 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.1 OUTLIER -145.18 145.85 31.51 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.883 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.495 ' HG2' ' HG2' ' B' ' 277' ' ' GLU . 0.8 OUTLIER -138.53 110.4 7.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.37 -0.831 . . . . 0.0 109.25 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 303' ' ' PHE . . . . . 0.681 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 5.1 m-85 -89.9 -168.44 2.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.564 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 304' ' ' ASN . . . . . 0.83 ' HB3' HG21 ' B' ' 310' ' ' VAL . 13.3 p-10 -137.55 -40.72 0.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 305' ' ' GLY . . . . . 0.701 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -148.1 -65.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 306' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 164.9 56.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -1.146 . . . . 0.0 109.546 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -148.04 -41.04 0.04 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -154.86 -169.31 3.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -1.209 . . . . 0.0 109.542 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 309' ' ' VAL . . . . . 0.573 HG11 ' HE1' ' B' ' 301' ' ' PHE . 50.0 t -99.24 151.41 4.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 109.286 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 310' ' ' VAL . . . . . 0.83 HG21 ' HB3' ' B' ' 304' ' ' ASN . 45.3 t -121.74 -63.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 311' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' B' ' 302' ' ' ARG . 13.8 m -116.48 165.62 13.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.154 -0.966 . . . . 0.0 109.518 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 312' ' ' MET . . . . . 0.516 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 28.8 ttp -155.18 156.48 35.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.754 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 313' ' ' ARG . . . . . 0.515 ' NE ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -123.98 179.85 4.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.351 -0.843 . . . . 0.0 108.998 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 314' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' B' ' 238' ' ' ASP . . . -138.42 125.14 20.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.977 -1.077 . . . . 0.0 110.529 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 315' ' ' LEU . . . . . 1.006 HD11 ' HB2' ' A' ' 79' ' ' ALA . 5.6 tp -104.44 -175.32 2.76 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 316' ' ' PHE . . . . . 0.76 ' HE1' HG22 ' B' ' 240' ' ' VAL . 0.0 OUTLIER 99.56 -160.73 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.626 0.726 . . . . 0.0 109.889 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 317' ' ' GLY . . . . . 0.662 ' N ' ' CG ' ' B' ' 316' ' ' PHE . . . 160.42 -162.33 33.25 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 318' ' ' GLU . . . . . 0.494 ' HA ' HD12 ' B' ' 321' ' ' ILE . 5.1 tt0 -78.16 6.45 8.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -1.143 . . . . 0.0 109.622 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -115.17 -17.85 11.29 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.192 -0.943 . . . . 0.0 110.078 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 320' ' ' ASN . . . . . 0.535 ' O ' ' HB3' ' B' ' 296' ' ' ALA . 0.2 OUTLIER -88.8 -14.9 35.92 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.215 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 321' ' ' ILE . . . . . 0.929 ' CG2' HG22 ' B' ' 295' ' ' VAL . 0.9 OUTLIER -87.84 -164.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 322' ' ' HIS . . . . . 0.729 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.0 OUTLIER -150.99 154.84 37.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.969 -1.082 . . . . 0.0 109.756 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.474 ' HA ' HG22 ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.468 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 3' ' ' THR . 11.1 t . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.84 -9.69 25.18 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.889 1.468 . . . . 0.0 110.065 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -66.35 -49.45 66.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.229 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -52.7 61.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.192 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 mtm -59.62 -25.58 64.76 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.329 -0.857 . . . . 0.0 109.346 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -72.98 -30.69 64.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 0.0 109.128 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.25 -51.97 66.17 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.863 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -47.91 -29.13 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.163 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.943 HG11 HG21 ' A' ' 71' ' ' VAL . 24.9 t -87.95 -45.18 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.5 -0.75 . . . . 0.0 109.363 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 13' ' ' ARG . 3.6 tt0 -58.43 -73.37 0.08 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.0 OUTLIER -43.02 -44.78 4.89 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.079 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.643 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -50.5 -44.26 55.94 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.489 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.924 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -86.37 -41.46 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 108.99 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -49.41 -35.19 18.41 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.677 ' HB1' ' OD1' ' A' ' 22' ' ' ASP . . . -74.25 -32.82 63.1 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.924 HD12 ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -65.1 -57.13 9.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.48 -39.73 24.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.01 -11.57 43.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.583 -0.698 . . . . 0.0 109.464 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 1.008 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 62.68 25.92 67.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.677 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 16.0 p30 -89.41 85.48 6.56 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.131 -1.217 . . . . 0.0 109.649 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.036 ' CD2' HD22 ' A' ' 59' ' ' LEU . 3.6 mm? -49.76 -21.8 1.21 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.259 -0.901 . . . . 0.0 109.783 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.53 -51.8 68.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -40.8 95.02 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.56 HD12 HD13 ' A' ' 23' ' ' LEU . 7.7 mt -59.86 -54.67 31.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 23' ' ' LEU . 48.5 t -64.33 -41.18 91.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.17 -49.82 70.9 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.863 HD21 ' HA ' ' A' ' 10' ' ' VAL . 2.0 tp -67.14 -14.22 62.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.733 ' CZ ' ' HE3' ' A' ' 112' ' ' MET . 3.0 m-85 -89.48 136.01 33.27 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' CB ' HG22 ' A' ' 110' ' ' VAL . . . -54.42 -167.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 109.552 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -76.89 -23.51 52.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.251 -0.906 . . . . 0.0 109.7 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.549 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -143.66 45.51 1.49 Allowed 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -59.04 157.63 9.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.966 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.556 ' HG1' ' HG ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -117.81 139.27 51.32 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.485 -0.759 . . . . 0.0 109.284 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.754 ' CG2' HD12 ' A' ' 51' ' ' ILE . 42.7 t -129.24 141.1 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.418 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.526 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 11.5 mt-10 -111.24 112.79 24.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.493 ' HA ' ' C ' ' A' ' 39' ' ' PRO . 19.7 t70 -179.27 141.38 0.36 Allowed Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.568 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.51 ' O ' HG22 ' A' ' 40' ' ' VAL . 46.2 Cg_endo -72.56 131.69 23.34 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.286 -1.964 . . . . 0.0 110.6 -0.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 39' ' ' PRO . 14.0 m 40.73 -147.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.464 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.473 ' N ' HG23 ' A' ' 40' ' ' VAL . . . -67.28 1.21 6.95 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.04 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.472 ' OG ' ' HG2' ' A' ' 39' ' ' PRO . 68.8 m -48.06 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.902 -1.352 . . . . 0.0 110.163 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 4.2 pt-20 -133.29 107.64 12.28 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.003 . . . . 0.0 110.608 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 42.5 Cg_endo -68.47 -167.74 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 124.016 1.535 . . . . 0.0 110.428 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.662 ' HD3' ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -151.43 112.31 4.26 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.532 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.2 OUTLIER -103.57 140.2 37.85 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 110.257 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 107.8 160.81 20.93 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.487 HG23 ' CG1' ' A' ' 27' ' ' VAL . 3.0 m -76.07 -42.38 47.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.269 -1.136 . . . . 0.0 109.086 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.63 -38.11 83.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.29 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.662 ' HB1' ' HD3' ' A' ' 45' ' ' ARG . . . -73.48 -43.59 59.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.314 -0.866 . . . . 0.0 109.368 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.754 HD12 ' CG2' ' A' ' 36' ' ' VAL . 5.4 mm -58.49 -46.45 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.31 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.53 ' CG ' HG21 ' A' ' 27' ' ' VAL . 36.7 ttt-85 -66.31 -55.46 15.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 108.945 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 52' ' ' ARG . 2.3 mt-10 -45.09 -28.56 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 108.568 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.607 ' CG ' ' HG3' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -85.09 -70.08 0.61 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.422 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.692 ' C ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -51.73 -20.95 2.37 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . . . -82.21 -46.0 14.32 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 24.5 t-20 -60.96 -50.04 75.01 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.4 t -51.79 -26.27 9.34 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.036 HD22 ' CD2' ' A' ' 23' ' ' LEU . 5.4 tp -76.95 -28.24 55.13 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.591 -0.693 . . . . 0.0 109.739 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -44.35 -31.44 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 108.633 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.057 ' CD2' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.19 100.27 11.35 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 45.9 Cg_endo -71.71 129.54 15.7 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.991 1.521 . . . . 0.0 111.899 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.057 HD21 ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -139.98 178.04 7.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.999 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -92.23 127.8 37.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.264 -0.898 . . . . 0.0 108.58 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.52 112.18 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 110.056 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -150.86 105.3 3.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.812 . . . . 0.0 109.193 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 67' ' ' LEU . 2.3 mp -55.5 173.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.96 . . . . 0.0 109.861 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -134.72 -81.13 0.44 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.339 -0.851 . . . . 0.0 109.327 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.557 ' H ' HG23 ' A' ' 68' ' ' THR . 5.5 pt20 -60.22 -143.28 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.647 -0.658 . . . . 0.0 109.435 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -114.29 134.8 54.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.963 -1.086 . . . . 0.0 110.001 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.022 HG13 ' HB3' ' A' ' 80' ' ' PHE . 10.6 t -63.09 148.71 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.423 -0.798 . . . . 0.0 109.036 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 3.4 mmm180 -98.97 130.57 45.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.931 . . . . 0.0 109.287 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.533 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -145.92 135.96 23.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 109.342 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.9 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -163.9 155.48 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.67 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.807 ' HB2' ' O ' ' B' ' 240' ' ' VAL . . . 49.76 -152.03 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.473 -0.767 . . . . 0.0 109.855 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 103' ' ' PHE . 98.3 m-20 -87.36 16.98 4.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.454 -0.779 . . . . 0.0 109.331 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.498 ' HG3' ' HA ' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -123.6 -159.26 0.84 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.342 -0.849 . . . . 0.0 109.076 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.96 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 178.04 160.3 0.53 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.439 -0.788 . . . . 0.0 109.542 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.835 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.27 133.54 16.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.015 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 1.022 ' HB3' HG13 ' A' ' 71' ' ' VAL . 33.5 p90 -148.96 163.67 36.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.836 -1.165 . . . . 0.0 110.241 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.964 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -140.78 150.13 42.97 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -149.56 -172.51 4.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.175 -0.953 . . . . 0.0 109.401 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.29 141.74 51.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.406 -0.808 . . . . 0.0 109.611 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.939 HG11 HD22 ' A' ' 63' ' ' LEU . 19.9 t -112.01 111.71 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.394 -0.816 . . . . 0.0 109.156 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.999 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -106.12 113.1 26.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.824 . . . . 0.0 109.57 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' A' ' 86' ' ' PHE . 0.8 OUTLIER -128.02 148.13 50.53 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.195 -0.941 . . . . 0.0 109.536 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -91.7 178.64 5.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.541 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.576 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.5 OUTLIER -142.19 -163.49 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.34 -0.85 . . . . 0.0 109.382 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.69 60.95 2.87 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.026 -1.047 . . . . 0.0 109.491 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.84 3.41 26.69 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -136.81 164.36 28.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.137 -1.213 . . . . 0.0 109.667 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' CD ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -126.52 122.27 34.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.844 . . . . 0.0 109.233 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.576 ' OG1' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -117.23 154.6 30.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.722 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.622 HG12 ' HB3' ' A' ' 122' ' ' HIS . 7.3 p -138.46 170.75 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 108.861 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 1.029 HG12 ' HD3' ' A' ' 97' ' ' PRO . 3.5 t -144.91 147.05 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.034 -1.041 . . . . 0.0 109.268 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.437 ' O ' ' CG ' ' A' ' 120' ' ' ASN . . . -132.55 69.65 79.67 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.121 -0.987 . . . . 0.0 111.026 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 1.029 ' HD3' HG12 ' A' ' 95' ' ' VAL . 49.3 Cg_endo -96.35 -173.08 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.503 1.469 . . . . 0.0 110.424 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.964 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.9 mp -134.46 157.36 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 15.8 t0 -127.05 153.25 46.2 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.156 -0.965 . . . . 0.0 110.11 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.518 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -108.88 171.27 7.53 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.96 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -142.37 148.38 37.79 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.101 -0.999 . . . . 0.0 110.486 -178.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.539 ' CD ' ' HB2' ' A' ' 111' ' ' SER . 0.0 OUTLIER -133.85 107.43 7.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.561 -0.712 . . . . 0.0 109.085 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.639 ' CZ ' ' CG2' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -89.72 -176.37 4.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 109.56 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.932 ' OD1' HG23 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -138.9 -100.08 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.433 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.67 -38.93 0.04 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -171.48 32.8 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.45 -1.029 . . . . 0.0 108.74 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 108' ' ' LYS . . . -123.72 15.56 7.96 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 22.2 mmmt 81.79 -150.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.653 -0.91 . . . . 0.0 109.624 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.66 HG23 HG22 ' A' ' 10' ' ' VAL . 18.2 t -88.2 122.66 40.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.932 HG23 ' OD1' ' A' ' 104' ' ' ASN . 49.1 t -105.24 -8.58 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.079 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.556 ' HG ' ' HG1' ' A' ' 35' ' ' THR . 0.6 OUTLIER -160.37 153.22 21.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.957 -1.089 . . . . 0.0 110.137 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.733 ' HE3' ' CZ ' ' A' ' 30' ' ' PHE . 19.0 ttm -160.05 141.82 12.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.494 -0.754 . . . . 0.0 109.211 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 1.0 OUTLIER -123.56 174.21 7.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.116 -0.99 . . . . 0.0 109.269 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 99' ' ' ASP . . . -147.47 134.91 20.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.945 . . . . 0.0 109.263 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.879 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.1 OUTLIER -125.01 141.17 52.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 110.063 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.784 ' O ' HG21 ' B' ' 274' ' ' VAL . 50.0 p90 172.86 -160.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.564 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 172.31 -171.03 44.0 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.542 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 3.1 tt0 -69.87 -5.01 22.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.444 -1.033 . . . . 0.0 109.7 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.453 ' HE3' ' OE2' ' B' ' 270' ' ' GLU . 0.3 OUTLIER -90.47 -31.74 16.66 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.958 0.885 . . . . 0.0 109.142 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.437 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.8 m-20 -89.36 8.6 29.83 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.19 0.519 . . . . 0.0 109.665 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.724 HG22 ' H ' ' A' ' 122' ' ' HIS . 4.9 mm -90.28 -172.53 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 108.897 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.724 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -151.7 156.76 41.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.914 . . . . 0.0 109.506 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.426 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -154.7 135.24 13.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.506 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.59 138.66 9.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.202 -1.175 . . . . 0.0 109.535 -179.861 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.242 0.544 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -116.06 92.6 3.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.441 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.92 119.42 69.38 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.827 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.32 -4.69 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.858 1.452 . . . . 0.0 109.586 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.04 -40.84 68.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.373 -0.83 . . . . 0.0 109.237 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -65.83 -55.7 15.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.128 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 15.4 mtm -55.98 -24.62 39.68 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.289 -0.882 . . . . 0.0 109.13 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 5.4 m -73.91 -34.06 64.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.346 -0.846 . . . . 0.0 109.136 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.1 -46.44 65.25 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.183 -0.948 . . . . 0.0 108.482 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.753 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.0 OUTLIER -54.97 -24.84 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.816 HG11 HG21 ' B' ' 271' ' ' VAL . 16.8 t -90.21 -43.94 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.421 -0.799 . . . . 0.0 109.045 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 212' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' B' ' 213' ' ' ARG . 7.6 tt0 -60.45 -73.61 0.09 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.963 ' HD3' HD13 ' B' ' 229' ' ' LEU . 0.0 OUTLIER -43.22 -45.23 5.62 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.236 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 214' ' ' TYR . . . . . 0.641 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -50.09 -44.84 52.19 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.92 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -86.94 -39.32 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.317 -0.865 . . . . 0.0 109.172 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 216' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.35 -36.51 14.62 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -73.97 -33.87 64.02 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.92 HD12 ' HA ' ' B' ' 215' ' ' VAL . 2.7 mt -64.05 -59.07 4.91 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -51.19 -45.5 61.84 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.509 0.671 . . . . 0.0 109.194 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.54 8.6 30.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.579 -0.701 . . . . 0.0 109.681 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.823 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 49.48 33.72 17.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 222' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.5 t70 -90.58 67.73 6.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -1.131 . . . . 0.0 109.685 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 223' ' ' LEU . . . . . 1.066 HD12 HD12 ' B' ' 226' ' ' ILE . 7.3 tp -50.38 -45.2 55.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.076 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' B' ' 223' ' ' LEU . 5.3 m-20 -43.44 -32.64 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -83.86 -33.51 21.14 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 1.066 HD12 HD12 ' B' ' 223' ' ' LEU . 17.2 mt -61.9 -56.02 20.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.651 HG11 HG23 ' B' ' 248' ' ' THR . 97.0 t -59.71 -37.33 70.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.93 -51.82 68.06 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.963 HD13 ' HD3' ' B' ' 213' ' ' ARG . 2.9 tp -68.06 -14.89 63.32 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.536 -0.727 . . . . 0.0 109.057 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 230' ' ' PHE . . . . . 0.771 ' CD2' HG21 ' B' ' 251' ' ' ILE . 2.4 m-85 -94.78 149.18 21.51 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.457 -0.777 . . . . 0.0 109.527 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -59.24 168.23 1.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.429 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.449 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -55.72 -24.4 34.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.372 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.532 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 8.8 p-10 -150.56 51.36 0.88 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.717 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -60.58 158.94 11.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.608 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 235' ' ' THR . . . . . 0.53 ' CG2' ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -100.27 141.34 33.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.447 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.545 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 85.4 t -134.41 136.39 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.258 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 237' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 1.5 mt-10 -112.39 113.28 25.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 108.559 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 238' ' ' ASP . . . . . 0.524 ' O ' ' CE2' ' B' ' 254' ' ' PHE . 9.6 t70 -179.55 141.74 0.36 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 109.664 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 239' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' B' ' 241' ' ' GLY . 49.1 Cg_endo -75.14 -176.65 18.56 Favored 'Cis proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.25 -1.979 . . . . 0.0 110.485 -0.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.807 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 6.2 m -65.18 75.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.284 -0.885 . . . . 0.0 108.982 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 241' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' B' ' 239' ' ' PRO . . . -162.78 24.37 0.2 Allowed Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 242' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' B' ' 241' ' ' GLY . 0.5 OUTLIER 67.24 48.92 1.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -1.14 . . . . 0.0 109.741 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 243' ' ' GLU . . . . . 0.517 ' N ' ' HD3' ' B' ' 244' ' ' PRO . 2.1 mt-10 -131.89 58.57 38.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.144 -0.972 . . . . 0.0 109.466 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 244' ' ' PRO . . . . . 0.545 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 48.5 Cg_endo -77.83 169.69 20.24 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 124.276 1.671 . . . . 0.0 110.942 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.466 ' HD2' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -151.32 100.79 2.78 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.72 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.2 OUTLIER -92.02 161.77 14.65 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.121 -0.987 . . . . 0.0 110.152 -178.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 247' ' ' GLY . . . . . 0.631 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 100.66 158.26 27.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 248' ' ' THR . . . . . 0.651 HG23 HG11 ' B' ' 227' ' ' VAL . 5.3 m -69.98 -48.7 57.17 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.195 -1.179 . . . . 0.0 108.971 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -61.81 -25.27 67.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.904 . . . . 0.0 109.274 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -90.13 -58.78 2.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.394 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.771 HG21 ' CD2' ' B' ' 230' ' ' PHE . 17.4 mt -47.45 -41.22 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.284 -0.885 . . . . 0.0 109.012 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 252' ' ' ARG . . . . . 0.762 ' CG ' HD23 ' B' ' 223' ' ' LEU . 28.6 ttt180 -76.75 -57.99 3.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.456 -0.778 . . . . 0.0 108.978 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 253' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 62.5 mt-10 -45.27 -28.32 0.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.025 -1.047 . . . . 0.0 108.589 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' B' ' 238' ' ' ASP . 0.8 OUTLIER -85.39 -71.02 0.55 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 255' ' ' PHE . . . . . 1.048 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -49.12 -23.59 1.31 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 256' ' ' ALA . . . . . 0.711 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -76.38 -49.67 16.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 257' ' ' ASN . . . . . 0.472 ' HA ' ' HE2' ' B' ' 260' ' ' LYS . 30.1 t-20 -55.33 -29.43 58.29 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 42.9 t -75.44 -31.8 60.46 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 259' ' ' LEU . . . . . 0.823 HD21 ' CA ' ' B' ' 221' ' ' GLY . 7.3 tp -71.77 -25.78 62.17 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.44 -0.787 . . . . 0.0 109.302 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 260' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' B' ' 257' ' ' ASN . 12.0 mtmt -54.12 -23.83 15.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.296 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 261' ' ' LEU . . . . . 0.955 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.8 OUTLIER -89.92 120.34 69.35 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 0.0 108.698 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 262' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' B' ' 286' ' ' PHE . 42.9 Cg_endo -69.94 104.05 1.29 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.752 1.396 . . . . 0.0 110.584 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.955 ' CD2' HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -138.91 149.79 45.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.742 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 264' ' ' ALA . . . . . 0.906 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -91.62 129.55 37.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -0.824 . . . . 0.0 108.925 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 265' ' ' VAL . . . . . 0.699 HG21 ' HB3' ' B' ' 218' ' ' LEU . 3.0 t -110.18 116.09 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.87 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.1 OUTLIER -150.33 91.47 1.76 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 0.0 109.24 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -45.21 170.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.724 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.1 -39.56 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.299 -0.876 . . . . 0.0 109.675 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 269' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -87.75 -154.2 0.25 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 270' ' ' GLU . . . . . 0.453 ' OE2' ' HE3' ' A' ' 119' ' ' LYS . 51.7 tt0 -107.39 131.24 54.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.138 -0.976 . . . . 0.0 109.53 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 271' ' ' VAL . . . . . 0.93 HG13 ' HB3' ' B' ' 280' ' ' PHE . 26.7 t -67.35 150.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.292 -0.88 . . . . 0.0 108.762 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 5.5 mtt180 -104.01 136.94 42.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 109.963 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 273' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.18 126.14 10.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.412 -0.805 . . . . 0.0 109.275 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 274' ' ' VAL . . . . . 0.784 HG21 ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -155.33 160.74 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.215 -0.928 . . . . 0.0 109.4 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 275' ' ' ALA . . . . . 0.51 ' HB2' HG23 ' A' ' 40' ' ' VAL . . . 43.87 -145.56 0.1 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 276' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' B' ' 303' ' ' PHE . 1.5 t-20 -90.59 13.26 16.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 0.0 109.708 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 277' ' ' GLU . . . . . 0.492 ' HG3' ' HA ' ' B' ' 302' ' ' ARG . 0.9 OUTLIER -122.16 -161.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.078 -1.014 . . . . 0.0 109.733 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 278' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 177.74 148.79 0.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 279' ' ' ALA . . . . . 0.879 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -134.69 139.69 45.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.007 -1.058 . . . . 0.0 108.868 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 280' ' ' PHE . . . . . 0.93 ' HB3' HG13 ' B' ' 271' ' ' VAL . 33.3 p90 -150.47 165.18 33.99 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.694 -1.254 . . . . 0.0 110.651 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.992 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -143.45 176.86 8.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 282' ' ' PHE . . . . . 0.408 ' HE1' ' CE2' ' B' ' 280' ' ' PHE . 14.4 p90 -178.14 -170.21 0.23 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.284 -0.885 . . . . 0.0 109.6 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.58 142.33 50.74 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.518 -0.739 . . . . 0.0 109.551 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 284' ' ' VAL . . . . . 0.755 HG12 ' HD1' ' B' ' 286' ' ' PHE . 45.2 t -113.89 113.6 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.453 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 285' ' ' SER . . . . . 0.906 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 91.9 p -105.75 110.6 22.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.168 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.755 ' HD1' HG12 ' B' ' 284' ' ' VAL . 4.3 p90 -127.43 157.86 38.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.164 -0.96 . . . . 0.0 109.787 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 287' ' ' GLU . . . . . 0.49 ' HG3' ' HB2' ' B' ' 292' ' ' LYS . 11.6 tm-20 -144.71 167.61 22.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.307 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 288' ' ' PHE . . . . . 0.419 ' N ' ' CD ' ' B' ' 287' ' ' GLU . 0.1 OUTLIER -122.02 -75.98 0.59 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.052 -1.03 . . . . 0.0 109.894 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 289' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' B' ' 289' ' ' GLN . 1.0 OUTLIER -158.99 60.1 0.42 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.503 -0.748 . . . . 0.0 109.778 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 129.88 -45.76 1.12 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -103.26 129.67 50.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.374 -1.074 . . . . 0.0 109.189 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 292' ' ' LYS . . . . . 0.49 ' HB2' ' HG3' ' B' ' 287' ' ' GLU . 0.2 OUTLIER -118.54 145.7 45.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 109.701 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 293' ' ' THR . . . . . 0.585 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -136.16 145.39 45.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.666 -0.646 . . . . 0.0 109.649 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 294' ' ' VAL . . . . . 0.665 HG23 ' HA ' ' B' ' 285' ' ' SER . 0.5 OUTLIER -117.32 176.35 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 108.581 179.563 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 1.041 HG12 ' HD3' ' B' ' 297' ' ' PRO . 2.5 t -149.58 145.25 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.227 -0.921 . . . . 0.0 109.069 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 296' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -131.02 71.3 82.45 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.079 -1.013 . . . . 0.0 110.923 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 297' ' ' PRO . . . . . 1.041 ' HD3' HG12 ' B' ' 295' ' ' VAL . 52.3 Cg_endo -96.88 -173.08 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.717 1.611 . . . . 0.0 110.677 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.992 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.5 mp -139.49 151.97 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 299' ' ' ASP . . . . . 0.619 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 17.5 t0 -124.13 160.2 28.33 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.999 -1.063 . . . . 0.0 110.311 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 300' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' B' ' 312' ' ' MET . 51.4 t-80 -110.88 173.79 6.17 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 301' ' ' PHE . . . . . 0.901 ' CE1' HG21 ' B' ' 309' ' ' VAL . 0.1 OUTLIER -149.55 138.96 21.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 110.491 -178.402 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.522 ' CB ' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -123.46 110.36 15.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.423 -0.798 . . . . 0.0 109.097 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 303' ' ' PHE . . . . . 0.618 ' CZ ' ' CG2' ' B' ' 210' ' ' VAL . 0.4 OUTLIER -89.78 -176.21 4.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 0.0 109.687 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 304' ' ' ASN . . . . . 0.946 ' OD1' HG23 ' B' ' 310' ' ' VAL . 0.1 OUTLIER -142.05 -100.06 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.583 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 305' ' ' GLY . . . . . 0.698 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -98.8 -55.58 1.06 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 306' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 163.13 76.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -1.099 . . . . 0.0 109.39 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -167.53 -51.73 0.03 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 308' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' B' ' 308' ' ' LYS . 0.0 OUTLIER -150.11 -167.43 2.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -1.213 . . . . 0.0 109.659 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 309' ' ' VAL . . . . . 0.901 HG21 ' CE1' ' B' ' 301' ' ' PHE . 62.0 t -102.66 148.28 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.332 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 310' ' ' VAL . . . . . 0.946 HG23 ' OD1' ' B' ' 304' ' ' ASN . 24.1 t -110.97 -31.91 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.089 -1.007 . . . . 0.0 110.192 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 311' ' ' SER . . . . . 0.522 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 1.3 m -144.94 165.02 29.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.789 -1.194 . . . . 0.0 110.009 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 312' ' ' MET . . . . . 0.523 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 11.0 ttp -156.2 161.5 40.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.695 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 313' ' ' ARG . . . . . 0.576 HH22 HG12 ' B' ' 240' ' ' VAL . 9.0 tpt180 -150.39 117.18 5.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.226 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 314' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' B' ' 299' ' ' ASP . . . -94.59 144.93 25.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.152 -0.968 . . . . 0.0 110.033 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 315' ' ' LEU . . . . . 0.835 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -132.31 139.72 48.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 109.564 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 316' ' ' PHE . . . . . 0.9 ' O ' HG11 ' A' ' 74' ' ' VAL . 47.9 p90 170.68 -158.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 317' ' ' GLY . . . . . 0.603 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 178.83 -175.7 47.51 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 318' ' ' GLU . . . . . 0.546 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 25.7 tt0 -73.36 -1.91 20.07 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.295 -1.121 . . . . 0.0 109.442 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -92.71 -29.62 15.97 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.24 -0.912 . . . . 0.0 108.983 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 320' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -88.89 16.01 7.57 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 321' ' ' ILE . . . . . 0.68 HG22 ' H ' ' B' ' 322' ' ' HIS . 5.1 mm -89.72 -165.07 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 322' ' ' HIS . . . . . 0.68 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.2 OUTLIER -151.9 161.27 42.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.94 -1.1 . . . . 0.0 109.67 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 109.361 179.845 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 3' ' ' THR . 1.8 t . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 44.5 Cg_endo -71.2 -3.82 13.68 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.891 1.469 . . . . 0.0 110.379 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -72.8 -25.58 61.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.912 . . . . 0.0 109.224 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.47 -59.31 2.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -51.47 -21.39 2.37 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.118 -0.989 . . . . 0.0 109.722 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 11' ' ' VAL . 14.3 m -74.66 -39.81 61.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.222 -0.924 . . . . 0.0 109.099 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.89 -42.76 48.68 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.779 ' HA ' HD21 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -53.82 -23.95 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.132 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.801 HG11 ' CG2' ' A' ' 71' ' ' VAL . 10.1 t -89.94 -43.06 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.349 -0.844 . . . . 0.0 109.066 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 13' ' ' ARG . 24.6 tt0 -61.82 -73.52 0.1 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.281 1.039 . . . . 0.0 108.284 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.745 ' HD3' HD13 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -42.45 -44.29 3.97 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 1.068 ' CE1' HD11 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -51.27 -48.45 62.2 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.917 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -82.24 -44.24 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.382 -0.824 . . . . 0.0 109.375 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -47.57 -37.99 13.45 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.51 ' HA ' ' HB3' ' A' ' 22' ' ' ASP . . . -72.84 -36.04 67.38 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.068 HD11 ' CE1' ' A' ' 14' ' ' TYR . 2.9 mt -61.0 -59.82 4.77 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -53.49 -42.67 67.54 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.48 0.657 . . . . 0.0 109.762 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.19 5.54 44.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.82 . . . . 0.0 110.006 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.898 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 54.76 46.11 76.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.51 ' HB3' ' HA ' ' A' ' 17' ' ' ALA . 15.6 t0 -104.74 58.35 0.7 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -1.068 . . . . 0.0 109.945 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.028 HD11 ' HB3' ' A' ' 55' ' ' PHE . 6.0 tp -52.86 -45.84 67.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.131 -0.981 . . . . 0.0 108.921 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -46.74 -42.99 17.68 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -75.17 -29.57 60.22 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.001 HD12 HD12 ' A' ' 23' ' ' LEU . 32.5 mt -63.66 -59.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 30' ' ' PHE . 92.9 t -49.45 -35.7 9.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -60.04 -40.83 90.73 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.779 HD21 ' HA ' ' A' ' 10' ' ' VAL . 1.9 tp -75.39 -20.15 59.12 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.471 ' HB2' ' HA ' ' A' ' 27' ' ' VAL . 4.9 m-85 -95.99 141.86 28.89 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.532 -0.73 . . . . 0.0 109.642 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -49.0 177.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.927 . . . . 0.0 109.457 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.63 -24.12 63.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.24 -0.912 . . . . 0.0 109.826 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.529 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 4.9 p-10 -144.83 52.33 1.23 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.972 ' O ' HD11 ' A' ' 51' ' ' ILE . . . -59.38 165.02 2.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.443 -0.786 . . . . 0.0 110.194 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.595 HG23 ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -115.75 140.94 48.73 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 37' ' ' GLU . 25.0 t -128.51 170.29 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 109.654 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.585 ' N ' HG12 ' A' ' 36' ' ' VAL . 5.0 mt-10 -141.27 113.3 7.89 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.583 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 6.0 t70 -168.37 139.95 2.26 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.759 -1.213 . . . . 0.0 109.957 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 43.8 Cg_endo -74.95 -78.27 0.0 OUTLIER 'Cis proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.441 -1.9 . . . . 0.0 111.608 0.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 39' ' ' PRO . 1.3 m -153.3 66.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.876 -1.14 . . . . 0.0 109.331 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . -173.05 46.99 0.16 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER 72.97 51.14 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -1.132 . . . . 0.0 110.077 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.543 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 2.3 mt-10 -132.92 58.66 37.2 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.056 -1.027 . . . . 0.0 109.742 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 43' ' ' GLU . 50.7 Cg_endo -79.99 -179.29 5.16 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.066 1.561 . . . . 0.0 111.284 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.59 ' HG3' ' CD1' ' A' ' 54' ' ' PHE . 23.2 mmt180 -150.88 96.16 2.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.595 ' HB3' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -92.81 158.35 15.93 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.19 -0.944 . . . . 0.0 110.285 -178.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 33' ' ' ASP . . . 88.95 -169.93 37.26 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -103.13 -51.85 3.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.076 -1.249 . . . . 0.0 108.842 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -52.05 -23.49 5.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.312 -0.867 . . . . 0.0 109.15 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 46' ' ' SER . . . -90.32 -55.28 3.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.388 -0.82 . . . . 0.0 109.607 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.972 HD11 ' O ' ' A' ' 34' ' ' ALA . 59.7 mt -54.08 -43.41 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 109.132 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.802 ' HG3' HD23 ' A' ' 23' ' ' LEU . 16.2 ttt180 -70.28 -47.91 59.12 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.193 -0.942 . . . . 0.0 108.784 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 5.4 mt-10 -51.12 -34.19 29.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.038 . . . . 0.0 108.44 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.59 ' CD1' ' HG3' ' A' ' 45' ' ' ARG . 1.4 t80 -82.93 -70.5 0.55 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 1.028 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -44.63 -26.76 0.41 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -75.03 -53.22 9.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 108.993 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 56' ' ' ALA . 14.1 t-20 -45.66 -34.6 3.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 108.609 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 t -71.87 -33.56 68.49 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.898 HD21 ' CA ' ' A' ' 21' ' ' GLY . 5.3 tp -77.21 -33.87 56.16 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.326 -0.859 . . . . 0.0 109.329 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -61.94 -26.97 68.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 109.443 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.574 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -89.43 131.87 38.97 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 0.0 108.681 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 86' ' ' PHE . 41.6 Cg_endo -68.04 80.64 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.755 1.398 . . . . 0.0 110.501 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.978 HD22 ' CG1' ' A' ' 84' ' ' VAL . 3.2 mt -111.22 146.55 36.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.435 -0.79 . . . . 0.0 109.605 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.635 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -91.91 126.75 37.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 108.647 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 18' ' ' LEU . 2.7 t -113.45 118.13 57.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.673 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 67' ' ' LEU . 27.1 tt0 -150.16 104.54 3.28 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.337 -0.852 . . . . 0.0 109.169 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.5 mp -45.59 171.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.222 -0.924 . . . . 0.0 109.847 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -144.38 -82.27 0.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.403 -0.811 . . . . 0.0 109.01 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 2.9 pt20 -60.08 -146.06 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 61.5 tt0 -114.84 130.37 56.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.066 -1.021 . . . . 0.0 109.761 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.91 HG13 ' HB3' ' A' ' 80' ' ' PHE . 88.7 t -60.0 145.03 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.292 -0.88 . . . . 0.0 109.14 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.539 ' HD3' ' CD2' ' B' ' 315' ' ' LEU . 17.7 mtt180 -111.72 130.04 55.92 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.396 -0.921 . . . . 0.0 109.931 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.52 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -139.74 157.7 45.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.868 HG11 HG21 ' B' ' 240' ' ' VAL . 0.5 OUTLIER -157.22 -153.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 110.312 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.557 ' CB ' ' HA3' ' B' ' 241' ' ' GLY . . . -33.91 -96.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 120.926 0.393 . . . . 0.0 111.161 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 103' ' ' PHE . 65.4 m-20 -114.37 26.96 9.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.948 -1.095 . . . . 0.0 110.496 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.572 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.4 OUTLIER -137.55 -160.98 1.11 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.026 -1.046 . . . . 0.0 109.388 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.9 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 171.28 143.48 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.476 -0.765 . . . . 0.0 109.861 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.854 ' CB ' HD11 ' B' ' 315' ' ' LEU . . . -132.62 130.46 40.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 108.786 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.91 ' HB3' HG13 ' A' ' 71' ' ' VAL . 2.1 p90 -150.6 156.06 40.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.759 -1.213 . . . . 0.0 109.989 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.093 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -133.32 156.49 47.51 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.611 0.719 . . . . 0.0 110.33 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 99' ' ' ASP . 3.7 p90 -149.46 -171.06 3.8 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.87 140.09 52.83 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.076 -1.015 . . . . 0.0 109.972 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.978 ' CG1' HD22 ' A' ' 63' ' ' LEU . 38.3 t -116.76 115.2 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.726 ' HB3' HG23 ' A' ' 94' ' ' VAL . 78.2 p -126.67 99.73 5.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.086 -1.009 . . . . 0.0 110.334 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.589 ' HB3' HD23 ' A' ' 63' ' ' LEU . 52.8 p90 -93.36 -164.22 1.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.204 -0.935 . . . . 0.0 108.629 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -144.19 152.06 40.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.022 -1.049 . . . . 0.0 110.086 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.409 ' CZ ' ' HE2' ' A' ' 86' ' ' PHE . 4.2 m-85 -107.21 -173.35 2.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.403 -0.811 . . . . 0.0 109.39 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -49.19 -54.6 15.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.358 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -138.04 4.61 3.23 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -105.86 -177.4 3.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 109.515 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -145.49 118.98 9.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.297 -0.877 . . . . 0.0 109.752 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -120.26 143.35 48.36 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.389 -0.82 . . . . 0.0 109.417 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 85' ' ' SER . 13.3 p -126.23 169.52 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.22 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.851 HG22 HG23 ' A' ' 121' ' ' ILE . 53.1 t -140.63 152.11 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.765 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.442 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . -129.56 71.63 82.06 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 109.222 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.629 ' HD3' HG12 ' A' ' 95' ' ' VAL . 48.7 Cg_endo -97.34 -178.6 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.726 1.617 . . . . 0.0 111.578 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.093 HG23 ' HB2' ' A' ' 81' ' ' ALA . 3.1 mp -138.6 169.4 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 23.4 t0 -135.76 154.79 51.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.907 -1.121 . . . . 0.0 110.041 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.522 ' CB ' ' HB3' ' A' ' 113' ' ' ARG . 1.0 OUTLIER -114.08 175.23 5.56 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.9 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -150.42 152.4 34.26 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.999 -1.063 . . . . 0.0 110.823 -178.658 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.497 ' HD2' ' HB2' ' A' ' 111' ' ' SER . 0.0 OUTLIER -142.25 108.31 5.2 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.662 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -89.24 -177.53 5.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 109.598 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.65 ' HB3' HG21 ' A' ' 110' ' ' VAL . 17.2 p-10 -149.75 -176.09 5.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.339 -0.851 . . . . 0.0 109.698 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.88 76.78 1.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -172.34 -75.15 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.22 -1.164 . . . . 0.0 109.58 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 157.66 -20.6 0.38 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.49 -164.31 1.03 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -1.174 . . . . 0.0 109.587 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.583 HG23 HG22 ' A' ' 10' ' ' VAL . 60.9 t -109.43 148.97 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.897 . . . . 0.0 109.176 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 104' ' ' ASN . 96.9 t -125.93 -61.75 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.055 -1.028 . . . . 0.0 109.678 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.497 ' HB2' ' HD2' ' A' ' 102' ' ' ARG . 1.5 m -112.29 161.6 16.44 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.876 -1.14 . . . . 0.0 109.738 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 100' ' ' HIS . 15.2 ttp -158.97 155.89 28.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 109.448 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.522 ' HB3' ' CB ' ' A' ' 100' ' ' HIS . 30.8 ttm180 -140.34 168.2 20.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.87 . . . . 0.0 108.946 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.505 ' N ' ' CG ' ' A' ' 113' ' ' ARG . . . -144.58 130.86 19.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.976 -1.077 . . . . 0.0 109.682 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.766 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.3 OUTLIER -111.84 132.48 54.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 109.723 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.998 ' O ' HG11 ' B' ' 274' ' ' VAL . 9.0 p90 167.7 -158.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.537 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 164.35 -163.93 36.4 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.508 ' HA ' HG13 ' A' ' 121' ' ' ILE . 4.3 tt0 -73.88 -2.35 23.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -1.185 . . . . 0.0 109.261 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -92.57 -29.44 16.16 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.954 0.883 . . . . 0.0 109.057 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 96' ' ' ALA . 1.5 m-20 -89.04 10.73 20.57 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.332 0.587 . . . . 0.0 109.476 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.851 HG23 HG22 ' A' ' 95' ' ' VAL . 4.3 mm -94.23 -167.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.331 -0.856 . . . . 0.0 108.738 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.681 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -151.21 153.8 35.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.098 -1.001 . . . . 0.0 109.609 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.01 89.13 1.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -91.81 139.67 14.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.262 -1.14 . . . . 0.0 109.449 -179.973 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.5 ptt? . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.182 0.515 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.441 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 1.4 t-20 175.48 171.24 0.32 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.668 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 203' ' ' THR . . . . . 0.431 HG22 ' HB2' ' B' ' 205' ' ' GLU . 2.5 m -59.34 110.03 2.39 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.331 -0.856 . . . . 0.0 109.53 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 204' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.8 Cg_endo -73.63 -7.15 19.82 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.994 1.523 . . . . 0.0 110.074 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 205' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' B' ' 203' ' ' THR . 2.0 mt-10 -68.57 -45.21 72.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.329 -0.857 . . . . 0.0 109.191 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.56 -52.42 63.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.214 -0.929 . . . . 0.0 109.107 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 207' ' ' MET . . . . . 0.609 ' HA ' ' CZ ' ' B' ' 303' ' ' PHE . 74.9 mtm -62.06 -42.35 99.1 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.334 -0.854 . . . . 0.0 109.498 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 9.6 m -56.1 -37.15 68.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.171 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.42 -46.23 66.28 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.818 ' HA ' HD21 ' B' ' 229' ' ' LEU . 2.5 t -53.24 -30.38 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.723 HG11 ' CG2' ' B' ' 271' ' ' VAL . 21.0 t -84.47 -43.52 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.225 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 212' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.4 tt0 -61.71 -73.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.088 0.947 . . . . 0.0 108.624 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 1.014 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.0 OUTLIER -41.4 -45.18 3.04 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 214' ' ' TYR . . . . . 0.696 ' CE1' HD11 ' B' ' 218' ' ' LEU . 1.6 t80 -45.41 -45.45 12.77 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.973 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.1 t -90.51 -40.35 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 216' ' ' ALA . . . . . 0.708 ' HB3' ' HA ' ' B' ' 213' ' ' ARG . . . -49.21 -37.58 23.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.623 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -73.05 -31.64 64.54 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.973 HD12 ' HA ' ' B' ' 215' ' ' VAL . 5.5 mt -66.91 -59.89 3.12 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -55.59 -37.56 68.25 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.564 0.697 . . . . 0.0 109.534 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -88.59 -6.1 57.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 109.624 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.926 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 55.41 47.52 75.4 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 222' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' B' ' 224' ' ' ASP . 16.5 t70 -114.32 77.04 1.03 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -1.092 . . . . 0.0 109.753 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 223' ' ' LEU . . . . . 1.055 HD13 HD12 ' B' ' 226' ' ' ILE . 1.4 mm? -46.75 -27.2 1.12 Allowed 'General case' 0 C--N 1.307 -1.239 0 O-C-N 121.138 -0.977 . . . . 0.0 109.561 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.436 ' HB3' ' OD2' ' B' ' 222' ' ' ASP . 16.4 t0 -60.01 -50.03 75.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.325 -0.86 . . . . 0.0 109.596 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -66.64 -29.28 74.5 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 1.055 HD12 HD13 ' B' ' 223' ' ' LEU . 11.4 mt -66.19 -60.65 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.443 -1.034 . . . . 0.0 108.35 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' B' ' 252' ' ' ARG . 38.9 t -58.14 -42.31 82.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -53.25 -51.35 62.48 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 1.014 HD22 ' HB3' ' B' ' 213' ' ' ARG . 8.7 tp -64.23 -19.55 65.44 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 230' ' ' PHE . . . . . 0.686 ' CD2' HG21 ' B' ' 251' ' ' ILE . 5.9 m-85 -93.04 145.94 24.01 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.429 -0.794 . . . . 0.0 109.93 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -57.63 -163.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 109.406 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' B' ' 248' ' ' THR . 0.3 OUTLIER -77.76 -24.26 49.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.558 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 3.2 p30 -150.4 45.06 0.88 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.578 -0.701 . . . . 0.0 109.481 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.851 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -54.71 175.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 109.518 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 235' ' ' THR . . . . . 0.864 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -129.07 137.93 51.56 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.26 -0.9 . . . . 0.0 110.233 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.513 HG22 ' CE ' ' B' ' 312' ' ' MET . 7.0 t -124.32 119.72 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 237' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 0.0 OUTLIER -88.52 111.22 21.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 238' ' ' ASP . . . . . 0.487 ' OD1' ' HA ' ' B' ' 239' ' ' PRO . 30.6 t70 -179.93 143.23 0.36 Allowed Pre-proline 0 C--N 1.301 -1.511 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.561 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 239' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 48.9 Cg_endo -73.96 172.79 59.73 Favored 'Cis proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.214 -1.994 . . . . 0.0 110.782 -0.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.868 HG21 HG11 ' A' ' 74' ' ' VAL . 3.3 m -57.92 146.7 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 109.037 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 241' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 75' ' ' ALA . . . 68.39 7.58 52.94 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 242' ' ' SER . . . . . 0.506 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -111.66 -153.77 0.53 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -1.121 . . . . 0.0 109.235 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -122.99 130.88 24.43 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.039 -1.038 . . . . 0.0 110.169 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 244' ' ' PRO . . . . . 0.604 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.4 Cg_endo -63.4 -165.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.138 1.599 . . . . 0.0 111.334 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.761 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -151.74 146.15 25.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.864 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.3 OUTLIER -136.98 138.67 40.79 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.931 -1.105 . . . . 0.0 110.865 -178.348 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 247' ' ' GLY . . . . . 0.558 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 122.88 146.58 7.19 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 248' ' ' THR . . . . . 0.501 ' N ' ' O ' ' B' ' 232' ' ' ASP . 3.1 m -57.85 -70.21 0.14 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.406 -1.055 . . . . 0.0 109.553 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' B' ' 248' ' ' THR . . . -45.36 -25.68 0.43 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 109.173 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.761 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -84.21 -57.51 3.14 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.366 -0.834 . . . . 0.0 109.55 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.851 HD11 ' N ' ' B' ' 234' ' ' ALA . 45.0 mt -44.82 -36.94 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -0.981 . . . . 0.0 108.944 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 252' ' ' ARG . . . . . 0.555 ' HB2' HG21 ' B' ' 227' ' ' VAL . 5.5 ttp180 -76.76 -52.73 9.03 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.506 -0.746 . . . . 0.0 109.14 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -50.9 -32.26 20.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 108.831 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.503 ' HB2' ' HD3' ' B' ' 245' ' ' ARG . 1.0 OUTLIER -82.62 -71.14 0.5 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 255' ' ' PHE . . . . . 1.004 ' CG ' HG21 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -46.96 -26.03 0.92 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 256' ' ' ALA . . . . . 0.529 ' HA ' HD21 ' B' ' 223' ' ' LEU . . . -74.33 -51.33 15.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 108.614 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -46.94 -32.2 3.68 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 35.2 t -69.5 -37.89 77.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.1 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 259' ' ' LEU . . . . . 0.926 HD21 ' CA ' ' B' ' 221' ' ' GLY . 7.3 tp -71.64 -32.3 67.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.526 -0.734 . . . . 0.0 109.888 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -47.27 -25.98 1.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.184 -0.947 . . . . 0.0 109.284 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 261' ' ' LEU . . . . . 0.794 HD22 HD21 ' B' ' 263' ' ' LEU . 0.3 OUTLIER -96.52 120.42 62.22 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 109.101 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 262' ' ' PRO . . . . . 0.448 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 46.7 Cg_endo -72.42 108.59 2.55 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.743 1.391 . . . . 0.0 110.728 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.794 HD21 HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -137.97 163.4 31.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.193 -0.942 . . . . 0.0 109.719 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 264' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' B' ' 284' ' ' VAL . . . -92.25 130.23 38.01 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 265' ' ' VAL . . . . . 0.519 HG21 ' HB3' ' B' ' 218' ' ' LEU . 2.0 t -117.66 117.58 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 110.104 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 29.8 tt0 -150.22 108.82 3.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.17 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.546 HD23 ' O ' ' B' ' 281' ' ' ALA . 0.6 OUTLIER -48.68 178.42 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.258 -0.901 . . . . 0.0 109.849 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 268' ' ' THR . . . . . 0.465 ' O ' ' O ' ' B' ' 269' ' ' GLN . 29.6 p -143.56 -82.71 0.17 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.84 . . . . 0.0 109.291 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 269' ' ' GLN . . . . . 0.509 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 12.0 pt20 -60.36 -144.41 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 270' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 38.7 tt0 -114.54 134.08 55.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 109.833 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 271' ' ' VAL . . . . . 0.723 ' CG2' HG11 ' B' ' 211' ' ' VAL . 41.6 t -62.09 158.69 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.374 -0.829 . . . . 0.0 109.153 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.511 ' O ' ' HB1' ' B' ' 278' ' ' ALA . 0.0 OUTLIER -122.82 135.32 54.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.025 -1.047 . . . . 0.0 110.262 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 273' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.19 128.45 12.05 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 274' ' ' VAL . . . . . 0.998 HG11 ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -137.81 152.7 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.902 -1.124 . . . . 0.0 110.557 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 275' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . 37.72 -96.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.881 -0.512 . . . . 0.0 110.524 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 276' ' ' ASN . . . . . 0.588 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 2.9 p-10 -124.97 -10.95 7.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.082 -1.011 . . . . 0.0 109.97 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 277' ' ' GLU . . . . . 0.472 ' HG3' ' HA ' ' B' ' 302' ' ' ARG . 1.0 OUTLIER -99.7 -163.57 1.04 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.834 -1.166 . . . . 0.0 109.199 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 278' ' ' ALA . . . . . 0.551 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . 179.68 166.86 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 110.047 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 279' ' ' ALA . . . . . 0.766 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -150.07 132.93 16.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 280' ' ' PHE . . . . . 0.625 ' CD1' HG22 ' B' ' 211' ' ' VAL . 21.9 p90 -150.25 170.44 18.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.624 -1.298 . . . . 0.0 110.315 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.968 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -145.27 -175.27 4.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.634 -0.666 . . . . 0.0 109.625 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 282' ' ' PHE . . . . . 0.509 ' CE1' ' CE2' ' B' ' 280' ' ' PHE . 8.1 p90 -179.14 -173.86 0.3 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.327 -0.858 . . . . 0.0 109.333 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.81 153.83 50.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.442 -0.786 . . . . 0.0 109.733 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 284' ' ' VAL . . . . . 0.718 HG13 ' CB ' ' B' ' 263' ' ' LEU . 3.7 t -142.6 119.28 6.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.373 -0.829 . . . . 0.0 109.102 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 285' ' ' SER . . . . . 0.552 ' HB3' HG23 ' B' ' 294' ' ' VAL . 0.1 OUTLIER -117.85 100.46 7.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.155 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.678 ' CD1' HD23 ' B' ' 263' ' ' LEU . 37.1 p90 -110.53 164.34 12.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.172 -0.955 . . . . 0.0 109.712 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 287' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' B' ' 288' ' ' PHE . 2.8 tm-20 -132.8 169.66 16.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 288' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' B' ' 288' ' ' PHE . 0.0 OUTLIER -118.23 -78.13 0.58 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.928 . . . . 0.0 109.88 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.22 10.48 1.29 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.388 -0.82 . . . . 0.0 110.046 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 290' ' ' GLY . . . . . 0.461 ' N ' ' OE2' ' B' ' 287' ' ' GLU . . . -178.34 -71.54 0.06 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 291' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' B' ' 287' ' ' GLU . 0.3 OUTLIER -73.72 151.59 40.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.238 -1.154 . . . . 0.0 109.06 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 292' ' ' LYS . . . . . 0.44 ' O ' ' HD2' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -128.09 120.02 26.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.062 -1.024 . . . . 0.0 110.066 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 293' ' ' THR . . . . . 0.6 HG21 ' HB2' ' B' ' 322' ' ' HIS . 0.6 OUTLIER -97.25 -167.17 1.5 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 294' ' ' VAL . . . . . 0.718 HG22 ' H ' ' B' ' 295' ' ' VAL . 1.7 p -153.61 -169.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.719 -1.238 . . . . 0.0 109.579 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 1.003 HG12 ' HD3' ' B' ' 297' ' ' PRO . 6.7 t -154.87 141.05 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.809 -1.182 . . . . 0.0 109.184 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 296' ' ' ALA . . . . . . . . . . . . . . . -141.25 69.87 27.49 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.091 -1.005 . . . . 0.0 109.779 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 297' ' ' PRO . . . . . 1.003 ' HD3' HG12 ' B' ' 295' ' ' VAL . 52.1 Cg_endo -98.7 169.27 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.869 1.713 . . . . 0.0 112.454 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.968 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.5 mp -136.56 135.42 49.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 299' ' ' ASP . . . . . 0.612 ' HB3' ' CE1' ' B' ' 280' ' ' PHE . 3.9 t0 -112.33 156.68 22.06 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.782 -1.199 . . . . 0.0 111.054 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 300' ' ' HIS . . . . . 0.533 ' O ' ' HG2' ' B' ' 312' ' ' MET . 45.7 t-80 -108.62 171.59 7.33 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 301' ' ' PHE . . . . . 0.646 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.49 145.61 29.2 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.461 -1.399 . . . . 0.0 111.131 -178.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' B' ' 311' ' ' SER . 8.7 ttt85 -141.16 120.24 12.85 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 303' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' B' ' 207' ' ' MET . 2.7 m-85 -90.88 -175.41 4.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.108 -0.995 . . . . 0.0 109.879 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 304' ' ' ASN . . . . . 0.638 ' HB3' HG21 ' B' ' 310' ' ' VAL . 0.6 OUTLIER -114.23 -44.32 3.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 109.291 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 305' ' ' GLY . . . . . 0.687 ' O ' ' HB3' ' B' ' 306' ' ' ALA . . . -178.02 40.75 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 306' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' B' ' 305' ' ' GLY . . . 77.02 66.11 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -1.09 . . . . 0.0 109.625 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -159.6 -65.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.92 -166.25 2.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -1.14 . . . . 0.0 109.338 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 309' ' ' VAL . . . . . 0.754 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 42.5 t -90.0 157.3 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.138 -0.976 . . . . 0.0 109.115 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 310' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' B' ' 304' ' ' ASN . 0.7 OUTLIER -133.22 -38.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 109.779 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 311' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 68.6 m -143.67 163.51 33.04 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.088 -1.008 . . . . 0.0 109.319 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 312' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 300' ' ' HIS . 2.1 ttp -157.08 167.66 29.76 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.279 -0.888 . . . . 0.0 109.936 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 313' ' ' ARG . . . . . 0.519 ' HA ' ' HB2' ' B' ' 237' ' ' GLU . 5.2 mmt180 -146.83 151.81 37.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.406 -0.808 . . . . 0.0 108.972 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -113.38 147.39 37.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 110.1 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 315' ' ' LEU . . . . . 0.854 HD11 ' CB ' ' A' ' 79' ' ' ALA . 3.1 tp -110.22 -143.01 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.729 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 316' ' ' PHE . . . . . 0.676 ' CD1' ' O ' ' B' ' 315' ' ' LEU . 42.4 p90 44.84 -165.35 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.713 . . . . 0.0 110.029 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 317' ' ' GLY . . . . . 0.59 ' HA2' HG21 ' B' ' 240' ' ' VAL . . . -163.66 -161.08 12.29 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 318' ' ' GLU . . . . . 0.522 ' HA ' HG12 ' B' ' 321' ' ' ILE . 7.2 tt0 -79.26 5.07 13.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -1.169 . . . . 0.0 109.606 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.6 -34.81 13.17 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.185 -0.947 . . . . 0.0 109.5 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 320' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -101.05 32.12 3.35 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 321' ' ' ILE . . . . . 0.642 HG22 ' N ' ' B' ' 322' ' ' HIS . 19.6 mm -94.96 -116.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.738 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 322' ' ' HIS . . . . . 0.642 ' N ' HG22 ' B' ' 321' ' ' ILE . 5.8 p-80 -88.22 101.61 14.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.719 . . . . 0.0 112.5 -176.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.451 0 O-C-N 121.503 -0.748 . . . . 0.0 109.488 177.971 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.434 ' O ' ' CB ' ' A' ' 8' ' ' THR . 44.9 Cg_endo -71.85 -9.63 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.968 1.51 . . . . 0.0 110.038 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.64 -48.85 75.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.386 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -54.39 36.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.235 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.3 mtt -60.97 -31.0 70.59 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.176 -0.952 . . . . 0.0 109.294 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 11' ' ' VAL . 6.9 m -69.27 -36.65 77.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.12 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.06 -43.04 50.95 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.987 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.5 t -56.73 -22.67 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.847 HG22 ' CE2' ' A' ' 101' ' ' PHE . 15.9 t -90.35 -43.24 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.38 -0.825 . . . . 0.0 109.02 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 15' ' ' VAL . 6.6 tt0 -61.73 -74.0 0.09 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -42.77 -45.16 4.7 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.233 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.6 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -49.36 -44.7 45.0 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.919 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -87.65 -37.86 11.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.367 -0.833 . . . . 0.0 109.052 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.444 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -49.05 -37.55 21.31 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.7 -32.01 65.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.919 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.2 mt -67.23 -58.58 4.58 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 65' ' ' VAL . 4.4 t-20 -50.86 -42.56 58.88 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.481 0.657 . . . . 0.0 109.435 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.27 -2.58 58.52 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 109.573 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.891 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 56.73 47.77 82.81 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' CB ' ' A' ' 24' ' ' ASP . 6.9 t0 -112.08 82.23 1.59 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.204 -1.174 . . . . 0.0 109.909 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.019 ' CD2' HD22 ' A' ' 59' ' ' LEU . 3.2 mm? -48.96 -22.54 0.87 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.216 -0.928 . . . . 0.0 109.616 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' CB ' ' OD1' ' A' ' 22' ' ' ASP . 19.3 t0 -58.26 -49.83 75.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.837 . . . . 0.0 109.393 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.79 -43.07 92.57 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.722 HD12 HD13 ' A' ' 23' ' ' LEU . 9.7 mt -56.19 -52.84 46.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 23' ' ' LEU . 7.1 t -65.68 -47.44 86.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.49 -46.81 57.22 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 10' ' ' VAL . 7.8 tp -68.66 -21.37 64.45 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.763 ' CD2' HG21 ' A' ' 51' ' ' ILE . 3.1 m-85 -82.78 139.17 33.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.538 -0.726 . . . . 0.0 109.651 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . -60.49 -169.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.456 ' C ' ' HG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -70.94 -23.69 62.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.377 -0.827 . . . . 0.0 109.788 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.53 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -148.95 49.96 0.98 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.653 -0.655 . . . . 0.0 109.476 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -58.86 167.55 1.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.543 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -126.32 138.07 53.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.632 ' CG2' HD12 ' A' ' 51' ' ' ILE . 23.6 t -129.0 167.68 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.064 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.572 ' N ' HG12 ' A' ' 36' ' ' VAL . 3.0 mt-10 -143.74 118.07 9.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 108.936 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.608 ' OD2' ' HB3' ' A' ' 114' ' ' ALA . 4.1 t70 -174.94 139.7 0.63 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 109.594 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 41' ' ' GLY . 45.3 Cg_endo -71.81 -174.3 11.37 Favored 'Cis proline' 0 N--CA 1.489 1.259 0 C-N-CA 122.15 -2.021 . . . . 0.0 110.649 0.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.826 HG21 ' HB ' ' B' ' 274' ' ' VAL . 15.4 m -67.02 59.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 109.625 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 39' ' ' PRO . . . -140.42 -83.56 0.09 OUTLIER Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.422 ' C ' ' HG2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -165.5 50.92 0.1 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.641 -0.917 . . . . 0.0 109.708 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.556 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 2.4 mm-40 -134.7 58.6 29.86 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.678 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.528 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 48.5 Cg_endo -79.29 -177.74 4.11 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.204 1.633 . . . . 0.0 110.394 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 1.006 ' HG3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -150.39 102.44 3.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 108.96 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -92.25 149.34 21.51 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.146 -0.971 . . . . 0.0 110.203 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 98.67 168.22 31.06 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.459 HG23 ' CG1' ' A' ' 27' ' ' VAL . 3.7 m -80.88 -57.06 3.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -1.114 . . . . 0.0 109.093 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.87 -30.53 46.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.139 -0.976 . . . . 0.0 109.118 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.006 ' HB1' ' HG3' ' A' ' 45' ' ' ARG . . . -78.75 -53.43 7.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.431 -0.793 . . . . 0.0 109.094 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.763 HG21 ' CD2' ' A' ' 30' ' ' PHE . 6.5 mm -50.36 -36.07 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.392 -0.818 . . . . 0.0 109.294 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.721 ' HG3' HG21 ' A' ' 27' ' ' VAL . 7.6 ttp180 -74.58 -59.94 2.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 109.083 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 52' ' ' ARG . 2.0 tt0 -44.32 -27.4 0.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 108.825 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.576 ' CD1' ' HD3' ' A' ' 45' ' ' ARG . 0.6 OUTLIER -85.66 -70.08 0.62 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.352 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.709 ' C ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -53.05 -18.69 2.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.821 -0.549 . . . . 0.0 109.764 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.535 ' CB ' ' HG ' ' A' ' 23' ' ' LEU . . . -86.06 -35.78 20.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.957 . . . . 0.0 108.7 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 4.3 t30 -69.06 -39.7 78.96 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 t -63.93 -33.81 76.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 108.821 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.019 HD22 ' CD2' ' A' ' 23' ' ' LEU . 8.5 tp -63.75 -20.63 65.9 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.39 -0.819 . . . . 0.0 109.645 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -53.43 -20.97 5.25 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.079 -1.013 . . . . 0.0 108.914 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.14 HD22 HD21 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.8 113.73 58.03 Favored Pre-proline 0 N--CA 1.486 1.34 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 43.8 Cg_endo -70.56 106.14 1.75 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.791 1.416 . . . . 0.0 111.149 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.14 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.65 160.23 39.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.897 . . . . 0.0 109.718 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.28 127.87 36.27 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.766 HG21 ' HB3' ' A' ' 18' ' ' LEU . 17.6 t -105.96 114.13 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.136 -0.977 . . . . 0.0 109.916 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 67' ' ' LEU . 28.2 tt0 -150.47 98.51 2.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.25 -0.906 . . . . 0.0 109.041 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -47.04 173.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.909 . . . . 0.0 109.507 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 69' ' ' GLN . 2.5 p -142.94 -81.86 0.19 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.375 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -58.43 -151.72 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.443 ' CD ' ' HE2' ' B' ' 319' ' ' LYS . 39.8 tt0 -108.94 131.67 54.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.102 -0.999 . . . . 0.0 109.761 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.039 HG13 ' HB3' ' A' ' 80' ' ' PHE . 54.1 t -58.41 147.56 6.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.375 -0.828 . . . . 0.0 109.21 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -104.01 132.61 50.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 109.673 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.75 141.15 36.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.773 ' CG1' HG21 ' B' ' 240' ' ' VAL . 0.2 OUTLIER -123.71 -157.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.899 . . . . 0.0 109.315 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -38.67 -93.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 110.22 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 3.4 m120 -104.63 -18.24 14.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -0.998 . . . . 0.0 109.79 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 4.4 mt-10 -90.35 -161.82 0.83 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.125 -0.984 . . . . 0.0 109.293 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.752 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 177.55 164.75 0.61 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 1.041 ' HB2' HD11 ' B' ' 315' ' ' LEU . . . -150.37 138.88 20.56 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 1.039 ' HB3' HG13 ' A' ' 71' ' ' VAL . 22.2 p90 -150.42 161.34 42.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.76 -1.213 . . . . 0.0 110.335 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.816 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -139.43 160.37 40.0 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 82' ' ' PHE . 1.5 p90 -157.69 -176.68 6.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 0.0 109.558 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -118.24 143.03 46.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.452 -0.78 . . . . 0.0 109.284 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.808 HG12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -120.83 124.1 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.556 ' HA ' HG23 ' A' ' 94' ' ' VAL . 1.7 p -109.94 110.55 21.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 108.918 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 93' ' ' THR . 9.0 p90 -131.39 167.47 19.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.064 -1.022 . . . . 0.0 110.225 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.52 ' HB2' ' CB ' ' A' ' 92' ' ' LYS . 42.9 tt0 -148.73 167.35 25.78 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -146.77 -100.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.952 -1.093 . . . . 0.0 110.192 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.491 ' HG2' ' N ' ' A' ' 90' ' ' GLY . 1.0 OUTLIER -61.39 -25.4 67.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 110.005 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.491 ' N ' ' HG2' ' A' ' 89' ' ' GLN . . . 168.36 -65.92 0.18 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.53 ' O ' ' CE1' ' A' ' 88' ' ' PHE . 1.6 ttm180 -55.77 118.46 4.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -1.115 . . . . 0.0 108.977 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.52 ' CB ' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -90.57 125.23 35.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.091 -1.006 . . . . 0.0 109.592 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.753 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -106.11 143.36 34.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.333 -0.855 . . . . 0.0 109.451 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.631 HG13 ' N ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER -108.31 178.07 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 1.022 HG12 ' HD3' ' A' ' 97' ' ' PRO . 3.5 t -150.87 144.78 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.029 -1.044 . . . . 0.0 110.038 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.472 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . -133.29 71.36 76.73 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.532 -0.73 . . . . 0.0 110.037 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 1.022 ' HD3' HG12 ' A' ' 95' ' ' VAL . 51.9 Cg_endo -95.56 -175.57 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.529 1.486 . . . . 0.0 110.986 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.816 HG23 ' HB2' ' A' ' 81' ' ' ALA . 3.0 mp -139.91 136.23 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.619 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 5.1 t0 -109.74 161.92 14.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.995 -1.065 . . . . 0.0 110.071 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' A' ' 112' ' ' MET . 59.6 t-80 -109.47 171.23 7.56 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.847 ' CE2' HG22 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -146.23 145.28 30.35 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.952 -1.093 . . . . 0.0 110.544 -178.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.457 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 3.3 ttm180 -144.57 114.64 7.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 0.0 108.973 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.627 ' CE2' HG21 ' A' ' 10' ' ' VAL . 4.2 m-85 -94.97 -171.72 2.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.191 -0.943 . . . . 0.0 109.489 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.805 ' HB3' HG11 ' A' ' 110' ' ' VAL . 8.9 p-10 -127.19 -34.12 2.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.446 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -161.38 24.3 0.24 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 105' ' ' GLY . . . 71.15 60.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -1.106 . . . . 0.0 109.515 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.19 -62.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -128.13 -164.7 1.4 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -1.134 . . . . 0.0 109.407 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' A' ' 30' ' ' PHE . 62.7 t -106.13 139.89 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.172 -0.955 . . . . 0.0 109.376 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.805 HG11 ' HB3' ' A' ' 104' ' ' ASN . 0.5 OUTLIER -123.27 -24.56 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -0.971 . . . . 0.0 109.833 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.79 156.32 37.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.986 . . . . 0.0 109.576 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.62 ' HE3' ' CE1' ' A' ' 30' ' ' PHE . 12.4 ttm -160.09 145.97 15.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.935 . . . . 0.0 109.671 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.473 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 7.7 mtt-85 -128.71 150.38 50.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 0.0 109.063 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.609 ' O ' HG12 ' A' ' 40' ' ' VAL . . . -118.49 150.87 38.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 109.693 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.8 OUTLIER -146.88 145.24 29.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.325 -0.859 . . . . 0.0 109.665 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.82 ' O ' HG11 ' B' ' 274' ' ' VAL . 33.9 p90 164.45 -163.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 121' ' ' ILE . . . -179.9 -169.26 39.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.516 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 21.7 tt0 -68.93 -6.65 28.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -1.076 . . . . 0.0 109.465 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -88.47 -29.8 19.88 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 122.016 0.913 . . . . 0.0 109.071 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -88.79 3.73 50.04 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.651 HG23 HG22 ' A' ' 95' ' ' VAL . 2.8 mm -91.41 -164.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.753 ' O ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -151.8 176.91 10.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.819 -1.176 . . . . 0.0 109.896 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.539 ' HA ' ' CG2' ' A' ' 93' ' ' THR . . . -155.43 136.02 13.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -0.804 . . . . 0.0 109.254 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 92' ' ' LYS . . . 76.73 -117.43 4.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.249 -1.148 . . . . 0.0 109.49 180.0 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 1.6 ttp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.234 0.54 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.447 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 3.0 t-20 65.6 63.29 0.62 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 109.581 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 203' ' ' THR . . . . . 0.539 HG23 ' O ' ' B' ' 203' ' ' THR . 2.1 t -43.61 103.29 0.31 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.933 . . . . 0.0 109.589 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 204' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 47.8 Cg_endo -74.11 -13.18 23.61 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.987 1.519 . . . . 0.0 110.348 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.9 -46.45 87.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.617 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -60.15 -52.41 65.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.086 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 207' ' ' MET . . . . . 0.611 ' HB3' ' HB1' ' B' ' 273' ' ' ALA . 73.7 mtm -68.06 -18.36 64.66 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.421 -0.8 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.487 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 5.9 m -84.22 -33.78 24.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -57.96 -48.68 79.23 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.201 -0.937 . . . . 0.0 109.206 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.65 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -49.6 -32.58 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.935 . . . . 0.0 108.531 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.527 HG11 HG21 ' B' ' 271' ' ' VAL . 4.4 t -71.83 -39.83 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 109.419 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 212' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.2 tt0 -64.82 -74.54 0.1 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.815 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.4 OUTLIER -42.0 -44.14 3.41 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 122.031 0.919 . . . . 0.0 108.697 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 214' ' ' TYR . . . . . 0.634 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -49.46 -45.41 46.63 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.266 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 1.059 HG11 HD11 ' B' ' 267' ' ' LEU . 1.4 t -88.75 -37.36 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.3 -0.875 . . . . 0.0 109.127 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 216' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' B' ' 213' ' ' ARG . . . -48.82 -34.69 12.92 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.559 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -75.24 -33.91 61.36 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.906 HD12 ' HA ' ' B' ' 215' ' ' VAL . 2.2 mt -65.09 -58.53 5.81 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -48.36 -41.03 27.51 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.593 0.711 . . . . 0.0 109.182 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.45 4.42 49.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.71 . . . . 0.0 109.842 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.919 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 48.77 31.63 10.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -97.97 87.46 3.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.325 -1.103 . . . . 0.0 109.787 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 223' ' ' LEU . . . . . 0.986 ' CD2' HD22 ' B' ' 259' ' ' LEU . 3.7 mm? -51.9 -19.95 2.04 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.193 -0.942 . . . . 0.0 109.848 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.58 -54.06 48.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.256 -0.902 . . . . 0.0 109.264 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -61.05 -38.37 95.44 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.897 HD12 HD13 ' B' ' 223' ' ' LEU . 8.7 mt -61.32 -57.32 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.726 HG23 ' O ' ' B' ' 223' ' ' LEU . 24.7 t -60.7 -42.98 94.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.11 -50.17 67.48 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.815 HD22 ' HB3' ' B' ' 213' ' ' ARG . 8.2 tp -67.92 -22.87 65.04 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 230' ' ' PHE . . . . . 0.653 ' CD2' HG21 ' B' ' 251' ' ' ILE . 5.3 m-85 -88.41 136.58 32.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.572 -0.705 . . . . 0.0 109.915 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -52.21 -174.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 109.354 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -25.07 49.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.749 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.545 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 0.2 OUTLIER -135.32 44.99 2.52 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.654 ' HB1' ' O ' ' B' ' 310' ' ' VAL . . . -63.62 150.17 44.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.357 -0.839 . . . . 0.0 109.989 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 235' ' ' THR . . . . . 1.037 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -108.83 149.18 29.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.478 -0.764 . . . . 0.0 109.033 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 48.7 t -140.12 122.39 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 109.695 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 237' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.6 mt-10 -89.6 104.1 16.69 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 238' ' ' ASP . . . . . 0.546 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 22.7 t70 179.66 142.16 0.33 Allowed Pre-proline 0 C--N 1.301 -1.535 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.027 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 239' ' ' PRO . . . . . 0.521 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 47.5 Cg_endo -72.71 176.34 40.68 Favored 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.283 -1.965 . . . . 0.0 111.041 0.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.773 HG21 ' CG1' ' A' ' 74' ' ' VAL . 5.0 m -61.29 153.58 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 0.0 109.15 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 55.76 18.23 16.82 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 242' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -118.05 -154.57 0.57 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.41 -1.053 . . . . 0.0 109.257 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -124.63 128.88 24.81 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 110.126 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 244' ' ' PRO . . . . . 0.539 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.3 Cg_endo -64.93 -174.11 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.934 1.492 . . . . 0.0 111.145 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.917 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.65 103.24 3.09 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 246' ' ' SER . . . . . 1.037 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.24 152.12 21.75 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.17 -0.956 . . . . 0.0 109.674 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 247' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 110.25 162.64 18.8 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 5.3 m -77.16 -36.57 55.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.184 -1.186 . . . . 0.0 109.129 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -73.79 -19.69 60.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 108.97 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.917 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -90.36 -45.07 9.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.401 -0.812 . . . . 0.0 109.306 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.653 HG21 ' CD2' ' B' ' 230' ' ' PHE . 10.3 mm -61.89 -50.48 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 0.0 109.521 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 252' ' ' ARG . . . . . 0.511 ' O ' ' CB ' ' B' ' 256' ' ' ALA . 21.0 ttp180 -66.34 -52.39 47.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.049 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 253' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' B' ' 257' ' ' ASN . 22.4 mt-10 -47.91 -32.48 6.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.966 -1.083 . . . . 0.0 108.448 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.546 ' CZ ' ' O ' ' B' ' 238' ' ' ASP . 0.6 OUTLIER -84.48 -70.81 0.55 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 255' ' ' PHE . . . . . 0.698 ' CD2' HD13 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -49.64 -22.57 1.37 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.469 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 256' ' ' ALA . . . . . 0.608 ' HB2' ' HG ' ' B' ' 223' ' ' LEU . . . -84.35 -49.11 9.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 108.744 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 257' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' B' ' 253' ' ' GLU . 10.7 t-20 -57.38 -37.49 72.76 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 7.6 t -65.57 -32.34 73.88 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 259' ' ' LEU . . . . . 0.986 HD22 ' CD2' ' B' ' 223' ' ' LEU . 9.5 tp -64.68 -22.43 66.98 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.413 -0.804 . . . . 0.0 109.248 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 260' ' ' LYS . . . . . 0.502 ' O ' ' HD3' ' B' ' 262' ' ' PRO . 0.0 OUTLIER -50.75 -22.53 2.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.838 . . . . 0.0 108.9 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 261' ' ' LEU . . . . . 1.028 HD21 HD21 ' B' ' 263' ' ' LEU . 0.0 OUTLIER -98.89 103.68 20.84 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 262' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 51.5 Cg_endo -76.68 125.27 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.812 1.427 . . . . 0.0 112.11 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 1.028 HD21 HD21 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -145.59 176.68 9.43 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.737 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.53 125.08 36.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 26.1 t -111.48 115.38 49.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 109.979 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 266' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.2 tp10 -150.14 89.56 1.6 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.387 -0.821 . . . . 0.0 108.938 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 1.059 HD11 HG11 ' B' ' 215' ' ' VAL . 1.0 OUTLIER -52.84 -170.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.351 -0.843 . . . . 0.0 110.0 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 268' ' ' THR . . . . . 0.667 ' O ' ' N ' ' B' ' 270' ' ' GLU . 6.5 p -136.68 53.13 1.92 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.844 . . . . 0.0 108.819 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 269' ' ' GLN . . . . . 0.549 ' CG ' ' O ' ' B' ' 268' ' ' THR . 17.9 pt20 50.7 -55.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 270' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' B' ' 268' ' ' THR . 35.5 tt0 -48.89 115.26 1.2 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.492 -1.38 . . . . 0.0 110.213 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 271' ' ' VAL . . . . . 0.588 HG13 ' HB3' ' B' ' 280' ' ' PHE . 37.7 t -138.14 154.31 28.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.7 OUTLIER -114.66 130.21 56.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.857 -1.152 . . . . 0.0 110.003 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 273' ' ' ALA . . . . . 0.611 ' HB1' ' HB3' ' B' ' 207' ' ' MET . . . -150.47 133.21 15.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.396 -0.815 . . . . 0.0 109.001 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 274' ' ' VAL . . . . . 0.826 ' HB ' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -150.34 158.86 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.935 -1.103 . . . . 0.0 110.435 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 275' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 40' ' ' VAL . . . 39.26 -101.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.77 -0.581 . . . . 0.0 110.321 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 276' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 6.0 m-80 -121.35 -20.47 6.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.957 -1.089 . . . . 0.0 109.691 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 277' ' ' GLU . . . . . 0.51 ' HG3' ' HG2' ' B' ' 302' ' ' ARG . 3.9 mt-10 -92.59 -164.95 1.25 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.042 -1.037 . . . . 0.0 109.5 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 278' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' B' ' 273' ' ' ALA . . . 177.77 154.69 0.32 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 109.519 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 279' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -136.79 141.17 42.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.945 . . . . 0.0 108.66 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 280' ' ' PHE . . . . . 0.606 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 37.9 p90 -150.72 171.15 17.61 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.735 -1.228 . . . . 0.0 110.028 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.53 ' HB2' ' CG1' ' B' ' 298' ' ' ILE . . . -145.68 -179.86 6.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.751 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 282' ' ' PHE . . . . . 0.406 ' CE1' ' HE2' ' B' ' 280' ' ' PHE . 7.0 p90 -174.32 -173.58 0.79 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.292 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 283' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -124.7 141.53 52.04 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.413 -0.805 . . . . 0.0 109.541 179.63 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 284' ' ' VAL . . . . . 1.0 HG11 HD22 ' B' ' 263' ' ' LEU . 42.1 t -120.04 113.87 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 109.469 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 1.2 p -106.14 131.75 53.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.033 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' B' ' 286' ' ' PHE . 1.0 OUTLIER -149.73 157.69 43.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.977 -1.077 . . . . 0.0 110.009 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 287' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' B' ' 292' ' ' LYS . 1.2 pt-20 -98.19 158.09 15.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 109.14 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 288' ' ' PHE . . . . . 0.499 ' C ' ' CG ' ' B' ' 289' ' ' GLN . 0.6 OUTLIER -124.63 77.55 1.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.897 . . . . 0.0 109.594 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 289' ' ' GLN . . . . . 0.499 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 0.4 OUTLIER 40.36 57.36 2.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.424 -0.797 . . . . 0.0 110.262 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 107.63 -2.06 34.28 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.207 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -127.37 173.9 9.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.056 -1.261 . . . . 0.0 109.635 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 292' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' B' ' 287' ' ' GLU . 0.1 OUTLIER -138.17 140.1 39.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.384 179.534 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 293' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.94 148.59 34.01 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.715 -0.616 . . . . 0.0 109.464 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 294' ' ' VAL . . . . . 0.621 HG12 ' HB3' ' B' ' 322' ' ' HIS . 9.8 p -125.96 170.46 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.169 -0.957 . . . . 0.0 108.468 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 1.057 HG12 ' HD3' ' B' ' 297' ' ' PRO . 3.8 t -147.46 145.81 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.004 -1.06 . . . . 0.0 109.784 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 296' ' ' ALA . . . . . 0.471 ' O ' ' OD1' ' B' ' 320' ' ' ASN . . . -130.18 72.67 81.83 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 110.148 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 297' ' ' PRO . . . . . 1.057 ' HD3' HG12 ' B' ' 295' ' ' VAL . 50.7 Cg_endo -92.5 -175.42 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.757 1.398 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.53 ' CG1' ' HB2' ' B' ' 281' ' ' ALA . 3.2 mp -143.43 134.8 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 299' ' ' ASP . . . . . 0.606 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 11.3 t0 -108.42 162.89 13.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.951 -1.093 . . . . 0.0 110.317 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 300' ' ' HIS . . . . . 0.527 ' O ' ' CG ' ' B' ' 312' ' ' MET . 51.8 t-80 -112.58 172.71 6.76 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 301' ' ' PHE . . . . . 0.612 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.13 145.12 29.47 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.994 -1.066 . . . . 0.0 110.475 -178.478 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.538 ' CD ' ' HB2' ' B' ' 311' ' ' SER . 2.6 ttt-85 -139.3 107.0 5.61 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 303' ' ' PHE . . . . . 0.623 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 5.4 m-85 -90.72 -171.38 3.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.184 -0.948 . . . . 0.0 109.871 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 304' ' ' ASN . . . . . 0.837 ' HB3' HG21 ' B' ' 310' ' ' VAL . 0.5 OUTLIER -124.32 -37.65 2.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.854 . . . . 0.0 109.271 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 305' ' ' GLY . . . . . 0.7 ' O ' ' HB3' ' B' ' 306' ' ' ALA . . . -164.29 24.42 0.18 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 306' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' B' ' 305' ' ' GLY . . . 75.76 64.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -1.183 . . . . 0.0 109.581 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -158.53 -58.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.32 -168.29 1.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -1.14 . . . . 0.0 109.381 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 309' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' B' ' 230' ' ' PHE . 70.1 t -108.49 135.05 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -0.947 . . . . 0.0 109.115 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 310' ' ' VAL . . . . . 0.837 HG21 ' HB3' ' B' ' 304' ' ' ASN . 10.0 t -110.54 -75.33 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.021 . . . . 0.0 109.979 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 311' ' ' SER . . . . . 0.538 ' HB2' ' CD ' ' B' ' 302' ' ' ARG . 28.8 m -107.45 162.01 14.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.634 -1.291 . . . . 0.0 109.615 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 312' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 15.3 ttp -153.95 150.31 28.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 313' ' ' ARG . . . . . 0.509 ' CG ' ' HB2' ' B' ' 237' ' ' GLU . 2.0 mtm-85 -127.79 150.47 49.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.377 -0.827 . . . . 0.0 109.068 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 314' ' ' ALA . . . . . 0.49 ' CB ' ' OD1' ' B' ' 238' ' ' ASP . . . -110.52 130.44 55.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.084 -1.01 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 315' ' ' LEU . . . . . 1.041 HD11 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -124.99 135.98 53.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.092 -1.005 . . . . 0.0 110.074 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 316' ' ' PHE . . . . . 0.675 ' O ' HG13 ' A' ' 74' ' ' VAL . 34.3 p90 165.91 -156.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 317' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' B' ' 321' ' ' ILE . . . 165.1 -174.47 41.01 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 318' ' ' GLU . . . . . 0.54 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 13.0 tt0 -68.25 -7.18 28.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -1.134 . . . . 0.0 109.474 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 319' ' ' LYS . . . . . 0.443 ' HE2' ' CD ' ' A' ' 70' ' ' GLU . 3.5 tttp -89.55 -30.48 18.17 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.04 0.924 . . . . 0.0 109.108 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 320' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.11 6.46 39.83 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 321' ' ' ILE . . . . . 0.652 HG22 ' H ' ' B' ' 322' ' ' HIS . 4.1 mm -90.09 -170.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 322' ' ' HIS . . . . . 0.652 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.0 OUTLIER -151.9 174.05 14.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.909 -1.119 . . . . 0.0 110.11 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.078 179.593 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.98 -4.25 15.08 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.871 1.458 . . . . 0.0 110.202 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.97 -44.77 53.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -50.53 72.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.41 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.58 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 64.9 mtm -60.89 -27.76 68.39 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.214 -0.929 . . . . 0.0 109.735 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.448 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 15.9 m -76.99 -37.49 55.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.366 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.59 -46.38 77.26 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.183 -0.948 . . . . 0.0 108.953 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.951 ' HA ' HD21 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -49.46 -43.43 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 8' ' ' THR . 4.9 t -60.15 -40.08 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.709 -0.619 . . . . 0.0 109.725 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 13' ' ' ARG . 17.3 tt0 -63.83 -75.63 0.08 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.158 -0.963 . . . . 0.0 108.621 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.985 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -43.06 -44.64 4.93 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.612 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -49.33 -46.13 46.44 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.943 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -88.28 -39.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.59 -36.43 15.62 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.586 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -73.82 -33.2 64.07 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.943 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.0 mt -64.2 -58.24 7.15 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -51.08 -46.75 61.86 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.708 0.766 . . . . 0.0 109.149 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.32 10.14 23.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.533 -0.729 . . . . 0.0 109.445 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.688 ' HA2' HD11 ' A' ' 59' ' ' LEU . . . 47.77 30.1 6.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 17' ' ' ALA . 19.2 t70 -90.03 62.75 5.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -1.152 . . . . 0.0 109.81 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.098 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -47.58 -38.03 13.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.11 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 23' ' ' LEU . 1.7 m-20 -43.21 -36.71 1.85 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.97 -30.86 30.47 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.853 HD12 HD12 ' A' ' 23' ' ' LEU . 49.6 mt -61.51 -55.97 20.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 52' ' ' ARG . 29.7 t -60.0 -38.2 75.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.28 -54.17 50.0 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.985 HD22 ' HB3' ' A' ' 13' ' ' ARG . 9.1 tp -62.58 -23.43 67.02 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.535 ' HD2' HG21 ' A' ' 51' ' ' ILE . 3.6 m-30 -91.27 142.79 27.33 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.483 -0.761 . . . . 0.0 109.7 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -52.36 -174.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.383 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.468 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.4 OUTLIER -81.32 -24.69 36.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.651 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.586 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -132.7 42.41 3.09 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.586 -0.696 . . . . 0.0 109.446 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.62 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -59.95 157.39 12.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 109.896 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.938 HG23 ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -111.66 144.91 40.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.007 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 55.7 t -133.1 130.64 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.069 -1.019 . . . . 0.0 109.835 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.569 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 23.1 mt-10 -107.92 110.13 21.81 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.823 ' OD1' ' HB3' ' A' ' 114' ' ' ALA . 17.6 t70 179.19 139.89 0.28 Allowed Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.782 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 38' ' ' ASP . 43.5 Cg_endo -69.65 -179.84 20.09 Favored 'Cis proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.353 -1.936 . . . . 0.0 111.055 -0.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 40' ' ' VAL . 2.4 t -55.07 139.99 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 110.024 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.449 ' HA3' ' HB1' ' B' ' 275' ' ' ALA . . . 49.55 38.39 28.21 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.524 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -116.03 -141.77 0.37 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.41 -1.053 . . . . 0.0 109.802 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 7.1 pm0 -119.12 101.48 49.73 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.838 -1.164 . . . . 0.0 110.764 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.569 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 37.5 Cg_endo -63.31 175.87 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.984 1.518 . . . . 0.0 110.707 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.95 ' HG3' ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -151.49 114.27 4.67 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.938 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -99.93 155.47 17.67 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 110.074 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 109.21 155.95 16.86 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 7.3 m -66.92 -56.46 10.16 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.322 -1.105 . . . . 0.0 108.977 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -57.93 -18.92 26.33 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.291 -0.881 . . . . 0.0 109.119 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.95 ' HB1' ' HG3' ' A' ' 45' ' ' ARG . . . -89.54 -54.84 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.381 -0.824 . . . . 0.0 109.182 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.537 HD13 ' O ' ' A' ' 45' ' ' ARG . 2.9 mm -51.58 -39.88 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.391 -0.818 . . . . 0.0 109.203 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.915 ' HG3' HD23 ' A' ' 23' ' ' LEU . 5.0 ttt85 -74.38 -55.34 6.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.026 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 4.8 mt-10 -49.12 -27.75 3.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.07 -1.019 . . . . 0.0 108.867 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -87.65 -71.5 0.57 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 1.098 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -47.28 -39.06 13.68 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 52' ' ' ARG . . . -57.82 -50.92 71.65 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 39.6 t-20 -53.99 -42.55 69.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.9 t -59.58 -31.55 69.56 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.688 HD11 ' HA2' ' A' ' 21' ' ' GLY . 7.5 tp -68.76 -20.26 64.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 11.8 mttm -67.75 -6.35 20.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.563 -0.711 . . . . 0.0 109.252 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.907 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -88.31 113.17 54.07 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.886 ' HD2' HD13 ' A' ' 61' ' ' LEU . 47.0 Cg_endo -73.39 82.16 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.737 1.388 . . . . 0.0 112.047 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.007 ' HB2' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -140.18 164.6 29.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.027 -1.045 . . . . 0.0 109.048 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.999 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -89.82 129.39 36.21 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.967 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.793 HG11 ' HB3' ' A' ' 18' ' ' LEU . 2.2 t -101.61 117.31 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.665 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -140.09 108.87 5.95 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.317 -0.865 . . . . 0.0 109.226 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.674 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -48.52 178.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.805 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.686 ' O ' ' N ' ' A' ' 70' ' ' GLU . 4.6 p -126.89 44.53 2.88 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.384 -0.822 . . . . 0.0 109.094 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.537 ' CG ' ' O ' ' A' ' 68' ' ' THR . 4.2 pt20 49.94 -55.39 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.686 ' N ' ' O ' ' A' ' 68' ' ' THR . 67.7 tt0 -63.32 118.15 7.62 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.535 -1.353 . . . . 0.0 110.227 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.9 t -130.57 146.0 34.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 1.001 ' CG ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -118.17 130.65 56.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.895 -1.128 . . . . 0.0 109.731 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.558 ' N ' ' HD2' ' A' ' 72' ' ' ARG . . . -147.44 117.45 7.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.717 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.667 HG21 ' O ' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -135.77 160.72 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.964 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . 40.48 -143.43 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.751 -0.593 . . . . 0.0 109.914 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 103' ' ' PHE . 7.6 m-20 -90.38 12.24 19.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.105 -0.997 . . . . 0.0 109.611 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.511 ' CG ' ' HG3' ' A' ' 102' ' ' ARG . 2.3 mt-10 -115.51 -161.51 0.79 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.09 -1.006 . . . . 0.0 109.466 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.987 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . -179.24 163.89 1.32 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.388 -0.82 . . . . 0.0 109.962 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 1.069 ' HB2' HD11 ' B' ' 315' ' ' LEU . . . -151.7 131.68 13.4 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 31.3 p90 -151.09 174.89 12.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.733 -1.229 . . . . 0.0 109.958 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.897 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -144.39 176.94 8.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 109.91 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -165.05 -169.0 1.55 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.496 -0.753 . . . . 0.0 109.133 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.75 147.8 50.1 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 110.104 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.007 HG12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -117.51 124.33 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 109.067 179.55 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.999 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 27.8 p -118.17 120.76 38.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.588 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.778 ' CD1' HD23 ' A' ' 63' ' ' LEU . 7.2 p90 -147.04 -173.5 4.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -121.79 169.33 10.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 -159.35 0.95 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 109.957 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -104.0 89.11 3.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.25 -18.17 52.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -143.91 167.11 23.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -1.08 . . . . 0.0 109.264 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.34 145.06 41.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.35 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -139.14 142.75 38.02 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 110.178 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.731 HG12 ' CB ' ' A' ' 122' ' ' HIS . 0.8 OUTLIER -123.62 179.19 2.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 1.063 HG22 HG23 ' A' ' 121' ' ' ILE . 6.8 t -146.81 142.26 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.891 -1.131 . . . . 0.0 109.796 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 120' ' ' ASN . . . -134.08 72.2 72.23 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.527 -0.733 . . . . 0.0 109.956 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 1.013 ' HD3' HG12 ' A' ' 95' ' ' VAL . 48.8 Cg_endo -94.7 -175.36 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.631 1.554 . . . . 0.0 110.973 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.897 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.7 mp -137.55 163.83 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 12.2 t0 -132.98 156.33 47.52 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.011 -1.056 . . . . 0.0 110.234 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 101' ' ' PHE . 53.5 t60 -111.84 167.84 10.05 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.987 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -139.08 153.92 48.1 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 110.607 -178.496 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.555 ' O ' HG23 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -143.15 98.84 3.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 109.186 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 7' ' ' MET . 5.8 m-85 -90.09 159.73 16.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 109.62 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.685 ' HB3' HG21 ' A' ' 110' ' ' VAL . 17.2 p-10 -101.24 4.45 41.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.204 -0.935 . . . . 0.0 109.795 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 165.37 -76.41 0.15 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 177.96 71.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -1.159 . . . . 0.0 109.592 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.06 -65.88 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.87 -163.8 1.22 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -1.1 . . . . 0.0 109.327 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.619 HG23 ' CG2' ' A' ' 10' ' ' VAL . 37.7 t -106.27 158.16 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.099 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.685 HG21 ' HB3' ' A' ' 104' ' ' ASN . 0.1 OUTLIER -127.44 -75.15 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.177 -0.952 . . . . 0.0 109.266 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 102' ' ' ARG . 3.3 m -108.36 161.77 14.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.11 -0.994 . . . . 0.0 109.167 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 11.5 ttp -160.01 148.25 17.01 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.178 -0.951 . . . . 0.0 110.072 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.612 ' NH2' ' CE1' ' B' ' 300' ' ' HIS . 0.0 OUTLIER -134.33 158.39 43.92 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.823 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . . . -125.77 141.71 51.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 109.78 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.713 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.7 OUTLIER -129.21 146.65 51.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.357 -0.839 . . . . 0.0 109.485 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.63 ' O ' HG11 ' B' ' 274' ' ' VAL . 0.1 OUTLIER 176.54 -155.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.691 0.758 . . . . 0.0 109.484 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.502 ' N ' ' CG ' ' A' ' 116' ' ' PHE . . . 163.38 176.84 35.77 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.512 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 24.2 tt0 -68.64 -7.74 35.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -1.109 . . . . 0.0 109.49 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.503 ' CE ' ' OE2' ' B' ' 270' ' ' GLU . 14.5 tttp -89.52 -27.54 20.23 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.997 0.904 . . . . 0.0 108.778 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -89.16 9.81 24.21 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.063 HG23 HG22 ' A' ' 95' ' ' VAL . 3.6 mm -96.04 -159.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.278 -0.889 . . . . 0.0 108.637 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.731 ' CB ' HG12 ' A' ' 94' ' ' VAL . 20.3 t-80 -151.32 168.88 23.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.074 -1.016 . . . . 0.0 109.864 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 122' ' ' HIS . . . -144.77 167.83 21.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.372 -0.83 . . . . 0.0 109.413 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.46 177.65 35.9 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.223 -1.163 . . . . 0.0 109.492 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 80.9 mtp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.272 0.558 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -166.41 46.43 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.394 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 203' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 203' ' ' THR . 7.5 t -58.54 121.86 56.21 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 109.702 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.06 -4.89 15.79 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.853 1.449 . . . . 0.0 109.478 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -55.25 32.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.367 -0.833 . . . . 0.0 109.301 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -49.61 75.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 108.857 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 207' ' ' MET . . . . . 0.626 ' HE1' ' HA ' ' B' ' 306' ' ' ALA . 24.0 mmt -50.28 -41.84 51.34 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.348 -0.845 . . . . 0.0 109.404 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 4.8 m -60.36 -34.93 74.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.485 -0.759 . . . . 0.0 109.084 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -51.36 -42.74 61.52 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.291 -0.881 . . . . 0.0 108.739 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 1.008 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -57.75 -26.62 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.846 HG22 ' CE2' ' B' ' 301' ' ' PHE . 25.5 t -90.09 -44.63 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.858 . . . . 0.0 109.308 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 212' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 213' ' ' ARG . 5.4 tt0 -58.05 -73.19 0.08 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.475 ' HD3' HD13 ' B' ' 229' ' ' LEU . 0.3 OUTLIER -43.42 -45.14 6.13 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.98 0.895 . . . . 0.0 108.693 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 214' ' ' TYR . . . . . 0.626 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.3 OUTLIER -52.02 -42.46 63.07 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.931 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -87.67 -38.88 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.284 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 216' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.66 -35.08 13.02 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.551 ' HB1' HG13 ' B' ' 226' ' ' ILE . . . -75.32 -32.79 61.05 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.931 HD12 ' HA ' ' B' ' 215' ' ' VAL . 1.7 mt -64.59 -57.9 7.83 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 219' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 8.5 t30 -54.35 -46.33 72.93 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.497 0.665 . . . . 0.0 109.312 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -88.92 9.6 24.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.599 -0.688 . . . . 0.0 109.733 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.987 ' HA2' HD21 ' B' ' 259' ' ' LEU . . . 48.9 34.29 15.24 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 222' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' B' ' 217' ' ' ALA . 16.8 t0 -91.56 61.66 4.34 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.251 -1.146 . . . . 0.0 109.812 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 223' ' ' LEU . . . . . 1.055 HD12 HD12 ' B' ' 226' ' ' ILE . 6.7 tp -46.31 -43.58 15.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 108.695 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' B' ' 223' ' ' LEU . 2.2 m-20 -42.69 -33.28 0.7 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 225' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' B' ' 228' ' ' ALA . . . -85.15 -33.93 16.17 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 1.055 HD12 HD12 ' B' ' 223' ' ' LEU . 23.3 mt -60.82 -53.78 44.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.533 ' CG1' HG23 ' B' ' 248' ' ' THR . 72.5 t -59.18 -35.97 60.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' B' ' 225' ' ' GLY . . . -58.69 -56.1 26.6 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 1.008 HD21 ' HA ' ' B' ' 210' ' ' VAL . 9.3 tp -58.7 -21.6 55.18 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 230' ' ' PHE . . . . . 1.021 ' CD2' HG21 ' B' ' 251' ' ' ILE . 5.0 m-85 -86.89 139.59 30.48 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.497 -0.752 . . . . 0.0 109.61 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -54.8 -167.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.674 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.476 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.5 OUTLIER -81.12 -23.15 38.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.0 109.373 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.557 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 0.1 OUTLIER -144.4 44.81 1.42 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.856 ' HB3' HD13 ' B' ' 251' ' ' ILE . . . -56.76 -170.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.648 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 235' ' ' THR . . . . . 0.62 HG22 ' HB2' ' B' ' 246' ' ' SER . 0.1 OUTLIER -134.61 141.01 46.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.4 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.706 ' CG2' HG23 ' B' ' 251' ' ' ILE . 34.6 t -116.43 166.84 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.189 -0.945 . . . . 0.0 109.112 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 237' ' ' GLU . . . . . 0.574 ' N ' HG12 ' B' ' 236' ' ' VAL . 1.1 mm-40 -151.66 116.95 5.29 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 238' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' B' ' 239' ' ' PRO . 0.8 OUTLIER 175.01 167.12 0.36 Allowed Pre-proline 0 C--N 1.301 -1.5 0 C-N-CA 118.118 -1.433 . . . . 0.0 110.354 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 239' ' ' PRO . . . . . 0.834 ' O ' HG13 ' B' ' 240' ' ' VAL . 45.7 Cg_endo -73.12 -28.03 7.52 Favored 'Cis proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.727 -2.197 . . . . 0.0 110.649 0.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.834 HG13 ' O ' ' B' ' 239' ' ' PRO . 2.1 m -166.88 101.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 109.197 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.23 42.96 63.88 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 242' ' ' SER . . . . . 0.519 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 27.8 m -118.83 -112.44 0.34 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.314 -1.109 . . . . 0.0 109.817 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 243' ' ' GLU . . . . . 0.445 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 39.0 mt-10 -121.82 100.62 43.31 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.915 -1.116 . . . . 0.0 110.383 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 244' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 39.4 Cg_endo -65.43 -172.6 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.561 1.507 . . . . 0.0 110.652 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 1.019 ' HG3' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.52 98.05 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.063 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.7 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.35 166.62 13.63 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.301 -0.875 . . . . 0.0 109.896 -179.284 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 247' ' ' GLY . . . . . 0.606 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 90.48 171.09 43.84 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 248' ' ' THR . . . . . 0.533 HG23 ' CG1' ' B' ' 227' ' ' VAL . 1.8 m -89.42 -22.36 22.57 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.749 -1.442 . . . . 0.0 109.27 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -82.0 -28.02 32.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.268 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 1.019 ' HB1' ' HG3' ' B' ' 245' ' ' ARG . . . -88.98 -53.48 4.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.322 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 1.021 HG21 ' CD2' ' B' ' 230' ' ' PHE . 94.6 mt -45.25 -36.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.942 . . . . 0.0 108.852 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 252' ' ' ARG . . . . . 0.745 ' CG ' HD23 ' B' ' 223' ' ' LEU . 28.8 ttp180 -79.86 -54.18 6.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -48.95 -28.49 3.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.043 -1.035 . . . . 0.0 108.239 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.618 ' CD1' ' CD ' ' B' ' 245' ' ' ARG . 0.7 OUTLIER -83.54 -70.74 0.54 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 255' ' ' PHE . . . . . 1.039 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.1 OUTLIER -47.2 -24.96 0.8 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 256' ' ' ALA . . . . . 0.678 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -76.32 -48.61 19.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 108.642 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 257' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 31.1 t-20 -59.13 -31.96 69.42 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 3.0 t -72.72 -35.94 67.67 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 259' ' ' LEU . . . . . 0.987 HD21 ' HA2' ' B' ' 221' ' ' GLY . 8.3 tp -66.81 -26.56 66.99 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.406 -0.809 . . . . 0.0 109.145 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 260' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 2.1 mttt -46.15 -25.91 0.67 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.06 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 261' ' ' LEU . . . . . 0.753 HD23 HD23 ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.75 112.31 51.22 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 262' ' ' PRO . . . . . 0.508 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 44.4 Cg_endo -71.39 117.49 5.18 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.854 1.45 . . . . 0.0 110.841 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.87 ' CB ' HG13 ' B' ' 284' ' ' VAL . 0.0 OUTLIER -145.88 164.4 32.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 109.614 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 264' ' ' ALA . . . . . 0.74 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -95.11 123.75 38.78 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 265' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' B' ' 219' ' ' ASN . 6.2 t -113.46 115.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.291 -0.88 . . . . 0.0 109.794 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 266' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.1 OUTLIER -149.84 99.37 2.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -0.906 . . . . 0.0 109.229 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -45.15 170.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.912 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 12.0 p -142.24 -37.96 0.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 109.608 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 269' ' ' GLN . . . . . 0.507 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 3.7 pt20 -95.93 -144.74 0.27 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.654 -0.654 . . . . 0.0 109.324 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 270' ' ' GLU . . . . . 0.518 ' O ' ' CZ ' ' B' ' 272' ' ' ARG . 22.2 tt0 -117.53 134.1 55.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.041 -1.037 . . . . 0.0 109.829 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 271' ' ' VAL . . . . . 0.942 HG13 ' HB3' ' B' ' 280' ' ' PHE . 76.1 t -64.84 148.97 11.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.414 -0.804 . . . . 0.0 109.17 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 11.9 mmt180 -103.4 137.84 40.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 273' ' ' ALA . . . . . 0.459 ' C ' HG22 ' B' ' 274' ' ' VAL . . . -148.76 139.22 22.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 109.077 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 274' ' ' VAL . . . . . 0.63 HG11 ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -160.3 157.58 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.068 -1.02 . . . . 0.0 110.088 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 275' ' ' ALA . . . . . 0.449 ' HB1' ' HA3' ' A' ' 41' ' ' GLY . . . 40.59 -102.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.653 -0.655 . . . . 0.0 110.095 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 276' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 98.3 m-20 -129.3 5.31 5.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.898 -1.126 . . . . 0.0 109.628 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 277' ' ' GLU . . . . . 0.536 ' CG ' ' HG2' ' B' ' 302' ' ' ARG . 0.3 OUTLIER -112.6 -162.65 0.81 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.087 -1.008 . . . . 0.0 108.972 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 278' ' ' ALA . . . . . 0.573 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . 177.17 142.47 0.08 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.623 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 279' ' ' ALA . . . . . 0.713 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -125.92 136.45 53.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 108.604 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 280' ' ' PHE . . . . . 0.942 ' HB3' HG13 ' B' ' 271' ' ' VAL . 30.0 p90 -149.72 172.46 15.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.74 -1.225 . . . . 0.0 109.982 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.576 ' HB2' ' CG1' ' B' ' 298' ' ' ILE . . . -148.23 -164.95 2.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.808 . . . . 0.0 109.991 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 282' ' ' PHE . . . . . 0.49 ' CD2' ' C ' ' B' ' 281' ' ' ALA . 14.2 p90 172.14 -169.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.45 -0.781 . . . . 0.0 109.384 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.15 147.3 52.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.394 -0.816 . . . . 0.0 109.645 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 284' ' ' VAL . . . . . 0.87 HG13 ' CB ' ' B' ' 263' ' ' LEU . 3.3 t -123.8 121.13 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.868 . . . . 0.0 109.429 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 285' ' ' SER . . . . . 0.74 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 16.7 p -115.52 117.84 31.47 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' B' ' 293' ' ' THR . 11.4 p90 -142.24 173.65 11.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.084 -1.01 . . . . 0.0 110.217 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 287' ' ' GLU . . . . . 0.509 ' HG2' ' N ' ' B' ' 288' ' ' PHE . 36.1 tt0 -148.42 154.03 39.35 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 288' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' B' ' 288' ' ' PHE . 0.1 OUTLIER -128.01 -96.36 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.036 -1.04 . . . . 0.0 110.358 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -110.16 93.92 4.75 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.122 -0.987 . . . . 0.0 110.443 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 62.14 11.34 32.01 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 291' ' ' ARG . . . . . 0.593 ' HB3' ' CE2' ' B' ' 288' ' ' PHE . 26.9 mtt180 -130.94 144.79 51.73 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.206 -1.173 . . . . 0.0 109.578 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 292' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' B' ' 287' ' ' GLU . 0.0 OUTLIER -136.2 120.78 18.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.347 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 293' ' ' THR . . . . . 0.673 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -122.57 143.58 49.65 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.403 -0.81 . . . . 0.0 109.717 -179.588 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 294' ' ' VAL . . . . . 0.553 HG13 ' N ' ' B' ' 295' ' ' VAL . 0.8 OUTLIER -112.92 173.55 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 1.011 HG12 ' HD3' ' B' ' 297' ' ' PRO . 2.6 t -150.41 144.41 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.955 -1.091 . . . . 0.0 110.034 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 296' ' ' ALA . . . . . 0.439 ' O ' ' CG ' ' B' ' 320' ' ' ASN . . . -133.34 73.81 73.14 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.425 -0.797 . . . . 0.0 109.208 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 297' ' ' PRO . . . . . 1.011 ' HD3' HG12 ' B' ' 295' ' ' VAL . 50.2 Cg_endo -94.48 -179.21 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.907 1.478 . . . . 0.0 111.797 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.576 ' CG1' ' HB2' ' B' ' 281' ' ' ALA . 2.9 mp -137.34 138.45 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 299' ' ' ASP . . . . . 0.613 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 14.7 t0 -113.75 164.16 14.08 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.984 -1.073 . . . . 0.0 110.24 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 300' ' ' HIS . . . . . 0.612 ' CE1' ' NH2' ' A' ' 113' ' ' ARG . 7.4 t-160 -112.22 173.43 6.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 109.09 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 301' ' ' PHE . . . . . 0.846 ' CE2' HG22 ' B' ' 211' ' ' VAL . 0.2 OUTLIER -145.27 149.03 34.13 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.214 -0.929 . . . . 0.0 110.163 -178.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.536 ' HG2' ' CG ' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -138.01 104.26 5.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.828 . . . . 0.0 109.284 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 303' ' ' PHE . . . . . 0.717 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 11.6 m-85 -89.96 171.62 9.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.081 -1.012 . . . . 0.0 109.512 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 304' ' ' ASN . . . . . 0.59 ' HB3' HG21 ' B' ' 310' ' ' VAL . 9.2 p-10 -119.16 -14.25 9.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.427 -0.796 . . . . 0.0 109.132 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 305' ' ' GLY . . . . . 0.707 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -172.49 -62.81 0.05 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 306' ' ' ALA . . . . . 0.707 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 162.74 76.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -1.097 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.52 -64.48 0.06 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -119.35 -172.94 2.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -1.148 . . . . 0.0 109.664 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 309' ' ' VAL . . . . . 1.039 HG11 ' CE ' ' B' ' 312' ' ' MET . 89.7 t -110.43 150.33 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.216 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 310' ' ' VAL . . . . . 0.59 HG21 ' HB3' ' B' ' 304' ' ' ASN . 42.6 t -123.27 -20.22 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.141 -0.974 . . . . 0.0 109.923 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 311' ' ' SER . . . . . 0.531 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -157.85 166.86 31.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.952 -1.092 . . . . 0.0 110.023 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 312' ' ' MET . . . . . 1.039 ' CE ' HG11 ' B' ' 309' ' ' VAL . 1.6 ttm -156.69 154.29 29.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -0.853 . . . . 0.0 109.428 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 313' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' B' ' 299' ' ' ASP . 1.2 ttt180 -130.14 153.38 48.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.227 -0.92 . . . . 0.0 109.378 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 314' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' B' ' 237' ' ' GLU . . . -100.45 157.18 16.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.738 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 315' ' ' LEU . . . . . 1.069 HD11 ' HB2' ' A' ' 79' ' ' ALA . 9.0 tp -137.1 -143.78 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.427 -0.796 . . . . 0.0 109.019 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 316' ' ' PHE . . . . . 0.667 ' O ' HG21 ' A' ' 74' ' ' VAL . 31.0 p90 39.4 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.772 0.796 . . . . 0.0 110.313 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 317' ' ' GLY . . . . . 0.703 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 173.62 -152.52 15.52 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 318' ' ' GLU . . . . . 0.542 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 6.8 tt0 -72.25 -2.36 18.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -1.153 . . . . 0.0 109.71 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.2 -32.58 15.02 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.221 -0.925 . . . . 0.0 109.316 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 320' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' B' ' 316' ' ' PHE . 1.1 m-20 -89.31 19.23 4.51 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.251 0.548 . . . . 0.0 109.821 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 321' ' ' ILE . . . . . 0.706 HG22 ' H ' ' B' ' 322' ' ' HIS . 5.1 mm -89.82 -167.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 322' ' ' HIS . . . . . 0.706 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.2 OUTLIER -151.67 155.14 37.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.056 -1.027 . . . . 0.0 109.247 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.116 -0.99 . . . . 0.0 109.773 -179.946 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.707 HG23 ' O ' ' A' ' 3' ' ' THR . 9.8 t . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.477 ' O ' ' HB ' ' A' ' 8' ' ' THR . 45.5 Cg_endo -72.78 -10.52 25.04 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.869 1.457 . . . . 0.0 110.17 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -32.77 68.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 109.692 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.85 -51.0 5.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.926 . . . . 0.0 109.423 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.441 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 17.3 mtt -61.14 -48.19 82.76 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.268 -0.895 . . . . 0.0 109.902 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 4' ' ' PRO . 17.7 m -53.53 -39.05 64.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.487 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.81 -48.06 73.26 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.259 -0.901 . . . . 0.0 108.866 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.655 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.2 t -52.49 -28.68 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.934 HG22 ' CE2' ' A' ' 101' ' ' PHE . 6.6 t -85.47 -42.61 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.239 -0.913 . . . . 0.0 109.354 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.2 tt0 -59.61 -73.65 0.08 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.806 ' HD2' HD13 ' A' ' 29' ' ' LEU . 2.7 mtm180 -43.45 -46.12 6.63 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.709 ' CE1' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -53.13 -41.22 64.85 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.916 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -84.01 -36.58 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.092 -1.005 . . . . 0.0 108.928 179.389 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.71 -39.55 65.3 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -71.22 -32.36 68.7 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -63.27 -58.18 8.01 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.13 -42.47 60.75 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.64 0.733 . . . . 0.0 109.269 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.58 2.35 53.23 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.68 -0.637 . . . . 0.0 109.604 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 1.086 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 49.79 38.24 29.61 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.47 ' O ' HG13 ' A' ' 26' ' ' ILE . 29.6 t70 -92.18 77.85 5.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -1.033 . . . . 0.0 109.865 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.083 ' CD2' HD22 ' A' ' 59' ' ' LEU . 2.8 mm? -50.69 -29.05 10.27 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.334 -0.853 . . . . 0.0 110.12 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -63.93 -56.43 15.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.975 . . . . 0.0 109.366 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.43 ' N ' ' OD2' ' A' ' 22' ' ' ASP . . . -59.0 -28.24 63.41 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.023 HD12 HD13 ' A' ' 23' ' ' LEU . 55.8 mt -63.62 -58.08 8.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.948 HG11 HG23 ' A' ' 48' ' ' THR . 43.6 t -55.82 -41.26 65.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.48 -49.98 71.09 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.806 HD13 ' HD2' ' A' ' 13' ' ' ARG . 2.9 tp -72.35 -21.0 61.37 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.553 -0.717 . . . . 0.0 109.265 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.602 ' CZ ' ' CE ' ' A' ' 112' ' ' MET . 7.2 m-85 -92.41 140.84 29.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.372 -0.83 . . . . 0.0 109.561 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -51.67 178.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.073 -1.017 . . . . 0.0 109.344 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.02 -23.89 59.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.175 -0.953 . . . . 0.0 109.241 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.51 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -137.75 30.41 2.56 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.759 -0.588 . . . . 0.0 109.633 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.737 ' N ' HD11 ' A' ' 51' ' ' ILE . . . -53.21 -173.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.159 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.661 HG23 ' HB2' ' A' ' 46' ' ' SER . 0.2 OUTLIER -145.3 147.38 32.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.16 -0.963 . . . . 0.0 110.187 -179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.52 ' O ' ' HB3' ' A' ' 44' ' ' PRO . 9.5 t -134.56 118.16 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.521 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 2.3 mm-40 -88.3 104.94 17.21 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.529 ' O ' ' CE2' ' A' ' 54' ' ' PHE . 9.9 t0 -176.99 142.76 0.53 Allowed Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.92 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 47.8 Cg_endo -73.85 -166.48 4.63 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.28 -1.967 . . . . 0.0 110.651 -0.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.961 HG21 HG11 ' B' ' 274' ' ' VAL . 15.3 m -75.97 141.64 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.132 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.29 1.63 64.98 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.509 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -105.59 -155.26 0.54 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.265 -1.138 . . . . 0.0 109.355 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.442 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 27.9 mm-40 -127.74 131.88 24.05 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.08 -1.012 . . . . 0.0 110.07 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.521 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.0 Cg_endo -64.0 -166.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.575 1.517 . . . . 0.0 111.073 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 1.037 ' CG ' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -150.62 102.64 3.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.509 -0.744 . . . . 0.0 109.049 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.661 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.2 147.04 24.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.21 -0.931 . . . . 0.0 109.768 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 111.26 159.8 16.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.948 HG23 HG11 ' A' ' 27' ' ' VAL . 11.3 m -70.97 -43.33 68.29 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.059 -1.26 . . . . 0.0 109.291 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -66.78 -31.78 72.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.15 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.037 ' HB1' ' CG ' ' A' ' 45' ' ' ARG . . . -80.44 -60.37 2.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.898 . . . . 0.0 109.331 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.737 HD11 ' N ' ' A' ' 34' ' ' ALA . 39.3 mt -43.35 -38.28 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.371 -0.831 . . . . 0.0 109.003 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.518 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 4.8 ttt-85 -84.98 -55.18 4.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.536 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 26.1 tt0 -47.71 -26.08 1.43 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.565 ' CD1' ' HD3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -84.2 -71.79 0.5 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.717 ' CE1' HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -52.46 -20.82 3.13 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.24 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.479 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . . . -76.4 -44.73 34.84 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 48.8 t30 -64.49 -32.0 73.45 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 t -72.09 -35.35 69.2 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.086 HD21 ' CA ' ' A' ' 21' ' ' GLY . 3.1 tp -69.61 -24.82 63.72 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.458 -0.776 . . . . 0.0 109.383 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -43.85 -27.5 0.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 108.823 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.047 HD22 HD21 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -91.63 109.02 33.67 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.444 ' C ' ' HG ' ' A' ' 63' ' ' LEU . 45.1 Cg_endo -70.65 110.85 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.844 1.444 . . . . 0.0 111.332 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.047 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -138.46 173.1 11.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 109.497 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.843 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -102.36 127.54 49.32 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 18' ' ' LEU . 95.8 t -108.23 124.72 64.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 110.034 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -150.04 112.12 4.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.537 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.711 HD22 ' CG2' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -48.03 176.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.219 -0.926 . . . . 0.0 109.811 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.52 -81.97 0.43 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.278 -0.889 . . . . 0.0 109.293 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.594 ' HG2' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -123.43 -55.33 1.75 Allowed 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.807 -179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.594 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 17.2 tt0 -140.55 153.99 46.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.94 -1.1 . . . . 0.0 110.442 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.949 HG13 ' HB3' ' A' ' 80' ' ' PHE . 19.0 t -99.57 149.12 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -95.26 128.96 42.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.483 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.562 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -148.25 137.1 21.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.142 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.815 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -165.64 154.19 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 109.793 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 1.036 ' CB ' HG12 ' B' ' 240' ' ' VAL . . . 43.14 -147.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 0.0 109.827 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 103' ' ' PHE . 30.8 m-80 -88.98 26.54 1.54 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.279 -0.888 . . . . 0.0 109.609 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.9 OUTLIER -129.68 -159.57 0.97 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.268 -0.895 . . . . 0.0 109.061 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.86 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 168.18 157.59 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.41 -0.806 . . . . 0.0 109.794 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.733 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -151.2 139.37 20.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 108.902 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.949 ' HB3' HG13 ' A' ' 71' ' ' VAL . 24.4 p90 -149.57 161.77 41.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.655 -1.278 . . . . 0.0 109.787 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.608 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -130.69 -174.99 3.52 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.574 0.702 . . . . 0.0 110.016 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CE2' ' CE2' ' A' ' 80' ' ' PHE . 19.6 p90 172.21 -172.11 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.546 -0.721 . . . . 0.0 109.22 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -128.34 141.11 51.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.482 -0.761 . . . . 0.0 109.551 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.579 HG12 ' CB ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -101.83 122.13 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 108.952 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.843 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 1.1 p -118.07 102.76 9.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 109.683 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.85 ' CD1' HD23 ' A' ' 63' ' ' LEU . 17.7 p90 -123.02 159.72 27.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.096 -1.003 . . . . 0.0 109.276 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -95.71 171.01 8.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.133 -0.979 . . . . 0.0 109.651 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.08 -160.99 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 109.578 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.83 36.44 1.54 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.319 -0.863 . . . . 0.0 109.095 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.49 -30.3 0.17 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -137.29 -167.78 2.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -1.172 . . . . 0.0 109.352 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.01 136.18 50.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 109.692 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -120.4 157.48 29.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.271 -0.893 . . . . 0.0 109.874 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.548 HG13 ' CB ' ' A' ' 122' ' ' HIS . 12.0 p -138.24 163.9 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.314 -0.866 . . . . 0.0 109.138 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 120' ' ' ASN . 41.4 t -142.44 155.49 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.987 -1.071 . . . . 0.0 109.93 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 120' ' ' ASN . . . -127.86 73.81 78.77 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.494 -0.754 . . . . 0.0 109.818 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.561 ' HD3' HG12 ' A' ' 95' ' ' VAL . 44.0 Cg_endo -95.39 175.49 0.98 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.586 1.524 . . . . 0.0 111.578 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.608 HG23 ' HB2' ' A' ' 81' ' ' ALA . 3.4 mp -143.19 152.39 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.623 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 12.7 t0 -125.42 161.49 26.94 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.004 -1.06 . . . . 0.0 110.229 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 113' ' ' ARG . 5.2 t60 -108.22 179.82 4.1 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.934 ' CE2' HG22 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -146.24 160.18 42.33 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.756 -1.215 . . . . 0.0 110.597 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.554 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -147.09 103.92 3.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.655 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -90.0 -171.06 3.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.165 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.794 ' OD1' HG23 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -139.42 -101.89 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.462 -0.774 . . . . 0.0 109.526 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.692 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -96.44 21.03 47.8 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 105' ' ' GLY . . . 77.35 66.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -1.112 . . . . 0.0 109.502 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.54 -65.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -128.93 -178.23 4.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -1.134 . . . . 0.0 109.507 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.766 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 45.3 t -94.0 141.52 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.375 -0.828 . . . . 0.0 109.395 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.794 HG23 ' OD1' ' A' ' 104' ' ' ASN . 24.6 t -121.95 -15.22 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 109.976 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.554 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.3 OUTLIER -158.68 157.32 31.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.93 -1.106 . . . . 0.0 109.956 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.724 ' HE2' ' CE1' ' A' ' 101' ' ' PHE . 8.0 ttm -155.46 160.43 40.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.426 -0.796 . . . . 0.0 109.456 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 100' ' ' HIS . 10.1 ttp180 -149.75 114.41 5.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.858 . . . . 0.0 109.403 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 99' ' ' ASP . . . -89.98 137.59 32.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.082 -1.011 . . . . 0.0 109.461 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.954 HD22 ' CB ' ' B' ' 279' ' ' ALA . 1.0 OUTLIER -134.12 143.65 48.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.965 . . . . 0.0 110.102 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.559 ' O ' HG11 ' B' ' 274' ' ' VAL . 32.9 p90 164.36 -163.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.609 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . -176.15 -179.86 46.85 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.246 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.524 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 11.9 tt0 -50.63 -21.46 1.58 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -1.138 . . . . 0.0 109.304 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -22.55 60.7 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.017 0.913 . . . . 0.0 108.668 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.633 ' O ' HG13 ' A' ' 95' ' ' VAL . 1.0 OUTLIER -88.72 3.27 51.45 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.676 -179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 122' ' ' HIS . 4.2 mm -93.39 -179.34 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.028 -1.045 . . . . 0.0 109.372 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.612 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.7 OUTLIER -151.56 161.46 42.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.509 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.38 152.86 29.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.513 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.9 -128.4 9.49 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.277 -1.131 . . . . 0.0 109.505 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.219 0.533 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -120.92 55.79 1.03 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.1 111.0 44.3 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.348 -0.845 . . . . 0.0 109.558 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 204' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' B' ' 208' ' ' THR . 44.3 Cg_endo -71.38 -8.57 23.63 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.832 1.438 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -66.41 -45.46 79.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.043 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -55.69 6.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 109.161 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 13.0 mmt -53.52 -41.96 66.89 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.432 ' CB ' ' O ' ' B' ' 204' ' ' PRO . 6.0 m -63.38 -35.51 80.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 109.06 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -51.13 -44.08 61.29 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.218 -0.926 . . . . 0.0 108.72 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 1.016 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.1 t -57.08 -25.44 22.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.893 HG22 ' CE2' ' B' ' 301' ' ' PHE . 23.9 t -88.43 -44.88 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.832 . . . . 0.0 109.159 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 212' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' B' ' 213' ' ' ARG . 24.6 tt0 -58.99 -73.96 0.07 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' B' ' 212' ' ' GLN . 0.2 OUTLIER -42.77 -44.53 4.44 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 214' ' ' TYR . . . . . 0.64 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -51.21 -44.87 61.71 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.543 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.907 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.08 -41.23 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 216' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.39 -35.03 11.82 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.57 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -75.86 -33.46 60.0 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' B' ' 215' ' ' VAL . 3.1 mt -62.84 -57.39 11.03 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 219' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' B' ' 265' ' ' VAL . 4.6 t30 -53.68 -45.67 70.4 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.576 0.703 . . . . 0.0 109.578 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.14 7.23 36.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.476 -0.765 . . . . 0.0 109.745 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.862 ' HA2' HD11 ' B' ' 259' ' ' LEU . . . 51.83 42.06 52.51 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 222' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' B' ' 217' ' ' ALA . 18.0 t70 -97.8 61.44 1.57 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.112 . . . . 0.0 109.928 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 223' ' ' LEU . . . . . 1.054 HD12 HD12 ' B' ' 226' ' ' ILE . 7.1 tp -47.79 -44.12 28.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 108.883 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' B' ' 223' ' ' LEU . 3.9 t0 -43.86 -39.5 3.92 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 225' ' ' GLY . . . . . 0.481 ' HA3' ' OD2' ' B' ' 222' ' ' ASP . . . -80.77 -32.35 33.42 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 1.054 HD12 HD12 ' B' ' 223' ' ' LEU . 13.8 mt -61.97 -58.48 7.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.458 ' HA ' ' HB2' ' B' ' 230' ' ' PHE . 50.7 t -54.57 -39.73 47.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.71 -54.63 41.94 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 1.016 HD21 ' HA ' ' B' ' 210' ' ' VAL . 7.7 tp -61.76 -22.9 65.8 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 230' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' B' ' 231' ' ' ALA . 6.5 m-85 -90.85 132.43 35.9 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.428 -0.795 . . . . 0.0 109.918 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' B' ' 309' ' ' VAL . . . -50.66 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 0.0 109.652 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' B' ' 248' ' ' THR . 0.2 OUTLIER -76.31 -24.4 54.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 109.733 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.521 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 0.1 OUTLIER -133.46 39.76 3.2 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.474 -0.766 . . . . 0.0 109.764 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.899 ' O ' HD11 ' B' ' 251' ' ' ILE . . . -64.0 144.49 57.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.138 -0.976 . . . . 0.0 109.346 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 235' ' ' THR . . . . . 0.99 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -106.18 139.58 40.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 0.0 109.6 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' B' ' 244' ' ' PRO . 55.2 t -132.72 118.39 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.411 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 237' ' ' GLU . . . . . 0.515 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 29.3 mt-10 -89.42 106.24 18.32 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 238' ' ' ASP . . . . . 0.53 ' O ' ' CE2' ' B' ' 254' ' ' PHE . 28.4 t70 -179.67 141.68 0.35 Allowed Pre-proline 0 C--N 1.302 -1.484 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.492 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 239' ' ' PRO . . . . . 0.492 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 48.4 Cg_endo -74.11 169.89 72.47 Favored 'Cis proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.295 -1.961 . . . . 0.0 110.545 0.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 1.036 HG12 ' CB ' ' A' ' 75' ' ' ALA . 8.0 t -67.47 113.99 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.179 -0.951 . . . . 0.0 109.236 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 112.93 -2.52 25.74 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 242' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 17.5 m -109.38 -113.05 0.31 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -1.124 . . . . 0.0 109.212 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 243' ' ' GLU . . . . . 0.469 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 1.2 pp20? -164.34 131.46 2.42 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.904 -1.122 . . . . 0.0 109.612 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 244' ' ' PRO . . . . . 0.515 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.8 Cg_endo -64.83 -177.34 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.011 1.532 . . . . 0.0 111.13 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.77 ' HB3' ' HB1' ' B' ' 250' ' ' ALA . 11.1 mmt180 -150.54 99.94 2.8 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.99 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -88.88 164.71 15.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.32 -0.863 . . . . 0.0 109.748 -179.153 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 247' ' ' GLY . . . . . 0.521 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 101.46 162.19 27.19 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 248' ' ' THR . . . . . 0.525 ' N ' ' O ' ' B' ' 232' ' ' ASP . 5.9 m -70.04 -52.81 20.99 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.163 -1.198 . . . . 0.0 109.382 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -59.68 -40.75 88.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.162 -0.961 . . . . 0.0 109.438 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.77 ' HB1' ' HB3' ' B' ' 245' ' ' ARG . . . -68.37 -54.9 14.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 109.605 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.899 HD11 ' O ' ' B' ' 234' ' ' ALA . 8.5 mm -47.39 -36.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.115 -0.991 . . . . 0.0 109.116 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 252' ' ' ARG . . . . . 0.839 ' CG ' HD23 ' B' ' 223' ' ' LEU . 6.9 ttt180 -84.96 -55.16 4.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 253' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 5.5 mt-10 -48.7 -26.98 2.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.992 -1.068 . . . . 0.0 108.327 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.549 ' CD1' ' HG3' ' B' ' 245' ' ' ARG . 0.2 OUTLIER -86.71 -72.6 0.5 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 255' ' ' PHE . . . . . 0.981 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -49.1 -26.55 2.77 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.18 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 256' ' ' ALA . . . . . 0.618 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -70.38 -41.69 72.75 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -58.86 -27.4 65.13 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 41.9 t -77.69 -34.27 52.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 259' ' ' LEU . . . . . 0.862 HD11 ' HA2' ' B' ' 221' ' ' GLY . 7.9 tp -70.04 -26.7 64.16 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.436 -0.79 . . . . 0.0 109.47 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -49.43 -31.43 9.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.278 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 261' ' ' LEU . . . . . 0.978 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.9 OUTLIER -90.03 114.6 61.45 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.287 -0.883 . . . . 0.0 109.006 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 262' ' ' PRO . . . . . 0.454 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 43.3 Cg_endo -70.44 109.25 2.39 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.719 1.379 . . . . 0.0 110.665 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.978 ' CD2' HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -140.29 159.65 41.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.486 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -92.81 128.41 38.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.87 . . . . 0.0 108.694 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 265' ' ' VAL . . . . . 0.758 HG21 ' HB3' ' B' ' 218' ' ' LEU . 11.0 t -107.67 113.83 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 109.697 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 266' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' B' ' 267' ' ' LEU . 6.7 tt0 -150.47 95.47 2.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.4 -0.813 . . . . 0.0 109.042 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.867 HD23 ' O ' ' B' ' 281' ' ' ALA . 1.5 mp -44.75 169.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.2 -0.938 . . . . 0.0 109.836 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 5.1 t -127.65 -31.64 2.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 269' ' ' GLN . . . . . 0.524 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 13.7 pt20 -107.88 -151.42 0.47 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.524 -0.735 . . . . 0.0 109.459 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 270' ' ' GLU . . . . . 0.524 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 42.2 tt0 -106.64 129.96 54.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.486 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 271' ' ' VAL . . . . . 0.897 HG13 ' HB3' ' B' ' 280' ' ' PHE . 16.6 t -60.24 150.85 6.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.398 -0.813 . . . . 0.0 109.367 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 4.9 tpp180 -104.98 131.36 52.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 108.875 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 273' ' ' ALA . . . . . 0.529 ' HA ' ' CB ' ' B' ' 278' ' ' ALA . . . -148.0 126.23 12.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.089 -1.007 . . . . 0.0 109.9 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 274' ' ' VAL . . . . . 0.961 HG11 HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -121.95 -155.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.245 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 275' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' B' ' 276' ' ' ASN . . . -83.85 126.5 33.02 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.384 -0.822 . . . . 0.0 110.678 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 276' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' B' ' 275' ' ' ALA . 57.1 m-20 69.27 -2.35 1.88 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.706 -0.621 . . . . 0.0 111.721 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 277' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 3.4 tt0 -150.67 -160.47 1.17 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.418 -1.426 . . . . 0.0 110.518 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 278' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' B' ' 277' ' ' GLU . . . 165.45 152.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 279' ' ' ALA . . . . . 0.954 ' CB ' HD22 ' A' ' 115' ' ' LEU . . . -138.91 136.92 36.0 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 280' ' ' PHE . . . . . 0.897 ' HB3' HG13 ' B' ' 271' ' ' VAL . 33.5 p90 -149.97 167.38 26.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.831 -1.168 . . . . 0.0 110.546 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.95 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -142.68 -162.02 1.35 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.415 0.626 . . . . 0.0 109.448 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 282' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 0.0 OUTLIER 163.92 -175.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.885 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 283' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -127.86 141.11 51.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.436 -0.79 . . . . 0.0 109.733 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 284' ' ' VAL . . . . . 0.975 HG11 HD22 ' B' ' 263' ' ' LEU . 66.6 t -111.24 113.53 44.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.47 -0.769 . . . . 0.0 108.929 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 53.7 p -105.63 84.26 2.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.908 . . . . 0.0 110.028 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.58 ' CE1' ' HB ' ' B' ' 293' ' ' THR . 34.3 p90 -89.95 177.5 6.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.878 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -127.58 153.47 46.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.12 -0.988 . . . . 0.0 109.617 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -103.11 -98.03 0.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.379 -0.826 . . . . 0.0 109.586 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -140.31 47.09 1.8 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.194 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 139.99 -42.31 1.23 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -94.63 -166.69 1.52 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.508 -0.995 . . . . 0.0 108.877 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 292' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.29 123.35 9.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.044 -1.035 . . . . 0.0 109.744 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 293' ' ' THR . . . . . 0.58 ' HB ' ' CE1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -111.04 147.28 35.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.377 -0.827 . . . . 0.0 109.22 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 294' ' ' VAL . . . . . 0.747 HG13 ' HB2' ' B' ' 322' ' ' HIS . 11.1 p -127.52 167.95 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 109.681 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 1.041 HG12 ' HD3' ' B' ' 297' ' ' PRO . 3.5 t -140.18 148.21 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 108.999 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 296' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 320' ' ' ASN . . . -132.1 71.48 79.89 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 0.0 110.895 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 297' ' ' PRO . . . . . 1.041 ' HD3' HG12 ' B' ' 295' ' ' VAL . 51.1 Cg_endo -93.82 -174.28 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.486 1.458 . . . . 0.0 110.292 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.95 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.6 mp -140.04 162.64 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.875 . . . . 0.0 108.945 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 299' ' ' ASP . . . . . 0.608 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 14.0 t0 -133.1 157.49 45.16 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.11 -0.994 . . . . 0.0 110.084 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 300' ' ' HIS . . . . . 0.785 ' NE2' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -112.81 167.25 10.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 301' ' ' PHE . . . . . 0.893 ' CE2' HG22 ' B' ' 211' ' ' VAL . 0.2 OUTLIER -137.94 157.74 45.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.979 -1.076 . . . . 0.0 110.536 -178.701 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.516 ' HB3' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -150.09 104.33 3.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.56 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 303' ' ' PHE . . . . . 0.665 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 6.9 m-85 -89.6 129.72 36.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.469 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 304' ' ' ASN . . . . . 0.566 ' ND2' ' N ' ' B' ' 304' ' ' ASN . 0.0 OUTLIER -137.42 14.63 2.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.294 -0.878 . . . . 0.0 109.428 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . -135.69 5.87 4.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . 50.1 25.22 1.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -1.134 . . . . 0.0 109.602 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -161.25 -42.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -123.54 -168.12 1.72 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -1.091 . . . . 0.0 109.46 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 309' ' ' VAL . . . . . 0.766 HG23 ' CG2' ' B' ' 210' ' ' VAL . 38.2 t -111.84 138.26 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.941 . . . . 0.0 108.993 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 310' ' ' VAL . . . . . 0.534 ' HB ' ' ND2' ' B' ' 304' ' ' ASN . 2.7 t -121.3 -6.93 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.849 -1.157 . . . . 0.0 109.788 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 311' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.4 OUTLIER -155.23 152.93 29.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 0.0 109.347 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 312' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 300' ' ' HIS . 5.7 ttp -160.22 154.97 24.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 109.865 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 313' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' B' ' 299' ' ' ASP . 0.0 OUTLIER -137.77 163.7 30.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 109.067 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -142.5 141.56 32.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.019 -1.051 . . . . 0.0 109.72 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 315' ' ' LEU . . . . . 0.733 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -137.9 139.13 39.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 109.726 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 316' ' ' PHE . . . . . 0.815 ' O ' HG11 ' A' ' 74' ' ' VAL . 14.6 p90 173.76 -157.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.567 0.699 . . . . 0.0 109.352 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 317' ' ' GLY . . . . . 0.437 ' N ' ' CD2' ' B' ' 316' ' ' PHE . . . 165.29 -168.37 39.31 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 318' ' ' GLU . . . . . 0.534 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 15.7 tt0 -71.54 -4.37 26.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -1.164 . . . . 0.0 109.355 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 319' ' ' LYS . . . . . 0.484 ' HD3' ' OE1' ' A' ' 70' ' ' GLU . 2.4 tttm -89.72 -28.39 19.44 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 122.02 0.914 . . . . 0.0 108.87 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 320' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' B' ' 296' ' ' ALA . 1.4 m-20 -89.24 4.48 48.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 321' ' ' ILE . . . . . 0.92 HG23 HG22 ' B' ' 295' ' ' VAL . 5.0 mm -89.86 -173.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.325 -0.86 . . . . 0.0 108.83 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 322' ' ' HIS . . . . . 0.747 ' HB2' HG13 ' B' ' 294' ' ' VAL . 0.2 OUTLIER -150.86 -164.74 2.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.071 -1.018 . . . . 0.0 109.792 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.081 179.839 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.58 ' O ' ' CE1' ' A' ' 6' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.08 -4.81 15.0 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.761 1.401 . . . . 0.0 109.877 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -52.81 63.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.304 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 3' ' ' THR . 36.9 p-80 -70.3 -41.94 72.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.903 . . . . 0.0 109.273 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.577 ' CG ' ' NE2' ' A' ' 6' ' ' HIS . 10.3 mtt -59.07 -44.29 91.83 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.199 -0.938 . . . . 0.0 109.342 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.477 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 14.2 m -64.9 -38.46 91.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.315 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.66 77.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 108.872 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.802 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.4 t -55.12 -20.68 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.813 HG11 ' CG2' ' A' ' 71' ' ' VAL . 18.5 t -90.61 -43.5 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.409 -0.807 . . . . 0.0 109.236 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 13' ' ' ARG . 24.1 tt0 -61.19 -73.72 0.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.259 1.028 . . . . 0.0 108.313 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.864 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -42.07 -44.16 3.5 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.157 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.642 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -50.01 -46.61 52.94 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.915 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -86.23 -39.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.355 -0.84 . . . . 0.0 109.083 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -48.61 -36.68 16.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.553 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -74.37 -32.0 62.59 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.915 HD12 ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -65.3 -58.4 6.01 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.439 ' CG ' ' O ' ' A' ' 65' ' ' VAL . 24.4 t30 -52.56 -46.4 66.83 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.596 0.712 . . . . 0.0 109.089 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.96 10.67 20.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.649 -0.657 . . . . 0.0 109.476 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 1.006 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 45.52 27.81 2.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 17' ' ' ALA . 1.8 t70 -89.93 67.81 7.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -1.091 . . . . 0.0 109.866 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.12 HD11 ' HB3' ' A' ' 55' ' ' PHE . 4.6 tp -47.8 -41.31 23.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 109.165 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' LEU . 5.2 m-20 -41.49 -28.83 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -88.04 -35.87 8.71 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.006 HD12 HD12 ' A' ' 23' ' ' LEU . 22.0 mt -59.54 -53.82 43.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.54 HG21 ' CG ' ' A' ' 52' ' ' ARG . 91.1 t -59.72 -43.23 91.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.98 -43.62 66.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.864 HD22 ' HB3' ' A' ' 13' ' ' ARG . 6.6 tp -73.39 -27.91 61.72 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.531 ' HD2' HG22 ' A' ' 26' ' ' ILE . 8.8 m-85 -84.83 138.45 32.56 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.32 -0.862 . . . . 0.0 109.841 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -51.68 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 109.697 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.461 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -70.72 -23.42 62.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.622 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.548 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -148.51 41.08 0.95 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.623 -0.673 . . . . 0.0 109.264 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.632 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -52.95 151.77 4.44 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.253 -0.904 . . . . 0.0 109.699 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.34 144.44 29.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.387 -0.82 . . . . 0.0 109.432 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.597 ' CG2' HD12 ' A' ' 51' ' ' ILE . 2.1 t -123.58 169.14 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 108.899 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.632 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -142.65 105.39 4.52 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.205 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.491 ' HB2' ' O ' ' A' ' 37' ' ' GLU . 4.6 t70 177.67 142.93 0.26 Allowed Pre-proline 0 N--CA 1.495 1.777 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.065 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 46.6 Cg_endo -75.45 -176.34 18.04 Favored 'Cis proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.191 -2.004 . . . . 0.0 110.163 -0.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 115' ' ' LEU . 3.5 m -80.11 83.73 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.091 -1.006 . . . . 0.0 109.125 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.86 -13.92 1.33 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.533 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -108.57 -149.23 0.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -1.084 . . . . 0.0 109.417 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -109.93 133.92 20.83 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.916 -1.115 . . . . 0.0 110.721 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.3 Cg_endo -63.65 -161.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.157 1.904 . . . . 0.0 111.369 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.618 ' HD2' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -150.17 123.31 8.86 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.568 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -116.94 152.3 34.85 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.025 -1.047 . . . . 0.0 110.448 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 93.85 162.83 36.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 2.9 m -72.12 -57.58 4.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -1.113 . . . . 0.0 109.17 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -47.66 -29.28 2.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 46' ' ' SER . . . -90.07 -61.88 1.59 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.35 -0.844 . . . . 0.0 109.383 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.618 HD13 ' HD2' ' A' ' 45' ' ' ARG . 7.7 mm -45.36 -33.7 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.307 -0.871 . . . . 0.0 109.173 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.892 ' CG ' HD23 ' A' ' 23' ' ' LEU . 53.6 ttp85 -86.83 -61.45 1.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 108.924 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 26.1 tt0 -44.38 -28.8 0.59 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 108.564 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.556 ' CD2' ' HB3' ' A' ' 45' ' ' ARG . 1.2 t80 -80.71 -70.6 0.51 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 1.12 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -47.0 -25.52 0.82 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.717 ' HB2' HD22 ' A' ' 23' ' ' LEU . . . -76.24 -55.08 5.9 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -51.25 -30.77 18.7 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.6 t -76.09 -34.31 59.52 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.006 HD21 ' CA ' ' A' ' 21' ' ' GLY . 7.7 tp -68.82 -21.59 64.3 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.418 -0.802 . . . . 0.0 108.995 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -55.35 -18.68 7.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.364 -0.835 . . . . 0.0 109.049 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.779 HD22 ' CD2' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -89.64 125.34 61.55 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.281 -0.887 . . . . 0.0 108.881 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 86' ' ' PHE . 44.8 Cg_endo -71.44 103.08 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.791 1.416 . . . . 0.0 110.621 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.804 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -136.8 160.03 40.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.1 -1.0 . . . . 0.0 110.021 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.911 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -99.47 129.1 45.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.752 HG21 ' HB3' ' A' ' 18' ' ' LEU . 3.3 t -111.55 114.87 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.716 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -150.5 101.1 2.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.582 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -49.82 -179.71 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.234 -0.916 . . . . 0.0 109.556 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.442 HG23 ' N ' ' A' ' 69' ' ' GLN . 10.6 t -162.2 -37.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.199 -0.938 . . . . 0.0 109.773 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -93.67 -147.68 0.25 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.57 -0.706 . . . . 0.0 109.27 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 23.4 tt0 -115.82 130.39 56.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.188 -0.945 . . . . 0.0 109.687 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.813 ' CG2' HG11 ' A' ' 11' ' ' VAL . 33.7 t -64.19 154.51 6.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.396 -0.815 . . . . 0.0 109.115 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.508 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 3.9 mmt180 -115.56 130.27 56.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.534 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.65 128.32 14.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -0.851 . . . . 0.0 109.228 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.772 HG21 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -152.3 160.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 0.0 109.26 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.582 ' HB3' HG12 ' B' ' 240' ' ' VAL . . . 47.95 -144.43 0.37 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.263 -0.898 . . . . 0.0 109.387 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -90.16 -8.44 51.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.088 -1.008 . . . . 0.0 109.645 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 3.1 mt-10 -104.13 -162.87 0.93 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.236 -0.915 . . . . 0.0 109.501 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.851 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . -175.71 168.56 3.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.0 109.677 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.917 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.52 136.66 18.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.02 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.699 ' HB3' HG13 ' A' ' 71' ' ' VAL . 15.2 p90 -150.01 167.46 26.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.953 -1.092 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.683 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -142.85 168.14 20.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.456 0.646 . . . . 0.0 109.622 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 82' ' ' PHE . 4.5 p90 -164.59 -169.05 1.64 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -0.838 . . . . 0.0 109.277 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.87 141.83 50.34 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.484 -0.76 . . . . 0.0 109.814 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.804 HG12 ' HB3' ' A' ' 63' ' ' LEU . 16.4 t -118.12 112.98 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.364 -0.835 . . . . 0.0 109.116 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.911 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 96.5 p -107.42 99.07 8.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.205 -0.935 . . . . 0.0 109.271 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.547 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . 21.4 p90 -117.41 176.36 5.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.377 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 88' ' ' PHE . 60.7 tt0 -149.98 151.23 33.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.756 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.566 ' CZ ' ' OG1' ' A' ' 93' ' ' THR . 7.9 m-85 -96.71 -141.85 0.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.412 -0.805 . . . . 0.0 109.289 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -102.68 45.59 0.96 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.02 -1.05 . . . . 0.0 109.321 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.52 -42.95 0.46 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -107.7 164.75 11.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -1.191 . . . . 0.0 109.488 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -133.54 123.63 25.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 109.531 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -117.8 148.68 41.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.845 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.789 HG12 ' CG ' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -117.95 178.17 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 108.812 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.975 HG12 ' HD3' ' A' ' 97' ' ' PRO . 2.5 t -150.33 141.36 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.099 -1.001 . . . . 0.0 109.848 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 120' ' ' ASN . . . -129.1 73.02 81.98 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.482 -0.761 . . . . 0.0 109.877 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.975 ' HD3' HG12 ' A' ' 95' ' ' VAL . 50.4 Cg_endo -95.16 -179.37 0.58 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.448 1.432 . . . . 0.0 111.648 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.683 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.7 mp -141.48 133.42 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 5.2 t0 -107.29 162.73 13.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.865 -1.147 . . . . 0.0 110.413 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.527 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -114.75 173.66 6.36 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.111 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.851 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -145.44 146.38 31.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.895 -1.128 . . . . 0.0 110.72 -178.802 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.507 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -138.55 102.5 4.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.419 -0.801 . . . . 0.0 109.375 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.497 ' CE2' HG21 ' A' ' 10' ' ' VAL . 16.6 m-85 -89.6 174.28 7.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 109.381 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.909 ' HB3' HG21 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -114.27 -14.35 12.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.858 . . . . 0.0 109.122 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.716 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 114.93 78.84 0.8 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 163.23 -21.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.35 -1.088 . . . . 0.0 109.721 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 122.19 -35.65 3.43 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -59.56 175.5 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -1.184 . . . . 0.0 109.567 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.732 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 45.8 t -113.27 145.96 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.064 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.909 HG21 ' HB3' ' A' ' 104' ' ' ASN . 5.1 t -121.18 -73.39 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.103 -0.998 . . . . 0.0 109.389 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.439 ' HB2' ' HD2' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -114.66 166.64 11.52 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.029 -1.044 . . . . 0.0 109.047 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 19.6 ttp -154.92 137.41 15.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.165 -0.96 . . . . 0.0 109.902 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.506 ' HA ' ' HB2' ' A' ' 37' ' ' GLU . 3.0 mtm180 -111.55 161.59 16.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.79 . . . . 0.0 108.955 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.409 ' O ' ' CG1' ' A' ' 40' ' ' VAL . . . -143.47 132.26 22.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.98 -1.075 . . . . 0.0 109.77 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.897 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.3 OUTLIER -123.3 137.09 54.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.771 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.811 ' O ' HG11 ' B' ' 274' ' ' VAL . 0.3 OUTLIER 171.14 -162.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 120' ' ' ASN . . . 167.75 175.96 38.0 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.359 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.5 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 37.4 tt0 -48.95 -22.91 0.94 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -1.194 . . . . 0.0 109.281 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.483 ' NZ ' ' CD ' ' B' ' 270' ' ' GLU . 0.3 OUTLIER -73.33 -22.55 60.29 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.043 0.925 . . . . 0.0 108.92 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.708 ' ND2' HD13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -88.54 0.73 56.03 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.634 -179.422 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.708 HD13 ' ND2' ' A' ' 120' ' ' ASN . 3.0 mm -89.59 -159.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.912 -1.117 . . . . 0.0 108.703 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.789 ' CG ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.39 -168.4 3.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 109.637 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.41 147.16 23.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.542 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.91 118.45 1.47 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.264 -1.139 . . . . 0.0 109.479 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 34.1 mtp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.312 0.577 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -121.11 96.37 5.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.543 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 203' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 203' ' ' THR . 2.5 t -45.92 109.51 0.99 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.316 -0.865 . . . . 0.0 109.565 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.38 -2.95 12.49 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.894 1.471 . . . . 0.0 110.182 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.3 -49.25 77.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 109.35 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -65.11 -51.72 59.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.583 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 207' ' ' MET . . . . . 0.47 ' HE1' ' O ' ' B' ' 275' ' ' ALA . 25.2 mtt -60.24 -47.5 85.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.257 -0.902 . . . . 0.0 109.789 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 15.6 m -56.6 -38.72 72.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.164 -0.96 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -56.62 -49.07 76.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.121 -0.987 . . . . 0.0 108.99 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 1.022 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -52.27 -24.16 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.509 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.754 HG22 ' CE2' ' B' ' 301' ' ' PHE . 23.2 t -85.82 -44.77 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.4 -0.813 . . . . 0.0 109.302 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 212' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' B' ' 213' ' ' ARG . 7.4 tt0 -57.11 -73.89 0.06 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' B' ' 212' ' ' GLN . 1.3 mtt85 -43.59 -44.89 6.46 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 214' ' ' TYR . . . . . 0.63 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -51.24 -45.4 61.97 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.878 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.0 OUTLIER -86.14 -37.7 11.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 216' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -49.13 -36.01 18.0 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.572 ' HB1' HG13 ' B' ' 226' ' ' ILE . . . -74.3 -31.84 62.64 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.878 HD12 ' HA ' ' B' ' 215' ' ' VAL . 0.8 OUTLIER -65.65 -57.72 7.44 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.591 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 219' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 0.2 OUTLIER -56.04 -45.12 79.3 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.542 0.687 . . . . 0.0 109.148 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 220' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' B' ' 221' ' ' GLY . . . -89.36 11.21 19.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.525 -0.734 . . . . 0.0 109.603 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.952 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 45.3 32.51 3.72 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 222' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.2 t70 -90.18 63.19 5.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.48 -1.012 . . . . 0.0 109.829 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 223' ' ' LEU . . . . . 1.144 HD12 HD12 ' B' ' 226' ' ' ILE . 6.1 tp -48.51 -43.97 35.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.099 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' B' ' 223' ' ' LEU . 26.2 t0 -42.49 -31.02 0.39 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 225' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' B' ' 228' ' ' ALA . . . -86.33 -32.56 16.24 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 1.144 HD12 HD12 ' B' ' 223' ' ' LEU . 27.2 mt -62.77 -56.66 16.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.809 HG11 HG23 ' B' ' 248' ' ' THR . 78.7 t -56.3 -35.19 42.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 225' ' ' GLY . . . -60.58 -56.38 22.07 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 1.022 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.0 tp -59.9 -25.79 65.39 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.556 -0.715 . . . . 0.0 109.08 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 230' ' ' PHE . . . . . 0.67 ' HD2' ' HB3' ' B' ' 234' ' ' ALA . 7.4 m-85 -86.42 130.07 34.63 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.496 -0.752 . . . . 0.0 109.779 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -43.0 166.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 109.665 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -24.2 5.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.349 -0.844 . . . . 0.0 110.071 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.522 ' CB ' ' HA2' ' B' ' 247' ' ' GLY . 2.0 p30 -148.84 54.13 0.99 Allowed 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.572 -0.705 . . . . 0.0 109.437 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.826 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -68.04 165.08 18.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.659 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 235' ' ' THR . . . . . 0.994 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -115.71 156.54 25.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 109.767 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.524 ' O ' ' HB3' ' B' ' 244' ' ' PRO . 53.9 t -143.31 116.83 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.076 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 237' ' ' GLU . . . . . 0.547 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.2 mt-10 -88.9 105.52 17.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 108.873 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 238' ' ' ASP . . . . . 0.539 ' OD2' ' HB3' ' B' ' 314' ' ' ALA . 9.9 t70 179.54 141.63 0.31 Allowed Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.919 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 239' ' ' PRO . . . . . 0.474 ' HG2' ' OG ' ' B' ' 242' ' ' SER . 48.5 Cg_endo -74.63 -173.85 12.81 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.048 -2.063 . . . . 0.0 110.343 -0.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' A' ' 75' ' ' ALA . 1.2 t -76.84 135.12 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.131 -0.98 . . . . 0.0 109.124 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 89.73 -3.78 83.34 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 242' ' ' SER . . . . . 0.474 ' OG ' ' HG2' ' B' ' 239' ' ' PRO . 67.5 m -107.08 -132.76 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -1.145 . . . . 0.0 109.149 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 243' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' B' ' 242' ' ' SER . 19.9 mt-10 -148.43 133.62 9.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 120.616 -1.303 . . . . 0.0 110.042 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 244' ' ' PRO . . . . . 0.547 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.4 Cg_endo -64.39 -172.7 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.133 1.596 . . . . 0.0 111.3 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.595 ' HD3' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.69 105.99 3.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.994 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -93.0 162.24 14.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.282 -0.887 . . . . 0.0 110.616 -178.702 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 247' ' ' GLY . . . . . 0.627 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 97.51 159.35 30.9 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 248' ' ' THR . . . . . 0.809 HG23 HG11 ' B' ' 227' ' ' VAL . 7.3 m -73.23 -45.39 56.32 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.162 -1.199 . . . . 0.0 109.014 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -63.95 -24.17 67.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.826 . . . . 0.0 109.025 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -90.02 -59.05 2.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.313 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.826 HD11 ' N ' ' B' ' 234' ' ' ALA . 21.7 mt -47.58 -39.25 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.364 -0.835 . . . . 0.0 109.255 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 252' ' ' ARG . . . . . 0.778 ' CG ' HD23 ' B' ' 223' ' ' LEU . 15.6 ttt180 -76.0 -57.16 4.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 109.068 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 253' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 8.0 mt-10 -46.4 -29.39 1.68 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.033 -1.042 . . . . 0.0 108.609 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.8 OUTLIER -83.74 -72.64 0.45 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 255' ' ' PHE . . . . . 1.119 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.1 OUTLIER -48.84 -24.54 1.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.552 -0.718 . . . . 0.0 109.166 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 256' ' ' ALA . . . . . 0.561 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -74.91 -44.91 46.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 108.707 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 257' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 5.3 t30 -56.73 -34.33 67.41 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 18.8 t -72.29 -47.0 53.34 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.49 -0.756 . . . . 0.0 109.179 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 259' ' ' LEU . . . . . 0.952 HD21 ' CA ' ' B' ' 221' ' ' GLY . 9.5 tp -57.46 -18.11 16.68 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.345 -0.847 . . . . 0.0 109.315 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 260' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 1.8 mttm -64.44 -19.6 65.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 109.592 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 261' ' ' LEU . . . . . 0.96 HD22 HD21 ' B' ' 263' ' ' LEU . 0.3 OUTLIER -89.37 120.43 69.7 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 262' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 45.0 Cg_endo -70.57 94.55 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.791 1.416 . . . . 0.0 110.755 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.96 HD21 HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -133.15 157.16 46.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.0 109.498 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 264' ' ' ALA . . . . . 0.518 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -92.35 127.03 37.68 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 265' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' B' ' 218' ' ' LEU . 30.9 t -107.28 114.26 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 2.3 tt0 -150.1 95.76 2.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.084 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.54 HD11 HG11 ' B' ' 215' ' ' VAL . 2.7 mp -43.86 169.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 268' ' ' THR . . . . . 0.465 ' O ' ' O ' ' B' ' 269' ' ' GLN . 0.0 OUTLIER -129.01 -78.56 0.56 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.523 -0.736 . . . . 0.0 109.213 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 269' ' ' GLN . . . . . 0.823 ' OE1' ' HB3' ' B' ' 281' ' ' ALA . 2.0 pt20 -59.3 -149.19 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 270' ' ' GLU . . . . . 0.483 ' CD ' ' NZ ' ' A' ' 119' ' ' LYS . 31.6 tt0 -111.51 131.45 55.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.033 -1.042 . . . . 0.0 109.68 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 271' ' ' VAL . . . . . 1.054 HG13 ' HB3' ' B' ' 280' ' ' PHE . 72.8 t -52.85 144.06 4.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.32 -0.863 . . . . 0.0 109.342 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.544 ' HD2' ' CD1' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -105.75 130.25 53.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.935 . . . . 0.0 109.503 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 273' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' B' ' 278' ' ' ALA . . . -147.25 137.09 23.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 109.321 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 274' ' ' VAL . . . . . 0.811 HG11 ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -155.07 149.71 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 0.0 109.174 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 275' ' ' ALA . . . . . 0.47 ' O ' ' HE1' ' B' ' 207' ' ' MET . . . 49.82 -144.86 0.47 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.159 -0.963 . . . . 0.0 109.358 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 276' ' ' ASN . . . . . 0.471 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 2.0 m-20 -83.71 -20.7 32.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.728 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 277' ' ' GLU . . . . . 0.582 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 0.7 OUTLIER -89.88 -161.71 0.81 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.161 -0.962 . . . . 0.0 109.583 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 278' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' B' ' 277' ' ' GLU . . . 170.1 162.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.755 . . . . 0.0 109.079 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 279' ' ' ALA . . . . . 0.897 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -150.66 141.51 22.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.065 . . . . 0.0 109.236 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 280' ' ' PHE . . . . . 1.054 ' HB3' HG13 ' B' ' 271' ' ' VAL . 21.1 p90 -141.63 154.55 45.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.827 -1.171 . . . . 0.0 110.705 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 1.062 ' CB ' HD12 ' B' ' 298' ' ' ILE . . . -119.43 168.53 10.86 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 282' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 0.0 OUTLIER -177.14 -173.44 0.45 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.898 . . . . 0.0 109.766 179.287 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 283' ' ' THR . . . . . 0.981 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -135.19 141.1 45.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.375 -0.828 . . . . 0.0 110.215 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 284' ' ' VAL . . . . . 0.834 HG11 HD22 ' B' ' 263' ' ' LEU . 8.0 t -109.21 134.56 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 108.795 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 285' ' ' SER . . . . . 0.518 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 29.0 p -125.73 100.78 6.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.987 . . . . 0.0 110.08 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.592 ' CE1' ' HB ' ' B' ' 293' ' ' THR . 33.9 p90 -117.34 -168.73 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 108.785 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 287' ' ' GLU . . . . . 0.469 ' N ' ' CD2' ' B' ' 286' ' ' PHE . 16.7 tt0 -149.85 158.59 44.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.93 -1.106 . . . . 0.0 110.09 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 288' ' ' PHE . . . . . 0.405 ' CZ ' ' HE2' ' B' ' 286' ' ' PHE . 33.1 m-85 -105.6 -167.84 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.451 -0.781 . . . . 0.0 109.587 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.91 -20.94 3.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.378 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -160.66 -45.24 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -74.49 142.72 44.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -1.165 . . . . 0.0 109.522 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 292' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' B' ' 293' ' ' THR . 2.3 tmtt? -103.85 145.32 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.277 -0.89 . . . . 0.0 109.412 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 293' ' ' THR . . . . . 0.728 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -135.88 143.29 44.96 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.452 -0.78 . . . . 0.0 110.297 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 294' ' ' VAL . . . . . 0.613 HG12 ' CB ' ' B' ' 322' ' ' HIS . 9.0 p -121.26 169.41 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 0.981 ' O ' HG22 ' B' ' 283' ' ' THR . 22.8 t -136.48 160.71 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.758 -1.214 . . . . 0.0 110.499 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 296' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' B' ' 320' ' ' ASN . . . -140.62 62.54 18.62 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.629 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 297' ' ' PRO . . . . . 1.036 ' O ' HD13 ' B' ' 298' ' ' ILE . 43.5 Cg_endo -97.37 167.28 0.87 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.449 1.433 . . . . 0.0 112.01 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 1.062 HD12 ' CB ' ' B' ' 281' ' ' ALA . 3.9 mm -129.2 165.05 30.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 299' ' ' ASP . . . . . 0.648 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 14.7 t0 -135.06 156.27 49.31 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.201 -0.937 . . . . 0.0 109.909 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 300' ' ' HIS . . . . . 0.535 ' O ' ' CG ' ' B' ' 312' ' ' MET . 0.2 OUTLIER -108.19 175.36 5.5 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 301' ' ' PHE . . . . . 0.754 ' CE2' HG22 ' B' ' 211' ' ' VAL . 0.1 OUTLIER -149.74 136.62 19.48 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 110.026 -178.839 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.612 ' O ' HG23 ' B' ' 310' ' ' VAL . 10.4 ttt85 -138.48 113.76 9.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 109.11 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 303' ' ' PHE . . . . . 0.652 ' CE2' HG21 ' B' ' 210' ' ' VAL . 3.9 m-85 -95.09 178.82 5.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.468 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 304' ' ' ASN . . . . . 0.719 ' HB3' HG11 ' B' ' 310' ' ' VAL . 6.8 p-10 -111.87 -21.8 11.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.358 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . 122.35 32.76 0.94 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . -144.49 9.47 1.39 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.218 -1.166 . . . . 0.0 109.964 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 87.05 -19.28 31.31 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.81 -177.26 6.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -1.205 . . . . 0.0 109.561 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 309' ' ' VAL . . . . . 0.547 ' CG2' HG22 ' B' ' 210' ' ' VAL . 61.0 t -112.69 137.12 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.163 -0.961 . . . . 0.0 109.154 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 310' ' ' VAL . . . . . 0.719 HG11 ' HB3' ' B' ' 304' ' ' ASN . 0.0 OUTLIER -119.37 -61.57 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.079 -1.013 . . . . 0.0 109.799 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.91 162.85 17.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.045 -1.035 . . . . 0.0 109.67 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 312' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 29.2 ttp -159.02 145.93 17.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 313' ' ' ARG . . . . . 0.53 ' HB2' ' CB ' ' B' ' 300' ' ' HIS . 48.1 mtp180 -125.18 173.15 8.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.223 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 314' ' ' ALA . . . . . 0.539 ' HB3' ' OD2' ' B' ' 238' ' ' ASP . . . -150.17 150.88 32.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.032 . . . . 0.0 109.445 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 315' ' ' LEU . . . . . 0.917 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -136.25 142.52 44.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 110.048 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 316' ' ' PHE . . . . . 0.772 ' O ' HG21 ' A' ' 74' ' ' VAL . 1.2 p90 174.63 -155.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.652 0.739 . . . . 0.0 109.125 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 317' ' ' GLY . . . . . 0.471 ' N ' ' CG ' ' B' ' 316' ' ' PHE . . . 159.79 -172.14 36.28 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 318' ' ' GLU . . . . . 0.654 ' HA ' HD12 ' B' ' 321' ' ' ILE . 6.3 tt0 -65.29 -6.73 10.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -1.108 . . . . 0.0 109.7 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -101.12 -17.99 16.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.323 -0.861 . . . . 0.0 109.699 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 320' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' B' ' 296' ' ' ALA . 1.4 m-20 -88.94 -23.18 22.75 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.607 -0.683 . . . . 0.0 110.189 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 321' ' ' ILE . . . . . 0.922 ' CG2' HG22 ' B' ' 295' ' ' VAL . 0.6 OUTLIER -87.18 -158.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.072 -1.018 . . . . 0.0 108.546 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 322' ' ' HIS . . . . . 0.728 ' O ' HG22 ' B' ' 293' ' ' THR . 0.3 OUTLIER -151.61 161.61 42.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.974 -1.079 . . . . 0.0 110.064 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.353 -0.842 . . . . 0.0 109.414 179.868 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 3' ' ' THR . 7.1 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.41 -8.68 23.83 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.864 1.455 . . . . 0.0 109.784 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -61.81 -60.26 3.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.812 . . . . 0.0 109.243 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -61.33 -45.19 95.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.156 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.5 mtt -58.73 -28.81 66.2 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.223 -0.923 . . . . 0.0 109.333 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 11' ' ' VAL . 17.5 m -74.33 -44.14 53.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 109.059 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.25 -40.23 23.99 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.004 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.2 t -53.35 -26.76 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.866 HG11 ' CG2' ' A' ' 71' ' ' VAL . 7.6 t -90.02 -42.55 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.491 -0.756 . . . . 0.0 109.101 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 15' ' ' VAL . 20.7 tt0 -62.05 -73.92 0.1 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.482 ' HB3' HD22 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -41.61 -44.18 2.99 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 122.041 0.924 . . . . 0.0 108.524 178.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.641 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -53.39 -45.58 69.33 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.42 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.897 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -84.63 -38.98 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 0.0 109.555 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.69 -35.74 14.63 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.56 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -74.88 -31.69 61.66 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.984 ' HB3' HG21 ' A' ' 65' ' ' VAL . 1.2 mt -65.7 -58.83 4.77 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -51.9 -45.38 64.18 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . -89.5 9.98 24.53 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.574 -0.704 . . . . 0.0 109.645 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.959 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 45.32 31.52 3.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 17' ' ' ALA . 6.8 t0 -89.82 68.64 7.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -1.062 . . . . 0.0 109.936 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.042 HD11 ' HB3' ' A' ' 55' ' ' PHE . 4.9 tp -49.35 -42.12 40.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -42.1 -30.56 0.3 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -87.96 -37.2 7.95 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.955 HD12 HD12 ' A' ' 23' ' ' LEU . 22.0 mt -59.64 -53.59 46.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.536 HG21 ' CG ' ' A' ' 52' ' ' ARG . 84.9 t -58.57 -36.17 58.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -60.6 -50.83 71.94 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.004 HD21 ' HA ' ' A' ' 10' ' ' VAL . 7.5 tp -65.61 -21.72 66.6 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.547 -0.721 . . . . 0.0 109.182 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.524 ' CG ' HG21 ' A' ' 51' ' ' ILE . 2.8 m-85 -84.6 135.5 34.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.419 -0.801 . . . . 0.0 109.609 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -54.17 -175.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.46 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.4 OUTLIER -75.76 -23.23 55.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.885 . . . . 0.0 109.54 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.548 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -140.13 36.76 1.92 Allowed 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.59 -0.694 . . . . 0.0 109.357 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -51.38 -176.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.499 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.553 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.3 OUTLIER -142.49 134.13 26.72 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.373 -0.83 . . . . 0.0 109.432 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.802 ' CG2' HD12 ' A' ' 51' ' ' ILE . 31.6 t -127.27 128.3 70.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.337 -0.852 . . . . 0.0 108.88 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 21.9 mt-10 -101.15 114.18 27.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.475 ' HA ' ' C ' ' A' ' 39' ' ' PRO . 12.1 t70 -179.33 142.63 0.38 Allowed Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.608 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 38' ' ' ASP . 46.9 Cg_endo -73.75 -179.26 24.86 Favored 'Cis proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.194 -2.002 . . . . 0.0 110.797 -0.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.841 HG21 HG11 ' B' ' 274' ' ' VAL . 27.6 m -66.9 82.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . -170.69 28.5 0.12 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER 70.5 47.46 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -1.11 . . . . 0.0 109.86 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.55 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 4.7 mt-10 -132.83 57.5 28.8 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 109.844 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 50.3 Cg_endo -79.84 177.22 8.62 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 124.163 1.612 . . . . 0.0 110.653 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' HD3' ' CA ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -151.59 107.22 3.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 109.251 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.648 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -89.56 157.45 18.06 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.263 -0.898 . . . . 0.0 110.117 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 100.52 166.37 28.55 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.513 HG23 HG13 ' A' ' 27' ' ' VAL . 3.0 m -75.2 -58.63 3.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.138 -1.213 . . . . 0.0 109.012 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -54.44 -44.88 72.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.211 -0.931 . . . . 0.0 109.076 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 46' ' ' SER . . . -59.26 -34.01 71.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.45 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.802 HD12 ' CG2' ' A' ' 36' ' ' VAL . 7.6 mm -79.72 -36.23 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.685 ' CG ' HD23 ' A' ' 23' ' ' LEU . 26.7 ttp85 -78.51 -56.64 4.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.068 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.9 mt-10 -45.76 -27.25 0.79 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.494 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -83.14 -70.22 0.57 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.174 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 1.042 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.26 -24.1 1.08 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.322 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.611 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -78.85 -47.31 16.83 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 19.2 t-20 -64.65 -28.37 69.57 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.6 t -78.08 -42.26 32.72 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.959 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.9 tp -60.85 -17.86 52.57 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.405 -0.809 . . . . 0.0 108.903 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 4.8 mttm -55.16 -18.64 6.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.479 -0.763 . . . . 0.0 108.972 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.78 HD23 HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -89.16 118.25 69.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.162 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 43.8 Cg_endo -71.34 110.42 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.748 1.393 . . . . 0.0 110.716 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.78 ' HB2' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -145.82 176.44 9.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.888 . . . . 0.0 110.053 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.73 126.12 54.88 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.984 HG21 ' HB3' ' A' ' 18' ' ' LEU . 3.7 t -104.29 117.96 50.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.682 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -146.09 105.57 3.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.133 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.519 ' O ' HG23 ' A' ' 68' ' ' THR . 0.7 OUTLIER -47.41 175.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -0.929 . . . . 0.0 109.633 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 67' ' ' LEU . 2.7 p -155.8 -38.01 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.705 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.492 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 5.7 pt20 -99.21 -152.47 0.41 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.63 -0.669 . . . . 0.0 109.198 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 30.4 tt0 -109.8 130.38 55.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.15 -0.969 . . . . 0.0 109.787 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.866 ' CG2' HG11 ' A' ' 11' ' ' VAL . 37.2 t -60.01 145.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.333 -0.855 . . . . 0.0 108.996 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.645 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 1.7 ttm180 -106.26 134.48 49.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.662 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.497 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -146.7 145.51 30.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 109.232 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.833 ' CG1' HG21 ' B' ' 240' ' ' VAL . 0.2 OUTLIER -136.03 -151.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.191 -0.943 . . . . 0.0 109.562 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -34.59 -90.85 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.973 -0.454 . . . . 0.0 110.804 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 4.9 p-10 -112.89 -15.8 12.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.083 -1.011 . . . . 0.0 110.328 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.652 ' HG2' ' N ' ' A' ' 78' ' ' ALA . 1.4 tt0 -108.5 162.55 14.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.019 -1.051 . . . . 0.0 108.999 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.652 ' N ' ' HG2' ' A' ' 77' ' ' GLU . . . -143.12 177.16 8.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.38 -0.825 . . . . 0.0 110.224 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.912 ' HB2' HD11 ' B' ' 315' ' ' LEU . . . -150.1 137.07 19.41 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.66 ' CE1' ' CE2' ' A' ' 101' ' ' PHE . 31.8 p90 -150.32 170.83 18.09 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.706 -1.246 . . . . 0.0 110.137 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.878 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -139.62 -166.4 2.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.556 -0.715 . . . . 0.0 109.56 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CD2' ' C ' ' A' ' 81' ' ' ALA . 6.8 p90 174.23 -171.46 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.441 -0.787 . . . . 0.0 109.075 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.73 144.0 50.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.357 -0.84 . . . . 0.0 109.808 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.78 HG13 ' HB2' ' A' ' 63' ' ' LEU . 12.1 t -116.78 115.0 47.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.537 ' HA ' HG23 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -106.58 103.43 12.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.077 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.578 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 4.3 p90 -122.23 177.04 5.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.228 -0.92 . . . . 0.0 109.561 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -106.25 -179.95 4.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.174 -0.954 . . . . 0.0 110.466 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.497 ' C ' ' CG ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -137.67 43.18 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 109.549 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.497 ' CG ' ' C ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER 39.71 75.97 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.421 -0.799 . . . . 0.0 109.886 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.52 -41.49 2.01 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -125.46 179.35 5.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.41 -1.053 . . . . 0.0 108.928 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.502 ' HG2' ' N ' ' A' ' 93' ' ' THR . 0.4 OUTLIER -126.11 140.8 52.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.007 -1.058 . . . . 0.0 109.884 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.572 ' HB ' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -136.81 152.58 50.44 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.801 HG12 ' CG ' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -126.52 -178.85 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.994 . . . . 0.0 109.112 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 1.078 HG22 HG23 ' A' ' 121' ' ' ILE . 2.9 t -150.01 141.04 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 108.992 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.38 71.63 82.03 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.394 -0.816 . . . . 0.0 110.528 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.965 ' HD3' HG12 ' A' ' 95' ' ' VAL . 54.0 Cg_endo -95.88 -173.55 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.559 1.506 . . . . 0.0 110.854 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.878 HG23 ' HB2' ' A' ' 81' ' ' ALA . 3.1 mp -141.88 167.03 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 32.8 t0 -135.24 159.26 42.12 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 109.828 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.525 ' NE2' ' HG3' ' A' ' 77' ' ' GLU . 71.2 t60 -123.78 133.71 53.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.426 -0.797 . . . . 0.0 108.876 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.66 ' CE2' ' CE1' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -109.76 145.67 36.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.203 -0.935 . . . . 0.0 109.89 -179.039 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 111' ' ' SER . 6.2 ttt180 -145.06 114.22 7.0 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.784 ' CE2' HG21 ' A' ' 10' ' ' VAL . 21.4 m-85 -89.61 -166.58 1.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.046 -1.034 . . . . 0.0 109.693 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.41 ' HB3' HG21 ' A' ' 110' ' ' VAL . 11.4 p-10 -132.11 -43.01 0.97 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.711 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -142.78 -62.23 0.02 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 163.87 76.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -1.149 . . . . 0.0 109.608 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -166.07 -49.53 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.27 -162.7 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -1.209 . . . . 0.0 109.545 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.655 HG23 HG22 ' A' ' 10' ' ' VAL . 54.5 t -97.46 143.18 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.331 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 56.6 t -125.12 -11.93 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.777 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.49 ' HB2' ' HB3' ' A' ' 102' ' ' ARG . 13.0 m -159.09 156.1 28.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.412 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.562 ' SD ' ' CE1' ' A' ' 101' ' ' PHE . 8.4 ttp -160.31 149.3 17.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.969 . . . . 0.0 109.86 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -129.7 147.24 51.47 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.77 132.33 54.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.999 -1.063 . . . . 0.0 110.035 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.854 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.4 OUTLIER -122.43 141.65 51.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.363 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.55 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 4.3 p90 175.02 -152.47 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.476 ' N ' ' CG ' ' A' ' 116' ' ' PHE . . . 166.31 169.08 29.46 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.484 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 19.8 tt0 -68.64 -6.45 25.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -1.096 . . . . 0.0 109.473 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' CD ' ' HG3' ' B' ' 204' ' ' PRO . 0.0 OUTLIER -91.85 -26.17 18.62 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.981 0.896 . . . . 0.0 108.886 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.496 ' OD1' ' NH2' ' B' ' 272' ' ' ARG . 0.1 OUTLIER -88.9 14.12 11.15 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.078 HG23 HG22 ' A' ' 95' ' ' VAL . 4.5 mm -90.68 -150.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.801 ' CG ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.79 174.19 13.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.005 . . . . 0.0 109.538 179.372 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.56 88.12 1.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.9 . . . . 0.0 109.32 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -66.77 133.62 32.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.347 -1.09 . . . . 0.0 109.508 -179.972 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 201' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.244 0.545 . . . . 0.0 110.144 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' B' ' 201' ' ' MET . 4.1 m-80 61.88 77.48 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -0.828 . . . . 0.0 109.673 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 203' ' ' THR . . . . . 0.513 HG23 ' O ' ' B' ' 203' ' ' THR . 3.0 t -61.96 116.69 23.03 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.668 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 204' ' ' PRO . . . . . 0.407 ' HG3' ' CD ' ' A' ' 119' ' ' LYS . 44.5 Cg_endo -71.52 -3.8 13.75 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.868 1.457 . . . . 0.0 109.96 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -59.71 -63.11 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.489 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -58.06 -43.98 87.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 109.397 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 18.1 mtt -57.61 -28.53 63.73 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.289 -0.882 . . . . 0.0 109.629 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.448 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 6.0 m -76.69 -35.89 57.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.076 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -53.85 -45.45 70.93 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.238 -0.914 . . . . 0.0 108.809 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 1.095 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.2 t -51.72 -27.1 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.983 HG11 HG21 ' B' ' 271' ' ' VAL . 40.1 t -83.4 -46.05 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.485 -0.759 . . . . 0.0 109.706 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 212' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' B' ' 213' ' ' ARG . 28.4 tt0 -56.86 -73.6 0.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.245 1.022 . . . . 0.0 108.312 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' B' ' 212' ' ' GLN . 1.6 mtt85 -43.06 -44.38 4.8 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.972 0.891 . . . . 0.0 108.655 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 214' ' ' TYR . . . . . 0.637 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -51.26 -45.3 62.0 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.568 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.952 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.2 t -88.42 -40.12 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.903 . . . . 0.0 109.359 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 216' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.23 -36.23 13.47 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.527 ' HB1' HG13 ' B' ' 226' ' ' ILE . . . -74.56 -33.63 62.74 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' B' ' 215' ' ' VAL . 3.4 mt -63.86 -58.58 6.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -53.38 -46.1 69.49 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.461 0.648 . . . . 0.0 109.476 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.32 9.22 26.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.529 -0.732 . . . . 0.0 109.649 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.92 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 48.6 37.19 19.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 222' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' B' ' 217' ' ' ALA . 25.5 t0 -97.93 61.17 1.52 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -1.114 . . . . 0.0 109.791 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 223' ' ' LEU . . . . . 1.085 HD11 ' HB3' ' B' ' 255' ' ' PHE . 2.2 tp -46.89 -39.45 12.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.03 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' B' ' 223' ' ' LEU . 0.5 OUTLIER -40.63 -31.31 0.15 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 225' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' B' ' 223' ' ' LEU . . . -88.86 -37.27 7.39 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.918 HD12 HD12 ' B' ' 223' ' ' LEU . 12.5 mt -58.54 -54.11 37.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.474 HG21 ' HG3' ' B' ' 252' ' ' ARG . 46.6 t -58.43 -41.69 82.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.34 -46.88 76.35 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 1.095 HD21 ' HA ' ' B' ' 210' ' ' VAL . 4.4 tp -69.75 -30.16 67.68 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.594 -0.691 . . . . 0.0 109.234 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 230' ' ' PHE . . . . . 0.736 ' CD2' HG21 ' B' ' 251' ' ' ILE . 4.8 m-85 -79.46 129.92 34.92 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.393 -0.817 . . . . 0.0 109.726 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -49.19 179.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.462 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -66.91 -23.49 65.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.769 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.517 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 0.0 OUTLIER -146.94 53.76 1.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.482 -0.761 . . . . 0.0 109.584 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.675 ' HB3' ' HD2' ' B' ' 230' ' ' PHE . . . -64.47 155.91 31.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 235' ' ' THR . . . . . 0.608 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -98.36 160.06 14.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.399 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.712 HG23 ' CD1' ' B' ' 251' ' ' ILE . 1.9 t -139.49 173.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 108.875 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 237' ' ' GLU . . . . . 0.583 ' N ' ' CG1' ' B' ' 236' ' ' VAL . 4.7 mt-10 -150.14 104.29 3.26 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 238' ' ' ASP . . . . . 0.546 ' OD2' ' CB ' ' B' ' 314' ' ' ALA . 0.4 OUTLIER -177.37 139.03 0.42 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.95 -1.094 . . . . 0.0 109.559 -178.684 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 239' ' ' PRO . . . . . 0.514 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 45.9 Cg_endo -72.87 -173.21 10.54 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.185 -2.006 . . . . 0.0 110.358 -0.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.833 HG21 ' CG1' ' A' ' 74' ' ' VAL . 34.8 m -70.52 81.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.968 . . . . 0.0 109.292 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 241' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' B' ' 242' ' ' SER . . . -174.57 35.22 0.11 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 242' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' B' ' 241' ' ' GLY . 0.5 OUTLIER 70.16 53.25 0.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -1.141 . . . . 0.0 109.786 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 243' ' ' GLU . . . . . 0.474 ' HB2' ' C ' ' B' ' 238' ' ' ASP . 1.4 mt-10 -130.11 61.37 58.09 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.374 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 244' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 50.7 Cg_endo -78.03 169.24 20.76 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.287 1.678 . . . . 0.0 110.822 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.525 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.36 99.09 2.74 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.705 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -91.23 167.62 12.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 110.348 -178.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 247' ' ' GLY . . . . . 0.517 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 92.42 162.51 37.21 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 248' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 1.9 m -75.13 -49.44 19.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -1.16 . . . . 0.0 108.882 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -56.6 -42.24 78.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.891 . . . . 0.0 109.122 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -66.44 -55.01 17.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.935 . . . . 0.0 109.362 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.736 HG21 ' CD2' ' B' ' 230' ' ' PHE . 12.6 mm -53.71 -45.54 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 252' ' ' ARG . . . . . 0.832 ' HG3' HD23 ' B' ' 223' ' ' LEU . 8.4 ttm180 -73.39 -57.82 3.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.128 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 253' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 31.2 tt0 -45.64 -27.83 0.86 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.095 -1.003 . . . . 0.0 108.704 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 1.0 OUTLIER -87.49 -71.09 0.58 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 255' ' ' PHE . . . . . 1.085 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -48.24 -24.44 1.18 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 256' ' ' ALA . . . . . 0.5 ' HB2' HD22 ' B' ' 223' ' ' LEU . . . -79.72 -48.44 13.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.857 . . . . 0.0 108.89 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 257' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 18.4 t30 -60.04 -33.52 72.15 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.34 -0.85 . . . . 0.0 108.743 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 9.7 t -71.44 -38.26 71.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 259' ' ' LEU . . . . . 0.92 HD21 ' CA ' ' B' ' 221' ' ' GLY . 9.2 tp -62.59 -21.43 65.62 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.392 -0.818 . . . . 0.0 109.028 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 260' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 20.9 mtmt -64.48 -11.12 30.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.313 -0.867 . . . . 0.0 109.178 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 261' ' ' LEU . . . . . 0.982 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.3 OUTLIER -89.3 117.69 68.44 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 262' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 41.5 Cg_endo -68.72 80.21 0.63 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.833 1.438 . . . . 0.0 110.683 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.982 ' CD2' HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -118.27 165.47 13.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.357 -0.839 . . . . 0.0 109.616 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 264' ' ' ALA . . . . . 0.707 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -101.8 130.81 48.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -0.816 . . . . 0.0 108.859 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 30.0 t -116.92 114.3 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.031 -1.043 . . . . 0.0 110.085 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 28.7 tt0 -150.33 100.78 2.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.83 . . . . 0.0 109.148 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.527 ' O ' ' CG2' ' B' ' 268' ' ' THR . 0.6 OUTLIER -48.27 177.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.725 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 268' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' B' ' 267' ' ' LEU . 80.8 p -159.16 -37.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.336 -0.852 . . . . 0.0 109.768 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 269' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' B' ' 270' ' ' GLU . 0.0 OUTLIER -93.55 -150.45 0.28 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.563 -0.71 . . . . 0.0 109.427 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 270' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' B' ' 269' ' ' GLN . 27.1 tt0 -112.55 130.56 55.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.652 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 271' ' ' VAL . . . . . 1.074 HG13 ' HB3' ' B' ' 280' ' ' PHE . 75.5 t -67.54 147.71 12.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.356 -0.84 . . . . 0.0 109.082 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.63 ' CZ ' HD11 ' A' ' 98' ' ' ILE . 0.8 OUTLIER -103.71 138.11 40.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.175 -0.953 . . . . 0.0 109.896 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 273' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.1 132.32 15.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 274' ' ' VAL . . . . . 0.841 HG11 HG21 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -125.87 -152.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.95 . . . . 0.0 109.797 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 275' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' B' ' 274' ' ' VAL . . . -35.7 -96.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.898 -0.502 . . . . 0.0 110.899 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 276' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' B' ' 303' ' ' PHE . 1.9 m-20 -110.42 17.09 21.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.017 -1.052 . . . . 0.0 110.268 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 277' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 0.5 OUTLIER -124.33 -160.04 0.91 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.932 -1.105 . . . . 0.0 109.628 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 278' ' ' ALA . . . . . 1.011 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 172.08 160.18 0.1 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.545 -0.722 . . . . 0.0 109.65 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 279' ' ' ALA . . . . . 0.854 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -150.73 133.93 16.16 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 280' ' ' PHE . . . . . 1.074 ' HB3' HG13 ' B' ' 271' ' ' VAL . 22.6 p90 -150.2 168.5 23.8 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.838 -1.164 . . . . 0.0 110.275 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.958 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -138.46 -164.83 1.7 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 282' ' ' PHE . . . . . 0.439 ' CD2' ' C ' ' B' ' 281' ' ' ALA . 8.2 p90 168.16 -169.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 283' ' ' THR . . . . . 0.463 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -124.07 141.17 52.28 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 109.54 179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 284' ' ' VAL . . . . . 0.75 HG11 HD22 ' B' ' 263' ' ' LEU . 40.0 t -124.35 113.21 35.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.158 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 285' ' ' SER . . . . . 0.707 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 3.5 p -113.76 117.44 31.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.325 -0.86 . . . . 0.0 109.452 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.568 ' CE1' ' HB ' ' B' ' 293' ' ' THR . 17.0 p90 -123.27 176.27 6.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.19 -0.944 . . . . 0.0 109.555 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 287' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' B' ' 291' ' ' ARG . 29.8 tt0 -128.46 151.93 48.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.555 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 288' ' ' PHE . . . . . 0.47 ' CE2' ' CZ ' ' B' ' 286' ' ' PHE . 28.1 m-85 -95.16 -107.2 0.14 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.213 -0.93 . . . . 0.0 109.388 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.61 -17.92 7.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.984 -1.072 . . . . 0.0 109.444 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -149.59 -40.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 291' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' B' ' 287' ' ' GLU . 33.1 mtt85 -90.4 -176.91 4.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -1.117 . . . . 0.0 109.417 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 292' ' ' LYS . . . . . 0.468 ' CD ' ' O ' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -136.75 133.95 36.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.312 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 293' ' ' THR . . . . . 0.795 HG22 ' HA ' ' B' ' 323' ' ' ALA . 0.0 OUTLIER -118.32 145.99 44.68 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.186 -0.946 . . . . 0.0 110.094 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 294' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' B' ' 322' ' ' HIS . 11.8 p -116.47 163.74 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.335 -0.853 . . . . 0.0 108.866 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 0.9 HG22 HG23 ' B' ' 321' ' ' ILE . 49.1 t -139.41 156.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.032 -1.043 . . . . 0.0 110.444 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 296' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' B' ' 320' ' ' ASN . . . -142.13 68.73 22.63 Favored Pre-proline 0 N--CA 1.495 1.802 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 297' ' ' PRO . . . . . 0.609 ' HD3' HG12 ' B' ' 295' ' ' VAL . 48.3 Cg_endo -97.03 -175.42 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.877 1.718 . . . . 0.0 111.487 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.958 HG23 ' HB2' ' B' ' 281' ' ' ALA . 3.0 mp -140.44 169.4 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 299' ' ' ASP . . . . . 0.606 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 39.1 t0 -138.86 158.8 43.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.021 -1.049 . . . . 0.0 110.014 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 300' ' ' HIS . . . . . 0.533 ' HB2' ' CB ' ' B' ' 313' ' ' ARG . 0.2 OUTLIER -113.87 172.96 6.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.382 -0.824 . . . . 0.0 108.944 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 301' ' ' PHE . . . . . 1.011 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.2 OUTLIER -144.95 146.64 32.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.123 -0.986 . . . . 0.0 110.49 -178.657 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.549 ' HB3' ' CB ' ' B' ' 311' ' ' SER . 25.4 ttt180 -144.16 108.72 4.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.476 -0.765 . . . . 0.0 108.952 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 303' ' ' PHE . . . . . 0.708 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 37.3 m-85 -89.83 179.88 5.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.799 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 304' ' ' ASN . . . . . 0.635 ' CB ' HG21 ' B' ' 310' ' ' VAL . 8.6 p-10 -150.13 16.79 0.85 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.332 -0.855 . . . . 0.0 109.245 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 305' ' ' GLY . . . . . 0.715 ' O ' ' HB3' ' B' ' 306' ' ' ALA . . . 98.21 154.03 28.98 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 306' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 305' ' ' GLY . . . 79.49 -5.68 1.9 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.405 -1.056 . . . . 0.0 109.824 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 83.14 -10.19 58.9 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.3 174.15 4.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.103 -1.233 . . . . 0.0 109.455 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 309' ' ' VAL . . . . . 0.621 HG11 ' CE ' ' B' ' 312' ' ' MET . 95.1 t -109.89 151.9 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.158 -0.964 . . . . 0.0 109.027 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 310' ' ' VAL . . . . . 0.666 ' O ' ' HB1' ' B' ' 234' ' ' ALA . 53.3 t -137.32 -56.56 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.957 -1.089 . . . . 0.0 110.156 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 311' ' ' SER . . . . . 0.549 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -118.48 160.61 21.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.615 -1.303 . . . . 0.0 109.917 -179.541 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 312' ' ' MET . . . . . 0.621 ' HE3' ' CZ ' ' B' ' 230' ' ' PHE . 10.2 ttm -159.92 141.69 12.92 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.431 -0.793 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 313' ' ' ARG . . . . . 0.533 ' CB ' ' HB2' ' B' ' 300' ' ' HIS . 0.3 OUTLIER -116.95 158.38 24.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.393 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 314' ' ' ALA . . . . . 0.546 ' CB ' ' OD2' ' B' ' 238' ' ' ASP . . . -124.31 138.03 54.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.28 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 315' ' ' LEU . . . . . 0.912 HD11 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -133.73 142.27 47.89 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.137 -0.977 . . . . 0.0 109.89 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 316' ' ' PHE . . . . . 0.543 ' O ' HG13 ' A' ' 74' ' ' VAL . 53.7 p90 171.18 -156.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 317' ' ' GLY . . . . . 0.737 ' O ' HD12 ' B' ' 321' ' ' ILE . . . 154.71 176.59 27.15 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 318' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' B' ' 318' ' ' GLU . 13.4 tt0 -55.43 -17.74 5.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -1.185 . . . . 0.0 109.136 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -87.49 -24.99 23.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.871 0.843 . . . . 0.0 109.077 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 320' ' ' ASN . . . . . 0.708 ' O ' ' HB3' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.27 -34.89 16.44 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 321' ' ' ILE . . . . . 0.9 HG23 HG22 ' B' ' 295' ' ' VAL . 0.9 OUTLIER -86.32 -172.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.799 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 322' ' ' HIS . . . . . 0.694 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.0 OUTLIER -151.63 172.8 15.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.091 -1.005 . . . . 0.0 109.814 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.795 ' HA ' HG22 ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.402 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.584 ' O ' ' HE2' ' A' ' 7' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.03 1.65 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.973 1.512 . . . . 0.0 110.279 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -58.63 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 110.048 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.517 ' NE2' ' HB ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -45.57 -32.75 2.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.115 -0.99 . . . . 0.0 109.279 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . 1.014 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 25.3 mtm -70.89 -57.69 4.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 109.732 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 11' ' ' VAL . 16.6 m -58.57 -38.14 77.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.81 -42.66 47.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.195 -0.941 . . . . 0.0 108.652 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.893 HG11 ' CE1' ' A' ' 103' ' ' PHE . 2.9 t -60.03 -20.93 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.867 HG11 HG21 ' A' ' 71' ' ' VAL . 40.0 t -90.47 -47.91 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -58.26 -61.76 2.33 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.125 -0.984 . . . . 0.0 109.022 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.77 ' HB3' HD22 ' A' ' 29' ' ' LEU . 3.2 mtm-85 -53.97 -46.66 71.7 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.909 0.861 . . . . 0.0 108.838 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.632 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -48.72 -42.69 35.93 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.964 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.3 t -88.5 -38.74 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.315 -0.866 . . . . 0.0 109.379 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.45 -37.72 18.0 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.608 ' HB3' HG12 ' A' ' 26' ' ' ILE . . . -72.62 -33.76 66.87 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.964 HD12 ' HA ' ' A' ' 15' ' ' VAL . 4.5 mt -65.31 -60.58 2.83 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -51.0 -41.19 59.6 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.567 0.698 . . . . 0.0 109.23 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.31 2.26 54.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.484 -0.76 . . . . 0.0 109.55 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 1.046 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 52.24 41.89 54.96 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.421 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 45.6 t0 -105.17 80.18 1.57 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -1.091 . . . . 0.0 110.052 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.028 HD13 HD12 ' A' ' 26' ' ' ILE . 3.9 mm? -51.37 -20.67 1.84 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.188 -0.945 . . . . 0.0 109.745 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -61.12 -54.85 39.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.256 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -64.71 -29.57 75.59 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.028 HD12 HD13 ' A' ' 23' ' ' LEU . 6.9 mt -66.26 -59.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.772 HG21 ' HB2' ' A' ' 52' ' ' ARG . 60.0 t -61.53 -40.55 86.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.13 -51.83 65.19 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.77 HD22 ' HB3' ' A' ' 13' ' ' ARG . 8.6 tp -64.3 -26.4 68.47 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.486 ' HB2' ' HA ' ' A' ' 27' ' ' VAL . 5.2 m-85 -87.57 131.11 34.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.495 -0.753 . . . . 0.0 109.766 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -45.44 171.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.834 . . . . 0.0 109.642 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.405 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -61.75 -24.02 66.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.709 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.543 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -141.05 52.03 1.59 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.571 -0.706 . . . . 0.0 109.681 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -67.16 168.51 10.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.718 HG23 ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -127.76 137.67 52.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.391 -0.818 . . . . 0.0 109.302 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 55.8 t -133.29 123.73 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.275 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.511 ' OE2' ' NH1' ' A' ' 113' ' ' ARG . 96.0 mt-10 -89.17 108.4 19.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 108.58 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 39' ' ' PRO . 9.8 t0 -177.99 142.29 0.45 Allowed Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 119.229 -0.989 . . . . 0.0 110.058 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.512 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 47.7 Cg_endo -72.75 -179.24 23.67 Favored 'Cis proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.214 -1.994 . . . . 0.0 110.564 -0.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 40' ' ' VAL . 14.4 m -73.57 112.81 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.511 ' HA2' ' ND2' ' B' ' 276' ' ' ASN . . . 103.99 12.65 29.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.512 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 4.0 m -118.56 -107.04 0.38 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -1.145 . . . . 0.0 109.458 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -166.87 130.64 1.53 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.874 -1.141 . . . . 0.0 109.88 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 41.6 Cg_endo -67.3 -168.25 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.952 1.501 . . . . 0.0 111.201 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.999 ' HG3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -150.43 102.82 3.08 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.718 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.93 152.04 21.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.325 -0.86 . . . . 0.0 110.024 -179.151 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 104.43 173.96 25.03 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.457 HG23 HG11 ' A' ' 27' ' ' VAL . 4.7 m -79.36 -68.81 0.63 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.05 -1.265 . . . . 0.0 109.376 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -47.16 -32.92 4.7 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.135 -0.978 . . . . 0.0 109.012 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.999 ' HB1' ' HG3' ' A' ' 45' ' ' ARG . . . -70.96 -51.17 27.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.18 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 47' ' ' GLY . 7.5 mm -58.67 -43.65 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.534 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.772 ' HB2' HG21 ' A' ' 27' ' ' VAL . 18.8 ttt180 -73.29 -56.11 5.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 108.983 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 52' ' ' ARG . 14.6 tt0 -45.74 -27.04 0.74 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 108.617 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -88.27 -71.09 0.6 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.72 0.772 . . . . 0.0 108.918 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.585 ' C ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -52.1 -20.92 2.79 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.476 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 52' ' ' ARG . . . -80.82 -45.52 16.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.175 -0.953 . . . . 0.0 108.452 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 2.4 t30 -56.82 -30.52 63.83 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.4 t -69.92 -37.8 76.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.046 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.0 tp -67.27 -19.68 65.53 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.45 -0.781 . . . . 0.0 109.735 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 2.7 mtmt -56.36 -25.57 49.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.906 HD22 ' CD2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.89 125.69 59.94 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.179 -0.951 . . . . 0.0 109.079 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 44.1 Cg_endo -70.78 101.1 1.01 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.759 1.4 . . . . 0.0 110.349 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.906 ' CD2' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -137.99 150.31 46.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.568 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.704 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -89.65 127.52 35.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.193 -0.942 . . . . 0.0 108.793 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 t -108.43 114.01 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 0.0 109.851 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 67' ' ' LEU . 16.8 tt0 -150.44 98.68 2.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.384 -0.822 . . . . 0.0 109.194 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.8 mp -45.38 170.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 109.807 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 t -144.58 -38.63 0.28 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.404 -0.81 . . . . 0.0 109.612 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.508 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 13.9 pt20 -90.92 -146.31 0.19 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.553 -0.717 . . . . 0.0 109.268 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.508 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 23.6 tt0 -115.34 135.2 54.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.106 -0.996 . . . . 0.0 109.768 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.867 HG21 HG11 ' A' ' 11' ' ' VAL . 78.1 t -72.06 145.2 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.293 -0.879 . . . . 0.0 109.345 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.524 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -107.5 135.46 48.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 0.0 109.65 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.014 ' HB1' ' HB3' ' A' ' 7' ' ' MET . . . -150.37 129.79 12.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 109.878 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.83 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -138.38 145.68 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 109.899 179.577 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . 41.68 -101.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.466 -0.771 . . . . 0.0 110.077 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.574 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -121.39 -11.44 8.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.952 -1.092 . . . . 0.0 109.69 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.639 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -89.74 -161.12 0.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.121 -0.987 . . . . 0.0 109.06 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.951 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 169.22 159.38 0.05 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.272 -0.893 . . . . 0.0 109.972 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.973 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -149.96 132.33 15.59 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.861 ' HB3' HG13 ' A' ' 71' ' ' VAL . 37.4 p90 -150.42 168.77 23.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.891 -1.131 . . . . 0.0 110.436 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.838 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -143.8 161.86 37.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.683 -0.636 . . . . 0.0 109.312 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 82' ' ' PHE . 2.1 p90 -157.13 -169.72 3.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.213 -0.929 . . . . 0.0 109.335 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.61 141.12 52.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.457 -0.777 . . . . 0.0 109.903 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.699 HG11 HD22 ' A' ' 63' ' ' LEU . 73.3 t -112.7 114.15 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.704 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 19.5 p -108.69 97.32 6.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.182 -0.949 . . . . 0.0 110.296 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 18.4 p90 -111.17 -176.45 2.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.264 -0.897 . . . . 0.0 108.618 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 2.7 tm-20 -148.78 150.33 32.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.885 -1.134 . . . . 0.0 110.126 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.41 ' CZ ' ' HE2' ' A' ' 86' ' ' PHE . 65.6 m-85 -90.29 -116.07 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.31 1.03 19.83 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.912 -1.117 . . . . 0.0 109.446 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -164.19 -58.8 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 3.3 mtt85 -81.76 158.51 24.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -1.133 . . . . 0.0 109.485 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -119.59 132.44 55.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 109.765 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -114.89 143.84 44.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.863 . . . . 0.0 109.255 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.701 HG23 ' HA ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -117.23 173.44 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 108.922 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 1.005 HG12 ' HD3' ' A' ' 97' ' ' PRO . 2.8 t -145.96 145.93 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 109.32 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.413 ' O ' ' CG ' ' A' ' 120' ' ' ASN . . . -127.71 72.95 78.52 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 1.005 ' HD3' HG12 ' A' ' 95' ' ' VAL . 50.0 Cg_endo -91.58 -177.0 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.731 1.385 . . . . 0.0 110.821 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.838 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.5 mp -140.84 142.8 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 13.6 t0 -116.46 160.05 21.14 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.952 -1.092 . . . . 0.0 110.215 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.538 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -113.12 176.25 5.1 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.951 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -148.14 137.86 22.38 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.035 -1.041 . . . . 0.0 109.926 -179.145 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.5 ' HA ' ' HG3' ' A' ' 77' ' ' GLU . 64.2 ttt-85 -141.44 103.15 4.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.893 ' CE1' HG11 ' A' ' 10' ' ' VAL . 10.9 m-30 -92.31 -171.81 2.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.591 ' HB3' HG21 ' A' ' 110' ' ' VAL . 7.8 p-10 -112.66 -25.45 9.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -157.62 -69.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 171.38 73.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -1.103 . . . . 0.0 109.388 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -178.84 -52.44 0.08 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -117.61 174.3 6.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -1.117 . . . . 0.0 109.498 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.623 HG12 ' N ' ' A' ' 110' ' ' VAL . 88.8 t -97.83 167.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.069 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.625 ' O ' ' HB1' ' A' ' 34' ' ' ALA . 3.1 t -140.52 -72.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.028 -1.045 . . . . 0.0 109.964 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.437 ' HB2' ' HD3' ' A' ' 102' ' ' ARG . 19.7 m -119.43 163.41 17.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 109.939 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.538 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 2.8 ttp -148.28 164.39 34.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.467 -0.77 . . . . 0.0 109.555 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.511 ' NH1' ' OE2' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -143.24 123.45 13.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 109.318 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.429 ' HB3' ' OD2' ' A' ' 38' ' ' ASP . . . -104.99 130.46 53.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.105 -0.997 . . . . 0.0 109.652 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.6 OUTLIER -126.15 147.58 49.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.608 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.541 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 9.7 p90 174.09 -155.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.56 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 167.8 -179.23 41.26 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.527 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 24.4 tt0 -70.26 -4.77 23.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -1.165 . . . . 0.0 109.694 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -90.62 -29.64 17.66 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -89.29 13.31 13.74 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.198 0.523 . . . . 0.0 109.697 -179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.944 HG23 HG22 ' A' ' 95' ' ' VAL . 4.4 mm -91.91 -163.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.146 -0.971 . . . . 0.0 108.748 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.701 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -151.43 161.63 42.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.427 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.53 113.18 3.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.8 -119.61 4.21 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.29 -1.123 . . . . 0.0 109.545 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 201' ' ' MET . . . . . 0.402 ' CE ' ' OE1' ' A' ' 118' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.222 0.534 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.449 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 7.4 m-80 44.94 68.85 0.5 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.568 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 203' ' ' THR . . . . . 0.687 HG23 ' O ' ' B' ' 203' ' ' THR . 9.7 t -52.51 107.74 0.91 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 0.0 109.661 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 204' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 50.6 Cg_endo -77.2 5.9 4.71 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.912 1.48 . . . . 0.0 110.491 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 205' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' B' ' 204' ' ' PRO . 0.0 OUTLIER -40.76 -72.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.289 -0.882 . . . . 0.0 110.183 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 206' ' ' HIS . . . . . 0.59 ' CE1' ' HG3' ' B' ' 207' ' ' MET . 11.8 p80 -54.59 -35.84 63.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 109.957 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 207' ' ' MET . . . . . 0.59 ' HG3' ' CE1' ' B' ' 206' ' ' HIS . 15.8 mtt -65.57 -56.92 9.68 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.172 -0.955 . . . . 0.0 109.836 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.466 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 8.2 m -56.18 -31.1 63.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.701 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.99 -51.37 67.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.149 -0.969 . . . . 0.0 108.696 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.82 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.0 OUTLIER -55.56 -20.61 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.853 HG11 HG21 ' B' ' 271' ' ' VAL . 16.2 t -90.24 -43.01 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.553 -0.717 . . . . 0.0 109.123 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 212' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' B' ' 213' ' ' ARG . 6.0 tt0 -60.66 -74.09 0.08 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.944 ' HB3' HD22 ' B' ' 229' ' ' LEU . 1.6 mtt-85 -42.3 -44.88 4.03 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.964 0.888 . . . . 0.0 108.605 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 214' ' ' TYR . . . . . 0.581 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -49.7 -45.15 48.68 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.891 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.24 -38.88 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.309 -0.869 . . . . 0.0 109.097 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 216' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' B' ' 213' ' ' ARG . . . -49.1 -35.75 17.03 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -75.3 -31.0 60.53 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.891 HD12 ' HA ' ' B' ' 215' ' ' VAL . 1.1 mt -65.4 -56.4 12.73 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 219' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 0.2 OUTLIER -53.06 -47.31 68.55 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.604 0.716 . . . . 0.0 109.348 179.462 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.22 6.56 39.65 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.713 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.834 ' HA2' HD11 ' B' ' 259' ' ' LEU . . . 51.48 39.55 44.93 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 222' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.9 t0 -96.04 66.48 2.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.306 -1.114 . . . . 0.0 109.893 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 223' ' ' LEU . . . . . 1.107 HD12 HD12 ' B' ' 226' ' ' ILE . 6.1 tp -47.59 -43.34 25.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.163 -0.96 . . . . 0.0 108.909 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -43.59 -38.21 2.88 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -80.6 -29.01 45.23 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 1.107 HD12 HD12 ' B' ' 223' ' ' LEU . 36.9 mt -65.92 -56.27 15.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.743 HG11 HG23 ' B' ' 248' ' ' THR . 77.3 t -59.86 -35.97 63.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.22 -56.21 24.38 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.944 HD22 ' HB3' ' B' ' 213' ' ' ARG . 9.2 tp -59.3 -23.0 62.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 230' ' ' PHE . . . . . 0.543 ' CD2' HG21 ' B' ' 251' ' ' ILE . 3.9 m-85 -88.92 143.35 26.93 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.41 -0.806 . . . . 0.0 109.484 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -53.79 -170.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.855 . . . . 0.0 109.322 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.441 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -75.61 -24.2 56.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 109.673 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.542 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 15.1 p30 -145.06 44.2 1.33 Allowed 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.592 -0.693 . . . . 0.0 109.608 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.689 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -55.9 168.53 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.918 . . . . 0.0 109.339 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 235' ' ' THR . . . . . 0.894 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -121.68 142.68 49.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.611 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 32.3 t -131.63 121.16 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 109.507 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 237' ' ' GLU . . . . . 0.511 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.1 mt-10 -88.53 112.43 22.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 238' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' B' ' 239' ' ' PRO . 12.6 t70 -176.08 145.57 0.75 Allowed Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.265 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 239' ' ' PRO . . . . . 0.549 ' O ' ' HA ' ' B' ' 238' ' ' ASP . 53.6 Cg_endo -79.66 -92.41 0.0 OUTLIER 'Cis proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.506 -1.872 . . . . 0.0 110.915 -0.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.38 126.55 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.912 -1.118 . . . . 0.0 108.95 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 86.53 -8.37 75.26 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 242' ' ' SER . . . . . 0.545 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.2 OUTLIER -97.93 -146.24 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -1.062 . . . . 0.0 109.152 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -135.17 141.78 39.29 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.882 -1.136 . . . . 0.0 110.247 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 244' ' ' PRO . . . . . 0.539 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.4 Cg_endo -64.55 -169.5 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.271 1.669 . . . . 0.0 110.883 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.965 ' HB3' ' HB1' ' B' ' 250' ' ' ALA . 1.5 mtt-85 -150.34 101.77 3.01 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.894 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.2 164.38 15.0 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.307 -0.87 . . . . 0.0 110.119 -179.03 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 247' ' ' GLY . . . . . 0.602 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 98.39 160.45 30.17 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 248' ' ' THR . . . . . 0.743 HG23 HG11 ' B' ' 227' ' ' VAL . 4.1 m -74.32 -33.15 63.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.167 -1.196 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -72.63 -43.88 62.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.281 -0.887 . . . . 0.0 109.34 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.965 ' HB1' ' HB3' ' B' ' 245' ' ' ARG . . . -67.75 -56.97 7.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.445 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.689 HD11 ' N ' ' B' ' 234' ' ' ALA . 43.2 mt -47.53 -40.27 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.878 . . . . 0.0 108.885 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 252' ' ' ARG . . . . . 0.812 ' CG ' HD23 ' B' ' 223' ' ' LEU . 25.1 ttp85 -78.02 -52.72 8.35 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 253' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 4.0 mt-10 -50.82 -26.53 5.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 108.472 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.57 ' CD1' ' HG3' ' B' ' 245' ' ' ARG . 0.8 OUTLIER -87.65 -71.36 0.57 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 255' ' ' PHE . . . . . 1.02 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.1 OUTLIER -48.95 -33.26 10.56 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 256' ' ' ALA . . . . . 0.568 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -63.8 -49.71 71.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 257' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 8.5 t30 -54.99 -36.49 65.48 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 4.7 t -65.63 -36.19 82.99 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.429 -0.794 . . . . 0.0 108.961 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 259' ' ' LEU . . . . . 0.834 HD11 ' HA2' ' B' ' 221' ' ' GLY . 8.1 tp -67.07 -22.5 65.84 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.493 -0.754 . . . . 0.0 109.189 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 260' ' ' LYS . . . . . 0.488 ' O ' ' HD3' ' B' ' 262' ' ' PRO . 1.2 mttm -56.25 -20.34 17.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.132 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 261' ' ' LEU . . . . . 0.969 ' CD2' HD21 ' B' ' 263' ' ' LEU . 0.3 OUTLIER -92.35 107.38 23.15 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 262' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 49.4 Cg_endo -74.44 107.4 2.44 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.822 1.433 . . . . 0.0 112.151 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.969 HD21 ' CD2' ' B' ' 261' ' ' LEU . 0.0 OUTLIER -141.91 -162.83 1.46 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 0.0 109.567 178.608 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -123.67 125.84 45.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 265' ' ' VAL . . . . . 0.77 HG21 ' HB3' ' B' ' 218' ' ' LEU . 21.6 t -105.4 119.11 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.97 . . . . 0.0 109.806 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 266' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.2 OUTLIER -147.88 107.33 3.93 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.234 -0.916 . . . . 0.0 109.284 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.7 OUTLIER -49.77 -179.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.905 . . . . 0.0 109.574 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.15 -39.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 109.677 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 269' ' ' GLN . . . . . 0.692 ' NE2' ' HB3' ' B' ' 281' ' ' ALA . 8.9 pt20 -98.72 -148.62 0.34 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 109.231 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 270' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 28.1 tt0 -113.11 131.25 55.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.106 -0.996 . . . . 0.0 109.516 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 271' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' B' ' 280' ' ' PHE . 48.1 t -65.6 148.52 12.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.12 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 1.2 mtt180 -103.24 133.49 48.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -0.95 . . . . 0.0 109.732 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 273' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.14 137.44 19.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.368 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 274' ' ' VAL . . . . . 0.555 ' CB ' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -130.02 -152.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 0.0 109.589 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 275' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . -32.67 -91.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.147 0.498 . . . . 0.0 110.799 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 276' ' ' ASN . . . . . 0.511 ' ND2' ' HA2' ' A' ' 41' ' ' GLY . 11.2 p30 -112.54 -18.18 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.944 -1.098 . . . . 0.0 110.269 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 277' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 2.8 mt-10 -90.62 -163.27 1.0 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 109.578 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 278' ' ' ALA . . . . . 0.76 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 174.89 163.79 0.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.516 -0.74 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 279' ' ' ALA . . . . . 0.756 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -150.55 138.81 20.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 108.623 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 280' ' ' PHE . . . . . 0.9 ' HB3' HG13 ' B' ' 271' ' ' VAL . 33.3 p90 -150.39 167.25 27.63 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.71 -1.244 . . . . 0.0 110.462 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 1.002 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -142.96 151.7 41.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.719 -0.613 . . . . 0.0 109.378 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 282' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 1.2 p90 -145.37 -169.95 3.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.181 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.57 142.95 47.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.461 -0.774 . . . . 0.0 109.961 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 284' ' ' VAL . . . . . 0.899 ' CG1' HD22 ' B' ' 263' ' ' LEU . 2.9 t -125.86 115.54 43.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 285' ' ' SER . . . . . 0.655 ' HB3' HG23 ' B' ' 294' ' ' VAL . 53.1 p -119.7 106.02 11.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 109.988 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.772 ' CD1' HD23 ' B' ' 263' ' ' LEU . 13.6 p90 -114.41 173.82 6.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.0 108.846 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.11 157.09 16.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.024 -1.048 . . . . 0.0 110.803 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 288' ' ' PHE . . . . . 0.54 ' O ' ' N ' ' B' ' 290' ' ' GLY . 0.0 OUTLIER -117.57 74.09 0.92 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.594 -0.691 . . . . 0.0 109.147 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 289' ' ' GLN . . . . . 0.513 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 0.2 OUTLIER 43.94 -91.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.062 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 290' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' B' ' 288' ' ' PHE . . . -101.0 7.11 57.01 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.295 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -132.72 -178.94 5.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -1.22 . . . . 0.0 109.803 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 292' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -122.42 144.2 49.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.84 . . . . 0.0 109.344 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 293' ' ' THR . . . . . 0.636 ' CB ' ' HB2' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -140.22 159.19 42.73 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.148 -0.97 . . . . 0.0 109.364 -179.06 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 294' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 295' ' ' VAL . 3.9 p -151.65 -177.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 120.686 -1.259 . . . . 0.0 110.266 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 1.047 HG12 ' HD3' ' B' ' 297' ' ' PRO . 29.0 t -151.95 148.89 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.106 -1.621 . . . . 0.0 109.187 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 296' ' ' ALA . . . . . 0.428 ' N ' ' HD3' ' B' ' 297' ' ' PRO . . . -145.07 67.84 13.58 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.068 -1.02 . . . . 0.0 110.238 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 297' ' ' PRO . . . . . 1.047 ' HD3' HG12 ' B' ' 295' ' ' VAL . 50.0 Cg_endo -98.03 -175.78 0.22 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.94 1.76 . . . . 0.0 111.018 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 1.002 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.9 mp -139.88 147.29 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 299' ' ' ASP . . . . . 0.617 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 9.4 t0 -118.42 157.83 26.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.858 -1.151 . . . . 0.0 110.223 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 300' ' ' HIS . . . . . 0.525 ' O ' ' CG ' ' B' ' 312' ' ' MET . 1.4 t60 -110.52 172.3 6.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 301' ' ' PHE . . . . . 0.76 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.1 OUTLIER -146.48 133.94 20.83 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.048 -1.032 . . . . 0.0 110.129 -178.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.497 ' HG2' ' HG3' ' B' ' 277' ' ' GLU . 0.3 OUTLIER -139.69 111.96 7.63 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 303' ' ' PHE . . . . . 0.67 ' CE1' HG11 ' B' ' 210' ' ' VAL . 8.3 m-30 -91.87 177.63 6.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.268 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 304' ' ' ASN . . . . . 0.617 ' N ' HG21 ' B' ' 310' ' ' VAL . 6.7 p30 -92.61 -28.9 16.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.931 . . . . 0.0 109.276 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 305' ' ' GLY . . . . . 0.714 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -166.53 -50.74 0.03 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 306' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 163.04 76.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -1.135 . . . . 0.0 109.336 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.52 -63.71 0.06 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.53 -163.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -1.179 . . . . 0.0 109.841 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 309' ' ' VAL . . . . . 0.972 HG11 ' HE1' ' B' ' 312' ' ' MET . 17.0 t -106.98 168.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.338 -0.851 . . . . 0.0 109.162 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 310' ' ' VAL . . . . . 0.639 ' O ' ' HB1' ' B' ' 234' ' ' ALA . 24.6 t -139.86 -73.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 0.0 109.919 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 311' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' B' ' 235' ' ' THR . 9.3 m -125.38 163.24 23.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.185 -0.947 . . . . 0.0 110.164 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 312' ' ' MET . . . . . 0.972 ' HE1' HG11 ' B' ' 309' ' ' VAL . 0.0 OUTLIER -143.44 171.3 14.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -0.822 . . . . 0.0 109.487 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 313' ' ' ARG . . . . . 0.504 ' NH2' HD12 ' B' ' 315' ' ' LEU . 1.5 ttp85 -150.2 120.0 7.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 109.571 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 314' ' ' ALA . . . . . 0.621 ' HB1' ' HE2' ' B' ' 316' ' ' PHE . . . -101.07 136.63 40.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.977 . . . . 0.0 109.721 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 315' ' ' LEU . . . . . 0.973 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -126.24 148.7 49.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.896 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 316' ' ' PHE . . . . . 0.83 ' O ' HG11 ' A' ' 74' ' ' VAL . 2.2 p90 168.22 -169.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 317' ' ' GLY . . . . . 0.589 ' HA2' HG11 ' A' ' 74' ' ' VAL . . . -157.24 167.58 33.94 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.262 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 318' ' ' GLU . . . . . 0.548 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 5.8 tt0 -63.81 -9.88 17.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.43 -1.041 . . . . 0.0 109.889 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -88.37 -32.81 18.19 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 320' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.44 28.64 4.03 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 321' ' ' ILE . . . . . 0.564 HG22 ' N ' ' B' ' 322' ' ' HIS . 19.5 mm -91.01 -120.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.005 -1.059 . . . . 0.0 110.332 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 322' ' ' HIS . . . . . 0.636 ' HB2' ' CB ' ' B' ' 293' ' ' THR . 14.4 p80 -125.69 134.25 51.88 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.016 -1.052 . . . . 0.0 112.489 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.377 0 O-C-N 121.393 -0.817 . . . . 0.0 109.841 177.818 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.709 HG23 ' CE1' ' A' ' 6' ' ' HIS . 1.3 t . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.54 ' HA ' ' HB2' ' A' ' 7' ' ' MET . 46.3 Cg_endo -73.9 -0.46 9.49 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.863 1.454 . . . . 0.0 110.185 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.19 -92.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.602 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.709 ' CE1' HG23 ' A' ' 3' ' ' THR . 1.2 p80 -52.54 -41.28 63.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.143 -0.973 . . . . 0.0 109.259 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.54 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 34.5 mmt -53.17 -39.86 63.93 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.199 -0.938 . . . . 0.0 109.788 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.43 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 6.0 m -74.19 -36.63 64.02 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.21 -43.81 64.44 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.082 ' HA ' HD21 ' A' ' 29' ' ' LEU . 2.1 t -49.55 -33.93 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.859 HG22 ' CE2' ' A' ' 101' ' ' PHE . 29.9 t -76.33 -45.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.438 -0.789 . . . . 0.0 109.791 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 13' ' ' ARG . 17.0 tt0 -59.4 -73.68 0.08 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.212 1.006 . . . . 0.0 108.494 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.3 mtt180 -42.68 -44.91 4.5 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.636 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -49.5 -44.98 46.51 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.457 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.936 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.3 t -88.88 -38.72 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.334 -0.854 . . . . 0.0 109.243 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -48.94 -36.47 17.44 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -74.0 -32.58 63.47 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.936 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.4 mt -64.96 -58.75 5.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -51.14 -45.8 61.77 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . -89.58 10.19 23.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.64 -0.662 . . . . 0.0 109.459 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 1.06 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 45.7 31.92 4.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' ALA . 7.6 t70 -89.75 66.19 7.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.501 -0.999 . . . . 0.0 109.804 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.097 HD11 ' HB3' ' A' ' 55' ' ' PHE . 8.2 tp -47.9 -42.61 27.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 108.962 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -42.03 -32.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.4 -36.82 10.29 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.019 HD12 HD12 ' A' ' 23' ' ' LEU . 25.3 mt -59.32 -54.07 39.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.513 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 52.4 t -58.18 -40.9 79.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.22 -52.73 60.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.082 HD21 ' HA ' ' A' ' 10' ' ' VAL . 9.6 tp -61.71 -27.89 69.02 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.679 ' CG ' HG21 ' A' ' 51' ' ' ILE . 5.6 m-85 -79.08 128.33 33.14 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.556 -0.715 . . . . 0.0 109.811 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -45.86 172.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 109.655 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.431 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -60.08 -24.15 64.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 109.87 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.558 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -148.01 38.66 0.91 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.58 -0.7 . . . . 0.0 109.506 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.676 ' O ' HD11 ' A' ' 51' ' ' ILE . . . -54.91 173.65 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.632 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.564 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -114.57 140.09 49.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.426 -0.796 . . . . 0.0 109.127 179.657 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.561 HG11 ' CD2' ' A' ' 54' ' ' PHE . 1.2 t -113.43 171.83 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 108.715 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.609 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -151.26 121.11 7.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.882 . . . . 0.0 108.873 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.505 ' OD1' ' HB3' ' A' ' 114' ' ' ALA . 0.2 OUTLIER 172.69 148.2 0.2 Allowed Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.549 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.581 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 46.7 Cg_endo -80.93 -84.38 0.0 OUTLIER 'Cis proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.165 -2.015 . . . . 0.0 110.599 -0.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.773 ' O ' ' HB2' ' B' ' 275' ' ' ALA . 2.2 m -146.95 73.71 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.203 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.29 -5.5 3.88 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.581 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 3.4 t -97.27 -131.04 0.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.19 -1.183 . . . . 0.0 109.199 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -138.62 128.37 14.7 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.565 -1.334 . . . . 0.0 110.423 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.609 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 37.9 Cg_endo -62.5 -175.56 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.707 1.605 . . . . 0.0 111.055 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.824 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -151.11 100.52 2.78 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.45 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.895 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -90.37 171.58 9.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.205 -0.935 . . . . 0.0 110.63 -178.49 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 95.77 154.85 30.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 5.5 m -64.7 -36.83 85.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.19 -1.182 . . . . 0.0 109.259 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -70.79 -43.97 67.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.154 -0.966 . . . . 0.0 109.319 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.895 ' HB3' ' O ' ' A' ' 46' ' ' SER . . . -74.41 -57.13 4.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.679 HG21 ' CG ' ' A' ' 30' ' ' PHE . 43.0 mt -43.71 -37.11 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.235 -0.916 . . . . 0.0 109.052 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.513 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 2.5 ttt180 -81.25 -63.62 1.36 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.0 109.147 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 4.2 tt0 -45.11 -28.75 0.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.934 . . . . 0.0 108.825 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.561 ' CD2' HG11 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -79.88 -71.42 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.274 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 1.097 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -46.62 -25.75 0.77 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.632 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -71.2 -47.17 59.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 11.1 t-20 -57.51 -30.87 65.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.388 -0.82 . . . . 0.0 108.793 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 t -72.55 -40.83 66.37 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.06 HD21 ' CA ' ' A' ' 21' ' ' GLY . 9.0 tp -65.11 -21.93 66.87 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.453 -0.779 . . . . 0.0 109.273 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 4.8 mttp -47.47 -27.5 1.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.043 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.743 HD23 HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -90.03 107.72 21.26 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.306 -0.871 . . . . 0.0 108.718 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 44.5 Cg_endo -70.93 116.09 4.53 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.795 1.419 . . . . 0.0 110.675 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.038 HD13 HG13 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -150.3 -171.13 3.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.969 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.59 126.84 54.71 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.822 HG21 ' HB3' ' A' ' 18' ' ' LEU . 2.2 t -105.38 123.52 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 109.895 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -150.23 98.71 2.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.141 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 66' ' ' GLU . 2.1 mp -44.87 170.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 110.039 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 69' ' ' GLN . 0.6 OUTLIER -129.27 -83.3 0.56 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 68' ' ' THR . 2.8 pt20 -59.37 -148.07 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.675 -0.641 . . . . 0.0 109.319 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.45 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 31.6 tt0 -109.1 132.43 54.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.056 -1.028 . . . . 0.0 109.647 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.888 HG13 ' HB3' ' A' ' 80' ' ' PHE . 48.7 t -57.4 149.48 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.293 -0.88 . . . . 0.0 109.259 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -114.28 132.91 55.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.029 -1.044 . . . . 0.0 109.968 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -150.17 112.04 4.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.39 -0.819 . . . . 0.0 109.253 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.769 HG21 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -131.81 158.71 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.225 -0.922 . . . . 0.0 109.501 -179.814 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 48.58 -147.52 0.26 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.304 -0.873 . . . . 0.0 109.622 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 8.8 m-20 -82.24 -24.12 34.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 102' ' ' ARG . 3.3 mt-10 -89.92 -162.41 0.88 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.111 -0.993 . . . . 0.0 109.539 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.681 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . -178.46 168.95 1.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.522 -0.736 . . . . 0.0 109.366 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.818 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.17 136.27 18.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.155 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.888 ' HB3' HG13 ' A' ' 71' ' ' VAL . 14.4 p90 -149.79 162.25 40.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.95 -1.094 . . . . 0.0 110.15 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.958 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -136.45 -173.0 3.29 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.638 0.732 . . . . 0.0 110.118 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.527 ' CD2' ' C ' ' A' ' 81' ' ' ALA . 6.0 p90 177.08 -169.81 0.07 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 1.011 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -133.33 140.41 47.39 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 110.042 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.038 HG13 HD13 ' A' ' 63' ' ' LEU . 37.7 t -107.94 113.35 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.533 ' CA ' HG23 ' A' ' 94' ' ' VAL . 33.6 p -108.12 84.7 1.99 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 109.743 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.584 ' CE1' ' HB ' ' A' ' 93' ' ' THR . 15.5 p90 -93.62 -179.21 4.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.083 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.433 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 18.5 tt0 -111.36 149.59 30.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.034 -1.041 . . . . 0.0 110.325 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.58 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -114.19 104.98 12.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.453 -0.779 . . . . 0.0 109.021 179.443 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.497 ' CG ' ' C ' ' A' ' 88' ' ' PHE . 1.1 pt20 40.74 -93.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.412 -0.805 . . . . 0.0 109.894 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 88' ' ' PHE . . . -101.9 -31.84 5.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -90.08 -178.27 5.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -1.232 . . . . 0.0 109.632 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.497 ' HE3' ' OXT' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -127.46 140.63 52.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.584 ' HB ' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -124.59 159.81 29.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.393 -0.817 . . . . 0.0 109.645 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.644 HG22 ' H ' ' A' ' 95' ' ' VAL . 7.2 p -139.28 174.88 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.165 -0.96 . . . . 0.0 109.31 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 1.011 ' O ' HG22 ' A' ' 83' ' ' THR . 78.3 t -142.94 163.12 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.078 -1.014 . . . . 0.0 109.942 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.576 ' N ' HG12 ' A' ' 95' ' ' VAL . . . -138.0 70.63 49.32 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.527 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.523 ' HD3' HG12 ' A' ' 95' ' ' VAL . 46.1 Cg_endo -97.83 179.25 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.871 1.714 . . . . 0.0 111.447 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.958 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.8 mp -142.06 156.25 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.597 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 19.9 t0 -130.16 159.58 36.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.967 -1.083 . . . . 0.0 110.072 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 113' ' ' ARG . 85.9 t60 -109.87 170.74 7.88 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.859 ' CE2' HG22 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -140.85 136.02 31.95 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.07 -1.018 . . . . 0.0 110.006 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.541 ' HA ' ' CG ' ' A' ' 77' ' ' GLU . 3.2 ttt85 -131.3 109.13 10.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.871 ' CE1' HG11 ' A' ' 10' ' ' VAL . 10.1 m-85 -108.42 -177.48 3.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 107' ' ' GLY . 6.1 p30 -106.72 6.34 29.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.573 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.685 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 120.51 -30.51 5.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 164.36 37.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -1.151 . . . . 0.0 109.364 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 108' ' ' LYS . . . -130.58 47.62 1.01 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 7.3 mmtt 84.19 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.055 -0.674 . . . . 0.0 109.421 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.78 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 40.4 t -89.83 166.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 109.329 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.597 ' N ' HG12 ' A' ' 109' ' ' VAL . 72.3 t -138.19 -59.78 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.531 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.528 ' HB2' ' CD ' ' A' ' 102' ' ' ARG . 1.1 m -139.6 163.5 32.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.612 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.516 ' HG3' ' O ' ' A' ' 100' ' ' HIS . 0.9 OUTLIER -145.45 155.37 43.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.883 . . . . 0.0 109.779 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -141.31 108.18 5.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.376 -0.828 . . . . 0.0 108.985 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.505 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . . . -89.89 148.02 23.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.071 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' B' ' 279' ' ' ALA . 1.4 tt -136.36 139.98 42.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.433 -0.792 . . . . 0.0 109.575 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.783 ' O ' HG21 ' B' ' 274' ' ' VAL . 2.8 p90 172.42 -158.44 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.624 0.726 . . . . 0.0 109.4 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.586 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 174.49 179.85 45.36 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.528 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 18.6 tt0 -72.73 -3.22 23.86 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.311 -1.111 . . . . 0.0 109.397 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -91.16 -29.15 17.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.946 0.879 . . . . 0.0 108.996 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -88.85 15.95 7.64 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.324 0.583 . . . . 0.0 109.712 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.809 HG23 HG22 ' A' ' 95' ' ' VAL . 4.0 mm -89.97 -162.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.621 ' H ' HG22 ' A' ' 121' ' ' ILE . 2.9 t-80 -151.67 153.56 34.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.862 -1.149 . . . . 0.0 110.047 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.446 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.8 125.3 6.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.336 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.12 -164.95 32.59 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.497 ' OXT' ' HE3' ' A' ' 92' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.325 -1.103 . . . . 0.0 109.45 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 201' ' ' MET . . . . . 0.427 ' O ' ' C ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.251 0.548 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.471 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 30.7 m120 43.7 74.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.484 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 203' ' ' THR . . . . . 0.611 HG23 ' O ' ' B' ' 203' ' ' THR . 4.8 t -87.64 109.61 27.95 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.625 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 204' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.4 Cg_endo -72.93 -1.35 10.34 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.91 1.479 . . . . 0.0 110.245 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -49.39 72.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -66.15 -55.0 18.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.504 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 207' ' ' MET . . . . . 0.533 ' HB3' ' HB1' ' B' ' 273' ' ' ALA . 69.2 mtm -58.32 -43.72 88.32 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.231 -0.918 . . . . 0.0 109.781 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 19.1 m -70.79 -42.04 70.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.574 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.35 -45.2 65.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 108.747 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.928 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.3 t -56.99 -20.64 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.926 HG11 HG21 ' B' ' 271' ' ' VAL . 10.7 t -90.29 -41.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 0.0 109.198 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 212' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' B' ' 213' ' ' ARG . 14.0 tt0 -60.49 -74.77 0.07 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.95 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.0 OUTLIER -42.09 -43.43 3.26 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 122.137 0.97 . . . . 0.0 108.697 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 214' ' ' TYR . . . . . 0.635 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 1.2 t80 -55.84 -49.27 73.76 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.415 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.854 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -83.01 -42.58 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.722 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 216' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.45 -36.67 10.36 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -74.89 -32.98 61.98 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.854 HD12 ' HA ' ' B' ' 215' ' ' VAL . 0.9 OUTLIER -62.68 -56.18 20.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.719 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 219' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' B' ' 265' ' ' VAL . 4.0 t-20 -53.24 -48.41 68.24 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.652 0.739 . . . . 0.0 109.523 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.01 10.0 23.13 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.845 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.628 ' HA2' HD11 ' B' ' 259' ' ' LEU . . . 50.06 37.83 30.72 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 222' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' B' ' 217' ' ' ALA . 9.4 t0 -93.03 61.29 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.332 -1.099 . . . . 0.0 109.815 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 223' ' ' LEU . . . . . 1.086 HD11 ' HB3' ' B' ' 255' ' ' PHE . 5.8 tp -46.2 -42.53 14.27 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.153 -0.967 . . . . 0.0 108.648 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -43.7 -37.88 2.86 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -81.78 -33.46 27.26 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 1.027 HD12 HD12 ' B' ' 223' ' ' LEU . 27.9 mt -61.25 -55.18 26.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.523 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 88.8 t -58.02 -37.13 59.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.19 25.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.95 HD22 ' HB3' ' B' ' 213' ' ' ARG . 9.8 tp -59.71 -24.39 63.94 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 230' ' ' PHE . . . . . 0.477 ' HB2' ' HA ' ' B' ' 227' ' ' VAL . 5.1 m-85 -82.59 136.62 34.77 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.494 -0.754 . . . . 0.0 109.362 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.844 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -52.33 -174.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.382 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.449 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.3 OUTLIER -69.67 -26.38 64.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.445 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.54 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 3.5 p30 -151.4 54.87 0.86 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.498 -0.751 . . . . 0.0 109.68 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.697 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -60.36 -167.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 235' ' ' THR . . . . . 0.473 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.2 OUTLIER -130.6 133.96 46.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.895 . . . . 0.0 109.244 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.569 HG12 ' N ' ' B' ' 237' ' ' GLU . 23.1 t -111.95 167.66 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -0.865 . . . . 0.0 109.188 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 237' ' ' GLU . . . . . 0.569 ' N ' HG12 ' B' ' 236' ' ' VAL . 21.8 mt-10 -150.88 115.54 5.19 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 238' ' ' ASP . . . . . 0.539 ' OD1' ' HA ' ' B' ' 239' ' ' PRO . 0.6 OUTLIER -177.11 148.17 0.73 Allowed Pre-proline 0 N--CA 1.491 1.582 0 C-N-CA 118.355 -1.338 . . . . 0.0 110.38 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 239' ' ' PRO . . . . . 0.539 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 47.6 Cg_endo -73.34 -55.32 0.14 OUTLIER 'Cis proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.941 -2.108 . . . . 0.0 110.989 -0.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.64 ' O ' HG23 ' B' ' 240' ' ' VAL . 34.6 m -150.43 111.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 109.792 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.14 43.39 63.12 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 242' ' ' SER . . . . . 0.534 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 73.7 m -114.73 -96.57 0.45 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -1.117 . . . . 0.0 109.944 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 243' ' ' GLU . . . . . 0.437 ' HA ' ' HD2' ' B' ' 244' ' ' PRO . 0.0 OUTLIER -142.86 89.9 7.82 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.272 -0.893 . . . . 0.0 110.609 -179.467 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 244' ' ' PRO . . . . . 0.564 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.9 Cg_endo -63.38 179.57 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.117 1.588 . . . . 0.0 110.507 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.753 ' HB3' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.64 100.46 2.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.952 . . . . 0.0 109.629 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.835 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.79 167.05 13.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.32 -0.863 . . . . 0.0 109.64 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 247' ' ' GLY . . . . . 0.628 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 97.78 159.5 30.66 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 248' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 2.1 m -69.58 -38.57 77.41 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.946 -1.326 . . . . 0.0 109.145 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -69.48 -41.4 76.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.835 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -72.92 -56.99 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.697 HD11 ' N ' ' B' ' 234' ' ' ALA . 30.0 mt -46.67 -42.26 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.188 -0.945 . . . . 0.0 108.772 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 252' ' ' ARG . . . . . 0.735 ' CG ' HD23 ' B' ' 223' ' ' LEU . 8.3 ttt180 -79.08 -50.75 10.55 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 253' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 46.4 mt-10 -51.12 -31.03 18.05 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' B' ' 245' ' ' ARG . 1.1 t80 -83.47 -71.93 0.48 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 255' ' ' PHE . . . . . 1.086 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -46.0 -26.34 0.7 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 256' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' B' ' 252' ' ' ARG . . . -70.65 -48.26 55.86 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 257' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 8.6 t30 -61.98 -31.02 71.34 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 2.8 t -71.56 -32.59 68.28 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 259' ' ' LEU . . . . . 0.628 HD11 ' HA2' ' B' ' 221' ' ' GLY . 8.7 tp -66.19 -22.15 66.34 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 260' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 16.1 mtmt -61.51 -13.57 22.26 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 261' ' ' LEU . . . . . 0.867 HD12 ' CG ' ' B' ' 263' ' ' LEU . 0.1 OUTLIER -88.63 110.46 37.26 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.248 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 262' ' ' PRO . . . . . 0.777 ' HD2' HD13 ' B' ' 261' ' ' LEU . 52.1 Cg_endo -80.94 91.68 1.12 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.705 1.371 . . . . 0.0 112.328 -178.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.976 HD23 ' CD1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -138.48 163.77 31.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.082 -1.011 . . . . 0.0 108.819 178.186 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 264' ' ' ALA . . . . . 0.875 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -89.81 127.27 35.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.18 -0.95 . . . . 0.0 109.021 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 265' ' ' VAL . . . . . 0.507 ' O ' ' ND2' ' B' ' 219' ' ' ASN . 93.9 t -104.44 112.44 38.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.269 -0.895 . . . . 0.0 109.528 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 266' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.6 tp10 -147.47 98.14 2.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.053 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.528 ' HA ' ' CB ' ' B' ' 282' ' ' PHE . 1.7 mp -44.41 169.35 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 110.059 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 268' ' ' THR . . . . . 0.502 ' OG1' ' N ' ' B' ' 269' ' ' GLN . 0.4 OUTLIER -122.28 -83.08 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 269' ' ' GLN . . . . . 0.502 ' N ' ' OG1' ' B' ' 268' ' ' THR . 2.6 pt20 -61.17 -140.4 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -117.57 130.67 56.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.875 -1.141 . . . . 0.0 109.993 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 271' ' ' VAL . . . . . 1.021 HG13 ' HB3' ' B' ' 280' ' ' PHE . 56.5 t -48.71 149.19 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.355 -0.841 . . . . 0.0 108.936 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.838 HH21 HD12 ' A' ' 98' ' ' ILE . 31.1 mtp85 -108.11 129.18 55.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.043 -1.036 . . . . 0.0 109.714 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 273' ' ' ALA . . . . . 0.589 ' C ' HG22 ' B' ' 274' ' ' VAL . . . -143.91 144.95 31.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.292 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 274' ' ' VAL . . . . . 0.783 HG21 ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -167.31 146.55 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 109.099 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 275' ' ' ALA . . . . . 0.773 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . 58.27 -139.11 0.81 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.093 -1.005 . . . . 0.0 109.094 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 276' ' ' ASN . . . . . 0.544 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 18.0 m-20 -91.31 -31.26 16.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.977 -1.077 . . . . 0.0 109.891 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 277' ' ' GLU . . . . . 0.683 ' HG2' ' N ' ' B' ' 278' ' ' ALA . 0.0 OUTLIER -97.99 153.6 18.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 109.647 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 278' ' ' ALA . . . . . 0.683 ' N ' ' HG2' ' B' ' 277' ' ' GLU . . . -136.04 169.66 17.25 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.388 0.613 . . . . 0.0 109.877 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 279' ' ' ALA . . . . . 0.759 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -141.66 141.66 33.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.388 -0.82 . . . . 0.0 109.182 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 280' ' ' PHE . . . . . 1.021 ' HB3' HG13 ' B' ' 271' ' ' VAL . 36.0 p90 -150.26 157.92 43.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.848 -1.158 . . . . 0.0 110.324 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 1.051 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -137.26 -169.27 2.46 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.484 0.659 . . . . 0.0 110.038 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 282' ' ' PHE . . . . . 0.528 ' CB ' ' HA ' ' B' ' 267' ' ' LEU . 30.5 p90 168.55 -168.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 283' ' ' THR . . . . . 0.923 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -130.92 140.79 50.23 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.346 -0.846 . . . . 0.0 109.527 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 284' ' ' VAL . . . . . 0.883 HG12 ' HB2' ' B' ' 263' ' ' LEU . 0.4 OUTLIER -100.87 119.32 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -0.872 . . . . 0.0 108.892 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 285' ' ' SER . . . . . 0.875 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 86.7 p -109.17 118.23 36.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 0.0 109.836 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.976 ' CD1' HD23 ' B' ' 263' ' ' LEU . 0.7 OUTLIER -140.32 153.43 46.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.935 . . . . 0.0 109.44 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 287' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' B' ' 291' ' ' ARG . 81.9 tt0 -96.5 164.53 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 288' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' B' ' 289' ' ' GLN . 1.0 OUTLIER -115.42 -173.8 2.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.688 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 289' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' B' ' 288' ' ' PHE . 0.0 OUTLIER -43.22 -30.43 0.48 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.707 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -150.0 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 291' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' B' ' 287' ' ' GLU . 0.0 OUTLIER -83.35 -165.03 0.99 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -1.188 . . . . 0.0 109.532 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 292' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' B' ' 287' ' ' GLU . 0.3 OUTLIER -149.78 143.64 25.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.85 . . . . 0.0 109.306 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 293' ' ' THR . . . . . 0.699 HG23 ' CZ ' ' B' ' 286' ' ' PHE . 1.4 t -129.5 -176.19 3.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.999 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 294' ' ' VAL . . . . . 0.679 HG12 ' HB3' ' B' ' 322' ' ' HIS . 6.3 p -152.2 171.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 0.923 ' O ' HG22 ' B' ' 283' ' ' THR . 46.0 t -143.6 155.52 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.86 -1.15 . . . . 0.0 109.835 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 296' ' ' ALA . . . . . 0.52 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -126.33 72.83 72.6 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 297' ' ' PRO . . . . . 0.561 ' HD3' HG12 ' B' ' 295' ' ' VAL . 43.9 Cg_endo -95.85 176.27 0.82 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.539 1.493 . . . . 0.0 111.188 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 1.051 HG23 ' HB2' ' B' ' 281' ' ' ALA . 3.0 mp -142.35 158.79 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 299' ' ' ASP . . . . . 0.628 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 17.1 t0 -131.27 168.24 17.85 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.115 -0.99 . . . . 0.0 109.959 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 300' ' ' HIS . . . . . 0.672 ' CE1' ' HB2' ' B' ' 279' ' ' ALA . 1.2 t-80 -131.5 138.61 49.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 108.983 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 301' ' ' PHE . . . . . 0.589 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.4 OUTLIER -112.65 150.13 31.88 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 -178.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.5 ' HB3' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -140.8 142.83 34.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.607 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 303' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' B' ' 210' ' ' VAL . 2.1 m-85 -128.99 175.43 8.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.843 . . . . 0.0 108.967 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 304' ' ' ASN . . . . . 0.666 ' OD1' HG21 ' B' ' 310' ' ' VAL . 0.2 OUTLIER -150.3 18.59 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.242 -0.911 . . . . 0.0 109.142 178.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 305' ' ' GLY . . . . . 0.715 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -160.69 -88.53 0.07 OUTLIER Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 306' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 162.75 63.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -1.108 . . . . 0.0 109.666 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 307' ' ' GLY . . . . . 0.475 ' O ' ' HD3' ' B' ' 308' ' ' LYS . . . 166.96 -26.15 0.15 Allowed Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.079 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 308' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' B' ' 307' ' ' GLY . 1.2 mmtp -128.98 164.02 24.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -1.208 . . . . 0.0 109.918 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 309' ' ' VAL . . . . . 0.844 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 2.5 t -103.9 157.04 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 310' ' ' VAL . . . . . 0.666 HG21 ' OD1' ' B' ' 304' ' ' ASN . 22.1 t -142.77 -35.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.913 -1.117 . . . . 0.0 110.279 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 311' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -126.25 150.71 48.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.714 -1.241 . . . . 0.0 109.921 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 312' ' ' MET . . . . . 0.528 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 8.4 ttp -154.84 149.58 26.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.477 -0.764 . . . . 0.0 109.337 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 313' ' ' ARG . . . . . 0.465 ' HA ' ' HB2' ' B' ' 237' ' ' GLU . 13.4 ttp180 -141.92 124.39 15.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 109.625 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 314' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' B' ' 299' ' ' ASP . . . -97.95 130.83 44.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.449 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 315' ' ' LEU . . . . . 0.818 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -117.84 136.06 53.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.908 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 316' ' ' PHE . . . . . 0.769 ' O ' HG21 ' A' ' 74' ' ' VAL . 7.2 p90 170.46 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 317' ' ' GLY . . . . . 0.471 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 169.77 -173.46 43.95 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 318' ' ' GLU . . . . . 0.458 ' C ' HG12 ' B' ' 321' ' ' ILE . 19.0 tt0 -73.51 -2.46 22.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.286 -1.126 . . . . 0.0 109.161 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 16.8 tttp -91.67 -27.69 17.94 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.935 0.874 . . . . 0.0 108.887 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 320' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -88.88 17.34 5.76 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.335 0.588 . . . . 0.0 109.665 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 321' ' ' ILE . . . . . 0.508 HG22 ' H ' ' B' ' 322' ' ' HIS . 4.9 mm -89.83 178.21 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 322' ' ' HIS . . . . . 0.679 ' HB3' HG12 ' B' ' 294' ' ' VAL . 0.2 OUTLIER -152.26 64.43 0.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.835 -1.166 . . . . 0.0 110.312 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.494 ' HA ' ' OG1' ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.075 -1.016 . . . . 0.0 109.532 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 3' ' ' THR . 10.7 t . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.476 ' HB2' ' OG1' ' A' ' 8' ' ' THR . 46.6 Cg_endo -72.88 -8.55 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.941 1.495 . . . . 0.0 110.12 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -45.36 -36.75 4.4 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -90.31 -59.46 2.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.71 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.581 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -55.32 -22.04 17.42 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.142 -0.974 . . . . 0.0 109.946 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 4' ' ' PRO . 17.4 m -83.42 -40.6 19.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.431 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.78 -39.47 38.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 108.841 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.995 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.1 t -56.45 -26.82 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.072 HG11 HG21 ' A' ' 71' ' ' VAL . 3.5 t -81.63 -39.14 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.405 -0.81 . . . . 0.0 109.327 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 13' ' ' ARG . 7.5 tt0 -62.87 -74.73 0.09 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.135 0.969 . . . . 0.0 108.434 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.716 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -42.78 -44.56 4.47 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.994 0.902 . . . . 0.0 108.6 179.361 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.613 ' CD1' HG23 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -50.74 -44.47 58.39 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.925 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.4 t -90.13 -39.87 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.304 -0.873 . . . . 0.0 109.401 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -49.05 -33.41 11.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 22' ' ' ASP . . . -77.3 -31.91 55.04 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.925 HD12 ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -64.2 -56.75 12.51 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.609 ' ND2' ' O ' ' A' ' 65' ' ' VAL . 4.1 t-20 -53.58 -48.81 68.86 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.624 0.726 . . . . 0.0 109.488 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.85 11.49 17.79 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.668 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.749 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 47.04 35.27 8.2 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' ALA . 15.0 t0 -89.8 62.15 5.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -1.094 . . . . 0.0 109.615 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.056 HD11 ' HB3' ' A' ' 55' ' ' PHE . 6.5 tp -46.69 -43.4 17.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 108.85 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -42.73 -33.17 0.69 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -84.13 -38.03 10.6 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.053 HD12 HD12 ' A' ' 23' ' ' LEU . 14.7 mt -57.71 -56.68 14.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.512 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 43.8 t -55.85 -41.59 67.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -56.02 -53.28 58.81 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.995 HD21 ' HA ' ' A' ' 10' ' ' VAL . 7.7 tp -66.24 -20.72 66.2 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.693 ' HD2' ' HB3' ' A' ' 34' ' ' ALA . 3.0 m-85 -88.41 131.98 34.64 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.546 -0.721 . . . . 0.0 109.654 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -47.98 176.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.836 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.4 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.5 OUTLIER -67.07 -24.78 66.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.55 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 7.0 p-10 -144.0 54.1 1.3 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 109.55 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.783 ' O ' HD11 ' A' ' 51' ' ' ILE . . . -72.69 155.29 40.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.641 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.688 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -101.93 167.06 10.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.235 -0.915 . . . . 0.0 109.25 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 35' ' ' THR . 35.0 t -161.85 108.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.55 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 9.2 mp0 -88.66 103.51 16.0 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.582 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 27.5 t70 -173.16 143.74 1.1 Allowed Pre-proline 0 C--N 1.3 -1.568 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.919 -177.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 49.6 Cg_endo -73.5 174.84 48.5 Favored 'Cis proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.345 -1.94 . . . . 0.0 111.227 -0.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 40' ' ' VAL . 21.9 m -63.89 105.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.81 . . . . 0.0 109.253 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.529 ' CA ' ' HB1' ' B' ' 275' ' ' ALA . . . 122.13 -6.98 10.05 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.523 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -105.09 -155.93 0.56 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.36 -1.082 . . . . 0.0 109.02 179.702 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -125.16 128.96 24.66 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.029 -1.044 . . . . 0.0 109.964 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.55 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 36.9 Cg_endo -62.01 179.19 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.638 1.558 . . . . 0.0 111.371 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.986 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -150.42 105.91 3.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.647 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -88.66 157.31 18.6 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.248 -0.907 . . . . 0.0 110.015 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.55 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 109.24 162.03 19.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 3.9 m -67.25 -58.38 4.95 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.148 -1.207 . . . . 0.0 109.11 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.531 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -55.56 -37.83 68.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.273 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.986 ' HB1' ' HB3' ' A' ' 45' ' ' ARG . . . -68.99 -51.67 36.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.701 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.783 HD11 ' O ' ' A' ' 34' ' ' ALA . 8.8 mm -55.8 -47.14 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 109.283 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.817 ' CG ' HD23 ' A' ' 23' ' ' LEU . 26.3 ttp180 -73.58 -52.48 13.31 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 23.6 tt0 -48.38 -30.79 5.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.089 -1.007 . . . . 0.0 108.469 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.582 ' CZ ' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -83.78 -72.05 0.48 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 1.056 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -47.31 -25.04 0.88 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.618 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -74.15 -47.96 32.52 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 5.4 t30 -57.41 -37.36 72.62 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 t -67.66 -35.74 79.43 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.749 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.2 tp -67.48 -29.23 68.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.456 -0.777 . . . . 0.0 109.053 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 17.0 mttm -47.08 -30.48 2.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 108.911 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.822 HD22 HD21 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.4 110.52 39.4 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.9 111.06 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.85 1.447 . . . . 0.0 111.027 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.822 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.94 162.96 31.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.347 -0.845 . . . . 0.0 109.715 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.736 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -92.08 127.95 37.74 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.609 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 21.8 t -115.13 120.08 63.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.054 -1.029 . . . . 0.0 109.967 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 67' ' ' LEU . 1.0 OUTLIER -150.12 106.25 3.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.494 HD22 HG23 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -47.8 177.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 0.0 109.924 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 69' ' ' GLN . 21.9 p -145.07 -81.63 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.386 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.7 OUTLIER -59.88 -144.86 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.479 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 48.9 tt0 -114.44 131.63 56.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.007 -1.058 . . . . 0.0 109.933 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.072 HG21 HG11 ' A' ' 11' ' ' VAL . 13.1 t -61.92 160.49 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.465 -0.772 . . . . 0.0 109.087 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 5.1 ttp180 -122.52 134.74 54.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.229 -0.919 . . . . 0.0 109.824 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . . . -147.89 160.45 42.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.405 -0.809 . . . . 0.0 109.183 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.088 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -159.14 -159.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.725 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -29.52 -85.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.055 -0.403 . . . . 0.0 111.35 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.504 ' O ' ' N ' ' A' ' 103' ' ' PHE . 9.9 m120 -124.62 21.07 8.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.904 -1.123 . . . . 0.0 110.781 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -129.99 -160.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.916 -1.115 . . . . 0.0 109.442 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.951 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 170.05 147.55 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.981 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 72' ' ' ARG . . . -136.12 130.73 33.78 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 30.2 p90 -147.92 170.1 18.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.792 -1.192 . . . . 0.0 110.462 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.752 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -143.96 -166.43 2.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.599 -0.688 . . . . 0.0 109.893 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 81' ' ' ALA . 18.9 p90 168.83 -168.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 0.0 109.238 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.824 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -130.76 144.78 51.68 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.649 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.587 HG11 HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -112.96 122.24 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.166 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.736 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 1.4 p -117.75 107.11 13.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 109.029 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.781 ' CD1' HD23 ' A' ' 63' ' ' LEU . 2.0 p90 -130.04 151.74 50.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.068 -1.02 . . . . 0.0 110.181 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.523 ' HG2' ' N ' ' A' ' 88' ' ' PHE . 84.2 tt0 -127.75 159.93 33.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.441 -0.787 . . . . 0.0 109.039 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -150.5 -99.61 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.058 -1.026 . . . . 0.0 110.326 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.468 ' HG2' ' N ' ' A' ' 90' ' ' GLY . 19.1 tt0 -48.91 -99.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 109.898 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.468 ' N ' ' HG2' ' A' ' 89' ' ' GLN . . . -123.92 -28.19 1.3 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -96.66 150.18 20.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -1.116 . . . . 0.0 109.352 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -113.11 146.53 39.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.103 -0.998 . . . . 0.0 109.172 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.0 145.97 51.1 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.53 -0.731 . . . . 0.0 109.842 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.78 HG13 ' CB ' ' A' ' 122' ' ' HIS . 5.4 p -121.19 166.38 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.922 . . . . 0.0 108.861 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.824 ' O ' HG22 ' A' ' 83' ' ' THR . 62.3 t -140.94 160.21 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.019 -1.05 . . . . 0.0 110.304 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.521 ' N ' HG12 ' A' ' 95' ' ' VAL . . . -138.76 75.11 37.37 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.562 -0.711 . . . . 0.0 109.51 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.504 ' HD3' HG12 ' A' ' 95' ' ' VAL . 48.1 Cg_endo -97.11 -175.6 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.814 1.676 . . . . 0.0 111.2 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.752 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.6 mp -135.26 157.1 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 7.6 t0 -128.66 162.25 27.78 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.204 -0.935 . . . . 0.0 109.813 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.591 ' NE2' ' CD2' ' B' ' 300' ' ' HIS . 0.2 OUTLIER -114.11 173.54 6.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 108.906 179.49 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.951 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -148.16 144.9 28.08 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.97 -1.081 . . . . 0.0 110.45 -178.561 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.527 ' NH1' ' HD2' ' B' ' 313' ' ' ARG . 0.4 OUTLIER -139.99 105.63 5.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.151 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.588 ' CZ ' HG11 ' A' ' 10' ' ' VAL . 5.2 m-85 -91.06 -171.21 2.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.71 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.992 ' HB3' HG21 ' A' ' 110' ' ' VAL . 5.9 p-10 -126.28 -47.97 1.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.272 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.703 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -163.94 27.24 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 105' ' ' GLY . . . 77.07 67.62 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.169 -1.194 . . . . 0.0 109.545 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.27 -39.33 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -165.6 -162.54 0.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -1.113 . . . . 0.0 109.258 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 41.0 t -106.25 144.24 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.248 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.992 HG21 ' HB3' ' A' ' 104' ' ' ASN . 5.0 t -125.99 -28.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 109.898 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.523 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -149.59 155.11 39.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.067 -1.021 . . . . 0.0 109.472 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.523 ' HE3' ' CG ' ' A' ' 99' ' ' ASP . 3.2 ttp -155.91 148.74 24.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.194 -0.941 . . . . 0.0 109.926 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.518 ' HD2' ' NH1' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -130.55 173.52 10.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 108.964 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.56 ' O ' HG12 ' A' ' 40' ' ' VAL . . . -144.37 142.85 30.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.149 -0.97 . . . . 0.0 109.52 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.576 ' HA ' HG11 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -138.61 140.24 38.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.172 -0.955 . . . . 0.0 109.907 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.879 ' O ' HG11 ' B' ' 274' ' ' VAL . 51.9 p90 170.21 -161.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.578 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 174.6 -165.6 37.04 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.536 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 8.3 tt0 -73.13 -3.32 25.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.444 -1.033 . . . . 0.0 109.337 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.26 -31.31 16.18 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.97 0.89 . . . . 0.0 109.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.481 HD21 HD11 ' A' ' 98' ' ' ILE . 1.9 m-20 -89.61 8.58 30.63 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.233 0.54 . . . . 0.0 109.559 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.82 HG23 HG22 ' A' ' 95' ' ' VAL . 4.5 mm -91.89 -170.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 108.84 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.78 ' CB ' HG13 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.35 159.75 44.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.097 -1.002 . . . . 0.0 109.618 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.78 133.94 12.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.959 . . . . 0.0 109.479 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 134.35 -123.69 3.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.291 -1.123 . . . . 0.0 109.444 -179.81 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.0 ptp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.208 0.528 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.462 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 18.7 p-10 -113.15 100.09 8.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.558 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 203' ' ' THR . . . . . 0.738 HG23 ' O ' ' B' ' 203' ' ' THR . 12.5 t -90.34 108.44 26.72 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.542 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 204' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' B' ' 208' ' ' THR . 45.1 Cg_endo -72.15 -1.96 10.87 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.853 1.449 . . . . 0.0 110.457 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.77 -47.37 83.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.557 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -54.9 24.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.267 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 75.9 mtm -61.42 -41.27 96.91 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.286 -0.884 . . . . 0.0 109.382 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 208' ' ' THR . . . . . 0.499 ' CB ' ' O ' ' B' ' 204' ' ' PRO . 15.4 m -64.18 -35.95 82.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.84 . . . . 0.0 109.235 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.09 -42.37 49.99 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.139 -0.976 . . . . 0.0 108.59 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.981 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.5 t -60.06 -20.7 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 1.04 HG21 HG11 ' B' ' 271' ' ' VAL . 4.4 t -88.32 -40.61 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.833 . . . . 0.0 108.89 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 212' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' B' ' 213' ' ' ARG . 24.6 tt0 -61.53 -74.35 0.08 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.659 ' HD2' HD13 ' B' ' 229' ' ' LEU . 1.0 OUTLIER -43.68 -45.52 7.0 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 214' ' ' TYR . . . . . 0.59 ' CD1' HG23 ' B' ' 215' ' ' VAL . 0.5 OUTLIER -49.88 -42.88 48.75 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.511 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.924 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.4 t -89.77 -37.85 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.251 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 216' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -49.49 -35.6 20.35 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.606 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -74.69 -30.95 61.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.924 HD12 ' HA ' ' B' ' 215' ' ' VAL . 2.3 mt -66.86 -58.11 5.66 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -50.85 -45.31 59.73 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.602 0.715 . . . . 0.0 109.302 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.31 1.36 55.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.624 -0.672 . . . . 0.0 109.748 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 1.066 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 53.76 44.13 70.0 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 222' ' ' ASP . . . . . 0.48 ' O ' HG13 ' B' ' 226' ' ' ILE . 30.3 t0 -102.87 83.96 2.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.902 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 223' ' ' LEU . . . . . 1.066 ' CD2' HD22 ' B' ' 259' ' ' LEU . 3.7 mm? -53.04 -18.4 2.03 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.139 -0.976 . . . . 0.0 110.063 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -64.05 -57.16 10.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.093 -1.004 . . . . 0.0 109.473 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -62.92 -27.64 70.61 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.961 HD12 HD13 ' B' ' 223' ' ' LEU . 7.0 mt -67.86 -61.46 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.454 -1.027 . . . . 0.0 108.315 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.7 HG21 ' HB2' ' B' ' 252' ' ' ARG . 51.2 t -59.49 -40.33 81.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.87 -53.47 55.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 229' ' ' LEU . . . . . 0.981 HD21 ' HA ' ' B' ' 210' ' ' VAL . 4.7 tp -62.8 -21.78 66.14 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 230' ' ' PHE . . . . . 0.478 ' HA ' ' HB ' ' B' ' 309' ' ' VAL . 3.7 m-30 -92.71 139.11 30.9 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.452 -0.78 . . . . 0.0 109.784 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -50.71 -176.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 109.822 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -25.16 64.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.879 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 233' ' ' ASP . . . . . 0.543 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 10.0 p-10 -144.17 52.51 1.28 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.495 -0.753 . . . . 0.0 109.137 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' B' ' 310' ' ' VAL . . . -65.43 158.6 26.31 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 109.617 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 235' ' ' THR . . . . . 0.716 HG23 ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -107.34 147.18 30.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.875 . . . . 0.0 109.107 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 52.8 t -141.4 111.05 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 237' ' ' GLU . . . . . 0.528 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 1.5 mm-40 -89.91 105.14 17.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 238' ' ' ASP . . . . . 0.623 ' OD1' ' HB3' ' B' ' 314' ' ' ALA . 21.8 t70 178.91 143.24 0.31 Allowed Pre-proline 0 C--N 1.301 -1.528 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.307 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 239' ' ' PRO . . . . . 0.518 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 48.5 Cg_endo -73.6 173.87 53.66 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.264 -1.973 . . . . 0.0 110.905 -0.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.584 HG22 ' CZ ' ' B' ' 316' ' ' PHE . 6.5 m -69.81 112.7 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 108.972 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 241' ' ' GLY . . . . . 0.492 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . 115.06 -2.13 22.67 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 242' ' ' SER . . . . . 0.479 ' OG ' ' HG2' ' B' ' 239' ' ' PRO . 64.6 m -113.35 -134.83 0.35 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.305 -1.114 . . . . 0.0 108.893 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 243' ' ' GLU . . . . . 0.531 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 4.3 mt-10 -142.03 133.52 13.26 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.863 -1.148 . . . . 0.0 109.755 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 244' ' ' PRO . . . . . 0.528 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.9 Cg_endo -63.39 -171.53 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.082 1.569 . . . . 0.0 111.34 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.964 ' HG3' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.74 96.91 2.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 246' ' ' SER . . . . . 0.716 ' HB3' HG23 ' B' ' 235' ' ' THR . 0.2 OUTLIER -88.88 150.47 22.86 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.238 -0.914 . . . . 0.0 109.987 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 247' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.24 163.18 21.88 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 2.2 m -70.04 -61.45 1.77 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -1.209 . . . . 0.0 109.148 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -55.36 -22.98 21.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.241 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.964 ' HB1' ' HG3' ' B' ' 245' ' ' ARG . . . -88.45 -48.62 7.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.587 HD11 ' O ' ' B' ' 234' ' ' ALA . 4.5 mm -53.65 -43.7 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.132 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 252' ' ' ARG . . . . . 0.7 ' HB2' HG21 ' B' ' 227' ' ' VAL . 44.0 ttp85 -75.54 -52.65 10.13 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 108.94 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 253' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 29.9 mt-10 -48.4 -27.72 2.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.809 -1.182 . . . . 0.0 108.427 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.585 ' CE2' ' O ' ' B' ' 238' ' ' ASP . 0.3 OUTLIER -85.84 -71.7 0.52 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.681 0.753 . . . . 0.0 109.021 179.739 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 255' ' ' PHE . . . . . 0.7 ' C ' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -52.6 -21.76 4.25 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.241 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 256' ' ' ALA . . . . . 0.55 ' HB2' ' HG ' ' B' ' 223' ' ' LEU . . . -80.33 -46.8 15.5 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 257' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 18.7 t-20 -58.19 -31.17 67.04 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 33.7 t -70.66 -31.63 68.62 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 259' ' ' LEU . . . . . 1.066 HD21 ' CA ' ' B' ' 221' ' ' GLY . 5.7 tp -71.12 -27.72 63.78 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 260' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 0.7 OUTLIER -44.73 -27.83 0.55 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.455 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 261' ' ' LEU . . . . . 0.807 HD23 HD23 ' B' ' 263' ' ' LEU . 0.3 OUTLIER -90.72 114.29 60.8 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.033 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 262' ' ' PRO . . . . . 0.499 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 44.3 Cg_endo -72.02 107.93 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.766 1.403 . . . . 0.0 110.892 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 263' ' ' LEU . . . . . 0.856 ' CB ' HG13 ' B' ' 284' ' ' VAL . 0.0 OUTLIER -137.3 162.54 33.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 109.854 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 264' ' ' ALA . . . . . 0.818 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -96.46 123.67 40.19 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 265' ' ' VAL . . . . . 0.795 HG21 ' HB3' ' B' ' 218' ' ' LEU . 4.4 t -105.06 117.32 50.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.643 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 266' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' B' ' 267' ' ' LEU . 2.0 tt0 -147.78 104.97 3.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.22 -0.925 . . . . 0.0 109.153 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.1 mt -47.11 174.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.293 -0.879 . . . . 0.0 109.695 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 1.7 t -146.54 -40.31 0.21 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.67 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 269' ' ' GLN . . . . . 0.508 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 13.7 pt20 -102.66 -152.25 0.44 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.647 -0.658 . . . . 0.0 109.267 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 270' ' ' GLU . . . . . 0.508 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 26.6 tt0 -106.43 130.59 54.21 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.61 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 271' ' ' VAL . . . . . 1.04 HG11 HG21 ' B' ' 211' ' ' VAL . 81.4 t -66.81 147.62 12.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.344 -0.848 . . . . 0.0 109.245 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 2.4 tpm_? -102.89 135.95 43.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.952 . . . . 0.0 109.765 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 273' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -149.8 146.36 27.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.39 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 274' ' ' VAL . . . . . 0.879 HG11 ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -162.24 146.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.13 -0.981 . . . . 0.0 110.228 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 275' ' ' ALA . . . . . 0.529 ' HB1' ' CA ' ' A' ' 41' ' ' GLY . . . 39.57 -97.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.802 -0.561 . . . . 0.0 110.621 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 276' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' B' ' 303' ' ' PHE . 60.1 m-20 -130.74 34.04 4.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.025 -1.047 . . . . 0.0 110.237 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 277' ' ' GLU . . . . . 0.7 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 0.9 OUTLIER -139.49 -158.4 0.85 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 108.792 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 278' ' ' ALA . . . . . 0.876 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . 165.96 149.6 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.72 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 279' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -135.98 130.75 34.1 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 280' ' ' PHE . . . . . 1.011 ' HB3' HG13 ' B' ' 271' ' ' VAL . 22.8 p90 -150.07 175.45 11.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.601 -1.312 . . . . 0.0 110.697 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.61 ' HB2' ' CG1' ' B' ' 298' ' ' ILE . . . -150.11 -179.0 6.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.585 -0.697 . . . . 0.0 109.197 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 282' ' ' PHE . . . . . 0.54 ' CE2' HG23 ' B' ' 284' ' ' VAL . 2.8 p90 -172.92 -162.14 0.16 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 109.492 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 283' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -133.61 147.44 51.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.512 -0.742 . . . . 0.0 109.887 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 284' ' ' VAL . . . . . 0.856 HG13 ' CB ' ' B' ' 263' ' ' LEU . 4.0 t -123.36 116.53 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 109.41 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 285' ' ' SER . . . . . 0.818 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 90.9 p -111.95 114.69 27.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 109.098 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.57 ' HD1' HG12 ' B' ' 284' ' ' VAL . 55.6 p90 -143.21 167.39 22.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 110.084 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 287' ' ' GLU . . . . . 0.459 ' HG2' ' N ' ' B' ' 288' ' ' PHE . 30.1 tt0 -144.1 153.25 41.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 109.255 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 288' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' B' ' 288' ' ' PHE . 0.3 OUTLIER -135.89 4.34 3.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.716 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -170.3 -148.81 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.254 -0.904 . . . . 0.0 109.383 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -74.8 -11.95 83.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -113.8 140.41 48.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -1.115 . . . . 0.0 109.273 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 292' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' B' ' 292' ' ' LYS . 18.9 ptmt -125.78 172.47 9.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 109.635 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 293' ' ' THR . . . . . 0.837 HG23 ' HA ' ' B' ' 323' ' ' ALA . 32.2 m -156.65 171.53 20.17 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.366 -0.834 . . . . 0.0 109.095 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 294' ' ' VAL . . . . . 0.662 HG12 ' CB ' ' B' ' 322' ' ' HIS . 0.4 OUTLIER -134.17 165.94 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 1.061 HG22 HG23 ' B' ' 321' ' ' ILE . 3.4 t -136.81 145.8 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.016 -1.052 . . . . 0.0 109.66 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 296' ' ' ALA . . . . . 0.463 ' O ' ' OD1' ' B' ' 320' ' ' ASN . . . -132.52 72.9 77.5 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.433 -0.792 . . . . 0.0 110.023 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 297' ' ' PRO . . . . . 0.986 ' HD3' HG12 ' B' ' 295' ' ' VAL . 49.2 Cg_endo -92.95 -177.01 0.67 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.87 1.458 . . . . 0.0 111.113 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.675 HG23 ' O ' ' B' ' 280' ' ' PHE . 2.7 mp -134.38 144.61 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 299' ' ' ASP . . . . . 0.612 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 5.6 t0 -117.13 166.95 11.63 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.824 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 300' ' ' HIS . . . . . 0.591 ' CD2' ' NE2' ' A' ' 100' ' ' HIS . 1.6 t-80 -117.58 173.58 6.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 108.916 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 301' ' ' PHE . . . . . 0.876 ' CB ' ' HB3' ' B' ' 278' ' ' ALA . 0.1 OUTLIER -145.67 145.82 31.06 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.071 -1.018 . . . . 0.0 110.583 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.498 ' HD3' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -137.66 98.73 3.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 109.156 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 303' ' ' PHE . . . . . 0.672 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 4.5 m-85 -89.74 176.51 6.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 109.57 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 304' ' ' ASN . . . . . 0.882 ' HB3' HG21 ' B' ' 310' ' ' VAL . 9.1 p-10 -118.64 -27.03 5.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.222 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 305' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -159.35 -63.96 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 306' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 163.63 76.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -1.127 . . . . 0.0 109.563 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 175.87 -57.14 0.11 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -111.33 -172.75 2.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -1.149 . . . . 0.0 109.504 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 309' ' ' VAL . . . . . 0.565 HG12 ' N ' ' B' ' 310' ' ' VAL . 85.8 t -119.72 164.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.033 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 310' ' ' VAL . . . . . 0.882 HG21 ' HB3' ' B' ' 304' ' ' ASN . 5.0 t -134.82 -72.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.963 -1.085 . . . . 0.0 110.018 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 311' ' ' SER . . . . . 0.498 ' HB2' ' HD3' ' B' ' 302' ' ' ARG . 31.6 m -112.44 162.48 15.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.899 -1.126 . . . . 0.0 109.837 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 312' ' ' MET . . . . . 0.544 ' CE ' ' CE2' ' B' ' 214' ' ' TYR . 2.6 ttt -159.94 137.99 10.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 313' ' ' ARG . . . . . 0.527 ' HD2' ' NH1' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -125.69 159.27 32.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.144 -0.972 . . . . 0.0 108.812 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 314' ' ' ALA . . . . . 0.623 ' HB3' ' OD1' ' B' ' 238' ' ' ASP . . . -125.18 150.38 47.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.904 -1.122 . . . . 0.0 109.841 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 315' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -141.02 140.8 34.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.39 -0.819 . . . . 0.0 109.774 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 316' ' ' PHE . . . . . 1.088 ' O ' HG11 ' A' ' 74' ' ' VAL . 53.7 p90 173.12 -160.96 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 317' ' ' GLY . . . . . 0.48 ' O ' HG12 ' B' ' 321' ' ' ILE . . . 173.48 -172.38 45.17 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 318' ' ' GLU . . . . . 0.52 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 22.3 tt0 -68.4 -6.69 25.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.419 -1.047 . . . . 0.0 109.714 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -87.08 -31.84 20.26 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.045 0.926 . . . . 0.0 108.939 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 320' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.61 14.28 11.99 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.742 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 321' ' ' ILE . . . . . 1.061 HG23 HG22 ' B' ' 295' ' ' VAL . 4.0 mm -100.84 -166.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 0.0 108.902 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 322' ' ' HIS . . . . . 0.677 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.3 OUTLIER -151.25 -172.41 4.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.116 -0.99 . . . . 0.0 109.613 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.837 ' HA ' HG23 ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.225 0.536 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.452 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 12.1 t-20 -152.29 157.53 41.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 109.597 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.42 ' N ' ' OD1' ' A' ' 2' ' ' ASN . 0.6 OUTLIER -88.07 109.97 31.98 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.322 -0.861 . . . . 0.0 109.64 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 45.6 Cg_endo -72.45 -3.63 13.77 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.852 1.448 . . . . 0.0 110.19 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.24 -45.38 72.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.877 . . . . 0.0 109.385 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.472 ' NE2' ' O ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -66.68 -55.39 15.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.59 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.434 ' SD ' ' O ' ' A' ' 75' ' ' ALA . 27.4 mtt -58.0 -48.74 79.11 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.231 -0.918 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 m -54.4 -38.1 65.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.285 -0.884 . . . . 0.0 109.054 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -49.29 -43.06 42.9 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.828 HG11 ' CE1' ' A' ' 103' ' ' PHE . 2.3 t -55.76 -49.92 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.99 HG11 HG21 ' A' ' 71' ' ' VAL . 5.1 t -54.71 -41.09 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 13' ' ' ARG . 25.7 tt0 -63.17 -75.13 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.344 1.068 . . . . 0.0 108.145 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.515 ' HB3' HD13 ' A' ' 29' ' ' LEU . 6.6 mtp85 -43.67 -45.97 7.18 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -48.93 -45.72 42.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.923 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -86.0 -37.48 11.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.383 -0.823 . . . . 0.0 109.071 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.89 -37.92 21.12 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.489 ' HB3' HG12 ' A' ' 26' ' ' ILE . . . -72.0 -32.87 67.62 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.923 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.4 mt -67.34 -59.45 3.4 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -48.02 -39.86 21.05 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.599 0.714 . . . . 0.0 109.25 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.41 6.06 42.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.545 -0.722 . . . . 0.0 109.652 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.984 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 47.73 30.87 7.02 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -96.94 88.4 4.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -1.106 . . . . 0.0 109.723 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.074 HD13 HD12 ' A' ' 26' ' ' ILE . 3.3 mm? -51.83 -20.25 2.13 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.195 -0.94 . . . . 0.0 109.815 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.14 -56.26 16.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.253 -0.904 . . . . 0.0 109.303 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.35 -29.34 63.11 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.074 HD12 HD13 ' A' ' 23' ' ' LEU . 12.3 mt -69.06 -62.27 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.549 HG21 ' HB2' ' A' ' 52' ' ' ARG . 60.4 t -57.34 -37.91 59.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.95 26.33 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 10' ' ' VAL . 7.8 tp -59.1 -22.7 61.25 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.939 ' CE2' HG22 ' A' ' 26' ' ' ILE . 20.4 m-30 -88.47 136.53 32.94 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.675 -0.641 . . . . 0.0 109.651 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -51.12 -178.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.273 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -23.52 66.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 109.527 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.534 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 25.2 p-10 -148.37 45.55 1.05 Allowed 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.835 ' HB3' HD13 ' A' ' 51' ' ' ILE . . . -51.61 -178.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.791 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -126.05 135.92 52.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.501 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 37' ' ' GLU . 6.6 t -113.84 169.02 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.129 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.57 ' N ' ' CG1' ' A' ' 36' ' ' VAL . 28.1 mt-10 -150.4 106.07 3.4 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.541 ' OD1' ' HA ' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -174.45 153.71 1.89 Allowed Pre-proline 0 C--N 1.3 -1.575 0 C-N-CA 118.607 -1.237 . . . . 0.0 109.804 -178.002 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.558 ' O ' HG13 ' A' ' 40' ' ' VAL . 44.7 Cg_endo -73.88 -66.67 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.916 -2.118 . . . . 0.0 111.522 0.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 40' ' ' VAL . 23.8 m -159.06 87.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.948 -1.095 . . . . 0.0 109.596 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . 164.33 38.75 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER 72.92 55.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.325 -1.103 . . . . 0.0 109.962 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.548 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 3.8 mt-10 -132.57 58.38 35.77 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.807 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 52.1 Cg_endo -79.71 175.07 10.96 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.825 1.683 . . . . 0.0 111.271 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.788 ' CD ' ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -150.99 100.17 2.77 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.601 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -89.43 166.73 13.52 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.186 -0.946 . . . . 0.0 110.103 -179.202 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 33' ' ' ASP . . . 86.36 -169.8 41.96 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.546 HG23 HG11 ' A' ' 27' ' ' VAL . 3.4 m -103.45 -46.63 4.51 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.223 -1.163 . . . . 0.0 108.978 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -58.29 -23.74 57.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.247 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.788 ' HB1' ' CD ' ' A' ' 45' ' ' ARG . . . -89.86 -52.51 4.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.398 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.835 HD13 ' HB3' ' A' ' 34' ' ' ALA . 80.1 mt -57.22 -46.8 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.197 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.549 ' HB2' HG21 ' A' ' 27' ' ' VAL . 1.5 ttt180 -70.0 -56.25 7.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -0.888 . . . . 0.0 108.906 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 14.4 tt0 -45.88 -29.92 1.54 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 108.658 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.57 ' CD2' ' HG3' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -84.1 -70.28 0.58 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.624 ' C ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -46.7 -28.05 1.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.444 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . . . -75.07 -50.8 15.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 12.8 t-20 -55.51 -34.55 64.75 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.774 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 14.3 t -64.83 -36.63 84.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.984 HD21 ' CA ' ' A' ' 21' ' ' GLY . 7.4 tp -69.45 -19.28 63.77 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.535 -0.728 . . . . 0.0 109.706 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 33.9 mtmt -55.53 -25.58 38.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 109.36 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.007 HD22 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -89.87 121.32 69.05 Favored Pre-proline 0 C--N 1.305 -1.328 0 O-C-N 121.272 -0.893 . . . . 0.0 108.777 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 48.7 Cg_endo -74.04 103.2 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.71 1.374 . . . . 0.0 111.152 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.007 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.15 -178.54 5.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.006 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -117.88 127.29 53.72 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.521 HG13 ' CD2' ' A' ' 82' ' ' PHE . 4.6 t -116.43 115.92 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.181 -0.95 . . . . 0.0 109.841 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 67' ' ' LEU . 1.2 tt0 -150.17 95.74 2.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.294 -0.879 . . . . 0.0 109.216 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.691 HD21 HG21 ' A' ' 15' ' ' VAL . 4.4 mt -42.81 166.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.974 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.67 -39.9 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.565 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -81.77 -146.01 0.06 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 25.0 tt0 -113.15 129.61 56.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.09 -1.006 . . . . 0.0 109.642 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.99 HG21 HG11 ' A' ' 11' ' ' VAL . 19.2 t -67.92 152.28 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.38 -0.825 . . . . 0.0 108.919 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 19.2 mtt-85 -114.64 135.29 54.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.136 -0.978 . . . . 0.0 109.672 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.525 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -149.95 112.86 4.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.293 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -130.09 155.71 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -0.903 . . . . 0.0 109.489 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.434 ' O ' ' SD ' ' A' ' 7' ' ' MET . . . 43.64 -147.42 0.07 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 81.6 m-20 -82.64 -3.19 55.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.941 . . . . 0.0 109.526 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.578 ' CG ' ' HG3' ' A' ' 102' ' ' ARG . 0.8 OUTLIER -104.85 -163.55 0.97 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.219 -0.926 . . . . 0.0 109.613 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 178.37 166.33 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 109.485 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.762 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.31 140.06 21.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 108.948 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.626 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 39.8 p90 -150.58 169.23 22.04 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.877 -1.14 . . . . 0.0 109.941 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.753 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -141.84 -175.37 4.37 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.502 -0.749 . . . . 0.0 109.591 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.645 ' HB3' HD22 ' A' ' 67' ' ' LEU . 9.8 p90 177.05 -159.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.805 . . . . 0.0 109.351 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -137.92 151.79 48.34 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.564 -0.71 . . . . 0.0 109.73 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.633 HG12 ' CB ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -122.11 124.34 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.416 -0.802 . . . . 0.0 109.081 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 1.006 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 5.1 p -114.66 92.81 4.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.6 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.708 ' CZ ' H221 ' A' ' 126' ' ' NTH . 18.8 p90 -115.47 177.93 4.48 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.345 -0.847 . . . . 0.0 109.126 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 88' ' ' PHE . 30.7 tt0 -107.37 166.92 10.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 110.12 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.526 ' CZ ' ' O23' ' A' ' 126' ' ' NTH . 0.1 OUTLIER -116.84 -161.31 0.8 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.4 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -7.44 28.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 109.78 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.11 -40.38 0.03 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.4 mtt-85 -95.72 -176.9 3.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -1.161 . . . . 0.0 109.609 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -115.62 127.19 55.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.897 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -118.3 142.57 47.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.776 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 122' ' ' HIS . 1.2 t -116.15 175.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 1.056 HG12 ' HD3' ' A' ' 97' ' ' PRO . 4.1 t -145.37 144.14 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.881 -1.137 . . . . 0.0 109.737 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.436 ' O ' ' CG ' ' A' ' 120' ' ' ASN . . . -133.06 71.64 77.4 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.345 -0.847 . . . . 0.0 110.408 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 1.056 ' HD3' HG12 ' A' ' 95' ' ' VAL . 49.6 Cg_endo -95.23 -176.18 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 121.492 1.461 . . . . 0.0 110.947 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.753 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.9 mp -137.68 139.59 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.626 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 8.9 t0 -111.99 163.14 14.59 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.95 -1.093 . . . . 0.0 110.261 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.536 ' HB3' ' CB ' ' A' ' 113' ' ' ARG . 4.3 t-80 -116.39 176.29 5.17 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.561 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -149.94 142.63 24.59 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.008 -1.057 . . . . 0.0 110.556 -178.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.612 ' O ' HG23 ' A' ' 110' ' ' VAL . 3.1 ttm180 -135.65 107.64 7.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.484 -0.76 . . . . 0.0 109.106 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.828 ' CE1' HG11 ' A' ' 10' ' ' VAL . 14.2 m-85 -105.42 179.5 4.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.607 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -127.04 -0.67 6.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.933 . . . . 0.0 109.596 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -175.43 -87.57 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 176.05 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -1.184 . . . . 0.0 109.598 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -127.56 -37.16 0.46 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 107' ' ' GLY . 8.0 mtmm -146.7 -164.76 2.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -1.125 . . . . 0.0 109.255 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.574 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 91.2 t -115.16 158.87 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.027 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -132.6 -54.21 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.567 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.56 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -127.17 156.9 41.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.041 -1.037 . . . . 0.0 109.013 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.512 ' HE1' ' CE1' ' A' ' 30' ' ' PHE . 21.5 ttm -154.0 147.24 24.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.122 -0.986 . . . . 0.0 109.655 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.536 ' CB ' ' HB3' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -123.33 174.21 7.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.377 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 99' ' ' ASP . . . -147.83 149.13 31.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.706 HD13 ' HB2' ' B' ' 279' ' ' ALA . 1.7 tt -143.03 143.73 32.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.138 -0.976 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.528 ' O ' ' CG2' ' B' ' 274' ' ' VAL . 15.4 p90 171.95 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.561 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 167.07 -176.9 41.92 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.561 -1.305 . . . . 0.0 110.185 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.545 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 17.6 tt0 -69.39 -6.06 27.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.433 -1.04 . . . . 0.0 109.509 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -91.38 -29.24 17.2 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.928 0.87 . . . . 0.0 108.936 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.8 m-20 -88.79 12.51 14.82 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.707 HG22 ' H ' ' A' ' 122' ' ' HIS . 5.0 mm -89.87 -169.92 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.897 ' O ' HG22 ' A' ' 93' ' ' THR . 0.1 OUTLIER -151.63 99.79 2.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 109.805 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -117.13 135.74 53.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.149 -0.97 . . . . 0.0 109.549 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 152.85 -145.91 13.89 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.177 -1.19 . . . . 0.0 109.509 179.944 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.463 ' O ' ' CB ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.239 0.542 . . . . 0.0 110.174 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' B' ' 201' ' ' MET . 0.6 OUTLIER 72.6 98.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.563 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 203' ' ' THR . . . . . 0.429 ' C ' ' O ' ' B' ' 202' ' ' ASN . 1.2 t -43.43 112.04 1.18 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.0 109.54 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.49 -3.29 13.16 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.828 1.436 . . . . 0.0 110.046 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -38.62 84.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.884 . . . . 0.0 109.385 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -51.8 56.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.351 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 207' ' ' MET . . . . . 0.522 ' HB2' ' HB1' ' B' ' 273' ' ' ALA . 21.9 mtm -59.91 -30.06 68.78 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.293 -0.879 . . . . 0.0 109.624 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 5.0 m -72.55 -33.81 67.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.91 . . . . 0.0 109.195 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.9 75.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.934 . . . . 0.0 108.859 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.856 HG11 ' CE1' ' B' ' 303' ' ' PHE . 2.3 t -52.74 -45.99 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.818 HG11 HG21 ' B' ' 271' ' ' VAL . 4.4 t -61.86 -39.63 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.599 -0.688 . . . . 0.0 109.951 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 212' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' B' ' 213' ' ' ARG . 21.8 tt0 -62.63 -75.4 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.758 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.0 OUTLIER -43.35 -44.84 5.81 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.971 0.891 . . . . 0.0 108.622 179.157 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 214' ' ' TYR . . . . . 0.633 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -50.42 -46.98 56.74 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.865 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -85.77 -37.65 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.359 -0.838 . . . . 0.0 109.297 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 216' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.72 -36.5 16.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -73.08 -34.19 66.06 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' B' ' 215' ' ' VAL . 1.2 mt -65.26 -58.22 6.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -50.37 -45.04 54.98 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.555 0.693 . . . . 0.0 109.164 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.64 5.95 43.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.52 -0.737 . . . . 0.0 109.633 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.686 ' HA2' HD11 ' B' ' 259' ' ' LEU . . . 50.4 37.96 33.35 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' B' ' 217' ' ' ALA . 11.3 t0 -97.77 72.41 2.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.42 -1.047 . . . . 0.0 109.864 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 223' ' ' LEU . . . . . 1.038 HD11 ' HB3' ' B' ' 255' ' ' PHE . 7.7 tp -47.08 -43.65 20.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 108.705 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -43.32 -35.28 1.45 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -80.32 -35.79 25.6 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 1.007 HD12 HD12 ' B' ' 223' ' ' LEU . 19.9 mt -62.1 -57.19 13.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.637 ' CG1' HG23 ' B' ' 248' ' ' THR . 92.6 t -56.44 -37.41 51.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.07 -54.92 41.58 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.773 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.3 tp -63.8 -22.06 66.73 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 230' ' ' PHE . . . . . 0.693 ' CG ' HG21 ' B' ' 251' ' ' ILE . 2.0 m-85 -85.42 130.01 34.68 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.525 -0.735 . . . . 0.0 109.383 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -47.0 172.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.152 -0.968 . . . . 0.0 109.383 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.3 -24.99 58.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 109.816 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.527 ' CB ' ' HA2' ' B' ' 247' ' ' GLY . 13.2 p-10 -150.24 45.55 0.89 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.583 -0.698 . . . . 0.0 109.212 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.822 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -57.57 159.9 4.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.334 -0.854 . . . . 0.0 109.706 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 235' ' ' THR . . . . . 1.006 HG23 ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -106.95 144.12 34.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.558 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.55 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 42.8 t -132.72 121.4 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.081 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 237' ' ' GLU . . . . . 0.551 ' HB2' ' CG ' ' B' ' 313' ' ' ARG . 3.3 mt-10 -89.26 109.18 20.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 108.89 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 238' ' ' ASP . . . . . 0.506 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 9.8 t70 -179.17 141.92 0.38 Allowed Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.837 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' B' ' 238' ' ' ASP . 47.3 Cg_endo -72.66 -177.57 18.89 Favored 'Cis proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.291 -1.962 . . . . 0.0 110.761 -0.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 8.0 m -62.34 152.34 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.254 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.07 20.73 9.27 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' SER . . . . . 0.498 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -116.59 -155.41 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -1.066 . . . . 0.0 109.511 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.77 128.84 25.58 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.066 -1.022 . . . . 0.0 109.894 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 244' ' ' PRO . . . . . 0.55 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.4 Cg_endo -65.25 -169.94 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.983 1.518 . . . . 0.0 111.243 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.712 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.5 OUTLIER -151.14 100.88 2.82 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 246' ' ' SER . . . . . 1.006 ' HB3' HG23 ' B' ' 235' ' ' THR . 0.2 OUTLIER -89.44 153.61 20.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 110.363 -178.42 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 247' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' B' ' 233' ' ' ASP . . . 108.03 159.94 20.45 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 248' ' ' THR . . . . . 0.637 HG23 ' CG1' ' B' ' 227' ' ' VAL . 6.3 m -70.4 -44.74 67.37 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.219 -1.165 . . . . 0.0 109.103 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -63.08 -36.84 84.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -0.911 . . . . 0.0 109.06 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.712 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -74.18 -59.84 2.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.822 HD11 ' N ' ' B' ' 234' ' ' ALA . 30.1 mt -48.45 -41.23 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.28 -0.887 . . . . 0.0 108.916 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 252' ' ' ARG . . . . . 0.641 ' CG ' HD23 ' B' ' 223' ' ' LEU . 13.0 ttm180 -78.34 -56.49 4.41 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 253' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 17.5 tt0 -46.65 -27.03 1.03 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.058 -1.027 . . . . 0.0 108.29 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 0.6 OUTLIER -86.22 -71.14 0.56 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.307 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 1.038 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -48.09 -31.62 5.77 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 256' ' ' ALA . . . . . 0.704 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -67.04 -47.73 70.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -56.49 -31.94 64.53 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 258' ' ' SER . . . . . 0.58 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 29.6 t -73.14 -36.37 66.66 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 0.686 HD11 ' HA2' ' B' ' 221' ' ' GLY . 8.2 tp -68.22 -27.84 66.72 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.382 -0.824 . . . . 0.0 109.282 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -47.21 -25.74 1.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.235 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' LEU . . . . . 0.709 ' O ' HD23 ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.74 112.67 53.3 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.403 -0.811 . . . . 0.0 108.912 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 262' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.34 97.75 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.823 1.433 . . . . 0.0 110.493 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.976 HD13 HG13 ' B' ' 284' ' ' VAL . 0.3 OUTLIER -131.66 -172.07 2.77 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.79 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 264' ' ' ALA . . . . . 0.987 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -119.19 127.4 53.26 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 265' ' ' VAL . . . . . 0.71 HG21 ' HB3' ' B' ' 218' ' ' LEU . 3.6 t -107.88 118.8 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.281 -0.887 . . . . 0.0 109.575 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 266' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.4 tt0 -150.08 106.81 3.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 109.285 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.9 OUTLIER -47.15 174.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.839 . . . . 0.0 109.767 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 1.7 p -148.49 -38.92 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.63 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 269' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' B' ' 270' ' ' GLU . 0.6 OUTLIER -99.69 -147.06 0.34 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 109.405 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.442 ' N ' ' CG ' ' B' ' 269' ' ' GLN . 26.0 tt0 -111.45 132.24 54.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.205 -0.934 . . . . 0.0 109.562 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 271' ' ' VAL . . . . . 0.822 HG13 ' HB3' ' B' ' 280' ' ' PHE . 30.3 t -64.04 151.11 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.263 -0.898 . . . . 0.0 109.12 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' B' ' 279' ' ' ALA . 0.0 OUTLIER -117.46 135.44 53.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.082 -1.011 . . . . 0.0 109.742 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 273' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' B' ' 207' ' ' MET . . . -147.13 127.72 14.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.865 . . . . 0.0 109.464 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 274' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -140.27 156.39 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 0.0 109.567 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 275' ' ' ALA . . . . . 0.446 ' O ' ' SD ' ' B' ' 207' ' ' MET . . . 42.35 -145.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.447 -0.783 . . . . 0.0 109.469 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 276' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 2.4 m-20 -83.54 -11.08 57.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.116 -0.99 . . . . 0.0 109.473 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 277' ' ' GLU . . . . . 0.5 ' HG2' ' HG3' ' B' ' 302' ' ' ARG . 1.5 mt-10 -93.28 -162.44 0.94 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.431 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 278' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 178.15 160.8 0.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.452 -0.78 . . . . 0.0 109.623 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 279' ' ' ALA . . . . . 0.706 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -147.67 139.62 24.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.044 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 280' ' ' PHE . . . . . 0.822 ' HB3' HG13 ' B' ' 271' ' ' VAL . 26.4 p90 -150.76 171.38 17.27 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.906 -1.121 . . . . 0.0 109.748 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.912 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -143.11 164.34 30.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.298 -0.877 . . . . 0.0 110.238 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 282' ' ' PHE . . . . . 0.5 ' O ' ' HD2' ' B' ' 297' ' ' PRO . 2.1 p90 -158.45 -172.57 3.91 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 283' ' ' THR . . . . . 0.878 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -130.31 141.22 50.61 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 284' ' ' VAL . . . . . 0.976 HG13 HD13 ' B' ' 263' ' ' LEU . 23.9 t -106.21 112.09 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 108.974 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 285' ' ' SER . . . . . 0.987 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 15.7 p -101.25 76.62 1.73 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.879 . . . . 0.0 109.257 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.76 ' CE1' H221 ' B' ' 326' ' ' NTH . 13.8 p90 -89.86 176.33 6.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.346 -0.846 . . . . 0.0 109.591 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -128.33 151.51 49.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.333 -0.855 . . . . 0.0 109.306 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.444 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.6 OUTLIER -100.94 -166.09 1.27 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.395 -0.816 . . . . 0.0 109.376 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.9 43.51 1.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 0.0 109.075 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 154.29 -22.24 0.66 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 291' ' ' ARG . . . . . 0.483 ' O ' ' HD3' ' B' ' 292' ' ' LYS . 8.8 mtt180 -123.92 176.22 6.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.555 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 292' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' B' ' 291' ' ' ARG . 7.7 mmtp -131.22 115.05 15.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.223 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 293' ' ' THR . . . . . 0.482 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -119.73 142.91 48.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.206 -0.933 . . . . 0.0 110.025 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 294' ' ' VAL . . . . . 0.572 HG22 ' N ' ' B' ' 295' ' ' VAL . 12.4 p -120.99 170.96 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 0.975 HG22 HG23 ' B' ' 321' ' ' ILE . 54.2 t -139.81 158.21 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.911 -1.118 . . . . 0.0 110.07 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 296' ' ' ALA . . . . . 0.435 ' N ' HG12 ' B' ' 295' ' ' VAL . . . -137.43 74.29 47.68 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.812 . . . . 0.0 109.791 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 297' ' ' PRO . . . . . 0.594 ' HD3' HG12 ' B' ' 295' ' ' VAL . 47.3 Cg_endo -97.36 -173.36 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.623 1.549 . . . . 0.0 110.749 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.912 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.7 mp -139.79 161.99 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 299' ' ' ASP . . . . . 0.61 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 11.5 t0 -131.75 155.69 47.27 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.097 -1.002 . . . . 0.0 110.012 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' B' ' 299' ' ' ASP . 0.1 OUTLIER -111.66 174.06 6.05 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 301' ' ' PHE . . . . . 0.593 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.91 151.78 36.44 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.014 -1.054 . . . . 0.0 110.473 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.5 ' HG3' ' HG2' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -145.0 94.44 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 109.533 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 303' ' ' PHE . . . . . 0.856 ' CE1' HG11 ' B' ' 210' ' ' VAL . 12.2 m-85 -90.63 -163.52 1.04 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 304' ' ' ASN . . . . . 0.737 ' ND2' HG22 ' B' ' 310' ' ' VAL . 1.8 p30 -139.6 7.31 2.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.727 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . 116.22 68.31 0.41 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . 54.35 41.26 32.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -1.165 . . . . 0.0 109.444 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 307' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' B' ' 308' ' ' LYS . . . -125.1 35.2 3.18 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 308' ' ' LYS . . . . . 0.558 ' CB ' ' O ' ' B' ' 307' ' ' GLY . 9.2 mttm 83.05 -161.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 122.012 -0.699 . . . . 0.0 109.404 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 309' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 98.6 t -99.36 136.52 30.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.342 -0.849 . . . . 0.0 109.501 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.737 HG22 ' ND2' ' B' ' 304' ' ' ASN . 2.9 t -108.78 -71.45 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 109.357 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 311' ' ' SER . . . . . 0.499 ' HB2' ' HD3' ' B' ' 302' ' ' ARG . 0.4 OUTLIER -113.9 169.0 9.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.183 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 312' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' B' ' 300' ' ' HIS . 13.4 ttp -158.65 152.27 23.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.947 . . . . 0.0 109.778 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 313' ' ' ARG . . . . . 0.551 ' CG ' ' HB2' ' B' ' 237' ' ' GLU . 0.1 OUTLIER -131.07 170.22 14.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.38 -0.825 . . . . 0.0 109.29 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -144.9 130.02 18.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.192 -0.943 . . . . 0.0 109.247 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 315' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 79' ' ' ALA . 1.1 tt -123.93 144.54 49.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.182 -0.949 . . . . 0.0 109.925 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 316' ' ' PHE . . . . . 0.531 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 12.2 p90 173.57 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 317' ' ' GLY . . . . . 0.576 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 162.4 -176.07 38.79 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 318' ' ' GLU . . . . . 0.518 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 6.2 tt0 -72.36 -3.4 23.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -1.139 . . . . 0.0 109.385 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -93.75 -29.12 15.54 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.955 0.883 . . . . 0.0 108.873 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 320' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' B' ' 296' ' ' ALA . 1.4 m-20 -89.02 7.87 32.59 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 321' ' ' ILE . . . . . 0.975 HG23 HG22 ' B' ' 295' ' ' VAL . 4.6 mm -90.65 -167.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 322' ' ' HIS . . . . . 0.684 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.2 OUTLIER -151.06 158.88 44.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 0.0 109.593 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.4 ' HA ' HG22 ' B' ' 293' ' ' THR . . . -155.26 81.46 1.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 109.518 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -115.68 177.65 17.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.244 -1.151 . . . . 0.0 109.493 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 126' ' ' NTH . . . . . 0.774 ' H11' ' OG ' ' A' ' 58' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 326' ' ' NTH . . . . . 0.76 H221 ' CE1' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.527 ' O ' ' CE ' ' A' ' 7' ' ' MET . 1.1 ptp . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.331 0.586 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.3 t30 45.57 -167.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 3' ' ' THR . 13.4 t -71.87 122.52 87.5 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.719 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HA ' ' CE ' ' A' ' 7' ' ' MET . 43.8 Cg_endo -70.67 -5.44 16.77 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.926 1.487 . . . . 0.0 109.535 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -43.93 88.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.496 -0.752 . . . . 0.0 109.361 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -61.52 -47.05 87.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.211 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.527 ' CE ' ' O ' ' A' ' 1' ' ' MET . 11.6 mtt -57.52 -39.5 76.71 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.29 -0.881 . . . . 0.0 109.227 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 m -52.77 -37.01 58.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.335 -0.853 . . . . 0.0 108.987 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.17 -50.67 73.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.297 -0.877 . . . . 0.0 109.051 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.748 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.1 t -48.79 -34.48 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 108.788 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.717 HG11 ' CG2' ' A' ' 71' ' ' VAL . 8.0 t -81.07 -41.91 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.399 -0.813 . . . . 0.0 109.222 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 15' ' ' VAL . 8.5 tt0 -63.35 -73.54 0.11 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.272 1.034 . . . . 0.0 108.573 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.827 ' HD2' HD13 ' A' ' 29' ' ' LEU . 1.1 mtm180 -42.62 -45.13 4.51 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.629 ' CE1' HD11 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -44.21 -41.9 6.13 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.005 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.958 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.5 t -90.43 -38.53 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.742 . . . . 0.0 109.02 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -48.87 -35.31 14.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.597 ' HB3' HG12 ' A' ' 26' ' ' ILE . . . -74.15 -35.42 64.04 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.958 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.3 mt -62.13 -58.47 7.67 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -50.69 -38.27 46.0 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.439 0.638 . . . . 0.0 109.334 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.86 -2.31 58.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.635 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.877 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 52.51 40.14 54.15 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.474 ' O ' HG13 ' A' ' 26' ' ' ILE . 8.5 t70 -106.76 86.37 2.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -1.087 . . . . 0.0 109.608 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.971 ' CD2' HD22 ' A' ' 59' ' ' LEU . 3.5 mm? -52.08 -20.02 2.25 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 2.2 m-20 -65.36 -56.74 10.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.486 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -61.14 -27.66 67.72 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.862 HD12 HD13 ' A' ' 23' ' ' LEU . 10.1 mt -71.31 -64.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.844 HG21 ' HB2' ' A' ' 52' ' ' ARG . 96.6 t -58.3 -35.79 55.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 24' ' ' ASP . . . -60.02 -56.41 21.98 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.827 HD13 ' HD2' ' A' ' 13' ' ' ARG . 5.9 tp -58.87 -25.53 63.41 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.7 ' CE1' ' HE1' ' A' ' 112' ' ' MET . 14.6 m-30 -87.67 148.35 24.83 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.752 -0.593 . . . . 0.0 109.636 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -55.0 -166.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.739 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.437 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -83.09 -23.88 32.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 109.577 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.54 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 21.7 p-10 -144.37 39.45 1.3 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.616 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -54.09 177.71 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.468 -0.77 . . . . 0.0 109.795 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.462 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -129.32 135.69 49.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.387 -0.821 . . . . 0.0 109.232 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 27.2 t -123.63 120.35 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.631 ' O ' ' HB3' ' A' ' 114' ' ' ALA . 3.2 mt-10 -91.11 104.77 17.31 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.65 ' OD2' ' H10' ' A' ' 126' ' ' NTH . 30.2 t70 -178.92 137.05 0.32 Allowed Pre-proline 0 C--N 1.298 -1.647 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.165 -178.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.549 ' O ' ' O ' ' A' ' 40' ' ' VAL . 47.5 Cg_endo -71.91 -148.97 0.41 Allowed 'Cis proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.311 -1.954 . . . . 0.0 110.644 0.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.957 HG11 HG11 ' B' ' 274' ' ' VAL . 5.4 m -52.8 -140.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 122.084 0.945 . . . . 0.0 111.834 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.694 ' N ' HG23 ' A' ' 40' ' ' VAL . . . -39.26 -23.66 0.03 OUTLIER Glycine 0 N--CA 1.495 2.575 0 O-C-N 121.174 -0.954 . . . . 0.0 111.604 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.541 ' CB ' ' HG2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -29.56 -93.7 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.016 -0.697 . . . . 0.0 110.874 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 42' ' ' SER . 0.0 OUTLIER 169.42 122.32 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.992 -1.068 . . . . 0.0 111.005 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.9 Cg_endo -66.24 -167.85 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.662 1.575 . . . . 0.0 111.281 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 1.083 ' CG ' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -151.57 130.3 12.37 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.211 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.462 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.5 OUTLIER -112.7 147.47 36.73 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.672 -1.268 . . . . 0.0 110.702 -178.225 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.54 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 105.02 163.19 23.92 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 2.7 m -69.15 -64.51 0.86 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.076 -1.25 . . . . 0.0 108.902 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -48.11 -23.7 0.91 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.159 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.083 ' HB1' ' CG ' ' A' ' 45' ' ' ARG . . . -90.02 -56.54 3.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.506 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 51' ' ' ILE . 9.0 mm -52.34 -41.87 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.309 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.844 ' HB2' HG21 ' A' ' 27' ' ' VAL . 19.5 ttt180 -73.38 -49.12 28.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 108.814 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 14.0 mt-10 -52.34 -30.0 26.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.146 -0.971 . . . . 0.0 108.486 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -81.82 -71.5 0.48 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.581 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.858 ' CD1' HG21 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -48.89 -29.1 4.31 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.11 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 52' ' ' ARG . . . -72.61 -38.05 67.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.491 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 23.9 t30 -65.22 -33.62 76.44 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.598 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 45.7 t -69.09 -41.75 77.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.475 -0.765 . . . . 0.0 108.941 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.971 HD22 ' CD2' ' A' ' 23' ' ' LEU . 9.5 tp -59.57 -18.95 45.16 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.271 -0.893 . . . . 0.0 109.074 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 57' ' ' ASN . 28.9 mtmt -69.66 -5.58 25.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 108.973 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.812 HD12 H122 ' A' ' 126' ' ' NTH . 0.3 OUTLIER -89.12 112.52 51.55 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.569 ' HD2' HD23 ' A' ' 61' ' ' LEU . 42.1 Cg_endo -68.56 91.03 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.713 1.375 . . . . 0.0 111.076 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.789 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -150.59 167.42 27.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.222 -0.924 . . . . 0.0 110.108 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.37 127.4 52.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.77 124.53 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.786 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.99 113.34 4.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.21 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.31 177.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 109.845 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.455 HG23 ' N ' ' A' ' 69' ' ' GLN . 9.9 t -156.24 -38.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 109.816 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 3.1 pt20 -97.71 -147.24 0.31 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.551 -0.718 . . . . 0.0 109.361 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.494 ' O ' ' NE ' ' A' ' 72' ' ' ARG . 29.9 tt0 -114.55 135.54 54.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.945 . . . . 0.0 109.649 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.717 ' CG2' HG11 ' A' ' 11' ' ' VAL . 79.3 t -66.21 152.2 9.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.365 -0.835 . . . . 0.0 109.154 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -118.33 140.48 49.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.089 . . . . 0.0 110.138 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . . . -150.25 134.67 17.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.428 -0.795 . . . . 0.0 109.141 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.684 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -159.62 163.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.943 -1.098 . . . . 0.0 110.212 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.52 ' HB1' ' HA3' ' B' ' 241' ' ' GLY . . . 39.17 -97.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.786 -0.571 . . . . 0.0 110.232 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 103' ' ' PHE . 4.1 m-20 -135.74 10.3 3.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.022 -1.049 . . . . 0.0 109.717 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.506 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -116.22 -161.17 0.78 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.148 -0.97 . . . . 0.0 109.371 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.873 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . -176.58 129.81 0.2 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.475 -0.766 . . . . 0.0 109.629 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -114.88 130.82 56.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.998 . . . . 0.0 109.287 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.631 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 15.2 p90 -150.47 173.19 14.35 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.819 -1.176 . . . . 0.0 109.783 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.572 ' HB2' ' CG1' ' A' ' 98' ' ' ILE . . . -150.27 -167.58 2.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 110.627 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.481 ' O ' ' HD2' ' A' ' 97' ' ' PRO . 9.1 p90 178.06 -168.93 0.08 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -135.94 141.16 44.46 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 110.05 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.735 HG13 ' CB ' ' A' ' 63' ' ' LEU . 2.2 t -110.95 118.19 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 108.882 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.725 ' HA ' HG23 ' A' ' 94' ' ' VAL . 1.7 p -118.65 110.08 16.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.128 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.572 ' CZ ' ' HB ' ' A' ' 93' ' ' THR . 10.5 p90 -130.23 -177.71 4.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.289 -0.882 . . . . 0.0 109.712 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -122.93 152.25 41.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.389 -0.819 . . . . 0.0 109.09 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER -110.08 178.5 4.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.223 -0.923 . . . . 0.0 109.775 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -65.23 68.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.442 -0.786 . . . . 0.0 109.679 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 88' ' ' PHE . . . 115.81 -30.06 6.82 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 23.3 mtt85 -111.6 -171.9 1.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -1.157 . . . . 0.0 109.691 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -147.03 146.97 30.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 109.346 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.572 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -141.3 153.84 45.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.435 -0.791 . . . . 0.0 110.223 -179.309 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.725 HG23 ' HA ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -132.79 172.33 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.751 HG22 HG23 ' A' ' 121' ' ' ILE . 52.5 t -150.15 146.73 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.542 -1.349 . . . . 0.0 110.646 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.69 74.22 78.3 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.707 ' HD3' HG12 ' A' ' 95' ' ' VAL . 48.5 Cg_endo -94.76 -179.36 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.58 1.52 . . . . 0.0 111.833 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 80' ' ' PHE . 3.2 mp -143.74 144.18 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 4.3 t0 -117.87 163.12 17.02 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 110.155 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.2 OUTLIER -115.55 176.56 5.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.873 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -150.29 135.88 18.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.026 -1.046 . . . . 0.0 110.383 -178.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.506 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -121.01 107.67 12.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.381 -0.824 . . . . 0.0 109.075 179.345 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.748 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -89.26 166.22 13.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.363 -0.836 . . . . 0.0 109.38 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.773 ' HB3' HG21 ' A' ' 110' ' ' VAL . 8.9 p-10 -115.81 -5.97 12.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 109.166 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.711 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 177.26 -60.92 0.1 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 161.17 77.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.507 -0.996 . . . . 0.0 109.38 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.54 -66.32 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.572 ' O ' ' CE1' ' A' ' 103' ' ' PHE . 14.8 mttm -108.4 178.13 4.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -1.191 . . . . 0.0 109.602 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.646 ' CG2' HG22 ' A' ' 10' ' ' VAL . 49.6 t -109.05 153.35 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.336 -0.852 . . . . 0.0 109.233 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.773 HG21 ' HB3' ' A' ' 104' ' ' ASN . 44.8 t -124.18 -62.37 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -0.969 . . . . 0.0 109.53 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -116.31 164.53 14.38 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.974 -1.079 . . . . 0.0 109.463 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.7 ' HE1' ' CE1' ' A' ' 30' ' ' PHE . 19.3 ttm -153.29 137.67 16.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.325 -0.86 . . . . 0.0 109.5 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.506 ' HB2' ' HB3' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -113.21 168.57 9.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.448 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . -150.4 130.11 13.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.16 -0.962 . . . . 0.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 1.06 HD22 ' HB3' ' B' ' 279' ' ' ALA . 0.6 OUTLIER -130.94 142.6 50.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.783 ' CZ ' ' H62' ' A' ' 126' ' ' NTH . 50.3 p90 166.5 -162.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.603 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . 177.5 178.83 47.41 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.219 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.51 ' HA ' HG12 ' A' ' 121' ' ' ILE . 16.8 tt0 -50.2 -21.83 1.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.145 -1.209 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.48 ' HD3' ' OE2' ' B' ' 270' ' ' GLU . 0.6 OUTLIER -73.41 -22.11 60.32 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.009 0.909 . . . . 0.0 108.829 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.68 ' ND2' ' CD1' ' A' ' 121' ' ' ILE . 0.5 OUTLIER -88.56 -4.57 58.56 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.5 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.751 HG23 HG22 ' A' ' 95' ' ' VAL . 2.2 mm -91.75 -162.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.03 -1.044 . . . . 0.0 108.212 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.615 ' CB ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -152.25 -169.4 3.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.004 -1.06 . . . . 0.0 109.606 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.55 -176.24 5.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.875 . . . . 0.0 109.54 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.81 -175.35 41.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.275 -1.133 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.524 ' O ' ' CB ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.298 0.57 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' B' ' 201' ' ' MET . 2.6 t30 77.05 177.9 0.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.239 -0.913 . . . . 0.0 109.713 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.37 128.57 66.69 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.398 -0.814 . . . . 0.0 109.736 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 204' ' ' PRO . . . . . 0.441 ' HA ' ' CE ' ' B' ' 207' ' ' MET . 42.5 Cg_endo -69.76 -7.01 19.96 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.023 1.539 . . . . 0.0 109.153 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 205' ' ' GLU . . . . . 0.446 ' O ' ' HB ' ' B' ' 208' ' ' THR . 0.3 OUTLIER -61.66 -45.67 93.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.436 -0.79 . . . . 0.0 108.91 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -64.1 -43.7 94.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 108.904 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' MET . . . . . 0.441 ' CE ' ' HA ' ' B' ' 204' ' ' PRO . 16.7 mtt -54.9 -24.66 24.55 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.29 -0.881 . . . . 0.0 109.156 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' B' ' 205' ' ' GLU . 11.2 m -72.7 -41.64 65.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.405 -0.809 . . . . 0.0 108.983 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.35 -41.34 51.41 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.319 -0.863 . . . . 0.0 108.761 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.994 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.2 t -54.81 -44.58 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.818 HG11 ' CG2' ' B' ' 271' ' ' VAL . 6.6 t -72.42 -41.66 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.459 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 213' ' ' ARG . 23.7 tt0 -59.92 -74.16 0.08 Allowed 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.265 1.031 . . . . 0.0 108.281 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.469 ' HB3' HD22 ' B' ' 229' ' ' LEU . 2.7 mtt85 -43.54 -45.51 6.62 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.977 0.894 . . . . 0.0 108.659 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 214' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.5 OUTLIER -49.9 -44.77 50.26 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.907 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -87.17 -38.54 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.372 -0.83 . . . . 0.0 109.274 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 216' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.42 -37.74 17.88 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' B' ' 222' ' ' ASP . . . -72.06 -34.39 68.7 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' B' ' 215' ' ' VAL . 1.9 mt -64.54 -57.97 7.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -49.97 -42.27 48.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.567 0.698 . . . . 0.0 109.224 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.49 -1.04 57.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.884 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.876 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 57.43 47.58 87.06 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 222' ' ' ASP . . . . . 0.536 ' O ' ' HB1' ' B' ' 217' ' ' ALA . 26.7 t70 -113.38 92.64 4.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.852 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 223' ' ' LEU . . . . . 1.079 HD13 HD12 ' B' ' 226' ' ' ILE . 2.5 mm? -62.46 -12.48 22.25 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.184 -0.947 . . . . 0.0 109.565 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -59.36 3.5 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.293 -0.879 . . . . 0.0 109.424 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -59.6 -28.44 65.23 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 1.079 HD12 HD13 ' B' ' 223' ' ' LEU . 23.0 mt -69.02 -62.01 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.545 -0.973 . . . . 0.0 108.47 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.888 HG11 HG23 ' B' ' 248' ' ' THR . 65.3 t -58.37 -36.11 57.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -57.33 13.47 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.994 HD21 ' HA ' ' B' ' 210' ' ' VAL . 9.8 tp -57.19 -29.07 63.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 230' ' ' PHE . . . . . 0.696 ' CE2' HG22 ' B' ' 226' ' ' ILE . 17.1 m-30 -82.18 127.22 32.94 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.644 -0.66 . . . . 0.0 109.619 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -45.68 171.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 109.582 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -24.39 66.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.729 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.577 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 55.4 p-10 -134.03 44.43 2.73 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.668 -0.645 . . . . 0.0 109.556 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' B' ' 310' ' ' VAL . . . -71.41 -169.94 0.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 235' ' ' THR . . . . . 0.715 HG22 ' HB2' ' B' ' 246' ' ' SER . 15.1 p -142.34 175.06 10.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.303 -0.873 . . . . 0.0 109.329 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.583 HG23 ' O ' ' B' ' 235' ' ' THR . 40.0 t -158.94 110.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 237' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 17.7 mt-10 -88.27 105.98 17.91 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 238' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 8.8 t0 -174.68 142.47 0.77 Allowed Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.106 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.512 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 47.1 Cg_endo -72.14 -168.49 5.53 Favored 'Cis proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.345 -1.939 . . . . 0.0 110.873 -0.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' B' ' 315' ' ' LEU . 3.7 m -64.79 146.14 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.276 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 241' ' ' GLY . . . . . 0.52 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . 54.12 32.22 49.87 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 242' ' ' SER . . . . . 0.512 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.2 OUTLIER -120.1 -156.38 0.66 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -1.096 . . . . 0.0 109.607 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 243' ' ' GLU . . . . . 0.429 ' HA ' ' HD2' ' B' ' 244' ' ' PRO . 19.5 mt-10 -120.76 118.37 30.67 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.166 -0.959 . . . . 0.0 110.026 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 244' ' ' PRO . . . . . 0.578 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.1 Cg_endo -64.82 -169.05 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.938 1.494 . . . . 0.0 111.55 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.766 ' HB3' ' HB1' ' B' ' 250' ' ' ALA . 6.5 mtt180 -150.83 106.17 3.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.866 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.19 158.08 18.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 110.154 -179.071 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 247' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 87.7 157.2 31.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 248' ' ' THR . . . . . 0.888 HG23 HG11 ' B' ' 227' ' ' VAL . 6.9 m -67.2 -41.41 85.88 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.35 -1.088 . . . . 0.0 109.197 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -60.92 -32.85 72.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.291 -0.881 . . . . 0.0 109.186 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -89.8 -55.07 3.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.372 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.551 HD12 ' C ' ' B' ' 247' ' ' GLY . 14.3 mt -54.11 -44.9 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 0.0 108.887 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 252' ' ' ARG . . . . . 0.712 ' HB2' HG21 ' B' ' 227' ' ' VAL . 25.8 ttt-85 -70.56 -53.14 17.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 253' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 23.2 tt0 -50.41 -32.31 17.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.151 -0.968 . . . . 0.0 109.015 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.582 ' CD2' ' HG3' ' B' ' 245' ' ' ARG . 0.2 OUTLIER -80.26 -70.51 0.52 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 0.538 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -47.89 -26.4 1.68 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 256' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' B' ' 252' ' ' ARG . . . -76.61 -44.39 34.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.085 -1.009 . . . . 0.0 108.675 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 257' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 5.6 t30 -65.09 -25.63 67.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 108.75 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 21.5 t -75.36 -39.37 59.34 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 0.906 HD22 ' CD2' ' B' ' 223' ' ' LEU . 8.2 tp -64.96 -20.04 66.28 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.456 -0.777 . . . . 0.0 109.17 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 260' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 2.2 mttt -49.14 -27.73 3.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.413 -0.805 . . . . 0.0 109.505 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 261' ' ' LEU . . . . . 0.899 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.5 OUTLIER -89.95 118.88 69.28 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.217 -0.927 . . . . 0.0 109.078 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 262' ' ' PRO . . . . . 0.43 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 43.9 Cg_endo -70.21 105.06 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.768 1.404 . . . . 0.0 110.535 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.899 ' CD2' HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -137.73 153.17 49.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.509 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -89.98 129.12 36.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 108.877 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 265' ' ' VAL . . . . . 0.551 HG11 HG22 ' B' ' 215' ' ' VAL . 98.3 t -111.98 118.58 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.663 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 4.1 tt0 -150.26 96.51 2.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.308 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.9 mp -45.14 171.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.752 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 34.2 p -146.86 -37.97 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.87 . . . . 0.0 109.711 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 269' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 15.3 pt20 -91.46 -146.61 0.21 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 109.433 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 58.1 tt0 -115.06 134.67 54.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.677 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 271' ' ' VAL . . . . . 0.818 ' CG2' HG11 ' B' ' 211' ' ' VAL . 56.3 t -65.7 153.36 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.372 -0.83 . . . . 0.0 109.189 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.0 OUTLIER -113.97 135.72 53.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.078 -1.013 . . . . 0.0 110.134 -179.648 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 273' ' ' ALA . . . . . 0.438 ' HB1' ' CB ' ' B' ' 207' ' ' MET . . . -150.1 149.49 30.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.148 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 274' ' ' VAL . . . . . 0.957 HG11 HG11 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -153.38 -155.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.039 -1.038 . . . . 0.0 109.939 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 275' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . -23.39 -96.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 120.954 0.406 . . . . 0.0 111.815 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 276' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' B' ' 303' ' ' PHE . 47.5 t30 -116.23 -1.57 12.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.855 -1.153 . . . . 0.0 110.725 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 277' ' ' GLU . . . . . 0.468 ' HG3' ' HG3' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -109.25 -162.08 0.79 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.811 -1.181 . . . . 0.0 109.557 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 278' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . -179.98 159.99 0.84 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.49 -0.756 . . . . 0.0 109.349 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 279' ' ' ALA . . . . . 1.06 ' HB3' HD22 ' A' ' 115' ' ' LEU . . . -150.33 138.27 20.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 109.041 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 280' ' ' PHE . . . . . 0.748 ' CD2' HG22 ' B' ' 211' ' ' VAL . 35.0 p90 -150.61 172.06 16.13 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.931 -1.106 . . . . 0.0 109.851 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.828 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -146.44 -168.62 3.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 0.0 109.962 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 282' ' ' PHE . . . . . 0.451 ' HB3' ' O ' ' B' ' 281' ' ' ALA . 31.3 p90 170.28 -167.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.227 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.93 142.51 50.92 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.443 -0.786 . . . . 0.0 109.677 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 284' ' ' VAL . . . . . 0.813 HG11 HD22 ' B' ' 263' ' ' LEU . 74.4 t -114.36 113.02 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.862 . . . . 0.0 109.322 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 4.4 p -109.14 115.07 29.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.308 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.786 ' CZ ' H221 ' B' ' 326' ' ' NTH . 6.5 p90 -137.65 160.79 38.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -137.76 153.03 49.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.501 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 2.3 p90 -148.02 12.67 0.98 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 109.871 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -168.07 -147.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.113 -0.992 . . . . 0.0 109.406 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -76.66 -23.33 70.28 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -105.48 -179.82 4.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -1.09 . . . . 0.0 109.298 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 292' ' ' LYS . . . . . 0.454 ' O ' ' HD2' ' B' ' 292' ' ' LYS . 0.1 OUTLIER -149.26 128.16 12.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.525 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 293' ' ' THR . . . . . 0.815 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -105.19 142.72 34.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.248 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 294' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' B' ' 322' ' ' HIS . 0.6 OUTLIER -113.52 174.96 2.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.192 -0.943 . . . . 0.0 108.615 179.715 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 1.073 HG22 HG23 ' B' ' 321' ' ' ILE . 3.0 t -145.87 145.17 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -0.981 . . . . 0.0 109.426 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 296' ' ' ALA . . . . . 0.524 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -132.58 71.36 78.93 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.223 -0.923 . . . . 0.0 110.362 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 297' ' ' PRO . . . . . 1.046 ' HD3' HG12 ' B' ' 295' ' ' VAL . 49.9 Cg_endo -95.61 -173.45 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.575 1.516 . . . . 0.0 110.692 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.828 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.7 mp -140.99 149.72 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 299' ' ' ASP . . . . . 0.622 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 5.7 t0 -115.0 161.07 18.83 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.929 -1.107 . . . . 0.0 110.111 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.513 ' HB3' ' HB2' ' B' ' 313' ' ' ARG . 0.1 OUTLIER -117.85 166.76 12.09 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 301' ' ' PHE . . . . . 0.808 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.2 OUTLIER -142.27 149.36 39.46 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.146 -0.971 . . . . 0.0 110.774 -178.597 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.468 ' HG3' ' HG3' ' B' ' 277' ' ' GLU . 30.8 ttt-85 -142.74 107.79 4.94 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 303' ' ' PHE . . . . . 0.774 ' CE1' HG21 ' B' ' 210' ' ' VAL . 26.0 m-85 -89.28 -174.84 4.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 109.358 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 304' ' ' ASN . . . . . 0.693 ' HB3' HG21 ' B' ' 310' ' ' VAL . 0.5 OUTLIER -112.63 -43.3 3.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.46 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 305' ' ' GLY . . . . . 0.688 ' O ' ' HB3' ' B' ' 306' ' ' ALA . . . -165.05 27.85 0.2 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 306' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' B' ' 305' ' ' GLY . . . 74.87 38.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -1.18 . . . . 0.0 109.534 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -131.43 -39.21 0.25 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 308' ' ' LYS . . . . . 0.457 ' HG3' ' OD1' ' B' ' 304' ' ' ASN . 2.1 pttt -153.65 -175.3 5.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -1.134 . . . . 0.0 109.497 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 309' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 84.9 t -89.87 159.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 109.332 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.693 HG21 ' HB3' ' B' ' 304' ' ' ASN . 45.0 t -136.18 -75.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.722 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 311' ' ' SER . . . . . 0.504 ' CB ' ' OG1' ' B' ' 235' ' ' THR . 70.5 m -122.22 160.7 24.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.032 . . . . 0.0 110.057 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 312' ' ' MET . . . . . 0.676 ' HE1' ' CE1' ' B' ' 230' ' ' PHE . 2.3 ttm -139.04 158.45 44.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.435 -0.791 . . . . 0.0 109.531 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 313' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' B' ' 300' ' ' HIS . 0.8 OUTLIER -133.7 149.34 51.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 109.325 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 314' ' ' ALA . . . . . 0.406 ' CB ' ' OD2' ' B' ' 238' ' ' ASP . . . -125.29 132.4 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.973 . . . . 0.0 109.708 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 315' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' A' ' 79' ' ' ALA . 1.2 tt -131.84 143.52 50.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.592 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 316' ' ' PHE . . . . . 0.684 ' O ' HG11 ' A' ' 74' ' ' VAL . 14.2 p90 171.91 -158.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 317' ' ' GLY . . . . . 0.548 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 168.87 -177.3 42.77 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 318' ' ' GLU . . . . . 0.537 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 13.1 tt0 -71.14 -4.8 27.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -1.118 . . . . 0.0 109.374 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -90.7 -30.86 16.85 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.902 0.858 . . . . 0.0 109.012 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 320' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -89.3 7.27 36.45 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.2 0.524 . . . . 0.0 109.59 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 321' ' ' ILE . . . . . 1.073 HG23 HG22 ' B' ' 295' ' ' VAL . 4.2 mm -90.82 -162.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 322' ' ' HIS . . . . . 0.815 ' O ' HG22 ' B' ' 293' ' ' THR . 60.3 t60 -151.27 154.32 36.55 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.087 -1.008 . . . . 0.0 109.637 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -155.14 86.54 1.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.925 . . . . 0.0 109.414 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -127.36 159.94 21.42 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.219 -1.165 . . . . 0.0 109.528 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 126' ' ' NTH . . . . . 0.812 H122 HD12 ' A' ' 61' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 326' ' ' NTH . . . . . 0.786 H221 ' CZ ' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 tpp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.23 0.538 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.46 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 73.5 m-80 -49.94 108.76 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 0.0 109.408 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.92 111.5 22.18 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.277 -0.889 . . . . 0.0 109.608 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 8' ' ' THR . 44.1 Cg_endo -71.64 -3.74 13.68 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.913 1.481 . . . . 0.0 110.039 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -57.41 -41.32 80.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.938 . . . . 0.0 109.407 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.22 -62.87 1.24 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.944 . . . . 0.0 108.989 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.707 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 27.5 mmt -54.39 -33.28 58.93 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.271 -0.893 . . . . 0.0 109.691 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 6.9 m -66.46 -34.25 77.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.406 -0.808 . . . . 0.0 109.207 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.61 -46.43 70.43 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.172 -0.955 . . . . 0.0 108.662 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.035 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.5 t -58.27 -19.57 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.868 HG21 HG11 ' A' ' 71' ' ' VAL . 14.4 t -90.51 -42.9 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.492 -0.755 . . . . 0.0 109.07 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' ARG . 25.9 tt0 -61.55 -74.22 0.09 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.231 1.015 . . . . 0.0 108.292 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' GLN . 4.2 mtm-85 -42.78 -45.59 4.87 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.601 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -49.24 -43.21 42.53 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.908 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.1 t -88.72 -38.67 11.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.458 -0.776 . . . . 0.0 109.253 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.47 -35.69 13.52 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.554 ' CB ' HG13 ' A' ' 26' ' ' ILE . . . -74.13 -34.56 63.92 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.908 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.2 mt -63.63 -58.71 6.07 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -51.36 -44.8 62.17 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.35 11.0 20.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.687 -0.633 . . . . 0.0 109.533 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.792 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 45.69 29.63 3.04 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' ALA . 10.4 t0 -92.09 60.44 3.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.454 -1.027 . . . . 0.0 109.812 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.072 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -45.8 -37.16 5.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 108.888 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' LEU . 5.9 m-20 -41.06 -29.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -89.17 -36.89 7.38 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.585 HG22 ' HD2' ' A' ' 30' ' ' PHE . 28.7 mt -59.24 -55.13 25.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.542 ' CG1' HG23 ' A' ' 48' ' ' THR . 60.0 t -54.82 -39.63 48.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -57.24 -52.47 65.2 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.035 HD21 ' HA ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -67.58 -15.86 63.88 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.094 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.722 ' CG ' HG21 ' A' ' 51' ' ' ILE . 2.6 m-85 -94.26 119.75 33.5 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.476 -0.765 . . . . 0.0 109.675 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -46.53 171.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.44 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.434 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.2 OUTLIER -73.72 -25.36 60.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.52 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.582 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -121.24 41.23 3.38 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.403 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -71.88 153.89 41.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.882 . . . . 0.0 109.919 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.661 HG23 ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -112.8 159.67 18.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.235 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.609 ' CG2' HD12 ' A' ' 51' ' ' ILE . 24.0 t -148.19 167.98 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.327 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.562 ' N ' HG12 ' A' ' 36' ' ' VAL . 14.1 mt-10 -147.39 111.22 5.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.788 ' OD1' ' HB3' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -178.31 149.63 0.68 Allowed Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 118.695 -1.202 . . . . 0.0 110.075 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.541 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 48.3 Cg_endo -74.13 175.31 47.21 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.052 -2.062 . . . . 0.0 111.014 -0.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.932 HG13 ' CE1' ' A' ' 116' ' ' PHE . 7.2 m -42.12 122.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.489 -0.757 . . . . 0.0 109.652 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . 112.56 53.16 0.5 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.1 OUTLIER 78.53 -151.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -1.079 . . . . 0.0 109.961 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.638 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 4.1 mt-10 67.53 54.36 0.7 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.266 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.638 ' HD3' ' N ' ' A' ' 43' ' ' GLU . 55.7 Cg_endo -86.44 174.41 5.96 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.725 1.381 . . . . 0.0 110.576 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.904 ' HG3' ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -151.41 109.1 3.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.661 ' HB3' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -105.04 136.61 44.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.018 -1.051 . . . . 0.0 110.492 -178.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 103.43 158.44 24.91 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.542 HG23 ' CG1' ' A' ' 27' ' ' VAL . 7.2 m -60.88 -64.19 1.04 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.412 -1.052 . . . . 0.0 109.194 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -45.79 -25.2 0.47 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.088 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.904 ' HB1' ' HG3' ' A' ' 45' ' ' ARG . . . -86.92 -53.25 5.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.309 -0.869 . . . . 0.0 109.519 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.722 HG21 ' CG ' ' A' ' 30' ' ' PHE . 4.1 mm -55.74 -48.92 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.347 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.851 ' HA ' HD21 ' A' ' 23' ' ' LEU . 6.7 ttt180 -68.48 -53.01 26.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.406 -0.809 . . . . 0.0 109.119 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 13.1 tt0 -51.26 -32.16 23.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 108.66 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -83.87 -70.62 0.55 Allowed 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 1.072 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -45.34 -31.17 1.51 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.578 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 52' ' ' ARG . . . -66.4 -46.22 77.34 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 37.1 t-20 -60.62 -36.17 77.94 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.743 ' OG ' H112 ' A' ' 126' ' ' NTH . 39.4 t -68.6 -35.28 77.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.792 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.9 tp -64.94 -20.39 66.44 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.456 -0.777 . . . . 0.0 109.051 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 3.1 mttp -67.04 -7.72 24.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.486 -0.759 . . . . 0.0 109.341 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.017 ' CD2' HD21 ' A' ' 63' ' ' LEU . 13.5 tp -88.88 108.94 26.62 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 48.7 Cg_endo -73.82 92.15 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.846 1.445 . . . . 0.0 111.909 -178.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.046 HD22 ' CG1' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -140.62 178.61 7.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.014 . . . . 0.0 109.366 178.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.577 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -103.17 129.02 49.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.6 t -112.56 113.54 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.692 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' LEU . 4.7 tt0 -150.59 97.19 2.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.815 . . . . 0.0 109.076 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.9 mp -44.84 170.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.338 -0.851 . . . . 0.0 109.67 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.463 HG23 ' N ' ' A' ' 69' ' ' GLN . 14.6 t -146.53 -38.86 0.22 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.704 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.463 ' N ' HG23 ' A' ' 68' ' ' THR . 5.9 pt20 -90.33 -148.39 0.2 Allowed 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 109.331 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -117.15 131.81 56.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.765 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.022 HG13 ' HB3' ' A' ' 80' ' ' PHE . 93.4 t -60.88 148.47 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.365 -0.834 . . . . 0.0 109.226 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -112.66 92.68 4.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 109.819 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 7' ' ' MET . . . -108.0 147.83 30.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.152 -0.968 . . . . 0.0 109.873 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.006 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -160.76 152.63 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.301 -0.874 . . . . 0.0 110.009 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.795 ' HB1' ' HA3' ' B' ' 241' ' ' GLY . . . 41.53 -145.43 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.595 -0.691 . . . . 0.0 109.964 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 103' ' ' PHE . 4.1 m-20 -85.01 4.06 35.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 110.001 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -113.27 -160.49 0.72 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 109.441 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.985 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 174.01 162.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.732 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.25 133.29 16.16 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 1.022 ' HB3' HG13 ' A' ' 71' ' ' VAL . 34.4 p90 -149.51 167.98 24.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.797 -1.189 . . . . 0.0 110.298 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -141.62 167.76 21.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.54 -0.725 . . . . 0.0 109.679 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -159.35 -172.78 3.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.25 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.96 140.44 53.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.378 -0.826 . . . . 0.0 109.658 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.046 ' CG1' HD22 ' A' ' 63' ' ' LEU . 22.6 t -121.17 116.04 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.484 -0.76 . . . . 0.0 109.177 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.662 ' CB ' HG23 ' A' ' 94' ' ' VAL . 69.6 p -118.2 128.17 54.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.96 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.682 ' CD1' HD23 ' A' ' 63' ' ' LEU . 3.0 p90 -143.95 171.01 14.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.379 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.47 ' HA ' ' HG3' ' A' ' 92' ' ' LYS . 2.5 tm-20 -104.6 156.65 17.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.636 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.556 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -117.82 -161.16 0.81 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 109.306 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.64 75.95 2.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 109.686 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . 116.61 -11.7 15.9 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 19.8 mtp180 -149.67 164.15 35.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -1.153 . . . . 0.0 109.592 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' A' ' 87' ' ' GLU . 18.4 tttt -107.91 151.75 25.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.552 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.592 ' HB ' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -138.13 155.14 49.03 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.317 -0.864 . . . . 0.0 109.915 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.662 HG23 ' CB ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -140.22 170.46 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 1.001 HG12 ' HD3' ' A' ' 97' ' ' PRO . 4.8 t -146.53 145.52 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.823 -1.173 . . . . 0.0 109.941 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . -136.46 71.88 58.74 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.434 -0.791 . . . . 0.0 109.786 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 1.001 ' HD3' HG12 ' A' ' 95' ' ' VAL . 52.1 Cg_endo -95.69 -171.11 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 121.741 1.627 . . . . 0.0 110.86 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.706 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.8 mp -140.82 146.34 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 23.0 t0 -118.61 160.94 20.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.921 -1.112 . . . . 0.0 109.83 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -109.74 -179.72 3.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.432 -0.793 . . . . 0.0 108.916 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.985 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -150.14 147.18 27.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.12 -0.987 . . . . 0.0 110.553 -178.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.54 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -140.98 102.61 4.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.264 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.725 ' CZ ' HG11 ' A' ' 10' ' ' VAL . 4.0 m-85 -89.77 -175.88 4.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.928 ' HB3' HG21 ' A' ' 110' ' ' VAL . 9.6 p-10 -126.53 -34.93 2.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 109.372 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.681 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -155.45 -63.29 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 164.6 61.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -1.17 . . . . 0.0 109.404 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.52 -53.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -129.43 -166.23 1.63 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -1.126 . . . . 0.0 109.705 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.598 HG22 ' CG1' ' A' ' 10' ' ' VAL . 25.8 t -109.93 160.72 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 108.906 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.928 HG21 ' HB3' ' A' ' 104' ' ' ASN . 54.2 t -132.61 -60.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.962 -1.086 . . . . 0.0 110.181 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.54 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -122.42 157.22 32.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.869 -1.144 . . . . 0.0 109.969 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.512 ' CE ' ' OD2' ' A' ' 99' ' ' ASP . 8.9 ttp -152.75 157.0 40.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.393 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.533 ' NH1' ' HB3' ' A' ' 37' ' ' GLU . 1.1 tpt180 -139.18 132.0 29.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 109.308 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.788 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . . . -93.0 129.08 39.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.06 -1.025 . . . . 0.0 109.663 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.747 HD13 ' CE1' ' B' ' 300' ' ' HIS . 0.6 OUTLIER -127.21 143.31 51.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.859 . . . . 0.0 109.632 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.932 ' CE1' HG13 ' A' ' 40' ' ' VAL . 47.1 p90 168.94 -154.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.506 ' O ' HG12 ' A' ' 121' ' ' ILE . . . 167.35 161.68 17.28 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.58 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 11.8 tt0 -44.12 -24.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.398 -1.06 . . . . 0.0 109.783 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 117' ' ' GLY . 0.8 OUTLIER -71.37 -35.06 70.98 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.821 0.819 . . . . 0.0 109.723 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 117' ' ' GLY . 0.4 OUTLIER -89.54 1.47 55.9 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.051 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.686 HG23 HG22 ' A' ' 95' ' ' VAL . 3.7 mm -91.44 -171.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 0.0 108.502 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.665 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -151.93 143.22 23.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.702 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.419 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.16 114.87 3.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.97 -116.21 0.7 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.346 -1.091 . . . . 0.0 109.386 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.243 0.544 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.472 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 4.6 m-20 -149.3 68.03 1.03 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 109.628 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 203' ' ' THR . . . . . 0.423 HG22 ' HB2' ' B' ' 205' ' ' GLU . 1.5 m -67.4 111.54 7.64 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.875 . . . . 0.0 109.624 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 204' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 49.1 Cg_endo -74.74 0.19 9.07 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.923 1.486 . . . . 0.0 110.367 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 205' ' ' GLU . . . . . 0.423 ' HB2' HG22 ' B' ' 203' ' ' THR . 7.3 mt-10 -65.81 -57.08 8.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 109.598 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -60.57 -48.55 81.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 207' ' ' MET . . . . . 0.546 ' HA ' ' CZ ' ' B' ' 303' ' ' PHE . 19.8 mtm -61.56 -15.19 36.35 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.332 -0.855 . . . . 0.0 109.896 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.433 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 15.5 m -81.85 -38.54 25.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.253 -0.904 . . . . 0.0 109.253 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.9 -42.83 59.62 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.26 -0.9 . . . . 0.0 108.599 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.693 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -52.31 -24.86 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.193 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.966 HG11 HG21 ' B' ' 271' ' ' VAL . 26.1 t -86.86 -45.24 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.481 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 212' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.6 tt0 -57.74 -73.49 0.07 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.922 ' HD2' HD13 ' B' ' 229' ' ' LEU . 0.7 OUTLIER -43.88 -45.34 7.49 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 214' ' ' TYR . . . . . 0.602 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -48.28 -43.17 32.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.31 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.958 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.1 t -89.27 -39.9 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.297 -0.877 . . . . 0.0 109.003 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' B' ' 213' ' ' ARG . . . -48.34 -36.36 14.29 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.649 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -74.08 -35.62 64.25 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.958 HD12 ' HA ' ' B' ' 215' ' ' VAL . 3.3 mt -61.56 -59.27 5.48 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.0 -41.07 46.34 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -88.91 5.33 44.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 1.042 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 46.86 35.81 8.13 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -97.33 78.35 2.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -1.071 . . . . 0.0 109.887 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' LEU . . . . . 1.05 ' CD2' HD22 ' B' ' 259' ' ' LEU . 3.9 mm? -50.45 -21.13 1.34 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.286 -0.884 . . . . 0.0 109.856 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -62.17 -54.54 39.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.902 . . . . 0.0 109.536 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 225' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' B' ' 229' ' ' LEU . . . -64.3 -34.4 89.81 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.748 HG21 ' CD2' ' B' ' 255' ' ' PHE . 6.9 mt -62.36 -56.02 20.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.715 HG21 ' HB2' ' B' ' 252' ' ' ARG . 26.9 t -63.37 -43.03 98.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.74 -49.79 69.95 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.922 HD13 ' HD2' ' B' ' 213' ' ' ARG . 2.4 tp -68.99 -16.7 63.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 230' ' ' PHE . . . . . 0.474 ' HB2' ' HA ' ' B' ' 227' ' ' VAL . 2.2 m-85 -91.72 140.3 29.83 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.334 -0.854 . . . . 0.0 109.517 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -49.18 177.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.575 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -24.18 66.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.547 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.531 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 4.4 p30 -146.96 47.1 1.17 Allowed 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.651 -0.656 . . . . 0.0 109.31 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.583 ' O ' HD11 ' B' ' 251' ' ' ILE . . . -59.45 167.09 2.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.329 -0.857 . . . . 0.0 109.496 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 235' ' ' THR . . . . . 0.907 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -109.4 164.84 12.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.581 HG23 HD12 ' B' ' 251' ' ' ILE . 46.1 t -154.68 115.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.91 . . . . 0.0 109.488 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 237' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.0 mm-40 -94.85 109.68 21.64 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 238' ' ' ASP . . . . . 0.618 ' OD2' ' H62' ' B' ' 326' ' ' NTH . 10.0 t70 -178.21 142.69 0.45 Allowed Pre-proline 0 C--N 1.302 -1.486 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.042 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 47.0 Cg_endo -73.41 174.87 48.23 Favored 'Cis proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.29 -1.962 . . . . 0.0 111.072 -0.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.649 HG13 ' CE1' ' B' ' 316' ' ' PHE . 29.2 m -57.01 115.3 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.84 . . . . 0.0 109.598 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 241' ' ' GLY . . . . . 0.795 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . 83.28 57.35 2.51 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 242' ' ' SER . . . . . 0.506 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 3.3 m -149.01 -105.03 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -1.187 . . . . 0.0 109.747 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 243' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' B' ' 243' ' ' GLU . 7.5 pt-20 -165.85 111.08 0.75 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.931 -1.106 . . . . 0.0 110.185 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 244' ' ' PRO . . . . . 0.583 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.9 Cg_endo -65.75 179.15 1.87 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.97 1.511 . . . . 0.0 111.239 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.608 ' HB2' ' CD2' ' B' ' 254' ' ' PHE . 0.3 OUTLIER -150.9 103.0 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.907 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.28 150.57 22.55 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.252 -0.905 . . . . 0.0 110.166 -179.133 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 247' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 117.32 157.56 10.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 4.5 m -54.73 -72.18 0.07 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.228 -1.16 . . . . 0.0 108.937 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -52.67 -32.73 43.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 0.0 109.164 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.552 ' HB3' ' C ' ' B' ' 246' ' ' SER . . . -71.11 -23.96 62.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.558 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.583 HD11 ' O ' ' B' ' 234' ' ' ALA . 4.7 mm -90.11 -37.27 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.202 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 252' ' ' ARG . . . . . 0.715 ' HB2' HG21 ' B' ' 227' ' ' VAL . 21.7 ttm180 -79.6 -59.64 2.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.133 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 253' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 4.7 tt0 -45.6 -26.86 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.981 -1.074 . . . . 0.0 108.863 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.608 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.1 OUTLIER -86.44 -69.81 0.65 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 0.748 ' CD2' HG21 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -52.75 -20.43 3.17 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.466 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 256' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' B' ' 252' ' ' ARG . . . -80.95 -43.96 18.92 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 257' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 10.0 t-20 -61.14 -38.89 88.02 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 33.8 t -62.1 -31.82 72.31 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 1.05 HD22 ' CD2' ' B' ' 223' ' ' LEU . 6.7 tp -70.97 -26.52 63.2 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.467 -0.771 . . . . 0.0 109.366 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 260' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 7.7 mttp -48.91 -23.03 0.96 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.222 -0.924 . . . . 0.0 109.152 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 261' ' ' LEU . . . . . 0.91 HD22 HD21 ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.46 112.9 54.3 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 262' ' ' PRO . . . . . 0.505 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 43.2 Cg_endo -70.28 107.83 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.806 1.424 . . . . 0.0 110.618 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.91 HD21 HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -139.84 173.04 11.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.751 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 264' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' B' ' 284' ' ' VAL . . . -104.65 127.28 52.36 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 265' ' ' VAL . . . . . 0.401 HG11 HG22 ' B' ' 215' ' ' VAL . 77.9 t -112.29 112.63 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.962 . . . . 0.0 110.142 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 13.4 tt0 -150.49 97.14 2.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.34 -0.85 . . . . 0.0 109.158 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -44.7 170.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 110.016 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.92 -38.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 109.558 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 269' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 19.4 pt20 -93.2 -146.34 0.23 Allowed 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.635 -0.665 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 28.7 tt0 -115.32 133.09 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.0 109.659 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 271' ' ' VAL . . . . . 0.999 HG13 ' HB3' ' B' ' 280' ' ' PHE . 53.4 t -68.31 147.49 12.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 109.245 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.536 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.4 OUTLIER -103.01 139.26 38.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 109.952 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 273' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -148.25 147.39 29.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 109.083 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 274' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.2 OUTLIER -138.27 -155.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.114 -0.992 . . . . 0.0 109.99 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 275' ' ' ALA . . . . . 0.454 ' O ' ' SD ' ' B' ' 207' ' ' MET . . . -39.71 -87.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.639 -0.663 . . . . 0.0 110.468 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 276' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' B' ' 303' ' ' PHE . 6.7 m120 -116.45 20.53 14.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.146 -0.971 . . . . 0.0 110.276 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 277' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 0.3 OUTLIER -128.18 -160.05 0.99 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.007 -1.058 . . . . 0.0 109.399 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 278' ' ' ALA . . . . . 1.041 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 171.06 157.93 0.08 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.477 -0.764 . . . . 0.0 109.932 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 279' ' ' ALA . . . . . 0.625 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -150.31 136.14 18.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 280' ' ' PHE . . . . . 0.999 ' HB3' HG13 ' B' ' 271' ' ' VAL . 43.9 p90 -150.11 168.45 23.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.785 -1.197 . . . . 0.0 110.564 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.949 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -145.83 169.32 18.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.699 -0.625 . . . . 0.0 109.417 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 282' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 6.9 p90 -166.1 -169.11 1.38 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.78 141.43 51.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.436 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 284' ' ' VAL . . . . . 0.846 HG11 HD22 ' B' ' 263' ' ' LEU . 42.9 t -128.95 112.47 25.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.294 -0.878 . . . . 0.0 109.29 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 285' ' ' SER . . . . . 0.636 ' OG ' HG23 ' B' ' 294' ' ' VAL . 0.1 OUTLIER -104.49 122.89 46.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 109.448 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.505 ' HB2' ' O ' ' B' ' 262' ' ' PRO . 7.1 p90 -137.72 171.26 14.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.223 -0.923 . . . . 0.0 109.907 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 287' ' ' GLU . . . . . 0.424 ' OE1' ' HB3' ' B' ' 292' ' ' LYS . 42.5 tt0 -150.35 150.56 31.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.477 -0.765 . . . . 0.0 109.073 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.1 OUTLIER -137.72 2.46 2.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 109.881 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 289' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' B' ' 290' ' ' GLY . 2.1 tt0 -169.86 -173.63 1.63 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.099 -1.0 . . . . 0.0 109.113 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 290' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' B' ' 289' ' ' GLN . . . -46.65 -25.41 2.18 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 291' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' B' ' 325' ' ' ALA . 2.3 mtm105 -100.43 130.8 46.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -1.074 . . . . 0.0 109.285 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 292' ' ' LYS . . . . . 0.424 ' HB3' ' OE1' ' B' ' 287' ' ' GLU . 0.0 OUTLIER -106.03 141.44 37.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.521 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 293' ' ' THR . . . . . 0.715 HG22 ' HA ' ' B' ' 323' ' ' ALA . 0.0 OUTLIER -119.49 146.08 45.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 0.0 109.861 -179.516 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 294' ' ' VAL . . . . . 0.636 HG23 ' OG ' ' B' ' 285' ' ' SER . 3.9 p -113.53 171.08 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 108.845 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 1.015 HG12 ' HD3' ' B' ' 297' ' ' PRO . 24.6 t -142.13 144.04 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 110.355 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 296' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' B' ' 320' ' ' ASN . . . -138.52 70.86 45.43 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.599 -0.688 . . . . 0.0 109.683 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 297' ' ' PRO . . . . . 1.015 ' HD3' HG12 ' B' ' 295' ' ' VAL . 51.4 Cg_endo -95.67 -175.12 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.732 1.621 . . . . 0.0 111.545 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.949 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.5 mp -139.18 147.04 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 299' ' ' ASP . . . . . 0.623 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 7.1 t0 -118.51 164.03 15.89 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.862 -1.149 . . . . 0.0 110.362 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.747 ' CE1' HD13 ' A' ' 115' ' ' LEU . 1.7 t60 -113.8 175.99 5.23 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 301' ' ' PHE . . . . . 1.041 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.1 OUTLIER -150.09 141.52 23.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.014 -1.054 . . . . 0.0 110.922 -178.457 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.504 ' HA ' ' HG2' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -130.24 105.97 8.27 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 303' ' ' PHE . . . . . 0.649 ' CZ ' HG21 ' B' ' 210' ' ' VAL . 0.4 OUTLIER -89.29 179.15 6.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.593 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 304' ' ' ASN . . . . . 0.879 ' OD1' HG23 ' B' ' 310' ' ' VAL . 0.5 OUTLIER -139.54 7.87 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 0.0 109.617 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 305' ' ' GLY . . . . . 0.698 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . 150.39 -68.22 0.34 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 306' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 164.83 76.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -1.135 . . . . 0.0 109.541 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.32 -35.74 0.02 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -165.84 -174.82 3.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -1.119 . . . . 0.0 109.39 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 309' ' ' VAL . . . . . 0.56 HG21 ' HE1' ' B' ' 301' ' ' PHE . 40.4 t -104.36 149.87 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 109.025 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.879 HG23 ' OD1' ' B' ' 304' ' ' ASN . 38.8 t -122.97 -22.48 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.008 . . . . 0.0 109.691 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 311' ' ' SER . . . . . 0.503 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -151.09 156.28 40.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.97 . . . . 0.0 109.494 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 312' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 17.8 ttp -160.16 148.07 16.65 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.2 -0.937 . . . . 0.0 109.811 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 313' ' ' ARG . . . . . 0.472 ' HB2' ' HB2' ' B' ' 300' ' ' HIS . 0.1 OUTLIER -130.24 175.01 9.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.42 -0.8 . . . . 0.0 108.955 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 314' ' ' ALA . . . . . 0.599 ' O ' HG12 ' B' ' 240' ' ' VAL . . . -142.68 145.34 33.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 109.662 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 315' ' ' LEU . . . . . 0.732 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -136.64 139.76 42.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.893 . . . . 0.0 109.417 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 316' ' ' PHE . . . . . 1.006 ' O ' HG11 ' A' ' 74' ' ' VAL . 31.0 p90 173.13 -160.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 317' ' ' GLY . . . . . 0.725 ' C ' HD12 ' B' ' 321' ' ' ILE . . . 157.4 -174.87 34.89 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 318' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -54.21 -17.84 3.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 109.57 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.39 -28.26 27.08 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.852 0.835 . . . . 0.0 109.533 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 320' ' ' ASN . . . . . 0.721 ' OD1' HD12 ' B' ' 298' ' ' ILE . 0.3 OUTLIER -91.79 -30.33 16.28 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.357 0.599 . . . . 0.0 109.401 -179.536 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 321' ' ' ILE . . . . . 0.964 ' CG2' HG22 ' B' ' 295' ' ' VAL . 1.4 mt -87.0 -171.54 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 322' ' ' HIS . . . . . 0.748 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.1 OUTLIER -151.02 163.01 39.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.037 -1.039 . . . . 0.0 109.922 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.715 ' HA ' HG22 ' B' ' 293' ' ' THR . . . -155.62 119.07 4.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -172.81 -174.3 39.89 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 325' ' ' ALA . . . . . 0.454 ' HA ' ' HG2' ' B' ' 291' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.338 -1.095 . . . . 0.0 109.432 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' NTH . . . . . 0.743 H112 ' OG ' ' A' ' 58' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 326' ' ' NTH . . . . . 0.641 ' O17' HD13 ' B' ' 261' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.47 ' HG2' ' OD1' ' A' ' 2' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.332 0.587 . . . . 0.0 110.189 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.474 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.7 m120 -156.25 108.18 2.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -0.918 . . . . 0.0 109.391 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.722 HG23 ' O ' ' A' ' 3' ' ' THR . 9.0 t -90.15 108.48 26.58 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.858 . . . . 0.0 109.504 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 45.2 Cg_endo -72.26 -10.11 25.27 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.923 1.486 . . . . 0.0 110.112 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -52.85 59.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.343 -0.848 . . . . 0.0 109.416 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -63.4 -52.21 62.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.39 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.573 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 8.6 mtt -65.49 -9.66 27.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.356 -0.84 . . . . 0.0 109.684 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.408 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 13.1 m -86.64 -39.56 15.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.298 -0.876 . . . . 0.0 109.428 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.411 ' HB1' HH12 ' A' ' 13' ' ' ARG . . . -58.27 -47.58 83.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.952 . . . . 0.0 109.349 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.89 ' HA ' HD21 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -48.03 -24.13 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 108.778 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.754 HG11 ' CG2' ' A' ' 71' ' ' VAL . 12.5 t -86.26 -42.56 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 109.538 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 13' ' ' ARG . 14.6 tt0 -61.23 -74.15 0.09 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.231 1.015 . . . . 0.0 108.323 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.933 ' HD2' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -42.75 -44.49 4.4 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.958 0.885 . . . . 0.0 108.711 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -51.39 -49.59 61.26 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.83 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -81.51 -41.37 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.398 -0.814 . . . . 0.0 109.362 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.23 -37.04 15.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.757 -1.214 . . . . 0.0 107.736 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -73.83 -32.09 63.53 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.83 HD12 ' HA ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -65.42 -56.57 11.78 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.01 -42.47 38.09 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.582 0.706 . . . . 0.0 109.312 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.978 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . . . -89.22 -6.73 56.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.518 -0.739 . . . . 0.0 109.705 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.772 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 62.43 21.31 62.19 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.978 ' OD2' ' HB3' ' A' ' 20' ' ' ALA . 1.5 p30 -89.35 68.56 7.98 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.994 -1.297 . . . . 0.0 109.732 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.053 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -46.54 -35.55 5.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.249 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' A' ' 22' ' ' ASP . 8.5 p-10 -41.92 -34.79 0.73 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -86.46 -32.27 16.67 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.561 HD12 HD12 ' A' ' 23' ' ' LEU . 40.5 mt -62.67 -56.66 16.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' A' ' 52' ' ' ARG . 49.2 t -56.83 -34.29 43.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -62.3 -55.7 25.68 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.933 HD13 ' HD2' ' A' ' 13' ' ' ARG . 3.5 tp -62.99 -21.92 66.48 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' ALA . 9.4 m-30 -87.63 138.69 31.25 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -50.59 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 109.726 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.2 -24.39 62.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.594 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.549 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 4.6 p-10 -150.16 53.49 0.91 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.822 ' N ' HD11 ' A' ' 51' ' ' ILE . . . -65.78 151.86 45.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 109.653 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 145.99 23.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 109.256 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 53.2 t -137.98 116.6 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.103 -0.998 . . . . 0.0 109.711 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 3.1 mm-40 -89.2 110.91 21.6 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.502 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 9.7 t70 -178.86 143.98 0.43 Allowed Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.702 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 48.9 Cg_endo -74.13 -168.27 6.08 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.258 -1.976 . . . . 0.0 110.925 -0.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.728 ' HB ' HG11 ' B' ' 274' ' ' VAL . 32.7 m -80.53 50.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.8 . . . . 0.0 109.351 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.37 34.18 0.05 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.518 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -153.54 -148.06 0.24 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.445 -1.032 . . . . 0.0 109.144 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -125.47 140.25 35.9 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.997 -1.065 . . . . 0.0 110.073 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.527 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 37.9 Cg_endo -63.58 -176.0 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.276 1.672 . . . . 0.0 111.051 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.789 ' CG ' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -150.87 108.15 3.61 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.17 151.82 21.96 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.167 -178.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.549 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 110.45 158.04 16.12 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.513 HG23 ' CG1' ' A' ' 27' ' ' VAL . 7.8 m -67.04 -51.36 55.73 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.13 -1.218 . . . . 0.0 109.146 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -58.4 -41.47 84.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.227 -0.921 . . . . 0.0 109.08 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.789 ' HB1' ' CG ' ' A' ' 45' ' ' ARG . . . -67.31 -57.51 6.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.153 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.822 HD11 ' N ' ' A' ' 34' ' ' ALA . 23.5 mt -55.02 -47.89 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.901 ' HG3' HD23 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -69.14 -57.87 4.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.118 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 37.4 tt0 -45.59 -30.01 1.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.053 -1.03 . . . . 0.0 108.839 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.502 ' CZ ' ' O ' ' A' ' 38' ' ' ASP . 1.3 t80 -82.44 -69.5 0.62 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 1.053 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -48.58 -36.08 14.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.76 -47.33 75.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 109.039 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 23.1 t-20 -57.51 -41.45 80.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.32 -0.862 . . . . 0.0 108.921 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.436 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 11.9 t -65.43 -32.34 73.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.348 -0.845 . . . . 0.0 109.005 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.772 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.1 tp -67.02 -19.6 65.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -57.25 -22.54 42.03 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.779 HD23 HD23 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -89.62 119.39 69.52 Favored Pre-proline 0 C--N 1.306 -1.324 0 O-C-N 121.189 -0.944 . . . . 0.0 108.528 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 49.1 Cg_endo -74.94 106.86 2.35 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.768 1.404 . . . . 0.0 110.762 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.831 ' CB ' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.84 163.08 33.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 110.055 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.023 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -97.26 124.01 41.23 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.6 t -107.4 114.15 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.908 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 67' ' ' LEU . 6.2 tt0 -150.34 101.31 2.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 109.195 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 81' ' ' ALA . 1.9 mp -44.97 170.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.864 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.9 p -133.41 -36.51 0.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.742 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.564 ' NE2' ' O ' ' A' ' 70' ' ' GLU . 3.4 pt20 -101.38 -145.18 0.35 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.512 -0.743 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.564 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 26.9 tt0 -110.78 133.03 53.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 109.513 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.754 ' CG2' HG11 ' A' ' 11' ' ' VAL . 28.5 t -58.03 154.71 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.342 -0.849 . . . . 0.0 109.412 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 1.9 mpt_? -121.01 130.2 53.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.516 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.418 ' HB1' ' CB ' ' A' ' 7' ' ' MET . . . -150.5 120.39 7.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.629 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.647 ' CB ' HG21 ' B' ' 240' ' ' VAL . 0.0 OUTLIER -122.44 -161.32 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 109.672 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 76' ' ' ASN . . . -81.73 144.88 30.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.444 -0.785 . . . . 0.0 110.216 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 75' ' ' ALA . 1.3 t-20 80.95 -44.18 0.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.733 -0.605 . . . . 0.0 110.422 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -144.39 -159.93 1.06 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.961 -1.087 . . . . 0.0 110.412 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 1.008 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . -169.21 163.15 10.9 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.912 ' HB3' HD22 ' B' ' 315' ' ' LEU . . . -149.4 138.78 21.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.91 -1.118 . . . . 0.0 109.962 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.665 ' HB3' HG13 ' A' ' 71' ' ' VAL . 29.7 p90 -150.34 167.48 26.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.023 -1.048 . . . . 0.0 109.384 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.967 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -139.94 -169.68 2.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 110.518 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.639 ' CD1' ' N ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER 172.84 -175.11 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -127.96 141.22 51.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.248 -0.908 . . . . 0.0 109.592 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.831 HG13 ' CB ' ' A' ' 63' ' ' LEU . 14.2 t -108.95 115.53 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.277 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 1.023 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 21.8 p -112.11 106.4 15.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.12 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.773 ' CE2' H221 ' A' ' 126' ' ' NTH . 6.6 p90 -125.62 176.26 7.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.743 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -121.28 164.77 16.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.596 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.584 ' CE1' ' CE1' ' A' ' 86' ' ' PHE . 0.9 OUTLIER -115.58 -92.3 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.649 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -137.42 -36.21 0.65 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.864 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.78 -28.12 1.19 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.488 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 45.5 mtt85 -126.64 -179.51 4.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -1.184 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -127.6 122.43 33.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.679 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.855 HG23 ' HA ' ' A' ' 123' ' ' ALA . 19.3 m -96.55 172.15 8.1 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.344 -0.847 . . . . 0.0 109.559 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.611 HG13 ' CB ' ' A' ' 122' ' ' HIS . 14.0 p -148.0 170.99 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 108.715 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.624 ' O ' HG22 ' A' ' 83' ' ' THR . 43.9 t -148.22 156.78 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.079 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.476 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . -135.28 75.27 59.54 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.457 -0.777 . . . . 0.0 109.339 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.581 ' HD3' HG12 ' A' ' 95' ' ' VAL . 45.7 Cg_endo -98.19 178.48 0.39 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.789 1.659 . . . . 0.0 111.539 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.967 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.8 mp -137.93 151.93 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.624 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 13.5 t0 -122.8 164.48 18.3 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.941 -1.1 . . . . 0.0 110.203 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.505 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -112.16 172.15 7.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 109.236 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 1.008 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -147.28 140.86 25.54 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.24 -0.912 . . . . 0.0 110.374 -178.692 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.502 ' HA ' ' HG3' ' A' ' 77' ' ' GLU . 1.4 ttt180 -130.31 110.42 11.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.871 . . . . 0.0 109.121 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.615 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -89.73 176.15 6.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.333 -0.855 . . . . 0.0 109.664 -179.511 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.761 ' HB3' HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -114.03 -36.39 4.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.298 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 176.54 -46.07 0.11 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 163.29 76.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -1.169 . . . . 0.0 109.593 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.411 ' C ' ' HD3' ' A' ' 108' ' ' LYS . . . -171.0 -45.44 0.04 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 107' ' ' GLY . 0.0 OUTLIER -161.83 -169.43 2.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -1.133 . . . . 0.0 109.292 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.615 HG12 ' N ' ' A' ' 110' ' ' VAL . 54.5 t -94.04 166.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.209 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.761 HG21 ' HB3' ' A' ' 104' ' ' ASN . 10.8 t -131.76 -63.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -0.958 . . . . 0.0 109.745 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.461 ' HB2' ' HD3' ' A' ' 102' ' ' ARG . 3.2 m -128.18 171.05 12.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.946 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.511 ' CE ' ' OD2' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -151.75 147.53 26.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.42 -0.8 . . . . 0.0 109.081 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -121.36 162.18 20.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.568 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -111.01 133.48 53.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.848 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.834 HD11 ' HB2' ' B' ' 279' ' ' ALA . 9.3 tp -109.48 -143.47 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.808 . . . . 0.0 108.957 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.734 ' O ' HG22 ' B' ' 274' ' ' VAL . 26.2 p90 39.0 -161.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.725 0.774 . . . . 0.0 110.481 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.644 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 179.4 -149.37 8.67 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.46 ' C ' HG12 ' A' ' 121' ' ' ILE . 21.5 tt0 -80.69 -1.98 44.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -1.155 . . . . 0.0 109.412 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.521 ' HE2' ' CG ' ' B' ' 204' ' ' PRO . 5.7 tttm -93.19 -26.94 17.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 122.064 0.935 . . . . 0.0 108.921 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -88.55 17.7 5.2 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.349 0.595 . . . . 0.0 109.437 -179.628 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.644 HD11 ' O ' ' A' ' 117' ' ' GLY . 5.2 mm -90.01 -174.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.633 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -150.87 173.6 14.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.962 -1.086 . . . . 0.0 109.899 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.855 ' HA ' HG23 ' A' ' 93' ' ' THR . . . -152.34 110.36 3.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.409 -0.807 . . . . 0.0 109.29 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.37 115.07 3.95 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.328 -1.101 . . . . 0.0 109.47 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.498 ' CG ' ' O ' ' B' ' 201' ' ' MET . 1.4 ptt? . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.256 0.551 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' B' ' 203' ' ' THR . 0.7 OUTLIER -127.09 64.91 1.3 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 203' ' ' THR . . . . . 0.612 HG23 ' O ' ' B' ' 203' ' ' THR . 5.0 t -43.92 109.1 0.77 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.476 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 204' ' ' PRO . . . . . 0.521 ' CG ' ' HE2' ' A' ' 119' ' ' LYS . 44.5 Cg_endo -71.42 -4.11 14.33 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.957 1.504 . . . . 0.0 110.264 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -45.88 56.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.196 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 206' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.2 OUTLIER -62.26 -51.41 67.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.362 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 12.5 mtm -59.81 -51.15 70.97 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.242 -0.911 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 8.2 m -53.26 -33.02 51.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 109.193 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 209' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 206' ' ' HIS . . . -52.55 -46.23 66.7 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.051 -1.031 . . . . 0.0 108.405 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 1.035 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -53.48 -43.24 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.979 HG11 HG21 ' B' ' 271' ' ' VAL . 11.3 t -59.4 -41.72 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.594 -0.691 . . . . 0.0 109.834 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 212' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' B' ' 213' ' ' ARG . 9.7 tt0 -60.47 -75.26 0.06 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.767 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.6 OUTLIER -43.83 -44.38 6.8 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 214' ' ' TYR . . . . . 0.633 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 3.8 t80 -53.71 -49.25 68.5 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.931 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -83.25 -44.36 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.406 -0.809 . . . . 0.0 109.832 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 216' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.0 -37.04 8.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 0.0 108.022 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.545 ' HB1' HG13 ' B' ' 226' ' ' ILE . . . -74.1 -34.68 64.03 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.931 HD12 ' HA ' ' B' ' 215' ' ' VAL . 5.2 mt -63.29 -59.91 4.1 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 219' ' ' ASN . . . . . 0.414 ' ND2' ' OE1' ' B' ' 266' ' ' GLU . 16.4 t30 -51.01 -45.6 61.26 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.565 0.697 . . . . 0.0 109.289 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.38 9.68 25.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.572 -0.705 . . . . 0.0 109.511 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.583 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 48.06 32.21 8.98 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 222' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' B' ' 217' ' ' ALA . 12.5 t70 -89.99 66.49 6.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -1.117 . . . . 0.0 109.743 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 223' ' ' LEU . . . . . 1.069 HD11 ' HB3' ' B' ' 255' ' ' PHE . 5.9 tp -47.58 -42.38 23.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 108.736 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' B' ' 223' ' ' LEU . 3.4 m-20 -42.28 -31.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 225' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' B' ' 228' ' ' ALA . . . -88.14 -38.71 7.18 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.826 HD12 HD12 ' B' ' 223' ' ' LEU . 17.1 mt -58.23 -53.36 47.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 85.0 t -57.17 -37.99 58.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' B' ' 225' ' ' GLY . . . -58.33 -54.82 42.67 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 1.035 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.5 tp -63.32 -20.48 65.53 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 230' ' ' PHE . . . . . 0.803 ' CG ' HG21 ' B' ' 251' ' ' ILE . 0.6 OUTLIER -82.71 132.08 35.19 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.492 -0.755 . . . . 0.0 109.502 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -51.04 -177.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.268 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -25.89 66.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 109.885 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.552 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 13.4 p-10 -150.61 53.84 0.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.62 -0.675 . . . . 0.0 109.341 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' B' ' 310' ' ' VAL . . . -62.19 165.55 5.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.742 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 235' ' ' THR . . . . . 0.848 HG23 ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -116.25 140.78 48.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.22 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.521 HG23 HD12 ' B' ' 251' ' ' ILE . 38.9 t -130.11 117.8 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -0.885 . . . . 0.0 109.126 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 237' ' ' GLU . . . . . 0.544 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 27.7 mt-10 -88.84 106.98 18.73 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 238' ' ' ASP . . . . . 0.487 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 9.8 t70 -176.03 142.17 0.61 Allowed Pre-proline 0 C--N 1.3 -1.577 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.597 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' B' ' 238' ' ' ASP . 47.2 Cg_endo -73.74 -165.09 3.61 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.216 -1.993 . . . . 0.0 110.685 0.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.647 HG21 ' CB ' ' A' ' 74' ' ' VAL . 5.5 m -87.8 41.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 109.345 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -165.71 26.01 0.17 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 242' ' ' SER . . . . . 0.427 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 1.4 m -148.01 -141.82 0.12 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.415 -1.05 . . . . 0.0 108.913 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -133.72 142.35 43.39 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.914 -1.116 . . . . 0.0 109.954 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 244' ' ' PRO . . . . . 0.544 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.8 Cg_endo -63.39 -170.86 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.284 1.676 . . . . 0.0 111.436 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.736 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -151.09 111.5 4.18 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.848 ' HB3' HG23 ' B' ' 235' ' ' THR . 1.9 p -94.04 155.28 17.2 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.101 -0.999 . . . . 0.0 110.452 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 247' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.21 162.32 21.78 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 6.5 m -73.7 -44.91 55.18 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.185 -1.185 . . . . 0.0 109.093 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -64.26 -20.25 65.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.244 -0.91 . . . . 0.0 109.207 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.736 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -90.15 -54.43 4.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.352 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.803 HG21 ' CG ' ' B' ' 230' ' ' PHE . 6.4 mm -54.97 -44.58 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 252' ' ' ARG . . . . . 0.761 ' HG3' HD23 ' B' ' 223' ' ' LEU . 17.8 ttt85 -73.34 -56.03 5.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.212 -0.93 . . . . 0.0 108.807 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 253' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 17.7 tt0 -45.94 -27.92 1.01 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.024 . . . . 0.0 108.546 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 1.0 OUTLIER -85.79 -70.94 0.56 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 1.069 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -48.45 -23.97 1.12 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 256' ' ' ALA . . . . . 0.724 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -80.49 -51.16 9.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 108.898 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 257' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 0.2 OUTLIER -56.62 -35.02 67.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 258' ' ' SER . . . . . 0.613 ' HG ' ' H8 ' ' B' ' 326' ' ' NTH . 1.6 t -74.81 -38.6 62.04 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 0.583 HD21 ' CA ' ' B' ' 221' ' ' GLY . 8.6 tp -62.22 -29.47 70.41 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.373 -0.829 . . . . 0.0 109.02 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 260' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 14.7 mttm -44.35 -27.11 0.4 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 261' ' ' LEU . . . . . 0.868 HD13 ' H17' ' B' ' 326' ' ' NTH . 3.3 tt -89.69 113.85 58.37 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 262' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 48.7 Cg_endo -73.59 107.27 2.36 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.915 1.481 . . . . 0.0 112.176 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.909 HD22 ' CG1' ' B' ' 284' ' ' VAL . 0.8 OUTLIER -130.24 -170.28 2.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.398 -0.814 . . . . 0.0 109.43 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 264' ' ' ALA . . . . . 0.72 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -119.9 128.0 53.22 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 265' ' ' VAL . . . . . 0.551 HG21 ' HB3' ' B' ' 218' ' ' LEU . 43.0 t -115.43 113.25 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.055 -1.028 . . . . 0.0 110.037 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 266' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.3 tp10 -150.31 94.16 2.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.417 -0.802 . . . . 0.0 108.942 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.524 HD11 HG11 ' B' ' 215' ' ' VAL . 1.4 mp -46.89 175.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 0.0 110.004 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 268' ' ' THR . . . . . 0.456 ' O ' ' O ' ' B' ' 269' ' ' GLN . 41.7 p -133.57 -76.28 0.48 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.46 -0.775 . . . . 0.0 108.951 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 269' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' B' ' 268' ' ' THR . 15.7 pt20 -61.07 -143.7 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.415 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 24.4 tt0 -115.76 131.31 56.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 109.872 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 271' ' ' VAL . . . . . 1.011 HG13 ' HB3' ' B' ' 280' ' ' PHE . 83.0 t -45.41 146.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.386 -0.822 . . . . 0.0 109.042 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.52 ' NE ' HD11 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -102.08 82.19 2.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.696 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -89.38 145.03 25.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.115 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 274' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 116' ' ' PHE . 0.5 OUTLIER -122.43 -169.02 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.156 -0.965 . . . . 0.0 109.924 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 275' ' ' ALA . . . . . 0.588 ' H ' HG12 ' B' ' 274' ' ' VAL . . . -38.39 -94.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.574 -0.704 . . . . 0.0 110.787 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 276' ' ' ASN . . . . . 0.451 ' O ' ' OD1' ' B' ' 276' ' ' ASN . 21.8 t-20 -92.76 -28.24 16.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.115 -0.991 . . . . 0.0 110.621 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 277' ' ' GLU . . . . . 0.527 ' CG ' ' HG3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -92.74 -166.6 1.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.952 -1.092 . . . . 0.0 109.575 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 278' ' ' ALA . . . . . 0.93 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . -160.69 161.14 32.22 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.468 -0.77 . . . . 0.0 109.571 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 279' ' ' ALA . . . . . 0.834 ' HB2' HD11 ' A' ' 115' ' ' LEU . . . -150.9 131.13 13.58 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 280' ' ' PHE . . . . . 1.011 ' HB3' HG13 ' B' ' 271' ' ' VAL . 41.8 p90 -147.55 159.53 43.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.797 -1.19 . . . . 0.0 110.491 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 1.009 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -139.57 160.88 38.85 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.406 0.622 . . . . 0.0 109.375 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 282' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 3.8 p90 -162.29 -168.34 1.84 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 108.982 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.27 139.78 53.59 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.713 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 284' ' ' VAL . . . . . 0.909 ' CG1' HD22 ' B' ' 263' ' ' LEU . 42.0 t -107.83 114.7 47.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 285' ' ' SER . . . . . 0.72 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 96.9 p -115.5 98.99 7.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.955 . . . . 0.0 110.119 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.868 ' CD1' HD23 ' B' ' 263' ' ' LEU . 30.0 p90 -108.75 -171.86 1.94 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 108.815 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.45 153.1 33.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.98 -1.075 . . . . 0.0 109.809 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.527 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.1 OUTLIER -105.55 -163.91 0.98 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.43 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -40.58 92.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.924 . . . . 0.0 109.972 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -139.65 4.51 2.75 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.148 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -140.82 -176.25 4.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -1.186 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 292' ' ' LYS . . . . . 0.477 ' O ' ' HD3' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -118.75 140.98 49.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.178 -0.952 . . . . 0.0 109.305 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 293' ' ' THR . . . . . 0.595 ' HB ' ' CE1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -125.32 146.04 49.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.406 -0.809 . . . . 0.0 109.433 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 294' ' ' VAL . . . . . 0.572 HG22 ' H ' ' B' ' 295' ' ' VAL . 7.9 p -125.28 171.89 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.143 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 1.025 HG12 ' HD3' ' B' ' 297' ' ' PRO . 2.8 t -149.43 146.98 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 109.065 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 296' ' ' ALA . . . . . . . . . . . . . . . -125.84 71.32 67.77 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.179 -0.951 . . . . 0.0 111.266 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 297' ' ' PRO . . . . . 1.025 ' HD3' HG12 ' B' ' 295' ' ' VAL . 53.3 Cg_endo -93.24 179.68 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.593 1.312 . . . . 0.0 110.996 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 1.009 HG23 ' HB2' ' B' ' 281' ' ' ALA . 3.0 mp -141.38 148.81 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 299' ' ' ASP . . . . . 0.619 ' HB3' ' CE1' ' B' ' 280' ' ' PHE . 17.2 t0 -121.38 157.52 30.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.958 -1.089 . . . . 0.0 110.401 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.561 ' ND1' HD11 ' A' ' 115' ' ' LEU . 5.4 t60 -113.73 151.7 31.54 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 301' ' ' PHE . . . . . 0.93 ' CB ' ' HB3' ' B' ' 278' ' ' ALA . 0.5 OUTLIER -126.91 151.86 47.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.271 -0.893 . . . . 0.0 110.828 -178.271 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.529 ' O ' HG23 ' B' ' 310' ' ' VAL . 0.0 OUTLIER -146.27 93.56 2.33 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 303' ' ' PHE . . . . . 0.755 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 8.2 m-30 -89.81 -165.55 1.37 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.126 -0.984 . . . . 0.0 109.962 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 304' ' ' ASN . . . . . 0.537 ' OD1' ' CG1' ' B' ' 310' ' ' VAL . 0.4 OUTLIER -140.15 27.22 2.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.427 -0.796 . . . . 0.0 109.437 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 305' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . 119.54 -61.08 0.49 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 306' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 179.67 33.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -1.127 . . . . 0.0 109.272 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 307' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' B' ' 308' ' ' LYS . . . -108.35 33.3 6.33 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 308' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' B' ' 307' ' ' GLY . 0.3 OUTLIER 83.51 -162.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.972 -0.722 . . . . 0.0 109.164 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 309' ' ' VAL . . . . . 0.615 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 49.7 t -90.5 143.81 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.384 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.537 ' CG1' ' OD1' ' B' ' 304' ' ' ASN . 0.1 OUTLIER -126.19 -27.1 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.102 -0.999 . . . . 0.0 109.991 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 311' ' ' SER . . . . . 0.497 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -143.41 164.04 31.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.109 -0.994 . . . . 0.0 109.374 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 312' ' ' MET . . . . . 0.469 ' O ' ' HG3' ' B' ' 237' ' ' GLU . 0.0 OUTLIER -160.38 155.85 25.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 313' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' B' ' 300' ' ' HIS . 0.0 OUTLIER -150.22 118.47 6.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.159 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 314' ' ' ALA . . . . . 0.428 ' O ' HG12 ' B' ' 240' ' ' VAL . . . -100.07 139.73 35.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 110.629 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 315' ' ' LEU . . . . . 0.912 HD22 ' HB3' ' A' ' 79' ' ' ALA . 3.7 tt -128.65 138.46 52.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.84 . . . . 0.0 109.335 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 316' ' ' PHE . . . . . 0.578 ' CD2' ' OD1' ' B' ' 320' ' ' ASN . 0.1 OUTLIER 172.51 -159.51 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 317' ' ' GLY . . . . . 0.487 ' O ' ' OD1' ' B' ' 320' ' ' ASN . . . 171.27 177.63 41.2 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.292 -1.433 . . . . 0.0 110.485 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 318' ' ' GLU . . . . . 0.508 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 47.9 tt0 -51.54 -21.41 2.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.201 -1.176 . . . . 0.0 108.931 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.14 -22.18 59.56 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.019 0.914 . . . . 0.0 108.726 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 320' ' ' ASN . . . . . 0.67 ' ND2' HG13 ' B' ' 295' ' ' VAL . 0.3 OUTLIER -88.51 1.51 54.7 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 321' ' ' ILE . . . . . 0.789 ' HA ' HG22 ' B' ' 295' ' ' VAL . 4.0 mm -89.89 179.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.121 -0.987 . . . . 0.0 108.504 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 322' ' ' HIS . . . . . 0.542 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.2 OUTLIER -151.51 177.42 10.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.967 -1.083 . . . . 0.0 109.807 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -155.23 126.67 7.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.462 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -120.88 120.95 4.66 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.224 -1.162 . . . . 0.0 109.495 -179.943 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 126' ' ' NTH . . . . . 0.773 H221 ' CE2' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 326' ' ' NTH . . . . . 0.868 ' H17' HD13 ' B' ' 261' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.446 ' O ' ' C ' ' A' ' 2' ' ' ASN . 7.4 mtt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.126 0.489 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.465 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.4 p-10 39.85 61.11 1.53 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.516 -0.74 . . . . 0.0 109.677 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.62 110.37 24.36 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 44.2 Cg_endo -71.3 -3.5 13.07 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.854 1.449 . . . . 0.0 110.285 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -61.88 -39.22 91.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.257 -0.902 . . . . 0.0 109.292 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -86.93 -43.99 11.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.335 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.6 mtt -56.94 -35.87 69.59 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.261 -0.899 . . . . 0.0 109.542 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.443 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 11.2 m -67.41 -39.16 85.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -43.66 62.77 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.674 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.3 t -53.96 -22.64 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.711 HG11 ' CG2' ' A' ' 71' ' ' VAL . 4.3 t -90.12 -41.35 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 108.979 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.3 tt0 -65.5 -74.18 0.11 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.903 ' HB3' HD22 ' A' ' 29' ' ' LEU . 2.2 mtt85 -42.27 -45.46 4.2 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.608 ' CD1' HG23 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -46.1 -43.73 15.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.095 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.915 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.4 t -90.34 -37.24 9.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.544 -0.722 . . . . 0.0 109.136 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -49.26 -34.91 16.29 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.564 ' HB3' HG12 ' A' ' 26' ' ' ILE . . . -74.73 -33.3 62.34 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.915 HD12 ' HA ' ' A' ' 15' ' ' VAL . 3.8 mt -65.96 -58.85 4.6 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.75 -41.86 24.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.621 0.724 . . . . 0.0 109.251 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.85 7.98 31.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.863 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 47.94 31.94 8.43 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 16.7 t0 -100.17 92.99 5.48 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.324 -1.104 . . . . 0.0 109.755 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.028 HD13 HD12 ' A' ' 26' ' ' ILE . 3.4 mm? -59.17 -15.27 13.82 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.224 -0.923 . . . . 0.0 109.529 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.23 -54.14 45.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 109.178 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.12 -35.68 92.41 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.028 HD12 HD13 ' A' ' 23' ' ' LEU . 8.8 mt -62.8 -56.45 17.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' A' ' 52' ' ' ARG . 95.7 t -63.72 -37.9 80.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.28 74.1 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.903 HD22 ' HB3' ' A' ' 13' ' ' ARG . 7.7 tp -66.08 -23.32 66.5 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CD2' HG22 ' A' ' 26' ' ' ILE . 3.6 m-85 -88.4 141.1 28.81 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.562 -0.711 . . . . 0.0 109.655 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -48.5 172.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 109.458 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.29 -24.1 67.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 109.294 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.632 ' C ' HD11 ' A' ' 51' ' ' ILE . 20.4 p-10 -146.58 35.12 0.95 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.972 ' N ' HD11 ' A' ' 51' ' ' ILE . . . -51.01 169.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.822 . . . . 0.0 109.772 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 1.007 HG23 ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -122.76 140.31 53.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.541 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.515 HG22 ' HB3' ' A' ' 112' ' ' MET . 48.2 t -131.49 120.66 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.262 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 3.4 mt-10 -88.46 107.0 18.64 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.569 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 9.1 t0 -179.78 143.29 0.37 Allowed Pre-proline 0 C--N 1.302 -1.486 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.547 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HA ' ' CG ' ' A' ' 38' ' ' ASP . 50.1 Cg_endo -76.25 -175.14 15.86 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.205 -1.998 . . . . 0.0 110.403 -0.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.004 HG21 HG11 ' B' ' 274' ' ' VAL . 19.8 m -72.58 150.89 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 108.875 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.35 -1.76 69.48 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.463 ' OG ' ' HG2' ' A' ' 39' ' ' PRO . 1.4 m -115.46 -142.3 0.38 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.27 -1.135 . . . . 0.0 109.308 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.24 141.76 16.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.987 -1.071 . . . . 0.0 110.048 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 39.6 Cg_endo -65.56 -175.44 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.817 1.678 . . . . 0.0 111.592 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.598 ' HB2' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -150.78 106.86 3.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 1.007 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.28 157.01 18.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.276 -0.89 . . . . 0.0 110.601 -178.35 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.557 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 106.3 157.18 21.69 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 m -64.55 -55.26 21.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.243 -1.151 . . . . 0.0 109.138 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -55.27 -33.02 62.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.89 . . . . 0.0 109.009 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.576 ' HB1' ' CG ' ' A' ' 45' ' ' ARG . . . -77.46 -60.52 2.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.383 -0.823 . . . . 0.0 109.357 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.972 HD11 ' N ' ' A' ' 34' ' ' ALA . 44.5 mt -48.08 -40.9 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.267 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB2' HG21 ' A' ' 27' ' ' VAL . 49.2 ttp180 -79.1 -58.39 3.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.814 . . . . 0.0 109.124 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.532 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 49.8 tt0 -46.2 -27.37 0.97 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.021 -1.05 . . . . 0.0 108.619 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.598 ' CD2' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -85.02 -71.36 0.53 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.587 ' HB3' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -49.31 -33.01 12.21 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.451 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . . . -69.12 -46.82 66.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 108.78 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 26.9 t-20 -58.41 -35.45 72.09 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.707 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 25.6 t -64.93 -38.09 89.82 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.921 HD22 ' CD2' ' A' ' 23' ' ' LEU . 7.6 tp -68.78 -22.04 64.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.486 -0.759 . . . . 0.0 109.68 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 25.9 mtpt -50.39 -26.37 4.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 109.692 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.895 HD22 ' CD2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.71 126.7 56.96 Favored Pre-proline 0 C--N 1.305 -1.349 0 O-C-N 121.226 -0.921 . . . . 0.0 109.049 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.454 ' C ' ' HG ' ' A' ' 63' ' ' LEU . 44.0 Cg_endo -71.49 101.62 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.834 1.439 . . . . 0.0 110.371 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.895 ' CD2' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -138.64 155.86 47.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.462 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -89.79 132.66 35.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 108.778 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.608 HG11 ' HB3' ' A' ' 18' ' ' LEU . 16.2 t -107.22 125.02 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.048 -1.033 . . . . 0.0 110.127 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' LEU . 14.8 tt0 -150.26 103.12 3.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.44 -0.788 . . . . 0.0 108.961 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.763 HD11 ' HB ' ' A' ' 15' ' ' VAL . 3.8 mt -55.09 -108.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 110.062 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.668 ' O ' ' N ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER 158.26 43.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.685 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.555 ' CG ' ' O ' ' A' ' 68' ' ' THR . 5.1 pt20 50.64 -54.02 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' A' ' 68' ' ' THR . 23.1 tt0 -60.77 116.19 4.23 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.624 -1.297 . . . . 0.0 110.761 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.711 ' CG2' HG11 ' A' ' 11' ' ' VAL . 35.8 t -135.3 163.54 35.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.702 ' CZ ' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -132.03 135.12 46.28 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.454 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' N ' ' NE ' ' A' ' 72' ' ' ARG . . . -145.44 111.63 5.66 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.041 HG11 HG21 ' B' ' 240' ' ' VAL . 0.1 OUTLIER -100.11 -163.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 110.429 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -35.69 -94.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.771 -0.581 . . . . 0.0 111.241 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 8.1 t-20 -100.32 -2.9 32.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.07 -1.019 . . . . 0.0 110.748 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.515 ' OE1' ' NE ' ' B' ' 313' ' ' ARG . 0.4 OUTLIER -111.29 -162.03 0.78 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.769 -1.207 . . . . 0.0 109.719 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 1.04 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . -176.09 162.14 2.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.602 -0.686 . . . . 0.0 109.372 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 1.006 ' HB2' HD11 ' B' ' 315' ' ' LEU . . . -150.17 130.09 13.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.172 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 31.4 p90 -150.83 168.79 23.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.678 -1.263 . . . . 0.0 109.948 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.888 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -141.8 -178.3 5.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.472 -0.767 . . . . 0.0 109.862 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CB ' ' HA ' ' A' ' 67' ' ' LEU . 1.9 p90 -172.65 -159.25 0.12 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.386 -0.821 . . . . 0.0 109.257 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.86 149.43 43.41 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.083 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.611 HG11 HD22 ' A' ' 63' ' ' LEU . 55.6 t -124.77 112.51 32.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.51 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -113.5 103.9 11.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.902 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.679 ' CZ ' H221 ' A' ' 126' ' ' NTH . 45.6 p90 -123.1 164.77 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.393 -0.817 . . . . 0.0 108.931 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 38.0 tt0 -141.46 152.25 44.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.059 -1.026 . . . . 0.0 109.83 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.437 ' N ' ' HG2' ' A' ' 87' ' ' GLU . 7.3 m-85 -93.61 -146.4 0.24 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.419 -0.801 . . . . 0.0 109.297 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -0.72 30.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.958 . . . . 0.0 109.719 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.71 -68.63 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 1.6 ttt85 -55.49 155.11 5.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -1.137 . . . . 0.0 109.557 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.439 ' HD2' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -131.71 120.43 22.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.757 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -121.46 143.26 49.34 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER -117.37 179.52 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.103 -0.998 . . . . 0.0 108.74 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 1.012 HG12 ' HD3' ' A' ' 97' ' ' PRO . 3.0 t -148.15 146.5 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.07 -1.019 . . . . 0.0 109.533 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.44 ' O ' ' CG ' ' A' ' 120' ' ' ASN . . . -133.64 71.13 75.51 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.34 -0.85 . . . . 0.0 110.281 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 1.012 ' HD3' HG12 ' A' ' 95' ' ' VAL . 49.7 Cg_endo -95.46 -174.54 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.537 1.491 . . . . 0.0 110.973 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.888 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.9 mp -139.14 166.28 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 21.1 t0 -131.27 154.66 48.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.922 -1.111 . . . . 0.0 110.192 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.517 ' NE2' ' CD1' ' B' ' 315' ' ' LEU . 0.3 OUTLIER -108.77 172.75 6.66 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 1.04 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -147.41 150.88 35.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.82 -1.175 . . . . 0.0 110.857 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.488 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -139.78 109.53 6.33 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.674 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -89.27 -166.12 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 109.777 -179.332 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.871 ' HB3' HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -135.9 -38.71 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.439 -0.788 . . . . 0.0 109.34 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.714 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -174.46 -47.67 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 163.2 77.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -1.094 . . . . 0.0 109.503 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -167.21 -67.94 0.03 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -139.78 -163.87 1.58 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.232 -1.158 . . . . 0.0 109.482 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.774 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 94.0 t -100.79 147.63 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.871 . . . . 0.0 109.337 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.871 HG21 ' HB3' ' A' ' 104' ' ' ASN . 93.2 t -111.9 -66.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 109.746 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -116.25 166.25 12.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.055 -1.028 . . . . 0.0 109.736 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.515 ' HB3' HG22 ' A' ' 36' ' ' VAL . 12.2 ttp -160.28 154.61 23.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.345 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.49 HH22 HD12 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -144.35 126.59 15.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.167 -0.958 . . . . 0.0 109.482 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.554 ' HB3' ' OD2' ' A' ' 38' ' ' ASP . . . -96.71 132.21 42.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 109.752 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.653 HD13 ' HB2' ' B' ' 279' ' ' ALA . 1.3 tt -117.92 143.84 45.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.002 . . . . 0.0 109.834 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.549 ' CE1' HG13 ' A' ' 40' ' ' VAL . 9.2 p90 172.54 -158.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.622 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 169.53 -173.05 43.79 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.517 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 26.6 tt0 -72.79 -2.65 21.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.302 -1.117 . . . . 0.0 109.68 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -92.71 -30.96 15.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.997 0.903 . . . . 0.0 108.995 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.3 m-20 -89.11 11.38 18.69 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.679 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.982 HG23 HG22 ' A' ' 95' ' ' VAL . 4.4 mm -92.66 -160.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.191 -0.943 . . . . 0.0 108.587 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.697 ' O ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -151.22 159.93 44.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.071 . . . . 0.0 109.795 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.66 81.74 1.03 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.371 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -119.19 140.16 14.82 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.207 -1.173 . . . . 0.0 109.454 179.889 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.405 ' O ' ' C ' ' B' ' 202' ' ' ASN . 5.1 mpp? . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.258 0.551 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.477 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 8.8 m120 45.33 44.48 9.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.436 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 203' ' ' THR . . . . . 0.515 ' CG2' ' HB2' ' B' ' 205' ' ' GLU . 5.3 m -89.59 108.64 26.46 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 204' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.4 Cg_endo -72.26 -2.48 11.73 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.973 1.512 . . . . 0.0 110.165 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 205' ' ' GLU . . . . . 0.515 ' HB2' ' CG2' ' B' ' 203' ' ' THR . 3.5 tt0 -58.92 -63.48 1.28 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -0.869 . . . . 0.0 109.353 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -61.98 -45.03 95.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.915 . . . . 0.0 109.51 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 207' ' ' MET . . . . . 0.434 ' HA ' ' CE2' ' B' ' 303' ' ' PHE . 73.3 mtm -60.9 -41.48 96.15 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.255 -0.903 . . . . 0.0 109.608 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 18.1 m -64.46 -44.08 92.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.946 . . . . 0.0 109.252 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.64 -43.73 57.19 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.845 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -53.57 -26.03 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.817 HG11 ' CG2' ' B' ' 271' ' ' VAL . 13.5 t -89.8 -43.27 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 108.984 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 212' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' B' ' 215' ' ' VAL . 5.7 tt0 -62.71 -73.98 0.1 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.833 ' HB3' HD22 ' B' ' 229' ' ' LEU . 1.4 mtt85 -42.21 -45.06 3.99 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 214' ' ' TYR . . . . . 0.639 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.3 OUTLIER -48.05 -43.13 30.04 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.28 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.952 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.16 -40.25 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.407 -0.808 . . . . 0.0 109.178 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 216' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.8 -37.24 13.17 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.609 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -72.97 -35.21 66.87 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' B' ' 215' ' ' VAL . 5.2 mt -63.84 -60.84 2.77 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -49.29 -40.36 34.37 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.532 0.682 . . . . 0.0 109.252 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.22 0.02 57.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.553 -0.717 . . . . 0.0 109.799 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.972 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 54.52 45.4 76.9 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 222' ' ' ASP . . . . . 0.454 ' O ' HG13 ' B' ' 226' ' ' ILE . 45.7 t0 -111.14 83.75 1.82 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 110.061 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 223' ' ' LEU . . . . . 0.984 ' CD2' HD22 ' B' ' 259' ' ' LEU . 3.9 mm? -53.31 -19.37 3.23 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.24 -0.913 . . . . 0.0 109.78 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.89 -56.94 11.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.235 -0.916 . . . . 0.0 109.213 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -60.61 -31.92 76.62 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.896 HD12 HD13 ' B' ' 223' ' ' LEU . 7.2 mt -65.28 -60.45 2.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.726 HG21 ' HB2' ' B' ' 252' ' ' ARG . 61.1 t -59.14 -40.26 80.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.16 -51.33 66.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.845 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.6 tp -66.48 -21.83 66.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 230' ' ' PHE . . . . . 0.493 ' O ' ' O ' ' B' ' 227' ' ' VAL . 3.9 m-30 -95.71 134.93 38.06 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.338 -0.851 . . . . 0.0 110.015 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -44.54 164.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.036 -1.04 . . . . 0.0 109.383 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' B' ' 248' ' ' THR . 0.1 OUTLIER -61.9 -24.63 67.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.489 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.553 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 2.6 p30 -138.53 43.08 2.15 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' B' ' 310' ' ' VAL . . . -64.04 169.26 4.49 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.327 -0.858 . . . . 0.0 109.808 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 235' ' ' THR . . . . . 0.873 HG23 ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -119.79 140.07 51.33 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.446 -0.784 . . . . 0.0 109.007 179.572 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.502 ' O ' ' HB3' ' B' ' 244' ' ' PRO . 37.3 t -132.44 121.19 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.577 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 237' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' B' ' 314' ' ' ALA . 1.5 mt-10 -89.2 105.85 18.05 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 238' ' ' ASP . . . . . 0.581 ' OD2' ' H62' ' B' ' 326' ' ' NTH . 27.0 t70 -179.61 142.06 0.36 Allowed Pre-proline 0 C--N 1.302 -1.464 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.337 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.503 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 47.7 Cg_endo -72.61 -176.72 16.71 Favored 'Cis proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.209 -1.996 . . . . 0.0 110.693 -0.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 1.041 HG21 HG11 ' A' ' 74' ' ' VAL . 26.9 m -82.86 49.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -175.1 30.88 0.09 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 242' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 75.4 m -149.46 -99.1 0.07 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -1.118 . . . . 0.0 109.38 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -176.9 139.46 0.46 Allowed Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.099 -1.001 . . . . 0.0 110.037 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 244' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' B' ' 236' ' ' VAL . 38.1 Cg_endo -65.12 -176.64 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.123 1.591 . . . . 0.0 111.138 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.74 ' HG2' ' HB1' ' B' ' 250' ' ' ALA . 12.1 ttm-85 -151.88 121.76 7.05 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.873 ' HB3' HG23 ' B' ' 235' ' ' THR . 1.0 OUTLIER -103.21 155.71 18.23 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.011 -1.056 . . . . 0.0 110.164 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 247' ' ' GLY . . . . . 0.553 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.89 161.96 21.07 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 248' ' ' THR . . . . . 0.454 ' N ' ' O ' ' B' ' 232' ' ' ASP . 3.7 m -70.02 -59.75 2.72 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.22 -1.165 . . . . 0.0 109.259 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -53.66 -23.53 11.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.313 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.74 ' HB1' ' HG2' ' B' ' 245' ' ' ARG . . . -87.69 -54.34 4.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.62 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.528 HD11 ' O ' ' B' ' 234' ' ' ALA . 7.1 mm -53.35 -40.93 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 109.543 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 252' ' ' ARG . . . . . 0.726 ' HB2' HG21 ' B' ' 227' ' ' VAL . 24.6 ttp85 -79.09 -51.54 9.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.064 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 253' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 21.6 tt0 -52.06 -27.32 13.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.03 -1.044 . . . . 0.0 108.578 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.1 OUTLIER -83.9 -70.11 0.59 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.319 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 0.588 ' C ' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -52.94 -20.43 3.37 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.389 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 256' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' B' ' 252' ' ' ARG . . . -79.31 -39.67 32.27 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 257' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 62.4 t30 -62.86 -26.13 68.62 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 258' ' ' SER . . . . . 0.446 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 30.3 t -74.71 -41.55 59.99 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 0.984 HD22 ' CD2' ' B' ' 223' ' ' LEU . 9.9 tp -61.4 -23.4 65.77 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.499 -0.751 . . . . 0.0 109.378 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 260' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' B' ' 262' ' ' PRO . 0.0 OUTLIER -50.62 -29.51 11.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.889 . . . . 0.0 109.345 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 261' ' ' LEU . . . . . 1.051 HD22 HD21 ' B' ' 263' ' ' LEU . 0.8 OUTLIER -92.64 107.36 23.54 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 108.534 179.385 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 262' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 47.9 Cg_endo -73.52 115.21 4.26 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.899 1.473 . . . . 0.0 111.702 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 1.051 HD21 HD22 ' B' ' 261' ' ' LEU . 0.1 OUTLIER -138.96 -166.49 2.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.477 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 264' ' ' ALA . . . . . 0.746 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -114.28 127.25 55.78 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.86 118.75 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -0.999 . . . . 0.0 109.919 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.2 OUTLIER -150.14 108.5 3.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.334 -0.854 . . . . 0.0 109.2 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.9 OUTLIER -47.38 174.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.504 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.43 -39.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.663 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 269' ' ' GLN . . . . . 0.497 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 7.5 pt20 -94.63 -148.82 0.28 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.638 -0.664 . . . . 0.0 109.294 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.497 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 32.5 tt0 -113.42 131.52 55.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 109.72 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 271' ' ' VAL . . . . . 0.817 ' CG2' HG11 ' B' ' 211' ' ' VAL . 57.0 t -65.1 153.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.347 -0.845 . . . . 0.0 109.247 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 2.5 mtt180 -116.12 131.59 56.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.212 -0.93 . . . . 0.0 109.964 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 273' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.19 133.97 16.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.391 -0.818 . . . . 0.0 109.179 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 274' ' ' VAL . . . . . 1.004 HG11 HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -127.3 -163.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.104 -0.997 . . . . 0.0 109.811 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 275' ' ' ALA . . . . . 0.542 ' O ' ' CB ' ' B' ' 276' ' ' ASN . . . -86.38 68.17 10.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.433 -0.792 . . . . 0.0 110.386 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 276' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' B' ' 275' ' ' ALA . 2.9 m-20 160.69 -61.36 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.421 -0.799 . . . . 0.0 109.47 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 277' ' ' GLU . . . . . 0.495 ' HG2' ' HG2' ' B' ' 302' ' ' ARG . 0.0 OUTLIER -122.39 -161.11 0.92 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.455 -0.778 . . . . 0.0 109.214 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 278' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . -169.78 139.41 1.96 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.478 -0.764 . . . . 0.0 109.12 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 279' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -126.73 139.49 53.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.96 -1.087 . . . . 0.0 109.456 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 280' ' ' PHE . . . . . 0.68 ' HB3' HG13 ' B' ' 271' ' ' VAL . 23.8 p90 -150.57 172.47 15.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.054 -1.029 . . . . 0.0 109.631 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.899 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -147.18 175.59 10.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 110.183 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 282' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 6.7 p90 -167.76 -167.89 0.92 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 283' ' ' THR . . . . . 0.673 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -132.73 141.78 48.71 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.987 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 284' ' ' VAL . . . . . 0.718 ' CG1' HD22 ' B' ' 263' ' ' LEU . 0.5 OUTLIER -114.7 120.93 65.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 285' ' ' SER . . . . . 0.746 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 37.8 p -123.86 80.7 1.83 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.11 -0.994 . . . . 0.0 109.97 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.661 ' HB3' HD23 ' B' ' 263' ' ' LEU . 44.1 p90 -89.89 -172.5 3.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.202 -0.936 . . . . 0.0 108.643 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.72 150.42 49.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.873 -1.142 . . . . 0.0 110.099 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.568 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.4 OUTLIER -117.21 88.49 2.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 0.0 108.99 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 289' ' ' GLN . . . . . 0.52 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 1.3 pt20 42.13 -93.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.269 -0.894 . . . . 0.0 110.021 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 290' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' B' ' 288' ' ' PHE . . . -101.55 -13.43 32.66 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 291' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' B' ' 288' ' ' PHE . 7.8 mtt-85 -101.98 159.85 15.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.239 . . . . 0.0 109.774 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 292' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -122.01 129.74 52.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 293' ' ' THR . . . . . 0.571 ' HB ' ' CZ ' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -123.18 144.47 49.34 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.258 -0.901 . . . . 0.0 109.921 -179.437 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 294' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' B' ' 322' ' ' HIS . 12.3 p -126.19 168.25 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.875 . . . . 0.0 108.773 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 0.929 HG22 ' CG2' ' B' ' 321' ' ' ILE . 30.9 t -137.7 160.17 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.944 -1.098 . . . . 0.0 110.62 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 296' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' B' ' 320' ' ' ASN . . . -144.49 64.62 12.16 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 297' ' ' PRO . . . . . 0.583 ' HD3' HG12 ' B' ' 295' ' ' VAL . 46.3 Cg_endo -97.57 179.78 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.707 1.605 . . . . 0.0 111.749 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.899 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.6 mp -141.05 154.46 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 299' ' ' ASP . . . . . 0.627 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 18.4 t0 -123.01 164.25 18.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.784 -1.198 . . . . 0.0 110.541 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.516 ' O ' ' CG ' ' B' ' 312' ' ' MET . 0.1 OUTLIER -116.66 166.32 12.25 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 301' ' ' PHE . . . . . 0.683 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.1 OUTLIER -145.18 145.85 31.51 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.883 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.495 ' HG2' ' HG2' ' B' ' 277' ' ' GLU . 0.8 OUTLIER -138.53 110.4 7.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.37 -0.831 . . . . 0.0 109.25 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 303' ' ' PHE . . . . . 0.681 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 5.1 m-85 -89.9 -168.44 2.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.564 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 304' ' ' ASN . . . . . 0.83 ' HB3' HG21 ' B' ' 310' ' ' VAL . 13.3 p-10 -137.55 -40.72 0.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 305' ' ' GLY . . . . . 0.701 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -148.1 -65.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 306' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 164.9 56.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -1.146 . . . . 0.0 109.546 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -148.04 -41.04 0.04 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -154.86 -169.31 3.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -1.209 . . . . 0.0 109.542 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 309' ' ' VAL . . . . . 0.573 HG11 ' HE1' ' B' ' 301' ' ' PHE . 50.0 t -99.24 151.41 4.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 109.286 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.83 HG21 ' HB3' ' B' ' 304' ' ' ASN . 45.3 t -121.74 -63.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 311' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' B' ' 302' ' ' ARG . 13.8 m -116.48 165.62 13.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.154 -0.966 . . . . 0.0 109.518 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 312' ' ' MET . . . . . 0.516 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 28.8 ttp -155.18 156.48 35.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.754 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 313' ' ' ARG . . . . . 0.515 ' NE ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -123.98 179.85 4.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.351 -0.843 . . . . 0.0 108.998 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 314' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' B' ' 238' ' ' ASP . . . -138.42 125.14 20.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.977 -1.077 . . . . 0.0 110.529 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 315' ' ' LEU . . . . . 1.006 HD11 ' HB2' ' A' ' 79' ' ' ALA . 5.6 tp -104.44 -175.32 2.76 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 316' ' ' PHE . . . . . 0.76 ' HE1' HG22 ' B' ' 240' ' ' VAL . 0.0 OUTLIER 99.56 -160.73 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.626 0.726 . . . . 0.0 109.889 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 317' ' ' GLY . . . . . 0.662 ' N ' ' CG ' ' B' ' 316' ' ' PHE . . . 160.42 -162.33 33.25 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 318' ' ' GLU . . . . . 0.494 ' HA ' HD12 ' B' ' 321' ' ' ILE . 5.1 tt0 -78.16 6.45 8.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -1.143 . . . . 0.0 109.622 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -115.17 -17.85 11.29 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.192 -0.943 . . . . 0.0 110.078 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 320' ' ' ASN . . . . . 0.535 ' O ' ' HB3' ' B' ' 296' ' ' ALA . 0.2 OUTLIER -88.8 -14.9 35.92 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.215 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 321' ' ' ILE . . . . . 0.929 ' CG2' HG22 ' B' ' 295' ' ' VAL . 0.9 OUTLIER -87.84 -164.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 322' ' ' HIS . . . . . 0.729 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.0 OUTLIER -150.99 154.84 37.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.969 -1.082 . . . . 0.0 109.756 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.474 ' HA ' HG22 ' B' ' 293' ' ' THR . . . -155.52 110.89 3.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.468 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -171.33 -132.55 1.5 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.3 -1.118 . . . . 0.0 109.508 -179.841 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 126' ' ' NTH . . . . . 0.707 ' H11' ' OG ' ' A' ' 58' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 326' ' ' NTH . . . . . 0.876 ' O17' HD13 ' B' ' 261' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.227 0.536 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 3' ' ' THR . 28.6 m120 -131.76 43.96 2.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.364 -0.835 . . . . 0.0 109.393 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 3' ' ' THR . 11.1 t -44.2 108.73 0.75 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.48 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.84 -9.69 25.18 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.889 1.468 . . . . 0.0 110.065 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -66.35 -49.45 66.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.229 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -52.7 61.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.192 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 mtm -59.62 -25.58 64.76 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.329 -0.857 . . . . 0.0 109.346 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -72.98 -30.69 64.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 0.0 109.128 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.25 -51.97 66.17 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.863 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -47.91 -29.13 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.163 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.943 HG11 HG21 ' A' ' 71' ' ' VAL . 24.9 t -87.95 -45.18 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.5 -0.75 . . . . 0.0 109.363 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 13' ' ' ARG . 3.6 tt0 -58.43 -73.37 0.08 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.0 OUTLIER -43.02 -44.78 4.89 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.079 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.643 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -50.5 -44.26 55.94 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.489 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.924 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -86.37 -41.46 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 108.99 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -49.41 -35.19 18.41 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.677 ' HB1' ' OD1' ' A' ' 22' ' ' ASP . . . -74.25 -32.82 63.1 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.924 HD12 ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -65.1 -57.13 9.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.48 -39.73 24.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.01 -11.57 43.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.583 -0.698 . . . . 0.0 109.464 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 1.008 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 62.68 25.92 67.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.677 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 16.0 p30 -89.41 85.48 6.56 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.131 -1.217 . . . . 0.0 109.649 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.036 ' CD2' HD22 ' A' ' 59' ' ' LEU . 3.6 mm? -49.76 -21.8 1.21 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.259 -0.901 . . . . 0.0 109.783 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.53 -51.8 68.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -40.8 95.02 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.56 HD12 HD13 ' A' ' 23' ' ' LEU . 7.7 mt -59.86 -54.67 31.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 23' ' ' LEU . 48.5 t -64.33 -41.18 91.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.17 -49.82 70.9 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.863 HD21 ' HA ' ' A' ' 10' ' ' VAL . 2.0 tp -67.14 -14.22 62.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.733 ' CZ ' ' HE3' ' A' ' 112' ' ' MET . 3.0 m-85 -89.48 136.01 33.27 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' CB ' HG22 ' A' ' 110' ' ' VAL . . . -54.42 -167.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 109.552 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -76.89 -23.51 52.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.251 -0.906 . . . . 0.0 109.7 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.549 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -143.66 45.51 1.49 Allowed 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -59.04 157.63 9.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.966 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.556 ' HG1' ' HG ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -117.81 139.27 51.32 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.485 -0.759 . . . . 0.0 109.284 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.754 ' CG2' HD12 ' A' ' 51' ' ' ILE . 42.7 t -129.24 141.1 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.418 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.526 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 11.5 mt-10 -111.24 112.79 24.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.643 ' OD2' ' H62' ' A' ' 126' ' ' NTH . 19.7 t70 -179.27 141.38 0.36 Allowed Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.568 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.51 ' O ' HG22 ' A' ' 40' ' ' VAL . 46.2 Cg_endo -72.56 131.69 23.34 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.286 -1.964 . . . . 0.0 110.6 -0.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 39' ' ' PRO . 14.0 m 40.73 -147.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.464 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.473 ' N ' HG23 ' A' ' 40' ' ' VAL . . . -67.28 1.21 6.95 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.04 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.472 ' OG ' ' HG2' ' A' ' 39' ' ' PRO . 68.8 m -48.06 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.902 -1.352 . . . . 0.0 110.163 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 4.2 pt-20 -133.29 107.64 12.28 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.003 . . . . 0.0 110.608 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 42.5 Cg_endo -68.47 -167.74 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 124.016 1.535 . . . . 0.0 110.428 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.662 ' HD3' ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -151.43 112.31 4.26 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.532 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.2 OUTLIER -103.57 140.2 37.85 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 110.257 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 107.8 160.81 20.93 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.487 HG23 ' CG1' ' A' ' 27' ' ' VAL . 3.0 m -76.07 -42.38 47.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.269 -1.136 . . . . 0.0 109.086 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.63 -38.11 83.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.29 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.662 ' HB1' ' HD3' ' A' ' 45' ' ' ARG . . . -73.48 -43.59 59.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.314 -0.866 . . . . 0.0 109.368 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.754 HD12 ' CG2' ' A' ' 36' ' ' VAL . 5.4 mm -58.49 -46.45 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.31 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.53 ' CG ' HG21 ' A' ' 27' ' ' VAL . 36.7 ttt-85 -66.31 -55.46 15.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 108.945 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 52' ' ' ARG . 2.3 mt-10 -45.09 -28.56 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 108.568 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.607 ' CG ' ' HG3' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -85.09 -70.08 0.61 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.422 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.692 ' C ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -51.73 -20.95 2.37 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . . . -82.21 -46.0 14.32 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 24.5 t-20 -60.96 -50.04 75.01 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.61 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 7.4 t -51.79 -26.27 9.34 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.036 HD22 ' CD2' ' A' ' 23' ' ' LEU . 5.4 tp -76.95 -28.24 55.13 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.591 -0.693 . . . . 0.0 109.739 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -44.35 -31.44 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 108.633 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.057 ' CD2' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.19 100.27 11.35 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 45.9 Cg_endo -71.71 129.54 15.7 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.991 1.521 . . . . 0.0 111.899 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.057 HD21 ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -139.98 178.04 7.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.999 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -92.23 127.8 37.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.264 -0.898 . . . . 0.0 108.58 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.52 112.18 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 110.056 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -150.86 105.3 3.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.812 . . . . 0.0 109.193 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 67' ' ' LEU . 2.3 mp -55.5 173.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.96 . . . . 0.0 109.861 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -134.72 -81.13 0.44 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.339 -0.851 . . . . 0.0 109.327 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.557 ' H ' HG23 ' A' ' 68' ' ' THR . 5.5 pt20 -60.22 -143.28 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.647 -0.658 . . . . 0.0 109.435 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -114.29 134.8 54.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.963 -1.086 . . . . 0.0 110.001 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.022 HG13 ' HB3' ' A' ' 80' ' ' PHE . 10.6 t -63.09 148.71 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.423 -0.798 . . . . 0.0 109.036 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 3.4 mmm180 -98.97 130.57 45.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.931 . . . . 0.0 109.287 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.533 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -145.92 135.96 23.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 109.342 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.9 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -163.9 155.48 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.67 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.807 ' HB2' ' O ' ' B' ' 240' ' ' VAL . . . 49.76 -152.03 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.473 -0.767 . . . . 0.0 109.855 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 103' ' ' PHE . 98.3 m-20 -87.36 16.98 4.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.454 -0.779 . . . . 0.0 109.331 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.498 ' HG3' ' HA ' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -123.6 -159.26 0.84 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.342 -0.849 . . . . 0.0 109.076 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.96 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 178.04 160.3 0.53 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.439 -0.788 . . . . 0.0 109.542 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.835 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.27 133.54 16.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.015 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 1.022 ' HB3' HG13 ' A' ' 71' ' ' VAL . 33.5 p90 -148.96 163.67 36.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.836 -1.165 . . . . 0.0 110.241 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.964 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -140.78 150.13 42.97 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -149.56 -172.51 4.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.175 -0.953 . . . . 0.0 109.401 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.29 141.74 51.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.406 -0.808 . . . . 0.0 109.611 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.939 HG11 HD22 ' A' ' 63' ' ' LEU . 19.9 t -112.01 111.71 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.394 -0.816 . . . . 0.0 109.156 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.999 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -106.12 113.1 26.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.824 . . . . 0.0 109.57 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.894 ' CE2' H221 ' A' ' 126' ' ' NTH . 0.8 OUTLIER -128.02 148.13 50.53 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.195 -0.941 . . . . 0.0 109.536 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -91.7 178.64 5.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.541 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.576 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.5 OUTLIER -142.19 -163.49 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.34 -0.85 . . . . 0.0 109.382 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.69 60.95 2.87 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.026 -1.047 . . . . 0.0 109.491 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.84 3.41 26.69 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -136.81 164.36 28.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.137 -1.213 . . . . 0.0 109.667 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' CD ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -126.52 122.27 34.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.844 . . . . 0.0 109.233 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.576 ' OG1' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -117.23 154.6 30.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.722 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.622 HG12 ' HB3' ' A' ' 122' ' ' HIS . 7.3 p -138.46 170.75 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 108.861 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 1.029 HG12 ' HD3' ' A' ' 97' ' ' PRO . 3.5 t -144.91 147.05 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.034 -1.041 . . . . 0.0 109.268 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.437 ' O ' ' CG ' ' A' ' 120' ' ' ASN . . . -132.55 69.65 79.67 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.121 -0.987 . . . . 0.0 111.026 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 1.029 ' HD3' HG12 ' A' ' 95' ' ' VAL . 49.3 Cg_endo -96.35 -173.08 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.503 1.469 . . . . 0.0 110.424 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.964 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.9 mp -134.46 157.36 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 15.8 t0 -127.05 153.25 46.2 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.156 -0.965 . . . . 0.0 110.11 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.518 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -108.88 171.27 7.53 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.96 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -142.37 148.38 37.79 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.101 -0.999 . . . . 0.0 110.486 -178.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.539 ' CD ' ' HB2' ' A' ' 111' ' ' SER . 0.0 OUTLIER -133.85 107.43 7.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.561 -0.712 . . . . 0.0 109.085 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.639 ' CZ ' ' CG2' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -89.72 -176.37 4.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 109.56 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.932 ' OD1' HG23 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -138.9 -100.08 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.433 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.67 -38.93 0.04 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -171.48 32.8 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.45 -1.029 . . . . 0.0 108.74 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 108' ' ' LYS . . . -123.72 15.56 7.96 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 22.2 mmmt 81.79 -150.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.653 -0.91 . . . . 0.0 109.624 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.66 HG23 HG22 ' A' ' 10' ' ' VAL . 18.2 t -88.2 122.66 40.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.932 HG23 ' OD1' ' A' ' 104' ' ' ASN . 49.1 t -105.24 -8.58 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.079 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.556 ' HG ' ' HG1' ' A' ' 35' ' ' THR . 0.6 OUTLIER -160.37 153.22 21.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.957 -1.089 . . . . 0.0 110.137 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.733 ' HE3' ' CZ ' ' A' ' 30' ' ' PHE . 19.0 ttm -160.05 141.82 12.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.494 -0.754 . . . . 0.0 109.211 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 1.0 OUTLIER -123.56 174.21 7.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.116 -0.99 . . . . 0.0 109.269 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 99' ' ' ASP . . . -147.47 134.91 20.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.945 . . . . 0.0 109.263 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.879 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.1 OUTLIER -125.01 141.17 52.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 110.063 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.784 ' O ' HG21 ' B' ' 274' ' ' VAL . 50.0 p90 172.86 -160.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.564 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 172.31 -171.03 44.0 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.542 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 3.1 tt0 -69.87 -5.01 22.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.444 -1.033 . . . . 0.0 109.7 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.453 ' HE3' ' OE2' ' B' ' 270' ' ' GLU . 0.3 OUTLIER -90.47 -31.74 16.66 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.958 0.885 . . . . 0.0 109.142 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.437 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.8 m-20 -89.36 8.6 29.83 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.19 0.519 . . . . 0.0 109.665 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.724 HG22 ' H ' ' A' ' 122' ' ' HIS . 4.9 mm -90.28 -172.53 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 108.897 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.724 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -151.7 156.76 41.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.914 . . . . 0.0 109.506 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.426 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -154.7 135.24 13.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.506 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.59 138.66 9.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.202 -1.175 . . . . 0.0 109.535 -179.861 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.242 0.544 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -116.06 92.6 3.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.441 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.92 119.42 69.38 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.827 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.32 -4.69 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.858 1.452 . . . . 0.0 109.586 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.04 -40.84 68.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.373 -0.83 . . . . 0.0 109.237 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -65.83 -55.7 15.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.128 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 15.4 mtm -55.98 -24.62 39.68 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.289 -0.882 . . . . 0.0 109.13 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 5.4 m -73.91 -34.06 64.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.346 -0.846 . . . . 0.0 109.136 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.1 -46.44 65.25 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.183 -0.948 . . . . 0.0 108.482 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.753 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.0 OUTLIER -54.97 -24.84 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.816 HG11 HG21 ' B' ' 271' ' ' VAL . 16.8 t -90.21 -43.94 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.421 -0.799 . . . . 0.0 109.045 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 212' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' B' ' 213' ' ' ARG . 7.6 tt0 -60.45 -73.61 0.09 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.963 ' HD3' HD13 ' B' ' 229' ' ' LEU . 0.0 OUTLIER -43.22 -45.23 5.62 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.236 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 214' ' ' TYR . . . . . 0.641 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -50.09 -44.84 52.19 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.92 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -86.94 -39.32 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.317 -0.865 . . . . 0.0 109.172 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 216' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.35 -36.51 14.62 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -73.97 -33.87 64.02 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.92 HD12 ' HA ' ' B' ' 215' ' ' VAL . 2.7 mt -64.05 -59.07 4.91 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -51.19 -45.5 61.84 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.509 0.671 . . . . 0.0 109.194 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.54 8.6 30.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.579 -0.701 . . . . 0.0 109.681 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.823 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 49.48 33.72 17.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 222' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.5 t70 -90.58 67.73 6.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -1.131 . . . . 0.0 109.685 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 223' ' ' LEU . . . . . 1.066 HD12 HD12 ' B' ' 226' ' ' ILE . 7.3 tp -50.38 -45.2 55.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.076 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' B' ' 223' ' ' LEU . 5.3 m-20 -43.44 -32.64 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -83.86 -33.51 21.14 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 1.066 HD12 HD12 ' B' ' 223' ' ' LEU . 17.2 mt -61.9 -56.02 20.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.651 HG11 HG23 ' B' ' 248' ' ' THR . 97.0 t -59.71 -37.33 70.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.93 -51.82 68.06 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.963 HD13 ' HD3' ' B' ' 213' ' ' ARG . 2.9 tp -68.06 -14.89 63.32 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.536 -0.727 . . . . 0.0 109.057 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 230' ' ' PHE . . . . . 0.771 ' CD2' HG21 ' B' ' 251' ' ' ILE . 2.4 m-85 -94.78 149.18 21.51 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.457 -0.777 . . . . 0.0 109.527 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -59.24 168.23 1.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.429 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.449 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -55.72 -24.4 34.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.372 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.532 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 8.8 p-10 -150.56 51.36 0.88 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.717 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -60.58 158.94 11.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.608 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 235' ' ' THR . . . . . 0.53 ' CG2' ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -100.27 141.34 33.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.447 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.545 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 85.4 t -134.41 136.39 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.258 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 237' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 1.5 mt-10 -112.39 113.28 25.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 108.559 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 238' ' ' ASP . . . . . 0.524 ' O ' ' CE2' ' B' ' 254' ' ' PHE . 9.6 t70 -179.55 141.74 0.36 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 109.664 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' B' ' 241' ' ' GLY . 49.1 Cg_endo -75.14 -176.65 18.56 Favored 'Cis proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.25 -1.979 . . . . 0.0 110.485 -0.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.807 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 6.2 m -65.18 75.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.284 -0.885 . . . . 0.0 108.982 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 241' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' B' ' 239' ' ' PRO . . . -162.78 24.37 0.2 Allowed Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 242' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' B' ' 241' ' ' GLY . 0.5 OUTLIER 67.24 48.92 1.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -1.14 . . . . 0.0 109.741 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 243' ' ' GLU . . . . . 0.517 ' N ' ' HD3' ' B' ' 244' ' ' PRO . 2.1 mt-10 -131.89 58.57 38.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.144 -0.972 . . . . 0.0 109.466 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 244' ' ' PRO . . . . . 0.545 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 48.5 Cg_endo -77.83 169.69 20.24 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 124.276 1.671 . . . . 0.0 110.942 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.466 ' HD2' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -151.32 100.79 2.78 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.72 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.2 OUTLIER -92.02 161.77 14.65 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.121 -0.987 . . . . 0.0 110.152 -178.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 247' ' ' GLY . . . . . 0.631 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 100.66 158.26 27.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 248' ' ' THR . . . . . 0.651 HG23 HG11 ' B' ' 227' ' ' VAL . 5.3 m -69.98 -48.7 57.17 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.195 -1.179 . . . . 0.0 108.971 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -61.81 -25.27 67.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.904 . . . . 0.0 109.274 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -90.13 -58.78 2.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.394 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.771 HG21 ' CD2' ' B' ' 230' ' ' PHE . 17.4 mt -47.45 -41.22 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.284 -0.885 . . . . 0.0 109.012 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 252' ' ' ARG . . . . . 0.762 ' CG ' HD23 ' B' ' 223' ' ' LEU . 28.6 ttt180 -76.75 -57.99 3.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.456 -0.778 . . . . 0.0 108.978 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 253' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 62.5 mt-10 -45.27 -28.32 0.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.025 -1.047 . . . . 0.0 108.589 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' B' ' 238' ' ' ASP . 0.8 OUTLIER -85.39 -71.02 0.55 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 1.048 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -49.12 -23.59 1.31 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 256' ' ' ALA . . . . . 0.711 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -76.38 -49.67 16.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 257' ' ' ASN . . . . . 0.472 ' HA ' ' HE2' ' B' ' 260' ' ' LYS . 30.1 t-20 -55.33 -29.43 58.29 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 258' ' ' SER . . . . . 0.547 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 42.9 t -75.44 -31.8 60.46 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 0.823 HD21 ' CA ' ' B' ' 221' ' ' GLY . 7.3 tp -71.77 -25.78 62.17 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.44 -0.787 . . . . 0.0 109.302 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 260' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' B' ' 257' ' ' ASN . 12.0 mtmt -54.12 -23.83 15.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.296 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 261' ' ' LEU . . . . . 0.955 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.8 OUTLIER -89.92 120.34 69.35 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 0.0 108.698 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 262' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' B' ' 286' ' ' PHE . 42.9 Cg_endo -69.94 104.05 1.29 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.752 1.396 . . . . 0.0 110.584 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.955 ' CD2' HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -138.91 149.79 45.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.742 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 264' ' ' ALA . . . . . 0.906 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -91.62 129.55 37.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -0.824 . . . . 0.0 108.925 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 265' ' ' VAL . . . . . 0.699 HG21 ' HB3' ' B' ' 218' ' ' LEU . 3.0 t -110.18 116.09 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.87 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.1 OUTLIER -150.33 91.47 1.76 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 0.0 109.24 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -45.21 170.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.724 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.1 -39.56 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.299 -0.876 . . . . 0.0 109.675 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 269' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -87.75 -154.2 0.25 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.453 ' OE2' ' HE3' ' A' ' 119' ' ' LYS . 51.7 tt0 -107.39 131.24 54.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.138 -0.976 . . . . 0.0 109.53 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 271' ' ' VAL . . . . . 0.93 HG13 ' HB3' ' B' ' 280' ' ' PHE . 26.7 t -67.35 150.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.292 -0.88 . . . . 0.0 108.762 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 5.5 mtt180 -104.01 136.94 42.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 109.963 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 273' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.18 126.14 10.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.412 -0.805 . . . . 0.0 109.275 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 274' ' ' VAL . . . . . 0.784 HG21 ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -155.33 160.74 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.215 -0.928 . . . . 0.0 109.4 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 275' ' ' ALA . . . . . 0.51 ' HB2' HG23 ' A' ' 40' ' ' VAL . . . 43.87 -145.56 0.1 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 276' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' B' ' 303' ' ' PHE . 1.5 t-20 -90.59 13.26 16.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 0.0 109.708 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 277' ' ' GLU . . . . . 0.492 ' HG3' ' HA ' ' B' ' 302' ' ' ARG . 0.9 OUTLIER -122.16 -161.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.078 -1.014 . . . . 0.0 109.733 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 278' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 177.74 148.79 0.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 279' ' ' ALA . . . . . 0.879 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -134.69 139.69 45.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.007 -1.058 . . . . 0.0 108.868 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 280' ' ' PHE . . . . . 0.93 ' HB3' HG13 ' B' ' 271' ' ' VAL . 33.3 p90 -150.47 165.18 33.99 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.694 -1.254 . . . . 0.0 110.651 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.992 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -143.45 176.86 8.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 282' ' ' PHE . . . . . 0.408 ' HE1' ' CE2' ' B' ' 280' ' ' PHE . 14.4 p90 -178.14 -170.21 0.23 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.284 -0.885 . . . . 0.0 109.6 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.58 142.33 50.74 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.518 -0.739 . . . . 0.0 109.551 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 284' ' ' VAL . . . . . 0.755 HG12 ' HD1' ' B' ' 286' ' ' PHE . 45.2 t -113.89 113.6 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.453 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 285' ' ' SER . . . . . 0.906 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 91.9 p -105.75 110.6 22.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.168 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.933 ' CZ ' H221 ' B' ' 326' ' ' NTH . 4.3 p90 -127.43 157.86 38.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.164 -0.96 . . . . 0.0 109.787 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 287' ' ' GLU . . . . . 0.49 ' HG3' ' HB2' ' B' ' 292' ' ' LYS . 11.6 tm-20 -144.71 167.61 22.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.307 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.419 ' N ' ' CD ' ' B' ' 287' ' ' GLU . 0.1 OUTLIER -122.02 -75.98 0.59 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.052 -1.03 . . . . 0.0 109.894 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 289' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' B' ' 289' ' ' GLN . 1.0 OUTLIER -158.99 60.1 0.42 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.503 -0.748 . . . . 0.0 109.778 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 129.88 -45.76 1.12 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -103.26 129.67 50.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.374 -1.074 . . . . 0.0 109.189 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 292' ' ' LYS . . . . . 0.49 ' HB2' ' HG3' ' B' ' 287' ' ' GLU . 0.2 OUTLIER -118.54 145.7 45.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 109.701 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 293' ' ' THR . . . . . 0.585 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -136.16 145.39 45.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.666 -0.646 . . . . 0.0 109.649 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 294' ' ' VAL . . . . . 0.665 HG23 ' HA ' ' B' ' 285' ' ' SER . 0.5 OUTLIER -117.32 176.35 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 108.581 179.563 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 1.041 HG12 ' HD3' ' B' ' 297' ' ' PRO . 2.5 t -149.58 145.25 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.227 -0.921 . . . . 0.0 109.069 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 296' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -131.02 71.3 82.45 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.079 -1.013 . . . . 0.0 110.923 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 297' ' ' PRO . . . . . 1.041 ' HD3' HG12 ' B' ' 295' ' ' VAL . 52.3 Cg_endo -96.88 -173.08 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.717 1.611 . . . . 0.0 110.677 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.992 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.5 mp -139.49 151.97 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 299' ' ' ASP . . . . . 0.619 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 17.5 t0 -124.13 160.2 28.33 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.999 -1.063 . . . . 0.0 110.311 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' B' ' 312' ' ' MET . 51.4 t-80 -110.88 173.79 6.17 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 301' ' ' PHE . . . . . 0.901 ' CE1' HG21 ' B' ' 309' ' ' VAL . 0.1 OUTLIER -149.55 138.96 21.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 110.491 -178.402 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.522 ' CB ' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -123.46 110.36 15.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.423 -0.798 . . . . 0.0 109.097 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 303' ' ' PHE . . . . . 0.618 ' CZ ' ' CG2' ' B' ' 210' ' ' VAL . 0.4 OUTLIER -89.78 -176.21 4.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 0.0 109.687 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 304' ' ' ASN . . . . . 0.946 ' OD1' HG23 ' B' ' 310' ' ' VAL . 0.1 OUTLIER -142.05 -100.06 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.583 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 305' ' ' GLY . . . . . 0.698 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -98.8 -55.58 1.06 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 306' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 163.13 76.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -1.099 . . . . 0.0 109.39 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -167.53 -51.73 0.03 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 308' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' B' ' 308' ' ' LYS . 0.0 OUTLIER -150.11 -167.43 2.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -1.213 . . . . 0.0 109.659 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 309' ' ' VAL . . . . . 0.901 HG21 ' CE1' ' B' ' 301' ' ' PHE . 62.0 t -102.66 148.28 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.332 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.946 HG23 ' OD1' ' B' ' 304' ' ' ASN . 24.1 t -110.97 -31.91 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.089 -1.007 . . . . 0.0 110.192 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 311' ' ' SER . . . . . 0.522 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 1.3 m -144.94 165.02 29.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.789 -1.194 . . . . 0.0 110.009 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 312' ' ' MET . . . . . 0.523 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 11.0 ttp -156.2 161.5 40.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.695 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 313' ' ' ARG . . . . . 0.576 HH22 HG12 ' B' ' 240' ' ' VAL . 9.0 tpt180 -150.39 117.18 5.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.226 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 314' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' B' ' 299' ' ' ASP . . . -94.59 144.93 25.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.152 -0.968 . . . . 0.0 110.033 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 315' ' ' LEU . . . . . 0.835 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -132.31 139.72 48.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 109.564 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 316' ' ' PHE . . . . . 0.9 ' O ' HG11 ' A' ' 74' ' ' VAL . 47.9 p90 170.68 -158.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 317' ' ' GLY . . . . . 0.603 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 178.83 -175.7 47.51 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 318' ' ' GLU . . . . . 0.546 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 25.7 tt0 -73.36 -1.91 20.07 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.295 -1.121 . . . . 0.0 109.442 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -92.71 -29.62 15.97 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.24 -0.912 . . . . 0.0 108.983 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 320' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -88.89 16.01 7.57 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 321' ' ' ILE . . . . . 0.68 HG22 ' H ' ' B' ' 322' ' ' HIS . 5.1 mm -89.72 -165.07 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 322' ' ' HIS . . . . . 0.68 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.2 OUTLIER -151.9 161.27 42.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.94 -1.1 . . . . 0.0 109.67 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -155.37 113.47 3.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 109.361 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -120.8 152.87 16.75 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.263 -1.14 . . . . 0.0 109.479 179.931 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 126' ' ' NTH . . . . . 0.894 H221 ' CE2' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 326' ' ' NTH . . . . . 0.933 H221 ' CZ ' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.505 ' CE ' ' OE1' ' B' ' 318' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.24 0.543 . . . . 0.0 110.221 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.439 ' ND2' ' SD ' ' A' ' 7' ' ' MET . 33.4 t30 -120.57 125.71 48.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 0.0 109.43 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 3' ' ' THR . 1.8 t -44.26 106.7 0.54 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.875 . . . . 0.0 109.351 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 44.5 Cg_endo -71.2 -3.82 13.68 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.891 1.469 . . . . 0.0 110.379 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -72.8 -25.58 61.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.912 . . . . 0.0 109.224 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.47 -59.31 2.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -51.47 -21.39 2.37 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.118 -0.989 . . . . 0.0 109.722 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 11' ' ' VAL . 14.3 m -74.66 -39.81 61.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.222 -0.924 . . . . 0.0 109.099 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.89 -42.76 48.68 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.779 ' HA ' HD21 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -53.82 -23.95 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.132 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.801 HG11 ' CG2' ' A' ' 71' ' ' VAL . 10.1 t -89.94 -43.06 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.349 -0.844 . . . . 0.0 109.066 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 13' ' ' ARG . 24.6 tt0 -61.82 -73.52 0.1 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.281 1.039 . . . . 0.0 108.284 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.745 ' HD3' HD13 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -42.45 -44.29 3.97 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 1.068 ' CE1' HD11 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -51.27 -48.45 62.2 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.917 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -82.24 -44.24 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.382 -0.824 . . . . 0.0 109.375 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -47.57 -37.99 13.45 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.51 ' HA ' ' HB3' ' A' ' 22' ' ' ASP . . . -72.84 -36.04 67.38 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.068 HD11 ' CE1' ' A' ' 14' ' ' TYR . 2.9 mt -61.0 -59.82 4.77 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -53.49 -42.67 67.54 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.48 0.657 . . . . 0.0 109.762 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.19 5.54 44.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.82 . . . . 0.0 110.006 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.898 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 54.76 46.11 76.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.51 ' HB3' ' HA ' ' A' ' 17' ' ' ALA . 15.6 t0 -104.74 58.35 0.7 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -1.068 . . . . 0.0 109.945 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.028 HD11 ' HB3' ' A' ' 55' ' ' PHE . 6.0 tp -52.86 -45.84 67.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.131 -0.981 . . . . 0.0 108.921 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -46.74 -42.99 17.68 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -75.17 -29.57 60.22 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.001 HD12 HD12 ' A' ' 23' ' ' LEU . 32.5 mt -63.66 -59.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 30' ' ' PHE . 92.9 t -49.45 -35.7 9.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -60.04 -40.83 90.73 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.779 HD21 ' HA ' ' A' ' 10' ' ' VAL . 1.9 tp -75.39 -20.15 59.12 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.471 ' HB2' ' HA ' ' A' ' 27' ' ' VAL . 4.9 m-85 -95.99 141.86 28.89 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.532 -0.73 . . . . 0.0 109.642 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -49.0 177.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.927 . . . . 0.0 109.457 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.63 -24.12 63.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.24 -0.912 . . . . 0.0 109.826 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.529 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 4.9 p-10 -144.83 52.33 1.23 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.972 ' O ' HD11 ' A' ' 51' ' ' ILE . . . -59.38 165.02 2.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.443 -0.786 . . . . 0.0 110.194 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.595 HG23 ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -115.75 140.94 48.73 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 37' ' ' GLU . 25.0 t -128.51 170.29 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 109.654 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.585 ' N ' HG12 ' A' ' 36' ' ' VAL . 5.0 mt-10 -141.27 113.3 7.89 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.583 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 6.0 t70 -168.37 139.95 2.26 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.759 -1.213 . . . . 0.0 109.957 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 43.8 Cg_endo -74.95 -78.27 0.0 OUTLIER 'Cis proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.441 -1.9 . . . . 0.0 111.608 0.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 39' ' ' PRO . 1.3 m -153.3 66.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.876 -1.14 . . . . 0.0 109.331 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . -173.05 46.99 0.16 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER 72.97 51.14 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -1.132 . . . . 0.0 110.077 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.543 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 2.3 mt-10 -132.92 58.66 37.2 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.056 -1.027 . . . . 0.0 109.742 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 43' ' ' GLU . 50.7 Cg_endo -79.99 -179.29 5.16 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.066 1.561 . . . . 0.0 111.284 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.59 ' HG3' ' CD1' ' A' ' 54' ' ' PHE . 23.2 mmt180 -150.88 96.16 2.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.595 ' HB3' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -92.81 158.35 15.93 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.19 -0.944 . . . . 0.0 110.285 -178.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 33' ' ' ASP . . . 88.95 -169.93 37.26 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -103.13 -51.85 3.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.076 -1.249 . . . . 0.0 108.842 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -52.05 -23.49 5.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.312 -0.867 . . . . 0.0 109.15 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 46' ' ' SER . . . -90.32 -55.28 3.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.388 -0.82 . . . . 0.0 109.607 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.972 HD11 ' O ' ' A' ' 34' ' ' ALA . 59.7 mt -54.08 -43.41 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 109.132 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.802 ' HG3' HD23 ' A' ' 23' ' ' LEU . 16.2 ttt180 -70.28 -47.91 59.12 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.193 -0.942 . . . . 0.0 108.784 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 5.4 mt-10 -51.12 -34.19 29.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.038 . . . . 0.0 108.44 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.59 ' CD1' ' HG3' ' A' ' 45' ' ' ARG . 1.4 t80 -82.93 -70.5 0.55 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 1.028 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -44.63 -26.76 0.41 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -75.03 -53.22 9.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 108.993 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 56' ' ' ALA . 14.1 t-20 -45.66 -34.6 3.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 108.609 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.772 ' HB2' ' H11' ' A' ' 126' ' ' NTH . 5.8 t -71.87 -33.56 68.49 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.898 HD21 ' CA ' ' A' ' 21' ' ' GLY . 5.3 tp -77.21 -33.87 56.16 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.326 -0.859 . . . . 0.0 109.329 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -61.94 -26.97 68.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 109.443 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.574 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -89.43 131.87 38.97 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 0.0 108.681 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 86' ' ' PHE . 41.6 Cg_endo -68.04 80.64 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.755 1.398 . . . . 0.0 110.501 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.978 HD22 ' CG1' ' A' ' 84' ' ' VAL . 3.2 mt -111.22 146.55 36.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.435 -0.79 . . . . 0.0 109.605 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.635 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -91.91 126.75 37.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 108.647 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 18' ' ' LEU . 2.7 t -113.45 118.13 57.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.673 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 67' ' ' LEU . 27.1 tt0 -150.16 104.54 3.28 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.337 -0.852 . . . . 0.0 109.169 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.5 mp -45.59 171.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.222 -0.924 . . . . 0.0 109.847 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -144.38 -82.27 0.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.403 -0.811 . . . . 0.0 109.01 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 2.9 pt20 -60.08 -146.06 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 61.5 tt0 -114.84 130.37 56.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.066 -1.021 . . . . 0.0 109.761 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.91 HG13 ' HB3' ' A' ' 80' ' ' PHE . 88.7 t -60.0 145.03 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.292 -0.88 . . . . 0.0 109.14 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.539 ' HD3' ' CD2' ' B' ' 315' ' ' LEU . 17.7 mtt180 -111.72 130.04 55.92 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.396 -0.921 . . . . 0.0 109.931 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.52 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -139.74 157.7 45.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.868 HG11 HG21 ' B' ' 240' ' ' VAL . 0.5 OUTLIER -157.22 -153.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 110.312 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.557 ' CB ' ' HA3' ' B' ' 241' ' ' GLY . . . -33.91 -96.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 120.926 0.393 . . . . 0.0 111.161 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 103' ' ' PHE . 65.4 m-20 -114.37 26.96 9.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.948 -1.095 . . . . 0.0 110.496 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.572 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.4 OUTLIER -137.55 -160.98 1.11 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.026 -1.046 . . . . 0.0 109.388 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.9 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 171.28 143.48 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.476 -0.765 . . . . 0.0 109.861 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.854 ' CB ' HD11 ' B' ' 315' ' ' LEU . . . -132.62 130.46 40.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 108.786 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.91 ' HB3' HG13 ' A' ' 71' ' ' VAL . 2.1 p90 -150.6 156.06 40.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.759 -1.213 . . . . 0.0 109.989 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.093 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -133.32 156.49 47.51 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.611 0.719 . . . . 0.0 110.33 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 99' ' ' ASP . 3.7 p90 -149.46 -171.06 3.8 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.87 140.09 52.83 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.076 -1.015 . . . . 0.0 109.972 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.978 ' CG1' HD22 ' A' ' 63' ' ' LEU . 38.3 t -116.76 115.2 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.726 ' HB3' HG23 ' A' ' 94' ' ' VAL . 78.2 p -126.67 99.73 5.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.086 -1.009 . . . . 0.0 110.334 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.696 ' CE1' H221 ' A' ' 126' ' ' NTH . 52.8 p90 -93.36 -164.22 1.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.204 -0.935 . . . . 0.0 108.629 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -144.19 152.06 40.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.022 -1.049 . . . . 0.0 110.086 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.409 ' CZ ' ' HE2' ' A' ' 86' ' ' PHE . 4.2 m-85 -107.21 -173.35 2.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.403 -0.811 . . . . 0.0 109.39 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -49.19 -54.6 15.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.358 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -138.04 4.61 3.23 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -105.86 -177.4 3.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 109.515 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -145.49 118.98 9.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.297 -0.877 . . . . 0.0 109.752 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -120.26 143.35 48.36 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.389 -0.82 . . . . 0.0 109.417 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 85' ' ' SER . 13.3 p -126.23 169.52 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.22 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.851 HG22 HG23 ' A' ' 121' ' ' ILE . 53.1 t -140.63 152.11 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.765 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.442 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . -129.56 71.63 82.06 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 109.222 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.629 ' HD3' HG12 ' A' ' 95' ' ' VAL . 48.7 Cg_endo -97.34 -178.6 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.726 1.617 . . . . 0.0 111.578 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.093 HG23 ' HB2' ' A' ' 81' ' ' ALA . 3.1 mp -138.6 169.4 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 23.4 t0 -135.76 154.79 51.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.907 -1.121 . . . . 0.0 110.041 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.522 ' CB ' ' HB3' ' A' ' 113' ' ' ARG . 1.0 OUTLIER -114.08 175.23 5.56 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.9 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -150.42 152.4 34.26 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.999 -1.063 . . . . 0.0 110.823 -178.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.497 ' HD2' ' HB2' ' A' ' 111' ' ' SER . 0.0 OUTLIER -142.25 108.31 5.2 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.662 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -89.24 -177.53 5.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 109.598 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.65 ' HB3' HG21 ' A' ' 110' ' ' VAL . 17.2 p-10 -149.75 -176.09 5.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.339 -0.851 . . . . 0.0 109.698 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.88 76.78 1.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -172.34 -75.15 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.22 -1.164 . . . . 0.0 109.58 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 157.66 -20.6 0.38 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.49 -164.31 1.03 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -1.174 . . . . 0.0 109.587 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.583 HG23 HG22 ' A' ' 10' ' ' VAL . 60.9 t -109.43 148.97 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.897 . . . . 0.0 109.176 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 104' ' ' ASN . 96.9 t -125.93 -61.75 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.055 -1.028 . . . . 0.0 109.678 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.497 ' HB2' ' HD2' ' A' ' 102' ' ' ARG . 1.5 m -112.29 161.6 16.44 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.876 -1.14 . . . . 0.0 109.738 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 100' ' ' HIS . 15.2 ttp -158.97 155.89 28.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 109.448 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.522 ' HB3' ' CB ' ' A' ' 100' ' ' HIS . 30.8 ttm180 -140.34 168.2 20.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.87 . . . . 0.0 108.946 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.505 ' N ' ' CG ' ' A' ' 113' ' ' ARG . . . -144.58 130.86 19.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.976 -1.077 . . . . 0.0 109.682 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.766 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.3 OUTLIER -111.84 132.48 54.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 109.723 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.998 ' O ' HG11 ' B' ' 274' ' ' VAL . 9.0 p90 167.7 -158.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.537 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 164.35 -163.93 36.4 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.508 ' HA ' HG13 ' A' ' 121' ' ' ILE . 4.3 tt0 -73.88 -2.35 23.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -1.185 . . . . 0.0 109.261 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -92.57 -29.44 16.16 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.954 0.883 . . . . 0.0 109.057 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 96' ' ' ALA . 1.5 m-20 -89.04 10.73 20.57 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.332 0.587 . . . . 0.0 109.476 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.851 HG23 HG22 ' A' ' 95' ' ' VAL . 4.3 mm -94.23 -167.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.331 -0.856 . . . . 0.0 108.738 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.681 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -151.21 153.8 35.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.098 -1.001 . . . . 0.0 109.609 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.01 89.13 1.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -91.81 139.67 14.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.262 -1.14 . . . . 0.0 109.449 -179.973 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.5 ptt? . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.182 0.515 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.441 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 1.4 t-20 175.48 171.24 0.32 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.668 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 203' ' ' THR . . . . . 0.431 HG22 ' HB2' ' B' ' 205' ' ' GLU . 2.5 m -59.34 110.03 2.39 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.331 -0.856 . . . . 0.0 109.53 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 204' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.8 Cg_endo -73.63 -7.15 19.82 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.994 1.523 . . . . 0.0 110.074 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 205' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' B' ' 203' ' ' THR . 2.0 mt-10 -68.57 -45.21 72.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.329 -0.857 . . . . 0.0 109.191 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.56 -52.42 63.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.214 -0.929 . . . . 0.0 109.107 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 207' ' ' MET . . . . . 0.609 ' HA ' ' CZ ' ' B' ' 303' ' ' PHE . 74.9 mtm -62.06 -42.35 99.1 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.334 -0.854 . . . . 0.0 109.498 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 9.6 m -56.1 -37.15 68.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.171 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.42 -46.23 66.28 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.818 ' HA ' HD21 ' B' ' 229' ' ' LEU . 2.5 t -53.24 -30.38 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.723 HG11 ' CG2' ' B' ' 271' ' ' VAL . 21.0 t -84.47 -43.52 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.225 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 212' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.4 tt0 -61.71 -73.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.088 0.947 . . . . 0.0 108.624 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 1.014 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.0 OUTLIER -41.4 -45.18 3.04 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 214' ' ' TYR . . . . . 0.696 ' CE1' HD11 ' B' ' 218' ' ' LEU . 1.6 t80 -45.41 -45.45 12.77 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.973 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.1 t -90.51 -40.35 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 216' ' ' ALA . . . . . 0.708 ' HB3' ' HA ' ' B' ' 213' ' ' ARG . . . -49.21 -37.58 23.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.623 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -73.05 -31.64 64.54 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.973 HD12 ' HA ' ' B' ' 215' ' ' VAL . 5.5 mt -66.91 -59.89 3.12 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -55.59 -37.56 68.25 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.564 0.697 . . . . 0.0 109.534 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -88.59 -6.1 57.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 109.624 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.926 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 55.41 47.52 75.4 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 222' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' B' ' 224' ' ' ASP . 16.5 t70 -114.32 77.04 1.03 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -1.092 . . . . 0.0 109.753 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 223' ' ' LEU . . . . . 1.055 HD13 HD12 ' B' ' 226' ' ' ILE . 1.4 mm? -46.75 -27.2 1.12 Allowed 'General case' 0 C--N 1.307 -1.239 0 O-C-N 121.138 -0.977 . . . . 0.0 109.561 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.436 ' HB3' ' OD2' ' B' ' 222' ' ' ASP . 16.4 t0 -60.01 -50.03 75.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.325 -0.86 . . . . 0.0 109.596 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -66.64 -29.28 74.5 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 1.055 HD12 HD13 ' B' ' 223' ' ' LEU . 11.4 mt -66.19 -60.65 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.443 -1.034 . . . . 0.0 108.35 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' B' ' 252' ' ' ARG . 38.9 t -58.14 -42.31 82.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -53.25 -51.35 62.48 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 1.014 HD22 ' HB3' ' B' ' 213' ' ' ARG . 8.7 tp -64.23 -19.55 65.44 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 230' ' ' PHE . . . . . 0.686 ' CD2' HG21 ' B' ' 251' ' ' ILE . 5.9 m-85 -93.04 145.94 24.01 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.429 -0.794 . . . . 0.0 109.93 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -57.63 -163.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 109.406 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' B' ' 248' ' ' THR . 0.3 OUTLIER -77.76 -24.26 49.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.558 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 3.2 p30 -150.4 45.06 0.88 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.578 -0.701 . . . . 0.0 109.481 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.851 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -54.71 175.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 109.518 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 235' ' ' THR . . . . . 0.864 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -129.07 137.93 51.56 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.26 -0.9 . . . . 0.0 110.233 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.513 HG22 ' CE ' ' B' ' 312' ' ' MET . 7.0 t -124.32 119.72 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 237' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 0.0 OUTLIER -88.52 111.22 21.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 238' ' ' ASP . . . . . 0.672 ' OD2' ' H62' ' B' ' 326' ' ' NTH . 30.6 t70 -179.93 143.23 0.36 Allowed Pre-proline 0 C--N 1.301 -1.511 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.561 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 48.9 Cg_endo -73.96 172.79 59.73 Favored 'Cis proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.214 -1.994 . . . . 0.0 110.782 -0.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.868 HG21 HG11 ' A' ' 74' ' ' VAL . 3.3 m -57.92 146.7 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 109.037 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 241' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 75' ' ' ALA . . . 68.39 7.58 52.94 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 242' ' ' SER . . . . . 0.506 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -111.66 -153.77 0.53 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -1.121 . . . . 0.0 109.235 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -122.99 130.88 24.43 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.039 -1.038 . . . . 0.0 110.169 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 244' ' ' PRO . . . . . 0.604 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.4 Cg_endo -63.4 -165.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.138 1.599 . . . . 0.0 111.334 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.761 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -151.74 146.15 25.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.864 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.3 OUTLIER -136.98 138.67 40.79 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.931 -1.105 . . . . 0.0 110.865 -178.348 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 247' ' ' GLY . . . . . 0.558 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 122.88 146.58 7.19 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 248' ' ' THR . . . . . 0.501 ' N ' ' O ' ' B' ' 232' ' ' ASP . 3.1 m -57.85 -70.21 0.14 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.406 -1.055 . . . . 0.0 109.553 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' B' ' 248' ' ' THR . . . -45.36 -25.68 0.43 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 109.173 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.761 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -84.21 -57.51 3.14 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.366 -0.834 . . . . 0.0 109.55 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.851 HD11 ' N ' ' B' ' 234' ' ' ALA . 45.0 mt -44.82 -36.94 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -0.981 . . . . 0.0 108.944 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 252' ' ' ARG . . . . . 0.555 ' HB2' HG21 ' B' ' 227' ' ' VAL . 5.5 ttp180 -76.76 -52.73 9.03 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.506 -0.746 . . . . 0.0 109.14 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -50.9 -32.26 20.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 108.831 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.503 ' HB2' ' HD3' ' B' ' 245' ' ' ARG . 1.0 OUTLIER -82.62 -71.14 0.5 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 1.004 ' CG ' HG21 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -46.96 -26.03 0.92 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 256' ' ' ALA . . . . . 0.529 ' HA ' HD21 ' B' ' 223' ' ' LEU . . . -74.33 -51.33 15.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 108.614 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -46.94 -32.2 3.68 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 258' ' ' SER . . . . . 0.798 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 35.2 t -69.5 -37.89 77.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.1 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 0.926 HD21 ' CA ' ' B' ' 221' ' ' GLY . 7.3 tp -71.64 -32.3 67.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.526 -0.734 . . . . 0.0 109.888 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -47.27 -25.98 1.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.184 -0.947 . . . . 0.0 109.284 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 261' ' ' LEU . . . . . 0.794 HD22 HD21 ' B' ' 263' ' ' LEU . 0.3 OUTLIER -96.52 120.42 62.22 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 109.101 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 262' ' ' PRO . . . . . 0.448 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 46.7 Cg_endo -72.42 108.59 2.55 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.743 1.391 . . . . 0.0 110.728 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.794 HD21 HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -137.97 163.4 31.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.193 -0.942 . . . . 0.0 109.719 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 264' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' B' ' 284' ' ' VAL . . . -92.25 130.23 38.01 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 265' ' ' VAL . . . . . 0.519 HG21 ' HB3' ' B' ' 218' ' ' LEU . 2.0 t -117.66 117.58 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 110.104 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 29.8 tt0 -150.22 108.82 3.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.17 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.546 HD23 ' O ' ' B' ' 281' ' ' ALA . 0.6 OUTLIER -48.68 178.42 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.258 -0.901 . . . . 0.0 109.849 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 268' ' ' THR . . . . . 0.465 ' O ' ' O ' ' B' ' 269' ' ' GLN . 29.6 p -143.56 -82.71 0.17 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.84 . . . . 0.0 109.291 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 269' ' ' GLN . . . . . 0.509 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 12.0 pt20 -60.36 -144.41 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 38.7 tt0 -114.54 134.08 55.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 109.833 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 271' ' ' VAL . . . . . 0.723 ' CG2' HG11 ' B' ' 211' ' ' VAL . 41.6 t -62.09 158.69 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.374 -0.829 . . . . 0.0 109.153 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.511 ' O ' ' HB1' ' B' ' 278' ' ' ALA . 0.0 OUTLIER -122.82 135.32 54.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.025 -1.047 . . . . 0.0 110.262 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 273' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.19 128.45 12.05 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 274' ' ' VAL . . . . . 0.998 HG11 ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -137.81 152.7 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.902 -1.124 . . . . 0.0 110.557 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 275' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . 37.72 -96.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.881 -0.512 . . . . 0.0 110.524 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 276' ' ' ASN . . . . . 0.588 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 2.9 p-10 -124.97 -10.95 7.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.082 -1.011 . . . . 0.0 109.97 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 277' ' ' GLU . . . . . 0.472 ' HG3' ' HA ' ' B' ' 302' ' ' ARG . 1.0 OUTLIER -99.7 -163.57 1.04 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.834 -1.166 . . . . 0.0 109.199 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 278' ' ' ALA . . . . . 0.551 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . 179.68 166.86 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 110.047 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 279' ' ' ALA . . . . . 0.766 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -150.07 132.93 16.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 280' ' ' PHE . . . . . 0.625 ' CD1' HG22 ' B' ' 211' ' ' VAL . 21.9 p90 -150.25 170.44 18.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.624 -1.298 . . . . 0.0 110.315 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.968 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -145.27 -175.27 4.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.634 -0.666 . . . . 0.0 109.625 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 282' ' ' PHE . . . . . 0.509 ' CE1' ' CE2' ' B' ' 280' ' ' PHE . 8.1 p90 -179.14 -173.86 0.3 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.327 -0.858 . . . . 0.0 109.333 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.81 153.83 50.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.442 -0.786 . . . . 0.0 109.733 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 284' ' ' VAL . . . . . 0.718 HG13 ' CB ' ' B' ' 263' ' ' LEU . 3.7 t -142.6 119.28 6.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.373 -0.829 . . . . 0.0 109.102 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 285' ' ' SER . . . . . 0.552 ' HB3' HG23 ' B' ' 294' ' ' VAL . 0.1 OUTLIER -117.85 100.46 7.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.155 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.678 ' CD1' HD23 ' B' ' 263' ' ' LEU . 37.1 p90 -110.53 164.34 12.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.172 -0.955 . . . . 0.0 109.712 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 287' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' B' ' 288' ' ' PHE . 2.8 tm-20 -132.8 169.66 16.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' B' ' 288' ' ' PHE . 0.0 OUTLIER -118.23 -78.13 0.58 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.928 . . . . 0.0 109.88 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.22 10.48 1.29 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.388 -0.82 . . . . 0.0 110.046 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 290' ' ' GLY . . . . . 0.461 ' N ' ' OE2' ' B' ' 287' ' ' GLU . . . -178.34 -71.54 0.06 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 291' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' B' ' 287' ' ' GLU . 0.3 OUTLIER -73.72 151.59 40.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.238 -1.154 . . . . 0.0 109.06 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 292' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' B' ' 324' ' ' GLY . 0.0 OUTLIER -128.09 120.02 26.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.062 -1.024 . . . . 0.0 110.066 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 293' ' ' THR . . . . . 0.6 HG21 ' HB2' ' B' ' 322' ' ' HIS . 0.6 OUTLIER -97.25 -167.17 1.5 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 294' ' ' VAL . . . . . 0.718 HG22 ' H ' ' B' ' 295' ' ' VAL . 1.7 p -153.61 -169.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.719 -1.238 . . . . 0.0 109.579 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 1.003 HG12 ' HD3' ' B' ' 297' ' ' PRO . 6.7 t -154.87 141.05 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.809 -1.182 . . . . 0.0 109.184 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 296' ' ' ALA . . . . . . . . . . . . . . . -141.25 69.87 27.49 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.091 -1.005 . . . . 0.0 109.779 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 297' ' ' PRO . . . . . 1.003 ' HD3' HG12 ' B' ' 295' ' ' VAL . 52.1 Cg_endo -98.7 169.27 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.869 1.713 . . . . 0.0 112.454 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.968 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.5 mp -136.56 135.42 49.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 299' ' ' ASP . . . . . 0.612 ' HB3' ' CE1' ' B' ' 280' ' ' PHE . 3.9 t0 -112.33 156.68 22.06 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.782 -1.199 . . . . 0.0 111.054 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.533 ' O ' ' HG2' ' B' ' 312' ' ' MET . 45.7 t-80 -108.62 171.59 7.33 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 301' ' ' PHE . . . . . 0.646 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.49 145.61 29.2 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.461 -1.399 . . . . 0.0 111.131 -178.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' B' ' 311' ' ' SER . 8.7 ttt85 -141.16 120.24 12.85 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 303' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' B' ' 207' ' ' MET . 2.7 m-85 -90.88 -175.41 4.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.108 -0.995 . . . . 0.0 109.879 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 304' ' ' ASN . . . . . 0.638 ' HB3' HG21 ' B' ' 310' ' ' VAL . 0.6 OUTLIER -114.23 -44.32 3.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 109.291 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 305' ' ' GLY . . . . . 0.687 ' O ' ' HB3' ' B' ' 306' ' ' ALA . . . -178.02 40.75 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 306' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' B' ' 305' ' ' GLY . . . 77.02 66.11 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -1.09 . . . . 0.0 109.625 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -159.6 -65.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.92 -166.25 2.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -1.14 . . . . 0.0 109.338 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 309' ' ' VAL . . . . . 0.754 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 42.5 t -90.0 157.3 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.138 -0.976 . . . . 0.0 109.115 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' B' ' 304' ' ' ASN . 0.7 OUTLIER -133.22 -38.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 109.779 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 311' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 68.6 m -143.67 163.51 33.04 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.088 -1.008 . . . . 0.0 109.319 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 312' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 300' ' ' HIS . 2.1 ttp -157.08 167.66 29.76 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.279 -0.888 . . . . 0.0 109.936 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 313' ' ' ARG . . . . . 0.519 ' HA ' ' HB2' ' B' ' 237' ' ' GLU . 5.2 mmt180 -146.83 151.81 37.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.406 -0.808 . . . . 0.0 108.972 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -113.38 147.39 37.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 110.1 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 315' ' ' LEU . . . . . 0.854 HD11 ' CB ' ' A' ' 79' ' ' ALA . 3.1 tp -110.22 -143.01 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.729 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 316' ' ' PHE . . . . . 0.693 ' HZ ' ' H61' ' B' ' 326' ' ' NTH . 42.4 p90 44.84 -165.35 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.713 . . . . 0.0 110.029 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 317' ' ' GLY . . . . . 0.59 ' HA2' HG21 ' B' ' 240' ' ' VAL . . . -163.66 -161.08 12.29 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 318' ' ' GLU . . . . . 0.522 ' HA ' HG12 ' B' ' 321' ' ' ILE . 7.2 tt0 -79.26 5.07 13.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -1.169 . . . . 0.0 109.606 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.6 -34.81 13.17 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.185 -0.947 . . . . 0.0 109.5 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 320' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -101.05 32.12 3.35 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 321' ' ' ILE . . . . . 0.642 HG22 ' N ' ' B' ' 322' ' ' HIS . 19.6 mm -94.96 -116.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.738 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 322' ' ' HIS . . . . . 0.642 ' N ' HG22 ' B' ' 321' ' ' ILE . 5.8 p-80 -88.22 101.61 14.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.719 . . . . 0.0 112.5 -176.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -156.28 115.25 3.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.503 -0.748 . . . . 0.0 109.488 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 324' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' B' ' 292' ' ' LYS . . . 179.69 139.45 3.72 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.191 -1.182 . . . . 0.0 109.497 -179.984 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 126' ' ' NTH . . . . . 0.772 ' H11' ' HB2' ' A' ' 58' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 326' ' ' NTH . . . . . 0.798 ' H11' ' OG ' ' B' ' 258' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.313 0.578 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.539 ' HB3' ' CE ' ' A' ' 7' ' ' MET . 7.9 m120 -108.71 148.14 30.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.504 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.58 107.99 0.98 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.668 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 44.9 Cg_endo -71.85 -9.63 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.968 1.51 . . . . 0.0 110.038 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.64 -48.85 75.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.386 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -54.39 36.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.235 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.539 ' CE ' ' HB3' ' A' ' 2' ' ' ASN . 22.3 mtt -60.97 -31.0 70.59 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.176 -0.952 . . . . 0.0 109.294 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 11' ' ' VAL . 6.9 m -69.27 -36.65 77.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.12 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.06 -43.04 50.95 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.987 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.5 t -56.73 -22.67 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.847 HG22 ' CE2' ' A' ' 101' ' ' PHE . 15.9 t -90.35 -43.24 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.38 -0.825 . . . . 0.0 109.02 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 15' ' ' VAL . 6.6 tt0 -61.73 -74.0 0.09 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -42.77 -45.16 4.7 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.233 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.6 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -49.36 -44.7 45.0 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.919 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -87.65 -37.86 11.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.367 -0.833 . . . . 0.0 109.052 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.444 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -49.05 -37.55 21.31 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.7 -32.01 65.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.919 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.2 mt -67.23 -58.58 4.58 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 65' ' ' VAL . 4.4 t-20 -50.86 -42.56 58.88 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.481 0.657 . . . . 0.0 109.435 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.27 -2.58 58.52 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 109.573 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.891 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 56.73 47.77 82.81 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' CB ' ' A' ' 24' ' ' ASP . 6.9 t0 -112.08 82.23 1.59 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.204 -1.174 . . . . 0.0 109.909 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.019 ' CD2' HD22 ' A' ' 59' ' ' LEU . 3.2 mm? -48.96 -22.54 0.87 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.216 -0.928 . . . . 0.0 109.616 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' CB ' ' OD1' ' A' ' 22' ' ' ASP . 19.3 t0 -58.26 -49.83 75.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.837 . . . . 0.0 109.393 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.79 -43.07 92.57 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.722 HD12 HD13 ' A' ' 23' ' ' LEU . 9.7 mt -56.19 -52.84 46.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 23' ' ' LEU . 7.1 t -65.68 -47.44 86.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.49 -46.81 57.22 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 10' ' ' VAL . 7.8 tp -68.66 -21.37 64.45 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.763 ' CD2' HG21 ' A' ' 51' ' ' ILE . 3.1 m-85 -82.78 139.17 33.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.538 -0.726 . . . . 0.0 109.651 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . -60.49 -169.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.456 ' C ' ' HG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -70.94 -23.69 62.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.377 -0.827 . . . . 0.0 109.788 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.53 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -148.95 49.96 0.98 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.653 -0.655 . . . . 0.0 109.476 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -58.86 167.55 1.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.543 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -126.32 138.07 53.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.632 ' CG2' HD12 ' A' ' 51' ' ' ILE . 23.6 t -129.0 167.68 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.064 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.572 ' N ' HG12 ' A' ' 36' ' ' VAL . 3.0 mt-10 -143.74 118.07 9.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 108.936 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.608 ' OD2' ' HB3' ' A' ' 114' ' ' ALA . 4.1 t70 -174.94 139.7 0.63 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 109.594 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 41' ' ' GLY . 45.3 Cg_endo -71.81 -174.3 11.37 Favored 'Cis proline' 0 N--CA 1.489 1.259 0 C-N-CA 122.15 -2.021 . . . . 0.0 110.649 0.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.826 HG21 ' HB ' ' B' ' 274' ' ' VAL . 15.4 m -67.02 59.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 109.625 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 39' ' ' PRO . . . -140.42 -83.56 0.09 OUTLIER Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.422 ' C ' ' HG2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -165.5 50.92 0.1 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.641 -0.917 . . . . 0.0 109.708 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.556 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 2.4 mm-40 -134.7 58.6 29.86 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.678 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.528 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 48.5 Cg_endo -79.29 -177.74 4.11 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.204 1.633 . . . . 0.0 110.394 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 1.006 ' HG3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -150.39 102.44 3.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 108.96 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -92.25 149.34 21.51 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.146 -0.971 . . . . 0.0 110.203 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 98.67 168.22 31.06 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.459 HG23 ' CG1' ' A' ' 27' ' ' VAL . 3.7 m -80.88 -57.06 3.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -1.114 . . . . 0.0 109.093 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.87 -30.53 46.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.139 -0.976 . . . . 0.0 109.118 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.006 ' HB1' ' HG3' ' A' ' 45' ' ' ARG . . . -78.75 -53.43 7.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.431 -0.793 . . . . 0.0 109.094 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.763 HG21 ' CD2' ' A' ' 30' ' ' PHE . 6.5 mm -50.36 -36.07 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.392 -0.818 . . . . 0.0 109.294 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.721 ' HG3' HG21 ' A' ' 27' ' ' VAL . 7.6 ttp180 -74.58 -59.94 2.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 109.083 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 52' ' ' ARG . 2.0 tt0 -44.32 -27.4 0.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 108.825 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.576 ' CD1' ' HD3' ' A' ' 45' ' ' ARG . 0.6 OUTLIER -85.66 -70.08 0.62 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.352 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.709 ' C ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -53.05 -18.69 2.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.821 -0.549 . . . . 0.0 109.764 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.535 ' CB ' ' HG ' ' A' ' 23' ' ' LEU . . . -86.06 -35.78 20.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.957 . . . . 0.0 108.7 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 4.3 t30 -69.06 -39.7 78.96 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.6 ' OG ' ' H10' ' A' ' 126' ' ' NTH . 3.4 t -63.93 -33.81 76.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 108.821 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.019 HD22 ' CD2' ' A' ' 23' ' ' LEU . 8.5 tp -63.75 -20.63 65.9 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.39 -0.819 . . . . 0.0 109.645 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -53.43 -20.97 5.25 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.079 -1.013 . . . . 0.0 108.914 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.14 HD22 HD21 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.8 113.73 58.03 Favored Pre-proline 0 N--CA 1.486 1.34 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 43.8 Cg_endo -70.56 106.14 1.75 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.791 1.416 . . . . 0.0 111.149 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.14 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.65 160.23 39.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.897 . . . . 0.0 109.718 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.28 127.87 36.27 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.766 HG21 ' HB3' ' A' ' 18' ' ' LEU . 17.6 t -105.96 114.13 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.136 -0.977 . . . . 0.0 109.916 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 67' ' ' LEU . 28.2 tt0 -150.47 98.51 2.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.25 -0.906 . . . . 0.0 109.041 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -47.04 173.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.909 . . . . 0.0 109.507 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 69' ' ' GLN . 2.5 p -142.94 -81.86 0.19 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.375 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -58.43 -151.72 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.443 ' CD ' ' HE2' ' B' ' 319' ' ' LYS . 39.8 tt0 -108.94 131.67 54.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.102 -0.999 . . . . 0.0 109.761 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.039 HG13 ' HB3' ' A' ' 80' ' ' PHE . 54.1 t -58.41 147.56 6.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.375 -0.828 . . . . 0.0 109.21 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -104.01 132.61 50.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 109.673 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.75 141.15 36.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.773 ' CG1' HG21 ' B' ' 240' ' ' VAL . 0.2 OUTLIER -123.71 -157.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.899 . . . . 0.0 109.315 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -38.67 -93.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 110.22 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 3.4 m120 -104.63 -18.24 14.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -0.998 . . . . 0.0 109.79 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 4.4 mt-10 -90.35 -161.82 0.83 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.125 -0.984 . . . . 0.0 109.293 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.752 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 177.55 164.75 0.61 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 1.041 ' HB2' HD11 ' B' ' 315' ' ' LEU . . . -150.37 138.88 20.56 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 1.039 ' HB3' HG13 ' A' ' 71' ' ' VAL . 22.2 p90 -150.42 161.34 42.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.76 -1.213 . . . . 0.0 110.335 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.816 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -139.43 160.37 40.0 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 82' ' ' PHE . 1.5 p90 -157.69 -176.68 6.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 0.0 109.558 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -118.24 143.03 46.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.452 -0.78 . . . . 0.0 109.284 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.808 HG12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -120.83 124.1 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.556 ' HA ' HG23 ' A' ' 94' ' ' VAL . 1.7 p -109.94 110.55 21.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 108.918 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.631 ' CZ ' H211 ' A' ' 126' ' ' NTH . 9.0 p90 -131.39 167.47 19.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.064 -1.022 . . . . 0.0 110.225 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.52 ' HB2' ' CB ' ' A' ' 92' ' ' LYS . 42.9 tt0 -148.73 167.35 25.78 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -146.77 -100.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.952 -1.093 . . . . 0.0 110.192 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.491 ' HG2' ' N ' ' A' ' 90' ' ' GLY . 1.0 OUTLIER -61.39 -25.4 67.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 110.005 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.491 ' N ' ' HG2' ' A' ' 89' ' ' GLN . . . 168.36 -65.92 0.18 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.53 ' O ' ' CE1' ' A' ' 88' ' ' PHE . 1.6 ttm180 -55.77 118.46 4.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -1.115 . . . . 0.0 108.977 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.52 ' CB ' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -90.57 125.23 35.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.091 -1.006 . . . . 0.0 109.592 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.753 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -106.11 143.36 34.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.333 -0.855 . . . . 0.0 109.451 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.631 HG13 ' N ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER -108.31 178.07 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 1.022 HG12 ' HD3' ' A' ' 97' ' ' PRO . 3.5 t -150.87 144.78 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.029 -1.044 . . . . 0.0 110.038 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.472 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . -133.29 71.36 76.73 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.532 -0.73 . . . . 0.0 110.037 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 1.022 ' HD3' HG12 ' A' ' 95' ' ' VAL . 51.9 Cg_endo -95.56 -175.57 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.529 1.486 . . . . 0.0 110.986 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.816 HG23 ' HB2' ' A' ' 81' ' ' ALA . 3.0 mp -139.91 136.23 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.619 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 5.1 t0 -109.74 161.92 14.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.995 -1.065 . . . . 0.0 110.071 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' A' ' 112' ' ' MET . 59.6 t-80 -109.47 171.23 7.56 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.847 ' CE2' HG22 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -146.23 145.28 30.35 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.952 -1.093 . . . . 0.0 110.544 -178.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.457 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 3.3 ttm180 -144.57 114.64 7.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 0.0 108.973 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.627 ' CE2' HG21 ' A' ' 10' ' ' VAL . 4.2 m-85 -94.97 -171.72 2.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.191 -0.943 . . . . 0.0 109.489 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.805 ' HB3' HG11 ' A' ' 110' ' ' VAL . 8.9 p-10 -127.19 -34.12 2.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.446 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -161.38 24.3 0.24 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 105' ' ' GLY . . . 71.15 60.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -1.106 . . . . 0.0 109.515 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.19 -62.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -128.13 -164.7 1.4 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -1.134 . . . . 0.0 109.407 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' A' ' 30' ' ' PHE . 62.7 t -106.13 139.89 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.172 -0.955 . . . . 0.0 109.376 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.805 HG11 ' HB3' ' A' ' 104' ' ' ASN . 0.5 OUTLIER -123.27 -24.56 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -0.971 . . . . 0.0 109.833 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.79 156.32 37.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.986 . . . . 0.0 109.576 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.62 ' HE3' ' CE1' ' A' ' 30' ' ' PHE . 12.4 ttm -160.09 145.97 15.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.935 . . . . 0.0 109.671 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.473 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 7.7 mtt-85 -128.71 150.38 50.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 0.0 109.063 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.609 ' O ' HG12 ' A' ' 40' ' ' VAL . . . -118.49 150.87 38.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 109.693 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.8 OUTLIER -146.88 145.24 29.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.325 -0.859 . . . . 0.0 109.665 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.82 ' O ' HG11 ' B' ' 274' ' ' VAL . 33.9 p90 164.45 -163.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 121' ' ' ILE . . . -179.9 -169.26 39.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.516 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 21.7 tt0 -68.93 -6.65 28.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -1.076 . . . . 0.0 109.465 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -88.47 -29.8 19.88 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 122.016 0.913 . . . . 0.0 109.071 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -88.79 3.73 50.04 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.651 HG23 HG22 ' A' ' 95' ' ' VAL . 2.8 mm -91.41 -164.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.753 ' O ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -151.8 176.91 10.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.819 -1.176 . . . . 0.0 109.896 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.539 ' HA ' ' CG2' ' A' ' 93' ' ' THR . . . -155.43 136.02 13.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -0.804 . . . . 0.0 109.254 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 92' ' ' LYS . . . 76.73 -117.43 4.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.249 -1.148 . . . . 0.0 109.49 180.0 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 1.6 ttp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.234 0.54 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.447 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 3.0 t-20 65.6 63.29 0.62 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 109.581 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 203' ' ' THR . . . . . 0.539 HG23 ' O ' ' B' ' 203' ' ' THR . 2.1 t -43.61 103.29 0.31 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.933 . . . . 0.0 109.589 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 204' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 47.8 Cg_endo -74.11 -13.18 23.61 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.987 1.519 . . . . 0.0 110.348 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.9 -46.45 87.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.617 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -60.15 -52.41 65.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.086 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 207' ' ' MET . . . . . 0.611 ' HB3' ' HB1' ' B' ' 273' ' ' ALA . 73.7 mtm -68.06 -18.36 64.66 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.421 -0.8 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.487 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 5.9 m -84.22 -33.78 24.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -57.96 -48.68 79.23 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.201 -0.937 . . . . 0.0 109.206 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.65 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -49.6 -32.58 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.935 . . . . 0.0 108.531 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.527 HG11 HG21 ' B' ' 271' ' ' VAL . 4.4 t -71.83 -39.83 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 109.419 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 212' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.2 tt0 -64.82 -74.54 0.1 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.815 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.4 OUTLIER -42.0 -44.14 3.41 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 122.031 0.919 . . . . 0.0 108.697 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 214' ' ' TYR . . . . . 0.634 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -49.46 -45.41 46.63 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.266 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 1.059 HG11 HD11 ' B' ' 267' ' ' LEU . 1.4 t -88.75 -37.36 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.3 -0.875 . . . . 0.0 109.127 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' B' ' 213' ' ' ARG . . . -48.82 -34.69 12.92 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.559 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -75.24 -33.91 61.36 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.906 HD12 ' HA ' ' B' ' 215' ' ' VAL . 2.2 mt -65.09 -58.53 5.81 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -48.36 -41.03 27.51 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.593 0.711 . . . . 0.0 109.182 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.45 4.42 49.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.71 . . . . 0.0 109.842 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.919 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 48.77 31.63 10.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -97.97 87.46 3.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.325 -1.103 . . . . 0.0 109.787 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' LEU . . . . . 0.986 ' CD2' HD22 ' B' ' 259' ' ' LEU . 3.7 mm? -51.9 -19.95 2.04 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.193 -0.942 . . . . 0.0 109.848 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.58 -54.06 48.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.256 -0.902 . . . . 0.0 109.264 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -61.05 -38.37 95.44 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.897 HD12 HD13 ' B' ' 223' ' ' LEU . 8.7 mt -61.32 -57.32 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.726 HG23 ' O ' ' B' ' 223' ' ' LEU . 24.7 t -60.7 -42.98 94.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.11 -50.17 67.48 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.815 HD22 ' HB3' ' B' ' 213' ' ' ARG . 8.2 tp -67.92 -22.87 65.04 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 230' ' ' PHE . . . . . 0.653 ' CD2' HG21 ' B' ' 251' ' ' ILE . 5.3 m-85 -88.41 136.58 32.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.572 -0.705 . . . . 0.0 109.915 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -52.21 -174.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 109.354 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -25.07 49.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.749 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.545 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 0.2 OUTLIER -135.32 44.99 2.52 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.654 ' HB1' ' O ' ' B' ' 310' ' ' VAL . . . -63.62 150.17 44.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.357 -0.839 . . . . 0.0 109.989 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 235' ' ' THR . . . . . 1.037 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -108.83 149.18 29.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.478 -0.764 . . . . 0.0 109.033 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 48.7 t -140.12 122.39 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 109.695 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 237' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.6 mt-10 -89.6 104.1 16.69 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 238' ' ' ASP . . . . . 0.546 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 22.7 t70 179.66 142.16 0.33 Allowed Pre-proline 0 C--N 1.301 -1.535 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.027 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.521 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 47.5 Cg_endo -72.71 176.34 40.68 Favored 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.283 -1.965 . . . . 0.0 111.041 0.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.773 HG21 ' CG1' ' A' ' 74' ' ' VAL . 5.0 m -61.29 153.58 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 0.0 109.15 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 55.76 18.23 16.82 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 242' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -118.05 -154.57 0.57 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.41 -1.053 . . . . 0.0 109.257 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -124.63 128.88 24.81 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 110.126 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 244' ' ' PRO . . . . . 0.539 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.3 Cg_endo -64.93 -174.11 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.934 1.492 . . . . 0.0 111.145 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.917 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.65 103.24 3.09 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 246' ' ' SER . . . . . 1.037 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.24 152.12 21.75 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.17 -0.956 . . . . 0.0 109.674 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 247' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 110.25 162.64 18.8 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 5.3 m -77.16 -36.57 55.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.184 -1.186 . . . . 0.0 109.129 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -73.79 -19.69 60.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 108.97 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.917 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -90.36 -45.07 9.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.401 -0.812 . . . . 0.0 109.306 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.653 HG21 ' CD2' ' B' ' 230' ' ' PHE . 10.3 mm -61.89 -50.48 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 0.0 109.521 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 252' ' ' ARG . . . . . 0.511 ' O ' ' CB ' ' B' ' 256' ' ' ALA . 21.0 ttp180 -66.34 -52.39 47.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.049 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 253' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' B' ' 257' ' ' ASN . 22.4 mt-10 -47.91 -32.48 6.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.966 -1.083 . . . . 0.0 108.448 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.546 ' CZ ' ' O ' ' B' ' 238' ' ' ASP . 0.6 OUTLIER -84.48 -70.81 0.55 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 0.698 ' CD2' HD13 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -49.64 -22.57 1.37 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.469 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 256' ' ' ALA . . . . . 0.608 ' HB2' ' HG ' ' B' ' 223' ' ' LEU . . . -84.35 -49.11 9.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 108.744 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 257' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' B' ' 253' ' ' GLU . 10.7 t-20 -57.38 -37.49 72.76 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 258' ' ' SER . . . . . 0.683 ' OG ' H111 ' B' ' 326' ' ' NTH . 7.6 t -65.57 -32.34 73.88 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 0.986 HD22 ' CD2' ' B' ' 223' ' ' LEU . 9.5 tp -64.68 -22.43 66.98 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.413 -0.804 . . . . 0.0 109.248 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 260' ' ' LYS . . . . . 0.502 ' O ' ' HD3' ' B' ' 262' ' ' PRO . 0.0 OUTLIER -50.75 -22.53 2.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.838 . . . . 0.0 108.9 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 261' ' ' LEU . . . . . 1.028 HD21 HD21 ' B' ' 263' ' ' LEU . 0.0 OUTLIER -98.89 103.68 20.84 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 262' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 51.5 Cg_endo -76.68 125.27 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.812 1.427 . . . . 0.0 112.11 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 1.028 HD21 HD21 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -145.59 176.68 9.43 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.53 125.08 36.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 26.1 t -111.48 115.38 49.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 109.979 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 266' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.2 tp10 -150.14 89.56 1.6 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.387 -0.821 . . . . 0.0 108.938 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 1.059 HD11 HG11 ' B' ' 215' ' ' VAL . 1.0 OUTLIER -52.84 -170.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.351 -0.843 . . . . 0.0 110.0 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 268' ' ' THR . . . . . 0.667 ' O ' ' N ' ' B' ' 270' ' ' GLU . 6.5 p -136.68 53.13 1.92 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.844 . . . . 0.0 108.819 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 269' ' ' GLN . . . . . 0.549 ' CG ' ' O ' ' B' ' 268' ' ' THR . 17.9 pt20 50.7 -55.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' B' ' 268' ' ' THR . 35.5 tt0 -48.89 115.26 1.2 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.492 -1.38 . . . . 0.0 110.213 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 271' ' ' VAL . . . . . 0.588 HG13 ' HB3' ' B' ' 280' ' ' PHE . 37.7 t -138.14 154.31 28.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.7 OUTLIER -114.66 130.21 56.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.857 -1.152 . . . . 0.0 110.003 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 273' ' ' ALA . . . . . 0.611 ' HB1' ' HB3' ' B' ' 207' ' ' MET . . . -150.47 133.21 15.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.396 -0.815 . . . . 0.0 109.001 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 274' ' ' VAL . . . . . 0.826 ' HB ' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -150.34 158.86 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.935 -1.103 . . . . 0.0 110.435 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 275' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 40' ' ' VAL . . . 39.26 -101.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.77 -0.581 . . . . 0.0 110.321 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 276' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 6.0 m-80 -121.35 -20.47 6.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.957 -1.089 . . . . 0.0 109.691 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 277' ' ' GLU . . . . . 0.51 ' HG3' ' HG2' ' B' ' 302' ' ' ARG . 3.9 mt-10 -92.59 -164.95 1.25 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.042 -1.037 . . . . 0.0 109.5 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 278' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' B' ' 273' ' ' ALA . . . 177.77 154.69 0.32 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 109.519 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 279' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -136.79 141.17 42.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.945 . . . . 0.0 108.66 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 280' ' ' PHE . . . . . 0.606 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 37.9 p90 -150.72 171.15 17.61 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.735 -1.228 . . . . 0.0 110.028 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.53 ' HB2' ' CG1' ' B' ' 298' ' ' ILE . . . -145.68 -179.86 6.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.751 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 282' ' ' PHE . . . . . 0.406 ' CE1' ' HE2' ' B' ' 280' ' ' PHE . 7.0 p90 -174.32 -173.58 0.79 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.292 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 283' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -124.7 141.53 52.04 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.413 -0.805 . . . . 0.0 109.541 179.63 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 284' ' ' VAL . . . . . 1.0 HG11 HD22 ' B' ' 263' ' ' LEU . 42.1 t -120.04 113.87 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 109.469 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 1.2 p -106.14 131.75 53.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.033 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.891 ' CZ ' H212 ' B' ' 326' ' ' NTH . 1.0 OUTLIER -149.73 157.69 43.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.977 -1.077 . . . . 0.0 110.009 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 287' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' B' ' 292' ' ' LYS . 1.2 pt-20 -98.19 158.09 15.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 109.14 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.499 ' C ' ' CG ' ' B' ' 289' ' ' GLN . 0.6 OUTLIER -124.63 77.55 1.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.897 . . . . 0.0 109.594 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 289' ' ' GLN . . . . . 0.499 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 0.4 OUTLIER 40.36 57.36 2.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.424 -0.797 . . . . 0.0 110.262 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 107.63 -2.06 34.28 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.207 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -127.37 173.9 9.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.056 -1.261 . . . . 0.0 109.635 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 292' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' B' ' 287' ' ' GLU . 0.1 OUTLIER -138.17 140.1 39.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.384 179.534 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 293' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.94 148.59 34.01 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.715 -0.616 . . . . 0.0 109.464 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 294' ' ' VAL . . . . . 0.621 HG12 ' HB3' ' B' ' 322' ' ' HIS . 9.8 p -125.96 170.46 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.169 -0.957 . . . . 0.0 108.468 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 1.057 HG12 ' HD3' ' B' ' 297' ' ' PRO . 3.8 t -147.46 145.81 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.004 -1.06 . . . . 0.0 109.784 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 296' ' ' ALA . . . . . 0.471 ' O ' ' OD1' ' B' ' 320' ' ' ASN . . . -130.18 72.67 81.83 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 110.148 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 297' ' ' PRO . . . . . 1.057 ' HD3' HG12 ' B' ' 295' ' ' VAL . 50.7 Cg_endo -92.5 -175.42 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.757 1.398 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.53 ' CG1' ' HB2' ' B' ' 281' ' ' ALA . 3.2 mp -143.43 134.8 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 299' ' ' ASP . . . . . 0.606 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 11.3 t0 -108.42 162.89 13.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.951 -1.093 . . . . 0.0 110.317 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.527 ' O ' ' CG ' ' B' ' 312' ' ' MET . 51.8 t-80 -112.58 172.71 6.76 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 301' ' ' PHE . . . . . 0.612 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.13 145.12 29.47 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.994 -1.066 . . . . 0.0 110.475 -178.478 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.538 ' CD ' ' HB2' ' B' ' 311' ' ' SER . 2.6 ttt-85 -139.3 107.0 5.61 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 303' ' ' PHE . . . . . 0.623 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 5.4 m-85 -90.72 -171.38 3.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.184 -0.948 . . . . 0.0 109.871 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 304' ' ' ASN . . . . . 0.837 ' HB3' HG21 ' B' ' 310' ' ' VAL . 0.5 OUTLIER -124.32 -37.65 2.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.854 . . . . 0.0 109.271 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 305' ' ' GLY . . . . . 0.7 ' O ' ' HB3' ' B' ' 306' ' ' ALA . . . -164.29 24.42 0.18 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 306' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' B' ' 305' ' ' GLY . . . 75.76 64.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -1.183 . . . . 0.0 109.581 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -158.53 -58.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.32 -168.29 1.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -1.14 . . . . 0.0 109.381 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 309' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' B' ' 230' ' ' PHE . 70.1 t -108.49 135.05 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -0.947 . . . . 0.0 109.115 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.837 HG21 ' HB3' ' B' ' 304' ' ' ASN . 10.0 t -110.54 -75.33 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.021 . . . . 0.0 109.979 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 311' ' ' SER . . . . . 0.538 ' HB2' ' CD ' ' B' ' 302' ' ' ARG . 28.8 m -107.45 162.01 14.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.634 -1.291 . . . . 0.0 109.615 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 312' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 15.3 ttp -153.95 150.31 28.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 313' ' ' ARG . . . . . 0.509 ' CG ' ' HB2' ' B' ' 237' ' ' GLU . 2.0 mtm-85 -127.79 150.47 49.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.377 -0.827 . . . . 0.0 109.068 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 314' ' ' ALA . . . . . 0.49 ' CB ' ' OD1' ' B' ' 238' ' ' ASP . . . -110.52 130.44 55.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.084 -1.01 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 315' ' ' LEU . . . . . 1.041 HD11 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -124.99 135.98 53.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.092 -1.005 . . . . 0.0 110.074 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 316' ' ' PHE . . . . . 0.675 ' O ' HG13 ' A' ' 74' ' ' VAL . 34.3 p90 165.91 -156.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 317' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' B' ' 321' ' ' ILE . . . 165.1 -174.47 41.01 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 318' ' ' GLU . . . . . 0.54 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 13.0 tt0 -68.25 -7.18 28.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -1.134 . . . . 0.0 109.474 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 319' ' ' LYS . . . . . 0.443 ' HE2' ' CD ' ' A' ' 70' ' ' GLU . 3.5 tttp -89.55 -30.48 18.17 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.04 0.924 . . . . 0.0 109.108 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 320' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.11 6.46 39.83 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 321' ' ' ILE . . . . . 0.652 HG22 ' H ' ' B' ' 322' ' ' HIS . 4.1 mm -90.09 -170.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 322' ' ' HIS . . . . . 0.652 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.0 OUTLIER -151.9 174.05 14.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.909 -1.119 . . . . 0.0 110.11 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -155.67 173.68 16.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.078 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 174.95 141.58 3.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.172 -1.193 . . . . 0.0 109.595 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 126' ' ' NTH . . . . . 1.0 H183 HD13 ' A' ' 61' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 326' ' ' NTH . . . . . 1.012 H121 HD22 ' B' ' 261' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 2' ' ' ASN . 1.4 mtt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.207 0.527 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.486 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 33.8 m-20 -169.03 44.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.93 . . . . 0.0 109.626 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.3 m -83.2 110.6 24.83 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.824 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 46.6 Cg_endo -72.98 -4.25 15.08 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.871 1.458 . . . . 0.0 110.202 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.97 -44.77 53.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -50.53 72.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.41 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.58 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 64.9 mtm -60.89 -27.76 68.39 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.214 -0.929 . . . . 0.0 109.735 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.448 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 15.9 m -76.99 -37.49 55.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.366 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.59 -46.38 77.26 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.183 -0.948 . . . . 0.0 108.953 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.951 ' HA ' HD21 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -49.46 -43.43 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 8' ' ' THR . 4.9 t -60.15 -40.08 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.709 -0.619 . . . . 0.0 109.725 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 13' ' ' ARG . 17.3 tt0 -63.83 -75.63 0.08 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.158 -0.963 . . . . 0.0 108.621 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.985 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -43.06 -44.64 4.93 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.612 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -49.33 -46.13 46.44 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.943 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -88.28 -39.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.59 -36.43 15.62 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.586 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -73.82 -33.2 64.07 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.943 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.0 mt -64.2 -58.24 7.15 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -51.08 -46.75 61.86 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.708 0.766 . . . . 0.0 109.149 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.32 10.14 23.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.533 -0.729 . . . . 0.0 109.445 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.688 ' HA2' HD11 ' A' ' 59' ' ' LEU . . . 47.77 30.1 6.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 17' ' ' ALA . 19.2 t70 -90.03 62.75 5.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -1.152 . . . . 0.0 109.81 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.098 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -47.58 -38.03 13.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.11 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 23' ' ' LEU . 1.7 m-20 -43.21 -36.71 1.85 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.97 -30.86 30.47 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.853 HD12 HD12 ' A' ' 23' ' ' LEU . 49.6 mt -61.51 -55.97 20.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 52' ' ' ARG . 29.7 t -60.0 -38.2 75.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.28 -54.17 50.0 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.985 HD22 ' HB3' ' A' ' 13' ' ' ARG . 9.1 tp -62.58 -23.43 67.02 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.535 ' HD2' HG21 ' A' ' 51' ' ' ILE . 3.6 m-30 -91.27 142.79 27.33 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.483 -0.761 . . . . 0.0 109.7 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -52.36 -174.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.383 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.4 OUTLIER -81.32 -24.69 36.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.651 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.586 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -132.7 42.41 3.09 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.586 -0.696 . . . . 0.0 109.446 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.62 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -59.95 157.39 12.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 109.896 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.938 HG23 ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -111.66 144.91 40.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.007 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 55.7 t -133.1 130.64 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.069 -1.019 . . . . 0.0 109.835 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.569 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 23.1 mt-10 -107.92 110.13 21.81 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.823 ' OD1' ' HB3' ' A' ' 114' ' ' ALA . 17.6 t70 179.19 139.89 0.28 Allowed Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.782 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 38' ' ' ASP . 43.5 Cg_endo -69.65 -179.84 20.09 Favored 'Cis proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.353 -1.936 . . . . 0.0 111.055 -0.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 40' ' ' VAL . 2.4 t -55.07 139.99 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 110.024 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.449 ' HA3' ' HB1' ' B' ' 275' ' ' ALA . . . 49.55 38.39 28.21 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.524 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -116.03 -141.77 0.37 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.41 -1.053 . . . . 0.0 109.802 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 7.1 pm0 -119.12 101.48 49.73 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.838 -1.164 . . . . 0.0 110.764 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.569 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 37.5 Cg_endo -63.31 175.87 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.984 1.518 . . . . 0.0 110.707 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.95 ' HG3' ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -151.49 114.27 4.67 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.938 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -99.93 155.47 17.67 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 110.074 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 109.21 155.95 16.86 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 7.3 m -66.92 -56.46 10.16 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.322 -1.105 . . . . 0.0 108.977 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -57.93 -18.92 26.33 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.291 -0.881 . . . . 0.0 109.119 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.95 ' HB1' ' HG3' ' A' ' 45' ' ' ARG . . . -89.54 -54.84 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.381 -0.824 . . . . 0.0 109.182 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.537 HD13 ' O ' ' A' ' 45' ' ' ARG . 2.9 mm -51.58 -39.88 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.391 -0.818 . . . . 0.0 109.203 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.915 ' HG3' HD23 ' A' ' 23' ' ' LEU . 5.0 ttt85 -74.38 -55.34 6.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.026 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 4.8 mt-10 -49.12 -27.75 3.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.07 -1.019 . . . . 0.0 108.867 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -87.65 -71.5 0.57 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 1.098 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -47.28 -39.06 13.68 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 52' ' ' ARG . . . -57.82 -50.92 71.65 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 39.6 t-20 -53.99 -42.55 69.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.822 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 6.9 t -59.58 -31.55 69.56 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.688 HD11 ' HA2' ' A' ' 21' ' ' GLY . 7.5 tp -68.76 -20.26 64.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 11.8 mttm -67.75 -6.35 20.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.563 -0.711 . . . . 0.0 109.252 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.907 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -88.31 113.17 54.07 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.886 ' HD2' HD13 ' A' ' 61' ' ' LEU . 47.0 Cg_endo -73.39 82.16 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.737 1.388 . . . . 0.0 112.047 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.007 ' HB2' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -140.18 164.6 29.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.027 -1.045 . . . . 0.0 109.048 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.999 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -89.82 129.39 36.21 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.967 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.793 HG11 ' HB3' ' A' ' 18' ' ' LEU . 2.2 t -101.61 117.31 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.665 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -140.09 108.87 5.95 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.317 -0.865 . . . . 0.0 109.226 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.674 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -48.52 178.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.805 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.686 ' O ' ' N ' ' A' ' 70' ' ' GLU . 4.6 p -126.89 44.53 2.88 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.384 -0.822 . . . . 0.0 109.094 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.537 ' CG ' ' O ' ' A' ' 68' ' ' THR . 4.2 pt20 49.94 -55.39 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.686 ' N ' ' O ' ' A' ' 68' ' ' THR . 67.7 tt0 -63.32 118.15 7.62 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.535 -1.353 . . . . 0.0 110.227 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.9 t -130.57 146.0 34.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 1.001 ' CG ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -118.17 130.65 56.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.895 -1.128 . . . . 0.0 109.731 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.558 ' N ' ' HD2' ' A' ' 72' ' ' ARG . . . -147.44 117.45 7.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.717 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.667 HG21 ' O ' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -135.77 160.72 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.964 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . 40.48 -143.43 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.751 -0.593 . . . . 0.0 109.914 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 103' ' ' PHE . 7.6 m-20 -90.38 12.24 19.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.105 -0.997 . . . . 0.0 109.611 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.511 ' CG ' ' HG3' ' A' ' 102' ' ' ARG . 2.3 mt-10 -115.51 -161.51 0.79 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.09 -1.006 . . . . 0.0 109.466 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.987 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . -179.24 163.89 1.32 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.388 -0.82 . . . . 0.0 109.962 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 1.069 ' HB2' HD11 ' B' ' 315' ' ' LEU . . . -151.7 131.68 13.4 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 31.3 p90 -151.09 174.89 12.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.733 -1.229 . . . . 0.0 109.958 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.897 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -144.39 176.94 8.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 109.91 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -165.05 -169.0 1.55 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.496 -0.753 . . . . 0.0 109.133 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.75 147.8 50.1 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 110.104 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.007 HG12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -117.51 124.33 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 109.067 179.55 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.999 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 27.8 p -118.17 120.76 38.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.588 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.778 ' CD1' HD23 ' A' ' 63' ' ' LEU . 7.2 p90 -147.04 -173.5 4.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -121.79 169.33 10.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 -159.35 0.95 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 109.957 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -104.0 89.11 3.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.25 -18.17 52.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -143.91 167.11 23.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -1.08 . . . . 0.0 109.264 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.34 145.06 41.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.35 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -139.14 142.75 38.02 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 110.178 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.731 HG12 ' CB ' ' A' ' 122' ' ' HIS . 0.8 OUTLIER -123.62 179.19 2.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 1.063 HG22 HG23 ' A' ' 121' ' ' ILE . 6.8 t -146.81 142.26 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.891 -1.131 . . . . 0.0 109.796 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 120' ' ' ASN . . . -134.08 72.2 72.23 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.527 -0.733 . . . . 0.0 109.956 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 1.013 ' HD3' HG12 ' A' ' 95' ' ' VAL . 48.8 Cg_endo -94.7 -175.36 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.631 1.554 . . . . 0.0 110.973 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.897 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.7 mp -137.55 163.83 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 12.2 t0 -132.98 156.33 47.52 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.011 -1.056 . . . . 0.0 110.234 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 101' ' ' PHE . 53.5 t60 -111.84 167.84 10.05 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.987 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -139.08 153.92 48.1 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 110.607 -178.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.555 ' O ' HG23 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -143.15 98.84 3.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 109.186 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 7' ' ' MET . 5.8 m-85 -90.09 159.73 16.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 109.62 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.685 ' HB3' HG21 ' A' ' 110' ' ' VAL . 17.2 p-10 -101.24 4.45 41.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.204 -0.935 . . . . 0.0 109.795 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 165.37 -76.41 0.15 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 177.96 71.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -1.159 . . . . 0.0 109.592 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.06 -65.88 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.87 -163.8 1.22 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -1.1 . . . . 0.0 109.327 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.619 HG23 ' CG2' ' A' ' 10' ' ' VAL . 37.7 t -106.27 158.16 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.099 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.685 HG21 ' HB3' ' A' ' 104' ' ' ASN . 0.1 OUTLIER -127.44 -75.15 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.177 -0.952 . . . . 0.0 109.266 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 102' ' ' ARG . 3.3 m -108.36 161.77 14.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.11 -0.994 . . . . 0.0 109.167 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 11.5 ttp -160.01 148.25 17.01 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.178 -0.951 . . . . 0.0 110.072 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.612 ' NH2' ' CE1' ' B' ' 300' ' ' HIS . 0.0 OUTLIER -134.33 158.39 43.92 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.823 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . . . -125.77 141.71 51.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 109.78 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.713 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.7 OUTLIER -129.21 146.65 51.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.357 -0.839 . . . . 0.0 109.485 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.63 ' O ' HG11 ' B' ' 274' ' ' VAL . 0.1 OUTLIER 176.54 -155.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.691 0.758 . . . . 0.0 109.484 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.502 ' N ' ' CG ' ' A' ' 116' ' ' PHE . . . 163.38 176.84 35.77 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.512 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 24.2 tt0 -68.64 -7.74 35.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -1.109 . . . . 0.0 109.49 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.503 ' CE ' ' OE2' ' B' ' 270' ' ' GLU . 14.5 tttp -89.52 -27.54 20.23 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.997 0.904 . . . . 0.0 108.778 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -89.16 9.81 24.21 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.063 HG23 HG22 ' A' ' 95' ' ' VAL . 3.6 mm -96.04 -159.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.278 -0.889 . . . . 0.0 108.637 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.731 ' CB ' HG12 ' A' ' 94' ' ' VAL . 20.3 t-80 -151.32 168.88 23.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.074 -1.016 . . . . 0.0 109.864 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 122' ' ' HIS . . . -144.77 167.83 21.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.372 -0.83 . . . . 0.0 109.413 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.46 177.65 35.9 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.223 -1.163 . . . . 0.0 109.492 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 80.9 mtp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.272 0.558 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -166.41 46.43 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.394 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 203' ' ' THR . 7.5 t -58.54 121.86 56.21 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 109.702 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.06 -4.89 15.79 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.853 1.449 . . . . 0.0 109.478 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -55.25 32.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.367 -0.833 . . . . 0.0 109.301 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -49.61 75.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 108.857 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 207' ' ' MET . . . . . 0.626 ' HE1' ' HA ' ' B' ' 306' ' ' ALA . 24.0 mmt -50.28 -41.84 51.34 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.348 -0.845 . . . . 0.0 109.404 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 4.8 m -60.36 -34.93 74.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.485 -0.759 . . . . 0.0 109.084 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -51.36 -42.74 61.52 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.291 -0.881 . . . . 0.0 108.739 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 1.008 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -57.75 -26.62 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.846 HG22 ' CE2' ' B' ' 301' ' ' PHE . 25.5 t -90.09 -44.63 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.858 . . . . 0.0 109.308 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 212' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 213' ' ' ARG . 5.4 tt0 -58.05 -73.19 0.08 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.475 ' HD3' HD13 ' B' ' 229' ' ' LEU . 0.3 OUTLIER -43.42 -45.14 6.13 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.98 0.895 . . . . 0.0 108.693 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 214' ' ' TYR . . . . . 0.626 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.3 OUTLIER -52.02 -42.46 63.07 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.931 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -87.67 -38.88 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.284 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 216' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.66 -35.08 13.02 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.551 ' HB1' HG13 ' B' ' 226' ' ' ILE . . . -75.32 -32.79 61.05 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.931 HD12 ' HA ' ' B' ' 215' ' ' VAL . 1.7 mt -64.59 -57.9 7.83 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 219' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 8.5 t30 -54.35 -46.33 72.93 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.497 0.665 . . . . 0.0 109.312 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -88.92 9.6 24.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.599 -0.688 . . . . 0.0 109.733 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.987 ' HA2' HD21 ' B' ' 259' ' ' LEU . . . 48.9 34.29 15.24 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 222' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' B' ' 217' ' ' ALA . 16.8 t0 -91.56 61.66 4.34 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.251 -1.146 . . . . 0.0 109.812 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 223' ' ' LEU . . . . . 1.055 HD12 HD12 ' B' ' 226' ' ' ILE . 6.7 tp -46.31 -43.58 15.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 108.695 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' B' ' 223' ' ' LEU . 2.2 m-20 -42.69 -33.28 0.7 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 225' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' B' ' 228' ' ' ALA . . . -85.15 -33.93 16.17 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 1.055 HD12 HD12 ' B' ' 223' ' ' LEU . 23.3 mt -60.82 -53.78 44.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.533 ' CG1' HG23 ' B' ' 248' ' ' THR . 72.5 t -59.18 -35.97 60.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' B' ' 225' ' ' GLY . . . -58.69 -56.1 26.6 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 1.008 HD21 ' HA ' ' B' ' 210' ' ' VAL . 9.3 tp -58.7 -21.6 55.18 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 230' ' ' PHE . . . . . 1.021 ' CD2' HG21 ' B' ' 251' ' ' ILE . 5.0 m-85 -86.89 139.59 30.48 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.497 -0.752 . . . . 0.0 109.61 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -54.8 -167.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.674 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.476 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.5 OUTLIER -81.12 -23.15 38.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.0 109.373 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.557 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 0.1 OUTLIER -144.4 44.81 1.42 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.856 ' HB3' HD13 ' B' ' 251' ' ' ILE . . . -56.76 -170.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.648 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 235' ' ' THR . . . . . 0.62 HG22 ' HB2' ' B' ' 246' ' ' SER . 0.1 OUTLIER -134.61 141.01 46.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.4 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.706 ' CG2' HG23 ' B' ' 251' ' ' ILE . 34.6 t -116.43 166.84 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.189 -0.945 . . . . 0.0 109.112 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 237' ' ' GLU . . . . . 0.574 ' N ' HG12 ' B' ' 236' ' ' VAL . 1.1 mm-40 -151.66 116.95 5.29 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 238' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' B' ' 239' ' ' PRO . 0.8 OUTLIER 175.01 167.12 0.36 Allowed Pre-proline 0 C--N 1.301 -1.5 0 C-N-CA 118.118 -1.433 . . . . 0.0 110.354 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.834 ' O ' HG13 ' B' ' 240' ' ' VAL . 45.7 Cg_endo -73.12 -28.03 7.52 Favored 'Cis proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.727 -2.197 . . . . 0.0 110.649 0.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.834 HG13 ' O ' ' B' ' 239' ' ' PRO . 2.1 m -166.88 101.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 109.197 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.23 42.96 63.88 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 242' ' ' SER . . . . . 0.519 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 27.8 m -118.83 -112.44 0.34 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.314 -1.109 . . . . 0.0 109.817 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 243' ' ' GLU . . . . . 0.445 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 39.0 mt-10 -121.82 100.62 43.31 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.915 -1.116 . . . . 0.0 110.383 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 244' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 39.4 Cg_endo -65.43 -172.6 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.561 1.507 . . . . 0.0 110.652 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 1.019 ' HG3' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.52 98.05 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.063 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.7 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.35 166.62 13.63 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.301 -0.875 . . . . 0.0 109.896 -179.284 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 247' ' ' GLY . . . . . 0.606 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 90.48 171.09 43.84 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 248' ' ' THR . . . . . 0.533 HG23 ' CG1' ' B' ' 227' ' ' VAL . 1.8 m -89.42 -22.36 22.57 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.749 -1.442 . . . . 0.0 109.27 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -82.0 -28.02 32.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.268 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 1.019 ' HB1' ' HG3' ' B' ' 245' ' ' ARG . . . -88.98 -53.48 4.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.322 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 1.021 HG21 ' CD2' ' B' ' 230' ' ' PHE . 94.6 mt -45.25 -36.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.942 . . . . 0.0 108.852 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 252' ' ' ARG . . . . . 0.745 ' CG ' HD23 ' B' ' 223' ' ' LEU . 28.8 ttp180 -79.86 -54.18 6.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -48.95 -28.49 3.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.043 -1.035 . . . . 0.0 108.239 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.618 ' CD1' ' CD ' ' B' ' 245' ' ' ARG . 0.7 OUTLIER -83.54 -70.74 0.54 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 1.039 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.1 OUTLIER -47.2 -24.96 0.8 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 256' ' ' ALA . . . . . 0.678 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -76.32 -48.61 19.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 108.642 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 257' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 31.1 t-20 -59.13 -31.96 69.42 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 258' ' ' SER . . . . . 0.719 ' OG ' H111 ' B' ' 326' ' ' NTH . 3.0 t -72.72 -35.94 67.67 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 0.987 HD21 ' HA2' ' B' ' 221' ' ' GLY . 8.3 tp -66.81 -26.56 66.99 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.406 -0.809 . . . . 0.0 109.145 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 260' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 2.1 mttt -46.15 -25.91 0.67 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.06 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 261' ' ' LEU . . . . . 0.753 HD23 HD23 ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.75 112.31 51.22 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 262' ' ' PRO . . . . . 0.508 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 44.4 Cg_endo -71.39 117.49 5.18 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.854 1.45 . . . . 0.0 110.841 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.87 ' CB ' HG13 ' B' ' 284' ' ' VAL . 0.0 OUTLIER -145.88 164.4 32.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 109.614 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 264' ' ' ALA . . . . . 0.74 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -95.11 123.75 38.78 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 265' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' B' ' 219' ' ' ASN . 6.2 t -113.46 115.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.291 -0.88 . . . . 0.0 109.794 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 266' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.1 OUTLIER -149.84 99.37 2.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -0.906 . . . . 0.0 109.229 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -45.15 170.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.912 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 12.0 p -142.24 -37.96 0.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 109.608 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 269' ' ' GLN . . . . . 0.507 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 3.7 pt20 -95.93 -144.74 0.27 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.654 -0.654 . . . . 0.0 109.324 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.518 ' O ' ' CZ ' ' B' ' 272' ' ' ARG . 22.2 tt0 -117.53 134.1 55.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.041 -1.037 . . . . 0.0 109.829 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 271' ' ' VAL . . . . . 0.942 HG13 ' HB3' ' B' ' 280' ' ' PHE . 76.1 t -64.84 148.97 11.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.414 -0.804 . . . . 0.0 109.17 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 11.9 mmt180 -103.4 137.84 40.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 273' ' ' ALA . . . . . 0.459 ' C ' HG22 ' B' ' 274' ' ' VAL . . . -148.76 139.22 22.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 109.077 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 274' ' ' VAL . . . . . 0.63 HG11 ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -160.3 157.58 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.068 -1.02 . . . . 0.0 110.088 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 275' ' ' ALA . . . . . 0.449 ' HB1' ' HA3' ' A' ' 41' ' ' GLY . . . 40.59 -102.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.653 -0.655 . . . . 0.0 110.095 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 276' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 98.3 m-20 -129.3 5.31 5.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.898 -1.126 . . . . 0.0 109.628 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 277' ' ' GLU . . . . . 0.536 ' CG ' ' HG2' ' B' ' 302' ' ' ARG . 0.3 OUTLIER -112.6 -162.65 0.81 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.087 -1.008 . . . . 0.0 108.972 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 278' ' ' ALA . . . . . 0.573 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . 177.17 142.47 0.08 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.623 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 279' ' ' ALA . . . . . 0.713 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -125.92 136.45 53.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 108.604 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 280' ' ' PHE . . . . . 0.942 ' HB3' HG13 ' B' ' 271' ' ' VAL . 30.0 p90 -149.72 172.46 15.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.74 -1.225 . . . . 0.0 109.982 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.576 ' HB2' ' CG1' ' B' ' 298' ' ' ILE . . . -148.23 -164.95 2.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.808 . . . . 0.0 109.991 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 282' ' ' PHE . . . . . 0.49 ' CD2' ' C ' ' B' ' 281' ' ' ALA . 14.2 p90 172.14 -169.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.45 -0.781 . . . . 0.0 109.384 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.15 147.3 52.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.394 -0.816 . . . . 0.0 109.645 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 284' ' ' VAL . . . . . 0.87 HG13 ' CB ' ' B' ' 263' ' ' LEU . 3.3 t -123.8 121.13 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.868 . . . . 0.0 109.429 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 285' ' ' SER . . . . . 0.74 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 16.7 p -115.52 117.84 31.47 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.637 ' CZ ' H221 ' B' ' 326' ' ' NTH . 11.4 p90 -142.24 173.65 11.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.084 -1.01 . . . . 0.0 110.217 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 287' ' ' GLU . . . . . 0.509 ' HG2' ' N ' ' B' ' 288' ' ' PHE . 36.1 tt0 -148.42 154.03 39.35 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' B' ' 288' ' ' PHE . 0.1 OUTLIER -128.01 -96.36 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.036 -1.04 . . . . 0.0 110.358 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -110.16 93.92 4.75 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.122 -0.987 . . . . 0.0 110.443 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 62.14 11.34 32.01 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 291' ' ' ARG . . . . . 0.593 ' HB3' ' CE2' ' B' ' 288' ' ' PHE . 26.9 mtt180 -130.94 144.79 51.73 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.206 -1.173 . . . . 0.0 109.578 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 292' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' B' ' 287' ' ' GLU . 0.0 OUTLIER -136.2 120.78 18.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.347 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 293' ' ' THR . . . . . 0.673 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -122.57 143.58 49.65 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.403 -0.81 . . . . 0.0 109.717 -179.588 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 294' ' ' VAL . . . . . 0.553 HG13 ' N ' ' B' ' 295' ' ' VAL . 0.8 OUTLIER -112.92 173.55 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 1.011 HG12 ' HD3' ' B' ' 297' ' ' PRO . 2.6 t -150.41 144.41 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.955 -1.091 . . . . 0.0 110.034 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 296' ' ' ALA . . . . . 0.439 ' O ' ' CG ' ' B' ' 320' ' ' ASN . . . -133.34 73.81 73.14 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.425 -0.797 . . . . 0.0 109.208 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 297' ' ' PRO . . . . . 1.011 ' HD3' HG12 ' B' ' 295' ' ' VAL . 50.2 Cg_endo -94.48 -179.21 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.907 1.478 . . . . 0.0 111.797 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.576 ' CG1' ' HB2' ' B' ' 281' ' ' ALA . 2.9 mp -137.34 138.45 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 299' ' ' ASP . . . . . 0.613 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 14.7 t0 -113.75 164.16 14.08 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.984 -1.073 . . . . 0.0 110.24 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.612 ' CE1' ' NH2' ' A' ' 113' ' ' ARG . 7.4 t-160 -112.22 173.43 6.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 109.09 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 301' ' ' PHE . . . . . 0.846 ' CE2' HG22 ' B' ' 211' ' ' VAL . 0.2 OUTLIER -145.27 149.03 34.13 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.214 -0.929 . . . . 0.0 110.163 -178.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.536 ' HG2' ' CG ' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -138.01 104.26 5.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.828 . . . . 0.0 109.284 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 303' ' ' PHE . . . . . 0.717 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 11.6 m-85 -89.96 171.62 9.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.081 -1.012 . . . . 0.0 109.512 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 304' ' ' ASN . . . . . 0.59 ' HB3' HG21 ' B' ' 310' ' ' VAL . 9.2 p-10 -119.16 -14.25 9.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.427 -0.796 . . . . 0.0 109.132 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 305' ' ' GLY . . . . . 0.707 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -172.49 -62.81 0.05 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 306' ' ' ALA . . . . . 0.707 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 162.74 76.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -1.097 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.52 -64.48 0.06 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -119.35 -172.94 2.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -1.148 . . . . 0.0 109.664 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 309' ' ' VAL . . . . . 1.039 HG11 ' CE ' ' B' ' 312' ' ' MET . 89.7 t -110.43 150.33 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.216 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.59 HG21 ' HB3' ' B' ' 304' ' ' ASN . 42.6 t -123.27 -20.22 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.141 -0.974 . . . . 0.0 109.923 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 311' ' ' SER . . . . . 0.531 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -157.85 166.86 31.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.952 -1.092 . . . . 0.0 110.023 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 312' ' ' MET . . . . . 1.039 ' CE ' HG11 ' B' ' 309' ' ' VAL . 1.6 ttm -156.69 154.29 29.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -0.853 . . . . 0.0 109.428 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 313' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' B' ' 299' ' ' ASP . 1.2 ttt180 -130.14 153.38 48.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.227 -0.92 . . . . 0.0 109.378 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 314' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' B' ' 237' ' ' GLU . . . -100.45 157.18 16.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.738 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 315' ' ' LEU . . . . . 1.069 HD11 ' HB2' ' A' ' 79' ' ' ALA . 9.0 tp -137.1 -143.78 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.427 -0.796 . . . . 0.0 109.019 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 316' ' ' PHE . . . . . 0.667 ' O ' HG21 ' A' ' 74' ' ' VAL . 31.0 p90 39.4 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.772 0.796 . . . . 0.0 110.313 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 317' ' ' GLY . . . . . 0.703 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 173.62 -152.52 15.52 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 318' ' ' GLU . . . . . 0.542 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 6.8 tt0 -72.25 -2.36 18.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -1.153 . . . . 0.0 109.71 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.2 -32.58 15.02 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.221 -0.925 . . . . 0.0 109.316 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 320' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' B' ' 316' ' ' PHE . 1.1 m-20 -89.31 19.23 4.51 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.251 0.548 . . . . 0.0 109.821 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 321' ' ' ILE . . . . . 0.706 HG22 ' H ' ' B' ' 322' ' ' HIS . 5.1 mm -89.82 -167.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 322' ' ' HIS . . . . . 0.706 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.2 OUTLIER -151.67 155.14 37.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.056 -1.027 . . . . 0.0 109.247 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -156.15 89.26 1.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.116 -0.99 . . . . 0.0 109.773 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -107.3 111.05 3.36 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.409 -1.054 . . . . 0.0 109.441 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 126' ' ' NTH . . . . . 0.822 ' H11' ' OG ' ' A' ' 58' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 326' ' ' NTH . . . . . 0.719 H111 ' OG ' ' B' ' 258' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' C ' ' A' ' 2' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.209 0.528 . . . . 0.0 110.12 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.491 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.3 t30 43.62 40.43 2.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.707 HG23 ' O ' ' A' ' 3' ' ' THR . 9.8 t -90.58 107.68 21.93 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.389 -0.819 . . . . 0.0 109.536 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 45.5 Cg_endo -72.78 -10.52 25.04 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.869 1.457 . . . . 0.0 110.17 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -32.77 68.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 109.692 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.85 -51.0 5.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.926 . . . . 0.0 109.423 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.441 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 17.3 mtt -61.14 -48.19 82.76 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.268 -0.895 . . . . 0.0 109.902 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 4' ' ' PRO . 17.7 m -53.53 -39.05 64.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.487 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.81 -48.06 73.26 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.259 -0.901 . . . . 0.0 108.866 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.655 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.2 t -52.49 -28.68 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.934 HG22 ' CE2' ' A' ' 101' ' ' PHE . 6.6 t -85.47 -42.61 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.239 -0.913 . . . . 0.0 109.354 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.2 tt0 -59.61 -73.65 0.08 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.806 ' HD2' HD13 ' A' ' 29' ' ' LEU . 2.7 mtm180 -43.45 -46.12 6.63 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.709 ' CE1' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -53.13 -41.22 64.85 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.916 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -84.01 -36.58 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.092 -1.005 . . . . 0.0 108.928 179.389 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.71 -39.55 65.3 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -71.22 -32.36 68.7 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -63.27 -58.18 8.01 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.13 -42.47 60.75 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.64 0.733 . . . . 0.0 109.269 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.58 2.35 53.23 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.68 -0.637 . . . . 0.0 109.604 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 1.086 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 49.79 38.24 29.61 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.47 ' O ' HG13 ' A' ' 26' ' ' ILE . 29.6 t70 -92.18 77.85 5.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -1.033 . . . . 0.0 109.865 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.083 ' CD2' HD22 ' A' ' 59' ' ' LEU . 2.8 mm? -50.69 -29.05 10.27 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.334 -0.853 . . . . 0.0 110.12 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -63.93 -56.43 15.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.975 . . . . 0.0 109.366 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.43 ' N ' ' OD2' ' A' ' 22' ' ' ASP . . . -59.0 -28.24 63.41 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.023 HD12 HD13 ' A' ' 23' ' ' LEU . 55.8 mt -63.62 -58.08 8.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.948 HG11 HG23 ' A' ' 48' ' ' THR . 43.6 t -55.82 -41.26 65.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.48 -49.98 71.09 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.806 HD13 ' HD2' ' A' ' 13' ' ' ARG . 2.9 tp -72.35 -21.0 61.37 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.553 -0.717 . . . . 0.0 109.265 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.602 ' CZ ' ' CE ' ' A' ' 112' ' ' MET . 7.2 m-85 -92.41 140.84 29.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.372 -0.83 . . . . 0.0 109.561 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -51.67 178.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.073 -1.017 . . . . 0.0 109.344 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.02 -23.89 59.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.175 -0.953 . . . . 0.0 109.241 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.51 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -137.75 30.41 2.56 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.759 -0.588 . . . . 0.0 109.633 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.737 ' N ' HD11 ' A' ' 51' ' ' ILE . . . -53.21 -173.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.159 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.661 HG23 ' HB2' ' A' ' 46' ' ' SER . 0.2 OUTLIER -145.3 147.38 32.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.16 -0.963 . . . . 0.0 110.187 -179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.52 ' O ' ' HB3' ' A' ' 44' ' ' PRO . 9.5 t -134.56 118.16 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.521 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 2.3 mm-40 -88.3 104.94 17.21 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.529 ' O ' ' CE2' ' A' ' 54' ' ' PHE . 9.9 t0 -176.99 142.76 0.53 Allowed Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.92 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 47.8 Cg_endo -73.85 -166.48 4.63 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.28 -1.967 . . . . 0.0 110.651 -0.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.961 HG21 HG11 ' B' ' 274' ' ' VAL . 15.3 m -75.97 141.64 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.132 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.29 1.63 64.98 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.509 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -105.59 -155.26 0.54 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.265 -1.138 . . . . 0.0 109.355 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.442 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 27.9 mm-40 -127.74 131.88 24.05 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.08 -1.012 . . . . 0.0 110.07 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.521 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.0 Cg_endo -64.0 -166.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.575 1.517 . . . . 0.0 111.073 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 1.037 ' CG ' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -150.62 102.64 3.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.509 -0.744 . . . . 0.0 109.049 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.661 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.2 147.04 24.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.21 -0.931 . . . . 0.0 109.768 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 111.26 159.8 16.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.948 HG23 HG11 ' A' ' 27' ' ' VAL . 11.3 m -70.97 -43.33 68.29 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.059 -1.26 . . . . 0.0 109.291 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -66.78 -31.78 72.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.15 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.037 ' HB1' ' CG ' ' A' ' 45' ' ' ARG . . . -80.44 -60.37 2.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.898 . . . . 0.0 109.331 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.737 HD11 ' N ' ' A' ' 34' ' ' ALA . 39.3 mt -43.35 -38.28 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.371 -0.831 . . . . 0.0 109.003 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.518 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 4.8 ttt-85 -84.98 -55.18 4.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.536 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 26.1 tt0 -47.71 -26.08 1.43 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.565 ' CD1' ' HD3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -84.2 -71.79 0.5 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.717 ' CE1' HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -52.46 -20.82 3.13 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.24 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.479 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . . . -76.4 -44.73 34.84 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 48.8 t30 -64.49 -32.0 73.45 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 t -72.09 -35.35 69.2 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.086 HD21 ' CA ' ' A' ' 21' ' ' GLY . 3.1 tp -69.61 -24.82 63.72 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.458 -0.776 . . . . 0.0 109.383 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -43.85 -27.5 0.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 108.823 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.047 HD22 HD21 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -91.63 109.02 33.67 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.444 ' C ' ' HG ' ' A' ' 63' ' ' LEU . 45.1 Cg_endo -70.65 110.85 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.844 1.444 . . . . 0.0 111.332 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.047 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -138.46 173.1 11.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 109.497 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.843 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -102.36 127.54 49.32 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 18' ' ' LEU . 95.8 t -108.23 124.72 64.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 110.034 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -150.04 112.12 4.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.537 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.711 HD22 ' CG2' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -48.03 176.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.219 -0.926 . . . . 0.0 109.811 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.52 -81.97 0.43 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.278 -0.889 . . . . 0.0 109.293 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.594 ' HG2' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -123.43 -55.33 1.75 Allowed 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.807 -179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.594 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 17.2 tt0 -140.55 153.99 46.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.94 -1.1 . . . . 0.0 110.442 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.949 HG13 ' HB3' ' A' ' 80' ' ' PHE . 19.0 t -99.57 149.12 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -95.26 128.96 42.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.483 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.562 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -148.25 137.1 21.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.142 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.815 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -165.64 154.19 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 109.793 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 1.036 ' CB ' HG12 ' B' ' 240' ' ' VAL . . . 43.14 -147.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 0.0 109.827 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 103' ' ' PHE . 30.8 m-80 -88.98 26.54 1.54 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.279 -0.888 . . . . 0.0 109.609 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.9 OUTLIER -129.68 -159.57 0.97 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.268 -0.895 . . . . 0.0 109.061 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.86 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 168.18 157.59 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.41 -0.806 . . . . 0.0 109.794 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.733 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -151.2 139.37 20.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 108.902 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.949 ' HB3' HG13 ' A' ' 71' ' ' VAL . 24.4 p90 -149.57 161.77 41.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.655 -1.278 . . . . 0.0 109.787 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.608 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -130.69 -174.99 3.52 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.574 0.702 . . . . 0.0 110.016 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CE2' ' CE2' ' A' ' 80' ' ' PHE . 19.6 p90 172.21 -172.11 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.546 -0.721 . . . . 0.0 109.22 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -128.34 141.11 51.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.482 -0.761 . . . . 0.0 109.551 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.579 HG12 ' CB ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -101.83 122.13 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 108.952 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.843 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 1.1 p -118.07 102.76 9.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 109.683 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.85 ' CD1' HD23 ' A' ' 63' ' ' LEU . 17.7 p90 -123.02 159.72 27.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.096 -1.003 . . . . 0.0 109.276 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -95.71 171.01 8.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.133 -0.979 . . . . 0.0 109.651 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.08 -160.99 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 109.578 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.83 36.44 1.54 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.319 -0.863 . . . . 0.0 109.095 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.49 -30.3 0.17 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -137.29 -167.78 2.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -1.172 . . . . 0.0 109.352 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.01 136.18 50.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 109.692 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -120.4 157.48 29.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.271 -0.893 . . . . 0.0 109.874 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.548 HG13 ' CB ' ' A' ' 122' ' ' HIS . 12.0 p -138.24 163.9 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.314 -0.866 . . . . 0.0 109.138 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 120' ' ' ASN . 41.4 t -142.44 155.49 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.987 -1.071 . . . . 0.0 109.93 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 120' ' ' ASN . . . -127.86 73.81 78.77 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.494 -0.754 . . . . 0.0 109.818 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.561 ' HD3' HG12 ' A' ' 95' ' ' VAL . 44.0 Cg_endo -95.39 175.49 0.98 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.586 1.524 . . . . 0.0 111.578 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.608 HG23 ' HB2' ' A' ' 81' ' ' ALA . 3.4 mp -143.19 152.39 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.623 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 12.7 t0 -125.42 161.49 26.94 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.004 -1.06 . . . . 0.0 110.229 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 113' ' ' ARG . 5.2 t60 -108.22 179.82 4.1 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.934 ' CE2' HG22 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -146.24 160.18 42.33 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.756 -1.215 . . . . 0.0 110.597 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.554 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -147.09 103.92 3.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.655 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -90.0 -171.06 3.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.165 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.794 ' OD1' HG23 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -139.42 -101.89 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.462 -0.774 . . . . 0.0 109.526 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.692 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -96.44 21.03 47.8 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 105' ' ' GLY . . . 77.35 66.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -1.112 . . . . 0.0 109.502 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.54 -65.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -128.93 -178.23 4.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -1.134 . . . . 0.0 109.507 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.766 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 45.3 t -94.0 141.52 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.375 -0.828 . . . . 0.0 109.395 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.794 HG23 ' OD1' ' A' ' 104' ' ' ASN . 24.6 t -121.95 -15.22 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 109.976 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.554 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.3 OUTLIER -158.68 157.32 31.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.93 -1.106 . . . . 0.0 109.956 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.724 ' HE2' ' CE1' ' A' ' 101' ' ' PHE . 8.0 ttm -155.46 160.43 40.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.426 -0.796 . . . . 0.0 109.456 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 100' ' ' HIS . 10.1 ttp180 -149.75 114.41 5.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.858 . . . . 0.0 109.403 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 99' ' ' ASP . . . -89.98 137.59 32.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.082 -1.011 . . . . 0.0 109.461 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.954 HD22 ' CB ' ' B' ' 279' ' ' ALA . 1.0 OUTLIER -134.12 143.65 48.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.965 . . . . 0.0 110.102 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.716 ' CE2' ' H61' ' A' ' 126' ' ' NTH . 32.9 p90 164.36 -163.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.609 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . -176.15 -179.86 46.85 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.246 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.524 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 11.9 tt0 -50.63 -21.46 1.58 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -1.138 . . . . 0.0 109.304 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -22.55 60.7 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.017 0.913 . . . . 0.0 108.668 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.633 ' O ' HG13 ' A' ' 95' ' ' VAL . 1.0 OUTLIER -88.72 3.27 51.45 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.676 -179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 122' ' ' HIS . 4.2 mm -93.39 -179.34 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.028 -1.045 . . . . 0.0 109.372 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.612 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.7 OUTLIER -151.56 161.46 42.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.509 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.38 152.86 29.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.513 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.9 -128.4 9.49 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.277 -1.131 . . . . 0.0 109.505 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.219 0.533 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -120.92 55.79 1.03 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.1 111.0 44.3 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.348 -0.845 . . . . 0.0 109.558 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 204' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' B' ' 208' ' ' THR . 44.3 Cg_endo -71.38 -8.57 23.63 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.832 1.438 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -66.41 -45.46 79.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.043 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -55.69 6.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 109.161 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 13.0 mmt -53.52 -41.96 66.89 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.432 ' CB ' ' O ' ' B' ' 204' ' ' PRO . 6.0 m -63.38 -35.51 80.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 109.06 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -51.13 -44.08 61.29 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.218 -0.926 . . . . 0.0 108.72 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 1.016 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.1 t -57.08 -25.44 22.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.893 HG22 ' CE2' ' B' ' 301' ' ' PHE . 23.9 t -88.43 -44.88 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.832 . . . . 0.0 109.159 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 212' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' B' ' 213' ' ' ARG . 24.6 tt0 -58.99 -73.96 0.07 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' B' ' 212' ' ' GLN . 0.2 OUTLIER -42.77 -44.53 4.44 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 214' ' ' TYR . . . . . 0.64 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -51.21 -44.87 61.71 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.543 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.907 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.08 -41.23 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 216' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.39 -35.03 11.82 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.57 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -75.86 -33.46 60.0 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' B' ' 215' ' ' VAL . 3.1 mt -62.84 -57.39 11.03 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 219' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' B' ' 265' ' ' VAL . 4.6 t30 -53.68 -45.67 70.4 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.576 0.703 . . . . 0.0 109.578 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.14 7.23 36.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.476 -0.765 . . . . 0.0 109.745 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.862 ' HA2' HD11 ' B' ' 259' ' ' LEU . . . 51.83 42.06 52.51 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 222' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' B' ' 217' ' ' ALA . 18.0 t70 -97.8 61.44 1.57 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.112 . . . . 0.0 109.928 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 223' ' ' LEU . . . . . 1.054 HD12 HD12 ' B' ' 226' ' ' ILE . 7.1 tp -47.79 -44.12 28.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 108.883 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' B' ' 223' ' ' LEU . 3.9 t0 -43.86 -39.5 3.92 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 225' ' ' GLY . . . . . 0.481 ' HA3' ' OD2' ' B' ' 222' ' ' ASP . . . -80.77 -32.35 33.42 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 1.054 HD12 HD12 ' B' ' 223' ' ' LEU . 13.8 mt -61.97 -58.48 7.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.458 ' HA ' ' HB2' ' B' ' 230' ' ' PHE . 50.7 t -54.57 -39.73 47.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.71 -54.63 41.94 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 1.016 HD21 ' HA ' ' B' ' 210' ' ' VAL . 7.7 tp -61.76 -22.9 65.8 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 230' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' B' ' 231' ' ' ALA . 6.5 m-85 -90.85 132.43 35.9 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.428 -0.795 . . . . 0.0 109.918 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' B' ' 309' ' ' VAL . . . -50.66 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 0.0 109.652 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' B' ' 248' ' ' THR . 0.2 OUTLIER -76.31 -24.4 54.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 109.733 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.521 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 0.1 OUTLIER -133.46 39.76 3.2 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.474 -0.766 . . . . 0.0 109.764 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.899 ' O ' HD11 ' B' ' 251' ' ' ILE . . . -64.0 144.49 57.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.138 -0.976 . . . . 0.0 109.346 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 235' ' ' THR . . . . . 0.99 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -106.18 139.58 40.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 0.0 109.6 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' B' ' 244' ' ' PRO . 55.2 t -132.72 118.39 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.411 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 237' ' ' GLU . . . . . 0.515 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 29.3 mt-10 -89.42 106.24 18.32 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 238' ' ' ASP . . . . . 0.653 ' OD2' ' H62' ' B' ' 326' ' ' NTH . 28.4 t70 -179.67 141.68 0.35 Allowed Pre-proline 0 C--N 1.302 -1.484 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.492 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.492 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 48.4 Cg_endo -74.11 169.89 72.47 Favored 'Cis proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.295 -1.961 . . . . 0.0 110.545 0.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 1.036 HG12 ' CB ' ' A' ' 75' ' ' ALA . 8.0 t -67.47 113.99 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.179 -0.951 . . . . 0.0 109.236 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 112.93 -2.52 25.74 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 242' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 17.5 m -109.38 -113.05 0.31 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -1.124 . . . . 0.0 109.212 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 243' ' ' GLU . . . . . 0.469 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 1.2 pp20? -164.34 131.46 2.42 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.904 -1.122 . . . . 0.0 109.612 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 244' ' ' PRO . . . . . 0.515 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.8 Cg_endo -64.83 -177.34 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.011 1.532 . . . . 0.0 111.13 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.77 ' HB3' ' HB1' ' B' ' 250' ' ' ALA . 11.1 mmt180 -150.54 99.94 2.8 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.99 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -88.88 164.71 15.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.32 -0.863 . . . . 0.0 109.748 -179.153 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 247' ' ' GLY . . . . . 0.521 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 101.46 162.19 27.19 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 248' ' ' THR . . . . . 0.525 ' N ' ' O ' ' B' ' 232' ' ' ASP . 5.9 m -70.04 -52.81 20.99 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.163 -1.198 . . . . 0.0 109.382 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -59.68 -40.75 88.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.162 -0.961 . . . . 0.0 109.438 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.77 ' HB1' ' HB3' ' B' ' 245' ' ' ARG . . . -68.37 -54.9 14.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 109.605 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.899 HD11 ' O ' ' B' ' 234' ' ' ALA . 8.5 mm -47.39 -36.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.115 -0.991 . . . . 0.0 109.116 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 252' ' ' ARG . . . . . 0.839 ' CG ' HD23 ' B' ' 223' ' ' LEU . 6.9 ttt180 -84.96 -55.16 4.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 253' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 5.5 mt-10 -48.7 -26.98 2.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.992 -1.068 . . . . 0.0 108.327 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.549 ' CD1' ' HG3' ' B' ' 245' ' ' ARG . 0.2 OUTLIER -86.71 -72.6 0.5 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 0.981 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -49.1 -26.55 2.77 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.18 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 256' ' ' ALA . . . . . 0.618 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -70.38 -41.69 72.75 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -58.86 -27.4 65.13 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 258' ' ' SER . . . . . 0.71 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 41.9 t -77.69 -34.27 52.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 0.862 HD11 ' HA2' ' B' ' 221' ' ' GLY . 7.9 tp -70.04 -26.7 64.16 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.436 -0.79 . . . . 0.0 109.47 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -49.43 -31.43 9.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.278 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 261' ' ' LEU . . . . . 0.978 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.9 OUTLIER -90.03 114.6 61.45 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.287 -0.883 . . . . 0.0 109.006 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 262' ' ' PRO . . . . . 0.454 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 43.3 Cg_endo -70.44 109.25 2.39 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.719 1.379 . . . . 0.0 110.665 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.978 ' CD2' HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -140.29 159.65 41.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.486 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -92.81 128.41 38.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.87 . . . . 0.0 108.694 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 265' ' ' VAL . . . . . 0.758 HG21 ' HB3' ' B' ' 218' ' ' LEU . 11.0 t -107.67 113.83 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 109.697 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 266' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' B' ' 267' ' ' LEU . 6.7 tt0 -150.47 95.47 2.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.4 -0.813 . . . . 0.0 109.042 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.867 HD23 ' O ' ' B' ' 281' ' ' ALA . 1.5 mp -44.75 169.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.2 -0.938 . . . . 0.0 109.836 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 5.1 t -127.65 -31.64 2.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 269' ' ' GLN . . . . . 0.524 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 13.7 pt20 -107.88 -151.42 0.47 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.524 -0.735 . . . . 0.0 109.459 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.524 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 42.2 tt0 -106.64 129.96 54.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.486 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 271' ' ' VAL . . . . . 0.897 HG13 ' HB3' ' B' ' 280' ' ' PHE . 16.6 t -60.24 150.85 6.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.398 -0.813 . . . . 0.0 109.367 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 4.9 tpp180 -104.98 131.36 52.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 108.875 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 273' ' ' ALA . . . . . 0.529 ' HA ' ' CB ' ' B' ' 278' ' ' ALA . . . -148.0 126.23 12.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.089 -1.007 . . . . 0.0 109.9 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 274' ' ' VAL . . . . . 0.961 HG11 HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -121.95 -155.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.245 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 275' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' B' ' 276' ' ' ASN . . . -83.85 126.5 33.02 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.384 -0.822 . . . . 0.0 110.678 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 276' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' B' ' 275' ' ' ALA . 57.1 m-20 69.27 -2.35 1.88 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.706 -0.621 . . . . 0.0 111.721 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 277' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 3.4 tt0 -150.67 -160.47 1.17 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.418 -1.426 . . . . 0.0 110.518 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 278' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' B' ' 277' ' ' GLU . . . 165.45 152.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 279' ' ' ALA . . . . . 0.954 ' CB ' HD22 ' A' ' 115' ' ' LEU . . . -138.91 136.92 36.0 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 280' ' ' PHE . . . . . 0.897 ' HB3' HG13 ' B' ' 271' ' ' VAL . 33.5 p90 -149.97 167.38 26.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.831 -1.168 . . . . 0.0 110.546 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.95 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -142.68 -162.02 1.35 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.415 0.626 . . . . 0.0 109.448 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 282' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 0.0 OUTLIER 163.92 -175.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.885 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 283' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -127.86 141.11 51.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.436 -0.79 . . . . 0.0 109.733 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 284' ' ' VAL . . . . . 0.975 HG11 HD22 ' B' ' 263' ' ' LEU . 66.6 t -111.24 113.53 44.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.47 -0.769 . . . . 0.0 108.929 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 53.7 p -105.63 84.26 2.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.908 . . . . 0.0 110.028 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.884 ' CE1' H221 ' B' ' 326' ' ' NTH . 34.3 p90 -89.95 177.5 6.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.878 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -127.58 153.47 46.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.12 -0.988 . . . . 0.0 109.617 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -103.11 -98.03 0.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.379 -0.826 . . . . 0.0 109.586 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -140.31 47.09 1.8 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.194 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 139.99 -42.31 1.23 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -94.63 -166.69 1.52 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.508 -0.995 . . . . 0.0 108.877 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 292' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.29 123.35 9.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.044 -1.035 . . . . 0.0 109.744 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 293' ' ' THR . . . . . 0.58 ' HB ' ' CE1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -111.04 147.28 35.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.377 -0.827 . . . . 0.0 109.22 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 294' ' ' VAL . . . . . 0.747 HG13 ' HB2' ' B' ' 322' ' ' HIS . 11.1 p -127.52 167.95 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 109.681 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 1.041 HG12 ' HD3' ' B' ' 297' ' ' PRO . 3.5 t -140.18 148.21 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 108.999 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 296' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 320' ' ' ASN . . . -132.1 71.48 79.89 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 0.0 110.895 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 297' ' ' PRO . . . . . 1.041 ' HD3' HG12 ' B' ' 295' ' ' VAL . 51.1 Cg_endo -93.82 -174.28 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.486 1.458 . . . . 0.0 110.292 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.95 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.6 mp -140.04 162.64 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.875 . . . . 0.0 108.945 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 299' ' ' ASP . . . . . 0.608 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 14.0 t0 -133.1 157.49 45.16 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.11 -0.994 . . . . 0.0 110.084 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.785 ' NE2' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -112.81 167.25 10.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 301' ' ' PHE . . . . . 0.893 ' CE2' HG22 ' B' ' 211' ' ' VAL . 0.2 OUTLIER -137.94 157.74 45.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.979 -1.076 . . . . 0.0 110.536 -178.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.516 ' HB3' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -150.09 104.33 3.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.56 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 303' ' ' PHE . . . . . 0.665 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 6.9 m-85 -89.6 129.72 36.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.469 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 304' ' ' ASN . . . . . 0.566 ' ND2' ' N ' ' B' ' 304' ' ' ASN . 0.0 OUTLIER -137.42 14.63 2.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.294 -0.878 . . . . 0.0 109.428 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . -135.69 5.87 4.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . 50.1 25.22 1.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -1.134 . . . . 0.0 109.602 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -161.25 -42.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -123.54 -168.12 1.72 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -1.091 . . . . 0.0 109.46 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 309' ' ' VAL . . . . . 0.766 HG23 ' CG2' ' B' ' 210' ' ' VAL . 38.2 t -111.84 138.26 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.941 . . . . 0.0 108.993 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.534 ' HB ' ' ND2' ' B' ' 304' ' ' ASN . 2.7 t -121.3 -6.93 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.849 -1.157 . . . . 0.0 109.788 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 311' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.4 OUTLIER -155.23 152.93 29.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 0.0 109.347 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 312' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 300' ' ' HIS . 5.7 ttp -160.22 154.97 24.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 109.865 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 313' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' B' ' 299' ' ' ASP . 0.0 OUTLIER -137.77 163.7 30.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 109.067 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -142.5 141.56 32.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.019 -1.051 . . . . 0.0 109.72 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 315' ' ' LEU . . . . . 0.733 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -137.9 139.13 39.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 109.726 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 316' ' ' PHE . . . . . 0.815 ' O ' HG11 ' A' ' 74' ' ' VAL . 14.6 p90 173.76 -157.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.567 0.699 . . . . 0.0 109.352 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 317' ' ' GLY . . . . . 0.437 ' N ' ' CD2' ' B' ' 316' ' ' PHE . . . 165.29 -168.37 39.31 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 318' ' ' GLU . . . . . 0.534 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 15.7 tt0 -71.54 -4.37 26.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -1.164 . . . . 0.0 109.355 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 319' ' ' LYS . . . . . 0.484 ' HD3' ' OE1' ' A' ' 70' ' ' GLU . 2.4 tttm -89.72 -28.39 19.44 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 122.02 0.914 . . . . 0.0 108.87 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 320' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' B' ' 296' ' ' ALA . 1.4 m-20 -89.24 4.48 48.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 321' ' ' ILE . . . . . 0.92 HG23 HG22 ' B' ' 295' ' ' VAL . 5.0 mm -89.86 -173.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.325 -0.86 . . . . 0.0 108.83 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 322' ' ' HIS . . . . . 0.747 ' HB2' HG13 ' B' ' 294' ' ' VAL . 0.2 OUTLIER -150.86 -164.74 2.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.071 -1.018 . . . . 0.0 109.792 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -146.62 -175.08 4.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.081 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -170.52 154.31 22.76 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.306 -1.114 . . . . 0.0 109.459 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 126' ' ' NTH . . . . . 0.852 ' O17' HD13 ' A' ' 61' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 326' ' ' NTH . . . . . 0.884 H221 ' CE1' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.173 0.511 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.422 ' HB3' ' HE2' ' A' ' 7' ' ' MET . 99.5 m-20 -59.8 152.73 22.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.395 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.58 ' O ' ' CE1' ' A' ' 6' ' ' HIS . 0.8 OUTLIER -80.72 116.67 63.76 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.343 -0.848 . . . . 0.0 109.786 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.528 ' HA ' ' HE3' ' A' ' 7' ' ' MET . 42.6 Cg_endo -70.08 -4.81 15.0 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.761 1.401 . . . . 0.0 109.877 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -52.81 63.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.304 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 3' ' ' THR . 36.9 p-80 -70.3 -41.94 72.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.903 . . . . 0.0 109.273 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.577 ' CG ' ' NE2' ' A' ' 6' ' ' HIS . 10.3 mtt -59.07 -44.29 91.83 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.199 -0.938 . . . . 0.0 109.342 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.477 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 14.2 m -64.9 -38.46 91.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.315 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.66 77.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 108.872 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.802 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.4 t -55.12 -20.68 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.813 HG11 ' CG2' ' A' ' 71' ' ' VAL . 18.5 t -90.61 -43.5 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.409 -0.807 . . . . 0.0 109.236 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 13' ' ' ARG . 24.1 tt0 -61.19 -73.72 0.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.259 1.028 . . . . 0.0 108.313 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.864 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -42.07 -44.16 3.5 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.157 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.642 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -50.01 -46.61 52.94 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.915 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -86.23 -39.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.355 -0.84 . . . . 0.0 109.083 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -48.61 -36.68 16.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.553 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -74.37 -32.0 62.59 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.915 HD12 ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -65.3 -58.4 6.01 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.439 ' CG ' ' O ' ' A' ' 65' ' ' VAL . 24.4 t30 -52.56 -46.4 66.83 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.596 0.712 . . . . 0.0 109.089 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.96 10.67 20.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.649 -0.657 . . . . 0.0 109.476 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 1.006 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 45.52 27.81 2.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 17' ' ' ALA . 1.8 t70 -89.93 67.81 7.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -1.091 . . . . 0.0 109.866 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.12 HD11 ' HB3' ' A' ' 55' ' ' PHE . 4.6 tp -47.8 -41.31 23.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 109.165 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' LEU . 5.2 m-20 -41.49 -28.83 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -88.04 -35.87 8.71 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.006 HD12 HD12 ' A' ' 23' ' ' LEU . 22.0 mt -59.54 -53.82 43.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.54 HG21 ' CG ' ' A' ' 52' ' ' ARG . 91.1 t -59.72 -43.23 91.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.98 -43.62 66.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.864 HD22 ' HB3' ' A' ' 13' ' ' ARG . 6.6 tp -73.39 -27.91 61.72 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.531 ' HD2' HG22 ' A' ' 26' ' ' ILE . 8.8 m-85 -84.83 138.45 32.56 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.32 -0.862 . . . . 0.0 109.841 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -51.68 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 109.697 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.461 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -70.72 -23.42 62.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.622 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.548 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -148.51 41.08 0.95 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.623 -0.673 . . . . 0.0 109.264 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.632 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -52.95 151.77 4.44 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.253 -0.904 . . . . 0.0 109.699 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.34 144.44 29.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.387 -0.82 . . . . 0.0 109.432 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.597 ' CG2' HD12 ' A' ' 51' ' ' ILE . 2.1 t -123.58 169.14 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 108.899 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.632 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -142.65 105.39 4.52 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.205 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.491 ' HB2' ' O ' ' A' ' 37' ' ' GLU . 4.6 t70 177.67 142.93 0.26 Allowed Pre-proline 0 N--CA 1.495 1.777 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.065 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 46.6 Cg_endo -75.45 -176.34 18.04 Favored 'Cis proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.191 -2.004 . . . . 0.0 110.163 -0.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 115' ' ' LEU . 3.5 m -80.11 83.73 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.091 -1.006 . . . . 0.0 109.125 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.86 -13.92 1.33 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.533 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -108.57 -149.23 0.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -1.084 . . . . 0.0 109.417 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -109.93 133.92 20.83 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.916 -1.115 . . . . 0.0 110.721 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.3 Cg_endo -63.65 -161.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.157 1.904 . . . . 0.0 111.369 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.618 ' HD2' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -150.17 123.31 8.86 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.568 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -116.94 152.3 34.85 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.025 -1.047 . . . . 0.0 110.448 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 93.85 162.83 36.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 2.9 m -72.12 -57.58 4.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -1.113 . . . . 0.0 109.17 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -47.66 -29.28 2.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 46' ' ' SER . . . -90.07 -61.88 1.59 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.35 -0.844 . . . . 0.0 109.383 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.618 HD13 ' HD2' ' A' ' 45' ' ' ARG . 7.7 mm -45.36 -33.7 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.307 -0.871 . . . . 0.0 109.173 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.892 ' CG ' HD23 ' A' ' 23' ' ' LEU . 53.6 ttp85 -86.83 -61.45 1.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 108.924 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 26.1 tt0 -44.38 -28.8 0.59 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 108.564 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.556 ' CD2' ' HB3' ' A' ' 45' ' ' ARG . 1.2 t80 -80.71 -70.6 0.51 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 1.12 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -47.0 -25.52 0.82 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.717 ' HB2' HD22 ' A' ' 23' ' ' LEU . . . -76.24 -55.08 5.9 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -51.25 -30.77 18.7 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.721 ' OG ' H111 ' A' ' 126' ' ' NTH . 1.6 t -76.09 -34.31 59.52 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.006 HD21 ' CA ' ' A' ' 21' ' ' GLY . 7.7 tp -68.82 -21.59 64.3 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.418 -0.802 . . . . 0.0 108.995 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -55.35 -18.68 7.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.364 -0.835 . . . . 0.0 109.049 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.779 HD22 ' CD2' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -89.64 125.34 61.55 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.281 -0.887 . . . . 0.0 108.881 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 86' ' ' PHE . 44.8 Cg_endo -71.44 103.08 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.791 1.416 . . . . 0.0 110.621 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.804 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -136.8 160.03 40.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.1 -1.0 . . . . 0.0 110.021 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.911 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -99.47 129.1 45.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.752 HG21 ' HB3' ' A' ' 18' ' ' LEU . 3.3 t -111.55 114.87 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.716 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -150.5 101.1 2.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.582 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -49.82 -179.71 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.234 -0.916 . . . . 0.0 109.556 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.442 HG23 ' N ' ' A' ' 69' ' ' GLN . 10.6 t -162.2 -37.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.199 -0.938 . . . . 0.0 109.773 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -93.67 -147.68 0.25 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.57 -0.706 . . . . 0.0 109.27 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 23.4 tt0 -115.82 130.39 56.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.188 -0.945 . . . . 0.0 109.687 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.813 ' CG2' HG11 ' A' ' 11' ' ' VAL . 33.7 t -64.19 154.51 6.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.396 -0.815 . . . . 0.0 109.115 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.508 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 3.9 mmt180 -115.56 130.27 56.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.534 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.65 128.32 14.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -0.851 . . . . 0.0 109.228 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.772 HG21 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -152.3 160.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 0.0 109.26 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.582 ' HB3' HG12 ' B' ' 240' ' ' VAL . . . 47.95 -144.43 0.37 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.263 -0.898 . . . . 0.0 109.387 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -90.16 -8.44 51.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.088 -1.008 . . . . 0.0 109.645 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 3.1 mt-10 -104.13 -162.87 0.93 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.236 -0.915 . . . . 0.0 109.501 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.851 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . -175.71 168.56 3.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.0 109.677 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.917 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.52 136.66 18.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.02 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.699 ' HB3' HG13 ' A' ' 71' ' ' VAL . 15.2 p90 -150.01 167.46 26.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.953 -1.092 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.683 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -142.85 168.14 20.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.456 0.646 . . . . 0.0 109.622 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 82' ' ' PHE . 4.5 p90 -164.59 -169.05 1.64 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -0.838 . . . . 0.0 109.277 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.87 141.83 50.34 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.484 -0.76 . . . . 0.0 109.814 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.804 HG12 ' HB3' ' A' ' 63' ' ' LEU . 16.4 t -118.12 112.98 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.364 -0.835 . . . . 0.0 109.116 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.911 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 96.5 p -107.42 99.07 8.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.205 -0.935 . . . . 0.0 109.271 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.787 ' CE2' H211 ' A' ' 126' ' ' NTH . 21.4 p90 -117.41 176.36 5.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.377 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 88' ' ' PHE . 60.7 tt0 -149.98 151.23 33.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.756 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.566 ' CZ ' ' OG1' ' A' ' 93' ' ' THR . 7.9 m-85 -96.71 -141.85 0.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.412 -0.805 . . . . 0.0 109.289 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -102.68 45.59 0.96 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.02 -1.05 . . . . 0.0 109.321 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.52 -42.95 0.46 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -107.7 164.75 11.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -1.191 . . . . 0.0 109.488 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -133.54 123.63 25.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 109.531 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -117.8 148.68 41.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.845 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.789 HG12 ' CG ' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -117.95 178.17 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 108.812 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.975 HG12 ' HD3' ' A' ' 97' ' ' PRO . 2.5 t -150.33 141.36 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.099 -1.001 . . . . 0.0 109.848 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 120' ' ' ASN . . . -129.1 73.02 81.98 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.482 -0.761 . . . . 0.0 109.877 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.975 ' HD3' HG12 ' A' ' 95' ' ' VAL . 50.4 Cg_endo -95.16 -179.37 0.58 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.448 1.432 . . . . 0.0 111.648 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.683 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.7 mp -141.48 133.42 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 5.2 t0 -107.29 162.73 13.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.865 -1.147 . . . . 0.0 110.413 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.527 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -114.75 173.66 6.36 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.111 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.851 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -145.44 146.38 31.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.895 -1.128 . . . . 0.0 110.72 -178.802 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.507 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -138.55 102.5 4.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.419 -0.801 . . . . 0.0 109.375 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.497 ' CE2' HG21 ' A' ' 10' ' ' VAL . 16.6 m-85 -89.6 174.28 7.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 109.381 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.909 ' HB3' HG21 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -114.27 -14.35 12.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.858 . . . . 0.0 109.122 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.716 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 114.93 78.84 0.8 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 163.23 -21.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.35 -1.088 . . . . 0.0 109.721 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 122.19 -35.65 3.43 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -59.56 175.5 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -1.184 . . . . 0.0 109.567 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.732 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 45.8 t -113.27 145.96 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.064 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.909 HG21 ' HB3' ' A' ' 104' ' ' ASN . 5.1 t -121.18 -73.39 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.103 -0.998 . . . . 0.0 109.389 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.439 ' HB2' ' HD2' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -114.66 166.64 11.52 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.029 -1.044 . . . . 0.0 109.047 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 19.6 ttp -154.92 137.41 15.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.165 -0.96 . . . . 0.0 109.902 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.506 ' HA ' ' HB2' ' A' ' 37' ' ' GLU . 3.0 mtm180 -111.55 161.59 16.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.79 . . . . 0.0 108.955 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.409 ' O ' ' CG1' ' A' ' 40' ' ' VAL . . . -143.47 132.26 22.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.98 -1.075 . . . . 0.0 109.77 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.897 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.3 OUTLIER -123.3 137.09 54.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.771 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.811 ' O ' HG11 ' B' ' 274' ' ' VAL . 0.3 OUTLIER 171.14 -162.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 120' ' ' ASN . . . 167.75 175.96 38.0 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.359 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.5 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 37.4 tt0 -48.95 -22.91 0.94 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -1.194 . . . . 0.0 109.281 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.483 ' NZ ' ' CD ' ' B' ' 270' ' ' GLU . 0.3 OUTLIER -73.33 -22.55 60.29 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.043 0.925 . . . . 0.0 108.92 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.708 ' ND2' HD13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -88.54 0.73 56.03 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.634 -179.422 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.708 HD13 ' ND2' ' A' ' 120' ' ' ASN . 3.0 mm -89.59 -159.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.912 -1.117 . . . . 0.0 108.703 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.789 ' CG ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.39 -168.4 3.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 109.637 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.41 147.16 23.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.542 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.91 118.45 1.47 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.264 -1.139 . . . . 0.0 109.479 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 34.1 mtp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.312 0.577 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -121.11 96.37 5.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.543 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 203' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 203' ' ' THR . 2.5 t -45.92 109.51 0.99 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.316 -0.865 . . . . 0.0 109.565 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.38 -2.95 12.49 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.894 1.471 . . . . 0.0 110.182 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.3 -49.25 77.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 109.35 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -65.11 -51.72 59.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.583 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 207' ' ' MET . . . . . 0.47 ' HE1' ' O ' ' B' ' 275' ' ' ALA . 25.2 mtt -60.24 -47.5 85.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.257 -0.902 . . . . 0.0 109.789 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 15.6 m -56.6 -38.72 72.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.164 -0.96 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -56.62 -49.07 76.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.121 -0.987 . . . . 0.0 108.99 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 1.022 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -52.27 -24.16 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.509 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.754 HG22 ' CE2' ' B' ' 301' ' ' PHE . 23.2 t -85.82 -44.77 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.4 -0.813 . . . . 0.0 109.302 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 212' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' B' ' 213' ' ' ARG . 7.4 tt0 -57.11 -73.89 0.06 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' B' ' 212' ' ' GLN . 1.3 mtt85 -43.59 -44.89 6.46 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 214' ' ' TYR . . . . . 0.63 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -51.24 -45.4 61.97 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.878 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.0 OUTLIER -86.14 -37.7 11.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 216' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -49.13 -36.01 18.0 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.572 ' HB1' HG13 ' B' ' 226' ' ' ILE . . . -74.3 -31.84 62.64 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.878 HD12 ' HA ' ' B' ' 215' ' ' VAL . 0.8 OUTLIER -65.65 -57.72 7.44 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.591 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 219' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 0.2 OUTLIER -56.04 -45.12 79.3 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.542 0.687 . . . . 0.0 109.148 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' B' ' 221' ' ' GLY . . . -89.36 11.21 19.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.525 -0.734 . . . . 0.0 109.603 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.952 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 45.3 32.51 3.72 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 222' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.2 t70 -90.18 63.19 5.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.48 -1.012 . . . . 0.0 109.829 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 223' ' ' LEU . . . . . 1.144 HD12 HD12 ' B' ' 226' ' ' ILE . 6.1 tp -48.51 -43.97 35.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.099 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' B' ' 223' ' ' LEU . 26.2 t0 -42.49 -31.02 0.39 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 225' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' B' ' 228' ' ' ALA . . . -86.33 -32.56 16.24 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 1.144 HD12 HD12 ' B' ' 223' ' ' LEU . 27.2 mt -62.77 -56.66 16.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.809 HG11 HG23 ' B' ' 248' ' ' THR . 78.7 t -56.3 -35.19 42.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 225' ' ' GLY . . . -60.58 -56.38 22.07 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 1.022 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.0 tp -59.9 -25.79 65.39 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.556 -0.715 . . . . 0.0 109.08 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 230' ' ' PHE . . . . . 0.67 ' HD2' ' HB3' ' B' ' 234' ' ' ALA . 7.4 m-85 -86.42 130.07 34.63 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.496 -0.752 . . . . 0.0 109.779 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -43.0 166.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 109.665 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -24.2 5.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.349 -0.844 . . . . 0.0 110.071 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.522 ' CB ' ' HA2' ' B' ' 247' ' ' GLY . 2.0 p30 -148.84 54.13 0.99 Allowed 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.572 -0.705 . . . . 0.0 109.437 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.826 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -68.04 165.08 18.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.659 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 235' ' ' THR . . . . . 0.994 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -115.71 156.54 25.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 109.767 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.524 ' O ' ' HB3' ' B' ' 244' ' ' PRO . 53.9 t -143.31 116.83 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.076 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 237' ' ' GLU . . . . . 0.547 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.2 mt-10 -88.9 105.52 17.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 108.873 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 238' ' ' ASP . . . . . 0.539 ' OD2' ' HB3' ' B' ' 314' ' ' ALA . 9.9 t70 179.54 141.63 0.31 Allowed Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.919 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.474 ' HG2' ' OG ' ' B' ' 242' ' ' SER . 48.5 Cg_endo -74.63 -173.85 12.81 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.048 -2.063 . . . . 0.0 110.343 -0.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' A' ' 75' ' ' ALA . 1.2 t -76.84 135.12 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.131 -0.98 . . . . 0.0 109.124 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 89.73 -3.78 83.34 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 242' ' ' SER . . . . . 0.474 ' OG ' ' HG2' ' B' ' 239' ' ' PRO . 67.5 m -107.08 -132.76 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -1.145 . . . . 0.0 109.149 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 243' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' B' ' 242' ' ' SER . 19.9 mt-10 -148.43 133.62 9.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 120.616 -1.303 . . . . 0.0 110.042 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 244' ' ' PRO . . . . . 0.547 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.4 Cg_endo -64.39 -172.7 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.133 1.596 . . . . 0.0 111.3 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.595 ' HD3' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.69 105.99 3.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.994 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -93.0 162.24 14.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.282 -0.887 . . . . 0.0 110.616 -178.702 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 247' ' ' GLY . . . . . 0.627 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 97.51 159.35 30.9 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 248' ' ' THR . . . . . 0.809 HG23 HG11 ' B' ' 227' ' ' VAL . 7.3 m -73.23 -45.39 56.32 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.162 -1.199 . . . . 0.0 109.014 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -63.95 -24.17 67.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.826 . . . . 0.0 109.025 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -90.02 -59.05 2.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.313 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.826 HD11 ' N ' ' B' ' 234' ' ' ALA . 21.7 mt -47.58 -39.25 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.364 -0.835 . . . . 0.0 109.255 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 252' ' ' ARG . . . . . 0.778 ' CG ' HD23 ' B' ' 223' ' ' LEU . 15.6 ttt180 -76.0 -57.16 4.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 109.068 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 253' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 8.0 mt-10 -46.4 -29.39 1.68 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.033 -1.042 . . . . 0.0 108.609 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.8 OUTLIER -83.74 -72.64 0.45 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 1.119 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.1 OUTLIER -48.84 -24.54 1.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.552 -0.718 . . . . 0.0 109.166 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 256' ' ' ALA . . . . . 0.561 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -74.91 -44.91 46.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 108.707 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 257' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 5.3 t30 -56.73 -34.33 67.41 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 258' ' ' SER . . . . . 0.463 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 18.8 t -72.29 -47.0 53.34 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.49 -0.756 . . . . 0.0 109.179 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 0.952 HD21 ' CA ' ' B' ' 221' ' ' GLY . 9.5 tp -57.46 -18.11 16.68 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.345 -0.847 . . . . 0.0 109.315 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 260' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 1.8 mttm -64.44 -19.6 65.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 109.592 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 261' ' ' LEU . . . . . 0.96 HD22 HD21 ' B' ' 263' ' ' LEU . 0.3 OUTLIER -89.37 120.43 69.7 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 262' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 45.0 Cg_endo -70.57 94.55 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.791 1.416 . . . . 0.0 110.755 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.96 HD21 HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -133.15 157.16 46.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.0 109.498 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 264' ' ' ALA . . . . . 0.518 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -92.35 127.03 37.68 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 265' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' B' ' 218' ' ' LEU . 30.9 t -107.28 114.26 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 2.3 tt0 -150.1 95.76 2.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.084 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.54 HD11 HG11 ' B' ' 215' ' ' VAL . 2.7 mp -43.86 169.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 268' ' ' THR . . . . . 0.465 ' O ' ' O ' ' B' ' 269' ' ' GLN . 0.0 OUTLIER -129.01 -78.56 0.56 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.523 -0.736 . . . . 0.0 109.213 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 269' ' ' GLN . . . . . 0.823 ' OE1' ' HB3' ' B' ' 281' ' ' ALA . 2.0 pt20 -59.3 -149.19 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.483 ' CD ' ' NZ ' ' A' ' 119' ' ' LYS . 31.6 tt0 -111.51 131.45 55.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.033 -1.042 . . . . 0.0 109.68 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 271' ' ' VAL . . . . . 1.054 HG13 ' HB3' ' B' ' 280' ' ' PHE . 72.8 t -52.85 144.06 4.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.32 -0.863 . . . . 0.0 109.342 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.544 ' HD2' ' CD1' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -105.75 130.25 53.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.935 . . . . 0.0 109.503 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 273' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' B' ' 278' ' ' ALA . . . -147.25 137.09 23.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 109.321 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 274' ' ' VAL . . . . . 0.811 HG11 ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -155.07 149.71 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 0.0 109.174 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 275' ' ' ALA . . . . . 0.47 ' O ' ' HE1' ' B' ' 207' ' ' MET . . . 49.82 -144.86 0.47 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.159 -0.963 . . . . 0.0 109.358 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 276' ' ' ASN . . . . . 0.471 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 2.0 m-20 -83.71 -20.7 32.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.728 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 277' ' ' GLU . . . . . 0.582 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 0.7 OUTLIER -89.88 -161.71 0.81 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.161 -0.962 . . . . 0.0 109.583 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 278' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' B' ' 277' ' ' GLU . . . 170.1 162.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.755 . . . . 0.0 109.079 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 279' ' ' ALA . . . . . 0.897 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -150.66 141.51 22.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.065 . . . . 0.0 109.236 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 280' ' ' PHE . . . . . 1.054 ' HB3' HG13 ' B' ' 271' ' ' VAL . 21.1 p90 -141.63 154.55 45.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.827 -1.171 . . . . 0.0 110.705 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 1.062 ' CB ' HD12 ' B' ' 298' ' ' ILE . . . -119.43 168.53 10.86 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 282' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 0.0 OUTLIER -177.14 -173.44 0.45 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.898 . . . . 0.0 109.766 179.287 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 283' ' ' THR . . . . . 0.981 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -135.19 141.1 45.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.375 -0.828 . . . . 0.0 110.215 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 284' ' ' VAL . . . . . 0.834 HG11 HD22 ' B' ' 263' ' ' LEU . 8.0 t -109.21 134.56 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 108.795 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 285' ' ' SER . . . . . 0.518 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 29.0 p -125.73 100.78 6.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.987 . . . . 0.0 110.08 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.734 ' CE1' H221 ' B' ' 326' ' ' NTH . 33.9 p90 -117.34 -168.73 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 108.785 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 287' ' ' GLU . . . . . 0.469 ' N ' ' CD2' ' B' ' 286' ' ' PHE . 16.7 tt0 -149.85 158.59 44.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.93 -1.106 . . . . 0.0 110.09 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.405 ' CZ ' ' HE2' ' B' ' 286' ' ' PHE . 33.1 m-85 -105.6 -167.84 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.451 -0.781 . . . . 0.0 109.587 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.91 -20.94 3.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.378 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -160.66 -45.24 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 291' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' B' ' 325' ' ' ALA . 1.6 mtt180 -74.49 142.72 44.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -1.165 . . . . 0.0 109.522 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 292' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' B' ' 293' ' ' THR . 2.3 tmtt? -103.85 145.32 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.277 -0.89 . . . . 0.0 109.412 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 293' ' ' THR . . . . . 0.728 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -135.88 143.29 44.96 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.452 -0.78 . . . . 0.0 110.297 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 294' ' ' VAL . . . . . 0.613 HG12 ' CB ' ' B' ' 322' ' ' HIS . 9.0 p -121.26 169.41 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 0.981 ' O ' HG22 ' B' ' 283' ' ' THR . 22.8 t -136.48 160.71 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.758 -1.214 . . . . 0.0 110.499 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 296' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' B' ' 320' ' ' ASN . . . -140.62 62.54 18.62 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.629 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 297' ' ' PRO . . . . . 1.036 ' O ' HD13 ' B' ' 298' ' ' ILE . 43.5 Cg_endo -97.37 167.28 0.87 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.449 1.433 . . . . 0.0 112.01 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 1.062 HD12 ' CB ' ' B' ' 281' ' ' ALA . 3.9 mm -129.2 165.05 30.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 299' ' ' ASP . . . . . 0.648 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 14.7 t0 -135.06 156.27 49.31 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.201 -0.937 . . . . 0.0 109.909 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.535 ' O ' ' CG ' ' B' ' 312' ' ' MET . 0.2 OUTLIER -108.19 175.36 5.5 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 301' ' ' PHE . . . . . 0.754 ' CE2' HG22 ' B' ' 211' ' ' VAL . 0.1 OUTLIER -149.74 136.62 19.48 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 110.026 -178.839 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.612 ' O ' HG23 ' B' ' 310' ' ' VAL . 10.4 ttt85 -138.48 113.76 9.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 109.11 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 303' ' ' PHE . . . . . 0.652 ' CE2' HG21 ' B' ' 210' ' ' VAL . 3.9 m-85 -95.09 178.82 5.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.468 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 304' ' ' ASN . . . . . 0.719 ' HB3' HG11 ' B' ' 310' ' ' VAL . 6.8 p-10 -111.87 -21.8 11.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.358 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . 122.35 32.76 0.94 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . -144.49 9.47 1.39 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.218 -1.166 . . . . 0.0 109.964 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 87.05 -19.28 31.31 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.81 -177.26 6.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -1.205 . . . . 0.0 109.561 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 309' ' ' VAL . . . . . 0.547 ' CG2' HG22 ' B' ' 210' ' ' VAL . 61.0 t -112.69 137.12 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.163 -0.961 . . . . 0.0 109.154 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.719 HG11 ' HB3' ' B' ' 304' ' ' ASN . 0.0 OUTLIER -119.37 -61.57 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.079 -1.013 . . . . 0.0 109.799 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.91 162.85 17.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.045 -1.035 . . . . 0.0 109.67 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 312' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 29.2 ttp -159.02 145.93 17.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 313' ' ' ARG . . . . . 0.53 ' HB2' ' CB ' ' B' ' 300' ' ' HIS . 48.1 mtp180 -125.18 173.15 8.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.223 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 314' ' ' ALA . . . . . 0.539 ' HB3' ' OD2' ' B' ' 238' ' ' ASP . . . -150.17 150.88 32.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.032 . . . . 0.0 109.445 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 315' ' ' LEU . . . . . 0.917 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -136.25 142.52 44.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 110.048 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 316' ' ' PHE . . . . . 0.772 ' O ' HG21 ' A' ' 74' ' ' VAL . 1.2 p90 174.63 -155.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.652 0.739 . . . . 0.0 109.125 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 317' ' ' GLY . . . . . 0.471 ' N ' ' CG ' ' B' ' 316' ' ' PHE . . . 159.79 -172.14 36.28 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 318' ' ' GLU . . . . . 0.654 ' HA ' HD12 ' B' ' 321' ' ' ILE . 6.3 tt0 -65.29 -6.73 10.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -1.108 . . . . 0.0 109.7 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -101.12 -17.99 16.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.323 -0.861 . . . . 0.0 109.699 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 320' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' B' ' 296' ' ' ALA . 1.4 m-20 -88.94 -23.18 22.75 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.607 -0.683 . . . . 0.0 110.189 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 321' ' ' ILE . . . . . 0.922 ' CG2' HG22 ' B' ' 295' ' ' VAL . 0.6 OUTLIER -87.18 -158.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.072 -1.018 . . . . 0.0 108.546 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 322' ' ' HIS . . . . . 0.728 ' O ' HG22 ' B' ' 293' ' ' THR . 0.3 OUTLIER -151.61 161.61 42.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.974 -1.079 . . . . 0.0 110.064 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -155.27 110.58 3.04 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.353 -0.842 . . . . 0.0 109.414 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -121.93 160.17 16.38 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 325' ' ' ALA . . . . . 0.4 ' HA ' ' HG2' ' B' ' 291' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.361 -1.082 . . . . 0.0 109.415 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' NTH . . . . . 0.787 H211 ' CE2' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 326' ' ' NTH . . . . . 0.734 H221 ' CE1' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.486 ' O ' ' CB ' ' A' ' 2' ' ' ASN . 1.9 ttp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.275 0.56 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.3 OUTLIER 165.18 107.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.33 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 3' ' ' THR . 7.1 t -73.68 111.76 13.47 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.614 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 43.8 Cg_endo -71.41 -8.68 23.83 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.864 1.455 . . . . 0.0 109.784 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -61.81 -60.26 3.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.812 . . . . 0.0 109.243 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -61.33 -45.19 95.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.156 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.412 ' HE3' ' C ' ' A' ' 2' ' ' ASN . 27.5 mtt -58.73 -28.81 66.2 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.223 -0.923 . . . . 0.0 109.333 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 11' ' ' VAL . 17.5 m -74.33 -44.14 53.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 109.059 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.25 -40.23 23.99 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.004 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.2 t -53.35 -26.76 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.866 HG11 ' CG2' ' A' ' 71' ' ' VAL . 7.6 t -90.02 -42.55 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.491 -0.756 . . . . 0.0 109.101 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 15' ' ' VAL . 20.7 tt0 -62.05 -73.92 0.1 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.482 ' HB3' HD22 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -41.61 -44.18 2.99 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 122.041 0.924 . . . . 0.0 108.524 178.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.641 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -53.39 -45.58 69.33 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.42 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.897 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -84.63 -38.98 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 0.0 109.555 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.69 -35.74 14.63 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.56 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -74.88 -31.69 61.66 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.984 ' HB3' HG21 ' A' ' 65' ' ' VAL . 1.2 mt -65.7 -58.83 4.77 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -51.9 -45.38 64.18 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . -89.5 9.98 24.53 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.574 -0.704 . . . . 0.0 109.645 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.959 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 45.32 31.52 3.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 17' ' ' ALA . 6.8 t0 -89.82 68.64 7.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -1.062 . . . . 0.0 109.936 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.042 HD11 ' HB3' ' A' ' 55' ' ' PHE . 4.9 tp -49.35 -42.12 40.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -42.1 -30.56 0.3 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -87.96 -37.2 7.95 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.955 HD12 HD12 ' A' ' 23' ' ' LEU . 22.0 mt -59.64 -53.59 46.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.536 HG21 ' CG ' ' A' ' 52' ' ' ARG . 84.9 t -58.57 -36.17 58.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -60.6 -50.83 71.94 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.004 HD21 ' HA ' ' A' ' 10' ' ' VAL . 7.5 tp -65.61 -21.72 66.6 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.547 -0.721 . . . . 0.0 109.182 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.524 ' CG ' HG21 ' A' ' 51' ' ' ILE . 2.8 m-85 -84.6 135.5 34.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.419 -0.801 . . . . 0.0 109.609 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -54.17 -175.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.46 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.4 OUTLIER -75.76 -23.23 55.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.885 . . . . 0.0 109.54 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.548 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -140.13 36.76 1.92 Allowed 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.59 -0.694 . . . . 0.0 109.357 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -51.38 -176.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.499 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.553 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.3 OUTLIER -142.49 134.13 26.72 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.373 -0.83 . . . . 0.0 109.432 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.802 ' CG2' HD12 ' A' ' 51' ' ' ILE . 31.6 t -127.27 128.3 70.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.337 -0.852 . . . . 0.0 108.88 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 21.9 mt-10 -101.15 114.18 27.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.649 ' OD2' ' H61' ' A' ' 126' ' ' NTH . 12.1 t70 -179.33 142.63 0.38 Allowed Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.608 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 38' ' ' ASP . 46.9 Cg_endo -73.75 -179.26 24.86 Favored 'Cis proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.194 -2.002 . . . . 0.0 110.797 -0.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.841 HG21 HG11 ' B' ' 274' ' ' VAL . 27.6 m -66.9 82.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . -170.69 28.5 0.12 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER 70.5 47.46 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -1.11 . . . . 0.0 109.86 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.55 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 4.7 mt-10 -132.83 57.5 28.8 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 109.844 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 50.3 Cg_endo -79.84 177.22 8.62 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 124.163 1.612 . . . . 0.0 110.653 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' HD3' ' CA ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -151.59 107.22 3.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 109.251 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.648 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -89.56 157.45 18.06 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.263 -0.898 . . . . 0.0 110.117 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 100.52 166.37 28.55 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.513 HG23 HG13 ' A' ' 27' ' ' VAL . 3.0 m -75.2 -58.63 3.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.138 -1.213 . . . . 0.0 109.012 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -54.44 -44.88 72.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.211 -0.931 . . . . 0.0 109.076 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 46' ' ' SER . . . -59.26 -34.01 71.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.45 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.802 HD12 ' CG2' ' A' ' 36' ' ' VAL . 7.6 mm -79.72 -36.23 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.685 ' CG ' HD23 ' A' ' 23' ' ' LEU . 26.7 ttp85 -78.51 -56.64 4.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.068 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.9 mt-10 -45.76 -27.25 0.79 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.494 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -83.14 -70.22 0.57 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.174 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 1.042 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.26 -24.1 1.08 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.322 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.611 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -78.85 -47.31 16.83 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 19.2 t-20 -64.65 -28.37 69.57 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.65 ' OG ' H111 ' A' ' 126' ' ' NTH . 1.6 t -78.08 -42.26 32.72 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.959 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.9 tp -60.85 -17.86 52.57 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.405 -0.809 . . . . 0.0 108.903 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 4.8 mttm -55.16 -18.64 6.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.479 -0.763 . . . . 0.0 108.972 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.086 HD13 ' H17' ' A' ' 126' ' ' NTH . 0.3 OUTLIER -89.16 118.25 69.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.162 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 43.8 Cg_endo -71.34 110.42 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.748 1.393 . . . . 0.0 110.716 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.78 ' HB2' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -145.82 176.44 9.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.888 . . . . 0.0 110.053 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.73 126.12 54.88 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.984 HG21 ' HB3' ' A' ' 18' ' ' LEU . 3.7 t -104.29 117.96 50.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.682 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -146.09 105.57 3.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.133 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.519 ' O ' HG23 ' A' ' 68' ' ' THR . 0.7 OUTLIER -47.41 175.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -0.929 . . . . 0.0 109.633 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 67' ' ' LEU . 2.7 p -155.8 -38.01 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.705 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.492 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 5.7 pt20 -99.21 -152.47 0.41 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.63 -0.669 . . . . 0.0 109.198 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 30.4 tt0 -109.8 130.38 55.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.15 -0.969 . . . . 0.0 109.787 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.866 ' CG2' HG11 ' A' ' 11' ' ' VAL . 37.2 t -60.01 145.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.333 -0.855 . . . . 0.0 108.996 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.645 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 1.7 ttm180 -106.26 134.48 49.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.662 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.497 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -146.7 145.51 30.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 109.232 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.833 ' CG1' HG21 ' B' ' 240' ' ' VAL . 0.2 OUTLIER -136.03 -151.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.191 -0.943 . . . . 0.0 109.562 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -34.59 -90.85 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.973 -0.454 . . . . 0.0 110.804 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 4.9 p-10 -112.89 -15.8 12.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.083 -1.011 . . . . 0.0 110.328 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.652 ' HG2' ' N ' ' A' ' 78' ' ' ALA . 1.4 tt0 -108.5 162.55 14.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.019 -1.051 . . . . 0.0 108.999 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.652 ' N ' ' HG2' ' A' ' 77' ' ' GLU . . . -143.12 177.16 8.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.38 -0.825 . . . . 0.0 110.224 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.912 ' HB2' HD11 ' B' ' 315' ' ' LEU . . . -150.1 137.07 19.41 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.66 ' CE1' ' CE2' ' A' ' 101' ' ' PHE . 31.8 p90 -150.32 170.83 18.09 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.706 -1.246 . . . . 0.0 110.137 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.878 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -139.62 -166.4 2.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.556 -0.715 . . . . 0.0 109.56 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CD2' ' C ' ' A' ' 81' ' ' ALA . 6.8 p90 174.23 -171.46 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.441 -0.787 . . . . 0.0 109.075 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.73 144.0 50.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.357 -0.84 . . . . 0.0 109.808 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.78 HG13 ' HB2' ' A' ' 63' ' ' LEU . 12.1 t -116.78 115.0 47.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.537 ' HA ' HG23 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -106.58 103.43 12.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.077 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.578 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 4.3 p90 -122.23 177.04 5.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.228 -0.92 . . . . 0.0 109.561 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -106.25 -179.95 4.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.174 -0.954 . . . . 0.0 110.466 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.497 ' C ' ' CG ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -137.67 43.18 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 109.549 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.497 ' CG ' ' C ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER 39.71 75.97 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.421 -0.799 . . . . 0.0 109.886 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.52 -41.49 2.01 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -125.46 179.35 5.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.41 -1.053 . . . . 0.0 108.928 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.502 ' HG2' ' N ' ' A' ' 93' ' ' THR . 0.4 OUTLIER -126.11 140.8 52.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.007 -1.058 . . . . 0.0 109.884 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.572 ' HB ' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -136.81 152.58 50.44 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.801 HG12 ' CG ' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -126.52 -178.85 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.994 . . . . 0.0 109.112 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 1.078 HG22 HG23 ' A' ' 121' ' ' ILE . 2.9 t -150.01 141.04 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 108.992 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.38 71.63 82.03 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.394 -0.816 . . . . 0.0 110.528 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.965 ' HD3' HG12 ' A' ' 95' ' ' VAL . 54.0 Cg_endo -95.88 -173.55 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.559 1.506 . . . . 0.0 110.854 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.878 HG23 ' HB2' ' A' ' 81' ' ' ALA . 3.1 mp -141.88 167.03 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 32.8 t0 -135.24 159.26 42.12 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 109.828 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.525 ' NE2' ' HG3' ' A' ' 77' ' ' GLU . 71.2 t60 -123.78 133.71 53.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.426 -0.797 . . . . 0.0 108.876 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.66 ' CE2' ' CE1' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -109.76 145.67 36.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.203 -0.935 . . . . 0.0 109.89 -179.039 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 111' ' ' SER . 6.2 ttt180 -145.06 114.22 7.0 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.784 ' CE2' HG21 ' A' ' 10' ' ' VAL . 21.4 m-85 -89.61 -166.58 1.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.046 -1.034 . . . . 0.0 109.693 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.41 ' HB3' HG21 ' A' ' 110' ' ' VAL . 11.4 p-10 -132.11 -43.01 0.97 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.711 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -142.78 -62.23 0.02 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 163.87 76.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -1.149 . . . . 0.0 109.608 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -166.07 -49.53 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.27 -162.7 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -1.209 . . . . 0.0 109.545 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.655 HG23 HG22 ' A' ' 10' ' ' VAL . 54.5 t -97.46 143.18 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.331 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 56.6 t -125.12 -11.93 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.777 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.49 ' HB2' ' HB3' ' A' ' 102' ' ' ARG . 13.0 m -159.09 156.1 28.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.412 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.562 ' SD ' ' CE1' ' A' ' 101' ' ' PHE . 8.4 ttp -160.31 149.3 17.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.969 . . . . 0.0 109.86 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -129.7 147.24 51.47 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.77 132.33 54.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.999 -1.063 . . . . 0.0 110.035 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.854 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.4 OUTLIER -122.43 141.65 51.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.363 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.55 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 4.3 p90 175.02 -152.47 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.476 ' N ' ' CG ' ' A' ' 116' ' ' PHE . . . 166.31 169.08 29.46 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.484 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 19.8 tt0 -68.64 -6.45 25.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -1.096 . . . . 0.0 109.473 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' CD ' ' HG3' ' B' ' 204' ' ' PRO . 0.0 OUTLIER -91.85 -26.17 18.62 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.981 0.896 . . . . 0.0 108.886 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.496 ' OD1' ' NH2' ' B' ' 272' ' ' ARG . 0.1 OUTLIER -88.9 14.12 11.15 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.078 HG23 HG22 ' A' ' 95' ' ' VAL . 4.5 mm -90.68 -150.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.801 ' CG ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.79 174.19 13.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.005 . . . . 0.0 109.538 179.372 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.56 88.12 1.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.9 . . . . 0.0 109.32 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -66.77 133.62 32.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.347 -1.09 . . . . 0.0 109.508 -179.972 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.244 0.545 . . . . 0.0 110.144 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' B' ' 201' ' ' MET . 4.1 m-80 61.88 77.48 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -0.828 . . . . 0.0 109.673 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 203' ' ' THR . . . . . 0.513 HG23 ' O ' ' B' ' 203' ' ' THR . 3.0 t -61.96 116.69 23.03 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.668 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 204' ' ' PRO . . . . . 0.407 ' HG3' ' CD ' ' A' ' 119' ' ' LYS . 44.5 Cg_endo -71.52 -3.8 13.75 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.868 1.457 . . . . 0.0 109.96 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -59.71 -63.11 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.489 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -58.06 -43.98 87.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 109.397 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 18.1 mtt -57.61 -28.53 63.73 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.289 -0.882 . . . . 0.0 109.629 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.448 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 6.0 m -76.69 -35.89 57.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.076 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -53.85 -45.45 70.93 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.238 -0.914 . . . . 0.0 108.809 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 1.095 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.2 t -51.72 -27.1 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.983 HG11 HG21 ' B' ' 271' ' ' VAL . 40.1 t -83.4 -46.05 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.485 -0.759 . . . . 0.0 109.706 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 212' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' B' ' 213' ' ' ARG . 28.4 tt0 -56.86 -73.6 0.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.245 1.022 . . . . 0.0 108.312 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' B' ' 212' ' ' GLN . 1.6 mtt85 -43.06 -44.38 4.8 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.972 0.891 . . . . 0.0 108.655 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 214' ' ' TYR . . . . . 0.637 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -51.26 -45.3 62.0 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.568 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.952 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.2 t -88.42 -40.12 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.903 . . . . 0.0 109.359 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 216' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.23 -36.23 13.47 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.527 ' HB1' HG13 ' B' ' 226' ' ' ILE . . . -74.56 -33.63 62.74 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' B' ' 215' ' ' VAL . 3.4 mt -63.86 -58.58 6.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -53.38 -46.1 69.49 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.461 0.648 . . . . 0.0 109.476 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.32 9.22 26.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.529 -0.732 . . . . 0.0 109.649 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.92 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 48.6 37.19 19.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 222' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' B' ' 217' ' ' ALA . 25.5 t0 -97.93 61.17 1.52 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -1.114 . . . . 0.0 109.791 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 223' ' ' LEU . . . . . 1.085 HD11 ' HB3' ' B' ' 255' ' ' PHE . 2.2 tp -46.89 -39.45 12.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.03 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' B' ' 223' ' ' LEU . 0.5 OUTLIER -40.63 -31.31 0.15 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 225' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' B' ' 223' ' ' LEU . . . -88.86 -37.27 7.39 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.918 HD12 HD12 ' B' ' 223' ' ' LEU . 12.5 mt -58.54 -54.11 37.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.474 HG21 ' HG3' ' B' ' 252' ' ' ARG . 46.6 t -58.43 -41.69 82.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.34 -46.88 76.35 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 1.095 HD21 ' HA ' ' B' ' 210' ' ' VAL . 4.4 tp -69.75 -30.16 67.68 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.594 -0.691 . . . . 0.0 109.234 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 230' ' ' PHE . . . . . 0.736 ' CD2' HG21 ' B' ' 251' ' ' ILE . 4.8 m-85 -79.46 129.92 34.92 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.393 -0.817 . . . . 0.0 109.726 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -49.19 179.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.462 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -66.91 -23.49 65.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.769 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.517 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 0.0 OUTLIER -146.94 53.76 1.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.482 -0.761 . . . . 0.0 109.584 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.675 ' HB3' ' HD2' ' B' ' 230' ' ' PHE . . . -64.47 155.91 31.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 235' ' ' THR . . . . . 0.608 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -98.36 160.06 14.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.399 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.712 HG23 ' CD1' ' B' ' 251' ' ' ILE . 1.9 t -139.49 173.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 108.875 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 237' ' ' GLU . . . . . 0.583 ' N ' ' CG1' ' B' ' 236' ' ' VAL . 4.7 mt-10 -150.14 104.29 3.26 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 238' ' ' ASP . . . . . 0.546 ' OD2' ' CB ' ' B' ' 314' ' ' ALA . 0.4 OUTLIER -177.37 139.03 0.42 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.95 -1.094 . . . . 0.0 109.559 -178.684 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.514 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 45.9 Cg_endo -72.87 -173.21 10.54 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.185 -2.006 . . . . 0.0 110.358 -0.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.833 HG21 ' CG1' ' A' ' 74' ' ' VAL . 34.8 m -70.52 81.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.968 . . . . 0.0 109.292 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 241' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' B' ' 242' ' ' SER . . . -174.57 35.22 0.11 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 242' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' B' ' 241' ' ' GLY . 0.5 OUTLIER 70.16 53.25 0.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -1.141 . . . . 0.0 109.786 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 243' ' ' GLU . . . . . 0.474 ' HB2' ' C ' ' B' ' 238' ' ' ASP . 1.4 mt-10 -130.11 61.37 58.09 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.374 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 244' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 50.7 Cg_endo -78.03 169.24 20.76 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.287 1.678 . . . . 0.0 110.822 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.525 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.36 99.09 2.74 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.705 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -91.23 167.62 12.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 110.348 -178.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 247' ' ' GLY . . . . . 0.517 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 92.42 162.51 37.21 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 248' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 1.9 m -75.13 -49.44 19.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -1.16 . . . . 0.0 108.882 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -56.6 -42.24 78.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.891 . . . . 0.0 109.122 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -66.44 -55.01 17.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.935 . . . . 0.0 109.362 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.736 HG21 ' CD2' ' B' ' 230' ' ' PHE . 12.6 mm -53.71 -45.54 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 252' ' ' ARG . . . . . 0.832 ' HG3' HD23 ' B' ' 223' ' ' LEU . 8.4 ttm180 -73.39 -57.82 3.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.128 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 253' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 31.2 tt0 -45.64 -27.83 0.86 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.095 -1.003 . . . . 0.0 108.704 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 1.0 OUTLIER -87.49 -71.09 0.58 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 1.085 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -48.24 -24.44 1.18 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 256' ' ' ALA . . . . . 0.5 ' HB2' HD22 ' B' ' 223' ' ' LEU . . . -79.72 -48.44 13.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.857 . . . . 0.0 108.89 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 257' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 18.4 t30 -60.04 -33.52 72.15 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.34 -0.85 . . . . 0.0 108.743 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 258' ' ' SER . . . . . 0.639 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 9.7 t -71.44 -38.26 71.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 0.92 HD21 ' CA ' ' B' ' 221' ' ' GLY . 9.2 tp -62.59 -21.43 65.62 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.392 -0.818 . . . . 0.0 109.028 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 260' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 20.9 mtmt -64.48 -11.12 30.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.313 -0.867 . . . . 0.0 109.178 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 261' ' ' LEU . . . . . 0.982 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.3 OUTLIER -89.3 117.69 68.44 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 262' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 41.5 Cg_endo -68.72 80.21 0.63 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.833 1.438 . . . . 0.0 110.683 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.982 ' CD2' HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -118.27 165.47 13.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.357 -0.839 . . . . 0.0 109.616 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 264' ' ' ALA . . . . . 0.707 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -101.8 130.81 48.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -0.816 . . . . 0.0 108.859 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 30.0 t -116.92 114.3 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.031 -1.043 . . . . 0.0 110.085 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 28.7 tt0 -150.33 100.78 2.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.83 . . . . 0.0 109.148 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.527 ' O ' ' CG2' ' B' ' 268' ' ' THR . 0.6 OUTLIER -48.27 177.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.725 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 268' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' B' ' 267' ' ' LEU . 80.8 p -159.16 -37.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.336 -0.852 . . . . 0.0 109.768 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 269' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' B' ' 270' ' ' GLU . 0.0 OUTLIER -93.55 -150.45 0.28 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.563 -0.71 . . . . 0.0 109.427 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' B' ' 269' ' ' GLN . 27.1 tt0 -112.55 130.56 55.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.652 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 271' ' ' VAL . . . . . 1.074 HG13 ' HB3' ' B' ' 280' ' ' PHE . 75.5 t -67.54 147.71 12.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.356 -0.84 . . . . 0.0 109.082 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.63 ' CZ ' HD11 ' A' ' 98' ' ' ILE . 0.8 OUTLIER -103.71 138.11 40.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.175 -0.953 . . . . 0.0 109.896 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 273' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.1 132.32 15.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 274' ' ' VAL . . . . . 0.841 HG11 HG21 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -125.87 -152.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.95 . . . . 0.0 109.797 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 275' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' B' ' 274' ' ' VAL . . . -35.7 -96.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.898 -0.502 . . . . 0.0 110.899 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 276' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' B' ' 303' ' ' PHE . 1.9 m-20 -110.42 17.09 21.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.017 -1.052 . . . . 0.0 110.268 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 277' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 0.5 OUTLIER -124.33 -160.04 0.91 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.932 -1.105 . . . . 0.0 109.628 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 278' ' ' ALA . . . . . 1.011 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 172.08 160.18 0.1 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.545 -0.722 . . . . 0.0 109.65 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 279' ' ' ALA . . . . . 0.854 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -150.73 133.93 16.16 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 280' ' ' PHE . . . . . 1.074 ' HB3' HG13 ' B' ' 271' ' ' VAL . 22.6 p90 -150.2 168.5 23.8 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.838 -1.164 . . . . 0.0 110.275 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.958 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -138.46 -164.83 1.7 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 282' ' ' PHE . . . . . 0.439 ' CD2' ' C ' ' B' ' 281' ' ' ALA . 8.2 p90 168.16 -169.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 283' ' ' THR . . . . . 0.463 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -124.07 141.17 52.28 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 109.54 179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 284' ' ' VAL . . . . . 0.75 HG11 HD22 ' B' ' 263' ' ' LEU . 40.0 t -124.35 113.21 35.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.158 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 285' ' ' SER . . . . . 0.707 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 3.5 p -113.76 117.44 31.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.325 -0.86 . . . . 0.0 109.452 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.779 ' CE1' H221 ' B' ' 326' ' ' NTH . 17.0 p90 -123.27 176.27 6.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.19 -0.944 . . . . 0.0 109.555 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 287' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' B' ' 291' ' ' ARG . 29.8 tt0 -128.46 151.93 48.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.555 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.47 ' CE2' ' CZ ' ' B' ' 286' ' ' PHE . 28.1 m-85 -95.16 -107.2 0.14 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.213 -0.93 . . . . 0.0 109.388 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.61 -17.92 7.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.984 -1.072 . . . . 0.0 109.444 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -149.59 -40.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 291' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' B' ' 287' ' ' GLU . 33.1 mtt85 -90.4 -176.91 4.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -1.117 . . . . 0.0 109.417 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 292' ' ' LYS . . . . . 0.468 ' CD ' ' O ' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -136.75 133.95 36.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.312 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 293' ' ' THR . . . . . 0.795 HG22 ' HA ' ' B' ' 323' ' ' ALA . 0.0 OUTLIER -118.32 145.99 44.68 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.186 -0.946 . . . . 0.0 110.094 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 294' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' B' ' 322' ' ' HIS . 11.8 p -116.47 163.74 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.335 -0.853 . . . . 0.0 108.866 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 0.9 HG22 HG23 ' B' ' 321' ' ' ILE . 49.1 t -139.41 156.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.032 -1.043 . . . . 0.0 110.444 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 296' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' B' ' 320' ' ' ASN . . . -142.13 68.73 22.63 Favored Pre-proline 0 N--CA 1.495 1.802 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 297' ' ' PRO . . . . . 0.609 ' HD3' HG12 ' B' ' 295' ' ' VAL . 48.3 Cg_endo -97.03 -175.42 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.877 1.718 . . . . 0.0 111.487 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.958 HG23 ' HB2' ' B' ' 281' ' ' ALA . 3.0 mp -140.44 169.4 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 299' ' ' ASP . . . . . 0.606 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 39.1 t0 -138.86 158.8 43.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.021 -1.049 . . . . 0.0 110.014 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.533 ' HB2' ' CB ' ' B' ' 313' ' ' ARG . 0.2 OUTLIER -113.87 172.96 6.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.382 -0.824 . . . . 0.0 108.944 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 301' ' ' PHE . . . . . 1.011 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.2 OUTLIER -144.95 146.64 32.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.123 -0.986 . . . . 0.0 110.49 -178.657 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.549 ' HB3' ' CB ' ' B' ' 311' ' ' SER . 25.4 ttt180 -144.16 108.72 4.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.476 -0.765 . . . . 0.0 108.952 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 303' ' ' PHE . . . . . 0.708 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 37.3 m-85 -89.83 179.88 5.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.799 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 304' ' ' ASN . . . . . 0.635 ' CB ' HG21 ' B' ' 310' ' ' VAL . 8.6 p-10 -150.13 16.79 0.85 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.332 -0.855 . . . . 0.0 109.245 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 305' ' ' GLY . . . . . 0.715 ' O ' ' HB3' ' B' ' 306' ' ' ALA . . . 98.21 154.03 28.98 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 306' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 305' ' ' GLY . . . 79.49 -5.68 1.9 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.405 -1.056 . . . . 0.0 109.824 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 83.14 -10.19 58.9 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.3 174.15 4.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.103 -1.233 . . . . 0.0 109.455 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 309' ' ' VAL . . . . . 0.621 HG11 ' CE ' ' B' ' 312' ' ' MET . 95.1 t -109.89 151.9 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.158 -0.964 . . . . 0.0 109.027 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.666 ' O ' ' HB1' ' B' ' 234' ' ' ALA . 53.3 t -137.32 -56.56 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.957 -1.089 . . . . 0.0 110.156 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 311' ' ' SER . . . . . 0.549 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -118.48 160.61 21.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.615 -1.303 . . . . 0.0 109.917 -179.541 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 312' ' ' MET . . . . . 0.621 ' HE3' ' CZ ' ' B' ' 230' ' ' PHE . 10.2 ttm -159.92 141.69 12.92 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.431 -0.793 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 313' ' ' ARG . . . . . 0.533 ' CB ' ' HB2' ' B' ' 300' ' ' HIS . 0.3 OUTLIER -116.95 158.38 24.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.393 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 314' ' ' ALA . . . . . 0.546 ' CB ' ' OD2' ' B' ' 238' ' ' ASP . . . -124.31 138.03 54.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.28 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 315' ' ' LEU . . . . . 0.912 HD11 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -133.73 142.27 47.89 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.137 -0.977 . . . . 0.0 109.89 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 316' ' ' PHE . . . . . 0.543 ' O ' HG13 ' A' ' 74' ' ' VAL . 53.7 p90 171.18 -156.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 317' ' ' GLY . . . . . 0.737 ' O ' HD12 ' B' ' 321' ' ' ILE . . . 154.71 176.59 27.15 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 318' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' B' ' 318' ' ' GLU . 13.4 tt0 -55.43 -17.74 5.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -1.185 . . . . 0.0 109.136 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -87.49 -24.99 23.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.871 0.843 . . . . 0.0 109.077 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 320' ' ' ASN . . . . . 0.708 ' O ' ' HB3' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.27 -34.89 16.44 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 321' ' ' ILE . . . . . 0.9 HG23 HG22 ' B' ' 295' ' ' VAL . 0.9 OUTLIER -86.32 -172.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.799 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 322' ' ' HIS . . . . . 0.694 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.0 OUTLIER -151.63 172.8 15.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.091 -1.005 . . . . 0.0 109.814 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.795 ' HA ' HG22 ' B' ' 293' ' ' THR . . . -155.42 85.69 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.402 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -95.58 165.02 24.52 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.261 -1.14 . . . . 0.0 109.558 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 126' ' ' NTH . . . . . 1.086 ' H17' HD13 ' A' ' 61' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 326' ' ' NTH . . . . . 0.906 H121 HD13 ' B' ' 261' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ptt? . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.234 0.54 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.482 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 2.4 m-20 -127.82 126.39 41.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.87 . . . . 0.0 109.308 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.584 ' O ' ' HE2' ' A' ' 7' ' ' MET . 0.6 OUTLIER -90.19 108.98 30.05 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.789 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 48.5 Cg_endo -75.03 1.65 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.973 1.512 . . . . 0.0 110.279 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -58.63 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 110.048 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.517 ' NE2' ' HB ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -45.57 -32.75 2.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.115 -0.99 . . . . 0.0 109.279 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . 1.014 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 25.3 mtm -70.89 -57.69 4.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 109.732 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 11' ' ' VAL . 16.6 m -58.57 -38.14 77.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.81 -42.66 47.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.195 -0.941 . . . . 0.0 108.652 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.893 HG11 ' CE1' ' A' ' 103' ' ' PHE . 2.9 t -60.03 -20.93 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.867 HG11 HG21 ' A' ' 71' ' ' VAL . 40.0 t -90.47 -47.91 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -58.26 -61.76 2.33 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.125 -0.984 . . . . 0.0 109.022 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.77 ' HB3' HD22 ' A' ' 29' ' ' LEU . 3.2 mtm-85 -53.97 -46.66 71.7 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.909 0.861 . . . . 0.0 108.838 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.632 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -48.72 -42.69 35.93 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.964 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.3 t -88.5 -38.74 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.315 -0.866 . . . . 0.0 109.379 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.45 -37.72 18.0 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.608 ' HB3' HG12 ' A' ' 26' ' ' ILE . . . -72.62 -33.76 66.87 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.964 HD12 ' HA ' ' A' ' 15' ' ' VAL . 4.5 mt -65.31 -60.58 2.83 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -51.0 -41.19 59.6 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.567 0.698 . . . . 0.0 109.23 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.31 2.26 54.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.484 -0.76 . . . . 0.0 109.55 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 1.046 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 52.24 41.89 54.96 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.421 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 45.6 t0 -105.17 80.18 1.57 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -1.091 . . . . 0.0 110.052 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.028 HD13 HD12 ' A' ' 26' ' ' ILE . 3.9 mm? -51.37 -20.67 1.84 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.188 -0.945 . . . . 0.0 109.745 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -61.12 -54.85 39.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.256 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -64.71 -29.57 75.59 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.028 HD12 HD13 ' A' ' 23' ' ' LEU . 6.9 mt -66.26 -59.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.772 HG21 ' HB2' ' A' ' 52' ' ' ARG . 60.0 t -61.53 -40.55 86.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.13 -51.83 65.19 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.77 HD22 ' HB3' ' A' ' 13' ' ' ARG . 8.6 tp -64.3 -26.4 68.47 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.486 ' HB2' ' HA ' ' A' ' 27' ' ' VAL . 5.2 m-85 -87.57 131.11 34.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.495 -0.753 . . . . 0.0 109.766 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -45.44 171.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.834 . . . . 0.0 109.642 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.405 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -61.75 -24.02 66.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.709 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.543 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -141.05 52.03 1.59 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.571 -0.706 . . . . 0.0 109.681 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -67.16 168.51 10.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.718 HG23 ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -127.76 137.67 52.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.391 -0.818 . . . . 0.0 109.302 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 55.8 t -133.29 123.73 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.275 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.511 ' OE2' ' NH1' ' A' ' 113' ' ' ARG . 96.0 mt-10 -89.17 108.4 19.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 108.58 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 39' ' ' PRO . 9.8 t0 -177.99 142.29 0.45 Allowed Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 119.229 -0.989 . . . . 0.0 110.058 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.512 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 47.7 Cg_endo -72.75 -179.24 23.67 Favored 'Cis proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.214 -1.994 . . . . 0.0 110.564 -0.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 40' ' ' VAL . 14.4 m -73.57 112.81 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.511 ' HA2' ' ND2' ' B' ' 276' ' ' ASN . . . 103.99 12.65 29.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.512 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 4.0 m -118.56 -107.04 0.38 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -1.145 . . . . 0.0 109.458 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -166.87 130.64 1.53 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.874 -1.141 . . . . 0.0 109.88 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 41.6 Cg_endo -67.3 -168.25 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.952 1.501 . . . . 0.0 111.201 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.999 ' HG3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -150.43 102.82 3.08 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.718 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.93 152.04 21.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.325 -0.86 . . . . 0.0 110.024 -179.151 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 104.43 173.96 25.03 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.457 HG23 HG11 ' A' ' 27' ' ' VAL . 4.7 m -79.36 -68.81 0.63 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.05 -1.265 . . . . 0.0 109.376 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -47.16 -32.92 4.7 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.135 -0.978 . . . . 0.0 109.012 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.999 ' HB1' ' HG3' ' A' ' 45' ' ' ARG . . . -70.96 -51.17 27.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.18 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 47' ' ' GLY . 7.5 mm -58.67 -43.65 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.534 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.772 ' HB2' HG21 ' A' ' 27' ' ' VAL . 18.8 ttt180 -73.29 -56.11 5.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 108.983 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 52' ' ' ARG . 14.6 tt0 -45.74 -27.04 0.74 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 108.617 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -88.27 -71.09 0.6 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.72 0.772 . . . . 0.0 108.918 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.585 ' C ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -52.1 -20.92 2.79 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.476 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 52' ' ' ARG . . . -80.82 -45.52 16.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.175 -0.953 . . . . 0.0 108.452 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 2.4 t30 -56.82 -30.52 63.83 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.4 t -69.92 -37.8 76.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.046 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.0 tp -67.27 -19.68 65.53 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.45 -0.781 . . . . 0.0 109.735 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 2.7 mtmt -56.36 -25.57 49.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.906 HD22 ' CD2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.89 125.69 59.94 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.179 -0.951 . . . . 0.0 109.079 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 44.1 Cg_endo -70.78 101.1 1.01 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.759 1.4 . . . . 0.0 110.349 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.906 ' CD2' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -137.99 150.31 46.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.568 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.704 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -89.65 127.52 35.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.193 -0.942 . . . . 0.0 108.793 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 t -108.43 114.01 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 0.0 109.851 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 67' ' ' LEU . 16.8 tt0 -150.44 98.68 2.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.384 -0.822 . . . . 0.0 109.194 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.8 mp -45.38 170.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 109.807 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 t -144.58 -38.63 0.28 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.404 -0.81 . . . . 0.0 109.612 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.508 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 13.9 pt20 -90.92 -146.31 0.19 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.553 -0.717 . . . . 0.0 109.268 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.508 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 23.6 tt0 -115.34 135.2 54.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.106 -0.996 . . . . 0.0 109.768 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.867 HG21 HG11 ' A' ' 11' ' ' VAL . 78.1 t -72.06 145.2 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.293 -0.879 . . . . 0.0 109.345 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.524 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -107.5 135.46 48.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 0.0 109.65 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.014 ' HB1' ' HB3' ' A' ' 7' ' ' MET . . . -150.37 129.79 12.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 109.878 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.83 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -138.38 145.68 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 109.899 179.577 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . 41.68 -101.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.466 -0.771 . . . . 0.0 110.077 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.574 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -121.39 -11.44 8.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.952 -1.092 . . . . 0.0 109.69 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.639 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -89.74 -161.12 0.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.121 -0.987 . . . . 0.0 109.06 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.951 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 169.22 159.38 0.05 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.272 -0.893 . . . . 0.0 109.972 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.973 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -149.96 132.33 15.59 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.861 ' HB3' HG13 ' A' ' 71' ' ' VAL . 37.4 p90 -150.42 168.77 23.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.891 -1.131 . . . . 0.0 110.436 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.838 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -143.8 161.86 37.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.683 -0.636 . . . . 0.0 109.312 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 82' ' ' PHE . 2.1 p90 -157.13 -169.72 3.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.213 -0.929 . . . . 0.0 109.335 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.61 141.12 52.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.457 -0.777 . . . . 0.0 109.903 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.699 HG11 HD22 ' A' ' 63' ' ' LEU . 73.3 t -112.7 114.15 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.704 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 19.5 p -108.69 97.32 6.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.182 -0.949 . . . . 0.0 110.296 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.742 ' CZ ' H221 ' A' ' 126' ' ' NTH . 18.4 p90 -111.17 -176.45 2.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.264 -0.897 . . . . 0.0 108.618 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 2.7 tm-20 -148.78 150.33 32.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.885 -1.134 . . . . 0.0 110.126 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.41 ' CZ ' ' HE2' ' A' ' 86' ' ' PHE . 65.6 m-85 -90.29 -116.07 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.31 1.03 19.83 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.912 -1.117 . . . . 0.0 109.446 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -164.19 -58.8 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 3.3 mtt85 -81.76 158.51 24.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -1.133 . . . . 0.0 109.485 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -119.59 132.44 55.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 109.765 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -114.89 143.84 44.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.863 . . . . 0.0 109.255 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.701 HG23 ' HA ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -117.23 173.44 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 108.922 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 1.005 HG12 ' HD3' ' A' ' 97' ' ' PRO . 2.8 t -145.96 145.93 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 109.32 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.413 ' O ' ' CG ' ' A' ' 120' ' ' ASN . . . -127.71 72.95 78.52 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 1.005 ' HD3' HG12 ' A' ' 95' ' ' VAL . 50.0 Cg_endo -91.58 -177.0 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.731 1.385 . . . . 0.0 110.821 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.838 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.5 mp -140.84 142.8 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 13.6 t0 -116.46 160.05 21.14 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.952 -1.092 . . . . 0.0 110.215 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.538 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -113.12 176.25 5.1 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.951 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -148.14 137.86 22.38 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.035 -1.041 . . . . 0.0 109.926 -179.145 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.5 ' HA ' ' HG3' ' A' ' 77' ' ' GLU . 64.2 ttt-85 -141.44 103.15 4.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.893 ' CE1' HG11 ' A' ' 10' ' ' VAL . 10.9 m-30 -92.31 -171.81 2.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.591 ' HB3' HG21 ' A' ' 110' ' ' VAL . 7.8 p-10 -112.66 -25.45 9.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -157.62 -69.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 171.38 73.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -1.103 . . . . 0.0 109.388 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -178.84 -52.44 0.08 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -117.61 174.3 6.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -1.117 . . . . 0.0 109.498 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.623 HG12 ' N ' ' A' ' 110' ' ' VAL . 88.8 t -97.83 167.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.069 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.625 ' O ' ' HB1' ' A' ' 34' ' ' ALA . 3.1 t -140.52 -72.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.028 -1.045 . . . . 0.0 109.964 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.437 ' HB2' ' HD3' ' A' ' 102' ' ' ARG . 19.7 m -119.43 163.41 17.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 109.939 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.538 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 2.8 ttp -148.28 164.39 34.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.467 -0.77 . . . . 0.0 109.555 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' NH1' ' OE2' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -143.24 123.45 13.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 109.318 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.429 ' HB3' ' OD2' ' A' ' 38' ' ' ASP . . . -104.99 130.46 53.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.105 -0.997 . . . . 0.0 109.652 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.6 OUTLIER -126.15 147.58 49.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.608 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.541 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 9.7 p90 174.09 -155.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.56 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 167.8 -179.23 41.26 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.527 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 24.4 tt0 -70.26 -4.77 23.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -1.165 . . . . 0.0 109.694 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -90.62 -29.64 17.66 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -89.29 13.31 13.74 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.198 0.523 . . . . 0.0 109.697 -179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.944 HG23 HG22 ' A' ' 95' ' ' VAL . 4.4 mm -91.91 -163.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.146 -0.971 . . . . 0.0 108.748 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.701 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -151.43 161.63 42.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.427 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.53 113.18 3.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.8 -119.61 4.21 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.29 -1.123 . . . . 0.0 109.545 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.402 ' CE ' ' OE1' ' A' ' 118' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.222 0.534 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.449 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 7.4 m-80 44.94 68.85 0.5 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.568 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 203' ' ' THR . . . . . 0.687 HG23 ' O ' ' B' ' 203' ' ' THR . 9.7 t -52.51 107.74 0.91 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 0.0 109.661 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 204' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 50.6 Cg_endo -77.2 5.9 4.71 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.912 1.48 . . . . 0.0 110.491 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 205' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' B' ' 204' ' ' PRO . 0.0 OUTLIER -40.76 -72.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.289 -0.882 . . . . 0.0 110.183 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 206' ' ' HIS . . . . . 0.59 ' CE1' ' HG3' ' B' ' 207' ' ' MET . 11.8 p80 -54.59 -35.84 63.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 109.957 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 207' ' ' MET . . . . . 0.59 ' HG3' ' CE1' ' B' ' 206' ' ' HIS . 15.8 mtt -65.57 -56.92 9.68 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.172 -0.955 . . . . 0.0 109.836 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.466 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 8.2 m -56.18 -31.1 63.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.701 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.99 -51.37 67.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.149 -0.969 . . . . 0.0 108.696 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.82 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.0 OUTLIER -55.56 -20.61 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.853 HG11 HG21 ' B' ' 271' ' ' VAL . 16.2 t -90.24 -43.01 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.553 -0.717 . . . . 0.0 109.123 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 212' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' B' ' 213' ' ' ARG . 6.0 tt0 -60.66 -74.09 0.08 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.944 ' HB3' HD22 ' B' ' 229' ' ' LEU . 1.6 mtt-85 -42.3 -44.88 4.03 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.964 0.888 . . . . 0.0 108.605 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 214' ' ' TYR . . . . . 0.581 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -49.7 -45.15 48.68 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.891 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.24 -38.88 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.309 -0.869 . . . . 0.0 109.097 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 216' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' B' ' 213' ' ' ARG . . . -49.1 -35.75 17.03 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -75.3 -31.0 60.53 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.891 HD12 ' HA ' ' B' ' 215' ' ' VAL . 1.1 mt -65.4 -56.4 12.73 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 219' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 0.2 OUTLIER -53.06 -47.31 68.55 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.604 0.716 . . . . 0.0 109.348 179.462 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.22 6.56 39.65 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.713 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.834 ' HA2' HD11 ' B' ' 259' ' ' LEU . . . 51.48 39.55 44.93 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 222' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.9 t0 -96.04 66.48 2.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.306 -1.114 . . . . 0.0 109.893 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 223' ' ' LEU . . . . . 1.107 HD12 HD12 ' B' ' 226' ' ' ILE . 6.1 tp -47.59 -43.34 25.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.163 -0.96 . . . . 0.0 108.909 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -43.59 -38.21 2.88 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -80.6 -29.01 45.23 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 1.107 HD12 HD12 ' B' ' 223' ' ' LEU . 36.9 mt -65.92 -56.27 15.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.743 HG11 HG23 ' B' ' 248' ' ' THR . 77.3 t -59.86 -35.97 63.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.22 -56.21 24.38 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.944 HD22 ' HB3' ' B' ' 213' ' ' ARG . 9.2 tp -59.3 -23.0 62.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 230' ' ' PHE . . . . . 0.543 ' CD2' HG21 ' B' ' 251' ' ' ILE . 3.9 m-85 -88.92 143.35 26.93 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.41 -0.806 . . . . 0.0 109.484 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -53.79 -170.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.855 . . . . 0.0 109.322 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.441 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -75.61 -24.2 56.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 109.673 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.542 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 15.1 p30 -145.06 44.2 1.33 Allowed 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.592 -0.693 . . . . 0.0 109.608 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.689 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -55.9 168.53 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.918 . . . . 0.0 109.339 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 235' ' ' THR . . . . . 0.894 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -121.68 142.68 49.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.611 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 32.3 t -131.63 121.16 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 109.507 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 237' ' ' GLU . . . . . 0.511 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.1 mt-10 -88.53 112.43 22.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 238' ' ' ASP . . . . . 0.8 ' OD2' ' H61' ' B' ' 326' ' ' NTH . 12.6 t70 -176.08 145.57 0.75 Allowed Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.265 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.549 ' O ' ' HA ' ' B' ' 238' ' ' ASP . 53.6 Cg_endo -79.66 -92.41 0.0 OUTLIER 'Cis proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.506 -1.872 . . . . 0.0 110.915 -0.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.38 126.55 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.912 -1.118 . . . . 0.0 108.95 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 86.53 -8.37 75.26 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 242' ' ' SER . . . . . 0.545 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.2 OUTLIER -97.93 -146.24 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -1.062 . . . . 0.0 109.152 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -135.17 141.78 39.29 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.882 -1.136 . . . . 0.0 110.247 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 244' ' ' PRO . . . . . 0.539 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.4 Cg_endo -64.55 -169.5 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.271 1.669 . . . . 0.0 110.883 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.965 ' HB3' ' HB1' ' B' ' 250' ' ' ALA . 1.5 mtt-85 -150.34 101.77 3.01 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.894 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.2 164.38 15.0 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.307 -0.87 . . . . 0.0 110.119 -179.03 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 247' ' ' GLY . . . . . 0.602 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 98.39 160.45 30.17 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 248' ' ' THR . . . . . 0.743 HG23 HG11 ' B' ' 227' ' ' VAL . 4.1 m -74.32 -33.15 63.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.167 -1.196 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -72.63 -43.88 62.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.281 -0.887 . . . . 0.0 109.34 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.965 ' HB1' ' HB3' ' B' ' 245' ' ' ARG . . . -67.75 -56.97 7.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.445 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.689 HD11 ' N ' ' B' ' 234' ' ' ALA . 43.2 mt -47.53 -40.27 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.878 . . . . 0.0 108.885 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 252' ' ' ARG . . . . . 0.812 ' CG ' HD23 ' B' ' 223' ' ' LEU . 25.1 ttp85 -78.02 -52.72 8.35 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 253' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 4.0 mt-10 -50.82 -26.53 5.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 108.472 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.57 ' CD1' ' HG3' ' B' ' 245' ' ' ARG . 0.8 OUTLIER -87.65 -71.36 0.57 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 1.02 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.1 OUTLIER -48.95 -33.26 10.56 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 256' ' ' ALA . . . . . 0.568 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -63.8 -49.71 71.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 257' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 8.5 t30 -54.99 -36.49 65.48 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 258' ' ' SER . . . . . 0.657 ' HB2' ' H10' ' B' ' 326' ' ' NTH . 4.7 t -65.63 -36.19 82.99 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.429 -0.794 . . . . 0.0 108.961 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 0.834 HD11 ' HA2' ' B' ' 221' ' ' GLY . 8.1 tp -67.07 -22.5 65.84 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.493 -0.754 . . . . 0.0 109.189 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 260' ' ' LYS . . . . . 0.488 ' O ' ' HD3' ' B' ' 262' ' ' PRO . 1.2 mttm -56.25 -20.34 17.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.132 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 261' ' ' LEU . . . . . 0.969 ' CD2' HD21 ' B' ' 263' ' ' LEU . 0.3 OUTLIER -92.35 107.38 23.15 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 262' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 49.4 Cg_endo -74.44 107.4 2.44 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.822 1.433 . . . . 0.0 112.151 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.969 HD21 ' CD2' ' B' ' 261' ' ' LEU . 0.0 OUTLIER -141.91 -162.83 1.46 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 0.0 109.567 178.608 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -123.67 125.84 45.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 265' ' ' VAL . . . . . 0.77 HG21 ' HB3' ' B' ' 218' ' ' LEU . 21.6 t -105.4 119.11 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.97 . . . . 0.0 109.806 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 266' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.2 OUTLIER -147.88 107.33 3.93 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.234 -0.916 . . . . 0.0 109.284 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.7 OUTLIER -49.77 -179.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.905 . . . . 0.0 109.574 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.15 -39.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 109.677 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 269' ' ' GLN . . . . . 0.692 ' NE2' ' HB3' ' B' ' 281' ' ' ALA . 8.9 pt20 -98.72 -148.62 0.34 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 109.231 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 28.1 tt0 -113.11 131.25 55.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.106 -0.996 . . . . 0.0 109.516 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 271' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' B' ' 280' ' ' PHE . 48.1 t -65.6 148.52 12.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.12 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 1.2 mtt180 -103.24 133.49 48.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -0.95 . . . . 0.0 109.732 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 273' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.14 137.44 19.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.368 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 274' ' ' VAL . . . . . 0.555 ' CB ' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -130.02 -152.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 0.0 109.589 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 275' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . -32.67 -91.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.147 0.498 . . . . 0.0 110.799 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 276' ' ' ASN . . . . . 0.511 ' ND2' ' HA2' ' A' ' 41' ' ' GLY . 11.2 p30 -112.54 -18.18 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.944 -1.098 . . . . 0.0 110.269 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 277' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 2.8 mt-10 -90.62 -163.27 1.0 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 109.578 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 278' ' ' ALA . . . . . 0.76 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 174.89 163.79 0.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.516 -0.74 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 279' ' ' ALA . . . . . 0.756 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -150.55 138.81 20.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 108.623 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 280' ' ' PHE . . . . . 0.9 ' HB3' HG13 ' B' ' 271' ' ' VAL . 33.3 p90 -150.39 167.25 27.63 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.71 -1.244 . . . . 0.0 110.462 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 1.002 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -142.96 151.7 41.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.719 -0.613 . . . . 0.0 109.378 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 282' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 1.2 p90 -145.37 -169.95 3.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.181 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.57 142.95 47.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.461 -0.774 . . . . 0.0 109.961 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 284' ' ' VAL . . . . . 0.899 ' CG1' HD22 ' B' ' 263' ' ' LEU . 2.9 t -125.86 115.54 43.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 285' ' ' SER . . . . . 0.655 ' HB3' HG23 ' B' ' 294' ' ' VAL . 53.1 p -119.7 106.02 11.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 109.988 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.772 ' CD1' HD23 ' B' ' 263' ' ' LEU . 13.6 p90 -114.41 173.82 6.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.0 108.846 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.11 157.09 16.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.024 -1.048 . . . . 0.0 110.803 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.54 ' O ' ' N ' ' B' ' 290' ' ' GLY . 0.0 OUTLIER -117.57 74.09 0.92 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.594 -0.691 . . . . 0.0 109.147 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 289' ' ' GLN . . . . . 0.513 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 0.2 OUTLIER 43.94 -91.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.062 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 290' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' B' ' 288' ' ' PHE . . . -101.0 7.11 57.01 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.295 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -132.72 -178.94 5.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -1.22 . . . . 0.0 109.803 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 292' ' ' LYS . . . . . 0.535 ' O ' ' CA ' ' B' ' 324' ' ' GLY . 1.6 mmtp -122.42 144.2 49.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.84 . . . . 0.0 109.344 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 293' ' ' THR . . . . . 0.636 ' CB ' ' HB2' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -140.22 159.19 42.73 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.148 -0.97 . . . . 0.0 109.364 -179.06 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 294' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 295' ' ' VAL . 3.9 p -151.65 -177.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 120.686 -1.259 . . . . 0.0 110.266 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 1.047 HG12 ' HD3' ' B' ' 297' ' ' PRO . 29.0 t -151.95 148.89 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.106 -1.621 . . . . 0.0 109.187 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 296' ' ' ALA . . . . . 0.428 ' N ' ' HD3' ' B' ' 297' ' ' PRO . . . -145.07 67.84 13.58 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.068 -1.02 . . . . 0.0 110.238 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 297' ' ' PRO . . . . . 1.047 ' HD3' HG12 ' B' ' 295' ' ' VAL . 50.0 Cg_endo -98.03 -175.78 0.22 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.94 1.76 . . . . 0.0 111.018 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 1.002 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.9 mp -139.88 147.29 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 299' ' ' ASP . . . . . 0.617 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 9.4 t0 -118.42 157.83 26.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.858 -1.151 . . . . 0.0 110.223 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.525 ' O ' ' CG ' ' B' ' 312' ' ' MET . 1.4 t60 -110.52 172.3 6.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 301' ' ' PHE . . . . . 0.76 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.1 OUTLIER -146.48 133.94 20.83 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.048 -1.032 . . . . 0.0 110.129 -178.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.497 ' HG2' ' HG3' ' B' ' 277' ' ' GLU . 0.3 OUTLIER -139.69 111.96 7.63 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 303' ' ' PHE . . . . . 0.67 ' CE1' HG11 ' B' ' 210' ' ' VAL . 8.3 m-30 -91.87 177.63 6.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.268 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 304' ' ' ASN . . . . . 0.617 ' N ' HG21 ' B' ' 310' ' ' VAL . 6.7 p30 -92.61 -28.9 16.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.931 . . . . 0.0 109.276 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 305' ' ' GLY . . . . . 0.714 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -166.53 -50.74 0.03 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 306' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 163.04 76.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -1.135 . . . . 0.0 109.336 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.52 -63.71 0.06 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.53 -163.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -1.179 . . . . 0.0 109.841 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 309' ' ' VAL . . . . . 0.972 HG11 ' HE1' ' B' ' 312' ' ' MET . 17.0 t -106.98 168.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.338 -0.851 . . . . 0.0 109.162 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.639 ' O ' ' HB1' ' B' ' 234' ' ' ALA . 24.6 t -139.86 -73.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 0.0 109.919 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 311' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' B' ' 235' ' ' THR . 9.3 m -125.38 163.24 23.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.185 -0.947 . . . . 0.0 110.164 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 312' ' ' MET . . . . . 0.972 ' HE1' HG11 ' B' ' 309' ' ' VAL . 0.0 OUTLIER -143.44 171.3 14.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -0.822 . . . . 0.0 109.487 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 313' ' ' ARG . . . . . 0.504 ' NH2' HD12 ' B' ' 315' ' ' LEU . 1.5 ttp85 -150.2 120.0 7.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 109.571 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 314' ' ' ALA . . . . . 0.621 ' HB1' ' HE2' ' B' ' 316' ' ' PHE . . . -101.07 136.63 40.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.977 . . . . 0.0 109.721 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 315' ' ' LEU . . . . . 0.973 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -126.24 148.7 49.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.896 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 316' ' ' PHE . . . . . 0.83 ' O ' HG11 ' A' ' 74' ' ' VAL . 2.2 p90 168.22 -169.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 317' ' ' GLY . . . . . 0.589 ' HA2' HG11 ' A' ' 74' ' ' VAL . . . -157.24 167.58 33.94 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.262 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 318' ' ' GLU . . . . . 0.548 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 5.8 tt0 -63.81 -9.88 17.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.43 -1.041 . . . . 0.0 109.889 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -88.37 -32.81 18.19 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 320' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.44 28.64 4.03 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 321' ' ' ILE . . . . . 0.564 HG22 ' N ' ' B' ' 322' ' ' HIS . 19.5 mm -91.01 -120.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.005 -1.059 . . . . 0.0 110.332 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 322' ' ' HIS . . . . . 0.795 ' CD2' H212 ' B' ' 326' ' ' NTH . 14.4 p80 -125.69 134.25 51.88 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.016 -1.052 . . . . 0.0 112.489 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' B' ' 324' ' ' GLY . . . -159.54 122.13 3.5 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.393 -0.817 . . . . 0.0 109.841 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 324' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' B' ' 292' ' ' LYS . . . 40.94 -117.96 1.13 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.274 -1.133 . . . . 0.0 109.391 179.944 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 126' ' ' NTH . . . . . 0.742 H221 ' CZ ' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 326' ' ' NTH . . . . . 0.8 ' H61' ' OD2' ' B' ' 238' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.276 0.56 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.461 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 5.8 m-20 55.37 43.08 29.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.451 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.709 HG23 ' CE1' ' A' ' 6' ' ' HIS . 1.3 t -75.38 112.14 17.4 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.707 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.54 ' HA ' ' HB2' ' A' ' 7' ' ' MET . 46.3 Cg_endo -73.9 -0.46 9.49 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.863 1.454 . . . . 0.0 110.185 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.19 -92.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.602 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.709 ' CE1' HG23 ' A' ' 3' ' ' THR . 1.2 p80 -52.54 -41.28 63.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.143 -0.973 . . . . 0.0 109.259 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.54 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 34.5 mmt -53.17 -39.86 63.93 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.199 -0.938 . . . . 0.0 109.788 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.43 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 6.0 m -74.19 -36.63 64.02 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.21 -43.81 64.44 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.082 ' HA ' HD21 ' A' ' 29' ' ' LEU . 2.1 t -49.55 -33.93 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.859 HG22 ' CE2' ' A' ' 101' ' ' PHE . 29.9 t -76.33 -45.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.438 -0.789 . . . . 0.0 109.791 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 13' ' ' ARG . 17.0 tt0 -59.4 -73.68 0.08 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.212 1.006 . . . . 0.0 108.494 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.3 mtt180 -42.68 -44.91 4.5 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.636 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -49.5 -44.98 46.51 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.457 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.936 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.3 t -88.88 -38.72 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.334 -0.854 . . . . 0.0 109.243 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -48.94 -36.47 17.44 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -74.0 -32.58 63.47 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.936 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.4 mt -64.96 -58.75 5.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -51.14 -45.8 61.77 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . -89.58 10.19 23.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.64 -0.662 . . . . 0.0 109.459 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 1.06 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 45.7 31.92 4.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' ALA . 7.6 t70 -89.75 66.19 7.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.501 -0.999 . . . . 0.0 109.804 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.097 HD11 ' HB3' ' A' ' 55' ' ' PHE . 8.2 tp -47.9 -42.61 27.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 108.962 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -42.03 -32.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.4 -36.82 10.29 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.019 HD12 HD12 ' A' ' 23' ' ' LEU . 25.3 mt -59.32 -54.07 39.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.513 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 52.4 t -58.18 -40.9 79.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.22 -52.73 60.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.082 HD21 ' HA ' ' A' ' 10' ' ' VAL . 9.6 tp -61.71 -27.89 69.02 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.679 ' CG ' HG21 ' A' ' 51' ' ' ILE . 5.6 m-85 -79.08 128.33 33.14 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.556 -0.715 . . . . 0.0 109.811 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -45.86 172.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 109.655 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.431 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -60.08 -24.15 64.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 109.87 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.558 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -148.01 38.66 0.91 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.58 -0.7 . . . . 0.0 109.506 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.676 ' O ' HD11 ' A' ' 51' ' ' ILE . . . -54.91 173.65 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.632 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.564 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -114.57 140.09 49.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.426 -0.796 . . . . 0.0 109.127 179.657 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.561 HG11 ' CD2' ' A' ' 54' ' ' PHE . 1.2 t -113.43 171.83 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 108.715 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.609 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -151.26 121.11 7.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.882 . . . . 0.0 108.873 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.58 ' OD2' ' H62' ' A' ' 126' ' ' NTH . 0.2 OUTLIER 172.69 148.2 0.2 Allowed Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.549 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.581 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 46.7 Cg_endo -80.93 -84.38 0.0 OUTLIER 'Cis proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.165 -2.015 . . . . 0.0 110.599 -0.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.773 ' O ' ' HB2' ' B' ' 275' ' ' ALA . 2.2 m -146.95 73.71 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.203 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.29 -5.5 3.88 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.581 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 3.4 t -97.27 -131.04 0.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.19 -1.183 . . . . 0.0 109.199 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -138.62 128.37 14.7 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.565 -1.334 . . . . 0.0 110.423 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.609 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 37.9 Cg_endo -62.5 -175.56 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.707 1.605 . . . . 0.0 111.055 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.824 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -151.11 100.52 2.78 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.45 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.895 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -90.37 171.58 9.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.205 -0.935 . . . . 0.0 110.63 -178.49 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 95.77 154.85 30.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 5.5 m -64.7 -36.83 85.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.19 -1.182 . . . . 0.0 109.259 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -70.79 -43.97 67.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.154 -0.966 . . . . 0.0 109.319 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.895 ' HB3' ' O ' ' A' ' 46' ' ' SER . . . -74.41 -57.13 4.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.679 HG21 ' CG ' ' A' ' 30' ' ' PHE . 43.0 mt -43.71 -37.11 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.235 -0.916 . . . . 0.0 109.052 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.513 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 2.5 ttt180 -81.25 -63.62 1.36 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.0 109.147 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 4.2 tt0 -45.11 -28.75 0.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.934 . . . . 0.0 108.825 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.561 ' CD2' HG11 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -79.88 -71.42 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.274 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 1.097 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -46.62 -25.75 0.77 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.632 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -71.2 -47.17 59.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 11.1 t-20 -57.51 -30.87 65.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.388 -0.82 . . . . 0.0 108.793 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.566 ' OG ' ' H10' ' A' ' 126' ' ' NTH . 35.6 t -72.55 -40.83 66.37 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.06 HD21 ' CA ' ' A' ' 21' ' ' GLY . 9.0 tp -65.11 -21.93 66.87 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.453 -0.779 . . . . 0.0 109.273 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 4.8 mttp -47.47 -27.5 1.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.043 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.843 HD13 H183 ' A' ' 126' ' ' NTH . 0.3 OUTLIER -90.03 107.72 21.26 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.306 -0.871 . . . . 0.0 108.718 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 44.5 Cg_endo -70.93 116.09 4.53 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.795 1.419 . . . . 0.0 110.675 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.038 HD13 HG13 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -150.3 -171.13 3.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.969 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.59 126.84 54.71 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.822 HG21 ' HB3' ' A' ' 18' ' ' LEU . 2.2 t -105.38 123.52 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 109.895 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -150.23 98.71 2.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.141 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 66' ' ' GLU . 2.1 mp -44.87 170.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 110.039 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 69' ' ' GLN . 0.6 OUTLIER -129.27 -83.3 0.56 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 68' ' ' THR . 2.8 pt20 -59.37 -148.07 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.675 -0.641 . . . . 0.0 109.319 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.45 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 31.6 tt0 -109.1 132.43 54.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.056 -1.028 . . . . 0.0 109.647 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.888 HG13 ' HB3' ' A' ' 80' ' ' PHE . 48.7 t -57.4 149.48 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.293 -0.88 . . . . 0.0 109.259 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -114.28 132.91 55.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.029 -1.044 . . . . 0.0 109.968 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -150.17 112.04 4.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.39 -0.819 . . . . 0.0 109.253 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.769 HG21 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -131.81 158.71 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.225 -0.922 . . . . 0.0 109.501 -179.814 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 48.58 -147.52 0.26 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.304 -0.873 . . . . 0.0 109.622 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 8.8 m-20 -82.24 -24.12 34.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 102' ' ' ARG . 3.3 mt-10 -89.92 -162.41 0.88 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.111 -0.993 . . . . 0.0 109.539 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.681 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . -178.46 168.95 1.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.522 -0.736 . . . . 0.0 109.366 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.818 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.17 136.27 18.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.155 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.888 ' HB3' HG13 ' A' ' 71' ' ' VAL . 14.4 p90 -149.79 162.25 40.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.95 -1.094 . . . . 0.0 110.15 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.958 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -136.45 -173.0 3.29 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.638 0.732 . . . . 0.0 110.118 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.527 ' CD2' ' C ' ' A' ' 81' ' ' ALA . 6.0 p90 177.08 -169.81 0.07 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 1.011 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -133.33 140.41 47.39 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 110.042 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.038 HG13 HD13 ' A' ' 63' ' ' LEU . 37.7 t -107.94 113.35 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.533 ' CA ' HG23 ' A' ' 94' ' ' VAL . 33.6 p -108.12 84.7 1.99 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 109.743 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.904 ' CE1' H212 ' A' ' 126' ' ' NTH . 15.5 p90 -93.62 -179.21 4.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.083 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 18.5 tt0 -111.36 149.59 30.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.034 -1.041 . . . . 0.0 110.325 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.58 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -114.19 104.98 12.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.453 -0.779 . . . . 0.0 109.021 179.443 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.497 ' CG ' ' C ' ' A' ' 88' ' ' PHE . 1.1 pt20 40.74 -93.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.412 -0.805 . . . . 0.0 109.894 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 88' ' ' PHE . . . -101.9 -31.84 5.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -90.08 -178.27 5.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -1.232 . . . . 0.0 109.632 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.497 ' HE3' ' OXT' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -127.46 140.63 52.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.584 ' HB ' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -124.59 159.81 29.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.393 -0.817 . . . . 0.0 109.645 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.644 HG22 ' H ' ' A' ' 95' ' ' VAL . 7.2 p -139.28 174.88 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.165 -0.96 . . . . 0.0 109.31 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 1.011 ' O ' HG22 ' A' ' 83' ' ' THR . 78.3 t -142.94 163.12 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.078 -1.014 . . . . 0.0 109.942 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.576 ' N ' HG12 ' A' ' 95' ' ' VAL . . . -138.0 70.63 49.32 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.527 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.523 ' HD3' HG12 ' A' ' 95' ' ' VAL . 46.1 Cg_endo -97.83 179.25 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.871 1.714 . . . . 0.0 111.447 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.958 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.8 mp -142.06 156.25 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.597 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 19.9 t0 -130.16 159.58 36.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.967 -1.083 . . . . 0.0 110.072 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 113' ' ' ARG . 85.9 t60 -109.87 170.74 7.88 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.859 ' CE2' HG22 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -140.85 136.02 31.95 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.07 -1.018 . . . . 0.0 110.006 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.541 ' HA ' ' CG ' ' A' ' 77' ' ' GLU . 3.2 ttt85 -131.3 109.13 10.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.871 ' CE1' HG11 ' A' ' 10' ' ' VAL . 10.1 m-85 -108.42 -177.48 3.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 107' ' ' GLY . 6.1 p30 -106.72 6.34 29.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.573 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.685 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 120.51 -30.51 5.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 164.36 37.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -1.151 . . . . 0.0 109.364 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 108' ' ' LYS . . . -130.58 47.62 1.01 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 7.3 mmtt 84.19 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.055 -0.674 . . . . 0.0 109.421 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.78 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 40.4 t -89.83 166.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 109.329 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.597 ' N ' HG12 ' A' ' 109' ' ' VAL . 72.3 t -138.19 -59.78 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.531 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.528 ' HB2' ' CD ' ' A' ' 102' ' ' ARG . 1.1 m -139.6 163.5 32.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.612 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.516 ' HG3' ' O ' ' A' ' 100' ' ' HIS . 0.9 OUTLIER -145.45 155.37 43.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.883 . . . . 0.0 109.779 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -141.31 108.18 5.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.376 -0.828 . . . . 0.0 108.985 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.505 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . . . -89.89 148.02 23.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.071 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' B' ' 279' ' ' ALA . 1.4 tt -136.36 139.98 42.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.433 -0.792 . . . . 0.0 109.575 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.783 ' O ' HG21 ' B' ' 274' ' ' VAL . 2.8 p90 172.42 -158.44 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.624 0.726 . . . . 0.0 109.4 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.586 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 174.49 179.85 45.36 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.528 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 18.6 tt0 -72.73 -3.22 23.86 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.311 -1.111 . . . . 0.0 109.397 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -91.16 -29.15 17.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.946 0.879 . . . . 0.0 108.996 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -88.85 15.95 7.64 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.324 0.583 . . . . 0.0 109.712 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.809 HG23 HG22 ' A' ' 95' ' ' VAL . 4.0 mm -89.97 -162.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.621 ' H ' HG22 ' A' ' 121' ' ' ILE . 2.9 t-80 -151.67 153.56 34.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.862 -1.149 . . . . 0.0 110.047 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.446 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.8 125.3 6.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.336 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.12 -164.95 32.59 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.497 ' OXT' ' HE3' ' A' ' 92' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.325 -1.103 . . . . 0.0 109.45 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.427 ' O ' ' C ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.251 0.548 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.471 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 30.7 m120 43.7 74.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.484 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 203' ' ' THR . . . . . 0.611 HG23 ' O ' ' B' ' 203' ' ' THR . 4.8 t -87.64 109.61 27.95 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.625 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 204' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.4 Cg_endo -72.93 -1.35 10.34 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.91 1.479 . . . . 0.0 110.245 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -49.39 72.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -66.15 -55.0 18.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.504 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 207' ' ' MET . . . . . 0.533 ' HB3' ' HB1' ' B' ' 273' ' ' ALA . 69.2 mtm -58.32 -43.72 88.32 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.231 -0.918 . . . . 0.0 109.781 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 19.1 m -70.79 -42.04 70.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.574 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.35 -45.2 65.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 108.747 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.928 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.3 t -56.99 -20.64 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.926 HG11 HG21 ' B' ' 271' ' ' VAL . 10.7 t -90.29 -41.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 0.0 109.198 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 212' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' B' ' 213' ' ' ARG . 14.0 tt0 -60.49 -74.77 0.07 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.95 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.0 OUTLIER -42.09 -43.43 3.26 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 122.137 0.97 . . . . 0.0 108.697 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 214' ' ' TYR . . . . . 0.635 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 1.2 t80 -55.84 -49.27 73.76 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.415 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.854 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -83.01 -42.58 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.722 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 216' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.45 -36.67 10.36 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -74.89 -32.98 61.98 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.854 HD12 ' HA ' ' B' ' 215' ' ' VAL . 0.9 OUTLIER -62.68 -56.18 20.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.719 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 219' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' B' ' 265' ' ' VAL . 4.0 t-20 -53.24 -48.41 68.24 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.652 0.739 . . . . 0.0 109.523 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.01 10.0 23.13 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.845 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.628 ' HA2' HD11 ' B' ' 259' ' ' LEU . . . 50.06 37.83 30.72 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 222' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' B' ' 217' ' ' ALA . 9.4 t0 -93.03 61.29 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.332 -1.099 . . . . 0.0 109.815 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 223' ' ' LEU . . . . . 1.086 HD11 ' HB3' ' B' ' 255' ' ' PHE . 5.8 tp -46.2 -42.53 14.27 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.153 -0.967 . . . . 0.0 108.648 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -43.7 -37.88 2.86 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -81.78 -33.46 27.26 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 1.027 HD12 HD12 ' B' ' 223' ' ' LEU . 27.9 mt -61.25 -55.18 26.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.523 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 88.8 t -58.02 -37.13 59.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.19 25.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.95 HD22 ' HB3' ' B' ' 213' ' ' ARG . 9.8 tp -59.71 -24.39 63.94 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 230' ' ' PHE . . . . . 0.477 ' HB2' ' HA ' ' B' ' 227' ' ' VAL . 5.1 m-85 -82.59 136.62 34.77 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.494 -0.754 . . . . 0.0 109.362 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.844 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -52.33 -174.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.382 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.449 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.3 OUTLIER -69.67 -26.38 64.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.445 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.54 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 3.5 p30 -151.4 54.87 0.86 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.498 -0.751 . . . . 0.0 109.68 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.697 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -60.36 -167.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 235' ' ' THR . . . . . 0.473 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.2 OUTLIER -130.6 133.96 46.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.895 . . . . 0.0 109.244 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.569 HG12 ' N ' ' B' ' 237' ' ' GLU . 23.1 t -111.95 167.66 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -0.865 . . . . 0.0 109.188 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 237' ' ' GLU . . . . . 0.569 ' N ' HG12 ' B' ' 236' ' ' VAL . 21.8 mt-10 -150.88 115.54 5.19 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 238' ' ' ASP . . . . . 0.539 ' OD1' ' HA ' ' B' ' 239' ' ' PRO . 0.6 OUTLIER -177.11 148.17 0.73 Allowed Pre-proline 0 N--CA 1.491 1.582 0 C-N-CA 118.355 -1.338 . . . . 0.0 110.38 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.539 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 47.6 Cg_endo -73.34 -55.32 0.14 OUTLIER 'Cis proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.941 -2.108 . . . . 0.0 110.989 -0.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.64 ' O ' HG23 ' B' ' 240' ' ' VAL . 34.6 m -150.43 111.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 109.792 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.14 43.39 63.12 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 242' ' ' SER . . . . . 0.534 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 73.7 m -114.73 -96.57 0.45 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -1.117 . . . . 0.0 109.944 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 243' ' ' GLU . . . . . 0.437 ' HA ' ' HD2' ' B' ' 244' ' ' PRO . 0.0 OUTLIER -142.86 89.9 7.82 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.272 -0.893 . . . . 0.0 110.609 -179.467 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 244' ' ' PRO . . . . . 0.564 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.9 Cg_endo -63.38 179.57 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.117 1.588 . . . . 0.0 110.507 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.753 ' HB3' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.64 100.46 2.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.952 . . . . 0.0 109.629 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.835 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.79 167.05 13.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.32 -0.863 . . . . 0.0 109.64 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 247' ' ' GLY . . . . . 0.628 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 97.78 159.5 30.66 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 248' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 2.1 m -69.58 -38.57 77.41 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.946 -1.326 . . . . 0.0 109.145 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -69.48 -41.4 76.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.835 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -72.92 -56.99 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.697 HD11 ' N ' ' B' ' 234' ' ' ALA . 30.0 mt -46.67 -42.26 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.188 -0.945 . . . . 0.0 108.772 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 252' ' ' ARG . . . . . 0.735 ' CG ' HD23 ' B' ' 223' ' ' LEU . 8.3 ttt180 -79.08 -50.75 10.55 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 253' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 46.4 mt-10 -51.12 -31.03 18.05 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' B' ' 245' ' ' ARG . 1.1 t80 -83.47 -71.93 0.48 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 1.086 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -46.0 -26.34 0.7 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 256' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' B' ' 252' ' ' ARG . . . -70.65 -48.26 55.86 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 257' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 8.6 t30 -61.98 -31.02 71.34 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 258' ' ' SER . . . . . 0.796 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 2.8 t -71.56 -32.59 68.28 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 0.628 HD11 ' HA2' ' B' ' 221' ' ' GLY . 8.7 tp -66.19 -22.15 66.34 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 260' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 16.1 mtmt -61.51 -13.57 22.26 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 261' ' ' LEU . . . . . 0.867 HD12 ' CG ' ' B' ' 263' ' ' LEU . 0.1 OUTLIER -88.63 110.46 37.26 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.248 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 262' ' ' PRO . . . . . 0.777 ' HD2' HD13 ' B' ' 261' ' ' LEU . 52.1 Cg_endo -80.94 91.68 1.12 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.705 1.371 . . . . 0.0 112.328 -178.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.976 HD23 ' CD1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -138.48 163.77 31.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.082 -1.011 . . . . 0.0 108.819 178.186 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 264' ' ' ALA . . . . . 0.875 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -89.81 127.27 35.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.18 -0.95 . . . . 0.0 109.021 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 265' ' ' VAL . . . . . 0.507 ' O ' ' ND2' ' B' ' 219' ' ' ASN . 93.9 t -104.44 112.44 38.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.269 -0.895 . . . . 0.0 109.528 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 266' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.6 tp10 -147.47 98.14 2.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.053 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.528 ' HA ' ' CB ' ' B' ' 282' ' ' PHE . 1.7 mp -44.41 169.35 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 110.059 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 268' ' ' THR . . . . . 0.502 ' OG1' ' N ' ' B' ' 269' ' ' GLN . 0.4 OUTLIER -122.28 -83.08 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 269' ' ' GLN . . . . . 0.502 ' N ' ' OG1' ' B' ' 268' ' ' THR . 2.6 pt20 -61.17 -140.4 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -117.57 130.67 56.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.875 -1.141 . . . . 0.0 109.993 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 271' ' ' VAL . . . . . 1.021 HG13 ' HB3' ' B' ' 280' ' ' PHE . 56.5 t -48.71 149.19 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.355 -0.841 . . . . 0.0 108.936 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.838 HH21 HD12 ' A' ' 98' ' ' ILE . 31.1 mtp85 -108.11 129.18 55.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.043 -1.036 . . . . 0.0 109.714 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 273' ' ' ALA . . . . . 0.589 ' C ' HG22 ' B' ' 274' ' ' VAL . . . -143.91 144.95 31.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.292 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 274' ' ' VAL . . . . . 0.783 HG21 ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -167.31 146.55 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 109.099 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 275' ' ' ALA . . . . . 0.773 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . 58.27 -139.11 0.81 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.093 -1.005 . . . . 0.0 109.094 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 276' ' ' ASN . . . . . 0.544 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 18.0 m-20 -91.31 -31.26 16.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.977 -1.077 . . . . 0.0 109.891 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 277' ' ' GLU . . . . . 0.683 ' HG2' ' N ' ' B' ' 278' ' ' ALA . 0.0 OUTLIER -97.99 153.6 18.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 109.647 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 278' ' ' ALA . . . . . 0.683 ' N ' ' HG2' ' B' ' 277' ' ' GLU . . . -136.04 169.66 17.25 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.388 0.613 . . . . 0.0 109.877 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 279' ' ' ALA . . . . . 0.759 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -141.66 141.66 33.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.388 -0.82 . . . . 0.0 109.182 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 280' ' ' PHE . . . . . 1.021 ' HB3' HG13 ' B' ' 271' ' ' VAL . 36.0 p90 -150.26 157.92 43.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.848 -1.158 . . . . 0.0 110.324 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 1.051 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -137.26 -169.27 2.46 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.484 0.659 . . . . 0.0 110.038 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 282' ' ' PHE . . . . . 0.528 ' CB ' ' HA ' ' B' ' 267' ' ' LEU . 30.5 p90 168.55 -168.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 283' ' ' THR . . . . . 0.923 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -130.92 140.79 50.23 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.346 -0.846 . . . . 0.0 109.527 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 284' ' ' VAL . . . . . 0.883 HG12 ' HB2' ' B' ' 263' ' ' LEU . 0.4 OUTLIER -100.87 119.32 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -0.872 . . . . 0.0 108.892 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 285' ' ' SER . . . . . 0.875 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 86.7 p -109.17 118.23 36.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 0.0 109.836 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.976 ' CD1' HD23 ' B' ' 263' ' ' LEU . 0.7 OUTLIER -140.32 153.43 46.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.935 . . . . 0.0 109.44 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 287' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' B' ' 291' ' ' ARG . 81.9 tt0 -96.5 164.53 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' B' ' 289' ' ' GLN . 1.0 OUTLIER -115.42 -173.8 2.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.688 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 289' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' B' ' 288' ' ' PHE . 0.0 OUTLIER -43.22 -30.43 0.48 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.707 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -150.0 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 291' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' B' ' 287' ' ' GLU . 0.0 OUTLIER -83.35 -165.03 0.99 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -1.188 . . . . 0.0 109.532 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 292' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' B' ' 287' ' ' GLU . 0.3 OUTLIER -149.78 143.64 25.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.85 . . . . 0.0 109.306 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 293' ' ' THR . . . . . 0.699 HG23 ' CZ ' ' B' ' 286' ' ' PHE . 1.4 t -129.5 -176.19 3.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.999 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 294' ' ' VAL . . . . . 0.679 HG12 ' HB3' ' B' ' 322' ' ' HIS . 6.3 p -152.2 171.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 0.923 ' O ' HG22 ' B' ' 283' ' ' THR . 46.0 t -143.6 155.52 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.86 -1.15 . . . . 0.0 109.835 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 296' ' ' ALA . . . . . 0.52 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -126.33 72.83 72.6 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 297' ' ' PRO . . . . . 0.561 ' HD3' HG12 ' B' ' 295' ' ' VAL . 43.9 Cg_endo -95.85 176.27 0.82 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.539 1.493 . . . . 0.0 111.188 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 1.051 HG23 ' HB2' ' B' ' 281' ' ' ALA . 3.0 mp -142.35 158.79 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 299' ' ' ASP . . . . . 0.628 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 17.1 t0 -131.27 168.24 17.85 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.115 -0.99 . . . . 0.0 109.959 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.672 ' CE1' ' HB2' ' B' ' 279' ' ' ALA . 1.2 t-80 -131.5 138.61 49.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 108.983 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 301' ' ' PHE . . . . . 0.589 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.4 OUTLIER -112.65 150.13 31.88 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 -178.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.5 ' HB3' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -140.8 142.83 34.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.607 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 303' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' B' ' 210' ' ' VAL . 2.1 m-85 -128.99 175.43 8.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.843 . . . . 0.0 108.967 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 304' ' ' ASN . . . . . 0.666 ' OD1' HG21 ' B' ' 310' ' ' VAL . 0.2 OUTLIER -150.3 18.59 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.242 -0.911 . . . . 0.0 109.142 178.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 305' ' ' GLY . . . . . 0.715 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -160.69 -88.53 0.07 OUTLIER Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 306' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 162.75 63.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -1.108 . . . . 0.0 109.666 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 307' ' ' GLY . . . . . 0.475 ' O ' ' HD3' ' B' ' 308' ' ' LYS . . . 166.96 -26.15 0.15 Allowed Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.079 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 308' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' B' ' 307' ' ' GLY . 1.2 mmtp -128.98 164.02 24.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -1.208 . . . . 0.0 109.918 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 309' ' ' VAL . . . . . 0.844 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 2.5 t -103.9 157.04 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.666 HG21 ' OD1' ' B' ' 304' ' ' ASN . 22.1 t -142.77 -35.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.913 -1.117 . . . . 0.0 110.279 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 311' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -126.25 150.71 48.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.714 -1.241 . . . . 0.0 109.921 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 312' ' ' MET . . . . . 0.528 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 8.4 ttp -154.84 149.58 26.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.477 -0.764 . . . . 0.0 109.337 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 313' ' ' ARG . . . . . 0.465 ' HA ' ' HB2' ' B' ' 237' ' ' GLU . 13.4 ttp180 -141.92 124.39 15.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 109.625 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 314' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' B' ' 299' ' ' ASP . . . -97.95 130.83 44.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.449 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 315' ' ' LEU . . . . . 0.818 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -117.84 136.06 53.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.908 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 316' ' ' PHE . . . . . 0.794 ' CE2' ' H72' ' B' ' 326' ' ' NTH . 7.2 p90 170.46 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 317' ' ' GLY . . . . . 0.471 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 169.77 -173.46 43.95 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 318' ' ' GLU . . . . . 0.458 ' C ' HG12 ' B' ' 321' ' ' ILE . 19.0 tt0 -73.51 -2.46 22.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.286 -1.126 . . . . 0.0 109.161 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 16.8 tttp -91.67 -27.69 17.94 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.935 0.874 . . . . 0.0 108.887 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 320' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -88.88 17.34 5.76 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.335 0.588 . . . . 0.0 109.665 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 321' ' ' ILE . . . . . 0.508 HG22 ' H ' ' B' ' 322' ' ' HIS . 4.9 mm -89.83 178.21 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 322' ' ' HIS . . . . . 0.679 ' HB3' HG12 ' B' ' 294' ' ' VAL . 0.2 OUTLIER -152.26 64.43 0.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.835 -1.166 . . . . 0.0 110.312 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.494 ' HA ' ' OG1' ' B' ' 293' ' ' THR . . . -90.75 118.56 30.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.075 -1.016 . . . . 0.0 109.532 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 179.18 -123.74 0.87 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.186 -1.185 . . . . 0.0 109.507 179.845 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 126' ' ' NTH . . . . . 0.904 H212 ' CE1' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 326' ' ' NTH . . . . . 0.841 H221 ' CE2' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.289 0.566 . . . . 0.0 110.326 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.473 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 34.1 t30 -117.53 50.02 1.16 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.548 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 3' ' ' THR . 10.7 t -90.14 108.55 27.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 109.361 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.476 ' HB2' ' OG1' ' A' ' 8' ' ' THR . 46.6 Cg_endo -72.88 -8.55 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.941 1.495 . . . . 0.0 110.12 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -45.36 -36.75 4.4 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -90.31 -59.46 2.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.71 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.581 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -55.32 -22.04 17.42 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.142 -0.974 . . . . 0.0 109.946 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 4' ' ' PRO . 17.4 m -83.42 -40.6 19.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.431 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.78 -39.47 38.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 108.841 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.995 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.1 t -56.45 -26.82 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.072 HG11 HG21 ' A' ' 71' ' ' VAL . 3.5 t -81.63 -39.14 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.405 -0.81 . . . . 0.0 109.327 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 13' ' ' ARG . 7.5 tt0 -62.87 -74.73 0.09 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.135 0.969 . . . . 0.0 108.434 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.716 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -42.78 -44.56 4.47 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.994 0.902 . . . . 0.0 108.6 179.361 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.613 ' CD1' HG23 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -50.74 -44.47 58.39 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.925 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.4 t -90.13 -39.87 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.304 -0.873 . . . . 0.0 109.401 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -49.05 -33.41 11.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 22' ' ' ASP . . . -77.3 -31.91 55.04 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.925 HD12 ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -64.2 -56.75 12.51 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.609 ' ND2' ' O ' ' A' ' 65' ' ' VAL . 4.1 t-20 -53.58 -48.81 68.86 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.624 0.726 . . . . 0.0 109.488 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.85 11.49 17.79 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.668 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.749 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 47.04 35.27 8.2 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' ALA . 15.0 t0 -89.8 62.15 5.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -1.094 . . . . 0.0 109.615 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.056 HD11 ' HB3' ' A' ' 55' ' ' PHE . 6.5 tp -46.69 -43.4 17.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 108.85 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -42.73 -33.17 0.69 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -84.13 -38.03 10.6 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.053 HD12 HD12 ' A' ' 23' ' ' LEU . 14.7 mt -57.71 -56.68 14.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.512 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 43.8 t -55.85 -41.59 67.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -56.02 -53.28 58.81 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.995 HD21 ' HA ' ' A' ' 10' ' ' VAL . 7.7 tp -66.24 -20.72 66.2 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.693 ' HD2' ' HB3' ' A' ' 34' ' ' ALA . 3.0 m-85 -88.41 131.98 34.64 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.546 -0.721 . . . . 0.0 109.654 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -47.98 176.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.836 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.4 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.5 OUTLIER -67.07 -24.78 66.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.55 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 7.0 p-10 -144.0 54.1 1.3 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 109.55 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.783 ' O ' HD11 ' A' ' 51' ' ' ILE . . . -72.69 155.29 40.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.641 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.688 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -101.93 167.06 10.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.235 -0.915 . . . . 0.0 109.25 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 35' ' ' THR . 35.0 t -161.85 108.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.55 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 9.2 mp0 -88.66 103.51 16.0 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.638 ' OD2' ' H62' ' A' ' 126' ' ' NTH . 27.5 t70 -173.16 143.74 1.1 Allowed Pre-proline 0 C--N 1.3 -1.568 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.919 -177.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 49.6 Cg_endo -73.5 174.84 48.5 Favored 'Cis proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.345 -1.94 . . . . 0.0 111.227 -0.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 40' ' ' VAL . 21.9 m -63.89 105.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.81 . . . . 0.0 109.253 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.529 ' CA ' ' HB1' ' B' ' 275' ' ' ALA . . . 122.13 -6.98 10.05 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.523 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -105.09 -155.93 0.56 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.36 -1.082 . . . . 0.0 109.02 179.702 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -125.16 128.96 24.66 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.029 -1.044 . . . . 0.0 109.964 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.55 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 36.9 Cg_endo -62.01 179.19 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.638 1.558 . . . . 0.0 111.371 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.986 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -150.42 105.91 3.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.647 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -88.66 157.31 18.6 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.248 -0.907 . . . . 0.0 110.015 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.55 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 109.24 162.03 19.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 3.9 m -67.25 -58.38 4.95 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.148 -1.207 . . . . 0.0 109.11 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.531 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -55.56 -37.83 68.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.273 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.986 ' HB1' ' HB3' ' A' ' 45' ' ' ARG . . . -68.99 -51.67 36.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.701 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.783 HD11 ' O ' ' A' ' 34' ' ' ALA . 8.8 mm -55.8 -47.14 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 109.283 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.817 ' CG ' HD23 ' A' ' 23' ' ' LEU . 26.3 ttp180 -73.58 -52.48 13.31 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 23.6 tt0 -48.38 -30.79 5.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.089 -1.007 . . . . 0.0 108.469 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.582 ' CZ ' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -83.78 -72.05 0.48 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 1.056 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -47.31 -25.04 0.88 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.618 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -74.15 -47.96 32.52 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 5.4 t30 -57.41 -37.36 72.62 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.579 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 39.8 t -67.66 -35.74 79.43 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.749 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.2 tp -67.48 -29.23 68.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.456 -0.777 . . . . 0.0 109.053 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 17.0 mttm -47.08 -30.48 2.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 108.911 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.822 HD22 HD21 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.4 110.52 39.4 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.9 111.06 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.85 1.447 . . . . 0.0 111.027 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.822 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.94 162.96 31.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.347 -0.845 . . . . 0.0 109.715 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.736 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -92.08 127.95 37.74 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.609 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 21.8 t -115.13 120.08 63.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.054 -1.029 . . . . 0.0 109.967 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 67' ' ' LEU . 1.0 OUTLIER -150.12 106.25 3.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.494 HD22 HG23 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -47.8 177.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 0.0 109.924 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 69' ' ' GLN . 21.9 p -145.07 -81.63 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.386 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.7 OUTLIER -59.88 -144.86 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.479 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 48.9 tt0 -114.44 131.63 56.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.007 -1.058 . . . . 0.0 109.933 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.072 HG21 HG11 ' A' ' 11' ' ' VAL . 13.1 t -61.92 160.49 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.465 -0.772 . . . . 0.0 109.087 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 5.1 ttp180 -122.52 134.74 54.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.229 -0.919 . . . . 0.0 109.824 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . . . -147.89 160.45 42.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.405 -0.809 . . . . 0.0 109.183 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.088 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -159.14 -159.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.725 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -29.52 -85.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.055 -0.403 . . . . 0.0 111.35 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.504 ' O ' ' N ' ' A' ' 103' ' ' PHE . 9.9 m120 -124.62 21.07 8.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.904 -1.123 . . . . 0.0 110.781 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -129.99 -160.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.916 -1.115 . . . . 0.0 109.442 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.951 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 170.05 147.55 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.981 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 72' ' ' ARG . . . -136.12 130.73 33.78 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 30.2 p90 -147.92 170.1 18.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.792 -1.192 . . . . 0.0 110.462 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.752 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -143.96 -166.43 2.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.599 -0.688 . . . . 0.0 109.893 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 81' ' ' ALA . 18.9 p90 168.83 -168.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 0.0 109.238 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.824 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -130.76 144.78 51.68 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.649 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.587 HG11 HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -112.96 122.24 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.166 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.736 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 1.4 p -117.75 107.11 13.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 109.029 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.781 ' CD1' HD23 ' A' ' 63' ' ' LEU . 2.0 p90 -130.04 151.74 50.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.068 -1.02 . . . . 0.0 110.181 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.523 ' HG2' ' N ' ' A' ' 88' ' ' PHE . 84.2 tt0 -127.75 159.93 33.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.441 -0.787 . . . . 0.0 109.039 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -150.5 -99.61 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.058 -1.026 . . . . 0.0 110.326 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.468 ' HG2' ' N ' ' A' ' 90' ' ' GLY . 19.1 tt0 -48.91 -99.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 109.898 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.468 ' N ' ' HG2' ' A' ' 89' ' ' GLN . . . -123.92 -28.19 1.3 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -96.66 150.18 20.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -1.116 . . . . 0.0 109.352 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -113.11 146.53 39.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.103 -0.998 . . . . 0.0 109.172 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.0 145.97 51.1 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.53 -0.731 . . . . 0.0 109.842 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.78 HG13 ' CB ' ' A' ' 122' ' ' HIS . 5.4 p -121.19 166.38 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.922 . . . . 0.0 108.861 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.824 ' O ' HG22 ' A' ' 83' ' ' THR . 62.3 t -140.94 160.21 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.019 -1.05 . . . . 0.0 110.304 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.521 ' N ' HG12 ' A' ' 95' ' ' VAL . . . -138.76 75.11 37.37 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.562 -0.711 . . . . 0.0 109.51 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.504 ' HD3' HG12 ' A' ' 95' ' ' VAL . 48.1 Cg_endo -97.11 -175.6 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.814 1.676 . . . . 0.0 111.2 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.752 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.6 mp -135.26 157.1 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 7.6 t0 -128.66 162.25 27.78 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.204 -0.935 . . . . 0.0 109.813 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.591 ' NE2' ' CD2' ' B' ' 300' ' ' HIS . 0.2 OUTLIER -114.11 173.54 6.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 108.906 179.49 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.951 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -148.16 144.9 28.08 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.97 -1.081 . . . . 0.0 110.45 -178.561 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.527 ' NH1' ' HD2' ' B' ' 313' ' ' ARG . 0.4 OUTLIER -139.99 105.63 5.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.151 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.588 ' CZ ' HG11 ' A' ' 10' ' ' VAL . 5.2 m-85 -91.06 -171.21 2.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.71 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.992 ' HB3' HG21 ' A' ' 110' ' ' VAL . 5.9 p-10 -126.28 -47.97 1.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.272 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.703 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -163.94 27.24 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 105' ' ' GLY . . . 77.07 67.62 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.169 -1.194 . . . . 0.0 109.545 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.27 -39.33 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -165.6 -162.54 0.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -1.113 . . . . 0.0 109.258 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 41.0 t -106.25 144.24 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.248 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.992 HG21 ' HB3' ' A' ' 104' ' ' ASN . 5.0 t -125.99 -28.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 109.898 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.523 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -149.59 155.11 39.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.067 -1.021 . . . . 0.0 109.472 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.523 ' HE3' ' CG ' ' A' ' 99' ' ' ASP . 3.2 ttp -155.91 148.74 24.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.194 -0.941 . . . . 0.0 109.926 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.518 ' HD2' ' NH1' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -130.55 173.52 10.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 108.964 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.56 ' O ' HG12 ' A' ' 40' ' ' VAL . . . -144.37 142.85 30.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.149 -0.97 . . . . 0.0 109.52 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.576 ' HA ' HG11 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -138.61 140.24 38.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.172 -0.955 . . . . 0.0 109.907 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.879 ' O ' HG11 ' B' ' 274' ' ' VAL . 51.9 p90 170.21 -161.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.578 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 174.6 -165.6 37.04 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.536 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 8.3 tt0 -73.13 -3.32 25.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.444 -1.033 . . . . 0.0 109.337 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.26 -31.31 16.18 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.97 0.89 . . . . 0.0 109.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.481 HD21 HD11 ' A' ' 98' ' ' ILE . 1.9 m-20 -89.61 8.58 30.63 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.233 0.54 . . . . 0.0 109.559 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.82 HG23 HG22 ' A' ' 95' ' ' VAL . 4.5 mm -91.89 -170.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 108.84 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.78 ' CB ' HG13 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.35 159.75 44.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.097 -1.002 . . . . 0.0 109.618 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.78 133.94 12.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.959 . . . . 0.0 109.479 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 134.35 -123.69 3.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.291 -1.123 . . . . 0.0 109.444 -179.81 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.0 ptp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.208 0.528 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.462 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 18.7 p-10 -113.15 100.09 8.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.558 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 203' ' ' THR . . . . . 0.738 HG23 ' O ' ' B' ' 203' ' ' THR . 12.5 t -90.34 108.44 26.72 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.542 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 204' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' B' ' 208' ' ' THR . 45.1 Cg_endo -72.15 -1.96 10.87 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.853 1.449 . . . . 0.0 110.457 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.77 -47.37 83.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.557 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -54.9 24.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.267 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 75.9 mtm -61.42 -41.27 96.91 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.286 -0.884 . . . . 0.0 109.382 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.499 ' CB ' ' O ' ' B' ' 204' ' ' PRO . 15.4 m -64.18 -35.95 82.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.84 . . . . 0.0 109.235 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.09 -42.37 49.99 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.139 -0.976 . . . . 0.0 108.59 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.981 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.5 t -60.06 -20.7 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 1.04 HG21 HG11 ' B' ' 271' ' ' VAL . 4.4 t -88.32 -40.61 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.833 . . . . 0.0 108.89 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 212' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' B' ' 213' ' ' ARG . 24.6 tt0 -61.53 -74.35 0.08 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.659 ' HD2' HD13 ' B' ' 229' ' ' LEU . 1.0 OUTLIER -43.68 -45.52 7.0 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 214' ' ' TYR . . . . . 0.59 ' CD1' HG23 ' B' ' 215' ' ' VAL . 0.5 OUTLIER -49.88 -42.88 48.75 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.511 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.924 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.4 t -89.77 -37.85 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.251 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 216' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -49.49 -35.6 20.35 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.606 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -74.69 -30.95 61.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.924 HD12 ' HA ' ' B' ' 215' ' ' VAL . 2.3 mt -66.86 -58.11 5.66 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -50.85 -45.31 59.73 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.602 0.715 . . . . 0.0 109.302 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.31 1.36 55.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.624 -0.672 . . . . 0.0 109.748 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 1.066 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 53.76 44.13 70.0 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 222' ' ' ASP . . . . . 0.48 ' O ' HG13 ' B' ' 226' ' ' ILE . 30.3 t0 -102.87 83.96 2.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.902 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 223' ' ' LEU . . . . . 1.066 ' CD2' HD22 ' B' ' 259' ' ' LEU . 3.7 mm? -53.04 -18.4 2.03 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.139 -0.976 . . . . 0.0 110.063 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -64.05 -57.16 10.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.093 -1.004 . . . . 0.0 109.473 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -62.92 -27.64 70.61 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.961 HD12 HD13 ' B' ' 223' ' ' LEU . 7.0 mt -67.86 -61.46 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.454 -1.027 . . . . 0.0 108.315 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.7 HG21 ' HB2' ' B' ' 252' ' ' ARG . 51.2 t -59.49 -40.33 81.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.87 -53.47 55.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 229' ' ' LEU . . . . . 0.981 HD21 ' HA ' ' B' ' 210' ' ' VAL . 4.7 tp -62.8 -21.78 66.14 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 230' ' ' PHE . . . . . 0.478 ' HA ' ' HB ' ' B' ' 309' ' ' VAL . 3.7 m-30 -92.71 139.11 30.9 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.452 -0.78 . . . . 0.0 109.784 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -50.71 -176.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 109.822 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -25.16 64.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.879 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 233' ' ' ASP . . . . . 0.543 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 10.0 p-10 -144.17 52.51 1.28 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.495 -0.753 . . . . 0.0 109.137 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' B' ' 310' ' ' VAL . . . -65.43 158.6 26.31 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 109.617 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 235' ' ' THR . . . . . 0.716 HG23 ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -107.34 147.18 30.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.875 . . . . 0.0 109.107 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 52.8 t -141.4 111.05 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 237' ' ' GLU . . . . . 0.528 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 1.5 mm-40 -89.91 105.14 17.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 238' ' ' ASP . . . . . 0.623 ' OD1' ' HB3' ' B' ' 314' ' ' ALA . 21.8 t70 178.91 143.24 0.31 Allowed Pre-proline 0 C--N 1.301 -1.528 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.307 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.518 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 48.5 Cg_endo -73.6 173.87 53.66 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.264 -1.973 . . . . 0.0 110.905 -0.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.584 HG22 ' CZ ' ' B' ' 316' ' ' PHE . 6.5 m -69.81 112.7 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 108.972 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 241' ' ' GLY . . . . . 0.492 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . 115.06 -2.13 22.67 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 242' ' ' SER . . . . . 0.479 ' OG ' ' HG2' ' B' ' 239' ' ' PRO . 64.6 m -113.35 -134.83 0.35 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.305 -1.114 . . . . 0.0 108.893 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 243' ' ' GLU . . . . . 0.531 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 4.3 mt-10 -142.03 133.52 13.26 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.863 -1.148 . . . . 0.0 109.755 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 244' ' ' PRO . . . . . 0.528 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.9 Cg_endo -63.39 -171.53 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.082 1.569 . . . . 0.0 111.34 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.964 ' HG3' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.74 96.91 2.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 246' ' ' SER . . . . . 0.716 ' HB3' HG23 ' B' ' 235' ' ' THR . 0.2 OUTLIER -88.88 150.47 22.86 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.238 -0.914 . . . . 0.0 109.987 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 247' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.24 163.18 21.88 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 2.2 m -70.04 -61.45 1.77 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -1.209 . . . . 0.0 109.148 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -55.36 -22.98 21.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.241 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.964 ' HB1' ' HG3' ' B' ' 245' ' ' ARG . . . -88.45 -48.62 7.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.587 HD11 ' O ' ' B' ' 234' ' ' ALA . 4.5 mm -53.65 -43.7 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.132 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 252' ' ' ARG . . . . . 0.7 ' HB2' HG21 ' B' ' 227' ' ' VAL . 44.0 ttp85 -75.54 -52.65 10.13 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 108.94 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 253' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 29.9 mt-10 -48.4 -27.72 2.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.809 -1.182 . . . . 0.0 108.427 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.585 ' CE2' ' O ' ' B' ' 238' ' ' ASP . 0.3 OUTLIER -85.84 -71.7 0.52 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.681 0.753 . . . . 0.0 109.021 179.739 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 0.7 ' C ' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -52.6 -21.76 4.25 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.241 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 256' ' ' ALA . . . . . 0.55 ' HB2' ' HG ' ' B' ' 223' ' ' LEU . . . -80.33 -46.8 15.5 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 257' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 18.7 t-20 -58.19 -31.17 67.04 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 258' ' ' SER . . . . . 0.752 ' OG ' H112 ' B' ' 326' ' ' NTH . 33.7 t -70.66 -31.63 68.62 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 1.066 HD21 ' CA ' ' B' ' 221' ' ' GLY . 5.7 tp -71.12 -27.72 63.78 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 260' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 0.7 OUTLIER -44.73 -27.83 0.55 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.455 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 261' ' ' LEU . . . . . 0.807 HD23 HD23 ' B' ' 263' ' ' LEU . 0.3 OUTLIER -90.72 114.29 60.8 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.033 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 262' ' ' PRO . . . . . 0.499 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 44.3 Cg_endo -72.02 107.93 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.766 1.403 . . . . 0.0 110.892 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.856 ' CB ' HG13 ' B' ' 284' ' ' VAL . 0.0 OUTLIER -137.3 162.54 33.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 109.854 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 264' ' ' ALA . . . . . 0.818 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -96.46 123.67 40.19 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 265' ' ' VAL . . . . . 0.795 HG21 ' HB3' ' B' ' 218' ' ' LEU . 4.4 t -105.06 117.32 50.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.643 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 266' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' B' ' 267' ' ' LEU . 2.0 tt0 -147.78 104.97 3.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.22 -0.925 . . . . 0.0 109.153 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.1 mt -47.11 174.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.293 -0.879 . . . . 0.0 109.695 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 1.7 t -146.54 -40.31 0.21 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.67 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 269' ' ' GLN . . . . . 0.508 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 13.7 pt20 -102.66 -152.25 0.44 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.647 -0.658 . . . . 0.0 109.267 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.508 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 26.6 tt0 -106.43 130.59 54.21 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.61 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 271' ' ' VAL . . . . . 1.04 HG11 HG21 ' B' ' 211' ' ' VAL . 81.4 t -66.81 147.62 12.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.344 -0.848 . . . . 0.0 109.245 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 2.4 tpm_? -102.89 135.95 43.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.952 . . . . 0.0 109.765 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 273' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -149.8 146.36 27.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.39 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 274' ' ' VAL . . . . . 0.879 HG11 ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -162.24 146.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.13 -0.981 . . . . 0.0 110.228 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 275' ' ' ALA . . . . . 0.529 ' HB1' ' CA ' ' A' ' 41' ' ' GLY . . . 39.57 -97.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.802 -0.561 . . . . 0.0 110.621 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 276' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' B' ' 303' ' ' PHE . 60.1 m-20 -130.74 34.04 4.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.025 -1.047 . . . . 0.0 110.237 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 277' ' ' GLU . . . . . 0.7 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 0.9 OUTLIER -139.49 -158.4 0.85 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 108.792 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 278' ' ' ALA . . . . . 0.876 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . 165.96 149.6 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.72 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 279' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -135.98 130.75 34.1 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 280' ' ' PHE . . . . . 1.011 ' HB3' HG13 ' B' ' 271' ' ' VAL . 22.8 p90 -150.07 175.45 11.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.601 -1.312 . . . . 0.0 110.697 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.61 ' HB2' ' CG1' ' B' ' 298' ' ' ILE . . . -150.11 -179.0 6.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.585 -0.697 . . . . 0.0 109.197 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 282' ' ' PHE . . . . . 0.54 ' CE2' HG23 ' B' ' 284' ' ' VAL . 2.8 p90 -172.92 -162.14 0.16 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 109.492 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 283' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -133.61 147.44 51.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.512 -0.742 . . . . 0.0 109.887 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 284' ' ' VAL . . . . . 0.856 HG13 ' CB ' ' B' ' 263' ' ' LEU . 4.0 t -123.36 116.53 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 109.41 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 285' ' ' SER . . . . . 0.818 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 90.9 p -111.95 114.69 27.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 109.098 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.57 ' HD1' HG12 ' B' ' 284' ' ' VAL . 55.6 p90 -143.21 167.39 22.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 110.084 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 287' ' ' GLU . . . . . 0.459 ' HG2' ' N ' ' B' ' 288' ' ' PHE . 30.1 tt0 -144.1 153.25 41.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 109.255 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' B' ' 288' ' ' PHE . 0.3 OUTLIER -135.89 4.34 3.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.716 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -170.3 -148.81 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.254 -0.904 . . . . 0.0 109.383 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -74.8 -11.95 83.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 291' ' ' ARG . . . . . 0.471 ' HG2' ' HA ' ' B' ' 325' ' ' ALA . 14.5 mtp180 -113.8 140.41 48.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -1.115 . . . . 0.0 109.273 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 292' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' B' ' 292' ' ' LYS . 18.9 ptmt -125.78 172.47 9.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 109.635 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 293' ' ' THR . . . . . 0.837 HG23 ' HA ' ' B' ' 323' ' ' ALA . 32.2 m -156.65 171.53 20.17 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.366 -0.834 . . . . 0.0 109.095 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 294' ' ' VAL . . . . . 0.662 HG12 ' CB ' ' B' ' 322' ' ' HIS . 0.4 OUTLIER -134.17 165.94 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 1.061 HG22 HG23 ' B' ' 321' ' ' ILE . 3.4 t -136.81 145.8 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.016 -1.052 . . . . 0.0 109.66 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 296' ' ' ALA . . . . . 0.463 ' O ' ' OD1' ' B' ' 320' ' ' ASN . . . -132.52 72.9 77.5 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.433 -0.792 . . . . 0.0 110.023 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 297' ' ' PRO . . . . . 0.986 ' HD3' HG12 ' B' ' 295' ' ' VAL . 49.2 Cg_endo -92.95 -177.01 0.67 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.87 1.458 . . . . 0.0 111.113 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.675 HG23 ' O ' ' B' ' 280' ' ' PHE . 2.7 mp -134.38 144.61 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 299' ' ' ASP . . . . . 0.612 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 5.6 t0 -117.13 166.95 11.63 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.824 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 300' ' ' HIS . . . . . 0.591 ' CD2' ' NE2' ' A' ' 100' ' ' HIS . 1.6 t-80 -117.58 173.58 6.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 108.916 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 301' ' ' PHE . . . . . 0.876 ' CB ' ' HB3' ' B' ' 278' ' ' ALA . 0.1 OUTLIER -145.67 145.82 31.06 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.071 -1.018 . . . . 0.0 110.583 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.498 ' HD3' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -137.66 98.73 3.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 109.156 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 303' ' ' PHE . . . . . 0.672 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 4.5 m-85 -89.74 176.51 6.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 109.57 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 304' ' ' ASN . . . . . 0.882 ' HB3' HG21 ' B' ' 310' ' ' VAL . 9.1 p-10 -118.64 -27.03 5.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.222 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 305' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -159.35 -63.96 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 306' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 163.63 76.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -1.127 . . . . 0.0 109.563 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 175.87 -57.14 0.11 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -111.33 -172.75 2.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -1.149 . . . . 0.0 109.504 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 309' ' ' VAL . . . . . 0.565 HG12 ' N ' ' B' ' 310' ' ' VAL . 85.8 t -119.72 164.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.033 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.882 HG21 ' HB3' ' B' ' 304' ' ' ASN . 5.0 t -134.82 -72.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.963 -1.085 . . . . 0.0 110.018 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 311' ' ' SER . . . . . 0.498 ' HB2' ' HD3' ' B' ' 302' ' ' ARG . 31.6 m -112.44 162.48 15.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.899 -1.126 . . . . 0.0 109.837 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 312' ' ' MET . . . . . 0.544 ' CE ' ' CE2' ' B' ' 214' ' ' TYR . 2.6 ttt -159.94 137.99 10.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 313' ' ' ARG . . . . . 0.527 ' HD2' ' NH1' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -125.69 159.27 32.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.144 -0.972 . . . . 0.0 108.812 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 314' ' ' ALA . . . . . 0.623 ' HB3' ' OD1' ' B' ' 238' ' ' ASP . . . -125.18 150.38 47.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.904 -1.122 . . . . 0.0 109.841 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 315' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -141.02 140.8 34.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.39 -0.819 . . . . 0.0 109.774 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 316' ' ' PHE . . . . . 1.088 ' O ' HG11 ' A' ' 74' ' ' VAL . 53.7 p90 173.12 -160.96 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 317' ' ' GLY . . . . . 0.48 ' O ' HG12 ' B' ' 321' ' ' ILE . . . 173.48 -172.38 45.17 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 318' ' ' GLU . . . . . 0.52 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 22.3 tt0 -68.4 -6.69 25.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.419 -1.047 . . . . 0.0 109.714 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -87.08 -31.84 20.26 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.045 0.926 . . . . 0.0 108.939 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 320' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.61 14.28 11.99 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.742 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 321' ' ' ILE . . . . . 1.061 HG23 HG22 ' B' ' 295' ' ' VAL . 4.0 mm -100.84 -166.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 0.0 108.902 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 322' ' ' HIS . . . . . 0.677 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.3 OUTLIER -151.25 -172.41 4.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.116 -0.99 . . . . 0.0 109.613 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.837 ' HA ' HG23 ' B' ' 293' ' ' THR . . . -155.45 128.65 8.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -122.32 135.13 10.09 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 325' ' ' ALA . . . . . 0.471 ' HA ' ' HG2' ' B' ' 291' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.21 -1.17 . . . . 0.0 109.472 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' NTH . . . . . 0.769 H221 ' CE2' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 326' ' ' NTH . . . . . 0.752 H112 ' OG ' ' B' ' 258' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.45 -3.63 13.77 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.852 1.448 . . . . 0.0 110.19 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.24 -45.38 72.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.877 . . . . 0.0 109.385 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.472 ' NE2' ' O ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -66.68 -55.39 15.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.59 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.434 ' SD ' ' O ' ' A' ' 75' ' ' ALA . 27.4 mtt -58.0 -48.74 79.11 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.231 -0.918 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 m -54.4 -38.1 65.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.285 -0.884 . . . . 0.0 109.054 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -49.29 -43.06 42.9 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.828 HG11 ' CE1' ' A' ' 103' ' ' PHE . 2.3 t -55.76 -49.92 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.99 HG11 HG21 ' A' ' 71' ' ' VAL . 5.1 t -54.71 -41.09 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 13' ' ' ARG . 25.7 tt0 -63.17 -75.13 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.344 1.068 . . . . 0.0 108.145 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.515 ' HB3' HD13 ' A' ' 29' ' ' LEU . 6.6 mtp85 -43.67 -45.97 7.18 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -48.93 -45.72 42.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.923 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -86.0 -37.48 11.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.383 -0.823 . . . . 0.0 109.071 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.89 -37.92 21.12 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.489 ' HB3' HG12 ' A' ' 26' ' ' ILE . . . -72.0 -32.87 67.62 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.923 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.4 mt -67.34 -59.45 3.4 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -48.02 -39.86 21.05 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.599 0.714 . . . . 0.0 109.25 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.41 6.06 42.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.545 -0.722 . . . . 0.0 109.652 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.984 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 47.73 30.87 7.02 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -96.94 88.4 4.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -1.106 . . . . 0.0 109.723 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.074 HD13 HD12 ' A' ' 26' ' ' ILE . 3.3 mm? -51.83 -20.25 2.13 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.195 -0.94 . . . . 0.0 109.815 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.14 -56.26 16.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.253 -0.904 . . . . 0.0 109.303 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.35 -29.34 63.11 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.074 HD12 HD13 ' A' ' 23' ' ' LEU . 12.3 mt -69.06 -62.27 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.549 HG21 ' HB2' ' A' ' 52' ' ' ARG . 60.4 t -57.34 -37.91 59.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.95 26.33 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 10' ' ' VAL . 7.8 tp -59.1 -22.7 61.25 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.939 ' CE2' HG22 ' A' ' 26' ' ' ILE . 20.4 m-30 -88.47 136.53 32.94 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.675 -0.641 . . . . 0.0 109.651 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -51.12 -178.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.273 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -23.52 66.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 109.527 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.534 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 25.2 p-10 -148.37 45.55 1.05 Allowed 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.835 ' HB3' HD13 ' A' ' 51' ' ' ILE . . . -51.61 -178.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.791 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -126.05 135.92 52.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.501 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 37' ' ' GLU . 6.6 t -113.84 169.02 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.129 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.57 ' N ' ' CG1' ' A' ' 36' ' ' VAL . 28.1 mt-10 -150.4 106.07 3.4 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.541 ' OD1' ' HA ' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -174.45 153.71 1.89 Allowed Pre-proline 0 C--N 1.3 -1.575 0 C-N-CA 118.607 -1.237 . . . . 0.0 109.804 -178.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.558 ' O ' HG13 ' A' ' 40' ' ' VAL . 44.7 Cg_endo -73.88 -66.67 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.916 -2.118 . . . . 0.0 111.522 0.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.598 ' O ' HG23 ' A' ' 40' ' ' VAL . 23.8 m -159.06 87.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.948 -1.095 . . . . 0.0 109.596 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . 164.33 38.75 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER 72.92 55.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.325 -1.103 . . . . 0.0 109.962 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.548 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 3.8 mt-10 -132.57 58.38 35.77 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.807 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 52.1 Cg_endo -79.71 175.07 10.96 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.825 1.683 . . . . 0.0 111.271 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.788 ' CD ' ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -150.99 100.17 2.77 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.601 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -89.43 166.73 13.52 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.186 -0.946 . . . . 0.0 110.103 -179.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 33' ' ' ASP . . . 86.36 -169.8 41.96 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.546 HG23 HG11 ' A' ' 27' ' ' VAL . 3.4 m -103.45 -46.63 4.51 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.223 -1.163 . . . . 0.0 108.978 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -58.29 -23.74 57.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.247 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.788 ' HB1' ' CD ' ' A' ' 45' ' ' ARG . . . -89.86 -52.51 4.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.398 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.835 HD13 ' HB3' ' A' ' 34' ' ' ALA . 80.1 mt -57.22 -46.8 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.197 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.549 ' HB2' HG21 ' A' ' 27' ' ' VAL . 1.5 ttt180 -70.0 -56.25 7.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -0.888 . . . . 0.0 108.906 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 14.4 tt0 -45.88 -29.92 1.54 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 108.658 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.57 ' CD2' ' HG3' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -84.1 -70.28 0.58 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.624 ' C ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -46.7 -28.05 1.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.444 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . . . -75.07 -50.8 15.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 12.8 t-20 -55.51 -34.55 64.75 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 t -64.83 -36.63 84.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.984 HD21 ' CA ' ' A' ' 21' ' ' GLY . 7.4 tp -69.45 -19.28 63.77 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.535 -0.728 . . . . 0.0 109.706 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 33.9 mtmt -55.53 -25.58 38.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 109.36 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.007 HD22 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -89.87 121.32 69.05 Favored Pre-proline 0 C--N 1.305 -1.328 0 O-C-N 121.272 -0.893 . . . . 0.0 108.777 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 48.7 Cg_endo -74.04 103.2 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.71 1.374 . . . . 0.0 111.152 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.007 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.15 -178.54 5.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.006 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -117.88 127.29 53.72 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.521 HG13 ' CD2' ' A' ' 82' ' ' PHE . 4.6 t -116.43 115.92 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.181 -0.95 . . . . 0.0 109.841 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 67' ' ' LEU . 1.2 tt0 -150.17 95.74 2.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.294 -0.879 . . . . 0.0 109.216 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.691 HD21 HG21 ' A' ' 15' ' ' VAL . 4.4 mt -42.81 166.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.974 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.67 -39.9 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.565 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -81.77 -146.01 0.06 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 25.0 tt0 -113.15 129.61 56.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.09 -1.006 . . . . 0.0 109.642 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.99 HG21 HG11 ' A' ' 11' ' ' VAL . 19.2 t -67.92 152.28 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.38 -0.825 . . . . 0.0 108.919 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 19.2 mtt-85 -114.64 135.29 54.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.136 -0.978 . . . . 0.0 109.672 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.525 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -149.95 112.86 4.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.293 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -130.09 155.71 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -0.903 . . . . 0.0 109.489 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.434 ' O ' ' SD ' ' A' ' 7' ' ' MET . . . 43.64 -147.42 0.07 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 81.6 m-20 -82.64 -3.19 55.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.941 . . . . 0.0 109.526 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.578 ' CG ' ' HG3' ' A' ' 102' ' ' ARG . 0.8 OUTLIER -104.85 -163.55 0.97 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.219 -0.926 . . . . 0.0 109.613 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 178.37 166.33 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 109.485 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.762 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.31 140.06 21.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 108.948 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.626 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 39.8 p90 -150.58 169.23 22.04 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.877 -1.14 . . . . 0.0 109.941 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.753 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -141.84 -175.37 4.37 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.502 -0.749 . . . . 0.0 109.591 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.645 ' HB3' HD22 ' A' ' 67' ' ' LEU . 9.8 p90 177.05 -159.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.805 . . . . 0.0 109.351 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -137.92 151.79 48.34 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.564 -0.71 . . . . 0.0 109.73 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.633 HG12 ' CB ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -122.11 124.34 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.416 -0.802 . . . . 0.0 109.081 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 1.006 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 5.1 p -114.66 92.81 4.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.6 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.541 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . 18.8 p90 -115.47 177.93 4.48 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.345 -0.847 . . . . 0.0 109.126 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 88' ' ' PHE . 30.7 tt0 -107.37 166.92 10.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 110.12 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.521 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -116.84 -161.31 0.8 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.4 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -7.44 28.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 109.78 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.11 -40.38 0.03 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.4 mtt-85 -95.72 -176.9 3.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -1.161 . . . . 0.0 109.609 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -115.62 127.19 55.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.897 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -118.3 142.57 47.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.776 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 122' ' ' HIS . 1.2 t -116.15 175.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 1.056 HG12 ' HD3' ' A' ' 97' ' ' PRO . 4.1 t -145.37 144.14 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.881 -1.137 . . . . 0.0 109.737 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.436 ' O ' ' CG ' ' A' ' 120' ' ' ASN . . . -133.06 71.64 77.4 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.345 -0.847 . . . . 0.0 110.408 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 1.056 ' HD3' HG12 ' A' ' 95' ' ' VAL . 49.6 Cg_endo -95.23 -176.18 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 121.492 1.461 . . . . 0.0 110.947 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.753 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.9 mp -137.68 139.59 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.626 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 8.9 t0 -111.99 163.14 14.59 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.95 -1.093 . . . . 0.0 110.261 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.536 ' HB3' ' CB ' ' A' ' 113' ' ' ARG . 4.3 t-80 -116.39 176.29 5.17 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.561 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -149.94 142.63 24.59 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.008 -1.057 . . . . 0.0 110.556 -178.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.612 ' O ' HG23 ' A' ' 110' ' ' VAL . 3.1 ttm180 -135.65 107.64 7.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.484 -0.76 . . . . 0.0 109.106 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.828 ' CE1' HG11 ' A' ' 10' ' ' VAL . 14.2 m-85 -105.42 179.5 4.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.607 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -127.04 -0.67 6.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.933 . . . . 0.0 109.596 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -175.43 -87.57 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 176.05 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -1.184 . . . . 0.0 109.598 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -127.56 -37.16 0.46 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 107' ' ' GLY . 8.0 mtmm -146.7 -164.76 2.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -1.125 . . . . 0.0 109.255 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.574 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 91.2 t -115.16 158.87 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.027 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -132.6 -54.21 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.567 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.56 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -127.17 156.9 41.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.041 -1.037 . . . . 0.0 109.013 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.512 ' HE1' ' CE1' ' A' ' 30' ' ' PHE . 21.5 ttm -154.0 147.24 24.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.122 -0.986 . . . . 0.0 109.655 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.536 ' CB ' ' HB3' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -123.33 174.21 7.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.377 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 99' ' ' ASP . . . -147.83 149.13 31.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.706 HD13 ' HB2' ' B' ' 279' ' ' ALA . 1.7 tt -143.03 143.73 32.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.138 -0.976 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.528 ' O ' ' CG2' ' B' ' 274' ' ' VAL . 15.4 p90 171.95 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.561 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 167.07 -176.9 41.92 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.561 -1.305 . . . . 0.0 110.185 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.545 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 17.6 tt0 -69.39 -6.06 27.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.433 -1.04 . . . . 0.0 109.509 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -91.38 -29.24 17.2 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.928 0.87 . . . . 0.0 108.936 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.8 m-20 -88.79 12.51 14.82 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.707 HG22 ' H ' ' A' ' 122' ' ' HIS . 5.0 mm -89.87 -169.92 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.897 ' O ' HG22 ' A' ' 93' ' ' THR . 0.1 OUTLIER -151.63 99.79 2.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 109.805 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -117.13 135.74 53.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.149 -0.97 . . . . 0.0 109.549 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 152.85 -145.91 13.89 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.177 -1.19 . . . . 0.0 109.509 179.944 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . 0.463 ' O ' ' CB ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.239 0.542 . . . . 0.0 110.174 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' B' ' 201' ' ' MET . 0.6 OUTLIER 72.6 98.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.563 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . 0.429 ' C ' ' O ' ' B' ' 202' ' ' ASN . 1.2 t -43.43 112.04 1.18 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.0 109.54 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.49 -3.29 13.16 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.828 1.436 . . . . 0.0 110.046 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -38.62 84.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.884 . . . . 0.0 109.385 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -51.8 56.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.351 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' MET . . . . . 0.522 ' HB2' ' HB1' ' B' ' 273' ' ' ALA . 21.9 mtm -59.91 -30.06 68.78 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.293 -0.879 . . . . 0.0 109.624 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 5.0 m -72.55 -33.81 67.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.91 . . . . 0.0 109.195 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.9 75.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.934 . . . . 0.0 108.859 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.856 HG11 ' CE1' ' B' ' 303' ' ' PHE . 2.3 t -52.74 -45.99 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.818 HG11 HG21 ' B' ' 271' ' ' VAL . 4.4 t -61.86 -39.63 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.599 -0.688 . . . . 0.0 109.951 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' B' ' 213' ' ' ARG . 21.8 tt0 -62.63 -75.4 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.758 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.0 OUTLIER -43.35 -44.84 5.81 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.971 0.891 . . . . 0.0 108.622 179.157 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' TYR . . . . . 0.633 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -50.42 -46.98 56.74 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.865 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -85.77 -37.65 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.359 -0.838 . . . . 0.0 109.297 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.72 -36.5 16.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -73.08 -34.19 66.06 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' B' ' 215' ' ' VAL . 1.2 mt -65.26 -58.22 6.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -50.37 -45.04 54.98 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.555 0.693 . . . . 0.0 109.164 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.64 5.95 43.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.52 -0.737 . . . . 0.0 109.633 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.686 ' HA2' HD11 ' B' ' 259' ' ' LEU . . . 50.4 37.96 33.35 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' B' ' 217' ' ' ALA . 11.3 t0 -97.77 72.41 2.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.42 -1.047 . . . . 0.0 109.864 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' LEU . . . . . 1.038 HD11 ' HB3' ' B' ' 255' ' ' PHE . 7.7 tp -47.08 -43.65 20.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 108.705 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -43.32 -35.28 1.45 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -80.32 -35.79 25.6 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 1.007 HD12 HD12 ' B' ' 223' ' ' LEU . 19.9 mt -62.1 -57.19 13.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.637 ' CG1' HG23 ' B' ' 248' ' ' THR . 92.6 t -56.44 -37.41 51.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.07 -54.92 41.58 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.773 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.3 tp -63.8 -22.06 66.73 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . 0.693 ' CG ' HG21 ' B' ' 251' ' ' ILE . 2.0 m-85 -85.42 130.01 34.68 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.525 -0.735 . . . . 0.0 109.383 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -47.0 172.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.152 -0.968 . . . . 0.0 109.383 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.3 -24.99 58.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 109.816 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.527 ' CB ' ' HA2' ' B' ' 247' ' ' GLY . 13.2 p-10 -150.24 45.55 0.89 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.583 -0.698 . . . . 0.0 109.212 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.822 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -57.57 159.9 4.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.334 -0.854 . . . . 0.0 109.706 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' THR . . . . . 1.006 HG23 ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -106.95 144.12 34.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.558 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.55 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 42.8 t -132.72 121.4 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.081 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' GLU . . . . . 0.551 ' HB2' ' CG ' ' B' ' 313' ' ' ARG . 3.3 mt-10 -89.26 109.18 20.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 108.89 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' ASP . . . . . 0.506 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 9.8 t70 -179.17 141.92 0.38 Allowed Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.837 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' B' ' 238' ' ' ASP . 47.3 Cg_endo -72.66 -177.57 18.89 Favored 'Cis proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.291 -1.962 . . . . 0.0 110.761 -0.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 8.0 m -62.34 152.34 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.254 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.07 20.73 9.27 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' SER . . . . . 0.498 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -116.59 -155.41 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -1.066 . . . . 0.0 109.511 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.77 128.84 25.58 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.066 -1.022 . . . . 0.0 109.894 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' PRO . . . . . 0.55 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.4 Cg_endo -65.25 -169.94 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.983 1.518 . . . . 0.0 111.243 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.712 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.5 OUTLIER -151.14 100.88 2.82 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 1.006 ' HB3' HG23 ' B' ' 235' ' ' THR . 0.2 OUTLIER -89.44 153.61 20.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 110.363 -178.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' B' ' 233' ' ' ASP . . . 108.03 159.94 20.45 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' THR . . . . . 0.637 HG23 ' CG1' ' B' ' 227' ' ' VAL . 6.3 m -70.4 -44.74 67.37 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.219 -1.165 . . . . 0.0 109.103 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -63.08 -36.84 84.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -0.911 . . . . 0.0 109.06 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.712 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -74.18 -59.84 2.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.822 HD11 ' N ' ' B' ' 234' ' ' ALA . 30.1 mt -48.45 -41.23 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.28 -0.887 . . . . 0.0 108.916 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' ARG . . . . . 0.641 ' CG ' HD23 ' B' ' 223' ' ' LEU . 13.0 ttm180 -78.34 -56.49 4.41 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 253' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 17.5 tt0 -46.65 -27.03 1.03 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.058 -1.027 . . . . 0.0 108.29 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 0.6 OUTLIER -86.22 -71.14 0.56 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 255' ' ' PHE . . . . . 1.038 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -48.09 -31.62 5.77 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . 0.704 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -67.04 -47.73 70.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -56.49 -31.94 64.53 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 29.6 t -73.14 -36.37 66.66 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 259' ' ' LEU . . . . . 0.686 HD11 ' HA2' ' B' ' 221' ' ' GLY . 8.2 tp -68.22 -27.84 66.72 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.382 -0.824 . . . . 0.0 109.282 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -47.21 -25.74 1.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.235 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 261' ' ' LEU . . . . . 0.709 ' O ' HD23 ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.74 112.67 53.3 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.403 -0.811 . . . . 0.0 108.912 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 262' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.34 97.75 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.823 1.433 . . . . 0.0 110.493 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.976 HD13 HG13 ' B' ' 284' ' ' VAL . 0.3 OUTLIER -131.66 -172.07 2.77 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.79 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . 0.987 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -119.19 127.4 53.26 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 265' ' ' VAL . . . . . 0.71 HG21 ' HB3' ' B' ' 218' ' ' LEU . 3.6 t -107.88 118.8 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.281 -0.887 . . . . 0.0 109.575 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 266' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.4 tt0 -150.08 106.81 3.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 109.285 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.9 OUTLIER -47.15 174.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.839 . . . . 0.0 109.767 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 1.7 p -148.49 -38.92 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.63 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 269' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' B' ' 270' ' ' GLU . 0.6 OUTLIER -99.69 -147.06 0.34 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 109.405 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 270' ' ' GLU . . . . . 0.442 ' N ' ' CG ' ' B' ' 269' ' ' GLN . 26.0 tt0 -111.45 132.24 54.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.205 -0.934 . . . . 0.0 109.562 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 271' ' ' VAL . . . . . 0.822 HG13 ' HB3' ' B' ' 280' ' ' PHE . 30.3 t -64.04 151.11 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.263 -0.898 . . . . 0.0 109.12 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' B' ' 279' ' ' ALA . 0.0 OUTLIER -117.46 135.44 53.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.082 -1.011 . . . . 0.0 109.742 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' B' ' 207' ' ' MET . . . -147.13 127.72 14.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.865 . . . . 0.0 109.464 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 274' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -140.27 156.39 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 0.0 109.567 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 275' ' ' ALA . . . . . 0.446 ' O ' ' SD ' ' B' ' 207' ' ' MET . . . 42.35 -145.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.447 -0.783 . . . . 0.0 109.469 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 276' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 1.3 m120 -83.54 -11.08 57.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.116 -0.99 . . . . 0.0 109.473 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . 0.5 ' HG2' ' HG3' ' B' ' 302' ' ' ARG . 1.5 mt-10 -93.28 -162.44 0.94 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.431 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 278' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 178.15 160.8 0.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.452 -0.78 . . . . 0.0 109.623 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 279' ' ' ALA . . . . . 0.706 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -147.67 139.62 24.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.044 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . 0.822 ' HB3' HG13 ' B' ' 271' ' ' VAL . 26.4 p90 -150.76 171.38 17.27 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.906 -1.121 . . . . 0.0 109.748 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.912 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -143.11 164.34 30.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.298 -0.877 . . . . 0.0 110.238 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 282' ' ' PHE . . . . . 0.5 ' O ' ' HD2' ' B' ' 297' ' ' PRO . 2.1 p90 -158.45 -172.57 3.91 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 283' ' ' THR . . . . . 0.878 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -130.31 141.22 50.61 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 284' ' ' VAL . . . . . 0.976 HG13 HD13 ' B' ' 263' ' ' LEU . 23.9 t -106.21 112.09 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 108.974 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 285' ' ' SER . . . . . 0.987 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 15.7 p -101.25 76.62 1.73 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.879 . . . . 0.0 109.257 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.534 ' HB3' ' HB3' ' B' ' 263' ' ' LEU . 13.8 p90 -89.86 176.33 6.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.346 -0.846 . . . . 0.0 109.591 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -128.33 151.51 49.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.333 -0.855 . . . . 0.0 109.306 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . 0.444 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.6 OUTLIER -100.94 -166.09 1.27 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.395 -0.816 . . . . 0.0 109.376 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.9 43.51 1.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 0.0 109.075 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 154.29 -22.24 0.66 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 291' ' ' ARG . . . . . 0.483 ' O ' ' HD3' ' B' ' 292' ' ' LYS . 8.8 mtt180 -123.92 176.22 6.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.555 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 292' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' B' ' 291' ' ' ARG . 7.7 mmtp -131.22 115.05 15.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.223 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 293' ' ' THR . . . . . 0.482 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -119.73 142.91 48.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.206 -0.933 . . . . 0.0 110.025 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 294' ' ' VAL . . . . . 0.572 HG22 ' N ' ' B' ' 295' ' ' VAL . 12.4 p -120.99 170.96 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 0.975 HG22 HG23 ' B' ' 321' ' ' ILE . 54.2 t -139.81 158.21 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.911 -1.118 . . . . 0.0 110.07 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 296' ' ' ALA . . . . . 0.435 ' N ' HG12 ' B' ' 295' ' ' VAL . . . -137.43 74.29 47.68 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.812 . . . . 0.0 109.791 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 297' ' ' PRO . . . . . 0.594 ' HD3' HG12 ' B' ' 295' ' ' VAL . 47.3 Cg_endo -97.36 -173.36 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.623 1.549 . . . . 0.0 110.749 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.912 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.7 mp -139.79 161.99 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . 0.61 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 11.5 t0 -131.75 155.69 47.27 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.097 -1.002 . . . . 0.0 110.012 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 300' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' B' ' 299' ' ' ASP . 0.1 OUTLIER -111.66 174.06 6.05 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 301' ' ' PHE . . . . . 0.593 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.91 151.78 36.44 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.014 -1.054 . . . . 0.0 110.473 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.5 ' HG3' ' HG2' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -145.0 94.44 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 109.533 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 303' ' ' PHE . . . . . 0.856 ' CE1' HG11 ' B' ' 210' ' ' VAL . 12.2 m-85 -90.63 -163.52 1.04 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 304' ' ' ASN . . . . . 0.605 ' OD1' HG22 ' B' ' 310' ' ' VAL . 0.2 OUTLIER -139.6 7.31 2.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.727 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . 116.22 68.31 0.41 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . 54.35 41.26 32.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -1.165 . . . . 0.0 109.444 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 307' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' B' ' 308' ' ' LYS . . . -125.1 35.2 3.18 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 308' ' ' LYS . . . . . 0.558 ' CB ' ' O ' ' B' ' 307' ' ' GLY . 9.2 mttm 83.05 -161.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 122.012 -0.699 . . . . 0.0 109.404 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 309' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 98.6 t -99.36 136.52 30.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.342 -0.849 . . . . 0.0 109.501 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . 0.632 ' O ' ' HB1' ' B' ' 234' ' ' ALA . 2.9 t -108.78 -71.45 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 109.357 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . 0.499 ' HB2' ' HD3' ' B' ' 302' ' ' ARG . 0.4 OUTLIER -113.9 169.0 9.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.183 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 312' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' B' ' 300' ' ' HIS . 13.4 ttp -158.65 152.27 23.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.947 . . . . 0.0 109.778 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 313' ' ' ARG . . . . . 0.551 ' CG ' ' HB2' ' B' ' 237' ' ' GLU . 0.1 OUTLIER -131.07 170.22 14.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.38 -0.825 . . . . 0.0 109.29 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -144.9 130.02 18.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.192 -0.943 . . . . 0.0 109.247 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 315' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 79' ' ' ALA . 1.1 tt -123.93 144.54 49.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.182 -0.949 . . . . 0.0 109.925 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 316' ' ' PHE . . . . . 0.531 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 12.2 p90 173.57 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 317' ' ' GLY . . . . . 0.576 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 162.4 -176.07 38.79 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 318' ' ' GLU . . . . . 0.518 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 6.2 tt0 -72.36 -3.4 23.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -1.139 . . . . 0.0 109.385 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -93.75 -29.12 15.54 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.955 0.883 . . . . 0.0 108.873 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 320' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' B' ' 296' ' ' ALA . 1.4 m-20 -89.02 7.87 32.59 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 321' ' ' ILE . . . . . 0.975 HG23 HG22 ' B' ' 295' ' ' VAL . 4.6 mm -90.65 -167.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 322' ' ' HIS . . . . . 0.684 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.2 OUTLIER -151.06 158.88 44.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 0.0 109.593 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.4 ' HA ' HG22 ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 109.518 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.598 ' O ' HG23 ' A' ' 3' ' ' THR . 13.4 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HA ' ' CE ' ' A' ' 7' ' ' MET . 43.8 Cg_endo -70.67 -5.44 16.77 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.926 1.487 . . . . 0.0 109.535 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -43.93 88.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.496 -0.752 . . . . 0.0 109.361 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -61.52 -47.05 87.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.211 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.413 ' CE ' ' HA ' ' A' ' 4' ' ' PRO . 11.6 mtt -57.52 -39.5 76.71 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.29 -0.881 . . . . 0.0 109.227 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 m -52.77 -37.01 58.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.335 -0.853 . . . . 0.0 108.987 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.17 -50.67 73.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.297 -0.877 . . . . 0.0 109.051 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.748 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.1 t -48.79 -34.48 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 108.788 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.717 HG11 ' CG2' ' A' ' 71' ' ' VAL . 8.0 t -81.07 -41.91 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.399 -0.813 . . . . 0.0 109.222 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 15' ' ' VAL . 8.5 tt0 -63.35 -73.54 0.11 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.272 1.034 . . . . 0.0 108.573 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.827 ' HD2' HD13 ' A' ' 29' ' ' LEU . 1.1 mtm180 -42.62 -45.13 4.51 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.629 ' CE1' HD11 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -44.21 -41.9 6.13 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.005 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.958 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.5 t -90.43 -38.53 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.742 . . . . 0.0 109.02 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -48.87 -35.31 14.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.597 ' HB3' HG12 ' A' ' 26' ' ' ILE . . . -74.15 -35.42 64.04 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.958 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.3 mt -62.13 -58.47 7.67 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -50.69 -38.27 46.0 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.439 0.638 . . . . 0.0 109.334 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.86 -2.31 58.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.635 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.877 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 52.51 40.14 54.15 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.474 ' O ' HG13 ' A' ' 26' ' ' ILE . 8.5 t70 -106.76 86.37 2.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -1.087 . . . . 0.0 109.608 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.971 ' CD2' HD22 ' A' ' 59' ' ' LEU . 3.5 mm? -52.08 -20.02 2.25 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 2.2 m-20 -65.36 -56.74 10.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.486 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -61.14 -27.66 67.72 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.862 HD12 HD13 ' A' ' 23' ' ' LEU . 10.1 mt -71.31 -64.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.844 HG21 ' HB2' ' A' ' 52' ' ' ARG . 96.6 t -58.3 -35.79 55.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 24' ' ' ASP . . . -60.02 -56.41 21.98 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.827 HD13 ' HD2' ' A' ' 13' ' ' ARG . 5.9 tp -58.87 -25.53 63.41 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.7 ' CE1' ' HE1' ' A' ' 112' ' ' MET . 14.6 m-30 -87.67 148.35 24.83 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.752 -0.593 . . . . 0.0 109.636 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -55.0 -166.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.739 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.437 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -83.09 -23.88 32.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 109.577 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.54 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 21.7 p-10 -144.37 39.45 1.3 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.616 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -54.09 177.71 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.468 -0.77 . . . . 0.0 109.795 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.462 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -129.32 135.69 49.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.387 -0.821 . . . . 0.0 109.232 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 27.2 t -123.63 120.35 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.631 ' O ' ' HB3' ' A' ' 114' ' ' ALA . 3.2 mt-10 -91.11 104.77 17.31 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.572 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 30.2 t70 -178.92 137.05 0.32 Allowed Pre-proline 0 C--N 1.298 -1.647 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.165 -178.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.549 ' O ' ' O ' ' A' ' 40' ' ' VAL . 47.5 Cg_endo -71.91 -148.97 0.41 Allowed 'Cis proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.311 -1.954 . . . . 0.0 110.644 0.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.957 HG11 HG11 ' B' ' 274' ' ' VAL . 5.4 m -52.8 -140.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 122.084 0.945 . . . . 0.0 111.834 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.694 ' N ' HG23 ' A' ' 40' ' ' VAL . . . -39.26 -23.66 0.03 OUTLIER Glycine 0 N--CA 1.495 2.575 0 O-C-N 121.174 -0.954 . . . . 0.0 111.604 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.541 ' CB ' ' HG2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -29.56 -93.7 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.016 -0.697 . . . . 0.0 110.874 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 42' ' ' SER . 0.0 OUTLIER 169.42 122.32 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.992 -1.068 . . . . 0.0 111.005 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.9 Cg_endo -66.24 -167.85 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.662 1.575 . . . . 0.0 111.281 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 1.083 ' CG ' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -151.57 130.3 12.37 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.462 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.5 OUTLIER -112.7 147.47 36.73 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.672 -1.268 . . . . 0.0 110.702 -178.225 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.54 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 105.02 163.19 23.92 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 2.7 m -69.15 -64.51 0.86 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.076 -1.25 . . . . 0.0 108.902 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -48.11 -23.7 0.91 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.159 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.083 ' HB1' ' CG ' ' A' ' 45' ' ' ARG . . . -90.02 -56.54 3.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.506 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.474 ' HA ' HD13 ' A' ' 51' ' ' ILE . 9.0 mm -52.34 -41.87 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.309 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.844 ' HB2' HG21 ' A' ' 27' ' ' VAL . 19.5 ttt180 -73.38 -49.12 28.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 108.814 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 14.0 mt-10 -52.34 -30.0 26.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.146 -0.971 . . . . 0.0 108.486 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -81.82 -71.5 0.48 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.858 ' CD1' HG21 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -48.89 -29.1 4.31 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.11 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 52' ' ' ARG . . . -72.61 -38.05 67.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.491 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 23.9 t30 -65.22 -33.62 76.44 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 45.7 t -69.09 -41.75 77.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.475 -0.765 . . . . 0.0 108.941 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.971 HD22 ' CD2' ' A' ' 23' ' ' LEU . 9.5 tp -59.57 -18.95 45.16 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.271 -0.893 . . . . 0.0 109.074 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 57' ' ' ASN . 28.9 mtmt -69.66 -5.58 25.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 108.973 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.789 HD22 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -89.12 112.52 51.55 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.569 ' HD2' HD23 ' A' ' 61' ' ' LEU . 42.1 Cg_endo -68.56 91.03 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.713 1.375 . . . . 0.0 111.076 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.789 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -150.59 167.42 27.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.222 -0.924 . . . . 0.0 110.108 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.37 127.4 52.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.77 124.53 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.786 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.99 113.34 4.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.21 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.31 177.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 109.845 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.455 HG23 ' N ' ' A' ' 69' ' ' GLN . 9.9 t -156.24 -38.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 109.816 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 3.1 pt20 -97.71 -147.24 0.31 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.551 -0.718 . . . . 0.0 109.361 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.494 ' O ' ' NE ' ' A' ' 72' ' ' ARG . 29.9 tt0 -114.55 135.54 54.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.945 . . . . 0.0 109.649 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.717 ' CG2' HG11 ' A' ' 11' ' ' VAL . 79.3 t -66.21 152.2 9.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.365 -0.835 . . . . 0.0 109.154 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -118.33 140.48 49.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.089 . . . . 0.0 110.138 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . . . -150.25 134.67 17.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.428 -0.795 . . . . 0.0 109.141 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.684 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -159.62 163.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.943 -1.098 . . . . 0.0 110.212 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.52 ' HB1' ' HA3' ' B' ' 241' ' ' GLY . . . 39.17 -97.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.786 -0.571 . . . . 0.0 110.232 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 103' ' ' PHE . 4.1 m-20 -135.74 10.3 3.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.022 -1.049 . . . . 0.0 109.717 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.506 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -116.22 -161.17 0.78 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.148 -0.97 . . . . 0.0 109.371 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.873 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . -176.58 129.81 0.2 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.475 -0.766 . . . . 0.0 109.629 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -114.88 130.82 56.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.998 . . . . 0.0 109.287 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.631 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 15.2 p90 -150.47 173.19 14.35 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.819 -1.176 . . . . 0.0 109.783 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.572 ' HB2' ' CG1' ' A' ' 98' ' ' ILE . . . -150.27 -167.58 2.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 110.627 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.481 ' O ' ' HD2' ' A' ' 97' ' ' PRO . 9.1 p90 178.06 -168.93 0.08 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -135.94 141.16 44.46 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 110.05 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.735 HG13 ' CB ' ' A' ' 63' ' ' LEU . 2.2 t -110.95 118.19 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 108.882 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.725 ' HA ' HG23 ' A' ' 94' ' ' VAL . 1.7 p -118.65 110.08 16.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.128 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.572 ' CZ ' ' HB ' ' A' ' 93' ' ' THR . 10.5 p90 -130.23 -177.71 4.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.289 -0.882 . . . . 0.0 109.712 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -122.93 152.25 41.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.389 -0.819 . . . . 0.0 109.09 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER -110.08 178.5 4.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.223 -0.923 . . . . 0.0 109.775 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -65.23 68.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.442 -0.786 . . . . 0.0 109.679 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 88' ' ' PHE . . . 115.81 -30.06 6.82 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 23.3 mtt85 -111.6 -171.9 1.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -1.157 . . . . 0.0 109.691 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -147.03 146.97 30.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 109.346 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.572 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -141.3 153.84 45.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.435 -0.791 . . . . 0.0 110.223 -179.309 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.725 HG23 ' HA ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -132.79 172.33 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.751 HG22 HG23 ' A' ' 121' ' ' ILE . 52.5 t -150.15 146.73 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.542 -1.349 . . . . 0.0 110.646 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.69 74.22 78.3 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.707 ' HD3' HG12 ' A' ' 95' ' ' VAL . 48.5 Cg_endo -94.76 -179.36 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.58 1.52 . . . . 0.0 111.833 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 80' ' ' PHE . 3.2 mp -143.74 144.18 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 4.3 t0 -117.87 163.12 17.02 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 110.155 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.2 OUTLIER -115.55 176.56 5.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.873 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -150.29 135.88 18.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.026 -1.046 . . . . 0.0 110.383 -178.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.506 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -121.01 107.67 12.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.381 -0.824 . . . . 0.0 109.075 179.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.748 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -89.26 166.22 13.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.363 -0.836 . . . . 0.0 109.38 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.773 ' HB3' HG21 ' A' ' 110' ' ' VAL . 1.7 p30 -115.81 -5.97 12.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 109.166 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.711 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 177.26 -60.92 0.1 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 161.17 77.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.507 -0.996 . . . . 0.0 109.38 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.54 -66.32 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.572 ' O ' ' CE1' ' A' ' 103' ' ' PHE . 14.8 mttm -108.4 178.13 4.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -1.191 . . . . 0.0 109.602 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.646 ' CG2' HG22 ' A' ' 10' ' ' VAL . 49.6 t -109.05 153.35 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.336 -0.852 . . . . 0.0 109.233 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.773 HG21 ' HB3' ' A' ' 104' ' ' ASN . 44.8 t -124.18 -62.37 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -0.969 . . . . 0.0 109.53 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -116.31 164.53 14.38 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.974 -1.079 . . . . 0.0 109.463 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.7 ' HE1' ' CE1' ' A' ' 30' ' ' PHE . 19.3 ttm -153.29 137.67 16.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.325 -0.86 . . . . 0.0 109.5 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.506 ' HB2' ' HB3' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -113.21 168.57 9.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.448 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . -150.4 130.11 13.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.16 -0.962 . . . . 0.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 1.06 HD22 ' HB3' ' B' ' 279' ' ' ALA . 0.6 OUTLIER -130.94 142.6 50.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.532 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 50.3 p90 166.5 -162.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . 177.5 178.83 47.41 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.219 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.51 ' HA ' HG12 ' A' ' 121' ' ' ILE . 16.8 tt0 -50.2 -21.83 1.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.145 -1.209 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.48 ' HD3' ' OE2' ' B' ' 270' ' ' GLU . 0.6 OUTLIER -73.41 -22.11 60.32 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.009 0.909 . . . . 0.0 108.829 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.568 ' ND2' HG13 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -88.56 -4.57 58.56 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.5 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.751 HG23 HG22 ' A' ' 95' ' ' VAL . 2.2 mm -91.75 -162.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.03 -1.044 . . . . 0.0 108.212 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.615 ' CB ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -152.25 -169.4 3.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.004 -1.06 . . . . 0.0 109.606 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.55 -176.24 5.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.875 . . . . 0.0 109.54 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.81 -175.35 41.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.275 -1.133 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . 0.524 ' O ' ' CB ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.298 0.57 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' B' ' 201' ' ' MET . 2.6 t30 77.05 177.9 0.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.239 -0.913 . . . . 0.0 109.713 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.37 128.57 66.69 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.398 -0.814 . . . . 0.0 109.736 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' PRO . . . . . 0.441 ' HA ' ' CE ' ' B' ' 207' ' ' MET . 42.5 Cg_endo -69.76 -7.01 19.96 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.023 1.539 . . . . 0.0 109.153 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . 0.446 ' O ' ' HB ' ' B' ' 208' ' ' THR . 0.3 OUTLIER -61.66 -45.67 93.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.436 -0.79 . . . . 0.0 108.91 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -64.1 -43.7 94.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 108.904 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' MET . . . . . 0.441 ' CE ' ' HA ' ' B' ' 204' ' ' PRO . 16.7 mtt -54.9 -24.66 24.55 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.29 -0.881 . . . . 0.0 109.156 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' B' ' 205' ' ' GLU . 11.2 m -72.7 -41.64 65.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.405 -0.809 . . . . 0.0 108.983 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.35 -41.34 51.41 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.319 -0.863 . . . . 0.0 108.761 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.994 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.2 t -54.81 -44.58 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.818 HG11 ' CG2' ' B' ' 271' ' ' VAL . 6.6 t -72.42 -41.66 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.459 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 213' ' ' ARG . 23.7 tt0 -59.92 -74.16 0.08 Allowed 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.265 1.031 . . . . 0.0 108.281 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.469 ' HB3' HD22 ' B' ' 229' ' ' LEU . 2.7 mtt85 -43.54 -45.51 6.62 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.977 0.894 . . . . 0.0 108.659 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.5 OUTLIER -49.9 -44.77 50.26 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.907 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -87.17 -38.54 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.372 -0.83 . . . . 0.0 109.274 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.42 -37.74 17.88 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' B' ' 222' ' ' ASP . . . -72.06 -34.39 68.7 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' B' ' 215' ' ' VAL . 1.9 mt -64.54 -57.97 7.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -49.97 -42.27 48.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.567 0.698 . . . . 0.0 109.224 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.49 -1.04 57.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.884 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.876 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 57.43 47.58 87.06 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . 0.536 ' O ' ' HB1' ' B' ' 217' ' ' ALA . 26.7 t70 -113.38 92.64 4.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.852 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' LEU . . . . . 1.079 HD13 HD12 ' B' ' 226' ' ' ILE . 2.5 mm? -62.46 -12.48 22.25 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.184 -0.947 . . . . 0.0 109.565 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -59.36 3.5 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.293 -0.879 . . . . 0.0 109.424 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -59.6 -28.44 65.23 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 1.079 HD12 HD13 ' B' ' 223' ' ' LEU . 23.0 mt -69.02 -62.01 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.545 -0.973 . . . . 0.0 108.47 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.888 HG11 HG23 ' B' ' 248' ' ' THR . 65.3 t -58.37 -36.11 57.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -57.33 13.47 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.994 HD21 ' HA ' ' B' ' 210' ' ' VAL . 9.8 tp -57.19 -29.07 63.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . 0.696 ' CE2' HG22 ' B' ' 226' ' ' ILE . 17.1 m-30 -82.18 127.22 32.94 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.644 -0.66 . . . . 0.0 109.619 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -45.68 171.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 109.582 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -24.39 66.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.729 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.577 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 55.4 p-10 -134.03 44.43 2.73 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.668 -0.645 . . . . 0.0 109.556 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' B' ' 310' ' ' VAL . . . -71.41 -169.94 0.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' THR . . . . . 0.715 HG22 ' HB2' ' B' ' 246' ' ' SER . 15.1 p -142.34 175.06 10.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.303 -0.873 . . . . 0.0 109.329 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.583 HG23 ' O ' ' B' ' 235' ' ' THR . 40.0 t -158.94 110.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 17.7 mt-10 -88.27 105.98 17.91 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 8.8 t0 -174.68 142.47 0.77 Allowed Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.106 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . 0.512 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 47.1 Cg_endo -72.14 -168.49 5.53 Favored 'Cis proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.345 -1.939 . . . . 0.0 110.873 -0.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' B' ' 315' ' ' LEU . 3.7 m -64.79 146.14 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.276 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . 0.52 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . 54.12 32.22 49.87 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' SER . . . . . 0.512 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.2 OUTLIER -120.1 -156.38 0.66 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -1.096 . . . . 0.0 109.607 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . 0.429 ' HA ' ' HD2' ' B' ' 244' ' ' PRO . 19.5 mt-10 -120.76 118.37 30.67 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.166 -0.959 . . . . 0.0 110.026 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' PRO . . . . . 0.578 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.1 Cg_endo -64.82 -169.05 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.938 1.494 . . . . 0.0 111.55 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.766 ' HB3' ' HB1' ' B' ' 250' ' ' ALA . 6.5 mtt180 -150.83 106.17 3.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.866 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.19 158.08 18.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 110.154 -179.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 87.7 157.2 31.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' THR . . . . . 0.888 HG23 HG11 ' B' ' 227' ' ' VAL . 6.9 m -67.2 -41.41 85.88 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.35 -1.088 . . . . 0.0 109.197 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -60.92 -32.85 72.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.291 -0.881 . . . . 0.0 109.186 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -89.8 -55.07 3.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.372 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.551 HD12 ' C ' ' B' ' 247' ' ' GLY . 14.3 mt -54.11 -44.9 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 0.0 108.887 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' ARG . . . . . 0.712 ' HB2' HG21 ' B' ' 227' ' ' VAL . 25.8 ttt-85 -70.56 -53.14 17.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 253' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 23.2 tt0 -50.41 -32.31 17.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.151 -0.968 . . . . 0.0 109.015 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.582 ' CD2' ' HG3' ' B' ' 245' ' ' ARG . 0.2 OUTLIER -80.26 -70.51 0.52 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 255' ' ' PHE . . . . . 0.538 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -47.89 -26.4 1.68 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' B' ' 252' ' ' ARG . . . -76.61 -44.39 34.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.085 -1.009 . . . . 0.0 108.675 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 257' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 5.1 t-20 -65.09 -25.63 67.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 108.75 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 21.5 t -75.36 -39.37 59.34 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 259' ' ' LEU . . . . . 0.906 HD22 ' CD2' ' B' ' 223' ' ' LEU . 8.2 tp -64.96 -20.04 66.28 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.456 -0.777 . . . . 0.0 109.17 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 260' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 2.2 mttt -49.14 -27.73 3.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.413 -0.805 . . . . 0.0 109.505 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 261' ' ' LEU . . . . . 0.899 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.5 OUTLIER -89.95 118.88 69.28 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.217 -0.927 . . . . 0.0 109.078 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 262' ' ' PRO . . . . . 0.43 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 43.9 Cg_endo -70.21 105.06 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.768 1.404 . . . . 0.0 110.535 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.899 ' CD2' HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -137.73 153.17 49.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.509 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -89.98 129.12 36.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 108.877 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 265' ' ' VAL . . . . . 0.551 HG11 HG22 ' B' ' 215' ' ' VAL . 98.3 t -111.98 118.58 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.663 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 4.1 tt0 -150.26 96.51 2.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.308 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.9 mp -45.14 171.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.752 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 34.2 p -146.86 -37.97 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.87 . . . . 0.0 109.711 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 269' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 15.3 pt20 -91.46 -146.61 0.21 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 109.433 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 270' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 58.1 tt0 -115.06 134.67 54.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.677 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 271' ' ' VAL . . . . . 0.818 ' CG2' HG11 ' B' ' 211' ' ' VAL . 56.3 t -65.7 153.36 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.372 -0.83 . . . . 0.0 109.189 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.0 OUTLIER -113.97 135.72 53.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.078 -1.013 . . . . 0.0 110.134 -179.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . 0.438 ' HB1' ' CB ' ' B' ' 207' ' ' MET . . . -150.1 149.49 30.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.148 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 274' ' ' VAL . . . . . 0.957 HG11 HG11 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -153.38 -155.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.039 -1.038 . . . . 0.0 109.939 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 275' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . -23.39 -96.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 120.954 0.406 . . . . 0.0 111.815 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 276' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' B' ' 303' ' ' PHE . 47.5 t30 -116.23 -1.57 12.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.855 -1.153 . . . . 0.0 110.725 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . 0.468 ' HG3' ' HG3' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -109.25 -162.08 0.79 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.811 -1.181 . . . . 0.0 109.557 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 278' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . -179.98 159.99 0.84 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.49 -0.756 . . . . 0.0 109.349 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 279' ' ' ALA . . . . . 1.06 ' HB3' HD22 ' A' ' 115' ' ' LEU . . . -150.33 138.27 20.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 109.041 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . 0.748 ' CD2' HG22 ' B' ' 211' ' ' VAL . 35.0 p90 -150.61 172.06 16.13 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.931 -1.106 . . . . 0.0 109.851 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.828 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -146.44 -168.62 3.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 0.0 109.962 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 282' ' ' PHE . . . . . 0.451 ' HB3' ' O ' ' B' ' 281' ' ' ALA . 31.3 p90 170.28 -167.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.227 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.93 142.51 50.92 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.443 -0.786 . . . . 0.0 109.677 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 284' ' ' VAL . . . . . 0.813 HG11 HD22 ' B' ' 263' ' ' LEU . 74.4 t -114.36 113.02 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.862 . . . . 0.0 109.322 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 4.4 p -109.14 115.07 29.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.308 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' B' ' 286' ' ' PHE . 6.5 p90 -137.65 160.79 38.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -137.76 153.03 49.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.501 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 2.3 p90 -148.02 12.67 0.98 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 109.871 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -168.07 -147.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.113 -0.992 . . . . 0.0 109.406 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -76.66 -23.33 70.28 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -105.48 -179.82 4.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -1.09 . . . . 0.0 109.298 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 292' ' ' LYS . . . . . 0.454 ' O ' ' HD2' ' B' ' 292' ' ' LYS . 0.1 OUTLIER -149.26 128.16 12.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.525 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 293' ' ' THR . . . . . 0.815 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -105.19 142.72 34.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.248 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 294' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' B' ' 322' ' ' HIS . 0.6 OUTLIER -113.52 174.96 2.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.192 -0.943 . . . . 0.0 108.615 179.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 1.073 HG22 HG23 ' B' ' 321' ' ' ILE . 3.0 t -145.87 145.17 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -0.981 . . . . 0.0 109.426 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 296' ' ' ALA . . . . . 0.524 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -132.58 71.36 78.93 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.223 -0.923 . . . . 0.0 110.362 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 297' ' ' PRO . . . . . 1.046 ' HD3' HG12 ' B' ' 295' ' ' VAL . 49.9 Cg_endo -95.61 -173.45 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.575 1.516 . . . . 0.0 110.692 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.828 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.7 mp -140.99 149.72 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . 0.622 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 5.7 t0 -115.0 161.07 18.83 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.929 -1.107 . . . . 0.0 110.111 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 300' ' ' HIS . . . . . 0.513 ' HB3' ' HB2' ' B' ' 313' ' ' ARG . 0.1 OUTLIER -117.85 166.76 12.09 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 301' ' ' PHE . . . . . 0.808 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.2 OUTLIER -142.27 149.36 39.46 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.146 -0.971 . . . . 0.0 110.774 -178.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.468 ' HG3' ' HG3' ' B' ' 277' ' ' GLU . 30.8 ttt-85 -142.74 107.79 4.94 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 303' ' ' PHE . . . . . 0.774 ' CE1' HG21 ' B' ' 210' ' ' VAL . 26.0 m-85 -89.28 -174.84 4.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 109.358 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 304' ' ' ASN . . . . . 0.693 ' HB3' HG21 ' B' ' 310' ' ' VAL . 0.5 OUTLIER -112.63 -43.3 3.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.46 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 305' ' ' GLY . . . . . 0.688 ' O ' ' HB3' ' B' ' 306' ' ' ALA . . . -165.05 27.85 0.2 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 306' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' B' ' 305' ' ' GLY . . . 74.87 38.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -1.18 . . . . 0.0 109.534 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -131.43 -39.21 0.25 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 308' ' ' LYS . . . . . 0.457 ' HG3' ' OD1' ' B' ' 304' ' ' ASN . 2.1 pttt -153.65 -175.3 5.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -1.134 . . . . 0.0 109.497 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 309' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 84.9 t -89.87 159.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 109.332 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . 0.693 HG21 ' HB3' ' B' ' 304' ' ' ASN . 45.0 t -136.18 -75.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.722 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . 0.504 ' CB ' ' OG1' ' B' ' 235' ' ' THR . 70.5 m -122.22 160.7 24.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.032 . . . . 0.0 110.057 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 312' ' ' MET . . . . . 0.676 ' HE1' ' CE1' ' B' ' 230' ' ' PHE . 2.3 ttm -139.04 158.45 44.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.435 -0.791 . . . . 0.0 109.531 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 313' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' B' ' 300' ' ' HIS . 0.8 OUTLIER -133.7 149.34 51.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 109.325 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 314' ' ' ALA . . . . . 0.406 ' CB ' ' OD2' ' B' ' 238' ' ' ASP . . . -125.29 132.4 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.973 . . . . 0.0 109.708 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 315' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' A' ' 79' ' ' ALA . 1.2 tt -131.84 143.52 50.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.592 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 316' ' ' PHE . . . . . 0.684 ' O ' HG11 ' A' ' 74' ' ' VAL . 14.2 p90 171.91 -158.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 317' ' ' GLY . . . . . 0.548 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 168.87 -177.3 42.77 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 318' ' ' GLU . . . . . 0.537 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 13.1 tt0 -71.14 -4.8 27.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -1.118 . . . . 0.0 109.374 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -90.7 -30.86 16.85 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.902 0.858 . . . . 0.0 109.012 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 320' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -89.3 7.27 36.45 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.2 0.524 . . . . 0.0 109.59 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 321' ' ' ILE . . . . . 1.073 HG23 HG22 ' B' ' 295' ' ' VAL . 4.2 mm -90.82 -162.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 322' ' ' HIS . . . . . 0.815 ' O ' HG22 ' B' ' 293' ' ' THR . 60.3 t60 -151.27 154.32 36.55 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.087 -1.008 . . . . 0.0 109.637 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.925 . . . . 0.0 109.414 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 8' ' ' THR . 44.1 Cg_endo -71.64 -3.74 13.68 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.913 1.481 . . . . 0.0 110.039 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -57.41 -41.32 80.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.938 . . . . 0.0 109.407 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.22 -62.87 1.24 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.944 . . . . 0.0 108.989 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.707 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 27.5 mmt -54.39 -33.28 58.93 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.271 -0.893 . . . . 0.0 109.691 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 6.9 m -66.46 -34.25 77.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.406 -0.808 . . . . 0.0 109.207 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.61 -46.43 70.43 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.172 -0.955 . . . . 0.0 108.662 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.035 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.5 t -58.27 -19.57 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.868 HG21 HG11 ' A' ' 71' ' ' VAL . 14.4 t -90.51 -42.9 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.492 -0.755 . . . . 0.0 109.07 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' ARG . 25.9 tt0 -61.55 -74.22 0.09 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.231 1.015 . . . . 0.0 108.292 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' GLN . 4.2 mtm-85 -42.78 -45.59 4.87 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.601 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -49.24 -43.21 42.53 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.908 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.1 t -88.72 -38.67 11.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.458 -0.776 . . . . 0.0 109.253 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.47 -35.69 13.52 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.554 ' CB ' HG13 ' A' ' 26' ' ' ILE . . . -74.13 -34.56 63.92 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.908 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.2 mt -63.63 -58.71 6.07 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 65' ' ' VAL . 1.7 t-20 -51.36 -44.8 62.17 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.35 11.0 20.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.687 -0.633 . . . . 0.0 109.533 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.792 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 45.69 29.63 3.04 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' ALA . 10.4 t0 -92.09 60.44 3.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.454 -1.027 . . . . 0.0 109.812 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.072 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -45.8 -37.16 5.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 108.888 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' LEU . 5.9 m-20 -41.06 -29.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -89.17 -36.89 7.38 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.585 HG22 ' HD2' ' A' ' 30' ' ' PHE . 28.7 mt -59.24 -55.13 25.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.542 ' CG1' HG23 ' A' ' 48' ' ' THR . 60.0 t -54.82 -39.63 48.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -57.24 -52.47 65.2 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.035 HD21 ' HA ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -67.58 -15.86 63.88 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.722 ' CG ' HG21 ' A' ' 51' ' ' ILE . 2.6 m-85 -94.26 119.75 33.5 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.476 -0.765 . . . . 0.0 109.675 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -46.53 171.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.44 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.434 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.2 OUTLIER -73.72 -25.36 60.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.52 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.582 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -121.24 41.23 3.38 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.403 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -71.88 153.89 41.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.882 . . . . 0.0 109.919 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.661 HG23 ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -112.8 159.67 18.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.235 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.609 ' CG2' HD12 ' A' ' 51' ' ' ILE . 24.0 t -148.19 167.98 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.327 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.562 ' N ' HG12 ' A' ' 36' ' ' VAL . 14.1 mt-10 -147.39 111.22 5.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.788 ' OD1' ' HB3' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -178.31 149.63 0.68 Allowed Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 118.695 -1.202 . . . . 0.0 110.075 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.541 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 48.3 Cg_endo -74.13 175.31 47.21 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.052 -2.062 . . . . 0.0 111.014 -0.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.932 HG13 ' CE1' ' A' ' 116' ' ' PHE . 7.2 m -42.12 122.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.489 -0.757 . . . . 0.0 109.652 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . 112.56 53.16 0.5 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.1 OUTLIER 78.53 -151.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -1.079 . . . . 0.0 109.961 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.638 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 4.1 mt-10 67.53 54.36 0.7 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.266 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.638 ' HD3' ' N ' ' A' ' 43' ' ' GLU . 55.7 Cg_endo -86.44 174.41 5.96 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.725 1.381 . . . . 0.0 110.576 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.904 ' HG3' ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -151.41 109.1 3.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.661 ' HB3' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -105.04 136.61 44.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.018 -1.051 . . . . 0.0 110.492 -178.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 103.43 158.44 24.91 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.542 HG23 ' CG1' ' A' ' 27' ' ' VAL . 7.2 m -60.88 -64.19 1.04 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.412 -1.052 . . . . 0.0 109.194 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -45.79 -25.2 0.47 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.088 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.904 ' HB1' ' HG3' ' A' ' 45' ' ' ARG . . . -86.92 -53.25 5.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.309 -0.869 . . . . 0.0 109.519 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.722 HG21 ' CG ' ' A' ' 30' ' ' PHE . 4.1 mm -55.74 -48.92 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.347 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.851 ' HA ' HD21 ' A' ' 23' ' ' LEU . 6.7 ttt180 -68.48 -53.01 26.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.406 -0.809 . . . . 0.0 109.119 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 13.1 tt0 -51.26 -32.16 23.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 108.66 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -83.87 -70.62 0.55 Allowed 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 1.072 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -45.34 -31.17 1.51 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 52' ' ' ARG . . . -66.4 -46.22 77.34 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 37.1 t-20 -60.62 -36.17 77.94 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.4 t -68.6 -35.28 77.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.792 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.9 tp -64.94 -20.39 66.44 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.456 -0.777 . . . . 0.0 109.051 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 3.1 mttp -67.04 -7.72 24.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.486 -0.759 . . . . 0.0 109.341 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.017 ' CD2' HD21 ' A' ' 63' ' ' LEU . 13.5 tp -88.88 108.94 26.62 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 48.7 Cg_endo -73.82 92.15 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.846 1.445 . . . . 0.0 111.909 -178.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.046 HD22 ' CG1' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -140.62 178.61 7.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.014 . . . . 0.0 109.366 178.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.577 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -103.17 129.02 49.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.498 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 8.6 t -112.56 113.54 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.692 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' LEU . 4.7 tt0 -150.59 97.19 2.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.815 . . . . 0.0 109.076 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.9 mp -44.84 170.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.338 -0.851 . . . . 0.0 109.67 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.463 HG23 ' N ' ' A' ' 69' ' ' GLN . 14.6 t -146.53 -38.86 0.22 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.704 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.463 ' N ' HG23 ' A' ' 68' ' ' THR . 5.9 pt20 -90.33 -148.39 0.2 Allowed 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 109.331 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -117.15 131.81 56.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.765 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.022 HG13 ' HB3' ' A' ' 80' ' ' PHE . 93.4 t -60.88 148.47 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.365 -0.834 . . . . 0.0 109.226 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -112.66 92.68 4.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 109.819 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 7' ' ' MET . . . -108.0 147.83 30.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.152 -0.968 . . . . 0.0 109.873 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.006 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -160.76 152.63 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.301 -0.874 . . . . 0.0 110.009 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.795 ' HB1' ' HA3' ' B' ' 241' ' ' GLY . . . 41.53 -145.43 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.595 -0.691 . . . . 0.0 109.964 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -85.01 4.06 35.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 110.001 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -113.27 -160.49 0.72 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 109.441 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.985 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 174.01 162.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.732 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.25 133.29 16.16 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 1.022 ' HB3' HG13 ' A' ' 71' ' ' VAL . 34.4 p90 -149.51 167.98 24.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.797 -1.189 . . . . 0.0 110.298 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -141.62 167.76 21.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.54 -0.725 . . . . 0.0 109.679 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -159.35 -172.78 3.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.25 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.96 140.44 53.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.378 -0.826 . . . . 0.0 109.658 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.046 ' CG1' HD22 ' A' ' 63' ' ' LEU . 22.6 t -121.17 116.04 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.484 -0.76 . . . . 0.0 109.177 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.662 ' CB ' HG23 ' A' ' 94' ' ' VAL . 69.6 p -118.2 128.17 54.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.96 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.682 ' CD1' HD23 ' A' ' 63' ' ' LEU . 3.0 p90 -143.95 171.01 14.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.379 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.47 ' HA ' ' HG3' ' A' ' 92' ' ' LYS . 2.5 tm-20 -104.6 156.65 17.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.636 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.556 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -117.82 -161.16 0.81 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 109.306 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.64 75.95 2.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 109.686 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . 116.61 -11.7 15.9 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 19.8 mtp180 -149.67 164.15 35.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -1.153 . . . . 0.0 109.592 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' A' ' 87' ' ' GLU . 18.4 tttt -107.91 151.75 25.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.552 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.592 ' HB ' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -138.13 155.14 49.03 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.317 -0.864 . . . . 0.0 109.915 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.662 HG23 ' CB ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -140.22 170.46 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 1.001 HG12 ' HD3' ' A' ' 97' ' ' PRO . 4.8 t -146.53 145.52 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.823 -1.173 . . . . 0.0 109.941 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . -136.46 71.88 58.74 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.434 -0.791 . . . . 0.0 109.786 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 1.001 ' HD3' HG12 ' A' ' 95' ' ' VAL . 52.1 Cg_endo -95.69 -171.11 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 121.741 1.627 . . . . 0.0 110.86 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.706 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.8 mp -140.82 146.34 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 23.0 t0 -118.61 160.94 20.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.921 -1.112 . . . . 0.0 109.83 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -109.74 -179.72 3.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.432 -0.793 . . . . 0.0 108.916 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.985 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -150.14 147.18 27.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.12 -0.987 . . . . 0.0 110.553 -178.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.54 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -140.98 102.61 4.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.264 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.725 ' CZ ' HG11 ' A' ' 10' ' ' VAL . 4.0 m-85 -89.77 -175.88 4.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.928 ' HB3' HG21 ' A' ' 110' ' ' VAL . 2.7 p30 -126.53 -34.93 2.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 109.372 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.681 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -155.45 -63.29 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 164.6 61.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -1.17 . . . . 0.0 109.404 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.52 -53.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -129.43 -166.23 1.63 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -1.126 . . . . 0.0 109.705 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.598 HG22 ' CG1' ' A' ' 10' ' ' VAL . 25.8 t -109.93 160.72 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 108.906 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.928 HG21 ' HB3' ' A' ' 104' ' ' ASN . 54.2 t -132.61 -60.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.962 -1.086 . . . . 0.0 110.181 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.54 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -122.42 157.22 32.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.869 -1.144 . . . . 0.0 109.969 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.512 ' CE ' ' OD2' ' A' ' 99' ' ' ASP . 8.9 ttp -152.75 157.0 40.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.393 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.533 ' NH1' ' HB3' ' A' ' 37' ' ' GLU . 1.1 tpt180 -139.18 132.0 29.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 109.308 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.788 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . . . -93.0 129.08 39.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.06 -1.025 . . . . 0.0 109.663 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.747 HD13 ' CE1' ' B' ' 300' ' ' HIS . 0.6 OUTLIER -127.21 143.31 51.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.859 . . . . 0.0 109.632 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.932 ' CE1' HG13 ' A' ' 40' ' ' VAL . 47.1 p90 168.94 -154.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.506 ' O ' HG12 ' A' ' 121' ' ' ILE . . . 167.35 161.68 17.28 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.58 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 11.8 tt0 -44.12 -24.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.398 -1.06 . . . . 0.0 109.783 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 117' ' ' GLY . 0.8 OUTLIER -71.37 -35.06 70.98 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.821 0.819 . . . . 0.0 109.723 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 117' ' ' GLY . 0.4 OUTLIER -89.54 1.47 55.9 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.051 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.686 HG23 HG22 ' A' ' 95' ' ' VAL . 3.7 mm -91.44 -171.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 0.0 108.502 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.665 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -151.93 143.22 23.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.702 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.419 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.16 114.87 3.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.97 -116.21 0.7 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.346 -1.091 . . . . 0.0 109.386 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.243 0.544 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.472 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 4.6 m-20 -149.3 68.03 1.03 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 109.628 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . 0.423 HG22 ' HB2' ' B' ' 205' ' ' GLU . 1.5 m -67.4 111.54 7.64 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.875 . . . . 0.0 109.624 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 49.1 Cg_endo -74.74 0.19 9.07 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.923 1.486 . . . . 0.0 110.367 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . 0.423 ' HB2' HG22 ' B' ' 203' ' ' THR . 7.3 mt-10 -65.81 -57.08 8.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 109.598 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -60.57 -48.55 81.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' MET . . . . . 0.546 ' HA ' ' CZ ' ' B' ' 303' ' ' PHE . 19.8 mtm -61.56 -15.19 36.35 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.332 -0.855 . . . . 0.0 109.896 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.433 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 15.5 m -81.85 -38.54 25.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.253 -0.904 . . . . 0.0 109.253 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.9 -42.83 59.62 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.26 -0.9 . . . . 0.0 108.599 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.693 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -52.31 -24.86 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.193 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.966 HG11 HG21 ' B' ' 271' ' ' VAL . 26.1 t -86.86 -45.24 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.481 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.6 tt0 -57.74 -73.49 0.07 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.922 ' HD2' HD13 ' B' ' 229' ' ' LEU . 0.7 OUTLIER -43.88 -45.34 7.49 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' TYR . . . . . 0.602 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -48.28 -43.17 32.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.958 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.1 t -89.27 -39.9 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.297 -0.877 . . . . 0.0 109.003 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' B' ' 213' ' ' ARG . . . -48.34 -36.36 14.29 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.649 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -74.08 -35.62 64.25 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.958 HD12 ' HA ' ' B' ' 215' ' ' VAL . 3.3 mt -61.56 -59.27 5.48 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.0 -41.07 46.34 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -88.91 5.33 44.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 1.042 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 46.86 35.81 8.13 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -97.33 78.35 2.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -1.071 . . . . 0.0 109.887 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' LEU . . . . . 1.05 ' CD2' HD22 ' B' ' 259' ' ' LEU . 3.9 mm? -50.45 -21.13 1.34 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.286 -0.884 . . . . 0.0 109.856 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -62.17 -54.54 39.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.902 . . . . 0.0 109.536 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' B' ' 229' ' ' LEU . . . -64.3 -34.4 89.81 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.748 HG21 ' CD2' ' B' ' 255' ' ' PHE . 6.9 mt -62.36 -56.02 20.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.715 HG21 ' HB2' ' B' ' 252' ' ' ARG . 26.9 t -63.37 -43.03 98.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.74 -49.79 69.95 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.922 HD13 ' HD2' ' B' ' 213' ' ' ARG . 2.4 tp -68.99 -16.7 63.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . 0.474 ' HB2' ' HA ' ' B' ' 227' ' ' VAL . 2.2 m-85 -91.72 140.3 29.83 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.334 -0.854 . . . . 0.0 109.517 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -49.18 177.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.575 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -24.18 66.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.547 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.531 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 4.4 p30 -146.96 47.1 1.17 Allowed 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.651 -0.656 . . . . 0.0 109.31 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.583 ' O ' HD11 ' B' ' 251' ' ' ILE . . . -59.45 167.09 2.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.329 -0.857 . . . . 0.0 109.496 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' THR . . . . . 0.907 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -109.4 164.84 12.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.581 HG23 HD12 ' B' ' 251' ' ' ILE . 46.1 t -154.68 115.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.91 . . . . 0.0 109.488 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.0 mm-40 -94.85 109.68 21.64 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' ASP . . . . . 0.478 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 10.0 t70 -178.21 142.69 0.45 Allowed Pre-proline 0 C--N 1.302 -1.486 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.042 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 47.0 Cg_endo -73.41 174.87 48.23 Favored 'Cis proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.29 -1.962 . . . . 0.0 111.072 -0.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.649 HG13 ' CE1' ' B' ' 316' ' ' PHE . 29.2 m -57.01 115.3 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.84 . . . . 0.0 109.598 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . 0.795 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . 83.28 57.35 2.51 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' SER . . . . . 0.506 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 3.3 m -149.01 -105.03 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -1.187 . . . . 0.0 109.747 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' B' ' 243' ' ' GLU . 7.5 pt-20 -165.85 111.08 0.75 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.931 -1.106 . . . . 0.0 110.185 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' PRO . . . . . 0.583 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.9 Cg_endo -65.75 179.15 1.87 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.97 1.511 . . . . 0.0 111.239 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.608 ' HB2' ' CD2' ' B' ' 254' ' ' PHE . 0.3 OUTLIER -150.9 103.0 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.907 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.28 150.57 22.55 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.252 -0.905 . . . . 0.0 110.166 -179.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 117.32 157.56 10.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 4.5 m -54.73 -72.18 0.07 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.228 -1.16 . . . . 0.0 108.937 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -52.67 -32.73 43.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 0.0 109.164 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.552 ' HB3' ' C ' ' B' ' 246' ' ' SER . . . -71.11 -23.96 62.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.558 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.583 HD11 ' O ' ' B' ' 234' ' ' ALA . 4.7 mm -90.11 -37.27 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.202 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' ARG . . . . . 0.715 ' HB2' HG21 ' B' ' 227' ' ' VAL . 21.7 ttm180 -79.6 -59.64 2.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.133 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 253' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 4.7 tt0 -45.6 -26.86 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.981 -1.074 . . . . 0.0 108.863 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.608 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.1 OUTLIER -86.44 -69.81 0.65 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 255' ' ' PHE . . . . . 0.748 ' CD2' HG21 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -52.75 -20.43 3.17 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.466 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' B' ' 252' ' ' ARG . . . -80.95 -43.96 18.92 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 257' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 10.0 t-20 -61.14 -38.89 88.02 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 33.8 t -62.1 -31.82 72.31 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 259' ' ' LEU . . . . . 1.05 HD22 ' CD2' ' B' ' 223' ' ' LEU . 6.7 tp -70.97 -26.52 63.2 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.467 -0.771 . . . . 0.0 109.366 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 260' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 7.7 mttp -48.91 -23.03 0.96 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.222 -0.924 . . . . 0.0 109.152 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 261' ' ' LEU . . . . . 0.91 HD22 HD21 ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.46 112.9 54.3 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 262' ' ' PRO . . . . . 0.505 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 43.2 Cg_endo -70.28 107.83 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.806 1.424 . . . . 0.0 110.618 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.91 HD21 HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -139.84 173.04 11.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.751 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' B' ' 284' ' ' VAL . . . -104.65 127.28 52.36 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 265' ' ' VAL . . . . . 0.401 HG11 HG22 ' B' ' 215' ' ' VAL . 77.9 t -112.29 112.63 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.962 . . . . 0.0 110.142 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 13.4 tt0 -150.49 97.14 2.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.34 -0.85 . . . . 0.0 109.158 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -44.7 170.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 110.016 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.92 -38.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 109.558 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 269' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 19.4 pt20 -93.2 -146.34 0.23 Allowed 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.635 -0.665 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 270' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 28.7 tt0 -115.32 133.09 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.0 109.659 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 271' ' ' VAL . . . . . 0.999 HG13 ' HB3' ' B' ' 280' ' ' PHE . 53.4 t -68.31 147.49 12.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 109.245 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.536 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.4 OUTLIER -103.01 139.26 38.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 109.952 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -148.25 147.39 29.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 109.083 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 274' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.2 OUTLIER -138.27 -155.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.114 -0.992 . . . . 0.0 109.99 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 275' ' ' ALA . . . . . 0.454 ' O ' ' SD ' ' B' ' 207' ' ' MET . . . -39.71 -87.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.639 -0.663 . . . . 0.0 110.468 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 276' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' B' ' 303' ' ' PHE . 6.7 m120 -116.45 20.53 14.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.146 -0.971 . . . . 0.0 110.276 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 0.3 OUTLIER -128.18 -160.05 0.99 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.007 -1.058 . . . . 0.0 109.399 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 278' ' ' ALA . . . . . 1.041 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 171.06 157.93 0.08 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.477 -0.764 . . . . 0.0 109.932 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 279' ' ' ALA . . . . . 0.625 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -150.31 136.14 18.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . 0.999 ' HB3' HG13 ' B' ' 271' ' ' VAL . 43.9 p90 -150.11 168.45 23.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.785 -1.197 . . . . 0.0 110.564 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.949 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -145.83 169.32 18.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.699 -0.625 . . . . 0.0 109.417 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 282' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 6.9 p90 -166.1 -169.11 1.38 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.78 141.43 51.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.436 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 284' ' ' VAL . . . . . 0.846 HG11 HD22 ' B' ' 263' ' ' LEU . 42.9 t -128.95 112.47 25.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.294 -0.878 . . . . 0.0 109.29 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 285' ' ' SER . . . . . 0.636 ' OG ' HG23 ' B' ' 294' ' ' VAL . 0.1 OUTLIER -104.49 122.89 46.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 109.448 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.505 ' HB2' ' O ' ' B' ' 262' ' ' PRO . 7.1 p90 -137.72 171.26 14.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.223 -0.923 . . . . 0.0 109.907 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 287' ' ' GLU . . . . . 0.424 ' OE1' ' HB3' ' B' ' 292' ' ' LYS . 42.5 tt0 -150.35 150.56 31.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.477 -0.765 . . . . 0.0 109.073 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.1 OUTLIER -137.72 2.46 2.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 109.881 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' B' ' 290' ' ' GLY . 2.1 tt0 -169.86 -173.63 1.63 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.099 -1.0 . . . . 0.0 109.113 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 290' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' B' ' 289' ' ' GLN . . . -46.65 -25.41 2.18 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 2.3 mtm105 -100.43 130.8 46.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -1.074 . . . . 0.0 109.285 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 292' ' ' LYS . . . . . 0.424 ' HB3' ' OE1' ' B' ' 287' ' ' GLU . 0.0 OUTLIER -106.03 141.44 37.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.521 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 293' ' ' THR . . . . . 0.715 HG22 ' HA ' ' B' ' 323' ' ' ALA . 0.0 OUTLIER -119.49 146.08 45.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 0.0 109.861 -179.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 294' ' ' VAL . . . . . 0.636 HG23 ' OG ' ' B' ' 285' ' ' SER . 3.9 p -113.53 171.08 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 108.845 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 1.015 HG12 ' HD3' ' B' ' 297' ' ' PRO . 24.6 t -142.13 144.04 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 110.355 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 296' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' B' ' 320' ' ' ASN . . . -138.52 70.86 45.43 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.599 -0.688 . . . . 0.0 109.683 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 297' ' ' PRO . . . . . 1.015 ' HD3' HG12 ' B' ' 295' ' ' VAL . 51.4 Cg_endo -95.67 -175.12 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.732 1.621 . . . . 0.0 111.545 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.949 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.5 mp -139.18 147.04 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . 0.623 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 7.1 t0 -118.51 164.03 15.89 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.862 -1.149 . . . . 0.0 110.362 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 300' ' ' HIS . . . . . 0.747 ' CE1' HD13 ' A' ' 115' ' ' LEU . 1.7 t60 -113.8 175.99 5.23 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 301' ' ' PHE . . . . . 1.041 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.1 OUTLIER -150.09 141.52 23.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.014 -1.054 . . . . 0.0 110.922 -178.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.504 ' HA ' ' HG2' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -130.24 105.97 8.27 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 303' ' ' PHE . . . . . 0.649 ' CZ ' HG21 ' B' ' 210' ' ' VAL . 0.4 OUTLIER -89.29 179.15 6.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.593 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 304' ' ' ASN . . . . . 0.879 ' OD1' HG23 ' B' ' 310' ' ' VAL . 0.5 OUTLIER -139.54 7.87 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 0.0 109.617 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 305' ' ' GLY . . . . . 0.698 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . 150.39 -68.22 0.34 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 306' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 164.83 76.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -1.135 . . . . 0.0 109.541 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.32 -35.74 0.02 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -165.84 -174.82 3.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -1.119 . . . . 0.0 109.39 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 309' ' ' VAL . . . . . 0.56 HG21 ' HE1' ' B' ' 301' ' ' PHE . 40.4 t -104.36 149.87 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 109.025 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . 0.879 HG23 ' OD1' ' B' ' 304' ' ' ASN . 38.8 t -122.97 -22.48 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.008 . . . . 0.0 109.691 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . 0.503 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -151.09 156.28 40.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.97 . . . . 0.0 109.494 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 312' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 17.8 ttp -160.16 148.07 16.65 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.2 -0.937 . . . . 0.0 109.811 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 313' ' ' ARG . . . . . 0.472 ' HB2' ' HB2' ' B' ' 300' ' ' HIS . 0.1 OUTLIER -130.24 175.01 9.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.42 -0.8 . . . . 0.0 108.955 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 314' ' ' ALA . . . . . 0.599 ' O ' HG12 ' B' ' 240' ' ' VAL . . . -142.68 145.34 33.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 109.662 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 315' ' ' LEU . . . . . 0.732 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -136.64 139.76 42.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.893 . . . . 0.0 109.417 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 316' ' ' PHE . . . . . 1.006 ' O ' HG11 ' A' ' 74' ' ' VAL . 31.0 p90 173.13 -160.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 317' ' ' GLY . . . . . 0.725 ' C ' HD12 ' B' ' 321' ' ' ILE . . . 157.4 -174.87 34.89 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 318' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -54.21 -17.84 3.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 109.57 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.39 -28.26 27.08 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.852 0.835 . . . . 0.0 109.533 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 320' ' ' ASN . . . . . 0.721 ' OD1' HD12 ' B' ' 298' ' ' ILE . 0.3 OUTLIER -91.79 -30.33 16.28 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.357 0.599 . . . . 0.0 109.401 -179.536 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 321' ' ' ILE . . . . . 0.964 ' CG2' HG22 ' B' ' 295' ' ' VAL . 1.4 mt -87.0 -171.54 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 322' ' ' HIS . . . . . 0.748 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.1 OUTLIER -151.02 163.01 39.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.037 -1.039 . . . . 0.0 109.922 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.715 ' HA ' HG22 ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.722 ' O ' HG23 ' A' ' 3' ' ' THR . 9.0 t . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 8' ' ' THR . 45.2 Cg_endo -72.26 -10.11 25.27 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.923 1.486 . . . . 0.0 110.112 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -52.85 59.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.343 -0.848 . . . . 0.0 109.416 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -63.4 -52.21 62.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.39 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.573 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 8.6 mtt -65.49 -9.66 27.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.356 -0.84 . . . . 0.0 109.684 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.408 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 13.1 m -86.64 -39.56 15.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.298 -0.876 . . . . 0.0 109.428 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.411 ' HB1' HH12 ' A' ' 13' ' ' ARG . . . -58.27 -47.58 83.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.952 . . . . 0.0 109.349 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.89 ' HA ' HD21 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -48.03 -24.13 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 108.778 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.754 HG11 ' CG2' ' A' ' 71' ' ' VAL . 12.5 t -86.26 -42.56 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 109.538 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 13' ' ' ARG . 14.6 tt0 -61.23 -74.15 0.09 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.231 1.015 . . . . 0.0 108.323 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.933 ' HD2' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -42.75 -44.49 4.4 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.958 0.885 . . . . 0.0 108.711 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -51.39 -49.59 61.26 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.83 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -81.51 -41.37 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.398 -0.814 . . . . 0.0 109.362 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.23 -37.04 15.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.757 -1.214 . . . . 0.0 107.736 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -73.83 -32.09 63.53 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.83 HD12 ' HA ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -65.42 -56.57 11.78 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.01 -42.47 38.09 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.582 0.706 . . . . 0.0 109.312 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.978 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . . . -89.22 -6.73 56.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.518 -0.739 . . . . 0.0 109.705 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.772 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 62.43 21.31 62.19 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.978 ' OD2' ' HB3' ' A' ' 20' ' ' ALA . 1.5 p30 -89.35 68.56 7.98 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.994 -1.297 . . . . 0.0 109.732 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.053 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -46.54 -35.55 5.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.249 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' A' ' 22' ' ' ASP . 8.5 p-10 -41.92 -34.79 0.73 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -86.46 -32.27 16.67 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.561 HD12 HD12 ' A' ' 23' ' ' LEU . 40.5 mt -62.67 -56.66 16.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' A' ' 52' ' ' ARG . 49.2 t -56.83 -34.29 43.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -62.3 -55.7 25.68 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.933 HD13 ' HD2' ' A' ' 13' ' ' ARG . 3.5 tp -62.99 -21.92 66.48 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' ALA . 9.4 m-30 -87.63 138.69 31.25 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -50.59 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 109.726 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.2 -24.39 62.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.594 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.549 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 4.6 p-10 -150.16 53.49 0.91 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.822 ' N ' HD11 ' A' ' 51' ' ' ILE . . . -65.78 151.86 45.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 109.653 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 145.99 23.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 109.256 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 53.2 t -137.98 116.6 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.103 -0.998 . . . . 0.0 109.711 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 3.1 mm-40 -89.2 110.91 21.6 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.502 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 9.7 t70 -178.86 143.98 0.43 Allowed Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.702 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 48.9 Cg_endo -74.13 -168.27 6.08 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.258 -1.976 . . . . 0.0 110.925 -0.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.728 ' HB ' HG11 ' B' ' 274' ' ' VAL . 32.7 m -80.53 50.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.8 . . . . 0.0 109.351 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.37 34.18 0.05 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.518 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -153.54 -148.06 0.24 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.445 -1.032 . . . . 0.0 109.144 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -125.47 140.25 35.9 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.997 -1.065 . . . . 0.0 110.073 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.527 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 37.9 Cg_endo -63.58 -176.0 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.276 1.672 . . . . 0.0 111.051 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.789 ' CG ' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -150.87 108.15 3.61 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.17 151.82 21.96 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.167 -178.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.549 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 110.45 158.04 16.12 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.513 HG23 ' CG1' ' A' ' 27' ' ' VAL . 7.8 m -67.04 -51.36 55.73 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.13 -1.218 . . . . 0.0 109.146 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -58.4 -41.47 84.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.227 -0.921 . . . . 0.0 109.08 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.789 ' HB1' ' CG ' ' A' ' 45' ' ' ARG . . . -67.31 -57.51 6.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.153 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.822 HD11 ' N ' ' A' ' 34' ' ' ALA . 23.5 mt -55.02 -47.89 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.901 ' HG3' HD23 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -69.14 -57.87 4.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.118 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 37.4 tt0 -45.59 -30.01 1.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.053 -1.03 . . . . 0.0 108.839 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.502 ' CZ ' ' O ' ' A' ' 38' ' ' ASP . 1.3 t80 -82.44 -69.5 0.62 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 1.053 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -48.58 -36.08 14.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.76 -47.33 75.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 109.039 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 23.1 t-20 -57.51 -41.45 80.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.32 -0.862 . . . . 0.0 108.921 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.9 t -65.43 -32.34 73.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.348 -0.845 . . . . 0.0 109.005 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.772 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.1 tp -67.02 -19.6 65.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -57.25 -22.54 42.03 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.779 HD23 HD23 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -89.62 119.39 69.52 Favored Pre-proline 0 C--N 1.306 -1.324 0 O-C-N 121.189 -0.944 . . . . 0.0 108.528 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 49.1 Cg_endo -74.94 106.86 2.35 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.768 1.404 . . . . 0.0 110.762 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.831 ' CB ' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.84 163.08 33.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 110.055 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.023 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -97.26 124.01 41.23 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.6 t -107.4 114.15 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.908 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 67' ' ' LEU . 6.2 tt0 -150.34 101.31 2.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 109.195 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 81' ' ' ALA . 1.9 mp -44.97 170.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.864 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.9 p -133.41 -36.51 0.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.742 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 70' ' ' GLU . 1.2 pt20 -101.38 -145.18 0.35 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.512 -0.743 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 69' ' ' GLN . 26.9 tt0 -110.78 133.03 53.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 109.513 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.754 ' CG2' HG11 ' A' ' 11' ' ' VAL . 28.5 t -58.03 154.71 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.342 -0.849 . . . . 0.0 109.412 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 1.9 mpt_? -121.01 130.2 53.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.516 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.418 ' HB1' ' CB ' ' A' ' 7' ' ' MET . . . -150.5 120.39 7.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.629 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.647 ' CB ' HG21 ' B' ' 240' ' ' VAL . 0.0 OUTLIER -122.44 -161.32 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 109.672 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 76' ' ' ASN . . . -81.73 144.88 30.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.444 -0.785 . . . . 0.0 110.216 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 75' ' ' ALA . 1.3 t-20 80.95 -44.18 0.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.733 -0.605 . . . . 0.0 110.422 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -144.39 -159.93 1.06 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.961 -1.087 . . . . 0.0 110.412 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 1.008 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . -169.21 163.15 10.9 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.912 ' HB3' HD22 ' B' ' 315' ' ' LEU . . . -149.4 138.78 21.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.91 -1.118 . . . . 0.0 109.962 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.665 ' HB3' HG13 ' A' ' 71' ' ' VAL . 29.7 p90 -150.34 167.48 26.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.023 -1.048 . . . . 0.0 109.384 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.967 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -139.94 -169.68 2.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 110.518 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.639 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 0.0 OUTLIER 172.84 -175.11 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -127.96 141.22 51.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.248 -0.908 . . . . 0.0 109.592 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.831 HG13 ' CB ' ' A' ' 63' ' ' LEU . 14.2 t -108.95 115.53 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.277 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 1.023 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 21.8 p -112.11 106.4 15.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.12 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.604 ' CZ ' ' HB ' ' A' ' 93' ' ' THR . 6.6 p90 -125.62 176.26 7.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.743 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -121.28 164.77 16.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.596 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.584 ' CE1' ' CE1' ' A' ' 86' ' ' PHE . 0.9 OUTLIER -115.58 -92.3 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.649 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -137.42 -36.21 0.65 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.864 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.78 -28.12 1.19 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.488 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 45.5 mtt85 -126.64 -179.51 4.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -1.184 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -127.6 122.43 33.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.679 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.855 HG23 ' HA ' ' A' ' 123' ' ' ALA . 19.3 m -96.55 172.15 8.1 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.344 -0.847 . . . . 0.0 109.559 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.611 HG13 ' CB ' ' A' ' 122' ' ' HIS . 14.0 p -148.0 170.99 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 108.715 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.624 ' O ' HG22 ' A' ' 83' ' ' THR . 43.9 t -148.22 156.78 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.079 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.476 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . -135.28 75.27 59.54 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.457 -0.777 . . . . 0.0 109.339 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.581 ' HD3' HG12 ' A' ' 95' ' ' VAL . 45.7 Cg_endo -98.19 178.48 0.39 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.789 1.659 . . . . 0.0 111.539 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.967 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.8 mp -137.93 151.93 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.624 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 13.5 t0 -122.8 164.48 18.3 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.941 -1.1 . . . . 0.0 110.203 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.532 ' CE1' HD13 ' B' ' 315' ' ' LEU . 0.1 OUTLIER -112.16 172.15 7.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 109.236 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 1.008 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -147.28 140.86 25.54 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.24 -0.912 . . . . 0.0 110.374 -178.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.502 ' HA ' ' HG3' ' A' ' 77' ' ' GLU . 1.4 ttt180 -130.31 110.42 11.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.871 . . . . 0.0 109.121 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.615 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -89.73 176.15 6.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.333 -0.855 . . . . 0.0 109.664 -179.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.761 ' HB3' HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -114.03 -36.39 4.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.298 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 176.54 -46.07 0.11 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 163.29 76.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -1.169 . . . . 0.0 109.593 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.411 ' C ' ' HD3' ' A' ' 108' ' ' LYS . . . -171.0 -45.44 0.04 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 107' ' ' GLY . 0.0 OUTLIER -161.83 -169.43 2.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -1.133 . . . . 0.0 109.292 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.615 HG12 ' N ' ' A' ' 110' ' ' VAL . 54.5 t -94.04 166.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.209 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.761 HG21 ' HB3' ' A' ' 104' ' ' ASN . 10.8 t -131.76 -63.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -0.958 . . . . 0.0 109.745 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.461 ' HB2' ' HD3' ' A' ' 102' ' ' ARG . 3.2 m -128.18 171.05 12.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.946 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.511 ' CE ' ' OD2' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -151.75 147.53 26.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.42 -0.8 . . . . 0.0 109.081 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -121.36 162.18 20.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.568 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -111.01 133.48 53.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.848 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.834 HD11 ' HB2' ' B' ' 279' ' ' ALA . 9.3 tp -109.48 -143.47 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.808 . . . . 0.0 108.957 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.734 ' O ' HG22 ' B' ' 274' ' ' VAL . 26.2 p90 39.0 -161.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.725 0.774 . . . . 0.0 110.481 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.644 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 179.4 -149.37 8.67 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.46 ' C ' HG12 ' A' ' 121' ' ' ILE . 21.5 tt0 -80.69 -1.98 44.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -1.155 . . . . 0.0 109.412 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.521 ' HE2' ' CG ' ' B' ' 204' ' ' PRO . 5.7 tttm -93.19 -26.94 17.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 122.064 0.935 . . . . 0.0 108.921 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -88.55 17.7 5.2 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.349 0.595 . . . . 0.0 109.437 -179.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.644 HD11 ' O ' ' A' ' 117' ' ' GLY . 5.2 mm -90.01 -174.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.633 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -150.87 173.6 14.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.962 -1.086 . . . . 0.0 109.899 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.855 ' HA ' HG23 ' A' ' 93' ' ' THR . . . -152.34 110.36 3.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.409 -0.807 . . . . 0.0 109.29 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.37 115.07 3.95 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.328 -1.101 . . . . 0.0 109.47 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . 0.498 ' O ' ' CG ' ' B' ' 201' ' ' MET . 1.4 ptt? . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.256 0.551 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' B' ' 203' ' ' THR . 0.7 OUTLIER -127.09 64.91 1.3 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . 0.612 HG23 ' O ' ' B' ' 203' ' ' THR . 5.0 t -43.92 109.1 0.77 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.476 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' PRO . . . . . 0.521 ' CG ' ' HE2' ' A' ' 119' ' ' LYS . 44.5 Cg_endo -71.42 -4.11 14.33 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.957 1.504 . . . . 0.0 110.264 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -45.88 56.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.196 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.2 OUTLIER -62.26 -51.41 67.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.362 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 12.5 mtm -59.81 -51.15 70.97 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.242 -0.911 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 8.2 m -53.26 -33.02 51.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 109.193 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 206' ' ' HIS . . . -52.55 -46.23 66.7 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.051 -1.031 . . . . 0.0 108.405 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 1.035 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -53.48 -43.24 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.979 HG11 HG21 ' B' ' 271' ' ' VAL . 11.3 t -59.4 -41.72 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.594 -0.691 . . . . 0.0 109.834 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' B' ' 213' ' ' ARG . 9.7 tt0 -60.47 -75.26 0.06 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.767 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.6 OUTLIER -43.83 -44.38 6.8 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' TYR . . . . . 0.633 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 3.8 t80 -53.71 -49.25 68.5 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.931 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -83.25 -44.36 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.406 -0.809 . . . . 0.0 109.832 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.0 -37.04 8.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 0.0 108.022 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.545 ' HB1' HG13 ' B' ' 226' ' ' ILE . . . -74.1 -34.68 64.03 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.931 HD12 ' HA ' ' B' ' 215' ' ' VAL . 5.2 mt -63.29 -59.91 4.1 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' ASN . . . . . 0.414 ' ND2' ' OE1' ' B' ' 266' ' ' GLU . 16.4 t30 -51.01 -45.6 61.26 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.565 0.697 . . . . 0.0 109.289 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.38 9.68 25.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.572 -0.705 . . . . 0.0 109.511 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.583 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 48.06 32.21 8.98 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' B' ' 217' ' ' ALA . 12.5 t70 -89.99 66.49 6.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -1.117 . . . . 0.0 109.743 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' LEU . . . . . 1.069 HD11 ' HB3' ' B' ' 255' ' ' PHE . 5.9 tp -47.58 -42.38 23.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 108.736 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' B' ' 223' ' ' LEU . 3.4 m-20 -42.28 -31.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' B' ' 228' ' ' ALA . . . -88.14 -38.71 7.18 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.826 HD12 HD12 ' B' ' 223' ' ' LEU . 17.1 mt -58.23 -53.36 47.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 85.0 t -57.17 -37.99 58.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' B' ' 225' ' ' GLY . . . -58.33 -54.82 42.67 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 1.035 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.5 tp -63.32 -20.48 65.53 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . 0.803 ' CG ' HG21 ' B' ' 251' ' ' ILE . 0.6 OUTLIER -82.71 132.08 35.19 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.492 -0.755 . . . . 0.0 109.502 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -51.04 -177.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.268 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -25.89 66.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 109.885 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.552 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 13.4 p-10 -150.61 53.84 0.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.62 -0.675 . . . . 0.0 109.341 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' B' ' 310' ' ' VAL . . . -62.19 165.55 5.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.742 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' THR . . . . . 0.848 HG23 ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -116.25 140.78 48.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.22 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.521 HG23 HD12 ' B' ' 251' ' ' ILE . 38.9 t -130.11 117.8 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -0.885 . . . . 0.0 109.126 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' GLU . . . . . 0.544 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 27.7 mt-10 -88.84 106.98 18.73 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' ASP . . . . . 0.487 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 9.8 t70 -176.03 142.17 0.61 Allowed Pre-proline 0 C--N 1.3 -1.577 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.597 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' B' ' 238' ' ' ASP . 47.2 Cg_endo -73.74 -165.09 3.61 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.216 -1.993 . . . . 0.0 110.685 0.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.647 HG21 ' CB ' ' A' ' 74' ' ' VAL . 5.5 m -87.8 41.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 109.345 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -165.71 26.01 0.17 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' SER . . . . . 0.427 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 1.4 m -148.01 -141.82 0.12 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.415 -1.05 . . . . 0.0 108.913 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -133.72 142.35 43.39 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.914 -1.116 . . . . 0.0 109.954 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' PRO . . . . . 0.544 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.8 Cg_endo -63.39 -170.86 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.284 1.676 . . . . 0.0 111.436 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.736 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -151.09 111.5 4.18 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.848 ' HB3' HG23 ' B' ' 235' ' ' THR . 1.9 p -94.04 155.28 17.2 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.101 -0.999 . . . . 0.0 110.452 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.21 162.32 21.78 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 6.5 m -73.7 -44.91 55.18 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.185 -1.185 . . . . 0.0 109.093 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -64.26 -20.25 65.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.244 -0.91 . . . . 0.0 109.207 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.736 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -90.15 -54.43 4.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.352 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.803 HG21 ' CG ' ' B' ' 230' ' ' PHE . 6.4 mm -54.97 -44.58 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' ARG . . . . . 0.761 ' HG3' HD23 ' B' ' 223' ' ' LEU . 17.8 ttt85 -73.34 -56.03 5.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.212 -0.93 . . . . 0.0 108.807 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 253' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 17.7 tt0 -45.94 -27.92 1.01 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.024 . . . . 0.0 108.546 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 1.0 OUTLIER -85.79 -70.94 0.56 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 255' ' ' PHE . . . . . 1.069 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -48.45 -23.97 1.12 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . 0.724 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -80.49 -51.16 9.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 108.898 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 257' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 0.2 OUTLIER -56.62 -35.02 67.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 1.6 t -74.81 -38.6 62.04 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 259' ' ' LEU . . . . . 0.583 HD21 ' CA ' ' B' ' 221' ' ' GLY . 8.6 tp -62.22 -29.47 70.41 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.373 -0.829 . . . . 0.0 109.02 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 260' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 14.7 mttm -44.35 -27.11 0.4 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 261' ' ' LEU . . . . . 0.833 HD22 HD21 ' B' ' 263' ' ' LEU . 3.3 tt -89.69 113.85 58.37 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 262' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 48.7 Cg_endo -73.59 107.27 2.36 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.915 1.481 . . . . 0.0 112.176 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.909 HD22 ' CG1' ' B' ' 284' ' ' VAL . 0.8 OUTLIER -130.24 -170.28 2.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.398 -0.814 . . . . 0.0 109.43 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . 0.72 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -119.9 128.0 53.22 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 265' ' ' VAL . . . . . 0.551 HG21 ' HB3' ' B' ' 218' ' ' LEU . 43.0 t -115.43 113.25 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.055 -1.028 . . . . 0.0 110.037 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 266' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.3 tp10 -150.31 94.16 2.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.417 -0.802 . . . . 0.0 108.942 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.524 HD11 HG11 ' B' ' 215' ' ' VAL . 1.4 mp -46.89 175.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 0.0 110.004 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 268' ' ' THR . . . . . 0.456 ' O ' ' O ' ' B' ' 269' ' ' GLN . 41.7 p -133.57 -76.28 0.48 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.46 -0.775 . . . . 0.0 108.951 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 269' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' B' ' 268' ' ' THR . 3.4 pt20 -61.07 -143.7 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 270' ' ' GLU . . . . . 0.415 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 24.4 tt0 -115.76 131.31 56.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 109.872 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 271' ' ' VAL . . . . . 1.011 HG13 ' HB3' ' B' ' 280' ' ' PHE . 83.0 t -45.41 146.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.386 -0.822 . . . . 0.0 109.042 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.52 ' NE ' HD11 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -102.08 82.19 2.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.696 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -89.38 145.03 25.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.115 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 274' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 116' ' ' PHE . 0.5 OUTLIER -122.43 -169.02 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.156 -0.965 . . . . 0.0 109.924 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 275' ' ' ALA . . . . . 0.588 ' H ' HG12 ' B' ' 274' ' ' VAL . . . -38.39 -94.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.574 -0.704 . . . . 0.0 110.787 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 276' ' ' ASN . . . . . 0.451 ' O ' ' OD1' ' B' ' 276' ' ' ASN . 21.8 t-20 -92.76 -28.24 16.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.115 -0.991 . . . . 0.0 110.621 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . 0.527 ' CG ' ' HG3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -92.74 -166.6 1.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.952 -1.092 . . . . 0.0 109.575 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 278' ' ' ALA . . . . . 0.93 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . -160.69 161.14 32.22 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.468 -0.77 . . . . 0.0 109.571 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 279' ' ' ALA . . . . . 0.834 ' HB2' HD11 ' A' ' 115' ' ' LEU . . . -150.9 131.13 13.58 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . 1.011 ' HB3' HG13 ' B' ' 271' ' ' VAL . 41.8 p90 -147.55 159.53 43.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.797 -1.19 . . . . 0.0 110.491 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 1.009 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -139.57 160.88 38.85 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.406 0.622 . . . . 0.0 109.375 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 282' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 3.8 p90 -162.29 -168.34 1.84 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 108.982 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.27 139.78 53.59 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.713 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 284' ' ' VAL . . . . . 0.909 ' CG1' HD22 ' B' ' 263' ' ' LEU . 42.0 t -107.83 114.7 47.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 285' ' ' SER . . . . . 0.72 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 96.9 p -115.5 98.99 7.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.955 . . . . 0.0 110.119 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.868 ' CD1' HD23 ' B' ' 263' ' ' LEU . 30.0 p90 -108.75 -171.86 1.94 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 108.815 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.45 153.1 33.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.98 -1.075 . . . . 0.0 109.809 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . 0.527 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.1 OUTLIER -105.55 -163.91 0.98 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.43 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -40.58 92.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.924 . . . . 0.0 109.972 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -139.65 4.51 2.75 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.148 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -140.82 -176.25 4.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -1.186 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 292' ' ' LYS . . . . . 0.477 ' HD3' ' O ' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -118.75 140.98 49.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.178 -0.952 . . . . 0.0 109.305 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 293' ' ' THR . . . . . 0.595 ' HB ' ' CE1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -125.32 146.04 49.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.406 -0.809 . . . . 0.0 109.433 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 294' ' ' VAL . . . . . 0.572 HG22 ' H ' ' B' ' 295' ' ' VAL . 7.9 p -125.28 171.89 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.143 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 1.025 HG12 ' HD3' ' B' ' 297' ' ' PRO . 2.8 t -149.43 146.98 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 109.065 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 296' ' ' ALA . . . . . . . . . . . . . . . -125.84 71.32 67.77 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.179 -0.951 . . . . 0.0 111.266 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 297' ' ' PRO . . . . . 1.025 ' HD3' HG12 ' B' ' 295' ' ' VAL . 53.3 Cg_endo -93.24 179.68 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.593 1.312 . . . . 0.0 110.996 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 1.009 HG23 ' HB2' ' B' ' 281' ' ' ALA . 3.0 mp -141.38 148.81 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . 0.619 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 17.2 t0 -121.38 157.52 30.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.958 -1.089 . . . . 0.0 110.401 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 300' ' ' HIS . . . . . 0.761 ' CD2' HD11 ' A' ' 115' ' ' LEU . 3.0 t-160 -113.73 151.7 31.54 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 301' ' ' PHE . . . . . 0.93 ' CB ' ' HB3' ' B' ' 278' ' ' ALA . 0.5 OUTLIER -126.91 151.86 47.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.271 -0.893 . . . . 0.0 110.828 -178.271 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.529 ' O ' HG23 ' B' ' 310' ' ' VAL . 0.0 OUTLIER -146.27 93.56 2.33 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 303' ' ' PHE . . . . . 0.755 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 8.2 m-30 -89.81 -165.55 1.37 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.126 -0.984 . . . . 0.0 109.962 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 304' ' ' ASN . . . . . 0.537 ' OD1' ' CG1' ' B' ' 310' ' ' VAL . 0.4 OUTLIER -140.15 27.22 2.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.427 -0.796 . . . . 0.0 109.437 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 305' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . 119.54 -61.08 0.49 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 306' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 179.67 33.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -1.127 . . . . 0.0 109.272 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 307' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' B' ' 308' ' ' LYS . . . -108.35 33.3 6.33 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 308' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' B' ' 307' ' ' GLY . 0.3 OUTLIER 83.51 -162.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.972 -0.722 . . . . 0.0 109.164 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 309' ' ' VAL . . . . . 0.615 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 49.7 t -90.5 143.81 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.384 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . 0.537 ' CG1' ' OD1' ' B' ' 304' ' ' ASN . 0.1 OUTLIER -126.19 -27.1 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.102 -0.999 . . . . 0.0 109.991 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . 0.497 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -143.41 164.04 31.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.109 -0.994 . . . . 0.0 109.374 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 312' ' ' MET . . . . . 0.469 ' O ' ' HG3' ' B' ' 237' ' ' GLU . 0.0 OUTLIER -160.38 155.85 25.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 313' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' B' ' 300' ' ' HIS . 0.0 OUTLIER -150.22 118.47 6.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 314' ' ' ALA . . . . . 0.428 ' O ' HG12 ' B' ' 240' ' ' VAL . . . -100.07 139.73 35.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 110.629 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 315' ' ' LEU . . . . . 0.912 HD22 ' HB3' ' A' ' 79' ' ' ALA . 3.7 tt -128.65 138.46 52.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.84 . . . . 0.0 109.335 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 316' ' ' PHE . . . . . 0.578 ' CD2' ' OD1' ' B' ' 320' ' ' ASN . 0.1 OUTLIER 172.51 -159.51 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 317' ' ' GLY . . . . . 0.487 ' O ' ' OD1' ' B' ' 320' ' ' ASN . . . 171.27 177.63 41.2 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.292 -1.433 . . . . 0.0 110.485 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 318' ' ' GLU . . . . . 0.508 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 47.9 tt0 -51.54 -21.41 2.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.201 -1.176 . . . . 0.0 108.931 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.14 -22.18 59.56 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.019 0.914 . . . . 0.0 108.726 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 320' ' ' ASN . . . . . 0.67 ' ND2' HG13 ' B' ' 295' ' ' VAL . 0.3 OUTLIER -88.51 1.51 54.7 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 321' ' ' ILE . . . . . 0.789 ' HA ' HG22 ' B' ' 295' ' ' VAL . 4.0 mm -89.89 179.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.121 -0.987 . . . . 0.0 108.504 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 322' ' ' HIS . . . . . 0.542 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.2 OUTLIER -151.51 177.42 10.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.967 -1.083 . . . . 0.0 109.807 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.462 179.781 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.3 -3.5 13.07 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.854 1.449 . . . . 0.0 110.285 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -61.88 -39.22 91.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.257 -0.902 . . . . 0.0 109.292 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -86.93 -43.99 11.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.335 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.6 mtt -56.94 -35.87 69.59 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.261 -0.899 . . . . 0.0 109.542 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.443 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 11.2 m -67.41 -39.16 85.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -43.66 62.77 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.674 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.3 t -53.96 -22.64 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.711 HG11 ' CG2' ' A' ' 71' ' ' VAL . 4.3 t -90.12 -41.35 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 108.979 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.3 tt0 -65.5 -74.18 0.11 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.903 ' HB3' HD22 ' A' ' 29' ' ' LEU . 2.2 mtt85 -42.27 -45.46 4.2 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.608 ' CD1' HG23 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -46.1 -43.73 15.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.095 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.915 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.4 t -90.34 -37.24 9.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.544 -0.722 . . . . 0.0 109.136 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -49.26 -34.91 16.29 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.564 ' HB3' HG12 ' A' ' 26' ' ' ILE . . . -74.73 -33.3 62.34 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.915 HD12 ' HA ' ' A' ' 15' ' ' VAL . 3.8 mt -65.96 -58.85 4.6 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.75 -41.86 24.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.621 0.724 . . . . 0.0 109.251 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.85 7.98 31.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.863 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 47.94 31.94 8.43 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 16.7 t0 -100.17 92.99 5.48 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.324 -1.104 . . . . 0.0 109.755 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.028 HD13 HD12 ' A' ' 26' ' ' ILE . 3.4 mm? -59.17 -15.27 13.82 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.224 -0.923 . . . . 0.0 109.529 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.23 -54.14 45.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 109.178 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.12 -35.68 92.41 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.028 HD12 HD13 ' A' ' 23' ' ' LEU . 8.8 mt -62.8 -56.45 17.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' A' ' 52' ' ' ARG . 95.7 t -63.72 -37.9 80.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.28 74.1 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.903 HD22 ' HB3' ' A' ' 13' ' ' ARG . 7.7 tp -66.08 -23.32 66.5 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CD2' HG22 ' A' ' 26' ' ' ILE . 3.6 m-85 -88.4 141.1 28.81 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.562 -0.711 . . . . 0.0 109.655 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -48.5 172.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 109.458 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.29 -24.1 67.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 109.294 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.632 ' C ' HD11 ' A' ' 51' ' ' ILE . 20.4 p-10 -146.58 35.12 0.95 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.972 ' N ' HD11 ' A' ' 51' ' ' ILE . . . -51.01 169.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.822 . . . . 0.0 109.772 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 1.007 HG23 ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -122.76 140.31 53.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.541 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.515 HG22 ' HB3' ' A' ' 112' ' ' MET . 48.2 t -131.49 120.66 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.262 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 3.4 mt-10 -88.46 107.0 18.64 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.569 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 9.1 t0 -179.78 143.29 0.37 Allowed Pre-proline 0 C--N 1.302 -1.486 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.547 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HA ' ' CG ' ' A' ' 38' ' ' ASP . 50.1 Cg_endo -76.25 -175.14 15.86 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.205 -1.998 . . . . 0.0 110.403 -0.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.004 HG21 HG11 ' B' ' 274' ' ' VAL . 19.8 m -72.58 150.89 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 108.875 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.35 -1.76 69.48 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.463 ' OG ' ' HG2' ' A' ' 39' ' ' PRO . 1.4 m -115.46 -142.3 0.38 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.27 -1.135 . . . . 0.0 109.308 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.24 141.76 16.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.987 -1.071 . . . . 0.0 110.048 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 39.6 Cg_endo -65.56 -175.44 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.817 1.678 . . . . 0.0 111.592 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.598 ' HB2' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -150.78 106.86 3.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 1.007 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.28 157.01 18.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.276 -0.89 . . . . 0.0 110.601 -178.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.557 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 106.3 157.18 21.69 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 m -64.55 -55.26 21.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.243 -1.151 . . . . 0.0 109.138 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -55.27 -33.02 62.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.89 . . . . 0.0 109.009 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.576 ' HB1' ' CG ' ' A' ' 45' ' ' ARG . . . -77.46 -60.52 2.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.383 -0.823 . . . . 0.0 109.357 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.972 HD11 ' N ' ' A' ' 34' ' ' ALA . 44.5 mt -48.08 -40.9 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.267 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB2' HG21 ' A' ' 27' ' ' VAL . 49.2 ttp180 -79.1 -58.39 3.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.814 . . . . 0.0 109.124 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.532 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 49.8 tt0 -46.2 -27.37 0.97 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.021 -1.05 . . . . 0.0 108.619 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.598 ' CD2' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -85.02 -71.36 0.53 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.587 ' HB3' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -49.31 -33.01 12.21 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.451 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . . . -69.12 -46.82 66.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 108.78 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 26.9 t-20 -58.41 -35.45 72.09 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.6 t -64.93 -38.09 89.82 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.921 HD22 ' CD2' ' A' ' 23' ' ' LEU . 7.6 tp -68.78 -22.04 64.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.486 -0.759 . . . . 0.0 109.68 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 25.9 mtpt -50.39 -26.37 4.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 109.692 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.895 HD22 ' CD2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.71 126.7 56.96 Favored Pre-proline 0 C--N 1.305 -1.349 0 O-C-N 121.226 -0.921 . . . . 0.0 109.049 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.454 ' C ' ' HG ' ' A' ' 63' ' ' LEU . 44.0 Cg_endo -71.49 101.62 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.834 1.439 . . . . 0.0 110.371 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.895 ' CD2' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -138.64 155.86 47.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.462 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -89.79 132.66 35.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 108.778 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.608 HG11 ' HB3' ' A' ' 18' ' ' LEU . 16.2 t -107.22 125.02 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.048 -1.033 . . . . 0.0 110.127 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' LEU . 14.8 tt0 -150.26 103.12 3.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.44 -0.788 . . . . 0.0 108.961 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.763 HD11 ' HB ' ' A' ' 15' ' ' VAL . 3.8 mt -55.09 -108.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 110.062 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.668 ' O ' ' N ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER 158.26 43.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.555 ' CG ' ' O ' ' A' ' 68' ' ' THR . 5.1 pt20 50.64 -54.02 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' A' ' 68' ' ' THR . 23.1 tt0 -60.77 116.19 4.23 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.624 -1.297 . . . . 0.0 110.761 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.711 ' CG2' HG11 ' A' ' 11' ' ' VAL . 35.8 t -135.3 163.54 35.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.702 ' CZ ' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -132.03 135.12 46.28 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.454 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.527 ' N ' ' NE ' ' A' ' 72' ' ' ARG . . . -145.44 111.63 5.66 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.041 HG11 HG21 ' B' ' 240' ' ' VAL . 0.1 OUTLIER -100.11 -163.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 110.429 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -35.69 -94.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.771 -0.581 . . . . 0.0 111.241 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 8.1 t-20 -100.32 -2.9 32.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.07 -1.019 . . . . 0.0 110.748 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.515 ' OE1' ' NE ' ' B' ' 313' ' ' ARG . 0.4 OUTLIER -111.29 -162.03 0.78 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.769 -1.207 . . . . 0.0 109.719 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 1.04 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . -176.09 162.14 2.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.602 -0.686 . . . . 0.0 109.372 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 1.006 ' HB2' HD11 ' B' ' 315' ' ' LEU . . . -150.17 130.09 13.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.172 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 31.4 p90 -150.83 168.79 23.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.678 -1.263 . . . . 0.0 109.948 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.888 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -141.8 -178.3 5.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.472 -0.767 . . . . 0.0 109.862 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CB ' ' HA ' ' A' ' 67' ' ' LEU . 1.9 p90 -172.65 -159.25 0.12 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.386 -0.821 . . . . 0.0 109.257 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.86 149.43 43.41 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.083 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.611 HG11 HD22 ' A' ' 63' ' ' LEU . 55.6 t -124.77 112.51 32.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.51 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -113.5 103.9 11.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.902 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.583 ' CD2' HD23 ' A' ' 63' ' ' LEU . 45.6 p90 -123.1 164.77 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.393 -0.817 . . . . 0.0 108.931 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 38.0 tt0 -141.46 152.25 44.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.059 -1.026 . . . . 0.0 109.83 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.437 ' N ' ' HG2' ' A' ' 87' ' ' GLU . 7.3 m-85 -93.61 -146.4 0.24 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.419 -0.801 . . . . 0.0 109.297 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -0.72 30.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.958 . . . . 0.0 109.719 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.71 -68.63 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 1.6 ttt85 -55.49 155.11 5.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -1.137 . . . . 0.0 109.557 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.439 ' HD2' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -131.71 120.43 22.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.757 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -121.46 143.26 49.34 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER -117.37 179.52 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.103 -0.998 . . . . 0.0 108.74 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 1.012 HG12 ' HD3' ' A' ' 97' ' ' PRO . 3.0 t -148.15 146.5 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.07 -1.019 . . . . 0.0 109.533 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.44 ' O ' ' CG ' ' A' ' 120' ' ' ASN . . . -133.64 71.13 75.51 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.34 -0.85 . . . . 0.0 110.281 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 1.012 ' HD3' HG12 ' A' ' 95' ' ' VAL . 49.7 Cg_endo -95.46 -174.54 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.537 1.491 . . . . 0.0 110.973 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.888 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.9 mp -139.14 166.28 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 21.1 t0 -131.27 154.66 48.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.922 -1.111 . . . . 0.0 110.192 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.517 ' NE2' ' CD1' ' B' ' 315' ' ' LEU . 0.3 OUTLIER -108.77 172.75 6.66 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 1.04 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -147.41 150.88 35.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.82 -1.175 . . . . 0.0 110.857 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.488 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -139.78 109.53 6.33 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.674 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -89.27 -166.12 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 109.777 -179.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.871 ' HB3' HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -135.9 -38.71 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.439 -0.788 . . . . 0.0 109.34 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.714 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -174.46 -47.67 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 163.2 77.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -1.094 . . . . 0.0 109.503 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -167.21 -67.94 0.03 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -139.78 -163.87 1.58 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.232 -1.158 . . . . 0.0 109.482 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.774 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 94.0 t -100.79 147.63 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.871 . . . . 0.0 109.337 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.871 HG21 ' HB3' ' A' ' 104' ' ' ASN . 93.2 t -111.9 -66.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 109.746 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -116.25 166.25 12.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.055 -1.028 . . . . 0.0 109.736 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.515 ' HB3' HG22 ' A' ' 36' ' ' VAL . 12.2 ttp -160.28 154.61 23.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.345 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.49 HH22 HD12 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -144.35 126.59 15.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.167 -0.958 . . . . 0.0 109.482 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.554 ' HB3' ' OD2' ' A' ' 38' ' ' ASP . . . -96.71 132.21 42.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 109.752 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.653 HD13 ' HB2' ' B' ' 279' ' ' ALA . 1.3 tt -117.92 143.84 45.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.002 . . . . 0.0 109.834 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.549 ' CE1' HG13 ' A' ' 40' ' ' VAL . 9.2 p90 172.54 -158.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.622 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 169.53 -173.05 43.79 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.517 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 26.6 tt0 -72.79 -2.65 21.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.302 -1.117 . . . . 0.0 109.68 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -92.71 -30.96 15.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.997 0.903 . . . . 0.0 108.995 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.3 m-20 -89.11 11.38 18.69 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.679 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.982 HG23 HG22 ' A' ' 95' ' ' VAL . 4.4 mm -92.66 -160.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.191 -0.943 . . . . 0.0 108.587 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.697 ' O ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -151.22 159.93 44.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.071 . . . . 0.0 109.795 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.66 81.74 1.03 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.371 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -119.19 140.16 14.82 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.207 -1.173 . . . . 0.0 109.454 179.889 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . 0.405 ' O ' ' C ' ' B' ' 202' ' ' ASN . 5.1 mpp? . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.258 0.551 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.477 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 8.8 m120 45.33 44.48 9.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.436 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . 0.515 ' CG2' ' HB2' ' B' ' 205' ' ' GLU . 5.3 m -89.59 108.64 26.46 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.4 Cg_endo -72.26 -2.48 11.73 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.973 1.512 . . . . 0.0 110.165 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . 0.515 ' HB2' ' CG2' ' B' ' 203' ' ' THR . 3.5 tt0 -58.92 -63.48 1.28 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -0.869 . . . . 0.0 109.353 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -61.98 -45.03 95.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.915 . . . . 0.0 109.51 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' MET . . . . . 0.434 ' HA ' ' CE2' ' B' ' 303' ' ' PHE . 73.3 mtm -60.9 -41.48 96.15 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.255 -0.903 . . . . 0.0 109.608 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 18.1 m -64.46 -44.08 92.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.946 . . . . 0.0 109.252 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.64 -43.73 57.19 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.845 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -53.57 -26.03 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.817 HG11 ' CG2' ' B' ' 271' ' ' VAL . 13.5 t -89.8 -43.27 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 108.984 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' B' ' 215' ' ' VAL . 5.7 tt0 -62.71 -73.98 0.1 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.833 ' HB3' HD22 ' B' ' 229' ' ' LEU . 1.4 mtt85 -42.21 -45.06 3.99 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' TYR . . . . . 0.639 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.3 OUTLIER -48.05 -43.13 30.04 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.28 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.952 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.16 -40.25 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.407 -0.808 . . . . 0.0 109.178 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.8 -37.24 13.17 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.609 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -72.97 -35.21 66.87 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' B' ' 215' ' ' VAL . 5.2 mt -63.84 -60.84 2.77 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -49.29 -40.36 34.37 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.532 0.682 . . . . 0.0 109.252 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.22 0.02 57.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.553 -0.717 . . . . 0.0 109.799 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.972 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 54.52 45.4 76.9 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . 0.454 ' O ' HG13 ' B' ' 226' ' ' ILE . 45.7 t0 -111.14 83.75 1.82 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 110.061 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' LEU . . . . . 0.984 ' CD2' HD22 ' B' ' 259' ' ' LEU . 3.9 mm? -53.31 -19.37 3.23 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.24 -0.913 . . . . 0.0 109.78 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.89 -56.94 11.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.235 -0.916 . . . . 0.0 109.213 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -60.61 -31.92 76.62 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.896 HD12 HD13 ' B' ' 223' ' ' LEU . 7.2 mt -65.28 -60.45 2.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.726 HG21 ' HB2' ' B' ' 252' ' ' ARG . 61.1 t -59.14 -40.26 80.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.16 -51.33 66.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.845 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.6 tp -66.48 -21.83 66.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . 0.493 ' O ' ' O ' ' B' ' 227' ' ' VAL . 3.9 m-30 -95.71 134.93 38.06 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.338 -0.851 . . . . 0.0 110.015 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -44.54 164.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.036 -1.04 . . . . 0.0 109.383 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' B' ' 248' ' ' THR . 0.1 OUTLIER -61.9 -24.63 67.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.489 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.553 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 2.6 p30 -138.53 43.08 2.15 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' B' ' 310' ' ' VAL . . . -64.04 169.26 4.49 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.327 -0.858 . . . . 0.0 109.808 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' THR . . . . . 0.873 HG23 ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -119.79 140.07 51.33 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.446 -0.784 . . . . 0.0 109.007 179.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.502 ' O ' ' HB3' ' B' ' 244' ' ' PRO . 37.3 t -132.44 121.19 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.577 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' B' ' 314' ' ' ALA . 1.5 mt-10 -89.2 105.85 18.05 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' ASP . . . . . 0.533 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 27.0 t70 -179.61 142.06 0.36 Allowed Pre-proline 0 C--N 1.302 -1.464 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.337 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . 0.503 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 47.7 Cg_endo -72.61 -176.72 16.71 Favored 'Cis proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.209 -1.996 . . . . 0.0 110.693 -0.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 1.041 HG21 HG11 ' A' ' 74' ' ' VAL . 26.9 m -82.86 49.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -175.1 30.88 0.09 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 75.4 m -149.46 -99.1 0.07 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -1.118 . . . . 0.0 109.38 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -176.9 139.46 0.46 Allowed Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.099 -1.001 . . . . 0.0 110.037 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' PRO . . . . . 0.502 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.1 Cg_endo -65.12 -176.64 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.123 1.591 . . . . 0.0 111.138 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.74 ' HG2' ' HB1' ' B' ' 250' ' ' ALA . 12.1 ttm-85 -151.88 121.76 7.05 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.873 ' HB3' HG23 ' B' ' 235' ' ' THR . 1.0 OUTLIER -103.21 155.71 18.23 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.011 -1.056 . . . . 0.0 110.164 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . 0.553 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.89 161.96 21.07 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' THR . . . . . 0.454 ' N ' ' O ' ' B' ' 232' ' ' ASP . 3.7 m -70.02 -59.75 2.72 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.22 -1.165 . . . . 0.0 109.259 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -53.66 -23.53 11.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.313 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.74 ' HB1' ' HG2' ' B' ' 245' ' ' ARG . . . -87.69 -54.34 4.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.62 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.528 HD11 ' O ' ' B' ' 234' ' ' ALA . 7.1 mm -53.35 -40.93 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 109.543 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 252' ' ' ARG . . . . . 0.726 ' HB2' HG21 ' B' ' 227' ' ' VAL . 24.6 ttp85 -79.09 -51.54 9.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.064 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 253' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 21.6 tt0 -52.06 -27.32 13.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.03 -1.044 . . . . 0.0 108.578 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.1 OUTLIER -83.9 -70.11 0.59 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 255' ' ' PHE . . . . . 0.588 ' C ' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -52.94 -20.43 3.37 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.389 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' B' ' 252' ' ' ARG . . . -79.31 -39.67 32.27 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 257' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 62.4 t30 -62.86 -26.13 68.62 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 30.3 t -74.71 -41.55 59.99 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 259' ' ' LEU . . . . . 0.984 HD22 ' CD2' ' B' ' 223' ' ' LEU . 9.9 tp -61.4 -23.4 65.77 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.499 -0.751 . . . . 0.0 109.378 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 260' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' B' ' 262' ' ' PRO . 0.0 OUTLIER -50.62 -29.51 11.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.889 . . . . 0.0 109.345 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 261' ' ' LEU . . . . . 1.051 HD22 HD21 ' B' ' 263' ' ' LEU . 0.8 OUTLIER -92.64 107.36 23.54 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 108.534 179.385 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 262' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 47.9 Cg_endo -73.52 115.21 4.26 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.899 1.473 . . . . 0.0 111.702 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 1.051 HD21 HD22 ' B' ' 261' ' ' LEU . 0.1 OUTLIER -138.96 -166.49 2.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.477 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . 0.746 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -114.28 127.25 55.78 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.86 118.75 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -0.999 . . . . 0.0 109.919 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.2 OUTLIER -150.14 108.5 3.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.334 -0.854 . . . . 0.0 109.2 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.9 OUTLIER -47.38 174.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.504 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.43 -39.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.663 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 269' ' ' GLN . . . . . 0.497 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 7.5 pt20 -94.63 -148.82 0.28 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.638 -0.664 . . . . 0.0 109.294 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 270' ' ' GLU . . . . . 0.497 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 32.5 tt0 -113.42 131.52 55.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 109.72 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 271' ' ' VAL . . . . . 0.817 ' CG2' HG11 ' B' ' 211' ' ' VAL . 57.0 t -65.1 153.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.347 -0.845 . . . . 0.0 109.247 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 2.5 mtt180 -116.12 131.59 56.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.212 -0.93 . . . . 0.0 109.964 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.19 133.97 16.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.391 -0.818 . . . . 0.0 109.179 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 274' ' ' VAL . . . . . 1.004 HG11 HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -127.3 -163.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.104 -0.997 . . . . 0.0 109.811 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 275' ' ' ALA . . . . . 0.542 ' O ' ' CB ' ' B' ' 276' ' ' ASN . . . -86.38 68.17 10.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.433 -0.792 . . . . 0.0 110.386 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 276' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' B' ' 275' ' ' ALA . 2.9 m-20 160.69 -61.36 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.421 -0.799 . . . . 0.0 109.47 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . 0.495 ' HG2' ' HG2' ' B' ' 302' ' ' ARG . 0.0 OUTLIER -122.39 -161.11 0.92 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.455 -0.778 . . . . 0.0 109.214 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 278' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . -169.78 139.41 1.96 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.478 -0.764 . . . . 0.0 109.12 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 279' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -126.73 139.49 53.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.96 -1.087 . . . . 0.0 109.456 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . 0.68 ' HB3' HG13 ' B' ' 271' ' ' VAL . 23.8 p90 -150.57 172.47 15.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.054 -1.029 . . . . 0.0 109.631 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.899 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -147.18 175.59 10.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 110.183 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 282' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 6.7 p90 -167.76 -167.89 0.92 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 283' ' ' THR . . . . . 0.673 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -132.73 141.78 48.71 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.987 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 284' ' ' VAL . . . . . 0.718 ' CG1' HD22 ' B' ' 263' ' ' LEU . 0.5 OUTLIER -114.7 120.93 65.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 285' ' ' SER . . . . . 0.746 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 37.8 p -123.86 80.7 1.83 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.11 -0.994 . . . . 0.0 109.97 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.661 ' HB3' HD23 ' B' ' 263' ' ' LEU . 44.1 p90 -89.89 -172.5 3.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.202 -0.936 . . . . 0.0 108.643 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.72 150.42 49.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.873 -1.142 . . . . 0.0 110.099 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . 0.568 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.4 OUTLIER -117.21 88.49 2.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 0.0 108.99 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . 0.52 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 0.2 OUTLIER 42.13 -93.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.269 -0.894 . . . . 0.0 110.021 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 290' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' B' ' 288' ' ' PHE . . . -101.55 -13.43 32.66 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 291' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' B' ' 288' ' ' PHE . 7.8 mtt-85 -101.98 159.85 15.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.239 . . . . 0.0 109.774 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 292' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -122.01 129.74 52.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 293' ' ' THR . . . . . 0.571 ' HB ' ' CZ ' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -123.18 144.47 49.34 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.258 -0.901 . . . . 0.0 109.921 -179.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 294' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' B' ' 322' ' ' HIS . 12.3 p -126.19 168.25 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.875 . . . . 0.0 108.773 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 0.929 HG22 ' CG2' ' B' ' 321' ' ' ILE . 30.9 t -137.7 160.17 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.944 -1.098 . . . . 0.0 110.62 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 296' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' B' ' 320' ' ' ASN . . . -144.49 64.62 12.16 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 297' ' ' PRO . . . . . 0.583 ' HD3' HG12 ' B' ' 295' ' ' VAL . 46.3 Cg_endo -97.57 179.78 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.707 1.605 . . . . 0.0 111.749 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.899 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.6 mp -141.05 154.46 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . 0.627 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 18.4 t0 -123.01 164.25 18.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.784 -1.198 . . . . 0.0 110.541 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 300' ' ' HIS . . . . . 0.516 ' O ' ' CG ' ' B' ' 312' ' ' MET . 0.1 OUTLIER -116.66 166.32 12.25 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 301' ' ' PHE . . . . . 0.683 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.1 OUTLIER -145.18 145.85 31.51 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.883 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.495 ' HG2' ' HG2' ' B' ' 277' ' ' GLU . 0.8 OUTLIER -138.53 110.4 7.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.37 -0.831 . . . . 0.0 109.25 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 303' ' ' PHE . . . . . 0.681 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 5.1 m-85 -89.9 -168.44 2.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.564 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 304' ' ' ASN . . . . . 0.83 ' HB3' HG21 ' B' ' 310' ' ' VAL . 0.9 OUTLIER -137.55 -40.72 0.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 305' ' ' GLY . . . . . 0.701 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -148.1 -65.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 306' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 164.9 56.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -1.146 . . . . 0.0 109.546 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -148.04 -41.04 0.04 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -154.86 -169.31 3.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -1.209 . . . . 0.0 109.542 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 309' ' ' VAL . . . . . 0.573 HG11 ' HE1' ' B' ' 301' ' ' PHE . 50.0 t -99.24 151.41 4.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 109.286 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . 0.83 HG21 ' HB3' ' B' ' 304' ' ' ASN . 45.3 t -121.74 -63.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' B' ' 302' ' ' ARG . 13.8 m -116.48 165.62 13.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.154 -0.966 . . . . 0.0 109.518 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 312' ' ' MET . . . . . 0.516 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 28.8 ttp -155.18 156.48 35.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.754 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 313' ' ' ARG . . . . . 0.515 ' NE ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -123.98 179.85 4.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.351 -0.843 . . . . 0.0 108.998 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 314' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' B' ' 238' ' ' ASP . . . -138.42 125.14 20.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.977 -1.077 . . . . 0.0 110.529 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 315' ' ' LEU . . . . . 1.006 HD11 ' HB2' ' A' ' 79' ' ' ALA . 5.6 tp -104.44 -175.32 2.76 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 316' ' ' PHE . . . . . 0.76 ' HE1' HG22 ' B' ' 240' ' ' VAL . 0.0 OUTLIER 99.56 -160.73 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.626 0.726 . . . . 0.0 109.889 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 317' ' ' GLY . . . . . 0.662 ' N ' ' CG ' ' B' ' 316' ' ' PHE . . . 160.42 -162.33 33.25 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 318' ' ' GLU . . . . . 0.494 ' HA ' HD12 ' B' ' 321' ' ' ILE . 5.1 tt0 -78.16 6.45 8.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -1.143 . . . . 0.0 109.622 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -115.17 -17.85 11.29 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.192 -0.943 . . . . 0.0 110.078 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 320' ' ' ASN . . . . . 0.535 ' O ' ' HB3' ' B' ' 296' ' ' ALA . 0.2 OUTLIER -88.8 -14.9 35.92 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.215 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 321' ' ' ILE . . . . . 0.929 ' CG2' HG22 ' B' ' 295' ' ' VAL . 0.9 OUTLIER -87.84 -164.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 322' ' ' HIS . . . . . 0.729 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.0 OUTLIER -150.99 154.84 37.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.969 -1.082 . . . . 0.0 109.756 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.474 ' HA ' HG22 ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.468 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.736 ' O ' HG23 ' A' ' 3' ' ' THR . 11.1 t . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.84 -9.69 25.18 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.889 1.468 . . . . 0.0 110.065 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -66.35 -49.45 66.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.229 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -52.7 61.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.192 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 mtm -59.62 -25.58 64.76 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.329 -0.857 . . . . 0.0 109.346 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -72.98 -30.69 64.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 0.0 109.128 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.25 -51.97 66.17 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.863 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -47.91 -29.13 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.163 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.943 HG11 HG21 ' A' ' 71' ' ' VAL . 24.9 t -87.95 -45.18 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.5 -0.75 . . . . 0.0 109.363 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 13' ' ' ARG . 3.6 tt0 -58.43 -73.37 0.08 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.0 OUTLIER -43.02 -44.78 4.89 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.643 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -50.5 -44.26 55.94 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.924 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -86.37 -41.46 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 108.99 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -49.41 -35.19 18.41 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.677 ' HB1' ' OD1' ' A' ' 22' ' ' ASP . . . -74.25 -32.82 63.1 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.924 HD12 ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -65.1 -57.13 9.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.48 -39.73 24.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.01 -11.57 43.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.583 -0.698 . . . . 0.0 109.464 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 1.008 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 62.68 25.92 67.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.677 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 16.0 p30 -89.41 85.48 6.56 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.131 -1.217 . . . . 0.0 109.649 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.036 ' CD2' HD22 ' A' ' 59' ' ' LEU . 3.6 mm? -49.76 -21.8 1.21 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.259 -0.901 . . . . 0.0 109.783 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.53 -51.8 68.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -40.8 95.02 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.56 HD12 HD13 ' A' ' 23' ' ' LEU . 7.7 mt -59.86 -54.67 31.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 23' ' ' LEU . 48.5 t -64.33 -41.18 91.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.17 -49.82 70.9 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.863 HD21 ' HA ' ' A' ' 10' ' ' VAL . 2.0 tp -67.14 -14.22 62.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.733 ' CZ ' ' HE3' ' A' ' 112' ' ' MET . 3.0 m-85 -89.48 136.01 33.27 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' CB ' HG22 ' A' ' 110' ' ' VAL . . . -54.42 -167.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 109.552 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -76.89 -23.51 52.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.251 -0.906 . . . . 0.0 109.7 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.549 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -143.66 45.51 1.49 Allowed 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -59.04 157.63 9.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.966 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.556 ' HG1' ' HG ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -117.81 139.27 51.32 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.485 -0.759 . . . . 0.0 109.284 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.754 ' CG2' HD12 ' A' ' 51' ' ' ILE . 42.7 t -129.24 141.1 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.418 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.526 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 11.5 mt-10 -111.24 112.79 24.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.493 ' HA ' ' C ' ' A' ' 39' ' ' PRO . 19.7 t70 -179.27 141.38 0.36 Allowed Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.568 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.51 ' O ' HG22 ' A' ' 40' ' ' VAL . 46.2 Cg_endo -72.56 131.69 23.34 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.286 -1.964 . . . . 0.0 110.6 -0.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 39' ' ' PRO . 14.0 m 40.73 -147.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.464 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.473 ' N ' HG23 ' A' ' 40' ' ' VAL . . . -67.28 1.21 6.95 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.04 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.472 ' OG ' ' HG2' ' A' ' 39' ' ' PRO . 68.8 m -48.06 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.902 -1.352 . . . . 0.0 110.163 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 4.2 pt-20 -133.29 107.64 12.28 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.003 . . . . 0.0 110.608 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 42.5 Cg_endo -68.47 -167.74 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 124.016 1.535 . . . . 0.0 110.428 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.662 ' HD3' ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -151.43 112.31 4.26 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.532 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.2 OUTLIER -103.57 140.2 37.85 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 110.257 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 107.8 160.81 20.93 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.487 HG23 ' CG1' ' A' ' 27' ' ' VAL . 3.0 m -76.07 -42.38 47.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.269 -1.136 . . . . 0.0 109.086 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.63 -38.11 83.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.29 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.662 ' HB1' ' HD3' ' A' ' 45' ' ' ARG . . . -73.48 -43.59 59.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.314 -0.866 . . . . 0.0 109.368 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.754 HD12 ' CG2' ' A' ' 36' ' ' VAL . 5.4 mm -58.49 -46.45 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.31 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.53 ' CG ' HG21 ' A' ' 27' ' ' VAL . 36.7 ttt-85 -66.31 -55.46 15.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 108.945 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 52' ' ' ARG . 2.3 mt-10 -45.09 -28.56 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 108.568 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.607 ' CG ' ' HG3' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -85.09 -70.08 0.61 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.692 ' C ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -51.73 -20.95 2.37 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . . . -82.21 -46.0 14.32 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 24.5 t-20 -60.96 -50.04 75.01 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.4 t -51.79 -26.27 9.34 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.036 HD22 ' CD2' ' A' ' 23' ' ' LEU . 5.4 tp -76.95 -28.24 55.13 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.591 -0.693 . . . . 0.0 109.739 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -44.35 -31.44 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 108.633 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.057 ' CD2' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.19 100.27 11.35 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 45.9 Cg_endo -71.71 129.54 15.7 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.991 1.521 . . . . 0.0 111.899 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.057 HD21 ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -139.98 178.04 7.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.999 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -92.23 127.8 37.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.264 -0.898 . . . . 0.0 108.58 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.52 112.18 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 110.056 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -150.86 105.3 3.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.812 . . . . 0.0 109.193 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.51 HD12 ' H ' ' A' ' 67' ' ' LEU . 2.3 mp -55.5 173.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.96 . . . . 0.0 109.861 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -134.72 -81.13 0.44 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.339 -0.851 . . . . 0.0 109.327 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.557 ' H ' HG23 ' A' ' 68' ' ' THR . 5.5 pt20 -60.22 -143.28 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.647 -0.658 . . . . 0.0 109.435 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -114.29 134.8 54.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.963 -1.086 . . . . 0.0 110.001 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.022 HG13 ' HB3' ' A' ' 80' ' ' PHE . 10.6 t -63.09 148.71 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.423 -0.798 . . . . 0.0 109.036 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 3.4 mmm180 -98.97 130.57 45.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.931 . . . . 0.0 109.287 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.533 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -145.92 135.96 23.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 109.342 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.9 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -163.9 155.48 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.67 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.807 ' HB2' ' O ' ' B' ' 240' ' ' VAL . . . 49.76 -152.03 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.473 -0.767 . . . . 0.0 109.855 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 103' ' ' PHE . 98.3 m-20 -87.36 16.98 4.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.454 -0.779 . . . . 0.0 109.331 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.498 ' HG3' ' HA ' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -123.6 -159.26 0.84 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.342 -0.849 . . . . 0.0 109.076 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.96 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 178.04 160.3 0.53 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.439 -0.788 . . . . 0.0 109.542 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.835 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.27 133.54 16.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.015 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 1.022 ' HB3' HG13 ' A' ' 71' ' ' VAL . 33.5 p90 -148.96 163.67 36.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.836 -1.165 . . . . 0.0 110.241 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.964 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -140.78 150.13 42.97 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -149.56 -172.51 4.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.175 -0.953 . . . . 0.0 109.401 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.29 141.74 51.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.406 -0.808 . . . . 0.0 109.611 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.939 HG11 HD22 ' A' ' 63' ' ' LEU . 19.9 t -112.01 111.71 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.394 -0.816 . . . . 0.0 109.156 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.999 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -106.12 113.1 26.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.824 . . . . 0.0 109.57 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 86' ' ' PHE . 0.8 OUTLIER -128.02 148.13 50.53 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.195 -0.941 . . . . 0.0 109.536 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -91.7 178.64 5.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.541 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.576 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.5 OUTLIER -142.19 -163.49 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.34 -0.85 . . . . 0.0 109.382 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.69 60.95 2.87 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.026 -1.047 . . . . 0.0 109.491 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.84 3.41 26.69 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -136.81 164.36 28.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.137 -1.213 . . . . 0.0 109.667 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' CD ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -126.52 122.27 34.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.844 . . . . 0.0 109.233 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.576 ' OG1' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -117.23 154.6 30.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.722 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.622 HG12 ' HB3' ' A' ' 122' ' ' HIS . 7.3 p -138.46 170.75 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 108.861 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 1.029 HG12 ' HD3' ' A' ' 97' ' ' PRO . 3.5 t -144.91 147.05 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.034 -1.041 . . . . 0.0 109.268 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.437 ' O ' ' CG ' ' A' ' 120' ' ' ASN . . . -132.55 69.65 79.67 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.121 -0.987 . . . . 0.0 111.026 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 1.029 ' HD3' HG12 ' A' ' 95' ' ' VAL . 49.3 Cg_endo -96.35 -173.08 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.503 1.469 . . . . 0.0 110.424 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.964 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.9 mp -134.46 157.36 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 15.8 t0 -127.05 153.25 46.2 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.156 -0.965 . . . . 0.0 110.11 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.518 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -108.88 171.27 7.53 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.96 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -142.37 148.38 37.79 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.101 -0.999 . . . . 0.0 110.486 -178.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.539 ' CD ' ' HB2' ' A' ' 111' ' ' SER . 0.0 OUTLIER -133.85 107.43 7.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.561 -0.712 . . . . 0.0 109.085 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.639 ' CZ ' ' CG2' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -89.72 -176.37 4.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 109.56 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.932 ' OD1' HG23 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -138.9 -100.08 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.433 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.67 -38.93 0.04 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -171.48 32.8 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.45 -1.029 . . . . 0.0 108.74 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 108' ' ' LYS . . . -123.72 15.56 7.96 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 22.2 mmmt 81.79 -150.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.653 -0.91 . . . . 0.0 109.624 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.66 HG23 HG22 ' A' ' 10' ' ' VAL . 18.2 t -88.2 122.66 40.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.932 HG23 ' OD1' ' A' ' 104' ' ' ASN . 49.1 t -105.24 -8.58 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.079 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.556 ' HG ' ' HG1' ' A' ' 35' ' ' THR . 0.6 OUTLIER -160.37 153.22 21.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.957 -1.089 . . . . 0.0 110.137 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.733 ' HE3' ' CZ ' ' A' ' 30' ' ' PHE . 19.0 ttm -160.05 141.82 12.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.494 -0.754 . . . . 0.0 109.211 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 1.0 OUTLIER -123.56 174.21 7.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.116 -0.99 . . . . 0.0 109.269 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 99' ' ' ASP . . . -147.47 134.91 20.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.945 . . . . 0.0 109.263 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.879 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.1 OUTLIER -125.01 141.17 52.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 110.063 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.784 ' O ' HG21 ' B' ' 274' ' ' VAL . 50.0 p90 172.86 -160.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.564 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 172.31 -171.03 44.0 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.542 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 3.1 tt0 -69.87 -5.01 22.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.444 -1.033 . . . . 0.0 109.7 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.453 ' HE3' ' OE2' ' B' ' 270' ' ' GLU . 0.3 OUTLIER -90.47 -31.74 16.66 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.958 0.885 . . . . 0.0 109.142 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.437 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.8 m-20 -89.36 8.6 29.83 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.19 0.519 . . . . 0.0 109.665 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.724 HG22 ' H ' ' A' ' 122' ' ' HIS . 4.9 mm -90.28 -172.53 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 108.897 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.724 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -151.7 156.76 41.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.914 . . . . 0.0 109.506 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.426 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -154.7 135.24 13.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.506 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.59 138.66 9.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.202 -1.175 . . . . 0.0 109.535 -179.861 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.242 0.544 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -116.06 92.6 3.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.441 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.92 119.42 69.38 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.827 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.32 -4.69 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.858 1.452 . . . . 0.0 109.586 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.04 -40.84 68.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.373 -0.83 . . . . 0.0 109.237 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -65.83 -55.7 15.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.128 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 15.4 mtm -55.98 -24.62 39.68 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.289 -0.882 . . . . 0.0 109.13 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 5.4 m -73.91 -34.06 64.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.346 -0.846 . . . . 0.0 109.136 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.1 -46.44 65.25 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.183 -0.948 . . . . 0.0 108.482 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.753 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.0 OUTLIER -54.97 -24.84 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.816 HG11 HG21 ' B' ' 271' ' ' VAL . 16.8 t -90.21 -43.94 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.421 -0.799 . . . . 0.0 109.045 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' B' ' 213' ' ' ARG . 7.6 tt0 -60.45 -73.61 0.09 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.963 ' HD3' HD13 ' B' ' 229' ' ' LEU . 0.0 OUTLIER -43.22 -45.23 5.62 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' TYR . . . . . 0.641 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -50.09 -44.84 52.19 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.92 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -86.94 -39.32 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.317 -0.865 . . . . 0.0 109.172 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.35 -36.51 14.62 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -73.97 -33.87 64.02 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.92 HD12 ' HA ' ' B' ' 215' ' ' VAL . 2.7 mt -64.05 -59.07 4.91 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -51.19 -45.5 61.84 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.509 0.671 . . . . 0.0 109.194 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.54 8.6 30.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.579 -0.701 . . . . 0.0 109.681 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.823 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 49.48 33.72 17.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.5 t70 -90.58 67.73 6.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -1.131 . . . . 0.0 109.685 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' LEU . . . . . 1.066 HD12 HD12 ' B' ' 226' ' ' ILE . 7.3 tp -50.38 -45.2 55.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.076 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' B' ' 223' ' ' LEU . 5.3 m-20 -43.44 -32.64 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -83.86 -33.51 21.14 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 1.066 HD12 HD12 ' B' ' 223' ' ' LEU . 17.2 mt -61.9 -56.02 20.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.651 HG11 HG23 ' B' ' 248' ' ' THR . 97.0 t -59.71 -37.33 70.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.93 -51.82 68.06 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.963 HD13 ' HD3' ' B' ' 213' ' ' ARG . 2.9 tp -68.06 -14.89 63.32 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.536 -0.727 . . . . 0.0 109.057 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . 0.771 ' CD2' HG21 ' B' ' 251' ' ' ILE . 2.4 m-85 -94.78 149.18 21.51 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.457 -0.777 . . . . 0.0 109.527 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -59.24 168.23 1.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.429 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.449 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -55.72 -24.4 34.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.372 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.532 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 8.8 p-10 -150.56 51.36 0.88 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.717 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -60.58 158.94 11.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.608 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' THR . . . . . 0.53 ' CG2' ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -100.27 141.34 33.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.447 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.545 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 85.4 t -134.41 136.39 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.258 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 1.5 mt-10 -112.39 113.28 25.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 108.559 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' ASP . . . . . 0.524 ' O ' ' CE2' ' B' ' 254' ' ' PHE . 9.6 t70 -179.55 141.74 0.36 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 109.664 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' B' ' 241' ' ' GLY . 49.1 Cg_endo -75.14 -176.65 18.56 Favored 'Cis proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.25 -1.979 . . . . 0.0 110.485 -0.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.807 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 6.2 m -65.18 75.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.284 -0.885 . . . . 0.0 108.982 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' B' ' 239' ' ' PRO . . . -162.78 24.37 0.2 Allowed Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' B' ' 241' ' ' GLY . 0.5 OUTLIER 67.24 48.92 1.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -1.14 . . . . 0.0 109.741 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . 0.517 ' N ' ' HD3' ' B' ' 244' ' ' PRO . 2.1 mt-10 -131.89 58.57 38.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.144 -0.972 . . . . 0.0 109.466 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' PRO . . . . . 0.545 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 48.5 Cg_endo -77.83 169.69 20.24 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 124.276 1.671 . . . . 0.0 110.942 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.466 ' HD2' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -151.32 100.79 2.78 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.72 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.2 OUTLIER -92.02 161.77 14.65 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.121 -0.987 . . . . 0.0 110.152 -178.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . 0.631 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 100.66 158.26 27.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' THR . . . . . 0.651 HG23 HG11 ' B' ' 227' ' ' VAL . 5.3 m -69.98 -48.7 57.17 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.195 -1.179 . . . . 0.0 108.971 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -61.81 -25.27 67.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.904 . . . . 0.0 109.274 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -90.13 -58.78 2.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.394 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.771 HG21 ' CD2' ' B' ' 230' ' ' PHE . 17.4 mt -47.45 -41.22 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.284 -0.885 . . . . 0.0 109.012 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 252' ' ' ARG . . . . . 0.762 ' CG ' HD23 ' B' ' 223' ' ' LEU . 28.6 ttt180 -76.75 -57.99 3.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.456 -0.778 . . . . 0.0 108.978 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 253' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 62.5 mt-10 -45.27 -28.32 0.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.025 -1.047 . . . . 0.0 108.589 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' B' ' 238' ' ' ASP . 0.8 OUTLIER -85.39 -71.02 0.55 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 255' ' ' PHE . . . . . 1.048 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -49.12 -23.59 1.31 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . 0.711 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -76.38 -49.67 16.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 257' ' ' ASN . . . . . 0.54 ' ND2' ' HE2' ' B' ' 260' ' ' LYS . 0.3 OUTLIER -55.33 -29.43 58.29 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 42.9 t -75.44 -31.8 60.46 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 259' ' ' LEU . . . . . 0.823 HD21 ' CA ' ' B' ' 221' ' ' GLY . 7.3 tp -71.77 -25.78 62.17 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.44 -0.787 . . . . 0.0 109.302 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 260' ' ' LYS . . . . . 0.54 ' HE2' ' ND2' ' B' ' 257' ' ' ASN . 12.0 mtmt -54.12 -23.83 15.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.296 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 261' ' ' LEU . . . . . 0.955 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.8 OUTLIER -89.92 120.34 69.35 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 0.0 108.698 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 262' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' B' ' 286' ' ' PHE . 42.9 Cg_endo -69.94 104.05 1.29 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.752 1.396 . . . . 0.0 110.584 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.955 ' CD2' HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -138.91 149.79 45.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.742 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . 0.906 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -91.62 129.55 37.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -0.824 . . . . 0.0 108.925 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 265' ' ' VAL . . . . . 0.699 HG21 ' HB3' ' B' ' 218' ' ' LEU . 3.0 t -110.18 116.09 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.87 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.1 OUTLIER -150.33 91.47 1.76 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 0.0 109.24 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -45.21 170.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.724 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.1 -39.56 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.299 -0.876 . . . . 0.0 109.675 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 269' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' B' ' 281' ' ' ALA . 8.1 pt20 -87.75 -154.2 0.25 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 270' ' ' GLU . . . . . 0.453 ' OE2' ' HE3' ' A' ' 119' ' ' LYS . 51.7 tt0 -107.39 131.24 54.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.138 -0.976 . . . . 0.0 109.53 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 271' ' ' VAL . . . . . 0.93 HG13 ' HB3' ' B' ' 280' ' ' PHE . 26.7 t -67.35 150.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.292 -0.88 . . . . 0.0 108.762 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 5.5 mtt180 -104.01 136.94 42.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 109.963 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.18 126.14 10.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.412 -0.805 . . . . 0.0 109.275 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 274' ' ' VAL . . . . . 0.784 HG21 ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -155.33 160.74 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.215 -0.928 . . . . 0.0 109.4 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 275' ' ' ALA . . . . . 0.51 ' HB2' HG23 ' A' ' 40' ' ' VAL . . . 43.87 -145.56 0.1 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 276' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' B' ' 303' ' ' PHE . 1.5 t-20 -90.59 13.26 16.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 0.0 109.708 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . 0.492 ' HG3' ' HA ' ' B' ' 302' ' ' ARG . 0.9 OUTLIER -122.16 -161.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.078 -1.014 . . . . 0.0 109.733 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 278' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 177.74 148.79 0.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 279' ' ' ALA . . . . . 0.879 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -134.69 139.69 45.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.007 -1.058 . . . . 0.0 108.868 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . 0.93 ' HB3' HG13 ' B' ' 271' ' ' VAL . 33.3 p90 -150.47 165.18 33.99 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.694 -1.254 . . . . 0.0 110.651 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.992 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -143.45 176.86 8.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 282' ' ' PHE . . . . . 0.408 ' HE1' ' CE2' ' B' ' 280' ' ' PHE . 14.4 p90 -178.14 -170.21 0.23 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.284 -0.885 . . . . 0.0 109.6 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.58 142.33 50.74 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.518 -0.739 . . . . 0.0 109.551 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 284' ' ' VAL . . . . . 0.755 HG12 ' HD1' ' B' ' 286' ' ' PHE . 45.2 t -113.89 113.6 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.453 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 285' ' ' SER . . . . . 0.906 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 91.9 p -105.75 110.6 22.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.168 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.755 ' HD1' HG12 ' B' ' 284' ' ' VAL . 4.3 p90 -127.43 157.86 38.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.164 -0.96 . . . . 0.0 109.787 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 287' ' ' GLU . . . . . 0.49 ' HG3' ' HB2' ' B' ' 292' ' ' LYS . 11.6 tm-20 -144.71 167.61 22.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.307 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . 0.419 ' N ' ' CD ' ' B' ' 287' ' ' GLU . 0.1 OUTLIER -122.02 -75.98 0.59 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.052 -1.03 . . . . 0.0 109.894 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' B' ' 289' ' ' GLN . 0.0 OUTLIER -158.99 60.1 0.42 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.503 -0.748 . . . . 0.0 109.778 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 129.88 -45.76 1.12 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -103.26 129.67 50.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.374 -1.074 . . . . 0.0 109.189 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 292' ' ' LYS . . . . . 0.49 ' HB2' ' HG3' ' B' ' 287' ' ' GLU . 0.2 OUTLIER -118.54 145.7 45.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 109.701 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 293' ' ' THR . . . . . 0.585 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -136.16 145.39 45.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.666 -0.646 . . . . 0.0 109.649 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 294' ' ' VAL . . . . . 0.665 HG23 ' HA ' ' B' ' 285' ' ' SER . 0.5 OUTLIER -117.32 176.35 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 108.581 179.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 1.041 HG12 ' HD3' ' B' ' 297' ' ' PRO . 2.5 t -149.58 145.25 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.227 -0.921 . . . . 0.0 109.069 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 296' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -131.02 71.3 82.45 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.079 -1.013 . . . . 0.0 110.923 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 297' ' ' PRO . . . . . 1.041 ' HD3' HG12 ' B' ' 295' ' ' VAL . 52.3 Cg_endo -96.88 -173.08 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.717 1.611 . . . . 0.0 110.677 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.992 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.5 mp -139.49 151.97 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . 0.619 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 17.5 t0 -124.13 160.2 28.33 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.999 -1.063 . . . . 0.0 110.311 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 300' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' B' ' 312' ' ' MET . 63.0 t60 -110.88 173.79 6.17 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 301' ' ' PHE . . . . . 0.901 ' CE1' HG21 ' B' ' 309' ' ' VAL . 0.1 OUTLIER -149.55 138.96 21.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 110.491 -178.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.522 ' CB ' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -123.46 110.36 15.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.423 -0.798 . . . . 0.0 109.097 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 303' ' ' PHE . . . . . 0.618 ' CZ ' ' CG2' ' B' ' 210' ' ' VAL . 0.4 OUTLIER -89.78 -176.21 4.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 0.0 109.687 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 304' ' ' ASN . . . . . 0.946 ' OD1' HG23 ' B' ' 310' ' ' VAL . 0.1 OUTLIER -142.05 -100.06 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.583 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 305' ' ' GLY . . . . . 0.698 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -98.8 -55.58 1.06 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 306' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 163.13 76.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -1.099 . . . . 0.0 109.39 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -167.53 -51.73 0.03 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 308' ' ' LYS . . . . . 0.513 ' N ' ' HD2' ' B' ' 308' ' ' LYS . 0.0 OUTLIER -150.11 -167.43 2.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -1.213 . . . . 0.0 109.659 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 309' ' ' VAL . . . . . 0.901 HG21 ' CE1' ' B' ' 301' ' ' PHE . 62.0 t -102.66 148.28 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.332 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . 0.946 HG23 ' OD1' ' B' ' 304' ' ' ASN . 24.1 t -110.97 -31.91 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.089 -1.007 . . . . 0.0 110.192 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . 0.522 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 1.3 m -144.94 165.02 29.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.789 -1.194 . . . . 0.0 110.009 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 312' ' ' MET . . . . . 0.523 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 11.0 ttp -156.2 161.5 40.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.695 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 313' ' ' ARG . . . . . 0.576 HH22 HG12 ' B' ' 240' ' ' VAL . 9.0 tpt180 -150.39 117.18 5.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.226 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 314' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' B' ' 299' ' ' ASP . . . -94.59 144.93 25.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.152 -0.968 . . . . 0.0 110.033 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 315' ' ' LEU . . . . . 0.835 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -132.31 139.72 48.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 109.564 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 316' ' ' PHE . . . . . 0.9 ' O ' HG11 ' A' ' 74' ' ' VAL . 47.9 p90 170.68 -158.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 317' ' ' GLY . . . . . 0.603 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 178.83 -175.7 47.51 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 318' ' ' GLU . . . . . 0.546 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 25.7 tt0 -73.36 -1.91 20.07 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.295 -1.121 . . . . 0.0 109.442 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -92.71 -29.62 15.97 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.24 -0.912 . . . . 0.0 108.983 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 320' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -88.89 16.01 7.57 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 321' ' ' ILE . . . . . 0.68 HG22 ' H ' ' B' ' 322' ' ' HIS . 5.1 mm -89.72 -165.07 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 322' ' ' HIS . . . . . 0.68 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.2 OUTLIER -151.9 161.27 42.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.94 -1.1 . . . . 0.0 109.67 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 109.361 179.845 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 3' ' ' THR . 1.8 t . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 44.5 Cg_endo -71.2 -3.82 13.68 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.891 1.469 . . . . 0.0 110.379 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -72.8 -25.58 61.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.912 . . . . 0.0 109.224 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.47 -59.31 2.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -51.47 -21.39 2.37 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.118 -0.989 . . . . 0.0 109.722 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 11' ' ' VAL . 14.3 m -74.66 -39.81 61.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.222 -0.924 . . . . 0.0 109.099 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.89 -42.76 48.68 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.779 ' HA ' HD21 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -53.82 -23.95 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.801 HG11 ' CG2' ' A' ' 71' ' ' VAL . 10.1 t -89.94 -43.06 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.349 -0.844 . . . . 0.0 109.066 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 13' ' ' ARG . 24.6 tt0 -61.82 -73.52 0.1 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.281 1.039 . . . . 0.0 108.284 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.745 ' HD3' HD13 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -42.45 -44.29 3.97 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 1.068 ' CE1' HD11 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -51.27 -48.45 62.2 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.917 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -82.24 -44.24 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.382 -0.824 . . . . 0.0 109.375 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -47.57 -37.99 13.45 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.51 ' HA ' ' HB3' ' A' ' 22' ' ' ASP . . . -72.84 -36.04 67.38 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.068 HD11 ' CE1' ' A' ' 14' ' ' TYR . 2.9 mt -61.0 -59.82 4.77 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -53.49 -42.67 67.54 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.48 0.657 . . . . 0.0 109.762 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.19 5.54 44.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.82 . . . . 0.0 110.006 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.898 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 54.76 46.11 76.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.51 ' HB3' ' HA ' ' A' ' 17' ' ' ALA . 15.6 t0 -104.74 58.35 0.7 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -1.068 . . . . 0.0 109.945 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.028 HD11 ' HB3' ' A' ' 55' ' ' PHE . 6.0 tp -52.86 -45.84 67.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.131 -0.981 . . . . 0.0 108.921 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -46.74 -42.99 17.68 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -75.17 -29.57 60.22 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.001 HD12 HD12 ' A' ' 23' ' ' LEU . 32.5 mt -63.66 -59.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 30' ' ' PHE . 92.9 t -49.45 -35.7 9.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -60.04 -40.83 90.73 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.779 HD21 ' HA ' ' A' ' 10' ' ' VAL . 1.9 tp -75.39 -20.15 59.12 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.471 ' HB2' ' HA ' ' A' ' 27' ' ' VAL . 4.9 m-85 -95.99 141.86 28.89 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.532 -0.73 . . . . 0.0 109.642 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -49.0 177.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.927 . . . . 0.0 109.457 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.63 -24.12 63.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.24 -0.912 . . . . 0.0 109.826 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.529 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 4.9 p-10 -144.83 52.33 1.23 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.972 ' O ' HD11 ' A' ' 51' ' ' ILE . . . -59.38 165.02 2.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.443 -0.786 . . . . 0.0 110.194 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.595 HG23 ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -115.75 140.94 48.73 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 37' ' ' GLU . 25.0 t -128.51 170.29 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 109.654 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.585 ' N ' HG12 ' A' ' 36' ' ' VAL . 5.0 mt-10 -141.27 113.3 7.89 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.583 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 6.0 t70 -168.37 139.95 2.26 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.759 -1.213 . . . . 0.0 109.957 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 43.8 Cg_endo -74.95 -78.27 0.0 OUTLIER 'Cis proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.441 -1.9 . . . . 0.0 111.608 0.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 39' ' ' PRO . 1.3 m -153.3 66.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.876 -1.14 . . . . 0.0 109.331 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . -173.05 46.99 0.16 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER 72.97 51.14 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -1.132 . . . . 0.0 110.077 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.543 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 2.3 mt-10 -132.92 58.66 37.2 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.056 -1.027 . . . . 0.0 109.742 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 43' ' ' GLU . 50.7 Cg_endo -79.99 -179.29 5.16 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.066 1.561 . . . . 0.0 111.284 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.59 ' HG3' ' CD1' ' A' ' 54' ' ' PHE . 23.2 mmt180 -150.88 96.16 2.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.595 ' HB3' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -92.81 158.35 15.93 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.19 -0.944 . . . . 0.0 110.285 -178.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 33' ' ' ASP . . . 88.95 -169.93 37.26 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -103.13 -51.85 3.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.076 -1.249 . . . . 0.0 108.842 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -52.05 -23.49 5.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.312 -0.867 . . . . 0.0 109.15 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 46' ' ' SER . . . -90.32 -55.28 3.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.388 -0.82 . . . . 0.0 109.607 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.972 HD11 ' O ' ' A' ' 34' ' ' ALA . 59.7 mt -54.08 -43.41 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 109.132 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.802 ' HG3' HD23 ' A' ' 23' ' ' LEU . 16.2 ttt180 -70.28 -47.91 59.12 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.193 -0.942 . . . . 0.0 108.784 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 5.4 mt-10 -51.12 -34.19 29.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.038 . . . . 0.0 108.44 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.59 ' CD1' ' HG3' ' A' ' 45' ' ' ARG . 1.4 t80 -82.93 -70.5 0.55 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 1.028 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -44.63 -26.76 0.41 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -75.03 -53.22 9.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 108.993 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 56' ' ' ALA . 14.1 t-20 -45.66 -34.6 3.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 108.609 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 t -71.87 -33.56 68.49 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.898 HD21 ' CA ' ' A' ' 21' ' ' GLY . 5.3 tp -77.21 -33.87 56.16 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.326 -0.859 . . . . 0.0 109.329 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -61.94 -26.97 68.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 109.443 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.574 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -89.43 131.87 38.97 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 0.0 108.681 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 86' ' ' PHE . 41.6 Cg_endo -68.04 80.64 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.755 1.398 . . . . 0.0 110.501 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.978 HD22 ' CG1' ' A' ' 84' ' ' VAL . 3.2 mt -111.22 146.55 36.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.435 -0.79 . . . . 0.0 109.605 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.635 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -91.91 126.75 37.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 108.647 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 18' ' ' LEU . 2.7 t -113.45 118.13 57.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.673 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 67' ' ' LEU . 27.1 tt0 -150.16 104.54 3.28 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.337 -0.852 . . . . 0.0 109.169 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.5 mp -45.59 171.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.222 -0.924 . . . . 0.0 109.847 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -144.38 -82.27 0.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.403 -0.811 . . . . 0.0 109.01 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 2.9 pt20 -60.08 -146.06 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 61.5 tt0 -114.84 130.37 56.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.066 -1.021 . . . . 0.0 109.761 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.91 HG13 ' HB3' ' A' ' 80' ' ' PHE . 88.7 t -60.0 145.03 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.292 -0.88 . . . . 0.0 109.14 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.539 ' HD3' ' CD2' ' B' ' 315' ' ' LEU . 17.7 mtt180 -111.72 130.04 55.92 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.396 -0.921 . . . . 0.0 109.931 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.52 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -139.74 157.7 45.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.868 HG11 HG21 ' B' ' 240' ' ' VAL . 0.5 OUTLIER -157.22 -153.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 110.312 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.557 ' CB ' ' HA3' ' B' ' 241' ' ' GLY . . . -33.91 -96.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 120.926 0.393 . . . . 0.0 111.161 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 103' ' ' PHE . 65.4 m-20 -114.37 26.96 9.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.948 -1.095 . . . . 0.0 110.496 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.572 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.4 OUTLIER -137.55 -160.98 1.11 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.026 -1.046 . . . . 0.0 109.388 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.9 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 171.28 143.48 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.476 -0.765 . . . . 0.0 109.861 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.854 ' CB ' HD11 ' B' ' 315' ' ' LEU . . . -132.62 130.46 40.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 108.786 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.91 ' HB3' HG13 ' A' ' 71' ' ' VAL . 2.1 p90 -150.6 156.06 40.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.759 -1.213 . . . . 0.0 109.989 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.093 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -133.32 156.49 47.51 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.611 0.719 . . . . 0.0 110.33 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 99' ' ' ASP . 3.7 p90 -149.46 -171.06 3.8 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.87 140.09 52.83 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.076 -1.015 . . . . 0.0 109.972 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.978 ' CG1' HD22 ' A' ' 63' ' ' LEU . 38.3 t -116.76 115.2 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.726 ' HB3' HG23 ' A' ' 94' ' ' VAL . 78.2 p -126.67 99.73 5.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.086 -1.009 . . . . 0.0 110.334 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.589 ' HB3' HD23 ' A' ' 63' ' ' LEU . 52.8 p90 -93.36 -164.22 1.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.204 -0.935 . . . . 0.0 108.629 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -144.19 152.06 40.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.022 -1.049 . . . . 0.0 110.086 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.409 ' CZ ' ' HE2' ' A' ' 86' ' ' PHE . 4.2 m-85 -107.21 -173.35 2.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.403 -0.811 . . . . 0.0 109.39 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -49.19 -54.6 15.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.358 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -138.04 4.61 3.23 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -105.86 -177.4 3.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 109.515 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -145.49 118.98 9.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.297 -0.877 . . . . 0.0 109.752 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -120.26 143.35 48.36 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.389 -0.82 . . . . 0.0 109.417 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 85' ' ' SER . 13.3 p -126.23 169.52 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.22 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.851 HG22 HG23 ' A' ' 121' ' ' ILE . 53.1 t -140.63 152.11 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.765 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.442 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . -129.56 71.63 82.06 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 109.222 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.629 ' HD3' HG12 ' A' ' 95' ' ' VAL . 48.7 Cg_endo -97.34 -178.6 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.726 1.617 . . . . 0.0 111.578 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.093 HG23 ' HB2' ' A' ' 81' ' ' ALA . 3.1 mp -138.6 169.4 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 23.4 t0 -135.76 154.79 51.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.907 -1.121 . . . . 0.0 110.041 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.522 ' CB ' ' HB3' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -114.08 175.23 5.56 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.9 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -150.42 152.4 34.26 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.999 -1.063 . . . . 0.0 110.823 -178.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.497 ' HD2' ' HB2' ' A' ' 111' ' ' SER . 0.0 OUTLIER -142.25 108.31 5.2 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.662 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -89.24 -177.53 5.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 109.598 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.782 HD21 ' HB3' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -149.75 -176.09 5.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.339 -0.851 . . . . 0.0 109.698 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.88 76.78 1.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.782 ' HB3' HD21 ' A' ' 104' ' ' ASN . . . -172.34 -75.15 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.22 -1.164 . . . . 0.0 109.58 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 157.66 -20.6 0.38 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.49 -164.31 1.03 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -1.174 . . . . 0.0 109.587 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.583 HG23 HG22 ' A' ' 10' ' ' VAL . 60.9 t -109.43 148.97 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.897 . . . . 0.0 109.176 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 104' ' ' ASN . 96.9 t -125.93 -61.75 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.055 -1.028 . . . . 0.0 109.678 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.497 ' HB2' ' HD2' ' A' ' 102' ' ' ARG . 1.5 m -112.29 161.6 16.44 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.876 -1.14 . . . . 0.0 109.738 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 100' ' ' HIS . 15.2 ttp -158.97 155.89 28.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 109.448 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.522 ' HB3' ' CB ' ' A' ' 100' ' ' HIS . 30.8 ttm180 -140.34 168.2 20.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.87 . . . . 0.0 108.946 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.505 ' N ' ' CG ' ' A' ' 113' ' ' ARG . . . -144.58 130.86 19.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.976 -1.077 . . . . 0.0 109.682 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.766 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.3 OUTLIER -111.84 132.48 54.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 109.723 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.998 ' O ' HG11 ' B' ' 274' ' ' VAL . 9.0 p90 167.7 -158.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.537 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 164.35 -163.93 36.4 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.508 ' HA ' HG13 ' A' ' 121' ' ' ILE . 4.3 tt0 -73.88 -2.35 23.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -1.185 . . . . 0.0 109.261 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -92.57 -29.44 16.16 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.954 0.883 . . . . 0.0 109.057 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 96' ' ' ALA . 1.5 m-20 -89.04 10.73 20.57 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.332 0.587 . . . . 0.0 109.476 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.851 HG23 HG22 ' A' ' 95' ' ' VAL . 4.3 mm -94.23 -167.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.331 -0.856 . . . . 0.0 108.738 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.681 ' H ' HG22 ' A' ' 121' ' ' ILE . 1.6 t60 -151.21 153.8 35.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.098 -1.001 . . . . 0.0 109.609 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.01 89.13 1.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -91.81 139.67 14.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.262 -1.14 . . . . 0.0 109.449 -179.973 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.5 ptt? . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.182 0.515 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.441 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 1.4 t-20 175.48 171.24 0.32 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.668 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . 0.431 HG22 ' HB2' ' B' ' 205' ' ' GLU . 2.5 m -59.34 110.03 2.39 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.331 -0.856 . . . . 0.0 109.53 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.8 Cg_endo -73.63 -7.15 19.82 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.994 1.523 . . . . 0.0 110.074 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' B' ' 203' ' ' THR . 2.0 mt-10 -68.57 -45.21 72.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.329 -0.857 . . . . 0.0 109.191 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.56 -52.42 63.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.214 -0.929 . . . . 0.0 109.107 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' MET . . . . . 0.609 ' HA ' ' CZ ' ' B' ' 303' ' ' PHE . 74.9 mtm -62.06 -42.35 99.1 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.334 -0.854 . . . . 0.0 109.498 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 9.6 m -56.1 -37.15 68.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.171 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.42 -46.23 66.28 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.818 ' HA ' HD21 ' B' ' 229' ' ' LEU . 2.5 t -53.24 -30.38 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.723 HG11 ' CG2' ' B' ' 271' ' ' VAL . 21.0 t -84.47 -43.52 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.225 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.4 tt0 -61.71 -73.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.088 0.947 . . . . 0.0 108.624 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 1.014 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.0 OUTLIER -41.4 -45.18 3.04 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' TYR . . . . . 0.696 ' CE1' HD11 ' B' ' 218' ' ' LEU . 1.6 t80 -45.41 -45.45 12.77 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.973 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.1 t -90.51 -40.35 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . 0.708 ' HB3' ' HA ' ' B' ' 213' ' ' ARG . . . -49.21 -37.58 23.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.623 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -73.05 -31.64 64.54 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.973 HD12 ' HA ' ' B' ' 215' ' ' VAL . 5.5 mt -66.91 -59.89 3.12 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' B' ' 265' ' ' VAL . 0.7 OUTLIER -55.59 -37.56 68.25 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.564 0.697 . . . . 0.0 109.534 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -88.59 -6.1 57.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 109.624 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.926 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 55.41 47.52 75.4 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' B' ' 224' ' ' ASP . 16.5 t70 -114.32 77.04 1.03 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -1.092 . . . . 0.0 109.753 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' LEU . . . . . 1.055 HD13 HD12 ' B' ' 226' ' ' ILE . 1.4 mm? -46.75 -27.2 1.12 Allowed 'General case' 0 C--N 1.307 -1.239 0 O-C-N 121.138 -0.977 . . . . 0.0 109.561 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.436 ' HB3' ' OD2' ' B' ' 222' ' ' ASP . 16.4 t0 -60.01 -50.03 75.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.325 -0.86 . . . . 0.0 109.596 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -66.64 -29.28 74.5 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 1.055 HD12 HD13 ' B' ' 223' ' ' LEU . 11.4 mt -66.19 -60.65 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.443 -1.034 . . . . 0.0 108.35 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' B' ' 252' ' ' ARG . 38.9 t -58.14 -42.31 82.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -53.25 -51.35 62.48 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 1.014 HD22 ' HB3' ' B' ' 213' ' ' ARG . 8.7 tp -64.23 -19.55 65.44 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . 0.686 ' CD2' HG21 ' B' ' 251' ' ' ILE . 5.9 m-85 -93.04 145.94 24.01 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.429 -0.794 . . . . 0.0 109.93 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -57.63 -163.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 109.406 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' B' ' 248' ' ' THR . 0.3 OUTLIER -77.76 -24.26 49.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.558 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 3.2 p30 -150.4 45.06 0.88 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.578 -0.701 . . . . 0.0 109.481 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.851 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -54.71 175.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 109.518 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' THR . . . . . 0.864 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -129.07 137.93 51.56 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.26 -0.9 . . . . 0.0 110.233 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.513 HG22 ' CE ' ' B' ' 312' ' ' MET . 7.0 t -124.32 119.72 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 0.0 OUTLIER -88.52 111.22 21.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' ASP . . . . . 0.487 ' OD1' ' HA ' ' B' ' 239' ' ' PRO . 30.6 t70 -179.93 143.23 0.36 Allowed Pre-proline 0 C--N 1.301 -1.511 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.561 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 48.9 Cg_endo -73.96 172.79 59.73 Favored 'Cis proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.214 -1.994 . . . . 0.0 110.782 -0.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.868 HG21 HG11 ' A' ' 74' ' ' VAL . 3.3 m -57.92 146.7 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 109.037 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 75' ' ' ALA . . . 68.39 7.58 52.94 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' SER . . . . . 0.506 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -111.66 -153.77 0.53 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -1.121 . . . . 0.0 109.235 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -122.99 130.88 24.43 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.039 -1.038 . . . . 0.0 110.169 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' PRO . . . . . 0.604 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.4 Cg_endo -63.4 -165.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.138 1.599 . . . . 0.0 111.334 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.761 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -151.74 146.15 25.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.864 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.3 OUTLIER -136.98 138.67 40.79 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.931 -1.105 . . . . 0.0 110.865 -178.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . 0.558 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 122.88 146.58 7.19 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' THR . . . . . 0.501 ' N ' ' O ' ' B' ' 232' ' ' ASP . 3.1 m -57.85 -70.21 0.14 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.406 -1.055 . . . . 0.0 109.553 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' B' ' 248' ' ' THR . . . -45.36 -25.68 0.43 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 109.173 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.761 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -84.21 -57.51 3.14 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.366 -0.834 . . . . 0.0 109.55 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.851 HD11 ' N ' ' B' ' 234' ' ' ALA . 45.0 mt -44.82 -36.94 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -0.981 . . . . 0.0 108.944 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 252' ' ' ARG . . . . . 0.555 ' HB2' HG21 ' B' ' 227' ' ' VAL . 5.5 ttp180 -76.76 -52.73 9.03 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.506 -0.746 . . . . 0.0 109.14 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -50.9 -32.26 20.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 108.831 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.503 ' HB2' ' HD3' ' B' ' 245' ' ' ARG . 1.0 OUTLIER -82.62 -71.14 0.5 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 255' ' ' PHE . . . . . 1.004 ' CG ' HG21 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -46.96 -26.03 0.92 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . 0.529 ' HA ' HD21 ' B' ' 223' ' ' LEU . . . -74.33 -51.33 15.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 108.614 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -46.94 -32.2 3.68 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 35.2 t -69.5 -37.89 77.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.1 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 259' ' ' LEU . . . . . 0.926 HD21 ' CA ' ' B' ' 221' ' ' GLY . 7.3 tp -71.64 -32.3 67.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.526 -0.734 . . . . 0.0 109.888 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -47.27 -25.98 1.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.184 -0.947 . . . . 0.0 109.284 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 261' ' ' LEU . . . . . 0.794 HD22 HD21 ' B' ' 263' ' ' LEU . 0.3 OUTLIER -96.52 120.42 62.22 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 109.101 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 262' ' ' PRO . . . . . 0.448 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 46.7 Cg_endo -72.42 108.59 2.55 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.743 1.391 . . . . 0.0 110.728 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.794 HD21 HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -137.97 163.4 31.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.193 -0.942 . . . . 0.0 109.719 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' B' ' 284' ' ' VAL . . . -92.25 130.23 38.01 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 265' ' ' VAL . . . . . 0.527 ' O ' ' ND2' ' B' ' 219' ' ' ASN . 2.0 t -117.66 117.58 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 110.104 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 29.8 tt0 -150.22 108.82 3.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.17 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.546 HD23 ' O ' ' B' ' 281' ' ' ALA . 0.6 OUTLIER -48.68 178.42 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.258 -0.901 . . . . 0.0 109.849 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 268' ' ' THR . . . . . 0.465 ' O ' ' O ' ' B' ' 269' ' ' GLN . 29.6 p -143.56 -82.71 0.17 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.84 . . . . 0.0 109.291 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 269' ' ' GLN . . . . . 0.509 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 12.0 pt20 -60.36 -144.41 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 270' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 38.7 tt0 -114.54 134.08 55.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 109.833 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 271' ' ' VAL . . . . . 0.723 ' CG2' HG11 ' B' ' 211' ' ' VAL . 41.6 t -62.09 158.69 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.374 -0.829 . . . . 0.0 109.153 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.511 ' O ' ' HB1' ' B' ' 278' ' ' ALA . 0.0 OUTLIER -122.82 135.32 54.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.025 -1.047 . . . . 0.0 110.262 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.19 128.45 12.05 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 274' ' ' VAL . . . . . 0.998 HG11 ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -137.81 152.7 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.902 -1.124 . . . . 0.0 110.557 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 275' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . 37.72 -96.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.881 -0.512 . . . . 0.0 110.524 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 276' ' ' ASN . . . . . 0.588 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 2.9 p-10 -124.97 -10.95 7.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.082 -1.011 . . . . 0.0 109.97 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . 0.472 ' HG3' ' HA ' ' B' ' 302' ' ' ARG . 1.0 OUTLIER -99.7 -163.57 1.04 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.834 -1.166 . . . . 0.0 109.199 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 278' ' ' ALA . . . . . 0.551 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . 179.68 166.86 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 110.047 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 279' ' ' ALA . . . . . 0.766 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -150.07 132.93 16.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . 0.625 ' CD1' HG22 ' B' ' 211' ' ' VAL . 21.9 p90 -150.25 170.44 18.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.624 -1.298 . . . . 0.0 110.315 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.968 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -145.27 -175.27 4.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.634 -0.666 . . . . 0.0 109.625 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 282' ' ' PHE . . . . . 0.509 ' CE1' ' CE2' ' B' ' 280' ' ' PHE . 8.1 p90 -179.14 -173.86 0.3 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.327 -0.858 . . . . 0.0 109.333 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.81 153.83 50.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.442 -0.786 . . . . 0.0 109.733 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 284' ' ' VAL . . . . . 0.718 HG13 ' CB ' ' B' ' 263' ' ' LEU . 3.7 t -142.6 119.28 6.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.373 -0.829 . . . . 0.0 109.102 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 285' ' ' SER . . . . . 0.552 ' HB3' HG23 ' B' ' 294' ' ' VAL . 0.1 OUTLIER -117.85 100.46 7.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.155 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.678 ' CD1' HD23 ' B' ' 263' ' ' LEU . 37.1 p90 -110.53 164.34 12.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.172 -0.955 . . . . 0.0 109.712 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 287' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' B' ' 288' ' ' PHE . 2.8 tm-20 -132.8 169.66 16.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.0 OUTLIER -118.23 -78.13 0.58 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.928 . . . . 0.0 109.88 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.22 10.48 1.29 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.388 -0.82 . . . . 0.0 110.046 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 290' ' ' GLY . . . . . 0.461 ' N ' ' OE2' ' B' ' 287' ' ' GLU . . . -178.34 -71.54 0.06 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 291' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' B' ' 287' ' ' GLU . 0.3 OUTLIER -73.72 151.59 40.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.238 -1.154 . . . . 0.0 109.06 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 292' ' ' LYS . . . . . 0.44 ' O ' ' HD2' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -128.09 120.02 26.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.062 -1.024 . . . . 0.0 110.066 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 293' ' ' THR . . . . . 0.6 HG21 ' HB2' ' B' ' 322' ' ' HIS . 0.6 OUTLIER -97.25 -167.17 1.5 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 294' ' ' VAL . . . . . 0.718 HG22 ' H ' ' B' ' 295' ' ' VAL . 1.7 p -153.61 -169.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.719 -1.238 . . . . 0.0 109.579 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 1.003 HG12 ' HD3' ' B' ' 297' ' ' PRO . 6.7 t -154.87 141.05 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.809 -1.182 . . . . 0.0 109.184 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 296' ' ' ALA . . . . . . . . . . . . . . . -141.25 69.87 27.49 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.091 -1.005 . . . . 0.0 109.779 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 297' ' ' PRO . . . . . 1.003 ' HD3' HG12 ' B' ' 295' ' ' VAL . 52.1 Cg_endo -98.7 169.27 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.869 1.713 . . . . 0.0 112.454 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.968 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.5 mp -136.56 135.42 49.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . 0.612 ' HB3' ' CE1' ' B' ' 280' ' ' PHE . 3.9 t0 -112.33 156.68 22.06 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.782 -1.199 . . . . 0.0 111.054 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 300' ' ' HIS . . . . . 0.533 ' O ' ' HG2' ' B' ' 312' ' ' MET . 71.6 t60 -108.62 171.59 7.33 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 301' ' ' PHE . . . . . 0.646 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.49 145.61 29.2 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.461 -1.399 . . . . 0.0 111.131 -178.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' B' ' 311' ' ' SER . 8.7 ttt85 -141.16 120.24 12.85 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 303' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' B' ' 207' ' ' MET . 2.7 m-85 -90.88 -175.41 4.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.108 -0.995 . . . . 0.0 109.879 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 304' ' ' ASN . . . . . 0.638 ' HB3' HG21 ' B' ' 310' ' ' VAL . 0.6 OUTLIER -114.23 -44.32 3.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 109.291 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 305' ' ' GLY . . . . . 0.687 ' O ' ' HB3' ' B' ' 306' ' ' ALA . . . -178.02 40.75 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 306' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' B' ' 305' ' ' GLY . . . 77.02 66.11 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -1.09 . . . . 0.0 109.625 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -159.6 -65.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.92 -166.25 2.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -1.14 . . . . 0.0 109.338 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 309' ' ' VAL . . . . . 0.754 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 42.5 t -90.0 157.3 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.138 -0.976 . . . . 0.0 109.115 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' B' ' 304' ' ' ASN . 0.7 OUTLIER -133.22 -38.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 109.779 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 68.6 m -143.67 163.51 33.04 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.088 -1.008 . . . . 0.0 109.319 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 312' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 300' ' ' HIS . 2.1 ttp -157.08 167.66 29.76 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.279 -0.888 . . . . 0.0 109.936 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 313' ' ' ARG . . . . . 0.519 ' HA ' ' HB2' ' B' ' 237' ' ' GLU . 5.2 mmt180 -146.83 151.81 37.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.406 -0.808 . . . . 0.0 108.972 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -113.38 147.39 37.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 110.1 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 315' ' ' LEU . . . . . 0.854 HD11 ' CB ' ' A' ' 79' ' ' ALA . 3.1 tp -110.22 -143.01 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.729 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 316' ' ' PHE . . . . . 0.676 ' CD1' ' O ' ' B' ' 315' ' ' LEU . 42.4 p90 44.84 -165.35 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.713 . . . . 0.0 110.029 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 317' ' ' GLY . . . . . 0.59 ' HA2' HG21 ' B' ' 240' ' ' VAL . . . -163.66 -161.08 12.29 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 318' ' ' GLU . . . . . 0.522 ' HA ' HG12 ' B' ' 321' ' ' ILE . 7.2 tt0 -79.26 5.07 13.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -1.169 . . . . 0.0 109.606 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.6 -34.81 13.17 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.185 -0.947 . . . . 0.0 109.5 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 320' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -101.05 32.12 3.35 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 321' ' ' ILE . . . . . 0.642 HG22 ' N ' ' B' ' 322' ' ' HIS . 19.6 mm -94.96 -116.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.738 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 322' ' ' HIS . . . . . 0.642 ' N ' HG22 ' B' ' 321' ' ' ILE . 5.8 p-80 -88.22 101.61 14.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.719 . . . . 0.0 112.5 -176.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.451 0 O-C-N 121.503 -0.748 . . . . 0.0 109.488 177.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.434 ' O ' ' CB ' ' A' ' 8' ' ' THR . 44.9 Cg_endo -71.85 -9.63 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.968 1.51 . . . . 0.0 110.038 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.64 -48.85 75.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.386 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -54.39 36.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.235 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.3 mtt -60.97 -31.0 70.59 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.176 -0.952 . . . . 0.0 109.294 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 11' ' ' VAL . 6.9 m -69.27 -36.65 77.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.12 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.06 -43.04 50.95 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.987 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.5 t -56.73 -22.67 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.847 HG22 ' CE2' ' A' ' 101' ' ' PHE . 15.9 t -90.35 -43.24 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.38 -0.825 . . . . 0.0 109.02 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 15' ' ' VAL . 6.6 tt0 -61.73 -74.0 0.09 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -42.77 -45.16 4.7 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.6 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -49.36 -44.7 45.0 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.919 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -87.65 -37.86 11.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.367 -0.833 . . . . 0.0 109.052 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.444 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -49.05 -37.55 21.31 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.7 -32.01 65.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.919 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.2 mt -67.23 -58.58 4.58 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 65' ' ' VAL . 4.4 t-20 -50.86 -42.56 58.88 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.481 0.657 . . . . 0.0 109.435 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.27 -2.58 58.52 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 109.573 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.891 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 56.73 47.77 82.81 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' CB ' ' A' ' 24' ' ' ASP . 6.9 t0 -112.08 82.23 1.59 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.204 -1.174 . . . . 0.0 109.909 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.019 ' CD2' HD22 ' A' ' 59' ' ' LEU . 3.2 mm? -48.96 -22.54 0.87 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.216 -0.928 . . . . 0.0 109.616 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' CB ' ' OD1' ' A' ' 22' ' ' ASP . 19.3 t0 -58.26 -49.83 75.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.837 . . . . 0.0 109.393 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.79 -43.07 92.57 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.722 HD12 HD13 ' A' ' 23' ' ' LEU . 9.7 mt -56.19 -52.84 46.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 23' ' ' LEU . 7.1 t -65.68 -47.44 86.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.49 -46.81 57.22 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 10' ' ' VAL . 7.8 tp -68.66 -21.37 64.45 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.763 ' CD2' HG21 ' A' ' 51' ' ' ILE . 3.1 m-85 -82.78 139.17 33.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.538 -0.726 . . . . 0.0 109.651 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . -60.49 -169.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.456 ' C ' ' HG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -70.94 -23.69 62.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.377 -0.827 . . . . 0.0 109.788 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.53 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -148.95 49.96 0.98 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.653 -0.655 . . . . 0.0 109.476 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -58.86 167.55 1.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.543 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -126.32 138.07 53.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.632 ' CG2' HD12 ' A' ' 51' ' ' ILE . 23.6 t -129.0 167.68 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.064 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.572 ' N ' HG12 ' A' ' 36' ' ' VAL . 3.0 mt-10 -143.74 118.07 9.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 108.936 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.608 ' OD2' ' HB3' ' A' ' 114' ' ' ALA . 4.1 t70 -174.94 139.7 0.63 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 109.594 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 41' ' ' GLY . 45.3 Cg_endo -71.81 -174.3 11.37 Favored 'Cis proline' 0 N--CA 1.489 1.259 0 C-N-CA 122.15 -2.021 . . . . 0.0 110.649 0.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.826 HG21 ' HB ' ' B' ' 274' ' ' VAL . 15.4 m -67.02 59.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 109.625 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 39' ' ' PRO . . . -140.42 -83.56 0.09 OUTLIER Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.422 ' C ' ' HG2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -165.5 50.92 0.1 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.641 -0.917 . . . . 0.0 109.708 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.556 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 2.4 mm-40 -134.7 58.6 29.86 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.678 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.528 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 48.5 Cg_endo -79.29 -177.74 4.11 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.204 1.633 . . . . 0.0 110.394 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 1.006 ' HG3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -150.39 102.44 3.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 108.96 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -92.25 149.34 21.51 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.146 -0.971 . . . . 0.0 110.203 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 98.67 168.22 31.06 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.459 HG23 ' CG1' ' A' ' 27' ' ' VAL . 3.7 m -80.88 -57.06 3.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -1.114 . . . . 0.0 109.093 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.87 -30.53 46.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.139 -0.976 . . . . 0.0 109.118 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.006 ' HB1' ' HG3' ' A' ' 45' ' ' ARG . . . -78.75 -53.43 7.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.431 -0.793 . . . . 0.0 109.094 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.763 HG21 ' CD2' ' A' ' 30' ' ' PHE . 6.5 mm -50.36 -36.07 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.392 -0.818 . . . . 0.0 109.294 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.721 ' HG3' HG21 ' A' ' 27' ' ' VAL . 7.6 ttp180 -74.58 -59.94 2.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 109.083 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 52' ' ' ARG . 2.0 tt0 -44.32 -27.4 0.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 108.825 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.576 ' CD1' ' HD3' ' A' ' 45' ' ' ARG . 0.6 OUTLIER -85.66 -70.08 0.62 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.709 ' C ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -53.05 -18.69 2.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.821 -0.549 . . . . 0.0 109.764 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.535 ' CB ' ' HG ' ' A' ' 23' ' ' LEU . . . -86.06 -35.78 20.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.957 . . . . 0.0 108.7 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 4.3 t30 -69.06 -39.7 78.96 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 t -63.93 -33.81 76.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 108.821 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.019 HD22 ' CD2' ' A' ' 23' ' ' LEU . 8.5 tp -63.75 -20.63 65.9 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.39 -0.819 . . . . 0.0 109.645 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -53.43 -20.97 5.25 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.079 -1.013 . . . . 0.0 108.914 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.14 HD22 HD21 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.8 113.73 58.03 Favored Pre-proline 0 N--CA 1.486 1.34 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 43.8 Cg_endo -70.56 106.14 1.75 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.791 1.416 . . . . 0.0 111.149 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.14 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.65 160.23 39.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.897 . . . . 0.0 109.718 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.28 127.87 36.27 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.766 HG21 ' HB3' ' A' ' 18' ' ' LEU . 17.6 t -105.96 114.13 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.136 -0.977 . . . . 0.0 109.916 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 67' ' ' LEU . 28.2 tt0 -150.47 98.51 2.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.25 -0.906 . . . . 0.0 109.041 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -47.04 173.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.909 . . . . 0.0 109.507 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 69' ' ' GLN . 2.5 p -142.94 -81.86 0.19 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.375 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -58.43 -151.72 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.443 ' CD ' ' HE2' ' B' ' 319' ' ' LYS . 39.8 tt0 -108.94 131.67 54.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.102 -0.999 . . . . 0.0 109.761 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.039 HG13 ' HB3' ' A' ' 80' ' ' PHE . 54.1 t -58.41 147.56 6.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.375 -0.828 . . . . 0.0 109.21 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -104.01 132.61 50.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 109.673 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.75 141.15 36.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.773 ' CG1' HG21 ' B' ' 240' ' ' VAL . 0.2 OUTLIER -123.71 -157.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.899 . . . . 0.0 109.315 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -38.67 -93.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 110.22 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 3.4 m120 -104.63 -18.24 14.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -0.998 . . . . 0.0 109.79 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 4.4 mt-10 -90.35 -161.82 0.83 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.125 -0.984 . . . . 0.0 109.293 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.752 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 177.55 164.75 0.61 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 1.041 ' HB2' HD11 ' B' ' 315' ' ' LEU . . . -150.37 138.88 20.56 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 1.039 ' HB3' HG13 ' A' ' 71' ' ' VAL . 22.2 p90 -150.42 161.34 42.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.76 -1.213 . . . . 0.0 110.335 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.816 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -139.43 160.37 40.0 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.546 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 1.5 p90 -157.69 -176.68 6.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 0.0 109.558 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -118.24 143.03 46.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.452 -0.78 . . . . 0.0 109.284 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.808 HG12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -120.83 124.1 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.556 ' HA ' HG23 ' A' ' 94' ' ' VAL . 1.7 p -109.94 110.55 21.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 108.918 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 93' ' ' THR . 9.0 p90 -131.39 167.47 19.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.064 -1.022 . . . . 0.0 110.225 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.52 ' HB2' ' CB ' ' A' ' 92' ' ' LYS . 42.9 tt0 -148.73 167.35 25.78 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -146.77 -100.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.952 -1.093 . . . . 0.0 110.192 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.491 ' HG2' ' N ' ' A' ' 90' ' ' GLY . 1.0 OUTLIER -61.39 -25.4 67.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 110.005 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.491 ' N ' ' HG2' ' A' ' 89' ' ' GLN . . . 168.36 -65.92 0.18 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.53 ' O ' ' CE1' ' A' ' 88' ' ' PHE . 1.6 ttm180 -55.77 118.46 4.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -1.115 . . . . 0.0 108.977 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.52 ' CB ' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -90.57 125.23 35.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.091 -1.006 . . . . 0.0 109.592 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.753 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -106.11 143.36 34.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.333 -0.855 . . . . 0.0 109.451 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.631 HG13 ' N ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER -108.31 178.07 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 1.022 HG12 ' HD3' ' A' ' 97' ' ' PRO . 3.5 t -150.87 144.78 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.029 -1.044 . . . . 0.0 110.038 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.472 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . -133.29 71.36 76.73 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.532 -0.73 . . . . 0.0 110.037 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 1.022 ' HD3' HG12 ' A' ' 95' ' ' VAL . 51.9 Cg_endo -95.56 -175.57 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.529 1.486 . . . . 0.0 110.986 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.816 HG23 ' HB2' ' A' ' 81' ' ' ALA . 3.0 mp -139.91 136.23 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.619 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 5.1 t0 -109.74 161.92 14.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.995 -1.065 . . . . 0.0 110.071 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' A' ' 112' ' ' MET . 59.6 t-80 -109.47 171.23 7.56 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.847 ' CE2' HG22 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -146.23 145.28 30.35 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.952 -1.093 . . . . 0.0 110.544 -178.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.457 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 3.3 ttm180 -144.57 114.64 7.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 0.0 108.973 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.627 ' CE2' HG21 ' A' ' 10' ' ' VAL . 4.2 m-85 -94.97 -171.72 2.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.191 -0.943 . . . . 0.0 109.489 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.805 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.2 p30 -127.19 -34.12 2.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.446 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -161.38 24.3 0.24 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 105' ' ' GLY . . . 71.15 60.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -1.106 . . . . 0.0 109.515 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.19 -62.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -128.13 -164.7 1.4 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -1.134 . . . . 0.0 109.407 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' A' ' 30' ' ' PHE . 62.7 t -106.13 139.89 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.172 -0.955 . . . . 0.0 109.376 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.805 HG11 ' HB3' ' A' ' 104' ' ' ASN . 0.5 OUTLIER -123.27 -24.56 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -0.971 . . . . 0.0 109.833 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.79 156.32 37.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.986 . . . . 0.0 109.576 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.62 ' HE3' ' CE1' ' A' ' 30' ' ' PHE . 12.4 ttm -160.09 145.97 15.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.935 . . . . 0.0 109.671 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.473 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 7.7 mtt-85 -128.71 150.38 50.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 0.0 109.063 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.609 ' O ' HG12 ' A' ' 40' ' ' VAL . . . -118.49 150.87 38.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 109.693 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.8 OUTLIER -146.88 145.24 29.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.325 -0.859 . . . . 0.0 109.665 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.82 ' O ' HG11 ' B' ' 274' ' ' VAL . 33.9 p90 164.45 -163.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 121' ' ' ILE . . . -179.9 -169.26 39.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.516 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 21.7 tt0 -68.93 -6.65 28.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -1.076 . . . . 0.0 109.465 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -88.47 -29.8 19.88 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 122.016 0.913 . . . . 0.0 109.071 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -88.79 3.73 50.04 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.651 HG23 HG22 ' A' ' 95' ' ' VAL . 2.8 mm -91.41 -164.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.753 ' O ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -151.8 176.91 10.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.819 -1.176 . . . . 0.0 109.896 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.539 ' HA ' ' CG2' ' A' ' 93' ' ' THR . . . -155.43 136.02 13.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -0.804 . . . . 0.0 109.254 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 92' ' ' LYS . . . 76.73 -117.43 4.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.249 -1.148 . . . . 0.0 109.49 180.0 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 1.6 ttp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.234 0.54 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.447 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 21.7 t30 65.6 63.29 0.62 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 109.581 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . 0.539 HG23 ' O ' ' B' ' 203' ' ' THR . 2.1 t -43.61 103.29 0.31 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.933 . . . . 0.0 109.589 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 47.8 Cg_endo -74.11 -13.18 23.61 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.987 1.519 . . . . 0.0 110.348 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.9 -46.45 87.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.617 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -60.15 -52.41 65.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.086 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' MET . . . . . 0.611 ' HB3' ' HB1' ' B' ' 273' ' ' ALA . 73.7 mtm -68.06 -18.36 64.66 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.421 -0.8 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.487 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 5.9 m -84.22 -33.78 24.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -57.96 -48.68 79.23 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.201 -0.937 . . . . 0.0 109.206 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.65 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -49.6 -32.58 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.935 . . . . 0.0 108.531 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.527 HG11 HG21 ' B' ' 271' ' ' VAL . 4.4 t -71.83 -39.83 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 109.419 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.2 tt0 -64.82 -74.54 0.1 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.815 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.4 OUTLIER -42.0 -44.14 3.41 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 122.031 0.919 . . . . 0.0 108.697 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' TYR . . . . . 0.634 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -49.46 -45.41 46.63 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 1.059 HG11 HD11 ' B' ' 267' ' ' LEU . 1.4 t -88.75 -37.36 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.3 -0.875 . . . . 0.0 109.127 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' B' ' 213' ' ' ARG . . . -48.82 -34.69 12.92 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.559 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -75.24 -33.91 61.36 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.906 HD12 ' HA ' ' B' ' 215' ' ' VAL . 2.2 mt -65.09 -58.53 5.81 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -48.36 -41.03 27.51 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.593 0.711 . . . . 0.0 109.182 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.45 4.42 49.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.71 . . . . 0.0 109.842 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.919 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 48.77 31.63 10.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -97.97 87.46 3.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.325 -1.103 . . . . 0.0 109.787 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' LEU . . . . . 0.986 ' CD2' HD22 ' B' ' 259' ' ' LEU . 3.7 mm? -51.9 -19.95 2.04 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.193 -0.942 . . . . 0.0 109.848 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.58 -54.06 48.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.256 -0.902 . . . . 0.0 109.264 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -61.05 -38.37 95.44 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.897 HD12 HD13 ' B' ' 223' ' ' LEU . 8.7 mt -61.32 -57.32 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.726 HG23 ' O ' ' B' ' 223' ' ' LEU . 24.7 t -60.7 -42.98 94.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.11 -50.17 67.48 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.815 HD22 ' HB3' ' B' ' 213' ' ' ARG . 8.2 tp -67.92 -22.87 65.04 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . 0.653 ' CD2' HG21 ' B' ' 251' ' ' ILE . 5.3 m-85 -88.41 136.58 32.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.572 -0.705 . . . . 0.0 109.915 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -52.21 -174.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 109.354 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -25.07 49.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.749 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.545 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 0.2 OUTLIER -135.32 44.99 2.52 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.654 ' HB1' ' O ' ' B' ' 310' ' ' VAL . . . -63.62 150.17 44.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.357 -0.839 . . . . 0.0 109.989 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' THR . . . . . 1.037 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -108.83 149.18 29.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.478 -0.764 . . . . 0.0 109.033 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 48.7 t -140.12 122.39 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 109.695 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.6 mt-10 -89.6 104.1 16.69 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' ASP . . . . . 0.546 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 22.7 t70 179.66 142.16 0.33 Allowed Pre-proline 0 C--N 1.301 -1.535 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.027 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . 0.521 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 47.5 Cg_endo -72.71 176.34 40.68 Favored 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.283 -1.965 . . . . 0.0 111.041 0.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.773 HG21 ' CG1' ' A' ' 74' ' ' VAL . 5.0 m -61.29 153.58 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 0.0 109.15 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 55.76 18.23 16.82 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -118.05 -154.57 0.57 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.41 -1.053 . . . . 0.0 109.257 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -124.63 128.88 24.81 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 110.126 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' PRO . . . . . 0.539 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.3 Cg_endo -64.93 -174.11 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.934 1.492 . . . . 0.0 111.145 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.917 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.65 103.24 3.09 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 1.037 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.24 152.12 21.75 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.17 -0.956 . . . . 0.0 109.674 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 110.25 162.64 18.8 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 5.3 m -77.16 -36.57 55.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.184 -1.186 . . . . 0.0 109.129 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -73.79 -19.69 60.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 108.97 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.917 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -90.36 -45.07 9.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.401 -0.812 . . . . 0.0 109.306 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.653 HG21 ' CD2' ' B' ' 230' ' ' PHE . 10.3 mm -61.89 -50.48 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 0.0 109.521 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 252' ' ' ARG . . . . . 0.511 ' O ' ' CB ' ' B' ' 256' ' ' ALA . 21.0 ttp180 -66.34 -52.39 47.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.049 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 253' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' B' ' 257' ' ' ASN . 22.4 mt-10 -47.91 -32.48 6.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.966 -1.083 . . . . 0.0 108.448 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.546 ' CZ ' ' O ' ' B' ' 238' ' ' ASP . 0.6 OUTLIER -84.48 -70.81 0.55 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 255' ' ' PHE . . . . . 0.698 ' CD2' HD13 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -49.64 -22.57 1.37 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.469 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . 0.608 ' HB2' ' HG ' ' B' ' 223' ' ' LEU . . . -84.35 -49.11 9.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 108.744 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 257' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' B' ' 253' ' ' GLU . 0.3 OUTLIER -57.38 -37.49 72.76 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.236 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 7.6 t -65.57 -32.34 73.88 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 259' ' ' LEU . . . . . 0.986 HD22 ' CD2' ' B' ' 223' ' ' LEU . 9.5 tp -64.68 -22.43 66.98 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.413 -0.804 . . . . 0.0 109.248 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 260' ' ' LYS . . . . . 0.502 ' O ' ' HD3' ' B' ' 262' ' ' PRO . 0.0 OUTLIER -50.75 -22.53 2.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.838 . . . . 0.0 108.9 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 261' ' ' LEU . . . . . 1.028 HD21 HD21 ' B' ' 263' ' ' LEU . 0.0 OUTLIER -98.89 103.68 20.84 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 262' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 51.5 Cg_endo -76.68 125.27 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.812 1.427 . . . . 0.0 112.11 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 1.028 HD21 HD21 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -145.59 176.68 9.43 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.53 125.08 36.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 26.1 t -111.48 115.38 49.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 109.979 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 266' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.2 tp10 -150.14 89.56 1.6 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.387 -0.821 . . . . 0.0 108.938 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 1.059 HD11 HG11 ' B' ' 215' ' ' VAL . 1.0 OUTLIER -52.84 -170.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.351 -0.843 . . . . 0.0 110.0 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 268' ' ' THR . . . . . 0.667 ' O ' ' N ' ' B' ' 270' ' ' GLU . 6.5 p -136.68 53.13 1.92 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.844 . . . . 0.0 108.819 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 269' ' ' GLN . . . . . 0.549 ' CG ' ' O ' ' B' ' 268' ' ' THR . 17.9 pt20 50.7 -55.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 270' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' B' ' 268' ' ' THR . 35.5 tt0 -48.89 115.26 1.2 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.492 -1.38 . . . . 0.0 110.213 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 271' ' ' VAL . . . . . 0.588 HG13 ' HB3' ' B' ' 280' ' ' PHE . 37.7 t -138.14 154.31 28.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.7 OUTLIER -114.66 130.21 56.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.857 -1.152 . . . . 0.0 110.003 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . 0.611 ' HB1' ' HB3' ' B' ' 207' ' ' MET . . . -150.47 133.21 15.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.396 -0.815 . . . . 0.0 109.001 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 274' ' ' VAL . . . . . 0.826 ' HB ' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -150.34 158.86 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.935 -1.103 . . . . 0.0 110.435 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 275' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 40' ' ' VAL . . . 39.26 -101.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.77 -0.581 . . . . 0.0 110.321 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 276' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 2.8 m120 -121.35 -20.47 6.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.957 -1.089 . . . . 0.0 109.691 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . 0.51 ' HG3' ' HG2' ' B' ' 302' ' ' ARG . 3.9 mt-10 -92.59 -164.95 1.25 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.042 -1.037 . . . . 0.0 109.5 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 278' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' B' ' 273' ' ' ALA . . . 177.77 154.69 0.32 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 109.519 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 279' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -136.79 141.17 42.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.945 . . . . 0.0 108.66 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . 0.606 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 37.9 p90 -150.72 171.15 17.61 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.735 -1.228 . . . . 0.0 110.028 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.53 ' HB2' ' CG1' ' B' ' 298' ' ' ILE . . . -145.68 -179.86 6.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.751 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 282' ' ' PHE . . . . . 0.406 ' CE1' ' HE2' ' B' ' 280' ' ' PHE . 7.0 p90 -174.32 -173.58 0.79 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.292 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 283' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -124.7 141.53 52.04 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.413 -0.805 . . . . 0.0 109.541 179.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 284' ' ' VAL . . . . . 1.0 HG11 HD22 ' B' ' 263' ' ' LEU . 42.1 t -120.04 113.87 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 109.469 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 1.2 p -106.14 131.75 53.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.033 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' B' ' 286' ' ' PHE . 1.0 OUTLIER -149.73 157.69 43.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.977 -1.077 . . . . 0.0 110.009 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 287' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' B' ' 292' ' ' LYS . 1.2 pt-20 -98.19 158.09 15.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 109.14 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . 0.499 ' C ' ' CG ' ' B' ' 289' ' ' GLN . 0.6 OUTLIER -124.63 77.55 1.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.897 . . . . 0.0 109.594 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . 0.499 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 0.4 OUTLIER 40.36 57.36 2.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.424 -0.797 . . . . 0.0 110.262 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 107.63 -2.06 34.28 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.207 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -127.37 173.9 9.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.056 -1.261 . . . . 0.0 109.635 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 292' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' B' ' 287' ' ' GLU . 0.1 OUTLIER -138.17 140.1 39.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.384 179.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 293' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.94 148.59 34.01 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.715 -0.616 . . . . 0.0 109.464 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 294' ' ' VAL . . . . . 0.621 HG12 ' HB3' ' B' ' 322' ' ' HIS . 9.8 p -125.96 170.46 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.169 -0.957 . . . . 0.0 108.468 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 1.057 HG12 ' HD3' ' B' ' 297' ' ' PRO . 3.8 t -147.46 145.81 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.004 -1.06 . . . . 0.0 109.784 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 296' ' ' ALA . . . . . 0.471 ' O ' ' OD1' ' B' ' 320' ' ' ASN . . . -130.18 72.67 81.83 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 110.148 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 297' ' ' PRO . . . . . 1.057 ' HD3' HG12 ' B' ' 295' ' ' VAL . 50.7 Cg_endo -92.5 -175.42 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.757 1.398 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.53 ' CG1' ' HB2' ' B' ' 281' ' ' ALA . 3.2 mp -143.43 134.8 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . 0.606 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 11.3 t0 -108.42 162.89 13.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.951 -1.093 . . . . 0.0 110.317 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 300' ' ' HIS . . . . . 0.527 ' O ' ' CG ' ' B' ' 312' ' ' MET . 59.9 t60 -112.58 172.71 6.76 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 301' ' ' PHE . . . . . 0.612 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.13 145.12 29.47 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.994 -1.066 . . . . 0.0 110.475 -178.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.538 ' CD ' ' HB2' ' B' ' 311' ' ' SER . 2.6 ttt-85 -139.3 107.0 5.61 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 303' ' ' PHE . . . . . 0.623 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 5.4 m-85 -90.72 -171.38 3.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.184 -0.948 . . . . 0.0 109.871 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 304' ' ' ASN . . . . . 0.837 ' HB3' HG21 ' B' ' 310' ' ' VAL . 0.5 OUTLIER -124.32 -37.65 2.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.854 . . . . 0.0 109.271 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 305' ' ' GLY . . . . . 0.7 ' O ' ' HB3' ' B' ' 306' ' ' ALA . . . -164.29 24.42 0.18 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 306' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' B' ' 305' ' ' GLY . . . 75.76 64.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -1.183 . . . . 0.0 109.581 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -158.53 -58.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.32 -168.29 1.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -1.14 . . . . 0.0 109.381 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 309' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' B' ' 230' ' ' PHE . 70.1 t -108.49 135.05 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -0.947 . . . . 0.0 109.115 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . 0.837 HG21 ' HB3' ' B' ' 304' ' ' ASN . 10.0 t -110.54 -75.33 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.021 . . . . 0.0 109.979 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . 0.538 ' HB2' ' CD ' ' B' ' 302' ' ' ARG . 28.8 m -107.45 162.01 14.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.634 -1.291 . . . . 0.0 109.615 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 312' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 15.3 ttp -153.95 150.31 28.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 313' ' ' ARG . . . . . 0.509 ' CG ' ' HB2' ' B' ' 237' ' ' GLU . 2.0 mtm-85 -127.79 150.47 49.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.377 -0.827 . . . . 0.0 109.068 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 314' ' ' ALA . . . . . 0.49 ' CB ' ' OD1' ' B' ' 238' ' ' ASP . . . -110.52 130.44 55.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.084 -1.01 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 315' ' ' LEU . . . . . 1.041 HD11 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -124.99 135.98 53.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.092 -1.005 . . . . 0.0 110.074 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 316' ' ' PHE . . . . . 0.675 ' O ' HG13 ' A' ' 74' ' ' VAL . 34.3 p90 165.91 -156.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 317' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' B' ' 321' ' ' ILE . . . 165.1 -174.47 41.01 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 318' ' ' GLU . . . . . 0.54 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 13.0 tt0 -68.25 -7.18 28.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -1.134 . . . . 0.0 109.474 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 319' ' ' LYS . . . . . 0.443 ' HE2' ' CD ' ' A' ' 70' ' ' GLU . 3.5 tttp -89.55 -30.48 18.17 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.04 0.924 . . . . 0.0 109.108 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 320' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.11 6.46 39.83 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 321' ' ' ILE . . . . . 0.652 HG22 ' H ' ' B' ' 322' ' ' HIS . 4.1 mm -90.09 -170.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 322' ' ' HIS . . . . . 0.652 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.1 OUTLIER -151.9 174.05 14.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.909 -1.119 . . . . 0.0 110.11 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.078 179.593 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.98 -4.25 15.08 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.871 1.458 . . . . 0.0 110.202 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.97 -44.77 53.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -50.53 72.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.41 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.58 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 64.9 mtm -60.89 -27.76 68.39 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.214 -0.929 . . . . 0.0 109.735 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.448 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 15.9 m -76.99 -37.49 55.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.366 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.59 -46.38 77.26 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.183 -0.948 . . . . 0.0 108.953 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.951 ' HA ' HD21 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -49.46 -43.43 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 8' ' ' THR . 4.9 t -60.15 -40.08 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.709 -0.619 . . . . 0.0 109.725 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 13' ' ' ARG . 17.3 tt0 -63.83 -75.63 0.08 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.158 -0.963 . . . . 0.0 108.621 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.985 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -43.06 -44.64 4.93 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.612 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -49.33 -46.13 46.44 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.943 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -88.28 -39.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.59 -36.43 15.62 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.586 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -73.82 -33.2 64.07 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.943 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.0 mt -64.2 -58.24 7.15 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -51.08 -46.75 61.86 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.708 0.766 . . . . 0.0 109.149 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.32 10.14 23.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.533 -0.729 . . . . 0.0 109.445 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.688 ' HA2' HD11 ' A' ' 59' ' ' LEU . . . 47.77 30.1 6.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 17' ' ' ALA . 19.2 t70 -90.03 62.75 5.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -1.152 . . . . 0.0 109.81 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.098 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -47.58 -38.03 13.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.11 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 23' ' ' LEU . 1.7 m-20 -43.21 -36.71 1.85 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.97 -30.86 30.47 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.853 HD12 HD12 ' A' ' 23' ' ' LEU . 49.6 mt -61.51 -55.97 20.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 52' ' ' ARG . 29.7 t -60.0 -38.2 75.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.28 -54.17 50.0 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.985 HD22 ' HB3' ' A' ' 13' ' ' ARG . 9.1 tp -62.58 -23.43 67.02 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.535 ' HD2' HG21 ' A' ' 51' ' ' ILE . 3.6 m-30 -91.27 142.79 27.33 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.483 -0.761 . . . . 0.0 109.7 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -52.36 -174.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.383 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.468 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.4 OUTLIER -81.32 -24.69 36.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.651 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.586 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -132.7 42.41 3.09 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.586 -0.696 . . . . 0.0 109.446 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.62 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -59.95 157.39 12.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 109.896 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.938 HG23 ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -111.66 144.91 40.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.007 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 55.7 t -133.1 130.64 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.069 -1.019 . . . . 0.0 109.835 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.569 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 23.1 mt-10 -107.92 110.13 21.81 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.823 ' OD1' ' HB3' ' A' ' 114' ' ' ALA . 17.6 t70 179.19 139.89 0.28 Allowed Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.782 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 38' ' ' ASP . 43.5 Cg_endo -69.65 -179.84 20.09 Favored 'Cis proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.353 -1.936 . . . . 0.0 111.055 -0.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 40' ' ' VAL . 2.4 t -55.07 139.99 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 110.024 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.449 ' HA3' ' HB1' ' B' ' 275' ' ' ALA . . . 49.55 38.39 28.21 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.524 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -116.03 -141.77 0.37 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.41 -1.053 . . . . 0.0 109.802 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 7.1 pm0 -119.12 101.48 49.73 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.838 -1.164 . . . . 0.0 110.764 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.569 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 37.5 Cg_endo -63.31 175.87 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.984 1.518 . . . . 0.0 110.707 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.95 ' HG3' ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -151.49 114.27 4.67 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.938 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -99.93 155.47 17.67 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 110.074 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 109.21 155.95 16.86 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 7.3 m -66.92 -56.46 10.16 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.322 -1.105 . . . . 0.0 108.977 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -57.93 -18.92 26.33 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.291 -0.881 . . . . 0.0 109.119 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.95 ' HB1' ' HG3' ' A' ' 45' ' ' ARG . . . -89.54 -54.84 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.381 -0.824 . . . . 0.0 109.182 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.537 HD13 ' O ' ' A' ' 45' ' ' ARG . 2.9 mm -51.58 -39.88 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.391 -0.818 . . . . 0.0 109.203 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.915 ' HG3' HD23 ' A' ' 23' ' ' LEU . 5.0 ttt85 -74.38 -55.34 6.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.026 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 4.8 mt-10 -49.12 -27.75 3.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.07 -1.019 . . . . 0.0 108.867 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -87.65 -71.5 0.57 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 1.098 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -47.28 -39.06 13.68 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 52' ' ' ARG . . . -57.82 -50.92 71.65 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 39.6 t-20 -53.99 -42.55 69.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.9 t -59.58 -31.55 69.56 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.688 HD11 ' HA2' ' A' ' 21' ' ' GLY . 7.5 tp -68.76 -20.26 64.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 11.8 mttm -67.75 -6.35 20.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.563 -0.711 . . . . 0.0 109.252 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.907 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -88.31 113.17 54.07 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.886 ' HD2' HD13 ' A' ' 61' ' ' LEU . 47.0 Cg_endo -73.39 82.16 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.737 1.388 . . . . 0.0 112.047 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.007 ' HB2' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -140.18 164.6 29.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.027 -1.045 . . . . 0.0 109.048 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.999 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -89.82 129.39 36.21 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.967 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.793 HG11 ' HB3' ' A' ' 18' ' ' LEU . 2.2 t -101.61 117.31 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.665 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -140.09 108.87 5.95 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.317 -0.865 . . . . 0.0 109.226 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.674 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -48.52 178.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.805 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.686 ' O ' ' N ' ' A' ' 70' ' ' GLU . 4.6 p -126.89 44.53 2.88 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.384 -0.822 . . . . 0.0 109.094 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.537 ' CG ' ' O ' ' A' ' 68' ' ' THR . 4.2 pt20 49.94 -55.39 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.686 ' N ' ' O ' ' A' ' 68' ' ' THR . 67.7 tt0 -63.32 118.15 7.62 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.535 -1.353 . . . . 0.0 110.227 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.9 t -130.57 146.0 34.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 1.001 ' CG ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -118.17 130.65 56.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.895 -1.128 . . . . 0.0 109.731 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.558 ' N ' ' HD2' ' A' ' 72' ' ' ARG . . . -147.44 117.45 7.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.717 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.667 HG21 ' O ' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -135.77 160.72 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.964 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . 40.48 -143.43 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.751 -0.593 . . . . 0.0 109.914 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 103' ' ' PHE . 7.6 m-20 -90.38 12.24 19.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.105 -0.997 . . . . 0.0 109.611 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.511 ' CG ' ' HG3' ' A' ' 102' ' ' ARG . 2.3 mt-10 -115.51 -161.51 0.79 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.09 -1.006 . . . . 0.0 109.466 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.987 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . -179.24 163.89 1.32 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.388 -0.82 . . . . 0.0 109.962 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 1.069 ' HB2' HD11 ' B' ' 315' ' ' LEU . . . -151.7 131.68 13.4 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 31.3 p90 -151.09 174.89 12.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.733 -1.229 . . . . 0.0 109.958 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.897 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -144.39 176.94 8.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 109.91 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -165.05 -169.0 1.55 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.496 -0.753 . . . . 0.0 109.133 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.75 147.8 50.1 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 110.104 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.007 HG12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -117.51 124.33 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 109.067 179.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.999 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 27.8 p -118.17 120.76 38.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.588 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.778 ' CD1' HD23 ' A' ' 63' ' ' LEU . 7.2 p90 -147.04 -173.5 4.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -121.79 169.33 10.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 -159.35 0.95 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 109.957 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -104.0 89.11 3.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.25 -18.17 52.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -143.91 167.11 23.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -1.08 . . . . 0.0 109.264 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.34 145.06 41.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.35 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -139.14 142.75 38.02 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 110.178 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.731 HG12 ' CB ' ' A' ' 122' ' ' HIS . 0.8 OUTLIER -123.62 179.19 2.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 1.063 HG22 HG23 ' A' ' 121' ' ' ILE . 6.8 t -146.81 142.26 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.891 -1.131 . . . . 0.0 109.796 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 120' ' ' ASN . . . -134.08 72.2 72.23 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.527 -0.733 . . . . 0.0 109.956 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 1.013 ' HD3' HG12 ' A' ' 95' ' ' VAL . 48.8 Cg_endo -94.7 -175.36 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.631 1.554 . . . . 0.0 110.973 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.897 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.7 mp -137.55 163.83 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 12.2 t0 -132.98 156.33 47.52 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.011 -1.056 . . . . 0.0 110.234 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 101' ' ' PHE . 53.5 t60 -111.84 167.84 10.05 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.987 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -139.08 153.92 48.1 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 110.607 -178.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.555 ' O ' HG23 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -143.15 98.84 3.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 109.186 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 7' ' ' MET . 5.8 m-85 -90.09 159.73 16.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 109.62 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.685 ' HB3' HG21 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -101.24 4.45 41.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.204 -0.935 . . . . 0.0 109.795 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 165.37 -76.41 0.15 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 177.96 71.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -1.159 . . . . 0.0 109.592 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.06 -65.88 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.87 -163.8 1.22 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -1.1 . . . . 0.0 109.327 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.619 HG23 ' CG2' ' A' ' 10' ' ' VAL . 37.7 t -106.27 158.16 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.099 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.685 HG21 ' HB3' ' A' ' 104' ' ' ASN . 0.1 OUTLIER -127.44 -75.15 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.177 -0.952 . . . . 0.0 109.266 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 102' ' ' ARG . 3.3 m -108.36 161.77 14.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.11 -0.994 . . . . 0.0 109.167 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 11.5 ttp -160.01 148.25 17.01 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.178 -0.951 . . . . 0.0 110.072 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.612 ' NH2' ' CE1' ' B' ' 300' ' ' HIS . 0.0 OUTLIER -134.33 158.39 43.92 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.823 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . . . -125.77 141.71 51.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 109.78 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.713 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.7 OUTLIER -129.21 146.65 51.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.357 -0.839 . . . . 0.0 109.485 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.63 ' O ' HG11 ' B' ' 274' ' ' VAL . 0.1 OUTLIER 176.54 -155.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.691 0.758 . . . . 0.0 109.484 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.502 ' N ' ' CG ' ' A' ' 116' ' ' PHE . . . 163.38 176.84 35.77 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.512 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 24.2 tt0 -68.64 -7.74 35.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -1.109 . . . . 0.0 109.49 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.503 ' CE ' ' OE2' ' B' ' 270' ' ' GLU . 14.5 tttp -89.52 -27.54 20.23 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.997 0.904 . . . . 0.0 108.778 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -89.16 9.81 24.21 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.063 HG23 HG22 ' A' ' 95' ' ' VAL . 3.6 mm -96.04 -159.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.278 -0.889 . . . . 0.0 108.637 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.731 ' CB ' HG12 ' A' ' 94' ' ' VAL . 20.3 t-80 -151.32 168.88 23.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.074 -1.016 . . . . 0.0 109.864 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 122' ' ' HIS . . . -144.77 167.83 21.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.372 -0.83 . . . . 0.0 109.413 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.46 177.65 35.9 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.223 -1.163 . . . . 0.0 109.492 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 80.9 mtp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.272 0.558 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -166.41 46.43 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.394 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 203' ' ' THR . 7.5 t -58.54 121.86 56.21 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 109.702 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.06 -4.89 15.79 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.853 1.449 . . . . 0.0 109.478 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -55.25 32.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.367 -0.833 . . . . 0.0 109.301 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -49.61 75.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 108.857 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' MET . . . . . 0.626 ' HE1' ' HA ' ' B' ' 306' ' ' ALA . 24.0 mmt -50.28 -41.84 51.34 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.348 -0.845 . . . . 0.0 109.404 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 4.8 m -60.36 -34.93 74.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.485 -0.759 . . . . 0.0 109.084 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -51.36 -42.74 61.52 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.291 -0.881 . . . . 0.0 108.739 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 1.008 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -57.75 -26.62 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.846 HG22 ' CE2' ' B' ' 301' ' ' PHE . 25.5 t -90.09 -44.63 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.858 . . . . 0.0 109.308 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 213' ' ' ARG . 5.4 tt0 -58.05 -73.19 0.08 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.475 ' HD3' HD13 ' B' ' 229' ' ' LEU . 0.3 OUTLIER -43.42 -45.14 6.13 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.98 0.895 . . . . 0.0 108.693 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' TYR . . . . . 0.626 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.3 OUTLIER -52.02 -42.46 63.07 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.931 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -87.67 -38.88 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.284 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.66 -35.08 13.02 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.551 ' HB1' HG13 ' B' ' 226' ' ' ILE . . . -75.32 -32.79 61.05 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.931 HD12 ' HA ' ' B' ' 215' ' ' VAL . 1.7 mt -64.59 -57.9 7.83 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 8.5 t30 -54.35 -46.33 72.93 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.497 0.665 . . . . 0.0 109.312 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -88.92 9.6 24.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.599 -0.688 . . . . 0.0 109.733 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.987 ' HA2' HD21 ' B' ' 259' ' ' LEU . . . 48.9 34.29 15.24 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' B' ' 217' ' ' ALA . 16.8 t0 -91.56 61.66 4.34 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.251 -1.146 . . . . 0.0 109.812 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' LEU . . . . . 1.055 HD12 HD12 ' B' ' 226' ' ' ILE . 6.7 tp -46.31 -43.58 15.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 108.695 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' B' ' 223' ' ' LEU . 2.2 m-20 -42.69 -33.28 0.7 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' B' ' 228' ' ' ALA . . . -85.15 -33.93 16.17 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 1.055 HD12 HD12 ' B' ' 223' ' ' LEU . 23.3 mt -60.82 -53.78 44.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.533 ' CG1' HG23 ' B' ' 248' ' ' THR . 72.5 t -59.18 -35.97 60.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' B' ' 225' ' ' GLY . . . -58.69 -56.1 26.6 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 1.008 HD21 ' HA ' ' B' ' 210' ' ' VAL . 9.3 tp -58.7 -21.6 55.18 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . 1.021 ' CD2' HG21 ' B' ' 251' ' ' ILE . 5.0 m-85 -86.89 139.59 30.48 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.497 -0.752 . . . . 0.0 109.61 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -54.8 -167.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.674 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.476 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.5 OUTLIER -81.12 -23.15 38.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.0 109.373 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.557 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 0.1 OUTLIER -144.4 44.81 1.42 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.856 ' HB3' HD13 ' B' ' 251' ' ' ILE . . . -56.76 -170.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.648 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' THR . . . . . 0.62 HG22 ' HB2' ' B' ' 246' ' ' SER . 0.1 OUTLIER -134.61 141.01 46.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.4 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.706 ' CG2' HG23 ' B' ' 251' ' ' ILE . 34.6 t -116.43 166.84 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.189 -0.945 . . . . 0.0 109.112 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' GLU . . . . . 0.574 ' N ' HG12 ' B' ' 236' ' ' VAL . 1.1 mm-40 -151.66 116.95 5.29 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' B' ' 239' ' ' PRO . 0.8 OUTLIER 175.01 167.12 0.36 Allowed Pre-proline 0 C--N 1.301 -1.5 0 C-N-CA 118.118 -1.433 . . . . 0.0 110.354 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . 0.834 ' O ' HG13 ' B' ' 240' ' ' VAL . 45.7 Cg_endo -73.12 -28.03 7.52 Favored 'Cis proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.727 -2.197 . . . . 0.0 110.649 0.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.834 HG13 ' O ' ' B' ' 239' ' ' PRO . 2.1 m -166.88 101.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 109.197 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.23 42.96 63.88 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' SER . . . . . 0.519 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 27.8 m -118.83 -112.44 0.34 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.314 -1.109 . . . . 0.0 109.817 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . 0.445 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 39.0 mt-10 -121.82 100.62 43.31 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.915 -1.116 . . . . 0.0 110.383 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 39.4 Cg_endo -65.43 -172.6 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.561 1.507 . . . . 0.0 110.652 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 1.019 ' HG3' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.52 98.05 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.063 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.7 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.35 166.62 13.63 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.301 -0.875 . . . . 0.0 109.896 -179.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . 0.606 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 90.48 171.09 43.84 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' THR . . . . . 0.533 HG23 ' CG1' ' B' ' 227' ' ' VAL . 1.8 m -89.42 -22.36 22.57 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.749 -1.442 . . . . 0.0 109.27 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -82.0 -28.02 32.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.268 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 1.019 ' HB1' ' HG3' ' B' ' 245' ' ' ARG . . . -88.98 -53.48 4.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.322 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 1.021 HG21 ' CD2' ' B' ' 230' ' ' PHE . 94.6 mt -45.25 -36.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.942 . . . . 0.0 108.852 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 252' ' ' ARG . . . . . 0.745 ' CG ' HD23 ' B' ' 223' ' ' LEU . 28.8 ttp180 -79.86 -54.18 6.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -48.95 -28.49 3.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.043 -1.035 . . . . 0.0 108.239 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.618 ' CD1' ' CD ' ' B' ' 245' ' ' ARG . 0.7 OUTLIER -83.54 -70.74 0.54 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 255' ' ' PHE . . . . . 1.039 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.1 OUTLIER -47.2 -24.96 0.8 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . 0.678 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -76.32 -48.61 19.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 108.642 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 257' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 31.1 t-20 -59.13 -31.96 69.42 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 3.0 t -72.72 -35.94 67.67 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 259' ' ' LEU . . . . . 0.987 HD21 ' HA2' ' B' ' 221' ' ' GLY . 8.3 tp -66.81 -26.56 66.99 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.406 -0.809 . . . . 0.0 109.145 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 260' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 2.1 mttt -46.15 -25.91 0.67 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.06 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 261' ' ' LEU . . . . . 0.753 HD23 HD23 ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.75 112.31 51.22 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 262' ' ' PRO . . . . . 0.508 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 44.4 Cg_endo -71.39 117.49 5.18 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.854 1.45 . . . . 0.0 110.841 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.87 ' CB ' HG13 ' B' ' 284' ' ' VAL . 0.0 OUTLIER -145.88 164.4 32.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 109.614 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . 0.74 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -95.11 123.75 38.78 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 265' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' B' ' 219' ' ' ASN . 6.2 t -113.46 115.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.291 -0.88 . . . . 0.0 109.794 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 266' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.1 OUTLIER -149.84 99.37 2.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -0.906 . . . . 0.0 109.229 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -45.15 170.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.912 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 12.0 p -142.24 -37.96 0.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 109.608 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 269' ' ' GLN . . . . . 0.507 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 3.7 pt20 -95.93 -144.74 0.27 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.654 -0.654 . . . . 0.0 109.324 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 270' ' ' GLU . . . . . 0.518 ' O ' ' CZ ' ' B' ' 272' ' ' ARG . 22.2 tt0 -117.53 134.1 55.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.041 -1.037 . . . . 0.0 109.829 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 271' ' ' VAL . . . . . 0.942 HG13 ' HB3' ' B' ' 280' ' ' PHE . 76.1 t -64.84 148.97 11.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.414 -0.804 . . . . 0.0 109.17 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 11.9 mmt180 -103.4 137.84 40.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . 0.459 ' C ' HG22 ' B' ' 274' ' ' VAL . . . -148.76 139.22 22.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 109.077 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 274' ' ' VAL . . . . . 0.63 HG11 ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -160.3 157.58 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.068 -1.02 . . . . 0.0 110.088 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 275' ' ' ALA . . . . . 0.449 ' HB1' ' HA3' ' A' ' 41' ' ' GLY . . . 40.59 -102.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.653 -0.655 . . . . 0.0 110.095 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 276' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 98.3 m-20 -129.3 5.31 5.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.898 -1.126 . . . . 0.0 109.628 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . 0.536 ' CG ' ' HG2' ' B' ' 302' ' ' ARG . 0.3 OUTLIER -112.6 -162.65 0.81 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.087 -1.008 . . . . 0.0 108.972 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 278' ' ' ALA . . . . . 0.573 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . 177.17 142.47 0.08 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.623 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 279' ' ' ALA . . . . . 0.713 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -125.92 136.45 53.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 108.604 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . 0.942 ' HB3' HG13 ' B' ' 271' ' ' VAL . 30.0 p90 -149.72 172.46 15.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.74 -1.225 . . . . 0.0 109.982 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.576 ' HB2' ' CG1' ' B' ' 298' ' ' ILE . . . -148.23 -164.95 2.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.808 . . . . 0.0 109.991 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 282' ' ' PHE . . . . . 0.49 ' CD2' ' C ' ' B' ' 281' ' ' ALA . 14.2 p90 172.14 -169.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.45 -0.781 . . . . 0.0 109.384 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.15 147.3 52.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.394 -0.816 . . . . 0.0 109.645 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 284' ' ' VAL . . . . . 0.87 HG13 ' CB ' ' B' ' 263' ' ' LEU . 3.3 t -123.8 121.13 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.868 . . . . 0.0 109.429 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 285' ' ' SER . . . . . 0.74 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 16.7 p -115.52 117.84 31.47 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' B' ' 293' ' ' THR . 11.4 p90 -142.24 173.65 11.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.084 -1.01 . . . . 0.0 110.217 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 287' ' ' GLU . . . . . 0.509 ' HG2' ' N ' ' B' ' 288' ' ' PHE . 36.1 tt0 -148.42 154.03 39.35 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.1 OUTLIER -128.01 -96.36 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.036 -1.04 . . . . 0.0 110.358 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -110.16 93.92 4.75 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.122 -0.987 . . . . 0.0 110.443 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 62.14 11.34 32.01 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 291' ' ' ARG . . . . . 0.593 ' HB3' ' CE2' ' B' ' 288' ' ' PHE . 26.9 mtt180 -130.94 144.79 51.73 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.206 -1.173 . . . . 0.0 109.578 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 292' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' B' ' 287' ' ' GLU . 0.0 OUTLIER -136.2 120.78 18.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.347 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 293' ' ' THR . . . . . 0.673 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -122.57 143.58 49.65 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.403 -0.81 . . . . 0.0 109.717 -179.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 294' ' ' VAL . . . . . 0.553 HG13 ' N ' ' B' ' 295' ' ' VAL . 0.8 OUTLIER -112.92 173.55 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 1.011 HG12 ' HD3' ' B' ' 297' ' ' PRO . 2.6 t -150.41 144.41 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.955 -1.091 . . . . 0.0 110.034 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 296' ' ' ALA . . . . . 0.449 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -133.34 73.81 73.14 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.425 -0.797 . . . . 0.0 109.208 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 297' ' ' PRO . . . . . 1.011 ' HD3' HG12 ' B' ' 295' ' ' VAL . 50.2 Cg_endo -94.48 -179.21 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.907 1.478 . . . . 0.0 111.797 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.576 ' CG1' ' HB2' ' B' ' 281' ' ' ALA . 2.9 mp -137.34 138.45 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . 0.613 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 14.7 t0 -113.75 164.16 14.08 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.984 -1.073 . . . . 0.0 110.24 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 300' ' ' HIS . . . . . 0.612 ' CE1' ' NH2' ' A' ' 113' ' ' ARG . 7.4 t-160 -112.22 173.43 6.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 109.09 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 301' ' ' PHE . . . . . 0.846 ' CE2' HG22 ' B' ' 211' ' ' VAL . 0.2 OUTLIER -145.27 149.03 34.13 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.214 -0.929 . . . . 0.0 110.163 -178.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.536 ' HG2' ' CG ' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -138.01 104.26 5.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.828 . . . . 0.0 109.284 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 303' ' ' PHE . . . . . 0.717 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 11.6 m-85 -89.96 171.62 9.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.081 -1.012 . . . . 0.0 109.512 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 304' ' ' ASN . . . . . 0.59 ' HB3' HG21 ' B' ' 310' ' ' VAL . 1.4 p30 -119.16 -14.25 9.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.427 -0.796 . . . . 0.0 109.132 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 305' ' ' GLY . . . . . 0.707 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -172.49 -62.81 0.05 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 306' ' ' ALA . . . . . 0.707 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 162.74 76.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -1.097 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.52 -64.48 0.06 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -119.35 -172.94 2.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -1.148 . . . . 0.0 109.664 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 309' ' ' VAL . . . . . 1.039 HG11 ' CE ' ' B' ' 312' ' ' MET . 89.7 t -110.43 150.33 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.216 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . 0.59 HG21 ' HB3' ' B' ' 304' ' ' ASN . 42.6 t -123.27 -20.22 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.141 -0.974 . . . . 0.0 109.923 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . 0.531 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -157.85 166.86 31.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.952 -1.092 . . . . 0.0 110.023 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 312' ' ' MET . . . . . 1.039 ' CE ' HG11 ' B' ' 309' ' ' VAL . 1.6 ttm -156.69 154.29 29.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -0.853 . . . . 0.0 109.428 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 313' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' B' ' 299' ' ' ASP . 1.2 ttt180 -130.14 153.38 48.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.227 -0.92 . . . . 0.0 109.378 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 314' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' B' ' 237' ' ' GLU . . . -100.45 157.18 16.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.738 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 315' ' ' LEU . . . . . 1.069 HD11 ' HB2' ' A' ' 79' ' ' ALA . 9.0 tp -137.1 -143.78 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.427 -0.796 . . . . 0.0 109.019 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 316' ' ' PHE . . . . . 0.667 ' O ' HG21 ' A' ' 74' ' ' VAL . 31.0 p90 39.4 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.772 0.796 . . . . 0.0 110.313 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 317' ' ' GLY . . . . . 0.703 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 173.62 -152.52 15.52 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 318' ' ' GLU . . . . . 0.542 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 6.8 tt0 -72.25 -2.36 18.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -1.153 . . . . 0.0 109.71 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.2 -32.58 15.02 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.221 -0.925 . . . . 0.0 109.316 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 320' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -89.31 19.23 4.51 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.251 0.548 . . . . 0.0 109.821 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 321' ' ' ILE . . . . . 0.706 HG22 ' H ' ' B' ' 322' ' ' HIS . 5.1 mm -89.82 -167.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 322' ' ' HIS . . . . . 0.706 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.2 OUTLIER -151.67 155.14 37.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.056 -1.027 . . . . 0.0 109.247 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.116 -0.99 . . . . 0.0 109.773 -179.946 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 3' ' ' THR . 9.8 t . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.477 ' O ' ' HB ' ' A' ' 8' ' ' THR . 45.5 Cg_endo -72.78 -10.52 25.04 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.869 1.457 . . . . 0.0 110.17 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -32.77 68.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 109.692 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.85 -51.0 5.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.926 . . . . 0.0 109.423 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.441 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 17.3 mtt -61.14 -48.19 82.76 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.268 -0.895 . . . . 0.0 109.902 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 4' ' ' PRO . 17.7 m -53.53 -39.05 64.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.487 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.81 -48.06 73.26 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.259 -0.901 . . . . 0.0 108.866 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.655 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.2 t -52.49 -28.68 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.934 HG22 ' CE2' ' A' ' 101' ' ' PHE . 6.6 t -85.47 -42.61 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.239 -0.913 . . . . 0.0 109.354 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.2 tt0 -59.61 -73.65 0.08 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.806 ' HD2' HD13 ' A' ' 29' ' ' LEU . 2.7 mtm180 -43.45 -46.12 6.63 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.709 ' CE1' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -53.13 -41.22 64.85 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.916 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -84.01 -36.58 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.092 -1.005 . . . . 0.0 108.928 179.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.71 -39.55 65.3 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -71.22 -32.36 68.7 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -63.27 -58.18 8.01 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 65' ' ' VAL . 2.4 t-20 -51.13 -42.47 60.75 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.64 0.733 . . . . 0.0 109.269 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.58 2.35 53.23 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.68 -0.637 . . . . 0.0 109.604 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 1.086 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 49.79 38.24 29.61 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.47 ' O ' HG13 ' A' ' 26' ' ' ILE . 29.6 t70 -92.18 77.85 5.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -1.033 . . . . 0.0 109.865 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.083 ' CD2' HD22 ' A' ' 59' ' ' LEU . 2.8 mm? -50.69 -29.05 10.27 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.334 -0.853 . . . . 0.0 110.12 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -63.93 -56.43 15.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.975 . . . . 0.0 109.366 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.43 ' N ' ' OD2' ' A' ' 22' ' ' ASP . . . -59.0 -28.24 63.41 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.023 HD12 HD13 ' A' ' 23' ' ' LEU . 55.8 mt -63.62 -58.08 8.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.948 HG11 HG23 ' A' ' 48' ' ' THR . 43.6 t -55.82 -41.26 65.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.48 -49.98 71.09 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.806 HD13 ' HD2' ' A' ' 13' ' ' ARG . 2.9 tp -72.35 -21.0 61.37 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.553 -0.717 . . . . 0.0 109.265 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.602 ' CZ ' ' CE ' ' A' ' 112' ' ' MET . 7.2 m-85 -92.41 140.84 29.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.372 -0.83 . . . . 0.0 109.561 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -51.67 178.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.073 -1.017 . . . . 0.0 109.344 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.02 -23.89 59.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.175 -0.953 . . . . 0.0 109.241 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.51 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -137.75 30.41 2.56 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.759 -0.588 . . . . 0.0 109.633 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.737 ' N ' HD11 ' A' ' 51' ' ' ILE . . . -53.21 -173.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.159 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.661 HG23 ' HB2' ' A' ' 46' ' ' SER . 0.2 OUTLIER -145.3 147.38 32.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.16 -0.963 . . . . 0.0 110.187 -179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.52 ' O ' ' HB3' ' A' ' 44' ' ' PRO . 9.5 t -134.56 118.16 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.521 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 2.3 mm-40 -88.3 104.94 17.21 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.529 ' O ' ' CE2' ' A' ' 54' ' ' PHE . 9.9 t0 -176.99 142.76 0.53 Allowed Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.92 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 47.8 Cg_endo -73.85 -166.48 4.63 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.28 -1.967 . . . . 0.0 110.651 -0.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.961 HG21 HG11 ' B' ' 274' ' ' VAL . 15.3 m -75.97 141.64 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.132 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.29 1.63 64.98 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.509 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -105.59 -155.26 0.54 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.265 -1.138 . . . . 0.0 109.355 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.442 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 27.9 mm-40 -127.74 131.88 24.05 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.08 -1.012 . . . . 0.0 110.07 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.521 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.0 Cg_endo -64.0 -166.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.575 1.517 . . . . 0.0 111.073 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 1.037 ' CG ' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -150.62 102.64 3.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.509 -0.744 . . . . 0.0 109.049 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.661 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.2 147.04 24.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.21 -0.931 . . . . 0.0 109.768 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 111.26 159.8 16.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.948 HG23 HG11 ' A' ' 27' ' ' VAL . 11.3 m -70.97 -43.33 68.29 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.059 -1.26 . . . . 0.0 109.291 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -66.78 -31.78 72.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.15 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.037 ' HB1' ' CG ' ' A' ' 45' ' ' ARG . . . -80.44 -60.37 2.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.898 . . . . 0.0 109.331 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.737 HD11 ' N ' ' A' ' 34' ' ' ALA . 39.3 mt -43.35 -38.28 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.371 -0.831 . . . . 0.0 109.003 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.518 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 4.8 ttt-85 -84.98 -55.18 4.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.536 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 26.1 tt0 -47.71 -26.08 1.43 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.565 ' CD1' ' HD3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -84.2 -71.79 0.5 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.717 ' CE1' HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -52.46 -20.82 3.13 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.24 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.479 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . . . -76.4 -44.73 34.84 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 48.8 t30 -64.49 -32.0 73.45 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 t -72.09 -35.35 69.2 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.086 HD21 ' CA ' ' A' ' 21' ' ' GLY . 3.1 tp -69.61 -24.82 63.72 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.458 -0.776 . . . . 0.0 109.383 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -43.85 -27.5 0.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 108.823 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.047 HD22 HD21 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -91.63 109.02 33.67 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.444 ' C ' ' HG ' ' A' ' 63' ' ' LEU . 45.1 Cg_endo -70.65 110.85 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.844 1.444 . . . . 0.0 111.332 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.047 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -138.46 173.1 11.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 109.497 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.843 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -102.36 127.54 49.32 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 18' ' ' LEU . 95.8 t -108.23 124.72 64.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 110.034 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -150.04 112.12 4.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.711 HD22 ' CG2' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -48.03 176.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.219 -0.926 . . . . 0.0 109.811 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.52 -81.97 0.43 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.278 -0.889 . . . . 0.0 109.293 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.594 ' HG2' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -123.43 -55.33 1.75 Allowed 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.807 -179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.594 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 17.2 tt0 -140.55 153.99 46.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.94 -1.1 . . . . 0.0 110.442 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.949 HG13 ' HB3' ' A' ' 80' ' ' PHE . 19.0 t -99.57 149.12 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -95.26 128.96 42.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.483 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.562 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -148.25 137.1 21.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.142 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.815 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -165.64 154.19 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 109.793 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 1.036 ' CB ' HG12 ' B' ' 240' ' ' VAL . . . 43.14 -147.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 0.0 109.827 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 103' ' ' PHE . 30.8 m-80 -88.98 26.54 1.54 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.279 -0.888 . . . . 0.0 109.609 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.9 OUTLIER -129.68 -159.57 0.97 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.268 -0.895 . . . . 0.0 109.061 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.86 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 168.18 157.59 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.41 -0.806 . . . . 0.0 109.794 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.733 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -151.2 139.37 20.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 108.902 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.949 ' HB3' HG13 ' A' ' 71' ' ' VAL . 24.4 p90 -149.57 161.77 41.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.655 -1.278 . . . . 0.0 109.787 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.608 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -130.69 -174.99 3.52 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.574 0.702 . . . . 0.0 110.016 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CE2' ' CE2' ' A' ' 80' ' ' PHE . 19.6 p90 172.21 -172.11 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.546 -0.721 . . . . 0.0 109.22 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -128.34 141.11 51.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.482 -0.761 . . . . 0.0 109.551 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.579 HG12 ' CB ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -101.83 122.13 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 108.952 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.843 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 1.1 p -118.07 102.76 9.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 109.683 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.85 ' CD1' HD23 ' A' ' 63' ' ' LEU . 17.7 p90 -123.02 159.72 27.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.096 -1.003 . . . . 0.0 109.276 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -95.71 171.01 8.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.133 -0.979 . . . . 0.0 109.651 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.08 -160.99 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 109.578 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.83 36.44 1.54 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.319 -0.863 . . . . 0.0 109.095 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.49 -30.3 0.17 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -137.29 -167.78 2.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -1.172 . . . . 0.0 109.352 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.01 136.18 50.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 109.692 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -120.4 157.48 29.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.271 -0.893 . . . . 0.0 109.874 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.548 HG13 ' CB ' ' A' ' 122' ' ' HIS . 12.0 p -138.24 163.9 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.314 -0.866 . . . . 0.0 109.138 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 120' ' ' ASN . 41.4 t -142.44 155.49 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.987 -1.071 . . . . 0.0 109.93 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 120' ' ' ASN . . . -127.86 73.81 78.77 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.494 -0.754 . . . . 0.0 109.818 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.561 ' HD3' HG12 ' A' ' 95' ' ' VAL . 44.0 Cg_endo -95.39 175.49 0.98 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.586 1.524 . . . . 0.0 111.578 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.608 HG23 ' HB2' ' A' ' 81' ' ' ALA . 3.4 mp -143.19 152.39 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.623 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 12.7 t0 -125.42 161.49 26.94 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.004 -1.06 . . . . 0.0 110.229 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 113' ' ' ARG . 5.2 t60 -108.22 179.82 4.1 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.934 ' CE2' HG22 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -146.24 160.18 42.33 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.756 -1.215 . . . . 0.0 110.597 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.554 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -147.09 103.92 3.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.655 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -90.0 -171.06 3.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.165 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.794 ' OD1' HG23 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -139.42 -101.89 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.462 -0.774 . . . . 0.0 109.526 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.692 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -96.44 21.03 47.8 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 105' ' ' GLY . . . 77.35 66.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -1.112 . . . . 0.0 109.502 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.54 -65.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -128.93 -178.23 4.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -1.134 . . . . 0.0 109.507 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.766 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 45.3 t -94.0 141.52 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.375 -0.828 . . . . 0.0 109.395 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.794 HG23 ' OD1' ' A' ' 104' ' ' ASN . 24.6 t -121.95 -15.22 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 109.976 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.554 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.3 OUTLIER -158.68 157.32 31.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.93 -1.106 . . . . 0.0 109.956 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.724 ' HE2' ' CE1' ' A' ' 101' ' ' PHE . 8.0 ttm -155.46 160.43 40.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.426 -0.796 . . . . 0.0 109.456 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 100' ' ' HIS . 10.1 ttp180 -149.75 114.41 5.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.858 . . . . 0.0 109.403 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 99' ' ' ASP . . . -89.98 137.59 32.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.082 -1.011 . . . . 0.0 109.461 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.954 HD22 ' CB ' ' B' ' 279' ' ' ALA . 1.0 OUTLIER -134.12 143.65 48.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.965 . . . . 0.0 110.102 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.559 ' O ' HG11 ' B' ' 274' ' ' VAL . 32.9 p90 164.36 -163.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . -176.15 -179.86 46.85 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.246 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.524 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 11.9 tt0 -50.63 -21.46 1.58 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -1.138 . . . . 0.0 109.304 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -22.55 60.7 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.017 0.913 . . . . 0.0 108.668 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.633 ' O ' HG13 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -88.72 3.27 51.45 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.676 -179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 122' ' ' HIS . 4.2 mm -93.39 -179.34 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.028 -1.045 . . . . 0.0 109.372 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.612 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.7 OUTLIER -151.56 161.46 42.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.509 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.38 152.86 29.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.513 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.9 -128.4 9.49 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.277 -1.131 . . . . 0.0 109.505 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.219 0.533 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -120.92 55.79 1.03 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.1 111.0 44.3 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.348 -0.845 . . . . 0.0 109.558 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' B' ' 208' ' ' THR . 44.3 Cg_endo -71.38 -8.57 23.63 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.832 1.438 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -66.41 -45.46 79.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.043 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -55.69 6.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 109.161 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 13.0 mmt -53.52 -41.96 66.89 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.432 ' CB ' ' O ' ' B' ' 204' ' ' PRO . 6.0 m -63.38 -35.51 80.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 109.06 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -51.13 -44.08 61.29 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.218 -0.926 . . . . 0.0 108.72 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 1.016 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.1 t -57.08 -25.44 22.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.893 HG22 ' CE2' ' B' ' 301' ' ' PHE . 23.9 t -88.43 -44.88 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.832 . . . . 0.0 109.159 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' B' ' 213' ' ' ARG . 24.6 tt0 -58.99 -73.96 0.07 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' B' ' 212' ' ' GLN . 0.2 OUTLIER -42.77 -44.53 4.44 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' TYR . . . . . 0.64 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -51.21 -44.87 61.71 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.543 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.907 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.08 -41.23 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.39 -35.03 11.82 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.57 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -75.86 -33.46 60.0 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' B' ' 215' ' ' VAL . 3.1 mt -62.84 -57.39 11.03 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' B' ' 265' ' ' VAL . 4.6 t30 -53.68 -45.67 70.4 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.576 0.703 . . . . 0.0 109.578 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.14 7.23 36.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.476 -0.765 . . . . 0.0 109.745 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.862 ' HA2' HD11 ' B' ' 259' ' ' LEU . . . 51.83 42.06 52.51 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' B' ' 217' ' ' ALA . 18.0 t70 -97.8 61.44 1.57 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.112 . . . . 0.0 109.928 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' LEU . . . . . 1.054 HD12 HD12 ' B' ' 226' ' ' ILE . 7.1 tp -47.79 -44.12 28.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 108.883 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' B' ' 223' ' ' LEU . 3.9 t0 -43.86 -39.5 3.92 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . 0.481 ' HA3' ' OD2' ' B' ' 222' ' ' ASP . . . -80.77 -32.35 33.42 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 1.054 HD12 HD12 ' B' ' 223' ' ' LEU . 13.8 mt -61.97 -58.48 7.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.458 ' HA ' ' HB2' ' B' ' 230' ' ' PHE . 50.7 t -54.57 -39.73 47.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.71 -54.63 41.94 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 1.016 HD21 ' HA ' ' B' ' 210' ' ' VAL . 7.7 tp -61.76 -22.9 65.8 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' B' ' 231' ' ' ALA . 6.5 m-85 -90.85 132.43 35.9 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.428 -0.795 . . . . 0.0 109.918 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' B' ' 309' ' ' VAL . . . -50.66 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 0.0 109.652 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' B' ' 248' ' ' THR . 0.2 OUTLIER -76.31 -24.4 54.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 109.733 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.521 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 0.1 OUTLIER -133.46 39.76 3.2 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.474 -0.766 . . . . 0.0 109.764 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.899 ' O ' HD11 ' B' ' 251' ' ' ILE . . . -64.0 144.49 57.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.138 -0.976 . . . . 0.0 109.346 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' THR . . . . . 0.99 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -106.18 139.58 40.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 0.0 109.6 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' B' ' 244' ' ' PRO . 55.2 t -132.72 118.39 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.411 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' GLU . . . . . 0.515 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 29.3 mt-10 -89.42 106.24 18.32 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' ASP . . . . . 0.53 ' O ' ' CE2' ' B' ' 254' ' ' PHE . 28.4 t70 -179.67 141.68 0.35 Allowed Pre-proline 0 C--N 1.302 -1.484 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.492 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . 0.492 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 48.4 Cg_endo -74.11 169.89 72.47 Favored 'Cis proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.295 -1.961 . . . . 0.0 110.545 0.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 1.036 HG12 ' CB ' ' A' ' 75' ' ' ALA . 8.0 t -67.47 113.99 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.179 -0.951 . . . . 0.0 109.236 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 112.93 -2.52 25.74 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 17.5 m -109.38 -113.05 0.31 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -1.124 . . . . 0.0 109.212 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . 0.469 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 1.2 pp20? -164.34 131.46 2.42 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.904 -1.122 . . . . 0.0 109.612 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' PRO . . . . . 0.515 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.8 Cg_endo -64.83 -177.34 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.011 1.532 . . . . 0.0 111.13 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.77 ' HB3' ' HB1' ' B' ' 250' ' ' ALA . 11.1 mmt180 -150.54 99.94 2.8 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.99 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -88.88 164.71 15.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.32 -0.863 . . . . 0.0 109.748 -179.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . 0.521 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 101.46 162.19 27.19 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' THR . . . . . 0.525 ' N ' ' O ' ' B' ' 232' ' ' ASP . 5.9 m -70.04 -52.81 20.99 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.163 -1.198 . . . . 0.0 109.382 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -59.68 -40.75 88.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.162 -0.961 . . . . 0.0 109.438 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.77 ' HB1' ' HB3' ' B' ' 245' ' ' ARG . . . -68.37 -54.9 14.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 109.605 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.899 HD11 ' O ' ' B' ' 234' ' ' ALA . 8.5 mm -47.39 -36.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.115 -0.991 . . . . 0.0 109.116 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 252' ' ' ARG . . . . . 0.839 ' CG ' HD23 ' B' ' 223' ' ' LEU . 6.9 ttt180 -84.96 -55.16 4.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 253' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 5.5 mt-10 -48.7 -26.98 2.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.992 -1.068 . . . . 0.0 108.327 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.549 ' CD1' ' HG3' ' B' ' 245' ' ' ARG . 0.2 OUTLIER -86.71 -72.6 0.5 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 255' ' ' PHE . . . . . 0.981 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -49.1 -26.55 2.77 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.18 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . 0.618 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -70.38 -41.69 72.75 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -58.86 -27.4 65.13 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 41.9 t -77.69 -34.27 52.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 259' ' ' LEU . . . . . 0.862 HD11 ' HA2' ' B' ' 221' ' ' GLY . 7.9 tp -70.04 -26.7 64.16 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.436 -0.79 . . . . 0.0 109.47 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -49.43 -31.43 9.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.278 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 261' ' ' LEU . . . . . 0.978 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.9 OUTLIER -90.03 114.6 61.45 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.287 -0.883 . . . . 0.0 109.006 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 262' ' ' PRO . . . . . 0.454 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 43.3 Cg_endo -70.44 109.25 2.39 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.719 1.379 . . . . 0.0 110.665 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.978 ' CD2' HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -140.29 159.65 41.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.486 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -92.81 128.41 38.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.87 . . . . 0.0 108.694 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 265' ' ' VAL . . . . . 0.758 HG21 ' HB3' ' B' ' 218' ' ' LEU . 11.0 t -107.67 113.83 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 109.697 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 266' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' B' ' 267' ' ' LEU . 6.7 tt0 -150.47 95.47 2.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.4 -0.813 . . . . 0.0 109.042 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.867 HD23 ' O ' ' B' ' 281' ' ' ALA . 1.5 mp -44.75 169.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.2 -0.938 . . . . 0.0 109.836 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 5.1 t -127.65 -31.64 2.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 269' ' ' GLN . . . . . 0.524 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 13.7 pt20 -107.88 -151.42 0.47 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.524 -0.735 . . . . 0.0 109.459 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 270' ' ' GLU . . . . . 0.524 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 42.2 tt0 -106.64 129.96 54.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.486 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 271' ' ' VAL . . . . . 0.897 HG13 ' HB3' ' B' ' 280' ' ' PHE . 16.6 t -60.24 150.85 6.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.398 -0.813 . . . . 0.0 109.367 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 4.9 tpp180 -104.98 131.36 52.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 108.875 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . 0.529 ' HA ' ' CB ' ' B' ' 278' ' ' ALA . . . -148.0 126.23 12.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.089 -1.007 . . . . 0.0 109.9 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 274' ' ' VAL . . . . . 0.961 HG11 HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -121.95 -155.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.245 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 275' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' B' ' 276' ' ' ASN . . . -83.85 126.5 33.02 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.384 -0.822 . . . . 0.0 110.678 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 276' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' B' ' 275' ' ' ALA . 57.1 m-20 69.27 -2.35 1.88 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.706 -0.621 . . . . 0.0 111.721 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 3.4 tt0 -150.67 -160.47 1.17 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.418 -1.426 . . . . 0.0 110.518 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 278' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' B' ' 277' ' ' GLU . . . 165.45 152.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 279' ' ' ALA . . . . . 0.954 ' CB ' HD22 ' A' ' 115' ' ' LEU . . . -138.91 136.92 36.0 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . 0.897 ' HB3' HG13 ' B' ' 271' ' ' VAL . 33.5 p90 -149.97 167.38 26.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.831 -1.168 . . . . 0.0 110.546 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.95 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -142.68 -162.02 1.35 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.415 0.626 . . . . 0.0 109.448 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 282' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 0.0 OUTLIER 163.92 -175.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.885 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 283' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -127.86 141.11 51.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.436 -0.79 . . . . 0.0 109.733 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 284' ' ' VAL . . . . . 0.975 HG11 HD22 ' B' ' 263' ' ' LEU . 66.6 t -111.24 113.53 44.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.47 -0.769 . . . . 0.0 108.929 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 53.7 p -105.63 84.26 2.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.908 . . . . 0.0 110.028 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.58 ' CE1' ' HB ' ' B' ' 293' ' ' THR . 34.3 p90 -89.95 177.5 6.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.878 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -127.58 153.47 46.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.12 -0.988 . . . . 0.0 109.617 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -103.11 -98.03 0.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.379 -0.826 . . . . 0.0 109.586 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -140.31 47.09 1.8 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.194 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 139.99 -42.31 1.23 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -94.63 -166.69 1.52 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.508 -0.995 . . . . 0.0 108.877 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 292' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.29 123.35 9.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.044 -1.035 . . . . 0.0 109.744 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 293' ' ' THR . . . . . 0.58 ' HB ' ' CE1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -111.04 147.28 35.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.377 -0.827 . . . . 0.0 109.22 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 294' ' ' VAL . . . . . 0.747 HG13 ' HB2' ' B' ' 322' ' ' HIS . 11.1 p -127.52 167.95 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 109.681 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 1.041 HG12 ' HD3' ' B' ' 297' ' ' PRO . 3.5 t -140.18 148.21 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 108.999 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 296' ' ' ALA . . . . . 0.504 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -132.1 71.48 79.89 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 0.0 110.895 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 297' ' ' PRO . . . . . 1.041 ' HD3' HG12 ' B' ' 295' ' ' VAL . 51.1 Cg_endo -93.82 -174.28 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.486 1.458 . . . . 0.0 110.292 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.95 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.6 mp -140.04 162.64 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.875 . . . . 0.0 108.945 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . 0.608 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 14.0 t0 -133.1 157.49 45.16 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.11 -0.994 . . . . 0.0 110.084 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 300' ' ' HIS . . . . . 0.785 ' NE2' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -112.81 167.25 10.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 301' ' ' PHE . . . . . 0.893 ' CE2' HG22 ' B' ' 211' ' ' VAL . 0.2 OUTLIER -137.94 157.74 45.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.979 -1.076 . . . . 0.0 110.536 -178.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.516 ' HB3' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -150.09 104.33 3.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 303' ' ' PHE . . . . . 0.665 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 6.9 m-85 -89.6 129.72 36.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.469 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 304' ' ' ASN . . . . . 0.566 ' N ' ' ND2' ' B' ' 304' ' ' ASN . 0.0 OUTLIER -137.42 14.63 2.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.294 -0.878 . . . . 0.0 109.428 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . -135.69 5.87 4.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . 50.1 25.22 1.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -1.134 . . . . 0.0 109.602 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -161.25 -42.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -123.54 -168.12 1.72 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -1.091 . . . . 0.0 109.46 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 309' ' ' VAL . . . . . 0.766 HG23 ' CG2' ' B' ' 210' ' ' VAL . 38.2 t -111.84 138.26 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.941 . . . . 0.0 108.993 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . 0.534 ' HB ' ' ND2' ' B' ' 304' ' ' ASN . 2.7 t -121.3 -6.93 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.849 -1.157 . . . . 0.0 109.788 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.4 OUTLIER -155.23 152.93 29.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 0.0 109.347 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 312' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 300' ' ' HIS . 5.7 ttp -160.22 154.97 24.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 109.865 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 313' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' B' ' 299' ' ' ASP . 0.0 OUTLIER -137.77 163.7 30.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 109.067 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -142.5 141.56 32.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.019 -1.051 . . . . 0.0 109.72 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 315' ' ' LEU . . . . . 0.733 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -137.9 139.13 39.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 109.726 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 316' ' ' PHE . . . . . 0.815 ' O ' HG11 ' A' ' 74' ' ' VAL . 14.6 p90 173.76 -157.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.567 0.699 . . . . 0.0 109.352 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 317' ' ' GLY . . . . . 0.437 ' N ' ' CD2' ' B' ' 316' ' ' PHE . . . 165.29 -168.37 39.31 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 318' ' ' GLU . . . . . 0.534 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 15.7 tt0 -71.54 -4.37 26.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -1.164 . . . . 0.0 109.355 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 319' ' ' LYS . . . . . 0.484 ' HD3' ' OE1' ' A' ' 70' ' ' GLU . 2.4 tttm -89.72 -28.39 19.44 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 122.02 0.914 . . . . 0.0 108.87 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 320' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.1 OUTLIER -89.24 4.48 48.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 321' ' ' ILE . . . . . 0.92 HG23 HG22 ' B' ' 295' ' ' VAL . 5.0 mm -89.86 -173.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.325 -0.86 . . . . 0.0 108.83 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 322' ' ' HIS . . . . . 0.747 ' HB2' HG13 ' B' ' 294' ' ' VAL . 0.2 OUTLIER -150.86 -164.74 2.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.071 -1.018 . . . . 0.0 109.792 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.081 179.839 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.58 ' O ' ' CE1' ' A' ' 6' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.08 -4.81 15.0 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.761 1.401 . . . . 0.0 109.877 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -52.81 63.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.304 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 3' ' ' THR . 36.9 p-80 -70.3 -41.94 72.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.903 . . . . 0.0 109.273 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.577 ' CG ' ' NE2' ' A' ' 6' ' ' HIS . 10.3 mtt -59.07 -44.29 91.83 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.199 -0.938 . . . . 0.0 109.342 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.477 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 14.2 m -64.9 -38.46 91.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.315 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.66 77.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 108.872 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.802 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.4 t -55.12 -20.68 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.813 HG11 ' CG2' ' A' ' 71' ' ' VAL . 18.5 t -90.61 -43.5 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.409 -0.807 . . . . 0.0 109.236 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 13' ' ' ARG . 24.1 tt0 -61.19 -73.72 0.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.259 1.028 . . . . 0.0 108.313 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.864 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -42.07 -44.16 3.5 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.642 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -50.01 -46.61 52.94 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.915 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -86.23 -39.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.355 -0.84 . . . . 0.0 109.083 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -48.61 -36.68 16.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.553 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -74.37 -32.0 62.59 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.915 HD12 ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -65.3 -58.4 6.01 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.439 ' CG ' ' O ' ' A' ' 65' ' ' VAL . 24.4 t30 -52.56 -46.4 66.83 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.596 0.712 . . . . 0.0 109.089 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.96 10.67 20.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.649 -0.657 . . . . 0.0 109.476 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 1.006 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 45.52 27.81 2.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 17' ' ' ALA . 1.8 t70 -89.93 67.81 7.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -1.091 . . . . 0.0 109.866 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.12 HD11 ' HB3' ' A' ' 55' ' ' PHE . 4.6 tp -47.8 -41.31 23.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 109.165 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' LEU . 5.2 m-20 -41.49 -28.83 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -88.04 -35.87 8.71 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.006 HD12 HD12 ' A' ' 23' ' ' LEU . 22.0 mt -59.54 -53.82 43.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.54 HG21 ' CG ' ' A' ' 52' ' ' ARG . 91.1 t -59.72 -43.23 91.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.98 -43.62 66.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.864 HD22 ' HB3' ' A' ' 13' ' ' ARG . 6.6 tp -73.39 -27.91 61.72 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.531 ' HD2' HG22 ' A' ' 26' ' ' ILE . 8.8 m-85 -84.83 138.45 32.56 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.32 -0.862 . . . . 0.0 109.841 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -51.68 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 109.697 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.461 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -70.72 -23.42 62.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.622 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.548 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -148.51 41.08 0.95 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.623 -0.673 . . . . 0.0 109.264 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.632 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -52.95 151.77 4.44 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.253 -0.904 . . . . 0.0 109.699 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.34 144.44 29.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.387 -0.82 . . . . 0.0 109.432 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.597 ' CG2' HD12 ' A' ' 51' ' ' ILE . 2.1 t -123.58 169.14 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 108.899 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.632 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -142.65 105.39 4.52 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.205 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.491 ' HB2' ' O ' ' A' ' 37' ' ' GLU . 4.6 t70 177.67 142.93 0.26 Allowed Pre-proline 0 N--CA 1.495 1.777 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.065 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 46.6 Cg_endo -75.45 -176.34 18.04 Favored 'Cis proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.191 -2.004 . . . . 0.0 110.163 -0.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 115' ' ' LEU . 3.5 m -80.11 83.73 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.091 -1.006 . . . . 0.0 109.125 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.86 -13.92 1.33 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.533 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -108.57 -149.23 0.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -1.084 . . . . 0.0 109.417 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -109.93 133.92 20.83 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.916 -1.115 . . . . 0.0 110.721 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.3 Cg_endo -63.65 -161.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.157 1.904 . . . . 0.0 111.369 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.618 ' HD2' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -150.17 123.31 8.86 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.568 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -116.94 152.3 34.85 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.025 -1.047 . . . . 0.0 110.448 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 93.85 162.83 36.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 2.9 m -72.12 -57.58 4.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -1.113 . . . . 0.0 109.17 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -47.66 -29.28 2.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 46' ' ' SER . . . -90.07 -61.88 1.59 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.35 -0.844 . . . . 0.0 109.383 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.618 HD13 ' HD2' ' A' ' 45' ' ' ARG . 7.7 mm -45.36 -33.7 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.307 -0.871 . . . . 0.0 109.173 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.892 ' CG ' HD23 ' A' ' 23' ' ' LEU . 53.6 ttp85 -86.83 -61.45 1.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 108.924 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 26.1 tt0 -44.38 -28.8 0.59 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 108.564 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.556 ' CD2' ' HB3' ' A' ' 45' ' ' ARG . 1.2 t80 -80.71 -70.6 0.51 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 1.12 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -47.0 -25.52 0.82 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.717 ' HB2' HD22 ' A' ' 23' ' ' LEU . . . -76.24 -55.08 5.9 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -51.25 -30.77 18.7 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.6 t -76.09 -34.31 59.52 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.006 HD21 ' CA ' ' A' ' 21' ' ' GLY . 7.7 tp -68.82 -21.59 64.3 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.418 -0.802 . . . . 0.0 108.995 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -55.35 -18.68 7.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.364 -0.835 . . . . 0.0 109.049 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.779 HD22 ' CD2' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -89.64 125.34 61.55 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.281 -0.887 . . . . 0.0 108.881 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 86' ' ' PHE . 44.8 Cg_endo -71.44 103.08 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.791 1.416 . . . . 0.0 110.621 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.804 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -136.8 160.03 40.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.1 -1.0 . . . . 0.0 110.021 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.911 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -99.47 129.1 45.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.752 HG21 ' HB3' ' A' ' 18' ' ' LEU . 3.3 t -111.55 114.87 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.716 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -150.5 101.1 2.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.582 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -49.82 -179.71 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.234 -0.916 . . . . 0.0 109.556 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.442 HG23 ' N ' ' A' ' 69' ' ' GLN . 10.6 t -162.2 -37.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.199 -0.938 . . . . 0.0 109.773 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -93.67 -147.68 0.25 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.57 -0.706 . . . . 0.0 109.27 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 23.4 tt0 -115.82 130.39 56.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.188 -0.945 . . . . 0.0 109.687 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.813 ' CG2' HG11 ' A' ' 11' ' ' VAL . 33.7 t -64.19 154.51 6.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.396 -0.815 . . . . 0.0 109.115 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.508 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 3.9 mmt180 -115.56 130.27 56.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.534 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.65 128.32 14.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -0.851 . . . . 0.0 109.228 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.772 HG21 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -152.3 160.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 0.0 109.26 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.582 ' HB3' HG12 ' B' ' 240' ' ' VAL . . . 47.95 -144.43 0.37 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.263 -0.898 . . . . 0.0 109.387 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -90.16 -8.44 51.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.088 -1.008 . . . . 0.0 109.645 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 3.1 mt-10 -104.13 -162.87 0.93 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.236 -0.915 . . . . 0.0 109.501 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.851 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . -175.71 168.56 3.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.0 109.677 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.917 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.52 136.66 18.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.02 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.699 ' HB3' HG13 ' A' ' 71' ' ' VAL . 15.2 p90 -150.01 167.46 26.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.953 -1.092 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.683 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -142.85 168.14 20.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.456 0.646 . . . . 0.0 109.622 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 4.5 p90 -164.59 -169.05 1.64 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -0.838 . . . . 0.0 109.277 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.87 141.83 50.34 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.484 -0.76 . . . . 0.0 109.814 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.804 HG12 ' HB3' ' A' ' 63' ' ' LEU . 16.4 t -118.12 112.98 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.364 -0.835 . . . . 0.0 109.116 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.911 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 96.5 p -107.42 99.07 8.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.205 -0.935 . . . . 0.0 109.271 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.547 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . 21.4 p90 -117.41 176.36 5.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.377 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 88' ' ' PHE . 60.7 tt0 -149.98 151.23 33.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.756 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.566 ' CZ ' ' OG1' ' A' ' 93' ' ' THR . 7.9 m-85 -96.71 -141.85 0.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.412 -0.805 . . . . 0.0 109.289 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -102.68 45.59 0.96 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.02 -1.05 . . . . 0.0 109.321 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.52 -42.95 0.46 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -107.7 164.75 11.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -1.191 . . . . 0.0 109.488 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -133.54 123.63 25.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 109.531 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -117.8 148.68 41.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.845 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.789 HG12 ' CG ' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -117.95 178.17 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 108.812 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.975 HG12 ' HD3' ' A' ' 97' ' ' PRO . 2.5 t -150.33 141.36 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.099 -1.001 . . . . 0.0 109.848 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 120' ' ' ASN . . . -129.1 73.02 81.98 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.482 -0.761 . . . . 0.0 109.877 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.975 ' HD3' HG12 ' A' ' 95' ' ' VAL . 50.4 Cg_endo -95.16 -179.37 0.58 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.448 1.432 . . . . 0.0 111.648 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.683 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.7 mp -141.48 133.42 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 5.2 t0 -107.29 162.73 13.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.865 -1.147 . . . . 0.0 110.413 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.527 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -114.75 173.66 6.36 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.111 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.851 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -145.44 146.38 31.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.895 -1.128 . . . . 0.0 110.72 -178.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.507 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -138.55 102.5 4.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.419 -0.801 . . . . 0.0 109.375 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.497 ' CE2' HG21 ' A' ' 10' ' ' VAL . 16.6 m-85 -89.6 174.28 7.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 109.381 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.909 ' HB3' HG21 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -114.27 -14.35 12.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.858 . . . . 0.0 109.122 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.716 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 114.93 78.84 0.8 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 163.23 -21.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.35 -1.088 . . . . 0.0 109.721 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 122.19 -35.65 3.43 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -59.56 175.5 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -1.184 . . . . 0.0 109.567 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.732 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 45.8 t -113.27 145.96 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.064 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.909 HG21 ' HB3' ' A' ' 104' ' ' ASN . 5.1 t -121.18 -73.39 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.103 -0.998 . . . . 0.0 109.389 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.439 ' HB2' ' HD2' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -114.66 166.64 11.52 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.029 -1.044 . . . . 0.0 109.047 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 19.6 ttp -154.92 137.41 15.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.165 -0.96 . . . . 0.0 109.902 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.506 ' HA ' ' HB2' ' A' ' 37' ' ' GLU . 3.0 mtm180 -111.55 161.59 16.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.79 . . . . 0.0 108.955 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.409 ' O ' ' CG1' ' A' ' 40' ' ' VAL . . . -143.47 132.26 22.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.98 -1.075 . . . . 0.0 109.77 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.897 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.3 OUTLIER -123.3 137.09 54.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.771 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.811 ' O ' HG11 ' B' ' 274' ' ' VAL . 0.3 OUTLIER 171.14 -162.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.508 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . 167.75 175.96 38.0 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.359 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.5 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 37.4 tt0 -48.95 -22.91 0.94 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -1.194 . . . . 0.0 109.281 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.483 ' NZ ' ' CD ' ' B' ' 270' ' ' GLU . 0.3 OUTLIER -73.33 -22.55 60.29 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.043 0.925 . . . . 0.0 108.92 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.809 ' ND2' HG13 ' A' ' 95' ' ' VAL . 0.5 OUTLIER -88.54 0.73 56.03 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.634 -179.422 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.675 ' HA ' HG22 ' A' ' 95' ' ' VAL . 3.0 mm -89.59 -159.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.912 -1.117 . . . . 0.0 108.703 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.789 ' CG ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.39 -168.4 3.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 109.637 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.41 147.16 23.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.542 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.91 118.45 1.47 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.264 -1.139 . . . . 0.0 109.479 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 34.1 mtp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.312 0.577 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -121.11 96.37 5.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.543 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 203' ' ' THR . 2.5 t -45.92 109.51 0.99 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.316 -0.865 . . . . 0.0 109.565 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.38 -2.95 12.49 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.894 1.471 . . . . 0.0 110.182 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.3 -49.25 77.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 109.35 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -65.11 -51.72 59.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.583 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 207' ' ' MET . . . . . 0.47 ' HE1' ' O ' ' B' ' 275' ' ' ALA . 25.2 mtt -60.24 -47.5 85.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.257 -0.902 . . . . 0.0 109.789 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 15.6 m -56.6 -38.72 72.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.164 -0.96 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -56.62 -49.07 76.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.121 -0.987 . . . . 0.0 108.99 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 1.022 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -52.27 -24.16 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.509 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.754 HG22 ' CE2' ' B' ' 301' ' ' PHE . 23.2 t -85.82 -44.77 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.4 -0.813 . . . . 0.0 109.302 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' B' ' 213' ' ' ARG . 7.4 tt0 -57.11 -73.89 0.06 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' B' ' 212' ' ' GLN . 1.3 mtt85 -43.59 -44.89 6.46 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' TYR . . . . . 0.63 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -51.24 -45.4 61.97 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.878 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.0 OUTLIER -86.14 -37.7 11.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -49.13 -36.01 18.0 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.572 ' HB1' HG13 ' B' ' 226' ' ' ILE . . . -74.3 -31.84 62.64 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.878 HD12 ' HA ' ' B' ' 215' ' ' VAL . 0.8 OUTLIER -65.65 -57.72 7.44 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 0.2 OUTLIER -56.04 -45.12 79.3 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.542 0.687 . . . . 0.0 109.148 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' B' ' 221' ' ' GLY . . . -89.36 11.21 19.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.525 -0.734 . . . . 0.0 109.603 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.952 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 45.3 32.51 3.72 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.2 t70 -90.18 63.19 5.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.48 -1.012 . . . . 0.0 109.829 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' LEU . . . . . 1.144 HD12 HD12 ' B' ' 226' ' ' ILE . 6.1 tp -48.51 -43.97 35.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.099 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' B' ' 223' ' ' LEU . 26.2 t0 -42.49 -31.02 0.39 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' B' ' 228' ' ' ALA . . . -86.33 -32.56 16.24 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 1.144 HD12 HD12 ' B' ' 223' ' ' LEU . 27.2 mt -62.77 -56.66 16.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.809 HG11 HG23 ' B' ' 248' ' ' THR . 78.7 t -56.3 -35.19 42.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 225' ' ' GLY . . . -60.58 -56.38 22.07 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 1.022 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.0 tp -59.9 -25.79 65.39 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.556 -0.715 . . . . 0.0 109.08 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . 0.67 ' HD2' ' HB3' ' B' ' 234' ' ' ALA . 7.4 m-85 -86.42 130.07 34.63 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.496 -0.752 . . . . 0.0 109.779 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -43.0 166.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 109.665 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -24.2 5.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.349 -0.844 . . . . 0.0 110.071 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.522 ' CB ' ' HA2' ' B' ' 247' ' ' GLY . 2.0 p30 -148.84 54.13 0.99 Allowed 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.572 -0.705 . . . . 0.0 109.437 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.826 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -68.04 165.08 18.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.659 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' THR . . . . . 0.994 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -115.71 156.54 25.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 109.767 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.524 ' O ' ' HB3' ' B' ' 244' ' ' PRO . 53.9 t -143.31 116.83 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.076 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' GLU . . . . . 0.547 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.2 mt-10 -88.9 105.52 17.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 108.873 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' ASP . . . . . 0.539 ' OD2' ' HB3' ' B' ' 314' ' ' ALA . 9.9 t70 179.54 141.63 0.31 Allowed Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.919 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . 0.474 ' HG2' ' OG ' ' B' ' 242' ' ' SER . 48.5 Cg_endo -74.63 -173.85 12.81 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.048 -2.063 . . . . 0.0 110.343 -0.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' A' ' 75' ' ' ALA . 1.2 t -76.84 135.12 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.131 -0.98 . . . . 0.0 109.124 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 89.73 -3.78 83.34 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' SER . . . . . 0.474 ' OG ' ' HG2' ' B' ' 239' ' ' PRO . 67.5 m -107.08 -132.76 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -1.145 . . . . 0.0 109.149 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' B' ' 242' ' ' SER . 19.9 mt-10 -148.43 133.62 9.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 120.616 -1.303 . . . . 0.0 110.042 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' PRO . . . . . 0.547 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.4 Cg_endo -64.39 -172.7 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.133 1.596 . . . . 0.0 111.3 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.595 ' HD3' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.69 105.99 3.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.994 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -93.0 162.24 14.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.282 -0.887 . . . . 0.0 110.616 -178.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . 0.627 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 97.51 159.35 30.9 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 248' ' ' THR . . . . . 0.809 HG23 HG11 ' B' ' 227' ' ' VAL . 7.3 m -73.23 -45.39 56.32 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.162 -1.199 . . . . 0.0 109.014 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -63.95 -24.17 67.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.826 . . . . 0.0 109.025 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -90.02 -59.05 2.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.313 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.826 HD11 ' N ' ' B' ' 234' ' ' ALA . 21.7 mt -47.58 -39.25 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.364 -0.835 . . . . 0.0 109.255 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 252' ' ' ARG . . . . . 0.778 ' CG ' HD23 ' B' ' 223' ' ' LEU . 15.6 ttt180 -76.0 -57.16 4.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 109.068 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 253' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 8.0 mt-10 -46.4 -29.39 1.68 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.033 -1.042 . . . . 0.0 108.609 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.8 OUTLIER -83.74 -72.64 0.45 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 255' ' ' PHE . . . . . 1.119 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.1 OUTLIER -48.84 -24.54 1.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.552 -0.718 . . . . 0.0 109.166 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . 0.561 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -74.91 -44.91 46.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 108.707 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 257' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 5.3 t30 -56.73 -34.33 67.41 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 18.8 t -72.29 -47.0 53.34 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.49 -0.756 . . . . 0.0 109.179 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 259' ' ' LEU . . . . . 0.952 HD21 ' CA ' ' B' ' 221' ' ' GLY . 9.5 tp -57.46 -18.11 16.68 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.345 -0.847 . . . . 0.0 109.315 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 260' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 1.8 mttm -64.44 -19.6 65.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 109.592 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 261' ' ' LEU . . . . . 0.96 HD22 HD21 ' B' ' 263' ' ' LEU . 0.3 OUTLIER -89.37 120.43 69.7 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 262' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 45.0 Cg_endo -70.57 94.55 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.791 1.416 . . . . 0.0 110.755 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.96 HD21 HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -133.15 157.16 46.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.0 109.498 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . 0.518 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -92.35 127.03 37.68 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 265' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' B' ' 218' ' ' LEU . 30.9 t -107.28 114.26 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 2.3 tt0 -150.1 95.76 2.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.084 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.54 HD11 HG11 ' B' ' 215' ' ' VAL . 2.7 mp -43.86 169.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 268' ' ' THR . . . . . 0.465 ' O ' ' O ' ' B' ' 269' ' ' GLN . 0.0 OUTLIER -129.01 -78.56 0.56 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.523 -0.736 . . . . 0.0 109.213 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 269' ' ' GLN . . . . . 0.823 ' OE1' ' HB3' ' B' ' 281' ' ' ALA . 2.0 pt20 -59.3 -149.19 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 270' ' ' GLU . . . . . 0.483 ' CD ' ' NZ ' ' A' ' 119' ' ' LYS . 31.6 tt0 -111.51 131.45 55.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.033 -1.042 . . . . 0.0 109.68 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 271' ' ' VAL . . . . . 1.054 HG13 ' HB3' ' B' ' 280' ' ' PHE . 72.8 t -52.85 144.06 4.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.32 -0.863 . . . . 0.0 109.342 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.544 ' HD2' ' CD1' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -105.75 130.25 53.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.935 . . . . 0.0 109.503 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' B' ' 278' ' ' ALA . . . -147.25 137.09 23.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 109.321 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 274' ' ' VAL . . . . . 0.811 HG11 ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -155.07 149.71 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 0.0 109.174 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 275' ' ' ALA . . . . . 0.47 ' O ' ' HE1' ' B' ' 207' ' ' MET . . . 49.82 -144.86 0.47 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.159 -0.963 . . . . 0.0 109.358 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 276' ' ' ASN . . . . . 0.471 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 2.0 m-20 -83.71 -20.7 32.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.728 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . 0.582 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 0.7 OUTLIER -89.88 -161.71 0.81 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.161 -0.962 . . . . 0.0 109.583 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 278' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' B' ' 277' ' ' GLU . . . 170.1 162.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.755 . . . . 0.0 109.079 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 279' ' ' ALA . . . . . 0.897 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -150.66 141.51 22.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.065 . . . . 0.0 109.236 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . 1.054 ' HB3' HG13 ' B' ' 271' ' ' VAL . 21.1 p90 -141.63 154.55 45.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.827 -1.171 . . . . 0.0 110.705 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 1.062 ' CB ' HD12 ' B' ' 298' ' ' ILE . . . -119.43 168.53 10.86 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 282' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 0.0 OUTLIER -177.14 -173.44 0.45 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.898 . . . . 0.0 109.766 179.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 283' ' ' THR . . . . . 0.981 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -135.19 141.1 45.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.375 -0.828 . . . . 0.0 110.215 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 284' ' ' VAL . . . . . 0.834 HG11 HD22 ' B' ' 263' ' ' LEU . 8.0 t -109.21 134.56 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 108.795 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 285' ' ' SER . . . . . 0.518 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 29.0 p -125.73 100.78 6.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.987 . . . . 0.0 110.08 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.592 ' CE1' ' HB ' ' B' ' 293' ' ' THR . 33.9 p90 -117.34 -168.73 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 108.785 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 287' ' ' GLU . . . . . 0.469 ' N ' ' CD2' ' B' ' 286' ' ' PHE . 16.7 tt0 -149.85 158.59 44.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.93 -1.106 . . . . 0.0 110.09 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . 0.405 ' CZ ' ' HE2' ' B' ' 286' ' ' PHE . 33.1 m-85 -105.6 -167.84 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.451 -0.781 . . . . 0.0 109.587 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.91 -20.94 3.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.378 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -160.66 -45.24 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -74.49 142.72 44.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -1.165 . . . . 0.0 109.522 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 292' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' B' ' 293' ' ' THR . 2.3 tmtt? -103.85 145.32 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.277 -0.89 . . . . 0.0 109.412 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 293' ' ' THR . . . . . 0.728 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -135.88 143.29 44.96 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.452 -0.78 . . . . 0.0 110.297 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 294' ' ' VAL . . . . . 0.613 HG12 ' CB ' ' B' ' 322' ' ' HIS . 9.0 p -121.26 169.41 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 0.981 ' O ' HG22 ' B' ' 283' ' ' THR . 22.8 t -136.48 160.71 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.758 -1.214 . . . . 0.0 110.499 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 296' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' B' ' 320' ' ' ASN . . . -140.62 62.54 18.62 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.629 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 297' ' ' PRO . . . . . 1.036 ' O ' HD13 ' B' ' 298' ' ' ILE . 43.5 Cg_endo -97.37 167.28 0.87 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.449 1.433 . . . . 0.0 112.01 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 1.062 HD12 ' CB ' ' B' ' 281' ' ' ALA . 3.9 mm -129.2 165.05 30.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . 0.648 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 14.7 t0 -135.06 156.27 49.31 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.201 -0.937 . . . . 0.0 109.909 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 300' ' ' HIS . . . . . 0.535 ' O ' ' CG ' ' B' ' 312' ' ' MET . 0.2 OUTLIER -108.19 175.36 5.5 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 301' ' ' PHE . . . . . 0.754 ' CE2' HG22 ' B' ' 211' ' ' VAL . 0.1 OUTLIER -149.74 136.62 19.48 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 110.026 -178.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.612 ' O ' HG23 ' B' ' 310' ' ' VAL . 10.4 ttt85 -138.48 113.76 9.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 109.11 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 303' ' ' PHE . . . . . 0.652 ' CE2' HG21 ' B' ' 210' ' ' VAL . 3.9 m-85 -95.09 178.82 5.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.468 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 304' ' ' ASN . . . . . 0.719 ' HB3' HG11 ' B' ' 310' ' ' VAL . 3.6 p30 -111.87 -21.8 11.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.358 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . 122.35 32.76 0.94 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . -144.49 9.47 1.39 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.218 -1.166 . . . . 0.0 109.964 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 87.05 -19.28 31.31 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.81 -177.26 6.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -1.205 . . . . 0.0 109.561 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 309' ' ' VAL . . . . . 0.547 ' CG2' HG22 ' B' ' 210' ' ' VAL . 61.0 t -112.69 137.12 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.163 -0.961 . . . . 0.0 109.154 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . 0.719 HG11 ' HB3' ' B' ' 304' ' ' ASN . 0.0 OUTLIER -119.37 -61.57 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.079 -1.013 . . . . 0.0 109.799 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.91 162.85 17.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.045 -1.035 . . . . 0.0 109.67 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 312' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 29.2 ttp -159.02 145.93 17.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 313' ' ' ARG . . . . . 0.53 ' HB2' ' CB ' ' B' ' 300' ' ' HIS . 48.1 mtp180 -125.18 173.15 8.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.223 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 314' ' ' ALA . . . . . 0.539 ' HB3' ' OD2' ' B' ' 238' ' ' ASP . . . -150.17 150.88 32.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.032 . . . . 0.0 109.445 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 315' ' ' LEU . . . . . 0.917 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -136.25 142.52 44.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 110.048 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 316' ' ' PHE . . . . . 0.772 ' O ' HG21 ' A' ' 74' ' ' VAL . 1.2 p90 174.63 -155.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.652 0.739 . . . . 0.0 109.125 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 317' ' ' GLY . . . . . 0.471 ' N ' ' CG ' ' B' ' 316' ' ' PHE . . . 159.79 -172.14 36.28 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 318' ' ' GLU . . . . . 0.654 ' HA ' HD12 ' B' ' 321' ' ' ILE . 6.3 tt0 -65.29 -6.73 10.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -1.108 . . . . 0.0 109.7 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -101.12 -17.99 16.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.323 -0.861 . . . . 0.0 109.699 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 320' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' B' ' 296' ' ' ALA . 1.4 m-20 -88.94 -23.18 22.75 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.607 -0.683 . . . . 0.0 110.189 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 321' ' ' ILE . . . . . 0.922 ' CG2' HG22 ' B' ' 295' ' ' VAL . 0.6 OUTLIER -87.18 -158.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.072 -1.018 . . . . 0.0 108.546 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 322' ' ' HIS . . . . . 0.728 ' O ' HG22 ' B' ' 293' ' ' THR . 0.3 OUTLIER -151.61 161.61 42.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.974 -1.079 . . . . 0.0 110.064 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.353 -0.842 . . . . 0.0 109.414 179.868 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.655 ' O ' HG23 ' A' ' 3' ' ' THR . 7.1 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.41 -8.68 23.83 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.864 1.455 . . . . 0.0 109.784 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -61.81 -60.26 3.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.812 . . . . 0.0 109.243 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -61.33 -45.19 95.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.156 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.5 mtt -58.73 -28.81 66.2 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.223 -0.923 . . . . 0.0 109.333 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 11' ' ' VAL . 17.5 m -74.33 -44.14 53.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 109.059 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.25 -40.23 23.99 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.004 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.2 t -53.35 -26.76 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.866 HG11 ' CG2' ' A' ' 71' ' ' VAL . 7.6 t -90.02 -42.55 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.491 -0.756 . . . . 0.0 109.101 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 15' ' ' VAL . 20.7 tt0 -62.05 -73.92 0.1 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.482 ' HB3' HD22 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -41.61 -44.18 2.99 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 122.041 0.924 . . . . 0.0 108.524 178.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.641 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -53.39 -45.58 69.33 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.897 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -84.63 -38.98 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 0.0 109.555 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.69 -35.74 14.63 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.56 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -74.88 -31.69 61.66 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.984 ' HB3' HG21 ' A' ' 65' ' ' VAL . 1.2 mt -65.7 -58.83 4.77 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -51.9 -45.38 64.18 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . -89.5 9.98 24.53 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.574 -0.704 . . . . 0.0 109.645 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.959 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 45.32 31.52 3.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 17' ' ' ALA . 6.8 t0 -89.82 68.64 7.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -1.062 . . . . 0.0 109.936 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.042 HD11 ' HB3' ' A' ' 55' ' ' PHE . 4.9 tp -49.35 -42.12 40.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -42.1 -30.56 0.3 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -87.96 -37.2 7.95 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.955 HD12 HD12 ' A' ' 23' ' ' LEU . 22.0 mt -59.64 -53.59 46.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.536 HG21 ' CG ' ' A' ' 52' ' ' ARG . 84.9 t -58.57 -36.17 58.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -60.6 -50.83 71.94 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.004 HD21 ' HA ' ' A' ' 10' ' ' VAL . 7.5 tp -65.61 -21.72 66.6 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.547 -0.721 . . . . 0.0 109.182 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.524 ' CG ' HG21 ' A' ' 51' ' ' ILE . 2.8 m-85 -84.6 135.5 34.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.419 -0.801 . . . . 0.0 109.609 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -54.17 -175.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.46 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.4 OUTLIER -75.76 -23.23 55.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.885 . . . . 0.0 109.54 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.548 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -140.13 36.76 1.92 Allowed 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.59 -0.694 . . . . 0.0 109.357 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -51.38 -176.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.499 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.553 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.3 OUTLIER -142.49 134.13 26.72 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.373 -0.83 . . . . 0.0 109.432 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.802 ' CG2' HD12 ' A' ' 51' ' ' ILE . 31.6 t -127.27 128.3 70.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.337 -0.852 . . . . 0.0 108.88 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 21.9 mt-10 -101.15 114.18 27.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.475 ' HA ' ' C ' ' A' ' 39' ' ' PRO . 12.1 t70 -179.33 142.63 0.38 Allowed Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.608 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 38' ' ' ASP . 46.9 Cg_endo -73.75 -179.26 24.86 Favored 'Cis proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.194 -2.002 . . . . 0.0 110.797 -0.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.841 HG21 HG11 ' B' ' 274' ' ' VAL . 27.6 m -66.9 82.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . -170.69 28.5 0.12 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER 70.5 47.46 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -1.11 . . . . 0.0 109.86 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.55 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 4.7 mt-10 -132.83 57.5 28.8 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 109.844 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 50.3 Cg_endo -79.84 177.22 8.62 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 124.163 1.612 . . . . 0.0 110.653 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' HD3' ' CA ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -151.59 107.22 3.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 109.251 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.648 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -89.56 157.45 18.06 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.263 -0.898 . . . . 0.0 110.117 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 100.52 166.37 28.55 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.513 HG23 HG13 ' A' ' 27' ' ' VAL . 3.0 m -75.2 -58.63 3.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.138 -1.213 . . . . 0.0 109.012 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -54.44 -44.88 72.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.211 -0.931 . . . . 0.0 109.076 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 46' ' ' SER . . . -59.26 -34.01 71.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.45 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.802 HD12 ' CG2' ' A' ' 36' ' ' VAL . 7.6 mm -79.72 -36.23 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.685 ' CG ' HD23 ' A' ' 23' ' ' LEU . 26.7 ttp85 -78.51 -56.64 4.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.068 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.9 mt-10 -45.76 -27.25 0.79 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.494 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -83.14 -70.22 0.57 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.174 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 1.042 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.26 -24.1 1.08 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.611 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -78.85 -47.31 16.83 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 19.2 t-20 -64.65 -28.37 69.57 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.6 t -78.08 -42.26 32.72 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.959 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.9 tp -60.85 -17.86 52.57 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.405 -0.809 . . . . 0.0 108.903 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 4.8 mttm -55.16 -18.64 6.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.479 -0.763 . . . . 0.0 108.972 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.78 HD23 HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -89.16 118.25 69.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.162 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 43.8 Cg_endo -71.34 110.42 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.748 1.393 . . . . 0.0 110.716 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.78 ' HB2' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -145.82 176.44 9.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.888 . . . . 0.0 110.053 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.73 126.12 54.88 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.984 HG21 ' HB3' ' A' ' 18' ' ' LEU . 3.7 t -104.29 117.96 50.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.682 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -146.09 105.57 3.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.133 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.519 ' O ' HG23 ' A' ' 68' ' ' THR . 0.7 OUTLIER -47.41 175.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -0.929 . . . . 0.0 109.633 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 67' ' ' LEU . 2.7 p -155.8 -38.01 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.705 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.492 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 5.7 pt20 -99.21 -152.47 0.41 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.63 -0.669 . . . . 0.0 109.198 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 30.4 tt0 -109.8 130.38 55.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.15 -0.969 . . . . 0.0 109.787 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.866 ' CG2' HG11 ' A' ' 11' ' ' VAL . 37.2 t -60.01 145.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.333 -0.855 . . . . 0.0 108.996 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.645 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 1.7 ttm180 -106.26 134.48 49.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.662 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.497 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -146.7 145.51 30.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 109.232 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.833 ' CG1' HG21 ' B' ' 240' ' ' VAL . 0.2 OUTLIER -136.03 -151.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.191 -0.943 . . . . 0.0 109.562 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -34.59 -90.85 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.973 -0.454 . . . . 0.0 110.804 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 4.9 p-10 -112.89 -15.8 12.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.083 -1.011 . . . . 0.0 110.328 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.652 ' HG2' ' N ' ' A' ' 78' ' ' ALA . 1.4 tt0 -108.5 162.55 14.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.019 -1.051 . . . . 0.0 108.999 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.652 ' N ' ' HG2' ' A' ' 77' ' ' GLU . . . -143.12 177.16 8.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.38 -0.825 . . . . 0.0 110.224 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.912 ' HB2' HD11 ' B' ' 315' ' ' LEU . . . -150.1 137.07 19.41 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.66 ' CE1' ' CE2' ' A' ' 101' ' ' PHE . 31.8 p90 -150.32 170.83 18.09 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.706 -1.246 . . . . 0.0 110.137 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.878 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -139.62 -166.4 2.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.556 -0.715 . . . . 0.0 109.56 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CD2' ' C ' ' A' ' 81' ' ' ALA . 6.8 p90 174.23 -171.46 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.441 -0.787 . . . . 0.0 109.075 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.73 144.0 50.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.357 -0.84 . . . . 0.0 109.808 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.78 HG13 ' HB2' ' A' ' 63' ' ' LEU . 12.1 t -116.78 115.0 47.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.537 ' HA ' HG23 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -106.58 103.43 12.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.077 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.578 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 4.3 p90 -122.23 177.04 5.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.228 -0.92 . . . . 0.0 109.561 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -106.25 -179.95 4.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.174 -0.954 . . . . 0.0 110.466 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.497 ' C ' ' CG ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -137.67 43.18 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 109.549 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.497 ' CG ' ' C ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER 39.71 75.97 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.421 -0.799 . . . . 0.0 109.886 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.52 -41.49 2.01 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -125.46 179.35 5.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.41 -1.053 . . . . 0.0 108.928 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.502 ' HG2' ' N ' ' A' ' 93' ' ' THR . 0.4 OUTLIER -126.11 140.8 52.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.007 -1.058 . . . . 0.0 109.884 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.572 ' HB ' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -136.81 152.58 50.44 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.801 HG12 ' CG ' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -126.52 -178.85 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.994 . . . . 0.0 109.112 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 1.078 HG22 HG23 ' A' ' 121' ' ' ILE . 2.9 t -150.01 141.04 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 108.992 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.38 71.63 82.03 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.394 -0.816 . . . . 0.0 110.528 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.965 ' HD3' HG12 ' A' ' 95' ' ' VAL . 54.0 Cg_endo -95.88 -173.55 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.559 1.506 . . . . 0.0 110.854 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.878 HG23 ' HB2' ' A' ' 81' ' ' ALA . 3.1 mp -141.88 167.03 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 32.8 t0 -135.24 159.26 42.12 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 109.828 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.525 ' NE2' ' HG3' ' A' ' 77' ' ' GLU . 71.2 t60 -123.78 133.71 53.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.426 -0.797 . . . . 0.0 108.876 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.66 ' CE2' ' CE1' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -109.76 145.67 36.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.203 -0.935 . . . . 0.0 109.89 -179.039 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 111' ' ' SER . 6.2 ttt180 -145.06 114.22 7.0 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.784 ' CE2' HG21 ' A' ' 10' ' ' VAL . 21.4 m-85 -89.61 -166.58 1.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.046 -1.034 . . . . 0.0 109.693 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.41 ' HB3' HG21 ' A' ' 110' ' ' VAL . 1.4 p30 -132.11 -43.01 0.97 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.711 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -142.78 -62.23 0.02 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 163.87 76.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -1.149 . . . . 0.0 109.608 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -166.07 -49.53 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.27 -162.7 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -1.209 . . . . 0.0 109.545 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.655 HG23 HG22 ' A' ' 10' ' ' VAL . 54.5 t -97.46 143.18 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.331 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 56.6 t -125.12 -11.93 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.777 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.49 ' HB2' ' HB3' ' A' ' 102' ' ' ARG . 13.0 m -159.09 156.1 28.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.412 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.562 ' SD ' ' CE1' ' A' ' 101' ' ' PHE . 8.4 ttp -160.31 149.3 17.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.969 . . . . 0.0 109.86 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -129.7 147.24 51.47 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.77 132.33 54.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.999 -1.063 . . . . 0.0 110.035 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.854 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.4 OUTLIER -122.43 141.65 51.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.363 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.55 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 4.3 p90 175.02 -152.47 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.476 ' N ' ' CG ' ' A' ' 116' ' ' PHE . . . 166.31 169.08 29.46 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.484 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 19.8 tt0 -68.64 -6.45 25.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -1.096 . . . . 0.0 109.473 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' CD ' ' HG3' ' B' ' 204' ' ' PRO . 0.0 OUTLIER -91.85 -26.17 18.62 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.981 0.896 . . . . 0.0 108.886 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.496 ' OD1' ' NH2' ' B' ' 272' ' ' ARG . 0.1 OUTLIER -88.9 14.12 11.15 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.078 HG23 HG22 ' A' ' 95' ' ' VAL . 4.5 mm -90.68 -150.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.801 ' CG ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.79 174.19 13.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.005 . . . . 0.0 109.538 179.372 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.56 88.12 1.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.9 . . . . 0.0 109.32 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -66.77 133.62 32.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.347 -1.09 . . . . 0.0 109.508 -179.972 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.244 0.545 . . . . 0.0 110.144 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' B' ' 201' ' ' MET . 4.1 m-80 61.88 77.48 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -0.828 . . . . 0.0 109.673 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . 0.513 HG23 ' O ' ' B' ' 203' ' ' THR . 3.0 t -61.96 116.69 23.03 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.668 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 204' ' ' PRO . . . . . 0.407 ' HG3' ' CD ' ' A' ' 119' ' ' LYS . 44.5 Cg_endo -71.52 -3.8 13.75 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.868 1.457 . . . . 0.0 109.96 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -59.71 -63.11 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.489 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -58.06 -43.98 87.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 109.397 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 18.1 mtt -57.61 -28.53 63.73 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.289 -0.882 . . . . 0.0 109.629 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.448 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 6.0 m -76.69 -35.89 57.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.076 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -53.85 -45.45 70.93 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.238 -0.914 . . . . 0.0 108.809 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 1.095 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.2 t -51.72 -27.1 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.983 HG11 HG21 ' B' ' 271' ' ' VAL . 40.1 t -83.4 -46.05 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.485 -0.759 . . . . 0.0 109.706 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' B' ' 213' ' ' ARG . 28.4 tt0 -56.86 -73.6 0.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.245 1.022 . . . . 0.0 108.312 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' B' ' 212' ' ' GLN . 1.6 mtt85 -43.06 -44.38 4.8 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.972 0.891 . . . . 0.0 108.655 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' TYR . . . . . 0.637 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -51.26 -45.3 62.0 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.952 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.2 t -88.42 -40.12 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.903 . . . . 0.0 109.359 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.23 -36.23 13.47 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.527 ' HB1' HG13 ' B' ' 226' ' ' ILE . . . -74.56 -33.63 62.74 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' B' ' 215' ' ' VAL . 3.4 mt -63.86 -58.58 6.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -53.38 -46.1 69.49 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.461 0.648 . . . . 0.0 109.476 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.32 9.22 26.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.529 -0.732 . . . . 0.0 109.649 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.92 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 48.6 37.19 19.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' B' ' 217' ' ' ALA . 25.5 t0 -97.93 61.17 1.52 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -1.114 . . . . 0.0 109.791 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' LEU . . . . . 1.085 HD11 ' HB3' ' B' ' 255' ' ' PHE . 2.2 tp -46.89 -39.45 12.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.03 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' B' ' 223' ' ' LEU . 0.5 OUTLIER -40.63 -31.31 0.15 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' B' ' 223' ' ' LEU . . . -88.86 -37.27 7.39 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.918 HD12 HD12 ' B' ' 223' ' ' LEU . 12.5 mt -58.54 -54.11 37.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.474 HG21 ' HG3' ' B' ' 252' ' ' ARG . 46.6 t -58.43 -41.69 82.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.34 -46.88 76.35 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 1.095 HD21 ' HA ' ' B' ' 210' ' ' VAL . 4.4 tp -69.75 -30.16 67.68 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.594 -0.691 . . . . 0.0 109.234 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . 0.736 ' CD2' HG21 ' B' ' 251' ' ' ILE . 4.8 m-85 -79.46 129.92 34.92 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.393 -0.817 . . . . 0.0 109.726 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -49.19 179.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.462 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -66.91 -23.49 65.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.769 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.517 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 0.0 OUTLIER -146.94 53.76 1.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.482 -0.761 . . . . 0.0 109.584 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.675 ' HB3' ' HD2' ' B' ' 230' ' ' PHE . . . -64.47 155.91 31.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' THR . . . . . 0.608 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -98.36 160.06 14.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.399 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.712 HG23 ' CD1' ' B' ' 251' ' ' ILE . 1.9 t -139.49 173.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 108.875 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' GLU . . . . . 0.583 ' N ' ' CG1' ' B' ' 236' ' ' VAL . 4.7 mt-10 -150.14 104.29 3.26 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' ASP . . . . . 0.546 ' OD2' ' CB ' ' B' ' 314' ' ' ALA . 0.4 OUTLIER -177.37 139.03 0.42 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.95 -1.094 . . . . 0.0 109.559 -178.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . 0.514 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 45.9 Cg_endo -72.87 -173.21 10.54 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.185 -2.006 . . . . 0.0 110.358 -0.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.833 HG21 ' CG1' ' A' ' 74' ' ' VAL . 34.8 m -70.52 81.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.968 . . . . 0.0 109.292 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' B' ' 242' ' ' SER . . . -174.57 35.22 0.11 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' B' ' 241' ' ' GLY . 0.5 OUTLIER 70.16 53.25 0.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -1.141 . . . . 0.0 109.786 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . 0.474 ' HB2' ' C ' ' B' ' 238' ' ' ASP . 1.4 mt-10 -130.11 61.37 58.09 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.374 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 50.7 Cg_endo -78.03 169.24 20.76 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.287 1.678 . . . . 0.0 110.822 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.525 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.36 99.09 2.74 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.705 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -91.23 167.62 12.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 110.348 -178.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . 0.517 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 92.42 162.51 37.21 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 248' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 1.9 m -75.13 -49.44 19.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -1.16 . . . . 0.0 108.882 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -56.6 -42.24 78.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.891 . . . . 0.0 109.122 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -66.44 -55.01 17.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.935 . . . . 0.0 109.362 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.736 HG21 ' CD2' ' B' ' 230' ' ' PHE . 12.6 mm -53.71 -45.54 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 252' ' ' ARG . . . . . 0.832 ' HG3' HD23 ' B' ' 223' ' ' LEU . 8.4 ttm180 -73.39 -57.82 3.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.128 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 253' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 31.2 tt0 -45.64 -27.83 0.86 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.095 -1.003 . . . . 0.0 108.704 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 1.0 OUTLIER -87.49 -71.09 0.58 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 255' ' ' PHE . . . . . 1.085 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -48.24 -24.44 1.18 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . 0.5 ' HB2' HD22 ' B' ' 223' ' ' LEU . . . -79.72 -48.44 13.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.857 . . . . 0.0 108.89 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 257' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 18.4 t30 -60.04 -33.52 72.15 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.34 -0.85 . . . . 0.0 108.743 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 9.7 t -71.44 -38.26 71.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 259' ' ' LEU . . . . . 0.92 HD21 ' CA ' ' B' ' 221' ' ' GLY . 9.2 tp -62.59 -21.43 65.62 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.392 -0.818 . . . . 0.0 109.028 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 260' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 20.9 mtmt -64.48 -11.12 30.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.313 -0.867 . . . . 0.0 109.178 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 261' ' ' LEU . . . . . 0.982 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.3 OUTLIER -89.3 117.69 68.44 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 262' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 41.5 Cg_endo -68.72 80.21 0.63 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.833 1.438 . . . . 0.0 110.683 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.982 ' CD2' HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -118.27 165.47 13.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.357 -0.839 . . . . 0.0 109.616 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . 0.707 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -101.8 130.81 48.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -0.816 . . . . 0.0 108.859 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 30.0 t -116.92 114.3 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.031 -1.043 . . . . 0.0 110.085 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 28.7 tt0 -150.33 100.78 2.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.83 . . . . 0.0 109.148 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.527 ' O ' ' CG2' ' B' ' 268' ' ' THR . 0.6 OUTLIER -48.27 177.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.725 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 268' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' B' ' 267' ' ' LEU . 80.8 p -159.16 -37.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.336 -0.852 . . . . 0.0 109.768 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 269' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' B' ' 270' ' ' GLU . 0.0 OUTLIER -93.55 -150.45 0.28 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.563 -0.71 . . . . 0.0 109.427 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 270' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' B' ' 269' ' ' GLN . 27.1 tt0 -112.55 130.56 55.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.652 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 271' ' ' VAL . . . . . 1.074 HG13 ' HB3' ' B' ' 280' ' ' PHE . 75.5 t -67.54 147.71 12.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.356 -0.84 . . . . 0.0 109.082 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.63 ' CZ ' HD11 ' A' ' 98' ' ' ILE . 0.8 OUTLIER -103.71 138.11 40.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.175 -0.953 . . . . 0.0 109.896 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.1 132.32 15.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 274' ' ' VAL . . . . . 0.841 HG11 HG21 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -125.87 -152.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.95 . . . . 0.0 109.797 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 275' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' B' ' 274' ' ' VAL . . . -35.7 -96.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.898 -0.502 . . . . 0.0 110.899 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 276' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' B' ' 303' ' ' PHE . 1.9 m-20 -110.42 17.09 21.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.017 -1.052 . . . . 0.0 110.268 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 0.5 OUTLIER -124.33 -160.04 0.91 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.932 -1.105 . . . . 0.0 109.628 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 278' ' ' ALA . . . . . 1.011 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 172.08 160.18 0.1 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.545 -0.722 . . . . 0.0 109.65 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 279' ' ' ALA . . . . . 0.854 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -150.73 133.93 16.16 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . 1.074 ' HB3' HG13 ' B' ' 271' ' ' VAL . 22.6 p90 -150.2 168.5 23.8 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.838 -1.164 . . . . 0.0 110.275 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.958 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -138.46 -164.83 1.7 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 282' ' ' PHE . . . . . 0.439 ' CD2' ' C ' ' B' ' 281' ' ' ALA . 8.2 p90 168.16 -169.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 283' ' ' THR . . . . . 0.463 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -124.07 141.17 52.28 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 109.54 179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 284' ' ' VAL . . . . . 0.75 HG11 HD22 ' B' ' 263' ' ' LEU . 40.0 t -124.35 113.21 35.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.158 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 285' ' ' SER . . . . . 0.707 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 3.5 p -113.76 117.44 31.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.325 -0.86 . . . . 0.0 109.452 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.568 ' CE1' ' HB ' ' B' ' 293' ' ' THR . 17.0 p90 -123.27 176.27 6.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.19 -0.944 . . . . 0.0 109.555 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 287' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' B' ' 291' ' ' ARG . 29.8 tt0 -128.46 151.93 48.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.555 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . 0.47 ' CE2' ' CZ ' ' B' ' 286' ' ' PHE . 28.1 m-85 -95.16 -107.2 0.14 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.213 -0.93 . . . . 0.0 109.388 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.61 -17.92 7.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.984 -1.072 . . . . 0.0 109.444 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -149.59 -40.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 291' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' B' ' 287' ' ' GLU . 33.1 mtt85 -90.4 -176.91 4.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -1.117 . . . . 0.0 109.417 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 292' ' ' LYS . . . . . 0.468 ' O ' ' CD ' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -136.75 133.95 36.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.312 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 293' ' ' THR . . . . . 0.795 HG22 ' HA ' ' B' ' 323' ' ' ALA . 0.0 OUTLIER -118.32 145.99 44.68 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.186 -0.946 . . . . 0.0 110.094 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 294' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' B' ' 322' ' ' HIS . 11.8 p -116.47 163.74 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.335 -0.853 . . . . 0.0 108.866 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 0.9 HG22 HG23 ' B' ' 321' ' ' ILE . 49.1 t -139.41 156.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.032 -1.043 . . . . 0.0 110.444 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 296' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' B' ' 320' ' ' ASN . . . -142.13 68.73 22.63 Favored Pre-proline 0 N--CA 1.495 1.802 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 297' ' ' PRO . . . . . 0.609 ' HD3' HG12 ' B' ' 295' ' ' VAL . 48.3 Cg_endo -97.03 -175.42 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.877 1.718 . . . . 0.0 111.487 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.958 HG23 ' HB2' ' B' ' 281' ' ' ALA . 3.0 mp -140.44 169.4 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . 0.606 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 39.1 t0 -138.86 158.8 43.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.021 -1.049 . . . . 0.0 110.014 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 300' ' ' HIS . . . . . 0.533 ' HB2' ' CB ' ' B' ' 313' ' ' ARG . 0.2 OUTLIER -113.87 172.96 6.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.382 -0.824 . . . . 0.0 108.944 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 301' ' ' PHE . . . . . 1.011 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.2 OUTLIER -144.95 146.64 32.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.123 -0.986 . . . . 0.0 110.49 -178.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.549 ' HB3' ' CB ' ' B' ' 311' ' ' SER . 25.4 ttt180 -144.16 108.72 4.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.476 -0.765 . . . . 0.0 108.952 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 303' ' ' PHE . . . . . 0.708 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 37.3 m-85 -89.83 179.88 5.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.799 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 304' ' ' ASN . . . . . 0.635 ' CB ' HG21 ' B' ' 310' ' ' VAL . 0.1 OUTLIER -150.13 16.79 0.85 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.332 -0.855 . . . . 0.0 109.245 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 305' ' ' GLY . . . . . 0.715 ' O ' ' HB3' ' B' ' 306' ' ' ALA . . . 98.21 154.03 28.98 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 306' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 305' ' ' GLY . . . 79.49 -5.68 1.9 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.405 -1.056 . . . . 0.0 109.824 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 83.14 -10.19 58.9 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.3 174.15 4.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.103 -1.233 . . . . 0.0 109.455 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 309' ' ' VAL . . . . . 0.621 HG11 ' CE ' ' B' ' 312' ' ' MET . 95.1 t -109.89 151.9 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.158 -0.964 . . . . 0.0 109.027 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . 0.666 ' O ' ' HB1' ' B' ' 234' ' ' ALA . 53.3 t -137.32 -56.56 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.957 -1.089 . . . . 0.0 110.156 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . 0.549 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -118.48 160.61 21.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.615 -1.303 . . . . 0.0 109.917 -179.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 312' ' ' MET . . . . . 0.621 ' CE ' HG11 ' B' ' 309' ' ' VAL . 10.2 ttm -159.92 141.69 12.92 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.431 -0.793 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 313' ' ' ARG . . . . . 0.533 ' CB ' ' HB2' ' B' ' 300' ' ' HIS . 0.3 OUTLIER -116.95 158.38 24.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.393 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 314' ' ' ALA . . . . . 0.546 ' CB ' ' OD2' ' B' ' 238' ' ' ASP . . . -124.31 138.03 54.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.28 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 315' ' ' LEU . . . . . 0.912 HD11 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -133.73 142.27 47.89 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.137 -0.977 . . . . 0.0 109.89 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 316' ' ' PHE . . . . . 0.543 ' O ' HG13 ' A' ' 74' ' ' VAL . 53.7 p90 171.18 -156.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 317' ' ' GLY . . . . . 0.737 ' O ' HD12 ' B' ' 321' ' ' ILE . . . 154.71 176.59 27.15 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 318' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' B' ' 318' ' ' GLU . 13.4 tt0 -55.43 -17.74 5.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -1.185 . . . . 0.0 109.136 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -87.49 -24.99 23.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.871 0.843 . . . . 0.0 109.077 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 320' ' ' ASN . . . . . 0.708 ' O ' ' HB3' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.27 -34.89 16.44 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 321' ' ' ILE . . . . . 0.9 HG23 HG22 ' B' ' 295' ' ' VAL . 0.9 OUTLIER -86.32 -172.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 322' ' ' HIS . . . . . 0.694 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.0 OUTLIER -151.63 172.8 15.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.091 -1.005 . . . . 0.0 109.814 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.795 ' HA ' HG22 ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.402 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.584 ' O ' ' HE2' ' A' ' 7' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.03 1.65 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.973 1.512 . . . . 0.0 110.279 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -58.63 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 110.048 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.517 ' NE2' ' HB ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -45.57 -32.75 2.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.115 -0.99 . . . . 0.0 109.279 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 1.014 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 25.3 mtm -70.89 -57.69 4.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 109.732 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 11' ' ' VAL . 16.6 m -58.57 -38.14 77.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.81 -42.66 47.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.195 -0.941 . . . . 0.0 108.652 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.893 HG11 ' CE1' ' A' ' 103' ' ' PHE . 2.9 t -60.03 -20.93 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.867 HG11 HG21 ' A' ' 71' ' ' VAL . 40.0 t -90.47 -47.91 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -58.26 -61.76 2.33 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.125 -0.984 . . . . 0.0 109.022 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.77 ' HB3' HD22 ' A' ' 29' ' ' LEU . 3.2 mtm-85 -53.97 -46.66 71.7 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.909 0.861 . . . . 0.0 108.838 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.632 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -48.72 -42.69 35.93 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.964 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.3 t -88.5 -38.74 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.315 -0.866 . . . . 0.0 109.379 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.45 -37.72 18.0 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.608 ' HB3' HG12 ' A' ' 26' ' ' ILE . . . -72.62 -33.76 66.87 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.964 HD12 ' HA ' ' A' ' 15' ' ' VAL . 4.5 mt -65.31 -60.58 2.83 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -51.0 -41.19 59.6 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.567 0.698 . . . . 0.0 109.23 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.31 2.26 54.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.484 -0.76 . . . . 0.0 109.55 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 1.046 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 52.24 41.89 54.96 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.421 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 45.6 t0 -105.17 80.18 1.57 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -1.091 . . . . 0.0 110.052 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.028 ' CD2' HD22 ' A' ' 59' ' ' LEU . 3.9 mm? -51.37 -20.67 1.84 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.188 -0.945 . . . . 0.0 109.745 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -61.12 -54.85 39.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.256 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -64.71 -29.57 75.59 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.028 HD12 HD13 ' A' ' 23' ' ' LEU . 6.9 mt -66.26 -59.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.772 HG21 ' HB2' ' A' ' 52' ' ' ARG . 60.0 t -61.53 -40.55 86.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.13 -51.83 65.19 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.77 HD22 ' HB3' ' A' ' 13' ' ' ARG . 8.6 tp -64.3 -26.4 68.47 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.486 ' HB2' ' HA ' ' A' ' 27' ' ' VAL . 5.2 m-85 -87.57 131.11 34.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.495 -0.753 . . . . 0.0 109.766 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -45.44 171.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.834 . . . . 0.0 109.642 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.405 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -61.75 -24.02 66.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.709 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.543 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -141.05 52.03 1.59 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.571 -0.706 . . . . 0.0 109.681 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -67.16 168.51 10.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.718 HG23 ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -127.76 137.67 52.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.391 -0.818 . . . . 0.0 109.302 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 55.8 t -133.29 123.73 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.275 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.511 ' OE2' ' NH1' ' A' ' 113' ' ' ARG . 96.0 mt-10 -89.17 108.4 19.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 108.58 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 39' ' ' PRO . 9.8 t0 -177.99 142.29 0.45 Allowed Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 119.229 -0.989 . . . . 0.0 110.058 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.512 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 47.7 Cg_endo -72.75 -179.24 23.67 Favored 'Cis proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.214 -1.994 . . . . 0.0 110.564 -0.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.702 ' O ' HG23 ' A' ' 40' ' ' VAL . 14.4 m -73.57 112.81 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.511 ' HA2' ' ND2' ' B' ' 276' ' ' ASN . . . 103.99 12.65 29.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.512 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 4.0 m -118.56 -107.04 0.38 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -1.145 . . . . 0.0 109.458 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -166.87 130.64 1.53 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.874 -1.141 . . . . 0.0 109.88 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 41.6 Cg_endo -67.3 -168.25 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.952 1.501 . . . . 0.0 111.201 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.999 ' HG3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -150.43 102.82 3.08 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.718 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.93 152.04 21.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.325 -0.86 . . . . 0.0 110.024 -179.151 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 104.43 173.96 25.03 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.457 HG23 HG11 ' A' ' 27' ' ' VAL . 4.7 m -79.36 -68.81 0.63 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.05 -1.265 . . . . 0.0 109.376 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -47.16 -32.92 4.7 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.135 -0.978 . . . . 0.0 109.012 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.999 ' HB1' ' HG3' ' A' ' 45' ' ' ARG . . . -70.96 -51.17 27.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.18 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 47' ' ' GLY . 7.5 mm -58.67 -43.65 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.534 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.772 ' HB2' HG21 ' A' ' 27' ' ' VAL . 18.8 ttt180 -73.29 -56.11 5.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 108.983 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 52' ' ' ARG . 14.6 tt0 -45.74 -27.04 0.74 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 108.617 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -88.27 -71.09 0.6 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.72 0.772 . . . . 0.0 108.918 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.585 ' C ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -52.1 -20.92 2.79 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.476 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 52' ' ' ARG . . . -80.82 -45.52 16.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.175 -0.953 . . . . 0.0 108.452 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 2.4 t30 -56.82 -30.52 63.83 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.4 t -69.92 -37.8 76.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.046 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.0 tp -67.27 -19.68 65.53 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.45 -0.781 . . . . 0.0 109.735 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 2.7 mtmt -56.36 -25.57 49.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.906 HD22 ' CD2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.89 125.69 59.94 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.179 -0.951 . . . . 0.0 109.079 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 44.1 Cg_endo -70.78 101.1 1.01 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.759 1.4 . . . . 0.0 110.349 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.906 ' CD2' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -137.99 150.31 46.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.568 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.704 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -89.65 127.52 35.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.193 -0.942 . . . . 0.0 108.793 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 t -108.43 114.01 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 0.0 109.851 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 67' ' ' LEU . 16.8 tt0 -150.44 98.68 2.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.384 -0.822 . . . . 0.0 109.194 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.8 mp -45.38 170.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 109.807 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 t -144.58 -38.63 0.28 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.404 -0.81 . . . . 0.0 109.612 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.508 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 13.9 pt20 -90.92 -146.31 0.19 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.553 -0.717 . . . . 0.0 109.268 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.508 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 23.6 tt0 -115.34 135.2 54.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.106 -0.996 . . . . 0.0 109.768 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.867 HG21 HG11 ' A' ' 11' ' ' VAL . 78.1 t -72.06 145.2 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.293 -0.879 . . . . 0.0 109.345 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.524 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -107.5 135.46 48.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 0.0 109.65 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.014 ' HB1' ' HB3' ' A' ' 7' ' ' MET . . . -150.37 129.79 12.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 109.878 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.83 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -138.38 145.68 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 109.899 179.577 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . 41.68 -101.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.466 -0.771 . . . . 0.0 110.077 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.574 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -121.39 -11.44 8.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.952 -1.092 . . . . 0.0 109.69 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.639 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -89.74 -161.12 0.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.121 -0.987 . . . . 0.0 109.06 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.951 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 169.22 159.38 0.05 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.272 -0.893 . . . . 0.0 109.972 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.973 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -149.96 132.33 15.59 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.861 ' HB3' HG13 ' A' ' 71' ' ' VAL . 37.4 p90 -150.42 168.77 23.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.891 -1.131 . . . . 0.0 110.436 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.838 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -143.8 161.86 37.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.683 -0.636 . . . . 0.0 109.312 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 2.1 p90 -157.13 -169.72 3.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.213 -0.929 . . . . 0.0 109.335 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.61 141.12 52.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.457 -0.777 . . . . 0.0 109.903 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.699 HG11 HD22 ' A' ' 63' ' ' LEU . 73.3 t -112.7 114.15 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.704 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 19.5 p -108.69 97.32 6.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.182 -0.949 . . . . 0.0 110.296 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 62' ' ' PRO . 18.4 p90 -111.17 -176.45 2.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.264 -0.897 . . . . 0.0 108.618 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 2.7 tm-20 -148.78 150.33 32.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.885 -1.134 . . . . 0.0 110.126 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.41 ' O ' ' CD ' ' A' ' 87' ' ' GLU . 65.6 m-85 -90.29 -116.07 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.31 1.03 19.83 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.912 -1.117 . . . . 0.0 109.446 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -164.19 -58.8 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 3.3 mtt85 -81.76 158.51 24.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -1.133 . . . . 0.0 109.485 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -119.59 132.44 55.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 109.765 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -114.89 143.84 44.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.863 . . . . 0.0 109.255 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.701 HG23 ' HA ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -117.23 173.44 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 108.922 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 1.005 HG12 ' HD3' ' A' ' 97' ' ' PRO . 2.8 t -145.96 145.93 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 109.32 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.521 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . -127.71 72.95 78.52 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 1.005 ' HD3' HG12 ' A' ' 95' ' ' VAL . 50.0 Cg_endo -91.58 -177.0 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.731 1.385 . . . . 0.0 110.821 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.838 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.5 mp -140.84 142.8 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 13.6 t0 -116.46 160.05 21.14 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.952 -1.092 . . . . 0.0 110.215 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.538 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -113.12 176.25 5.1 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.951 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -148.14 137.86 22.38 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.035 -1.041 . . . . 0.0 109.926 -179.145 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.5 ' HA ' ' HG3' ' A' ' 77' ' ' GLU . 64.2 ttt-85 -141.44 103.15 4.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.893 ' CE1' HG11 ' A' ' 10' ' ' VAL . 10.9 m-30 -92.31 -171.81 2.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.591 ' HB3' HG21 ' A' ' 110' ' ' VAL . 3.6 p30 -112.66 -25.45 9.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -157.62 -69.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 171.38 73.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -1.103 . . . . 0.0 109.388 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -178.84 -52.44 0.08 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -117.61 174.3 6.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -1.117 . . . . 0.0 109.498 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.623 HG12 ' N ' ' A' ' 110' ' ' VAL . 88.8 t -97.83 167.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.069 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.625 ' O ' ' HB1' ' A' ' 34' ' ' ALA . 3.1 t -140.52 -72.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.028 -1.045 . . . . 0.0 109.964 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.437 ' HB2' ' HD3' ' A' ' 102' ' ' ARG . 19.7 m -119.43 163.41 17.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 109.939 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.538 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 2.8 ttp -148.28 164.39 34.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.467 -0.77 . . . . 0.0 109.555 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.511 ' NH1' ' OE2' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -143.24 123.45 13.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 109.318 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.429 ' HB3' ' OD2' ' A' ' 38' ' ' ASP . . . -104.99 130.46 53.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.105 -0.997 . . . . 0.0 109.652 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.6 OUTLIER -126.15 147.58 49.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.608 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.541 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 9.7 p90 174.09 -155.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.56 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 167.8 -179.23 41.26 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.527 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 24.4 tt0 -70.26 -4.77 23.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -1.165 . . . . 0.0 109.694 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -90.62 -29.64 17.66 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -89.29 13.31 13.74 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.198 0.523 . . . . 0.0 109.697 -179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.944 HG23 HG22 ' A' ' 95' ' ' VAL . 4.4 mm -91.91 -163.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.146 -0.971 . . . . 0.0 108.748 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.701 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -151.43 161.63 42.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.427 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.53 113.18 3.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.8 -119.61 4.21 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.29 -1.123 . . . . 0.0 109.545 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . 0.402 ' CE ' ' OE1' ' A' ' 118' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.222 0.534 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.449 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 7.4 m-80 44.94 68.85 0.5 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.568 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . 0.687 HG23 ' O ' ' B' ' 203' ' ' THR . 9.7 t -52.51 107.74 0.91 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 0.0 109.661 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 204' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 50.6 Cg_endo -77.2 5.9 4.71 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.912 1.48 . . . . 0.0 110.491 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' B' ' 204' ' ' PRO . 0.0 OUTLIER -40.76 -72.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.289 -0.882 . . . . 0.0 110.183 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 206' ' ' HIS . . . . . 0.59 ' CE1' ' HG3' ' B' ' 207' ' ' MET . 11.8 p80 -54.59 -35.84 63.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 109.957 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 207' ' ' MET . . . . . 0.59 ' HG3' ' CE1' ' B' ' 206' ' ' HIS . 15.8 mtt -65.57 -56.92 9.68 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.172 -0.955 . . . . 0.0 109.836 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.466 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 8.2 m -56.18 -31.1 63.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.701 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.99 -51.37 67.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.149 -0.969 . . . . 0.0 108.696 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.82 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.0 OUTLIER -55.56 -20.61 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.853 HG11 HG21 ' B' ' 271' ' ' VAL . 16.2 t -90.24 -43.01 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.553 -0.717 . . . . 0.0 109.123 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' B' ' 213' ' ' ARG . 6.0 tt0 -60.66 -74.09 0.08 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.944 ' HB3' HD22 ' B' ' 229' ' ' LEU . 1.6 mtt-85 -42.3 -44.88 4.03 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.964 0.888 . . . . 0.0 108.605 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' TYR . . . . . 0.581 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -49.7 -45.15 48.68 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.891 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.24 -38.88 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.309 -0.869 . . . . 0.0 109.097 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' B' ' 213' ' ' ARG . . . -49.1 -35.75 17.03 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -75.3 -31.0 60.53 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.891 HD12 ' HA ' ' B' ' 215' ' ' VAL . 1.1 mt -65.4 -56.4 12.73 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 0.2 OUTLIER -53.06 -47.31 68.55 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.604 0.716 . . . . 0.0 109.348 179.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.22 6.56 39.65 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.713 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.834 ' HA2' HD11 ' B' ' 259' ' ' LEU . . . 51.48 39.55 44.93 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.9 t0 -96.04 66.48 2.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.306 -1.114 . . . . 0.0 109.893 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' LEU . . . . . 1.107 HD12 HD12 ' B' ' 226' ' ' ILE . 6.1 tp -47.59 -43.34 25.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.163 -0.96 . . . . 0.0 108.909 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -43.59 -38.21 2.88 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -80.6 -29.01 45.23 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 1.107 HD12 HD12 ' B' ' 223' ' ' LEU . 36.9 mt -65.92 -56.27 15.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.743 HG11 HG23 ' B' ' 248' ' ' THR . 77.3 t -59.86 -35.97 63.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.22 -56.21 24.38 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.944 HD22 ' HB3' ' B' ' 213' ' ' ARG . 9.2 tp -59.3 -23.0 62.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . 0.543 ' CD2' HG21 ' B' ' 251' ' ' ILE . 3.9 m-85 -88.92 143.35 26.93 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.41 -0.806 . . . . 0.0 109.484 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -53.79 -170.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.855 . . . . 0.0 109.322 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.441 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -75.61 -24.2 56.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 109.673 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.542 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 15.1 p30 -145.06 44.2 1.33 Allowed 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.592 -0.693 . . . . 0.0 109.608 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.689 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -55.9 168.53 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.918 . . . . 0.0 109.339 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' THR . . . . . 0.894 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -121.68 142.68 49.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.611 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 32.3 t -131.63 121.16 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 109.507 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' GLU . . . . . 0.511 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.1 mt-10 -88.53 112.43 22.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' B' ' 239' ' ' PRO . 12.6 t70 -176.08 145.57 0.75 Allowed Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.265 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . 0.549 ' O ' ' HA ' ' B' ' 238' ' ' ASP . 53.6 Cg_endo -79.66 -92.41 0.0 OUTLIER 'Cis proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.506 -1.872 . . . . 0.0 110.915 -0.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.38 126.55 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.912 -1.118 . . . . 0.0 108.95 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 86.53 -8.37 75.26 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' SER . . . . . 0.545 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.2 OUTLIER -97.93 -146.24 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -1.062 . . . . 0.0 109.152 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -135.17 141.78 39.29 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.882 -1.136 . . . . 0.0 110.247 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' PRO . . . . . 0.539 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.4 Cg_endo -64.55 -169.5 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.271 1.669 . . . . 0.0 110.883 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.965 ' HB3' ' HB1' ' B' ' 250' ' ' ALA . 1.5 mtt-85 -150.34 101.77 3.01 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.894 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.2 164.38 15.0 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.307 -0.87 . . . . 0.0 110.119 -179.03 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . 0.602 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 98.39 160.45 30.17 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 248' ' ' THR . . . . . 0.743 HG23 HG11 ' B' ' 227' ' ' VAL . 4.1 m -74.32 -33.15 63.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.167 -1.196 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -72.63 -43.88 62.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.281 -0.887 . . . . 0.0 109.34 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.965 ' HB1' ' HB3' ' B' ' 245' ' ' ARG . . . -67.75 -56.97 7.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.445 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.689 HD11 ' N ' ' B' ' 234' ' ' ALA . 43.2 mt -47.53 -40.27 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.878 . . . . 0.0 108.885 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 252' ' ' ARG . . . . . 0.812 ' CG ' HD23 ' B' ' 223' ' ' LEU . 25.1 ttp85 -78.02 -52.72 8.35 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 253' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 4.0 mt-10 -50.82 -26.53 5.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 108.472 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.57 ' CD1' ' HG3' ' B' ' 245' ' ' ARG . 0.8 OUTLIER -87.65 -71.36 0.57 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 255' ' ' PHE . . . . . 1.02 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.1 OUTLIER -48.95 -33.26 10.56 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . 0.568 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -63.8 -49.71 71.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 257' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 8.5 t30 -54.99 -36.49 65.48 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 4.7 t -65.63 -36.19 82.99 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.429 -0.794 . . . . 0.0 108.961 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 259' ' ' LEU . . . . . 0.834 HD11 ' HA2' ' B' ' 221' ' ' GLY . 8.1 tp -67.07 -22.5 65.84 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.493 -0.754 . . . . 0.0 109.189 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 260' ' ' LYS . . . . . 0.488 ' O ' ' HD3' ' B' ' 262' ' ' PRO . 1.2 mttm -56.25 -20.34 17.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.132 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 261' ' ' LEU . . . . . 0.969 ' CD2' HD21 ' B' ' 263' ' ' LEU . 0.3 OUTLIER -92.35 107.38 23.15 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 262' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 49.4 Cg_endo -74.44 107.4 2.44 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.822 1.433 . . . . 0.0 112.151 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.969 HD21 ' CD2' ' B' ' 261' ' ' LEU . 0.0 OUTLIER -141.91 -162.83 1.46 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 0.0 109.567 178.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -123.67 125.84 45.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 265' ' ' VAL . . . . . 0.77 HG21 ' HB3' ' B' ' 218' ' ' LEU . 21.6 t -105.4 119.11 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.97 . . . . 0.0 109.806 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 266' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.2 OUTLIER -147.88 107.33 3.93 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.234 -0.916 . . . . 0.0 109.284 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.7 OUTLIER -49.77 -179.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.905 . . . . 0.0 109.574 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.15 -39.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 109.677 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 269' ' ' GLN . . . . . 0.692 ' NE2' ' HB3' ' B' ' 281' ' ' ALA . 8.9 pt20 -98.72 -148.62 0.34 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 109.231 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 270' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 28.1 tt0 -113.11 131.25 55.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.106 -0.996 . . . . 0.0 109.516 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 271' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' B' ' 280' ' ' PHE . 48.1 t -65.6 148.52 12.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.12 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 1.2 mtt180 -103.24 133.49 48.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -0.95 . . . . 0.0 109.732 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.14 137.44 19.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.368 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 274' ' ' VAL . . . . . 0.555 ' CB ' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -130.02 -152.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 0.0 109.589 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 275' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . -32.67 -91.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.147 0.498 . . . . 0.0 110.799 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 276' ' ' ASN . . . . . 0.511 ' ND2' ' HA2' ' A' ' 41' ' ' GLY . 11.2 p30 -112.54 -18.18 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.944 -1.098 . . . . 0.0 110.269 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 2.8 mt-10 -90.62 -163.27 1.0 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 109.578 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 278' ' ' ALA . . . . . 0.76 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 174.89 163.79 0.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.516 -0.74 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 279' ' ' ALA . . . . . 0.756 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -150.55 138.81 20.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 108.623 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . 0.9 ' HB3' HG13 ' B' ' 271' ' ' VAL . 33.3 p90 -150.39 167.25 27.63 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.71 -1.244 . . . . 0.0 110.462 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 1.002 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -142.96 151.7 41.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.719 -0.613 . . . . 0.0 109.378 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 282' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 1.2 p90 -145.37 -169.95 3.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.181 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.57 142.95 47.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.461 -0.774 . . . . 0.0 109.961 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 284' ' ' VAL . . . . . 0.899 ' CG1' HD22 ' B' ' 263' ' ' LEU . 2.9 t -125.86 115.54 43.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 285' ' ' SER . . . . . 0.655 ' HB3' HG23 ' B' ' 294' ' ' VAL . 53.1 p -119.7 106.02 11.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 109.988 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.772 ' CD1' HD23 ' B' ' 263' ' ' LEU . 13.6 p90 -114.41 173.82 6.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.0 108.846 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.11 157.09 16.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.024 -1.048 . . . . 0.0 110.803 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . 0.54 ' O ' ' N ' ' B' ' 290' ' ' GLY . 0.0 OUTLIER -117.57 74.09 0.92 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.594 -0.691 . . . . 0.0 109.147 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . 0.513 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 0.2 OUTLIER 43.94 -91.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.062 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 290' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' B' ' 288' ' ' PHE . . . -101.0 7.11 57.01 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.295 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -132.72 -178.94 5.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -1.22 . . . . 0.0 109.803 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 292' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -122.42 144.2 49.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.84 . . . . 0.0 109.344 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 293' ' ' THR . . . . . 0.636 ' CB ' ' HB2' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -140.22 159.19 42.73 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.148 -0.97 . . . . 0.0 109.364 -179.06 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 294' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 295' ' ' VAL . 3.9 p -151.65 -177.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 120.686 -1.259 . . . . 0.0 110.266 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 1.047 HG12 ' HD3' ' B' ' 297' ' ' PRO . 29.0 t -151.95 148.89 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.106 -1.621 . . . . 0.0 109.187 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 296' ' ' ALA . . . . . 0.428 ' N ' ' HD3' ' B' ' 297' ' ' PRO . . . -145.07 67.84 13.58 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.068 -1.02 . . . . 0.0 110.238 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 297' ' ' PRO . . . . . 1.047 ' HD3' HG12 ' B' ' 295' ' ' VAL . 50.0 Cg_endo -98.03 -175.78 0.22 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.94 1.76 . . . . 0.0 111.018 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 1.002 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.9 mp -139.88 147.29 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . 0.617 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 9.4 t0 -118.42 157.83 26.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.858 -1.151 . . . . 0.0 110.223 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 300' ' ' HIS . . . . . 0.525 ' O ' ' CG ' ' B' ' 312' ' ' MET . 0.3 OUTLIER -110.52 172.3 6.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.336 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 301' ' ' PHE . . . . . 0.76 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.1 OUTLIER -146.48 133.94 20.83 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.048 -1.032 . . . . 0.0 110.129 -178.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.497 ' HG2' ' HG3' ' B' ' 277' ' ' GLU . 0.3 OUTLIER -139.69 111.96 7.63 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 303' ' ' PHE . . . . . 0.67 ' CE1' HG11 ' B' ' 210' ' ' VAL . 8.3 m-30 -91.87 177.63 6.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.268 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 304' ' ' ASN . . . . . 0.617 ' N ' HG21 ' B' ' 310' ' ' VAL . 6.7 p30 -92.61 -28.9 16.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.931 . . . . 0.0 109.276 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 305' ' ' GLY . . . . . 0.714 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -166.53 -50.74 0.03 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 306' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 163.04 76.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -1.135 . . . . 0.0 109.336 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.52 -63.71 0.06 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.53 -163.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -1.179 . . . . 0.0 109.841 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 309' ' ' VAL . . . . . 0.972 HG11 ' HE1' ' B' ' 312' ' ' MET . 17.0 t -106.98 168.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.338 -0.851 . . . . 0.0 109.162 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . 0.639 ' O ' ' HB1' ' B' ' 234' ' ' ALA . 24.6 t -139.86 -73.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 0.0 109.919 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' B' ' 235' ' ' THR . 9.3 m -125.38 163.24 23.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.185 -0.947 . . . . 0.0 110.164 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 312' ' ' MET . . . . . 0.972 ' HE1' HG11 ' B' ' 309' ' ' VAL . 0.0 OUTLIER -143.44 171.3 14.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -0.822 . . . . 0.0 109.487 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 313' ' ' ARG . . . . . 0.504 ' NH2' HD12 ' B' ' 315' ' ' LEU . 1.5 ttp85 -150.2 120.0 7.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 109.571 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 314' ' ' ALA . . . . . 0.621 ' HB1' ' HE2' ' B' ' 316' ' ' PHE . . . -101.07 136.63 40.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.977 . . . . 0.0 109.721 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 315' ' ' LEU . . . . . 0.973 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -126.24 148.7 49.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.896 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 316' ' ' PHE . . . . . 0.83 ' O ' HG11 ' A' ' 74' ' ' VAL . 2.2 p90 168.22 -169.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 317' ' ' GLY . . . . . 0.589 ' HA2' HG11 ' A' ' 74' ' ' VAL . . . -157.24 167.58 33.94 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.262 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 318' ' ' GLU . . . . . 0.548 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 5.8 tt0 -63.81 -9.88 17.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.43 -1.041 . . . . 0.0 109.889 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -88.37 -32.81 18.19 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 320' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.44 28.64 4.03 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 321' ' ' ILE . . . . . 0.564 HG22 ' N ' ' B' ' 322' ' ' HIS . 19.5 mm -91.01 -120.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.005 -1.059 . . . . 0.0 110.332 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 322' ' ' HIS . . . . . 0.636 ' HB2' ' CB ' ' B' ' 293' ' ' THR . 14.4 p80 -125.69 134.25 51.88 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.016 -1.052 . . . . 0.0 112.489 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.377 0 O-C-N 121.393 -0.817 . . . . 0.0 109.841 177.818 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.501 HG23 ' NE2' ' A' ' 6' ' ' HIS . 1.3 t . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.54 ' HA ' ' HB2' ' A' ' 7' ' ' MET . 46.3 Cg_endo -73.9 -0.46 9.49 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.863 1.454 . . . . 0.0 110.185 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.19 -92.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.602 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.501 ' NE2' HG23 ' A' ' 3' ' ' THR . 1.6 p-80 -52.54 -41.28 63.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.143 -0.973 . . . . 0.0 109.259 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.54 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 34.5 mmt -53.17 -39.86 63.93 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.199 -0.938 . . . . 0.0 109.788 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.43 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 6.0 m -74.19 -36.63 64.02 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.21 -43.81 64.44 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.082 ' HA ' HD21 ' A' ' 29' ' ' LEU . 2.1 t -49.55 -33.93 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.859 HG22 ' CE2' ' A' ' 101' ' ' PHE . 29.9 t -76.33 -45.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.438 -0.789 . . . . 0.0 109.791 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 13' ' ' ARG . 17.0 tt0 -59.4 -73.68 0.08 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.212 1.006 . . . . 0.0 108.494 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.3 mtt180 -42.68 -44.91 4.5 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.636 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -49.5 -44.98 46.51 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.936 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.3 t -88.88 -38.72 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.334 -0.854 . . . . 0.0 109.243 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -48.94 -36.47 17.44 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -74.0 -32.58 63.47 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.936 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.4 mt -64.96 -58.75 5.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -51.14 -45.8 61.77 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . -89.58 10.19 23.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.64 -0.662 . . . . 0.0 109.459 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 1.06 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 45.7 31.92 4.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' ALA . 7.6 t70 -89.75 66.19 7.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.501 -0.999 . . . . 0.0 109.804 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.097 HD11 ' HB3' ' A' ' 55' ' ' PHE . 8.2 tp -47.9 -42.61 27.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 108.962 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -42.03 -32.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.4 -36.82 10.29 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.019 HD12 HD12 ' A' ' 23' ' ' LEU . 25.3 mt -59.32 -54.07 39.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.513 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 52.4 t -58.18 -40.9 79.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.22 -52.73 60.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.082 HD21 ' HA ' ' A' ' 10' ' ' VAL . 9.6 tp -61.71 -27.89 69.02 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.679 ' CG ' HG21 ' A' ' 51' ' ' ILE . 5.6 m-85 -79.08 128.33 33.14 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.556 -0.715 . . . . 0.0 109.811 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -45.86 172.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 109.655 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.431 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -60.08 -24.15 64.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 109.87 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.558 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -148.01 38.66 0.91 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.58 -0.7 . . . . 0.0 109.506 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.676 ' O ' HD11 ' A' ' 51' ' ' ILE . . . -54.91 173.65 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.632 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.564 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -114.57 140.09 49.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.426 -0.796 . . . . 0.0 109.127 179.657 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.561 HG11 ' CD2' ' A' ' 54' ' ' PHE . 1.2 t -113.43 171.83 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 108.715 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.609 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -151.26 121.11 7.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.882 . . . . 0.0 108.873 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.505 ' OD1' ' HB3' ' A' ' 114' ' ' ALA . 0.2 OUTLIER 172.69 148.2 0.2 Allowed Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.549 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.581 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 46.7 Cg_endo -80.93 -84.38 0.0 OUTLIER 'Cis proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.165 -2.015 . . . . 0.0 110.599 -0.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.773 ' O ' ' HB2' ' B' ' 275' ' ' ALA . 2.2 m -146.95 73.71 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.203 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.29 -5.5 3.88 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.581 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 3.4 t -97.27 -131.04 0.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.19 -1.183 . . . . 0.0 109.199 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -138.62 128.37 14.7 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.565 -1.334 . . . . 0.0 110.423 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.609 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 37.9 Cg_endo -62.5 -175.56 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.707 1.605 . . . . 0.0 111.055 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.824 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -151.11 100.52 2.78 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.895 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -90.37 171.58 9.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.205 -0.935 . . . . 0.0 110.63 -178.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 95.77 154.85 30.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 5.5 m -64.7 -36.83 85.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.19 -1.182 . . . . 0.0 109.259 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -70.79 -43.97 67.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.154 -0.966 . . . . 0.0 109.319 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.895 ' HB3' ' O ' ' A' ' 46' ' ' SER . . . -74.41 -57.13 4.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.679 HG21 ' CG ' ' A' ' 30' ' ' PHE . 43.0 mt -43.71 -37.11 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.235 -0.916 . . . . 0.0 109.052 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.513 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 2.5 ttt180 -81.25 -63.62 1.36 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.0 109.147 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 4.2 tt0 -45.11 -28.75 0.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.934 . . . . 0.0 108.825 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.561 ' CD2' HG11 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -79.88 -71.42 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 1.097 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -46.62 -25.75 0.77 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.632 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -71.2 -47.17 59.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 11.1 t-20 -57.51 -30.87 65.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.388 -0.82 . . . . 0.0 108.793 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 t -72.55 -40.83 66.37 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.06 HD21 ' CA ' ' A' ' 21' ' ' GLY . 9.0 tp -65.11 -21.93 66.87 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.453 -0.779 . . . . 0.0 109.273 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 4.8 mttp -47.47 -27.5 1.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.043 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.743 HD23 HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -90.03 107.72 21.26 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.306 -0.871 . . . . 0.0 108.718 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 44.5 Cg_endo -70.93 116.09 4.53 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.795 1.419 . . . . 0.0 110.675 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.038 HD13 HG13 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -150.3 -171.13 3.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.969 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.59 126.84 54.71 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.822 HG21 ' HB3' ' A' ' 18' ' ' LEU . 2.2 t -105.38 123.52 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 109.895 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -150.23 98.71 2.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.141 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 66' ' ' GLU . 2.1 mp -44.87 170.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 110.039 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 69' ' ' GLN . 0.6 OUTLIER -129.27 -83.3 0.56 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 68' ' ' THR . 2.8 pt20 -59.37 -148.07 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.675 -0.641 . . . . 0.0 109.319 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.45 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 31.6 tt0 -109.1 132.43 54.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.056 -1.028 . . . . 0.0 109.647 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.888 HG13 ' HB3' ' A' ' 80' ' ' PHE . 48.7 t -57.4 149.48 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.293 -0.88 . . . . 0.0 109.259 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -114.28 132.91 55.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.029 -1.044 . . . . 0.0 109.968 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -150.17 112.04 4.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.39 -0.819 . . . . 0.0 109.253 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.769 HG21 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -131.81 158.71 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.225 -0.922 . . . . 0.0 109.501 -179.814 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 48.58 -147.52 0.26 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.304 -0.873 . . . . 0.0 109.622 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -82.24 -24.12 34.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 102' ' ' ARG . 3.3 mt-10 -89.92 -162.41 0.88 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.111 -0.993 . . . . 0.0 109.539 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.681 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . -178.46 168.95 1.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.522 -0.736 . . . . 0.0 109.366 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.818 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.17 136.27 18.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.155 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.888 ' HB3' HG13 ' A' ' 71' ' ' VAL . 14.4 p90 -149.79 162.25 40.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.95 -1.094 . . . . 0.0 110.15 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.958 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -136.45 -173.0 3.29 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.638 0.732 . . . . 0.0 110.118 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.527 ' CD2' ' C ' ' A' ' 81' ' ' ALA . 6.0 p90 177.08 -169.81 0.07 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 1.011 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -133.33 140.41 47.39 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 110.042 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.038 HG13 HD13 ' A' ' 63' ' ' LEU . 37.7 t -107.94 113.35 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.533 ' CA ' HG23 ' A' ' 94' ' ' VAL . 33.6 p -108.12 84.7 1.99 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 109.743 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.584 ' CE1' ' HB ' ' A' ' 93' ' ' THR . 15.5 p90 -93.62 -179.21 4.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.083 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.433 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 18.5 tt0 -111.36 149.59 30.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.034 -1.041 . . . . 0.0 110.325 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.58 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -114.19 104.98 12.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.453 -0.779 . . . . 0.0 109.021 179.443 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.497 ' CG ' ' C ' ' A' ' 88' ' ' PHE . 1.1 pt20 40.74 -93.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.412 -0.805 . . . . 0.0 109.894 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 88' ' ' PHE . . . -101.9 -31.84 5.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -90.08 -178.27 5.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -1.232 . . . . 0.0 109.632 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.497 ' HE3' ' OXT' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -127.46 140.63 52.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.584 ' HB ' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -124.59 159.81 29.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.393 -0.817 . . . . 0.0 109.645 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.644 HG22 ' H ' ' A' ' 95' ' ' VAL . 7.2 p -139.28 174.88 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.165 -0.96 . . . . 0.0 109.31 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 1.011 ' O ' HG22 ' A' ' 83' ' ' THR . 78.3 t -142.94 163.12 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.078 -1.014 . . . . 0.0 109.942 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.576 ' N ' HG12 ' A' ' 95' ' ' VAL . . . -138.0 70.63 49.32 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.527 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.523 ' HD3' HG12 ' A' ' 95' ' ' VAL . 46.1 Cg_endo -97.83 179.25 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.871 1.714 . . . . 0.0 111.447 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.958 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.8 mp -142.06 156.25 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.597 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 19.9 t0 -130.16 159.58 36.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.967 -1.083 . . . . 0.0 110.072 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 113' ' ' ARG . 85.9 t60 -109.87 170.74 7.88 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.859 ' CE2' HG22 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -140.85 136.02 31.95 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.07 -1.018 . . . . 0.0 110.006 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.541 ' HA ' ' CG ' ' A' ' 77' ' ' GLU . 3.2 ttt85 -131.3 109.13 10.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.871 ' CE1' HG11 ' A' ' 10' ' ' VAL . 10.1 m-85 -108.42 -177.48 3.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 107' ' ' GLY . 6.1 p30 -106.72 6.34 29.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.573 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.685 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 120.51 -30.51 5.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 164.36 37.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -1.151 . . . . 0.0 109.364 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 108' ' ' LYS . . . -130.58 47.62 1.01 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 7.3 mmtt 84.19 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.055 -0.674 . . . . 0.0 109.421 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.78 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 40.4 t -89.83 166.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 109.329 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.597 ' N ' HG12 ' A' ' 109' ' ' VAL . 72.3 t -138.19 -59.78 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.531 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.528 ' HB2' ' CD ' ' A' ' 102' ' ' ARG . 1.1 m -139.6 163.5 32.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.612 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.516 ' HG3' ' O ' ' A' ' 100' ' ' HIS . 0.9 OUTLIER -145.45 155.37 43.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.883 . . . . 0.0 109.779 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -141.31 108.18 5.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.376 -0.828 . . . . 0.0 108.985 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.505 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . . . -89.89 148.02 23.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.071 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' B' ' 279' ' ' ALA . 1.4 tt -136.36 139.98 42.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.433 -0.792 . . . . 0.0 109.575 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.783 ' O ' HG21 ' B' ' 274' ' ' VAL . 2.8 p90 172.42 -158.44 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.624 0.726 . . . . 0.0 109.4 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.586 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 174.49 179.85 45.36 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.528 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 18.6 tt0 -72.73 -3.22 23.86 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.311 -1.111 . . . . 0.0 109.397 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -91.16 -29.15 17.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.946 0.879 . . . . 0.0 108.996 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -88.85 15.95 7.64 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.324 0.583 . . . . 0.0 109.712 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.809 HG23 HG22 ' A' ' 95' ' ' VAL . 4.0 mm -89.97 -162.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.621 ' H ' HG22 ' A' ' 121' ' ' ILE . 2.9 t-80 -151.67 153.56 34.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.862 -1.149 . . . . 0.0 110.047 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.446 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.8 125.3 6.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.336 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.12 -164.95 32.59 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.497 ' OXT' ' HE3' ' A' ' 92' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.325 -1.103 . . . . 0.0 109.45 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . 0.427 ' O ' ' C ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.251 0.548 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.471 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 30.7 m120 43.7 74.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.484 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . 0.611 HG23 ' O ' ' B' ' 203' ' ' THR . 4.8 t -87.64 109.61 27.95 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.625 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 204' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.4 Cg_endo -72.93 -1.35 10.34 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.91 1.479 . . . . 0.0 110.245 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -49.39 72.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -66.15 -55.0 18.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.504 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 207' ' ' MET . . . . . 0.533 ' HB3' ' HB1' ' B' ' 273' ' ' ALA . 69.2 mtm -58.32 -43.72 88.32 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.231 -0.918 . . . . 0.0 109.781 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 19.1 m -70.79 -42.04 70.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.574 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.35 -45.2 65.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 108.747 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.928 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.3 t -56.99 -20.64 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.926 HG11 HG21 ' B' ' 271' ' ' VAL . 10.7 t -90.29 -41.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 0.0 109.198 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' B' ' 213' ' ' ARG . 14.0 tt0 -60.49 -74.77 0.07 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.95 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.0 OUTLIER -42.09 -43.43 3.26 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 122.137 0.97 . . . . 0.0 108.697 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' TYR . . . . . 0.635 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 1.2 t80 -55.84 -49.27 73.76 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.415 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.854 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -83.01 -42.58 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.722 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.45 -36.67 10.36 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -74.89 -32.98 61.98 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.854 HD12 ' HA ' ' B' ' 215' ' ' VAL . 0.9 OUTLIER -62.68 -56.18 20.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' B' ' 265' ' ' VAL . 4.0 t-20 -53.24 -48.41 68.24 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.652 0.739 . . . . 0.0 109.523 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.01 10.0 23.13 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.845 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.628 ' HA2' HD11 ' B' ' 259' ' ' LEU . . . 50.06 37.83 30.72 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' B' ' 217' ' ' ALA . 9.4 t0 -93.03 61.29 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.332 -1.099 . . . . 0.0 109.815 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' LEU . . . . . 1.086 HD11 ' HB3' ' B' ' 255' ' ' PHE . 5.8 tp -46.2 -42.53 14.27 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.153 -0.967 . . . . 0.0 108.648 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -43.7 -37.88 2.86 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -81.78 -33.46 27.26 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 1.027 HD12 HD12 ' B' ' 223' ' ' LEU . 27.9 mt -61.25 -55.18 26.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.523 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 88.8 t -58.02 -37.13 59.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.19 25.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.95 HD22 ' HB3' ' B' ' 213' ' ' ARG . 9.8 tp -59.71 -24.39 63.94 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . 0.477 ' HB2' ' HA ' ' B' ' 227' ' ' VAL . 5.1 m-85 -82.59 136.62 34.77 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.494 -0.754 . . . . 0.0 109.362 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.844 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -52.33 -174.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.382 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.449 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.3 OUTLIER -69.67 -26.38 64.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.445 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.54 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 3.5 p30 -151.4 54.87 0.86 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.498 -0.751 . . . . 0.0 109.68 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.697 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -60.36 -167.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' THR . . . . . 0.473 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.2 OUTLIER -130.6 133.96 46.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.895 . . . . 0.0 109.244 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.569 HG12 ' N ' ' B' ' 237' ' ' GLU . 23.1 t -111.95 167.66 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -0.865 . . . . 0.0 109.188 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' GLU . . . . . 0.569 ' N ' HG12 ' B' ' 236' ' ' VAL . 21.8 mt-10 -150.88 115.54 5.19 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' ASP . . . . . 0.539 ' OD1' ' HA ' ' B' ' 239' ' ' PRO . 0.6 OUTLIER -177.11 148.17 0.73 Allowed Pre-proline 0 N--CA 1.491 1.582 0 C-N-CA 118.355 -1.338 . . . . 0.0 110.38 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . 0.539 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 47.6 Cg_endo -73.34 -55.32 0.14 OUTLIER 'Cis proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.941 -2.108 . . . . 0.0 110.989 -0.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.64 HG23 ' O ' ' B' ' 240' ' ' VAL . 34.6 m -150.43 111.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 109.792 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.14 43.39 63.12 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' SER . . . . . 0.534 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 73.7 m -114.73 -96.57 0.45 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -1.117 . . . . 0.0 109.944 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . 0.437 ' HA ' ' HD2' ' B' ' 244' ' ' PRO . 0.0 OUTLIER -142.86 89.9 7.82 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.272 -0.893 . . . . 0.0 110.609 -179.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' PRO . . . . . 0.564 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.9 Cg_endo -63.38 179.57 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.117 1.588 . . . . 0.0 110.507 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.753 ' HB3' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.64 100.46 2.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.952 . . . . 0.0 109.629 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.835 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.79 167.05 13.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.32 -0.863 . . . . 0.0 109.64 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . 0.628 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 97.78 159.5 30.66 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 248' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 2.1 m -69.58 -38.57 77.41 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.946 -1.326 . . . . 0.0 109.145 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -69.48 -41.4 76.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.835 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -72.92 -56.99 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.697 HD11 ' N ' ' B' ' 234' ' ' ALA . 30.0 mt -46.67 -42.26 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.188 -0.945 . . . . 0.0 108.772 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 252' ' ' ARG . . . . . 0.735 ' CG ' HD23 ' B' ' 223' ' ' LEU . 8.3 ttt180 -79.08 -50.75 10.55 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 253' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 46.4 mt-10 -51.12 -31.03 18.05 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' B' ' 245' ' ' ARG . 1.1 t80 -83.47 -71.93 0.48 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 255' ' ' PHE . . . . . 1.086 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -46.0 -26.34 0.7 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' B' ' 252' ' ' ARG . . . -70.65 -48.26 55.86 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 257' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 4.7 t-20 -61.98 -31.02 71.34 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 2.8 t -71.56 -32.59 68.28 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 259' ' ' LEU . . . . . 0.628 HD11 ' HA2' ' B' ' 221' ' ' GLY . 8.7 tp -66.19 -22.15 66.34 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 260' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 16.1 mtmt -61.51 -13.57 22.26 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 261' ' ' LEU . . . . . 0.867 HD12 ' CG ' ' B' ' 263' ' ' LEU . 0.1 OUTLIER -88.63 110.46 37.26 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.248 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 262' ' ' PRO . . . . . 0.777 ' HD2' HD13 ' B' ' 261' ' ' LEU . 52.1 Cg_endo -80.94 91.68 1.12 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.705 1.371 . . . . 0.0 112.328 -178.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.976 HD23 ' CD1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -138.48 163.77 31.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.082 -1.011 . . . . 0.0 108.819 178.186 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . 0.875 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -89.81 127.27 35.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.18 -0.95 . . . . 0.0 109.021 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 265' ' ' VAL . . . . . 0.507 ' O ' ' ND2' ' B' ' 219' ' ' ASN . 93.9 t -104.44 112.44 38.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.269 -0.895 . . . . 0.0 109.528 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 266' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.6 tp10 -147.47 98.14 2.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.053 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.528 ' HA ' ' CB ' ' B' ' 282' ' ' PHE . 1.7 mp -44.41 169.35 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 110.059 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 268' ' ' THR . . . . . 0.502 ' OG1' ' N ' ' B' ' 269' ' ' GLN . 0.4 OUTLIER -122.28 -83.08 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 269' ' ' GLN . . . . . 0.502 ' N ' ' OG1' ' B' ' 268' ' ' THR . 2.6 pt20 -61.17 -140.4 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -117.57 130.67 56.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.875 -1.141 . . . . 0.0 109.993 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 271' ' ' VAL . . . . . 1.021 HG13 ' HB3' ' B' ' 280' ' ' PHE . 56.5 t -48.71 149.19 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.355 -0.841 . . . . 0.0 108.936 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.838 HH21 HD12 ' A' ' 98' ' ' ILE . 31.1 mtp85 -108.11 129.18 55.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.043 -1.036 . . . . 0.0 109.714 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . 0.589 ' C ' HG22 ' B' ' 274' ' ' VAL . . . -143.91 144.95 31.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.292 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 274' ' ' VAL . . . . . 0.783 HG21 ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -167.31 146.55 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 109.099 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 275' ' ' ALA . . . . . 0.773 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . 58.27 -139.11 0.81 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.093 -1.005 . . . . 0.0 109.094 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 276' ' ' ASN . . . . . 0.544 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 18.0 m-20 -91.31 -31.26 16.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.977 -1.077 . . . . 0.0 109.891 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . 0.683 ' HG2' ' N ' ' B' ' 278' ' ' ALA . 0.0 OUTLIER -97.99 153.6 18.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 109.647 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 278' ' ' ALA . . . . . 0.683 ' N ' ' HG2' ' B' ' 277' ' ' GLU . . . -136.04 169.66 17.25 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.388 0.613 . . . . 0.0 109.877 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 279' ' ' ALA . . . . . 0.759 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -141.66 141.66 33.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.388 -0.82 . . . . 0.0 109.182 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . 1.021 ' HB3' HG13 ' B' ' 271' ' ' VAL . 36.0 p90 -150.26 157.92 43.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.848 -1.158 . . . . 0.0 110.324 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 1.051 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -137.26 -169.27 2.46 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.484 0.659 . . . . 0.0 110.038 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 282' ' ' PHE . . . . . 0.528 ' CB ' ' HA ' ' B' ' 267' ' ' LEU . 30.5 p90 168.55 -168.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 283' ' ' THR . . . . . 0.923 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -130.92 140.79 50.23 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.346 -0.846 . . . . 0.0 109.527 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 284' ' ' VAL . . . . . 0.883 HG12 ' HB2' ' B' ' 263' ' ' LEU . 0.4 OUTLIER -100.87 119.32 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -0.872 . . . . 0.0 108.892 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 285' ' ' SER . . . . . 0.875 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 86.7 p -109.17 118.23 36.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 0.0 109.836 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.976 ' CD1' HD23 ' B' ' 263' ' ' LEU . 0.7 OUTLIER -140.32 153.43 46.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.935 . . . . 0.0 109.44 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 287' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' B' ' 291' ' ' ARG . 81.9 tt0 -96.5 164.53 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' B' ' 289' ' ' GLN . 1.0 OUTLIER -115.42 -173.8 2.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.688 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' B' ' 288' ' ' PHE . 0.0 OUTLIER -43.22 -30.43 0.48 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.707 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -150.0 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 291' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' B' ' 287' ' ' GLU . 0.0 OUTLIER -83.35 -165.03 0.99 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -1.188 . . . . 0.0 109.532 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 292' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' B' ' 287' ' ' GLU . 0.3 OUTLIER -149.78 143.64 25.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.85 . . . . 0.0 109.306 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 293' ' ' THR . . . . . 0.699 HG23 ' CZ ' ' B' ' 286' ' ' PHE . 1.4 t -129.5 -176.19 3.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.999 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 294' ' ' VAL . . . . . 0.679 HG12 ' HB3' ' B' ' 322' ' ' HIS . 6.3 p -152.2 171.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 0.923 ' O ' HG22 ' B' ' 283' ' ' THR . 46.0 t -143.6 155.52 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.86 -1.15 . . . . 0.0 109.835 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 296' ' ' ALA . . . . . 0.52 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -126.33 72.83 72.6 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 297' ' ' PRO . . . . . 0.561 ' HD3' HG12 ' B' ' 295' ' ' VAL . 43.9 Cg_endo -95.85 176.27 0.82 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.539 1.493 . . . . 0.0 111.188 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 1.051 HG23 ' HB2' ' B' ' 281' ' ' ALA . 3.0 mp -142.35 158.79 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . 0.628 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 17.1 t0 -131.27 168.24 17.85 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.115 -0.99 . . . . 0.0 109.959 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 300' ' ' HIS . . . . . 0.672 ' CE1' ' HB2' ' B' ' 279' ' ' ALA . 1.2 t-80 -131.5 138.61 49.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 108.983 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 301' ' ' PHE . . . . . 0.589 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.4 OUTLIER -112.65 150.13 31.88 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 -178.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.5 ' HB3' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -140.8 142.83 34.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.607 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 303' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' B' ' 210' ' ' VAL . 2.1 m-85 -128.99 175.43 8.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.843 . . . . 0.0 108.967 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 304' ' ' ASN . . . . . 0.666 ' OD1' HG21 ' B' ' 310' ' ' VAL . 0.2 OUTLIER -150.3 18.59 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.242 -0.911 . . . . 0.0 109.142 178.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 305' ' ' GLY . . . . . 0.715 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -160.69 -88.53 0.07 OUTLIER Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 306' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 162.75 63.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -1.108 . . . . 0.0 109.666 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 307' ' ' GLY . . . . . 0.475 ' O ' ' HD3' ' B' ' 308' ' ' LYS . . . 166.96 -26.15 0.15 Allowed Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.079 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 308' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' B' ' 307' ' ' GLY . 1.2 mmtp -128.98 164.02 24.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -1.208 . . . . 0.0 109.918 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 309' ' ' VAL . . . . . 0.844 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 2.5 t -103.9 157.04 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . 0.666 HG21 ' OD1' ' B' ' 304' ' ' ASN . 22.1 t -142.77 -35.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.913 -1.117 . . . . 0.0 110.279 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -126.25 150.71 48.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.714 -1.241 . . . . 0.0 109.921 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 312' ' ' MET . . . . . 0.528 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 8.4 ttp -154.84 149.58 26.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.477 -0.764 . . . . 0.0 109.337 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 313' ' ' ARG . . . . . 0.465 ' HA ' ' HB2' ' B' ' 237' ' ' GLU . 13.4 ttp180 -141.92 124.39 15.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 109.625 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 314' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' B' ' 299' ' ' ASP . . . -97.95 130.83 44.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.449 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 315' ' ' LEU . . . . . 0.818 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -117.84 136.06 53.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.908 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 316' ' ' PHE . . . . . 0.769 ' O ' HG21 ' A' ' 74' ' ' VAL . 7.2 p90 170.46 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 317' ' ' GLY . . . . . 0.471 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 169.77 -173.46 43.95 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 318' ' ' GLU . . . . . 0.458 ' C ' HG12 ' B' ' 321' ' ' ILE . 19.0 tt0 -73.51 -2.46 22.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.286 -1.126 . . . . 0.0 109.161 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 16.8 tttp -91.67 -27.69 17.94 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.935 0.874 . . . . 0.0 108.887 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 320' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -88.88 17.34 5.76 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.335 0.588 . . . . 0.0 109.665 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 321' ' ' ILE . . . . . 0.508 HG22 ' H ' ' B' ' 322' ' ' HIS . 4.9 mm -89.83 178.21 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 322' ' ' HIS . . . . . 0.679 ' HB3' HG12 ' B' ' 294' ' ' VAL . 0.2 OUTLIER -152.26 64.43 0.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.835 -1.166 . . . . 0.0 110.312 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.494 ' HA ' ' OG1' ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.075 -1.016 . . . . 0.0 109.532 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 3' ' ' THR . 10.7 t . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.476 ' HB2' ' OG1' ' A' ' 8' ' ' THR . 46.6 Cg_endo -72.88 -8.55 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.941 1.495 . . . . 0.0 110.12 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -45.36 -36.75 4.4 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -90.31 -59.46 2.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.71 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.581 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -55.32 -22.04 17.42 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.142 -0.974 . . . . 0.0 109.946 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 4' ' ' PRO . 17.4 m -83.42 -40.6 19.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.431 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.78 -39.47 38.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 108.841 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.995 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.1 t -56.45 -26.82 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.072 HG11 HG21 ' A' ' 71' ' ' VAL . 3.5 t -81.63 -39.14 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.405 -0.81 . . . . 0.0 109.327 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 13' ' ' ARG . 7.5 tt0 -62.87 -74.73 0.09 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.135 0.969 . . . . 0.0 108.434 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.716 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -42.78 -44.56 4.47 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.994 0.902 . . . . 0.0 108.6 179.361 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.613 ' CD1' HG23 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -50.74 -44.47 58.39 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.925 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.4 t -90.13 -39.87 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.304 -0.873 . . . . 0.0 109.401 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -49.05 -33.41 11.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 22' ' ' ASP . . . -77.3 -31.91 55.04 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.925 HD12 ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -64.2 -56.75 12.51 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -53.58 -48.81 68.86 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.624 0.726 . . . . 0.0 109.488 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.85 11.49 17.79 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.668 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.749 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 47.04 35.27 8.2 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' ALA . 15.0 t0 -89.8 62.15 5.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -1.094 . . . . 0.0 109.615 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.056 HD11 ' HB3' ' A' ' 55' ' ' PHE . 6.5 tp -46.69 -43.4 17.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 108.85 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -42.73 -33.17 0.69 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -84.13 -38.03 10.6 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.053 HD12 HD12 ' A' ' 23' ' ' LEU . 14.7 mt -57.71 -56.68 14.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.512 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 43.8 t -55.85 -41.59 67.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -56.02 -53.28 58.81 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.995 HD21 ' HA ' ' A' ' 10' ' ' VAL . 7.7 tp -66.24 -20.72 66.2 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.693 ' HD2' ' HB3' ' A' ' 34' ' ' ALA . 3.0 m-85 -88.41 131.98 34.64 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.546 -0.721 . . . . 0.0 109.654 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -47.98 176.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.836 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.4 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.5 OUTLIER -67.07 -24.78 66.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.55 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 7.0 p-10 -144.0 54.1 1.3 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 109.55 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.783 ' O ' HD11 ' A' ' 51' ' ' ILE . . . -72.69 155.29 40.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.641 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.688 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -101.93 167.06 10.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.235 -0.915 . . . . 0.0 109.25 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 35' ' ' THR . 35.0 t -161.85 108.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.55 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 9.2 mp0 -88.66 103.51 16.0 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.582 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 27.5 t70 -173.16 143.74 1.1 Allowed Pre-proline 0 C--N 1.3 -1.568 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.919 -177.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 49.6 Cg_endo -73.5 174.84 48.5 Favored 'Cis proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.345 -1.94 . . . . 0.0 111.227 -0.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.706 ' O ' HG23 ' A' ' 40' ' ' VAL . 21.9 m -63.89 105.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.81 . . . . 0.0 109.253 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.529 ' CA ' ' HB1' ' B' ' 275' ' ' ALA . . . 122.13 -6.98 10.05 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.523 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -105.09 -155.93 0.56 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.36 -1.082 . . . . 0.0 109.02 179.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -125.16 128.96 24.66 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.029 -1.044 . . . . 0.0 109.964 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.55 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 36.9 Cg_endo -62.01 179.19 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.638 1.558 . . . . 0.0 111.371 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.986 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -150.42 105.91 3.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.647 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -88.66 157.31 18.6 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.248 -0.907 . . . . 0.0 110.015 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.55 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 109.24 162.03 19.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 3.9 m -67.25 -58.38 4.95 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.148 -1.207 . . . . 0.0 109.11 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.531 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -55.56 -37.83 68.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.273 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.986 ' HB1' ' HB3' ' A' ' 45' ' ' ARG . . . -68.99 -51.67 36.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.701 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.783 HD11 ' O ' ' A' ' 34' ' ' ALA . 8.8 mm -55.8 -47.14 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 109.283 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.817 ' CG ' HD23 ' A' ' 23' ' ' LEU . 26.3 ttp180 -73.58 -52.48 13.31 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 23.6 tt0 -48.38 -30.79 5.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.089 -1.007 . . . . 0.0 108.469 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.582 ' CZ ' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -83.78 -72.05 0.48 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 1.056 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -47.31 -25.04 0.88 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.618 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -74.15 -47.96 32.52 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 5.4 t30 -57.41 -37.36 72.62 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 t -67.66 -35.74 79.43 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.749 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.2 tp -67.48 -29.23 68.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.456 -0.777 . . . . 0.0 109.053 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 17.0 mttm -47.08 -30.48 2.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 108.911 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.822 HD22 HD21 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.4 110.52 39.4 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.9 111.06 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.85 1.447 . . . . 0.0 111.027 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.822 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.94 162.96 31.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.347 -0.845 . . . . 0.0 109.715 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.736 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -92.08 127.95 37.74 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 18' ' ' LEU . 21.8 t -115.13 120.08 63.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.054 -1.029 . . . . 0.0 109.967 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 67' ' ' LEU . 1.0 OUTLIER -150.12 106.25 3.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.494 HD22 HG23 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -47.8 177.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 0.0 109.924 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 69' ' ' GLN . 21.9 p -145.07 -81.63 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.386 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.7 OUTLIER -59.88 -144.86 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.479 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 48.9 tt0 -114.44 131.63 56.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.007 -1.058 . . . . 0.0 109.933 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.072 HG21 HG11 ' A' ' 11' ' ' VAL . 13.1 t -61.92 160.49 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.465 -0.772 . . . . 0.0 109.087 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 5.1 ttp180 -122.52 134.74 54.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.229 -0.919 . . . . 0.0 109.824 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . . . -147.89 160.45 42.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.405 -0.809 . . . . 0.0 109.183 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.088 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -159.14 -159.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.725 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -29.52 -85.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.055 -0.403 . . . . 0.0 111.35 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.504 ' O ' ' N ' ' A' ' 103' ' ' PHE . 9.9 m120 -124.62 21.07 8.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.904 -1.123 . . . . 0.0 110.781 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -129.99 -160.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.916 -1.115 . . . . 0.0 109.442 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.951 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 170.05 147.55 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.981 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 72' ' ' ARG . . . -136.12 130.73 33.78 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 30.2 p90 -147.92 170.1 18.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.792 -1.192 . . . . 0.0 110.462 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.752 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -143.96 -166.43 2.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.599 -0.688 . . . . 0.0 109.893 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 81' ' ' ALA . 18.9 p90 168.83 -168.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 0.0 109.238 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.824 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -130.76 144.78 51.68 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.649 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.587 HG11 HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -112.96 122.24 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.166 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.736 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 1.4 p -117.75 107.11 13.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 109.029 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.781 ' CD1' HD23 ' A' ' 63' ' ' LEU . 2.0 p90 -130.04 151.74 50.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.068 -1.02 . . . . 0.0 110.181 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.523 ' HG2' ' N ' ' A' ' 88' ' ' PHE . 84.2 tt0 -127.75 159.93 33.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.441 -0.787 . . . . 0.0 109.039 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -150.5 -99.61 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.058 -1.026 . . . . 0.0 110.326 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 88' ' ' PHE . 19.1 tt0 -48.91 -99.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 109.898 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.468 ' N ' ' HG2' ' A' ' 89' ' ' GLN . . . -123.92 -28.19 1.3 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -96.66 150.18 20.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -1.116 . . . . 0.0 109.352 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -113.11 146.53 39.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.103 -0.998 . . . . 0.0 109.172 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.0 145.97 51.1 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.53 -0.731 . . . . 0.0 109.842 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.78 HG13 ' CB ' ' A' ' 122' ' ' HIS . 5.4 p -121.19 166.38 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.922 . . . . 0.0 108.861 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.824 ' O ' HG22 ' A' ' 83' ' ' THR . 62.3 t -140.94 160.21 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.019 -1.05 . . . . 0.0 110.304 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.521 ' N ' HG12 ' A' ' 95' ' ' VAL . . . -138.76 75.11 37.37 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.562 -0.711 . . . . 0.0 109.51 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.504 ' HD3' HG12 ' A' ' 95' ' ' VAL . 48.1 Cg_endo -97.11 -175.6 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.814 1.676 . . . . 0.0 111.2 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.752 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.6 mp -135.26 157.1 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 7.6 t0 -128.66 162.25 27.78 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.204 -0.935 . . . . 0.0 109.813 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.591 ' NE2' ' CD2' ' B' ' 300' ' ' HIS . 0.2 OUTLIER -114.11 173.54 6.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 108.906 179.49 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.951 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -148.16 144.9 28.08 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.97 -1.081 . . . . 0.0 110.45 -178.561 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.527 ' NH1' ' HD2' ' B' ' 313' ' ' ARG . 0.4 OUTLIER -139.99 105.63 5.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.151 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.588 ' CZ ' HG11 ' A' ' 10' ' ' VAL . 5.2 m-85 -91.06 -171.21 2.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.71 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.992 ' HB3' HG21 ' A' ' 110' ' ' VAL . 4.3 p30 -126.28 -47.97 1.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.272 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.703 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -163.94 27.24 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 105' ' ' GLY . . . 77.07 67.62 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.169 -1.194 . . . . 0.0 109.545 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.27 -39.33 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -165.6 -162.54 0.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -1.113 . . . . 0.0 109.258 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 41.0 t -106.25 144.24 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.248 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.992 HG21 ' HB3' ' A' ' 104' ' ' ASN . 5.0 t -125.99 -28.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 109.898 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.523 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -149.59 155.11 39.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.067 -1.021 . . . . 0.0 109.472 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.523 ' HE3' ' CG ' ' A' ' 99' ' ' ASP . 3.2 ttp -155.91 148.74 24.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.194 -0.941 . . . . 0.0 109.926 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.518 ' HD2' ' NH1' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -130.55 173.52 10.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 108.964 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.56 ' O ' HG12 ' A' ' 40' ' ' VAL . . . -144.37 142.85 30.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.149 -0.97 . . . . 0.0 109.52 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.576 ' HA ' HG11 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -138.61 140.24 38.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.172 -0.955 . . . . 0.0 109.907 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.879 ' O ' HG11 ' B' ' 274' ' ' VAL . 51.9 p90 170.21 -161.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.578 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 174.6 -165.6 37.04 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.536 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 8.3 tt0 -73.13 -3.32 25.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.444 -1.033 . . . . 0.0 109.337 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.26 -31.31 16.18 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.97 0.89 . . . . 0.0 109.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.481 HD21 HD11 ' A' ' 98' ' ' ILE . 1.9 m-20 -89.61 8.58 30.63 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.233 0.54 . . . . 0.0 109.559 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.82 HG23 HG22 ' A' ' 95' ' ' VAL . 4.5 mm -91.89 -170.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 108.84 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.78 ' CB ' HG13 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.35 159.75 44.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.097 -1.002 . . . . 0.0 109.618 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.78 133.94 12.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.959 . . . . 0.0 109.479 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 134.35 -123.69 3.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.291 -1.123 . . . . 0.0 109.444 -179.81 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.0 ptp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.208 0.528 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.462 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 18.7 p-10 -113.15 100.09 8.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.558 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . 0.738 HG23 ' O ' ' B' ' 203' ' ' THR . 12.5 t -90.34 108.44 26.72 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.542 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 204' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' B' ' 208' ' ' THR . 45.1 Cg_endo -72.15 -1.96 10.87 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.853 1.449 . . . . 0.0 110.457 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.77 -47.37 83.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.557 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -54.9 24.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.267 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 75.9 mtm -61.42 -41.27 96.91 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.286 -0.884 . . . . 0.0 109.382 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . 0.499 ' CB ' ' O ' ' B' ' 204' ' ' PRO . 15.4 m -64.18 -35.95 82.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.84 . . . . 0.0 109.235 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.09 -42.37 49.99 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.139 -0.976 . . . . 0.0 108.59 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.981 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.5 t -60.06 -20.7 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 1.04 HG21 HG11 ' B' ' 271' ' ' VAL . 4.4 t -88.32 -40.61 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.833 . . . . 0.0 108.89 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' B' ' 213' ' ' ARG . 24.6 tt0 -61.53 -74.35 0.08 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.659 ' HD2' HD13 ' B' ' 229' ' ' LEU . 1.0 OUTLIER -43.68 -45.52 7.0 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' TYR . . . . . 0.59 ' CD1' HG23 ' B' ' 215' ' ' VAL . 0.5 OUTLIER -49.88 -42.88 48.75 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.924 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.4 t -89.77 -37.85 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.251 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -49.49 -35.6 20.35 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.606 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -74.69 -30.95 61.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.924 HD12 ' HA ' ' B' ' 215' ' ' VAL . 2.3 mt -66.86 -58.11 5.66 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' B' ' 265' ' ' VAL . 2.1 t-20 -50.85 -45.31 59.73 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.602 0.715 . . . . 0.0 109.302 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.31 1.36 55.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.624 -0.672 . . . . 0.0 109.748 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 1.066 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 53.76 44.13 70.0 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . 0.48 ' O ' HG13 ' B' ' 226' ' ' ILE . 30.3 t0 -102.87 83.96 2.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.902 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' LEU . . . . . 1.066 ' CD2' HD22 ' B' ' 259' ' ' LEU . 3.7 mm? -53.04 -18.4 2.03 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.139 -0.976 . . . . 0.0 110.063 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -64.05 -57.16 10.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.093 -1.004 . . . . 0.0 109.473 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -62.92 -27.64 70.61 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.961 HD12 HD13 ' B' ' 223' ' ' LEU . 7.0 mt -67.86 -61.46 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.454 -1.027 . . . . 0.0 108.315 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.7 HG21 ' HB2' ' B' ' 252' ' ' ARG . 51.2 t -59.49 -40.33 81.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.87 -53.47 55.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' LEU . . . . . 0.981 HD21 ' HA ' ' B' ' 210' ' ' VAL . 4.7 tp -62.8 -21.78 66.14 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . 0.478 ' HA ' ' HB ' ' B' ' 309' ' ' VAL . 3.7 m-30 -92.71 139.11 30.9 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.452 -0.78 . . . . 0.0 109.784 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -50.71 -176.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 109.822 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -25.16 64.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.879 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' ASP . . . . . 0.543 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 10.0 p-10 -144.17 52.51 1.28 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.495 -0.753 . . . . 0.0 109.137 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' B' ' 310' ' ' VAL . . . -65.43 158.6 26.31 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 109.617 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' THR . . . . . 0.716 HG23 ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -107.34 147.18 30.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.875 . . . . 0.0 109.107 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 52.8 t -141.4 111.05 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' GLU . . . . . 0.528 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 1.5 mm-40 -89.91 105.14 17.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' ASP . . . . . 0.623 ' OD1' ' HB3' ' B' ' 314' ' ' ALA . 21.8 t70 178.91 143.24 0.31 Allowed Pre-proline 0 C--N 1.301 -1.528 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.307 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . 0.518 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 48.5 Cg_endo -73.6 173.87 53.66 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.264 -1.973 . . . . 0.0 110.905 -0.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.584 HG22 ' CZ ' ' B' ' 316' ' ' PHE . 6.5 m -69.81 112.7 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 108.972 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . 0.492 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . 115.06 -2.13 22.67 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' SER . . . . . 0.479 ' OG ' ' HG2' ' B' ' 239' ' ' PRO . 64.6 m -113.35 -134.83 0.35 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.305 -1.114 . . . . 0.0 108.893 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . 0.531 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 4.3 mt-10 -142.03 133.52 13.26 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.863 -1.148 . . . . 0.0 109.755 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' PRO . . . . . 0.528 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.9 Cg_endo -63.39 -171.53 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.082 1.569 . . . . 0.0 111.34 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.964 ' HG3' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.74 96.91 2.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' SER . . . . . 0.716 ' HB3' HG23 ' B' ' 235' ' ' THR . 0.2 OUTLIER -88.88 150.47 22.86 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.238 -0.914 . . . . 0.0 109.987 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.24 163.18 21.88 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 2.2 m -70.04 -61.45 1.77 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -1.209 . . . . 0.0 109.148 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -55.36 -22.98 21.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.241 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.964 ' HB1' ' HG3' ' B' ' 245' ' ' ARG . . . -88.45 -48.62 7.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.587 HD11 ' O ' ' B' ' 234' ' ' ALA . 4.5 mm -53.65 -43.7 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.132 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 252' ' ' ARG . . . . . 0.7 ' HB2' HG21 ' B' ' 227' ' ' VAL . 44.0 ttp85 -75.54 -52.65 10.13 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 108.94 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 253' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 29.9 mt-10 -48.4 -27.72 2.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.809 -1.182 . . . . 0.0 108.427 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.585 ' CE2' ' O ' ' B' ' 238' ' ' ASP . 0.3 OUTLIER -85.84 -71.7 0.52 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.681 0.753 . . . . 0.0 109.021 179.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 255' ' ' PHE . . . . . 0.7 ' C ' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -52.6 -21.76 4.25 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.241 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . 0.55 ' HB2' ' HG ' ' B' ' 223' ' ' LEU . . . -80.33 -46.8 15.5 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 257' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 18.7 t-20 -58.19 -31.17 67.04 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 33.7 t -70.66 -31.63 68.62 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 259' ' ' LEU . . . . . 1.066 HD22 ' CD2' ' B' ' 223' ' ' LEU . 5.7 tp -71.12 -27.72 63.78 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 260' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 0.7 OUTLIER -44.73 -27.83 0.55 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 261' ' ' LEU . . . . . 0.807 HD23 HD23 ' B' ' 263' ' ' LEU . 0.3 OUTLIER -90.72 114.29 60.8 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 262' ' ' PRO . . . . . 0.499 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 44.3 Cg_endo -72.02 107.93 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.766 1.403 . . . . 0.0 110.892 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 263' ' ' LEU . . . . . 0.856 ' CB ' HG13 ' B' ' 284' ' ' VAL . 0.0 OUTLIER -137.3 162.54 33.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 109.854 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 264' ' ' ALA . . . . . 0.818 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -96.46 123.67 40.19 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 265' ' ' VAL . . . . . 0.795 HG21 ' HB3' ' B' ' 218' ' ' LEU . 4.4 t -105.06 117.32 50.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.643 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 266' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' B' ' 267' ' ' LEU . 2.0 tt0 -147.78 104.97 3.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.22 -0.925 . . . . 0.0 109.153 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.1 mt -47.11 174.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.293 -0.879 . . . . 0.0 109.695 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 1.7 t -146.54 -40.31 0.21 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.67 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 269' ' ' GLN . . . . . 0.508 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 13.7 pt20 -102.66 -152.25 0.44 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.647 -0.658 . . . . 0.0 109.267 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 270' ' ' GLU . . . . . 0.508 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 26.6 tt0 -106.43 130.59 54.21 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.61 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 271' ' ' VAL . . . . . 1.04 HG11 HG21 ' B' ' 211' ' ' VAL . 81.4 t -66.81 147.62 12.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.344 -0.848 . . . . 0.0 109.245 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 2.4 tpm_? -102.89 135.95 43.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.952 . . . . 0.0 109.765 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -149.8 146.36 27.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.39 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 274' ' ' VAL . . . . . 0.879 HG11 ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -162.24 146.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.13 -0.981 . . . . 0.0 110.228 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 275' ' ' ALA . . . . . 0.529 ' HB1' ' CA ' ' A' ' 41' ' ' GLY . . . 39.57 -97.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.802 -0.561 . . . . 0.0 110.621 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 276' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' B' ' 303' ' ' PHE . 60.1 m-20 -130.74 34.04 4.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.025 -1.047 . . . . 0.0 110.237 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . 0.7 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 0.9 OUTLIER -139.49 -158.4 0.85 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 108.792 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 278' ' ' ALA . . . . . 0.876 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . 165.96 149.6 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.72 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 279' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -135.98 130.75 34.1 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . 1.011 ' HB3' HG13 ' B' ' 271' ' ' VAL . 22.8 p90 -150.07 175.45 11.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.601 -1.312 . . . . 0.0 110.697 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.61 ' HB2' ' CG1' ' B' ' 298' ' ' ILE . . . -150.11 -179.0 6.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.585 -0.697 . . . . 0.0 109.197 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 282' ' ' PHE . . . . . 0.54 ' CE2' HG23 ' B' ' 284' ' ' VAL . 2.8 p90 -172.92 -162.14 0.16 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 109.492 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 283' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -133.61 147.44 51.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.512 -0.742 . . . . 0.0 109.887 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 284' ' ' VAL . . . . . 0.856 HG13 ' CB ' ' B' ' 263' ' ' LEU . 4.0 t -123.36 116.53 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 109.41 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 285' ' ' SER . . . . . 0.818 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 90.9 p -111.95 114.69 27.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 109.098 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.57 ' HD1' HG12 ' B' ' 284' ' ' VAL . 55.6 p90 -143.21 167.39 22.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 110.084 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 287' ' ' GLU . . . . . 0.459 ' HG2' ' N ' ' B' ' 288' ' ' PHE . 30.1 tt0 -144.1 153.25 41.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 109.255 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.3 OUTLIER -135.89 4.34 3.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.716 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -170.3 -148.81 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.254 -0.904 . . . . 0.0 109.383 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -74.8 -11.95 83.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -113.8 140.41 48.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -1.115 . . . . 0.0 109.273 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 292' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' B' ' 292' ' ' LYS . 18.9 ptmt -125.78 172.47 9.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 109.635 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 293' ' ' THR . . . . . 0.837 HG23 ' HA ' ' B' ' 323' ' ' ALA . 32.2 m -156.65 171.53 20.17 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.366 -0.834 . . . . 0.0 109.095 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 294' ' ' VAL . . . . . 0.662 HG12 ' CB ' ' B' ' 322' ' ' HIS . 0.4 OUTLIER -134.17 165.94 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 1.061 HG22 HG23 ' B' ' 321' ' ' ILE . 3.4 t -136.81 145.8 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.016 -1.052 . . . . 0.0 109.66 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 296' ' ' ALA . . . . . 0.463 ' O ' ' OD1' ' B' ' 320' ' ' ASN . . . -132.52 72.9 77.5 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.433 -0.792 . . . . 0.0 110.023 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 297' ' ' PRO . . . . . 0.986 ' HD3' HG12 ' B' ' 295' ' ' VAL . 49.2 Cg_endo -92.95 -177.01 0.67 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.87 1.458 . . . . 0.0 111.113 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.675 HG23 ' O ' ' B' ' 280' ' ' PHE . 2.7 mp -134.38 144.61 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . 0.612 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 5.6 t0 -117.13 166.95 11.63 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.824 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 300' ' ' HIS . . . . . 0.591 ' CD2' ' NE2' ' A' ' 100' ' ' HIS . 1.6 t-80 -117.58 173.58 6.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 108.916 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 301' ' ' PHE . . . . . 0.876 ' CB ' ' HB3' ' B' ' 278' ' ' ALA . 0.1 OUTLIER -145.67 145.82 31.06 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.071 -1.018 . . . . 0.0 110.583 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.498 ' HD3' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -137.66 98.73 3.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 109.156 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 303' ' ' PHE . . . . . 0.672 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 4.5 m-85 -89.74 176.51 6.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 109.57 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 304' ' ' ASN . . . . . 0.882 ' HB3' HG21 ' B' ' 310' ' ' VAL . 2.9 p30 -118.64 -27.03 5.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.222 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 305' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -159.35 -63.96 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 306' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 163.63 76.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -1.127 . . . . 0.0 109.563 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 175.87 -57.14 0.11 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -111.33 -172.75 2.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -1.149 . . . . 0.0 109.504 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 309' ' ' VAL . . . . . 0.565 HG12 ' N ' ' B' ' 310' ' ' VAL . 85.8 t -119.72 164.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.033 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . 0.882 HG21 ' HB3' ' B' ' 304' ' ' ASN . 5.0 t -134.82 -72.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.963 -1.085 . . . . 0.0 110.018 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . 0.498 ' HB2' ' HD3' ' B' ' 302' ' ' ARG . 31.6 m -112.44 162.48 15.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.899 -1.126 . . . . 0.0 109.837 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 312' ' ' MET . . . . . 0.544 ' CE ' ' CE2' ' B' ' 214' ' ' TYR . 2.6 ttt -159.94 137.99 10.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 313' ' ' ARG . . . . . 0.527 ' HD2' ' NH1' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -125.69 159.27 32.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.144 -0.972 . . . . 0.0 108.812 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 314' ' ' ALA . . . . . 0.623 ' HB3' ' OD1' ' B' ' 238' ' ' ASP . . . -125.18 150.38 47.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.904 -1.122 . . . . 0.0 109.841 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 315' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -141.02 140.8 34.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.39 -0.819 . . . . 0.0 109.774 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 316' ' ' PHE . . . . . 1.088 ' O ' HG11 ' A' ' 74' ' ' VAL . 53.7 p90 173.12 -160.96 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 317' ' ' GLY . . . . . 0.48 ' O ' HG12 ' B' ' 321' ' ' ILE . . . 173.48 -172.38 45.17 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 318' ' ' GLU . . . . . 0.52 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 22.3 tt0 -68.4 -6.69 25.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.419 -1.047 . . . . 0.0 109.714 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -87.08 -31.84 20.26 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.045 0.926 . . . . 0.0 108.939 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 320' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.61 14.28 11.99 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.742 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 321' ' ' ILE . . . . . 1.061 HG23 HG22 ' B' ' 295' ' ' VAL . 4.0 mm -100.84 -166.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 0.0 108.902 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 322' ' ' HIS . . . . . 0.677 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.3 OUTLIER -151.25 -172.41 4.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.116 -0.99 . . . . 0.0 109.613 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.837 ' HA ' HG23 ' B' ' 293' ' ' THR . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.225 0.536 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.565 ' ND2' ' N ' ' A' ' 3' ' ' THR . 0.8 OUTLIER -152.29 157.53 41.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 109.597 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.565 ' N ' ' ND2' ' A' ' 2' ' ' ASN . 0.6 OUTLIER -88.07 109.97 31.98 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.322 -0.861 . . . . 0.0 109.64 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 45.6 Cg_endo -72.45 -3.63 13.77 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.852 1.448 . . . . 0.0 110.19 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.24 -45.38 72.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.877 . . . . 0.0 109.385 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.472 ' NE2' ' O ' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -66.68 -55.39 15.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.59 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.443 ' CE ' ' ND2' ' A' ' 2' ' ' ASN . 27.4 mtt -58.0 -48.74 79.11 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.231 -0.918 . . . . 0.0 109.505 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 m -54.4 -38.1 65.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.285 -0.884 . . . . 0.0 109.054 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -49.29 -43.06 42.9 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.828 HG11 ' CE1' ' A' ' 103' ' ' PHE . 2.3 t -55.76 -49.92 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.99 HG11 HG21 ' A' ' 71' ' ' VAL . 5.1 t -54.71 -41.09 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 13' ' ' ARG . 25.7 tt0 -63.17 -75.13 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.344 1.068 . . . . 0.0 108.145 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.515 ' HB3' HD13 ' A' ' 29' ' ' LEU . 6.6 mtp85 -43.67 -45.97 7.18 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -48.93 -45.72 42.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.923 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -86.0 -37.48 11.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.383 -0.823 . . . . 0.0 109.071 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.89 -37.92 21.12 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.489 ' HB3' HG12 ' A' ' 26' ' ' ILE . . . -72.0 -32.87 67.62 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.923 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.4 mt -67.34 -59.45 3.4 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -48.02 -39.86 21.05 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.599 0.714 . . . . 0.0 109.25 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.41 6.06 42.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.545 -0.722 . . . . 0.0 109.652 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.984 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 47.73 30.87 7.02 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -96.94 88.4 4.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -1.106 . . . . 0.0 109.723 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.074 HD13 HD12 ' A' ' 26' ' ' ILE . 3.3 mm? -51.83 -20.25 2.13 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.195 -0.94 . . . . 0.0 109.815 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.14 -56.26 16.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.253 -0.904 . . . . 0.0 109.303 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.35 -29.34 63.11 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.074 HD12 HD13 ' A' ' 23' ' ' LEU . 12.3 mt -69.06 -62.27 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.549 HG21 ' HB2' ' A' ' 52' ' ' ARG . 60.4 t -57.34 -37.91 59.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.95 26.33 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 10' ' ' VAL . 7.8 tp -59.1 -22.7 61.25 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.939 ' CE2' HG22 ' A' ' 26' ' ' ILE . 20.4 m-30 -88.47 136.53 32.94 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.675 -0.641 . . . . 0.0 109.651 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -51.12 -178.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.273 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -23.52 66.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 109.527 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.534 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 25.2 p-10 -148.37 45.55 1.05 Allowed 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.835 ' HB3' HD13 ' A' ' 51' ' ' ILE . . . -51.61 -178.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.791 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -126.05 135.92 52.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.501 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 37' ' ' GLU . 6.6 t -113.84 169.02 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.129 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.57 ' N ' ' CG1' ' A' ' 36' ' ' VAL . 28.1 mt-10 -150.4 106.07 3.4 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.541 ' OD1' ' HA ' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -174.45 153.71 1.89 Allowed Pre-proline 0 C--N 1.3 -1.575 0 C-N-CA 118.607 -1.237 . . . . 0.0 109.804 -178.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.558 ' O ' HG13 ' A' ' 40' ' ' VAL . 44.7 Cg_endo -73.88 -66.67 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.916 -2.118 . . . . 0.0 111.522 0.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.598 ' O ' HG23 ' A' ' 40' ' ' VAL . 23.8 m -159.06 87.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.948 -1.095 . . . . 0.0 109.596 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . 164.33 38.75 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER 72.92 55.98 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.325 -1.103 . . . . 0.0 109.962 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.548 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 3.8 mt-10 -132.57 58.38 35.77 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.807 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 52.1 Cg_endo -79.71 175.07 10.96 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.825 1.683 . . . . 0.0 111.271 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.788 ' CD ' ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -150.99 100.17 2.77 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.601 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -89.43 166.73 13.52 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.186 -0.946 . . . . 0.0 110.103 -179.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 33' ' ' ASP . . . 86.36 -169.8 41.96 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.546 HG23 HG11 ' A' ' 27' ' ' VAL . 3.4 m -103.45 -46.63 4.51 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.223 -1.163 . . . . 0.0 108.978 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -58.29 -23.74 57.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.247 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.788 ' HB1' ' CD ' ' A' ' 45' ' ' ARG . . . -89.86 -52.51 4.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.398 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.835 HD13 ' HB3' ' A' ' 34' ' ' ALA . 80.1 mt -57.22 -46.8 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.197 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.549 ' HB2' HG21 ' A' ' 27' ' ' VAL . 1.5 ttt180 -70.0 -56.25 7.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.279 -0.888 . . . . 0.0 108.906 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 14.4 tt0 -45.88 -29.92 1.54 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 108.658 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.57 ' CD2' ' HG3' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -84.1 -70.28 0.58 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.624 ' C ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -46.7 -28.05 1.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.444 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . . . -75.07 -50.8 15.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 12.8 t-20 -55.51 -34.55 64.75 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.774 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 14.3 t -64.83 -36.63 84.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.984 HD21 ' CA ' ' A' ' 21' ' ' GLY . 7.4 tp -69.45 -19.28 63.77 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.535 -0.728 . . . . 0.0 109.706 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 33.9 mtmt -55.53 -25.58 38.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 109.36 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.007 HD22 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -89.87 121.32 69.05 Favored Pre-proline 0 C--N 1.305 -1.328 0 O-C-N 121.272 -0.893 . . . . 0.0 108.777 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 48.7 Cg_endo -74.04 103.2 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.71 1.374 . . . . 0.0 111.152 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.007 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.15 -178.54 5.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.006 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -117.88 127.29 53.72 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.521 HG13 ' CD2' ' A' ' 82' ' ' PHE . 4.6 t -116.43 115.92 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.181 -0.95 . . . . 0.0 109.841 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 67' ' ' LEU . 1.2 tt0 -150.17 95.74 2.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.294 -0.879 . . . . 0.0 109.216 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.691 HD21 HG21 ' A' ' 15' ' ' VAL . 4.4 mt -42.81 166.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.974 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.67 -39.9 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.565 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -81.77 -146.01 0.06 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 25.0 tt0 -113.15 129.61 56.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.09 -1.006 . . . . 0.0 109.642 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.99 HG21 HG11 ' A' ' 11' ' ' VAL . 19.2 t -67.92 152.28 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.38 -0.825 . . . . 0.0 108.919 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 19.2 mtt-85 -114.64 135.29 54.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.136 -0.978 . . . . 0.0 109.672 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.525 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -149.95 112.86 4.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.293 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -130.09 155.71 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -0.903 . . . . 0.0 109.489 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.434 ' O ' ' SD ' ' A' ' 7' ' ' MET . . . 43.64 -147.42 0.07 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 81.6 m-20 -82.64 -3.19 55.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.941 . . . . 0.0 109.526 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.578 ' CG ' ' HG3' ' A' ' 102' ' ' ARG . 0.8 OUTLIER -104.85 -163.55 0.97 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.219 -0.926 . . . . 0.0 109.613 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 178.37 166.33 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 109.485 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.762 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.31 140.06 21.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.839 . . . . 0.0 108.948 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.626 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 39.8 p90 -150.58 169.23 22.04 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.877 -1.14 . . . . 0.0 109.941 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.753 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -141.84 -175.37 4.37 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.502 -0.749 . . . . 0.0 109.591 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.645 ' HB3' HD22 ' A' ' 67' ' ' LEU . 9.8 p90 177.05 -159.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.805 . . . . 0.0 109.351 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -137.92 151.79 48.34 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.564 -0.71 . . . . 0.0 109.73 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.633 HG12 ' CB ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -122.11 124.34 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.416 -0.802 . . . . 0.0 109.081 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 1.006 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 5.1 p -114.66 92.81 4.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.6 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.708 ' CZ ' H221 ' A' ' 126' ' ' NTH . 18.8 p90 -115.47 177.93 4.48 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.345 -0.847 . . . . 0.0 109.126 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 88' ' ' PHE . 30.7 tt0 -107.37 166.92 10.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 110.12 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.526 ' CZ ' ' O23' ' A' ' 126' ' ' NTH . 0.1 OUTLIER -116.84 -161.31 0.8 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.4 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -7.44 28.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 109.78 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.11 -40.38 0.03 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.4 mtt-85 -95.72 -176.9 3.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -1.161 . . . . 0.0 109.609 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -115.62 127.19 55.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.897 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -118.3 142.57 47.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.776 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 122' ' ' HIS . 1.2 t -116.15 175.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 1.056 HG12 ' HD3' ' A' ' 97' ' ' PRO . 4.1 t -145.37 144.14 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.881 -1.137 . . . . 0.0 109.737 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.436 ' O ' ' CG ' ' A' ' 120' ' ' ASN . . . -133.06 71.64 77.4 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.345 -0.847 . . . . 0.0 110.408 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 1.056 ' HD3' HG12 ' A' ' 95' ' ' VAL . 49.6 Cg_endo -95.23 -176.18 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 121.492 1.461 . . . . 0.0 110.947 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.753 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.9 mp -137.68 139.59 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.626 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 8.9 t0 -111.99 163.14 14.59 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.95 -1.093 . . . . 0.0 110.261 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.536 ' HB3' ' CB ' ' A' ' 113' ' ' ARG . 4.3 t-80 -116.39 176.29 5.17 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.561 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -149.94 142.63 24.59 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.008 -1.057 . . . . 0.0 110.556 -178.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.612 ' O ' HG23 ' A' ' 110' ' ' VAL . 3.1 ttm180 -135.65 107.64 7.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.484 -0.76 . . . . 0.0 109.106 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.828 ' CE1' HG11 ' A' ' 10' ' ' VAL . 14.2 m-85 -105.42 179.5 4.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.607 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -127.04 -0.67 6.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.933 . . . . 0.0 109.596 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -175.43 -87.57 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 176.05 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -1.184 . . . . 0.0 109.598 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 108' ' ' LYS . . . -127.56 -37.16 0.46 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 107' ' ' GLY . 8.0 mtmm -146.7 -164.76 2.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -1.125 . . . . 0.0 109.255 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.574 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 91.2 t -115.16 158.87 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.308 -0.87 . . . . 0.0 109.027 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -132.6 -54.21 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.567 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.56 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -127.17 156.9 41.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.041 -1.037 . . . . 0.0 109.013 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.512 ' HE1' ' CE1' ' A' ' 30' ' ' PHE . 21.5 ttm -154.0 147.24 24.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.122 -0.986 . . . . 0.0 109.655 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.536 ' CB ' ' HB3' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -123.33 174.21 7.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.377 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 99' ' ' ASP . . . -147.83 149.13 31.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.706 HD13 ' HB2' ' B' ' 279' ' ' ALA . 1.7 tt -143.03 143.73 32.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.138 -0.976 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.528 ' O ' ' CG2' ' B' ' 274' ' ' VAL . 15.4 p90 171.95 -155.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.561 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 167.07 -176.9 41.92 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.561 -1.305 . . . . 0.0 110.185 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.545 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 17.6 tt0 -69.39 -6.06 27.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.433 -1.04 . . . . 0.0 109.509 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -91.38 -29.24 17.2 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.928 0.87 . . . . 0.0 108.936 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.8 m-20 -88.79 12.51 14.82 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.707 HG22 ' H ' ' A' ' 122' ' ' HIS . 5.0 mm -89.87 -169.92 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.897 ' O ' HG22 ' A' ' 93' ' ' THR . 0.1 OUTLIER -151.63 99.79 2.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 109.805 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -117.13 135.74 53.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.149 -0.97 . . . . 0.0 109.549 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 152.85 -145.91 13.89 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.177 -1.19 . . . . 0.0 109.509 179.944 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.463 ' O ' ' CB ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.239 0.542 . . . . 0.0 110.174 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' B' ' 201' ' ' MET . 0.6 OUTLIER 72.6 98.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.563 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . 0.429 ' C ' ' O ' ' B' ' 202' ' ' ASN . 1.2 t -43.43 112.04 1.18 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.0 109.54 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.49 -3.29 13.16 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.828 1.436 . . . . 0.0 110.046 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -38.62 84.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.884 . . . . 0.0 109.385 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -51.8 56.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.351 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . 0.522 ' HB2' ' HB1' ' B' ' 273' ' ' ALA . 21.9 mtm -59.91 -30.06 68.78 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.293 -0.879 . . . . 0.0 109.624 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 5.0 m -72.55 -33.81 67.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.91 . . . . 0.0 109.195 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.9 75.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.205 -0.934 . . . . 0.0 108.859 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.856 HG11 ' CE1' ' B' ' 303' ' ' PHE . 2.3 t -52.74 -45.99 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.818 HG11 HG21 ' B' ' 271' ' ' VAL . 4.4 t -61.86 -39.63 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.599 -0.688 . . . . 0.0 109.951 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' B' ' 213' ' ' ARG . 21.8 tt0 -62.63 -75.4 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.758 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.0 OUTLIER -43.35 -44.84 5.81 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.971 0.891 . . . . 0.0 108.622 179.157 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' TYR . . . . . 0.633 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -50.42 -46.98 56.74 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.865 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -85.77 -37.65 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.359 -0.838 . . . . 0.0 109.297 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.72 -36.5 16.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -73.08 -34.19 66.06 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' B' ' 215' ' ' VAL . 1.2 mt -65.26 -58.22 6.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -50.37 -45.04 54.98 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.555 0.693 . . . . 0.0 109.164 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.64 5.95 43.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.52 -0.737 . . . . 0.0 109.633 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.686 ' HA2' HD11 ' B' ' 259' ' ' LEU . . . 50.4 37.96 33.35 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' B' ' 217' ' ' ALA . 11.3 t0 -97.77 72.41 2.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.42 -1.047 . . . . 0.0 109.864 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' LEU . . . . . 1.038 HD11 ' HB3' ' B' ' 255' ' ' PHE . 7.7 tp -47.08 -43.65 20.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 108.705 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -43.32 -35.28 1.45 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -80.32 -35.79 25.6 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 1.007 HD12 HD12 ' B' ' 223' ' ' LEU . 19.9 mt -62.1 -57.19 13.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.637 ' CG1' HG23 ' B' ' 248' ' ' THR . 92.6 t -56.44 -37.41 51.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.07 -54.92 41.58 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.773 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.3 tp -63.8 -22.06 66.73 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . 0.693 ' CG ' HG21 ' B' ' 251' ' ' ILE . 2.0 m-85 -85.42 130.01 34.68 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.525 -0.735 . . . . 0.0 109.383 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -47.0 172.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.152 -0.968 . . . . 0.0 109.383 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.3 -24.99 58.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 109.816 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.527 ' CB ' ' HA2' ' B' ' 247' ' ' GLY . 13.2 p-10 -150.24 45.55 0.89 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.583 -0.698 . . . . 0.0 109.212 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.822 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -57.57 159.9 4.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.334 -0.854 . . . . 0.0 109.706 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' THR . . . . . 1.006 HG23 ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -106.95 144.12 34.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.558 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.55 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 42.8 t -132.72 121.4 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.081 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' GLU . . . . . 0.551 ' HB2' ' CG ' ' B' ' 313' ' ' ARG . 3.3 mt-10 -89.26 109.18 20.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 108.89 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' ASP . . . . . 0.506 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 9.8 t70 -179.17 141.92 0.38 Allowed Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.837 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' B' ' 238' ' ' ASP . 47.3 Cg_endo -72.66 -177.57 18.89 Favored 'Cis proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.291 -1.962 . . . . 0.0 110.761 -0.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 8.0 m -62.34 152.34 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.254 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.07 20.73 9.27 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' SER . . . . . 0.498 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -116.59 -155.41 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -1.066 . . . . 0.0 109.511 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.77 128.84 25.58 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.066 -1.022 . . . . 0.0 109.894 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' PRO . . . . . 0.55 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.4 Cg_endo -65.25 -169.94 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.983 1.518 . . . . 0.0 111.243 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.712 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.5 OUTLIER -151.14 100.88 2.82 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 1.006 ' HB3' HG23 ' B' ' 235' ' ' THR . 0.2 OUTLIER -89.44 153.61 20.69 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 110.363 -178.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' B' ' 233' ' ' ASP . . . 108.03 159.94 20.45 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' THR . . . . . 0.637 HG23 ' CG1' ' B' ' 227' ' ' VAL . 6.3 m -70.4 -44.74 67.37 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.219 -1.165 . . . . 0.0 109.103 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -63.08 -36.84 84.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -0.911 . . . . 0.0 109.06 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.712 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -74.18 -59.84 2.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.822 HD11 ' N ' ' B' ' 234' ' ' ALA . 30.1 mt -48.45 -41.23 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.28 -0.887 . . . . 0.0 108.916 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' ARG . . . . . 0.641 ' CG ' HD23 ' B' ' 223' ' ' LEU . 13.0 ttm180 -78.34 -56.49 4.41 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 17.5 tt0 -46.65 -27.03 1.03 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.058 -1.027 . . . . 0.0 108.29 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 0.6 OUTLIER -86.22 -71.14 0.56 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 1.038 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -48.09 -31.62 5.77 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . 0.704 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -67.04 -47.73 70.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -56.49 -31.94 64.53 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' SER . . . . . 0.58 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 29.6 t -73.14 -36.37 66.66 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 0.686 HD11 ' HA2' ' B' ' 221' ' ' GLY . 8.2 tp -68.22 -27.84 66.72 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.382 -0.824 . . . . 0.0 109.282 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -47.21 -25.74 1.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.235 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' LEU . . . . . 0.709 ' O ' HD23 ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.74 112.67 53.3 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.403 -0.811 . . . . 0.0 108.912 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.34 97.75 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.823 1.433 . . . . 0.0 110.493 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.976 HD13 HG13 ' B' ' 284' ' ' VAL . 0.3 OUTLIER -131.66 -172.07 2.77 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.79 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . 0.987 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -119.19 127.4 53.26 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . 0.71 HG21 ' HB3' ' B' ' 218' ' ' LEU . 3.6 t -107.88 118.8 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.281 -0.887 . . . . 0.0 109.575 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.4 tt0 -150.08 106.81 3.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 109.285 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.9 OUTLIER -47.15 174.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.839 . . . . 0.0 109.767 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 1.7 p -148.49 -38.92 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.63 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' B' ' 270' ' ' GLU . 0.6 OUTLIER -99.69 -147.06 0.34 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 109.405 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.442 ' N ' ' CG ' ' B' ' 269' ' ' GLN . 26.0 tt0 -111.45 132.24 54.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.205 -0.934 . . . . 0.0 109.562 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . 0.822 HG13 ' HB3' ' B' ' 280' ' ' PHE . 30.3 t -64.04 151.11 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.263 -0.898 . . . . 0.0 109.12 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' B' ' 279' ' ' ALA . 0.0 OUTLIER -117.46 135.44 53.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.082 -1.011 . . . . 0.0 109.742 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' B' ' 207' ' ' MET . . . -147.13 127.72 14.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.317 -0.865 . . . . 0.0 109.464 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -140.27 156.39 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 0.0 109.567 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . 0.446 ' O ' ' SD ' ' B' ' 207' ' ' MET . . . 42.35 -145.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.447 -0.783 . . . . 0.0 109.469 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 1.3 m120 -83.54 -11.08 57.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.116 -0.99 . . . . 0.0 109.473 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . 0.5 ' HG2' ' HG3' ' B' ' 302' ' ' ARG . 1.5 mt-10 -93.28 -162.44 0.94 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.431 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 178.15 160.8 0.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.452 -0.78 . . . . 0.0 109.623 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' ALA . . . . . 0.706 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -147.67 139.62 24.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.044 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . 0.822 ' HB3' HG13 ' B' ' 271' ' ' VAL . 26.4 p90 -150.76 171.38 17.27 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.906 -1.121 . . . . 0.0 109.748 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.912 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -143.11 164.34 30.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.298 -0.877 . . . . 0.0 110.238 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' PHE . . . . . 0.5 ' O ' ' HD2' ' B' ' 297' ' ' PRO . 2.1 p90 -158.45 -172.57 3.91 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' THR . . . . . 0.878 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -130.31 141.22 50.61 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 284' ' ' VAL . . . . . 0.976 HG13 HD13 ' B' ' 263' ' ' LEU . 23.9 t -106.21 112.09 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 108.974 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 285' ' ' SER . . . . . 0.987 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 15.7 p -101.25 76.62 1.73 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.879 . . . . 0.0 109.257 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.76 ' CE1' H221 ' B' ' 326' ' ' NTH . 13.8 p90 -89.86 176.33 6.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.346 -0.846 . . . . 0.0 109.591 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -128.33 151.51 49.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.333 -0.855 . . . . 0.0 109.306 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.444 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.6 OUTLIER -100.94 -166.09 1.27 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.395 -0.816 . . . . 0.0 109.376 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.9 43.51 1.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 0.0 109.075 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 154.29 -22.24 0.66 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 291' ' ' ARG . . . . . 0.483 ' O ' ' HD3' ' B' ' 292' ' ' LYS . 8.8 mtt180 -123.92 176.22 6.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -1.108 . . . . 0.0 109.555 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 292' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' B' ' 291' ' ' ARG . 7.7 mmtp -131.22 115.05 15.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.223 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 293' ' ' THR . . . . . 0.482 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -119.73 142.91 48.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.206 -0.933 . . . . 0.0 110.025 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 294' ' ' VAL . . . . . 0.572 HG22 ' N ' ' B' ' 295' ' ' VAL . 12.4 p -120.99 170.96 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 0.975 HG22 HG23 ' B' ' 321' ' ' ILE . 54.2 t -139.81 158.21 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.911 -1.118 . . . . 0.0 110.07 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 296' ' ' ALA . . . . . 0.435 ' N ' HG12 ' B' ' 295' ' ' VAL . . . -137.43 74.29 47.68 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.812 . . . . 0.0 109.791 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 297' ' ' PRO . . . . . 0.594 ' HD3' HG12 ' B' ' 295' ' ' VAL . 47.3 Cg_endo -97.36 -173.36 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.623 1.549 . . . . 0.0 110.749 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.912 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.7 mp -139.79 161.99 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . 0.61 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 11.5 t0 -131.75 155.69 47.27 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.097 -1.002 . . . . 0.0 110.012 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' B' ' 299' ' ' ASP . 0.1 OUTLIER -111.66 174.06 6.05 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' PHE . . . . . 0.593 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.91 151.78 36.44 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.014 -1.054 . . . . 0.0 110.473 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.5 ' HG3' ' HG2' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -145.0 94.44 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 109.533 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' PHE . . . . . 0.856 ' CE1' HG11 ' B' ' 210' ' ' VAL . 12.2 m-85 -90.63 -163.52 1.04 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 109.429 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' ASN . . . . . 0.605 ' OD1' HG22 ' B' ' 310' ' ' VAL . 0.2 OUTLIER -139.6 7.31 2.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.727 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . 116.22 68.31 0.41 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . 54.35 41.26 32.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -1.165 . . . . 0.0 109.444 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 307' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' B' ' 308' ' ' LYS . . . -125.1 35.2 3.18 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 308' ' ' LYS . . . . . 0.558 ' CB ' ' O ' ' B' ' 307' ' ' GLY . 9.2 mttm 83.05 -161.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 122.012 -0.699 . . . . 0.0 109.404 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 309' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 98.6 t -99.36 136.52 30.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.342 -0.849 . . . . 0.0 109.501 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.632 ' O ' ' HB1' ' B' ' 234' ' ' ALA . 2.9 t -108.78 -71.45 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 109.357 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . 0.499 ' HB2' ' HD3' ' B' ' 302' ' ' ARG . 0.4 OUTLIER -113.9 169.0 9.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.183 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 312' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' B' ' 300' ' ' HIS . 13.4 ttp -158.65 152.27 23.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.947 . . . . 0.0 109.778 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 313' ' ' ARG . . . . . 0.551 ' CG ' ' HB2' ' B' ' 237' ' ' GLU . 0.1 OUTLIER -131.07 170.22 14.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.38 -0.825 . . . . 0.0 109.29 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -144.9 130.02 18.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.192 -0.943 . . . . 0.0 109.247 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 315' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 79' ' ' ALA . 1.1 tt -123.93 144.54 49.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.182 -0.949 . . . . 0.0 109.925 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 316' ' ' PHE . . . . . 0.531 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 12.2 p90 173.57 -156.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 317' ' ' GLY . . . . . 0.576 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 162.4 -176.07 38.79 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 318' ' ' GLU . . . . . 0.518 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 6.2 tt0 -72.36 -3.4 23.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -1.139 . . . . 0.0 109.385 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -93.75 -29.12 15.54 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.955 0.883 . . . . 0.0 108.873 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 320' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' B' ' 296' ' ' ALA . 1.4 m-20 -89.02 7.87 32.59 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 321' ' ' ILE . . . . . 0.975 HG23 HG22 ' B' ' 295' ' ' VAL . 4.6 mm -90.65 -167.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 322' ' ' HIS . . . . . 0.684 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.2 OUTLIER -151.06 158.88 44.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 0.0 109.593 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.4 ' HA ' HG22 ' B' ' 293' ' ' THR . . . -155.26 81.46 1.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 109.518 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -115.68 177.65 17.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.244 -1.151 . . . . 0.0 109.493 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' NTH . . . . . 0.774 ' H11' ' OG ' ' A' ' 58' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 326' ' ' NTH . . . . . 0.76 H221 ' CE1' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.527 ' O ' ' CE ' ' A' ' 7' ' ' MET . 1.1 ptp . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.331 0.586 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.3 t30 45.57 -167.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.598 ' O ' HG23 ' A' ' 3' ' ' THR . 13.4 t -71.87 122.52 87.5 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.719 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HA ' ' CE ' ' A' ' 7' ' ' MET . 43.8 Cg_endo -70.67 -5.44 16.77 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.926 1.487 . . . . 0.0 109.535 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -43.93 88.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.496 -0.752 . . . . 0.0 109.361 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -61.52 -47.05 87.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.211 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.527 ' CE ' ' O ' ' A' ' 1' ' ' MET . 11.6 mtt -57.52 -39.5 76.71 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.29 -0.881 . . . . 0.0 109.227 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 m -52.77 -37.01 58.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.335 -0.853 . . . . 0.0 108.987 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.17 -50.67 73.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.297 -0.877 . . . . 0.0 109.051 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.748 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.1 t -48.79 -34.48 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 108.788 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.717 HG11 ' CG2' ' A' ' 71' ' ' VAL . 8.0 t -81.07 -41.91 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.399 -0.813 . . . . 0.0 109.222 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 15' ' ' VAL . 8.5 tt0 -63.35 -73.54 0.11 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.272 1.034 . . . . 0.0 108.573 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.827 ' HD2' HD13 ' A' ' 29' ' ' LEU . 1.1 mtm180 -42.62 -45.13 4.51 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.629 ' CE1' HD11 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -44.21 -41.9 6.13 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.005 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.958 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.5 t -90.43 -38.53 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.742 . . . . 0.0 109.02 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -48.87 -35.31 14.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.597 ' HB3' HG12 ' A' ' 26' ' ' ILE . . . -74.15 -35.42 64.04 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.958 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.3 mt -62.13 -58.47 7.67 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -50.69 -38.27 46.0 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.439 0.638 . . . . 0.0 109.334 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.86 -2.31 58.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.635 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.877 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 52.51 40.14 54.15 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.474 ' O ' HG13 ' A' ' 26' ' ' ILE . 8.5 t70 -106.76 86.37 2.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -1.087 . . . . 0.0 109.608 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.971 ' CD2' HD22 ' A' ' 59' ' ' LEU . 3.5 mm? -52.08 -20.02 2.25 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 2.2 m-20 -65.36 -56.74 10.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.486 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -61.14 -27.66 67.72 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.862 HD12 HD13 ' A' ' 23' ' ' LEU . 10.1 mt -71.31 -64.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.844 HG21 ' HB2' ' A' ' 52' ' ' ARG . 96.6 t -58.3 -35.79 55.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 24' ' ' ASP . . . -60.02 -56.41 21.98 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.827 HD13 ' HD2' ' A' ' 13' ' ' ARG . 5.9 tp -58.87 -25.53 63.41 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.7 ' CE1' ' HE1' ' A' ' 112' ' ' MET . 14.6 m-30 -87.67 148.35 24.83 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.752 -0.593 . . . . 0.0 109.636 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -55.0 -166.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.739 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.437 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -83.09 -23.88 32.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 109.577 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.54 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 21.7 p-10 -144.37 39.45 1.3 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.616 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -54.09 177.71 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.468 -0.77 . . . . 0.0 109.795 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.462 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -129.32 135.69 49.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.387 -0.821 . . . . 0.0 109.232 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 27.2 t -123.63 120.35 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.631 ' O ' ' HB3' ' A' ' 114' ' ' ALA . 3.2 mt-10 -91.11 104.77 17.31 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.65 ' OD2' ' H10' ' A' ' 126' ' ' NTH . 30.2 t70 -178.92 137.05 0.32 Allowed Pre-proline 0 C--N 1.298 -1.647 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.165 -178.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.549 ' O ' ' O ' ' A' ' 40' ' ' VAL . 47.5 Cg_endo -71.91 -148.97 0.41 Allowed 'Cis proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.311 -1.954 . . . . 0.0 110.644 0.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.957 HG11 HG11 ' B' ' 274' ' ' VAL . 5.4 m -52.8 -140.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 122.084 0.945 . . . . 0.0 111.834 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.694 ' N ' HG23 ' A' ' 40' ' ' VAL . . . -39.26 -23.66 0.03 OUTLIER Glycine 0 N--CA 1.495 2.575 0 O-C-N 121.174 -0.954 . . . . 0.0 111.604 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.541 ' CB ' ' HG2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -29.56 -93.7 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.016 -0.697 . . . . 0.0 110.874 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 42' ' ' SER . 0.0 OUTLIER 169.42 122.32 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.992 -1.068 . . . . 0.0 111.005 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.9 Cg_endo -66.24 -167.85 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.662 1.575 . . . . 0.0 111.281 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 1.083 ' CG ' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -151.57 130.3 12.37 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.462 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.5 OUTLIER -112.7 147.47 36.73 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.672 -1.268 . . . . 0.0 110.702 -178.225 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.54 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 105.02 163.19 23.92 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 2.7 m -69.15 -64.51 0.86 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.076 -1.25 . . . . 0.0 108.902 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -48.11 -23.7 0.91 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.159 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.083 ' HB1' ' CG ' ' A' ' 45' ' ' ARG . . . -90.02 -56.54 3.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.506 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.474 ' HA ' HD13 ' A' ' 51' ' ' ILE . 9.0 mm -52.34 -41.87 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.309 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.844 ' HB2' HG21 ' A' ' 27' ' ' VAL . 19.5 ttt180 -73.38 -49.12 28.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 108.814 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 14.0 mt-10 -52.34 -30.0 26.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.146 -0.971 . . . . 0.0 108.486 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -81.82 -71.5 0.48 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.858 ' CD1' HG21 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -48.89 -29.1 4.31 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.11 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 52' ' ' ARG . . . -72.61 -38.05 67.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.491 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 23.9 t30 -65.22 -33.62 76.44 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.598 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 45.7 t -69.09 -41.75 77.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.475 -0.765 . . . . 0.0 108.941 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.971 HD22 ' CD2' ' A' ' 23' ' ' LEU . 9.5 tp -59.57 -18.95 45.16 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.271 -0.893 . . . . 0.0 109.074 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 57' ' ' ASN . 28.9 mtmt -69.66 -5.58 25.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 108.973 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.812 HD12 H122 ' A' ' 126' ' ' NTH . 0.3 OUTLIER -89.12 112.52 51.55 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.569 ' HD2' HD23 ' A' ' 61' ' ' LEU . 42.1 Cg_endo -68.56 91.03 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.713 1.375 . . . . 0.0 111.076 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.789 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -150.59 167.42 27.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.222 -0.924 . . . . 0.0 110.108 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.37 127.4 52.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.77 124.53 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.786 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.99 113.34 4.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.21 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.31 177.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 109.845 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.455 HG23 ' N ' ' A' ' 69' ' ' GLN . 9.9 t -156.24 -38.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 109.816 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 3.1 pt20 -97.71 -147.24 0.31 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.551 -0.718 . . . . 0.0 109.361 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.494 ' O ' ' NE ' ' A' ' 72' ' ' ARG . 29.9 tt0 -114.55 135.54 54.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.945 . . . . 0.0 109.649 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.717 ' CG2' HG11 ' A' ' 11' ' ' VAL . 79.3 t -66.21 152.2 9.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.365 -0.835 . . . . 0.0 109.154 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -118.33 140.48 49.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.089 . . . . 0.0 110.138 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . . . -150.25 134.67 17.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.428 -0.795 . . . . 0.0 109.141 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.684 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -159.62 163.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.943 -1.098 . . . . 0.0 110.212 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.52 ' HB1' ' HA3' ' B' ' 241' ' ' GLY . . . 39.17 -97.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.786 -0.571 . . . . 0.0 110.232 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 103' ' ' PHE . 4.1 m-20 -135.74 10.3 3.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.022 -1.049 . . . . 0.0 109.717 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.506 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -116.22 -161.17 0.78 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.148 -0.97 . . . . 0.0 109.371 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.873 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . -176.58 129.81 0.2 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.475 -0.766 . . . . 0.0 109.629 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -114.88 130.82 56.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.998 . . . . 0.0 109.287 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.631 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 15.2 p90 -150.47 173.19 14.35 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.819 -1.176 . . . . 0.0 109.783 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.572 ' HB2' ' CG1' ' A' ' 98' ' ' ILE . . . -150.27 -167.58 2.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 110.627 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.481 ' O ' ' HD2' ' A' ' 97' ' ' PRO . 9.1 p90 178.06 -168.93 0.08 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -135.94 141.16 44.46 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 110.05 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.735 HG13 ' CB ' ' A' ' 63' ' ' LEU . 2.2 t -110.95 118.19 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 108.882 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.725 ' HA ' HG23 ' A' ' 94' ' ' VAL . 1.7 p -118.65 110.08 16.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.128 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.572 ' CZ ' ' HB ' ' A' ' 93' ' ' THR . 10.5 p90 -130.23 -177.71 4.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.289 -0.882 . . . . 0.0 109.712 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -122.93 152.25 41.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.389 -0.819 . . . . 0.0 109.09 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER -110.08 178.5 4.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.223 -0.923 . . . . 0.0 109.775 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -65.23 68.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.442 -0.786 . . . . 0.0 109.679 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 88' ' ' PHE . . . 115.81 -30.06 6.82 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 125' ' ' ALA . 23.3 mtt85 -111.6 -171.9 1.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -1.157 . . . . 0.0 109.691 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -147.03 146.97 30.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 109.346 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.572 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -141.3 153.84 45.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.435 -0.791 . . . . 0.0 110.223 -179.309 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.725 HG23 ' HA ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -132.79 172.33 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.751 HG22 HG23 ' A' ' 121' ' ' ILE . 52.5 t -150.15 146.73 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.542 -1.349 . . . . 0.0 110.646 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.69 74.22 78.3 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.707 ' HD3' HG12 ' A' ' 95' ' ' VAL . 48.5 Cg_endo -94.76 -179.36 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.58 1.52 . . . . 0.0 111.833 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 80' ' ' PHE . 3.2 mp -143.74 144.18 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 4.3 t0 -117.87 163.12 17.02 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 110.155 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.2 OUTLIER -115.55 176.56 5.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.873 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -150.29 135.88 18.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.026 -1.046 . . . . 0.0 110.383 -178.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.506 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -121.01 107.67 12.92 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.381 -0.824 . . . . 0.0 109.075 179.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.748 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -89.26 166.22 13.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.363 -0.836 . . . . 0.0 109.38 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.773 ' HB3' HG21 ' A' ' 110' ' ' VAL . 1.7 p30 -115.81 -5.97 12.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 109.166 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.711 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 177.26 -60.92 0.1 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 161.17 77.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.507 -0.996 . . . . 0.0 109.38 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.54 -66.32 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.572 ' O ' ' CE1' ' A' ' 103' ' ' PHE . 14.8 mttm -108.4 178.13 4.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -1.191 . . . . 0.0 109.602 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.646 ' CG2' HG22 ' A' ' 10' ' ' VAL . 49.6 t -109.05 153.35 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.336 -0.852 . . . . 0.0 109.233 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.773 HG21 ' HB3' ' A' ' 104' ' ' ASN . 44.8 t -124.18 -62.37 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -0.969 . . . . 0.0 109.53 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -116.31 164.53 14.38 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.974 -1.079 . . . . 0.0 109.463 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.7 ' HE1' ' CE1' ' A' ' 30' ' ' PHE . 19.3 ttm -153.29 137.67 16.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.325 -0.86 . . . . 0.0 109.5 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.506 ' HB2' ' HB3' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -113.21 168.57 9.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.448 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . -150.4 130.11 13.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.16 -0.962 . . . . 0.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 1.06 HD22 ' HB3' ' B' ' 279' ' ' ALA . 0.6 OUTLIER -130.94 142.6 50.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.783 ' CZ ' ' H62' ' A' ' 126' ' ' NTH . 50.3 p90 166.5 -162.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . 177.5 178.83 47.41 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.219 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.51 ' HA ' HG12 ' A' ' 121' ' ' ILE . 16.8 tt0 -50.2 -21.83 1.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.145 -1.209 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.48 ' HD3' ' OE2' ' B' ' 270' ' ' GLU . 0.6 OUTLIER -73.41 -22.11 60.32 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.009 0.909 . . . . 0.0 108.829 179.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.568 ' ND2' HG13 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -88.56 -4.57 58.56 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.5 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.751 HG23 HG22 ' A' ' 95' ' ' VAL . 2.2 mm -91.75 -162.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.03 -1.044 . . . . 0.0 108.212 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.615 ' CB ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -152.25 -169.4 3.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.004 -1.06 . . . . 0.0 109.606 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.55 -176.24 5.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.875 . . . . 0.0 109.54 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.81 -175.35 41.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.275 -1.133 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.524 ' O ' ' CB ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.298 0.57 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' B' ' 201' ' ' MET . 2.6 t30 77.05 177.9 0.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.239 -0.913 . . . . 0.0 109.713 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.37 128.57 66.69 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.398 -0.814 . . . . 0.0 109.736 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' PRO . . . . . 0.441 ' HA ' ' CE ' ' B' ' 207' ' ' MET . 42.5 Cg_endo -69.76 -7.01 19.96 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.023 1.539 . . . . 0.0 109.153 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . 0.446 ' O ' ' HB ' ' B' ' 208' ' ' THR . 0.3 OUTLIER -61.66 -45.67 93.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.436 -0.79 . . . . 0.0 108.91 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -64.1 -43.7 94.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 108.904 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . 0.441 ' CE ' ' HA ' ' B' ' 204' ' ' PRO . 16.7 mtt -54.9 -24.66 24.55 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.29 -0.881 . . . . 0.0 109.156 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' B' ' 205' ' ' GLU . 11.2 m -72.7 -41.64 65.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.405 -0.809 . . . . 0.0 108.983 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.35 -41.34 51.41 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.319 -0.863 . . . . 0.0 108.761 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.994 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.2 t -54.81 -44.58 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.818 HG11 ' CG2' ' B' ' 271' ' ' VAL . 6.6 t -72.42 -41.66 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 109.459 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 213' ' ' ARG . 23.7 tt0 -59.92 -74.16 0.08 Allowed 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.265 1.031 . . . . 0.0 108.281 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.469 ' HB3' HD22 ' B' ' 229' ' ' LEU . 2.7 mtt85 -43.54 -45.51 6.62 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.977 0.894 . . . . 0.0 108.659 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.5 OUTLIER -49.9 -44.77 50.26 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.907 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -87.17 -38.54 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.372 -0.83 . . . . 0.0 109.274 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.42 -37.74 17.88 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' B' ' 222' ' ' ASP . . . -72.06 -34.39 68.7 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' B' ' 215' ' ' VAL . 1.9 mt -64.54 -57.97 7.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -49.97 -42.27 48.49 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.567 0.698 . . . . 0.0 109.224 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.49 -1.04 57.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.884 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.876 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 57.43 47.58 87.06 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . 0.536 ' O ' ' HB1' ' B' ' 217' ' ' ALA . 26.7 t70 -113.38 92.64 4.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.852 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' LEU . . . . . 1.079 HD13 HD12 ' B' ' 226' ' ' ILE . 2.5 mm? -62.46 -12.48 22.25 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.184 -0.947 . . . . 0.0 109.565 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -59.36 3.5 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.293 -0.879 . . . . 0.0 109.424 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -59.6 -28.44 65.23 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 1.079 HD12 HD13 ' B' ' 223' ' ' LEU . 23.0 mt -69.02 -62.01 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.545 -0.973 . . . . 0.0 108.47 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.888 HG11 HG23 ' B' ' 248' ' ' THR . 65.3 t -58.37 -36.11 57.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -57.33 13.47 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.994 HD21 ' HA ' ' B' ' 210' ' ' VAL . 9.8 tp -57.19 -29.07 63.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . 0.696 ' CE2' HG22 ' B' ' 226' ' ' ILE . 17.1 m-30 -82.18 127.22 32.94 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.644 -0.66 . . . . 0.0 109.619 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -45.68 171.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 109.582 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -24.39 66.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.729 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.577 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 55.4 p-10 -134.03 44.43 2.73 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.668 -0.645 . . . . 0.0 109.556 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' B' ' 310' ' ' VAL . . . -71.41 -169.94 0.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' THR . . . . . 0.715 HG22 ' HB2' ' B' ' 246' ' ' SER . 15.1 p -142.34 175.06 10.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.303 -0.873 . . . . 0.0 109.329 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.583 HG23 ' O ' ' B' ' 235' ' ' THR . 40.0 t -158.94 110.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 17.7 mt-10 -88.27 105.98 17.91 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 8.8 t0 -174.68 142.47 0.77 Allowed Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.106 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.512 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 47.1 Cg_endo -72.14 -168.49 5.53 Favored 'Cis proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.345 -1.939 . . . . 0.0 110.873 -0.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' B' ' 315' ' ' LEU . 3.7 m -64.79 146.14 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.276 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . 0.52 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . 54.12 32.22 49.87 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' SER . . . . . 0.512 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.2 OUTLIER -120.1 -156.38 0.66 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -1.096 . . . . 0.0 109.607 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . 0.429 ' HA ' ' HD2' ' B' ' 244' ' ' PRO . 19.5 mt-10 -120.76 118.37 30.67 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.166 -0.959 . . . . 0.0 110.026 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' PRO . . . . . 0.578 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.1 Cg_endo -64.82 -169.05 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.938 1.494 . . . . 0.0 111.55 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.766 ' HB3' ' HB1' ' B' ' 250' ' ' ALA . 6.5 mtt180 -150.83 106.17 3.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.866 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.19 158.08 18.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 110.154 -179.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 87.7 157.2 31.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' THR . . . . . 0.888 HG23 HG11 ' B' ' 227' ' ' VAL . 6.9 m -67.2 -41.41 85.88 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.35 -1.088 . . . . 0.0 109.197 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -60.92 -32.85 72.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.291 -0.881 . . . . 0.0 109.186 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.866 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -89.8 -55.07 3.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.372 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.551 HD12 ' C ' ' B' ' 247' ' ' GLY . 14.3 mt -54.11 -44.9 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 0.0 108.887 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' ARG . . . . . 0.712 ' HB2' HG21 ' B' ' 227' ' ' VAL . 25.8 ttt-85 -70.56 -53.14 17.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 23.2 tt0 -50.41 -32.31 17.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.151 -0.968 . . . . 0.0 109.015 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.582 ' CD2' ' HG3' ' B' ' 245' ' ' ARG . 0.2 OUTLIER -80.26 -70.51 0.52 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 0.538 ' HB3' ' CD1' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -47.89 -26.4 1.68 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' B' ' 252' ' ' ARG . . . -76.61 -44.39 34.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.085 -1.009 . . . . 0.0 108.675 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 5.1 t-20 -65.09 -25.63 67.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 108.75 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 21.5 t -75.36 -39.37 59.34 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 0.906 HD22 ' CD2' ' B' ' 223' ' ' LEU . 8.2 tp -64.96 -20.04 66.28 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.456 -0.777 . . . . 0.0 109.17 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 2.2 mttt -49.14 -27.73 3.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.413 -0.805 . . . . 0.0 109.505 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' LEU . . . . . 0.899 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.5 OUTLIER -89.95 118.88 69.28 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.217 -0.927 . . . . 0.0 109.078 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' PRO . . . . . 0.43 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 43.9 Cg_endo -70.21 105.06 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.768 1.404 . . . . 0.0 110.535 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.899 ' CD2' HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -137.73 153.17 49.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.92 . . . . 0.0 109.509 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -89.98 129.12 36.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 108.877 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . 0.551 HG11 HG22 ' B' ' 215' ' ' VAL . 98.3 t -111.98 118.58 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.663 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 4.1 tt0 -150.26 96.51 2.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.308 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.9 mp -45.14 171.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.752 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 34.2 p -146.86 -37.97 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.87 . . . . 0.0 109.711 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 269' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 15.3 pt20 -91.46 -146.61 0.21 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.505 -0.747 . . . . 0.0 109.433 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 58.1 tt0 -115.06 134.67 54.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.677 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . 0.818 ' CG2' HG11 ' B' ' 211' ' ' VAL . 56.3 t -65.7 153.36 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.372 -0.83 . . . . 0.0 109.189 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.0 OUTLIER -113.97 135.72 53.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.078 -1.013 . . . . 0.0 110.134 -179.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . 0.438 ' HB1' ' CB ' ' B' ' 207' ' ' MET . . . -150.1 149.49 30.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.148 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 274' ' ' VAL . . . . . 0.957 HG11 HG11 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -153.38 -155.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.039 -1.038 . . . . 0.0 109.939 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . -23.39 -96.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 120.954 0.406 . . . . 0.0 111.815 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 276' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' B' ' 303' ' ' PHE . 47.5 t30 -116.23 -1.57 12.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.855 -1.153 . . . . 0.0 110.725 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . 0.468 ' HG3' ' HG3' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -109.25 -162.08 0.79 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.811 -1.181 . . . . 0.0 109.557 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 278' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . -179.98 159.99 0.84 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.49 -0.756 . . . . 0.0 109.349 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 279' ' ' ALA . . . . . 1.06 ' HB3' HD22 ' A' ' 115' ' ' LEU . . . -150.33 138.27 20.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 109.041 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . 0.748 ' CD2' HG22 ' B' ' 211' ' ' VAL . 35.0 p90 -150.61 172.06 16.13 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.931 -1.106 . . . . 0.0 109.851 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.828 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -146.44 -168.62 3.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 0.0 109.962 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 282' ' ' PHE . . . . . 0.451 ' HB3' ' O ' ' B' ' 281' ' ' ALA . 31.3 p90 170.28 -167.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.227 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.93 142.51 50.92 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.443 -0.786 . . . . 0.0 109.677 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 284' ' ' VAL . . . . . 0.813 HG11 HD22 ' B' ' 263' ' ' LEU . 74.4 t -114.36 113.02 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.862 . . . . 0.0 109.322 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 4.4 p -109.14 115.07 29.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.308 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.786 ' CZ ' H221 ' B' ' 326' ' ' NTH . 6.5 p90 -137.65 160.79 38.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -137.76 153.03 49.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.501 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 2.3 p90 -148.02 12.67 0.98 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 109.871 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -168.07 -147.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.113 -0.992 . . . . 0.0 109.406 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -76.66 -23.33 70.28 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -105.48 -179.82 4.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -1.09 . . . . 0.0 109.298 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 292' ' ' LYS . . . . . 0.454 ' O ' ' HD2' ' B' ' 292' ' ' LYS . 0.1 OUTLIER -149.26 128.16 12.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.525 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 293' ' ' THR . . . . . 0.815 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -105.19 142.72 34.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.248 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 294' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' B' ' 322' ' ' HIS . 0.6 OUTLIER -113.52 174.96 2.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.192 -0.943 . . . . 0.0 108.615 179.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 1.073 HG22 HG23 ' B' ' 321' ' ' ILE . 3.0 t -145.87 145.17 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -0.981 . . . . 0.0 109.426 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 296' ' ' ALA . . . . . 0.524 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -132.58 71.36 78.93 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.223 -0.923 . . . . 0.0 110.362 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 297' ' ' PRO . . . . . 1.046 ' HD3' HG12 ' B' ' 295' ' ' VAL . 49.9 Cg_endo -95.61 -173.45 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.575 1.516 . . . . 0.0 110.692 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.828 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.7 mp -140.99 149.72 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . 0.622 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 5.7 t0 -115.0 161.07 18.83 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.929 -1.107 . . . . 0.0 110.111 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.513 ' HB3' ' HB2' ' B' ' 313' ' ' ARG . 0.1 OUTLIER -117.85 166.76 12.09 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' PHE . . . . . 0.808 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.2 OUTLIER -142.27 149.36 39.46 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.146 -0.971 . . . . 0.0 110.774 -178.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.468 ' HG3' ' HG3' ' B' ' 277' ' ' GLU . 30.8 ttt-85 -142.74 107.79 4.94 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 303' ' ' PHE . . . . . 0.774 ' CE1' HG21 ' B' ' 210' ' ' VAL . 26.0 m-85 -89.28 -174.84 4.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.142 -0.974 . . . . 0.0 109.358 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 304' ' ' ASN . . . . . 0.693 ' HB3' HG21 ' B' ' 310' ' ' VAL . 0.5 OUTLIER -112.63 -43.3 3.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.46 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 305' ' ' GLY . . . . . 0.688 ' O ' ' HB3' ' B' ' 306' ' ' ALA . . . -165.05 27.85 0.2 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 306' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' B' ' 305' ' ' GLY . . . 74.87 38.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -1.18 . . . . 0.0 109.534 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -131.43 -39.21 0.25 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 308' ' ' LYS . . . . . 0.457 ' HG3' ' OD1' ' B' ' 304' ' ' ASN . 2.1 pttt -153.65 -175.3 5.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -1.134 . . . . 0.0 109.497 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 309' ' ' VAL . . . . . 0.779 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 84.9 t -89.87 159.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 109.332 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.693 HG21 ' HB3' ' B' ' 304' ' ' ASN . 45.0 t -136.18 -75.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -0.956 . . . . 0.0 109.722 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . 0.504 ' CB ' ' OG1' ' B' ' 235' ' ' THR . 70.5 m -122.22 160.7 24.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.032 . . . . 0.0 110.057 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 312' ' ' MET . . . . . 0.676 ' HE1' ' CE1' ' B' ' 230' ' ' PHE . 2.3 ttm -139.04 158.45 44.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.435 -0.791 . . . . 0.0 109.531 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 313' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' B' ' 300' ' ' HIS . 0.8 OUTLIER -133.7 149.34 51.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 109.325 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 314' ' ' ALA . . . . . 0.406 ' CB ' ' OD2' ' B' ' 238' ' ' ASP . . . -125.29 132.4 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.973 . . . . 0.0 109.708 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 315' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' A' ' 79' ' ' ALA . 1.2 tt -131.84 143.52 50.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.592 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 316' ' ' PHE . . . . . 0.684 ' O ' HG11 ' A' ' 74' ' ' VAL . 14.2 p90 171.91 -158.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 317' ' ' GLY . . . . . 0.548 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 168.87 -177.3 42.77 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 318' ' ' GLU . . . . . 0.537 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 13.1 tt0 -71.14 -4.8 27.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -1.118 . . . . 0.0 109.374 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -90.7 -30.86 16.85 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.902 0.858 . . . . 0.0 109.012 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 320' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -89.3 7.27 36.45 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.2 0.524 . . . . 0.0 109.59 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 321' ' ' ILE . . . . . 1.073 HG23 HG22 ' B' ' 295' ' ' VAL . 4.2 mm -90.82 -162.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 322' ' ' HIS . . . . . 0.815 ' O ' HG22 ' B' ' 293' ' ' THR . 60.3 t60 -151.27 154.32 36.55 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.087 -1.008 . . . . 0.0 109.637 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -155.14 86.54 1.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.925 . . . . 0.0 109.414 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -127.36 159.94 21.42 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.219 -1.165 . . . . 0.0 109.528 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' NTH . . . . . 0.812 H122 HD12 ' A' ' 61' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 326' ' ' NTH . . . . . 0.786 H221 ' CZ ' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 tpp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.23 0.538 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.46 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 73.5 m-80 -49.94 108.76 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 0.0 109.408 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.92 111.5 22.18 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.277 -0.889 . . . . 0.0 109.608 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 8' ' ' THR . 44.1 Cg_endo -71.64 -3.74 13.68 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.913 1.481 . . . . 0.0 110.039 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -57.41 -41.32 80.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.938 . . . . 0.0 109.407 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.22 -62.87 1.24 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.944 . . . . 0.0 108.989 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.707 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 27.5 mmt -54.39 -33.28 58.93 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.271 -0.893 . . . . 0.0 109.691 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 6.9 m -66.46 -34.25 77.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.406 -0.808 . . . . 0.0 109.207 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.61 -46.43 70.43 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.172 -0.955 . . . . 0.0 108.662 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.035 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.5 t -58.27 -19.57 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.868 HG21 HG11 ' A' ' 71' ' ' VAL . 14.4 t -90.51 -42.9 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.492 -0.755 . . . . 0.0 109.07 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' ARG . 25.9 tt0 -61.55 -74.22 0.09 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.231 1.015 . . . . 0.0 108.292 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' GLN . 4.2 mtm-85 -42.78 -45.59 4.87 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.601 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -49.24 -43.21 42.53 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.908 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.1 t -88.72 -38.67 11.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.458 -0.776 . . . . 0.0 109.253 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.47 -35.69 13.52 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.554 ' CB ' HG13 ' A' ' 26' ' ' ILE . . . -74.13 -34.56 63.92 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.908 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.2 mt -63.63 -58.71 6.07 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 65' ' ' VAL . 1.7 t-20 -51.36 -44.8 62.17 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.35 11.0 20.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.687 -0.633 . . . . 0.0 109.533 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.792 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 45.69 29.63 3.04 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' ALA . 10.4 t0 -92.09 60.44 3.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.454 -1.027 . . . . 0.0 109.812 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.072 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -45.8 -37.16 5.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 108.888 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' LEU . 5.9 m-20 -41.06 -29.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -89.17 -36.89 7.38 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.585 HG22 ' HD2' ' A' ' 30' ' ' PHE . 28.7 mt -59.24 -55.13 25.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.542 ' CG1' HG23 ' A' ' 48' ' ' THR . 60.0 t -54.82 -39.63 48.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -57.24 -52.47 65.2 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.035 HD21 ' HA ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -67.58 -15.86 63.88 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.722 ' CG ' HG21 ' A' ' 51' ' ' ILE . 2.6 m-85 -94.26 119.75 33.5 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.476 -0.765 . . . . 0.0 109.675 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -46.53 171.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.44 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.434 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.2 OUTLIER -73.72 -25.36 60.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.52 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.582 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -121.24 41.23 3.38 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.403 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -71.88 153.89 41.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.882 . . . . 0.0 109.919 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.661 HG23 ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -112.8 159.67 18.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.235 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.609 ' CG2' HD12 ' A' ' 51' ' ' ILE . 24.0 t -148.19 167.98 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.327 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.562 ' N ' HG12 ' A' ' 36' ' ' VAL . 14.1 mt-10 -147.39 111.22 5.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.788 ' OD1' ' HB3' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -178.31 149.63 0.68 Allowed Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 118.695 -1.202 . . . . 0.0 110.075 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.541 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 48.3 Cg_endo -74.13 175.31 47.21 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.052 -2.062 . . . . 0.0 111.014 -0.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.932 HG13 ' CE1' ' A' ' 116' ' ' PHE . 7.2 m -42.12 122.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.489 -0.757 . . . . 0.0 109.652 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 42' ' ' SER . . . 112.56 53.16 0.5 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.1 OUTLIER 78.53 -151.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -1.079 . . . . 0.0 109.961 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.638 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 4.1 mt-10 67.53 54.36 0.7 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.266 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.638 ' HD3' ' N ' ' A' ' 43' ' ' GLU . 55.7 Cg_endo -86.44 174.41 5.96 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.725 1.381 . . . . 0.0 110.576 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.904 ' HG3' ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -151.41 109.1 3.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.661 ' HB3' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -105.04 136.61 44.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.018 -1.051 . . . . 0.0 110.492 -178.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 103.43 158.44 24.91 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.542 HG23 ' CG1' ' A' ' 27' ' ' VAL . 7.2 m -60.88 -64.19 1.04 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.412 -1.052 . . . . 0.0 109.194 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.522 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -45.79 -25.2 0.47 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.088 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.904 ' HB1' ' HG3' ' A' ' 45' ' ' ARG . . . -86.92 -53.25 5.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.309 -0.869 . . . . 0.0 109.519 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.722 HG21 ' CG ' ' A' ' 30' ' ' PHE . 4.1 mm -55.74 -48.92 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.347 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.851 ' HA ' HD21 ' A' ' 23' ' ' LEU . 6.7 ttt180 -68.48 -53.01 26.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.406 -0.809 . . . . 0.0 109.119 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 13.1 tt0 -51.26 -32.16 23.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 108.66 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -83.87 -70.62 0.55 Allowed 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 1.072 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -45.34 -31.17 1.51 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 52' ' ' ARG . . . -66.4 -46.22 77.34 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 37.1 t-20 -60.62 -36.17 77.94 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.743 ' OG ' H112 ' A' ' 126' ' ' NTH . 39.4 t -68.6 -35.28 77.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.792 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.9 tp -64.94 -20.39 66.44 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.456 -0.777 . . . . 0.0 109.051 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 3.1 mttp -67.04 -7.72 24.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.486 -0.759 . . . . 0.0 109.341 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.017 ' CD2' HD21 ' A' ' 63' ' ' LEU . 13.5 tp -88.88 108.94 26.62 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 48.7 Cg_endo -73.82 92.15 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.846 1.445 . . . . 0.0 111.909 -178.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.046 HD22 ' CG1' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -140.62 178.61 7.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.014 . . . . 0.0 109.366 178.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.577 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -103.17 129.02 49.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.498 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 8.6 t -112.56 113.54 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.692 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' LEU . 4.7 tt0 -150.59 97.19 2.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.815 . . . . 0.0 109.076 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.9 mp -44.84 170.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.338 -0.851 . . . . 0.0 109.67 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.463 HG23 ' N ' ' A' ' 69' ' ' GLN . 14.6 t -146.53 -38.86 0.22 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.704 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.463 ' N ' HG23 ' A' ' 68' ' ' THR . 5.9 pt20 -90.33 -148.39 0.2 Allowed 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 109.331 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -117.15 131.81 56.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.765 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.022 HG13 ' HB3' ' A' ' 80' ' ' PHE . 93.4 t -60.88 148.47 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.365 -0.834 . . . . 0.0 109.226 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -112.66 92.68 4.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 109.819 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 7' ' ' MET . . . -108.0 147.83 30.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.152 -0.968 . . . . 0.0 109.873 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.006 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -160.76 152.63 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.301 -0.874 . . . . 0.0 110.009 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.795 ' HB1' ' HA3' ' B' ' 241' ' ' GLY . . . 41.53 -145.43 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.595 -0.691 . . . . 0.0 109.964 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -85.01 4.06 35.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 110.001 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -113.27 -160.49 0.72 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 109.441 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.985 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 174.01 162.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 110.131 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.732 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.25 133.29 16.16 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 1.022 ' HB3' HG13 ' A' ' 71' ' ' VAL . 34.4 p90 -149.51 167.98 24.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.797 -1.189 . . . . 0.0 110.298 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -141.62 167.76 21.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.54 -0.725 . . . . 0.0 109.679 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -159.35 -172.78 3.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.25 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.96 140.44 53.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.378 -0.826 . . . . 0.0 109.658 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.046 ' CG1' HD22 ' A' ' 63' ' ' LEU . 22.6 t -121.17 116.04 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.484 -0.76 . . . . 0.0 109.177 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.662 ' CB ' HG23 ' A' ' 94' ' ' VAL . 69.6 p -118.2 128.17 54.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.96 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.682 ' CD1' HD23 ' A' ' 63' ' ' LEU . 3.0 p90 -143.95 171.01 14.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.379 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.47 ' HA ' ' HG3' ' A' ' 92' ' ' LYS . 2.5 tm-20 -104.6 156.65 17.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.636 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.556 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -117.82 -161.16 0.81 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 109.306 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.64 75.95 2.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 109.686 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . 116.61 -11.7 15.9 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 19.8 mtp180 -149.67 164.15 35.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -1.153 . . . . 0.0 109.592 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' A' ' 87' ' ' GLU . 18.4 tttt -107.91 151.75 25.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.552 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.592 ' HB ' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -138.13 155.14 49.03 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.317 -0.864 . . . . 0.0 109.915 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.662 HG23 ' CB ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -140.22 170.46 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 1.001 HG12 ' HD3' ' A' ' 97' ' ' PRO . 4.8 t -146.53 145.52 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.823 -1.173 . . . . 0.0 109.941 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . -136.46 71.88 58.74 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.434 -0.791 . . . . 0.0 109.786 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 1.001 ' HD3' HG12 ' A' ' 95' ' ' VAL . 52.1 Cg_endo -95.69 -171.11 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 121.741 1.627 . . . . 0.0 110.86 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.706 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.8 mp -140.82 146.34 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 23.0 t0 -118.61 160.94 20.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.921 -1.112 . . . . 0.0 109.83 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -109.74 -179.72 3.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.432 -0.793 . . . . 0.0 108.916 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.985 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -150.14 147.18 27.43 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.12 -0.987 . . . . 0.0 110.553 -178.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.54 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -140.98 102.61 4.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.264 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.725 ' CZ ' HG11 ' A' ' 10' ' ' VAL . 4.0 m-85 -89.77 -175.88 4.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.928 ' HB3' HG21 ' A' ' 110' ' ' VAL . 2.7 p30 -126.53 -34.93 2.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 109.372 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.681 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -155.45 -63.29 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 164.6 61.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -1.17 . . . . 0.0 109.404 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.52 -53.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -129.43 -166.23 1.63 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -1.126 . . . . 0.0 109.705 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.598 HG22 ' CG1' ' A' ' 10' ' ' VAL . 25.8 t -109.93 160.72 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 108.906 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.928 HG21 ' HB3' ' A' ' 104' ' ' ASN . 54.2 t -132.61 -60.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.962 -1.086 . . . . 0.0 110.181 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.54 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -122.42 157.22 32.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.869 -1.144 . . . . 0.0 109.969 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.512 ' CE ' ' OD2' ' A' ' 99' ' ' ASP . 8.9 ttp -152.75 157.0 40.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.393 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.533 ' NH1' ' HB3' ' A' ' 37' ' ' GLU . 1.1 tpt180 -139.18 132.0 29.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 109.308 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.788 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . . . -93.0 129.08 39.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.06 -1.025 . . . . 0.0 109.663 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.747 HD13 ' CE1' ' B' ' 300' ' ' HIS . 0.6 OUTLIER -127.21 143.31 51.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.859 . . . . 0.0 109.632 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.932 ' CE1' HG13 ' A' ' 40' ' ' VAL . 47.1 p90 168.94 -154.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.506 ' O ' HG12 ' A' ' 121' ' ' ILE . . . 167.35 161.68 17.28 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.58 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 11.8 tt0 -44.12 -24.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.398 -1.06 . . . . 0.0 109.783 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 117' ' ' GLY . 0.8 OUTLIER -71.37 -35.06 70.98 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.821 0.819 . . . . 0.0 109.723 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 117' ' ' GLY . 0.4 OUTLIER -89.54 1.47 55.9 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.051 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.686 HG23 HG22 ' A' ' 95' ' ' VAL . 3.7 mm -91.44 -171.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 0.0 108.502 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.665 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -151.93 143.22 23.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.702 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.419 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.16 114.87 3.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.97 -116.21 0.7 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.346 -1.091 . . . . 0.0 109.386 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.243 0.544 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.472 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 4.6 m-20 -149.3 68.03 1.03 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 109.628 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . 0.423 HG22 ' HB2' ' B' ' 205' ' ' GLU . 1.5 m -67.4 111.54 7.64 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.875 . . . . 0.0 109.624 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 49.1 Cg_endo -74.74 0.19 9.07 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.923 1.486 . . . . 0.0 110.367 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . 0.423 ' HB2' HG22 ' B' ' 203' ' ' THR . 7.3 mt-10 -65.81 -57.08 8.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 109.598 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -60.57 -48.55 81.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . 0.546 ' HA ' ' CZ ' ' B' ' 303' ' ' PHE . 19.8 mtm -61.56 -15.19 36.35 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.332 -0.855 . . . . 0.0 109.896 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.433 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 15.5 m -81.85 -38.54 25.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.253 -0.904 . . . . 0.0 109.253 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.9 -42.83 59.62 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.26 -0.9 . . . . 0.0 108.599 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.693 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -52.31 -24.86 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.193 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.966 HG11 HG21 ' B' ' 271' ' ' VAL . 26.1 t -86.86 -45.24 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 109.481 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.6 tt0 -57.74 -73.49 0.07 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.922 ' HD2' HD13 ' B' ' 229' ' ' LEU . 0.7 OUTLIER -43.88 -45.34 7.49 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' TYR . . . . . 0.602 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -48.28 -43.17 32.5 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.958 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.1 t -89.27 -39.9 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.297 -0.877 . . . . 0.0 109.003 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' B' ' 213' ' ' ARG . . . -48.34 -36.36 14.29 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.649 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -74.08 -35.62 64.25 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.958 HD12 ' HA ' ' B' ' 215' ' ' VAL . 3.3 mt -61.56 -59.27 5.48 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.0 -41.07 46.34 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -88.91 5.33 44.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.614 -0.679 . . . . 0.0 109.423 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 1.042 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 46.86 35.81 8.13 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -97.33 78.35 2.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -1.071 . . . . 0.0 109.887 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' LEU . . . . . 1.05 ' CD2' HD22 ' B' ' 259' ' ' LEU . 3.9 mm? -50.45 -21.13 1.34 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.286 -0.884 . . . . 0.0 109.856 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -62.17 -54.54 39.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.902 . . . . 0.0 109.536 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' B' ' 229' ' ' LEU . . . -64.3 -34.4 89.81 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.748 HG21 ' CD2' ' B' ' 255' ' ' PHE . 6.9 mt -62.36 -56.02 20.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.715 HG21 ' HB2' ' B' ' 252' ' ' ARG . 26.9 t -63.37 -43.03 98.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.74 -49.79 69.95 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.922 HD13 ' HD2' ' B' ' 213' ' ' ARG . 2.4 tp -68.99 -16.7 63.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . 0.474 ' HB2' ' HA ' ' B' ' 227' ' ' VAL . 2.2 m-85 -91.72 140.3 29.83 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.334 -0.854 . . . . 0.0 109.517 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -49.18 177.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.575 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -24.18 66.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.547 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.531 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 4.4 p30 -146.96 47.1 1.17 Allowed 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.651 -0.656 . . . . 0.0 109.31 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.583 ' O ' HD11 ' B' ' 251' ' ' ILE . . . -59.45 167.09 2.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.329 -0.857 . . . . 0.0 109.496 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' THR . . . . . 0.907 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -109.4 164.84 12.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.581 HG23 HD12 ' B' ' 251' ' ' ILE . 46.1 t -154.68 115.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.91 . . . . 0.0 109.488 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.0 mm-40 -94.85 109.68 21.64 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' ASP . . . . . 0.618 ' OD2' ' H62' ' B' ' 326' ' ' NTH . 10.0 t70 -178.21 142.69 0.45 Allowed Pre-proline 0 C--N 1.302 -1.486 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.042 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 47.0 Cg_endo -73.41 174.87 48.23 Favored 'Cis proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.29 -1.962 . . . . 0.0 111.072 -0.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.649 HG13 ' CE1' ' B' ' 316' ' ' PHE . 29.2 m -57.01 115.3 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.84 . . . . 0.0 109.598 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . 0.795 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . 83.28 57.35 2.51 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' SER . . . . . 0.506 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 3.3 m -149.01 -105.03 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -1.187 . . . . 0.0 109.747 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' B' ' 243' ' ' GLU . 7.5 pt-20 -165.85 111.08 0.75 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.931 -1.106 . . . . 0.0 110.185 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' PRO . . . . . 0.583 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.9 Cg_endo -65.75 179.15 1.87 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.97 1.511 . . . . 0.0 111.239 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.608 ' HB2' ' CD2' ' B' ' 254' ' ' PHE . 0.3 OUTLIER -150.9 103.0 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.907 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.28 150.57 22.55 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.252 -0.905 . . . . 0.0 110.166 -179.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . 0.531 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 117.32 157.56 10.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 4.5 m -54.73 -72.18 0.07 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.228 -1.16 . . . . 0.0 108.937 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -52.67 -32.73 43.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 0.0 109.164 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.552 ' HB3' ' C ' ' B' ' 246' ' ' SER . . . -71.11 -23.96 62.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.558 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.583 HD11 ' O ' ' B' ' 234' ' ' ALA . 4.7 mm -90.11 -37.27 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.202 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' ARG . . . . . 0.715 ' HB2' HG21 ' B' ' 227' ' ' VAL . 21.7 ttm180 -79.6 -59.64 2.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.133 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 4.7 tt0 -45.6 -26.86 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.981 -1.074 . . . . 0.0 108.863 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.608 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.1 OUTLIER -86.44 -69.81 0.65 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 0.748 ' CD2' HG21 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -52.75 -20.43 3.17 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.466 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' B' ' 252' ' ' ARG . . . -80.95 -43.96 18.92 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 10.0 t-20 -61.14 -38.89 88.02 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' SER . . . . . . . . . . . . . 33.8 t -62.1 -31.82 72.31 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 1.05 HD22 ' CD2' ' B' ' 223' ' ' LEU . 6.7 tp -70.97 -26.52 63.2 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.467 -0.771 . . . . 0.0 109.366 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 7.7 mttp -48.91 -23.03 0.96 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.222 -0.924 . . . . 0.0 109.152 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' LEU . . . . . 0.91 HD22 HD21 ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.46 112.9 54.3 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' PRO . . . . . 0.505 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 43.2 Cg_endo -70.28 107.83 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.806 1.424 . . . . 0.0 110.618 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.91 HD21 HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -139.84 173.04 11.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.751 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' B' ' 284' ' ' VAL . . . -104.65 127.28 52.36 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . 0.401 HG11 HG22 ' B' ' 215' ' ' VAL . 77.9 t -112.29 112.63 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.962 . . . . 0.0 110.142 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 13.4 tt0 -150.49 97.14 2.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.34 -0.85 . . . . 0.0 109.158 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -44.7 170.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 110.016 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.92 -38.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 109.558 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 269' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 19.4 pt20 -93.2 -146.34 0.23 Allowed 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.635 -0.665 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 28.7 tt0 -115.32 133.09 56.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.0 109.659 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . 0.999 HG13 ' HB3' ' B' ' 280' ' ' PHE . 53.4 t -68.31 147.49 12.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 109.245 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.536 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.4 OUTLIER -103.01 139.26 38.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 109.952 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -148.25 147.39 29.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 109.083 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 274' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 116' ' ' PHE . 0.2 OUTLIER -138.27 -155.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.114 -0.992 . . . . 0.0 109.99 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . 0.454 ' O ' ' SD ' ' B' ' 207' ' ' MET . . . -39.71 -87.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.639 -0.663 . . . . 0.0 110.468 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 276' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' B' ' 303' ' ' PHE . 6.7 m120 -116.45 20.53 14.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.146 -0.971 . . . . 0.0 110.276 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 0.3 OUTLIER -128.18 -160.05 0.99 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.007 -1.058 . . . . 0.0 109.399 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 278' ' ' ALA . . . . . 1.041 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 171.06 157.93 0.08 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.477 -0.764 . . . . 0.0 109.932 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 279' ' ' ALA . . . . . 0.625 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -150.31 136.14 18.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . 0.999 ' HB3' HG13 ' B' ' 271' ' ' VAL . 43.9 p90 -150.11 168.45 23.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.785 -1.197 . . . . 0.0 110.564 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.949 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -145.83 169.32 18.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.699 -0.625 . . . . 0.0 109.417 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 282' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 6.9 p90 -166.1 -169.11 1.38 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.78 141.43 51.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.436 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 284' ' ' VAL . . . . . 0.846 HG11 HD22 ' B' ' 263' ' ' LEU . 42.9 t -128.95 112.47 25.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.294 -0.878 . . . . 0.0 109.29 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 285' ' ' SER . . . . . 0.636 ' OG ' HG23 ' B' ' 294' ' ' VAL . 0.1 OUTLIER -104.49 122.89 46.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 109.448 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.505 ' HB2' ' O ' ' B' ' 262' ' ' PRO . 7.1 p90 -137.72 171.26 14.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.223 -0.923 . . . . 0.0 109.907 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 287' ' ' GLU . . . . . 0.424 ' OE1' ' HB3' ' B' ' 292' ' ' LYS . 42.5 tt0 -150.35 150.56 31.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.477 -0.765 . . . . 0.0 109.073 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.1 OUTLIER -137.72 2.46 2.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 109.881 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' B' ' 290' ' ' GLY . 2.1 tt0 -169.86 -173.63 1.63 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.099 -1.0 . . . . 0.0 109.113 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 290' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' B' ' 289' ' ' GLN . . . -46.65 -25.41 2.18 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 291' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' B' ' 325' ' ' ALA . 2.3 mtm105 -100.43 130.8 46.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -1.074 . . . . 0.0 109.285 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 292' ' ' LYS . . . . . 0.424 ' HB3' ' OE1' ' B' ' 287' ' ' GLU . 0.0 OUTLIER -106.03 141.44 37.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.521 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 293' ' ' THR . . . . . 0.715 HG22 ' HA ' ' B' ' 323' ' ' ALA . 0.0 OUTLIER -119.49 146.08 45.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 0.0 109.861 -179.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 294' ' ' VAL . . . . . 0.636 HG23 ' OG ' ' B' ' 285' ' ' SER . 3.9 p -113.53 171.08 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 108.845 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 1.015 HG12 ' HD3' ' B' ' 297' ' ' PRO . 24.6 t -142.13 144.04 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 110.355 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 296' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' B' ' 320' ' ' ASN . . . -138.52 70.86 45.43 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.599 -0.688 . . . . 0.0 109.683 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 297' ' ' PRO . . . . . 1.015 ' HD3' HG12 ' B' ' 295' ' ' VAL . 51.4 Cg_endo -95.67 -175.12 0.31 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.732 1.621 . . . . 0.0 111.545 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.949 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.5 mp -139.18 147.04 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . 0.623 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 7.1 t0 -118.51 164.03 15.89 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.862 -1.149 . . . . 0.0 110.362 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.747 ' CE1' HD13 ' A' ' 115' ' ' LEU . 1.7 t60 -113.8 175.99 5.23 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' PHE . . . . . 1.041 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.1 OUTLIER -150.09 141.52 23.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.014 -1.054 . . . . 0.0 110.922 -178.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.504 ' HA ' ' HG2' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -130.24 105.97 8.27 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 303' ' ' PHE . . . . . 0.649 ' CZ ' HG21 ' B' ' 210' ' ' VAL . 0.4 OUTLIER -89.29 179.15 6.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.593 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 304' ' ' ASN . . . . . 0.879 ' OD1' HG23 ' B' ' 310' ' ' VAL . 0.5 OUTLIER -139.54 7.87 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 0.0 109.617 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 305' ' ' GLY . . . . . 0.698 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . 150.39 -68.22 0.34 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 306' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 164.83 76.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -1.135 . . . . 0.0 109.541 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.32 -35.74 0.02 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -165.84 -174.82 3.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -1.119 . . . . 0.0 109.39 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 309' ' ' VAL . . . . . 0.56 HG21 ' HE1' ' B' ' 301' ' ' PHE . 40.4 t -104.36 149.87 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 109.025 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.879 HG23 ' OD1' ' B' ' 304' ' ' ASN . 38.8 t -122.97 -22.48 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.008 . . . . 0.0 109.691 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . 0.503 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -151.09 156.28 40.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.97 . . . . 0.0 109.494 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 312' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 17.8 ttp -160.16 148.07 16.65 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.2 -0.937 . . . . 0.0 109.811 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 313' ' ' ARG . . . . . 0.472 ' HB2' ' HB2' ' B' ' 300' ' ' HIS . 0.1 OUTLIER -130.24 175.01 9.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.42 -0.8 . . . . 0.0 108.955 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 314' ' ' ALA . . . . . 0.599 ' O ' HG12 ' B' ' 240' ' ' VAL . . . -142.68 145.34 33.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 109.662 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 315' ' ' LEU . . . . . 0.732 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -136.64 139.76 42.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.893 . . . . 0.0 109.417 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 316' ' ' PHE . . . . . 1.006 ' O ' HG11 ' A' ' 74' ' ' VAL . 31.0 p90 173.13 -160.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 317' ' ' GLY . . . . . 0.725 ' C ' HD12 ' B' ' 321' ' ' ILE . . . 157.4 -174.87 34.89 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 318' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -54.21 -17.84 3.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 109.57 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.39 -28.26 27.08 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.852 0.835 . . . . 0.0 109.533 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 320' ' ' ASN . . . . . 0.721 ' OD1' HD12 ' B' ' 298' ' ' ILE . 0.3 OUTLIER -91.79 -30.33 16.28 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.357 0.599 . . . . 0.0 109.401 -179.536 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 321' ' ' ILE . . . . . 0.964 ' CG2' HG22 ' B' ' 295' ' ' VAL . 1.4 mt -87.0 -171.54 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 322' ' ' HIS . . . . . 0.748 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.1 OUTLIER -151.02 163.01 39.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.037 -1.039 . . . . 0.0 109.922 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.715 ' HA ' HG22 ' B' ' 293' ' ' THR . . . -155.62 119.07 4.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -172.81 -174.3 39.89 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 325' ' ' ALA . . . . . 0.454 ' HA ' ' HG2' ' B' ' 291' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.338 -1.095 . . . . 0.0 109.432 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' NTH . . . . . 0.743 H112 ' OG ' ' A' ' 58' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 326' ' ' NTH . . . . . 0.641 ' O17' HD13 ' B' ' 261' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.47 ' HG2' ' OD1' ' A' ' 2' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.332 0.587 . . . . 0.0 110.189 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.474 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.7 m120 -156.25 108.18 2.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -0.918 . . . . 0.0 109.391 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.722 ' O ' HG23 ' A' ' 3' ' ' THR . 9.0 t -90.15 108.48 26.58 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.858 . . . . 0.0 109.504 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 45.2 Cg_endo -72.26 -10.11 25.27 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.923 1.486 . . . . 0.0 110.112 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -52.85 59.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.343 -0.848 . . . . 0.0 109.416 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -63.4 -52.21 62.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.39 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.573 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 8.6 mtt -65.49 -9.66 27.8 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.356 -0.84 . . . . 0.0 109.684 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.408 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 13.1 m -86.64 -39.56 15.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.298 -0.876 . . . . 0.0 109.428 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.411 ' HB1' HH12 ' A' ' 13' ' ' ARG . . . -58.27 -47.58 83.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.952 . . . . 0.0 109.349 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.89 ' HA ' HD21 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -48.03 -24.13 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 108.778 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.754 HG11 ' CG2' ' A' ' 71' ' ' VAL . 12.5 t -86.26 -42.56 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 109.538 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 13' ' ' ARG . 14.6 tt0 -61.23 -74.15 0.09 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 122.231 1.015 . . . . 0.0 108.323 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.933 ' HD2' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -42.75 -44.49 4.4 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.958 0.885 . . . . 0.0 108.711 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -51.39 -49.59 61.26 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.83 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -81.51 -41.37 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.398 -0.814 . . . . 0.0 109.362 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.23 -37.04 15.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.757 -1.214 . . . . 0.0 107.736 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -73.83 -32.09 63.53 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.83 HD12 ' HA ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -65.42 -56.57 11.78 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.01 -42.47 38.09 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.582 0.706 . . . . 0.0 109.312 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.978 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . . . -89.22 -6.73 56.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.518 -0.739 . . . . 0.0 109.705 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.772 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 62.43 21.31 62.19 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.978 ' OD2' ' HB3' ' A' ' 20' ' ' ALA . 1.5 p30 -89.35 68.56 7.98 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.994 -1.297 . . . . 0.0 109.732 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.053 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -46.54 -35.55 5.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.249 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' A' ' 22' ' ' ASP . 8.5 p-10 -41.92 -34.79 0.73 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -86.46 -32.27 16.67 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.561 HD12 HD12 ' A' ' 23' ' ' LEU . 40.5 mt -62.67 -56.66 16.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' A' ' 52' ' ' ARG . 49.2 t -56.83 -34.29 43.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -62.3 -55.7 25.68 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.933 HD13 ' HD2' ' A' ' 13' ' ' ARG . 3.5 tp -62.99 -21.92 66.48 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' ALA . 9.4 m-30 -87.63 138.69 31.25 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -50.59 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 109.726 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.2 -24.39 62.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.594 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.549 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 4.6 p-10 -150.16 53.49 0.91 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.822 ' N ' HD11 ' A' ' 51' ' ' ILE . . . -65.78 151.86 45.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 109.653 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 145.99 23.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 109.256 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 53.2 t -137.98 116.6 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.103 -0.998 . . . . 0.0 109.711 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 3.1 mm-40 -89.2 110.91 21.6 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.502 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 9.7 t70 -178.86 143.98 0.43 Allowed Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.702 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 48.9 Cg_endo -74.13 -168.27 6.08 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.258 -1.976 . . . . 0.0 110.925 -0.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.728 ' HB ' HG11 ' B' ' 274' ' ' VAL . 32.7 m -80.53 50.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.8 . . . . 0.0 109.351 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.37 34.18 0.05 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.518 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -153.54 -148.06 0.24 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.445 -1.032 . . . . 0.0 109.144 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -125.47 140.25 35.9 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.997 -1.065 . . . . 0.0 110.073 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.527 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 37.9 Cg_endo -63.58 -176.0 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.276 1.672 . . . . 0.0 111.051 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.789 ' CG ' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -150.87 108.15 3.61 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.17 151.82 21.96 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.167 -178.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.549 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 110.45 158.04 16.12 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.513 HG23 ' CG1' ' A' ' 27' ' ' VAL . 7.8 m -67.04 -51.36 55.73 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.13 -1.218 . . . . 0.0 109.146 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -58.4 -41.47 84.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.227 -0.921 . . . . 0.0 109.08 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.789 ' HB1' ' CG ' ' A' ' 45' ' ' ARG . . . -67.31 -57.51 6.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.153 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.822 HD11 ' N ' ' A' ' 34' ' ' ALA . 23.5 mt -55.02 -47.89 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.901 ' HG3' HD23 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -69.14 -57.87 4.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.118 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 37.4 tt0 -45.59 -30.01 1.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.053 -1.03 . . . . 0.0 108.839 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.502 ' CZ ' ' O ' ' A' ' 38' ' ' ASP . 1.3 t80 -82.44 -69.5 0.62 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 1.053 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -48.58 -36.08 14.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.76 -47.33 75.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 109.039 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 23.1 t-20 -57.51 -41.45 80.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.32 -0.862 . . . . 0.0 108.921 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.436 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 11.9 t -65.43 -32.34 73.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.348 -0.845 . . . . 0.0 109.005 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.772 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.1 tp -67.02 -19.6 65.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -57.25 -22.54 42.03 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.779 HD23 HD23 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -89.62 119.39 69.52 Favored Pre-proline 0 C--N 1.306 -1.324 0 O-C-N 121.189 -0.944 . . . . 0.0 108.528 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 49.1 Cg_endo -74.94 106.86 2.35 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.768 1.404 . . . . 0.0 110.762 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.831 ' CB ' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -138.84 163.08 33.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 110.055 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.023 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -97.26 124.01 41.23 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.6 t -107.4 114.15 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.908 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 67' ' ' LEU . 6.2 tt0 -150.34 101.31 2.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 109.195 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 81' ' ' ALA . 1.9 mp -44.97 170.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.864 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.9 p -133.41 -36.51 0.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.742 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 70' ' ' GLU . 1.2 pt20 -101.38 -145.18 0.35 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.512 -0.743 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 69' ' ' GLN . 26.9 tt0 -110.78 133.03 53.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 109.513 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.754 ' CG2' HG11 ' A' ' 11' ' ' VAL . 28.5 t -58.03 154.71 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.342 -0.849 . . . . 0.0 109.412 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 1.9 mpt_? -121.01 130.2 53.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.516 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.418 ' HB1' ' CB ' ' A' ' 7' ' ' MET . . . -150.5 120.39 7.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.629 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.647 ' CB ' HG21 ' B' ' 240' ' ' VAL . 0.0 OUTLIER -122.44 -161.32 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 109.672 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 76' ' ' ASN . . . -81.73 144.88 30.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.444 -0.785 . . . . 0.0 110.216 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 75' ' ' ALA . 1.3 t-20 80.95 -44.18 0.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.733 -0.605 . . . . 0.0 110.422 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -144.39 -159.93 1.06 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.961 -1.087 . . . . 0.0 110.412 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 1.008 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . -169.21 163.15 10.9 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.912 ' HB3' HD22 ' B' ' 315' ' ' LEU . . . -149.4 138.78 21.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.91 -1.118 . . . . 0.0 109.962 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.665 ' HB3' HG13 ' A' ' 71' ' ' VAL . 29.7 p90 -150.34 167.48 26.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.023 -1.048 . . . . 0.0 109.384 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.967 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -139.94 -169.68 2.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 110.518 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.639 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 0.0 OUTLIER 172.84 -175.11 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -127.96 141.22 51.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.248 -0.908 . . . . 0.0 109.592 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.831 HG13 ' CB ' ' A' ' 63' ' ' LEU . 14.2 t -108.95 115.53 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.277 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 1.023 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 21.8 p -112.11 106.4 15.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.12 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.773 ' CE2' H221 ' A' ' 126' ' ' NTH . 6.6 p90 -125.62 176.26 7.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.743 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -121.28 164.77 16.47 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.596 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.584 ' CE1' ' CE1' ' A' ' 86' ' ' PHE . 0.9 OUTLIER -115.58 -92.3 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.649 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -137.42 -36.21 0.65 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.864 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.78 -28.12 1.19 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.488 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 45.5 mtt85 -126.64 -179.51 4.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -1.184 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -127.6 122.43 33.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.679 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.855 HG23 ' HA ' ' A' ' 123' ' ' ALA . 19.3 m -96.55 172.15 8.1 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.344 -0.847 . . . . 0.0 109.559 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.611 HG13 ' CB ' ' A' ' 122' ' ' HIS . 14.0 p -148.0 170.99 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 108.715 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.624 ' O ' HG22 ' A' ' 83' ' ' THR . 43.9 t -148.22 156.78 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.079 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.476 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . -135.28 75.27 59.54 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.457 -0.777 . . . . 0.0 109.339 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.581 ' HD3' HG12 ' A' ' 95' ' ' VAL . 45.7 Cg_endo -98.19 178.48 0.39 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.789 1.659 . . . . 0.0 111.539 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.967 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.8 mp -137.93 151.93 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.624 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 13.5 t0 -122.8 164.48 18.3 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.941 -1.1 . . . . 0.0 110.203 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.532 ' CE1' HD13 ' B' ' 315' ' ' LEU . 0.1 OUTLIER -112.16 172.15 7.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 109.236 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 1.008 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -147.28 140.86 25.54 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.24 -0.912 . . . . 0.0 110.374 -178.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.502 ' HA ' ' HG3' ' A' ' 77' ' ' GLU . 1.4 ttt180 -130.31 110.42 11.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.871 . . . . 0.0 109.121 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.615 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -89.73 176.15 6.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.333 -0.855 . . . . 0.0 109.664 -179.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.761 ' HB3' HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -114.03 -36.39 4.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.298 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 176.54 -46.07 0.11 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 163.29 76.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -1.169 . . . . 0.0 109.593 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.411 ' C ' ' HD3' ' A' ' 108' ' ' LYS . . . -171.0 -45.44 0.04 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 107' ' ' GLY . 0.0 OUTLIER -161.83 -169.43 2.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -1.133 . . . . 0.0 109.292 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.615 HG12 ' N ' ' A' ' 110' ' ' VAL . 54.5 t -94.04 166.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.209 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.761 HG21 ' HB3' ' A' ' 104' ' ' ASN . 10.8 t -131.76 -63.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -0.958 . . . . 0.0 109.745 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.461 ' HB2' ' HD3' ' A' ' 102' ' ' ARG . 3.2 m -128.18 171.05 12.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.946 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.511 ' CE ' ' OD2' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -151.75 147.53 26.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.42 -0.8 . . . . 0.0 109.081 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -121.36 162.18 20.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.568 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -111.01 133.48 53.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -0.926 . . . . 0.0 109.848 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.834 HD11 ' HB2' ' B' ' 279' ' ' ALA . 9.3 tp -109.48 -143.47 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.808 . . . . 0.0 108.957 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.734 ' O ' HG22 ' B' ' 274' ' ' VAL . 26.2 p90 39.0 -161.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.725 0.774 . . . . 0.0 110.481 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.644 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 179.4 -149.37 8.67 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.46 ' C ' HG12 ' A' ' 121' ' ' ILE . 21.5 tt0 -80.69 -1.98 44.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -1.155 . . . . 0.0 109.412 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.521 ' HE2' ' CG ' ' B' ' 204' ' ' PRO . 5.7 tttm -93.19 -26.94 17.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 122.064 0.935 . . . . 0.0 108.921 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 116' ' ' PHE . 0.3 OUTLIER -88.55 17.7 5.2 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.349 0.595 . . . . 0.0 109.437 -179.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.644 HD11 ' O ' ' A' ' 117' ' ' GLY . 5.2 mm -90.01 -174.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.633 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -150.87 173.6 14.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.962 -1.086 . . . . 0.0 109.899 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.855 ' HA ' HG23 ' A' ' 93' ' ' THR . . . -152.34 110.36 3.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.409 -0.807 . . . . 0.0 109.29 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.37 115.07 3.95 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.328 -1.101 . . . . 0.0 109.47 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.498 ' O ' ' CG ' ' B' ' 201' ' ' MET . 1.4 ptt? . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.256 0.551 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' B' ' 203' ' ' THR . 0.7 OUTLIER -127.09 64.91 1.3 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . 0.612 HG23 ' O ' ' B' ' 203' ' ' THR . 5.0 t -43.92 109.1 0.77 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.476 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' PRO . . . . . 0.521 ' CG ' ' HE2' ' A' ' 119' ' ' LYS . 44.5 Cg_endo -71.42 -4.11 14.33 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.957 1.504 . . . . 0.0 110.264 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -45.88 56.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.196 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' B' ' 209' ' ' ALA . 0.2 OUTLIER -62.26 -51.41 67.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.362 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 12.5 mtm -59.81 -51.15 70.97 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.242 -0.911 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 8.2 m -53.26 -33.02 51.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 109.193 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 206' ' ' HIS . . . -52.55 -46.23 66.7 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.051 -1.031 . . . . 0.0 108.405 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 1.035 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -53.48 -43.24 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.979 HG11 HG21 ' B' ' 271' ' ' VAL . 11.3 t -59.4 -41.72 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.594 -0.691 . . . . 0.0 109.834 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' B' ' 213' ' ' ARG . 9.7 tt0 -60.47 -75.26 0.06 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.767 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.6 OUTLIER -43.83 -44.38 6.8 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' TYR . . . . . 0.633 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 3.8 t80 -53.71 -49.25 68.5 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.931 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -83.25 -44.36 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.406 -0.809 . . . . 0.0 109.832 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.0 -37.04 8.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.833 -1.167 . . . . 0.0 108.022 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.545 ' HB1' HG13 ' B' ' 226' ' ' ILE . . . -74.1 -34.68 64.03 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.931 HD12 ' HA ' ' B' ' 215' ' ' VAL . 5.2 mt -63.29 -59.91 4.1 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . 0.414 ' ND2' ' OE1' ' B' ' 266' ' ' GLU . 16.4 t30 -51.01 -45.6 61.26 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.565 0.697 . . . . 0.0 109.289 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.38 9.68 25.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.572 -0.705 . . . . 0.0 109.511 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.583 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 48.06 32.21 8.98 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' B' ' 217' ' ' ALA . 12.5 t70 -89.99 66.49 6.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -1.117 . . . . 0.0 109.743 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' LEU . . . . . 1.069 HD11 ' HB3' ' B' ' 255' ' ' PHE . 5.9 tp -47.58 -42.38 23.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 108.736 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' B' ' 223' ' ' LEU . 3.4 m-20 -42.28 -31.42 0.39 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' B' ' 228' ' ' ALA . . . -88.14 -38.71 7.18 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.826 HD12 HD12 ' B' ' 223' ' ' LEU . 17.1 mt -58.23 -53.36 47.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 85.0 t -57.17 -37.99 58.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' B' ' 225' ' ' GLY . . . -58.33 -54.82 42.67 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 1.035 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.5 tp -63.32 -20.48 65.53 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . 0.803 ' CG ' HG21 ' B' ' 251' ' ' ILE . 0.6 OUTLIER -82.71 132.08 35.19 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.492 -0.755 . . . . 0.0 109.502 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -51.04 -177.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.268 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -25.89 66.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 109.885 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.552 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 13.4 p-10 -150.61 53.84 0.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.62 -0.675 . . . . 0.0 109.341 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' B' ' 310' ' ' VAL . . . -62.19 165.55 5.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.742 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' THR . . . . . 0.848 HG23 ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -116.25 140.78 48.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.22 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.521 HG23 HD12 ' B' ' 251' ' ' ILE . 38.9 t -130.11 117.8 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -0.885 . . . . 0.0 109.126 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' GLU . . . . . 0.544 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 27.7 mt-10 -88.84 106.98 18.73 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' ASP . . . . . 0.487 ' HA ' ' C ' ' B' ' 239' ' ' PRO . 9.8 t70 -176.03 142.17 0.61 Allowed Pre-proline 0 C--N 1.3 -1.577 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.597 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' B' ' 238' ' ' ASP . 47.2 Cg_endo -73.74 -165.09 3.61 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.216 -1.993 . . . . 0.0 110.685 0.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.647 HG21 ' CB ' ' A' ' 74' ' ' VAL . 5.5 m -87.8 41.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 109.345 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -165.71 26.01 0.17 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' SER . . . . . 0.427 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 1.4 m -148.01 -141.82 0.12 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.415 -1.05 . . . . 0.0 108.913 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -133.72 142.35 43.39 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.914 -1.116 . . . . 0.0 109.954 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' PRO . . . . . 0.544 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.8 Cg_endo -63.39 -170.86 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.284 1.676 . . . . 0.0 111.436 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.736 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -151.09 111.5 4.18 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.848 ' HB3' HG23 ' B' ' 235' ' ' THR . 1.9 p -94.04 155.28 17.2 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.101 -0.999 . . . . 0.0 110.452 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.21 162.32 21.78 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 6.5 m -73.7 -44.91 55.18 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.185 -1.185 . . . . 0.0 109.093 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.53 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -64.26 -20.25 65.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.244 -0.91 . . . . 0.0 109.207 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.736 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -90.15 -54.43 4.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.352 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.803 HG21 ' CG ' ' B' ' 230' ' ' PHE . 6.4 mm -54.97 -44.58 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' ARG . . . . . 0.761 ' HG3' HD23 ' B' ' 223' ' ' LEU . 17.8 ttt85 -73.34 -56.03 5.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.212 -0.93 . . . . 0.0 108.807 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 17.7 tt0 -45.94 -27.92 1.01 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.024 . . . . 0.0 108.546 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 1.0 OUTLIER -85.79 -70.94 0.56 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 1.069 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -48.45 -23.97 1.12 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . 0.724 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -80.49 -51.16 9.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 108.898 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 0.2 OUTLIER -56.62 -35.02 67.81 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' SER . . . . . 0.613 ' HG ' ' H8 ' ' B' ' 326' ' ' NTH . 1.6 t -74.81 -38.6 62.04 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 0.583 HD21 ' CA ' ' B' ' 221' ' ' GLY . 8.6 tp -62.22 -29.47 70.41 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.373 -0.829 . . . . 0.0 109.02 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 14.7 mttm -44.35 -27.11 0.4 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' LEU . . . . . 0.868 HD13 ' H17' ' B' ' 326' ' ' NTH . 3.3 tt -89.69 113.85 58.37 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 48.7 Cg_endo -73.59 107.27 2.36 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.915 1.481 . . . . 0.0 112.176 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.909 HD22 ' CG1' ' B' ' 284' ' ' VAL . 0.8 OUTLIER -130.24 -170.28 2.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.398 -0.814 . . . . 0.0 109.43 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . 0.72 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -119.9 128.0 53.22 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . 0.551 HG21 ' HB3' ' B' ' 218' ' ' LEU . 43.0 t -115.43 113.25 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.055 -1.028 . . . . 0.0 110.037 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.3 tp10 -150.31 94.16 2.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.417 -0.802 . . . . 0.0 108.942 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.524 HD11 HG11 ' B' ' 215' ' ' VAL . 1.4 mp -46.89 175.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 0.0 110.004 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 268' ' ' THR . . . . . 0.456 ' O ' ' O ' ' B' ' 269' ' ' GLN . 41.7 p -133.57 -76.28 0.48 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.46 -0.775 . . . . 0.0 108.951 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 269' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' B' ' 268' ' ' THR . 3.4 pt20 -61.07 -143.7 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.415 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 24.4 tt0 -115.76 131.31 56.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 109.872 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . 1.011 HG13 ' HB3' ' B' ' 280' ' ' PHE . 83.0 t -45.41 146.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.386 -0.822 . . . . 0.0 109.042 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.52 ' NE ' HD11 ' A' ' 98' ' ' ILE . 0.3 OUTLIER -102.08 82.19 2.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.696 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -89.38 145.03 25.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.115 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 274' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 116' ' ' PHE . 0.5 OUTLIER -122.43 -169.02 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.156 -0.965 . . . . 0.0 109.924 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . 0.588 ' H ' HG12 ' B' ' 274' ' ' VAL . . . -38.39 -94.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.574 -0.704 . . . . 0.0 110.787 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 276' ' ' ASN . . . . . 0.451 ' O ' ' OD1' ' B' ' 276' ' ' ASN . 21.8 t-20 -92.76 -28.24 16.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.115 -0.991 . . . . 0.0 110.621 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . 0.527 ' CG ' ' HG3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -92.74 -166.6 1.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.952 -1.092 . . . . 0.0 109.575 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 278' ' ' ALA . . . . . 0.93 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . -160.69 161.14 32.22 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.468 -0.77 . . . . 0.0 109.571 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 279' ' ' ALA . . . . . 0.834 ' HB2' HD11 ' A' ' 115' ' ' LEU . . . -150.9 131.13 13.58 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . 1.011 ' HB3' HG13 ' B' ' 271' ' ' VAL . 41.8 p90 -147.55 159.53 43.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.797 -1.19 . . . . 0.0 110.491 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 1.009 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -139.57 160.88 38.85 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.406 0.622 . . . . 0.0 109.375 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 282' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 3.8 p90 -162.29 -168.34 1.84 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 108.982 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.27 139.78 53.59 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.713 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 284' ' ' VAL . . . . . 0.909 ' CG1' HD22 ' B' ' 263' ' ' LEU . 42.0 t -107.83 114.7 47.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 285' ' ' SER . . . . . 0.72 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 96.9 p -115.5 98.99 7.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.955 . . . . 0.0 110.119 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.868 ' CD1' HD23 ' B' ' 263' ' ' LEU . 30.0 p90 -108.75 -171.86 1.94 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 108.815 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.45 153.1 33.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.98 -1.075 . . . . 0.0 109.809 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.527 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.1 OUTLIER -105.55 -163.91 0.98 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.43 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -40.58 92.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.924 . . . . 0.0 109.972 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -139.65 4.51 2.75 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.148 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -140.82 -176.25 4.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -1.186 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 292' ' ' LYS . . . . . 0.477 ' HD3' ' O ' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -118.75 140.98 49.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.178 -0.952 . . . . 0.0 109.305 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 293' ' ' THR . . . . . 0.595 ' HB ' ' CE1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -125.32 146.04 49.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.406 -0.809 . . . . 0.0 109.433 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 294' ' ' VAL . . . . . 0.572 HG22 ' H ' ' B' ' 295' ' ' VAL . 7.9 p -125.28 171.89 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.143 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 1.025 HG12 ' HD3' ' B' ' 297' ' ' PRO . 2.8 t -149.43 146.98 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 109.065 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 296' ' ' ALA . . . . . . . . . . . . . . . -125.84 71.32 67.77 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.179 -0.951 . . . . 0.0 111.266 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 297' ' ' PRO . . . . . 1.025 ' HD3' HG12 ' B' ' 295' ' ' VAL . 53.3 Cg_endo -93.24 179.68 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.593 1.312 . . . . 0.0 110.996 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 1.009 HG23 ' HB2' ' B' ' 281' ' ' ALA . 3.0 mp -141.38 148.81 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . 0.619 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 17.2 t0 -121.38 157.52 30.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.958 -1.089 . . . . 0.0 110.401 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.761 ' CD2' HD11 ' A' ' 115' ' ' LEU . 3.0 t-160 -113.73 151.7 31.54 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 301' ' ' PHE . . . . . 0.93 ' CB ' ' HB3' ' B' ' 278' ' ' ALA . 0.5 OUTLIER -126.91 151.86 47.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.271 -0.893 . . . . 0.0 110.828 -178.271 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.529 ' O ' HG23 ' B' ' 310' ' ' VAL . 0.0 OUTLIER -146.27 93.56 2.33 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 303' ' ' PHE . . . . . 0.755 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 8.2 m-30 -89.81 -165.55 1.37 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.126 -0.984 . . . . 0.0 109.962 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 304' ' ' ASN . . . . . 0.537 ' OD1' ' CG1' ' B' ' 310' ' ' VAL . 0.4 OUTLIER -140.15 27.22 2.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.427 -0.796 . . . . 0.0 109.437 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 305' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . 119.54 -61.08 0.49 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 306' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 179.67 33.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -1.127 . . . . 0.0 109.272 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 307' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' B' ' 308' ' ' LYS . . . -108.35 33.3 6.33 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 308' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' B' ' 307' ' ' GLY . 0.3 OUTLIER 83.51 -162.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.972 -0.722 . . . . 0.0 109.164 -179.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 309' ' ' VAL . . . . . 0.615 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 49.7 t -90.5 143.81 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.384 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.537 ' CG1' ' OD1' ' B' ' 304' ' ' ASN . 0.1 OUTLIER -126.19 -27.1 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.102 -0.999 . . . . 0.0 109.991 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . 0.497 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.1 OUTLIER -143.41 164.04 31.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.109 -0.994 . . . . 0.0 109.374 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 312' ' ' MET . . . . . 0.469 ' O ' ' HG3' ' B' ' 237' ' ' GLU . 0.0 OUTLIER -160.38 155.85 25.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 313' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' B' ' 300' ' ' HIS . 0.0 OUTLIER -150.22 118.47 6.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 314' ' ' ALA . . . . . 0.428 ' O ' HG12 ' B' ' 240' ' ' VAL . . . -100.07 139.73 35.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 110.629 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 315' ' ' LEU . . . . . 0.912 HD22 ' HB3' ' A' ' 79' ' ' ALA . 3.7 tt -128.65 138.46 52.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.355 -0.84 . . . . 0.0 109.335 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 316' ' ' PHE . . . . . 0.578 ' CD2' ' OD1' ' B' ' 320' ' ' ASN . 0.1 OUTLIER 172.51 -159.51 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 317' ' ' GLY . . . . . 0.487 ' O ' ' OD1' ' B' ' 320' ' ' ASN . . . 171.27 177.63 41.2 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.292 -1.433 . . . . 0.0 110.485 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 318' ' ' GLU . . . . . 0.508 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 47.9 tt0 -51.54 -21.41 2.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.201 -1.176 . . . . 0.0 108.931 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.14 -22.18 59.56 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.019 0.914 . . . . 0.0 108.726 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 320' ' ' ASN . . . . . 0.67 ' ND2' HG13 ' B' ' 295' ' ' VAL . 0.3 OUTLIER -88.51 1.51 54.7 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 321' ' ' ILE . . . . . 0.789 ' HA ' HG22 ' B' ' 295' ' ' VAL . 4.0 mm -89.89 179.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.121 -0.987 . . . . 0.0 108.504 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 322' ' ' HIS . . . . . 0.542 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.2 OUTLIER -151.51 177.42 10.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.967 -1.083 . . . . 0.0 109.807 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -155.23 126.67 7.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.462 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -120.88 120.95 4.66 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.224 -1.162 . . . . 0.0 109.495 -179.943 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' NTH . . . . . 0.773 H221 ' CE2' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 326' ' ' NTH . . . . . 0.868 ' H17' HD13 ' B' ' 261' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.446 ' O ' ' C ' ' A' ' 2' ' ' ASN . 7.4 mtt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.126 0.489 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.465 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.4 p-10 39.85 61.11 1.53 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.516 -0.74 . . . . 0.0 109.677 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.62 110.37 24.36 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 44.2 Cg_endo -71.3 -3.5 13.07 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.854 1.449 . . . . 0.0 110.285 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -61.88 -39.22 91.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.257 -0.902 . . . . 0.0 109.292 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -86.93 -43.99 11.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.335 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.6 mtt -56.94 -35.87 69.59 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.261 -0.899 . . . . 0.0 109.542 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.443 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 11.2 m -67.41 -39.16 85.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -43.66 62.77 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.674 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.3 t -53.96 -22.64 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.711 HG11 ' CG2' ' A' ' 71' ' ' VAL . 4.3 t -90.12 -41.35 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 108.979 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.3 tt0 -65.5 -74.18 0.11 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.903 ' HB3' HD22 ' A' ' 29' ' ' LEU . 2.2 mtt85 -42.27 -45.46 4.2 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.608 ' CD1' HG23 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -46.1 -43.73 15.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.095 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.915 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.4 t -90.34 -37.24 9.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.544 -0.722 . . . . 0.0 109.136 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -49.26 -34.91 16.29 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.564 ' HB3' HG12 ' A' ' 26' ' ' ILE . . . -74.73 -33.3 62.34 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.915 HD12 ' HA ' ' A' ' 15' ' ' VAL . 3.8 mt -65.96 -58.85 4.6 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.75 -41.86 24.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.621 0.724 . . . . 0.0 109.251 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.85 7.98 31.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.863 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 47.94 31.94 8.43 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 16.7 t0 -100.17 92.99 5.48 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.324 -1.104 . . . . 0.0 109.755 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.028 HD13 HD12 ' A' ' 26' ' ' ILE . 3.4 mm? -59.17 -15.27 13.82 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.224 -0.923 . . . . 0.0 109.529 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.23 -54.14 45.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 109.178 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.12 -35.68 92.41 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.028 HD12 HD13 ' A' ' 23' ' ' LEU . 8.8 mt -62.8 -56.45 17.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' A' ' 52' ' ' ARG . 95.7 t -63.72 -37.9 80.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.28 74.1 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.903 HD22 ' HB3' ' A' ' 13' ' ' ARG . 7.7 tp -66.08 -23.32 66.5 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CD2' HG22 ' A' ' 26' ' ' ILE . 3.6 m-85 -88.4 141.1 28.81 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.562 -0.711 . . . . 0.0 109.655 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -48.5 172.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 109.458 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.29 -24.1 67.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 109.294 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.632 ' C ' HD11 ' A' ' 51' ' ' ILE . 20.4 p-10 -146.58 35.12 0.95 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.972 ' N ' HD11 ' A' ' 51' ' ' ILE . . . -51.01 169.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.822 . . . . 0.0 109.772 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 1.007 HG23 ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -122.76 140.31 53.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.541 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.515 HG22 ' HB3' ' A' ' 112' ' ' MET . 48.2 t -131.49 120.66 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 109.262 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 3.4 mt-10 -88.46 107.0 18.64 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.569 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 9.1 t0 -179.78 143.29 0.37 Allowed Pre-proline 0 C--N 1.302 -1.486 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.547 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HA ' ' CG ' ' A' ' 38' ' ' ASP . 50.1 Cg_endo -76.25 -175.14 15.86 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.205 -1.998 . . . . 0.0 110.403 -0.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.004 HG21 HG11 ' B' ' 274' ' ' VAL . 19.8 m -72.58 150.89 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 108.875 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.35 -1.76 69.48 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.463 ' OG ' ' HG2' ' A' ' 39' ' ' PRO . 1.4 m -115.46 -142.3 0.38 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.27 -1.135 . . . . 0.0 109.308 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -146.24 141.76 16.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.987 -1.071 . . . . 0.0 110.048 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 39.6 Cg_endo -65.56 -175.44 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.817 1.678 . . . . 0.0 111.592 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.598 ' HB2' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -150.78 106.86 3.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 1.007 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.28 157.01 18.38 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.276 -0.89 . . . . 0.0 110.601 -178.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.557 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 106.3 157.18 21.69 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 m -64.55 -55.26 21.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.243 -1.151 . . . . 0.0 109.138 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -55.27 -33.02 62.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.89 . . . . 0.0 109.009 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.576 ' HB1' ' CG ' ' A' ' 45' ' ' ARG . . . -77.46 -60.52 2.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.383 -0.823 . . . . 0.0 109.357 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.972 HD11 ' N ' ' A' ' 34' ' ' ALA . 44.5 mt -48.08 -40.9 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.267 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB2' HG21 ' A' ' 27' ' ' VAL . 49.2 ttp180 -79.1 -58.39 3.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.814 . . . . 0.0 109.124 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.532 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 49.8 tt0 -46.2 -27.37 0.97 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.021 -1.05 . . . . 0.0 108.619 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.598 ' CD2' ' HB2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -85.02 -71.36 0.53 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.587 ' HB3' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -49.31 -33.01 12.21 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.451 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . . . -69.12 -46.82 66.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 108.78 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 26.9 t-20 -58.41 -35.45 72.09 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.707 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 25.6 t -64.93 -38.09 89.82 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.921 HD22 ' CD2' ' A' ' 23' ' ' LEU . 7.6 tp -68.78 -22.04 64.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.486 -0.759 . . . . 0.0 109.68 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 25.9 mtpt -50.39 -26.37 4.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 109.692 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.895 HD22 ' CD2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.71 126.7 56.96 Favored Pre-proline 0 C--N 1.305 -1.349 0 O-C-N 121.226 -0.921 . . . . 0.0 109.049 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.454 ' C ' ' HG ' ' A' ' 63' ' ' LEU . 44.0 Cg_endo -71.49 101.62 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.834 1.439 . . . . 0.0 110.371 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.895 ' CD2' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -138.64 155.86 47.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.462 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.456 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -89.79 132.66 35.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 108.778 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.608 HG11 ' HB3' ' A' ' 18' ' ' LEU . 16.2 t -107.22 125.02 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.048 -1.033 . . . . 0.0 110.127 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' LEU . 14.8 tt0 -150.26 103.12 3.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.44 -0.788 . . . . 0.0 108.961 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.763 HD11 ' HB ' ' A' ' 15' ' ' VAL . 3.8 mt -55.09 -108.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 110.062 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.668 ' O ' ' N ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER 158.26 43.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.555 ' CG ' ' O ' ' A' ' 68' ' ' THR . 5.1 pt20 50.64 -54.02 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' A' ' 68' ' ' THR . 23.1 tt0 -60.77 116.19 4.23 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.624 -1.297 . . . . 0.0 110.761 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.711 ' CG2' HG11 ' A' ' 11' ' ' VAL . 35.8 t -135.3 163.54 35.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.702 ' CZ ' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -132.03 135.12 46.28 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.454 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' N ' ' NE ' ' A' ' 72' ' ' ARG . . . -145.44 111.63 5.66 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.041 HG11 HG21 ' B' ' 240' ' ' VAL . 0.1 OUTLIER -100.11 -163.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.01 -1.056 . . . . 0.0 110.429 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -35.69 -94.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.771 -0.581 . . . . 0.0 111.241 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 8.1 t-20 -100.32 -2.9 32.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.07 -1.019 . . . . 0.0 110.748 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.515 ' OE1' ' NE ' ' B' ' 313' ' ' ARG . 0.4 OUTLIER -111.29 -162.03 0.78 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.769 -1.207 . . . . 0.0 109.719 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 1.04 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . -176.09 162.14 2.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.602 -0.686 . . . . 0.0 109.372 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 1.006 ' HB2' HD11 ' B' ' 315' ' ' LEU . . . -150.17 130.09 13.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.172 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 31.4 p90 -150.83 168.79 23.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.678 -1.263 . . . . 0.0 109.948 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.888 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -141.8 -178.3 5.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.472 -0.767 . . . . 0.0 109.862 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CB ' ' HA ' ' A' ' 67' ' ' LEU . 1.9 p90 -172.65 -159.25 0.12 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.386 -0.821 . . . . 0.0 109.257 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.86 149.43 43.41 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.083 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.611 HG11 HD22 ' A' ' 63' ' ' LEU . 55.6 t -124.77 112.51 32.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.51 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -113.5 103.9 11.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.902 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.679 ' CZ ' H221 ' A' ' 126' ' ' NTH . 45.6 p90 -123.1 164.77 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.393 -0.817 . . . . 0.0 108.931 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 38.0 tt0 -141.46 152.25 44.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.059 -1.026 . . . . 0.0 109.83 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.437 ' N ' ' HG2' ' A' ' 87' ' ' GLU . 7.3 m-85 -93.61 -146.4 0.24 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.419 -0.801 . . . . 0.0 109.297 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -0.72 30.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.958 . . . . 0.0 109.719 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.71 -68.63 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 1.6 ttt85 -55.49 155.11 5.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -1.137 . . . . 0.0 109.557 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.439 ' HD2' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -131.71 120.43 22.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.757 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -121.46 143.26 49.34 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER -117.37 179.52 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.103 -0.998 . . . . 0.0 108.74 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 1.012 HG12 ' HD3' ' A' ' 97' ' ' PRO . 3.0 t -148.15 146.5 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.07 -1.019 . . . . 0.0 109.533 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.44 ' O ' ' CG ' ' A' ' 120' ' ' ASN . . . -133.64 71.13 75.51 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.34 -0.85 . . . . 0.0 110.281 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 1.012 ' HD3' HG12 ' A' ' 95' ' ' VAL . 49.7 Cg_endo -95.46 -174.54 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.537 1.491 . . . . 0.0 110.973 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.888 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.9 mp -139.14 166.28 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 21.1 t0 -131.27 154.66 48.26 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.922 -1.111 . . . . 0.0 110.192 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.517 ' NE2' ' CD1' ' B' ' 315' ' ' LEU . 0.3 OUTLIER -108.77 172.75 6.66 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 1.04 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -147.41 150.88 35.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.82 -1.175 . . . . 0.0 110.857 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.488 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -139.78 109.53 6.33 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.674 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -89.27 -166.12 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 109.777 -179.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.871 ' HB3' HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -135.9 -38.71 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.439 -0.788 . . . . 0.0 109.34 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.714 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -174.46 -47.67 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 163.2 77.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -1.094 . . . . 0.0 109.503 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -167.21 -67.94 0.03 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.7 ptpt -139.78 -163.87 1.58 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.232 -1.158 . . . . 0.0 109.482 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.774 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 94.0 t -100.79 147.63 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.871 . . . . 0.0 109.337 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.871 HG21 ' HB3' ' A' ' 104' ' ' ASN . 93.2 t -111.9 -66.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 109.746 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -116.25 166.25 12.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.055 -1.028 . . . . 0.0 109.736 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.515 ' HB3' HG22 ' A' ' 36' ' ' VAL . 12.2 ttp -160.28 154.61 23.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.345 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.49 HH22 HD12 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -144.35 126.59 15.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.167 -0.958 . . . . 0.0 109.482 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.554 ' HB3' ' OD2' ' A' ' 38' ' ' ASP . . . -96.71 132.21 42.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 109.752 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.653 HD13 ' HB2' ' B' ' 279' ' ' ALA . 1.3 tt -117.92 143.84 45.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.002 . . . . 0.0 109.834 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.549 ' CE1' HG13 ' A' ' 40' ' ' VAL . 9.2 p90 172.54 -158.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.622 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 169.53 -173.05 43.79 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.517 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 26.6 tt0 -72.79 -2.65 21.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.302 -1.117 . . . . 0.0 109.68 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -92.71 -30.96 15.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.997 0.903 . . . . 0.0 108.995 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.3 m-20 -89.11 11.38 18.69 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.679 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.982 HG23 HG22 ' A' ' 95' ' ' VAL . 4.4 mm -92.66 -160.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.191 -0.943 . . . . 0.0 108.587 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.697 ' O ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -151.22 159.93 44.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.071 . . . . 0.0 109.795 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.66 81.74 1.03 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.371 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -119.19 140.16 14.82 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.207 -1.173 . . . . 0.0 109.454 179.889 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.405 ' O ' ' C ' ' B' ' 202' ' ' ASN . 5.1 mpp? . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.258 0.551 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.477 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 8.8 m120 45.33 44.48 9.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.436 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . 0.515 ' CG2' ' HB2' ' B' ' 205' ' ' GLU . 5.3 m -89.59 108.64 26.46 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.4 Cg_endo -72.26 -2.48 11.73 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.973 1.512 . . . . 0.0 110.165 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . 0.515 ' HB2' ' CG2' ' B' ' 203' ' ' THR . 3.5 tt0 -58.92 -63.48 1.28 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -0.869 . . . . 0.0 109.353 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -61.98 -45.03 95.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.915 . . . . 0.0 109.51 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . 0.434 ' HA ' ' CE2' ' B' ' 303' ' ' PHE . 73.3 mtm -60.9 -41.48 96.15 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.255 -0.903 . . . . 0.0 109.608 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 18.1 m -64.46 -44.08 92.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.946 . . . . 0.0 109.252 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.64 -43.73 57.19 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.845 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -53.57 -26.03 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.817 HG11 ' CG2' ' B' ' 271' ' ' VAL . 13.5 t -89.8 -43.27 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.387 -0.821 . . . . 0.0 108.984 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' B' ' 215' ' ' VAL . 5.7 tt0 -62.71 -73.98 0.1 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.833 ' HB3' HD22 ' B' ' 229' ' ' LEU . 1.4 mtt85 -42.21 -45.06 3.99 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' TYR . . . . . 0.639 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.3 OUTLIER -48.05 -43.13 30.04 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.28 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.952 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.16 -40.25 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.407 -0.808 . . . . 0.0 109.178 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.8 -37.24 13.17 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.609 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -72.97 -35.21 66.87 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' B' ' 215' ' ' VAL . 5.2 mt -63.84 -60.84 2.77 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -49.29 -40.36 34.37 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.532 0.682 . . . . 0.0 109.252 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.22 0.02 57.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.553 -0.717 . . . . 0.0 109.799 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.972 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 54.52 45.4 76.9 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . 0.454 ' O ' HG13 ' B' ' 226' ' ' ILE . 45.7 t0 -111.14 83.75 1.82 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 110.061 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' LEU . . . . . 0.984 ' CD2' HD22 ' B' ' 259' ' ' LEU . 3.9 mm? -53.31 -19.37 3.23 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.24 -0.913 . . . . 0.0 109.78 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.89 -56.94 11.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.235 -0.916 . . . . 0.0 109.213 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -60.61 -31.92 76.62 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.896 HD12 HD13 ' B' ' 223' ' ' LEU . 7.2 mt -65.28 -60.45 2.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.726 HG21 ' HB2' ' B' ' 252' ' ' ARG . 61.1 t -59.14 -40.26 80.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.16 -51.33 66.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.845 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.6 tp -66.48 -21.83 66.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . 0.493 ' O ' ' O ' ' B' ' 227' ' ' VAL . 3.9 m-30 -95.71 134.93 38.06 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.338 -0.851 . . . . 0.0 110.015 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -44.54 164.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.036 -1.04 . . . . 0.0 109.383 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' B' ' 248' ' ' THR . 0.1 OUTLIER -61.9 -24.63 67.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.489 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.553 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 2.6 p30 -138.53 43.08 2.15 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' B' ' 310' ' ' VAL . . . -64.04 169.26 4.49 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.327 -0.858 . . . . 0.0 109.808 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' THR . . . . . 0.873 HG23 ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -119.79 140.07 51.33 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.446 -0.784 . . . . 0.0 109.007 179.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.502 ' O ' ' HB3' ' B' ' 244' ' ' PRO . 37.3 t -132.44 121.19 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.577 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' B' ' 314' ' ' ALA . 1.5 mt-10 -89.2 105.85 18.05 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' ASP . . . . . 0.581 ' OD2' ' H62' ' B' ' 326' ' ' NTH . 27.0 t70 -179.61 142.06 0.36 Allowed Pre-proline 0 C--N 1.302 -1.464 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.337 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.503 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 47.7 Cg_endo -72.61 -176.72 16.71 Favored 'Cis proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.209 -1.996 . . . . 0.0 110.693 -0.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 1.041 HG21 HG11 ' A' ' 74' ' ' VAL . 26.9 m -82.86 49.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -175.1 30.88 0.09 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 75.4 m -149.46 -99.1 0.07 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -1.118 . . . . 0.0 109.38 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -176.9 139.46 0.46 Allowed Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.099 -1.001 . . . . 0.0 110.037 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' PRO . . . . . 0.502 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.1 Cg_endo -65.12 -176.64 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.123 1.591 . . . . 0.0 111.138 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.74 ' HG2' ' HB1' ' B' ' 250' ' ' ALA . 12.1 ttm-85 -151.88 121.76 7.05 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.873 ' HB3' HG23 ' B' ' 235' ' ' THR . 1.0 OUTLIER -103.21 155.71 18.23 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.011 -1.056 . . . . 0.0 110.164 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . 0.553 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.89 161.96 21.07 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' THR . . . . . 0.454 ' N ' ' O ' ' B' ' 232' ' ' ASP . 3.7 m -70.02 -59.75 2.72 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.22 -1.165 . . . . 0.0 109.259 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' B' ' 253' ' ' GLU . . . -53.66 -23.53 11.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.313 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.74 ' HB1' ' HG2' ' B' ' 245' ' ' ARG . . . -87.69 -54.34 4.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.62 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.528 HD11 ' O ' ' B' ' 234' ' ' ALA . 7.1 mm -53.35 -40.93 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 109.543 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' ARG . . . . . 0.726 ' HB2' HG21 ' B' ' 227' ' ' VAL . 24.6 ttp85 -79.09 -51.54 9.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.064 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' B' ' 249' ' ' ALA . 21.6 tt0 -52.06 -27.32 13.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.03 -1.044 . . . . 0.0 108.578 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.1 OUTLIER -83.9 -70.11 0.59 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 0.588 ' C ' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -52.94 -20.43 3.37 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.389 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' B' ' 252' ' ' ARG . . . -79.31 -39.67 32.27 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 62.4 t30 -62.86 -26.13 68.62 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' SER . . . . . 0.446 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 30.3 t -74.71 -41.55 59.99 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 0.984 HD22 ' CD2' ' B' ' 223' ' ' LEU . 9.9 tp -61.4 -23.4 65.77 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.499 -0.751 . . . . 0.0 109.378 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' B' ' 262' ' ' PRO . 0.0 OUTLIER -50.62 -29.51 11.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.889 . . . . 0.0 109.345 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' LEU . . . . . 1.051 HD22 HD21 ' B' ' 263' ' ' LEU . 0.8 OUTLIER -92.64 107.36 23.54 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 108.534 179.385 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 47.9 Cg_endo -73.52 115.21 4.26 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.899 1.473 . . . . 0.0 111.702 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 1.051 HD21 HD22 ' B' ' 261' ' ' LEU . 0.1 OUTLIER -138.96 -166.49 2.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.477 179.127 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . 0.746 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -114.28 127.25 55.78 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.86 118.75 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -0.999 . . . . 0.0 109.919 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.2 OUTLIER -150.14 108.5 3.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.334 -0.854 . . . . 0.0 109.2 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.9 OUTLIER -47.38 174.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.897 . . . . 0.0 109.504 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.43 -39.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.663 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 269' ' ' GLN . . . . . 0.497 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 7.5 pt20 -94.63 -148.82 0.28 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.638 -0.664 . . . . 0.0 109.294 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.497 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 32.5 tt0 -113.42 131.52 55.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 109.72 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . 0.817 ' CG2' HG11 ' B' ' 211' ' ' VAL . 57.0 t -65.1 153.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.347 -0.845 . . . . 0.0 109.247 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.526 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 2.5 mtt180 -116.12 131.59 56.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.212 -0.93 . . . . 0.0 109.964 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.19 133.97 16.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.391 -0.818 . . . . 0.0 109.179 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 274' ' ' VAL . . . . . 1.004 HG11 HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -127.3 -163.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.104 -0.997 . . . . 0.0 109.811 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . 0.542 ' O ' ' CB ' ' B' ' 276' ' ' ASN . . . -86.38 68.17 10.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.433 -0.792 . . . . 0.0 110.386 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 276' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' B' ' 275' ' ' ALA . 2.9 m-20 160.69 -61.36 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.421 -0.799 . . . . 0.0 109.47 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . 0.495 ' HG2' ' HG2' ' B' ' 302' ' ' ARG . 0.0 OUTLIER -122.39 -161.11 0.92 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.455 -0.778 . . . . 0.0 109.214 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 278' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . -169.78 139.41 1.96 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.478 -0.764 . . . . 0.0 109.12 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 279' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -126.73 139.49 53.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.96 -1.087 . . . . 0.0 109.456 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . 0.68 ' HB3' HG13 ' B' ' 271' ' ' VAL . 23.8 p90 -150.57 172.47 15.46 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.054 -1.029 . . . . 0.0 109.631 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.899 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -147.18 175.59 10.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 110.183 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 282' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 6.7 p90 -167.76 -167.89 0.92 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 283' ' ' THR . . . . . 0.673 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -132.73 141.78 48.71 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.987 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 284' ' ' VAL . . . . . 0.718 ' CG1' HD22 ' B' ' 263' ' ' LEU . 0.5 OUTLIER -114.7 120.93 65.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 285' ' ' SER . . . . . 0.746 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 37.8 p -123.86 80.7 1.83 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.11 -0.994 . . . . 0.0 109.97 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.661 ' HB3' HD23 ' B' ' 263' ' ' LEU . 44.1 p90 -89.89 -172.5 3.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.202 -0.936 . . . . 0.0 108.643 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.72 150.42 49.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.873 -1.142 . . . . 0.0 110.099 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.568 ' CD2' ' OG1' ' B' ' 293' ' ' THR . 0.4 OUTLIER -117.21 88.49 2.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 0.0 108.99 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . 0.52 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 0.2 OUTLIER 42.13 -93.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.269 -0.894 . . . . 0.0 110.021 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 290' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' B' ' 288' ' ' PHE . . . -101.55 -13.43 32.66 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 291' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' B' ' 288' ' ' PHE . 7.8 mtt-85 -101.98 159.85 15.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.239 . . . . 0.0 109.774 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 292' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -122.01 129.74 52.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 293' ' ' THR . . . . . 0.571 ' HB ' ' CZ ' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -123.18 144.47 49.34 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.258 -0.901 . . . . 0.0 109.921 -179.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 294' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' B' ' 322' ' ' HIS . 12.3 p -126.19 168.25 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.875 . . . . 0.0 108.773 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 0.929 HG22 ' CG2' ' B' ' 321' ' ' ILE . 30.9 t -137.7 160.17 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.944 -1.098 . . . . 0.0 110.62 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 296' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' B' ' 320' ' ' ASN . . . -144.49 64.62 12.16 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 297' ' ' PRO . . . . . 0.583 ' HD3' HG12 ' B' ' 295' ' ' VAL . 46.3 Cg_endo -97.57 179.78 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.707 1.605 . . . . 0.0 111.749 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.899 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.6 mp -141.05 154.46 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . 0.627 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 18.4 t0 -123.01 164.25 18.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.784 -1.198 . . . . 0.0 110.541 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.516 ' O ' ' CG ' ' B' ' 312' ' ' MET . 0.1 OUTLIER -116.66 166.32 12.25 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 301' ' ' PHE . . . . . 0.683 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.1 OUTLIER -145.18 145.85 31.51 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.883 -178.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.495 ' HG2' ' HG2' ' B' ' 277' ' ' GLU . 0.8 OUTLIER -138.53 110.4 7.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.37 -0.831 . . . . 0.0 109.25 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 303' ' ' PHE . . . . . 0.681 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 5.1 m-85 -89.9 -168.44 2.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.564 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 304' ' ' ASN . . . . . 0.83 ' HB3' HG21 ' B' ' 310' ' ' VAL . 0.9 OUTLIER -137.55 -40.72 0.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 305' ' ' GLY . . . . . 0.701 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -148.1 -65.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 306' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 164.9 56.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -1.146 . . . . 0.0 109.546 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -148.04 -41.04 0.04 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -154.86 -169.31 3.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -1.209 . . . . 0.0 109.542 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 309' ' ' VAL . . . . . 0.573 HG11 ' HE1' ' B' ' 301' ' ' PHE . 50.0 t -99.24 151.41 4.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 109.286 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.83 HG21 ' HB3' ' B' ' 304' ' ' ASN . 45.3 t -121.74 -63.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' B' ' 302' ' ' ARG . 13.8 m -116.48 165.62 13.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.154 -0.966 . . . . 0.0 109.518 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 312' ' ' MET . . . . . 0.516 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 28.8 ttp -155.18 156.48 35.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.754 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 313' ' ' ARG . . . . . 0.515 ' NE ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -123.98 179.85 4.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.351 -0.843 . . . . 0.0 108.998 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 314' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' B' ' 238' ' ' ASP . . . -138.42 125.14 20.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.977 -1.077 . . . . 0.0 110.529 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 315' ' ' LEU . . . . . 1.006 HD11 ' HB2' ' A' ' 79' ' ' ALA . 5.6 tp -104.44 -175.32 2.76 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 316' ' ' PHE . . . . . 0.76 ' HE1' HG22 ' B' ' 240' ' ' VAL . 0.0 OUTLIER 99.56 -160.73 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 CA-C-O 121.626 0.726 . . . . 0.0 109.889 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 317' ' ' GLY . . . . . 0.662 ' N ' ' CG ' ' B' ' 316' ' ' PHE . . . 160.42 -162.33 33.25 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 318' ' ' GLU . . . . . 0.494 ' HA ' HD12 ' B' ' 321' ' ' ILE . 5.1 tt0 -78.16 6.45 8.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -1.143 . . . . 0.0 109.622 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -115.17 -17.85 11.29 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.192 -0.943 . . . . 0.0 110.078 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 320' ' ' ASN . . . . . 0.535 ' O ' ' HB3' ' B' ' 296' ' ' ALA . 0.2 OUTLIER -88.8 -14.9 35.92 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.215 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 321' ' ' ILE . . . . . 0.929 ' CG2' HG22 ' B' ' 295' ' ' VAL . 0.9 OUTLIER -87.84 -164.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 322' ' ' HIS . . . . . 0.729 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.0 OUTLIER -150.99 154.84 37.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.969 -1.082 . . . . 0.0 109.756 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.474 ' HA ' HG22 ' B' ' 293' ' ' THR . . . -155.52 110.89 3.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.468 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -171.33 -132.55 1.5 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.3 -1.118 . . . . 0.0 109.508 -179.841 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' NTH . . . . . 0.707 ' H11' ' OG ' ' A' ' 58' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 326' ' ' NTH . . . . . 0.876 ' O17' HD13 ' B' ' 261' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.227 0.536 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 3' ' ' THR . 28.6 m120 -131.76 43.96 2.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.364 -0.835 . . . . 0.0 109.393 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.736 ' O ' HG23 ' A' ' 3' ' ' THR . 11.1 t -44.2 108.73 0.75 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.48 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.84 -9.69 25.18 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.889 1.468 . . . . 0.0 110.065 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -66.35 -49.45 66.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.229 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -52.7 61.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.192 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 mtm -59.62 -25.58 64.76 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.329 -0.857 . . . . 0.0 109.346 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -72.98 -30.69 64.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 0.0 109.128 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.25 -51.97 66.17 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.863 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -47.91 -29.13 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.163 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.943 HG11 HG21 ' A' ' 71' ' ' VAL . 24.9 t -87.95 -45.18 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.5 -0.75 . . . . 0.0 109.363 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 13' ' ' ARG . 3.6 tt0 -58.43 -73.37 0.08 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.0 OUTLIER -43.02 -44.78 4.89 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.643 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -50.5 -44.26 55.94 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.924 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -86.37 -41.46 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 108.99 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -49.41 -35.19 18.41 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.677 ' HB1' ' OD1' ' A' ' 22' ' ' ASP . . . -74.25 -32.82 63.1 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.924 HD12 ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -65.1 -57.13 9.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.48 -39.73 24.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.01 -11.57 43.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.583 -0.698 . . . . 0.0 109.464 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 1.008 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 62.68 25.92 67.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.677 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 16.0 p30 -89.41 85.48 6.56 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.131 -1.217 . . . . 0.0 109.649 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.036 ' CD2' HD22 ' A' ' 59' ' ' LEU . 3.6 mm? -49.76 -21.8 1.21 Allowed 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.259 -0.901 . . . . 0.0 109.783 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.53 -51.8 68.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -40.8 95.02 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.56 HD12 HD13 ' A' ' 23' ' ' LEU . 7.7 mt -59.86 -54.67 31.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 23' ' ' LEU . 48.5 t -64.33 -41.18 91.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.17 -49.82 70.9 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.863 HD21 ' HA ' ' A' ' 10' ' ' VAL . 2.0 tp -67.14 -14.22 62.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.733 ' CZ ' ' HE3' ' A' ' 112' ' ' MET . 3.0 m-85 -89.48 136.01 33.27 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' CB ' HG22 ' A' ' 110' ' ' VAL . . . -54.42 -167.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 109.552 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -76.89 -23.51 52.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.251 -0.906 . . . . 0.0 109.7 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.549 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -143.66 45.51 1.49 Allowed 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -59.04 157.63 9.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.966 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.556 ' HG1' ' HG ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -117.81 139.27 51.32 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.485 -0.759 . . . . 0.0 109.284 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.754 ' CG2' HD12 ' A' ' 51' ' ' ILE . 42.7 t -129.24 141.1 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.418 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.526 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 11.5 mt-10 -111.24 112.79 24.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.643 ' OD2' ' H62' ' A' ' 126' ' ' NTH . 19.7 t70 -179.27 141.38 0.36 Allowed Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.568 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.51 ' O ' HG22 ' A' ' 40' ' ' VAL . 46.2 Cg_endo -72.56 131.69 23.34 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.286 -1.964 . . . . 0.0 110.6 -0.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 39' ' ' PRO . 14.0 m 40.73 -147.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.464 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.473 ' N ' HG23 ' A' ' 40' ' ' VAL . . . -67.28 1.21 6.95 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.04 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.472 ' OG ' ' HG2' ' A' ' 39' ' ' PRO . 68.8 m -48.06 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.902 -1.352 . . . . 0.0 110.163 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 4.2 pt-20 -133.29 107.64 12.28 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.096 -1.003 . . . . 0.0 110.608 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 42.5 Cg_endo -68.47 -167.74 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 124.016 1.535 . . . . 0.0 110.428 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.662 ' HD3' ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -151.43 112.31 4.26 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.532 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.2 OUTLIER -103.57 140.2 37.85 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 110.257 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 107.8 160.81 20.93 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.487 HG23 ' CG1' ' A' ' 27' ' ' VAL . 3.0 m -76.07 -42.38 47.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.269 -1.136 . . . . 0.0 109.086 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.63 -38.11 83.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.29 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.662 ' HB1' ' HD3' ' A' ' 45' ' ' ARG . . . -73.48 -43.59 59.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.314 -0.866 . . . . 0.0 109.368 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.754 HD12 ' CG2' ' A' ' 36' ' ' VAL . 5.4 mm -58.49 -46.45 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.31 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.53 ' CG ' HG21 ' A' ' 27' ' ' VAL . 36.7 ttt-85 -66.31 -55.46 15.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 108.945 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 52' ' ' ARG . 2.3 mt-10 -45.09 -28.56 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 108.568 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.607 ' CG ' ' HG3' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -85.09 -70.08 0.61 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.692 ' C ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -51.73 -20.95 2.37 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . . . -82.21 -46.0 14.32 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 24.5 t-20 -60.96 -50.04 75.01 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.61 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 7.4 t -51.79 -26.27 9.34 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.036 HD22 ' CD2' ' A' ' 23' ' ' LEU . 5.4 tp -76.95 -28.24 55.13 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.591 -0.693 . . . . 0.0 109.739 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -44.35 -31.44 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 108.633 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.057 ' CD2' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -100.19 100.27 11.35 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 45.9 Cg_endo -71.71 129.54 15.7 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.991 1.521 . . . . 0.0 111.899 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.057 HD21 ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -139.98 178.04 7.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.999 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -92.23 127.8 37.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.264 -0.898 . . . . 0.0 108.58 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.52 112.18 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 110.056 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -150.86 105.3 3.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.812 . . . . 0.0 109.193 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.51 HD12 ' H ' ' A' ' 67' ' ' LEU . 2.3 mp -55.5 173.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.96 . . . . 0.0 109.861 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -134.72 -81.13 0.44 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.339 -0.851 . . . . 0.0 109.327 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.557 ' H ' HG23 ' A' ' 68' ' ' THR . 5.5 pt20 -60.22 -143.28 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.647 -0.658 . . . . 0.0 109.435 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -114.29 134.8 54.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.963 -1.086 . . . . 0.0 110.001 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.022 HG13 ' HB3' ' A' ' 80' ' ' PHE . 10.6 t -63.09 148.71 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.423 -0.798 . . . . 0.0 109.036 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 3.4 mmm180 -98.97 130.57 45.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.931 . . . . 0.0 109.287 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.533 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -145.92 135.96 23.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 109.342 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.9 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -163.9 155.48 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.67 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.807 ' HB2' ' O ' ' B' ' 240' ' ' VAL . . . 49.76 -152.03 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.473 -0.767 . . . . 0.0 109.855 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 103' ' ' PHE . 98.3 m-20 -87.36 16.98 4.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.454 -0.779 . . . . 0.0 109.331 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.498 ' HG3' ' HA ' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -123.6 -159.26 0.84 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.342 -0.849 . . . . 0.0 109.076 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.96 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 178.04 160.3 0.53 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.439 -0.788 . . . . 0.0 109.542 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.835 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.27 133.54 16.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.015 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 1.022 ' HB3' HG13 ' A' ' 71' ' ' VAL . 33.5 p90 -148.96 163.67 36.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.836 -1.165 . . . . 0.0 110.241 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.964 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -140.78 150.13 42.97 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -149.56 -172.51 4.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.175 -0.953 . . . . 0.0 109.401 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.29 141.74 51.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.406 -0.808 . . . . 0.0 109.611 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.939 HG11 HD22 ' A' ' 63' ' ' LEU . 19.9 t -112.01 111.71 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.394 -0.816 . . . . 0.0 109.156 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.999 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -106.12 113.1 26.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.824 . . . . 0.0 109.57 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.894 ' CE2' H221 ' A' ' 126' ' ' NTH . 0.8 OUTLIER -128.02 148.13 50.53 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.195 -0.941 . . . . 0.0 109.536 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -91.7 178.64 5.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.541 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.576 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.5 OUTLIER -142.19 -163.49 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.34 -0.85 . . . . 0.0 109.382 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.69 60.95 2.87 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.026 -1.047 . . . . 0.0 109.491 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.84 3.41 26.69 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -136.81 164.36 28.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.137 -1.213 . . . . 0.0 109.667 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' CD ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -126.52 122.27 34.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.844 . . . . 0.0 109.233 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.576 ' OG1' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -117.23 154.6 30.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.722 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.622 HG12 ' HB3' ' A' ' 122' ' ' HIS . 7.3 p -138.46 170.75 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 108.861 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 1.029 HG12 ' HD3' ' A' ' 97' ' ' PRO . 3.5 t -144.91 147.05 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.034 -1.041 . . . . 0.0 109.268 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.437 ' O ' ' CG ' ' A' ' 120' ' ' ASN . . . -132.55 69.65 79.67 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.121 -0.987 . . . . 0.0 111.026 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 1.029 ' HD3' HG12 ' A' ' 95' ' ' VAL . 49.3 Cg_endo -96.35 -173.08 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.503 1.469 . . . . 0.0 110.424 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.964 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.9 mp -134.46 157.36 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 15.8 t0 -127.05 153.25 46.2 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.156 -0.965 . . . . 0.0 110.11 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.518 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -108.88 171.27 7.53 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.96 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -142.37 148.38 37.79 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.101 -0.999 . . . . 0.0 110.486 -178.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.539 ' CD ' ' HB2' ' A' ' 111' ' ' SER . 0.0 OUTLIER -133.85 107.43 7.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.561 -0.712 . . . . 0.0 109.085 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.639 ' CZ ' ' CG2' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -89.72 -176.37 4.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 109.56 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.932 ' OD1' HG23 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -138.9 -100.08 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.433 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.67 -38.93 0.04 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -171.48 32.8 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.45 -1.029 . . . . 0.0 108.74 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 108' ' ' LYS . . . -123.72 15.56 7.96 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 22.2 mmmt 81.79 -150.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.653 -0.91 . . . . 0.0 109.624 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.66 HG23 HG22 ' A' ' 10' ' ' VAL . 18.2 t -88.2 122.66 40.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.932 HG23 ' OD1' ' A' ' 104' ' ' ASN . 49.1 t -105.24 -8.58 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.079 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.556 ' HG ' ' HG1' ' A' ' 35' ' ' THR . 0.6 OUTLIER -160.37 153.22 21.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.957 -1.089 . . . . 0.0 110.137 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.733 ' HE3' ' CZ ' ' A' ' 30' ' ' PHE . 19.0 ttm -160.05 141.82 12.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.494 -0.754 . . . . 0.0 109.211 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 1.0 OUTLIER -123.56 174.21 7.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.116 -0.99 . . . . 0.0 109.269 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 99' ' ' ASP . . . -147.47 134.91 20.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.945 . . . . 0.0 109.263 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.879 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.1 OUTLIER -125.01 141.17 52.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 110.063 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.784 ' O ' HG21 ' B' ' 274' ' ' VAL . 50.0 p90 172.86 -160.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.564 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 172.31 -171.03 44.0 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.542 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 3.1 tt0 -69.87 -5.01 22.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.444 -1.033 . . . . 0.0 109.7 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.453 ' HE3' ' OE2' ' B' ' 270' ' ' GLU . 0.3 OUTLIER -90.47 -31.74 16.66 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.958 0.885 . . . . 0.0 109.142 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.437 ' CG ' ' O ' ' A' ' 96' ' ' ALA . 1.8 m-20 -89.36 8.6 29.83 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.19 0.519 . . . . 0.0 109.665 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.724 HG22 ' H ' ' A' ' 122' ' ' HIS . 4.9 mm -90.28 -172.53 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 108.897 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.724 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -151.7 156.76 41.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.914 . . . . 0.0 109.506 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.426 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -154.7 135.24 13.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.506 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.59 138.66 9.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.202 -1.175 . . . . 0.0 109.535 -179.861 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.242 0.544 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -116.06 92.6 3.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.441 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.92 119.42 69.38 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.827 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.32 -4.69 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.858 1.452 . . . . 0.0 109.586 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.04 -40.84 68.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.373 -0.83 . . . . 0.0 109.237 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -65.83 -55.7 15.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.128 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 15.4 mtm -55.98 -24.62 39.68 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.289 -0.882 . . . . 0.0 109.13 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 5.4 m -73.91 -34.06 64.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.346 -0.846 . . . . 0.0 109.136 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.1 -46.44 65.25 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.183 -0.948 . . . . 0.0 108.482 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.753 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.0 OUTLIER -54.97 -24.84 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.816 HG11 HG21 ' B' ' 271' ' ' VAL . 16.8 t -90.21 -43.94 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.421 -0.799 . . . . 0.0 109.045 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' B' ' 213' ' ' ARG . 7.6 tt0 -60.45 -73.61 0.09 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.963 ' HD3' HD13 ' B' ' 229' ' ' LEU . 0.0 OUTLIER -43.22 -45.23 5.62 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' TYR . . . . . 0.641 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -50.09 -44.84 52.19 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.92 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -86.94 -39.32 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.317 -0.865 . . . . 0.0 109.172 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.35 -36.51 14.62 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -73.97 -33.87 64.02 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.92 HD12 ' HA ' ' B' ' 215' ' ' VAL . 2.7 mt -64.05 -59.07 4.91 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -51.19 -45.5 61.84 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.509 0.671 . . . . 0.0 109.194 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.54 8.6 30.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.579 -0.701 . . . . 0.0 109.681 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.823 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 49.48 33.72 17.96 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.5 t70 -90.58 67.73 6.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -1.131 . . . . 0.0 109.685 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' LEU . . . . . 1.066 HD12 HD12 ' B' ' 226' ' ' ILE . 7.3 tp -50.38 -45.2 55.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.076 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' B' ' 223' ' ' LEU . 5.3 m-20 -43.44 -32.64 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -83.86 -33.51 21.14 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 1.066 HD12 HD12 ' B' ' 223' ' ' LEU . 17.2 mt -61.9 -56.02 20.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.651 HG11 HG23 ' B' ' 248' ' ' THR . 97.0 t -59.71 -37.33 70.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.93 -51.82 68.06 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.963 HD13 ' HD3' ' B' ' 213' ' ' ARG . 2.9 tp -68.06 -14.89 63.32 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.536 -0.727 . . . . 0.0 109.057 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . 0.771 ' CD2' HG21 ' B' ' 251' ' ' ILE . 2.4 m-85 -94.78 149.18 21.51 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.457 -0.777 . . . . 0.0 109.527 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -59.24 168.23 1.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.429 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.449 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -55.72 -24.4 34.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.372 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.532 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 8.8 p-10 -150.56 51.36 0.88 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.717 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -60.58 158.94 11.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.608 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' THR . . . . . 0.53 ' CG2' ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -100.27 141.34 33.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.447 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.545 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 85.4 t -134.41 136.39 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.258 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 1.5 mt-10 -112.39 113.28 25.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 108.559 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' ASP . . . . . 0.524 ' O ' ' CE2' ' B' ' 254' ' ' PHE . 9.6 t70 -179.55 141.74 0.36 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 109.664 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' B' ' 241' ' ' GLY . 49.1 Cg_endo -75.14 -176.65 18.56 Favored 'Cis proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.25 -1.979 . . . . 0.0 110.485 -0.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.807 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 6.2 m -65.18 75.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.284 -0.885 . . . . 0.0 108.982 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' B' ' 239' ' ' PRO . . . -162.78 24.37 0.2 Allowed Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' B' ' 241' ' ' GLY . 0.5 OUTLIER 67.24 48.92 1.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -1.14 . . . . 0.0 109.741 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . 0.517 ' N ' ' HD3' ' B' ' 244' ' ' PRO . 2.1 mt-10 -131.89 58.57 38.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.144 -0.972 . . . . 0.0 109.466 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' PRO . . . . . 0.545 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 48.5 Cg_endo -77.83 169.69 20.24 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 124.276 1.671 . . . . 0.0 110.942 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.466 ' HD2' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -151.32 100.79 2.78 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.72 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.2 OUTLIER -92.02 161.77 14.65 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.121 -0.987 . . . . 0.0 110.152 -178.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . 0.631 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 100.66 158.26 27.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' THR . . . . . 0.651 HG23 HG11 ' B' ' 227' ' ' VAL . 5.3 m -69.98 -48.7 57.17 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.195 -1.179 . . . . 0.0 108.971 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -61.81 -25.27 67.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.904 . . . . 0.0 109.274 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -90.13 -58.78 2.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.394 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.771 HG21 ' CD2' ' B' ' 230' ' ' PHE . 17.4 mt -47.45 -41.22 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.284 -0.885 . . . . 0.0 109.012 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' ARG . . . . . 0.762 ' CG ' HD23 ' B' ' 223' ' ' LEU . 28.6 ttt180 -76.75 -57.99 3.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.456 -0.778 . . . . 0.0 108.978 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 62.5 mt-10 -45.27 -28.32 0.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.025 -1.047 . . . . 0.0 108.589 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' B' ' 238' ' ' ASP . 0.8 OUTLIER -85.39 -71.02 0.55 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 1.048 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -49.12 -23.59 1.31 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . 0.711 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -76.38 -49.67 16.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' ASN . . . . . 0.54 ' ND2' ' HE2' ' B' ' 260' ' ' LYS . 0.3 OUTLIER -55.33 -29.43 58.29 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' SER . . . . . 0.547 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 42.9 t -75.44 -31.8 60.46 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 0.823 HD21 ' CA ' ' B' ' 221' ' ' GLY . 7.3 tp -71.77 -25.78 62.17 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.44 -0.787 . . . . 0.0 109.302 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . 0.54 ' HE2' ' ND2' ' B' ' 257' ' ' ASN . 12.0 mtmt -54.12 -23.83 15.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.296 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' LEU . . . . . 0.955 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.8 OUTLIER -89.92 120.34 69.35 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 0.0 108.698 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' B' ' 286' ' ' PHE . 42.9 Cg_endo -69.94 104.05 1.29 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.752 1.396 . . . . 0.0 110.584 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.955 ' CD2' HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -138.91 149.79 45.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.742 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . 0.906 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -91.62 129.55 37.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -0.824 . . . . 0.0 108.925 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . 0.699 HG21 ' HB3' ' B' ' 218' ' ' LEU . 3.0 t -110.18 116.09 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.87 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.1 OUTLIER -150.33 91.47 1.76 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 0.0 109.24 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -45.21 170.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.724 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.1 -39.56 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.299 -0.876 . . . . 0.0 109.675 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 269' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' B' ' 281' ' ' ALA . 8.1 pt20 -87.75 -154.2 0.25 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.453 ' OE2' ' HE3' ' A' ' 119' ' ' LYS . 51.7 tt0 -107.39 131.24 54.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.138 -0.976 . . . . 0.0 109.53 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . 0.93 HG13 ' HB3' ' B' ' 280' ' ' PHE . 26.7 t -67.35 150.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.292 -0.88 . . . . 0.0 108.762 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 5.5 mtt180 -104.01 136.94 42.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 109.963 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.18 126.14 10.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.412 -0.805 . . . . 0.0 109.275 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 274' ' ' VAL . . . . . 0.784 HG21 ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -155.33 160.74 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.215 -0.928 . . . . 0.0 109.4 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . 0.51 ' HB2' HG23 ' A' ' 40' ' ' VAL . . . 43.87 -145.56 0.1 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 276' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' B' ' 303' ' ' PHE . 1.5 t-20 -90.59 13.26 16.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 0.0 109.708 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . 0.492 ' HG3' ' HA ' ' B' ' 302' ' ' ARG . 0.9 OUTLIER -122.16 -161.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.078 -1.014 . . . . 0.0 109.733 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 278' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 177.74 148.79 0.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 279' ' ' ALA . . . . . 0.879 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -134.69 139.69 45.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.007 -1.058 . . . . 0.0 108.868 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . 0.93 ' HB3' HG13 ' B' ' 271' ' ' VAL . 33.3 p90 -150.47 165.18 33.99 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.694 -1.254 . . . . 0.0 110.651 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.992 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -143.45 176.86 8.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 282' ' ' PHE . . . . . 0.408 ' HE1' ' CE2' ' B' ' 280' ' ' PHE . 14.4 p90 -178.14 -170.21 0.23 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.284 -0.885 . . . . 0.0 109.6 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.58 142.33 50.74 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.518 -0.739 . . . . 0.0 109.551 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 284' ' ' VAL . . . . . 0.755 HG12 ' HD1' ' B' ' 286' ' ' PHE . 45.2 t -113.89 113.6 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.453 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 285' ' ' SER . . . . . 0.906 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 91.9 p -105.75 110.6 22.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.168 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.933 ' CZ ' H221 ' B' ' 326' ' ' NTH . 4.3 p90 -127.43 157.86 38.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.164 -0.96 . . . . 0.0 109.787 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 287' ' ' GLU . . . . . 0.49 ' HG3' ' HB2' ' B' ' 292' ' ' LYS . 11.6 tm-20 -144.71 167.61 22.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.307 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.419 ' N ' ' CD ' ' B' ' 287' ' ' GLU . 0.1 OUTLIER -122.02 -75.98 0.59 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.052 -1.03 . . . . 0.0 109.894 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' B' ' 289' ' ' GLN . 0.0 OUTLIER -158.99 60.1 0.42 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.503 -0.748 . . . . 0.0 109.778 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 129.88 -45.76 1.12 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -103.26 129.67 50.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.374 -1.074 . . . . 0.0 109.189 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 292' ' ' LYS . . . . . 0.49 ' HB2' ' HG3' ' B' ' 287' ' ' GLU . 0.2 OUTLIER -118.54 145.7 45.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 109.701 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 293' ' ' THR . . . . . 0.585 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -136.16 145.39 45.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.666 -0.646 . . . . 0.0 109.649 -179.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 294' ' ' VAL . . . . . 0.665 HG23 ' HA ' ' B' ' 285' ' ' SER . 0.5 OUTLIER -117.32 176.35 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 108.581 179.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 1.041 HG12 ' HD3' ' B' ' 297' ' ' PRO . 2.5 t -149.58 145.25 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.227 -0.921 . . . . 0.0 109.069 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 296' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -131.02 71.3 82.45 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.079 -1.013 . . . . 0.0 110.923 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 297' ' ' PRO . . . . . 1.041 ' HD3' HG12 ' B' ' 295' ' ' VAL . 52.3 Cg_endo -96.88 -173.08 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.717 1.611 . . . . 0.0 110.677 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.992 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.5 mp -139.49 151.97 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . 0.619 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 17.5 t0 -124.13 160.2 28.33 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.999 -1.063 . . . . 0.0 110.311 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' B' ' 312' ' ' MET . 63.0 t60 -110.88 173.79 6.17 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 301' ' ' PHE . . . . . 0.901 ' CE1' HG21 ' B' ' 309' ' ' VAL . 0.1 OUTLIER -149.55 138.96 21.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 110.491 -178.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.522 ' CB ' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -123.46 110.36 15.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.423 -0.798 . . . . 0.0 109.097 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 303' ' ' PHE . . . . . 0.618 ' CZ ' ' CG2' ' B' ' 210' ' ' VAL . 0.4 OUTLIER -89.78 -176.21 4.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 0.0 109.687 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 304' ' ' ASN . . . . . 0.946 ' OD1' HG23 ' B' ' 310' ' ' VAL . 0.1 OUTLIER -142.05 -100.06 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.583 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 305' ' ' GLY . . . . . 0.698 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -98.8 -55.58 1.06 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 306' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 163.13 76.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -1.099 . . . . 0.0 109.39 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -167.53 -51.73 0.03 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 308' ' ' LYS . . . . . 0.513 ' N ' ' HD2' ' B' ' 308' ' ' LYS . 0.0 OUTLIER -150.11 -167.43 2.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -1.213 . . . . 0.0 109.659 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 309' ' ' VAL . . . . . 0.901 HG21 ' CE1' ' B' ' 301' ' ' PHE . 62.0 t -102.66 148.28 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.332 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.946 HG23 ' OD1' ' B' ' 304' ' ' ASN . 24.1 t -110.97 -31.91 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.089 -1.007 . . . . 0.0 110.192 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . 0.522 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 1.3 m -144.94 165.02 29.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.789 -1.194 . . . . 0.0 110.009 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 312' ' ' MET . . . . . 0.523 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 11.0 ttp -156.2 161.5 40.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.695 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 313' ' ' ARG . . . . . 0.576 HH22 HG12 ' B' ' 240' ' ' VAL . 9.0 tpt180 -150.39 117.18 5.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.226 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 314' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' B' ' 299' ' ' ASP . . . -94.59 144.93 25.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.152 -0.968 . . . . 0.0 110.033 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 315' ' ' LEU . . . . . 0.835 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -132.31 139.72 48.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 109.564 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 316' ' ' PHE . . . . . 0.9 ' O ' HG11 ' A' ' 74' ' ' VAL . 47.9 p90 170.68 -158.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 317' ' ' GLY . . . . . 0.603 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 178.83 -175.7 47.51 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 318' ' ' GLU . . . . . 0.546 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 25.7 tt0 -73.36 -1.91 20.07 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.295 -1.121 . . . . 0.0 109.442 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -92.71 -29.62 15.97 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.24 -0.912 . . . . 0.0 108.983 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 320' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -88.89 16.01 7.57 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 321' ' ' ILE . . . . . 0.68 HG22 ' H ' ' B' ' 322' ' ' HIS . 5.1 mm -89.72 -165.07 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 322' ' ' HIS . . . . . 0.68 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.2 OUTLIER -151.9 161.27 42.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.94 -1.1 . . . . 0.0 109.67 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -155.37 113.47 3.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 109.361 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -120.8 152.87 16.75 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.263 -1.14 . . . . 0.0 109.479 179.931 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' NTH . . . . . 0.894 H221 ' CE2' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 326' ' ' NTH . . . . . 0.933 H221 ' CZ ' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.505 ' CE ' ' OE1' ' B' ' 318' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.24 0.543 . . . . 0.0 110.221 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 3' ' ' THR . 8.2 t-20 -120.57 125.71 48.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 0.0 109.43 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 3' ' ' THR . 1.8 t -44.26 106.7 0.54 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.875 . . . . 0.0 109.351 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 44.5 Cg_endo -71.2 -3.82 13.68 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.891 1.469 . . . . 0.0 110.379 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -72.8 -25.58 61.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.912 . . . . 0.0 109.224 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.47 -59.31 2.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -51.47 -21.39 2.37 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.118 -0.989 . . . . 0.0 109.722 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 11' ' ' VAL . 14.3 m -74.66 -39.81 61.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.222 -0.924 . . . . 0.0 109.099 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.89 -42.76 48.68 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.779 ' HA ' HD21 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -53.82 -23.95 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.801 HG11 ' CG2' ' A' ' 71' ' ' VAL . 10.1 t -89.94 -43.06 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.349 -0.844 . . . . 0.0 109.066 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 13' ' ' ARG . 24.6 tt0 -61.82 -73.52 0.1 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.281 1.039 . . . . 0.0 108.284 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.745 ' HD3' HD13 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -42.45 -44.29 3.97 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 1.068 ' CE1' HD11 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -51.27 -48.45 62.2 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.917 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -82.24 -44.24 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.382 -0.824 . . . . 0.0 109.375 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -47.57 -37.99 13.45 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.51 ' HA ' ' HB3' ' A' ' 22' ' ' ASP . . . -72.84 -36.04 67.38 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.068 HD11 ' CE1' ' A' ' 14' ' ' TYR . 2.9 mt -61.0 -59.82 4.77 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -53.49 -42.67 67.54 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.48 0.657 . . . . 0.0 109.762 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.19 5.54 44.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.82 . . . . 0.0 110.006 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.898 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 54.76 46.11 76.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.51 ' HB3' ' HA ' ' A' ' 17' ' ' ALA . 15.6 t0 -104.74 58.35 0.7 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -1.068 . . . . 0.0 109.945 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.028 HD11 ' HB3' ' A' ' 55' ' ' PHE . 6.0 tp -52.86 -45.84 67.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.131 -0.981 . . . . 0.0 108.921 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -46.74 -42.99 17.68 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -75.17 -29.57 60.22 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.001 HD12 HD12 ' A' ' 23' ' ' LEU . 32.5 mt -63.66 -59.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 30' ' ' PHE . 92.9 t -49.45 -35.7 9.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -60.04 -40.83 90.73 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.779 HD21 ' HA ' ' A' ' 10' ' ' VAL . 1.9 tp -75.39 -20.15 59.12 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.471 ' HB2' ' HA ' ' A' ' 27' ' ' VAL . 4.9 m-85 -95.99 141.86 28.89 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.532 -0.73 . . . . 0.0 109.642 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -49.0 177.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.927 . . . . 0.0 109.457 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.63 -24.12 63.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.24 -0.912 . . . . 0.0 109.826 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.529 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 4.9 p-10 -144.83 52.33 1.23 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.972 ' O ' HD11 ' A' ' 51' ' ' ILE . . . -59.38 165.02 2.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.443 -0.786 . . . . 0.0 110.194 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.595 HG23 ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -115.75 140.94 48.73 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 37' ' ' GLU . 25.0 t -128.51 170.29 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 109.654 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.585 ' N ' HG12 ' A' ' 36' ' ' VAL . 5.0 mt-10 -141.27 113.3 7.89 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.583 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 6.0 t70 -168.37 139.95 2.26 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.759 -1.213 . . . . 0.0 109.957 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' ASP . 43.8 Cg_endo -74.95 -78.27 0.0 OUTLIER 'Cis proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.441 -1.9 . . . . 0.0 111.608 0.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 39' ' ' PRO . 1.3 m -153.3 66.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.876 -1.14 . . . . 0.0 109.331 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . -173.05 46.99 0.16 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER 72.97 51.14 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -1.132 . . . . 0.0 110.077 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.543 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 2.3 mt-10 -132.92 58.66 37.2 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.056 -1.027 . . . . 0.0 109.742 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 43' ' ' GLU . 50.7 Cg_endo -79.99 -179.29 5.16 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 124.066 1.561 . . . . 0.0 111.284 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.59 ' HG3' ' CD1' ' A' ' 54' ' ' PHE . 23.2 mmt180 -150.88 96.16 2.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.595 ' HB3' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -92.81 158.35 15.93 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.19 -0.944 . . . . 0.0 110.285 -178.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 33' ' ' ASP . . . 88.95 -169.93 37.26 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -103.13 -51.85 3.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.076 -1.249 . . . . 0.0 108.842 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -52.05 -23.49 5.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.312 -0.867 . . . . 0.0 109.15 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 46' ' ' SER . . . -90.32 -55.28 3.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.388 -0.82 . . . . 0.0 109.607 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.972 HD11 ' O ' ' A' ' 34' ' ' ALA . 59.7 mt -54.08 -43.41 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 109.132 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.802 ' HG3' HD23 ' A' ' 23' ' ' LEU . 16.2 ttt180 -70.28 -47.91 59.12 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.193 -0.942 . . . . 0.0 108.784 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 5.4 mt-10 -51.12 -34.19 29.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.038 . . . . 0.0 108.44 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.59 ' CD1' ' HG3' ' A' ' 45' ' ' ARG . 1.4 t80 -82.93 -70.5 0.55 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 1.028 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -44.63 -26.76 0.41 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -75.03 -53.22 9.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 108.993 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 56' ' ' ALA . 14.1 t-20 -45.66 -34.6 3.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 108.609 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.772 ' HB2' ' H11' ' A' ' 126' ' ' NTH . 5.8 t -71.87 -33.56 68.49 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.898 HD21 ' CA ' ' A' ' 21' ' ' GLY . 5.3 tp -77.21 -33.87 56.16 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.326 -0.859 . . . . 0.0 109.329 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -61.94 -26.97 68.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 109.443 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.574 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -89.43 131.87 38.97 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 0.0 108.681 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 86' ' ' PHE . 41.6 Cg_endo -68.04 80.64 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.755 1.398 . . . . 0.0 110.501 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.978 HD22 ' CG1' ' A' ' 84' ' ' VAL . 3.2 mt -111.22 146.55 36.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.435 -0.79 . . . . 0.0 109.605 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.635 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -91.91 126.75 37.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 108.647 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 18' ' ' LEU . 2.7 t -113.45 118.13 57.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.673 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 67' ' ' LEU . 27.1 tt0 -150.16 104.54 3.28 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.337 -0.852 . . . . 0.0 109.169 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.5 mp -45.59 171.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.222 -0.924 . . . . 0.0 109.847 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -144.38 -82.27 0.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.403 -0.811 . . . . 0.0 109.01 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 2.9 pt20 -60.08 -146.06 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 61.5 tt0 -114.84 130.37 56.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.066 -1.021 . . . . 0.0 109.761 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.91 HG13 ' HB3' ' A' ' 80' ' ' PHE . 88.7 t -60.0 145.03 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.292 -0.88 . . . . 0.0 109.14 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.539 ' HD3' ' CD2' ' B' ' 315' ' ' LEU . 17.7 mtt180 -111.72 130.04 55.92 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.396 -0.921 . . . . 0.0 109.931 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.52 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -139.74 157.7 45.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.868 HG11 HG21 ' B' ' 240' ' ' VAL . 0.5 OUTLIER -157.22 -153.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 110.312 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.557 ' CB ' ' HA3' ' B' ' 241' ' ' GLY . . . -33.91 -96.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 120.926 0.393 . . . . 0.0 111.161 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 103' ' ' PHE . 65.4 m-20 -114.37 26.96 9.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.948 -1.095 . . . . 0.0 110.496 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.572 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.4 OUTLIER -137.55 -160.98 1.11 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.026 -1.046 . . . . 0.0 109.388 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.9 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 171.28 143.48 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.476 -0.765 . . . . 0.0 109.861 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.854 ' CB ' HD11 ' B' ' 315' ' ' LEU . . . -132.62 130.46 40.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 108.786 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.91 ' HB3' HG13 ' A' ' 71' ' ' VAL . 2.1 p90 -150.6 156.06 40.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.759 -1.213 . . . . 0.0 109.989 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.093 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -133.32 156.49 47.51 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.611 0.719 . . . . 0.0 110.33 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 99' ' ' ASP . 3.7 p90 -149.46 -171.06 3.8 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.87 140.09 52.83 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.076 -1.015 . . . . 0.0 109.972 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.978 ' CG1' HD22 ' A' ' 63' ' ' LEU . 38.3 t -116.76 115.2 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.726 ' HB3' HG23 ' A' ' 94' ' ' VAL . 78.2 p -126.67 99.73 5.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.086 -1.009 . . . . 0.0 110.334 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.696 ' CE1' H221 ' A' ' 126' ' ' NTH . 52.8 p90 -93.36 -164.22 1.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.204 -0.935 . . . . 0.0 108.629 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -144.19 152.06 40.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.022 -1.049 . . . . 0.0 110.086 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.409 ' CZ ' ' HE2' ' A' ' 86' ' ' PHE . 4.2 m-85 -107.21 -173.35 2.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.403 -0.811 . . . . 0.0 109.39 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -49.19 -54.6 15.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.358 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -138.04 4.61 3.23 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -105.86 -177.4 3.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 109.515 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -145.49 118.98 9.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.297 -0.877 . . . . 0.0 109.752 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -120.26 143.35 48.36 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.389 -0.82 . . . . 0.0 109.417 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 85' ' ' SER . 13.3 p -126.23 169.52 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.22 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.851 HG22 HG23 ' A' ' 121' ' ' ILE . 53.1 t -140.63 152.11 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.765 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.442 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . -129.56 71.63 82.06 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 109.222 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.629 ' HD3' HG12 ' A' ' 95' ' ' VAL . 48.7 Cg_endo -97.34 -178.6 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.726 1.617 . . . . 0.0 111.578 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.093 HG23 ' HB2' ' A' ' 81' ' ' ALA . 3.1 mp -138.6 169.4 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 23.4 t0 -135.76 154.79 51.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.907 -1.121 . . . . 0.0 110.041 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.522 ' CB ' ' HB3' ' A' ' 113' ' ' ARG . 0.2 OUTLIER -114.08 175.23 5.56 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.9 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -150.42 152.4 34.26 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.999 -1.063 . . . . 0.0 110.823 -178.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.497 ' HD2' ' HB2' ' A' ' 111' ' ' SER . 0.0 OUTLIER -142.25 108.31 5.2 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.662 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -89.24 -177.53 5.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 109.598 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.782 HD21 ' HB3' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -149.75 -176.09 5.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.339 -0.851 . . . . 0.0 109.698 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.88 76.78 1.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.782 ' HB3' HD21 ' A' ' 104' ' ' ASN . . . -172.34 -75.15 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.22 -1.164 . . . . 0.0 109.58 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 157.66 -20.6 0.38 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.49 -164.31 1.03 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -1.174 . . . . 0.0 109.587 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.583 HG23 HG22 ' A' ' 10' ' ' VAL . 60.9 t -109.43 148.97 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.897 . . . . 0.0 109.176 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 104' ' ' ASN . 96.9 t -125.93 -61.75 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.055 -1.028 . . . . 0.0 109.678 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.497 ' HB2' ' HD2' ' A' ' 102' ' ' ARG . 1.5 m -112.29 161.6 16.44 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.876 -1.14 . . . . 0.0 109.738 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 100' ' ' HIS . 15.2 ttp -158.97 155.89 28.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 109.448 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.522 ' HB3' ' CB ' ' A' ' 100' ' ' HIS . 30.8 ttm180 -140.34 168.2 20.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.87 . . . . 0.0 108.946 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.505 ' N ' ' CG ' ' A' ' 113' ' ' ARG . . . -144.58 130.86 19.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.976 -1.077 . . . . 0.0 109.682 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.766 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.3 OUTLIER -111.84 132.48 54.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 109.723 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.998 ' O ' HG11 ' B' ' 274' ' ' VAL . 9.0 p90 167.7 -158.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.537 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 164.35 -163.93 36.4 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.508 ' HA ' HG13 ' A' ' 121' ' ' ILE . 4.3 tt0 -73.88 -2.35 23.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -1.185 . . . . 0.0 109.261 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -92.57 -29.44 16.16 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.954 0.883 . . . . 0.0 109.057 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 96' ' ' ALA . 1.5 m-20 -89.04 10.73 20.57 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.332 0.587 . . . . 0.0 109.476 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.851 HG23 HG22 ' A' ' 95' ' ' VAL . 4.3 mm -94.23 -167.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.331 -0.856 . . . . 0.0 108.738 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.681 ' H ' HG22 ' A' ' 121' ' ' ILE . 1.6 t60 -151.21 153.8 35.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.098 -1.001 . . . . 0.0 109.609 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.01 89.13 1.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -91.81 139.67 14.83 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.262 -1.14 . . . . 0.0 109.449 -179.973 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.5 ptt? . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.182 0.515 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.441 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 1.4 t-20 175.48 171.24 0.32 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.668 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . 0.431 HG22 ' HB2' ' B' ' 205' ' ' GLU . 2.5 m -59.34 110.03 2.39 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.331 -0.856 . . . . 0.0 109.53 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.8 Cg_endo -73.63 -7.15 19.82 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.994 1.523 . . . . 0.0 110.074 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' B' ' 203' ' ' THR . 2.0 mt-10 -68.57 -45.21 72.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.329 -0.857 . . . . 0.0 109.191 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.56 -52.42 63.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.214 -0.929 . . . . 0.0 109.107 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . 0.609 ' HA ' ' CZ ' ' B' ' 303' ' ' PHE . 74.9 mtm -62.06 -42.35 99.1 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.334 -0.854 . . . . 0.0 109.498 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 9.6 m -56.1 -37.15 68.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.171 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.42 -46.23 66.28 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.818 ' HA ' HD21 ' B' ' 229' ' ' LEU . 2.5 t -53.24 -30.38 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.723 HG11 ' CG2' ' B' ' 271' ' ' VAL . 21.0 t -84.47 -43.52 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.225 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.4 tt0 -61.71 -73.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.088 0.947 . . . . 0.0 108.624 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 1.014 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.0 OUTLIER -41.4 -45.18 3.04 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' TYR . . . . . 0.696 ' CE1' HD11 ' B' ' 218' ' ' LEU . 1.6 t80 -45.41 -45.45 12.77 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.973 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.1 t -90.51 -40.35 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . 0.708 ' HB3' ' HA ' ' B' ' 213' ' ' ARG . . . -49.21 -37.58 23.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.623 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -73.05 -31.64 64.54 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.973 HD12 ' HA ' ' B' ' 215' ' ' VAL . 5.5 mt -66.91 -59.89 3.12 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' B' ' 265' ' ' VAL . 0.7 OUTLIER -55.59 -37.56 68.25 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.564 0.697 . . . . 0.0 109.534 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -88.59 -6.1 57.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 109.624 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.926 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 55.41 47.52 75.4 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' B' ' 224' ' ' ASP . 16.5 t70 -114.32 77.04 1.03 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -1.092 . . . . 0.0 109.753 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' LEU . . . . . 1.055 HD13 HD12 ' B' ' 226' ' ' ILE . 1.4 mm? -46.75 -27.2 1.12 Allowed 'General case' 0 C--N 1.307 -1.239 0 O-C-N 121.138 -0.977 . . . . 0.0 109.561 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.436 ' HB3' ' OD2' ' B' ' 222' ' ' ASP . 16.4 t0 -60.01 -50.03 75.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.325 -0.86 . . . . 0.0 109.596 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -66.64 -29.28 74.5 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 1.055 HD12 HD13 ' B' ' 223' ' ' LEU . 11.4 mt -66.19 -60.65 2.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.443 -1.034 . . . . 0.0 108.35 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.555 HG21 ' HB2' ' B' ' 252' ' ' ARG . 38.9 t -58.14 -42.31 82.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -53.25 -51.35 62.48 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 1.014 HD22 ' HB3' ' B' ' 213' ' ' ARG . 8.7 tp -64.23 -19.55 65.44 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . 0.686 ' CD2' HG21 ' B' ' 251' ' ' ILE . 5.9 m-85 -93.04 145.94 24.01 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.429 -0.794 . . . . 0.0 109.93 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -57.63 -163.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 109.406 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' B' ' 248' ' ' THR . 0.3 OUTLIER -77.76 -24.26 49.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.558 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 3.2 p30 -150.4 45.06 0.88 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.578 -0.701 . . . . 0.0 109.481 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.851 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -54.71 175.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 109.518 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' THR . . . . . 0.864 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -129.07 137.93 51.56 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.26 -0.9 . . . . 0.0 110.233 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.513 HG22 ' CE ' ' B' ' 312' ' ' MET . 7.0 t -124.32 119.72 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 0.0 OUTLIER -88.52 111.22 21.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' ASP . . . . . 0.672 ' OD2' ' H62' ' B' ' 326' ' ' NTH . 30.6 t70 -179.93 143.23 0.36 Allowed Pre-proline 0 C--N 1.301 -1.511 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.561 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' B' ' 242' ' ' SER . 48.9 Cg_endo -73.96 172.79 59.73 Favored 'Cis proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.214 -1.994 . . . . 0.0 110.782 -0.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.868 HG21 HG11 ' A' ' 74' ' ' VAL . 3.3 m -57.92 146.7 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 109.037 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 75' ' ' ALA . . . 68.39 7.58 52.94 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' SER . . . . . 0.506 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -111.66 -153.77 0.53 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -1.121 . . . . 0.0 109.235 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -122.99 130.88 24.43 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.039 -1.038 . . . . 0.0 110.169 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' PRO . . . . . 0.604 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.4 Cg_endo -63.4 -165.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.138 1.599 . . . . 0.0 111.334 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.761 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -151.74 146.15 25.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.864 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.3 OUTLIER -136.98 138.67 40.79 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.931 -1.105 . . . . 0.0 110.865 -178.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . 0.558 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 122.88 146.58 7.19 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' THR . . . . . 0.501 ' N ' ' O ' ' B' ' 232' ' ' ASP . 3.1 m -57.85 -70.21 0.14 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.406 -1.055 . . . . 0.0 109.553 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' B' ' 248' ' ' THR . . . -45.36 -25.68 0.43 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 109.173 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.761 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -84.21 -57.51 3.14 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.366 -0.834 . . . . 0.0 109.55 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.851 HD11 ' N ' ' B' ' 234' ' ' ALA . 45.0 mt -44.82 -36.94 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -0.981 . . . . 0.0 108.944 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' ARG . . . . . 0.555 ' HB2' HG21 ' B' ' 227' ' ' VAL . 5.5 ttp180 -76.76 -52.73 9.03 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.506 -0.746 . . . . 0.0 109.14 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -50.9 -32.26 20.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 108.831 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.503 ' HB2' ' HD3' ' B' ' 245' ' ' ARG . 1.0 OUTLIER -82.62 -71.14 0.5 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 1.004 ' CG ' HG21 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -46.96 -26.03 0.92 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . 0.529 ' HA ' HD21 ' B' ' 223' ' ' LEU . . . -74.33 -51.33 15.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 108.614 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -46.94 -32.2 3.68 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' SER . . . . . 0.798 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 35.2 t -69.5 -37.89 77.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.1 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 0.926 HD21 ' CA ' ' B' ' 221' ' ' GLY . 7.3 tp -71.64 -32.3 67.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.526 -0.734 . . . . 0.0 109.888 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -47.27 -25.98 1.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.184 -0.947 . . . . 0.0 109.284 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' LEU . . . . . 0.794 HD22 HD21 ' B' ' 263' ' ' LEU . 0.3 OUTLIER -96.52 120.42 62.22 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 109.101 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' PRO . . . . . 0.448 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 46.7 Cg_endo -72.42 108.59 2.55 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.743 1.391 . . . . 0.0 110.728 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.794 HD21 HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -137.97 163.4 31.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.193 -0.942 . . . . 0.0 109.719 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' B' ' 284' ' ' VAL . . . -92.25 130.23 38.01 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . 0.527 ' O ' ' ND2' ' B' ' 219' ' ' ASN . 2.0 t -117.66 117.58 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 110.104 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 266' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' B' ' 267' ' ' LEU . 29.8 tt0 -150.22 108.82 3.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.17 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.546 HD23 ' O ' ' B' ' 281' ' ' ALA . 0.6 OUTLIER -48.68 178.42 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.258 -0.901 . . . . 0.0 109.849 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 268' ' ' THR . . . . . 0.465 ' O ' ' O ' ' B' ' 269' ' ' GLN . 29.6 p -143.56 -82.71 0.17 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.84 . . . . 0.0 109.291 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 269' ' ' GLN . . . . . 0.509 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 12.0 pt20 -60.36 -144.41 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 38.7 tt0 -114.54 134.08 55.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 109.833 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . 0.723 ' CG2' HG11 ' B' ' 211' ' ' VAL . 41.6 t -62.09 158.69 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.374 -0.829 . . . . 0.0 109.153 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.511 ' O ' ' HB1' ' B' ' 278' ' ' ALA . 0.0 OUTLIER -122.82 135.32 54.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.025 -1.047 . . . . 0.0 110.262 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.19 128.45 12.05 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 274' ' ' VAL . . . . . 0.998 HG11 ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -137.81 152.7 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.902 -1.124 . . . . 0.0 110.557 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . 37.72 -96.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.881 -0.512 . . . . 0.0 110.524 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 276' ' ' ASN . . . . . 0.588 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 2.9 p-10 -124.97 -10.95 7.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.082 -1.011 . . . . 0.0 109.97 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . 0.472 ' HG3' ' HA ' ' B' ' 302' ' ' ARG . 1.0 OUTLIER -99.7 -163.57 1.04 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.834 -1.166 . . . . 0.0 109.199 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 278' ' ' ALA . . . . . 0.551 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . 179.68 166.86 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 110.047 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 279' ' ' ALA . . . . . 0.766 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -150.07 132.93 16.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . 0.625 ' CD1' HG22 ' B' ' 211' ' ' VAL . 21.9 p90 -150.25 170.44 18.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.624 -1.298 . . . . 0.0 110.315 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.968 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -145.27 -175.27 4.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.634 -0.666 . . . . 0.0 109.625 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 282' ' ' PHE . . . . . 0.509 ' CE1' ' CE2' ' B' ' 280' ' ' PHE . 8.1 p90 -179.14 -173.86 0.3 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.327 -0.858 . . . . 0.0 109.333 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.81 153.83 50.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.442 -0.786 . . . . 0.0 109.733 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 284' ' ' VAL . . . . . 0.718 HG13 ' CB ' ' B' ' 263' ' ' LEU . 3.7 t -142.6 119.28 6.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.373 -0.829 . . . . 0.0 109.102 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 285' ' ' SER . . . . . 0.552 ' HB3' HG23 ' B' ' 294' ' ' VAL . 0.1 OUTLIER -117.85 100.46 7.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.155 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.678 ' CD1' HD23 ' B' ' 263' ' ' LEU . 37.1 p90 -110.53 164.34 12.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.172 -0.955 . . . . 0.0 109.712 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 287' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' B' ' 288' ' ' PHE . 2.8 tm-20 -132.8 169.66 16.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.0 OUTLIER -118.23 -78.13 0.58 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.928 . . . . 0.0 109.88 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.22 10.48 1.29 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.388 -0.82 . . . . 0.0 110.046 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 290' ' ' GLY . . . . . 0.461 ' N ' ' OE2' ' B' ' 287' ' ' GLU . . . -178.34 -71.54 0.06 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 291' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' B' ' 287' ' ' GLU . 0.3 OUTLIER -73.72 151.59 40.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.238 -1.154 . . . . 0.0 109.06 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 292' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' B' ' 324' ' ' GLY . 0.0 OUTLIER -128.09 120.02 26.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.062 -1.024 . . . . 0.0 110.066 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 293' ' ' THR . . . . . 0.6 HG21 ' HB2' ' B' ' 322' ' ' HIS . 0.6 OUTLIER -97.25 -167.17 1.5 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 294' ' ' VAL . . . . . 0.718 HG22 ' H ' ' B' ' 295' ' ' VAL . 1.7 p -153.61 -169.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.719 -1.238 . . . . 0.0 109.579 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 1.003 HG12 ' HD3' ' B' ' 297' ' ' PRO . 6.7 t -154.87 141.05 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.809 -1.182 . . . . 0.0 109.184 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 296' ' ' ALA . . . . . . . . . . . . . . . -141.25 69.87 27.49 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.091 -1.005 . . . . 0.0 109.779 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 297' ' ' PRO . . . . . 1.003 ' HD3' HG12 ' B' ' 295' ' ' VAL . 52.1 Cg_endo -98.7 169.27 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.869 1.713 . . . . 0.0 112.454 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.968 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.5 mp -136.56 135.42 49.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . 0.612 ' HB3' ' CE1' ' B' ' 280' ' ' PHE . 3.9 t0 -112.33 156.68 22.06 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.782 -1.199 . . . . 0.0 111.054 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.533 ' O ' ' HG2' ' B' ' 312' ' ' MET . 71.6 t60 -108.62 171.59 7.33 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 301' ' ' PHE . . . . . 0.646 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.49 145.61 29.2 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.461 -1.399 . . . . 0.0 111.131 -178.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' B' ' 311' ' ' SER . 8.7 ttt85 -141.16 120.24 12.85 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 303' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' B' ' 207' ' ' MET . 2.7 m-85 -90.88 -175.41 4.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.108 -0.995 . . . . 0.0 109.879 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 304' ' ' ASN . . . . . 0.638 ' HB3' HG21 ' B' ' 310' ' ' VAL . 0.6 OUTLIER -114.23 -44.32 3.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 109.291 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 305' ' ' GLY . . . . . 0.687 ' O ' ' HB3' ' B' ' 306' ' ' ALA . . . -178.02 40.75 0.09 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 306' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' B' ' 305' ' ' GLY . . . 77.02 66.11 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -1.09 . . . . 0.0 109.625 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -159.6 -65.16 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.92 -166.25 2.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -1.14 . . . . 0.0 109.338 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 309' ' ' VAL . . . . . 0.754 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 42.5 t -90.0 157.3 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.138 -0.976 . . . . 0.0 109.115 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' B' ' 304' ' ' ASN . 0.7 OUTLIER -133.22 -38.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 109.779 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 68.6 m -143.67 163.51 33.04 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.088 -1.008 . . . . 0.0 109.319 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 312' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 300' ' ' HIS . 2.1 ttp -157.08 167.66 29.76 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.279 -0.888 . . . . 0.0 109.936 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 313' ' ' ARG . . . . . 0.519 ' HA ' ' HB2' ' B' ' 237' ' ' GLU . 5.2 mmt180 -146.83 151.81 37.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.406 -0.808 . . . . 0.0 108.972 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -113.38 147.39 37.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 110.1 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 315' ' ' LEU . . . . . 0.854 HD11 ' CB ' ' A' ' 79' ' ' ALA . 3.1 tp -110.22 -143.01 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.729 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 316' ' ' PHE . . . . . 0.693 ' HZ ' ' H61' ' B' ' 326' ' ' NTH . 42.4 p90 44.84 -165.35 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.713 . . . . 0.0 110.029 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 317' ' ' GLY . . . . . 0.59 ' HA2' HG21 ' B' ' 240' ' ' VAL . . . -163.66 -161.08 12.29 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 318' ' ' GLU . . . . . 0.522 ' HA ' HG12 ' B' ' 321' ' ' ILE . 7.2 tt0 -79.26 5.07 13.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -1.169 . . . . 0.0 109.606 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.6 -34.81 13.17 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.185 -0.947 . . . . 0.0 109.5 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 320' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -101.05 32.12 3.35 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 321' ' ' ILE . . . . . 0.642 HG22 ' N ' ' B' ' 322' ' ' HIS . 19.6 mm -94.96 -116.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.738 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 322' ' ' HIS . . . . . 0.642 ' N ' HG22 ' B' ' 321' ' ' ILE . 5.8 p-80 -88.22 101.61 14.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.719 . . . . 0.0 112.5 -176.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -156.28 115.25 3.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.503 -0.748 . . . . 0.0 109.488 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' B' ' 292' ' ' LYS . . . 179.69 139.45 3.72 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.191 -1.182 . . . . 0.0 109.497 -179.984 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' NTH . . . . . 0.772 ' H11' ' HB2' ' A' ' 58' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 326' ' ' NTH . . . . . 0.798 ' H11' ' OG ' ' B' ' 258' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.313 0.578 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.539 ' HB3' ' CE ' ' A' ' 7' ' ' MET . 7.9 m120 -108.71 148.14 30.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.504 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.58 107.99 0.98 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.668 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 44.9 Cg_endo -71.85 -9.63 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.968 1.51 . . . . 0.0 110.038 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.64 -48.85 75.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.386 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -54.39 36.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.235 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.539 ' CE ' ' HB3' ' A' ' 2' ' ' ASN . 22.3 mtt -60.97 -31.0 70.59 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.176 -0.952 . . . . 0.0 109.294 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 11' ' ' VAL . 6.9 m -69.27 -36.65 77.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.12 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.06 -43.04 50.95 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.987 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.5 t -56.73 -22.67 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.847 HG22 ' CE2' ' A' ' 101' ' ' PHE . 15.9 t -90.35 -43.24 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.38 -0.825 . . . . 0.0 109.02 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 15' ' ' VAL . 6.6 tt0 -61.73 -74.0 0.09 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -42.77 -45.16 4.7 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.6 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -49.36 -44.7 45.0 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.919 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -87.65 -37.86 11.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.367 -0.833 . . . . 0.0 109.052 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.444 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -49.05 -37.55 21.31 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -72.7 -32.01 65.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.919 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.2 mt -67.23 -58.58 4.58 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 65' ' ' VAL . 4.4 t-20 -50.86 -42.56 58.88 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.481 0.657 . . . . 0.0 109.435 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.27 -2.58 58.52 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 109.573 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.891 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 56.73 47.77 82.81 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' OD1' ' CB ' ' A' ' 24' ' ' ASP . 6.9 t0 -112.08 82.23 1.59 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.204 -1.174 . . . . 0.0 109.909 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.019 ' CD2' HD22 ' A' ' 59' ' ' LEU . 3.2 mm? -48.96 -22.54 0.87 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.216 -0.928 . . . . 0.0 109.616 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' CB ' ' OD1' ' A' ' 22' ' ' ASP . 19.3 t0 -58.26 -49.83 75.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.837 . . . . 0.0 109.393 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.79 -43.07 92.57 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.722 HD12 HD13 ' A' ' 23' ' ' LEU . 9.7 mt -56.19 -52.84 46.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 23' ' ' LEU . 7.1 t -65.68 -47.44 86.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.49 -46.81 57.22 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 10' ' ' VAL . 7.8 tp -68.66 -21.37 64.45 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.763 ' CD2' HG21 ' A' ' 51' ' ' ILE . 3.1 m-85 -82.78 139.17 33.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.538 -0.726 . . . . 0.0 109.651 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' VAL . . . -60.49 -169.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.456 ' C ' ' HG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -70.94 -23.69 62.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.377 -0.827 . . . . 0.0 109.788 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.53 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -148.95 49.96 0.98 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.653 -0.655 . . . . 0.0 109.476 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -58.86 167.55 1.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.543 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -126.32 138.07 53.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.632 ' CG2' HD12 ' A' ' 51' ' ' ILE . 23.6 t -129.0 167.68 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.064 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.572 ' N ' HG12 ' A' ' 36' ' ' VAL . 3.0 mt-10 -143.74 118.07 9.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 108.936 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.608 ' OD2' ' HB3' ' A' ' 114' ' ' ALA . 4.1 t70 -174.94 139.7 0.63 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 109.594 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 41' ' ' GLY . 45.3 Cg_endo -71.81 -174.3 11.37 Favored 'Cis proline' 0 N--CA 1.489 1.259 0 C-N-CA 122.15 -2.021 . . . . 0.0 110.649 0.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.826 HG21 ' HB ' ' B' ' 274' ' ' VAL . 15.4 m -67.02 59.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 109.625 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 39' ' ' PRO . . . -140.42 -83.56 0.09 OUTLIER Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.422 ' C ' ' HG2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -165.5 50.92 0.1 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.641 -0.917 . . . . 0.0 109.708 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.556 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 2.4 mm-40 -134.7 58.6 29.86 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.114 -0.991 . . . . 0.0 109.678 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.528 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 48.5 Cg_endo -79.29 -177.74 4.11 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.204 1.633 . . . . 0.0 110.394 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 1.006 ' HG3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -150.39 102.44 3.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 108.96 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -92.25 149.34 21.51 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.146 -0.971 . . . . 0.0 110.203 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 98.67 168.22 31.06 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.459 HG23 ' CG1' ' A' ' 27' ' ' VAL . 3.7 m -80.88 -57.06 3.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -1.114 . . . . 0.0 109.093 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.87 -30.53 46.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.139 -0.976 . . . . 0.0 109.118 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.006 ' HB1' ' HG3' ' A' ' 45' ' ' ARG . . . -78.75 -53.43 7.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.431 -0.793 . . . . 0.0 109.094 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.763 HG21 ' CD2' ' A' ' 30' ' ' PHE . 6.5 mm -50.36 -36.07 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.392 -0.818 . . . . 0.0 109.294 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.721 ' HG3' HG21 ' A' ' 27' ' ' VAL . 7.6 ttp180 -74.58 -59.94 2.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 109.083 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 52' ' ' ARG . 2.0 tt0 -44.32 -27.4 0.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 108.825 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.576 ' CD1' ' HD3' ' A' ' 45' ' ' ARG . 0.6 OUTLIER -85.66 -70.08 0.62 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.709 ' C ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -53.05 -18.69 2.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.821 -0.549 . . . . 0.0 109.764 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.535 ' CB ' ' HG ' ' A' ' 23' ' ' LEU . . . -86.06 -35.78 20.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.957 . . . . 0.0 108.7 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 60' ' ' LYS . 4.3 t30 -69.06 -39.7 78.96 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.6 ' OG ' ' H10' ' A' ' 126' ' ' NTH . 3.4 t -63.93 -33.81 76.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 0.0 108.821 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.019 HD22 ' CD2' ' A' ' 23' ' ' LEU . 8.5 tp -63.75 -20.63 65.9 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.39 -0.819 . . . . 0.0 109.645 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -53.43 -20.97 5.25 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.079 -1.013 . . . . 0.0 108.914 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.14 HD22 HD21 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.8 113.73 58.03 Favored Pre-proline 0 N--CA 1.486 1.34 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 43.8 Cg_endo -70.56 106.14 1.75 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.791 1.416 . . . . 0.0 111.149 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.14 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.65 160.23 39.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.897 . . . . 0.0 109.718 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.28 127.87 36.27 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.766 HG21 ' HB3' ' A' ' 18' ' ' LEU . 17.6 t -105.96 114.13 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.136 -0.977 . . . . 0.0 109.916 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 67' ' ' LEU . 28.2 tt0 -150.47 98.51 2.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.25 -0.906 . . . . 0.0 109.041 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -47.04 173.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.909 . . . . 0.0 109.507 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 69' ' ' GLN . 2.5 p -142.94 -81.86 0.19 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 109.375 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -58.43 -151.72 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.443 ' CD ' ' HE2' ' B' ' 319' ' ' LYS . 39.8 tt0 -108.94 131.67 54.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.102 -0.999 . . . . 0.0 109.761 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.039 HG13 ' HB3' ' A' ' 80' ' ' PHE . 54.1 t -58.41 147.56 6.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.375 -0.828 . . . . 0.0 109.21 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -104.01 132.61 50.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 109.673 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.75 141.15 36.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.773 ' CG1' HG21 ' B' ' 240' ' ' VAL . 0.2 OUTLIER -123.71 -157.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.899 . . . . 0.0 109.315 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -38.67 -93.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 110.22 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 3.4 m120 -104.63 -18.24 14.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -0.998 . . . . 0.0 109.79 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 4.4 mt-10 -90.35 -161.82 0.83 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.125 -0.984 . . . . 0.0 109.293 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.752 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 177.55 164.75 0.61 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.761 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 1.041 ' HB2' HD11 ' B' ' 315' ' ' LEU . . . -150.37 138.88 20.56 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 1.039 ' HB3' HG13 ' A' ' 71' ' ' VAL . 22.2 p90 -150.42 161.34 42.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.76 -1.213 . . . . 0.0 110.335 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.816 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -139.43 160.37 40.0 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.546 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 1.5 p90 -157.69 -176.68 6.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 0.0 109.558 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -118.24 143.03 46.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.452 -0.78 . . . . 0.0 109.284 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.808 HG12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -120.83 124.1 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.556 ' HA ' HG23 ' A' ' 94' ' ' VAL . 1.7 p -109.94 110.55 21.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 108.918 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.631 ' CZ ' H211 ' A' ' 126' ' ' NTH . 9.0 p90 -131.39 167.47 19.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.064 -1.022 . . . . 0.0 110.225 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.52 ' HB2' ' CB ' ' A' ' 92' ' ' LYS . 42.9 tt0 -148.73 167.35 25.78 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -146.77 -100.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.952 -1.093 . . . . 0.0 110.192 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.491 ' HG2' ' N ' ' A' ' 90' ' ' GLY . 1.0 OUTLIER -61.39 -25.4 67.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 110.005 -179.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.491 ' N ' ' HG2' ' A' ' 89' ' ' GLN . . . 168.36 -65.92 0.18 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.53 ' O ' ' CE1' ' A' ' 88' ' ' PHE . 1.6 ttm180 -55.77 118.46 4.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -1.115 . . . . 0.0 108.977 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.52 ' CB ' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -90.57 125.23 35.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.091 -1.006 . . . . 0.0 109.592 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.753 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -106.11 143.36 34.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.333 -0.855 . . . . 0.0 109.451 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.631 HG13 ' N ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER -108.31 178.07 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 1.022 HG12 ' HD3' ' A' ' 97' ' ' PRO . 3.5 t -150.87 144.78 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.029 -1.044 . . . . 0.0 110.038 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.472 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . -133.29 71.36 76.73 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.532 -0.73 . . . . 0.0 110.037 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 1.022 ' HD3' HG12 ' A' ' 95' ' ' VAL . 51.9 Cg_endo -95.56 -175.57 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.529 1.486 . . . . 0.0 110.986 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.816 HG23 ' HB2' ' A' ' 81' ' ' ALA . 3.0 mp -139.91 136.23 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.619 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 5.1 t0 -109.74 161.92 14.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.995 -1.065 . . . . 0.0 110.071 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.523 ' O ' ' CG ' ' A' ' 112' ' ' MET . 59.6 t-80 -109.47 171.23 7.56 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.847 ' CE2' HG22 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -146.23 145.28 30.35 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.952 -1.093 . . . . 0.0 110.544 -178.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.457 ' HA ' ' HG2' ' A' ' 77' ' ' GLU . 3.3 ttm180 -144.57 114.64 7.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.472 -0.768 . . . . 0.0 108.973 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.627 ' CE2' HG21 ' A' ' 10' ' ' VAL . 4.2 m-85 -94.97 -171.72 2.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.191 -0.943 . . . . 0.0 109.489 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.805 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.2 p30 -127.19 -34.12 2.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.446 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -161.38 24.3 0.24 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 105' ' ' GLY . . . 71.15 60.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -1.106 . . . . 0.0 109.515 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.19 -62.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -128.13 -164.7 1.4 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -1.134 . . . . 0.0 109.407 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' A' ' 30' ' ' PHE . 62.7 t -106.13 139.89 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.172 -0.955 . . . . 0.0 109.376 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.805 HG11 ' HB3' ' A' ' 104' ' ' ASN . 0.5 OUTLIER -123.27 -24.56 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -0.971 . . . . 0.0 109.833 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.79 156.32 37.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.986 . . . . 0.0 109.576 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.62 ' HE3' ' CE1' ' A' ' 30' ' ' PHE . 12.4 ttm -160.09 145.97 15.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.935 . . . . 0.0 109.671 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.473 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 7.7 mtt-85 -128.71 150.38 50.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 0.0 109.063 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.609 ' O ' HG12 ' A' ' 40' ' ' VAL . . . -118.49 150.87 38.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 0.0 109.693 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.8 OUTLIER -146.88 145.24 29.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.325 -0.859 . . . . 0.0 109.665 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.82 ' O ' HG11 ' B' ' 274' ' ' VAL . 33.9 p90 164.45 -163.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 121' ' ' ILE . . . -179.9 -169.26 39.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.516 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 21.7 tt0 -68.93 -6.65 28.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -1.076 . . . . 0.0 109.465 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -88.47 -29.8 19.88 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 122.016 0.913 . . . . 0.0 109.071 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -88.79 3.73 50.04 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.651 HG23 HG22 ' A' ' 95' ' ' VAL . 2.8 mm -91.41 -164.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.753 ' O ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -151.8 176.91 10.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.819 -1.176 . . . . 0.0 109.896 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.539 ' HA ' ' CG2' ' A' ' 93' ' ' THR . . . -155.43 136.02 13.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -0.804 . . . . 0.0 109.254 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 92' ' ' LYS . . . 76.73 -117.43 4.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.249 -1.148 . . . . 0.0 109.49 180.0 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 1.6 ttp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.234 0.54 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.447 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 21.7 t30 65.6 63.29 0.62 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 109.581 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . 0.539 HG23 ' O ' ' B' ' 203' ' ' THR . 2.1 t -43.61 103.29 0.31 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.933 . . . . 0.0 109.589 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 47.8 Cg_endo -74.11 -13.18 23.61 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.987 1.519 . . . . 0.0 110.348 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.9 -46.45 87.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.617 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -60.15 -52.41 65.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.086 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . 0.611 ' HB3' ' HB1' ' B' ' 273' ' ' ALA . 73.7 mtm -68.06 -18.36 64.66 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.421 -0.8 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.487 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 5.9 m -84.22 -33.78 24.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -57.96 -48.68 79.23 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.201 -0.937 . . . . 0.0 109.206 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.65 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -49.6 -32.58 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.935 . . . . 0.0 108.531 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.527 HG11 HG21 ' B' ' 271' ' ' VAL . 4.4 t -71.83 -39.83 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 109.419 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' B' ' 215' ' ' VAL . 16.2 tt0 -64.82 -74.54 0.1 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.815 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.4 OUTLIER -42.0 -44.14 3.41 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 122.031 0.919 . . . . 0.0 108.697 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' TYR . . . . . 0.634 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -49.46 -45.41 46.63 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 1.059 HG11 HD11 ' B' ' 267' ' ' LEU . 1.4 t -88.75 -37.36 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.3 -0.875 . . . . 0.0 109.127 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' B' ' 213' ' ' ARG . . . -48.82 -34.69 12.92 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.559 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -75.24 -33.91 61.36 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.906 HD12 ' HA ' ' B' ' 215' ' ' VAL . 2.2 mt -65.09 -58.53 5.81 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -48.36 -41.03 27.51 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.593 0.711 . . . . 0.0 109.182 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.45 4.42 49.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.71 . . . . 0.0 109.842 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.919 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 48.77 31.63 10.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -97.97 87.46 3.99 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.325 -1.103 . . . . 0.0 109.787 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' LEU . . . . . 0.986 ' CD2' HD22 ' B' ' 259' ' ' LEU . 3.7 mm? -51.9 -19.95 2.04 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.193 -0.942 . . . . 0.0 109.848 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -61.58 -54.06 48.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.256 -0.902 . . . . 0.0 109.264 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -61.05 -38.37 95.44 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.897 HD12 HD13 ' B' ' 223' ' ' LEU . 8.7 mt -61.32 -57.32 12.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.726 HG23 ' O ' ' B' ' 223' ' ' LEU . 24.7 t -60.7 -42.98 94.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.11 -50.17 67.48 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.815 HD22 ' HB3' ' B' ' 213' ' ' ARG . 8.2 tp -67.92 -22.87 65.04 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . 0.653 ' CD2' HG21 ' B' ' 251' ' ' ILE . 5.3 m-85 -88.41 136.58 32.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.572 -0.705 . . . . 0.0 109.915 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -52.21 -174.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 109.354 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -25.07 49.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.749 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.545 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 0.2 OUTLIER -135.32 44.99 2.52 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.654 ' HB1' ' O ' ' B' ' 310' ' ' VAL . . . -63.62 150.17 44.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.357 -0.839 . . . . 0.0 109.989 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' THR . . . . . 1.037 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -108.83 149.18 29.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.478 -0.764 . . . . 0.0 109.033 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 48.7 t -140.12 122.39 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 109.695 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.6 mt-10 -89.6 104.1 16.69 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' ASP . . . . . 0.546 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 22.7 t70 179.66 142.16 0.33 Allowed Pre-proline 0 C--N 1.301 -1.535 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.027 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.521 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 47.5 Cg_endo -72.71 176.34 40.68 Favored 'Cis proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.283 -1.965 . . . . 0.0 111.041 0.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.773 HG21 ' CG1' ' A' ' 74' ' ' VAL . 5.0 m -61.29 153.58 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 0.0 109.15 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 55.76 18.23 16.82 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' B' ' 239' ' ' PRO . 0.1 OUTLIER -118.05 -154.57 0.57 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.41 -1.053 . . . . 0.0 109.257 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -124.63 128.88 24.81 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 110.126 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' PRO . . . . . 0.539 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.3 Cg_endo -64.93 -174.11 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.934 1.492 . . . . 0.0 111.145 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.917 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.65 103.24 3.09 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 1.037 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.24 152.12 21.75 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.17 -0.956 . . . . 0.0 109.674 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' B' ' 233' ' ' ASP . . . 110.25 162.64 18.8 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 5.3 m -77.16 -36.57 55.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.184 -1.186 . . . . 0.0 109.129 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -73.79 -19.69 60.69 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 108.97 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.917 ' HB1' ' CG ' ' B' ' 245' ' ' ARG . . . -90.36 -45.07 9.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.401 -0.812 . . . . 0.0 109.306 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.653 HG21 ' CD2' ' B' ' 230' ' ' PHE . 10.3 mm -61.89 -50.48 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 0.0 109.521 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' ARG . . . . . 0.511 ' O ' ' CB ' ' B' ' 256' ' ' ALA . 21.0 ttp180 -66.34 -52.39 47.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.049 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' B' ' 257' ' ' ASN . 22.4 mt-10 -47.91 -32.48 6.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.966 -1.083 . . . . 0.0 108.448 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.546 ' CZ ' ' O ' ' B' ' 238' ' ' ASP . 0.6 OUTLIER -84.48 -70.81 0.55 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 0.698 ' CD2' HD13 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -49.64 -22.57 1.37 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.469 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . 0.608 ' HB2' ' HG ' ' B' ' 223' ' ' LEU . . . -84.35 -49.11 9.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 108.744 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' B' ' 253' ' ' GLU . 0.3 OUTLIER -57.38 -37.49 72.76 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.236 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' SER . . . . . 0.683 ' OG ' H111 ' B' ' 326' ' ' NTH . 7.6 t -65.57 -32.34 73.88 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 0.986 HD22 ' CD2' ' B' ' 223' ' ' LEU . 9.5 tp -64.68 -22.43 66.98 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.413 -0.804 . . . . 0.0 109.248 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . 0.502 ' O ' ' HD3' ' B' ' 262' ' ' PRO . 0.0 OUTLIER -50.75 -22.53 2.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.838 . . . . 0.0 108.9 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' LEU . . . . . 1.028 HD21 HD21 ' B' ' 263' ' ' LEU . 0.0 OUTLIER -98.89 103.68 20.84 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 51.5 Cg_endo -76.68 125.27 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.812 1.427 . . . . 0.0 112.11 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 1.028 HD21 HD21 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -145.59 176.68 9.43 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.53 125.08 36.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 26.1 t -111.48 115.38 49.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 109.979 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 266' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.2 tp10 -150.14 89.56 1.6 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.387 -0.821 . . . . 0.0 108.938 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 1.059 HD11 HG11 ' B' ' 215' ' ' VAL . 1.0 OUTLIER -52.84 -170.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.351 -0.843 . . . . 0.0 110.0 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 268' ' ' THR . . . . . 0.667 ' O ' ' N ' ' B' ' 270' ' ' GLU . 6.5 p -136.68 53.13 1.92 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.844 . . . . 0.0 108.819 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 269' ' ' GLN . . . . . 0.549 ' CG ' ' O ' ' B' ' 268' ' ' THR . 17.9 pt20 50.7 -55.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' B' ' 268' ' ' THR . 35.5 tt0 -48.89 115.26 1.2 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.492 -1.38 . . . . 0.0 110.213 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . 0.588 HG13 ' HB3' ' B' ' 280' ' ' PHE . 37.7 t -138.14 154.31 28.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 0.7 OUTLIER -114.66 130.21 56.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.857 -1.152 . . . . 0.0 110.003 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . 0.611 ' HB1' ' HB3' ' B' ' 207' ' ' MET . . . -150.47 133.21 15.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.396 -0.815 . . . . 0.0 109.001 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 274' ' ' VAL . . . . . 0.826 ' HB ' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -150.34 158.86 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.935 -1.103 . . . . 0.0 110.435 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 40' ' ' VAL . . . 39.26 -101.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.77 -0.581 . . . . 0.0 110.321 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 276' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 2.8 m120 -121.35 -20.47 6.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.957 -1.089 . . . . 0.0 109.691 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . 0.51 ' HG3' ' HG2' ' B' ' 302' ' ' ARG . 3.9 mt-10 -92.59 -164.95 1.25 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.042 -1.037 . . . . 0.0 109.5 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 278' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' B' ' 273' ' ' ALA . . . 177.77 154.69 0.32 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 109.519 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 279' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -136.79 141.17 42.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.187 -0.945 . . . . 0.0 108.66 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . 0.606 ' CZ ' ' HB3' ' B' ' 299' ' ' ASP . 37.9 p90 -150.72 171.15 17.61 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.735 -1.228 . . . . 0.0 110.028 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.53 ' HB2' ' CG1' ' B' ' 298' ' ' ILE . . . -145.68 -179.86 6.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.751 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 282' ' ' PHE . . . . . 0.406 ' CE1' ' HE2' ' B' ' 280' ' ' PHE . 7.0 p90 -174.32 -173.58 0.79 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.292 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 283' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -124.7 141.53 52.04 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.413 -0.805 . . . . 0.0 109.541 179.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 284' ' ' VAL . . . . . 1.0 HG11 HD22 ' B' ' 263' ' ' LEU . 42.1 t -120.04 113.87 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 109.469 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 1.2 p -106.14 131.75 53.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.033 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.891 ' CZ ' H212 ' B' ' 326' ' ' NTH . 1.0 OUTLIER -149.73 157.69 43.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.977 -1.077 . . . . 0.0 110.009 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 287' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' B' ' 292' ' ' LYS . 1.2 pt-20 -98.19 158.09 15.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 109.14 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.499 ' C ' ' CG ' ' B' ' 289' ' ' GLN . 0.6 OUTLIER -124.63 77.55 1.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.897 . . . . 0.0 109.594 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . 0.499 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 0.4 OUTLIER 40.36 57.36 2.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.424 -0.797 . . . . 0.0 110.262 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 107.63 -2.06 34.28 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.207 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -127.37 173.9 9.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.056 -1.261 . . . . 0.0 109.635 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 292' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' B' ' 287' ' ' GLU . 0.1 OUTLIER -138.17 140.1 39.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.384 179.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 293' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.94 148.59 34.01 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.715 -0.616 . . . . 0.0 109.464 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 294' ' ' VAL . . . . . 0.621 HG12 ' HB3' ' B' ' 322' ' ' HIS . 9.8 p -125.96 170.46 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.169 -0.957 . . . . 0.0 108.468 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 1.057 HG12 ' HD3' ' B' ' 297' ' ' PRO . 3.8 t -147.46 145.81 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.004 -1.06 . . . . 0.0 109.784 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 296' ' ' ALA . . . . . 0.471 ' O ' ' OD1' ' B' ' 320' ' ' ASN . . . -130.18 72.67 81.83 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.524 -0.735 . . . . 0.0 110.148 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 297' ' ' PRO . . . . . 1.057 ' HD3' HG12 ' B' ' 295' ' ' VAL . 50.7 Cg_endo -92.5 -175.42 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.757 1.398 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.53 ' CG1' ' HB2' ' B' ' 281' ' ' ALA . 3.2 mp -143.43 134.8 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . 0.606 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 11.3 t0 -108.42 162.89 13.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.951 -1.093 . . . . 0.0 110.317 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.527 ' O ' ' CG ' ' B' ' 312' ' ' MET . 59.9 t60 -112.58 172.71 6.76 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 301' ' ' PHE . . . . . 0.612 ' CZ ' ' CG1' ' B' ' 210' ' ' VAL . 0.1 OUTLIER -147.13 145.12 29.47 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.994 -1.066 . . . . 0.0 110.475 -178.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.538 ' CD ' ' HB2' ' B' ' 311' ' ' SER . 2.6 ttt-85 -139.3 107.0 5.61 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 303' ' ' PHE . . . . . 0.623 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 5.4 m-85 -90.72 -171.38 3.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.184 -0.948 . . . . 0.0 109.871 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 304' ' ' ASN . . . . . 0.837 ' HB3' HG21 ' B' ' 310' ' ' VAL . 0.5 OUTLIER -124.32 -37.65 2.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.334 -0.854 . . . . 0.0 109.271 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 305' ' ' GLY . . . . . 0.7 ' O ' ' HB3' ' B' ' 306' ' ' ALA . . . -164.29 24.42 0.18 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 306' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' B' ' 305' ' ' GLY . . . 75.76 64.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -1.183 . . . . 0.0 109.581 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -158.53 -58.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.32 -168.29 1.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -1.14 . . . . 0.0 109.381 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 309' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' B' ' 230' ' ' PHE . 70.1 t -108.49 135.05 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -0.947 . . . . 0.0 109.115 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.837 HG21 ' HB3' ' B' ' 304' ' ' ASN . 10.0 t -110.54 -75.33 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.021 . . . . 0.0 109.979 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . 0.538 ' HB2' ' CD ' ' B' ' 302' ' ' ARG . 28.8 m -107.45 162.01 14.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.634 -1.291 . . . . 0.0 109.615 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 312' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 15.3 ttp -153.95 150.31 28.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 109.577 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 313' ' ' ARG . . . . . 0.509 ' CG ' ' HB2' ' B' ' 237' ' ' GLU . 2.0 mtm-85 -127.79 150.47 49.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.377 -0.827 . . . . 0.0 109.068 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 314' ' ' ALA . . . . . 0.49 ' CB ' ' OD1' ' B' ' 238' ' ' ASP . . . -110.52 130.44 55.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.084 -1.01 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 315' ' ' LEU . . . . . 1.041 HD11 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -124.99 135.98 53.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.092 -1.005 . . . . 0.0 110.074 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 316' ' ' PHE . . . . . 0.675 ' O ' HG13 ' A' ' 74' ' ' VAL . 34.3 p90 165.91 -156.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 317' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' B' ' 321' ' ' ILE . . . 165.1 -174.47 41.01 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 318' ' ' GLU . . . . . 0.54 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 13.0 tt0 -68.25 -7.18 28.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -1.134 . . . . 0.0 109.474 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 319' ' ' LYS . . . . . 0.443 ' HE2' ' CD ' ' A' ' 70' ' ' GLU . 3.5 tttp -89.55 -30.48 18.17 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.04 0.924 . . . . 0.0 109.108 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 320' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.11 6.46 39.83 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 321' ' ' ILE . . . . . 0.652 HG22 ' H ' ' B' ' 322' ' ' HIS . 4.1 mm -90.09 -170.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 322' ' ' HIS . . . . . 0.652 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.1 OUTLIER -151.9 174.05 14.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.909 -1.119 . . . . 0.0 110.11 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -155.67 173.68 16.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.078 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 174.95 141.58 3.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.172 -1.193 . . . . 0.0 109.595 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' NTH . . . . . 1.0 H183 HD13 ' A' ' 61' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 326' ' ' NTH . . . . . 1.012 H121 HD22 ' B' ' 261' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 2' ' ' ASN . 1.4 mtt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.207 0.527 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.486 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 33.8 m-20 -169.03 44.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.93 . . . . 0.0 109.626 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.3 m -83.2 110.6 24.83 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.824 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 46.6 Cg_endo -72.98 -4.25 15.08 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.871 1.458 . . . . 0.0 110.202 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.97 -44.77 53.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -50.53 72.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.41 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.58 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 64.9 mtm -60.89 -27.76 68.39 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.214 -0.929 . . . . 0.0 109.735 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.448 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 15.9 m -76.99 -37.49 55.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.366 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.59 -46.38 77.26 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.183 -0.948 . . . . 0.0 108.953 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.951 ' HA ' HD21 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -49.46 -43.43 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 8' ' ' THR . 4.9 t -60.15 -40.08 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.709 -0.619 . . . . 0.0 109.725 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 13' ' ' ARG . 17.3 tt0 -63.83 -75.63 0.08 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.158 -0.963 . . . . 0.0 108.621 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.985 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -43.06 -44.64 4.93 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.612 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -49.33 -46.13 46.44 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.943 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -88.28 -39.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.59 -36.43 15.62 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.586 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -73.82 -33.2 64.07 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.943 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.0 mt -64.2 -58.24 7.15 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -51.08 -46.75 61.86 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.708 0.766 . . . . 0.0 109.149 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.32 10.14 23.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.533 -0.729 . . . . 0.0 109.445 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.688 ' HA2' HD11 ' A' ' 59' ' ' LEU . . . 47.77 30.1 6.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 17' ' ' ALA . 19.2 t70 -90.03 62.75 5.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -1.152 . . . . 0.0 109.81 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.098 HD11 ' HB3' ' A' ' 55' ' ' PHE . 0.4 OUTLIER -47.58 -38.03 13.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.11 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 23' ' ' LEU . 1.7 m-20 -43.21 -36.71 1.85 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.97 -30.86 30.47 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.853 HD12 HD12 ' A' ' 23' ' ' LEU . 49.6 mt -61.51 -55.97 20.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 52' ' ' ARG . 29.7 t -60.0 -38.2 75.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.28 -54.17 50.0 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.985 HD22 ' HB3' ' A' ' 13' ' ' ARG . 9.1 tp -62.58 -23.43 67.02 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.535 ' HD2' HG21 ' A' ' 51' ' ' ILE . 3.6 m-30 -91.27 142.79 27.33 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.483 -0.761 . . . . 0.0 109.7 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' PHE . . . -52.36 -174.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.383 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.4 OUTLIER -81.32 -24.69 36.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.651 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.586 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -132.7 42.41 3.09 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.586 -0.696 . . . . 0.0 109.446 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.62 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -59.95 157.39 12.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.377 -0.827 . . . . 0.0 109.896 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.938 HG23 ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -111.66 144.91 40.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.007 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 55.7 t -133.1 130.64 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.069 -1.019 . . . . 0.0 109.835 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.569 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 23.1 mt-10 -107.92 110.13 21.81 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.823 ' OD1' ' HB3' ' A' ' 114' ' ' ALA . 17.6 t70 179.19 139.89 0.28 Allowed Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.782 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 38' ' ' ASP . 43.5 Cg_endo -69.65 -179.84 20.09 Favored 'Cis proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.353 -1.936 . . . . 0.0 111.055 -0.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 40' ' ' VAL . 2.4 t -55.07 139.99 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 110.024 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.449 ' HA3' ' HB1' ' B' ' 275' ' ' ALA . . . 49.55 38.39 28.21 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.524 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -116.03 -141.77 0.37 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.41 -1.053 . . . . 0.0 109.802 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 7.1 pm0 -119.12 101.48 49.73 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.838 -1.164 . . . . 0.0 110.764 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.569 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 37.5 Cg_endo -63.31 175.87 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.984 1.518 . . . . 0.0 110.707 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.95 ' HG3' ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -151.49 114.27 4.67 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.938 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -99.93 155.47 17.67 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 110.074 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 109.21 155.95 16.86 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 7.3 m -66.92 -56.46 10.16 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.322 -1.105 . . . . 0.0 108.977 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -57.93 -18.92 26.33 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.291 -0.881 . . . . 0.0 109.119 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.95 ' HB1' ' HG3' ' A' ' 45' ' ' ARG . . . -89.54 -54.84 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.381 -0.824 . . . . 0.0 109.182 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.537 HD13 ' O ' ' A' ' 45' ' ' ARG . 2.9 mm -51.58 -39.88 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.391 -0.818 . . . . 0.0 109.203 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.915 ' HG3' HD23 ' A' ' 23' ' ' LEU . 5.0 ttt85 -74.38 -55.34 6.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.026 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 4.8 mt-10 -49.12 -27.75 3.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.07 -1.019 . . . . 0.0 108.867 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -87.65 -71.5 0.57 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 1.098 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -47.28 -39.06 13.68 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 52' ' ' ARG . . . -57.82 -50.92 71.65 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 39.6 t-20 -53.99 -42.55 69.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.822 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 6.9 t -59.58 -31.55 69.56 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.688 HD11 ' HA2' ' A' ' 21' ' ' GLY . 7.5 tp -68.76 -20.26 64.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 11.8 mttm -67.75 -6.35 20.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.563 -0.711 . . . . 0.0 109.252 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.907 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -88.31 113.17 54.07 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.886 ' HD2' HD13 ' A' ' 61' ' ' LEU . 47.0 Cg_endo -73.39 82.16 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.737 1.388 . . . . 0.0 112.047 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.007 ' HB2' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -140.18 164.6 29.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.027 -1.045 . . . . 0.0 109.048 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.999 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -89.82 129.39 36.21 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.967 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.793 HG11 ' HB3' ' A' ' 18' ' ' LEU . 2.2 t -101.61 117.31 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.222 -0.924 . . . . 0.0 109.665 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -140.09 108.87 5.95 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.317 -0.865 . . . . 0.0 109.226 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.674 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -48.52 178.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.805 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.686 ' O ' ' N ' ' A' ' 70' ' ' GLU . 4.6 p -126.89 44.53 2.88 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.384 -0.822 . . . . 0.0 109.094 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.537 ' CG ' ' O ' ' A' ' 68' ' ' THR . 4.2 pt20 49.94 -55.39 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.686 ' N ' ' O ' ' A' ' 68' ' ' THR . 67.7 tt0 -63.32 118.15 7.62 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.535 -1.353 . . . . 0.0 110.227 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.9 t -130.57 146.0 34.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 1.001 ' CG ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -118.17 130.65 56.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.895 -1.128 . . . . 0.0 109.731 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.558 ' N ' ' HD2' ' A' ' 72' ' ' ARG . . . -147.44 117.45 7.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.717 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.667 HG21 ' O ' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -135.77 160.72 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.964 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . 40.48 -143.43 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.751 -0.593 . . . . 0.0 109.914 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 103' ' ' PHE . 7.6 m-20 -90.38 12.24 19.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.105 -0.997 . . . . 0.0 109.611 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.511 ' CG ' ' HG3' ' A' ' 102' ' ' ARG . 2.3 mt-10 -115.51 -161.51 0.79 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.09 -1.006 . . . . 0.0 109.466 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.987 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . -179.24 163.89 1.32 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.388 -0.82 . . . . 0.0 109.962 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 1.069 ' HB2' HD11 ' B' ' 315' ' ' LEU . . . -151.7 131.68 13.4 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 31.3 p90 -151.09 174.89 12.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.733 -1.229 . . . . 0.0 109.958 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.897 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -144.39 176.94 8.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 109.91 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -165.05 -169.0 1.55 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.496 -0.753 . . . . 0.0 109.133 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.75 147.8 50.1 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 110.104 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.007 HG12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -117.51 124.33 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 109.067 179.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.999 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 27.8 p -118.17 120.76 38.7 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.588 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.778 ' CD1' HD23 ' A' ' 63' ' ' LEU . 7.2 p90 -147.04 -173.5 4.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -121.79 169.33 10.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 -159.35 0.95 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 109.957 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -104.0 89.11 3.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.25 -18.17 52.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -143.91 167.11 23.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -1.08 . . . . 0.0 109.264 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.34 145.06 41.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.35 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -139.14 142.75 38.02 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 110.178 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.731 HG12 ' CB ' ' A' ' 122' ' ' HIS . 0.8 OUTLIER -123.62 179.19 2.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 1.063 HG22 HG23 ' A' ' 121' ' ' ILE . 6.8 t -146.81 142.26 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.891 -1.131 . . . . 0.0 109.796 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 120' ' ' ASN . . . -134.08 72.2 72.23 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.527 -0.733 . . . . 0.0 109.956 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 1.013 ' HD3' HG12 ' A' ' 95' ' ' VAL . 48.8 Cg_endo -94.7 -175.36 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.631 1.554 . . . . 0.0 110.973 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.897 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.7 mp -137.55 163.83 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 12.2 t0 -132.98 156.33 47.52 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.011 -1.056 . . . . 0.0 110.234 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 101' ' ' PHE . 53.5 t60 -111.84 167.84 10.05 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.987 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -139.08 153.92 48.1 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 110.607 -178.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.555 ' O ' HG23 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -143.15 98.84 3.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 109.186 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 7' ' ' MET . 5.8 m-85 -90.09 159.73 16.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 109.62 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.685 ' HB3' HG21 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -101.24 4.45 41.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.204 -0.935 . . . . 0.0 109.795 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 165.37 -76.41 0.15 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 177.96 71.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -1.159 . . . . 0.0 109.592 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.06 -65.88 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.87 -163.8 1.22 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -1.1 . . . . 0.0 109.327 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.619 HG23 ' CG2' ' A' ' 10' ' ' VAL . 37.7 t -106.27 158.16 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.099 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.685 HG21 ' HB3' ' A' ' 104' ' ' ASN . 0.1 OUTLIER -127.44 -75.15 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.177 -0.952 . . . . 0.0 109.266 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 102' ' ' ARG . 3.3 m -108.36 161.77 14.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.11 -0.994 . . . . 0.0 109.167 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 11.5 ttp -160.01 148.25 17.01 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.178 -0.951 . . . . 0.0 110.072 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.612 ' NH2' ' CE1' ' B' ' 300' ' ' HIS . 0.0 OUTLIER -134.33 158.39 43.92 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.823 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . . . -125.77 141.71 51.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 109.78 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.713 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.7 OUTLIER -129.21 146.65 51.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.357 -0.839 . . . . 0.0 109.485 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.63 ' O ' HG11 ' B' ' 274' ' ' VAL . 0.1 OUTLIER 176.54 -155.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.691 0.758 . . . . 0.0 109.484 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.502 ' N ' ' CG ' ' A' ' 116' ' ' PHE . . . 163.38 176.84 35.77 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.512 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 24.2 tt0 -68.64 -7.74 35.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -1.109 . . . . 0.0 109.49 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.503 ' CE ' ' OE2' ' B' ' 270' ' ' GLU . 14.5 tttp -89.52 -27.54 20.23 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.997 0.904 . . . . 0.0 108.778 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -89.16 9.81 24.21 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.063 HG23 HG22 ' A' ' 95' ' ' VAL . 3.6 mm -96.04 -159.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.278 -0.889 . . . . 0.0 108.637 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.731 ' CB ' HG12 ' A' ' 94' ' ' VAL . 20.3 t-80 -151.32 168.88 23.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.074 -1.016 . . . . 0.0 109.864 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 122' ' ' HIS . . . -144.77 167.83 21.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.372 -0.83 . . . . 0.0 109.413 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.46 177.65 35.9 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.223 -1.163 . . . . 0.0 109.492 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 80.9 mtp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.272 0.558 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -166.41 46.43 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.394 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 203' ' ' THR . 7.5 t -58.54 121.86 56.21 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 109.702 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.06 -4.89 15.79 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.853 1.449 . . . . 0.0 109.478 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -55.25 32.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.367 -0.833 . . . . 0.0 109.301 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -49.61 75.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 108.857 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . 0.626 ' HE1' ' HA ' ' B' ' 306' ' ' ALA . 24.0 mmt -50.28 -41.84 51.34 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.348 -0.845 . . . . 0.0 109.404 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 4.8 m -60.36 -34.93 74.57 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.485 -0.759 . . . . 0.0 109.084 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -51.36 -42.74 61.52 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.291 -0.881 . . . . 0.0 108.739 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 1.008 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -57.75 -26.62 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.846 HG22 ' CE2' ' B' ' 301' ' ' PHE . 25.5 t -90.09 -44.63 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.858 . . . . 0.0 109.308 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 213' ' ' ARG . 5.4 tt0 -58.05 -73.19 0.08 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.475 ' HD3' HD13 ' B' ' 229' ' ' LEU . 0.3 OUTLIER -43.42 -45.14 6.13 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.98 0.895 . . . . 0.0 108.693 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' TYR . . . . . 0.626 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.3 OUTLIER -52.02 -42.46 63.07 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.931 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -87.67 -38.88 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.284 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.66 -35.08 13.02 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.551 ' HB1' HG13 ' B' ' 226' ' ' ILE . . . -75.32 -32.79 61.05 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.931 HD12 ' HA ' ' B' ' 215' ' ' VAL . 1.7 mt -64.59 -57.9 7.83 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 8.5 t30 -54.35 -46.33 72.93 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.497 0.665 . . . . 0.0 109.312 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -88.92 9.6 24.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.599 -0.688 . . . . 0.0 109.733 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.987 ' HA2' HD21 ' B' ' 259' ' ' LEU . . . 48.9 34.29 15.24 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' B' ' 217' ' ' ALA . 16.8 t0 -91.56 61.66 4.34 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.251 -1.146 . . . . 0.0 109.812 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' LEU . . . . . 1.055 HD12 HD12 ' B' ' 226' ' ' ILE . 6.7 tp -46.31 -43.58 15.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 108.695 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' B' ' 223' ' ' LEU . 2.2 m-20 -42.69 -33.28 0.7 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' B' ' 228' ' ' ALA . . . -85.15 -33.93 16.17 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 1.055 HD12 HD12 ' B' ' 223' ' ' LEU . 23.3 mt -60.82 -53.78 44.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.533 ' CG1' HG23 ' B' ' 248' ' ' THR . 72.5 t -59.18 -35.97 60.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' B' ' 225' ' ' GLY . . . -58.69 -56.1 26.6 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 1.008 HD21 ' HA ' ' B' ' 210' ' ' VAL . 9.3 tp -58.7 -21.6 55.18 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . 1.021 ' CD2' HG21 ' B' ' 251' ' ' ILE . 5.0 m-85 -86.89 139.59 30.48 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.497 -0.752 . . . . 0.0 109.61 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -54.8 -167.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.674 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.476 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.5 OUTLIER -81.12 -23.15 38.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.0 109.373 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.557 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 0.1 OUTLIER -144.4 44.81 1.42 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.856 ' HB3' HD13 ' B' ' 251' ' ' ILE . . . -56.76 -170.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.648 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' THR . . . . . 0.62 HG22 ' HB2' ' B' ' 246' ' ' SER . 0.1 OUTLIER -134.61 141.01 46.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.4 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.706 ' CG2' HG23 ' B' ' 251' ' ' ILE . 34.6 t -116.43 166.84 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.189 -0.945 . . . . 0.0 109.112 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' GLU . . . . . 0.574 ' N ' HG12 ' B' ' 236' ' ' VAL . 1.1 mm-40 -151.66 116.95 5.29 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' B' ' 239' ' ' PRO . 0.8 OUTLIER 175.01 167.12 0.36 Allowed Pre-proline 0 C--N 1.301 -1.5 0 C-N-CA 118.118 -1.433 . . . . 0.0 110.354 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.834 ' O ' HG13 ' B' ' 240' ' ' VAL . 45.7 Cg_endo -73.12 -28.03 7.52 Favored 'Cis proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.727 -2.197 . . . . 0.0 110.649 0.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.834 HG13 ' O ' ' B' ' 239' ' ' PRO . 2.1 m -166.88 101.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 109.197 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.23 42.96 63.88 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' SER . . . . . 0.519 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 27.8 m -118.83 -112.44 0.34 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.314 -1.109 . . . . 0.0 109.817 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . 0.445 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 39.0 mt-10 -121.82 100.62 43.31 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.915 -1.116 . . . . 0.0 110.383 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 39.4 Cg_endo -65.43 -172.6 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.561 1.507 . . . . 0.0 110.652 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 1.019 ' HG3' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.52 98.05 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.063 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.7 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.35 166.62 13.63 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.301 -0.875 . . . . 0.0 109.896 -179.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . 0.606 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 90.48 171.09 43.84 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' THR . . . . . 0.533 HG23 ' CG1' ' B' ' 227' ' ' VAL . 1.8 m -89.42 -22.36 22.57 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.749 -1.442 . . . . 0.0 109.27 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -82.0 -28.02 32.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.268 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 1.019 ' HB1' ' HG3' ' B' ' 245' ' ' ARG . . . -88.98 -53.48 4.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.322 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 1.021 HG21 ' CD2' ' B' ' 230' ' ' PHE . 94.6 mt -45.25 -36.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.942 . . . . 0.0 108.852 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' ARG . . . . . 0.745 ' CG ' HD23 ' B' ' 223' ' ' LEU . 28.8 ttp180 -79.86 -54.18 6.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -48.95 -28.49 3.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.043 -1.035 . . . . 0.0 108.239 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.618 ' CD1' ' CD ' ' B' ' 245' ' ' ARG . 0.7 OUTLIER -83.54 -70.74 0.54 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 1.039 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.1 OUTLIER -47.2 -24.96 0.8 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . 0.678 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -76.32 -48.61 19.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 108.642 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 31.1 t-20 -59.13 -31.96 69.42 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' SER . . . . . 0.719 ' OG ' H111 ' B' ' 326' ' ' NTH . 3.0 t -72.72 -35.94 67.67 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 0.987 HD21 ' HA2' ' B' ' 221' ' ' GLY . 8.3 tp -66.81 -26.56 66.99 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.406 -0.809 . . . . 0.0 109.145 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 2.1 mttt -46.15 -25.91 0.67 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.06 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' LEU . . . . . 0.753 HD23 HD23 ' B' ' 263' ' ' LEU . 0.4 OUTLIER -89.75 112.31 51.22 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' PRO . . . . . 0.508 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 44.4 Cg_endo -71.39 117.49 5.18 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.854 1.45 . . . . 0.0 110.841 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.87 ' CB ' HG13 ' B' ' 284' ' ' VAL . 0.0 OUTLIER -145.88 164.4 32.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 109.614 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . 0.74 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -95.11 123.75 38.78 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' B' ' 219' ' ' ASN . 6.2 t -113.46 115.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.291 -0.88 . . . . 0.0 109.794 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 266' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.1 OUTLIER -149.84 99.37 2.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -0.906 . . . . 0.0 109.229 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.8 mp -45.15 170.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.912 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 12.0 p -142.24 -37.96 0.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 109.608 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 269' ' ' GLN . . . . . 0.507 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 3.7 pt20 -95.93 -144.74 0.27 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.654 -0.654 . . . . 0.0 109.324 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.518 ' O ' ' CZ ' ' B' ' 272' ' ' ARG . 22.2 tt0 -117.53 134.1 55.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.041 -1.037 . . . . 0.0 109.829 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . 0.942 HG13 ' HB3' ' B' ' 280' ' ' PHE . 76.1 t -64.84 148.97 11.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.414 -0.804 . . . . 0.0 109.17 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 11.9 mmt180 -103.4 137.84 40.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.109 -0.994 . . . . 0.0 110.153 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . 0.459 ' C ' HG22 ' B' ' 274' ' ' VAL . . . -148.76 139.22 22.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.804 . . . . 0.0 109.077 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 274' ' ' VAL . . . . . 0.63 HG11 ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -160.3 157.58 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.068 -1.02 . . . . 0.0 110.088 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . 0.449 ' HB1' ' HA3' ' A' ' 41' ' ' GLY . . . 40.59 -102.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.653 -0.655 . . . . 0.0 110.095 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 276' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' B' ' 303' ' ' PHE . 98.3 m-20 -129.3 5.31 5.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.898 -1.126 . . . . 0.0 109.628 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . 0.536 ' CG ' ' HG2' ' B' ' 302' ' ' ARG . 0.3 OUTLIER -112.6 -162.65 0.81 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.087 -1.008 . . . . 0.0 108.972 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 278' ' ' ALA . . . . . 0.573 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . 177.17 142.47 0.08 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.623 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 279' ' ' ALA . . . . . 0.713 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -125.92 136.45 53.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 108.604 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . 0.942 ' HB3' HG13 ' B' ' 271' ' ' VAL . 30.0 p90 -149.72 172.46 15.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.74 -1.225 . . . . 0.0 109.982 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.576 ' HB2' ' CG1' ' B' ' 298' ' ' ILE . . . -148.23 -164.95 2.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.808 . . . . 0.0 109.991 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 282' ' ' PHE . . . . . 0.49 ' CD2' ' C ' ' B' ' 281' ' ' ALA . 14.2 p90 172.14 -169.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.45 -0.781 . . . . 0.0 109.384 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.15 147.3 52.59 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.394 -0.816 . . . . 0.0 109.645 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 284' ' ' VAL . . . . . 0.87 HG13 ' CB ' ' B' ' 263' ' ' LEU . 3.3 t -123.8 121.13 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.868 . . . . 0.0 109.429 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 285' ' ' SER . . . . . 0.74 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 16.7 p -115.52 117.84 31.47 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.637 ' CZ ' H221 ' B' ' 326' ' ' NTH . 11.4 p90 -142.24 173.65 11.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.084 -1.01 . . . . 0.0 110.217 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 287' ' ' GLU . . . . . 0.509 ' HG2' ' N ' ' B' ' 288' ' ' PHE . 36.1 tt0 -148.42 154.03 39.35 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.1 OUTLIER -128.01 -96.36 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.036 -1.04 . . . . 0.0 110.358 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -110.16 93.92 4.75 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.122 -0.987 . . . . 0.0 110.443 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 62.14 11.34 32.01 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 291' ' ' ARG . . . . . 0.593 ' HB3' ' CE2' ' B' ' 288' ' ' PHE . 26.9 mtt180 -130.94 144.79 51.73 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.206 -1.173 . . . . 0.0 109.578 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 292' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' B' ' 287' ' ' GLU . 0.0 OUTLIER -136.2 120.78 18.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.347 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 293' ' ' THR . . . . . 0.673 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -122.57 143.58 49.65 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.403 -0.81 . . . . 0.0 109.717 -179.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 294' ' ' VAL . . . . . 0.553 HG13 ' N ' ' B' ' 295' ' ' VAL . 0.8 OUTLIER -112.92 173.55 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 1.011 HG12 ' HD3' ' B' ' 297' ' ' PRO . 2.6 t -150.41 144.41 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.955 -1.091 . . . . 0.0 110.034 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 296' ' ' ALA . . . . . 0.449 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -133.34 73.81 73.14 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.425 -0.797 . . . . 0.0 109.208 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 297' ' ' PRO . . . . . 1.011 ' HD3' HG12 ' B' ' 295' ' ' VAL . 50.2 Cg_endo -94.48 -179.21 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.907 1.478 . . . . 0.0 111.797 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.576 ' CG1' ' HB2' ' B' ' 281' ' ' ALA . 2.9 mp -137.34 138.45 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . 0.613 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 14.7 t0 -113.75 164.16 14.08 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.984 -1.073 . . . . 0.0 110.24 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.612 ' CE1' ' NH2' ' A' ' 113' ' ' ARG . 7.4 t-160 -112.22 173.43 6.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 109.09 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 301' ' ' PHE . . . . . 0.846 ' CE2' HG22 ' B' ' 211' ' ' VAL . 0.2 OUTLIER -145.27 149.03 34.13 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.214 -0.929 . . . . 0.0 110.163 -178.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.536 ' HG2' ' CG ' ' B' ' 277' ' ' GLU . 0.0 OUTLIER -138.01 104.26 5.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.828 . . . . 0.0 109.284 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 303' ' ' PHE . . . . . 0.717 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 11.6 m-85 -89.96 171.62 9.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.081 -1.012 . . . . 0.0 109.512 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 304' ' ' ASN . . . . . 0.59 ' HB3' HG21 ' B' ' 310' ' ' VAL . 1.4 p30 -119.16 -14.25 9.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.427 -0.796 . . . . 0.0 109.132 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 305' ' ' GLY . . . . . 0.707 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -172.49 -62.81 0.05 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 306' ' ' ALA . . . . . 0.707 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 162.74 76.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -1.097 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.52 -64.48 0.06 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -119.35 -172.94 2.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -1.148 . . . . 0.0 109.664 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 309' ' ' VAL . . . . . 1.039 HG11 ' CE ' ' B' ' 312' ' ' MET . 89.7 t -110.43 150.33 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.216 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.59 HG21 ' HB3' ' B' ' 304' ' ' ASN . 42.6 t -123.27 -20.22 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.141 -0.974 . . . . 0.0 109.923 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . 0.531 ' HB2' ' CB ' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -157.85 166.86 31.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.952 -1.092 . . . . 0.0 110.023 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 312' ' ' MET . . . . . 1.039 ' CE ' HG11 ' B' ' 309' ' ' VAL . 1.6 ttm -156.69 154.29 29.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -0.853 . . . . 0.0 109.428 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 313' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' B' ' 299' ' ' ASP . 1.2 ttt180 -130.14 153.38 48.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.227 -0.92 . . . . 0.0 109.378 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 314' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' B' ' 237' ' ' GLU . . . -100.45 157.18 16.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.738 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 315' ' ' LEU . . . . . 1.069 HD11 ' HB2' ' A' ' 79' ' ' ALA . 9.0 tp -137.1 -143.78 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.427 -0.796 . . . . 0.0 109.019 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 316' ' ' PHE . . . . . 0.667 ' O ' HG21 ' A' ' 74' ' ' VAL . 31.0 p90 39.4 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.772 0.796 . . . . 0.0 110.313 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 317' ' ' GLY . . . . . 0.703 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 173.62 -152.52 15.52 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 318' ' ' GLU . . . . . 0.542 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 6.8 tt0 -72.25 -2.36 18.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -1.153 . . . . 0.0 109.71 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.2 -32.58 15.02 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.221 -0.925 . . . . 0.0 109.316 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 320' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -89.31 19.23 4.51 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.251 0.548 . . . . 0.0 109.821 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 321' ' ' ILE . . . . . 0.706 HG22 ' H ' ' B' ' 322' ' ' HIS . 5.1 mm -89.82 -167.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 322' ' ' HIS . . . . . 0.706 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.2 OUTLIER -151.67 155.14 37.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.056 -1.027 . . . . 0.0 109.247 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -156.15 89.26 1.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.116 -0.99 . . . . 0.0 109.773 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -107.3 111.05 3.36 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.409 -1.054 . . . . 0.0 109.441 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' NTH . . . . . 0.822 ' H11' ' OG ' ' A' ' 58' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 326' ' ' NTH . . . . . 0.719 H111 ' OG ' ' B' ' 258' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' C ' ' A' ' 2' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.209 0.528 . . . . 0.0 110.12 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.491 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.3 t30 43.62 40.43 2.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 3' ' ' THR . 9.8 t -90.58 107.68 21.93 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.389 -0.819 . . . . 0.0 109.536 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 45.5 Cg_endo -72.78 -10.52 25.04 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.869 1.457 . . . . 0.0 110.17 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -32.77 68.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 109.692 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.85 -51.0 5.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.926 . . . . 0.0 109.423 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.441 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 17.3 mtt -61.14 -48.19 82.76 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.268 -0.895 . . . . 0.0 109.902 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 4' ' ' PRO . 17.7 m -53.53 -39.05 64.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.487 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.81 -48.06 73.26 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.259 -0.901 . . . . 0.0 108.866 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.655 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.2 t -52.49 -28.68 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.934 HG22 ' CE2' ' A' ' 101' ' ' PHE . 6.6 t -85.47 -42.61 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.239 -0.913 . . . . 0.0 109.354 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.2 tt0 -59.61 -73.65 0.08 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.806 ' HD2' HD13 ' A' ' 29' ' ' LEU . 2.7 mtm180 -43.45 -46.12 6.63 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.709 ' CE1' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -53.13 -41.22 64.85 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.916 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -84.01 -36.58 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.092 -1.005 . . . . 0.0 108.928 179.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.71 -39.55 65.3 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 21' ' ' GLY . . . -71.22 -32.36 68.7 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -63.27 -58.18 8.01 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 65' ' ' VAL . 2.4 t-20 -51.13 -42.47 60.75 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.64 0.733 . . . . 0.0 109.269 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.58 2.35 53.23 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.68 -0.637 . . . . 0.0 109.604 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 1.086 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 49.79 38.24 29.61 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.47 ' O ' HG13 ' A' ' 26' ' ' ILE . 29.6 t70 -92.18 77.85 5.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -1.033 . . . . 0.0 109.865 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.083 ' CD2' HD22 ' A' ' 59' ' ' LEU . 2.8 mm? -50.69 -29.05 10.27 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.334 -0.853 . . . . 0.0 110.12 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -63.93 -56.43 15.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.975 . . . . 0.0 109.366 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.43 ' N ' ' OD2' ' A' ' 22' ' ' ASP . . . -59.0 -28.24 63.41 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.023 HD12 HD13 ' A' ' 23' ' ' LEU . 55.8 mt -63.62 -58.08 8.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.948 HG11 HG23 ' A' ' 48' ' ' THR . 43.6 t -55.82 -41.26 65.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.48 -49.98 71.09 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.806 HD13 ' HD2' ' A' ' 13' ' ' ARG . 2.9 tp -72.35 -21.0 61.37 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.553 -0.717 . . . . 0.0 109.265 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.602 ' CZ ' ' CE ' ' A' ' 112' ' ' MET . 7.2 m-85 -92.41 140.84 29.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.372 -0.83 . . . . 0.0 109.561 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -51.67 178.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.073 -1.017 . . . . 0.0 109.344 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.02 -23.89 59.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.175 -0.953 . . . . 0.0 109.241 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.51 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -137.75 30.41 2.56 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.759 -0.588 . . . . 0.0 109.633 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.737 ' N ' HD11 ' A' ' 51' ' ' ILE . . . -53.21 -173.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.159 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.661 HG23 ' HB2' ' A' ' 46' ' ' SER . 0.2 OUTLIER -145.3 147.38 32.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.16 -0.963 . . . . 0.0 110.187 -179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.52 ' O ' ' HB3' ' A' ' 44' ' ' PRO . 9.5 t -134.56 118.16 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.521 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 2.3 mm-40 -88.3 104.94 17.21 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.529 ' O ' ' CE2' ' A' ' 54' ' ' PHE . 9.9 t0 -176.99 142.76 0.53 Allowed Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.92 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 47.8 Cg_endo -73.85 -166.48 4.63 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.28 -1.967 . . . . 0.0 110.651 -0.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.961 HG21 HG11 ' B' ' 274' ' ' VAL . 15.3 m -75.97 141.64 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.132 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.29 1.63 64.98 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.509 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -105.59 -155.26 0.54 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.265 -1.138 . . . . 0.0 109.355 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.442 ' O ' ' CZ ' ' A' ' 54' ' ' PHE . 27.9 mm-40 -127.74 131.88 24.05 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.08 -1.012 . . . . 0.0 110.07 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.521 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.0 Cg_endo -64.0 -166.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.575 1.517 . . . . 0.0 111.073 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 1.037 ' CG ' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -150.62 102.64 3.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.509 -0.744 . . . . 0.0 109.049 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.661 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.2 147.04 24.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.21 -0.931 . . . . 0.0 109.768 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 111.26 159.8 16.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.948 HG23 HG11 ' A' ' 27' ' ' VAL . 11.3 m -70.97 -43.33 68.29 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.059 -1.26 . . . . 0.0 109.291 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -66.78 -31.78 72.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.279 -0.888 . . . . 0.0 109.15 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.037 ' HB1' ' CG ' ' A' ' 45' ' ' ARG . . . -80.44 -60.37 2.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.898 . . . . 0.0 109.331 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.737 HD11 ' N ' ' A' ' 34' ' ' ALA . 39.3 mt -43.35 -38.28 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.371 -0.831 . . . . 0.0 109.003 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.518 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 4.8 ttt-85 -84.98 -55.18 4.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.536 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 26.1 tt0 -47.71 -26.08 1.43 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.565 ' CD1' ' HD3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -84.2 -71.79 0.5 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.717 ' CE1' HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -52.46 -20.82 3.13 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.24 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.479 ' HA ' ' HG ' ' A' ' 23' ' ' LEU . . . -76.4 -44.73 34.84 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 48.8 t30 -64.49 -32.0 73.45 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 t -72.09 -35.35 69.2 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.086 HD21 ' CA ' ' A' ' 21' ' ' GLY . 3.1 tp -69.61 -24.82 63.72 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.458 -0.776 . . . . 0.0 109.383 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -43.85 -27.5 0.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.844 . . . . 0.0 108.823 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.047 HD22 HD21 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -91.63 109.02 33.67 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.444 ' C ' ' HG ' ' A' ' 63' ' ' LEU . 45.1 Cg_endo -70.65 110.85 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.844 1.444 . . . . 0.0 111.332 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.047 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -138.46 173.1 11.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 109.497 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.843 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -102.36 127.54 49.32 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 18' ' ' LEU . 95.8 t -108.23 124.72 64.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 110.034 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -150.04 112.12 4.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.711 HD22 ' CG2' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -48.03 176.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.219 -0.926 . . . . 0.0 109.811 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.52 -81.97 0.43 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.278 -0.889 . . . . 0.0 109.293 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.594 ' HG2' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -123.43 -55.33 1.75 Allowed 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.807 -179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.594 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 17.2 tt0 -140.55 153.99 46.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.94 -1.1 . . . . 0.0 110.442 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.949 HG13 ' HB3' ' A' ' 80' ' ' PHE . 19.0 t -99.57 149.12 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -95.26 128.96 42.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.483 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.562 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -148.25 137.1 21.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.142 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.815 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -165.64 154.19 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 109.793 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 1.036 ' CB ' HG12 ' B' ' 240' ' ' VAL . . . 43.14 -147.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 0.0 109.827 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 103' ' ' PHE . 30.8 m-80 -88.98 26.54 1.54 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.279 -0.888 . . . . 0.0 109.609 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.9 OUTLIER -129.68 -159.57 0.97 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.268 -0.895 . . . . 0.0 109.061 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.86 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 168.18 157.59 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.41 -0.806 . . . . 0.0 109.794 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.733 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -151.2 139.37 20.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 108.902 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.949 ' HB3' HG13 ' A' ' 71' ' ' VAL . 24.4 p90 -149.57 161.77 41.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.655 -1.278 . . . . 0.0 109.787 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.608 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -130.69 -174.99 3.52 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.574 0.702 . . . . 0.0 110.016 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CE2' ' CE2' ' A' ' 80' ' ' PHE . 19.6 p90 172.21 -172.11 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.546 -0.721 . . . . 0.0 109.22 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -128.34 141.11 51.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.482 -0.761 . . . . 0.0 109.551 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.579 HG12 ' CB ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -101.83 122.13 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 108.952 179.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.843 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 1.1 p -118.07 102.76 9.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -0.988 . . . . 0.0 109.683 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.85 ' CD1' HD23 ' A' ' 63' ' ' LEU . 17.7 p90 -123.02 159.72 27.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.096 -1.003 . . . . 0.0 109.276 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -95.71 171.01 8.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.133 -0.979 . . . . 0.0 109.651 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.08 -160.99 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 109.578 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.83 36.44 1.54 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.319 -0.863 . . . . 0.0 109.095 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.49 -30.3 0.17 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -137.29 -167.78 2.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -1.172 . . . . 0.0 109.352 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.01 136.18 50.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 109.692 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -120.4 157.48 29.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.271 -0.893 . . . . 0.0 109.874 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.548 HG13 ' CB ' ' A' ' 122' ' ' HIS . 12.0 p -138.24 163.9 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.314 -0.866 . . . . 0.0 109.138 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 120' ' ' ASN . 41.4 t -142.44 155.49 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.987 -1.071 . . . . 0.0 109.93 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 120' ' ' ASN . . . -127.86 73.81 78.77 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.494 -0.754 . . . . 0.0 109.818 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.561 ' HD3' HG12 ' A' ' 95' ' ' VAL . 44.0 Cg_endo -95.39 175.49 0.98 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.586 1.524 . . . . 0.0 111.578 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.608 HG23 ' HB2' ' A' ' 81' ' ' ALA . 3.4 mp -143.19 152.39 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.623 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 12.7 t0 -125.42 161.49 26.94 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.004 -1.06 . . . . 0.0 110.229 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 113' ' ' ARG . 5.2 t60 -108.22 179.82 4.1 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.934 ' CE2' HG22 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -146.24 160.18 42.33 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.756 -1.215 . . . . 0.0 110.597 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.554 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -147.09 103.92 3.64 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.655 ' CZ ' HG21 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -90.0 -171.06 3.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.165 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.794 ' OD1' HG23 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -139.42 -101.89 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.462 -0.774 . . . . 0.0 109.526 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.692 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -96.44 21.03 47.8 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 105' ' ' GLY . . . 77.35 66.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -1.112 . . . . 0.0 109.502 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.54 -65.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -128.93 -178.23 4.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -1.134 . . . . 0.0 109.507 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.766 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 45.3 t -94.0 141.52 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.375 -0.828 . . . . 0.0 109.395 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.794 HG23 ' OD1' ' A' ' 104' ' ' ASN . 24.6 t -121.95 -15.22 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 109.976 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.554 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.3 OUTLIER -158.68 157.32 31.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.93 -1.106 . . . . 0.0 109.956 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.724 ' HE2' ' CE1' ' A' ' 101' ' ' PHE . 8.0 ttm -155.46 160.43 40.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.426 -0.796 . . . . 0.0 109.456 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 100' ' ' HIS . 10.1 ttp180 -149.75 114.41 5.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.858 . . . . 0.0 109.403 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 99' ' ' ASP . . . -89.98 137.59 32.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.082 -1.011 . . . . 0.0 109.461 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.954 HD22 ' CB ' ' B' ' 279' ' ' ALA . 1.0 OUTLIER -134.12 143.65 48.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.965 . . . . 0.0 110.102 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.716 ' CE2' ' H61' ' A' ' 126' ' ' NTH . 32.9 p90 164.36 -163.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . -176.15 -179.86 46.85 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.246 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.524 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 11.9 tt0 -50.63 -21.46 1.58 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -1.138 . . . . 0.0 109.304 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -22.55 60.7 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.017 0.913 . . . . 0.0 108.668 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.633 ' O ' HG13 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -88.72 3.27 51.45 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.676 -179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 122' ' ' HIS . 4.2 mm -93.39 -179.34 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.028 -1.045 . . . . 0.0 109.372 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.612 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.7 OUTLIER -151.56 161.46 42.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.509 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.38 152.86 29.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.513 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.9 -128.4 9.49 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.277 -1.131 . . . . 0.0 109.505 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.219 0.533 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -120.92 55.79 1.03 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.1 111.0 44.3 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.348 -0.845 . . . . 0.0 109.558 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' B' ' 208' ' ' THR . 44.3 Cg_endo -71.38 -8.57 23.63 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.832 1.438 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -66.41 -45.46 79.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.043 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -55.69 6.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 109.161 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 13.0 mmt -53.52 -41.96 66.89 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.432 ' CB ' ' O ' ' B' ' 204' ' ' PRO . 6.0 m -63.38 -35.51 80.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 109.06 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -51.13 -44.08 61.29 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.218 -0.926 . . . . 0.0 108.72 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 1.016 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.1 t -57.08 -25.44 22.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.893 HG22 ' CE2' ' B' ' 301' ' ' PHE . 23.9 t -88.43 -44.88 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.832 . . . . 0.0 109.159 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' B' ' 213' ' ' ARG . 24.6 tt0 -58.99 -73.96 0.07 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' B' ' 212' ' ' GLN . 0.2 OUTLIER -42.77 -44.53 4.44 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' TYR . . . . . 0.64 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.4 OUTLIER -51.21 -44.87 61.71 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.543 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.907 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.08 -41.23 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.39 -35.03 11.82 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.57 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -75.86 -33.46 60.0 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' B' ' 215' ' ' VAL . 3.1 mt -62.84 -57.39 11.03 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' B' ' 265' ' ' VAL . 4.6 t30 -53.68 -45.67 70.4 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.576 0.703 . . . . 0.0 109.578 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.14 7.23 36.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.476 -0.765 . . . . 0.0 109.745 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.862 ' HA2' HD11 ' B' ' 259' ' ' LEU . . . 51.83 42.06 52.51 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' B' ' 217' ' ' ALA . 18.0 t70 -97.8 61.44 1.57 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.112 . . . . 0.0 109.928 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' LEU . . . . . 1.054 HD12 HD12 ' B' ' 226' ' ' ILE . 7.1 tp -47.79 -44.12 28.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 108.883 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' B' ' 223' ' ' LEU . 3.9 t0 -43.86 -39.5 3.92 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . 0.481 ' HA3' ' OD2' ' B' ' 222' ' ' ASP . . . -80.77 -32.35 33.42 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 1.054 HD12 HD12 ' B' ' 223' ' ' LEU . 13.8 mt -61.97 -58.48 7.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.458 ' HA ' ' HB2' ' B' ' 230' ' ' PHE . 50.7 t -54.57 -39.73 47.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.71 -54.63 41.94 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 1.016 HD21 ' HA ' ' B' ' 210' ' ' VAL . 7.7 tp -61.76 -22.9 65.8 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' B' ' 231' ' ' ALA . 6.5 m-85 -90.85 132.43 35.9 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.428 -0.795 . . . . 0.0 109.918 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' B' ' 309' ' ' VAL . . . -50.66 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 0.0 109.652 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' B' ' 248' ' ' THR . 0.2 OUTLIER -76.31 -24.4 54.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 109.733 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.521 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 0.1 OUTLIER -133.46 39.76 3.2 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.474 -0.766 . . . . 0.0 109.764 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.899 ' O ' HD11 ' B' ' 251' ' ' ILE . . . -64.0 144.49 57.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.138 -0.976 . . . . 0.0 109.346 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' THR . . . . . 0.99 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -106.18 139.58 40.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 0.0 109.6 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' B' ' 244' ' ' PRO . 55.2 t -132.72 118.39 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.411 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' GLU . . . . . 0.515 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 29.3 mt-10 -89.42 106.24 18.32 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' ASP . . . . . 0.653 ' OD2' ' H62' ' B' ' 326' ' ' NTH . 28.4 t70 -179.67 141.68 0.35 Allowed Pre-proline 0 C--N 1.302 -1.484 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.492 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.492 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 48.4 Cg_endo -74.11 169.89 72.47 Favored 'Cis proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.295 -1.961 . . . . 0.0 110.545 0.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 1.036 HG12 ' CB ' ' A' ' 75' ' ' ALA . 8.0 t -67.47 113.99 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.179 -0.951 . . . . 0.0 109.236 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 112.93 -2.52 25.74 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' B' ' 239' ' ' PRO . 17.5 m -109.38 -113.05 0.31 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -1.124 . . . . 0.0 109.212 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . 0.469 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 1.2 pp20? -164.34 131.46 2.42 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.904 -1.122 . . . . 0.0 109.612 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' PRO . . . . . 0.515 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.8 Cg_endo -64.83 -177.34 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.011 1.532 . . . . 0.0 111.13 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.77 ' HB3' ' HB1' ' B' ' 250' ' ' ALA . 11.1 mmt180 -150.54 99.94 2.8 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.99 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -88.88 164.71 15.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.32 -0.863 . . . . 0.0 109.748 -179.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . 0.521 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 101.46 162.19 27.19 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' THR . . . . . 0.525 ' N ' ' O ' ' B' ' 232' ' ' ASP . 5.9 m -70.04 -52.81 20.99 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.163 -1.198 . . . . 0.0 109.382 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -59.68 -40.75 88.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.162 -0.961 . . . . 0.0 109.438 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.77 ' HB1' ' HB3' ' B' ' 245' ' ' ARG . . . -68.37 -54.9 14.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 109.605 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.899 HD11 ' O ' ' B' ' 234' ' ' ALA . 8.5 mm -47.39 -36.47 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.115 -0.991 . . . . 0.0 109.116 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' ARG . . . . . 0.839 ' CG ' HD23 ' B' ' 223' ' ' LEU . 6.9 ttt180 -84.96 -55.16 4.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 5.5 mt-10 -48.7 -26.98 2.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.992 -1.068 . . . . 0.0 108.327 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.549 ' CD1' ' HG3' ' B' ' 245' ' ' ARG . 0.2 OUTLIER -86.71 -72.6 0.5 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 0.981 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -49.1 -26.55 2.77 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.18 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . 0.618 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -70.38 -41.69 72.75 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -58.86 -27.4 65.13 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' SER . . . . . 0.71 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 41.9 t -77.69 -34.27 52.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 0.862 HD11 ' HA2' ' B' ' 221' ' ' GLY . 7.9 tp -70.04 -26.7 64.16 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.436 -0.79 . . . . 0.0 109.47 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -49.43 -31.43 9.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.278 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' LEU . . . . . 0.978 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.9 OUTLIER -90.03 114.6 61.45 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.287 -0.883 . . . . 0.0 109.006 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' PRO . . . . . 0.454 ' C ' ' HG ' ' B' ' 263' ' ' LEU . 43.3 Cg_endo -70.44 109.25 2.39 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.719 1.379 . . . . 0.0 110.665 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.978 ' CD2' HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -140.29 159.65 41.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.486 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -92.81 128.41 38.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.87 . . . . 0.0 108.694 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . 0.758 HG21 ' HB3' ' B' ' 218' ' ' LEU . 11.0 t -107.67 113.83 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 109.697 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 266' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' B' ' 267' ' ' LEU . 6.7 tt0 -150.47 95.47 2.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.4 -0.813 . . . . 0.0 109.042 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.867 HD23 ' O ' ' B' ' 281' ' ' ALA . 1.5 mp -44.75 169.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.2 -0.938 . . . . 0.0 109.836 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 5.1 t -127.65 -31.64 2.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 109.772 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 269' ' ' GLN . . . . . 0.524 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 13.7 pt20 -107.88 -151.42 0.47 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.524 -0.735 . . . . 0.0 109.459 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.524 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 42.2 tt0 -106.64 129.96 54.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.486 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . 0.897 HG13 ' HB3' ' B' ' 280' ' ' PHE . 16.6 t -60.24 150.85 6.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.398 -0.813 . . . . 0.0 109.367 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 4.9 tpp180 -104.98 131.36 52.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 108.875 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . 0.529 ' HA ' ' CB ' ' B' ' 278' ' ' ALA . . . -148.0 126.23 12.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.089 -1.007 . . . . 0.0 109.9 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 274' ' ' VAL . . . . . 0.961 HG11 HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -121.95 -155.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.901 . . . . 0.0 109.245 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' B' ' 276' ' ' ASN . . . -83.85 126.5 33.02 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.384 -0.822 . . . . 0.0 110.678 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 276' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' B' ' 275' ' ' ALA . 57.1 m-20 69.27 -2.35 1.88 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.706 -0.621 . . . . 0.0 111.721 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 3.4 tt0 -150.67 -160.47 1.17 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.418 -1.426 . . . . 0.0 110.518 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 278' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' B' ' 277' ' ' GLU . . . 165.45 152.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 279' ' ' ALA . . . . . 0.954 ' CB ' HD22 ' A' ' 115' ' ' LEU . . . -138.91 136.92 36.0 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . 0.897 ' HB3' HG13 ' B' ' 271' ' ' VAL . 33.5 p90 -149.97 167.38 26.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.831 -1.168 . . . . 0.0 110.546 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.95 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -142.68 -162.02 1.35 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.415 0.626 . . . . 0.0 109.448 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 282' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 0.0 OUTLIER 163.92 -175.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.885 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 283' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -127.86 141.11 51.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.436 -0.79 . . . . 0.0 109.733 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 284' ' ' VAL . . . . . 0.975 HG11 HD22 ' B' ' 263' ' ' LEU . 66.6 t -111.24 113.53 44.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.47 -0.769 . . . . 0.0 108.929 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 285' ' ' SER . . . . . . . . . . . . . 53.7 p -105.63 84.26 2.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.908 . . . . 0.0 110.028 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.884 ' CE1' H221 ' B' ' 326' ' ' NTH . 34.3 p90 -89.95 177.5 6.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 108.878 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -127.58 153.47 46.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.12 -0.988 . . . . 0.0 109.617 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -103.11 -98.03 0.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.379 -0.826 . . . . 0.0 109.586 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -140.31 47.09 1.8 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.194 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . 139.99 -42.31 1.23 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -94.63 -166.69 1.52 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.508 -0.995 . . . . 0.0 108.877 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 292' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.29 123.35 9.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.044 -1.035 . . . . 0.0 109.744 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 293' ' ' THR . . . . . 0.58 ' HB ' ' CE1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -111.04 147.28 35.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.377 -0.827 . . . . 0.0 109.22 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 294' ' ' VAL . . . . . 0.747 HG13 ' HB2' ' B' ' 322' ' ' HIS . 11.1 p -127.52 167.95 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 109.681 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 1.041 HG12 ' HD3' ' B' ' 297' ' ' PRO . 3.5 t -140.18 148.21 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 108.999 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 296' ' ' ALA . . . . . 0.504 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -132.1 71.48 79.89 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 0.0 110.895 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 297' ' ' PRO . . . . . 1.041 ' HD3' HG12 ' B' ' 295' ' ' VAL . 51.1 Cg_endo -93.82 -174.28 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.486 1.458 . . . . 0.0 110.292 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.95 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.6 mp -140.04 162.64 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.875 . . . . 0.0 108.945 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . 0.608 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 14.0 t0 -133.1 157.49 45.16 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.11 -0.994 . . . . 0.0 110.084 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.785 ' NE2' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -112.81 167.25 10.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 301' ' ' PHE . . . . . 0.893 ' CE2' HG22 ' B' ' 211' ' ' VAL . 0.2 OUTLIER -137.94 157.74 45.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.979 -1.076 . . . . 0.0 110.536 -178.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.516 ' HB3' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -150.09 104.33 3.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 303' ' ' PHE . . . . . 0.665 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 6.9 m-85 -89.6 129.72 36.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.469 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 304' ' ' ASN . . . . . 0.566 ' N ' ' ND2' ' B' ' 304' ' ' ASN . 0.0 OUTLIER -137.42 14.63 2.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.294 -0.878 . . . . 0.0 109.428 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . -135.69 5.87 4.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . 50.1 25.22 1.64 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -1.134 . . . . 0.0 109.602 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -161.25 -42.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -123.54 -168.12 1.72 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -1.091 . . . . 0.0 109.46 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 309' ' ' VAL . . . . . 0.766 HG23 ' CG2' ' B' ' 210' ' ' VAL . 38.2 t -111.84 138.26 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.941 . . . . 0.0 108.993 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.534 ' HB ' ' ND2' ' B' ' 304' ' ' ASN . 2.7 t -121.3 -6.93 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.849 -1.157 . . . . 0.0 109.788 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.4 OUTLIER -155.23 152.93 29.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 0.0 109.347 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 312' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 300' ' ' HIS . 5.7 ttp -160.22 154.97 24.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 109.865 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 313' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' B' ' 299' ' ' ASP . 0.0 OUTLIER -137.77 163.7 30.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 109.067 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -142.5 141.56 32.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.019 -1.051 . . . . 0.0 109.72 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 315' ' ' LEU . . . . . 0.733 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -137.9 139.13 39.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 109.726 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 316' ' ' PHE . . . . . 0.815 ' O ' HG11 ' A' ' 74' ' ' VAL . 14.6 p90 173.76 -157.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.567 0.699 . . . . 0.0 109.352 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 317' ' ' GLY . . . . . 0.437 ' N ' ' CD2' ' B' ' 316' ' ' PHE . . . 165.29 -168.37 39.31 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 318' ' ' GLU . . . . . 0.534 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 15.7 tt0 -71.54 -4.37 26.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -1.164 . . . . 0.0 109.355 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 319' ' ' LYS . . . . . 0.484 ' HD3' ' OE1' ' A' ' 70' ' ' GLU . 2.4 tttm -89.72 -28.39 19.44 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 122.02 0.914 . . . . 0.0 108.87 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 320' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.1 OUTLIER -89.24 4.48 48.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 321' ' ' ILE . . . . . 0.92 HG23 HG22 ' B' ' 295' ' ' VAL . 5.0 mm -89.86 -173.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.325 -0.86 . . . . 0.0 108.83 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 322' ' ' HIS . . . . . 0.747 ' HB2' HG13 ' B' ' 294' ' ' VAL . 0.2 OUTLIER -150.86 -164.74 2.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.071 -1.018 . . . . 0.0 109.792 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -146.62 -175.08 4.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.081 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -170.52 154.31 22.76 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.306 -1.114 . . . . 0.0 109.459 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' NTH . . . . . 0.852 ' O17' HD13 ' A' ' 61' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 326' ' ' NTH . . . . . 0.884 H221 ' CE1' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.173 0.511 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.422 ' HB3' ' HE2' ' A' ' 7' ' ' MET . 99.5 m-20 -59.8 152.73 22.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.395 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.58 ' O ' ' CE1' ' A' ' 6' ' ' HIS . 0.8 OUTLIER -80.72 116.67 63.76 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.343 -0.848 . . . . 0.0 109.786 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.528 ' HA ' ' HE3' ' A' ' 7' ' ' MET . 42.6 Cg_endo -70.08 -4.81 15.0 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.761 1.401 . . . . 0.0 109.877 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -52.81 63.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.304 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 3' ' ' THR . 36.9 p-80 -70.3 -41.94 72.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.903 . . . . 0.0 109.273 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.577 ' CG ' ' NE2' ' A' ' 6' ' ' HIS . 10.3 mtt -59.07 -44.29 91.83 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.199 -0.938 . . . . 0.0 109.342 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.477 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 14.2 m -64.9 -38.46 91.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.315 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.66 77.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 108.872 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.802 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.4 t -55.12 -20.68 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.813 HG11 ' CG2' ' A' ' 71' ' ' VAL . 18.5 t -90.61 -43.5 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.409 -0.807 . . . . 0.0 109.236 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 13' ' ' ARG . 24.1 tt0 -61.19 -73.72 0.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.259 1.028 . . . . 0.0 108.313 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.864 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -42.07 -44.16 3.5 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.642 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -50.01 -46.61 52.94 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.915 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -86.23 -39.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.355 -0.84 . . . . 0.0 109.083 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -48.61 -36.68 16.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.553 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -74.37 -32.0 62.59 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.915 HD12 ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -65.3 -58.4 6.01 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.439 ' CG ' ' O ' ' A' ' 65' ' ' VAL . 24.4 t30 -52.56 -46.4 66.83 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.596 0.712 . . . . 0.0 109.089 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.96 10.67 20.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.649 -0.657 . . . . 0.0 109.476 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 1.006 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 45.52 27.81 2.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 17' ' ' ALA . 1.8 t70 -89.93 67.81 7.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -1.091 . . . . 0.0 109.866 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.12 HD11 ' HB3' ' A' ' 55' ' ' PHE . 4.6 tp -47.8 -41.31 23.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 109.165 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' LEU . 5.2 m-20 -41.49 -28.83 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -88.04 -35.87 8.71 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.006 HD12 HD12 ' A' ' 23' ' ' LEU . 22.0 mt -59.54 -53.82 43.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.54 HG21 ' CG ' ' A' ' 52' ' ' ARG . 91.1 t -59.72 -43.23 91.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.98 -43.62 66.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.864 HD22 ' HB3' ' A' ' 13' ' ' ARG . 6.6 tp -73.39 -27.91 61.72 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.531 ' HD2' HG22 ' A' ' 26' ' ' ILE . 8.8 m-85 -84.83 138.45 32.56 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.32 -0.862 . . . . 0.0 109.841 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -51.68 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 109.697 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.461 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -70.72 -23.42 62.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.622 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.548 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -148.51 41.08 0.95 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.623 -0.673 . . . . 0.0 109.264 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.632 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -52.95 151.77 4.44 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.253 -0.904 . . . . 0.0 109.699 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.34 144.44 29.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.387 -0.82 . . . . 0.0 109.432 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.597 ' CG2' HD12 ' A' ' 51' ' ' ILE . 2.1 t -123.58 169.14 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 108.899 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.632 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -142.65 105.39 4.52 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.205 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.491 ' HB2' ' O ' ' A' ' 37' ' ' GLU . 4.6 t70 177.67 142.93 0.26 Allowed Pre-proline 0 N--CA 1.495 1.777 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.065 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 46.6 Cg_endo -75.45 -176.34 18.04 Favored 'Cis proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.191 -2.004 . . . . 0.0 110.163 -0.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 115' ' ' LEU . 3.5 m -80.11 83.73 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.091 -1.006 . . . . 0.0 109.125 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.86 -13.92 1.33 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.533 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -108.57 -149.23 0.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -1.084 . . . . 0.0 109.417 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -109.93 133.92 20.83 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.916 -1.115 . . . . 0.0 110.721 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 38.3 Cg_endo -63.65 -161.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.157 1.904 . . . . 0.0 111.369 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.618 ' HD2' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -150.17 123.31 8.86 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.568 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -116.94 152.3 34.85 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.025 -1.047 . . . . 0.0 110.448 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 93.85 162.83 36.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 2.9 m -72.12 -57.58 4.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -1.113 . . . . 0.0 109.17 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -47.66 -29.28 2.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 46' ' ' SER . . . -90.07 -61.88 1.59 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.35 -0.844 . . . . 0.0 109.383 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.618 HD13 ' HD2' ' A' ' 45' ' ' ARG . 7.7 mm -45.36 -33.7 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.307 -0.871 . . . . 0.0 109.173 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.892 ' CG ' HD23 ' A' ' 23' ' ' LEU . 53.6 ttp85 -86.83 -61.45 1.73 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 108.924 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 26.1 tt0 -44.38 -28.8 0.59 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 108.564 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.556 ' CD2' ' HB3' ' A' ' 45' ' ' ARG . 1.2 t80 -80.71 -70.6 0.51 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 1.12 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -47.0 -25.52 0.82 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.717 ' HB2' HD22 ' A' ' 23' ' ' LEU . . . -76.24 -55.08 5.9 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -51.25 -30.77 18.7 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.721 ' OG ' H111 ' A' ' 126' ' ' NTH . 1.6 t -76.09 -34.31 59.52 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.006 HD21 ' CA ' ' A' ' 21' ' ' GLY . 7.7 tp -68.82 -21.59 64.3 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.418 -0.802 . . . . 0.0 108.995 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -55.35 -18.68 7.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.364 -0.835 . . . . 0.0 109.049 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.779 HD22 ' CD2' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -89.64 125.34 61.55 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 121.281 -0.887 . . . . 0.0 108.881 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 86' ' ' PHE . 44.8 Cg_endo -71.44 103.08 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.791 1.416 . . . . 0.0 110.621 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.804 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -136.8 160.03 40.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.1 -1.0 . . . . 0.0 110.021 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.911 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -99.47 129.1 45.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.752 HG21 ' HB3' ' A' ' 18' ' ' LEU . 3.3 t -111.55 114.87 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.716 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -150.5 101.1 2.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.582 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -49.82 -179.71 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.234 -0.916 . . . . 0.0 109.556 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.442 HG23 ' N ' ' A' ' 69' ' ' GLN . 10.6 t -162.2 -37.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.199 -0.938 . . . . 0.0 109.773 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -93.67 -147.68 0.25 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.57 -0.706 . . . . 0.0 109.27 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 23.4 tt0 -115.82 130.39 56.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.188 -0.945 . . . . 0.0 109.687 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.813 ' CG2' HG11 ' A' ' 11' ' ' VAL . 33.7 t -64.19 154.51 6.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.396 -0.815 . . . . 0.0 109.115 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.508 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 3.9 mmt180 -115.56 130.27 56.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.534 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.65 128.32 14.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -0.851 . . . . 0.0 109.228 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.772 HG21 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -152.3 160.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 0.0 109.26 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.582 ' HB3' HG12 ' B' ' 240' ' ' VAL . . . 47.95 -144.43 0.37 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.263 -0.898 . . . . 0.0 109.387 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -90.16 -8.44 51.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.088 -1.008 . . . . 0.0 109.645 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 3.1 mt-10 -104.13 -162.87 0.93 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.236 -0.915 . . . . 0.0 109.501 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.851 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . -175.71 168.56 3.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.0 109.677 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.917 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.52 136.66 18.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.02 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.699 ' HB3' HG13 ' A' ' 71' ' ' VAL . 15.2 p90 -150.01 167.46 26.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.953 -1.092 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.683 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -142.85 168.14 20.41 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.456 0.646 . . . . 0.0 109.622 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 4.5 p90 -164.59 -169.05 1.64 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -0.838 . . . . 0.0 109.277 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.87 141.83 50.34 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.484 -0.76 . . . . 0.0 109.814 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.804 HG12 ' HB3' ' A' ' 63' ' ' LEU . 16.4 t -118.12 112.98 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.364 -0.835 . . . . 0.0 109.116 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.911 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 96.5 p -107.42 99.07 8.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.205 -0.935 . . . . 0.0 109.271 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.787 ' CE2' H211 ' A' ' 126' ' ' NTH . 21.4 p90 -117.41 176.36 5.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.377 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 88' ' ' PHE . 60.7 tt0 -149.98 151.23 33.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.756 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.566 ' CZ ' ' OG1' ' A' ' 93' ' ' THR . 7.9 m-85 -96.71 -141.85 0.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.412 -0.805 . . . . 0.0 109.289 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -102.68 45.59 0.96 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.02 -1.05 . . . . 0.0 109.321 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.52 -42.95 0.46 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -107.7 164.75 11.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -1.191 . . . . 0.0 109.488 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -133.54 123.63 25.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 109.531 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -117.8 148.68 41.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.845 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.789 HG12 ' CG ' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -117.95 178.17 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 108.812 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.975 HG12 ' HD3' ' A' ' 97' ' ' PRO . 2.5 t -150.33 141.36 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.099 -1.001 . . . . 0.0 109.848 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 120' ' ' ASN . . . -129.1 73.02 81.98 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.482 -0.761 . . . . 0.0 109.877 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.975 ' HD3' HG12 ' A' ' 95' ' ' VAL . 50.4 Cg_endo -95.16 -179.37 0.58 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.448 1.432 . . . . 0.0 111.648 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.683 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.7 mp -141.48 133.42 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 5.2 t0 -107.29 162.73 13.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.865 -1.147 . . . . 0.0 110.413 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.527 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -114.75 173.66 6.36 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.111 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.851 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -145.44 146.38 31.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.895 -1.128 . . . . 0.0 110.72 -178.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.507 ' HG2' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -138.55 102.5 4.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.419 -0.801 . . . . 0.0 109.375 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.497 ' CE2' HG21 ' A' ' 10' ' ' VAL . 16.6 m-85 -89.6 174.28 7.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 109.381 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.909 ' HB3' HG21 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -114.27 -14.35 12.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.328 -0.858 . . . . 0.0 109.122 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.716 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 114.93 78.84 0.8 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 163.23 -21.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.35 -1.088 . . . . 0.0 109.721 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 122.19 -35.65 3.43 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -59.56 175.5 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -1.184 . . . . 0.0 109.567 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.732 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 45.8 t -113.27 145.96 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.064 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.909 HG21 ' HB3' ' A' ' 104' ' ' ASN . 5.1 t -121.18 -73.39 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.103 -0.998 . . . . 0.0 109.389 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.439 ' HB2' ' HD2' ' A' ' 102' ' ' ARG . 0.6 OUTLIER -114.66 166.64 11.52 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.029 -1.044 . . . . 0.0 109.047 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 19.6 ttp -154.92 137.41 15.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.165 -0.96 . . . . 0.0 109.902 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.506 ' HA ' ' HB2' ' A' ' 37' ' ' GLU . 3.0 mtm180 -111.55 161.59 16.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.79 . . . . 0.0 108.955 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.409 ' O ' ' CG1' ' A' ' 40' ' ' VAL . . . -143.47 132.26 22.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.98 -1.075 . . . . 0.0 109.77 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.897 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.3 OUTLIER -123.3 137.09 54.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.771 179.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.811 ' O ' HG11 ' B' ' 274' ' ' VAL . 0.3 OUTLIER 171.14 -162.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.508 ' O ' ' OD1' ' A' ' 120' ' ' ASN . . . 167.75 175.96 38.0 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.359 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.5 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 37.4 tt0 -48.95 -22.91 0.94 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -1.194 . . . . 0.0 109.281 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.483 ' NZ ' ' CD ' ' B' ' 270' ' ' GLU . 0.3 OUTLIER -73.33 -22.55 60.29 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.043 0.925 . . . . 0.0 108.92 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.809 ' ND2' HG13 ' A' ' 95' ' ' VAL . 0.5 OUTLIER -88.54 0.73 56.03 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.634 -179.422 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.675 ' HA ' HG22 ' A' ' 95' ' ' VAL . 3.0 mm -89.59 -159.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.912 -1.117 . . . . 0.0 108.703 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.789 ' CG ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.39 -168.4 3.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 109.637 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.41 147.16 23.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.542 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.91 118.45 1.47 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.264 -1.139 . . . . 0.0 109.479 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 34.1 mtp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.312 0.577 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -121.11 96.37 5.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.543 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 203' ' ' THR . 2.5 t -45.92 109.51 0.99 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.316 -0.865 . . . . 0.0 109.565 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.38 -2.95 12.49 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.894 1.471 . . . . 0.0 110.182 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.3 -49.25 77.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 109.35 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -65.11 -51.72 59.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.583 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . 0.47 ' HE1' ' O ' ' B' ' 275' ' ' ALA . 25.2 mtt -60.24 -47.5 85.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.257 -0.902 . . . . 0.0 109.789 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 15.6 m -56.6 -38.72 72.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.164 -0.96 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -56.62 -49.07 76.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.121 -0.987 . . . . 0.0 108.99 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 1.022 ' HA ' HD21 ' B' ' 229' ' ' LEU . 0.9 OUTLIER -52.27 -24.16 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.509 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.754 HG22 ' CE2' ' B' ' 301' ' ' PHE . 23.2 t -85.82 -44.77 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.4 -0.813 . . . . 0.0 109.302 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' B' ' 213' ' ' ARG . 7.4 tt0 -57.11 -73.89 0.06 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' B' ' 212' ' ' GLN . 1.3 mtt85 -43.59 -44.89 6.46 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' TYR . . . . . 0.63 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.7 OUTLIER -51.24 -45.4 61.97 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.878 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.0 OUTLIER -86.14 -37.7 11.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -49.13 -36.01 18.0 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.572 ' HB1' HG13 ' B' ' 226' ' ' ILE . . . -74.3 -31.84 62.64 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.878 HD12 ' HA ' ' B' ' 215' ' ' VAL . 0.8 OUTLIER -65.65 -57.72 7.44 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 0.2 OUTLIER -56.04 -45.12 79.3 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.542 0.687 . . . . 0.0 109.148 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' B' ' 221' ' ' GLY . . . -89.36 11.21 19.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.525 -0.734 . . . . 0.0 109.603 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.952 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 45.3 32.51 3.72 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.2 t70 -90.18 63.19 5.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.48 -1.012 . . . . 0.0 109.829 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' LEU . . . . . 1.144 HD12 HD12 ' B' ' 226' ' ' ILE . 6.1 tp -48.51 -43.97 35.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.099 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' B' ' 223' ' ' LEU . 26.2 t0 -42.49 -31.02 0.39 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' B' ' 228' ' ' ALA . . . -86.33 -32.56 16.24 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 1.144 HD12 HD12 ' B' ' 223' ' ' LEU . 27.2 mt -62.77 -56.66 16.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.809 HG11 HG23 ' B' ' 248' ' ' THR . 78.7 t -56.3 -35.19 42.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 225' ' ' GLY . . . -60.58 -56.38 22.07 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 1.022 HD21 ' HA ' ' B' ' 210' ' ' VAL . 8.0 tp -59.9 -25.79 65.39 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.556 -0.715 . . . . 0.0 109.08 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . 0.67 ' HD2' ' HB3' ' B' ' 234' ' ' ALA . 7.4 m-85 -86.42 130.07 34.63 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.496 -0.752 . . . . 0.0 109.779 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' B' ' 230' ' ' PHE . . . -43.0 166.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.905 . . . . 0.0 109.665 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -24.2 5.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.349 -0.844 . . . . 0.0 110.071 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.522 ' CB ' ' HA2' ' B' ' 247' ' ' GLY . 2.0 p30 -148.84 54.13 0.99 Allowed 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.572 -0.705 . . . . 0.0 109.437 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.826 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -68.04 165.08 18.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.659 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' THR . . . . . 0.994 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -115.71 156.54 25.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 109.767 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.524 ' O ' ' HB3' ' B' ' 244' ' ' PRO . 53.9 t -143.31 116.83 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.076 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' GLU . . . . . 0.547 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.2 mt-10 -88.9 105.52 17.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 108.873 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' ASP . . . . . 0.539 ' OD2' ' HB3' ' B' ' 314' ' ' ALA . 9.9 t70 179.54 141.63 0.31 Allowed Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.919 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.474 ' HG2' ' OG ' ' B' ' 242' ' ' SER . 48.5 Cg_endo -74.63 -173.85 12.81 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.048 -2.063 . . . . 0.0 110.343 -0.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' A' ' 75' ' ' ALA . 1.2 t -76.84 135.12 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.131 -0.98 . . . . 0.0 109.124 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 89.73 -3.78 83.34 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' SER . . . . . 0.474 ' OG ' ' HG2' ' B' ' 239' ' ' PRO . 67.5 m -107.08 -132.76 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -1.145 . . . . 0.0 109.149 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' B' ' 242' ' ' SER . 19.9 mt-10 -148.43 133.62 9.28 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 120.616 -1.303 . . . . 0.0 110.042 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' PRO . . . . . 0.547 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 38.4 Cg_endo -64.39 -172.7 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.133 1.596 . . . . 0.0 111.3 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.595 ' HD3' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.69 105.99 3.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.994 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -93.0 162.24 14.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.282 -0.887 . . . . 0.0 110.616 -178.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . 0.627 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 97.51 159.35 30.9 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' THR . . . . . 0.809 HG23 HG11 ' B' ' 227' ' ' VAL . 7.3 m -73.23 -45.39 56.32 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.162 -1.199 . . . . 0.0 109.014 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -63.95 -24.17 67.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.826 . . . . 0.0 109.025 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -90.02 -59.05 2.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.313 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.826 HD11 ' N ' ' B' ' 234' ' ' ALA . 21.7 mt -47.58 -39.25 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.364 -0.835 . . . . 0.0 109.255 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' ARG . . . . . 0.778 ' CG ' HD23 ' B' ' 223' ' ' LEU . 15.6 ttt180 -76.0 -57.16 4.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 109.068 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 8.0 mt-10 -46.4 -29.39 1.68 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.033 -1.042 . . . . 0.0 108.609 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' B' ' 245' ' ' ARG . 0.8 OUTLIER -83.74 -72.64 0.45 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 1.119 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.1 OUTLIER -48.84 -24.54 1.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.552 -0.718 . . . . 0.0 109.166 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . 0.561 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -74.91 -44.91 46.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 108.707 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 257' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 5.3 t30 -56.73 -34.33 67.41 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 258' ' ' SER . . . . . 0.463 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 18.8 t -72.29 -47.0 53.34 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.49 -0.756 . . . . 0.0 109.179 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 0.952 HD21 ' CA ' ' B' ' 221' ' ' GLY . 9.5 tp -57.46 -18.11 16.68 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.345 -0.847 . . . . 0.0 109.315 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 1.8 mttm -64.44 -19.6 65.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 109.592 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 261' ' ' LEU . . . . . 0.96 HD22 HD21 ' B' ' 263' ' ' LEU . 0.3 OUTLIER -89.37 120.43 69.7 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 262' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 45.0 Cg_endo -70.57 94.55 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.791 1.416 . . . . 0.0 110.755 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.96 HD21 HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -133.15 157.16 46.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.0 109.498 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . 0.518 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -92.35 127.03 37.68 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' B' ' 218' ' ' LEU . 30.9 t -107.28 114.26 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 2.3 tt0 -150.1 95.76 2.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.084 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.54 HD11 HG11 ' B' ' 215' ' ' VAL . 2.7 mp -43.86 169.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 268' ' ' THR . . . . . 0.465 ' O ' ' O ' ' B' ' 269' ' ' GLN . 0.0 OUTLIER -129.01 -78.56 0.56 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.523 -0.736 . . . . 0.0 109.213 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 269' ' ' GLN . . . . . 0.823 ' OE1' ' HB3' ' B' ' 281' ' ' ALA . 2.0 pt20 -59.3 -149.19 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.483 ' CD ' ' NZ ' ' A' ' 119' ' ' LYS . 31.6 tt0 -111.51 131.45 55.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.033 -1.042 . . . . 0.0 109.68 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . 1.054 HG13 ' HB3' ' B' ' 280' ' ' PHE . 72.8 t -52.85 144.06 4.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.32 -0.863 . . . . 0.0 109.342 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.544 ' HD2' ' CD1' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -105.75 130.25 53.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.935 . . . . 0.0 109.503 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' B' ' 278' ' ' ALA . . . -147.25 137.09 23.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -0.843 . . . . 0.0 109.321 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 274' ' ' VAL . . . . . 0.811 HG11 ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -155.07 149.71 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 0.0 109.174 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . 0.47 ' O ' ' HE1' ' B' ' 207' ' ' MET . . . 49.82 -144.86 0.47 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.159 -0.963 . . . . 0.0 109.358 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 276' ' ' ASN . . . . . 0.471 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 2.0 m-20 -83.71 -20.7 32.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.728 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . 0.582 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 0.7 OUTLIER -89.88 -161.71 0.81 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.161 -0.962 . . . . 0.0 109.583 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 278' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' B' ' 277' ' ' GLU . . . 170.1 162.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.755 . . . . 0.0 109.079 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 279' ' ' ALA . . . . . 0.897 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -150.66 141.51 22.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.065 . . . . 0.0 109.236 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . 1.054 ' HB3' HG13 ' B' ' 271' ' ' VAL . 21.1 p90 -141.63 154.55 45.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.827 -1.171 . . . . 0.0 110.705 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 1.062 ' CB ' HD12 ' B' ' 298' ' ' ILE . . . -119.43 168.53 10.86 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 282' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 0.0 OUTLIER -177.14 -173.44 0.45 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.898 . . . . 0.0 109.766 179.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 283' ' ' THR . . . . . 0.981 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -135.19 141.1 45.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.375 -0.828 . . . . 0.0 110.215 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 284' ' ' VAL . . . . . 0.834 HG11 HD22 ' B' ' 263' ' ' LEU . 8.0 t -109.21 134.56 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 108.795 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 285' ' ' SER . . . . . 0.518 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 29.0 p -125.73 100.78 6.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.987 . . . . 0.0 110.08 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.734 ' CE1' H221 ' B' ' 326' ' ' NTH . 33.9 p90 -117.34 -168.73 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 108.785 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 287' ' ' GLU . . . . . 0.469 ' N ' ' CD2' ' B' ' 286' ' ' PHE . 16.7 tt0 -149.85 158.59 44.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.93 -1.106 . . . . 0.0 110.09 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.405 ' CZ ' ' HE2' ' B' ' 286' ' ' PHE . 33.1 m-85 -105.6 -167.84 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.451 -0.781 . . . . 0.0 109.587 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.91 -20.94 3.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.378 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -160.66 -45.24 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 291' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' B' ' 325' ' ' ALA . 1.6 mtt180 -74.49 142.72 44.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -1.165 . . . . 0.0 109.522 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 292' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' B' ' 293' ' ' THR . 2.3 tmtt? -103.85 145.32 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.277 -0.89 . . . . 0.0 109.412 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 293' ' ' THR . . . . . 0.728 HG22 ' O ' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -135.88 143.29 44.96 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.452 -0.78 . . . . 0.0 110.297 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 294' ' ' VAL . . . . . 0.613 HG12 ' CB ' ' B' ' 322' ' ' HIS . 9.0 p -121.26 169.41 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 0.981 ' O ' HG22 ' B' ' 283' ' ' THR . 22.8 t -136.48 160.71 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.758 -1.214 . . . . 0.0 110.499 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 296' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' B' ' 320' ' ' ASN . . . -140.62 62.54 18.62 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.629 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 297' ' ' PRO . . . . . 1.036 ' O ' HD13 ' B' ' 298' ' ' ILE . 43.5 Cg_endo -97.37 167.28 0.87 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.449 1.433 . . . . 0.0 112.01 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 1.062 HD12 ' CB ' ' B' ' 281' ' ' ALA . 3.9 mm -129.2 165.05 30.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . 0.648 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 14.7 t0 -135.06 156.27 49.31 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.201 -0.937 . . . . 0.0 109.909 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.535 ' O ' ' CG ' ' B' ' 312' ' ' MET . 0.2 OUTLIER -108.19 175.36 5.5 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 301' ' ' PHE . . . . . 0.754 ' CE2' HG22 ' B' ' 211' ' ' VAL . 0.1 OUTLIER -149.74 136.62 19.48 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 110.026 -178.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.612 ' O ' HG23 ' B' ' 310' ' ' VAL . 10.4 ttt85 -138.48 113.76 9.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 109.11 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 303' ' ' PHE . . . . . 0.652 ' CE2' HG21 ' B' ' 210' ' ' VAL . 3.9 m-85 -95.09 178.82 5.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.468 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 304' ' ' ASN . . . . . 0.719 ' HB3' HG11 ' B' ' 310' ' ' VAL . 3.6 p30 -111.87 -21.8 11.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.358 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 305' ' ' GLY . . . . . . . . . . . . . . . 122.35 32.76 0.94 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 306' ' ' ALA . . . . . . . . . . . . . . . -144.49 9.47 1.39 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.218 -1.166 . . . . 0.0 109.964 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 87.05 -19.28 31.31 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.81 -177.26 6.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -1.205 . . . . 0.0 109.561 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 309' ' ' VAL . . . . . 0.547 ' CG2' HG22 ' B' ' 210' ' ' VAL . 61.0 t -112.69 137.12 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.163 -0.961 . . . . 0.0 109.154 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.719 HG11 ' HB3' ' B' ' 304' ' ' ASN . 0.0 OUTLIER -119.37 -61.57 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.079 -1.013 . . . . 0.0 109.799 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.91 162.85 17.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.045 -1.035 . . . . 0.0 109.67 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 312' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 29.2 ttp -159.02 145.93 17.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 313' ' ' ARG . . . . . 0.53 ' HB2' ' CB ' ' B' ' 300' ' ' HIS . 48.1 mtp180 -125.18 173.15 8.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.223 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 314' ' ' ALA . . . . . 0.539 ' HB3' ' OD2' ' B' ' 238' ' ' ASP . . . -150.17 150.88 32.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.032 . . . . 0.0 109.445 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 315' ' ' LEU . . . . . 0.917 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -136.25 142.52 44.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 110.048 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 316' ' ' PHE . . . . . 0.772 ' O ' HG21 ' A' ' 74' ' ' VAL . 1.2 p90 174.63 -155.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.652 0.739 . . . . 0.0 109.125 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 317' ' ' GLY . . . . . 0.471 ' N ' ' CG ' ' B' ' 316' ' ' PHE . . . 159.79 -172.14 36.28 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 318' ' ' GLU . . . . . 0.654 ' HA ' HD12 ' B' ' 321' ' ' ILE . 6.3 tt0 -65.29 -6.73 10.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -1.108 . . . . 0.0 109.7 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -101.12 -17.99 16.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.323 -0.861 . . . . 0.0 109.699 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 320' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' B' ' 296' ' ' ALA . 1.4 m-20 -88.94 -23.18 22.75 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.607 -0.683 . . . . 0.0 110.189 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 321' ' ' ILE . . . . . 0.922 ' CG2' HG22 ' B' ' 295' ' ' VAL . 0.6 OUTLIER -87.18 -158.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.072 -1.018 . . . . 0.0 108.546 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 322' ' ' HIS . . . . . 0.728 ' O ' HG22 ' B' ' 293' ' ' THR . 0.3 OUTLIER -151.61 161.61 42.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.974 -1.079 . . . . 0.0 110.064 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -155.27 110.58 3.04 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.353 -0.842 . . . . 0.0 109.414 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -121.93 160.17 16.38 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 325' ' ' ALA . . . . . 0.4 ' HA ' ' HG2' ' B' ' 291' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.361 -1.082 . . . . 0.0 109.415 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' NTH . . . . . 0.787 H211 ' CE2' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 326' ' ' NTH . . . . . 0.734 H221 ' CE1' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.486 ' O ' ' CB ' ' A' ' 2' ' ' ASN . 1.9 ttp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.275 0.56 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 1' ' ' MET . 2.0 p30 165.18 107.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.33 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.655 ' O ' HG23 ' A' ' 3' ' ' THR . 7.1 t -73.68 111.76 13.47 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.614 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 43.8 Cg_endo -71.41 -8.68 23.83 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.864 1.455 . . . . 0.0 109.784 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -61.81 -60.26 3.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.812 . . . . 0.0 109.243 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -61.33 -45.19 95.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.156 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.412 ' HE3' ' C ' ' A' ' 2' ' ' ASN . 27.5 mtt -58.73 -28.81 66.2 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.223 -0.923 . . . . 0.0 109.333 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 11' ' ' VAL . 17.5 m -74.33 -44.14 53.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 109.059 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.25 -40.23 23.99 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.004 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.2 t -53.35 -26.76 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.866 HG11 ' CG2' ' A' ' 71' ' ' VAL . 7.6 t -90.02 -42.55 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.491 -0.756 . . . . 0.0 109.101 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 15' ' ' VAL . 20.7 tt0 -62.05 -73.92 0.1 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.482 ' HB3' HD22 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -41.61 -44.18 2.99 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 122.041 0.924 . . . . 0.0 108.524 178.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.641 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -53.39 -45.58 69.33 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.897 ' HA ' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -84.63 -38.98 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 0.0 109.555 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.69 -35.74 14.63 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.56 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -74.88 -31.69 61.66 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.984 ' HB3' HG21 ' A' ' 65' ' ' VAL . 1.2 mt -65.7 -58.83 4.77 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -51.9 -45.38 64.18 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . -89.5 9.98 24.53 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.574 -0.704 . . . . 0.0 109.645 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.959 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 45.32 31.52 3.33 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 17' ' ' ALA . 6.8 t0 -89.82 68.64 7.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -1.062 . . . . 0.0 109.936 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.042 HD11 ' HB3' ' A' ' 55' ' ' PHE . 4.9 tp -49.35 -42.12 40.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -42.1 -30.56 0.3 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -87.96 -37.2 7.95 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.955 HD12 HD12 ' A' ' 23' ' ' LEU . 22.0 mt -59.64 -53.59 46.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.536 HG21 ' CG ' ' A' ' 52' ' ' ARG . 84.9 t -58.57 -36.17 58.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -60.6 -50.83 71.94 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.004 HD21 ' HA ' ' A' ' 10' ' ' VAL . 7.5 tp -65.61 -21.72 66.6 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.547 -0.721 . . . . 0.0 109.182 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.524 ' CG ' HG21 ' A' ' 51' ' ' ILE . 2.8 m-85 -84.6 135.5 34.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.419 -0.801 . . . . 0.0 109.609 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -54.17 -175.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.46 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.4 OUTLIER -75.76 -23.23 55.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.885 . . . . 0.0 109.54 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.548 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -140.13 36.76 1.92 Allowed 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.59 -0.694 . . . . 0.0 109.357 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 110' ' ' VAL . . . -51.38 -176.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.499 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.553 ' CG2' ' HB2' ' A' ' 46' ' ' SER . 0.3 OUTLIER -142.49 134.13 26.72 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.373 -0.83 . . . . 0.0 109.432 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.802 ' CG2' HD12 ' A' ' 51' ' ' ILE . 31.6 t -127.27 128.3 70.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.337 -0.852 . . . . 0.0 108.88 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 21.9 mt-10 -101.15 114.18 27.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.649 ' OD2' ' H61' ' A' ' 126' ' ' NTH . 12.1 t70 -179.33 142.63 0.38 Allowed Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.608 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 38' ' ' ASP . 46.9 Cg_endo -73.75 -179.26 24.86 Favored 'Cis proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.194 -2.002 . . . . 0.0 110.797 -0.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.841 HG21 HG11 ' B' ' 274' ' ' VAL . 27.6 m -66.9 82.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.35 -0.844 . . . . 0.0 109.269 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . -170.69 28.5 0.12 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER 70.5 47.46 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -1.11 . . . . 0.0 109.86 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.55 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 4.7 mt-10 -132.83 57.5 28.8 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 109.844 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 50.3 Cg_endo -79.84 177.22 8.62 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 124.163 1.612 . . . . 0.0 110.653 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' HD3' ' CA ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -151.59 107.22 3.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 109.251 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.648 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -89.56 157.45 18.06 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.263 -0.898 . . . . 0.0 110.117 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 100.52 166.37 28.55 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.513 HG23 HG13 ' A' ' 27' ' ' VAL . 3.0 m -75.2 -58.63 3.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.138 -1.213 . . . . 0.0 109.012 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -54.44 -44.88 72.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.211 -0.931 . . . . 0.0 109.076 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 46' ' ' SER . . . -59.26 -34.01 71.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.45 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.802 HD12 ' CG2' ' A' ' 36' ' ' VAL . 7.6 mm -79.72 -36.23 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.685 ' CG ' HD23 ' A' ' 23' ' ' LEU . 26.7 ttp85 -78.51 -56.64 4.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.253 -0.904 . . . . 0.0 109.068 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.9 mt-10 -45.76 -27.25 0.79 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.494 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -83.14 -70.22 0.57 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.174 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 1.042 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.26 -24.1 1.08 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.611 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -78.85 -47.31 16.83 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 19.2 t-20 -64.65 -28.37 69.57 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.65 ' OG ' H111 ' A' ' 126' ' ' NTH . 1.6 t -78.08 -42.26 32.72 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.959 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.9 tp -60.85 -17.86 52.57 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.405 -0.809 . . . . 0.0 108.903 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 4.8 mttm -55.16 -18.64 6.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.479 -0.763 . . . . 0.0 108.972 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.086 HD13 ' H17' ' A' ' 126' ' ' NTH . 0.3 OUTLIER -89.16 118.25 69.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.162 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 43.8 Cg_endo -71.34 110.42 2.84 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.748 1.393 . . . . 0.0 110.716 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.78 ' HB2' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -145.82 176.44 9.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.888 . . . . 0.0 110.053 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.73 126.12 54.88 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.984 HG21 ' HB3' ' A' ' 18' ' ' LEU . 3.7 t -104.29 117.96 50.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.682 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -146.09 105.57 3.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.133 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.519 ' O ' HG23 ' A' ' 68' ' ' THR . 0.7 OUTLIER -47.41 175.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -0.929 . . . . 0.0 109.633 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 67' ' ' LEU . 2.7 p -155.8 -38.01 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.705 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.492 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 5.7 pt20 -99.21 -152.47 0.41 Allowed 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.63 -0.669 . . . . 0.0 109.198 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 30.4 tt0 -109.8 130.38 55.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.15 -0.969 . . . . 0.0 109.787 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.866 ' CG2' HG11 ' A' ' 11' ' ' VAL . 37.2 t -60.01 145.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.333 -0.855 . . . . 0.0 108.996 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.645 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 1.7 ttm180 -106.26 134.48 49.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.662 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.497 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -146.7 145.51 30.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 109.232 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.833 ' CG1' HG21 ' B' ' 240' ' ' VAL . 0.2 OUTLIER -136.03 -151.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.191 -0.943 . . . . 0.0 109.562 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -34.59 -90.85 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.973 -0.454 . . . . 0.0 110.804 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 4.9 p-10 -112.89 -15.8 12.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.083 -1.011 . . . . 0.0 110.328 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.652 ' HG2' ' N ' ' A' ' 78' ' ' ALA . 1.4 tt0 -108.5 162.55 14.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.019 -1.051 . . . . 0.0 108.999 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.652 ' N ' ' HG2' ' A' ' 77' ' ' GLU . . . -143.12 177.16 8.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.38 -0.825 . . . . 0.0 110.224 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.912 ' HB2' HD11 ' B' ' 315' ' ' LEU . . . -150.1 137.07 19.41 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.66 ' CE1' ' CE2' ' A' ' 101' ' ' PHE . 31.8 p90 -150.32 170.83 18.09 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.706 -1.246 . . . . 0.0 110.137 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.878 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -139.62 -166.4 2.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.556 -0.715 . . . . 0.0 109.56 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CD2' ' C ' ' A' ' 81' ' ' ALA . 6.8 p90 174.23 -171.46 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.441 -0.787 . . . . 0.0 109.075 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.73 144.0 50.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.357 -0.84 . . . . 0.0 109.808 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.78 HG13 ' HB2' ' A' ' 63' ' ' LEU . 12.1 t -116.78 115.0 47.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.537 ' HA ' HG23 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -106.58 103.43 12.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.077 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.578 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 4.3 p90 -122.23 177.04 5.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.228 -0.92 . . . . 0.0 109.561 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -106.25 -179.95 4.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.174 -0.954 . . . . 0.0 110.466 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.497 ' C ' ' CG ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -137.67 43.18 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 109.549 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.497 ' CG ' ' C ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER 39.71 75.97 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.421 -0.799 . . . . 0.0 109.886 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.52 -41.49 2.01 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -125.46 179.35 5.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.41 -1.053 . . . . 0.0 108.928 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.502 ' HG2' ' N ' ' A' ' 93' ' ' THR . 0.4 OUTLIER -126.11 140.8 52.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.007 -1.058 . . . . 0.0 109.884 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.572 ' HB ' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -136.81 152.58 50.44 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.801 HG12 ' CG ' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -126.52 -178.85 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.994 . . . . 0.0 109.112 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 1.078 HG22 HG23 ' A' ' 121' ' ' ILE . 2.9 t -150.01 141.04 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 108.992 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.38 71.63 82.03 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.394 -0.816 . . . . 0.0 110.528 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.965 ' HD3' HG12 ' A' ' 95' ' ' VAL . 54.0 Cg_endo -95.88 -173.55 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.559 1.506 . . . . 0.0 110.854 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.878 HG23 ' HB2' ' A' ' 81' ' ' ALA . 3.1 mp -141.88 167.03 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 32.8 t0 -135.24 159.26 42.12 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.134 -0.979 . . . . 0.0 109.828 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.525 ' NE2' ' HG3' ' A' ' 77' ' ' GLU . 71.2 t60 -123.78 133.71 53.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.426 -0.797 . . . . 0.0 108.876 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.66 ' CE2' ' CE1' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -109.76 145.67 36.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.203 -0.935 . . . . 0.0 109.89 -179.039 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 111' ' ' SER . 6.2 ttt180 -145.06 114.22 7.0 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.784 ' CE2' HG21 ' A' ' 10' ' ' VAL . 21.4 m-85 -89.61 -166.58 1.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.046 -1.034 . . . . 0.0 109.693 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.41 ' HB3' HG21 ' A' ' 110' ' ' VAL . 1.4 p30 -132.11 -43.01 0.97 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.711 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -142.78 -62.23 0.02 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 163.87 76.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -1.149 . . . . 0.0 109.608 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -166.07 -49.53 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.27 -162.7 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -1.209 . . . . 0.0 109.545 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.655 HG23 HG22 ' A' ' 10' ' ' VAL . 54.5 t -97.46 143.18 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.331 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 56.6 t -125.12 -11.93 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.777 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.49 ' HB2' ' HB3' ' A' ' 102' ' ' ARG . 13.0 m -159.09 156.1 28.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.412 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.562 ' SD ' ' CE1' ' A' ' 101' ' ' PHE . 8.4 ttp -160.31 149.3 17.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.149 -0.969 . . . . 0.0 109.86 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -129.7 147.24 51.47 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.499 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.77 132.33 54.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.999 -1.063 . . . . 0.0 110.035 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.854 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.4 OUTLIER -122.43 141.65 51.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.363 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.55 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 4.3 p90 175.02 -152.47 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.476 ' N ' ' CG ' ' A' ' 116' ' ' PHE . . . 166.31 169.08 29.46 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.484 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 19.8 tt0 -68.64 -6.45 25.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -1.096 . . . . 0.0 109.473 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' CD ' ' HG3' ' B' ' 204' ' ' PRO . 0.0 OUTLIER -91.85 -26.17 18.62 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.981 0.896 . . . . 0.0 108.886 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.496 ' OD1' ' NH2' ' B' ' 272' ' ' ARG . 0.1 OUTLIER -88.9 14.12 11.15 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.078 HG23 HG22 ' A' ' 95' ' ' VAL . 4.5 mm -90.68 -150.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.801 ' CG ' HG12 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.79 174.19 13.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.005 . . . . 0.0 109.538 179.372 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.56 88.12 1.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.9 . . . . 0.0 109.32 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -66.77 133.62 32.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.347 -1.09 . . . . 0.0 109.508 -179.972 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.244 0.545 . . . . 0.0 110.144 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' B' ' 201' ' ' MET . 4.1 m-80 61.88 77.48 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -0.828 . . . . 0.0 109.673 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . 0.513 HG23 ' O ' ' B' ' 203' ' ' THR . 3.0 t -61.96 116.69 23.03 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.668 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' PRO . . . . . 0.407 ' HG3' ' CD ' ' A' ' 119' ' ' LYS . 44.5 Cg_endo -71.52 -3.8 13.75 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.868 1.457 . . . . 0.0 109.96 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -59.71 -63.11 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.489 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -58.06 -43.98 87.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 109.397 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 18.1 mtt -57.61 -28.53 63.73 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.289 -0.882 . . . . 0.0 109.629 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.448 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 6.0 m -76.69 -35.89 57.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.076 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -53.85 -45.45 70.93 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.238 -0.914 . . . . 0.0 108.809 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 1.095 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.2 t -51.72 -27.1 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.983 HG11 HG21 ' B' ' 271' ' ' VAL . 40.1 t -83.4 -46.05 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.485 -0.759 . . . . 0.0 109.706 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' B' ' 213' ' ' ARG . 28.4 tt0 -56.86 -73.6 0.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.245 1.022 . . . . 0.0 108.312 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' B' ' 212' ' ' GLN . 1.6 mtt85 -43.06 -44.38 4.8 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.972 0.891 . . . . 0.0 108.655 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' TYR . . . . . 0.637 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -51.26 -45.3 62.0 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.952 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.2 t -88.42 -40.12 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.903 . . . . 0.0 109.359 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -48.23 -36.23 13.47 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.527 ' HB1' HG13 ' B' ' 226' ' ' ILE . . . -74.56 -33.63 62.74 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' B' ' 215' ' ' VAL . 3.4 mt -63.86 -58.58 6.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -53.38 -46.1 69.49 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.461 0.648 . . . . 0.0 109.476 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.32 9.22 26.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.529 -0.732 . . . . 0.0 109.649 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.92 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 48.6 37.19 19.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' B' ' 217' ' ' ALA . 25.5 t0 -97.93 61.17 1.52 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -1.114 . . . . 0.0 109.791 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' LEU . . . . . 1.085 HD11 ' HB3' ' B' ' 255' ' ' PHE . 2.2 tp -46.89 -39.45 12.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.03 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' B' ' 223' ' ' LEU . 0.5 OUTLIER -40.63 -31.31 0.15 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' B' ' 223' ' ' LEU . . . -88.86 -37.27 7.39 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.918 HD12 HD12 ' B' ' 223' ' ' LEU . 12.5 mt -58.54 -54.11 37.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.474 HG21 ' HG3' ' B' ' 252' ' ' ARG . 46.6 t -58.43 -41.69 82.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.34 -46.88 76.35 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 1.095 HD21 ' HA ' ' B' ' 210' ' ' VAL . 4.4 tp -69.75 -30.16 67.68 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.594 -0.691 . . . . 0.0 109.234 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . 0.736 ' CD2' HG21 ' B' ' 251' ' ' ILE . 4.8 m-85 -79.46 129.92 34.92 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.393 -0.817 . . . . 0.0 109.726 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -49.19 179.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.462 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -66.91 -23.49 65.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.769 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.517 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 0.0 OUTLIER -146.94 53.76 1.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.482 -0.761 . . . . 0.0 109.584 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.675 ' HB3' ' HD2' ' B' ' 230' ' ' PHE . . . -64.47 155.91 31.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' THR . . . . . 0.608 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -98.36 160.06 14.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.399 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.712 HG23 ' CD1' ' B' ' 251' ' ' ILE . 1.9 t -139.49 173.29 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 108.875 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' GLU . . . . . 0.583 ' N ' ' CG1' ' B' ' 236' ' ' VAL . 4.7 mt-10 -150.14 104.29 3.26 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' ASP . . . . . 0.546 ' OD2' ' CB ' ' B' ' 314' ' ' ALA . 0.4 OUTLIER -177.37 139.03 0.42 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.95 -1.094 . . . . 0.0 109.559 -178.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.514 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 45.9 Cg_endo -72.87 -173.21 10.54 Favored 'Cis proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.185 -2.006 . . . . 0.0 110.358 -0.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.833 HG21 ' CG1' ' A' ' 74' ' ' VAL . 34.8 m -70.52 81.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -0.968 . . . . 0.0 109.292 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' B' ' 242' ' ' SER . . . -174.57 35.22 0.11 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' B' ' 241' ' ' GLY . 0.5 OUTLIER 70.16 53.25 0.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -1.141 . . . . 0.0 109.786 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . 0.474 ' HB2' ' C ' ' B' ' 238' ' ' ASP . 1.4 mt-10 -130.11 61.37 58.09 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.374 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 50.7 Cg_endo -78.03 169.24 20.76 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.287 1.678 . . . . 0.0 110.822 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.525 ' CG ' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.36 99.09 2.74 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.705 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -91.23 167.62 12.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 110.348 -178.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . 0.517 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 92.42 162.51 37.21 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 1.9 m -75.13 -49.44 19.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -1.16 . . . . 0.0 108.882 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -56.6 -42.24 78.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.275 -0.891 . . . . 0.0 109.122 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -66.44 -55.01 17.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.935 . . . . 0.0 109.362 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.736 HG21 ' CD2' ' B' ' 230' ' ' PHE . 12.6 mm -53.71 -45.54 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' ARG . . . . . 0.832 ' HG3' HD23 ' B' ' 223' ' ' LEU . 8.4 ttm180 -73.39 -57.82 3.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.128 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 31.2 tt0 -45.64 -27.83 0.86 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.095 -1.003 . . . . 0.0 108.704 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' B' ' 250' ' ' ALA . 1.0 OUTLIER -87.49 -71.09 0.58 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 1.085 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -48.24 -24.44 1.18 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . 0.5 ' HB2' HD22 ' B' ' 223' ' ' LEU . . . -79.72 -48.44 13.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.857 . . . . 0.0 108.89 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 257' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 18.4 t30 -60.04 -33.52 72.15 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.34 -0.85 . . . . 0.0 108.743 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 258' ' ' SER . . . . . 0.639 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 9.7 t -71.44 -38.26 71.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 0.92 HD21 ' CA ' ' B' ' 221' ' ' GLY . 9.2 tp -62.59 -21.43 65.62 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.392 -0.818 . . . . 0.0 109.028 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 20.9 mtmt -64.48 -11.12 30.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.313 -0.867 . . . . 0.0 109.178 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 261' ' ' LEU . . . . . 0.982 HD22 ' CD2' ' B' ' 263' ' ' LEU . 0.3 OUTLIER -89.3 117.69 68.44 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 262' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 41.5 Cg_endo -68.72 80.21 0.63 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.833 1.438 . . . . 0.0 110.683 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.982 ' CD2' HD22 ' B' ' 261' ' ' LEU . 0.0 OUTLIER -118.27 165.47 13.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.357 -0.839 . . . . 0.0 109.616 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . 0.707 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -101.8 130.81 48.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -0.816 . . . . 0.0 108.859 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 30.0 t -116.92 114.3 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.031 -1.043 . . . . 0.0 110.085 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 266' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 267' ' ' LEU . 28.7 tt0 -150.33 100.78 2.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.83 . . . . 0.0 109.148 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.527 ' O ' ' CG2' ' B' ' 268' ' ' THR . 0.6 OUTLIER -48.27 177.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.725 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 268' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' B' ' 267' ' ' LEU . 80.8 p -159.16 -37.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.336 -0.852 . . . . 0.0 109.768 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 269' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' B' ' 270' ' ' GLU . 0.0 OUTLIER -93.55 -150.45 0.28 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.563 -0.71 . . . . 0.0 109.427 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' B' ' 269' ' ' GLN . 27.1 tt0 -112.55 130.56 55.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.652 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . 1.074 HG13 ' HB3' ' B' ' 280' ' ' PHE . 75.5 t -67.54 147.71 12.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.356 -0.84 . . . . 0.0 109.082 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.63 ' CZ ' HD11 ' A' ' 98' ' ' ILE . 0.8 OUTLIER -103.71 138.11 40.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.175 -0.953 . . . . 0.0 109.896 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.1 132.32 15.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 274' ' ' VAL . . . . . 0.841 HG11 HG21 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -125.87 -152.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.95 . . . . 0.0 109.797 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' B' ' 274' ' ' VAL . . . -35.7 -96.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.898 -0.502 . . . . 0.0 110.899 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 276' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' B' ' 303' ' ' PHE . 1.9 m-20 -110.42 17.09 21.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.017 -1.052 . . . . 0.0 110.268 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 0.5 OUTLIER -124.33 -160.04 0.91 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.932 -1.105 . . . . 0.0 109.628 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 278' ' ' ALA . . . . . 1.011 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 172.08 160.18 0.1 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.545 -0.722 . . . . 0.0 109.65 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 279' ' ' ALA . . . . . 0.854 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -150.73 133.93 16.16 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . 1.074 ' HB3' HG13 ' B' ' 271' ' ' VAL . 22.6 p90 -150.2 168.5 23.8 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.838 -1.164 . . . . 0.0 110.275 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.958 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -138.46 -164.83 1.7 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 282' ' ' PHE . . . . . 0.439 ' CD2' ' C ' ' B' ' 281' ' ' ALA . 8.2 p90 168.16 -169.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 283' ' ' THR . . . . . 0.463 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -124.07 141.17 52.28 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 109.54 179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 284' ' ' VAL . . . . . 0.75 HG11 HD22 ' B' ' 263' ' ' LEU . 40.0 t -124.35 113.21 35.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.158 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 285' ' ' SER . . . . . 0.707 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 3.5 p -113.76 117.44 31.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.325 -0.86 . . . . 0.0 109.452 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.779 ' CE1' H221 ' B' ' 326' ' ' NTH . 17.0 p90 -123.27 176.27 6.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.19 -0.944 . . . . 0.0 109.555 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 287' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' B' ' 291' ' ' ARG . 29.8 tt0 -128.46 151.93 48.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.555 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.47 ' CE2' ' CZ ' ' B' ' 286' ' ' PHE . 28.1 m-85 -95.16 -107.2 0.14 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.213 -0.93 . . . . 0.0 109.388 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.61 -17.92 7.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.984 -1.072 . . . . 0.0 109.444 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -149.59 -40.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 291' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' B' ' 287' ' ' GLU . 33.1 mtt85 -90.4 -176.91 4.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -1.117 . . . . 0.0 109.417 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 292' ' ' LYS . . . . . 0.468 ' O ' ' CD ' ' B' ' 292' ' ' LYS . 0.0 OUTLIER -136.75 133.95 36.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.312 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 293' ' ' THR . . . . . 0.795 HG22 ' HA ' ' B' ' 323' ' ' ALA . 0.0 OUTLIER -118.32 145.99 44.68 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.186 -0.946 . . . . 0.0 110.094 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 294' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' B' ' 322' ' ' HIS . 11.8 p -116.47 163.74 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.335 -0.853 . . . . 0.0 108.866 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 0.9 HG22 HG23 ' B' ' 321' ' ' ILE . 49.1 t -139.41 156.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.032 -1.043 . . . . 0.0 110.444 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 296' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' B' ' 320' ' ' ASN . . . -142.13 68.73 22.63 Favored Pre-proline 0 N--CA 1.495 1.802 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 297' ' ' PRO . . . . . 0.609 ' HD3' HG12 ' B' ' 295' ' ' VAL . 48.3 Cg_endo -97.03 -175.42 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.877 1.718 . . . . 0.0 111.487 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.958 HG23 ' HB2' ' B' ' 281' ' ' ALA . 3.0 mp -140.44 169.4 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . 0.606 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 39.1 t0 -138.86 158.8 43.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.021 -1.049 . . . . 0.0 110.014 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.533 ' HB2' ' CB ' ' B' ' 313' ' ' ARG . 0.2 OUTLIER -113.87 172.96 6.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.382 -0.824 . . . . 0.0 108.944 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 301' ' ' PHE . . . . . 1.011 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.2 OUTLIER -144.95 146.64 32.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.123 -0.986 . . . . 0.0 110.49 -178.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.549 ' HB3' ' CB ' ' B' ' 311' ' ' SER . 25.4 ttt180 -144.16 108.72 4.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.476 -0.765 . . . . 0.0 108.952 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 303' ' ' PHE . . . . . 0.708 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 37.3 m-85 -89.83 179.88 5.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.799 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 304' ' ' ASN . . . . . 0.635 ' CB ' HG21 ' B' ' 310' ' ' VAL . 0.1 OUTLIER -150.13 16.79 0.85 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.332 -0.855 . . . . 0.0 109.245 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 305' ' ' GLY . . . . . 0.715 ' O ' ' HB3' ' B' ' 306' ' ' ALA . . . 98.21 154.03 28.98 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 306' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 305' ' ' GLY . . . 79.49 -5.68 1.9 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.405 -1.056 . . . . 0.0 109.824 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 83.14 -10.19 58.9 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.3 174.15 4.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.103 -1.233 . . . . 0.0 109.455 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 309' ' ' VAL . . . . . 0.621 HG11 ' CE ' ' B' ' 312' ' ' MET . 95.1 t -109.89 151.9 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.158 -0.964 . . . . 0.0 109.027 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.666 ' O ' ' HB1' ' B' ' 234' ' ' ALA . 53.3 t -137.32 -56.56 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.957 -1.089 . . . . 0.0 110.156 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . 0.549 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -118.48 160.61 21.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.615 -1.303 . . . . 0.0 109.917 -179.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 312' ' ' MET . . . . . 0.621 ' CE ' HG11 ' B' ' 309' ' ' VAL . 10.2 ttm -159.92 141.69 12.92 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.431 -0.793 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 313' ' ' ARG . . . . . 0.533 ' CB ' ' HB2' ' B' ' 300' ' ' HIS . 0.3 OUTLIER -116.95 158.38 24.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.393 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 314' ' ' ALA . . . . . 0.546 ' CB ' ' OD2' ' B' ' 238' ' ' ASP . . . -124.31 138.03 54.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.28 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 315' ' ' LEU . . . . . 0.912 HD11 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -133.73 142.27 47.89 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.137 -0.977 . . . . 0.0 109.89 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 316' ' ' PHE . . . . . 0.543 ' O ' HG13 ' A' ' 74' ' ' VAL . 53.7 p90 171.18 -156.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 317' ' ' GLY . . . . . 0.737 ' O ' HD12 ' B' ' 321' ' ' ILE . . . 154.71 176.59 27.15 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 318' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' B' ' 318' ' ' GLU . 13.4 tt0 -55.43 -17.74 5.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -1.185 . . . . 0.0 109.136 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -87.49 -24.99 23.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.871 0.843 . . . . 0.0 109.077 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 320' ' ' ASN . . . . . 0.708 ' O ' ' HB3' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.27 -34.89 16.44 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 321' ' ' ILE . . . . . 0.9 HG23 HG22 ' B' ' 295' ' ' VAL . 0.9 OUTLIER -86.32 -172.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 322' ' ' HIS . . . . . 0.694 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.0 OUTLIER -151.63 172.8 15.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.091 -1.005 . . . . 0.0 109.814 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.795 ' HA ' HG22 ' B' ' 293' ' ' THR . . . -155.42 85.69 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.402 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -95.58 165.02 24.52 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.261 -1.14 . . . . 0.0 109.558 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' NTH . . . . . 1.086 ' H17' HD13 ' A' ' 61' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 326' ' ' NTH . . . . . 0.906 H121 HD13 ' B' ' 261' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ptt? . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.234 0.54 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.482 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.4 m120 -127.82 126.39 41.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.87 . . . . 0.0 109.308 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.584 ' O ' ' HE2' ' A' ' 7' ' ' MET . 0.6 OUTLIER -90.19 108.98 30.05 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.789 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 2' ' ' ASN . 48.5 Cg_endo -75.03 1.65 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.973 1.512 . . . . 0.0 110.279 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -58.63 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 110.048 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.517 ' NE2' ' HB ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -45.57 -32.75 2.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.115 -0.99 . . . . 0.0 109.279 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 1.014 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 25.3 mtm -70.89 -57.69 4.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 109.732 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 11' ' ' VAL . 16.6 m -58.57 -38.14 77.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.81 -42.66 47.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.195 -0.941 . . . . 0.0 108.652 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.893 HG11 ' CE1' ' A' ' 103' ' ' PHE . 2.9 t -60.03 -20.93 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.867 HG11 HG21 ' A' ' 71' ' ' VAL . 40.0 t -90.47 -47.91 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -58.26 -61.76 2.33 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.125 -0.984 . . . . 0.0 109.022 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.77 ' HB3' HD22 ' A' ' 29' ' ' LEU . 3.2 mtm-85 -53.97 -46.66 71.7 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.909 0.861 . . . . 0.0 108.838 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.632 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -48.72 -42.69 35.93 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.964 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.3 t -88.5 -38.74 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.315 -0.866 . . . . 0.0 109.379 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -48.45 -37.72 18.0 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.608 ' HB3' HG12 ' A' ' 26' ' ' ILE . . . -72.62 -33.76 66.87 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.964 HD12 ' HA ' ' A' ' 15' ' ' VAL . 4.5 mt -65.31 -60.58 2.83 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -51.0 -41.19 59.6 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.567 0.698 . . . . 0.0 109.23 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.31 2.26 54.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.484 -0.76 . . . . 0.0 109.55 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 1.046 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 52.24 41.89 54.96 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.421 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 45.6 t0 -105.17 80.18 1.57 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -1.091 . . . . 0.0 110.052 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.028 ' CD2' HD22 ' A' ' 59' ' ' LEU . 3.9 mm? -51.37 -20.67 1.84 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.188 -0.945 . . . . 0.0 109.745 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -61.12 -54.85 39.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.256 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -64.71 -29.57 75.59 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.028 HD12 HD13 ' A' ' 23' ' ' LEU . 6.9 mt -66.26 -59.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.772 HG21 ' HB2' ' A' ' 52' ' ' ARG . 60.0 t -61.53 -40.55 86.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.13 -51.83 65.19 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.77 HD22 ' HB3' ' A' ' 13' ' ' ARG . 8.6 tp -64.3 -26.4 68.47 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.486 ' HB2' ' HA ' ' A' ' 27' ' ' VAL . 5.2 m-85 -87.57 131.11 34.51 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.495 -0.753 . . . . 0.0 109.766 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -45.44 171.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.834 . . . . 0.0 109.642 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.405 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -61.75 -24.02 66.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.709 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.543 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -141.05 52.03 1.59 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.571 -0.706 . . . . 0.0 109.681 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 110' ' ' VAL . . . -67.16 168.51 10.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.718 HG23 ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -127.76 137.67 52.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.391 -0.818 . . . . 0.0 109.302 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 44' ' ' PRO . 55.8 t -133.29 123.73 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.275 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.511 ' OE2' ' NH1' ' A' ' 113' ' ' ARG . 96.0 mt-10 -89.17 108.4 19.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 108.58 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 39' ' ' PRO . 9.8 t0 -177.99 142.29 0.45 Allowed Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 119.229 -0.989 . . . . 0.0 110.058 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.512 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 47.7 Cg_endo -72.75 -179.24 23.67 Favored 'Cis proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.214 -1.994 . . . . 0.0 110.564 -0.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.702 ' O ' HG23 ' A' ' 40' ' ' VAL . 14.4 m -73.57 112.81 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.511 ' HA2' ' ND2' ' B' ' 276' ' ' ASN . . . 103.99 12.65 29.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.512 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 4.0 m -118.56 -107.04 0.38 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -1.145 . . . . 0.0 109.458 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -166.87 130.64 1.53 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.874 -1.141 . . . . 0.0 109.88 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 41.6 Cg_endo -67.3 -168.25 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.952 1.501 . . . . 0.0 111.201 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.999 ' HG3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -150.43 102.82 3.08 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.718 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.93 152.04 21.42 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.325 -0.86 . . . . 0.0 110.024 -179.151 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 104.43 173.96 25.03 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.457 HG23 HG11 ' A' ' 27' ' ' VAL . 4.7 m -79.36 -68.81 0.63 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.05 -1.265 . . . . 0.0 109.376 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -47.16 -32.92 4.7 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.135 -0.978 . . . . 0.0 109.012 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.999 ' HB1' ' HG3' ' A' ' 45' ' ' ARG . . . -70.96 -51.17 27.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.18 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 47' ' ' GLY . 7.5 mm -58.67 -43.65 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.534 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.772 ' HB2' HG21 ' A' ' 27' ' ' VAL . 18.8 ttt180 -73.29 -56.11 5.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 108.983 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 52' ' ' ARG . 14.6 tt0 -45.74 -27.04 0.74 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 108.617 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -88.27 -71.09 0.6 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.72 0.772 . . . . 0.0 108.918 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.585 ' C ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -52.1 -20.92 2.79 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.476 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 52' ' ' ARG . . . -80.82 -45.52 16.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.175 -0.953 . . . . 0.0 108.452 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 2.4 t30 -56.82 -30.52 63.83 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.4 t -69.92 -37.8 76.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.046 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.0 tp -67.27 -19.68 65.53 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.45 -0.781 . . . . 0.0 109.735 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 2.7 mtmt -56.36 -25.57 49.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.906 HD22 ' CD2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.89 125.69 59.94 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.179 -0.951 . . . . 0.0 109.079 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 86' ' ' PHE . 44.1 Cg_endo -70.78 101.1 1.01 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.759 1.4 . . . . 0.0 110.349 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.906 ' CD2' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -137.99 150.31 46.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.568 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.704 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -89.65 127.52 35.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.193 -0.942 . . . . 0.0 108.793 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 t -108.43 114.01 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 0.0 109.851 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 67' ' ' LEU . 16.8 tt0 -150.44 98.68 2.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.384 -0.822 . . . . 0.0 109.194 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 66' ' ' GLU . 1.8 mp -45.38 170.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.953 . . . . 0.0 109.807 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 t -144.58 -38.63 0.28 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.404 -0.81 . . . . 0.0 109.612 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.508 ' HG3' ' N ' ' A' ' 70' ' ' GLU . 13.9 pt20 -90.92 -146.31 0.19 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.553 -0.717 . . . . 0.0 109.268 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.508 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 23.6 tt0 -115.34 135.2 54.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.106 -0.996 . . . . 0.0 109.768 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.867 HG21 HG11 ' A' ' 11' ' ' VAL . 78.1 t -72.06 145.2 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.293 -0.879 . . . . 0.0 109.345 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.524 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -107.5 135.46 48.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 0.0 109.65 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.014 ' HB1' ' HB3' ' A' ' 7' ' ' MET . . . -150.37 129.79 12.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 109.878 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.83 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -138.38 145.68 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 109.899 179.577 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . 41.68 -101.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.466 -0.771 . . . . 0.0 110.077 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.574 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -121.39 -11.44 8.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.952 -1.092 . . . . 0.0 109.69 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.639 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -89.74 -161.12 0.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.121 -0.987 . . . . 0.0 109.06 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.951 ' HB3' ' CB ' ' A' ' 101' ' ' PHE . . . 169.22 159.38 0.05 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.272 -0.893 . . . . 0.0 109.972 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.973 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -149.96 132.33 15.59 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.861 ' HB3' HG13 ' A' ' 71' ' ' VAL . 37.4 p90 -150.42 168.77 23.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.891 -1.131 . . . . 0.0 110.436 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.838 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -143.8 161.86 37.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.683 -0.636 . . . . 0.0 109.312 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 82' ' ' PHE . 2.1 p90 -157.13 -169.72 3.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.213 -0.929 . . . . 0.0 109.335 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.61 141.12 52.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.457 -0.777 . . . . 0.0 109.903 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.699 HG11 HD22 ' A' ' 63' ' ' LEU . 73.3 t -112.7 114.15 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.704 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 19.5 p -108.69 97.32 6.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.182 -0.949 . . . . 0.0 110.296 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.742 ' CZ ' H221 ' A' ' 126' ' ' NTH . 18.4 p90 -111.17 -176.45 2.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.264 -0.897 . . . . 0.0 108.618 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 91' ' ' ARG . 2.7 tm-20 -148.78 150.33 32.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.885 -1.134 . . . . 0.0 110.126 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.41 ' O ' ' CD ' ' A' ' 87' ' ' GLU . 65.6 m-85 -90.29 -116.07 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.31 1.03 19.83 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.912 -1.117 . . . . 0.0 109.446 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -164.19 -58.8 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 3.3 mtt85 -81.76 158.51 24.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -1.133 . . . . 0.0 109.485 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -119.59 132.44 55.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 109.765 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -114.89 143.84 44.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.863 . . . . 0.0 109.255 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.701 HG23 ' HA ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -117.23 173.44 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 108.922 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 1.005 HG12 ' HD3' ' A' ' 97' ' ' PRO . 2.8 t -145.96 145.93 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 109.32 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.521 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . -127.71 72.95 78.52 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 1.005 ' HD3' HG12 ' A' ' 95' ' ' VAL . 50.0 Cg_endo -91.58 -177.0 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.731 1.385 . . . . 0.0 110.821 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.838 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.5 mp -140.84 142.8 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 13.6 t0 -116.46 160.05 21.14 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.952 -1.092 . . . . 0.0 110.215 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.538 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -113.12 176.25 5.1 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.951 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -148.14 137.86 22.38 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.035 -1.041 . . . . 0.0 109.926 -179.145 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.5 ' HA ' ' HG3' ' A' ' 77' ' ' GLU . 64.2 ttt-85 -141.44 103.15 4.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.893 ' CE1' HG11 ' A' ' 10' ' ' VAL . 10.9 m-30 -92.31 -171.81 2.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.591 ' HB3' HG21 ' A' ' 110' ' ' VAL . 3.6 p30 -112.66 -25.45 9.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . -157.62 -69.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 171.38 73.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -1.103 . . . . 0.0 109.388 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -178.84 -52.44 0.08 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -117.61 174.3 6.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -1.117 . . . . 0.0 109.498 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.623 HG12 ' N ' ' A' ' 110' ' ' VAL . 88.8 t -97.83 167.79 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.069 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.625 ' O ' ' HB1' ' A' ' 34' ' ' ALA . 3.1 t -140.52 -72.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.028 -1.045 . . . . 0.0 109.964 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.437 ' HB2' ' HD3' ' A' ' 102' ' ' ARG . 19.7 m -119.43 163.41 17.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 109.939 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.538 ' CG ' ' O ' ' A' ' 100' ' ' HIS . 2.8 ttp -148.28 164.39 34.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.467 -0.77 . . . . 0.0 109.555 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' NH1' ' OE2' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -143.24 123.45 13.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 109.318 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.429 ' HB3' ' OD2' ' A' ' 38' ' ' ASP . . . -104.99 130.46 53.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.105 -0.997 . . . . 0.0 109.652 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' B' ' 279' ' ' ALA . 0.6 OUTLIER -126.15 147.58 49.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.608 179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.541 ' O ' ' CG1' ' B' ' 274' ' ' VAL . 9.7 p90 174.09 -155.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.56 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 167.8 -179.23 41.26 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.527 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 24.4 tt0 -70.26 -4.77 23.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -1.165 . . . . 0.0 109.694 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -90.62 -29.64 17.66 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -89.29 13.31 13.74 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.198 0.523 . . . . 0.0 109.697 -179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.944 HG23 HG22 ' A' ' 95' ' ' VAL . 4.4 mm -91.91 -163.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.146 -0.971 . . . . 0.0 108.748 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.701 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -151.43 161.63 42.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.427 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.53 113.18 3.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.8 -119.61 4.21 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.29 -1.123 . . . . 0.0 109.545 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.402 ' CE ' ' OE1' ' A' ' 118' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.222 0.534 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.449 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 7.4 m-80 44.94 68.85 0.5 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.568 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . 0.687 HG23 ' O ' ' B' ' 203' ' ' THR . 9.7 t -52.51 107.74 0.91 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 0.0 109.661 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 50.6 Cg_endo -77.2 5.9 4.71 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.912 1.48 . . . . 0.0 110.491 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' B' ' 204' ' ' PRO . 0.0 OUTLIER -40.76 -72.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.289 -0.882 . . . . 0.0 110.183 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' HIS . . . . . 0.59 ' CE1' ' HG3' ' B' ' 207' ' ' MET . 11.8 p80 -54.59 -35.84 63.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 109.957 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . 0.59 ' HG3' ' CE1' ' B' ' 206' ' ' HIS . 15.8 mtt -65.57 -56.92 9.68 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.172 -0.955 . . . . 0.0 109.836 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.466 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 8.2 m -56.18 -31.1 63.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.701 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.99 -51.37 67.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.149 -0.969 . . . . 0.0 108.696 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.82 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.0 OUTLIER -55.56 -20.61 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.853 HG11 HG21 ' B' ' 271' ' ' VAL . 16.2 t -90.24 -43.01 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.553 -0.717 . . . . 0.0 109.123 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' B' ' 213' ' ' ARG . 6.0 tt0 -60.66 -74.09 0.08 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.944 ' HB3' HD22 ' B' ' 229' ' ' LEU . 1.6 mtt-85 -42.3 -44.88 4.03 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.964 0.888 . . . . 0.0 108.605 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' TYR . . . . . 0.581 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 0.6 OUTLIER -49.7 -45.15 48.68 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.891 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.0 OUTLIER -88.24 -38.88 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.309 -0.869 . . . . 0.0 109.097 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' B' ' 213' ' ' ARG . . . -49.1 -35.75 17.03 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -75.3 -31.0 60.53 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.891 HD12 ' HA ' ' B' ' 215' ' ' VAL . 1.1 mt -65.4 -56.4 12.73 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' B' ' 265' ' ' VAL . 0.2 OUTLIER -53.06 -47.31 68.55 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.604 0.716 . . . . 0.0 109.348 179.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.22 6.56 39.65 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.713 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.834 ' HA2' HD11 ' B' ' 259' ' ' LEU . . . 51.48 39.55 44.93 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' B' ' 217' ' ' ALA . 7.9 t0 -96.04 66.48 2.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.306 -1.114 . . . . 0.0 109.893 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' LEU . . . . . 1.107 HD12 HD12 ' B' ' 226' ' ' ILE . 6.1 tp -47.59 -43.34 25.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.163 -0.96 . . . . 0.0 108.909 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' B' ' 223' ' ' LEU . 0.2 OUTLIER -43.59 -38.21 2.88 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -80.6 -29.01 45.23 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 1.107 HD12 HD12 ' B' ' 223' ' ' LEU . 36.9 mt -65.92 -56.27 15.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.743 HG11 HG23 ' B' ' 248' ' ' THR . 77.3 t -59.86 -35.97 63.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.22 -56.21 24.38 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.944 HD22 ' HB3' ' B' ' 213' ' ' ARG . 9.2 tp -59.3 -23.0 62.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . 0.543 ' CD2' HG21 ' B' ' 251' ' ' ILE . 3.9 m-85 -88.92 143.35 26.93 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.41 -0.806 . . . . 0.0 109.484 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -53.79 -170.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.855 . . . . 0.0 109.322 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.441 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.2 OUTLIER -75.61 -24.2 56.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 0.0 109.673 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.542 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 15.1 p30 -145.06 44.2 1.33 Allowed 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.592 -0.693 . . . . 0.0 109.608 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.689 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -55.9 168.53 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.918 . . . . 0.0 109.339 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' THR . . . . . 0.894 HG23 ' HB2' ' B' ' 246' ' ' SER . 0.0 OUTLIER -121.68 142.68 49.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.611 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 32.3 t -131.63 121.16 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 109.507 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' GLU . . . . . 0.511 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 2.1 mt-10 -88.53 112.43 22.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' ASP . . . . . 0.8 ' OD2' ' H61' ' B' ' 326' ' ' NTH . 12.6 t70 -176.08 145.57 0.75 Allowed Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.265 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.549 ' O ' ' HA ' ' B' ' 238' ' ' ASP . 53.6 Cg_endo -79.66 -92.41 0.0 OUTLIER 'Cis proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.506 -1.872 . . . . 0.0 110.915 -0.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.38 126.55 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.912 -1.118 . . . . 0.0 108.95 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 86.53 -8.37 75.26 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' SER . . . . . 0.545 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 0.2 OUTLIER -97.93 -146.24 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -1.062 . . . . 0.0 109.152 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -135.17 141.78 39.29 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.882 -1.136 . . . . 0.0 110.247 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' PRO . . . . . 0.539 ' CB ' ' O ' ' B' ' 236' ' ' VAL . 38.4 Cg_endo -64.55 -169.5 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.271 1.669 . . . . 0.0 110.883 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.965 ' HB3' ' HB1' ' B' ' 250' ' ' ALA . 1.5 mtt-85 -150.34 101.77 3.01 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.894 ' HB2' HG23 ' B' ' 235' ' ' THR . 0.0 OUTLIER -89.2 164.38 15.0 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.307 -0.87 . . . . 0.0 110.119 -179.03 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . 0.602 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 98.39 160.45 30.17 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' THR . . . . . 0.743 HG23 HG11 ' B' ' 227' ' ' VAL . 4.1 m -74.32 -33.15 63.08 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.167 -1.196 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -72.63 -43.88 62.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.281 -0.887 . . . . 0.0 109.34 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.965 ' HB1' ' HB3' ' B' ' 245' ' ' ARG . . . -67.75 -56.97 7.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.445 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.689 HD11 ' N ' ' B' ' 234' ' ' ALA . 43.2 mt -47.53 -40.27 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -0.878 . . . . 0.0 108.885 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' ARG . . . . . 0.812 ' CG ' HD23 ' B' ' 223' ' ' LEU . 25.1 ttp85 -78.02 -52.72 8.35 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 4.0 mt-10 -50.82 -26.53 5.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 108.472 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.57 ' CD1' ' HG3' ' B' ' 245' ' ' ARG . 0.8 OUTLIER -87.65 -71.36 0.57 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 1.02 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.1 OUTLIER -48.95 -33.26 10.56 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . 0.568 ' HB2' ' CD2' ' B' ' 223' ' ' LEU . . . -63.8 -49.71 71.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 257' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 8.5 t30 -54.99 -36.49 65.48 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 258' ' ' SER . . . . . 0.657 ' HB2' ' H10' ' B' ' 326' ' ' NTH . 4.7 t -65.63 -36.19 82.99 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.429 -0.794 . . . . 0.0 108.961 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 0.834 HD11 ' HA2' ' B' ' 221' ' ' GLY . 8.1 tp -67.07 -22.5 65.84 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.493 -0.754 . . . . 0.0 109.189 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . 0.488 ' O ' ' HD3' ' B' ' 262' ' ' PRO . 1.2 mttm -56.25 -20.34 17.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.132 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 261' ' ' LEU . . . . . 0.969 ' CD2' HD21 ' B' ' 263' ' ' LEU . 0.3 OUTLIER -92.35 107.38 23.15 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 262' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' B' ' 260' ' ' LYS . 49.4 Cg_endo -74.44 107.4 2.44 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.822 1.433 . . . . 0.0 112.151 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.969 HD21 ' CD2' ' B' ' 261' ' ' LEU . 0.0 OUTLIER -141.91 -162.83 1.46 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 0.0 109.567 178.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -123.67 125.84 45.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . 0.77 HG21 ' HB3' ' B' ' 218' ' ' LEU . 21.6 t -105.4 119.11 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.97 . . . . 0.0 109.806 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 266' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' B' ' 267' ' ' LEU . 0.2 OUTLIER -147.88 107.33 3.93 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.234 -0.916 . . . . 0.0 109.284 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 266' ' ' GLU . 0.7 OUTLIER -49.77 -179.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.905 . . . . 0.0 109.574 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.15 -39.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 109.677 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 269' ' ' GLN . . . . . 0.692 ' NE2' ' HB3' ' B' ' 281' ' ' ALA . 8.9 pt20 -98.72 -148.62 0.34 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 109.231 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 28.1 tt0 -113.11 131.25 55.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.106 -0.996 . . . . 0.0 109.516 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' B' ' 280' ' ' PHE . 48.1 t -65.6 148.52 12.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.233 -0.917 . . . . 0.0 109.12 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 1.2 mtt180 -103.24 133.49 48.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -0.95 . . . . 0.0 109.732 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -150.14 137.44 19.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.878 . . . . 0.0 109.368 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 274' ' ' VAL . . . . . 0.555 ' CB ' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -130.02 -152.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 0.0 109.589 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' B' ' 274' ' ' VAL . . . -32.67 -91.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.147 0.498 . . . . 0.0 110.799 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 276' ' ' ASN . . . . . 0.511 ' ND2' ' HA2' ' A' ' 41' ' ' GLY . 11.2 p30 -112.54 -18.18 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.944 -1.098 . . . . 0.0 110.269 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 2.8 mt-10 -90.62 -163.27 1.0 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 109.578 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 278' ' ' ALA . . . . . 0.76 ' HB3' ' HB3' ' B' ' 301' ' ' PHE . . . 174.89 163.79 0.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.516 -0.74 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 279' ' ' ALA . . . . . 0.756 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -150.55 138.81 20.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 108.623 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . 0.9 ' HB3' HG13 ' B' ' 271' ' ' VAL . 33.3 p90 -150.39 167.25 27.63 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.71 -1.244 . . . . 0.0 110.462 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 1.002 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -142.96 151.7 41.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.719 -0.613 . . . . 0.0 109.378 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 282' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' B' ' 282' ' ' PHE . 1.2 p90 -145.37 -169.95 3.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.181 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.57 142.95 47.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.461 -0.774 . . . . 0.0 109.961 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 284' ' ' VAL . . . . . 0.899 ' CG1' HD22 ' B' ' 263' ' ' LEU . 2.9 t -125.86 115.54 43.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 285' ' ' SER . . . . . 0.655 ' HB3' HG23 ' B' ' 294' ' ' VAL . 53.1 p -119.7 106.02 11.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 109.988 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.772 ' CD1' HD23 ' B' ' 263' ' ' LEU . 13.6 p90 -114.41 173.82 6.26 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.0 108.846 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 287' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.11 157.09 16.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.024 -1.048 . . . . 0.0 110.803 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.54 ' O ' ' N ' ' B' ' 290' ' ' GLY . 0.0 OUTLIER -117.57 74.09 0.92 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.594 -0.691 . . . . 0.0 109.147 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . 0.513 ' CG ' ' C ' ' B' ' 288' ' ' PHE . 0.2 OUTLIER 43.94 -91.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.062 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 290' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' B' ' 288' ' ' PHE . . . -101.0 7.11 57.01 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.295 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 291' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -132.72 -178.94 5.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -1.22 . . . . 0.0 109.803 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 292' ' ' LYS . . . . . 0.535 ' O ' ' CA ' ' B' ' 324' ' ' GLY . 1.6 mmtp -122.42 144.2 49.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -0.84 . . . . 0.0 109.344 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 293' ' ' THR . . . . . 0.636 ' CB ' ' HB2' ' B' ' 322' ' ' HIS . 0.0 OUTLIER -140.22 159.19 42.73 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.148 -0.97 . . . . 0.0 109.364 -179.06 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 294' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 295' ' ' VAL . 3.9 p -151.65 -177.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 120.686 -1.259 . . . . 0.0 110.266 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 1.047 HG12 ' HD3' ' B' ' 297' ' ' PRO . 29.0 t -151.95 148.89 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.106 -1.621 . . . . 0.0 109.187 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 296' ' ' ALA . . . . . 0.428 ' N ' ' HD3' ' B' ' 297' ' ' PRO . . . -145.07 67.84 13.58 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.068 -1.02 . . . . 0.0 110.238 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 297' ' ' PRO . . . . . 1.047 ' HD3' HG12 ' B' ' 295' ' ' VAL . 50.0 Cg_endo -98.03 -175.78 0.22 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.94 1.76 . . . . 0.0 111.018 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 1.002 HG23 ' HB2' ' B' ' 281' ' ' ALA . 2.9 mp -139.88 147.29 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . 0.617 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 9.4 t0 -118.42 157.83 26.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.858 -1.151 . . . . 0.0 110.223 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.525 ' O ' ' CG ' ' B' ' 312' ' ' MET . 0.3 OUTLIER -110.52 172.3 6.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.336 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 301' ' ' PHE . . . . . 0.76 ' HB3' ' HB3' ' B' ' 278' ' ' ALA . 0.1 OUTLIER -146.48 133.94 20.83 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.048 -1.032 . . . . 0.0 110.129 -178.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.497 ' HG2' ' HG3' ' B' ' 277' ' ' GLU . 0.3 OUTLIER -139.69 111.96 7.63 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 303' ' ' PHE . . . . . 0.67 ' CE1' HG11 ' B' ' 210' ' ' VAL . 8.3 m-30 -91.87 177.63 6.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.268 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 304' ' ' ASN . . . . . 0.617 ' N ' HG21 ' B' ' 310' ' ' VAL . 6.7 p30 -92.61 -28.9 16.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.931 . . . . 0.0 109.276 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 305' ' ' GLY . . . . . 0.714 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -166.53 -50.74 0.03 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 306' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 163.04 76.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -1.135 . . . . 0.0 109.336 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.52 -63.71 0.06 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.53 -163.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -1.179 . . . . 0.0 109.841 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 309' ' ' VAL . . . . . 0.972 HG11 ' HE1' ' B' ' 312' ' ' MET . 17.0 t -106.98 168.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.338 -0.851 . . . . 0.0 109.162 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.639 ' O ' ' HB1' ' B' ' 234' ' ' ALA . 24.6 t -139.86 -73.2 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 0.0 109.919 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' B' ' 235' ' ' THR . 9.3 m -125.38 163.24 23.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.185 -0.947 . . . . 0.0 110.164 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 312' ' ' MET . . . . . 0.972 ' HE1' HG11 ' B' ' 309' ' ' VAL . 0.0 OUTLIER -143.44 171.3 14.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -0.822 . . . . 0.0 109.487 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 313' ' ' ARG . . . . . 0.504 ' NH2' HD12 ' B' ' 315' ' ' LEU . 1.5 ttp85 -150.2 120.0 7.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 109.571 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 314' ' ' ALA . . . . . 0.621 ' HB1' ' HE2' ' B' ' 316' ' ' PHE . . . -101.07 136.63 40.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.977 . . . . 0.0 109.721 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 315' ' ' LEU . . . . . 0.973 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -126.24 148.7 49.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.896 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 316' ' ' PHE . . . . . 0.83 ' O ' HG11 ' A' ' 74' ' ' VAL . 2.2 p90 168.22 -169.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 317' ' ' GLY . . . . . 0.589 ' HA2' HG11 ' A' ' 74' ' ' VAL . . . -157.24 167.58 33.94 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.262 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 318' ' ' GLU . . . . . 0.548 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 5.8 tt0 -63.81 -9.88 17.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.43 -1.041 . . . . 0.0 109.889 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -88.37 -32.81 18.19 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 109.416 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 320' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.44 28.64 4.03 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 321' ' ' ILE . . . . . 0.564 HG22 ' N ' ' B' ' 322' ' ' HIS . 19.5 mm -91.01 -120.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.005 -1.059 . . . . 0.0 110.332 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 322' ' ' HIS . . . . . 0.795 ' CD2' H212 ' B' ' 326' ' ' NTH . 14.4 p80 -125.69 134.25 51.88 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.016 -1.052 . . . . 0.0 112.489 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' B' ' 324' ' ' GLY . . . -159.54 122.13 3.5 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.393 -0.817 . . . . 0.0 109.841 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' B' ' 292' ' ' LYS . . . 40.94 -117.96 1.13 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.274 -1.133 . . . . 0.0 109.391 179.944 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' NTH . . . . . 0.742 H221 ' CZ ' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 326' ' ' NTH . . . . . 0.8 ' H61' ' OD2' ' B' ' 238' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.276 0.56 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.461 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 5.8 m-20 55.37 43.08 29.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.451 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.501 HG23 ' NE2' ' A' ' 6' ' ' HIS . 1.3 t -75.38 112.14 17.4 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.707 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.54 ' HA ' ' HB2' ' A' ' 7' ' ' MET . 46.3 Cg_endo -73.9 -0.46 9.49 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.863 1.454 . . . . 0.0 110.185 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.19 -92.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.602 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.501 ' NE2' HG23 ' A' ' 3' ' ' THR . 1.6 p-80 -52.54 -41.28 63.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.143 -0.973 . . . . 0.0 109.259 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.54 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 34.5 mmt -53.17 -39.86 63.93 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.199 -0.938 . . . . 0.0 109.788 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.43 ' O ' ' HB ' ' A' ' 11' ' ' VAL . 6.0 m -74.19 -36.63 64.02 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.21 -43.81 64.44 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.082 ' HA ' HD21 ' A' ' 29' ' ' LEU . 2.1 t -49.55 -33.93 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.859 HG22 ' CE2' ' A' ' 101' ' ' PHE . 29.9 t -76.33 -45.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.438 -0.789 . . . . 0.0 109.791 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 13' ' ' ARG . 17.0 tt0 -59.4 -73.68 0.08 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.212 1.006 . . . . 0.0 108.494 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' GLN . 1.3 mtt180 -42.68 -44.91 4.5 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.636 ' CE1' ' CD1' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -49.5 -44.98 46.51 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.936 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.3 t -88.88 -38.72 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.334 -0.854 . . . . 0.0 109.243 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . . . -48.94 -36.47 17.44 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB1' HG13 ' A' ' 26' ' ' ILE . . . -74.0 -32.58 63.47 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.936 HD12 ' HA ' ' A' ' 15' ' ' VAL . 2.4 mt -64.96 -58.75 5.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -51.14 -45.8 61.77 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 21' ' ' GLY . . . -89.58 10.19 23.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.64 -0.662 . . . . 0.0 109.459 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 1.06 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 45.7 31.92 4.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' ALA . 7.6 t70 -89.75 66.19 7.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.501 -0.999 . . . . 0.0 109.804 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.097 HD11 ' HB3' ' A' ' 55' ' ' PHE . 8.2 tp -47.9 -42.61 27.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 108.962 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -42.03 -32.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.4 -36.82 10.29 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.019 HD12 HD12 ' A' ' 23' ' ' LEU . 25.3 mt -59.32 -54.07 39.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.513 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 52.4 t -58.18 -40.9 79.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.22 -52.73 60.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.082 HD21 ' HA ' ' A' ' 10' ' ' VAL . 9.6 tp -61.71 -27.89 69.02 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.679 ' CG ' HG21 ' A' ' 51' ' ' ILE . 5.6 m-85 -79.08 128.33 33.14 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.556 -0.715 . . . . 0.0 109.811 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -45.86 172.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 109.655 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.431 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -60.08 -24.15 64.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 109.87 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.558 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -148.01 38.66 0.91 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.58 -0.7 . . . . 0.0 109.506 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.676 ' O ' HD11 ' A' ' 51' ' ' ILE . . . -54.91 173.65 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.632 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.564 ' CG2' ' HB3' ' A' ' 46' ' ' SER . 0.0 OUTLIER -114.57 140.09 49.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.426 -0.796 . . . . 0.0 109.127 179.657 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.561 HG11 ' CD2' ' A' ' 54' ' ' PHE . 1.2 t -113.43 171.83 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 108.715 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.609 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -151.26 121.11 7.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.882 . . . . 0.0 108.873 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.58 ' OD2' ' H62' ' A' ' 126' ' ' NTH . 0.2 OUTLIER 172.69 148.2 0.2 Allowed Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.549 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.581 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 46.7 Cg_endo -80.93 -84.38 0.0 OUTLIER 'Cis proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.165 -2.015 . . . . 0.0 110.599 -0.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.773 ' O ' ' HB2' ' B' ' 275' ' ' ALA . 2.2 m -146.95 73.71 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.222 -0.924 . . . . 0.0 109.203 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.29 -5.5 3.88 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.581 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 3.4 t -97.27 -131.04 0.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.19 -1.183 . . . . 0.0 109.199 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -138.62 128.37 14.7 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.565 -1.334 . . . . 0.0 110.423 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.609 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 37.9 Cg_endo -62.5 -175.56 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.707 1.605 . . . . 0.0 111.055 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.824 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -151.11 100.52 2.78 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.895 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -90.37 171.58 9.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.205 -0.935 . . . . 0.0 110.63 -178.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 33' ' ' ASP . . . 95.77 154.85 30.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 5.5 m -64.7 -36.83 85.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.19 -1.182 . . . . 0.0 109.259 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -70.79 -43.97 67.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.154 -0.966 . . . . 0.0 109.319 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.895 ' HB3' ' O ' ' A' ' 46' ' ' SER . . . -74.41 -57.13 4.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.679 HG21 ' CG ' ' A' ' 30' ' ' PHE . 43.0 mt -43.71 -37.11 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.235 -0.916 . . . . 0.0 109.052 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.513 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 2.5 ttt180 -81.25 -63.62 1.36 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.0 109.147 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 4.2 tt0 -45.11 -28.75 0.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.934 . . . . 0.0 108.825 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.561 ' CD2' HG11 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -79.88 -71.42 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 1.097 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -46.62 -25.75 0.77 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.632 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -71.2 -47.17 59.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 11.1 t-20 -57.51 -30.87 65.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.388 -0.82 . . . . 0.0 108.793 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.566 ' OG ' ' H10' ' A' ' 126' ' ' NTH . 35.6 t -72.55 -40.83 66.37 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.06 HD21 ' CA ' ' A' ' 21' ' ' GLY . 9.0 tp -65.11 -21.93 66.87 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.453 -0.779 . . . . 0.0 109.273 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 4.8 mttp -47.47 -27.5 1.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.043 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.843 HD13 H183 ' A' ' 126' ' ' NTH . 0.3 OUTLIER -90.03 107.72 21.26 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.306 -0.871 . . . . 0.0 108.718 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 44.5 Cg_endo -70.93 116.09 4.53 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.795 1.419 . . . . 0.0 110.675 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.038 HD13 HG13 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -150.3 -171.13 3.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.969 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.59 126.84 54.71 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.822 HG21 ' HB3' ' A' ' 18' ' ' LEU . 2.2 t -105.38 123.52 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 109.895 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -150.23 98.71 2.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.141 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 66' ' ' GLU . 2.1 mp -44.87 170.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 110.039 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 69' ' ' GLN . 0.6 OUTLIER -129.27 -83.3 0.56 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 68' ' ' THR . 2.8 pt20 -59.37 -148.07 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.675 -0.641 . . . . 0.0 109.319 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.45 ' N ' ' HG3' ' A' ' 69' ' ' GLN . 31.6 tt0 -109.1 132.43 54.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.056 -1.028 . . . . 0.0 109.647 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.888 HG13 ' HB3' ' A' ' 80' ' ' PHE . 48.7 t -57.4 149.48 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.293 -0.88 . . . . 0.0 109.259 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -114.28 132.91 55.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.029 -1.044 . . . . 0.0 109.968 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . . . -150.17 112.04 4.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.39 -0.819 . . . . 0.0 109.253 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.769 HG21 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -131.81 158.71 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.225 -0.922 . . . . 0.0 109.501 -179.814 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 48.58 -147.52 0.26 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.304 -0.873 . . . . 0.0 109.622 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -82.24 -24.12 34.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 102' ' ' ARG . 3.3 mt-10 -89.92 -162.41 0.88 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.111 -0.993 . . . . 0.0 109.539 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.681 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . -178.46 168.95 1.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.522 -0.736 . . . . 0.0 109.366 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.818 ' HB2' HD13 ' B' ' 315' ' ' LEU . . . -150.17 136.27 18.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.155 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.888 ' HB3' HG13 ' A' ' 71' ' ' VAL . 14.4 p90 -149.79 162.25 40.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.95 -1.094 . . . . 0.0 110.15 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.958 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -136.45 -173.0 3.29 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.638 0.732 . . . . 0.0 110.118 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.527 ' CD2' ' C ' ' A' ' 81' ' ' ALA . 6.0 p90 177.08 -169.81 0.07 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 1.011 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -133.33 140.41 47.39 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 110.042 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.038 HG13 HD13 ' A' ' 63' ' ' LEU . 37.7 t -107.94 113.35 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.533 ' CA ' HG23 ' A' ' 94' ' ' VAL . 33.6 p -108.12 84.7 1.99 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 109.743 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.904 ' CE1' H212 ' A' ' 126' ' ' NTH . 15.5 p90 -93.62 -179.21 4.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.083 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 18.5 tt0 -111.36 149.59 30.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.034 -1.041 . . . . 0.0 110.325 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.58 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -114.19 104.98 12.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.453 -0.779 . . . . 0.0 109.021 179.443 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.497 ' CG ' ' C ' ' A' ' 88' ' ' PHE . 1.1 pt20 40.74 -93.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.412 -0.805 . . . . 0.0 109.894 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 88' ' ' PHE . . . -101.9 -31.84 5.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -90.08 -178.27 5.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -1.232 . . . . 0.0 109.632 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.497 ' HE3' ' OXT' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -127.46 140.63 52.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.584 ' HB ' ' CE1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -124.59 159.81 29.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.393 -0.817 . . . . 0.0 109.645 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.644 HG22 ' H ' ' A' ' 95' ' ' VAL . 7.2 p -139.28 174.88 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.165 -0.96 . . . . 0.0 109.31 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 1.011 ' O ' HG22 ' A' ' 83' ' ' THR . 78.3 t -142.94 163.12 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.078 -1.014 . . . . 0.0 109.942 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.576 ' N ' HG12 ' A' ' 95' ' ' VAL . . . -138.0 70.63 49.32 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.527 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.523 ' HD3' HG12 ' A' ' 95' ' ' VAL . 46.1 Cg_endo -97.83 179.25 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.871 1.714 . . . . 0.0 111.447 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.958 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.8 mp -142.06 156.25 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.597 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 19.9 t0 -130.16 159.58 36.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.967 -1.083 . . . . 0.0 110.072 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 113' ' ' ARG . 85.9 t60 -109.87 170.74 7.88 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.859 ' CE2' HG22 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -140.85 136.02 31.95 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.07 -1.018 . . . . 0.0 110.006 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.541 ' HA ' ' CG ' ' A' ' 77' ' ' GLU . 3.2 ttt85 -131.3 109.13 10.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.871 ' CE1' HG11 ' A' ' 10' ' ' VAL . 10.1 m-85 -108.42 -177.48 3.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 107' ' ' GLY . 6.1 p30 -106.72 6.34 29.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.573 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.685 ' O ' ' HB2' ' A' ' 106' ' ' ALA . . . 120.51 -30.51 5.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 105' ' ' GLY . . . 164.36 37.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -1.151 . . . . 0.0 109.364 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.556 ' O ' ' CB ' ' A' ' 108' ' ' LYS . . . -130.58 47.62 1.01 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 7.3 mmtt 84.19 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.055 -0.674 . . . . 0.0 109.421 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.78 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 40.4 t -89.83 166.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 109.329 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.597 ' N ' HG12 ' A' ' 109' ' ' VAL . 72.3 t -138.19 -59.78 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.531 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.528 ' HB2' ' CD ' ' A' ' 102' ' ' ARG . 1.1 m -139.6 163.5 32.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.612 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.516 ' HG3' ' O ' ' A' ' 100' ' ' HIS . 0.9 OUTLIER -145.45 155.37 43.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.883 . . . . 0.0 109.779 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -141.31 108.18 5.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.376 -0.828 . . . . 0.0 108.985 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.505 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . . . -89.89 148.02 23.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.071 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' B' ' 279' ' ' ALA . 1.4 tt -136.36 139.98 42.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.433 -0.792 . . . . 0.0 109.575 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.783 ' O ' HG21 ' B' ' 274' ' ' VAL . 2.8 p90 172.42 -158.44 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.624 0.726 . . . . 0.0 109.4 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.586 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 174.49 179.85 45.36 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.528 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 18.6 tt0 -72.73 -3.22 23.86 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.311 -1.111 . . . . 0.0 109.397 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -91.16 -29.15 17.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.946 0.879 . . . . 0.0 108.996 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -88.85 15.95 7.64 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.324 0.583 . . . . 0.0 109.712 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.809 HG23 HG22 ' A' ' 95' ' ' VAL . 4.0 mm -89.97 -162.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.621 ' H ' HG22 ' A' ' 121' ' ' ILE . 2.9 t-80 -151.67 153.56 34.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.862 -1.149 . . . . 0.0 110.047 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.446 ' HA ' HG22 ' A' ' 93' ' ' THR . . . -155.8 125.3 6.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.336 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.12 -164.95 32.59 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.497 ' OXT' ' HE3' ' A' ' 92' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.325 -1.103 . . . . 0.0 109.45 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.427 ' O ' ' C ' ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.251 0.548 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.471 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 30.7 m120 43.7 74.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.484 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . 0.611 HG23 ' O ' ' B' ' 203' ' ' THR . 4.8 t -87.64 109.61 27.95 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.625 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' B' ' 202' ' ' ASN . 46.4 Cg_endo -72.93 -1.35 10.34 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.91 1.479 . . . . 0.0 110.245 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -49.39 72.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -66.15 -55.0 18.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.504 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . 0.533 ' HB3' ' HB1' ' B' ' 273' ' ' ALA . 69.2 mtm -58.32 -43.72 88.32 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.231 -0.918 . . . . 0.0 109.781 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' B' ' 211' ' ' VAL . 19.1 m -70.79 -42.04 70.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.574 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.35 -45.2 65.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 108.747 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.928 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.3 t -56.99 -20.64 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.926 HG11 HG21 ' B' ' 271' ' ' VAL . 10.7 t -90.29 -41.95 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 0.0 109.198 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' B' ' 213' ' ' ARG . 14.0 tt0 -60.49 -74.77 0.07 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.95 ' HB3' HD22 ' B' ' 229' ' ' LEU . 0.0 OUTLIER -42.09 -43.43 3.26 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 122.137 0.97 . . . . 0.0 108.697 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' TYR . . . . . 0.635 ' CE1' ' CD1' ' B' ' 218' ' ' LEU . 1.2 t80 -55.84 -49.27 73.76 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.415 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.854 ' HA ' HD12 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -83.01 -42.58 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.722 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -47.45 -36.67 10.36 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' B' ' 222' ' ' ASP . . . -74.89 -32.98 61.98 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.854 HD12 ' HA ' ' B' ' 215' ' ' VAL . 0.9 OUTLIER -62.68 -56.18 20.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' B' ' 265' ' ' VAL . 4.0 t-20 -53.24 -48.41 68.24 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.652 0.739 . . . . 0.0 109.523 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.01 10.0 23.13 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.845 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.628 ' HA2' HD11 ' B' ' 259' ' ' LEU . . . 50.06 37.83 30.72 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' B' ' 217' ' ' ALA . 9.4 t0 -93.03 61.29 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.332 -1.099 . . . . 0.0 109.815 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' LEU . . . . . 1.086 HD11 ' HB3' ' B' ' 255' ' ' PHE . 5.8 tp -46.2 -42.53 14.27 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.153 -0.967 . . . . 0.0 108.648 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -43.7 -37.88 2.86 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -81.78 -33.46 27.26 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 1.027 HD12 HD12 ' B' ' 223' ' ' LEU . 27.9 mt -61.25 -55.18 26.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.523 ' CG2' ' HB2' ' B' ' 252' ' ' ARG . 88.8 t -58.02 -37.13 59.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.19 25.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.95 HD22 ' HB3' ' B' ' 213' ' ' ARG . 9.8 tp -59.71 -24.39 63.94 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . 0.477 ' HB2' ' HA ' ' B' ' 227' ' ' VAL . 5.1 m-85 -82.59 136.62 34.77 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.494 -0.754 . . . . 0.0 109.362 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.844 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -52.33 -174.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.382 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.449 ' O ' ' OG1' ' B' ' 248' ' ' THR . 0.3 OUTLIER -69.67 -26.38 64.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.445 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.54 ' HA ' ' HA2' ' B' ' 247' ' ' GLY . 3.5 p30 -151.4 54.87 0.86 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.498 -0.751 . . . . 0.0 109.68 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.697 ' N ' HD11 ' B' ' 251' ' ' ILE . . . -60.36 -167.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' THR . . . . . 0.473 ' CG2' ' HB2' ' B' ' 246' ' ' SER . 0.2 OUTLIER -130.6 133.96 46.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.895 . . . . 0.0 109.244 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.569 HG12 ' N ' ' B' ' 237' ' ' GLU . 23.1 t -111.95 167.66 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -0.865 . . . . 0.0 109.188 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' GLU . . . . . 0.569 ' N ' HG12 ' B' ' 236' ' ' VAL . 21.8 mt-10 -150.88 115.54 5.19 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' ASP . . . . . 0.539 ' OD1' ' HA ' ' B' ' 239' ' ' PRO . 0.6 OUTLIER -177.11 148.17 0.73 Allowed Pre-proline 0 N--CA 1.491 1.582 0 C-N-CA 118.355 -1.338 . . . . 0.0 110.38 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.539 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 47.6 Cg_endo -73.34 -55.32 0.14 OUTLIER 'Cis proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.941 -2.108 . . . . 0.0 110.989 -0.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.64 HG23 ' O ' ' B' ' 240' ' ' VAL . 34.6 m -150.43 111.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 109.792 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . 53.14 43.39 63.12 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' SER . . . . . 0.534 ' CB ' ' HD2' ' B' ' 239' ' ' PRO . 73.7 m -114.73 -96.57 0.45 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -1.117 . . . . 0.0 109.944 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . 0.437 ' HA ' ' HD2' ' B' ' 244' ' ' PRO . 0.0 OUTLIER -142.86 89.9 7.82 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.272 -0.893 . . . . 0.0 110.609 -179.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' PRO . . . . . 0.564 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.9 Cg_endo -63.38 179.57 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.117 1.588 . . . . 0.0 110.507 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.753 ' HB3' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.64 100.46 2.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.952 . . . . 0.0 109.629 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.835 ' O ' ' HB3' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -89.79 167.05 13.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.32 -0.863 . . . . 0.0 109.64 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . 0.628 ' O ' HD12 ' B' ' 251' ' ' ILE . . . 97.78 159.5 30.66 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' B' ' 232' ' ' ASP . 2.1 m -69.58 -38.57 77.41 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.946 -1.326 . . . . 0.0 109.145 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -69.48 -41.4 76.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.835 ' HB3' ' O ' ' B' ' 246' ' ' SER . . . -72.92 -56.99 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.623 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.697 HD11 ' N ' ' B' ' 234' ' ' ALA . 30.0 mt -46.67 -42.26 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.188 -0.945 . . . . 0.0 108.772 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' ARG . . . . . 0.735 ' CG ' HD23 ' B' ' 223' ' ' LEU . 8.3 ttt180 -79.08 -50.75 10.55 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 46.4 mt-10 -51.12 -31.03 18.05 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' B' ' 245' ' ' ARG . 1.1 t80 -83.47 -71.93 0.48 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 1.086 ' HB3' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -46.0 -26.34 0.7 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' B' ' 252' ' ' ARG . . . -70.65 -48.26 55.86 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 257' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 4.7 t-20 -61.98 -31.02 71.34 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 258' ' ' SER . . . . . 0.796 ' OG ' ' H11' ' B' ' 326' ' ' NTH . 2.8 t -71.56 -32.59 68.28 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 0.628 HD11 ' HA2' ' B' ' 221' ' ' GLY . 8.7 tp -66.19 -22.15 66.34 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 16.1 mtmt -61.51 -13.57 22.26 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 261' ' ' LEU . . . . . 0.867 HD12 ' CG ' ' B' ' 263' ' ' LEU . 0.1 OUTLIER -88.63 110.46 37.26 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 179.248 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 262' ' ' PRO . . . . . 0.777 ' HD2' HD13 ' B' ' 261' ' ' LEU . 52.1 Cg_endo -80.94 91.68 1.12 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.705 1.371 . . . . 0.0 112.328 -178.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.976 HD23 ' CD1' ' B' ' 286' ' ' PHE . 0.0 OUTLIER -138.48 163.77 31.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.082 -1.011 . . . . 0.0 108.819 178.186 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . 0.875 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -89.81 127.27 35.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.18 -0.95 . . . . 0.0 109.021 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . 0.507 ' O ' ' ND2' ' B' ' 219' ' ' ASN . 93.9 t -104.44 112.44 38.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.269 -0.895 . . . . 0.0 109.528 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 266' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' B' ' 267' ' ' LEU . 1.6 tp10 -147.47 98.14 2.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.053 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.528 ' HA ' ' CB ' ' B' ' 282' ' ' PHE . 1.7 mp -44.41 169.35 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 110.059 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 268' ' ' THR . . . . . 0.502 ' OG1' ' N ' ' B' ' 269' ' ' GLN . 0.4 OUTLIER -122.28 -83.08 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 269' ' ' GLN . . . . . 0.502 ' N ' ' OG1' ' B' ' 268' ' ' THR . 2.6 pt20 -61.17 -140.4 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -117.57 130.67 56.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.875 -1.141 . . . . 0.0 109.993 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . 1.021 HG13 ' HB3' ' B' ' 280' ' ' PHE . 56.5 t -48.71 149.19 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.355 -0.841 . . . . 0.0 108.936 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.838 HH21 HD12 ' A' ' 98' ' ' ILE . 31.1 mtp85 -108.11 129.18 55.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.043 -1.036 . . . . 0.0 109.714 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . 0.589 ' C ' HG22 ' B' ' 274' ' ' VAL . . . -143.91 144.95 31.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.292 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 274' ' ' VAL . . . . . 0.783 HG21 ' O ' ' A' ' 116' ' ' PHE . 0.0 OUTLIER -167.31 146.55 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 109.099 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . 0.773 ' HB2' ' O ' ' A' ' 40' ' ' VAL . . . 58.27 -139.11 0.81 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.093 -1.005 . . . . 0.0 109.094 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 276' ' ' ASN . . . . . 0.544 ' O ' ' CD1' ' B' ' 303' ' ' PHE . 18.0 m-20 -91.31 -31.26 16.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.977 -1.077 . . . . 0.0 109.891 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . 0.683 ' HG2' ' N ' ' B' ' 278' ' ' ALA . 0.0 OUTLIER -97.99 153.6 18.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 109.647 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 278' ' ' ALA . . . . . 0.683 ' N ' ' HG2' ' B' ' 277' ' ' GLU . . . -136.04 169.66 17.25 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.388 0.613 . . . . 0.0 109.877 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 279' ' ' ALA . . . . . 0.759 ' HB2' HD13 ' A' ' 115' ' ' LEU . . . -141.66 141.66 33.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.388 -0.82 . . . . 0.0 109.182 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . 1.021 ' HB3' HG13 ' B' ' 271' ' ' VAL . 36.0 p90 -150.26 157.92 43.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.848 -1.158 . . . . 0.0 110.324 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 1.051 ' HB2' HG23 ' B' ' 298' ' ' ILE . . . -137.26 -169.27 2.46 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.484 0.659 . . . . 0.0 110.038 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 282' ' ' PHE . . . . . 0.528 ' CB ' ' HA ' ' B' ' 267' ' ' LEU . 30.5 p90 168.55 -168.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 283' ' ' THR . . . . . 0.923 HG22 ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -130.92 140.79 50.23 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.346 -0.846 . . . . 0.0 109.527 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 284' ' ' VAL . . . . . 0.883 HG12 ' HB2' ' B' ' 263' ' ' LEU . 0.4 OUTLIER -100.87 119.32 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -0.872 . . . . 0.0 108.892 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 285' ' ' SER . . . . . 0.875 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 86.7 p -109.17 118.23 36.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 0.0 109.836 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.976 ' CD1' HD23 ' B' ' 263' ' ' LEU . 0.7 OUTLIER -140.32 153.43 46.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.935 . . . . 0.0 109.44 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 287' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' B' ' 291' ' ' ARG . 81.9 tt0 -96.5 164.53 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.388 -0.82 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' B' ' 289' ' ' GLN . 1.0 OUTLIER -115.42 -173.8 2.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.688 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' B' ' 288' ' ' PHE . 0.0 OUTLIER -43.22 -30.43 0.48 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.707 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -150.0 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 291' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' B' ' 287' ' ' GLU . 0.0 OUTLIER -83.35 -165.03 0.99 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -1.188 . . . . 0.0 109.532 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 292' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' B' ' 287' ' ' GLU . 0.3 OUTLIER -149.78 143.64 25.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.85 . . . . 0.0 109.306 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 293' ' ' THR . . . . . 0.699 HG23 ' CZ ' ' B' ' 286' ' ' PHE . 1.4 t -129.5 -176.19 3.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.999 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 294' ' ' VAL . . . . . 0.679 HG12 ' HB3' ' B' ' 322' ' ' HIS . 6.3 p -152.2 171.14 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 0.923 ' O ' HG22 ' B' ' 283' ' ' THR . 46.0 t -143.6 155.52 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.86 -1.15 . . . . 0.0 109.835 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 296' ' ' ALA . . . . . 0.52 ' O ' ' ND2' ' B' ' 320' ' ' ASN . . . -126.33 72.83 72.6 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 297' ' ' PRO . . . . . 0.561 ' HD3' HG12 ' B' ' 295' ' ' VAL . 43.9 Cg_endo -95.85 176.27 0.82 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.539 1.493 . . . . 0.0 111.188 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 1.051 HG23 ' HB2' ' B' ' 281' ' ' ALA . 3.0 mp -142.35 158.79 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . 0.628 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 17.1 t0 -131.27 168.24 17.85 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.115 -0.99 . . . . 0.0 109.959 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.672 ' CE1' ' HB2' ' B' ' 279' ' ' ALA . 1.2 t-80 -131.5 138.61 49.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 108.983 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 301' ' ' PHE . . . . . 0.589 ' CE1' ' CG1' ' B' ' 210' ' ' VAL . 0.4 OUTLIER -112.65 150.13 31.88 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 -178.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.5 ' HB3' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -140.8 142.83 34.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.607 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 303' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' B' ' 210' ' ' VAL . 2.1 m-85 -128.99 175.43 8.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.843 . . . . 0.0 108.967 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 304' ' ' ASN . . . . . 0.666 ' OD1' HG21 ' B' ' 310' ' ' VAL . 0.2 OUTLIER -150.3 18.59 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.242 -0.911 . . . . 0.0 109.142 178.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 305' ' ' GLY . . . . . 0.715 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -160.69 -88.53 0.07 OUTLIER Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 306' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 162.75 63.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -1.108 . . . . 0.0 109.666 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 307' ' ' GLY . . . . . 0.475 ' O ' ' HD3' ' B' ' 308' ' ' LYS . . . 166.96 -26.15 0.15 Allowed Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.079 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 308' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' B' ' 307' ' ' GLY . 1.2 mmtp -128.98 164.02 24.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -1.208 . . . . 0.0 109.918 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 309' ' ' VAL . . . . . 0.844 ' O ' ' HB2' ' B' ' 231' ' ' ALA . 2.5 t -103.9 157.04 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.666 HG21 ' OD1' ' B' ' 304' ' ' ASN . 22.1 t -142.77 -35.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.913 -1.117 . . . . 0.0 110.279 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.5 OUTLIER -126.25 150.71 48.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.714 -1.241 . . . . 0.0 109.921 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 312' ' ' MET . . . . . 0.528 ' CG ' ' O ' ' B' ' 300' ' ' HIS . 8.4 ttp -154.84 149.58 26.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.477 -0.764 . . . . 0.0 109.337 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 313' ' ' ARG . . . . . 0.465 ' HA ' ' HB2' ' B' ' 237' ' ' GLU . 13.4 ttp180 -141.92 124.39 15.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 109.625 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 314' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' B' ' 299' ' ' ASP . . . -97.95 130.83 44.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.449 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 315' ' ' LEU . . . . . 0.818 HD13 ' HB2' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -117.84 136.06 53.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.908 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 316' ' ' PHE . . . . . 0.794 ' CE2' ' H72' ' B' ' 326' ' ' NTH . 7.2 p90 170.46 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 317' ' ' GLY . . . . . 0.471 ' O ' HD11 ' B' ' 321' ' ' ILE . . . 169.77 -173.46 43.95 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 318' ' ' GLU . . . . . 0.458 ' C ' HG12 ' B' ' 321' ' ' ILE . 19.0 tt0 -73.51 -2.46 22.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.286 -1.126 . . . . 0.0 109.161 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 16.8 tttp -91.67 -27.69 17.94 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.935 0.874 . . . . 0.0 108.887 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 320' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' B' ' 296' ' ' ALA . 0.0 OUTLIER -88.88 17.34 5.76 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.335 0.588 . . . . 0.0 109.665 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 321' ' ' ILE . . . . . 0.508 HG22 ' H ' ' B' ' 322' ' ' HIS . 4.9 mm -89.83 178.21 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 322' ' ' HIS . . . . . 0.679 ' HB3' HG12 ' B' ' 294' ' ' VAL . 0.2 OUTLIER -152.26 64.43 0.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.835 -1.166 . . . . 0.0 110.312 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.494 ' HA ' ' OG1' ' B' ' 293' ' ' THR . . . -90.75 118.56 30.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.075 -1.016 . . . . 0.0 109.532 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 179.18 -123.74 0.87 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.186 -1.185 . . . . 0.0 109.507 179.845 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' NTH . . . . . 0.904 H212 ' CE1' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 326' ' ' NTH . . . . . 0.841 H221 ' CE2' ' B' ' 286' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.289 0.566 . . . . 0.0 110.326 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.473 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 34.1 t30 -117.53 50.02 1.16 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.548 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 3' ' ' THR . 10.7 t -90.14 108.55 27.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 109.361 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.476 ' HB2' ' OG1' ' A' ' 8' ' ' THR . 46.6 Cg_endo -72.88 -8.55 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.941 1.495 . . . . 0.0 110.12 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -45.36 -36.75 4.4 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -90.31 -59.46 2.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.71 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.581 ' HA ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -55.32 -22.04 17.42 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.142 -0.974 . . . . 0.0 109.946 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 4' ' ' PRO . 17.4 m -83.42 -40.6 19.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.431 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.78 -39.47 38.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 108.841 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.995 ' HA ' HD21 ' A' ' 29' ' ' LEU . 1.1 t -56.45 -26.82 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.072 HG11 HG21 ' A' ' 71' ' ' VAL . 3.5 t -81.63 -39.14 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.405 -0.81 . . . . 0.0 109.327 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 13' ' ' ARG . 7.5 tt0 -62.87 -74.73 0.09 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.135 0.969 . . . . 0.0 108.434 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.716 ' HB3' HD22 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -42.78 -44.56 4.47 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.994 0.902 . . . . 0.0 108.6 179.361 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.613 ' CD1' HG23 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -50.74 -44.47 58.39 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.925 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.4 t -90.13 -39.87 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.304 -0.873 . . . . 0.0 109.401 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 15' ' ' VAL . . . -49.05 -33.41 11.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 22' ' ' ASP . . . -77.3 -31.91 55.04 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.925 HD12 ' HA ' ' A' ' 15' ' ' VAL . 1.8 mt -64.2 -56.75 12.51 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -53.58 -48.81 68.86 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.624 0.726 . . . . 0.0 109.488 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.85 11.49 17.79 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.668 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.749 ' CA ' HD21 ' A' ' 59' ' ' LEU . . . 47.04 35.27 8.2 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' ALA . 15.0 t0 -89.8 62.15 5.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -1.094 . . . . 0.0 109.615 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.056 HD11 ' HB3' ' A' ' 55' ' ' PHE . 6.5 tp -46.69 -43.4 17.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 108.85 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -42.73 -33.17 0.69 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -84.13 -38.03 10.6 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.053 HD12 HD12 ' A' ' 23' ' ' LEU . 14.7 mt -57.71 -56.68 14.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.512 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 43.8 t -55.85 -41.59 67.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 25' ' ' GLY . . . -56.02 -53.28 58.81 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.995 HD21 ' HA ' ' A' ' 10' ' ' VAL . 7.7 tp -66.24 -20.72 66.2 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.693 ' HD2' ' HB3' ' A' ' 34' ' ' ALA . 3.0 m-85 -88.41 131.98 34.64 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.546 -0.721 . . . . 0.0 109.654 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 109' ' ' VAL . . . -47.98 176.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.836 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.4 ' O ' ' OG1' ' A' ' 48' ' ' THR . 0.5 OUTLIER -67.07 -24.78 66.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.55 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 7.0 p-10 -144.0 54.1 1.3 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 109.55 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.783 ' O ' HD11 ' A' ' 51' ' ' ILE . . . -72.69 155.29 40.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.641 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.688 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -101.93 167.06 10.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.235 -0.915 . . . . 0.0 109.25 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 35' ' ' THR . 35.0 t -161.85 108.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.55 ' HA ' ' HB3' ' A' ' 44' ' ' PRO . 9.2 mp0 -88.66 103.51 16.0 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.638 ' OD2' ' H62' ' A' ' 126' ' ' NTH . 27.5 t70 -173.16 143.74 1.1 Allowed Pre-proline 0 C--N 1.3 -1.568 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.919 -177.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 42' ' ' SER . 49.6 Cg_endo -73.5 174.84 48.5 Favored 'Cis proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.345 -1.94 . . . . 0.0 111.227 -0.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.706 ' O ' HG23 ' A' ' 40' ' ' VAL . 21.9 m -63.89 105.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.403 -0.81 . . . . 0.0 109.253 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.529 ' CA ' ' HB1' ' B' ' 275' ' ' ALA . . . 122.13 -6.98 10.05 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.523 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -105.09 -155.93 0.56 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.36 -1.082 . . . . 0.0 109.02 179.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -125.16 128.96 24.66 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.029 -1.044 . . . . 0.0 109.964 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.55 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . 36.9 Cg_endo -62.01 179.19 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.638 1.558 . . . . 0.0 111.371 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.986 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -150.42 105.91 3.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.647 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -88.66 157.31 18.6 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.248 -0.907 . . . . 0.0 110.015 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.55 ' CA ' ' HA ' ' A' ' 33' ' ' ASP . . . 109.24 162.03 19.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 32' ' ' ASP . 3.9 m -67.25 -58.38 4.95 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.148 -1.207 . . . . 0.0 109.11 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.531 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -55.56 -37.83 68.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.273 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.986 ' HB1' ' HB3' ' A' ' 45' ' ' ARG . . . -68.99 -51.67 36.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 109.701 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.783 HD11 ' O ' ' A' ' 34' ' ' ALA . 8.8 mm -55.8 -47.14 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 109.283 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.817 ' CG ' HD23 ' A' ' 23' ' ' LEU . 26.3 ttp180 -73.58 -52.48 13.31 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 49' ' ' ALA . 23.6 tt0 -48.38 -30.79 5.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.089 -1.007 . . . . 0.0 108.469 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.582 ' CZ ' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -83.78 -72.05 0.48 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 1.056 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -47.31 -25.04 0.88 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.618 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -74.15 -47.96 32.52 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 60' ' ' LYS . 5.4 t30 -57.41 -37.36 72.62 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.579 ' OG ' ' H11' ' A' ' 126' ' ' NTH . 39.8 t -67.66 -35.74 79.43 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.749 HD21 ' CA ' ' A' ' 21' ' ' GLY . 8.2 tp -67.48 -29.23 68.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.456 -0.777 . . . . 0.0 109.053 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 17.0 mttm -47.08 -30.48 2.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 108.911 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.822 HD22 HD21 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -89.4 110.52 39.4 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.9 111.06 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.85 1.447 . . . . 0.0 111.027 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.822 HD21 HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.94 162.96 31.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.347 -0.845 . . . . 0.0 109.715 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.736 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -92.08 127.95 37.74 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 18' ' ' LEU . 21.8 t -115.13 120.08 63.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.054 -1.029 . . . . 0.0 109.967 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 67' ' ' LEU . 1.0 OUTLIER -150.12 106.25 3.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.494 HD22 HG23 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -47.8 177.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 0.0 109.924 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 69' ' ' GLN . 21.9 p -145.07 -81.63 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.386 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' A' ' 70' ' ' GLU . 0.7 OUTLIER -59.88 -144.86 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.479 ' N ' ' CG ' ' A' ' 69' ' ' GLN . 48.9 tt0 -114.44 131.63 56.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.007 -1.058 . . . . 0.0 109.933 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.072 HG21 HG11 ' A' ' 11' ' ' VAL . 13.1 t -61.92 160.49 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.465 -0.772 . . . . 0.0 109.087 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' A' ' 79' ' ' ALA . 5.1 ttp180 -122.52 134.74 54.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.229 -0.919 . . . . 0.0 109.824 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . . . -147.89 160.45 42.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.405 -0.809 . . . . 0.0 109.183 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.088 HG11 ' O ' ' B' ' 316' ' ' PHE . 0.0 OUTLIER -159.14 -159.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.725 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 74' ' ' VAL . . . -29.52 -85.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.055 -0.403 . . . . 0.0 111.35 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.504 ' O ' ' N ' ' A' ' 103' ' ' PHE . 9.9 m120 -124.62 21.07 8.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.904 -1.123 . . . . 0.0 110.781 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -129.99 -160.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.916 -1.115 . . . . 0.0 109.442 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.951 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . . . 170.05 147.55 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.981 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 72' ' ' ARG . . . -136.12 130.73 33.78 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 99' ' ' ASP . 30.2 p90 -147.92 170.1 18.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.792 -1.192 . . . . 0.0 110.462 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.752 ' HB2' HG23 ' A' ' 98' ' ' ILE . . . -143.96 -166.43 2.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.599 -0.688 . . . . 0.0 109.893 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 81' ' ' ALA . 18.9 p90 168.83 -168.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 0.0 109.238 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.824 HG22 ' O ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -130.76 144.78 51.68 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.649 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.587 HG11 HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -112.96 122.24 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.166 179.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.736 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 1.4 p -117.75 107.11 13.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 109.029 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.781 ' CD1' HD23 ' A' ' 63' ' ' LEU . 2.0 p90 -130.04 151.74 50.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.068 -1.02 . . . . 0.0 110.181 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.523 ' HG2' ' N ' ' A' ' 88' ' ' PHE . 84.2 tt0 -127.75 159.93 33.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.441 -0.787 . . . . 0.0 109.039 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -150.5 -99.61 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.058 -1.026 . . . . 0.0 110.326 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 88' ' ' PHE . 19.1 tt0 -48.91 -99.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 109.898 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.468 ' N ' ' HG2' ' A' ' 89' ' ' GLN . . . -123.92 -28.19 1.3 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -96.66 150.18 20.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -1.116 . . . . 0.0 109.352 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -113.11 146.53 39.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.103 -0.998 . . . . 0.0 109.172 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.0 145.97 51.1 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.53 -0.731 . . . . 0.0 109.842 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.78 HG13 ' CB ' ' A' ' 122' ' ' HIS . 5.4 p -121.19 166.38 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.922 . . . . 0.0 108.861 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.824 ' O ' HG22 ' A' ' 83' ' ' THR . 62.3 t -140.94 160.21 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.019 -1.05 . . . . 0.0 110.304 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.521 ' N ' HG12 ' A' ' 95' ' ' VAL . . . -138.76 75.11 37.37 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.562 -0.711 . . . . 0.0 109.51 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.504 ' HD3' HG12 ' A' ' 95' ' ' VAL . 48.1 Cg_endo -97.11 -175.6 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.814 1.676 . . . . 0.0 111.2 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.752 HG23 ' HB2' ' A' ' 81' ' ' ALA . 2.6 mp -135.26 157.1 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 7.6 t0 -128.66 162.25 27.78 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.204 -0.935 . . . . 0.0 109.813 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.591 ' NE2' ' CD2' ' B' ' 300' ' ' HIS . 0.2 OUTLIER -114.11 173.54 6.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 108.906 179.49 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.951 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -148.16 144.9 28.08 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.97 -1.081 . . . . 0.0 110.45 -178.561 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.527 ' NH1' ' HD2' ' B' ' 313' ' ' ARG . 0.4 OUTLIER -139.99 105.63 5.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.151 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.588 ' CZ ' HG11 ' A' ' 10' ' ' VAL . 5.2 m-85 -91.06 -171.21 2.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.71 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.992 ' HB3' HG21 ' A' ' 110' ' ' VAL . 4.3 p30 -126.28 -47.97 1.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.272 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.703 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -163.94 27.24 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 105' ' ' GLY . . . 77.07 67.62 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.169 -1.194 . . . . 0.0 109.545 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.27 -39.33 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -165.6 -162.54 0.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -1.113 . . . . 0.0 109.258 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 41.0 t -106.25 144.24 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.248 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.992 HG21 ' HB3' ' A' ' 104' ' ' ASN . 5.0 t -125.99 -28.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 109.898 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.523 ' CB ' ' HB3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -149.59 155.11 39.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.067 -1.021 . . . . 0.0 109.472 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.523 ' HE3' ' CG ' ' A' ' 99' ' ' ASP . 3.2 ttp -155.91 148.74 24.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.194 -0.941 . . . . 0.0 109.926 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.518 ' HD2' ' NH1' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -130.55 173.52 10.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 108.964 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.56 ' O ' HG12 ' A' ' 40' ' ' VAL . . . -144.37 142.85 30.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.149 -0.97 . . . . 0.0 109.52 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.576 ' HA ' HG11 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -138.61 140.24 38.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.172 -0.955 . . . . 0.0 109.907 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.879 ' O ' HG11 ' B' ' 274' ' ' VAL . 51.9 p90 170.21 -161.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.578 ' O ' HD11 ' A' ' 121' ' ' ILE . . . 174.6 -165.6 37.04 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.536 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 8.3 tt0 -73.13 -3.32 25.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.444 -1.033 . . . . 0.0 109.337 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.26 -31.31 16.18 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.97 0.89 . . . . 0.0 109.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.481 HD21 HD11 ' A' ' 98' ' ' ILE . 1.9 m-20 -89.61 8.58 30.63 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.233 0.54 . . . . 0.0 109.559 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.82 HG23 HG22 ' A' ' 95' ' ' VAL . 4.5 mm -91.89 -170.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.893 . . . . 0.0 108.84 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.78 ' CB ' HG13 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -151.35 159.75 44.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.097 -1.002 . . . . 0.0 109.618 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.78 133.94 12.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.959 . . . . 0.0 109.479 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 134.35 -123.69 3.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.291 -1.123 . . . . 0.0 109.444 -179.81 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.0 ptp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.208 0.528 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.462 ' O ' ' HD3' ' B' ' 204' ' ' PRO . 18.7 p-10 -113.15 100.09 8.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.558 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . 0.738 HG23 ' O ' ' B' ' 203' ' ' THR . 12.5 t -90.34 108.44 26.72 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.542 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' B' ' 208' ' ' THR . 45.1 Cg_endo -72.15 -1.96 10.87 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.853 1.449 . . . . 0.0 110.457 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.77 -47.37 83.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.557 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -54.9 24.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.267 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 75.9 mtm -61.42 -41.27 96.91 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.286 -0.884 . . . . 0.0 109.382 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.499 ' CB ' ' O ' ' B' ' 204' ' ' PRO . 15.4 m -64.18 -35.95 82.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.357 -0.84 . . . . 0.0 109.235 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' ALA . . . . . . . . . . . . . . . -50.09 -42.37 49.99 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.139 -0.976 . . . . 0.0 108.59 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.981 ' HA ' HD21 ' B' ' 229' ' ' LEU . 1.5 t -60.06 -20.7 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 1.04 HG21 HG11 ' B' ' 271' ' ' VAL . 4.4 t -88.32 -40.61 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.833 . . . . 0.0 108.89 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' B' ' 213' ' ' ARG . 24.6 tt0 -61.53 -74.35 0.08 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.659 ' HD2' HD13 ' B' ' 229' ' ' LEU . 1.0 OUTLIER -43.68 -45.52 7.0 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' TYR . . . . . 0.59 ' CD1' HG23 ' B' ' 215' ' ' VAL . 0.5 OUTLIER -49.88 -42.88 48.75 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.924 ' HA ' HD12 ' B' ' 218' ' ' LEU . 1.4 t -89.77 -37.85 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.255 -0.903 . . . . 0.0 109.251 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' B' ' 215' ' ' VAL . . . -49.49 -35.6 20.35 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.606 ' HB3' HG12 ' B' ' 226' ' ' ILE . . . -74.69 -30.95 61.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.924 HD12 ' HA ' ' B' ' 215' ' ' VAL . 2.3 mt -66.86 -58.11 5.66 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' B' ' 265' ' ' VAL . 2.1 t-20 -50.85 -45.31 59.73 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.602 0.715 . . . . 0.0 109.302 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -89.31 1.36 55.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.624 -0.672 . . . . 0.0 109.748 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 1.066 ' CA ' HD21 ' B' ' 259' ' ' LEU . . . 53.76 44.13 70.0 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . 0.48 ' O ' HG13 ' B' ' 226' ' ' ILE . 30.3 t0 -102.87 83.96 2.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.902 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' LEU . . . . . 1.066 ' CD2' HD22 ' B' ' 259' ' ' LEU . 3.7 mm? -53.04 -18.4 2.03 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.139 -0.976 . . . . 0.0 110.063 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -64.05 -57.16 10.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.093 -1.004 . . . . 0.0 109.473 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -62.92 -27.64 70.61 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.961 HD12 HD13 ' B' ' 223' ' ' LEU . 7.0 mt -67.86 -61.46 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.454 -1.027 . . . . 0.0 108.315 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.7 HG21 ' HB2' ' B' ' 252' ' ' ARG . 51.2 t -59.49 -40.33 81.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.87 -53.47 55.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' LEU . . . . . 0.981 HD21 ' HA ' ' B' ' 210' ' ' VAL . 4.7 tp -62.8 -21.78 66.14 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . 0.478 ' HA ' ' HB ' ' B' ' 309' ' ' VAL . 3.7 m-30 -92.71 139.11 30.9 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.452 -0.78 . . . . 0.0 109.784 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' B' ' 309' ' ' VAL . . . -50.71 -176.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 109.822 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -25.16 64.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.879 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' ASP . . . . . 0.543 ' HA ' ' CA ' ' B' ' 247' ' ' GLY . 10.0 p-10 -144.17 52.51 1.28 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.495 -0.753 . . . . 0.0 109.137 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' B' ' 310' ' ' VAL . . . -65.43 158.6 26.31 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 109.617 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' THR . . . . . 0.716 HG23 ' HB3' ' B' ' 246' ' ' SER . 0.0 OUTLIER -107.34 147.18 30.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.875 . . . . 0.0 109.107 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' B' ' 244' ' ' PRO . 52.8 t -141.4 111.05 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' GLU . . . . . 0.528 ' HA ' ' HB3' ' B' ' 244' ' ' PRO . 1.5 mm-40 -89.91 105.14 17.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' ASP . . . . . 0.623 ' OD1' ' HB3' ' B' ' 314' ' ' ALA . 21.8 t70 178.91 143.24 0.31 Allowed Pre-proline 0 C--N 1.301 -1.528 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.307 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.518 ' HA ' ' OD1' ' B' ' 238' ' ' ASP . 48.5 Cg_endo -73.6 173.87 53.66 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.264 -1.973 . . . . 0.0 110.905 -0.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.584 HG22 ' CZ ' ' B' ' 316' ' ' PHE . 6.5 m -69.81 112.7 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 108.972 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . 0.492 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . 115.06 -2.13 22.67 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' SER . . . . . 0.479 ' OG ' ' HG2' ' B' ' 239' ' ' PRO . 64.6 m -113.35 -134.83 0.35 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.305 -1.114 . . . . 0.0 108.893 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . 0.531 ' O ' ' CZ ' ' B' ' 254' ' ' PHE . 4.3 mt-10 -142.03 133.52 13.26 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.863 -1.148 . . . . 0.0 109.755 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' PRO . . . . . 0.528 ' HB3' ' HA ' ' B' ' 237' ' ' GLU . 37.9 Cg_endo -63.39 -171.53 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.082 1.569 . . . . 0.0 111.34 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.964 ' HG3' ' HB1' ' B' ' 250' ' ' ALA . 0.0 OUTLIER -150.74 96.91 2.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . 0.716 ' HB3' HG23 ' B' ' 235' ' ' THR . 0.2 OUTLIER -88.88 150.47 22.86 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.238 -0.914 . . . . 0.0 109.987 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' B' ' 233' ' ' ASP . . . 107.24 163.18 21.88 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' THR . . . . . . . . . . . . . 2.2 m -70.04 -61.45 1.77 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -1.209 . . . . 0.0 109.148 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' B' ' 253' ' ' GLU . . . -55.36 -22.98 21.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.241 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.964 ' HB1' ' HG3' ' B' ' 245' ' ' ARG . . . -88.45 -48.62 7.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.587 HD11 ' O ' ' B' ' 234' ' ' ALA . 4.5 mm -53.65 -43.7 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.132 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' ARG . . . . . 0.7 ' HB2' HG21 ' B' ' 227' ' ' VAL . 44.0 ttp85 -75.54 -52.65 10.13 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 108.94 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 29.9 mt-10 -48.4 -27.72 2.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.809 -1.182 . . . . 0.0 108.427 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.585 ' CE2' ' O ' ' B' ' 238' ' ' ASP . 0.3 OUTLIER -85.84 -71.7 0.52 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.681 0.753 . . . . 0.0 109.021 179.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 0.7 ' C ' HD11 ' B' ' 223' ' ' LEU . 0.2 OUTLIER -52.6 -21.76 4.25 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.241 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . 0.55 ' HB2' ' HG ' ' B' ' 223' ' ' LEU . . . -80.33 -46.8 15.5 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 257' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' B' ' 260' ' ' LYS . 18.7 t-20 -58.19 -31.17 67.04 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 258' ' ' SER . . . . . 0.752 ' OG ' H112 ' B' ' 326' ' ' NTH . 33.7 t -70.66 -31.63 68.62 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 1.066 HD22 ' CD2' ' B' ' 223' ' ' LEU . 5.7 tp -71.12 -27.72 63.78 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' B' ' 257' ' ' ASN . 0.7 OUTLIER -44.73 -27.83 0.55 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 261' ' ' LEU . . . . . 0.807 HD23 HD23 ' B' ' 263' ' ' LEU . 0.3 OUTLIER -90.72 114.29 60.8 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 262' ' ' PRO . . . . . 0.499 ' O ' ' HB2' ' B' ' 286' ' ' PHE . 44.3 Cg_endo -72.02 107.93 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.766 1.403 . . . . 0.0 110.892 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.856 ' CB ' HG13 ' B' ' 284' ' ' VAL . 0.0 OUTLIER -137.3 162.54 33.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 109.854 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . 0.818 ' HB3' ' OG ' ' B' ' 285' ' ' SER . . . -96.46 123.67 40.19 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . 0.795 HG21 ' HB3' ' B' ' 218' ' ' LEU . 4.4 t -105.06 117.32 50.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.643 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 266' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' B' ' 267' ' ' LEU . 2.0 tt0 -147.78 104.97 3.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.22 -0.925 . . . . 0.0 109.153 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' B' ' 266' ' ' GLU . 1.1 mt -47.11 174.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.293 -0.879 . . . . 0.0 109.695 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 268' ' ' THR . . . . . . . . . . . . . 1.7 t -146.54 -40.31 0.21 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.67 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 269' ' ' GLN . . . . . 0.508 ' HG3' ' N ' ' B' ' 270' ' ' GLU . 13.7 pt20 -102.66 -152.25 0.44 Allowed 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.647 -0.658 . . . . 0.0 109.267 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.508 ' N ' ' HG3' ' B' ' 269' ' ' GLN . 26.6 tt0 -106.43 130.59 54.21 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.61 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . 1.04 HG11 HG21 ' B' ' 211' ' ' VAL . 81.4 t -66.81 147.62 12.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.344 -0.848 . . . . 0.0 109.245 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' B' ' 279' ' ' ALA . 2.4 tpm_? -102.89 135.95 43.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.952 . . . . 0.0 109.765 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' B' ' 278' ' ' ALA . . . -149.8 146.36 27.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.39 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 274' ' ' VAL . . . . . 0.879 HG11 ' O ' ' A' ' 116' ' ' PHE . 0.1 OUTLIER -162.24 146.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.13 -0.981 . . . . 0.0 110.228 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . 0.529 ' HB1' ' CA ' ' A' ' 41' ' ' GLY . . . 39.57 -97.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.802 -0.561 . . . . 0.0 110.621 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 276' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' B' ' 303' ' ' PHE . 60.1 m-20 -130.74 34.04 4.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.025 -1.047 . . . . 0.0 110.237 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . 0.7 ' O ' ' HB2' ' B' ' 278' ' ' ALA . 0.9 OUTLIER -139.49 -158.4 0.85 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 108.792 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 278' ' ' ALA . . . . . 0.876 ' HB3' ' CB ' ' B' ' 301' ' ' PHE . . . 165.96 149.6 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.72 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 279' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' B' ' 272' ' ' ARG . . . -135.98 130.75 34.1 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . 1.011 ' HB3' HG13 ' B' ' 271' ' ' VAL . 22.8 p90 -150.07 175.45 11.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.601 -1.312 . . . . 0.0 110.697 -178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.61 ' HB2' ' CG1' ' B' ' 298' ' ' ILE . . . -150.11 -179.0 6.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.585 -0.697 . . . . 0.0 109.197 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 282' ' ' PHE . . . . . 0.54 ' CE2' HG23 ' B' ' 284' ' ' VAL . 2.8 p90 -172.92 -162.14 0.16 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 109.492 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 283' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' B' ' 295' ' ' VAL . 0.0 OUTLIER -133.61 147.44 51.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.512 -0.742 . . . . 0.0 109.887 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 284' ' ' VAL . . . . . 0.856 HG13 ' CB ' ' B' ' 263' ' ' LEU . 4.0 t -123.36 116.53 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 109.41 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 285' ' ' SER . . . . . 0.818 ' OG ' ' HB3' ' B' ' 264' ' ' ALA . 90.9 p -111.95 114.69 27.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 109.098 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.57 ' HD1' HG12 ' B' ' 284' ' ' VAL . 55.6 p90 -143.21 167.39 22.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 110.084 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 287' ' ' GLU . . . . . 0.459 ' HG2' ' N ' ' B' ' 288' ' ' PHE . 30.1 tt0 -144.1 153.25 41.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 109.255 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' B' ' 288' ' ' PHE . 0.3 OUTLIER -135.89 4.34 3.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.716 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -170.3 -148.81 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.254 -0.904 . . . . 0.0 109.383 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 290' ' ' GLY . . . . . . . . . . . . . . . -74.8 -11.95 83.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 291' ' ' ARG . . . . . 0.471 ' HG2' ' HA ' ' B' ' 325' ' ' ALA . 14.5 mtp180 -113.8 140.41 48.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -1.115 . . . . 0.0 109.273 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 292' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' B' ' 292' ' ' LYS . 18.9 ptmt -125.78 172.47 9.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.15 -0.969 . . . . 0.0 109.635 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 293' ' ' THR . . . . . 0.837 HG23 ' HA ' ' B' ' 323' ' ' ALA . 32.2 m -156.65 171.53 20.17 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.366 -0.834 . . . . 0.0 109.095 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 294' ' ' VAL . . . . . 0.662 HG12 ' CB ' ' B' ' 322' ' ' HIS . 0.4 OUTLIER -134.17 165.94 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 1.061 HG22 HG23 ' B' ' 321' ' ' ILE . 3.4 t -136.81 145.8 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.016 -1.052 . . . . 0.0 109.66 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 296' ' ' ALA . . . . . 0.463 ' O ' ' OD1' ' B' ' 320' ' ' ASN . . . -132.52 72.9 77.5 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.433 -0.792 . . . . 0.0 110.023 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 297' ' ' PRO . . . . . 0.986 ' HD3' HG12 ' B' ' 295' ' ' VAL . 49.2 Cg_endo -92.95 -177.01 0.67 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.87 1.458 . . . . 0.0 111.113 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.675 HG23 ' O ' ' B' ' 280' ' ' PHE . 2.7 mp -134.38 144.61 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . 0.612 ' HB3' ' CZ ' ' B' ' 280' ' ' PHE . 5.6 t0 -117.13 166.95 11.63 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.824 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 300' ' ' HIS . . . . . 0.591 ' CD2' ' NE2' ' A' ' 100' ' ' HIS . 1.6 t-80 -117.58 173.58 6.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -0.85 . . . . 0.0 108.916 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 301' ' ' PHE . . . . . 0.876 ' CB ' ' HB3' ' B' ' 278' ' ' ALA . 0.1 OUTLIER -145.67 145.82 31.06 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.071 -1.018 . . . . 0.0 110.583 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.498 ' HD3' ' HB2' ' B' ' 311' ' ' SER . 0.0 OUTLIER -137.66 98.73 3.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 109.156 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 303' ' ' PHE . . . . . 0.672 ' CZ ' HG11 ' B' ' 210' ' ' VAL . 4.5 m-85 -89.74 176.51 6.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 109.57 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 304' ' ' ASN . . . . . 0.882 ' HB3' HG21 ' B' ' 310' ' ' VAL . 2.9 p30 -118.64 -27.03 5.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.222 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 305' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' B' ' 306' ' ' ALA . . . -159.35 -63.96 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 306' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' B' ' 305' ' ' GLY . . . 163.63 76.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -1.127 . . . . 0.0 109.563 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 307' ' ' GLY . . . . . . . . . . . . . . . 175.87 -57.14 0.11 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 308' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -111.33 -172.75 2.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -1.149 . . . . 0.0 109.504 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 309' ' ' VAL . . . . . 0.565 HG12 ' N ' ' B' ' 310' ' ' VAL . 85.8 t -119.72 164.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.033 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.882 HG21 ' HB3' ' B' ' 304' ' ' ASN . 5.0 t -134.82 -72.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.963 -1.085 . . . . 0.0 110.018 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . 0.498 ' HB2' ' HD3' ' B' ' 302' ' ' ARG . 31.6 m -112.44 162.48 15.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.899 -1.126 . . . . 0.0 109.837 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 312' ' ' MET . . . . . 0.544 ' CE ' ' CE2' ' B' ' 214' ' ' TYR . 2.6 ttt -159.94 137.99 10.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 313' ' ' ARG . . . . . 0.527 ' HD2' ' NH1' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -125.69 159.27 32.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.144 -0.972 . . . . 0.0 108.812 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 314' ' ' ALA . . . . . 0.623 ' HB3' ' OD1' ' B' ' 238' ' ' ASP . . . -125.18 150.38 47.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.904 -1.122 . . . . 0.0 109.841 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 315' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' B' ' 316' ' ' PHE . 0.1 OUTLIER -141.02 140.8 34.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.39 -0.819 . . . . 0.0 109.774 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 316' ' ' PHE . . . . . 1.088 ' O ' HG11 ' A' ' 74' ' ' VAL . 53.7 p90 173.12 -160.96 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 317' ' ' GLY . . . . . 0.48 ' O ' HG12 ' B' ' 321' ' ' ILE . . . 173.48 -172.38 45.17 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 318' ' ' GLU . . . . . 0.52 ' HA ' ' CG1' ' B' ' 321' ' ' ILE . 22.3 tt0 -68.4 -6.69 25.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.419 -1.047 . . . . 0.0 109.714 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 319' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -87.08 -31.84 20.26 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.045 0.926 . . . . 0.0 108.939 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 320' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' B' ' 296' ' ' ALA . 0.3 OUTLIER -89.61 14.28 11.99 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.742 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 321' ' ' ILE . . . . . 1.061 HG23 HG22 ' B' ' 295' ' ' VAL . 4.0 mm -100.84 -166.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 0.0 108.902 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 322' ' ' HIS . . . . . 0.677 ' H ' HG22 ' B' ' 321' ' ' ILE . 0.3 OUTLIER -151.25 -172.41 4.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.116 -0.99 . . . . 0.0 109.613 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.837 ' HA ' HG23 ' B' ' 293' ' ' THR . . . -155.45 128.65 8.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . -122.32 135.13 10.09 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 325' ' ' ALA . . . . . 0.471 ' HA ' ' HG2' ' B' ' 291' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.21 -1.17 . . . . 0.0 109.472 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' NTH . . . . . 0.769 H221 ' CE2' ' A' ' 86' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 326' ' ' NTH . . . . . 0.752 H112 ' OG ' ' B' ' 258' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_